APC2	O	0
,	O	0
a	O	0
homologue	O	0
of	O	0
the	O	0
adenomatous	B-Disease	0
polyposis	I-Disease	0
coli	I-Disease	0
tumour	I-Disease	0
suppressor	O	0
.	O	0

The	O	1
adenomatous	B-Disease	1
polyposis	I-Disease	1
coli	I-Disease	1
(	I-Disease	1
APC	I-Disease	1
)	I-Disease	1
tumour	I-Disease	1
-	O	1
suppressor	O	1
protein	O	1
controls	O	1
the	O	1
Wnt	O	1
signalling	O	1
pathway	O	1
by	O	1
forming	O	1
a	O	1
complex	O	1
with	O	1
glycogen	O	1
synthase	O	1
kinase	O	1
3beta	O	1
(	O	1
GSK	O	1
-	O	1
3beta	O	1
)	O	1
,	O	1
axin	O	1
/	O	1
conductin	O	1
and	O	1
betacatenin	O	1
.	O	1

In	O	3
colon	B-Disease	3
carcinoma	I-Disease	3
cells	O	3
,	O	3
loss	O	3
of	O	3
APC	O	3
leads	O	3
to	O	3
the	O	3
accumulation	O	3
of	O	3
betacatenin	O	3
in	O	3
the	O	3
nucleus	O	3
,	O	3
where	O	3
it	O	3
binds	O	3
to	O	3
and	O	3
activates	O	3
the	O	3
Tcf	O	3
-	O	3
4	O	3
transcription	O	3
factor	O	3
(	O	3
reviewed	O	3
in	O	3
[	O	3
1	O	3
]	O	3
[	O	3
2	O	3
]	O	3
)	O	3
.	O	3

Like	O	6
APC	O	6
,	O	6
APC2	O	6
regulates	O	6
the	O	6
formation	O	6
of	O	6
active	O	6
betacatenin	O	6
-	O	6
Tcf	O	6
complexes	O	6
,	O	6
as	O	6
demonstrated	O	6
using	O	6
transient	O	6
transcriptional	O	6
activation	O	6
assays	O	6
in	O	6
APC	O	6
-	O	6
/	O	6
-	O	6
colon	B-Disease	6
carcinoma	I-Disease	6
cells	O	6
.	O	6

APC	O	9
and	O	9
APC2	O	9
may	O	9
therefore	O	9
have	O	9
comparable	O	9
functions	O	9
in	O	9
development	O	9
and	O	9
cancer	B-Disease	9
.	O	9

A	O	10
common	O	10
MSH2	O	10
mutation	O	10
in	O	10
English	O	10
and	O	10
North	O	10
American	O	10
HNPCC	B-Disease	10
families	O	10
:	O	10
origin	O	10
,	O	10
phenotypic	O	10
expression	O	10
,	O	10
and	O	10
sex	O	10
specific	O	10
differences	O	10
in	O	10
colorectal	B-Disease	10
cancer	I-Disease	10
.	O	10

The	O	11
frequency	O	11
,	O	11
origin	O	11
,	O	11
and	O	11
phenotypic	O	11
expression	O	11
of	O	11
a	O	11
germline	O	11
MSH2	O	11
gene	O	11
mutation	O	11
previously	O	11
identified	O	11
in	O	11
seven	O	11
kindreds	O	11
with	O	11
hereditary	B-Disease	11
non	I-Disease	11
-	I-Disease	11
polyposis	I-Disease	11
cancer	I-Disease	11
syndrome	I-Disease	11
(	O	11
HNPCC	B-Disease	11
)	O	11
was	O	11
investigated	O	11
.	O	11

Although	O	13
this	O	13
mutation	O	13
was	O	13
initially	O	13
detected	O	13
in	O	13
four	O	13
of	O	13
33	O	13
colorectal	B-Disease	13
cancer	I-Disease	13
families	O	13
analysed	O	13
from	O	13
eastern	O	13
England	O	13
,	O	13
more	O	13
extensive	O	13
analysis	O	13
has	O	13
reduced	O	13
the	O	13
frequency	O	13
to	O	13
four	O	13
of	O	13
52	O	13
(	O	13
8	O	13
%	O	13
)	O	13
English	O	13
HNPCC	B-Disease	13
kindreds	O	13
analysed	O	13
.	O	13

In	O	14
contrast	O	14
,	O	14
the	O	14
MSH2	O	14
mutation	O	14
was	O	14
identified	O	14
in	O	14
10	O	14
of	O	14
20	O	14
(	O	14
50	O	14
%	O	14
)	O	14
separately	O	14
identified	O	14
colorectal	B-Disease	14
families	O	14
from	O	14
Newfoundland	O	14
.	O	14

To	O	15
investigate	O	15
the	O	15
origin	O	15
of	O	15
this	O	15
mutation	O	15
in	O	15
colorectal	B-Disease	15
cancer	I-Disease	15
families	O	15
from	O	15
England	O	15
(	O	15
n	O	15
=	O	15
4	O	15
)	O	15
,	O	15
Newfoundland	O	15
(	O	15
n	O	15
=	O	15
10	O	15
)	O	15
,	O	15
and	O	15
the	O	15
United	O	15
States	O	15
(	O	15
n	O	15
=	O	15
3	O	15
)	O	15
,	O	15
haplotype	O	15
analysis	O	15
using	O	15
microsatellite	O	15
markers	O	15
linked	O	15
to	O	15
MSH2	O	15
was	O	15
performed	O	15
.	O	15

These	O	18
findings	O	18
suggested	O	18
a	O	18
founder	O	18
effect	O	18
within	O	18
Newfoundland	O	18
similar	O	18
to	O	18
that	O	18
reported	O	18
by	O	18
others	O	18
for	O	18
two	O	18
MLH1	O	18
mutations	O	18
in	O	18
Finnish	O	18
HNPCC	B-Disease	18
families	O	18
.	O	18

We	O	19
calculated	O	19
age	O	19
related	O	19
risks	O	19
of	O	19
all	O	19
,	O	19
colorectal	B-Disease	19
,	I-Disease	19
endometrial	I-Disease	19
,	I-Disease	19
and	I-Disease	19
ovarian	I-Disease	19
cancers	I-Disease	19
in	O	19
nt943	O	19
+	O	19
3	O	19
A	O	19
-	O	19
-	O	19
>	O	19
T	O	19
MSH2	O	19
mutation	O	19
carriers	O	19
(	O	19
n	O	19
=	O	19
76	O	19
)	O	19
for	O	19
all	O	19
patients	O	19
and	O	19
for	O	19
men	O	19
and	O	19
women	O	19
separately	O	19
.	O	19

For	O	20
both	O	20
sexes	O	20
combined	O	20
,	O	20
the	O	20
penetrances	O	20
at	O	20
age	O	20
60	O	20
years	O	20
for	O	20
all	O	20
cancers	B-Disease	20
and	O	20
for	O	20
colorectal	B-Disease	20
cancer	I-Disease	20
were	O	20
0	O	20
.	O	20

The	O	23
risk	O	23
of	O	23
colorectal	B-Disease	23
cancer	I-Disease	23
was	O	23
significantly	O	23
higher	O	23
(	O	23
p	O	23
<	O	23
0	O	23
.	O	23

For	O	29
females	O	29
there	O	29
was	O	29
a	O	29
high	O	29
risk	O	29
of	O	29
endometrial	B-Disease	29
cancer	I-Disease	29
(	O	29
0	O	29
.	O	29

5	O	30
at	O	30
age	O	30
60	O	30
years	O	30
)	O	30
and	O	30
premenopausal	B-Disease	30
ovarian	I-Disease	30
cancer	I-Disease	30
(	O	30
0	O	30
.	O	30

These	O	32
intersex	O	32
differences	O	32
in	O	32
colorectal	B-Disease	32
cancer	I-Disease	32
risks	O	32
have	O	32
implications	O	32
for	O	32
screening	O	32
programmes	O	32
and	O	32
for	O	32
attempts	O	32
to	O	32
identify	O	32
colorectal	B-Disease	32
cancer	I-Disease	32
susceptibility	O	32
modifiers	O	32
.	O	32

Age	O	33
of	O	33
onset	O	33
in	O	33
Huntington	B-Disease	33
disease	I-Disease	33
:	O	33
sex	O	33
specific	O	33
influence	O	33
of	O	33
apolipoprotein	O	33
E	O	33
genotype	O	33
and	O	33
normal	O	33
CAG	O	33
repeat	O	33
length	O	33
.	O	33

Age	O	34
of	O	34
onset	O	34
(	O	34
AO	O	34
)	O	34
of	O	34
Huntington	B-Disease	34
disease	I-Disease	34
(	O	34
HD	B-Disease	34
)	O	34
is	O	34
known	O	34
to	O	34
be	O	34
correlated	O	34
with	O	34
the	O	34
length	O	34
of	O	34
an	O	34
expanded	O	34
CAG	O	34
repeat	O	34
in	O	34
the	O	34
HD	B-Disease	34
gene	O	34
.	O	34

Apolipoprotein	O	35
E	O	35
(	O	35
APOE	O	35
)	O	35
genotype	O	35
,	O	35
in	O	35
turn	O	35
,	O	35
is	O	35
known	O	35
to	O	35
influence	O	35
AO	O	35
in	O	35
Alzheimer	B-Disease	35
disease	I-Disease	35
,	O	35
rendering	O	35
the	O	35
APOE	O	35
gene	O	35
a	O	35
likely	O	35
candidate	O	35
to	O	35
affect	O	35
AO	O	35
in	O	35
other	O	35
neurological	B-Disease	35
diseases	I-Disease	35
too	O	35
.	O	35

We	O	36
therefore	O	36
determined	O	36
APOE	O	36
genotype	O	36
and	O	36
normal	O	36
CAG	O	36
repeat	O	36
length	O	36
in	O	36
the	O	36
HD	B-Disease	36
gene	O	36
for	O	36
138	O	36
HD	B-Disease	36
patients	O	36
who	O	36
were	O	36
previously	O	36
analysed	O	36
with	O	36
respect	O	36
to	O	36
CAG	O	36
repeat	O	36
length	O	36
.	O	36

In	O	38
addition	O	38
to	O	38
highlighting	O	38
the	O	38
effect	O	38
of	O	38
the	O	38
normal	O	38
repeat	O	38
length	O	38
upon	O	38
AO	O	38
in	O	38
maternally	O	38
inherited	O	38
HD	B-Disease	38
and	O	38
in	O	38
male	O	38
patients	O	38
,	O	38
we	O	38
show	O	38
that	O	38
the	O	38
APOE	O	38
epsilon2epsilon3	O	38
genotype	O	38
is	O	38
associated	O	38
with	O	38
significantly	O	38
earlier	O	38
AO	O	38
in	O	38
males	O	38
than	O	38
in	O	38
females	O	38
.	O	38

Our	O	40
findings	O	40
suggest	O	40
that	O	40
subtle	O	40
differences	O	40
in	O	40
the	O	40
course	O	40
of	O	40
the	O	40
neurodegeneration	B-Disease	40
in	O	40
HD	B-Disease	40
may	O	40
allow	O	40
interacting	O	40
genes	O	40
to	O	40
exert	O	40
gender	O	40
specific	O	40
effects	O	40
upon	O	40
AO	O	40
.	O	40

Familial	B-Disease	41
deficiency	I-Disease	41
of	I-Disease	41
the	I-Disease	41
seventh	I-Disease	41
component	I-Disease	41
of	I-Disease	41
complement	I-Disease	41
associated	O	41
with	O	41
recurrent	O	41
bacteremic	B-Disease	41
infections	I-Disease	41
due	I-Disease	41
to	I-Disease	41
Neisseria	I-Disease	41
.	O	41

The	O	42
serum	O	42
of	O	42
a	O	42
29	O	42
-	O	42
year	O	42
old	O	42
woman	O	42
with	O	42
a	O	42
recent	O	42
episode	O	42
of	O	42
disseminated	B-Disease	42
gonococcal	I-Disease	42
infection	I-Disease	42
and	O	42
a	O	42
history	O	42
of	O	42
meningococcal	B-Disease	42
meningitis	I-Disease	42
and	O	42
arthritis	B-Disease	42
as	O	42
a	O	42
child	O	42
was	O	42
found	O	42
to	O	42
lack	O	42
serum	O	42
hemolytic	O	42
complement	O	42
activity	O	42
.	O	42

The	O	45
absence	B-Disease	45
of	I-Disease	45
functional	I-Disease	45
C7	I-Disease	45
activity	O	45
could	O	45
not	O	45
be	O	45
accounted	O	45
for	O	45
on	O	45
the	O	45
basis	O	45
of	O	45
an	O	45
inhibitor	O	45
.	O	45

Complete	B-Disease	47
absence	I-Disease	47
of	I-Disease	47
C7	I-Disease	47
was	O	47
also	O	47
found	O	47
in	O	47
one	O	47
sibling	O	47
who	O	47
had	O	47
the	O	47
clinical	O	47
syndrome	O	47
of	O	47
meningococcal	B-Disease	47
meningitis	I-Disease	47
and	O	47
arthritis	B-Disease	47
as	O	47
a	O	47
child	O	47
and	O	47
in	O	47
this	O	47
siblings	O	47
clinically	O	47
well	O	47
eight	O	47
-	O	47
year	O	47
-	O	47
old	O	47
son	O	47
.	O	47

HLA	O	48
histocompatibility	O	48
typing	O	48
of	O	48
the	O	48
family	O	48
members	O	48
did	O	48
not	O	48
demonstrate	O	48
evidence	O	48
for	O	48
genetic	O	48
linkage	O	48
of	O	48
C7	B-Disease	48
deficiency	I-Disease	48
with	O	48
the	O	48
major	O	48
histocompatibility	O	48
loci	O	48
.	O	48

This	O	49
report	O	49
represents	O	49
the	O	49
first	O	49
cases	O	49
of	O	49
C7	B-Disease	49
deficiency	I-Disease	49
associated	O	49
with	O	49
infectious	O	49
complications	O	49
and	O	49
suggests	O	49
that	O	49
bactericidal	O	49
activity	O	49
may	O	49
be	O	49
important	O	49
in	O	49
host	O	49
defense	O	49
against	O	49
bacteremic	B-Disease	49
neisseria	I-Disease	49
infections	I-Disease	49
.	O	49

Increased	O	50
incidence	O	50
of	O	50
cancer	B-Disease	50
in	O	50
patients	O	50
with	O	50
cartilage	B-Disease	50
-	I-Disease	50
hair	I-Disease	50
hypoplasia	I-Disease	50
.	O	50

OBJECTIVE	O	51
Previous	O	51
reports	O	51
have	O	51
suggested	O	51
an	O	51
increased	O	51
risk	O	51
of	O	51
cancer	B-Disease	51
among	O	51
patients	O	51
with	O	51
cartilage	B-Disease	51
-	I-Disease	51
hair	I-Disease	51
hypoplasia	I-Disease	51
(	O	51
CHH	B-Disease	51
)	O	51
.	O	51

This	O	52
study	O	52
was	O	52
carried	O	52
out	O	52
to	O	52
further	O	52
evaluate	O	52
this	O	52
risk	O	52
among	O	52
patients	O	52
with	O	52
CHH	B-Disease	52
and	O	52
their	O	52
first	O	52
-	O	52
degree	O	52
relatives	O	52
.	O	52

STUDY	O	53
DESIGN	O	53
One	O	53
hundred	O	53
twenty	O	53
-	O	53
two	O	53
patients	O	53
with	O	53
CHH	B-Disease	53
were	O	53
identified	O	53
through	O	53
2	O	53
countrywide	O	53
epidemiologic	O	53
surveys	O	53
in	O	53
1974	O	53
and	O	53
in	O	53
1986	O	53
.	O	53

This	O	55
cohort	O	55
underwent	O	55
follow	O	55
-	O	55
up	O	55
for	O	55
cancer	B-Disease	55
incidence	O	55
through	O	55
the	O	55
Finnish	O	55
Cancer	O	55
Registry	O	55
to	O	55
the	O	55
end	O	55
of	O	55
1995	O	55
.	O	55

RESULTS	O	56
A	O	56
statistically	O	56
significant	O	56
excess	O	56
risk	O	56
of	O	56
cancer	B-Disease	56
was	O	56
seen	O	56
among	O	56
the	O	56
patients	O	56
with	O	56
CHH	B-Disease	56
(	O	56
standardized	O	56
incidence	O	56
ratio	O	56
6	O	56
.	O	56

3	O	58
to	O	58
16	O	58
)	O	58
,	O	58
which	O	58
was	O	58
mainly	O	58
attributable	O	58
to	O	58
non	B-Disease	58
-	I-Disease	58
Hodgkins	I-Disease	58
lymphoma	I-Disease	58
(	O	58
standardized	O	58
incidence	O	58
ratio	O	58
90	O	58
,	O	58
95	O	58
%	O	58
confidence	O	58
interval	O	58
18	O	58
to	O	58
264	O	58
)	O	58
.	O	58

In	O	59
addition	O	59
,	O	59
a	O	59
significant	O	59
excess	O	59
risk	O	59
of	O	59
basal	B-Disease	59
cell	I-Disease	59
carcinoma	I-Disease	59
was	O	59
seen	O	59
(	O	59
standardized	O	59
incidence	O	59
ratio	O	59
35	O	59
,	O	59
95	O	59
%	O	59
confidence	O	59
interval	O	59
7	O	59
.	O	59

The	O	61
cancer	B-Disease	61
incidence	O	61
among	O	61
the	O	61
siblings	O	61
or	O	61
the	O	61
parents	O	61
did	O	61
not	O	61
differ	O	61
from	O	61
the	O	61
average	O	61
cancer	B-Disease	61
incidence	O	61
in	O	61
the	O	61
Finnish	O	61
population	O	61
.	O	61

CONCLUSIONS	O	62
This	O	62
study	O	62
confirms	O	62
an	O	62
increased	O	62
risk	O	62
of	O	62
cancer	B-Disease	62
,	O	62
especially	O	62
non	B-Disease	62
-	I-Disease	62
Hodgkins	I-Disease	62
lymphoma	I-Disease	62
,	O	62
probably	O	62
attributable	O	62
to	O	62
defective	O	62
immunity	O	62
,	O	62
among	O	62
patients	O	62
with	O	62
CHH	B-Disease	62
.	O	62

Genotype	O	63
and	O	63
phenotype	O	63
in	O	63
patients	O	63
with	O	63
dihydropyrimidine	B-Disease	63
dehydrogenase	I-Disease	63
deficiency	I-Disease	63
.	O	63

Dihydropyrimidine	B-Disease	64
dehydrogenase	I-Disease	64
(	I-Disease	64
DPD	I-Disease	64
)	I-Disease	64
deficiency	I-Disease	64
is	O	64
an	O	64
autosomal	B-Disease	64
recessive	I-Disease	64
disease	I-Disease	64
characterised	O	64
by	O	64
thymine	O	64
-	O	64
uraciluria	O	64
in	O	64
homozygous	O	64
deficient	O	64
patients	O	64
and	O	64
has	O	64
been	O	64
associated	O	64
with	O	64
a	O	64
variable	O	64
clinical	O	64
phenotype	O	64
.	O	64

In	O	65
order	O	65
to	O	65
understand	O	65
the	O	65
genetic	O	65
and	O	65
phenotypic	O	65
basis	O	65
for	O	65
DPD	B-Disease	65
deficiency	I-Disease	65
,	O	65
we	O	65
have	O	65
reviewed	O	65
17	O	65
families	O	65
presenting	O	65
22	O	65
patients	O	65
with	O	65
complete	O	65
deficiency	B-Disease	65
of	I-Disease	65
DPD	I-Disease	65
.	O	65

Analysis	O	67
of	O	67
the	O	67
prevalence	O	67
of	O	67
the	O	67
various	O	67
mutations	O	67
among	O	67
DPD	B-Disease	67
patients	O	67
has	O	67
shown	O	67
that	O	67
the	O	67
G	O	67
-	O	67
-	O	67
>	O	67
A	O	67
point	O	67
mutation	O	67
in	O	67
the	O	67
invariant	O	67
splice	O	67
donor	O	67
site	O	67
is	O	67
by	O	67
far	O	67
the	O	67
most	O	67
common	O	67
(	O	67
52	O	67
%	O	67
)	O	67
,	O	67
whereas	O	67
the	O	67
other	O	67
six	O	67
mutations	O	67
are	O	67
less	O	67
frequently	O	67
observed	O	67
.	O	67

A	O	68
large	O	68
phenotypic	O	68
variability	O	68
has	O	68
been	O	68
observed	O	68
,	O	68
with	O	68
convulsive	B-Disease	68
disorders	I-Disease	68
,	O	68
motor	B-Disease	68
retardation	I-Disease	68
and	O	68
mental	B-Disease	68
retardation	I-Disease	68
being	O	68
the	O	68
most	O	68
abundant	O	68
manifestations	O	68
.	O	68

An	O	70
altered	O	70
beta	O	70
-	O	70
alanine	O	70
,	O	70
uracil	O	70
and	O	70
thymine	O	70
homeostasis	O	70
might	O	70
underlie	O	70
the	O	70
various	O	70
clinical	B-Disease	70
abnormalities	I-Disease	70
encountered	O	70
in	O	70
patients	O	70
with	O	70
DPD	B-Disease	70
deficiency	I-Disease	70
.	O	70

Fibroblast	O	71
growth	O	71
factor	O	71
homologous	O	71
factor	O	71
2	O	71
(	O	71
FHF2	O	71
)	O	71
:	O	71
gene	O	71
structure	O	71
,	O	71
expression	O	71
and	O	71
mapping	O	71
to	O	71
the	O	71
Borjeson	B-Disease	71
-	I-Disease	71
Forssman	I-Disease	71
-	I-Disease	71
Lehmann	I-Disease	71
syndrome	I-Disease	71
region	O	71
in	O	71
Xq26	O	71
delineated	O	71
by	O	71
a	O	71
duplication	O	71
breakpoint	O	71
in	O	71
a	O	71
BFLS	B-Disease	71
-	O	71
like	O	71
patient	O	71
.	O	71

Borjeson	B-Disease	72
-	I-Disease	72
Forssman	I-Disease	72
-	I-Disease	72
Lehmann	I-Disease	72
syndrome	I-Disease	72
(	O	72
BFLS	B-Disease	72
)	O	72
is	O	72
a	O	72
syndromal	O	72
X	B-Disease	72
-	I-Disease	72
linked	I-Disease	72
mental	I-Disease	72
retardation	I-Disease	72
,	O	72
which	O	72
maps	O	72
by	O	72
linkage	O	72
to	O	72
the	O	72
q26	O	72
region	O	72
of	O	72
the	O	72
human	O	72
X	O	72
chromosome	O	72
.	O	72

We	O	73
have	O	73
identified	O	73
a	O	73
male	O	73
patient	O	73
with	O	73
BFLS	B-Disease	73
-	O	73
like	O	73
features	O	73
and	O	73
a	O	73
duplication	O	73
,	O	73
46	O	73
,	O	73
Y	O	73
,	O	73
dup	O	73
(	O	73
X	O	73
)	O	73
(	O	73
q26q28	O	73
)	O	73
,	O	73
inherited	O	73
from	O	73
his	O	73
phenotypically	O	73
normal	O	73
mother	O	73
.	O	73

The	O	82
FHF2	O	82
gene	O	82
localisation	O	82
and	O	82
tissue	O	82
-	O	82
specific	O	82
expression	O	82
pattern	O	82
suggest	O	82
it	O	82
to	O	82
be	O	82
a	O	82
candidate	O	82
gene	O	82
for	O	82
familial	O	82
cases	O	82
of	O	82
the	O	82
BFLS	B-Disease	82
syndrome	I-Disease	82
and	O	82
other	O	82
syndromal	O	82
and	O	82
non	O	82
-	O	82
specific	O	82
forms	O	82
of	O	82
X	B-Disease	82
-	I-Disease	82
linked	I-Disease	82
mental	I-Disease	82
retardation	I-Disease	82
mapping	O	82
to	O	82
the	O	82
region	O	82
.	O	82

Germline	O	83
E	O	83
-	O	83
cadherin	O	83
gene	O	83
(	O	83
CDH1	O	83
)	O	83
mutations	O	83
predispose	O	83
to	O	83
familial	B-Disease	83
gastric	I-Disease	83
cancer	I-Disease	83
and	O	83
colorectal	B-Disease	83
cancer	I-Disease	83
.	O	83

Inherited	O	84
mutations	O	84
in	O	84
the	O	84
E	O	84
-	O	84
cadherin	O	84
gene	O	84
(	O	84
CDH1	O	84
)	O	84
were	O	84
described	O	84
recently	O	84
in	O	84
three	O	84
Maori	O	84
kindreds	O	84
with	O	84
familial	B-Disease	84
gastric	I-Disease	84
cancer	I-Disease	84
.	O	84

Familial	B-Disease	85
gastric	I-Disease	85
cancer	I-Disease	85
is	O	85
genetically	O	85
heterogeneous	O	85
and	O	85
it	O	85
is	O	85
not	O	85
clear	O	85
what	O	85
proportion	O	85
of	O	85
gastric	B-Disease	85
cancer	I-Disease	85
susceptibility	O	85
in	O	85
non	O	85
-	O	85
Maori	O	85
populations	O	85
is	O	85
due	O	85
to	O	85
germline	O	85
CDH1	O	85
mutations	O	85
.	O	85

Therefore	O	86
,	O	86
we	O	86
screened	O	86
eight	O	86
familial	B-Disease	86
gastric	I-Disease	86
cancer	I-Disease	86
kindreds	O	86
of	O	86
British	O	86
and	O	86
Irish	O	86
origin	O	86
for	O	86
germline	O	86
CDH1	O	86
mutations	O	86
,	O	86
by	O	86
SSCP	O	86
analysis	O	86
of	O	86
all	O	86
16	O	86
exons	O	86
and	O	86
flanking	O	86
sequences	O	86
.	O	86

Each	O	87
family	O	87
contained	O	87
(	O	87
i	O	87
)	O	87
two	O	87
cases	O	87
of	O	87
gastric	B-Disease	87
cancer	I-Disease	87
in	O	87
first	O	87
degree	O	87
relatives	O	87
with	O	87
one	O	87
affected	O	87
before	O	87
age	O	87
50	O	87
years	O	87
;	O	87
or	O	87
(	O	87
ii	O	87
)	O	87
three	O	87
or	O	87
more	O	87
cases	O	87
of	O	87
gastric	B-Disease	87
cancer	I-Disease	87
.	O	87

In	O	90
one	O	90
family	O	90
there	O	90
was	O	90
evidence	O	90
of	O	90
non	O	90
-	O	90
penetrance	O	90
and	O	90
susceptibility	O	90
to	O	90
both	O	90
gastric	B-Disease	90
and	I-Disease	90
colorectal	I-Disease	90
cancer	I-Disease	90
;	O	90
thus	O	90
,	O	90
in	O	90
addition	O	90
to	O	90
six	O	90
cases	O	90
of	O	90
gastric	B-Disease	90
cancer	I-Disease	90
,	O	90
a	O	90
CDH1	O	90
mutation	O	90
carrier	O	90
developed	O	90
colorectal	B-Disease	90
cancer	I-Disease	90
at	O	90
age	O	90
30	O	90
years	O	90
.	O	90

We	O	91
have	O	91
confirmed	O	91
that	O	91
germline	O	91
mutations	O	91
in	O	91
the	O	91
CDH1	O	91
gene	O	91
cause	O	91
familial	B-Disease	91
gastric	I-Disease	91
cancer	I-Disease	91
in	O	91
non	O	91
-	O	91
Maori	O	91
populations	O	91
.	O	91

However	O	92
,	O	92
only	O	92
a	O	92
minority	O	92
of	O	92
familial	O	92
gastric	B-Disease	92
cancers	I-Disease	92
can	O	92
be	O	92
accounted	O	92
for	O	92
by	O	92
CDH1	O	92
mutations	O	92
.	O	92

Loss	O	93
of	O	93
E	O	93
-	O	93
cadherin	O	93
function	O	93
has	O	93
been	O	93
implicated	O	93
in	O	93
the	O	93
pathogenesis	O	93
of	O	93
sporadic	O	93
colorectal	B-Disease	93
and	I-Disease	93
other	I-Disease	93
cancers	I-Disease	93
,	O	93
and	O	93
our	O	93
findings	O	93
provide	O	93
evidence	O	93
that	O	93
germline	O	93
CDH1	O	93
mutations	O	93
predispose	O	93
to	O	93
early	O	93
onset	O	93
colorectal	B-Disease	93
cancer	I-Disease	93
.	O	93

Thus	O	94
,	O	94
CDH1	O	94
should	O	94
be	O	94
investigated	O	94
as	O	94
a	O	94
cause	O	94
of	O	94
inherited	O	94
susceptibility	O	94
to	O	94
both	O	94
gastric	B-Disease	94
and	I-Disease	94
colorectal	I-Disease	94
cancers	I-Disease	94
.	O	94

A	O	95
zinc	O	95
finger	O	95
truncation	O	95
of	O	95
murine	O	95
WT1	O	95
results	O	95
in	O	95
the	O	95
characteristic	O	95
urogenital	B-Disease	95
abnormalities	I-Disease	95
of	O	95
Denys	B-Disease	95
-	I-Disease	95
Drash	I-Disease	95
syndrome	I-Disease	95
.	O	95

The	O	96
Wilms	B-Disease	96
tumor	I-Disease	96
-	O	96
suppressor	O	96
gene	O	96
,	O	96
WT1	O	96
,	O	96
plays	O	96
a	O	96
key	O	96
role	O	96
in	O	96
urogenital	O	96
development	O	96
,	O	96
and	O	96
WT1	B-Disease	96
dysfunction	I-Disease	96
is	O	96
implicated	O	96
in	O	96
both	O	96
neoplastic	B-Disease	96
(	O	96
Wilms	B-Disease	96
tumor	I-Disease	96
,	O	96
mesothelioma	B-Disease	96
,	O	96
leukemias	B-Disease	96
,	O	96
and	O	96
breast	B-Disease	96
cancer	I-Disease	96
)	O	96
and	O	96
nonneoplastic	B-Disease	96
(	O	96
glomerulosclerosis	B-Disease	96
)	O	96
disease	O	96
.	O	96

The	O	97
analysis	O	97
of	O	97
diseases	O	97
linked	O	97
specifically	O	97
with	O	97
WT1	O	97
mutations	O	97
,	O	97
such	O	97
as	O	97
Denys	B-Disease	97
-	I-Disease	97
Drash	I-Disease	97
syndrome	I-Disease	97
(	O	97
DDS	B-Disease	97
)	O	97
,	O	97
can	O	97
provide	O	97
valuable	O	97
insight	O	97
concerning	O	97
the	O	97
role	O	97
of	O	97
WT1	O	97
in	O	97
development	O	97
and	O	97
disease	O	97
.	O	97

DDS	B-Disease	98
is	O	98
a	O	98
rare	O	98
childhood	O	98
disease	O	98
characterized	O	98
by	O	98
a	O	98
nephropathy	B-Disease	98
involving	O	98
mesangial	B-Disease	98
sclerosis	I-Disease	98
,	O	98
XY	O	98
pseudohermaphroditism	B-Disease	98
,	O	98
and	O	98
/	O	98
or	O	98
Wilms	B-Disease	98
tumor	I-Disease	98
(	O	98
WT	B-Disease	98
)	O	98
.	O	98

DDS	B-Disease	99
patients	O	99
are	O	99
constitutionally	O	99
heterozygous	O	99
for	O	99
exonic	O	99
point	O	99
mutations	O	99
in	O	99
WT1	O	99
,	O	99
which	O	99
include	O	99
mutations	O	99
predicted	O	99
to	O	99
truncate	O	99
the	O	99
protein	O	99
within	O	99
the	O	99
C	O	99
-	O	99
terminal	O	99
zinc	O	99
finger	O	99
(	O	99
ZF	O	99
)	O	99
region	O	99
.	O	99

We	O	100
report	O	100
that	O	100
heterozygosity	O	100
for	O	100
a	O	100
targeted	O	100
murine	O	100
Wt1	O	100
allele	O	100
,	O	100
Wt1	O	100
(	O	100
tmT396	O	100
)	O	100
,	O	100
which	O	100
truncates	O	100
ZF3	O	100
at	O	100
codon	O	100
396	O	100
,	O	100
induces	O	100
mesangial	B-Disease	100
sclerosis	I-Disease	100
characteristic	O	100
of	O	100
DDS	B-Disease	100
in	O	100
adult	O	100
heterozygous	O	100
and	O	100
chimeric	O	100
mice	O	100
.	O	100

Male	B-Disease	101
genital	I-Disease	101
defects	I-Disease	101
also	O	101
were	O	101
evident	O	101
and	O	101
there	O	101
was	O	101
a	O	101
single	O	101
case	O	101
of	O	101
Wilms	B-Disease	101
tumor	I-Disease	101
in	O	101
which	O	101
the	O	101
transcript	O	101
of	O	101
the	O	101
nontargeted	O	101
allele	O	101
showed	O	101
an	O	101
exon	O	101
9	O	101
skipping	O	101
event	O	101
,	O	101
implying	O	101
a	O	101
causal	O	101
link	O	101
between	O	101
Wt1	B-Disease	101
dysfunction	I-Disease	101
and	O	101
Wilms	B-Disease	101
tumorigenesis	I-Disease	101
in	O	101
mice	O	101
.	O	101

However	O	102
,	O	102
the	O	102
mutant	O	102
WT1	O	102
(	O	102
tmT396	O	102
)	O	102
protein	O	102
accounted	O	102
for	O	102
only	O	102
5	O	102
%	O	102
of	O	102
WT1	O	102
in	O	102
both	O	102
heterozygous	O	102
embryonic	O	102
stem	O	102
cells	O	102
and	O	102
the	O	102
WT	B-Disease	102
.	O	102

Mechanism	O	104
of	O	104
increased	O	104
iron	O	104
absorption	O	104
in	O	104
murine	O	104
model	O	104
of	O	104
hereditary	B-Disease	104
hemochromatosis	I-Disease	104
:	O	104
increased	O	104
duodenal	O	104
expression	O	104
of	O	104
the	O	104
iron	O	104
transporter	O	104
DMT1	O	104
.	O	104

Hereditary	B-Disease	105
hemochromatosis	I-Disease	105
(	O	105
HH	B-Disease	105
)	O	105
is	O	105
a	O	105
common	O	105
autosomal	B-Disease	105
recessive	I-Disease	105
disorder	I-Disease	105
characterized	O	105
by	O	105
tissue	O	105
iron	O	105
deposition	O	105
secondary	O	105
to	O	105
excessive	O	105
dietary	O	105
iron	O	105
absorption	O	105
.	O	105

We	O	106
recently	O	106
reported	O	106
that	O	106
HFE	O	106
,	O	106
the	O	106
protein	O	106
defective	O	106
in	O	106
HH	B-Disease	106
,	O	106
was	O	106
physically	O	106
associated	O	106
with	O	106
the	O	106
transferrin	O	106
receptor	O	106
(	O	106
TfR	O	106
)	O	106
in	O	106
duodenal	O	106
crypt	O	106
cells	O	106
and	O	106
proposed	O	106
that	O	106
mutations	O	106
in	O	106
HFE	O	106
attenuate	O	106
the	O	106
uptake	O	106
of	O	106
transferrin	O	106
-	O	106
bound	O	106
iron	O	106
from	O	106
plasma	O	106
by	O	106
duodenal	O	106
crypt	O	106
cells	O	106
,	O	106
leading	O	106
to	O	106
up	O	106
-	O	106
regulation	O	106
of	O	106
transporters	O	106
for	O	106
dietary	O	106
iron	O	106
.	O	106

The	O	114
positive	O	114
control	O	114
for	O	114
DMT1	O	114
up	O	114
-	O	114
regulation	O	114
was	O	114
a	O	114
murine	O	114
model	O	114
of	O	114
dietary	B-Disease	114
iron	I-Disease	114
deficiency	I-Disease	114
that	O	114
demonstrated	O	114
greatly	O	114
increased	O	114
levels	O	114
of	O	114
duodenal	O	114
DMT1	O	114
(	O	114
IRE	O	114
)	O	114
mRNA	O	114
.	O	114

Neurophysiologic	O	119
follow	O	119
-	O	119
up	O	119
of	O	119
long	O	119
-	O	119
term	O	119
dietary	O	119
treatment	O	119
in	O	119
adult	O	119
-	O	119
onset	O	119
adrenoleukodystrophy	B-Disease	119
.	O	119

OBJECTIVE	O	120
To	O	120
monitor	O	120
the	O	120
effects	O	120
of	O	120
dietary	O	120
treatment	O	120
in	O	120
adult	O	120
-	O	120
onset	O	120
adrenoleukodystrophy	B-Disease	120
(	O	120
ALD	B-Disease	120
)	O	120
by	O	120
means	O	120
of	O	120
somatosensory	O	120
evoked	O	120
potentials	O	120
(	O	120
SEPs	O	120
)	O	120
and	O	120
motor	O	120
evoked	O	120
potentials	O	120
(	O	120
MEPs	O	120
)	O	120
.	O	120

BACKGROUND	O	121
SEPs	O	121
and	O	121
MEPs	O	121
have	O	121
proved	O	121
useful	O	121
in	O	121
revealing	O	121
signs	O	121
of	O	121
progressively	O	121
severe	O	121
,	O	121
central	O	121
dying	B-Disease	121
-	I-Disease	121
back	I-Disease	121
axonopathy	I-Disease	121
in	O	121
early	O	121
stages	O	121
of	O	121
adult	O	121
-	O	121
onset	O	121
ALD	B-Disease	121
.	O	121

METHODS	O	122
Eight	O	122
patients	O	122
with	O	122
adult	O	122
-	O	122
onset	O	122
ALD	B-Disease	122
underwent	O	122
clinical	O	122
examination	O	122
,	O	122
brain	O	122
and	O	122
spine	O	122
MRI	O	122
,	O	122
and	O	122
SEP	O	122
and	O	122
MEP	O	122
studies	O	122
before	O	122
and	O	122
after	O	122
3	O	122
years	O	122
of	O	122
Lorenzos	O	122
oil	O	122
dietary	O	122
therapy	O	122
.	O	122

Three	O	124
of	O	124
these	O	124
patients	O	124
had	O	124
pure	O	124
spinal	B-Disease	124
SEP	I-Disease	124
abnormalities	I-Disease	124
and	O	124
in	O	124
the	O	124
remaining	O	124
two	O	124
patients	O	124
SEPs	O	124
showed	O	124
signs	O	124
of	O	124
involvement	O	124
of	O	124
both	O	124
the	O	124
spinal	O	124
and	O	124
cerebral	O	124
somatosensory	O	124
tracts	O	124
.	O	124

After	O	125
treatment	O	125
,	O	125
the	O	125
three	O	125
patients	O	125
with	O	125
pure	O	125
spinal	B-Disease	125
abnormalities	I-Disease	125
showed	O	125
clinical	O	125
and	O	125
neurophysiologic	O	125
worsening	O	125
,	O	125
whereas	O	125
the	O	125
two	O	125
patients	O	125
with	O	125
a	O	125
more	O	125
advanced	O	125
stage	O	125
of	O	125
disease	O	125
(	O	125
exhibited	O	125
by	O	125
SEPs	O	125
)	O	125
showed	O	125
substantially	O	125
unchanged	O	125
clinical	O	125
and	O	125
neurophysiologic	O	125
features	O	125
.	O	125

CONCLUSIONS	O	127
Lorenzos	O	127
oil	O	127
therapy	O	127
had	O	127
no	O	127
effect	O	127
on	O	127
patients	O	127
with	O	127
evidence	O	127
of	O	127
inflammatory	B-Disease	127
brain	I-Disease	127
lesions	I-Disease	127
.	O	127

GCH1	O	130
mutation	O	130
in	O	130
a	O	130
patient	O	130
with	O	130
adult	O	130
-	O	130
onset	O	130
oromandibular	B-Disease	130
dystonia	I-Disease	130
.	O	130

The	O	131
authors	O	131
report	O	131
a	O	131
mutation	O	131
in	O	131
exon	O	131
5	O	131
of	O	131
GCH1	O	131
in	O	131
a	O	131
patient	O	131
with	O	131
adult	O	131
-	O	131
onset	O	131
oromandibular	B-Disease	131
dystonia	I-Disease	131
and	O	131
no	O	131
obvious	O	131
family	O	131
history	O	131
of	O	131
dystonia	B-Disease	131
.	O	131

These	O	133
findings	O	133
demonstrate	O	133
that	O	133
GCH1	O	133
mutations	O	133
must	O	133
be	O	133
considered	O	133
even	O	133
in	O	133
patients	O	133
with	O	133
dystonic	B-Disease	133
symptoms	O	133
not	O	133
typical	O	133
of	O	133
dopa	B-Disease	133
-	I-Disease	133
responsive	I-Disease	133
dystonia	I-Disease	133
.	O	133

Germline	O	134
mutations	O	134
of	O	134
the	O	134
APC	B-Disease	134
gene	O	134
in	O	134
Korean	O	134
familial	B-Disease	134
adenomatous	I-Disease	134
polyposis	I-Disease	134
patients	O	134
.	O	134

We	O	135
extensively	O	135
analyzed	O	135
genomic	O	135
DNA	O	135
and	O	135
messenger	O	135
RNA	O	135
(	O	135
mRNA	O	135
)	O	135
from	O	135
62	O	135
unrelated	O	135
Korean	O	135
patients	O	135
with	O	135
familial	B-Disease	135
adenomatous	I-Disease	135
polyposis	I-Disease	135
(	O	135
FAP	B-Disease	135
)	O	135
for	O	135
identification	O	135
of	O	135
germline	O	135
adenomatous	B-Disease	135
polyposis	I-Disease	135
coli	I-Disease	135
(	O	135
APC	B-Disease	135
)	O	135
gene	O	135
mutations	O	135
.	O	135

Nineteen	O	139
of	O	139
the	O	139
detected	O	139
mutations	O	139
were	O	139
presumed	O	139
to	O	139
be	O	139
novel	O	139
,	O	139
thus	O	139
emphasizing	O	139
the	O	139
heterogeneity	O	139
of	O	139
the	O	139
mutational	O	139
spectrum	O	139
in	O	139
Korean	O	139
FAP	B-Disease	139
patients	O	139
.	O	139

Using	O	141
this	O	141
combined	O	141
approach	O	141
,	O	141
we	O	141
identified	O	141
germline	O	141
APC	B-Disease	141
gene	O	141
mutations	O	141
in	O	141
29	O	141
of	O	141
the	O	141
48	O	141
FAP	B-Disease	141
patients	O	141
(	O	141
60	O	141
%	O	141
)	O	141
,	O	141
including	O	141
6	O	141
patients	O	141
in	O	141
whom	O	141
SSCP	O	141
analysis	O	141
failed	O	141
to	O	141
distinguish	O	141
the	O	141
mutant	O	141
allele	O	141
.	O	141

Our	O	143
results	O	143
confirm	O	143
that	O	143
the	O	143
mutation	O	143
detection	O	143
rate	O	143
with	O	143
PTT	O	143
was	O	143
superior	O	143
to	O	143
that	O	143
with	O	143
SSCP	O	143
,	O	143
and	O	143
suggest	O	143
that	O	143
PTT	O	143
would	O	143
be	O	143
a	O	143
more	O	143
practical	O	143
screening	O	143
method	O	143
to	O	143
detect	O	143
germline	O	143
mutations	O	143
of	O	143
the	O	143
APC	B-Disease	143
gene	O	143
in	O	143
FAP	B-Disease	143
patients	O	143
.	O	143

Molecular	O	144
epidemiology	O	144
of	O	144
C9	B-Disease	144
deficiency	I-Disease	144
heterozygotes	O	144
with	O	144
an	O	144
Arg95Stop	O	144
mutation	O	144
of	O	144
the	O	144
C9	O	144
gene	O	144
in	O	144
Japan	O	144
.	O	144

Deficiency	B-Disease	145
of	I-Disease	145
the	I-Disease	145
ninth	I-Disease	145
component	I-Disease	145
of	I-Disease	145
human	I-Disease	145
complement	I-Disease	145
(	O	145
C9	O	145
)	O	145
is	O	145
the	O	145
most	O	145
common	O	145
complement	B-Disease	145
deficiency	I-Disease	145
in	O	145
Japan	O	145
,	O	145
with	O	145
an	O	145
incidence	O	145
of	O	145
approximately	O	145
one	O	145
homozygote	O	145
in	O	145
1000	O	145
,	O	145
but	O	145
is	O	145
very	O	145
rare	O	145
in	O	145
other	O	145
countries	O	145
.	O	145

Genetic	O	146
analyses	O	146
of	O	146
Japanese	O	146
C9	B-Disease	146
deficiency	I-Disease	146
have	O	146
shown	O	146
that	O	146
a	O	146
C	O	146
-	O	146
to	O	146
-	O	146
T	O	146
transition	O	146
leading	O	146
to	O	146
TGA	O	146
stop	O	146
codon	O	146
for	O	146
Arg95	O	146
in	O	146
exon	O	146
4	O	146
of	O	146
the	O	146
C9	O	146
gene	O	146
(	O	146
Arg95Stop	O	146
)	O	146
is	O	146
common	O	146
in	O	146
Japanese	O	146
C9	B-Disease	146
deficiency	I-Disease	146
.	O	146

12	O	154
%	O	154
)	O	154
of	O	154
complete	O	154
C9	B-Disease	154
deficiency	I-Disease	154
due	O	154
to	O	154
homozygous	O	154
Arg95Stop	O	154
mutation	O	154
was	O	154
consistent	O	154
with	O	154
frequencies	O	154
determined	O	154
by	O	154
serological	O	154
studies	O	154
The	O	154
hereditary	B-Disease	154
hemochromatosis	I-Disease	154
protein	O	154
,	O	154
HFE	O	154
,	O	154
specifically	O	154
regulates	O	154
transferrin	O	154
-	O	154
mediated	O	154
iron	O	154
uptake	O	154
in	O	154
HeLa	O	154
cells	O	154
.	O	154

HFE	O	155
is	O	155
the	O	155
protein	O	155
product	O	155
of	O	155
the	O	155
gene	O	155
mutated	O	155
in	O	155
the	O	155
autosomal	B-Disease	155
recessive	I-Disease	155
disease	I-Disease	155
hereditary	B-Disease	155
hemochromatosis	I-Disease	155
(	O	155
Feder	O	155
,	O	155
J	O	155
.	O	155

These	O	249
results	O	249
also	O	249
have	O	249
implications	O	249
for	O	249
the	O	249
understanding	O	249
of	O	249
cellular	O	249
iron	O	249
homeostasis	O	249
in	O	249
organs	O	249
such	O	249
as	O	249
the	O	249
liver	O	249
,	O	249
pancreas	O	249
,	O	249
heart	O	249
,	O	249
and	O	249
spleen	O	249
that	O	249
are	O	249
iron	O	249
loaded	O	249
in	O	249
hereditary	B-Disease	249
hemochromatotic	I-Disease	249
individuals	O	249
lacking	O	249
functional	O	249
HFE	O	249
.	O	249

Mutation	O	250
and	O	250
haplotype	O	250
studies	O	250
of	O	250
familial	B-Disease	250
Mediterranean	I-Disease	250
fever	I-Disease	250
reveal	O	250
new	O	250
ancestral	O	250
relationships	O	250
and	O	250
evidence	O	250
for	O	250
a	O	250
high	O	250
carrier	O	250
frequency	O	250
with	O	250
reduced	O	250
penetrance	O	250
in	O	250
the	O	250
Ashkenazi	O	250
Jewish	O	250
population	O	250
.	O	250

Familial	B-Disease	251
Mediterranean	I-Disease	251
fever	I-Disease	251
(	O	251
FMF	B-Disease	251
)	O	251
is	O	251
a	O	251
recessive	B-Disease	251
disorder	I-Disease	251
characterized	O	251
by	O	251
episodes	O	251
of	O	251
fever	O	251
with	O	251
serositis	B-Disease	251
or	O	251
synovitis	B-Disease	251
.	O	251

The	O	252
FMF	B-Disease	252
gene	O	252
(	O	252
MEFV	O	252
)	O	252
was	O	252
cloned	O	252
recently	O	252
,	O	252
and	O	252
four	O	252
missense	O	252
mutations	O	252
were	O	252
identified	O	252
.	O	252

Consistent	O	256
with	O	256
another	O	256
recent	O	256
report	O	256
,	O	256
the	O	256
E148Q	O	256
mutation	O	256
was	O	256
observed	O	256
in	O	256
patients	O	256
of	O	256
several	O	256
ethnicities	O	256
and	O	256
on	O	256
multiple	O	256
microsatellite	O	256
haplotypes	O	256
,	O	256
but	O	256
haplotype	O	256
data	O	256
indicate	O	256
an	O	256
ancestral	O	256
relationships	O	256
between	O	256
non	O	256
-	O	256
Jewish	O	256
Italian	O	256
and	O	256
Ashkenazi	O	256
Jewish	O	256
patients	O	256
with	O	256
FMF	B-Disease	256
and	O	256
other	O	256
affected	O	256
populations	O	256
.	O	256

Nevertheless	O	259
,	O	259
E148Q	O	259
helps	O	259
account	O	259
for	O	259
recessive	O	259
inheritance	O	259
in	O	259
an	O	259
Ashkenazi	O	259
family	O	259
previously	O	259
reported	O	259
as	O	259
an	O	259
unusual	O	259
case	O	259
of	O	259
dominantly	O	259
inherited	O	259
FMF	B-Disease	259
.	O	259

Autoimmune	B-Disease	261
lymphoproliferative	I-Disease	261
syndrome	I-Disease	261
with	O	261
defective	O	261
Fas	O	261
:	O	261
genotype	O	261
influences	O	261
penetrance	O	261
.	O	261

Autoimmune	B-Disease	262
lymphoproliferative	I-Disease	262
syndrome	I-Disease	262
(	O	262
ALPS	B-Disease	262
)	O	262
is	O	262
a	O	262
disorder	B-Disease	262
of	I-Disease	262
lymphocyte	I-Disease	262
homeostasis	I-Disease	262
and	I-Disease	262
immunological	I-Disease	262
tolerance	I-Disease	262
.	O	262

Of	O	264
17	O	264
unique	O	264
APT1	O	264
mutations	O	264
in	O	264
unrelated	O	264
ALPS	B-Disease	264
probands	O	264
,	O	264
12	O	264
(	O	264
71	O	264
%	O	264
)	O	264
occurred	O	264
in	O	264
exons	O	264
7	O	264
-	O	264
9	O	264
,	O	264
which	O	264
encode	O	264
the	O	264
intracellular	O	264
portion	O	264
of	O	264
Fas	O	264
.	O	264

Two	O	268
missense	O	268
Fas	O	268
variants	O	268
,	O	268
not	O	268
restricted	O	268
to	O	268
patients	O	268
with	O	268
ALPS	B-Disease	268
,	O	268
were	O	268
identified	O	268
.	O	268

Among	O	270
the	O	270
ALPS	B-Disease	270
-	O	270
associated	O	270
Fas	O	270
mutants	O	270
,	O	270
dominant	O	270
inhibition	O	270
of	O	270
apoptosis	O	270
was	O	270
much	O	270
more	O	270
pronounced	O	270
in	O	270
mutants	O	270
affecting	O	270
the	O	270
intracellular	O	270
,	O	270
versus	O	270
extracellular	O	270
,	O	270
portion	O	270
of	O	270
the	O	270
Fas	O	270
receptor	O	270
.	O	270

Mutations	O	271
causing	O	271
disruption	O	271
of	O	271
the	O	271
intracellular	O	271
Fas	O	271
death	O	271
domain	O	271
also	O	271
showed	O	271
a	O	271
higher	O	271
penetrance	O	271
of	O	271
ALPS	B-Disease	271
phenotype	O	271
features	O	271
in	O	271
mutation	O	271
-	O	271
bearing	O	271
relatives	O	271
.	O	271

Significant	O	272
ALPS	B-Disease	272
-	O	272
related	O	272
morbidity	O	272
occurred	O	272
in	O	272
44	O	272
%	O	272
of	O	272
relatives	O	272
with	O	272
intracellular	O	272
mutations	O	272
,	O	272
versus	O	272
0	O	272
%	O	272
of	O	272
relatives	O	272
with	O	272
extracellular	O	272
mutations	O	272
.	O	272

Thus	O	273
,	O	273
the	O	273
location	O	273
of	O	273
mutations	O	273
within	O	273
APT1	O	273
strongly	O	273
influences	O	273
the	O	273
development	O	273
and	O	273
the	O	273
severity	O	273
of	O	273
ALPS	B-Disease	273
.	O	273

Multicentric	O	274
origin	O	274
of	O	274
hemochromatosis	B-Disease	274
gene	O	274
(	O	274
HFE	O	274
)	O	274
mutations	O	274
.	O	274

Genetic	B-Disease	275
hemochromatosis	I-Disease	275
(	O	275
GH	B-Disease	275
)	O	275
is	O	275
believed	O	275
to	O	275
be	O	275
a	O	275
disease	O	275
restricted	O	275
to	O	275
those	O	275
of	O	275
European	O	275
ancestry	O	275
.	O	275

In	O	276
northwestern	O	276
Europe	O	276
,	O	276
>	O	276
80	O	276
%	O	276
of	O	276
GH	B-Disease	276
patients	O	276
are	O	276
homozygous	O	276
for	O	276
one	O	276
mutation	O	276
,	O	276
the	O	276
substitution	O	276
of	O	276
tyrosine	O	276
for	O	276
cysteine	O	276
at	O	276
position	O	276
282	O	276
(	O	276
C282Y	O	276
)	O	276
in	O	276
the	O	276
unprocessed	O	276
protein	O	276
.	O	276

In	O	277
a	O	277
proportion	O	277
of	O	277
GH	B-Disease	277
patients	O	277
,	O	277
two	O	277
mutations	O	277
are	O	277
present	O	277
,	O	277
C282Y	O	277
and	O	277
H63D	O	277
.	O	277

These	O	285
selection	O	285
pressures	O	285
could	O	285
be	O	285
due	O	285
to	O	285
infectious	B-Disease	285
diseases	I-Disease	285
,	O	285
environmental	O	285
conditions	O	285
,	O	285
or	O	285
other	O	285
genetic	B-Disease	285
disorders	I-Disease	285
such	O	285
as	O	285
anemia	B-Disease	285
.	O	285

We	O	287
have	O	287
retrospectively	O	287
analyzed	O	287
837	O	287
random	O	287
anonymized	O	287
dried	O	287
blood	O	287
spot	O	287
(	O	287
DBS	O	287
)	O	287
samples	O	287
from	O	287
neonatal	O	287
screening	O	287
programs	O	287
in	O	287
Scandinavia	O	287
for	O	287
mutations	O	287
in	O	287
HFE	O	287
,	O	287
the	O	287
candidate	O	287
gene	O	287
for	O	287
hemochromatosis	B-Disease	287
.	O	287

Identification	O	300
of	O	300
the	O	300
mutation	O	300
in	O	300
the	O	300
alkaptonuria	B-Disease	300
mouse	O	300
model	O	300
.	O	300

Alkaptonuria	B-Disease	301
(	O	301
aku	B-Disease	301
)	O	301
,	O	301
an	O	301
inborn	B-Disease	301
error	I-Disease	301
of	I-Disease	301
metabolism	I-Disease	301
caused	O	301
by	O	301
the	O	301
loss	O	301
of	O	301
homogentisate	O	301
1	O	301
,	O	301
2	O	301
-	O	301
dioxygenase	O	301
(	O	301
HGD	O	301
)	O	301
,	O	301
has	O	301
been	O	301
described	O	301
in	O	301
a	O	301
mouse	O	301
model	O	301
created	O	301
by	O	301
ethylnitrosourea	O	301
mutagenesis	O	301
but	O	301
the	O	301
mutation	O	301
in	O	301
these	O	301
mice	O	301
has	O	301
not	O	301
previously	O	301
been	O	301
identified	O	301
.	O	301

Non	B-Disease	306
-	I-Disease	306
syndromic	I-Disease	306
hearing	I-Disease	306
loss	I-Disease	306
associated	O	306
with	O	306
enlarged	B-Disease	306
vestibular	I-Disease	306
aqueduct	I-Disease	306
is	O	306
caused	O	306
by	O	306
PDS	B-Disease	306
mutations	O	306
.	O	306

Enlarged	B-Disease	307
vestibular	I-Disease	307
aqueduct	I-Disease	307
(	O	307
EVA	B-Disease	307
)	O	307
,	O	307
known	O	307
as	O	307
the	O	307
most	O	307
common	O	307
form	O	307
of	O	307
inner	B-Disease	307
ear	I-Disease	307
abnormality	I-Disease	307
,	O	307
has	O	307
recently	O	307
been	O	307
of	O	307
particular	O	307
genetic	O	307
interest	O	307
because	O	307
this	O	307
anomaly	O	307
is	O	307
inherited	O	307
in	O	307
a	O	307
recessive	O	307
manner	O	307
.	O	307

The	O	308
locus	O	308
for	O	308
non	B-Disease	308
-	I-Disease	308
syndromic	I-Disease	308
sensorineural	I-Disease	308
hearing	I-Disease	308
loss	I-Disease	308
with	O	308
EVA	B-Disease	308
has	O	308
been	O	308
mapped	O	308
to	O	308
the	O	308
same	O	308
chromosomal	O	308
region	O	308
,	O	308
7q31	O	308
,	O	308
as	O	308
the	O	308
Pendred	B-Disease	308
syndrome	I-Disease	308
locus	O	308
.	O	308

In	O	309
the	O	309
present	O	309
study	O	309
,	O	309
seven	O	309
mutations	O	309
in	O	309
the	O	309
PDS	B-Disease	309
gene	O	309
(	O	309
PDS	O	309
)	O	309
,	O	309
the	O	309
gene	O	309
responsible	O	309
for	O	309
Pendred	B-Disease	309
syndrome	I-Disease	309
,	O	309
have	O	309
been	O	309
found	O	309
in	O	309
families	O	309
of	O	309
non	B-Disease	309
-	I-Disease	309
syndromic	I-Disease	309
sensorineural	I-Disease	309
hearing	I-Disease	309
loss	I-Disease	309
with	O	309
EVA	B-Disease	309
.	O	309

The	O	311
present	O	311
results	O	311
provide	O	311
evidence	O	311
that	O	311
mutations	O	311
in	O	311
PDS	O	311
cause	O	311
both	O	311
syndromic	B-Disease	311
and	I-Disease	311
non	I-Disease	311
-	I-Disease	311
syndromic	I-Disease	311
hearing	I-Disease	311
loss	I-Disease	311
.	O	311

Mutational	O	313
analysis	O	313
and	O	313
genotype	O	313
-	O	313
phenotype	O	313
correlation	O	313
of	O	313
29	O	313
unrelated	O	313
Japanese	O	313
patients	O	313
with	O	313
X	B-Disease	313
-	I-Disease	313
linked	I-Disease	313
adrenoleukodystrophy	I-Disease	313
.	O	313

BACKGROUND	O	314
X	B-Disease	314
-	I-Disease	314
linked	I-Disease	314
adrenoleukodystrophy	I-Disease	314
(	O	314
ALD	B-Disease	314
)	O	314
is	O	314
an	O	314
inherited	B-Disease	314
disease	I-Disease	314
characterized	O	314
by	O	314
progressive	O	314
neurologic	B-Disease	314
dysfunction	I-Disease	314
,	O	314
occasionally	O	314
associated	O	314
with	O	314
adrenal	B-Disease	314
insufficiency	I-Disease	314
.	O	314

The	O	315
classic	O	315
form	O	315
of	O	315
ALD	B-Disease	315
usually	O	315
has	O	315
onset	O	315
in	O	315
childhood	O	315
(	O	315
childhood	B-Disease	315
cerebral	I-Disease	315
ALD	I-Disease	315
)	O	315
,	O	315
with	O	315
rapid	O	315
neurologic	B-Disease	315
deterioration	I-Disease	315
leading	O	315
to	O	315
a	O	315
vegetative	O	315
state	O	315
.	O	315

Adult	O	316
-	O	316
onset	O	316
cerebral	B-Disease	316
ALD	I-Disease	316
also	O	316
presents	O	316
with	O	316
rapidly	O	316
progressive	O	316
neurologic	B-Disease	316
dysfunction	I-Disease	316
.	O	316

Milder	O	317
phenotypes	O	317
such	O	317
as	O	317
adrenomyeloneuropathy	B-Disease	317
and	O	317
Addison	B-Disease	317
disease	I-Disease	317
only	O	317
also	O	317
have	O	317
been	O	317
recognized	O	317
.	O	317

OBJECTIVES	O	319
To	O	319
conduct	O	319
mutational	O	319
analyses	O	319
in	O	319
29	O	319
Japanese	O	319
patients	O	319
with	O	319
ALD	B-Disease	319
from	O	319
29	O	319
unrelated	O	319
families	O	319
,	O	319
to	O	319
obtain	O	319
knowledge	O	319
of	O	319
the	O	319
spectrum	O	319
of	O	319
mutations	O	319
in	O	319
this	O	319
gene	O	319
,	O	319
and	O	319
to	O	319
study	O	319
genotype	O	319
-	O	319
phenotype	O	319
correlations	O	319
in	O	319
Japanese	O	319
patients	O	319
.	O	319

METHODS	O	320
The	O	320
29	O	320
patients	O	320
comprised	O	320
13	O	320
patients	O	320
with	O	320
childhood	B-Disease	320
cerebral	I-Disease	320
ALD	I-Disease	320
,	O	320
11	O	320
patients	O	320
with	O	320
adult	O	320
-	O	320
onset	O	320
cerebral	B-Disease	320
ALD	I-Disease	320
,	O	320
and	O	320
5	O	320
patients	O	320
with	O	320
adrenomyeloneuropathy	B-Disease	320
.	O	320

We	O	321
conducted	O	321
detailed	O	321
mutational	O	321
analyses	O	321
of	O	321
29	O	321
unrelated	O	321
Japanese	O	321
patients	O	321
with	O	321
ALD	B-Disease	321
by	O	321
genomic	O	321
Southern	O	321
blot	O	321
analysis	O	321
and	O	321
direct	O	321
nucleotide	O	321
sequence	O	321
analysis	O	321
of	O	321
reverse	O	321
transcriptase	O	321
-	O	321
polymerase	O	321
chain	O	321
reaction	O	321
products	O	321
derived	O	321
from	O	321
total	O	321
RNA	O	321
that	O	321
was	O	321
extracted	O	321
from	O	321
cultured	O	321
skin	O	321
fibroblasts	O	321
,	O	321
lymphoblastoid	O	321
cells	O	321
,	O	321
or	O	321
peripheral	O	321
blood	O	321
leukocytes	O	321
.	O	321

RESULTS	O	322
Three	O	322
patients	O	322
with	O	322
adult	O	322
-	O	322
onset	O	322
cerebral	B-Disease	322
ALD	I-Disease	322
were	O	322
identified	O	322
as	O	322
having	O	322
large	O	322
genomic	O	322
rearrangements	O	322
.	O	322

The	O	323
remaining	O	323
26	O	323
patients	O	323
were	O	323
identified	O	323
as	O	323
having	O	323
21	O	323
independent	O	323
mutations	O	323
,	O	323
including	O	323
12	O	323
novel	O	323
mutations	O	323
resulting	O	323
in	O	323
small	O	323
nucleotide	O	323
alterations	O	323
in	O	323
the	O	323
ALD	B-Disease	323
gene	O	323
.	O	323

CONCLUSIONS	O	329
There	O	329
are	O	329
no	O	329
obvious	O	329
correlations	O	329
between	O	329
the	O	329
phenotypes	O	329
of	O	329
patients	O	329
with	O	329
ALD	B-Disease	329
and	O	329
their	O	329
genotypes	O	329
,	O	329
suggesting	O	329
that	O	329
other	O	329
genetic	O	329
or	O	329
environmental	O	329
factors	O	329
modify	O	329
the	O	329
phenotypic	O	329
expressions	O	329
of	O	329
ALD	B-Disease	329
.	O	329

A	O	331
common	O	331
human	O	331
skin	B-Disease	331
tumour	I-Disease	331
is	O	331
caused	O	331
by	O	331
activating	O	331
mutations	O	331
in	O	331
beta	O	331
-	O	331
catenin	O	331
.	O	331

One	O	334
of	O	334
the	O	334
target	O	334
genes	O	334
for	O	334
beta	O	334
-	O	334
catenin	O	334
/	O	334
TCF	O	334
encodes	O	334
c	O	334
-	O	334
MYC	O	334
,	O	334
explaining	O	334
why	O	334
constitutive	O	334
activation	O	334
of	O	334
the	O	334
WNT	O	334
pathway	O	334
can	O	334
lead	O	334
to	O	334
cancer	B-Disease	334
,	O	334
particularly	O	334
in	O	334
the	O	334
colon	O	334
.	O	334

Most	O	335
colon	B-Disease	335
cancers	I-Disease	335
arise	O	335
from	O	335
mutations	O	335
in	O	335
the	O	335
gene	O	335
encoding	O	335
adenomatous	B-Disease	335
polyposis	I-Disease	335
coli	I-Disease	335
(	O	335
APC	B-Disease	335
)	O	335
,	O	335
a	O	335
protein	O	335
required	O	335
for	O	335
ubiquitin	O	335
-	O	335
mediated	O	335
degradation	O	335
of	O	335
beta	O	335
-	O	335
catenin	O	335
,	O	335
but	O	335
a	O	335
small	O	335
percentage	O	335
of	O	335
colon	B-Disease	335
and	I-Disease	335
some	I-Disease	335
other	I-Disease	335
cancers	I-Disease	335
harbour	O	335
beta	O	335
-	O	335
catenin	O	335
-	O	335
stabilizing	O	335
mutations	O	335
.	O	335

Recently	O	336
,	O	336
we	O	336
discovered	O	336
that	O	336
transgenic	O	336
mice	O	336
expressing	O	336
an	O	336
activated	O	336
beta	O	336
-	O	336
catenin	O	336
are	O	336
predisposed	O	336
to	O	336
developing	O	336
skin	B-Disease	336
tumours	I-Disease	336
resembling	O	336
pilomatricomas	B-Disease	336
.	O	336

Given	O	337
that	O	337
the	O	337
skin	O	337
of	O	337
these	O	337
adult	O	337
mice	O	337
also	O	337
exhibits	O	337
signs	O	337
of	O	337
de	O	337
novo	O	337
hair	O	337
-	O	337
follicle	O	337
morphogenesis	O	337
,	O	337
we	O	337
wondered	O	337
whether	O	337
human	O	337
pilomatricomas	B-Disease	337
might	O	337
originate	O	337
from	O	337
hair	O	337
matrix	O	337
cells	O	337
and	O	337
whether	O	337
they	O	337
might	O	337
possess	O	337
beta	O	337
-	O	337
catenin	O	337
-	O	337
stabilizing	O	337
mutations	O	337
.	O	337

Here	O	338
,	O	338
we	O	338
explore	O	338
the	O	338
cell	O	338
origin	O	338
and	O	338
aetiology	O	338
of	O	338
this	O	338
common	O	338
human	O	338
skin	B-Disease	338
tumour	I-Disease	338
.	O	338

We	O	339
found	O	339
nuclear	O	339
LEF	O	339
-	O	339
1	O	339
in	O	339
the	O	339
dividing	O	339
tumour	B-Disease	339
cells	O	339
,	O	339
providing	O	339
biochemical	O	339
evidence	O	339
that	O	339
pilomatricomas	B-Disease	339
are	O	339
derived	O	339
from	O	339
hair	O	339
matrix	O	339
cells	O	339
.	O	339

At	O	340
least	O	340
75	O	340
%	O	340
of	O	340
these	O	340
tumours	B-Disease	340
possess	O	340
mutations	O	340
affecting	O	340
the	O	340
amino	O	340
-	O	340
terminal	O	340
segment	O	340
,	O	340
normally	O	340
involved	O	340
in	O	340
phosphorylation	O	340
-	O	340
dependent	O	340
,	O	340
ubiquitin	O	340
-	O	340
mediated	O	340
degradation	O	340
of	O	340
the	O	340
protein	O	340
.	O	340

This	O	341
percentage	O	341
of	O	341
CTNNB1	O	341
mutations	O	341
is	O	341
greater	O	341
than	O	341
in	O	341
all	O	341
other	O	341
human	O	341
tumours	B-Disease	341
examined	O	341
thus	O	341
far	O	341
,	O	341
and	O	341
directly	O	341
implicates	O	341
beta	O	341
-	O	341
catenin	O	341
/	O	341
LEF	O	341
misregulation	O	341
as	O	341
the	O	341
major	O	341
cause	O	341
of	O	341
hair	O	341
matrix	O	341
cell	O	341
tumorigenesis	O	341
in	O	341
humans	O	341
.	O	341

The	O	343
Pendred	B-Disease	343
syndrome	I-Disease	343
gene	O	343
encodes	O	343
a	O	343
chloride	O	343
-	O	343
iodide	O	343
transport	O	343
protein	O	343
.	O	343

Pendred	B-Disease	344
syndrome	I-Disease	344
is	O	344
the	O	344
most	O	344
common	O	344
form	O	344
of	O	344
syndromic	B-Disease	344
deafness	I-Disease	344
and	O	344
characterized	O	344
by	O	344
congenital	O	344
sensorineural	B-Disease	344
hearing	I-Disease	344
loss	I-Disease	344
and	O	344
goitre	B-Disease	344
.	O	344

This	O	345
disorder	O	345
was	O	345
mapped	O	345
to	O	345
chromosome	O	345
7	O	345
and	O	345
the	O	345
gene	O	345
causing	O	345
Pendred	B-Disease	345
syndrome	I-Disease	345
(	O	345
PDS	B-Disease	345
)	O	345
was	O	345
subsequently	O	345
identified	O	345
by	O	345
positional	O	345
cloning	O	345
.	O	345

Pendrin	O	347
is	O	347
closely	O	347
related	O	347
to	O	347
a	O	347
family	O	347
of	O	347
sulfate	O	347
transport	O	347
proteins	O	347
that	O	347
includes	O	347
the	O	347
rat	O	347
sulfate	O	347
-	O	347
anion	O	347
transporter	O	347
(	O	347
encoded	O	347
by	O	347
Sat	O	347
-	O	347
1	O	347
;	O	347
29	O	347
%	O	347
amino	O	347
acid	O	347
sequence	O	347
identity	O	347
)	O	347
,	O	347
the	O	347
human	O	347
diastrophic	B-Disease	347
dysplasia	I-Disease	347
sulfate	O	347
transporter	O	347
(	O	347
encoded	O	347
by	O	347
DTD	O	347
;	O	347
32	O	347
%	O	347
)	O	347
and	O	347
the	O	347
human	O	347
sulfate	O	347
transporter	O	347
downregulated	O	347
in	O	347
adenoma	B-Disease	347
(	O	347
encoded	O	347
by	O	347
DRA	O	347
;	O	347
45	O	347
%	O	347
)	O	347
.	O	347

Our	O	351
results	O	351
demonstrate	O	351
that	O	351
pendrin	O	351
functions	O	351
as	O	351
a	O	351
transporter	O	351
of	O	351
chloride	O	351
and	O	351
iodide	O	351
,	O	351
but	O	351
not	O	351
sulfate	O	351
,	O	351
and	O	351
may	O	351
provide	O	351
insight	O	351
into	O	351
thyroid	O	351
physiology	O	351
and	O	351
the	O	351
pathophysiology	O	351
of	O	351
Pendred	B-Disease	351
syndrome	I-Disease	351
.	O	351

HFE	O	353
mutations	O	353
analysis	O	353
in	O	353
711	O	353
hemochromatosis	B-Disease	353
probands	O	353
:	O	353
evidence	O	353
for	O	353
S65C	O	353
implication	O	353
in	O	353
mild	O	353
form	O	353
of	O	353
hemochromatosis	B-Disease	353
.	O	353

Hereditary	B-Disease	354
hemochromatosis	I-Disease	354
(	O	354
HH	B-Disease	354
)	O	354
is	O	354
a	O	354
common	O	354
autosomal	B-Disease	354
recessive	I-Disease	354
genetic	I-Disease	354
disorder	I-Disease	354
of	O	354
iron	O	354
metabolism	O	354
.	O	354

The	O	355
HFE	O	355
candidate	O	355
gene	O	355
encoding	O	355
an	O	355
HLA	O	355
class	O	355
I	O	355
-	O	355
like	O	355
protein	O	355
involved	O	355
in	O	355
HH	B-Disease	355
was	O	355
identified	O	355
in	O	355
1996	O	355
.	O	355

Two	O	356
missense	O	356
mutations	O	356
have	O	356
been	O	356
described	O	356
C282Y	O	356
,	O	356
accounting	O	356
for	O	356
80	O	356
%	O	356
to	O	356
90	O	356
%	O	356
of	O	356
HH	B-Disease	356
chromosomes	O	356
,	O	356
and	O	356
H63D	O	356
,	O	356
which	O	356
is	O	356
associated	O	356
with	O	356
a	O	356
milder	O	356
form	O	356
of	O	356
the	O	356
disease	O	356
representing	O	356
40	O	356
%	O	356
to	O	356
70	O	356
%	O	356
of	O	356
non	O	356
-	O	356
C282Y	O	356
HH	B-Disease	356
chromosomes	O	356
.	O	356

The	O	358
results	O	358
confirm	O	358
that	O	358
the	O	358
C282Y	O	358
substitution	O	358
was	O	358
the	O	358
main	O	358
mutation	O	358
involved	O	358
in	O	358
hemochromatosis	B-Disease	358
,	O	358
accounting	O	358
for	O	358
85	O	358
%	O	358
of	O	358
carrier	O	358
chromosomes	O	358
,	O	358
whereas	O	358
the	O	358
H63D	O	358
substitution	O	358
represented	O	358
39	O	358
%	O	358
of	O	358
the	O	358
HH	B-Disease	358
chromosomes	O	358
that	O	358
did	O	358
not	O	358
carry	O	358
the	O	358
C282Y	O	358
mutation	O	358
.	O	358

8	O	361
%	O	361
of	O	361
HH	B-Disease	361
chromosomes	O	361
that	O	361
were	O	361
neither	O	361
C282Y	O	361
nor	O	361
H63D	O	361
.	O	361

This	O	362
enrichment	O	362
of	O	362
S65C	O	362
among	O	362
HH	B-Disease	362
chromosomes	O	362
suggests	O	362
that	O	362
the	O	362
S65C	O	362
substitution	O	362
is	O	362
associated	O	362
with	O	362
the	O	362
mild	O	362
form	O	362
of	O	362
hemochromatosis	B-Disease	362
.	O	362

Germline	O	363
BRCA1	O	363
alterations	O	363
in	O	363
a	O	363
population	O	363
-	O	363
based	O	363
series	O	363
of	O	363
ovarian	B-Disease	363
cancer	I-Disease	363
cases	O	363
.	O	363

The	O	364
objective	O	364
of	O	364
this	O	364
study	O	364
was	O	364
to	O	364
provide	O	364
more	O	364
accurate	O	364
frequency	O	364
estimates	O	364
of	O	364
breast	B-Disease	364
cancer	I-Disease	364
susceptibility	O	364
gene	O	364
1	O	364
(	O	364
BRCA1	O	364
)	O	364
germline	O	364
alterations	O	364
in	O	364
the	O	364
ovarian	B-Disease	364
cancer	I-Disease	364
population	O	364
.	O	364

To	O	365
achieve	O	365
this	O	365
,	O	365
we	O	365
determined	O	365
the	O	365
prevalence	O	365
of	O	365
BRCA1	O	365
alterations	O	365
in	O	365
a	O	365
population	O	365
-	O	365
based	O	365
series	O	365
of	O	365
consecutive	O	365
ovarian	B-Disease	365
cancer	I-Disease	365
cases	O	365
.	O	365

This	O	366
is	O	366
the	O	366
first	O	366
population	O	366
-	O	366
based	O	366
ovarian	B-Disease	366
cancer	I-Disease	366
study	O	366
reporting	O	366
BRCA1	O	366
alterations	O	366
derived	O	366
from	O	366
a	O	366
comprehensive	O	366
screen	O	366
of	O	366
the	O	366
entire	O	366
coding	O	366
region	O	366
.	O	366

One	O	367
hundred	O	367
and	O	367
seven	O	367
ovarian	B-Disease	367
cancer	I-Disease	367
cases	O	367
were	O	367
analyzed	O	367
for	O	367
BRCA1	O	367
alterations	O	367
using	O	367
the	O	367
RNase	O	367
mismatch	O	367
cleavage	O	367
assay	O	367
followed	O	367
by	O	367
direct	O	367
sequencing	O	367
.	O	367

Both	O	369
patients	O	369
had	O	369
a	O	369
family	O	369
history	O	369
of	O	369
breast	B-Disease	369
or	I-Disease	369
ovarian	I-Disease	369
cancer	I-Disease	369
.	O	369

Several	O	370
novel	O	370
as	O	370
well	O	370
as	O	370
previously	O	370
reported	O	370
uncharacterized	O	370
variants	O	370
were	O	370
also	O	370
identified	O	370
,	O	370
some	O	370
of	O	370
which	O	370
were	O	370
associated	O	370
with	O	370
a	O	370
family	O	370
history	O	370
of	O	370
cancer	B-Disease	370
.	O	370

The	O	371
frequency	O	371
distribution	O	371
of	O	371
common	O	371
polymorphisms	O	371
was	O	371
determined	O	371
in	O	371
the	O	371
91	O	371
Caucasian	O	371
cancer	B-Disease	371
cases	O	371
in	O	371
this	O	371
series	O	371
and	O	371
24	O	371
sister	O	371
controls	O	371
using	O	371
allele	O	371
-	O	371
specific	O	371
amplification	O	371
.	O	371

03	O	373
)	O	373
associated	O	373
with	O	373
a	O	373
family	O	373
history	O	373
of	O	373
ovarian	B-Disease	373
cancer	I-Disease	373
,	O	373
suggesting	O	373
that	O	373
this	O	373
polymorphism	O	373
may	O	373
influence	O	373
ovarian	B-Disease	373
cancer	I-Disease	373
risk	O	373
.	O	373

In	O	374
summary	O	374
,	O	374
our	O	374
data	O	374
suggest	O	374
a	O	374
role	O	374
for	O	374
some	O	374
uncharacterized	O	374
variants	O	374
and	O	374
rare	O	374
forms	O	374
of	O	374
polymorphisms	O	374
in	O	374
determining	O	374
ovarian	B-Disease	374
cancer	I-Disease	374
risk	O	374
,	O	374
and	O	374
highlight	O	374
the	O	374
necessity	O	374
to	O	374
screen	O	374
for	O	374
missense	O	374
alterations	O	374
as	O	374
well	O	374
as	O	374
truncating	O	374
mutations	O	374
in	O	374
this	O	374
population	O	374
.	O	374

Adrenoleukodystrophy	O	375
-	O	375
related	O	375
protein	O	375
can	O	375
compensate	O	375
functionally	O	375
for	O	375
adrenoleukodystrophy	B-Disease	375
protein	I-Disease	375
deficiency	I-Disease	375
(	O	375
X	B-Disease	375
-	I-Disease	375
ALD	I-Disease	375
)	O	375
:	O	375
implications	O	375
for	O	375
therapy	O	375
.	O	375

Inherited	B-Disease	376
defects	I-Disease	376
in	O	376
the	O	376
peroxisomal	O	376
ATP	O	376
-	O	376
binding	O	376
cassette	O	376
(	O	376
ABC	O	376
)	O	376
transporter	O	376
adrenoleukodystrophy	B-Disease	376
protein	O	376
(	O	376
ALDP	O	376
)	O	376
lead	O	376
to	O	376
the	O	376
lethal	O	376
peroxisomal	B-Disease	376
disorder	I-Disease	376
X	B-Disease	376
-	I-Disease	376
linked	I-Disease	376
adrenoleukodystrophy	I-Disease	376
(	O	376
X	B-Disease	376
-	I-Disease	376
ALD	I-Disease	376
)	O	376
,	O	376
for	O	376
which	O	376
no	O	376
efficient	O	376
treatment	O	376
has	O	376
been	O	376
established	O	376
so	O	376
far	O	376
.	O	376

By	O	378
using	O	378
transient	O	378
and	O	378
stable	O	378
overexpression	O	378
of	O	378
human	O	378
cDNAs	O	378
encoding	O	378
ALDP	O	378
and	O	378
its	O	378
closest	O	378
relative	O	378
ALDRP	O	378
,	O	378
we	O	378
could	O	378
restore	O	378
the	O	378
impaired	O	378
peroxisomal	O	378
beta	O	378
-	O	378
oxidation	O	378
in	O	378
fibroblasts	O	378
of	O	378
X	B-Disease	378
-	I-Disease	378
ALD	I-Disease	378
patients	O	378
.	O	378

These	O	382
results	O	382
suggest	O	382
that	O	382
a	O	382
correction	O	382
of	O	382
the	O	382
biochemical	O	382
defect	O	382
in	O	382
X	B-Disease	382
-	I-Disease	382
ALD	I-Disease	382
could	O	382
be	O	382
possible	O	382
by	O	382
drug	O	382
-	O	382
induced	O	382
overexpression	O	382
or	O	382
ectopic	O	382
expression	O	382
of	O	382
ALDRP	O	382
.	O	382

Germline	O	385
mutations	O	385
of	O	385
the	O	385
Brca1	O	385
tumor	B-Disease	385
suppressor	O	385
gene	O	385
predispose	O	385
women	O	385
to	O	385
breast	B-Disease	385
and	I-Disease	385
ovarian	I-Disease	385
cancers	I-Disease	385
.	O	385

However	O	388
,	O	388
a	O	388
defective	O	388
G2	O	388
-	O	388
M	O	388
checkpoint	O	388
in	O	388
these	O	388
cells	O	388
is	O	388
accompanied	O	388
by	O	388
extensive	O	388
chromosomal	B-Disease	388
abnormalities	I-Disease	388
.	O	388

Mutant	O	389
fibroblasts	O	389
contain	O	389
multiple	O	389
,	O	389
functional	O	389
centrosomes	O	389
,	O	389
which	O	389
lead	O	389
to	O	389
unequal	O	389
chromosome	O	389
segregation	O	389
,	O	389
abnormal	O	389
nuclear	O	389
division	O	389
,	O	389
and	O	389
aneuploidy	B-Disease	389
.	O	389

Defective	O	392
CD95	O	392
/	O	392
APO	O	392
-	O	392
1	O	392
/	O	392
Fas	O	392
signal	O	392
complex	O	392
formation	O	392
in	O	392
the	O	392
human	O	392
autoimmune	B-Disease	392
lymphoproliferative	I-Disease	392
syndrome	I-Disease	392
,	I-Disease	392
type	I-Disease	392
Ia	I-Disease	392
.	O	392

Heterozygous	O	393
mutations	O	393
in	O	393
the	O	393
CD95	O	393
(	O	393
APO	O	393
-	O	393
1	O	393
/	O	393
Fas	O	393
)	O	393
receptor	O	393
occur	O	393
in	O	393
most	O	393
individuals	O	393
with	O	393
autoimmune	B-Disease	393
lymphoproliferative	I-Disease	393
syndrome	I-Disease	393
(	O	393
ALPS	B-Disease	393
)	O	393
and	O	393
dominantly	O	393
interfere	O	393
with	O	393
apoptosis	O	393
by	O	393
an	O	393
unknown	O	393
mechanism	O	393
.	O	393

We	O	394
show	O	394
that	O	394
local	O	394
or	O	394
global	O	394
alterations	O	394
in	O	394
the	O	394
structure	O	394
of	O	394
the	O	394
cytoplasmic	O	394
death	O	394
domain	O	394
from	O	394
nine	O	394
independent	O	394
ALPS	B-Disease	394
CD95	O	394
death	O	394
-	O	394
domain	O	394
mutations	O	394
result	O	394
in	O	394
a	O	394
failure	O	394
to	O	394
bind	O	394
the	O	394
FADD	O	394
/	O	394
MORT1	O	394
signaling	O	394
protein	O	394
.	O	394

Despite	O	395
heterozygosity	O	395
for	O	395
the	O	395
abnormal	O	395
allele	O	395
,	O	395
lymphocytes	O	395
from	O	395
ALPS	B-Disease	395
patients	O	395
showed	O	395
markedly	O	395
decreased	O	395
FADD	O	395
association	O	395
and	O	395
a	O	395
loss	O	395
of	O	395
caspase	O	395
recruitment	O	395
and	O	395
activation	O	395
after	O	395
CD95	O	395
crosslinking	O	395
.	O	395

These	O	396
data	O	396
suggest	O	396
that	O	396
intracytoplasmic	O	396
CD95	O	396
mutations	O	396
in	O	396
ALPS	B-Disease	396
impair	O	396
apoptosis	O	396
chiefly	O	396
by	O	396
disrupting	O	396
death	O	396
-	O	396
domain	O	396
interactions	O	396
with	O	396
the	O	396
signaling	O	396
protein	O	396
FADD	O	396
/	O	396
MORT1	O	396
.	O	396

Analysis	O	398
of	O	398
alkaptonuria	B-Disease	398
(	O	398
AKU	B-Disease	398
)	O	398
mutations	O	398
and	O	398
polymorphisms	O	398
reveals	O	398
that	O	398
the	O	398
CCC	O	398
sequence	O	398
motif	O	398
is	O	398
a	O	398
mutational	O	398
hot	O	398
spot	O	398
in	O	398
the	O	398
homogentisate	O	398
1	O	398
,	O	398
2	O	398
dioxygenase	O	398
gene	O	398
(	O	398
HGO	O	398
)	O	398
.	O	398

We	O	399
recently	O	399
showed	O	399
that	O	399
alkaptonuria	B-Disease	399
(	O	399
AKU	B-Disease	399
)	O	399
is	O	399
caused	O	399
by	O	399
loss	O	399
-	O	399
of	O	399
-	O	399
function	O	399
mutations	O	399
in	O	399
the	O	399
homogentisate	O	399
1	O	399
,	O	399
2	O	399
dioxygenase	O	399
gene	O	399
(	O	399
HGO	O	399
)	O	399
.	O	399

Herein	O	400
we	O	400
describe	O	400
haplotype	O	400
and	O	400
mutational	O	400
analyses	O	400
of	O	400
HGO	O	400
in	O	400
seven	O	400
new	O	400
AKU	B-Disease	400
pedigrees	O	400
.	O	400

These	O	401
analyses	O	401
identified	O	401
two	O	401
novel	O	401
single	O	401
-	O	401
nucleotide	O	401
polymorphisms	O	401
(	O	401
INV4	O	401
+	O	401
31A	O	401
-	O	401
-	O	401
>	O	401
G	O	401
and	O	401
INV11	O	401
+	O	401
18A	O	401
-	O	401
-	O	401
>	O	401
G	O	401
)	O	401
and	O	401
six	O	401
novel	O	401
AKU	B-Disease	401
mutations	O	401
(	O	401
INV1	O	401
-	O	401
1G	O	401
-	O	401
-	O	401
>	O	401
A	O	401
,	O	401
W60G	O	401
,	O	401
Y62C	O	401
,	O	401
A122D	O	401
,	O	401
P230T	O	401
,	O	401
and	O	401
D291E	O	401
)	O	401
,	O	401
which	O	401
further	O	401
illustrates	O	401
the	O	401
remarkable	O	401
allelic	O	401
heterogeneity	O	401
found	O	401
in	O	401
AKU	B-Disease	401
.	O	401

Fabry	B-Disease	406
disease	I-Disease	406
:	O	406
identification	O	406
of	O	406
novel	O	406
alpha	O	406
-	O	406
galactosidase	O	406
A	O	406
mutations	O	406
and	O	406
molecular	O	406
carrier	O	406
detection	O	406
by	O	406
use	O	406
of	O	406
fluorescent	O	406
chemical	O	406
cleavage	O	406
of	O	406
mismatches	O	406
.	O	406

Fabry	B-Disease	407
disease	I-Disease	407
(	O	407
FD	B-Disease	407
)	O	407
(	O	407
angiokeratoma	B-Disease	407
corporis	I-Disease	407
diffusum	I-Disease	407
)	O	407
is	O	407
an	O	407
X	B-Disease	407
-	I-Disease	407
linked	I-Disease	407
inborn	I-Disease	407
error	I-Disease	407
of	I-Disease	407
glycosphingolipid	I-Disease	407
metabolism	I-Disease	407
caused	O	407
by	O	407
defects	O	407
in	O	407
the	O	407
lysosomal	O	407
alpha	O	407
-	O	407
galactosidase	O	407
A	O	407
gene	O	407
(	O	407
GLA	O	407
)	O	407
.	O	407

Clinically	O	409
,	O	409
affected	O	409
hemizygous	O	409
males	O	409
have	O	409
angiokeratoma	B-Disease	409
,	O	409
severe	B-Disease	409
acroparesthesia	I-Disease	409
,	O	409
renal	B-Disease	409
failure	I-Disease	409
,	O	409
and	O	409
vasculopathy	B-Disease	409
of	I-Disease	409
the	I-Disease	409
heart	I-Disease	409
and	I-Disease	409
brain	I-Disease	409
.	O	409

While	O	410
demonstration	O	410
of	O	410
alpha	B-Disease	410
-	I-Disease	410
galactosidase	I-Disease	410
deficiency	I-Disease	410
in	O	410
leukocytes	O	410
is	O	410
diagnostic	O	410
in	O	410
affected	O	410
males	O	410
,	O	410
enzymatic	O	410
detection	O	410
of	O	410
female	O	410
carriers	O	410
is	O	410
often	O	410
inconclusive	O	410
,	O	410
due	O	410
to	O	410
random	O	410
X	O	410
-	O	410
chromosomal	O	410
inactivation	O	410
,	O	410
underlining	O	410
the	O	410
need	O	410
of	O	410
molecular	O	410
investigations	O	410
for	O	410
accurate	O	410
genetic	O	410
counseling	O	410
.	O	410

By	O	411
use	O	411
of	O	411
chemical	O	411
cleavage	O	411
of	O	411
mismatches	O	411
adapted	O	411
to	O	411
fluorescence	O	411
-	O	411
based	O	411
detection	O	411
systems	O	411
,	O	411
we	O	411
have	O	411
characterized	O	411
the	O	411
mutations	O	411
underlying	O	411
alpha	B-Disease	411
-	I-Disease	411
Gal	I-Disease	411
A	I-Disease	411
deficiency	I-Disease	411
in	O	411
16	O	411
individuals	O	411
from	O	411
six	O	411
unrelated	O	411
families	O	411
with	O	411
FD	B-Disease	411
.	O	411

Prenatal	O	416
diagnosis	O	416
by	O	416
FISH	O	416
in	O	416
a	O	416
family	O	416
with	O	416
Pelizaeus	B-Disease	416
-	I-Disease	416
Merzbacher	I-Disease	416
disease	I-Disease	416
caused	O	416
by	O	416
duplication	O	416
of	O	416
PLP	O	416
gene	O	416
.	O	416

A	O	417
diagnosis	O	417
of	O	417
Pelizaeus	B-Disease	417
-	I-Disease	417
Merzbacher	I-Disease	417
disease	I-Disease	417
(	O	417
MIM	O	417
312080	O	417
)	O	417
was	O	417
made	O	417
in	O	417
a	O	417
young	O	417
boy	O	417
.	O	417

The	O	421
proband	O	421
was	O	421
found	O	421
to	O	421
carry	O	421
the	O	421
duplication	O	421
,	O	421
thus	O	421
confirming	O	421
the	O	421
diagnosis	O	421
of	O	421
Pelizaeus	B-Disease	421
Merzbacher	I-Disease	421
disease	I-Disease	421
,	O	421
but	O	421
neither	O	421
the	O	421
aunt	O	421
nor	O	421
the	O	421
fetus	O	421
carried	O	421
a	O	421
duplication	O	421
.	O	421

Dominant	O	423
negative	O	423
effect	O	423
of	O	423
the	O	423
APC1309	O	423
mutation	O	423
:	O	423
a	O	423
possible	O	423
explanation	O	423
for	O	423
genotype	O	423
-	O	423
phenotype	O	423
correlations	O	423
in	O	423
familial	B-Disease	423
adenomatous	I-Disease	423
polyposis	I-Disease	423
.	O	423

Inactivation	O	424
of	O	424
the	O	424
adenomatous	B-Disease	424
polyposis	I-Disease	424
coli	I-Disease	424
(	O	424
APC	B-Disease	424
)	O	424
gene	O	424
product	O	424
initiates	O	424
colorectal	O	424
tumorigenesis	O	424
.	O	424

Patients	O	425
with	O	425
familial	B-Disease	425
APC	I-Disease	425
(	O	425
FAP	B-Disease	425
)	O	425
carry	O	425
germ	O	425
-	O	425
line	O	425
mutations	O	425
in	O	425
the	O	425
APC	B-Disease	425
gene	O	425
and	O	425
develop	O	425
multiple	O	425
colorectal	B-Disease	425
adenomas	I-Disease	425
and	O	425
subsequent	O	425
carcinomas	B-Disease	425
early	O	425
in	O	425
life	O	425
.	O	425

The	O	426
severity	O	426
of	O	426
the	O	426
disease	O	426
correlates	O	426
with	O	426
the	O	426
position	O	426
of	O	426
the	O	426
inherited	O	426
APC	B-Disease	426
mutation	O	426
(	O	426
genotype	O	426
-	O	426
phenotype	O	426
correlation	O	426
)	O	426
.	O	426

Together	O	427
with	O	427
the	O	427
fact	O	427
that	O	427
both	O	427
germ	O	427
-	O	427
line	O	427
and	O	427
sporadic	O	427
APC	B-Disease	427
mutations	O	427
cluster	O	427
in	O	427
the	O	427
central	O	427
region	O	427
of	O	427
the	O	427
APC	B-Disease	427
gene	O	427
,	O	427
this	O	427
points	O	427
to	O	427
a	O	427
dominant	O	427
negative	O	427
effect	O	427
of	O	427
certain	O	427
APC	B-Disease	427
mutants	O	427
.	O	427

Loss	O	428
of	O	428
APC	B-Disease	428
function	O	428
was	O	428
recently	O	428
shown	O	428
to	O	428
result	O	428
in	O	428
enhanced	O	428
beta	O	428
-	O	428
catenin	O	428
-	O	428
/	O	428
Tcf	O	428
-	O	428
mediated	O	428
transcription	O	428
in	O	428
colon	O	428
epithelial	O	428
cells	O	428
.	O	428

Here	O	429
,	O	429
we	O	429
provide	O	429
experimental	O	429
evidence	O	429
for	O	429
a	O	429
dominant	O	429
negative	O	429
effect	O	429
of	O	429
APC	B-Disease	429
gene	O	429
products	O	429
associated	O	429
with	O	429
severe	O	429
polyposis	B-Disease	429
.	O	429

Wild	O	430
-	O	430
type	O	430
APC	B-Disease	430
activity	O	430
in	O	430
beta	O	430
-	O	430
catenin	O	430
-	O	430
/	O	430
Tcf	O	430
-	O	430
mediated	O	430
transcription	O	430
was	O	430
strongly	O	430
inhibited	O	430
by	O	430
a	O	430
mutant	O	430
APC	B-Disease	430
that	O	430
is	O	430
truncated	O	430
at	O	430
codon	O	430
1309	O	430
.	O	430

In	O	431
contrast	O	431
,	O	431
mutant	O	431
APC	B-Disease	431
gene	O	431
products	O	431
that	O	431
are	O	431
associated	O	431
with	O	431
attenuated	B-Disease	431
polyposis	I-Disease	431
(	O	431
codon	O	431
386	O	431
or	O	431
1465	O	431
)	O	431
interfered	O	431
only	O	431
weakly	O	431
with	O	431
wild	O	431
-	O	431
type	O	431
APC	B-Disease	431
activity	O	431
.	O	431

These	O	432
results	O	432
suggest	O	432
a	O	432
molecular	O	432
explanation	O	432
for	O	432
the	O	432
genotype	O	432
-	O	432
phenotype	O	432
correlation	O	432
in	O	432
FAP	B-Disease	432
patients	O	432
and	O	432
support	O	432
the	O	432
idea	O	432
that	O	432
colorectal	B-Disease	432
tumor	I-Disease	432
growth	O	432
might	O	432
be	O	432
,	O	432
in	O	432
part	O	432
,	O	432
driven	O	432
by	O	432
selection	O	432
for	O	432
a	O	432
mutation	O	432
in	O	432
the	O	432
mutation	O	432
cluster	O	432
region	O	432
.	O	432

Germ	O	435
-	O	435
line	O	435
mutations	O	435
in	O	435
the	O	435
BRCA1	O	435
tumor	O	435
-	O	435
suppressor	O	435
gene	O	435
are	O	435
associated	O	435
with	O	435
an	O	435
increased	O	435
susceptibility	O	435
to	O	435
breast	B-Disease	435
and	I-Disease	435
ovarian	I-Disease	435
cancer	I-Disease	435
.	O	435

Combined	B-Disease	443
genetic	I-Disease	443
deficiency	I-Disease	443
of	I-Disease	443
C6	I-Disease	443
and	I-Disease	443
C7	I-Disease	443
in	O	443
man	O	443
.	O	443

By	O	444
routine	O	444
screening	O	444
of	O	444
sera	O	444
,	O	444
a	O	444
subject	O	444
was	O	444
discovered	O	444
who	O	444
showed	O	444
a	O	444
sub	B-Disease	444
-	I-Disease	444
total	I-Disease	444
deficiency	I-Disease	444
of	I-Disease	444
C6	I-Disease	444
and	I-Disease	444
C7	I-Disease	444
.	O	444

No	O	445
clinical	O	445
disease	O	445
was	O	445
associated	O	445
with	O	445
this	O	445
deficiency	O	445
which	O	445
was	O	445
transmitted	O	445
through	O	445
the	O	445
subjects	O	445
family	O	445
as	O	445
a	O	445
single	O	445
genetic	O	445
characteristic	O	445
,	O	445
the	O	445
C6	B-Disease	445
deficiency	I-Disease	445
being	O	445
associated	O	445
with	O	445
a	O	445
silent	O	445
allele	O	445
at	O	445
the	O	445
structural	O	445
locus	O	445
.	O	445

Changes	O	450
at	O	450
P183	O	450
of	O	450
emerin	O	450
weaken	O	450
its	O	450
protein	O	450
-	O	450
protein	O	450
interactions	O	450
resulting	O	450
in	O	450
X	B-Disease	450
-	I-Disease	450
linked	I-Disease	450
Emery	I-Disease	450
-	I-Disease	450
Dreifuss	I-Disease	450
muscular	I-Disease	450
dystrophy	I-Disease	450
.	O	450

Emery	B-Disease	451
-	I-Disease	451
Dreifuss	I-Disease	451
muscular	I-Disease	451
dystrophy	I-Disease	451
(	O	451
EDMD	B-Disease	451
)	O	451
is	O	451
an	O	451
X	B-Disease	451
-	I-Disease	451
linked	I-Disease	451
recessive	I-Disease	451
muscular	I-Disease	451
dystrophy	I-Disease	451
characterized	O	451
by	O	451
early	O	451
contractures	B-Disease	451
of	I-Disease	451
the	I-Disease	451
elbows	I-Disease	451
,	I-Disease	451
Achilles	I-Disease	451
tendons	I-Disease	451
and	I-Disease	451
spine	I-Disease	451
,	O	451
slowly	O	451
progressive	O	451
muscle	B-Disease	451
wasting	I-Disease	451
and	O	451
weakness	B-Disease	451
,	O	451
and	O	451
cardiomyopathy	B-Disease	451
associated	O	451
with	O	451
cardiac	B-Disease	451
conduction	I-Disease	451
defects	I-Disease	451
.	O	451

Mutations	O	453
spanning	O	453
the	O	453
emerin	O	453
gene	O	453
have	O	453
been	O	453
identified	O	453
in	O	453
patients	O	453
with	O	453
EDMD	B-Disease	453
.	O	453

We	O	454
present	O	454
here	O	454
the	O	454
effect	O	454
,	O	454
on	O	454
emerin	O	454
protein	O	454
expression	O	454
,	O	454
of	O	454
two	O	454
missense	O	454
mutations	O	454
identified	O	454
in	O	454
unrelated	O	454
EDMD	B-Disease	454
patients	O	454
.	O	454

In	O	457
comparison	O	457
with	O	457
the	O	457
usual	O	457
EDMD	B-Disease	457
phenotype	O	457
,	O	457
patients	O	457
with	O	457
P183	O	457
missense	O	457
mutations	O	457
have	O	457
a	O	457
later	O	457
age	O	457
at	O	457
onset	O	457
of	O	457
first	O	457
symptoms	O	457
,	O	457
elbow	B-Disease	457
contractures	I-Disease	457
,	O	457
ankle	B-Disease	457
contractures	I-Disease	457
,	O	457
upper	B-Disease	457
limb	I-Disease	457
weakness	I-Disease	457
and	O	457
lower	B-Disease	457
limb	I-Disease	457
weakness	I-Disease	457
,	O	457
but	O	457
there	O	457
is	O	457
no	O	457
difference	O	457
for	O	457
the	O	457
age	O	457
at	O	457
onset	O	457
of	O	457
cardiac	B-Disease	457
involvement	I-Disease	457
.	O	457

This	O	458
is	O	458
the	O	458
first	O	458
report	O	458
of	O	458
protein	O	458
studies	O	458
on	O	458
patients	O	458
with	O	458
missense	O	458
mutations	O	458
resulting	O	458
in	O	458
the	O	458
clinical	O	458
features	O	458
of	O	458
EDMD	B-Disease	458
.	O	458

Microdeletions	O	461
at	O	461
chromosome	O	461
bands	O	461
1q32	O	461
-	O	461
q41	O	461
as	O	461
a	O	461
cause	O	461
of	O	461
Van	B-Disease	461
der	I-Disease	461
Woude	I-Disease	461
syndrome	I-Disease	461
.	O	461

Van	B-Disease	462
der	I-Disease	462
Woude	I-Disease	462
syndrome	I-Disease	462
(	O	462
VWS	B-Disease	462
)	O	462
is	O	462
an	O	462
autosomal	B-Disease	462
dominant	I-Disease	462
disorder	I-Disease	462
comprising	O	462
cleft	B-Disease	462
lip	I-Disease	462
and	O	462
/	O	462
or	O	462
cleft	B-Disease	462
palate	I-Disease	462
and	O	462
lip	B-Disease	462
pits	I-Disease	462
.	O	462

Along	O	465
with	O	465
cleft	B-Disease	465
lip	I-Disease	465
/	I-Disease	465
palate	I-Disease	465
and	O	465
lip	B-Disease	465
pits	I-Disease	465
,	O	465
affected	O	465
relatives	O	465
exhibit	O	465
developmental	B-Disease	465
delays	I-Disease	465
,	O	465
suggesting	O	465
that	O	465
the	O	465
function	O	465
of	O	465
a	O	465
gene	O	465
nearby	O	465
may	O	465
also	O	465
be	O	465
disrupted	O	465
.	O	465

To	O	466
further	O	466
localize	O	466
the	O	466
VWS	B-Disease	466
gene	O	466
we	O	466
searched	O	466
for	O	466
other	O	466
deletions	O	466
that	O	466
cause	O	466
VWS	B-Disease	466
.	O	466

In	O	469
this	O	469
family	O	469
,	O	469
the	O	469
phenotype	O	469
in	O	469
three	O	469
generations	O	469
of	O	469
affected	O	469
individuals	O	469
was	O	469
confined	O	469
to	O	469
the	O	469
cardinal	O	469
signs	O	469
of	O	469
VWS	B-Disease	469
.	O	469

No	O	472
deletions	O	472
were	O	472
detected	O	472
in	O	472
seven	O	472
cases	O	472
of	O	472
popliteal	B-Disease	472
pterygia	I-Disease	472
syndrome	I-Disease	472
,	O	472
76	O	472
cases	O	472
of	O	472
mixed	O	472
syndromic	B-Disease	472
forms	I-Disease	472
of	I-Disease	472
cleft	I-Disease	472
lip	I-Disease	472
and	I-Disease	472
palate	I-Disease	472
,	O	472
and	O	472
178	O	472
cases	O	472
of	O	472
nonsyndromic	B-Disease	472
cleft	I-Disease	472
lip	I-Disease	472
and	I-Disease	472
palate	I-Disease	472
.	O	472

Splicing	O	473
defects	O	473
in	O	473
the	O	473
ataxia	B-Disease	473
-	I-Disease	473
telangiectasia	I-Disease	473
gene	O	473
,	O	473
ATM	O	473
:	O	473
underlying	O	473
mutations	O	473
and	O	473
consequences	O	473
.	O	473

Mutations	O	474
resulting	O	474
in	O	474
defective	O	474
splicing	O	474
constitute	O	474
a	O	474
significant	O	474
proportion	O	474
(	O	474
30	O	474
/	O	474
62	O	474
[	O	474
48	O	474
%	O	474
]	O	474
)	O	474
of	O	474
a	O	474
new	O	474
series	O	474
of	O	474
mutations	O	474
in	O	474
the	O	474
ATM	O	474
gene	O	474
in	O	474
patients	O	474
with	O	474
ataxia	B-Disease	474
-	I-Disease	474
telangiectasia	I-Disease	474
(	O	474
AT	B-Disease	474
)	O	474
that	O	474
were	O	474
detected	O	474
by	O	474
the	O	474
protein	O	474
-	O	474
truncation	O	474
assay	O	474
followed	O	474
by	O	474
sequence	O	474
analysis	O	474
of	O	474
genomic	O	474
DNA	O	474
.	O	474

No	O	479
ATM	O	479
protein	O	479
was	O	479
detected	O	479
by	O	479
western	O	479
blotting	O	479
in	O	479
any	O	479
AT	B-Disease	479
cell	O	479
line	O	479
in	O	479
which	O	479
splicing	O	479
mutations	O	479
were	O	479
identified	O	479
.	O	479

Alpha	O	482
-	O	482
cardiac	O	482
actin	O	482
is	O	482
a	O	482
novel	O	482
disease	O	482
gene	O	482
in	O	482
familial	B-Disease	482
hypertrophic	I-Disease	482
cardiomyopathy	I-Disease	482
.	O	482

We	O	483
identified	O	483
the	O	483
alpha	O	483
-	O	483
cardiac	O	483
actin	O	483
gene	O	483
(	O	483
ACTC	O	483
)	O	483
as	O	483
a	O	483
novel	O	483
disease	O	483
gene	O	483
in	O	483
a	O	483
pedigree	O	483
suffering	O	483
from	O	483
familial	B-Disease	483
hypertrophic	I-Disease	483
cardiomyopathy	I-Disease	483
(	O	483
FHC	B-Disease	483
)	O	483
.	O	483

Linkage	O	484
analyses	O	484
excluded	O	484
all	O	484
the	O	484
previously	O	484
reported	O	484
FHC	B-Disease	484
loci	O	484
as	O	484
possible	O	484
disease	O	484
loci	O	484
in	O	484
the	O	484
family	O	484
studied	O	484
,	O	484
with	O	484
lod	O	484
scores	O	484
varying	O	484
between	O	484
-	O	484
2	O	484
.	O	484

Mutation	O	489
analysis	O	489
of	O	489
ACTC	O	489
revealed	O	489
an	O	489
Ala295Ser	O	489
mutation	O	489
in	O	489
exon	O	489
5	O	489
close	O	489
to	O	489
2	O	489
missense	O	489
mutations	O	489
recently	O	489
described	O	489
to	O	489
cause	O	489
the	O	489
inherited	O	489
form	O	489
of	O	489
idiopathic	B-Disease	489
dilated	I-Disease	489
cardiomyopathy	I-Disease	489
(	O	489
IDC	B-Disease	489
)	O	489
.	O	489

Overgrowth	B-Disease	490
of	I-Disease	490
oral	I-Disease	490
mucosa	I-Disease	490
and	I-Disease	490
facial	I-Disease	490
skin	I-Disease	490
,	O	490
a	O	490
novel	O	490
feature	O	490
of	O	490
aspartylglucosaminuria	B-Disease	490
.	O	490

Aspartylglucosaminuria	B-Disease	491
(	O	491
AGU	B-Disease	491
)	O	491
is	O	491
a	O	491
lysosomal	B-Disease	491
storage	I-Disease	491
disorder	I-Disease	491
caused	O	491
by	O	491
deficiency	B-Disease	491
of	I-Disease	491
aspartylglucosaminidase	I-Disease	491
(	O	491
AGA	O	491
)	O	491
.	O	491

The	O	492
main	O	492
symptom	O	492
is	O	492
progressive	O	492
mental	B-Disease	492
retardation	I-Disease	492
.	O	492

We	O	494
were	O	494
able	O	494
to	O	494
examine	O	494
66	O	494
Finnish	O	494
AGU	B-Disease	494
patients	O	494
for	O	494
changes	O	494
in	O	494
the	O	494
oral	O	494
mucosa	O	494
and	O	494
44	O	494
of	O	494
these	O	494
for	O	494
changes	O	494
in	O	494
facial	O	494
skin	O	494
.	O	494

Biopsy	O	495
specimens	O	495
of	O	495
16	O	495
oral	O	495
lesions	O	495
,	O	495
12	O	495
of	O	495
them	O	495
associated	O	495
with	O	495
the	O	495
teeth	O	495
,	O	495
plus	O	495
two	O	495
facial	B-Disease	495
lesions	I-Disease	495
were	O	495
studied	O	495
histologically	O	495
.	O	495

Skin	O	497
was	O	497
seborrhoeic	O	497
in	O	497
adolescent	O	497
and	O	497
adult	O	497
patients	O	497
,	O	497
with	O	497
erythema	B-Disease	497
of	I-Disease	497
the	I-Disease	497
facial	I-Disease	497
skin	I-Disease	497
already	O	497
common	O	497
in	O	497
childhood	O	497
.	O	497

Of	O	498
44	O	498
patients	O	498
,	O	498
nine	O	498
(	O	498
20	O	498
%	O	498
)	O	498
had	O	498
facial	B-Disease	498
angiofibromas	I-Disease	498
,	O	498
tumours	B-Disease	498
primarily	O	498
occurring	O	498
in	O	498
association	O	498
with	O	498
tuberous	B-Disease	498
sclerosis	I-Disease	498
.	O	498

Oedemic	B-Disease	499
buccal	I-Disease	499
mucosa	I-Disease	499
(	O	499
leucoedema	B-Disease	499
)	O	499
and	O	499
gingival	B-Disease	499
overgrowths	I-Disease	499
were	O	499
more	O	499
frequent	O	499
in	O	499
AGU	B-Disease	499
patients	O	499
than	O	499
in	O	499
controls	O	499
(	O	499
p	O	499
<	O	499
0	O	499
.	O	499

Of	O	501
16	O	501
oral	B-Disease	501
mucosal	I-Disease	501
lesions	I-Disease	501
studied	O	501
histologically	O	501
,	O	501
15	O	501
represented	O	501
fibroepithelial	B-Disease	501
or	I-Disease	501
epithelial	I-Disease	501
hyperplasias	I-Disease	501
and	O	501
were	O	501
reactive	O	501
in	O	501
nature	O	501
.	O	501

Immunohistochemically	O	503
,	O	503
expression	O	503
of	O	503
AGA	O	503
in	O	503
AGU	B-Disease	503
patients	O	503
mucosal	B-Disease	503
lesions	I-Disease	503
did	O	503
not	O	503
differ	O	503
from	O	503
that	O	503
seen	O	503
in	O	503
corresponding	O	503
lesions	O	503
of	O	503
normal	O	503
subjects	O	503
.	O	503

Thus	O	504
,	O	504
the	O	504
high	O	504
frequency	O	504
of	O	504
mucosal	B-Disease	504
overgrowth	I-Disease	504
in	O	504
AGU	B-Disease	504
patients	O	504
does	O	504
not	O	504
appear	O	504
to	O	504
be	O	504
directly	O	504
associated	O	504
with	O	504
lysosomal	O	504
storage	O	504
or	O	504
with	O	504
alterations	O	504
in	O	504
the	O	504
level	O	504
of	O	504
AGA	O	504
expression	O	504
.	O	504

Characterization	O	505
of	O	505
a	O	505
germline	O	505
mosaicism	O	505
in	O	505
families	O	505
with	O	505
Lowe	B-Disease	505
syndrome	I-Disease	505
,	O	505
and	O	505
identification	O	505
of	O	505
seven	O	505
novel	O	505
mutations	O	505
in	O	505
the	O	505
OCRL1	O	505
gene	O	505
.	O	505

The	O	506
oculocerebrorenal	B-Disease	506
syndrome	I-Disease	506
of	I-Disease	506
Lowe	I-Disease	506
(	O	506
OCRL	B-Disease	506
)	O	506
is	O	506
an	O	506
X	B-Disease	506
-	I-Disease	506
linked	I-Disease	506
disorder	I-Disease	506
characterized	O	506
by	O	506
major	O	506
abnormalities	B-Disease	506
of	I-Disease	506
eyes	I-Disease	506
,	I-Disease	506
nervous	I-Disease	506
system	I-Disease	506
,	I-Disease	506
and	I-Disease	506
kidneys	I-Disease	506
.	O	506

We	O	509
have	O	509
examined	O	509
the	O	509
OCRL1	O	509
gene	O	509
in	O	509
eight	O	509
unrelated	O	509
patients	O	509
with	O	509
OCRL	B-Disease	509
and	O	509
have	O	509
found	O	509
seven	O	509
new	O	509
mutations	O	509
and	O	509
one	O	509
recurrent	O	509
in	O	509
-	O	509
frame	O	509
deletion	O	509
.	O	509

This	O	515
observation	O	515
has	O	515
direct	O	515
implications	O	515
for	O	515
genetic	O	515
counseling	O	515
of	O	515
Lowe	B-Disease	515
syndrome	I-Disease	515
families	O	515
.	O	515

MEFV	O	517
-	O	517
Gene	O	517
analysis	O	517
in	O	517
armenian	O	517
patients	O	517
with	O	517
Familial	B-Disease	517
Mediterranean	I-Disease	517
fever	I-Disease	517
:	O	517
diagnostic	O	517
value	O	517
and	O	517
unfavorable	O	517
renal	O	517
prognosis	O	517
of	O	517
the	O	517
M694V	O	517
homozygous	O	517
genotype	O	517
-	O	517
genetic	O	517
and	O	517
therapeutic	O	517
implications	O	517
.	O	517

Familial	B-Disease	518
Mediterranean	I-Disease	518
fever	I-Disease	518
(	O	518
FMF	B-Disease	518
)	O	518
is	O	518
a	O	518
recessively	B-Disease	518
inherited	I-Disease	518
disorder	I-Disease	518
that	O	518
is	O	518
common	O	518
in	O	518
patients	O	518
of	O	518
Armenian	O	518
ancestry	O	518
.	O	518

To	O	519
date	O	519
,	O	519
its	O	519
diagnosis	O	519
,	O	519
which	O	519
can	O	519
be	O	519
made	O	519
only	O	519
retrospectively	O	519
,	O	519
is	O	519
one	O	519
of	O	519
exclusion	O	519
,	O	519
based	O	519
entirely	O	519
on	O	519
nonspecific	O	519
clinical	O	519
signs	O	519
that	O	519
result	O	519
from	O	519
serosal	B-Disease	519
inflammation	I-Disease	519
and	O	519
that	O	519
may	O	519
lead	O	519
to	O	519
unnecessary	O	519
surgery	O	519
.	O	519

Renal	B-Disease	520
amyloidosis	I-Disease	520
,	O	520
prevented	O	520
by	O	520
colchicine	O	520
,	O	520
is	O	520
the	O	520
most	O	520
severe	O	520
complication	O	520
of	O	520
FMF	B-Disease	520
,	O	520
a	O	520
disorder	O	520
associated	O	520
with	O	520
mutations	O	520
in	O	520
the	O	520
MEFV	O	520
gene	O	520
.	O	520

To	O	521
evaluate	O	521
the	O	521
diagnostic	O	521
and	O	521
prognostic	O	521
value	O	521
of	O	521
MEFV	O	521
-	O	521
gene	O	521
analysis	O	521
,	O	521
we	O	521
investigated	O	521
90	O	521
Armenian	O	521
FMF	B-Disease	521
patients	O	521
from	O	521
77	O	521
unrelated	O	521
families	O	521
that	O	521
were	O	521
not	O	521
selected	O	521
through	O	521
genetic	O	521
-	O	521
linkage	O	521
analysis	O	521
.	O	521

Eight	O	522
mutations	O	522
,	O	522
one	O	522
of	O	522
which	O	522
(	O	522
R408Q	O	522
)	O	522
is	O	522
new	O	522
,	O	522
were	O	522
found	O	522
to	O	522
account	O	522
for	O	522
93	O	522
%	O	522
of	O	522
the	O	522
163	O	522
independent	O	522
FMF	B-Disease	522
alleles	O	522
,	O	522
with	O	522
both	O	522
FMF	B-Disease	522
alleles	O	522
identified	O	522
in	O	522
89	O	522
%	O	522
of	O	522
the	O	522
patients	O	522
.	O	522

The	O	524
M694V	O	524
homozygous	O	524
genotype	O	524
was	O	524
found	O	524
to	O	524
be	O	524
associated	O	524
with	O	524
a	O	524
higher	O	524
prevalence	O	524
of	O	524
renal	B-Disease	524
amyloidosis	I-Disease	524
and	O	524
arthritis	B-Disease	524
,	O	524
compared	O	524
with	O	524
other	O	524
genotypes	O	524
(	O	524
P	O	524
=	O	524
.	O	524

Noninvasive	O	528
test	O	528
for	O	528
fragile	B-Disease	528
X	I-Disease	528
syndrome	I-Disease	528
,	O	528
using	O	528
hair	O	528
root	O	528
analysis	O	528
.	O	528

Identification	O	529
of	O	529
the	O	529
FMR1	O	529
gene	O	529
and	O	529
the	O	529
repeat	O	529
-	O	529
amplification	O	529
mechanism	O	529
causing	O	529
fragile	B-Disease	529
X	I-Disease	529
syndrome	I-Disease	529
led	O	529
to	O	529
development	O	529
of	O	529
reliable	O	529
DNA	O	529
-	O	529
based	O	529
diagnostic	O	529
methods	O	529
,	O	529
including	O	529
Southern	O	529
blot	O	529
hybridization	O	529
and	O	529
PCR	O	529
.	O	529

Using	O	531
an	O	531
immunocytochemical	O	531
technique	O	531
on	O	531
blood	O	531
smears	O	531
,	O	531
we	O	531
recently	O	531
developed	O	531
a	O	531
novel	O	531
test	O	531
for	O	531
identification	O	531
of	O	531
patients	O	531
with	O	531
fragile	B-Disease	531
X	I-Disease	531
syndrome	I-Disease	531
.	O	531

Here	O	535
we	O	535
describe	O	535
a	O	535
new	O	535
diagnostic	O	535
test	O	535
to	O	535
identify	O	535
male	O	535
patients	O	535
with	O	535
fragile	B-Disease	535
X	I-Disease	535
syndrome	I-Disease	535
,	O	535
on	O	535
the	O	535
basis	O	535
of	O	535
lack	O	535
of	O	535
FMRP	O	535
in	O	535
their	O	535
hair	O	535
roots	O	535
.	O	535

Expression	O	536
of	O	536
FMRP	O	536
in	O	536
hair	O	536
roots	O	536
was	O	536
studied	O	536
by	O	536
use	O	536
of	O	536
an	O	536
FMRP	O	536
-	O	536
specific	O	536
antibody	O	536
test	O	536
,	O	536
and	O	536
the	O	536
percentage	O	536
of	O	536
FMRP	O	536
-	O	536
expressing	O	536
hair	O	536
roots	O	536
in	O	536
controls	O	536
and	O	536
in	O	536
male	O	536
fragile	B-Disease	536
X	I-Disease	536
patients	O	536
was	O	536
determined	O	536
.	O	536

Control	O	537
individuals	O	537
showed	O	537
clear	O	537
expression	O	537
of	O	537
FMRP	O	537
in	O	537
nearly	O	537
every	O	537
hair	O	537
root	O	537
,	O	537
whereas	O	537
male	O	537
fragile	B-Disease	537
X	I-Disease	537
patients	O	537
lacked	O	537
expression	O	537
of	O	537
FMRP	O	537
in	O	537
almost	O	537
all	O	537
their	O	537
hair	O	537
roots	O	537
.	O	537

Mentally	B-Disease	538
retarded	I-Disease	538
female	O	538
patients	O	538
with	O	538
a	O	538
full	O	538
mutation	O	538
showed	O	538
FMRP	O	538
expression	O	538
in	O	538
only	O	538
some	O	538
of	O	538
their	O	538
hair	O	538
roots	O	538
(	O	538
<	O	538
55	O	538
%	O	538
)	O	538
,	O	538
and	O	538
no	O	538
overlap	O	538
with	O	538
normal	O	538
female	O	538
controls	O	538
was	O	538
observed	O	538
.	O	538

The	O	539
advantages	O	539
of	O	539
this	O	539
test	O	539
are	O	539
(	O	539
1	O	539
)	O	539
plucking	O	539
of	O	539
hair	O	539
follicles	O	539
does	O	539
no	O	539
appreciable	O	539
harm	O	539
to	O	539
the	O	539
mentally	B-Disease	539
retarded	I-Disease	539
patient	O	539
,	O	539
(	O	539
2	O	539
)	O	539
hairs	O	539
can	O	539
be	O	539
sent	O	539
in	O	539
a	O	539
simple	O	539
envelope	O	539
to	O	539
a	O	539
diagnostic	O	539
center	O	539
,	O	539
and	O	539
(	O	539
3	O	539
)	O	539
the	O	539
result	O	539
of	O	539
the	O	539
test	O	539
is	O	539
available	O	539
within	O	539
5	O	539
h	O	539
of	O	539
plucking	O	539
.	O	539

In	O	540
addition	O	540
,	O	540
this	O	540
test	O	540
enabled	O	540
us	O	540
to	O	540
identify	O	540
two	O	540
fragile	B-Disease	540
X	I-Disease	540
patients	O	540
who	O	540
did	O	540
not	O	540
show	O	540
the	O	540
full	O	540
mutation	O	540
by	O	540
analysis	O	540
of	O	540
DNA	O	540
isolated	O	540
from	O	540
blood	O	540
cells	O	540
.	O	540

In	O	542
Swedish	O	542
families	O	542
with	O	542
hereditary	B-Disease	542
prostate	I-Disease	542
cancer	I-Disease	542
,	O	542
linkage	O	542
to	O	542
the	O	542
HPC1	O	542
locus	O	542
on	O	542
chromosome	O	542
1q24	O	542
-	O	542
25	O	542
is	O	542
restricted	O	542
to	O	542
families	O	542
with	O	542
early	O	542
-	O	542
onset	O	542
prostate	B-Disease	542
cancer	I-Disease	542
.	O	542

Prostate	B-Disease	543
cancer	I-Disease	543
clusters	O	543
in	O	543
some	O	543
families	O	543
,	O	543
and	O	543
an	O	543
estimated	O	543
5	O	543
%	O	543
-	O	543
10	O	543
%	O	543
of	O	543
all	O	543
cases	O	543
are	O	543
estimated	O	543
to	O	543
result	O	543
from	O	543
inheritance	O	543
of	O	543
prostate	O	543
cancer	O	543
-	O	543
susceptibility	O	543
genes	O	543
.	O	543

We	O	544
previously	O	544
reported	O	544
evidence	O	544
of	O	544
linkage	O	544
to	O	544
the	O	544
1q24	O	544
-	O	544
25	O	544
region	O	544
(	O	544
HPC1	O	544
)	O	544
in	O	544
91	O	544
North	O	544
American	O	544
and	O	544
Swedish	O	544
families	O	544
each	O	544
with	O	544
multiple	O	544
cases	O	544
of	O	544
prostate	B-Disease	544
cancer	I-Disease	544
(	O	544
Smith	O	544
et	O	544
al	O	544
.	O	544

In	O	546
the	O	546
present	O	546
report	O	546
we	O	546
analyze	O	546
40	O	546
(	O	546
12	O	546
original	O	546
and	O	546
28	O	546
newly	O	546
identified	O	546
)	O	546
Swedish	O	546
families	O	546
with	O	546
hereditary	B-Disease	546
prostate	I-Disease	546
cancer	I-Disease	546
(	O	546
HPC	B-Disease	546
)	O	546
that	O	546
,	O	546
on	O	546
the	O	546
basis	O	546
of	O	546
40	O	546
markers	O	546
spanning	O	546
a	O	546
25	O	546
-	O	546
cM	O	546
interval	O	546
within	O	546
1q24	O	546
-	O	546
25	O	546
,	O	546
have	O	546
evidence	O	546
of	O	546
linkage	O	546
.	O	546

These	O	557
results	O	557
are	O	557
consistent	O	557
with	O	557
the	O	557
hypothesis	O	557
of	O	557
linkage	O	557
to	O	557
HPC1	O	557
in	O	557
a	O	557
subset	O	557
of	O	557
families	O	557
with	O	557
prostate	B-Disease	557
cancer	I-Disease	557
,	O	557
particularly	O	557
those	O	557
with	O	557
an	O	557
early	O	557
age	O	557
at	O	557
diagnosis	O	557
.	O	557

Molecular	O	558
basis	O	558
of	O	558
feline	O	558
beta	B-Disease	558
-	I-Disease	558
glucuronidase	I-Disease	558
deficiency	I-Disease	558
:	O	558
an	O	558
animal	O	558
model	O	558
of	O	558
mucopolysaccharidosis	B-Disease	558
VII	I-Disease	558
.	O	558

A	O	559
family	O	559
of	O	559
domestic	O	559
cats	O	559
was	O	559
found	O	559
that	O	559
exhibited	O	559
clinical	O	559
and	O	559
biochemical	O	559
abnormalities	O	559
consistent	O	559
with	O	559
mucopolysaccharidosis	B-Disease	559
VII	I-Disease	559
,	O	559
an	O	559
autosomal	B-Disease	559
recessive	I-Disease	559
lysosomal	I-Disease	559
storage	I-Disease	559
disorder	I-Disease	559
caused	O	559
by	O	559
beta	B-Disease	559
-	I-Disease	559
glucuronidase	I-Disease	559
deficiency	I-Disease	559
.	O	559

Carriers	O	566
identified	O	566
in	O	566
this	O	566
manner	O	566
produced	O	566
affected	O	566
kittens	O	566
in	O	566
prospective	O	566
breedings	O	566
,	O	566
and	O	566
a	O	566
feline	O	566
MPS	B-Disease	566
VII	I-Disease	566
breeding	O	566
colony	O	566
has	O	566
been	O	566
established	O	566
.	O	566

A	O	568
common	O	568
molecular	O	568
basis	O	568
for	O	568
rearrangement	B-Disease	568
disorders	I-Disease	568
on	O	568
chromosome	O	568
22q11	O	568
.	O	568

The	O	569
chromosome	O	569
22q11	O	569
region	O	569
is	O	569
susceptible	O	569
to	O	569
rearrangements	O	569
that	O	569
are	O	569
associated	O	569
with	O	569
congenital	B-Disease	569
anomaly	I-Disease	569
disorders	I-Disease	569
and	O	569
malignant	B-Disease	569
tumors	I-Disease	569
.	O	569

Three	O	570
congenital	B-Disease	570
anomaly	I-Disease	570
disorders	I-Disease	570
,	O	570
cat	B-Disease	570
-	I-Disease	570
eye	I-Disease	570
syndrome	I-Disease	570
,	O	570
der	B-Disease	570
(	I-Disease	570
)	I-Disease	570
syndrome	I-Disease	570
and	O	570
velo	B-Disease	570
-	I-Disease	570
cardio	I-Disease	570
-	I-Disease	570
facial	I-Disease	570
syndrome	I-Disease	570
/	O	570
DiGeorge	B-Disease	570
syndrome	I-Disease	570
(	O	570
VCFS	B-Disease	570
/	O	570
DGS	B-Disease	570
)	O	570
are	O	570
associated	O	570
with	O	570
tetrasomy	O	570
,	O	570
trisomy	O	570
or	O	570
monosomy	O	570
,	O	570
respectively	O	570
,	O	570
for	O	570
part	O	570
of	O	570
chromosome	O	570
22q11	O	570
.	O	570

VCFS	B-Disease	571
/	O	571
DGS	B-Disease	571
is	O	571
the	O	571
most	O	571
common	O	571
syndrome	O	571
associated	O	571
with	O	571
22q11	O	571
rearrangements	O	571
.	O	571

In	O	572
order	O	572
to	O	572
determine	O	572
whether	O	572
there	O	572
are	O	572
particular	O	572
regions	O	572
on	O	572
22q11	O	572
that	O	572
are	O	572
prone	O	572
to	O	572
rearrangements	O	572
,	O	572
the	O	572
deletion	O	572
end	O	572
-	O	572
points	O	572
in	O	572
a	O	572
large	O	572
number	O	572
of	O	572
VCFS	B-Disease	572
/	O	572
DGS	B-Disease	572
patients	O	572
were	O	572
defined	O	572
by	O	572
haplotype	O	572
analysis	O	572
.	O	572

Most	O	573
VCFS	B-Disease	573
/	O	573
DGS	B-Disease	573
patients	O	573
have	O	573
a	O	573
similar	O	573
3	O	573
Mb	O	573
deletion	O	573
,	O	573
some	O	573
have	O	573
a	O	573
nested	O	573
distal	O	573
deletion	O	573
breakpoint	O	573
resulting	O	573
in	O	573
a	O	573
1	O	573
.	O	573

To	O	576
investigate	O	576
this	O	576
hypothesis	O	576
,	O	576
we	O	576
developed	O	576
hamster	O	576
-	O	576
human	O	576
somatic	O	576
hybrid	O	576
cell	O	576
lines	O	576
from	O	576
VCFS	B-Disease	576
/	O	576
DGS	B-Disease	576
patients	O	576
with	O	576
all	O	576
three	O	576
classes	O	576
of	O	576
deletions	O	576
and	O	576
we	O	576
now	O	576
show	O	576
that	O	576
the	O	576
breakpoints	O	576
occur	O	576
within	O	576
similar	O	576
low	O	576
copy	O	576
repeats	O	576
,	O	576
termed	O	576
LCR22s	O	576
.	O	576

To	O	577
support	O	577
this	O	577
idea	O	577
further	O	577
,	O	577
we	O	577
identified	O	577
a	O	577
family	O	577
that	O	577
carries	O	577
an	O	577
interstitial	O	577
duplication	O	577
of	O	577
the	O	577
same	O	577
3	O	577
Mb	O	577
region	O	577
that	O	577
is	O	577
deleted	O	577
in	O	577
VCFS	B-Disease	577
/	O	577
DGS	B-Disease	577
patients	O	577
.	O	577

We	O	578
present	O	578
models	O	578
to	O	578
explain	O	578
how	O	578
the	O	578
LCR22s	O	578
can	O	578
mediate	O	578
different	O	578
homologous	O	578
recombination	O	578
events	O	578
,	O	578
thereby	O	578
generating	O	578
a	O	578
number	O	578
of	O	578
rearrangements	O	578
that	O	578
are	O	578
associated	O	578
with	O	578
congenital	B-Disease	578
anomaly	I-Disease	578
disorders	I-Disease	578
.	O	578

Functional	O	580
consequences	O	580
of	O	580
mutations	O	580
in	O	580
the	O	580
early	O	580
growth	O	580
response	O	580
2	O	580
gene	O	580
(	O	580
EGR2	O	580
)	O	580
correlate	O	580
with	O	580
severity	O	580
of	O	580
human	O	580
myelinopathies	B-Disease	580
.	O	580

This	O	582
idea	O	582
is	O	582
based	O	582
partly	O	582
on	O	582
the	O	582
phenotype	O	582
of	O	582
homozygous	O	582
Krox20	O	582
(	O	582
Egr2	O	582
)	O	582
knockout	O	582
mice	O	582
,	O	582
which	O	582
display	O	582
hypomyelination	B-Disease	582
of	I-Disease	582
the	I-Disease	582
PNS	I-Disease	582
and	O	582
a	O	582
block	O	582
of	O	582
Schwann	O	582
cells	O	582
at	O	582
an	O	582
early	O	582
stage	O	582
of	O	582
differentiation	O	582
.	O	582

Mutations	O	583
in	O	583
the	O	583
human	O	583
EGR2	O	583
gene	O	583
have	O	583
recently	O	583
been	O	583
associated	O	583
with	O	583
the	O	583
inherited	B-Disease	583
peripheral	I-Disease	583
neuropathies	I-Disease	583
Charcot	B-Disease	583
-	I-Disease	583
Marie	I-Disease	583
-	I-Disease	583
Tooth	I-Disease	583
type	I-Disease	583
1	I-Disease	583
,	O	583
Dejerine	B-Disease	583
-	I-Disease	583
Sottas	I-Disease	583
syndrome	I-Disease	583
and	O	583
congenital	B-Disease	583
hypomyelinating	I-Disease	583
neuropathy	I-Disease	583
.	O	583

Autosomal	B-Disease	591
recessive	I-Disease	591
familial	I-Disease	591
neurohypophyseal	I-Disease	591
diabetes	I-Disease	591
insipidus	I-Disease	591
with	O	591
continued	O	591
secretion	O	591
of	O	591
mutant	O	591
weakly	O	591
active	O	591
vasopressin	O	591
.	O	591

Familial	B-Disease	592
neurohypophyseal	I-Disease	592
diabetes	I-Disease	592
insipidus	I-Disease	592
is	O	592
an	O	592
autosomal	B-Disease	592
dominant	I-Disease	592
disorder	I-Disease	592
characterized	O	592
by	O	592
post	O	592
-	O	592
natal	O	592
development	O	592
of	O	592
arginine	B-Disease	592
vasopressin	I-Disease	592
(	I-Disease	592
AVP	I-Disease	592
)	I-Disease	592
deficiency	I-Disease	592
due	O	592
to	O	592
mutations	O	592
in	O	592
the	O	592
AVP	O	592
gene	O	592
.	O	592

All	O	593
published	O	593
mutations	O	593
affect	O	593
the	O	593
signal	O	593
peptide	O	593
or	O	593
the	O	593
neurophysin	O	593
-	O	593
II	O	593
carrier	O	593
protein	O	593
and	O	593
are	O	593
presumed	O	593
to	O	593
interfere	O	593
with	O	593
processing	O	593
of	O	593
the	O	593
preprohormone	O	593
,	O	593
leading	O	593
to	O	593
neuronal	B-Disease	593
damage	I-Disease	593
.	O	593

We	O	594
studied	O	594
an	O	594
unusual	O	594
Palestinian	O	594
family	O	594
consisting	O	594
of	O	594
asymptomatic	O	594
first	O	594
cousin	O	594
parents	O	594
and	O	594
three	O	594
children	O	594
affected	O	594
with	O	594
neurohypophyseal	B-Disease	594
diabetes	I-Disease	594
insipidus	I-Disease	594
,	O	594
suggesting	O	594
autosomal	O	594
recessive	O	594
inheritance	O	594
.	O	594

The	O	598
youngest	O	598
child	O	598
(	O	598
2	O	598
years	O	598
old	O	598
)	O	598
was	O	598
only	O	598
mildly	O	598
affected	O	598
but	O	598
had	O	598
Leu	O	598
-	O	598
AVP	O	598
levels	O	598
similar	O	598
to	O	598
her	O	598
severely	O	598
affected	O	598
8	O	598
-	O	598
year	O	598
-	O	598
old	O	598
brother	O	598
,	O	598
suggesting	O	598
that	O	598
unknown	O	598
mechanisms	O	598
may	O	598
partially	O	598
compensate	O	598
for	O	598
a	O	598
deficiency	B-Disease	598
of	I-Disease	598
active	I-Disease	598
AVP	I-Disease	598
in	O	598
very	O	598
young	O	598
children	O	598
.	O	598

A	O	601
somatic	O	601
mutation	O	601
in	O	601
the	O	601
X	O	601
linked	O	601
PIGA	O	601
gene	O	601
is	O	601
responsible	O	601
for	O	601
the	O	601
deficiency	B-Disease	601
of	I-Disease	601
glycosyl	I-Disease	601
phosphatidylinositol	I-Disease	601
(	I-Disease	601
GPI	I-Disease	601
)	I-Disease	601
-	I-Disease	601
anchored	I-Disease	601
proteins	I-Disease	601
on	O	601
blood	O	601
cells	O	601
from	O	601
patients	O	601
with	O	601
paroxysmal	B-Disease	601
nocturnal	I-Disease	601
hemoglobinuria	I-Disease	601
.	O	601

No	O	602
inherited	O	602
form	O	602
of	O	602
GPI	B-Disease	602
-	I-Disease	602
anchor	I-Disease	602
deficiency	I-Disease	602
has	O	602
been	O	602
described	O	602
.	O	602

Because	O	603
conventional	O	603
Piga	O	603
gene	O	603
knockout	O	603
is	O	603
associated	O	603
with	O	603
high	O	603
embryonic	B-Disease	603
lethality	I-Disease	603
in	O	603
chimeric	O	603
mice	O	603
,	O	603
we	O	603
used	O	603
the	O	603
Cre	O	603
/	O	603
loxP	O	603
system	O	603
.	O	603

PIGA	O	609
(	O	609
-	O	609
)	O	609
cells	O	609
had	O	609
no	O	609
growth	O	609
advantage	O	609
,	O	609
suggesting	O	609
that	O	609
other	O	609
factors	O	609
are	O	609
needed	O	609
for	O	609
their	O	609
clonal	O	609
dominance	O	609
in	O	609
patients	O	609
with	O	609
paroxysmal	B-Disease	609
nocturnal	I-Disease	609
hemoglobinuria	I-Disease	609
.	O	609

The	O	611
C282Y	O	611
mutation	O	611
causing	O	611
hereditary	B-Disease	611
hemochromatosis	I-Disease	611
does	O	611
not	O	611
produce	O	611
a	O	611
nan	O	611
allele	O	611
.	O	611

Targeted	O	612
mutagenesis	O	612
was	O	612
used	O	612
to	O	612
produce	O	612
two	O	612
mutations	O	612
in	O	612
the	O	612
murine	O	612
hemochromatosis	B-Disease	612
gene	O	612
(	O	612
Hfe	O	612
)	O	612
locus	O	612
.	O	612

This	O	615
mutation	O	615
is	O	615
identical	O	615
to	O	615
the	O	615
disease	O	615
-	O	615
causing	O	615
mutation	O	615
in	O	615
patients	O	615
with	O	615
hereditary	B-Disease	615
hemochromatosis	I-Disease	615
.	O	615

Genotype	O	623
-	O	623
phenotype	O	623
analysis	O	623
in	O	623
X	B-Disease	623
-	I-Disease	623
linked	I-Disease	623
Emery	I-Disease	623
-	I-Disease	623
Dreifuss	I-Disease	623
muscular	I-Disease	623
dystrophy	I-Disease	623
and	O	623
identification	O	623
of	O	623
a	O	623
missense	O	623
mutation	O	623
associated	O	623
with	O	623
a	O	623
milder	O	623
phenotype	O	623
.	O	623

Direct	O	624
sequencing	O	624
of	O	624
the	O	624
emerin	O	624
gene	O	624
in	O	624
22	O	624
families	O	624
with	O	624
Emery	B-Disease	624
-	I-Disease	624
Dreifuss	I-Disease	624
muscular	I-Disease	624
dystrophy	I-Disease	624
(	O	624
EMD	B-Disease	624
)	O	624
revealed	O	624
mutations	O	624
in	O	624
21	O	624
(	O	624
95	O	624
%	O	624
)	O	624
,	O	624
confirming	O	624
that	O	624
emerin	O	624
mutations	O	624
can	O	624
be	O	624
identified	O	624
in	O	624
the	O	624
majority	O	624
of	O	624
families	O	624
with	O	624
X	B-Disease	624
-	I-Disease	624
linked	I-Disease	624
EMD	I-Disease	624
.	O	624

Age	O	630
at	O	630
onset	O	630
was	O	630
later	O	630
for	O	630
first	O	630
symptoms	O	630
and	O	630
for	O	630
development	O	630
of	O	630
ankle	B-Disease	630
contractures	I-Disease	630
and	O	630
muscle	B-Disease	630
weakness	I-Disease	630
.	O	630

Severe	O	633
clinical	O	633
expression	O	633
in	O	633
X	B-Disease	633
-	I-Disease	633
linked	I-Disease	633
Emery	I-Disease	633
-	I-Disease	633
Dreifuss	I-Disease	633
muscular	I-Disease	633
dystrophy	I-Disease	633
.	O	633

X	B-Disease	634
-	I-Disease	634
linked	I-Disease	634
Emery	I-Disease	634
-	I-Disease	634
Dreifuss	I-Disease	634
muscular	I-Disease	634
dystrophy	I-Disease	634
(	O	634
EDMD	B-Disease	634
)	O	634
is	O	634
a	O	634
relatively	O	634
rare	O	634
benign	B-Disease	634
neuromuscular	I-Disease	634
disorder	I-Disease	634
which	O	634
can	O	634
vary	O	634
remarkably	O	634
in	O	634
onset	O	634
,	O	634
course	O	634
and	O	634
severity	O	634
.	O	634

In	O	635
the	O	635
present	O	635
study	O	635
,	O	635
a	O	635
TCTAC	O	635
deletion	O	635
spanning	O	635
the	O	635
nucleotides	O	635
631	O	635
-	O	635
635	O	635
of	O	635
the	O	635
emerin	O	635
gene	O	635
caused	O	635
an	O	635
unusually	O	635
severe	O	635
disease	O	635
phenotype	O	635
including	O	635
loss	B-Disease	635
of	I-Disease	635
ambulation	I-Disease	635
and	O	635
severe	O	635
muscle	B-Disease	635
wasting	I-Disease	635
in	O	635
two	O	635
affected	O	635
brothers	O	635
.	O	635

The	O	637
interfamilial	O	637
heterogeneity	O	637
in	O	637
distribution	O	637
and	O	637
in	O	637
severity	O	637
of	O	637
the	O	637
features	O	637
in	O	637
the	O	637
two	O	637
families	O	637
point	O	637
to	O	637
environmental	O	637
or	O	637
genetic	O	637
modification	O	637
as	O	637
the	O	637
cause	O	637
of	O	637
clinical	O	637
variability	O	637
in	O	637
Emery	B-Disease	637
-	I-Disease	637
Dreifuss	I-Disease	637
muscular	I-Disease	637
dystrophy	I-Disease	637
.	O	637

Common	O	639
mutations	O	639
in	O	639
BRCA1	O	639
and	O	639
BRCA2	O	639
do	O	639
not	O	639
contribute	O	639
to	O	639
early	O	639
prostate	B-Disease	639
cancer	I-Disease	639
in	O	639
Jewish	O	639
men	O	639
.	O	639

BACKGROUND	O	640
Families	O	640
with	O	640
a	O	640
high	O	640
incidence	O	640
of	O	640
hereditary	B-Disease	640
breast	I-Disease	640
cancer	I-Disease	640
,	O	640
and	O	640
subsequently	O	640
shown	O	640
to	O	640
have	O	640
terminating	O	640
mutations	O	640
in	O	640
BRCA1	O	640
or	O	640
BRCA2	O	640
,	O	640
appear	O	640
to	O	640
have	O	640
a	O	640
higher	O	640
incidence	O	640
of	O	640
prostate	B-Disease	640
cancer	I-Disease	640
among	O	640
male	O	640
relatives	O	640
.	O	640

We	O	641
aimed	O	641
to	O	641
determine	O	641
whether	O	641
the	O	641
common	O	641
germline	O	641
mutations	O	641
of	O	641
BRCA1	O	641
or	O	641
BRCA2	O	641
in	O	641
Ashkenazi	O	641
Jewish	O	641
men	O	641
predisposed	O	641
them	O	641
to	O	641
prostate	B-Disease	641
cancer	I-Disease	641
.	O	641

METHODS	O	642
We	O	642
examined	O	642
genomic	O	642
DNA	O	642
from	O	642
83	O	642
(	O	642
for	O	642
BRCA1	O	642
185delAG	O	642
)	O	642
or	O	642
82	O	642
(	O	642
for	O	642
BRCA2	O	642
6174delT	O	642
)	O	642
Ashkenazi	O	642
Jewish	O	642
prostate	B-Disease	642
cancer	I-Disease	642
patients	O	642
,	O	642
most	O	642
of	O	642
whom	O	642
were	O	642
treated	O	642
at	O	642
a	O	642
relatively	O	642
young	O	642
age	O	642
,	O	642
for	O	642
the	O	642
most	O	642
common	O	642
germline	O	642
mutation	O	642
in	O	642
each	O	642
gene	O	642
seen	O	642
in	O	642
the	O	642
Ashkenazi	O	642
population	O	642
.	O	642

RESULTS	O	643
Our	O	643
study	O	643
should	O	643
have	O	643
been	O	643
able	O	643
to	O	643
detect	O	643
a	O	643
4	O	643
-	O	643
5	O	643
-	O	643
fold	O	643
increase	O	643
in	O	643
the	O	643
risk	O	643
of	O	643
prostate	B-Disease	643
cancer	I-Disease	643
due	O	643
to	O	643
mutation	O	643
of	O	643
BRCA1	O	643
or	O	643
BRCA2	O	643
.	O	643

CONCLUSIONS	O	649
The	O	649
incidence	O	649
of	O	649
each	O	649
of	O	649
the	O	649
germline	O	649
mutations	O	649
in	O	649
these	O	649
prostate	B-Disease	649
cancer	I-Disease	649
patients	O	649
closely	O	649
matched	O	649
their	O	649
incidence	O	649
(	O	649
about	O	649
1	O	649
%	O	649
)	O	649
in	O	649
the	O	649
general	O	649
Ashkenazi	O	649
Jewish	O	649
population	O	649
.	O	649

This	O	650
suggests	O	650
that	O	650
unlike	O	650
cases	O	650
of	O	650
breast	B-Disease	650
and	I-Disease	650
ovarian	I-Disease	650
cancers	I-Disease	650
,	O	650
mutations	O	650
in	O	650
BRCA1	O	650
or	O	650
BRCA2	O	650
do	O	650
not	O	650
significantly	O	650
predispose	O	650
men	O	650
to	O	650
prostate	B-Disease	650
cancer	I-Disease	650
Beta	O	650
-	O	650
catenin	O	650
accumulation	O	650
and	O	650
mutation	O	650
of	O	650
the	O	650
CTNNB1	O	650
gene	O	650
in	O	650
hepatoblastoma	B-Disease	650
.	O	650

Hepatoblastoma	B-Disease	651
is	O	651
a	O	651
rare	O	651
malignant	B-Disease	651
tumor	I-Disease	651
of	I-Disease	651
the	I-Disease	651
liver	I-Disease	651
that	O	651
occurs	O	651
in	O	651
children	O	651
at	O	651
an	O	651
average	O	651
age	O	651
of	O	651
2	O	651
to	O	651
3	O	651
years	O	651
.	O	651

Epidemiologic	O	652
studies	O	652
have	O	652
shown	O	652
an	O	652
increased	O	652
frequency	O	652
of	O	652
this	O	652
tumor	B-Disease	652
type	O	652
in	O	652
families	O	652
affected	O	652
by	O	652
adenomatous	B-Disease	652
polyposis	I-Disease	652
coli	I-Disease	652
.	O	652

In	O	653
addition	O	653
to	O	653
the	O	653
epidemiologic	O	653
data	O	653
,	O	653
molecular	O	653
genetic	O	653
studies	O	653
suggest	O	653
that	O	653
inactivation	O	653
of	O	653
the	O	653
APC	B-Disease	653
tumor	I-Disease	653
suppressor	O	653
may	O	653
be	O	653
involved	O	653
in	O	653
hepatoblastoma	B-Disease	653
tumorigenesis	O	653
.	O	653

In	O	655
an	O	655
ongoing	O	655
immunohistochemical	O	655
study	O	655
of	O	655
beta	O	655
-	O	655
catenin	O	655
expression	O	655
in	O	655
sporadic	O	655
cases	O	655
of	O	655
tumor	B-Disease	655
types	O	655
that	O	655
are	O	655
associated	O	655
with	O	655
adenomatous	B-Disease	655
polyposis	I-Disease	655
coli	I-Disease	655
,	O	655
we	O	655
observed	O	655
increased	O	655
beta	O	655
-	O	655
catenin	O	655
levels	O	655
in	O	655
the	O	655
cytoplasm	O	655
and	O	655
in	O	655
the	O	655
nuclei	O	655
of	O	655
three	O	655
investigated	O	655
hepatoblastomas	B-Disease	655
.	O	655

Sequencing	O	656
of	O	656
exon	O	656
3	O	656
of	O	656
the	O	656
beta	O	656
-	O	656
catenin	O	656
gene	O	656
(	O	656
CTNNB1	O	656
)	O	656
revealed	O	656
an	O	656
activating	O	656
mutation	O	656
in	O	656
one	O	656
of	O	656
the	O	656
tumor	B-Disease	656
samples	O	656
.	O	656

Our	O	657
data	O	657
indicate	O	657
for	O	657
the	O	657
first	O	657
time	O	657
that	O	657
beta	O	657
-	O	657
catenin	O	657
accumulation	O	657
may	O	657
play	O	657
a	O	657
role	O	657
in	O	657
the	O	657
development	O	657
of	O	657
hepatoblastoma	B-Disease	657
and	O	657
that	O	657
activating	O	657
mutations	O	657
of	O	657
the	O	657
beta	O	657
-	O	657
catenin	O	657
gene	O	657
may	O	657
substitute	O	657
biallelic	O	657
APC	O	657
inactivation	O	657
in	O	657
this	O	657
tumor	B-Disease	657
type	O	657
.	O	657

Decrease	O	660
in	O	660
GTP	O	660
cyclohydrolase	O	660
I	O	660
gene	O	660
expression	O	660
caused	O	660
by	O	660
inactivation	O	660
of	O	660
one	O	660
allele	O	660
in	O	660
hereditary	B-Disease	660
progressive	I-Disease	660
dystonia	I-Disease	660
with	O	660
marked	O	660
diurnal	O	660
fluctuation	O	660
.	O	660

Hereditary	B-Disease	661
progressive	I-Disease	661
dystonia	I-Disease	661
with	O	661
marked	O	661
diurnal	O	661
fluctuation	O	661
(	O	661
HPD	B-Disease	661
;	O	661
dopa	B-Disease	661
-	I-Disease	661
responsive	I-Disease	661
dystonia	I-Disease	661
,	O	661
DRD	B-Disease	661
)	O	661
have	O	661
been	O	661
recently	O	661
found	O	661
to	O	661
be	O	661
caused	O	661
by	O	661
a	O	661
genetic	B-Disease	661
defect	I-Disease	661
in	O	661
the	O	661
GTP	O	661
cyclohydrolase	O	661
I	O	661
(	O	661
GCH1	O	661
)	O	661
gene	O	661
.	O	661

These	O	665
results	O	665
suggest	O	665
that	O	665
some	O	665
novel	O	665
mutations	O	665
should	O	665
exist	O	665
on	O	665
one	O	665
of	O	665
the	O	665
alleles	O	665
in	O	665
some	O	665
unknown	O	665
region	O	665
of	O	665
the	O	665
GCH1	O	665
gene	O	665
,	O	665
and	O	665
may	O	665
decrease	O	665
the	O	665
GCH1	O	665
mRNA	O	665
causing	O	665
the	O	665
HPD	B-Disease	665
/	O	665
DRD	B-Disease	665
symptoms	O	665
.	O	665

Sulfate	O	667
transport	O	667
is	O	667
not	O	667
impaired	O	667
in	O	667
pendred	B-Disease	667
syndrome	I-Disease	667
thyrocytes	O	667
.	O	667

Pendred	B-Disease	668
syndrome	I-Disease	668
is	O	668
the	O	668
most	O	668
common	O	668
form	O	668
of	O	668
syndromic	B-Disease	668
deafness	I-Disease	668
,	O	668
characterized	O	668
by	O	668
dyshormonogenic	B-Disease	668
goiter	I-Disease	668
associated	O	668
with	O	668
sensory	B-Disease	668
-	I-Disease	668
neural	I-Disease	668
deafness	I-Disease	668
.	O	668

The	O	669
gene	O	669
responsible	O	669
for	O	669
the	O	669
disease	O	669
(	O	669
PDS	B-Disease	669
)	O	669
has	O	669
been	O	669
cloned	O	669
,	O	669
but	O	669
its	O	669
function	O	669
is	O	669
as	O	669
yet	O	669
unknown	O	669
and	O	669
the	O	669
connection	O	669
between	O	669
thyroid	B-Disease	669
goiter	I-Disease	669
and	O	669
sensory	B-Disease	669
-	I-Disease	669
neural	I-Disease	669
deafness	I-Disease	669
remains	O	669
an	O	669
enigma	O	669
.	O	669

We	O	672
tested	O	672
sulfate	O	672
transport	O	672
in	O	672
thyrocytes	O	672
obtained	O	672
from	O	672
Pendred	B-Disease	672
syndrome	I-Disease	672
patients	O	672
and	O	672
found	O	672
that	O	672
it	O	672
was	O	672
not	O	672
defective	O	672
.	O	672

Small	O	675
deletions	O	675
in	O	675
the	O	675
type	O	675
II	O	675
collagen	O	675
triple	O	675
helix	O	675
produce	O	675
kniest	B-Disease	675
dysplasia	I-Disease	675
.	O	675

Kniest	B-Disease	676
dysplasia	I-Disease	676
is	O	676
a	O	676
moderately	O	676
severe	O	676
type	B-Disease	676
II	I-Disease	676
collagenopathy	I-Disease	676
,	O	676
characterized	O	676
by	O	676
short	O	676
trunk	O	676
and	O	676
limbs	O	676
,	O	676
kyphoscoliosis	B-Disease	676
,	O	676
midface	B-Disease	676
hypoplasia	I-Disease	676
,	O	676
severe	O	676
myopia	B-Disease	676
,	O	676
and	O	676
hearing	B-Disease	676
loss	I-Disease	676
.	O	676

Mutations	O	677
in	O	677
the	O	677
gene	O	677
that	O	677
encodes	O	677
type	O	677
II	O	677
collagen	O	677
(	O	677
COL2A1	O	677
)	O	677
,	O	677
the	O	677
predominant	O	677
protein	O	677
of	O	677
cartilage	O	677
,	O	677
have	O	677
been	O	677
identified	O	677
in	O	677
a	O	677
number	O	677
of	O	677
individuals	O	677
with	O	677
Kniest	B-Disease	677
dysplasia	I-Disease	677
.	O	677

We	O	680
used	O	680
heteroduplex	O	680
analysis	O	680
to	O	680
identify	O	680
sequence	O	680
anomalies	O	680
in	O	680
five	O	680
individuals	O	680
with	O	680
Kniest	B-Disease	680
dysplasia	I-Disease	680
.	O	680

Sequencing	O	681
of	O	681
the	O	681
index	O	681
patients	O	681
genomic	O	681
DNA	O	681
identified	O	681
four	O	681
new	O	681
dominant	O	681
mutations	O	681
in	O	681
COL2A1	O	681
that	O	681
result	O	681
in	O	681
Kniest	B-Disease	681
dysplasia	I-Disease	681
a	O	681
21	O	681
-	O	681
bp	O	681
deletion	O	681
in	O	681
exon	O	681
16	O	681
,	O	681
an	O	681
18	O	681
-	O	681
bp	O	681
deletion	O	681
in	O	681
exon	O	681
19	O	681
,	O	681
and	O	681
4	O	681
-	O	681
bp	O	681
deletions	O	681
in	O	681
the	O	681
splice	O	681
donor	O	681
sites	O	681
of	O	681
introns	O	681
14	O	681
and	O	681
20	O	681
.	O	681

These	O	684
data	O	684
suggest	O	684
that	O	684
Kniest	B-Disease	684
dysplasia	I-Disease	684
results	O	684
from	O	684
shorter	O	684
type	O	684
II	O	684
collagen	O	684
monomers	O	684
,	O	684
and	O	684
support	O	684
the	O	684
hypothesis	O	684
that	O	684
alteration	O	684
of	O	684
a	O	684
specific	O	684
COL2A1	O	684
domain	O	684
,	O	684
which	O	684
may	O	684
span	O	684
from	O	684
exons	O	684
12	O	684
to	O	684
24	O	684
,	O	684
leads	O	684
to	O	684
the	O	684
Kniest	B-Disease	684
dysplasia	I-Disease	684
phenotype	O	684
.	O	684

Classical	B-Disease	686
galactosemia	I-Disease	686
and	O	686
mutations	O	686
at	O	686
the	O	686
galactose	O	686
-	O	686
1	O	686
-	O	686
phosphate	O	686
uridyl	O	686
transferase	O	686
(	O	686
GALT	O	686
)	O	686
gene	O	686
.	O	686

Classical	B-Disease	687
galactosemia	I-Disease	687
is	O	687
caused	O	687
by	O	687
a	O	687
deficiency	O	687
in	O	687
activity	O	687
of	O	687
the	O	687
enzyme	O	687
galactose	O	687
-	O	687
1	O	687
-	O	687
phosphate	O	687
uridyl	O	687
transferase	O	687
(	O	687
GALT	O	687
)	O	687
,	O	687
which	O	687
,	O	687
in	O	687
turn	O	687
,	O	687
is	O	687
caused	O	687
by	O	687
mutations	O	687
at	O	687
the	O	687
GALT	O	687
gene	O	687
.	O	687

The	O	702
considerable	O	702
genetic	O	702
heterogeneity	O	702
documented	O	702
to	O	702
date	O	702
undoubtedly	O	702
contributes	O	702
to	O	702
the	O	702
phenotypic	O	702
heterogeneity	O	702
that	O	702
is	O	702
observed	O	702
in	O	702
galactosemia	B-Disease	702
.	O	702

Mutations	O	705
of	O	705
the	O	705
VHL	B-Disease	705
gene	O	705
in	O	705
sporadic	B-Disease	705
renal	I-Disease	705
cell	I-Disease	705
carcinoma	I-Disease	705
:	O	705
definition	O	705
of	O	705
a	O	705
risk	O	705
factor	O	705
for	O	705
VHL	B-Disease	705
patients	O	705
to	O	705
develop	O	705
an	O	705
RCC	B-Disease	705
.	O	705

To	O	706
investigate	O	706
the	O	706
nature	O	706
of	O	706
somatic	O	706
von	B-Disease	706
Hippel	I-Disease	706
-	I-Disease	706
Lindau	I-Disease	706
(	O	706
VHL	B-Disease	706
)	O	706
mutations	O	706
,	O	706
we	O	706
analyzed	O	706
173	O	706
primary	O	706
sporadic	O	706
human	O	706
renal	B-Disease	706
cell	I-Disease	706
carcinomas	I-Disease	706
for	O	706
mutations	O	706
of	O	706
the	O	706
VHL	B-Disease	706
tumor	I-Disease	706
suppressor	O	706
gene	O	706
,	O	706
using	O	706
polymerase	O	706
chain	O	706
reaction	O	706
(	O	706
PCR	O	706
)	O	706
and	O	706
single	O	706
-	O	706
strand	O	706
conformational	O	706
polymorphism	O	706
analysis	O	706
(	O	706
SSCP	O	706
)	O	706
of	O	706
DNA	O	706
.	O	706

VHL	B-Disease	710
mutations	O	710
were	O	710
found	O	710
only	O	710
in	O	710
the	O	710
nonpapillary	B-Disease	710
renal	I-Disease	710
cell	I-Disease	710
carcinoma	I-Disease	710
(	O	710
RCC	B-Disease	710
)	O	710
subtype	O	710
,	O	710
as	O	710
previously	O	710
reported	O	710
.	O	710

To	O	711
compare	O	711
somatic	O	711
and	O	711
germline	O	711
mutations	O	711
,	O	711
we	O	711
used	O	711
the	O	711
VHL	B-Disease	711
database	O	711
,	O	711
which	O	711
includes	O	711
507	O	711
mutations	O	711
.	O	711

We	O	714
postulated	O	714
that	O	714
a	O	714
specific	O	714
pattern	O	714
of	O	714
VHL	B-Disease	714
mutations	O	714
is	O	714
associated	O	714
with	O	714
sporadic	B-Disease	714
RCC	I-Disease	714
.	O	714

We	O	716
then	O	716
analyzed	O	716
the	O	716
occurrence	O	716
of	O	716
RCC	B-Disease	716
in	O	716
VHL	B-Disease	716
families	O	716
,	O	716
based	O	716
on	O	716
the	O	716
nature	O	716
of	O	716
mutations	O	716
.	O	716

We	O	717
observed	O	717
RCC	B-Disease	717
in	O	717
at	O	717
least	O	717
one	O	717
member	O	717
of	O	717
the	O	717
VHL	B-Disease	717
families	O	717
in	O	717
77	O	717
%	O	717
of	O	717
cases	O	717
with	O	717
mutations	O	717
leading	O	717
to	O	717
truncated	O	717
proteins	O	717
versus	O	717
55	O	717
%	O	717
in	O	717
cases	O	717
with	O	717
missense	O	717
mutations	O	717
(	O	717
P	O	717
<	O	717
0	O	717
.	O	717

Thus	O	719
,	O	719
mutations	O	719
resulting	O	719
in	O	719
truncated	O	719
proteins	O	719
may	O	719
lead	O	719
to	O	719
a	O	719
higher	O	719
risk	O	719
of	O	719
RCC	B-Disease	719
in	O	719
VHL	B-Disease	719
patients	O	719
Defective	O	719
CTLA	O	719
-	O	719
4	O	719
cycling	O	719
pathway	O	719
in	O	719
Chediak	B-Disease	719
-	I-Disease	719
Higashi	I-Disease	719
syndrome	I-Disease	719
:	O	719
a	O	719
possible	O	719
mechanism	O	719
for	O	719
deregulation	O	719
of	O	719
T	O	719
lymphocyte	O	719
activation	O	719
.	O	719

Chediak	B-Disease	722
-	I-Disease	722
Higashi	I-Disease	722
syndrome	I-Disease	722
(	O	722
CHS	B-Disease	722
)	O	722
is	O	722
an	O	722
inherited	B-Disease	722
disorder	I-Disease	722
caused	O	722
by	O	722
mutations	O	722
in	O	722
the	O	722
lysosomal	O	722
trafficking	O	722
regulator	O	722
gene	O	722
,	O	722
LYST	O	722
.	O	722

It	O	723
results	O	723
in	O	723
defective	O	723
membrane	O	723
targeting	O	723
of	O	723
the	O	723
proteins	O	723
present	O	723
in	O	723
secretory	O	723
lysosomes	O	723
,	O	723
and	O	723
it	O	723
is	O	723
associated	O	723
with	O	723
a	O	723
variety	O	723
of	O	723
features	O	723
,	O	723
including	O	723
a	O	723
lymphoproliferative	B-Disease	723
syndrome	I-Disease	723
with	O	723
hemophagocytosis	B-Disease	723
.	O	723

The	O	724
murine	O	724
equivalent	O	724
of	O	724
CHS	B-Disease	724
,	O	724
beige	O	724
mice	O	724
,	O	724
present	O	724
similar	O	724
characteristics	O	724
but	O	724
do	O	724
not	O	724
develop	O	724
the	O	724
lymphoproliferative	B-Disease	724
syndrome	I-Disease	724
.	O	724

We	O	725
show	O	725
herein	O	725
that	O	725
CTLA	O	725
-	O	725
4	O	725
is	O	725
present	O	725
in	O	725
enlarged	O	725
,	O	725
abnormal	O	725
vesicles	O	725
in	O	725
CHS	B-Disease	725
T	O	725
cells	O	725
and	O	725
is	O	725
not	O	725
properly	O	725
expressed	O	725
at	O	725
the	O	725
cell	O	725
surface	O	725
after	O	725
T	O	725
cell	O	725
activation	O	725
,	O	725
whereas	O	725
its	O	725
surface	O	725
expression	O	725
is	O	725
not	O	725
impaired	O	725
.	O	725

It	O	726
is	O	726
therefore	O	726
proposed	O	726
that	O	726
the	O	726
defective	O	726
surface	O	726
expression	O	726
of	O	726
CTLA	O	726
-	O	726
4	O	726
by	O	726
CHS	B-Disease	726
T	O	726
cells	O	726
is	O	726
involved	O	726
in	O	726
the	O	726
generation	O	726
of	O	726
lymphoproliferative	B-Disease	726
disease	I-Disease	726
.	O	726

Proteolipoprotein	O	729
gene	O	729
analysis	O	729
in	O	729
82	O	729
patients	O	729
with	O	729
sporadic	O	729
Pelizaeus	B-Disease	729
-	I-Disease	729
Merzbacher	I-Disease	729
Disease	I-Disease	729
:	O	729
duplications	O	729
,	O	729
the	O	729
major	O	729
cause	O	729
of	O	729
the	O	729
disease	O	729
,	O	729
originate	O	729
more	O	729
frequently	O	729
in	O	729
male	O	729
germ	O	729
cells	O	729
,	O	729
but	O	729
point	O	729
mutations	O	729
do	O	729
not	O	729
.	O	729

The	O	730
Clinical	O	730
European	O	730
Network	O	730
on	O	730
Brain	B-Disease	730
Dysmyelinating	I-Disease	730
Disease	I-Disease	730
.	O	730

Pelizaeus	B-Disease	731
-	I-Disease	731
Merzbacher	I-Disease	731
Disease	I-Disease	731
(	O	731
PMD	B-Disease	731
)	O	731
is	O	731
an	O	731
X	B-Disease	731
-	I-Disease	731
linked	I-Disease	731
developmental	I-Disease	731
defect	I-Disease	731
of	I-Disease	731
myelination	I-Disease	731
affecting	O	731
the	O	731
central	O	731
nervous	O	731
system	O	731
and	O	731
segregating	O	731
with	O	731
the	O	731
proteolipoprotein	O	731
(	O	731
PLP	O	731
)	O	731
locus	O	731
.	O	731

Investigating	O	732
82	O	732
strictly	O	732
selected	O	732
sporadic	O	732
cases	O	732
of	O	732
PMD	B-Disease	732
,	O	732
we	O	732
found	O	732
PLP	O	732
mutations	O	732
in	O	732
77	O	732
%	O	732
;	O	732
complete	O	732
PLP	O	732
-	O	732
gene	O	732
duplications	O	732
were	O	732
the	O	732
most	O	732
frequent	O	732
abnormality	O	732
(	O	732
62	O	732
%	O	732
)	O	732
,	O	732
whereas	O	732
point	O	732
mutations	O	732
in	O	732
coding	O	732
or	O	732
splice	O	732
-	O	732
site	O	732
regions	O	732
of	O	732
the	O	732
gene	O	732
were	O	732
involved	O	732
less	O	732
frequently	O	732
(	O	732
38	O	732
%	O	732
)	O	732
.	O	732

Chromosome	O	741
breakage	O	741
in	O	741
the	O	741
Prader	B-Disease	741
-	I-Disease	741
Willi	I-Disease	741
and	I-Disease	741
Angelman	I-Disease	741
syndromes	I-Disease	741
involves	O	741
recombination	O	741
between	O	741
large	O	741
,	O	741
transcribed	O	741
repeats	O	741
at	O	741
proximal	O	741
and	O	741
distal	O	741
breakpoints	O	741
.	O	741

Prader	B-Disease	742
-	I-Disease	742
Willi	I-Disease	742
syndrome	I-Disease	742
(	O	742
PWS	B-Disease	742
)	O	742
and	O	742
Angelman	B-Disease	742
syndrome	I-Disease	742
(	O	742
AS	B-Disease	742
)	O	742
are	O	742
distinct	O	742
neurobehavioral	B-Disease	742
disorders	I-Disease	742
that	O	742
most	O	742
often	O	742
arise	O	742
from	O	742
a	O	742
4	O	742
-	O	742
Mb	O	742
deletion	O	742
of	O	742
chromosome	O	742
15q11	O	742
-	O	742
q13	O	742
during	O	742
paternal	O	742
or	O	742
maternal	O	742
gametogenesis	O	742
,	O	742
respectively	O	742
.	O	742

One	O	749
of	O	749
five	O	749
PWS	B-Disease	749
/	O	749
AS	B-Disease	749
patients	O	749
analyzed	O	749
to	O	749
date	O	749
has	O	749
an	O	749
identifiable	O	749
,	O	749
rearranged	O	749
HERC2	O	749
transcript	O	749
derived	O	749
from	O	749
the	O	749
deletion	O	749
event	O	749
.	O	749

Linkage	O	752
analysis	O	752
in	O	752
a	O	752
large	O	752
Brazilian	O	752
family	O	752
with	O	752
van	B-Disease	752
der	I-Disease	752
Woude	I-Disease	752
syndrome	I-Disease	752
suggests	O	752
the	O	752
existence	O	752
of	O	752
a	O	752
susceptibility	O	752
locus	O	752
for	O	752
cleft	B-Disease	752
palate	I-Disease	752
at	O	752
17p11	O	752
.	O	752

van	B-Disease	755
der	I-Disease	755
Woude	I-Disease	755
syndrome	I-Disease	755
(	O	755
VWS	B-Disease	755
)	O	755
,	O	755
which	O	755
has	O	755
been	O	755
mapped	O	755
to	O	755
1q32	O	755
-	O	755
41	O	755
,	O	755
is	O	755
characterized	O	755
by	O	755
pits	B-Disease	755
and	I-Disease	755
/	I-Disease	755
or	I-Disease	755
sinuses	I-Disease	755
of	I-Disease	755
the	I-Disease	755
lower	I-Disease	755
lip	I-Disease	755
,	O	755
cleft	B-Disease	755
lip	I-Disease	755
/	I-Disease	755
palate	I-Disease	755
(	O	755
CL	B-Disease	755
/	I-Disease	755
P	I-Disease	755
)	O	755
,	O	755
cleft	B-Disease	755
palate	I-Disease	755
(	O	755
CP	B-Disease	755
)	O	755
,	O	755
bifid	B-Disease	755
uvula	I-Disease	755
,	O	755
and	O	755
hypodontia	B-Disease	755
(	O	755
H	B-Disease	755
)	O	755
.	O	755

The	O	756
expression	O	756
of	O	756
VWS	B-Disease	756
,	O	756
which	O	756
has	O	756
incomplete	O	756
penetrance	O	756
,	O	756
is	O	756
highly	O	756
variable	O	756
.	O	756

Both	O	757
the	O	757
occurrence	O	757
of	O	757
CL	B-Disease	757
/	I-Disease	757
P	I-Disease	757
and	O	757
CP	B-Disease	757
within	O	757
the	O	757
same	O	757
genealogy	O	757
and	O	757
a	O	757
recurrence	O	757
risk	O	757
<	O	757
40	O	757
%	O	757
for	O	757
CP	B-Disease	757
among	O	757
descendants	O	757
with	O	757
VWS	B-Disease	757
have	O	757
suggested	O	757
that	O	757
the	O	757
development	O	757
of	O	757
clefts	B-Disease	757
in	O	757
this	O	757
syndrome	O	757
is	O	757
influenced	O	757
by	O	757
modifying	O	757
genes	O	757
at	O	757
other	O	757
loci	O	757
.	O	757

To	O	758
test	O	758
this	O	758
hypothesis	O	758
,	O	758
we	O	758
have	O	758
conducted	O	758
linkage	O	758
analysis	O	758
in	O	758
a	O	758
large	O	758
Brazilian	O	758
kindred	O	758
with	O	758
VWS	B-Disease	758
,	O	758
considering	O	758
as	O	758
affected	O	758
the	O	758
individuals	O	758
with	O	758
CP	B-Disease	758
,	O	758
regardless	O	758
of	O	758
whether	O	758
it	O	758
is	O	758
associated	O	758
with	O	758
other	O	758
clinical	O	758
signs	O	758
of	O	758
VWS	B-Disease	758
.	O	758

1	O	761
,	O	761
together	O	761
with	O	761
the	O	761
VWS	B-Disease	761
gene	O	761
at	O	761
1p32	O	761
-	O	761
41	O	761
,	O	761
enhances	O	761
the	O	761
probability	O	761
of	O	761
CP	B-Disease	761
in	O	761
an	O	761
individual	O	761
carrying	O	761
the	O	761
two	O	761
at	O	761
-	O	761
risk	O	761
genes	O	761
.	O	761

If	O	762
this	O	762
hypothesis	O	762
is	O	762
confirmed	O	762
in	O	762
other	O	762
VWS	B-Disease	762
pedigrees	O	762
,	O	762
it	O	762
will	O	762
represent	O	762
one	O	762
of	O	762
the	O	762
first	O	762
examples	O	762
of	O	762
a	O	762
gene	O	762
,	O	762
mapped	O	762
through	O	762
linkage	O	762
analysis	O	762
,	O	762
which	O	762
modifies	O	762
the	O	762
expression	O	762
of	O	762
a	O	762
major	O	762
gene	O	762
.	O	762

The	O	764
gene	O	764
for	O	764
ataxia	B-Disease	764
-	I-Disease	764
telangiectasia	I-Disease	764
,	O	764
ATM	O	764
,	O	764
spans	O	764
about	O	764
150	O	764
kb	O	764
of	O	764
genomic	O	764
DNA	O	764
.	O	764

Using	O	766
DNA	O	766
as	O	766
the	O	766
starting	O	766
material	O	766
,	O	766
we	O	766
screened	O	766
the	O	766
ATM	O	766
gene	O	766
in	O	766
92	O	766
A	B-Disease	766
-	I-Disease	766
T	I-Disease	766
patients	O	766
,	O	766
using	O	766
an	O	766
optimized	O	766
single	O	766
-	O	766
strand	O	766
conformation	O	766
polymorphism	O	766
(	O	766
SSCP	O	766
)	O	766
technique	O	766
that	O	766
detected	O	766
all	O	766
previously	O	766
known	O	766
mutations	O	766
in	O	766
the	O	766
polymerase	O	766
chain	O	766
reaction	O	766
(	O	766
PCR	O	766
)	O	766
segments	O	766
being	O	766
analyzed	O	766
.	O	766

A	O	775
novel	O	775
frameshift	O	775
mutation	O	775
in	O	775
the	O	775
McLeod	B-Disease	775
syndrome	I-Disease	775
gene	O	775
in	O	775
a	O	775
Japanese	O	775
family	O	775
.	O	775

We	O	776
report	O	776
a	O	776
novel	O	776
mutation	O	776
in	O	776
the	O	776
XK	O	776
gene	O	776
(	O	776
XK	O	776
)	O	776
in	O	776
a	O	776
Japanese	O	776
patient	O	776
with	O	776
McLeod	B-Disease	776
syndrome	I-Disease	776
.	O	776

A	O	777
50	O	777
-	O	777
year	O	777
-	O	777
old	O	777
man	O	777
showed	O	777
progressive	O	777
muscular	B-Disease	777
atrophy	I-Disease	777
,	O	777
choreic	B-Disease	777
movement	I-Disease	777
,	O	777
elevated	O	777
level	O	777
of	O	777
serum	O	777
creatinine	O	777
kinase	O	777
,	O	777
and	O	777
acanthocytosis	B-Disease	777
.	O	777

We	O	780
conclude	O	780
this	O	780
single	O	780
-	O	780
base	O	780
deletion	O	780
causes	O	780
defective	O	780
Kx	O	780
protein	O	780
,	O	780
which	O	780
is	O	780
responsible	O	780
for	O	780
the	O	780
McLeod	B-Disease	780
phenotype	O	780
in	O	780
this	O	780
patient	O	780
.	O	780

BRCA1	O	783
encodes	O	783
a	O	783
tumor	B-Disease	783
suppressor	O	783
that	O	783
is	O	783
mutated	O	783
in	O	783
familial	B-Disease	783
breast	I-Disease	783
and	I-Disease	783
ovarian	I-Disease	783
cancers	I-Disease	783
.	O	783

Formation	O	786
of	O	786
irradiation	O	786
-	O	786
induced	O	786
foci	O	786
positive	O	786
for	O	786
BRCA1	O	786
,	O	786
hRad50	O	786
,	O	786
hMre11	O	786
,	O	786
or	O	786
p95	O	786
was	O	786
dramatically	O	786
reduced	O	786
in	O	786
HCC	O	786
/	O	786
1937	O	786
breast	B-Disease	786
cancer	I-Disease	786
cells	O	786
carrying	O	786
a	O	786
homozygous	O	786
mutation	O	786
in	O	786
BRCA1	O	786
but	O	786
was	O	786
restored	O	786
by	O	786
transfection	O	786
of	O	786
wild	O	786
-	O	786
type	O	786
BRCA1	O	786
.	O	786

Relationship	O	790
among	O	790
genotype	O	790
,	O	790
biochemical	O	790
phenotype	O	790
,	O	790
and	O	790
cognitive	O	790
performance	O	790
in	O	790
females	O	790
with	O	790
phenylalanine	B-Disease	790
hydroxylase	I-Disease	790
deficiency	I-Disease	790
:	O	790
report	O	790
from	O	790
the	O	790
Maternal	B-Disease	790
Phenylketonuria	I-Disease	790
Collaborative	O	790
Study	O	790
.	O	790

OBJECTIVE	O	791
To	O	791
examine	O	791
the	O	791
relationship	O	791
of	O	791
phenylalanine	O	791
hydroxylase	O	791
(	O	791
PAH	O	791
)	O	791
genotypes	O	791
to	O	791
biochemical	O	791
phenotype	O	791
and	O	791
cognitive	O	791
development	O	791
in	O	791
maternal	B-Disease	791
phenylketonuria	I-Disease	791
(	O	791
PKU	B-Disease	791
)	O	791
.	O	791

METHODOLOGY	O	792
PAH	O	792
gene	O	792
mutations	O	792
were	O	792
examined	O	792
in	O	792
222	O	792
hyperphenylalaninemic	B-Disease	792
females	O	792
enrolled	O	792
in	O	792
the	O	792
Maternal	B-Disease	792
PKU	I-Disease	792
Collaborative	O	792
Study	O	792
(	O	792
MPKUCS	O	792
)	O	792
.	O	792

Based	O	794
on	O	794
previous	O	794
knowledge	O	794
about	O	794
mutation	O	794
-	O	794
phenotype	O	794
associations	O	794
,	O	794
78	O	794
of	O	794
the	O	794
mutations	O	794
could	O	794
be	O	794
assigned	O	794
to	O	794
one	O	794
of	O	794
four	O	794
classes	O	794
of	O	794
severity	O	794
(	O	794
severe	O	794
PKU	B-Disease	794
,	O	794
moderate	O	794
PKU	B-Disease	794
,	O	794
mild	O	794
PKU	B-Disease	794
,	O	794
and	O	794
mild	B-Disease	794
hyperphenylalaninemia	I-Disease	794
[	O	794
MHP	B-Disease	794
]	O	794
)	O	794
.	O	794

The	O	800
IQ	O	800
of	O	800
PAH	B-Disease	800
-	I-Disease	800
deficient	I-Disease	800
mothers	O	800
with	O	800
a	O	800
severe	O	800
PKU	B-Disease	800
mutation	O	800
in	O	800
combination	O	800
with	O	800
a	O	800
MHP	B-Disease	800
mutation	O	800
or	O	800
a	O	800
mild	O	800
PKU	B-Disease	800
mutation	O	800
was	O	800
99	O	800
and	O	800
96	O	800
,	O	800
respectively	O	800
,	O	800
whereas	O	800
the	O	800
IQ	O	800
of	O	800
PKU	B-Disease	800
mothers	O	800
with	O	800
two	O	800
severe	O	800
PKU	B-Disease	800
mutations	O	800
or	O	800
with	O	800
one	O	800
severe	O	800
and	O	800
one	O	800
moderate	O	800
PKU	B-Disease	800
mutation	O	800
was	O	800
83	O	800
and	O	800
84	O	800
,	O	800
respectively	O	800
.	O	800

Of	O	801
the	O	801
patients	O	801
with	O	801
PKU	B-Disease	801
,	O	801
92	O	801
%	O	801
had	O	801
been	O	801
treated	O	801
during	O	801
childhood	O	801
.	O	801

Females	O	803
with	O	803
moderate	O	803
or	O	803
mild	O	803
PKU	B-Disease	803
who	O	803
were	O	803
treated	O	803
early	O	803
and	O	803
treated	O	803
for	O	803
>	O	803
6	O	803
years	O	803
showed	O	803
IQ	O	803
scores	O	803
10	O	803
points	O	803
above	O	803
average	O	803
for	O	803
their	O	803
group	O	803
.	O	803

CONCLUSIONS	O	804
The	O	804
reproductive	O	804
outcome	O	804
in	O	804
maternal	B-Disease	804
phenylketonuria	I-Disease	804
is	O	804
dependent	O	804
on	O	804
prenatal	O	804
metabolic	O	804
control	O	804
and	O	804
postnatal	O	804
environmental	O	804
circumstances	O	804
.	O	804

Both	O	805
factors	O	805
depend	O	805
on	O	805
the	O	805
intellectual	O	805
resources	O	805
of	O	805
the	O	805
mother	O	805
with	O	805
PKU	B-Disease	805
.	O	805

The	O	806
significant	O	806
relationship	O	806
among	O	806
genotype	O	806
,	O	806
biochemical	O	806
phenotype	O	806
,	O	806
and	O	806
cognitive	O	806
performance	O	806
observed	O	806
in	O	806
the	O	806
present	O	806
study	O	806
is	O	806
of	O	806
importance	O	806
for	O	806
the	O	806
development	O	806
of	O	806
an	O	806
optimal	O	806
strategy	O	806
for	O	806
future	O	806
treatment	O	806
of	O	806
females	O	806
with	O	806
PKU	B-Disease	806
who	O	806
plan	O	806
pregnancy	O	806
.	O	806

Spinal	B-Disease	808
xanthomatosis	I-Disease	808
:	O	808
a	O	808
variant	O	808
of	O	808
cerebrotendinous	B-Disease	808
xanthomatosis	I-Disease	808
.	O	808

We	O	809
describe	O	809
seven	O	809
Dutch	O	809
patients	O	809
from	O	809
six	O	809
families	O	809
with	O	809
a	O	809
slowly	O	809
progressive	O	809
,	O	809
mainly	O	809
spinal	B-Disease	809
cord	I-Disease	809
syndrome	I-Disease	809
that	O	809
remained	O	809
for	O	809
many	O	809
years	O	809
the	O	809
sole	O	809
expression	O	809
of	O	809
cerebrotendinous	B-Disease	809
xanthomatosis	I-Disease	809
(	O	809
CTX	B-Disease	809
)	O	809
.	O	809

MRI	O	810
demonstrated	O	810
white	B-Disease	810
matter	I-Disease	810
abnormalities	I-Disease	810
in	O	810
the	O	810
lateral	O	810
and	O	810
dorsal	O	810
columns	O	810
of	O	810
the	O	810
spinal	O	810
cord	O	810
.	O	810

We	O	813
conclude	O	813
that	O	813
spinal	B-Disease	813
xanthomatosis	I-Disease	813
is	O	813
a	O	813
clinical	O	813
and	O	813
radiological	O	813
separate	O	813
entity	O	813
of	O	813
CTX	B-Disease	813
that	O	813
should	O	813
be	O	813
included	O	813
in	O	813
the	O	813
differential	O	813
diagnosis	O	813
of	O	813
chronic	B-Disease	813
myelopathy	I-Disease	813
.	O	813

A	O	815
transgene	O	815
insertion	O	815
creating	O	815
a	O	815
heritable	O	815
chromosome	O	815
deletion	O	815
mouse	O	815
model	O	815
of	O	815
Prader	B-Disease	815
-	I-Disease	815
Willi	I-Disease	815
and	I-Disease	815
angelman	I-Disease	815
syndromes	I-Disease	815
.	O	815

Prader	B-Disease	816
-	I-Disease	816
Willi	I-Disease	816
syndrome	I-Disease	816
(	O	816
PWS	B-Disease	816
)	O	816
and	O	816
Angelman	B-Disease	816
syndrome	I-Disease	816
(	O	816
AS	B-Disease	816
)	O	816
result	O	816
from	O	816
the	O	816
loss	O	816
of	O	816
function	O	816
of	O	816
imprinted	O	816
genes	O	816
in	O	816
human	O	816
chromosome	O	816
15q11	O	816
-	O	816
q13	O	816
.	O	816

We	O	818
report	O	818
here	O	818
the	O	818
characterization	O	818
of	O	818
a	O	818
transgene	O	818
insertion	O	818
(	O	818
Epstein	O	818
-	O	818
Barr	O	818
virus	O	818
Latent	O	818
Membrane	O	818
Protein	O	818
2A	O	818
,	O	818
LMP2A	O	818
)	O	818
into	O	818
mouse	O	818
chromosome	O	818
7C	O	818
,	O	818
which	O	818
has	O	818
resulted	O	818
in	O	818
mouse	O	818
models	O	818
for	O	818
PWS	B-Disease	818
and	O	818
AS	B-Disease	818
dependent	O	818
on	O	818
the	O	818
sex	O	818
of	O	818
the	O	818
transmitting	O	818
parent	O	818
.	O	818

Epigenotype	O	819
(	O	819
allelic	O	819
expression	O	819
and	O	819
DNA	O	819
methylation	O	819
)	O	819
and	O	819
fluorescence	O	819
in	O	819
situ	O	819
hybridization	O	819
analyses	O	819
indicate	O	819
that	O	819
the	O	819
transgene	O	819
-	O	819
induced	O	819
mutation	O	819
has	O	819
generated	O	819
a	O	819
complete	O	819
deletion	O	819
of	O	819
the	O	819
PWS	B-Disease	819
/	O	819
AS	B-Disease	819
-	O	819
homologous	O	819
region	O	819
but	O	819
has	O	819
not	O	819
deleted	O	819
flanking	O	819
loci	O	819
.	O	819

Because	O	820
the	O	820
intact	O	820
chromosome	O	820
7	O	820
,	O	820
opposite	O	820
the	O	820
deleted	O	820
homolog	O	820
,	O	820
maintains	O	820
the	O	820
correct	O	820
imprint	O	820
in	O	820
somatic	O	820
cells	O	820
of	O	820
PWS	B-Disease	820
and	O	820
AS	B-Disease	820
mice	O	820
and	O	820
establishes	O	820
the	O	820
correct	O	820
imprint	O	820
in	O	820
male	O	820
and	O	820
female	O	820
germ	O	820
cells	O	820
of	O	820
AS	B-Disease	820
mice	O	820
,	O	820
homologous	O	820
association	O	820
and	O	820
replication	O	820
asynchrony	O	820
are	O	820
not	O	820
part	O	820
of	O	820
the	O	820
imprinting	O	820
mechanism	O	820
.	O	820

This	O	821
heritable	O	821
-	O	821
deletion	O	821
mouse	O	821
model	O	821
will	O	821
be	O	821
particularly	O	821
useful	O	821
for	O	821
the	O	821
identification	O	821
of	O	821
the	O	821
etiological	O	821
genes	O	821
and	O	821
mechanisms	O	821
,	O	821
phenotypic	O	821
basis	O	821
,	O	821
and	O	821
investigation	O	821
of	O	821
therapeutic	O	821
approaches	O	821
for	O	821
PWS	B-Disease	821
.	O	821

Linkage	O	823
analysis	O	823
of	O	823
5	O	823
novel	O	823
van	B-Disease	823
der	I-Disease	823
Woude	I-Disease	823
syndrome	I-Disease	823
kindreds	O	823
to	O	823
1q32	O	823
-	O	823
q41	O	823
markers	O	823
further	O	823
supports	O	823
locus	O	823
homogeneity	O	823
of	O	823
the	O	823
disease	O	823
trait	O	823
.	O	823

van	B-Disease	824
der	I-Disease	824
Woude	I-Disease	824
syndrome	I-Disease	824
(	O	824
vWS	B-Disease	824
,	O	824
MIM	O	824
119300	O	824
)	O	824
is	O	824
a	O	824
rare	O	824
autosomal	B-Disease	824
dominant	I-Disease	824
clefting	I-Disease	824
condition	I-Disease	824
with	O	824
cardinal	O	824
features	O	824
of	O	824
mucous	B-Disease	824
cysts	I-Disease	824
(	O	824
lower	B-Disease	824
-	I-Disease	824
lip	I-Disease	824
pits	I-Disease	824
)	O	824
and	O	824
clefts	B-Disease	824
to	I-Disease	824
the	I-Disease	824
lip	I-Disease	824
and	I-Disease	824
/	I-Disease	824
or	I-Disease	824
palate	I-Disease	824
.	O	824

The	O	825
vWS	B-Disease	825
gene	O	825
has	O	825
been	O	825
assigned	O	825
to	O	825
a	O	825
locus	O	825
in	O	825
1q32	O	825
-	O	825
q41	O	825
by	O	825
linkage	O	825
analysis	O	825
and	O	825
physical	O	825
mapping	O	825
.	O	825

We	O	826
have	O	826
investigated	O	826
5	O	826
novel	O	826
vWS	B-Disease	826
families	O	826
through	O	826
probands	O	826
attended	O	826
for	O	826
cleft	B-Disease	826
lip	I-Disease	826
and	I-Disease	826
/	I-Disease	826
or	I-Disease	826
palate	I-Disease	826
repair	O	826
at	O	826
the	O	826
Department	O	826
of	O	826
Maxillofacial	O	826
Surgery	O	826
of	O	826
Hopital	O	826
Trousseau	O	826
,	O	826
Paris	O	826
,	O	826
in	O	826
order	O	826
to	O	826
tentatively	O	826
refine	O	826
the	O	826
genetic	O	826
map	O	826
of	O	826
the	O	826
vWS	B-Disease	826
region	O	826
in	O	826
1q32	O	826
-	O	826
q41	O	826
and	O	826
possibly	O	826
identify	O	826
unlinked	O	826
pedigrees	O	826
.	O	826

Our	O	831
results	O	831
support	O	831
linkage	O	831
of	O	831
vWS	B-Disease	831
within	O	831
a	O	831
region	O	831
of	O	831
tightly	O	831
linked	O	831
markers	O	831
and	O	831
do	O	831
not	O	831
favour	O	831
locus	O	831
heterogeneity	O	831
of	O	831
the	O	831
disease	O	831
trait	O	831
.	O	831

Null	O	832
mutation	O	832
of	O	832
the	O	832
murine	O	832
ATP7B	O	832
(	O	832
Wilson	B-Disease	832
disease	I-Disease	832
)	O	832
gene	O	832
results	O	832
in	O	832
intracellular	B-Disease	832
copper	I-Disease	832
accumulation	I-Disease	832
and	O	832
late	B-Disease	832
-	I-Disease	832
onset	I-Disease	832
hepatic	I-Disease	832
nodular	I-Disease	832
transformation	I-Disease	832
.	O	832

Mutations	O	834
in	O	834
the	O	834
ATP7B	O	834
gene	O	834
lead	O	834
to	O	834
Wilson	B-Disease	834
disease	I-Disease	834
,	O	834
a	O	834
copper	B-Disease	834
toxicity	I-Disease	834
disorder	I-Disease	834
characterized	O	834
by	O	834
dramatic	O	834
build	O	834
-	O	834
up	O	834
of	O	834
intracellular	O	834
hepatic	O	834
copper	O	834
with	O	834
subsequent	O	834
hepatic	B-Disease	834
and	I-Disease	834
neuro	I-Disease	834
-	I-Disease	834
logical	I-Disease	834
abnormalities	I-Disease	834
.	O	834

Using	O	835
homologous	O	835
recombination	O	835
to	O	835
disrupt	O	835
the	O	835
normal	O	835
translation	O	835
of	O	835
ATP7B	O	835
,	O	835
we	O	835
have	O	835
generated	O	835
a	O	835
strain	O	835
of	O	835
mice	O	835
that	O	835
are	O	835
homozygous	O	835
mutants	O	835
(	O	835
nan	O	835
)	O	835
for	O	835
the	O	835
Wilson	B-Disease	835
disease	I-Disease	835
gene	O	835
.	O	835

An	O	837
increase	O	837
in	O	837
copper	O	837
concentration	O	837
was	O	837
also	O	837
observed	O	837
in	O	837
the	O	837
kidney	O	837
,	O	837
brain	O	837
,	O	837
placenta	O	837
and	O	837
lactating	O	837
mammary	O	837
glands	O	837
of	O	837
homo	O	837
-	O	837
zygous	O	837
mutants	O	837
,	O	837
although	O	837
milk	O	837
from	O	837
the	O	837
mutant	O	837
glands	O	837
was	O	837
copper	B-Disease	837
deficient	I-Disease	837
.	O	837

Morphological	B-Disease	838
abnormalities	I-Disease	838
resembling	O	838
cirrhosis	B-Disease	838
developed	O	838
in	O	838
the	O	838
majority	O	838
of	O	838
the	O	838
livers	O	838
from	O	838
homozygous	O	838
mutants	O	838
older	O	838
than	O	838
7	O	838
months	O	838
of	O	838
age	O	838
.	O	838

Progeny	O	839
of	O	839
the	O	839
homozygous	O	839
mutant	O	839
females	O	839
demonstrated	O	839
neurological	B-Disease	839
abnormalities	I-Disease	839
and	O	839
growth	B-Disease	839
retardation	I-Disease	839
characteristic	O	839
of	O	839
copper	B-Disease	839
deficiency	I-Disease	839
.	O	839

In	O	841
summary	O	841
,	O	841
inactivation	O	841
of	O	841
the	O	841
murine	O	841
ATP7B	O	841
gene	O	841
produces	O	841
a	O	841
form	O	841
of	O	841
cirrhotic	B-Disease	841
liver	I-Disease	841
disease	I-Disease	841
that	O	841
resembles	O	841
Wilson	B-Disease	841
disease	I-Disease	841
in	O	841
humans	O	841
and	O	841
the	O	841
toxic	O	841
milk	O	841
phenotype	O	841
in	O	841
the	O	841
mouse	O	841
.	O	841

French	O	843
Machado	B-Disease	843
-	I-Disease	843
Joseph	I-Disease	843
disease	I-Disease	843
patients	O	843
do	O	843
not	O	843
exhibit	O	843
gametic	O	843
segregation	O	843
distortion	O	843
:	O	843
a	O	843
sperm	O	843
typing	O	843
analysis	O	843
.	O	843

Segregation	O	844
distortion	O	844
has	O	844
been	O	844
reported	O	844
to	O	844
occur	O	844
in	O	844
a	O	844
number	O	844
of	O	844
the	O	844
trinucleotide	B-Disease	844
repeat	I-Disease	844
disorders	I-Disease	844
.	O	844

On	O	845
the	O	845
basis	O	845
of	O	845
a	O	845
sperm	O	845
typing	O	845
study	O	845
performed	O	845
in	O	845
patients	O	845
of	O	845
Japanese	O	845
descent	O	845
with	O	845
Machado	B-Disease	845
-	I-Disease	845
Joseph	I-Disease	845
disease	I-Disease	845
(	O	845
MJD	B-Disease	845
)	O	845
,	O	845
it	O	845
was	O	845
reported	O	845
that	O	845
disease	O	845
alleles	O	845
are	O	845
preferentially	O	845
transmitted	O	845
during	O	845
meiosis	O	845
.	O	845

We	O	846
performed	O	846
a	O	846
sperm	O	846
typing	O	846
study	O	846
of	O	846
five	O	846
MJD	B-Disease	846
patients	O	846
of	O	846
French	O	846
descent	O	846
and	O	846
analysis	O	846
of	O	846
the	O	846
pooled	O	846
data	O	846
shows	O	846
a	O	846
ratio	O	846
of	O	846
mutant	O	846
to	O	846
normal	O	846
alleles	O	846
of	O	846
379	O	846
436	O	846
(	O	846
46	O	846
.	O	846

However	O	858
,	O	858
analysis	O	858
of	O	858
the	O	858
variance	O	858
in	O	858
repeat	O	858
number	O	858
in	O	858
sperm	O	858
from	O	858
the	O	858
French	O	858
MJD	B-Disease	858
patients	O	858
overlapped	O	858
significantly	O	858
with	O	858
the	O	858
variance	O	858
in	O	858
repeat	O	858
number	O	858
observed	O	858
in	O	858
the	O	858
C	O	858
/	O	858
C	O	858
homozygous	O	858
Japanese	O	858
patients	O	858
.	O	858

Missense	O	859
mutation	O	859
in	O	859
the	O	859
alternative	O	859
splice	O	859
region	O	859
of	O	859
the	O	859
PAX6	O	859
gene	O	859
in	O	859
eye	B-Disease	859
anomalies	I-Disease	859
.	O	859

The	O	860
PAX6	O	860
gene	O	860
is	O	860
involved	O	860
in	O	860
ocular	O	860
morphogenesis	O	860
,	O	860
and	O	860
PAX6	O	860
mutations	O	860
have	O	860
been	O	860
detected	O	860
in	O	860
various	O	860
types	O	860
of	O	860
ocular	B-Disease	860
anomalies	I-Disease	860
,	O	860
including	O	860
aniridia	B-Disease	860
,	O	860
Peters	B-Disease	860
anomaly	I-Disease	860
,	O	860
corneal	B-Disease	860
dystrophy	I-Disease	860
,	O	860
congenital	B-Disease	860
cataract	I-Disease	860
,	O	860
and	O	860
foveal	B-Disease	860
hypoplasia	I-Disease	860
.	O	860

We	O	866
ascertained	O	866
a	O	866
novel	O	866
missense	O	866
mutation	O	866
in	O	866
four	O	866
pedigrees	O	866
with	O	866
Peters	B-Disease	866
anomaly	I-Disease	866
,	O	866
congenital	B-Disease	866
cataract	I-Disease	866
,	O	866
Axenfeldt	B-Disease	866
anomaly	I-Disease	866
,	O	866
and	O	866
/	O	866
or	O	866
foveal	B-Disease	866
hypoplasia	I-Disease	866
,	O	866
which	O	866
,	O	866
to	O	866
our	O	866
knowledge	O	866
,	O	866
is	O	866
the	O	866
first	O	866
mutation	O	866
identified	O	866
in	O	866
the	O	866
splice	O	866
-	O	866
variant	O	866
region	O	866
.	O	866

Penetrances	O	870
of	O	870
BRCA1	O	870
1675delA	O	870
and	O	870
1135insA	O	870
with	O	870
respect	O	870
to	O	870
breast	B-Disease	870
cancer	I-Disease	870
and	O	870
ovarian	B-Disease	870
cancer	I-Disease	870
.	O	870

For	O	871
genetic	O	871
counseling	O	871
and	O	871
predictive	O	871
testing	O	871
in	O	871
families	O	871
with	O	871
inherited	B-Disease	871
breast	I-Disease	871
-	I-Disease	871
ovarian	I-Disease	871
cancer	I-Disease	871
,	O	871
penetrances	O	871
and	O	871
expressions	O	871
of	O	871
the	O	871
underlying	O	871
mutations	O	871
should	O	871
be	O	871
known	O	871
.	O	871

Index	O	873
cases	O	873
for	O	873
the	O	873
present	O	873
study	O	873
were	O	873
found	O	873
two	O	873
different	O	873
ways	O	873
through	O	873
a	O	873
series	O	873
of	O	873
consecutive	O	873
ovarian	B-Disease	873
cancers	I-Disease	873
(	O	873
n	O	873
=	O	873
16	O	873
)	O	873
and	O	873
through	O	873
our	O	873
family	O	873
cancer	B-Disease	873
clinic	O	873
(	O	873
n	O	873
=	O	873
14	O	873
)	O	873
.	O	873

Their	O	875
relatives	O	875
were	O	875
described	O	875
with	O	875
respect	O	875
to	O	875
absence	O	875
/	O	875
presence	O	875
of	O	875
breast	B-Disease	875
and	I-Disease	875
/	I-Disease	875
or	I-Disease	875
ovarian	I-Disease	875
cancer	I-Disease	875
.	O	875

The	O	878
overall	O	878
findings	O	878
were	O	878
that	O	878
disease	O	878
started	O	878
to	O	878
occur	O	878
at	O	878
age	O	878
30	O	878
years	O	878
and	O	878
that	O	878
by	O	878
age	O	878
50	O	878
years	O	878
48	O	878
%	O	878
of	O	878
the	O	878
mutation	O	878
-	O	878
carrying	O	878
women	O	878
had	O	878
experienced	O	878
breast	B-Disease	878
and	I-Disease	878
/	I-Disease	878
or	I-Disease	878
ovarian	I-Disease	878
cancer	I-Disease	878
.	O	878

More	O	879
ovarian	B-Disease	879
cancers	I-Disease	879
than	O	879
breast	B-Disease	879
cancers	I-Disease	879
were	O	879
recorded	O	879
.	O	879

Both	O	880
penetrance	O	880
and	O	880
expression	O	880
(	O	880
breast	B-Disease	880
cancer	I-Disease	880
vs	O	880
.	O	880

ovarian	B-Disease	881
cancer	I-Disease	881
)	O	881
were	O	881
different	O	881
from	O	881
those	O	881
in	O	881
reports	O	881
of	O	881
the	O	881
Ashkenazi	O	881
founder	O	881
mutations	O	881
.	O	881

The	O	887
dermatofibrosarcoma	B-Disease	887
protuberans	I-Disease	887
-	O	887
associated	O	887
collagen	O	887
type	O	887
Ialpha1	O	887
/	O	887
platelet	O	887
-	O	887
derived	O	887
growth	O	887
factor	O	887
(	O	887
PDGF	O	887
)	O	887
B	O	887
-	O	887
chain	O	887
fusion	O	887
gene	O	887
generates	O	887
a	O	887
transforming	O	887
protein	O	887
that	O	887
is	O	887
processed	O	887
to	O	887
functional	O	887
PDGF	O	887
-	O	887
BB	O	887
.	O	887

Dermatofibrosarcoma	B-Disease	888
protuberans	I-Disease	888
(	O	888
DFSP	B-Disease	888
)	O	888
displays	O	888
chromosomal	O	888
rearrangements	O	888
involving	O	888
chromosome	O	888
17	O	888
and	O	888
22	O	888
,	O	888
which	O	888
fuse	O	888
the	O	888
collagen	O	888
type	O	888
Ialpha1	O	888
(	O	888
COLIA1	O	888
)	O	888
gene	O	888
to	O	888
the	O	888
platelet	O	888
-	O	888
derived	O	888
growth	O	888
factor	O	888
(	O	888
PDGF	O	888
)	O	888
B	O	888
-	O	888
chain	O	888
(	O	888
PDGFB	O	888
)	O	888
gene	O	888
.	O	888

Finally	O	894
,	O	894
COLIA1	O	894
/	O	894
PDGFB	O	894
-	O	894
expressing	O	894
cells	O	894
generated	O	894
tumors	B-Disease	894
after	O	894
s	O	894
.	O	894

injection	O	896
into	O	896
nude	O	896
mice	O	896
,	O	896
and	O	896
tumor	B-Disease	896
growth	O	896
was	O	896
reduced	O	896
by	O	896
treatment	O	896
with	O	896
CGP57148B	O	896
.	O	896

We	O	897
conclude	O	897
that	O	897
the	O	897
COLIA1	O	897
/	O	897
PDGFB	O	897
fusion	O	897
associated	O	897
with	O	897
DFSP	B-Disease	897
contributes	O	897
to	O	897
tumor	B-Disease	897
development	O	897
through	O	897
ectopic	O	897
production	O	897
of	O	897
PDGF	O	897
-	O	897
BB	O	897
and	O	897
the	O	897
formation	O	897
of	O	897
an	O	897
autocrine	O	897
loop	O	897
.	O	897

Our	O	898
findings	O	898
,	O	898
thus	O	898
,	O	898
suggest	O	898
that	O	898
PDGF	O	898
receptors	O	898
could	O	898
be	O	898
a	O	898
target	O	898
for	O	898
pharmacological	O	898
treatment	O	898
of	O	898
DFSP	B-Disease	898
and	O	898
giant	B-Disease	898
cell	I-Disease	898
fibroblastoma	I-Disease	898
,	O	898
e	O	898
.	O	898

Identification	O	901
of	O	901
a	O	901
common	O	901
PEX1	O	901
mutation	O	901
in	O	901
Zellweger	B-Disease	901
syndrome	I-Disease	901
.	O	901

The	O	902
Zellweger	B-Disease	902
spectrum	I-Disease	902
of	I-Disease	902
disease	I-Disease	902
,	O	902
encompassing	O	902
Zellweger	B-Disease	902
syndrome	I-Disease	902
and	O	902
the	O	902
progressively	O	902
milder	O	902
phenotypes	O	902
of	O	902
neonatal	B-Disease	902
adrenoleukodystrophy	I-Disease	902
and	O	902
infantile	B-Disease	902
Refsum	I-Disease	902
disease	I-Disease	902
,	O	902
is	O	902
due	O	902
to	O	902
a	O	902
failure	O	902
to	O	902
form	O	902
functional	O	902
peroxisomes	O	902
.	O	902

However	O	905
,	O	905
previous	O	905
studies	O	905
have	O	905
focused	O	905
on	O	905
mildly	O	905
affected	O	905
patients	O	905
and	O	905
there	O	905
is	O	905
still	O	905
no	O	905
report	O	905
of	O	905
two	O	905
mutant	O	905
PEX1	O	905
alleles	O	905
in	O	905
any	O	905
Zellweger	B-Disease	905
syndrome	I-Disease	905
patient	O	905
.	O	905

Furthermore	O	906
,	O	906
mutations	O	906
in	O	906
the	O	906
PMP70	O	906
gene	O	906
have	O	906
also	O	906
been	O	906
identified	O	906
in	O	906
two	O	906
Zellweger	B-Disease	906
syndrome	I-Disease	906
patients	O	906
from	O	906
CG1	O	906
,	O	906
raising	O	906
the	O	906
possibility	O	906
that	O	906
CG1	O	906
patients	O	906
may	O	906
represent	O	906
a	O	906
mixture	O	906
of	O	906
PEX1	O	906
-	O	906
deficient	O	906
and	O	906
PMP70	O	906
-	O	906
deficient	O	906
individuals	O	906
.	O	906

To	O	907
address	O	907
the	O	907
molecular	O	907
basis	O	907
of	O	907
disease	O	907
in	O	907
Zellweger	B-Disease	907
syndrome	I-Disease	907
patients	O	907
from	O	907
CG1	O	907
,	O	907
we	O	907
examined	O	907
all	O	907
24	O	907
PEX1	O	907
exons	O	907
in	O	907
four	O	907
patients	O	907
,	O	907
including	O	907
both	O	907
patients	O	907
that	O	907
have	O	907
mutations	O	907
in	O	907
PMP70	O	907
.	O	907

Subsequent	O	910
studies	O	910
demonstrated	O	910
that	O	910
this	O	910
mutation	O	910
is	O	910
present	O	910
in	O	910
one	O	910
-	O	910
half	O	910
of	O	910
all	O	910
CG1	O	910
patients	O	910
and	O	910
correlates	O	910
with	O	910
the	O	910
Zellweger	B-Disease	910
syndrome	I-Disease	910
phenotype	O	910
.	O	910

As	O	911
this	O	911
mutation	O	911
leads	O	911
to	O	911
a	O	911
loss	O	911
of	O	911
protein	O	911
function	O	911
its	O	911
frequency	O	911
makes	O	911
it	O	911
the	O	911
most	O	911
common	O	911
cause	O	911
of	O	911
Zellweger	B-Disease	911
syndrome	I-Disease	911
,	O	911
helping	O	911
to	O	911
explain	O	911
the	O	911
high	O	911
percentage	O	911
of	O	911
patients	O	911
that	O	911
belong	O	911
to	O	911
CG1	O	911
.	O	911

Novel	O	912
mutations	O	912
in	O	912
the	O	912
Wiskott	B-Disease	912
-	I-Disease	912
Aldrich	I-Disease	912
syndrome	I-Disease	912
protein	O	912
gene	O	912
and	O	912
their	O	912
effects	O	912
on	O	912
transcriptional	O	912
,	O	912
translational	O	912
,	O	912
and	O	912
clinical	O	912
phenotypes	O	912
.	O	912

Wiskott	B-Disease	913
-	I-Disease	913
Aldrich	I-Disease	913
syndrome	I-Disease	913
(	O	913
WAS	B-Disease	913
)	O	913
is	O	913
an	O	913
X	B-Disease	913
-	I-Disease	913
linked	I-Disease	913
recessive	I-Disease	913
immunodeficiency	I-Disease	913
characterized	O	913
by	O	913
thrombocytopenia	B-Disease	913
,	O	913
eczema	B-Disease	913
,	O	913
and	O	913
recurrent	O	913
infections	O	913
,	O	913
and	O	913
caused	O	913
by	O	913
mutations	O	913
in	O	913
the	O	913
WAS	B-Disease	913
protein	O	913
(	O	913
WASP	O	913
)	O	913
gene	O	913
.	O	913

No	O	924
protein	O	924
was	O	924
detected	O	924
in	O	924
two	O	924
individuals	O	924
with	O	924
severe	O	924
WAS	B-Disease	924
.	O	924

Reduced	O	925
levels	O	925
of	O	925
a	O	925
normal	O	925
-	O	925
size	O	925
WASP	O	925
with	O	925
a	O	925
missense	O	925
mutation	O	925
were	O	925
seen	O	925
in	O	925
two	O	925
individuals	O	925
with	O	925
XLT	B-Disease	925
.	O	925

Duchenne	B-Disease	930
muscular	I-Disease	930
dystrophy	I-Disease	930
(	O	930
DMD	B-Disease	930
)	O	930
is	O	930
caused	O	930
by	O	930
mutations	O	930
in	O	930
the	O	930
dystrophin	O	930
gene	O	930
,	O	930
leading	O	930
to	O	930
the	O	930
absence	O	930
of	O	930
the	O	930
dystrophin	O	930
protein	O	930
in	O	930
striated	O	930
muscle	O	930
.	O	930

On	O	932
the	O	932
basis	O	932
of	O	932
the	O	932
observation	O	932
that	O	932
aminoglycoside	O	932
treatment	O	932
can	O	932
suppress	O	932
stop	O	932
codons	O	932
in	O	932
cultured	O	932
cells	O	932
,	O	932
we	O	932
tested	O	932
the	O	932
effect	O	932
of	O	932
gentamicin	O	932
on	O	932
cultured	O	932
muscle	O	932
cells	O	932
from	O	932
the	O	932
mdx	O	932
mouse	O	932
-	O	932
an	O	932
animal	O	932
model	O	932
for	O	932
DMD	B-Disease	932
that	O	932
possesses	O	932
a	O	932
premature	O	932
stop	O	932
codon	O	932
in	O	932
the	O	932
dystrophin	O	932
gene	O	932
.	O	932

We	O	935
identified	O	935
a	O	935
treatment	O	935
regimen	O	935
that	O	935
resulted	O	935
in	O	935
the	O	935
presence	O	935
of	O	935
dystrophin	O	935
in	O	935
the	O	935
cell	O	935
membrane	O	935
in	O	935
all	O	935
striated	O	935
muscles	O	935
examined	O	935
and	O	935
that	O	935
provided	O	935
functional	O	935
protection	O	935
against	O	935
muscular	B-Disease	935
injury	I-Disease	935
.	O	935

Furthermore	O	937
,	O	937
these	O	937
results	O	937
raise	O	937
the	O	937
possibility	O	937
of	O	937
a	O	937
novel	O	937
treatment	O	937
regimen	O	937
for	O	937
muscular	B-Disease	937
dystrophy	I-Disease	937
and	O	937
other	O	937
diseases	O	937
caused	O	937
by	O	937
premature	O	937
stop	O	937
codon	O	937
mutations	O	937
.	O	937

This	O	938
treatment	O	938
could	O	938
prove	O	938
effective	O	938
in	O	938
up	O	938
to	O	938
15	O	938
%	O	938
of	O	938
patients	O	938
with	O	938
DMD	B-Disease	938
.	O	938

Loss	O	940
of	O	940
the	O	940
ataxia	B-Disease	940
-	I-Disease	940
telangiectasia	I-Disease	940
gene	O	940
product	O	940
causes	O	940
oxidative	O	940
damage	O	940
in	O	940
target	O	940
organs	O	940
.	O	940

Ataxia	B-Disease	941
-	I-Disease	941
telangiectasia	I-Disease	941
(	O	941
A	B-Disease	941
-	I-Disease	941
T	I-Disease	941
)	O	941
is	O	941
characterized	O	941
by	O	941
a	O	941
markedly	O	941
increased	O	941
sensitivity	O	941
to	O	941
ionizing	O	941
radiation	O	941
,	O	941
increased	O	941
incidence	O	941
of	O	941
cancer	B-Disease	941
,	O	941
and	O	941
neurodegeneration	B-Disease	941
,	O	941
especially	O	941
of	O	941
the	O	941
cerebellar	O	941
Purkinje	O	941
cells	O	941
.	O	941

We	O	943
therefore	O	943
hypothesized	O	943
that	O	943
A	B-Disease	943
-	I-Disease	943
T	I-Disease	943
is	O	943
due	O	943
to	O	943
oxidative	O	943
damage	O	943
resulting	O	943
from	O	943
loss	O	943
of	O	943
function	O	943
of	O	943
the	O	943
A	B-Disease	943
-	I-Disease	943
T	I-Disease	943
gene	O	943
product	O	943
.	O	943

To	O	944
assess	O	944
this	O	944
hypothesis	O	944
,	O	944
we	O	944
employed	O	944
an	O	944
animal	O	944
model	O	944
of	O	944
A	B-Disease	944
-	I-Disease	944
T	I-Disease	944
,	O	944
the	O	944
mouse	O	944
with	O	944
a	O	944
disrupted	O	944
Atm	O	944
gene	O	944
.	O	944

These	O	946
observations	O	946
provide	O	946
a	O	946
mechanistic	O	946
basis	O	946
for	O	946
the	O	946
A	B-Disease	946
-	I-Disease	946
T	I-Disease	946
phenotype	O	946
and	O	946
lay	O	946
a	O	946
rational	O	946
foundation	O	946
for	O	946
therapeutic	O	946
intervention	O	946
.	O	946

Recessively	O	948
inherited	O	948
multiple	B-Disease	948
epiphyseal	I-Disease	948
dysplasia	I-Disease	948
with	O	948
normal	O	948
stature	O	948
,	O	948
club	B-Disease	948
foot	I-Disease	948
,	O	948
and	O	948
double	B-Disease	948
layered	I-Disease	948
patella	I-Disease	948
caused	O	948
by	O	948
a	O	948
DTDST	O	948
mutation	O	948
.	O	948

We	O	949
have	O	949
observed	O	949
over	O	949
25	O	949
different	O	949
mutations	O	949
in	O	949
the	O	949
diastrophic	B-Disease	949
dysplasia	I-Disease	949
sulphate	O	949
transporter	O	949
gene	O	949
(	O	949
DTDST	O	949
)	O	949
in	O	949
association	O	949
with	O	949
the	O	949
recessive	B-Disease	949
disorders	I-Disease	949
achondrogenesis	B-Disease	949
1B	I-Disease	949
,	O	949
atelosteogenesis	B-Disease	949
2	I-Disease	949
,	O	949
and	O	949
diastrophic	B-Disease	949
dysplasia	I-Disease	949
.	O	949

We	O	951
had	O	951
not	O	951
seen	O	951
a	O	951
case	O	951
of	O	951
homozygosity	O	951
for	O	951
c862t	O	951
(	O	951
R279W	O	951
)	O	951
until	O	951
we	O	951
analysed	O	951
DNA	O	951
from	O	951
a	O	951
36	O	951
year	O	951
old	O	951
male	O	951
with	O	951
tall	O	951
-	O	951
normal	O	951
stature	O	951
(	O	951
180	O	951
cm	O	951
)	O	951
who	O	951
asked	O	951
for	O	951
genetic	O	951
counselling	O	951
for	O	951
suspected	O	951
multiple	B-Disease	951
epiphyseal	I-Disease	951
dysplasia	I-Disease	951
.	O	951

He	O	952
was	O	952
treated	O	952
for	O	952
club	B-Disease	952
foot	I-Disease	952
and	O	952
hip	B-Disease	952
dysplasia	I-Disease	952
at	O	952
birth	O	952
.	O	952

Skeletal	O	953
changes	O	953
consistent	O	953
with	O	953
multiple	B-Disease	953
epiphyseal	I-Disease	953
dysplasia	I-Disease	953
,	O	953
with	O	953
the	O	953
peculiar	O	953
finding	O	953
of	O	953
a	O	953
double	B-Disease	953
layered	I-Disease	953
patella	I-Disease	953
,	O	953
were	O	953
recognised	O	953
during	O	953
childhood	O	953
.	O	953

Cleft	B-Disease	954
palate	I-Disease	954
,	O	954
swelling	B-Disease	954
of	I-Disease	954
the	I-Disease	954
ear	I-Disease	954
pinna	I-Disease	954
,	O	954
and	O	954
hitch	B-Disease	954
hiker	I-Disease	954
thumb	I-Disease	954
were	O	954
absent	O	954
.	O	954

He	O	955
was	O	955
found	O	955
to	O	955
be	O	955
homozygous	O	955
,	O	955
and	O	955
both	O	955
healthy	O	955
parents	O	955
heterozygous	O	955
,	O	955
for	O	955
the	O	955
R279W	O	955
mutation	O	955
in	O	955
DTDST	O	955
,	O	955
and	O	955
his	O	955
fibroblasts	O	955
showed	O	955
a	O	955
sulphate	O	955
incorporation	O	955
defect	O	955
typical	O	955
of	O	955
DTDST	B-Disease	955
disorders	I-Disease	955
.	O	955

Counselling	O	956
was	O	956
given	O	956
for	O	956
a	O	956
recessive	B-Disease	956
disorder	I-Disease	956
,	O	956
thereby	O	956
considerably	O	956
reducing	O	956
the	O	956
probability	O	956
of	O	956
affected	O	956
offspring	O	956
.	O	956

Multiple	B-Disease	957
epiphyseal	I-Disease	957
dysplasia	I-Disease	957
is	O	957
more	O	957
frequently	O	957
caused	O	957
by	O	957
dominant	O	957
mutations	O	957
in	O	957
the	O	957
COMP	O	957
(	O	957
EDM1	B-Disease	957
,	O	957
McKusick	O	957
132400	O	957
)	O	957
and	O	957
COL9A2	O	957
genes	O	957
(	O	957
EDM2	B-Disease	957
,	O	957
McKusick	O	957
600204	O	957
)	O	957
.	O	957

A	O	958
few	O	958
other	O	958
patients	O	958
and	O	958
families	O	958
with	O	958
features	O	958
similar	O	958
to	O	958
our	O	958
proband	O	958
have	O	958
been	O	958
described	O	958
previously	O	958
and	O	958
considered	O	958
to	O	958
have	O	958
autosomal	O	958
recessive	O	958
MED	B-Disease	958
(	O	958
EDM4	B-Disease	958
,	O	958
McKusick	O	958
226900	O	958
)	O	958
.	O	958

Homozygosity	O	961
for	O	961
a	O	961
novel	O	961
DTDST	O	961
mutation	O	961
in	O	961
a	O	961
child	O	961
with	O	961
a	O	961
'	O	961
broad	O	961
bone	O	961
-	O	961
platyspondylic	O	961
'	O	961
variant	O	961
of	O	961
diastrophic	B-Disease	961
dysplasia	I-Disease	961
.	O	961

Atypical	O	962
or	O	962
variant	O	962
forms	O	962
of	O	962
well	O	962
-	O	962
known	O	962
chondrodysplasias	B-Disease	962
may	O	962
pose	O	962
diagnostic	O	962
problems	O	962
.	O	962

We	O	963
report	O	963
on	O	963
a	O	963
girl	O	963
with	O	963
clinical	O	963
features	O	963
suggesting	O	963
diastrophic	B-Disease	963
dysplasia	I-Disease	963
but	O	963
with	O	963
unusual	O	963
radiographic	O	963
features	O	963
including	O	963
severe	O	963
platyspondyly	B-Disease	963
,	O	963
wide	O	963
metaphyses	O	963
,	O	963
and	O	963
fibular	O	963
overgrowth	O	963
,	O	963
which	O	963
are	O	963
partially	O	963
reminiscent	O	963
of	O	963
metatropic	B-Disease	963
dysplasia	I-Disease	963
.	O	963

The	O	967
type	O	967
of	O	967
somatic	O	967
mutation	O	967
at	O	967
APC	O	967
in	O	967
familial	B-Disease	967
adenomatous	I-Disease	967
polyposis	I-Disease	967
is	O	967
determined	O	967
by	O	967
the	O	967
site	O	967
of	O	967
the	O	967
germline	O	967
mutation	O	967
:	O	967
a	O	967
new	O	967
facet	O	967
to	O	967
Knudson	O	967
'	O	967
s	O	967
'	O	967
two	O	967
-	O	967
hit	O	967
'	O	967
hypothesis	O	967
.	O	967

APC	O	968
is	O	968
often	O	968
cited	O	968
as	O	968
a	O	968
prime	O	968
example	O	968
of	O	968
a	O	968
tumor	B-Disease	968
suppressor	O	968
gene	O	968
.	O	968

Truncating	O	969
germline	O	969
and	O	969
somatic	O	969
mutations	O	969
(	O	969
or	O	969
,	O	969
infrequently	O	969
,	O	969
allelic	O	969
loss	O	969
)	O	969
occur	O	969
in	O	969
tumors	B-Disease	969
in	O	969
FAP	B-Disease	969
(	O	969
familial	B-Disease	969
adenomatous	I-Disease	969
polyposis	I-Disease	969
)	O	969
.	O	969

Most	O	970
sporadic	B-Disease	970
colorectal	I-Disease	970
cancers	I-Disease	970
also	O	970
have	O	970
two	O	970
APC	B-Disease	970
mutations	O	970
.	O	970

Clues	O	971
from	O	971
attenuated	B-Disease	971
polyposis	I-Disease	971
,	O	971
missense	O	971
germline	O	971
variants	O	971
with	O	971
mild	O	971
disease	O	971
and	O	971
the	O	971
somatic	O	971
mutation	O	971
cluster	O	971
region	O	971
(	O	971
codons	O	971
1	O	971
,	O	971
250	O	971
-	O	971
1	O	971
,	O	971
450	O	971
)	O	971
indicate	O	971
,	O	971
however	O	971
,	O	971
that	O	971
APC	B-Disease	971
mutations	O	971
might	O	971
not	O	971
result	O	971
in	O	971
simple	O	971
loss	O	971
of	O	971
protein	O	971
function	O	971
.	O	971

We	O	972
have	O	972
found	O	972
that	O	972
FAP	B-Disease	972
patients	O	972
with	O	972
germline	O	972
APC	B-Disease	972
mutations	O	972
within	O	972
a	O	972
small	O	972
region	O	972
(	O	972
codons	O	972
1	O	972
,	O	972
194	O	972
-	O	972
1	O	972
,	O	972
392	O	972
at	O	972
most	O	972
)	O	972
mainly	O	972
show	O	972
allelic	O	972
loss	O	972
in	O	972
their	O	972
colorectal	B-Disease	972
adenomas	I-Disease	972
,	O	972
in	O	972
contrast	O	972
to	O	972
other	O	972
FAP	B-Disease	972
patients	O	972
,	O	972
whose	O	972
second	O	972
hits	O	972
tend	O	972
to	O	972
occur	O	972
by	O	972
truncating	O	972
mutations	O	972
in	O	972
the	O	972
mutation	O	972
cluster	O	972
region	O	972
.	O	972

Our	O	973
results	O	973
indicate	O	973
that	O	973
different	O	973
APC	B-Disease	973
mutations	O	973
provide	O	973
cells	O	973
with	O	973
different	O	973
selective	O	973
advantages	O	973
,	O	973
with	O	973
mutations	O	973
close	O	973
to	O	973
codon	O	973
1	O	973
,	O	973
300	O	973
providing	O	973
the	O	973
greatest	O	973
advantage	O	973
.	O	973

A	O	975
different	O	975
germline	O	975
-	O	975
somatic	O	975
APC	B-Disease	975
mutation	O	975
association	O	975
exists	O	975
in	O	975
FAP	B-Disease	975
desmoids	I-Disease	975
.	O	975

APC	O	976
is	O	976
not	O	976
,	O	976
therefore	O	976
,	O	976
a	O	976
classical	O	976
tumor	B-Disease	976
suppressor	O	976
.	O	976

Our	O	977
findings	O	977
also	O	977
indicate	O	977
a	O	977
new	O	977
mechanism	O	977
for	O	977
disease	O	977
severity	O	977
if	O	977
a	O	977
broader	O	977
spectrum	O	977
of	O	977
mutations	O	977
is	O	977
selected	O	977
in	O	977
tumors	B-Disease	977
,	O	977
the	O	977
somatic	O	977
mutation	O	977
rate	O	977
is	O	977
effectively	O	977
higher	O	977
and	O	977
more	O	977
tumors	B-Disease	977
grow	O	977
.	O	977

Mxi1	O	979
mutations	O	979
in	O	979
human	O	979
neurofibrosarcomas	B-Disease	979
.	O	979

Mxi1	O	980
is	O	980
thought	O	980
to	O	980
negatively	O	980
regulate	O	980
Myc	O	980
function	O	980
and	O	980
may	O	980
therefore	O	980
be	O	980
a	O	980
potential	O	980
tumor	B-Disease	980
suppressor	O	980
gene	O	980
.	O	980

Little	O	981
effort	O	981
has	O	981
yet	O	981
been	O	981
made	O	981
to	O	981
find	O	981
alterations	O	981
involving	O	981
this	O	981
gene	O	981
in	O	981
human	O	981
solid	B-Disease	981
tumors	I-Disease	981
.	O	981

We	O	982
screened	O	982
31	O	982
human	O	982
gastric	B-Disease	982
cancers	I-Disease	982
,	O	982
7	O	982
esophageal	B-Disease	982
cancers	I-Disease	982
,	O	982
85	O	982
bone	B-Disease	982
and	I-Disease	982
soft	I-Disease	982
tissue	I-Disease	982
tumors	I-Disease	982
of	O	982
various	O	982
types	O	982
,	O	982
including	O	982
4	O	982
neurofibrosarcomas	B-Disease	982
.	O	982

We	O	983
also	O	983
examined	O	983
29	O	983
human	O	983
tumor	B-Disease	983
cell	O	983
lines	O	983
consisting	O	983
of	O	983
12	O	983
esophageal	B-Disease	983
cancers	I-Disease	983
,	O	983
7	O	983
glioma	B-Disease	983
/	O	983
glioblastomas	B-Disease	983
and	O	983
10	O	983
others	O	983
for	O	983
Mxi1	O	983
mutations	O	983
in	O	983
exons	O	983
1	O	983
,	O	983
2	O	983
,	O	983
4	O	983
(	O	983
HLH	O	983
domain	O	983
)	O	983
,	O	983
5	O	983
and	O	983
6	O	983
.	O	983

We	O	985
discovered	O	985
a	O	985
missense	O	985
mutation	O	985
,	O	985
GCA	O	985
to	O	985
GTA	O	985
(	O	985
Ala	O	985
54	O	985
Val	O	985
)	O	985
,	O	985
in	O	985
exon	O	985
2	O	985
in	O	985
a	O	985
neurofibrosarcoma	B-Disease	985
patient	O	985
(	O	985
case	O	985
1	O	985
)	O	985
,	O	985
two	O	985
missense	O	985
mutations	O	985
,	O	985
AAA	O	985
to	O	985
CAA	O	985
(	O	985
Lys	O	985
118	O	985
Gln	O	985
)	O	985
and	O	985
GAA	O	985
to	O	985
GGA	O	985
(	O	985
Glu	O	985
154	O	985
Gly	O	985
)	O	985
in	O	985
exon	O	985
5	O	985
of	O	985
another	O	985
neurofibrosarcoma	B-Disease	985
patient	O	985
(	O	985
case	O	985
2	O	985
)	O	985
,	O	985
and	O	985
3	O	985
amino	O	985
acid	O	985
substitutions	O	985
,	O	985
GTG	O	985
to	O	985
GCG	O	985
(	O	985
Val	O	985
179	O	985
Ala	O	985
)	O	985
,	O	985
GTT	O	985
to	O	985
GCT	O	985
(	O	985
Val	O	985
181	O	985
Ala	O	985
)	O	985
and	O	985
TTC	O	985
to	O	985
CTC	O	985
(	O	985
Phe	O	985
186	O	985
Leu	O	985
)	O	985
,	O	985
in	O	985
a	O	985
third	O	985
neurofibrosarcoma	B-Disease	985
patient	O	985
(	O	985
case	O	985
3	O	985
)	O	985
.	O	985

Our	O	987
data	O	987
demonstrate	O	987
that	O	987
mutations	O	987
occur	O	987
in	O	987
the	O	987
Mxi1	O	987
gene	O	987
in	O	987
neurofibrosarcoma	B-Disease	987
.	O	987

Missense	O	988
mutations	O	988
in	O	988
the	O	988
functional	O	988
domain	O	988
of	O	988
Mxi1	O	988
in	O	988
these	O	988
cases	O	988
may	O	988
be	O	988
involved	O	988
in	O	988
the	O	988
pathogenesis	O	988
of	O	988
neurofibrosarcoma	B-Disease	988
.	O	988

A	O	990
population	O	990
-	O	990
based	O	990
study	O	990
of	O	990
the	O	990
clinical	O	990
expression	O	990
of	O	990
the	O	990
hemochromatosis	B-Disease	990
gene	O	990
.	O	990

BACKGROUND	O	991
AND	O	991
METHODS	O	991
Hereditary	B-Disease	991
hemochromatosis	I-Disease	991
is	O	991
associated	O	991
with	O	991
homozygosity	O	991
for	O	991
the	O	991
C282Y	O	991
mutation	O	991
in	O	991
the	O	991
hemochromatosis	B-Disease	991
(	O	991
HFE	O	991
)	O	991
gene	O	991
on	O	991
chromosome	O	991
6	O	991
,	O	991
elevated	O	991
serum	O	991
transferrin	O	991
saturation	O	991
,	O	991
and	O	991
excess	B-Disease	991
iron	I-Disease	991
deposits	I-Disease	991
throughout	O	991
the	O	991
body	O	991
.	O	991

Four	O	1001
of	O	1001
the	O	1001
homozygous	O	1001
subjects	O	1001
had	O	1001
previously	O	1001
been	O	1001
given	O	1001
a	O	1001
diagnosis	O	1001
of	O	1001
hemochromatosis	B-Disease	1001
,	O	1001
and	O	1001
12	O	1001
had	O	1001
not	O	1001
.	O	1001

Eleven	O	1004
of	O	1004
the	O	1004
16	O	1004
homozygous	O	1004
subjects	O	1004
underwent	O	1004
liver	O	1004
biopsy	O	1004
;	O	1004
3	O	1004
had	O	1004
hepatic	B-Disease	1004
fibrosis	I-Disease	1004
,	O	1004
and	O	1004
1	O	1004
,	O	1004
who	O	1004
had	O	1004
a	O	1004
history	O	1004
of	O	1004
excessive	B-Disease	1004
alcohol	I-Disease	1004
consumption	I-Disease	1004
,	O	1004
had	O	1004
cirrhosis	B-Disease	1004
and	O	1004
mild	O	1004
microvesicular	B-Disease	1004
steatosis	I-Disease	1004
.	O	1004

Eight	O	1005
of	O	1005
the	O	1005
16	O	1005
homozygous	O	1005
subjects	O	1005
had	O	1005
clinical	O	1005
findings	O	1005
that	O	1005
were	O	1005
consistent	O	1005
with	O	1005
the	O	1005
presence	O	1005
of	O	1005
hereditary	B-Disease	1005
hemochromatosis	I-Disease	1005
,	O	1005
such	O	1005
as	O	1005
hepatomegaly	B-Disease	1005
,	O	1005
skin	B-Disease	1005
pigmentation	I-Disease	1005
,	O	1005
and	O	1005
arthritis	B-Disease	1005
.	O	1005

However	O	1008
,	O	1008
only	O	1008
half	O	1008
of	O	1008
those	O	1008
who	O	1008
were	O	1008
homozygous	O	1008
had	O	1008
clinical	O	1008
features	O	1008
of	O	1008
hemochromatosis	B-Disease	1008
,	O	1008
and	O	1008
one	O	1008
quarter	O	1008
had	O	1008
serum	O	1008
ferritin	O	1008
levels	O	1008
that	O	1008
remained	O	1008
normal	O	1008
over	O	1008
a	O	1008
four	O	1008
-	O	1008
year	O	1008
period	O	1008
.	O	1008

The	O	1010
clinical	O	1010
use	O	1010
of	O	1010
molecular	O	1010
analyses	O	1010
in	O	1010
recessive	B-Disease	1010
disorders	I-Disease	1010
relies	O	1010
on	O	1010
the	O	1010
exact	O	1010
characterization	O	1010
of	O	1010
both	O	1010
mutant	O	1010
alleles	O	1010
in	O	1010
the	O	1010
affected	O	1010
patient	O	1010
.	O	1010

We	O	1012
present	O	1012
a	O	1012
child	O	1012
in	O	1012
whom	O	1012
phenylketonuria	B-Disease	1012
was	O	1012
apparently	O	1012
caused	O	1012
by	O	1012
homozygosity	O	1012
for	O	1012
the	O	1012
mutation	O	1012
E390G	O	1012
in	O	1012
exon	O	1012
11	O	1012
of	O	1012
the	O	1012
phenylalanine	O	1012
hydroxylase	O	1012
(	O	1012
PAH	O	1012
)	O	1012
gene	O	1012
.	O	1012

Early	O	1017
onset	O	1017
of	O	1017
X	B-Disease	1017
-	I-Disease	1017
linked	I-Disease	1017
Emery	I-Disease	1017
-	I-Disease	1017
Dreifuss	I-Disease	1017
muscular	I-Disease	1017
dystrophy	I-Disease	1017
in	O	1017
a	O	1017
boy	O	1017
with	O	1017
emerin	O	1017
gene	O	1017
deletion	O	1017
.	O	1017

A	O	1018
boy	O	1018
developed	O	1018
contractures	B-Disease	1018
of	I-Disease	1018
the	I-Disease	1018
Achilles	I-Disease	1018
tendons	I-Disease	1018
at	O	1018
3	O	1018
years	O	1018
and	O	1018
of	O	1018
the	O	1018
postcervical	O	1018
muscles	O	1018
at	O	1018
7	O	1018
years	O	1018
,	O	1018
although	O	1018
neither	O	1018
contractures	B-Disease	1018
of	I-Disease	1018
the	I-Disease	1018
elbows	I-Disease	1018
nor	O	1018
cardiac	B-Disease	1018
abnormality	I-Disease	1018
were	O	1018
recognized	O	1018
by	O	1018
the	O	1018
age	O	1018
of	O	1018
9	O	1018
years	O	1018
.	O	1018

These	O	1021
results	O	1021
confirmed	O	1021
the	O	1021
diagnosis	O	1021
of	O	1021
X	B-Disease	1021
-	I-Disease	1021
linked	I-Disease	1021
Emery	I-Disease	1021
-	I-Disease	1021
Dreifuss	I-Disease	1021
muscular	I-Disease	1021
dystrophy	I-Disease	1021
(	O	1021
EDMD	B-Disease	1021
)	O	1021
,	O	1021
and	O	1021
reinforce	O	1021
the	O	1021
necessity	O	1021
of	O	1021
molecular	O	1021
genetic	O	1021
diagnosis	O	1021
of	O	1021
the	O	1021
membrane	O	1021
protein	O	1021
emerin	O	1021
in	O	1021
younger	O	1021
patients	O	1021
with	O	1021
possible	O	1021
EDMD	B-Disease	1021
before	O	1021
appearance	O	1021
of	O	1021
the	O	1021
typical	O	1021
symptoms	O	1021
,	O	1021
to	O	1021
avoid	O	1021
sudden	B-Disease	1021
cardiac	I-Disease	1021
death	I-Disease	1021
.	O	1021

Duchenne	B-Disease	1023
/	I-Disease	1023
Becker	I-Disease	1023
muscular	I-Disease	1023
dystrophy	I-Disease	1023
:	O	1023
correlation	O	1023
of	O	1023
phenotype	O	1023
by	O	1023
electroretinography	O	1023
with	O	1023
sites	O	1023
of	O	1023
dystrophin	O	1023
mutations	O	1023
.	O	1023

The	O	1024
dark	O	1024
-	O	1024
adapted	O	1024
electroretinogram	O	1024
(	O	1024
ERG	O	1024
)	O	1024
of	O	1024
patients	O	1024
with	O	1024
Duchenne	B-Disease	1024
and	I-Disease	1024
Becker	I-Disease	1024
muscular	I-Disease	1024
dystrophy	I-Disease	1024
(	O	1024
DMD	B-Disease	1024
/	O	1024
BMD	B-Disease	1024
)	O	1024
shows	O	1024
a	O	1024
marked	O	1024
reduction	O	1024
in	O	1024
b	O	1024
-	O	1024
wave	O	1024
amplitude	O	1024
.	O	1024

Genotype	O	1025
-	O	1025
phenotype	O	1025
studies	O	1025
of	O	1025
mouse	O	1025
models	O	1025
for	O	1025
DMD	B-Disease	1025
show	O	1025
position	O	1025
-	O	1025
specific	O	1025
effects	O	1025
of	O	1025
the	O	1025
mutations	O	1025
upon	O	1025
the	O	1025
phenotype	O	1025
mice	O	1025
with	O	1025
5	O	1025
defects	O	1025
of	O	1025
dystrophin	O	1025
have	O	1025
normal	O	1025
ERGs	O	1025
,	O	1025
those	O	1025
with	O	1025
defects	O	1025
in	O	1025
the	O	1025
central	O	1025
region	O	1025
have	O	1025
a	O	1025
normal	O	1025
b	O	1025
-	O	1025
wave	O	1025
amplitude	O	1025
associated	O	1025
with	O	1025
prolonged	O	1025
implicit	O	1025
times	O	1025
for	O	1025
both	O	1025
the	O	1025
b	O	1025
-	O	1025
wave	O	1025
and	O	1025
oscillatory	O	1025
potentials	O	1025
,	O	1025
and	O	1025
mice	O	1025
with	O	1025
3	O	1025
defects	O	1025
have	O	1025
a	O	1025
phenotype	O	1025
similar	O	1025
to	O	1025
that	O	1025
seen	O	1025
in	O	1025
DMD	B-Disease	1025
/	O	1025
BMD	B-Disease	1025
patients	O	1025
.	O	1025

We	O	1027
have	O	1027
undertaken	O	1027
a	O	1027
systematic	O	1027
evaluation	O	1027
of	O	1027
DMD	B-Disease	1027
/	O	1027
BMD	B-Disease	1027
patients	O	1027
through	O	1027
clinical	O	1027
examination	O	1027
and	O	1027
review	O	1027
of	O	1027
the	O	1027
literature	O	1027
in	O	1027
order	O	1027
to	O	1027
determine	O	1027
whether	O	1027
the	O	1027
position	O	1027
-	O	1027
specific	O	1027
effects	O	1027
of	O	1027
mutations	O	1027
noted	O	1027
in	O	1027
the	O	1027
mouse	O	1027
are	O	1027
present	O	1027
in	O	1027
man	O	1027
.	O	1027

We	O	1028
have	O	1028
found	O	1028
that	O	1028
,	O	1028
in	O	1028
man	O	1028
,	O	1028
a	O	1028
wider	O	1028
variation	O	1028
of	O	1028
DMD	B-Disease	1028
defects	I-Disease	1028
correlate	O	1028
with	O	1028
reductions	O	1028
in	O	1028
the	O	1028
b	O	1028
-	O	1028
wave	O	1028
amplitude	O	1028
.	O	1028

Our	O	1030
results	O	1030
suggest	O	1030
that	O	1030
the	O	1030
most	O	1030
important	O	1030
determinant	O	1030
in	O	1030
the	O	1030
ERG	O	1030
b	O	1030
-	O	1030
wave	O	1030
phenotype	O	1030
is	O	1030
the	O	1030
mutation	O	1030
position	O	1030
,	O	1030
rather	O	1030
than	O	1030
muscle	B-Disease	1030
disease	I-Disease	1030
severity	O	1030
.	O	1030

Cis	O	1034
and	O	1034
trans	O	1034
effects	O	1034
of	O	1034
the	O	1034
myotonic	B-Disease	1034
dystrophy	I-Disease	1034
(	O	1034
DM	B-Disease	1034
)	O	1034
mutation	O	1034
in	O	1034
a	O	1034
cell	O	1034
culture	O	1034
model	O	1034
.	O	1034

The	O	1035
mutation	O	1035
causing	O	1035
myotonic	B-Disease	1035
dystrophy	I-Disease	1035
(	O	1035
DM	B-Disease	1035
)	O	1035
has	O	1035
been	O	1035
identified	O	1035
as	O	1035
a	O	1035
CTG	O	1035
expansion	O	1035
in	O	1035
the	O	1035
3	O	1035
-	O	1035
untranslated	O	1035
region	O	1035
(	O	1035
3	O	1035
-	O	1035
UTR	O	1035
)	O	1035
of	O	1035
the	O	1035
DM	B-Disease	1035
protein	O	1035
kinase	O	1035
gene	O	1035
(	O	1035
DMPK	O	1035
)	O	1035
,	O	1035
but	O	1035
the	O	1035
mechanism	O	1035
(	O	1035
s	O	1035
)	O	1035
of	O	1035
pathogenesis	O	1035
remain	O	1035
unknown	O	1035
.	O	1035

Studies	O	1036
using	O	1036
DM	B-Disease	1036
patient	O	1036
materials	O	1036
have	O	1036
often	O	1036
produced	O	1036
confusing	O	1036
results	O	1036
.	O	1036

Therefore	O	1037
,	O	1037
to	O	1037
study	O	1037
the	O	1037
effects	O	1037
of	O	1037
the	O	1037
DM	B-Disease	1037
mutation	O	1037
in	O	1037
a	O	1037
controlled	O	1037
environment	O	1037
,	O	1037
we	O	1037
have	O	1037
established	O	1037
a	O	1037
cell	O	1037
culture	O	1037
model	O	1037
system	O	1037
using	O	1037
C2C12	O	1037
mouse	O	1037
myoblasts	O	1037
.	O	1037

By	O	1038
expressing	O	1038
chimeric	O	1038
reporter	O	1038
constructs	O	1038
containing	O	1038
a	O	1038
reporter	O	1038
gene	O	1038
fused	O	1038
to	O	1038
a	O	1038
human	O	1038
DMPK	O	1038
3	O	1038
-	O	1038
UTR	O	1038
,	O	1038
we	O	1038
identified	O	1038
both	O	1038
cis	O	1038
and	O	1038
trans	O	1038
effects	O	1038
that	O	1038
are	O	1038
mediated	O	1038
by	O	1038
the	O	1038
DM	B-Disease	1038
mutation	O	1038
.	O	1038

These	O	1044
results	O	1044
provide	O	1044
evidence	O	1044
that	O	1044
the	O	1044
DM	B-Disease	1044
mutation	O	1044
acts	O	1044
in	O	1044
cis	O	1044
to	O	1044
reduce	O	1044
protein	O	1044
production	O	1044
(	O	1044
consistent	O	1044
with	O	1044
DMPK	B-Disease	1044
haploinsufficiency	I-Disease	1044
)	O	1044
and	O	1044
in	O	1044
trans	O	1044
as	O	1044
a	O	1044
riboregulator	O	1044
to	O	1044
inhibit	O	1044
myogenesis	O	1044
.	O	1044

Coats	B-Disease	1046
'	I-Disease	1046
disease	I-Disease	1046
of	O	1046
the	O	1046
retina	O	1046
(	O	1046
unilateral	B-Disease	1046
retinal	I-Disease	1046
telangiectasis	I-Disease	1046
)	O	1046
caused	O	1046
by	O	1046
somatic	O	1046
mutation	O	1046
in	O	1046
the	O	1046
NDP	O	1046
gene	O	1046
:	O	1046
a	O	1046
role	O	1046
for	O	1046
norrin	O	1046
in	O	1046
retinal	O	1046
angiogenesis	O	1046
.	O	1046

Coats	B-Disease	1047
disease	I-Disease	1047
is	O	1047
characterized	O	1047
by	O	1047
abnormal	B-Disease	1047
retinal	I-Disease	1047
vascular	I-Disease	1047
development	I-Disease	1047
(	O	1047
so	O	1047
-	O	1047
called	O	1047
retinal	B-Disease	1047
telangiectasis	I-Disease	1047
)	O	1047
which	O	1047
results	O	1047
in	O	1047
massive	O	1047
intraretinal	B-Disease	1047
and	I-Disease	1047
subretinal	I-Disease	1047
lipid	I-Disease	1047
accumulation	I-Disease	1047
(	O	1047
exudative	B-Disease	1047
retinal	I-Disease	1047
detachment	I-Disease	1047
)	O	1047
.	O	1047

The	O	1048
classical	O	1048
form	O	1048
of	O	1048
Coats	B-Disease	1048
disease	I-Disease	1048
is	O	1048
almost	O	1048
invariably	O	1048
isolated	O	1048
,	O	1048
unilateral	O	1048
and	O	1048
seen	O	1048
in	O	1048
males	O	1048
.	O	1048

A	O	1049
female	O	1049
with	O	1049
a	O	1049
unilateral	O	1049
variant	O	1049
of	O	1049
Coats	B-Disease	1049
disease	I-Disease	1049
gave	O	1049
birth	O	1049
to	O	1049
a	O	1049
son	O	1049
affected	O	1049
by	O	1049
Norrie	B-Disease	1049
disease	I-Disease	1049
.	O	1049

Subsequently	O	1052
analysis	O	1052
of	O	1052
the	O	1052
retinas	O	1052
of	O	1052
nine	O	1052
enucleated	O	1052
eyes	O	1052
from	O	1052
males	O	1052
with	O	1052
Coats	B-Disease	1052
disease	I-Disease	1052
demonstrated	O	1052
in	O	1052
one	O	1052
a	O	1052
somatic	O	1052
mutation	O	1052
in	O	1052
the	O	1052
NDP	O	1052
gene	O	1052
which	O	1052
was	O	1052
not	O	1052
present	O	1052
within	O	1052
non	O	1052
-	O	1052
retinal	O	1052
tissue	O	1052
.	O	1052

We	O	1053
suggest	O	1053
that	O	1053
Coats	B-Disease	1053
telangiectasis	I-Disease	1053
is	O	1053
secondary	O	1053
to	O	1053
somatic	O	1053
mutation	O	1053
in	O	1053
the	O	1053
NDP	O	1053
gene	O	1053
which	O	1053
results	O	1053
in	O	1053
a	O	1053
deficiency	B-Disease	1053
of	I-Disease	1053
norrin	I-Disease	1053
(	O	1053
the	O	1053
protein	O	1053
product	O	1053
of	O	1053
the	O	1053
NDP	O	1053
gene	O	1053
)	O	1053
within	O	1053
the	O	1053
developing	O	1053
retina	O	1053
.	O	1053

Hereditary	O	1055
TP53	O	1055
codon	O	1055
292	O	1055
and	O	1055
somatic	O	1055
P16INK4A	O	1055
codon	O	1055
94	O	1055
mutations	O	1055
in	O	1055
a	O	1055
Li	B-Disease	1055
-	I-Disease	1055
Fraumeni	I-Disease	1055
syndrome	I-Disease	1055
family	O	1055
.	O	1055

Li	B-Disease	1056
-	I-Disease	1056
Fraumeni	I-Disease	1056
syndrome	I-Disease	1056
is	O	1056
an	O	1056
autosomal	B-Disease	1056
dominant	I-Disease	1056
disorder	I-Disease	1056
that	O	1056
is	O	1056
characterized	O	1056
by	O	1056
various	O	1056
types	O	1056
of	O	1056
cancer	B-Disease	1056
in	O	1056
childhood	O	1056
and	O	1056
adult	O	1056
cases	O	1056
.	O	1056

Although	O	1057
hereditary	O	1057
TP53	O	1057
mutation	O	1057
is	O	1057
very	O	1057
rare	O	1057
in	O	1057
different	O	1057
human	O	1057
cancers	B-Disease	1057
,	O	1057
it	O	1057
has	O	1057
been	O	1057
frequently	O	1057
reported	O	1057
in	O	1057
Li	B-Disease	1057
-	I-Disease	1057
Fraumeni	I-Disease	1057
syndrome	I-Disease	1057
.	O	1057

On	O	1058
the	O	1058
other	O	1058
hand	O	1058
,	O	1058
hereditary	O	1058
mutations	O	1058
of	O	1058
TP57KIP2	O	1058
,	O	1058
P15INK4B	O	1058
,	O	1058
and	O	1058
P16INK4A	O	1058
,	O	1058
which	O	1058
affect	O	1058
the	O	1058
cell	O	1058
cycle	O	1058
similar	O	1058
to	O	1058
TP53	O	1058
,	O	1058
were	O	1058
observed	O	1058
in	O	1058
some	O	1058
types	O	1058
of	O	1058
cancer	B-Disease	1058
.	O	1058

In	O	1059
a	O	1059
Turkish	O	1059
family	O	1059
with	O	1059
the	O	1059
diagnosis	O	1059
of	O	1059
Li	B-Disease	1059
-	I-Disease	1059
Fraumeni	I-Disease	1059
syndrome	I-Disease	1059
,	O	1059
we	O	1059
analyzed	O	1059
the	O	1059
mutation	O	1059
pattern	O	1059
of	O	1059
TP53	O	1059
,	O	1059
P57KIP2	O	1059
,	O	1059
P15INK4B	O	1059
,	O	1059
and	O	1059
P16INK4A	O	1059
in	O	1059
the	O	1059
peripheral	O	1059
blood	O	1059
,	O	1059
and	O	1059
loss	O	1059
of	O	1059
heterozygosity	O	1059
(	O	1059
homo	O	1059
/	O	1059
hemizygous	O	1059
deletion	O	1059
)	O	1059
pattern	O	1059
of	O	1059
TP53	O	1059
and	O	1059
P15INK4B	O	1059
/	O	1059
P16INK4A	O	1059
in	O	1059
two	O	1059
tumor	B-Disease	1059
tissues	O	1059
.	O	1059

The	O	1060
propositus	O	1060
had	O	1060
a	O	1060
seminoma	B-Disease	1060
,	O	1060
his	O	1060
daughter	O	1060
a	O	1060
medulloblastoma	B-Disease	1060
,	O	1060
and	O	1060
one	O	1060
of	O	1060
his	O	1060
healthy	O	1060
cousins	O	1060
,	O	1060
a	O	1060
TP53	O	1060
codon	O	1060
292	O	1060
missense	O	1060
point	O	1060
mutation	O	1060
(	O	1060
AAA	O	1060
-	O	1060
-	O	1060
>	O	1060
ATA	O	1060
;	O	1060
Lys	O	1060
-	O	1060
-	O	1060
>	O	1060
Ile	O	1060
)	O	1060
in	O	1060
the	O	1060
peripheral	O	1060
blood	O	1060
cells	O	1060
.	O	1060

Tumor	O	1061
tissue	O	1061
obtained	O	1061
from	O	1061
the	O	1061
propositus	O	1061
with	O	1061
the	O	1061
seminoma	B-Disease	1061
revealed	O	1061
loss	O	1061
of	O	1061
heterozygosity	O	1061
in	O	1061
the	O	1061
TP53	O	1061
gene	O	1061
.	O	1061

In	O	1062
the	O	1062
analyses	O	1062
of	O	1062
tumor	B-Disease	1062
tissues	O	1062
from	O	1062
the	O	1062
propositus	O	1062
and	O	1062
his	O	1062
daughter	O	1062
,	O	1062
a	O	1062
P16INK4A	O	1062
codon	O	1062
94	O	1062
missense	O	1062
point	O	1062
mutation	O	1062
(	O	1062
GCG	O	1062
-	O	1062
-	O	1062
>	O	1062
GAG	O	1062
;	O	1062
Ala	O	1062
-	O	1062
-	O	1062
>	O	1062
Glu	O	1062
)	O	1062
was	O	1062
observed	O	1062
with	O	1062
the	O	1062
hereditary	O	1062
TP53	O	1062
mutation	O	1062
.	O	1062

P16INK4A	O	1063
codon	O	1063
94	O	1063
mutation	O	1063
observed	O	1063
in	O	1063
our	O	1063
family	O	1063
is	O	1063
a	O	1063
novel	O	1063
mutation	O	1063
in	O	1063
Li	B-Disease	1063
-	I-Disease	1063
Fraumeni	I-Disease	1063
syndrome	I-Disease	1063
.	O	1063

Existence	O	1065
of	O	1065
the	O	1065
P16INK4A	O	1065
mutation	O	1065
and	O	1065
the	O	1065
hereditary	O	1065
TP53	O	1065
mutation	O	1065
with	O	1065
or	O	1065
without	O	1065
loss	O	1065
of	O	1065
heterozygosity	O	1065
in	O	1065
the	O	1065
TP53	O	1065
gene	O	1065
(	O	1065
seminoma	B-Disease	1065
/	O	1065
medulloblastoma	B-Disease	1065
)	O	1065
may	O	1065
be	O	1065
evidence	O	1065
for	O	1065
a	O	1065
common	O	1065
mechanism	O	1065
involved	O	1065
in	O	1065
tumorogenesis	B-Disease	1065
.	O	1065

The	O	1066
gene	O	1066
alterations	O	1066
in	O	1066
TP53	O	1066
and	O	1066
P16INK4A	O	1066
genes	O	1066
may	O	1066
be	O	1066
used	O	1066
as	O	1066
tumor	B-Disease	1066
markers	O	1066
in	O	1066
our	O	1066
family	O	1066
.	O	1066

A	O	1068
novel	O	1068
mutation	O	1068
in	O	1068
the	O	1068
sodium	O	1068
/	O	1068
iodide	O	1068
symporter	O	1068
gene	O	1068
in	O	1068
the	O	1068
largest	O	1068
family	O	1068
with	O	1068
iodide	B-Disease	1068
transport	I-Disease	1068
defect	I-Disease	1068
.	O	1068

We	O	1069
previously	O	1069
reported	O	1069
nine	O	1069
children	O	1069
with	O	1069
an	O	1069
autosomally	O	1069
recessive	O	1069
form	O	1069
of	O	1069
congenital	B-Disease	1069
hypothyroidism	I-Disease	1069
due	O	1069
to	O	1069
an	O	1069
iodide	B-Disease	1069
transport	I-Disease	1069
defect	I-Disease	1069
in	O	1069
a	O	1069
large	O	1069
Hutterite	O	1069
family	O	1069
with	O	1069
extensive	O	1069
consanguinity	O	1069
living	O	1069
in	O	1069
central	O	1069
Canada	O	1069
.	O	1069

Since	O	1070
the	O	1070
original	O	1070
report	O	1070
,	O	1070
we	O	1070
have	O	1070
diagnosed	O	1070
congenital	B-Disease	1070
hypothyroidism	I-Disease	1070
by	O	1070
newborn	O	1070
TSH	O	1070
screening	O	1070
in	O	1070
9	O	1070
additional	O	1070
children	O	1070
from	O	1070
the	O	1070
family	O	1070
.	O	1070

Expression	O	1075
experiments	O	1075
by	O	1075
transfection	O	1075
of	O	1075
the	O	1075
mutant	O	1075
NIS	O	1075
complimentary	O	1075
DNA	O	1075
into	O	1075
COS	O	1075
-	O	1075
7	O	1075
cells	O	1075
showed	O	1075
no	O	1075
perchlorate	O	1075
-	O	1075
sensitive	O	1075
iodide	O	1075
uptake	O	1075
,	O	1075
confirming	O	1075
that	O	1075
the	O	1075
mutation	O	1075
is	O	1075
the	O	1075
direct	O	1075
cause	O	1075
of	O	1075
the	O	1075
iodide	B-Disease	1075
transport	I-Disease	1075
defect	I-Disease	1075
in	O	1075
these	O	1075
patients	O	1075
.	O	1075

It	O	1078
is	O	1078
now	O	1078
possible	O	1078
to	O	1078
use	O	1078
gene	O	1078
diagnostics	O	1078
of	O	1078
this	O	1078
unique	O	1078
NIS	O	1078
mutation	O	1078
to	O	1078
identify	O	1078
patients	O	1078
with	O	1078
congenital	B-Disease	1078
hypothyroidism	I-Disease	1078
due	O	1078
to	O	1078
an	O	1078
iodide	B-Disease	1078
transport	I-Disease	1078
defect	I-Disease	1078
in	O	1078
this	O	1078
family	O	1078
and	O	1078
to	O	1078
determine	O	1078
the	O	1078
carrier	O	1078
state	O	1078
of	O	1078
potential	O	1078
parents	O	1078
for	O	1078
genetic	O	1078
counseling	O	1078
and	O	1078
arranging	O	1078
rapid	O	1078
and	O	1078
early	O	1078
diagnosis	O	1078
of	O	1078
their	O	1078
infants	O	1078
.	O	1078

Molecular	O	1079
analysis	O	1079
in	O	1079
familial	B-Disease	1079
neurohypophyseal	I-Disease	1079
diabetes	I-Disease	1079
insipidus	I-Disease	1079
:	O	1079
early	O	1079
diagnosis	O	1079
of	O	1079
an	O	1079
asymptomatic	O	1079
carrier	O	1079
.	O	1079

Familial	B-Disease	1080
neurohypophyseal	I-Disease	1080
diabetes	I-Disease	1080
insipidus	I-Disease	1080
(	O	1080
FNDI	B-Disease	1080
)	O	1080
is	O	1080
an	O	1080
inherited	O	1080
deficiency	B-Disease	1080
of	I-Disease	1080
the	I-Disease	1080
hormone	I-Disease	1080
arginine	I-Disease	1080
vasopressin	I-Disease	1080
(	O	1080
AVP	O	1080
)	O	1080
and	O	1080
is	O	1080
transmitted	O	1080
as	O	1080
an	O	1080
autosomal	O	1080
dominant	O	1080
trait	O	1080
.	O	1080

The	O	1088
alteration	O	1088
found	O	1088
in	O	1088
the	O	1088
second	O	1088
exon	O	1088
of	O	1088
the	O	1088
gene	O	1088
in	O	1088
this	O	1088
family	O	1088
seems	O	1088
to	O	1088
be	O	1088
responsible	O	1088
for	O	1088
the	O	1088
disease	O	1088
,	O	1088
as	O	1088
all	O	1088
individuals	O	1088
harboring	O	1088
the	O	1088
mutation	O	1088
had	O	1088
been	O	1088
previously	O	1088
diagnosed	O	1088
or	O	1088
have	O	1088
eventually	O	1088
developed	O	1088
FNDI	B-Disease	1088
.	O	1088

Identification	O	1089
of	O	1089
the	O	1089
molecular	O	1089
defect	O	1089
underlying	O	1089
FNDI	B-Disease	1089
in	O	1089
affected	O	1089
families	O	1089
is	O	1089
a	O	1089
powerful	O	1089
tool	O	1089
for	O	1089
early	O	1089
asymptomatic	O	1089
diagnosis	O	1089
in	O	1089
infants	O	1089
.	O	1089

Deficit	O	1091
of	O	1091
in	O	1091
vivo	O	1091
mitochondrial	O	1091
ATP	O	1091
production	O	1091
in	O	1091
patients	O	1091
with	O	1091
Friedreich	B-Disease	1091
ataxia	I-Disease	1091
.	O	1091

Friedreich	B-Disease	1092
ataxia	I-Disease	1092
(	O	1092
FRDA	B-Disease	1092
)	O	1092
,	O	1092
the	O	1092
most	O	1092
common	O	1092
of	O	1092
the	O	1092
inherited	B-Disease	1092
ataxias	I-Disease	1092
,	O	1092
is	O	1092
an	O	1092
autosomal	B-Disease	1092
recessive	I-Disease	1092
degenerative	I-Disease	1092
disorder	I-Disease	1092
,	O	1092
characterized	O	1092
clinically	O	1092
by	O	1092
onset	O	1092
before	O	1092
the	O	1092
age	O	1092
of	O	1092
25	O	1092
of	O	1092
progressive	B-Disease	1092
gait	I-Disease	1092
and	I-Disease	1092
limb	I-Disease	1092
ataxia	I-Disease	1092
,	O	1092
absence	B-Disease	1092
of	I-Disease	1092
deep	I-Disease	1092
tendon	I-Disease	1092
reflexes	I-Disease	1092
,	O	1092
extensor	B-Disease	1092
plantar	I-Disease	1092
responses	I-Disease	1092
,	O	1092
and	O	1092
loss	B-Disease	1092
of	I-Disease	1092
position	I-Disease	1092
and	I-Disease	1092
vibration	I-Disease	1092
sense	I-Disease	1092
in	O	1092
the	O	1092
lower	O	1092
limbs	O	1092
.	O	1092

FRDA	B-Disease	1093
is	O	1093
caused	O	1093
by	O	1093
a	O	1093
GAA	O	1093
triplet	O	1093
expansion	O	1093
in	O	1093
the	O	1093
first	O	1093
intron	O	1093
of	O	1093
the	O	1093
FRDA	B-Disease	1093
gene	O	1093
on	O	1093
chromosome	O	1093
9q13	O	1093
in	O	1093
97	O	1093
%	O	1093
of	O	1093
patients	O	1093
.	O	1093

The	O	1094
FRDA	B-Disease	1094
gene	O	1094
encodes	O	1094
a	O	1094
widely	O	1094
expressed	O	1094
210	O	1094
-	O	1094
aa	O	1094
protein	O	1094
,	O	1094
frataxin	O	1094
,	O	1094
which	O	1094
is	O	1094
located	O	1094
in	O	1094
mitochondria	O	1094
and	O	1094
is	O	1094
severely	O	1094
reduced	O	1094
in	O	1094
FRDA	B-Disease	1094
patients	O	1094
.	O	1094

Here	O	1096
we	O	1096
report	O	1096
in	O	1096
vivo	O	1096
evidence	O	1096
of	O	1096
impaired	O	1096
mitochondrial	O	1096
respiration	O	1096
in	O	1096
skeletal	O	1096
muscle	O	1096
of	O	1096
FRDA	B-Disease	1096
patients	O	1096
.	O	1096

Using	O	1097
phosphorus	O	1097
magnetic	O	1097
resonance	O	1097
spectroscopy	O	1097
we	O	1097
demonstrated	O	1097
a	O	1097
maximum	O	1097
rate	O	1097
of	O	1097
muscle	O	1097
mitochondrial	O	1097
ATP	O	1097
production	O	1097
(	O	1097
V	O	1097
(	O	1097
max	O	1097
)	O	1097
)	O	1097
below	O	1097
the	O	1097
normal	O	1097
range	O	1097
in	O	1097
all	O	1097
12	O	1097
FRDA	B-Disease	1097
patients	O	1097
and	O	1097
a	O	1097
strong	O	1097
negative	O	1097
correlation	O	1097
between	O	1097
mitochondrial	O	1097
V	O	1097
(	O	1097
max	O	1097
)	O	1097
and	O	1097
the	O	1097
number	O	1097
of	O	1097
GAA	O	1097
repeats	O	1097
in	O	1097
the	O	1097
smaller	O	1097
allele	O	1097
.	O	1097

Our	O	1098
results	O	1098
show	O	1098
that	O	1098
FRDA	B-Disease	1098
is	O	1098
a	O	1098
nuclear	O	1098
-	O	1098
encoded	O	1098
mitochondrial	B-Disease	1098
disorder	I-Disease	1098
affecting	O	1098
oxidative	O	1098
phosphorylation	O	1098
and	O	1098
give	O	1098
a	O	1098
rationale	O	1098
for	O	1098
treatments	O	1098
aimed	O	1098
to	O	1098
improve	O	1098
mitochondrial	O	1098
function	O	1098
in	O	1098
this	O	1098
condition	O	1098
.	O	1098

Identification	O	1100
of	O	1100
a	O	1100
novel	O	1100
R21X	O	1100
mutation	O	1100
in	O	1100
the	O	1100
liver	O	1100
-	O	1100
type	O	1100
arginase	O	1100
gene	O	1100
(	O	1100
ARG1	O	1100
)	O	1100
in	O	1100
four	O	1100
Portuguese	O	1100
patients	O	1100
with	O	1100
argininemia	B-Disease	1100
.	O	1100

Argininemia	B-Disease	1101
is	O	1101
a	O	1101
rare	O	1101
autossomal	B-Disease	1101
recessive	I-Disease	1101
disorder	I-Disease	1101
caused	O	1101
by	O	1101
deficiency	B-Disease	1101
in	I-Disease	1101
the	I-Disease	1101
cytosolic	I-Disease	1101
liver	I-Disease	1101
-	I-Disease	1101
type	I-Disease	1101
arginase	I-Disease	1101
enzyme	I-Disease	1101
(	O	1101
L	O	1101
-	O	1101
arginine	O	1101
urea	O	1101
-	O	1101
hydrolase	O	1101
;	O	1101
E	O	1101
.	O	1101

In	O	1107
order	O	1107
to	O	1107
investigate	O	1107
the	O	1107
molecular	O	1107
basis	O	1107
for	O	1107
argininemia	B-Disease	1107
in	O	1107
four	O	1107
unrelated	O	1107
Portuguese	O	1107
patients	O	1107
(	O	1107
two	O	1107
from	O	1107
northern	O	1107
Portugal	O	1107
and	O	1107
two	O	1107
from	O	1107
Madeira	O	1107
Island	O	1107
)	O	1107
we	O	1107
performed	O	1107
a	O	1107
DNA	O	1107
sequence	O	1107
analysis	O	1107
of	O	1107
all	O	1107
the	O	1107
exons	O	1107
and	O	1107
exon	O	1107
/	O	1107
intron	O	1107
boundaries	O	1107
of	O	1107
the	O	1107
liver	O	1107
-	O	1107
type	O	1107
arginase	O	1107
gene	O	1107
(	O	1107
ARG1	O	1107
)	O	1107
.	O	1107

Mutation	O	1110
of	O	1110
the	O	1110
sterol	O	1110
27	O	1110
-	O	1110
hydroxylase	O	1110
gene	O	1110
(	O	1110
CYP27	O	1110
)	O	1110
results	O	1110
in	O	1110
truncation	O	1110
of	O	1110
mRNA	O	1110
expressed	O	1110
in	O	1110
leucocytes	O	1110
in	O	1110
a	O	1110
Japanese	O	1110
family	O	1110
with	O	1110
cerebrotendinous	B-Disease	1110
xanthomatosis	I-Disease	1110
.	O	1110

OBJECTIVES	O	1111
A	O	1111
Japanese	O	1111
family	O	1111
with	O	1111
cerebrotendinous	B-Disease	1111
xanthomatosis	I-Disease	1111
(	O	1111
CTX	B-Disease	1111
)	O	1111
was	O	1111
investigated	O	1111
for	O	1111
a	O	1111
sequence	O	1111
alteration	O	1111
in	O	1111
the	O	1111
sterol	O	1111
27	O	1111
-	O	1111
hydroxylase	O	1111
gene	O	1111
(	O	1111
CYP27	O	1111
)	O	1111
.	O	1111

The	O	1119
application	O	1119
of	O	1119
blood	O	1119
leucocytes	O	1119
can	O	1119
be	O	1119
a	O	1119
simple	O	1119
technique	O	1119
on	O	1119
analysing	O	1119
a	O	1119
constructive	O	1119
abnormality	B-Disease	1119
of	I-Disease	1119
CYP27	I-Disease	1119
mRNA	O	1119
.	O	1119

Clinical	O	1121
and	O	1121
molecular	O	1121
genetic	O	1121
analysis	O	1121
of	O	1121
19	O	1121
Wolfram	B-Disease	1121
syndrome	I-Disease	1121
kindreds	O	1121
demonstrating	O	1121
a	O	1121
wide	O	1121
spectrum	O	1121
of	O	1121
mutations	O	1121
in	O	1121
WFS1	O	1121
.	O	1121

Wolfram	B-Disease	1122
syndrome	I-Disease	1122
is	O	1122
an	O	1122
autosomal	B-Disease	1122
recessive	I-Disease	1122
neurodegenerative	I-Disease	1122
disorder	I-Disease	1122
characterized	O	1122
by	O	1122
juvenile	B-Disease	1122
-	I-Disease	1122
onset	I-Disease	1122
diabetes	I-Disease	1122
mellitus	I-Disease	1122
and	O	1122
progressive	O	1122
optic	B-Disease	1122
atrophy	I-Disease	1122
.	O	1122

Direct	O	1124
DNA	O	1124
sequencing	O	1124
was	O	1124
done	O	1124
to	O	1124
screen	O	1124
the	O	1124
entire	O	1124
coding	O	1124
region	O	1124
of	O	1124
the	O	1124
WFS1	O	1124
gene	O	1124
in	O	1124
30	O	1124
patients	O	1124
from	O	1124
19	O	1124
British	O	1124
kindreds	O	1124
with	O	1124
Wolfram	B-Disease	1124
syndrome	I-Disease	1124
.	O	1124

Hence	O	1133
,	O	1133
molecular	O	1133
screening	O	1133
for	O	1133
Wolfram	B-Disease	1133
syndrome	I-Disease	1133
in	O	1133
affected	O	1133
families	O	1133
and	O	1133
for	O	1133
Wolfram	B-Disease	1133
syndrome	I-Disease	1133
-	O	1133
carrier	O	1133
status	O	1133
in	O	1133
subjects	O	1133
with	O	1133
psychiatric	B-Disease	1133
disorders	I-Disease	1133
or	O	1133
diabetes	B-Disease	1133
mellitus	I-Disease	1133
will	O	1133
require	O	1133
complete	O	1133
analysis	O	1133
of	O	1133
exon	O	1133
8	O	1133
and	O	1133
upstream	O	1133
exons	O	1133
.	O	1133

Late	O	1135
-	O	1135
onset	O	1135
familial	B-Disease	1135
Mediterranean	I-Disease	1135
fever	I-Disease	1135
(	O	1135
FMF	B-Disease	1135
)	O	1135
:	O	1135
a	O	1135
subset	O	1135
with	O	1135
distinct	O	1135
clinical	O	1135
,	O	1135
demographic	O	1135
,	O	1135
and	O	1135
molecular	O	1135
genetic	O	1135
characteristics	O	1135
.	O	1135

To	O	1136
determine	O	1136
the	O	1136
prevalence	O	1136
and	O	1136
characterize	O	1136
demographic	O	1136
,	O	1136
clinical	O	1136
,	O	1136
and	O	1136
genetic	O	1136
features	O	1136
of	O	1136
familial	B-Disease	1136
Mediterranean	I-Disease	1136
fever	I-Disease	1136
(	O	1136
FMF	B-Disease	1136
)	O	1136
of	O	1136
late	O	1136
onset	O	1136
,	O	1136
all	O	1136
patients	O	1136
experiencing	O	1136
their	O	1136
first	O	1136
FMF	B-Disease	1136
attack	O	1136
at	O	1136
age	O	1136
40	O	1136
years	O	1136
or	O	1136
more	O	1136
were	O	1136
identified	O	1136
using	O	1136
the	O	1136
computerized	O	1136
registry	O	1136
of	O	1136
our	O	1136
FMF	B-Disease	1136
clinic	O	1136
,	O	1136
and	O	1136
then	O	1136
thoroughly	O	1136
interviewed	O	1136
and	O	1136
examined	O	1136
.	O	1136

The	O	1137
control	O	1137
group	O	1137
consisted	O	1137
of	O	1137
40	O	1137
consecutive	O	1137
FMF	B-Disease	1137
patients	O	1137
,	O	1137
who	O	1137
arrived	O	1137
at	O	1137
the	O	1137
FMF	B-Disease	1137
clinic	O	1137
for	O	1137
their	O	1137
regular	O	1137
follow	O	1137
-	O	1137
up	O	1137
visit	O	1137
and	O	1137
were	O	1137
40	O	1137
years	O	1137
of	O	1137
age	O	1137
or	O	1137
older	O	1137
at	O	1137
the	O	1137
time	O	1137
of	O	1137
the	O	1137
examination	O	1137
.	O	1137

Mutational	O	1139
analysis	O	1139
in	O	1139
the	O	1139
FMF	B-Disease	1139
gene	O	1139
was	O	1139
performed	O	1139
using	O	1139
a	O	1139
commercial	O	1139
kit	O	1139
.	O	1139

5	O	1141
%	O	1141
)	O	1141
patients	O	1141
had	O	1141
late	O	1141
-	O	1141
onset	O	1141
FMF	B-Disease	1141
.	O	1141

None	O	1146
had	O	1146
chronic	O	1146
or	O	1146
prolonged	O	1146
manifestations	O	1146
of	O	1146
FMF	B-Disease	1146
,	O	1146
for	O	1146
example	O	1146
,	O	1146
amyloidosis	B-Disease	1146
,	O	1146
chronic	B-Disease	1146
arthritis	I-Disease	1146
,	O	1146
or	O	1146
protracted	O	1146
myalgia	B-Disease	1146
,	O	1146
P	O	1146
<	O	1146
0	O	1146
.	O	1146

01	O	1153
,	O	1153
compared	O	1153
to	O	1153
our	O	1153
regular	O	1153
FMF	B-Disease	1153
population	O	1153
.	O	1153

We	O	1154
conclude	O	1154
that	O	1154
the	O	1154
onset	O	1154
of	O	1154
FMF	B-Disease	1154
in	O	1154
a	O	1154
late	O	1154
age	O	1154
defines	O	1154
a	O	1154
milder	O	1154
form	O	1154
of	O	1154
disease	O	1154
with	O	1154
typical	O	1154
clinical	O	1154
,	O	1154
demographic	O	1154
,	O	1154
and	O	1154
molecular	O	1154
genetic	O	1154
characteristics	O	1154
A	O	1154
highly	O	1154
accurate	O	1154
,	O	1154
low	O	1154
cost	O	1154
test	O	1154
for	O	1154
BRCA1	O	1154
mutations	O	1154
.	O	1154

The	O	1155
hereditary	B-Disease	1155
breast	I-Disease	1155
and	I-Disease	1155
ovarian	I-Disease	1155
cancer	I-Disease	1155
syndrome	I-Disease	1155
is	O	1155
associated	O	1155
with	O	1155
a	O	1155
high	O	1155
frequency	O	1155
of	O	1155
BRCA1	O	1155
mutations	O	1155
.	O	1155

Maternal	B-Disease	1165
uniparental	I-Disease	1165
disomy	I-Disease	1165
for	I-Disease	1165
chromosome	I-Disease	1165
14	I-Disease	1165
in	O	1165
a	O	1165
boy	O	1165
with	O	1165
a	O	1165
normal	O	1165
karyotype	O	1165
.	O	1165

We	O	1166
report	O	1166
on	O	1166
a	O	1166
boy	O	1166
with	O	1166
a	O	1166
maternal	B-Disease	1166
uniparental	I-Disease	1166
disomy	I-Disease	1166
for	I-Disease	1166
chromosome	I-Disease	1166
14	I-Disease	1166
(	O	1166
UPD	B-Disease	1166
(	O	1166
14	O	1166
)	O	1166
)	O	1166
.	O	1166

At	O	1167
7	O	1167
years	O	1167
of	O	1167
age	O	1167
he	O	1167
was	O	1167
referred	O	1167
to	O	1167
us	O	1167
by	O	1167
the	O	1167
paediatrician	O	1167
because	O	1167
of	O	1167
symptoms	O	1167
of	O	1167
Prader	B-Disease	1167
-	I-Disease	1167
Willi	I-Disease	1167
syndrome	I-Disease	1167
(	O	1167
PWS	B-Disease	1167
)	O	1167
.	O	1167

He	O	1168
showed	O	1168
short	B-Disease	1168
stature	I-Disease	1168
,	O	1168
obesity	B-Disease	1168
,	O	1168
mild	O	1168
developmental	B-Disease	1168
delay	I-Disease	1168
,	O	1168
cryptorchidism	B-Disease	1168
,	O	1168
and	O	1168
some	O	1168
mild	O	1168
dysmorphic	B-Disease	1168
features	I-Disease	1168
.	O	1168

The	O	1169
history	O	1169
further	O	1169
indicated	O	1169
intrauterine	B-Disease	1169
growth	I-Disease	1169
retardation	I-Disease	1169
at	O	1169
the	O	1169
end	O	1169
of	O	1169
the	O	1169
pregnancy	O	1169
.	O	1169

After	O	1171
birth	O	1171
he	O	1171
showed	O	1171
hypotonia	B-Disease	1171
with	O	1171
poor	O	1171
sucking	O	1171
,	O	1171
for	O	1171
which	O	1171
gavage	O	1171
feeding	O	1171
was	O	1171
needed	O	1171
.	O	1171

After	O	1173
1	O	1173
year	O	1173
he	O	1173
became	O	1173
obese	B-Disease	1173
despite	O	1173
a	O	1173
normal	O	1173
appetite	O	1173
.	O	1173

Recurrent	O	1174
middle	B-Disease	1174
ear	I-Disease	1174
infections	I-Disease	1174
,	O	1174
a	O	1174
high	O	1174
pain	O	1174
threshold	O	1174
,	O	1174
and	O	1174
a	O	1174
great	O	1174
skill	O	1174
with	O	1174
jigsaw	O	1174
puzzles	O	1174
were	O	1174
reported	O	1174
.	O	1174

DNA	O	1177
analysis	O	1177
for	O	1177
Prader	B-Disease	1177
-	I-Disease	1177
Willi	I-Disease	1177
syndrome	I-Disease	1177
showed	O	1177
no	O	1177
abnormalities	O	1177
.	O	1177

Two	O	1178
years	O	1178
later	O	1178
he	O	1178
was	O	1178
re	O	1178
-	O	1178
examined	O	1178
because	O	1178
we	O	1178
thought	O	1178
his	O	1178
features	O	1178
fitted	O	1178
the	O	1178
PWS	B-Disease	1178
-	O	1178
like	O	1178
phenotype	O	1178
associated	O	1178
with	O	1178
maternal	O	1178
UPD	B-Disease	1178
(	O	1178
14	O	1178
)	O	1178
.	O	1178

DNA	O	1180
analysis	O	1180
showed	O	1180
maternal	B-Disease	1180
heterodisomy	I-Disease	1180
for	O	1180
chromosome	O	1180
14	O	1180
.	O	1180

In	O	1181
all	O	1181
the	O	1181
previously	O	1181
described	O	1181
11	O	1181
cases	O	1181
with	O	1181
maternal	O	1181
UPD	B-Disease	1181
(	O	1181
14	O	1181
)	O	1181
,	O	1181
a	O	1181
Robertsonian	O	1181
translocation	O	1181
involving	O	1181
chromosome	O	1181
14	O	1181
was	O	1181
detected	O	1181
cytogenetically	O	1181
before	O	1181
DNA	O	1181
analysis	O	1181
.	O	1181

This	O	1182
is	O	1182
the	O	1182
first	O	1182
report	O	1182
of	O	1182
diagnosis	O	1182
of	O	1182
maternal	O	1182
UPD	B-Disease	1182
(	O	1182
14	O	1182
)	O	1182
based	O	1182
on	O	1182
clinical	O	1182
features	O	1182
.	O	1182

This	O	1183
finding	O	1183
underlines	O	1183
the	O	1183
importance	O	1183
of	O	1183
DNA	O	1183
analysis	O	1183
for	O	1183
maternal	O	1183
UPD	O	1183
(	O	1183
14	O	1183
)	O	1183
in	O	1183
patients	O	1183
with	O	1183
a	O	1183
similar	O	1183
PWS	B-Disease	1183
-	O	1183
like	O	1183
phenotype	O	1183
even	O	1183
without	O	1183
previous	O	1183
identification	O	1183
of	O	1183
a	O	1183
Robertsonian	O	1183
translocation	O	1183
involving	O	1183
chromosome	O	1183
14	O	1183
.	O	1183

Clinical	O	1185
and	O	1185
genetic	O	1185
study	O	1185
of	O	1185
Friedreich	B-Disease	1185
ataxia	I-Disease	1185
in	O	1185
an	O	1185
Australian	O	1185
population	O	1185
.	O	1185

Friedreich	B-Disease	1186
ataxia	I-Disease	1186
is	O	1186
an	O	1186
autosomal	B-Disease	1186
recessive	I-Disease	1186
disorder	I-Disease	1186
caused	O	1186
by	O	1186
mutations	O	1186
in	O	1186
the	O	1186
FRDA	B-Disease	1186
gene	O	1186
that	O	1186
encodes	O	1186
a	O	1186
210	O	1186
-	O	1186
amino	O	1186
acid	O	1186
protein	O	1186
called	O	1186
frataxin	O	1186
.	O	1186

We	O	1190
found	O	1190
a	O	1190
correlation	O	1190
between	O	1190
the	O	1190
size	O	1190
of	O	1190
the	O	1190
smaller	O	1190
of	O	1190
the	O	1190
two	O	1190
expanded	O	1190
alleles	O	1190
and	O	1190
age	O	1190
at	O	1190
onset	O	1190
,	O	1190
age	O	1190
into	O	1190
wheelchair	O	1190
,	O	1190
scoliosis	B-Disease	1190
,	O	1190
impaired	O	1190
vibration	O	1190
sense	O	1190
,	O	1190
and	O	1190
the	O	1190
presence	O	1190
of	O	1190
foot	B-Disease	1190
deformity	I-Disease	1190
.	O	1190

There	O	1191
was	O	1191
no	O	1191
significant	O	1191
correlation	O	1191
between	O	1191
the	O	1191
size	O	1191
of	O	1191
the	O	1191
smaller	O	1191
allele	O	1191
and	O	1191
cardiomyopathy	B-Disease	1191
,	O	1191
diabetes	B-Disease	1191
mellitus	I-Disease	1191
,	O	1191
loss	B-Disease	1191
of	I-Disease	1191
proprioception	I-Disease	1191
,	O	1191
or	O	1191
bladder	B-Disease	1191
symptoms	I-Disease	1191
.	O	1191

The	O	1192
larger	O	1192
allele	O	1192
size	O	1192
correlated	O	1192
with	O	1192
bladder	B-Disease	1192
symptoms	I-Disease	1192
and	O	1192
the	O	1192
presence	O	1192
of	O	1192
foot	B-Disease	1192
deformity	I-Disease	1192
.	O	1192

The	O	1193
duration	O	1193
of	O	1193
disease	O	1193
is	O	1193
correlated	O	1193
with	O	1193
wheelchair	O	1193
use	O	1193
and	O	1193
the	O	1193
presence	O	1193
of	O	1193
diabetes	B-Disease	1193
,	O	1193
scoliosis	B-Disease	1193
,	O	1193
bladder	B-Disease	1193
symptoms	I-Disease	1193
and	O	1193
impaired	B-Disease	1193
proprioception	I-Disease	1193
,	O	1193
and	O	1193
vibration	O	1193
sense	O	1193
but	O	1193
no	O	1193
other	O	1193
complications	O	1193
studied	O	1193
.	O	1193

Novel	O	1195
mutations	O	1195
in	O	1195
XLRS1	O	1195
causing	O	1195
retinoschisis	B-Disease	1195
,	O	1195
including	O	1195
first	O	1195
evidence	O	1195
of	O	1195
putative	O	1195
leader	O	1195
sequence	O	1195
change	O	1195
.	O	1195

Juvenile	B-Disease	1196
retinoschisis	I-Disease	1196
is	O	1196
an	O	1196
X	B-Disease	1196
-	I-Disease	1196
linked	I-Disease	1196
recessive	I-Disease	1196
disease	I-Disease	1196
caused	O	1196
by	O	1196
mutations	O	1196
in	O	1196
the	O	1196
XLRS1	O	1196
gene	O	1196
.	O	1196

We	O	1197
screened	O	1197
31	O	1197
new	O	1197
unrelated	O	1197
patients	O	1197
and	O	1197
families	O	1197
for	O	1197
XLRS1	O	1197
mutations	O	1197
in	O	1197
addition	O	1197
to	O	1197
previously	O	1197
reported	O	1197
mutations	O	1197
for	O	1197
60	O	1197
of	O	1197
our	O	1197
families	O	1197
(	O	1197
Retinoschisis	B-Disease	1197
Consortium	O	1197
,	O	1197
Hum	O	1197
Mol	O	1197
Genet	O	1197
1998	O	1197
;	O	1197
7	O	1197
1185	O	1197
-	O	1197
1192	O	1197
)	O	1197
.	O	1197

Mutations	O	1203
in	O	1203
25	O	1203
of	O	1203
the	O	1203
families	O	1203
were	O	1203
localized	O	1203
to	O	1203
exons	O	1203
4	O	1203
-	O	1203
6	O	1203
,	O	1203
emphasizing	O	1203
the	O	1203
critical	O	1203
functional	O	1203
significance	O	1203
of	O	1203
the	O	1203
discoidin	O	1203
domain	O	1203
of	O	1203
the	O	1203
XLRS1	O	1203
protein	O	1203
Growth	O	1203
hormone	O	1203
treatment	O	1203
increases	O	1203
CO	O	1203
(	O	1203
2	O	1203
)	O	1203
response	O	1203
,	O	1203
ventilation	O	1203
and	O	1203
central	O	1203
inspiratory	O	1203
drive	O	1203
in	O	1203
children	O	1203
with	O	1203
Prader	B-Disease	1203
-	I-Disease	1203
Willi	I-Disease	1203
syndrome	I-Disease	1203
.	O	1203

We	O	1204
studied	O	1204
whether	O	1204
the	O	1204
beneficial	O	1204
effects	O	1204
of	O	1204
growth	O	1204
hormone	O	1204
(	O	1204
GH	O	1204
)	O	1204
treatment	O	1204
on	O	1204
growth	O	1204
and	O	1204
body	O	1204
composition	O	1204
in	O	1204
PWS	B-Disease	1204
are	O	1204
accompanied	O	1204
by	O	1204
an	O	1204
improvement	O	1204
in	O	1204
respiratory	O	1204
function	O	1204
.	O	1204

CONCLUSION	O	1213
Treatment	O	1213
of	O	1213
children	O	1213
with	O	1213
Prader	B-Disease	1213
-	I-Disease	1213
Willi	I-Disease	1213
syndrome	I-Disease	1213
(	O	1213
PWS	B-Disease	1213
)	O	1213
seems	O	1213
to	O	1213
have	O	1213
a	O	1213
stimulatory	O	1213
effect	O	1213
on	O	1213
central	O	1213
respiratory	O	1213
structures	O	1213
.	O	1213

The	O	1214
observed	O	1214
increase	O	1214
in	O	1214
ventilation	O	1214
and	O	1214
inspiratory	O	1214
drive	O	1214
may	O	1214
contribute	O	1214
to	O	1214
the	O	1214
improved	O	1214
activity	O	1214
level	O	1214
reported	O	1214
by	O	1214
parents	O	1214
of	O	1214
PWS	B-Disease	1214
children	O	1214
during	O	1214
growth	O	1214
hormone	O	1214
therapy	O	1214
G130V	O	1214
,	O	1214
a	O	1214
common	O	1214
FRDA	B-Disease	1214
point	O	1214
mutation	O	1214
,	O	1214
appears	O	1214
to	O	1214
have	O	1214
arisen	O	1214
from	O	1214
a	O	1214
common	O	1214
founder	O	1214
.	O	1214

Friedreich	B-Disease	1215
ataxia	I-Disease	1215
(	O	1215
FRDA	B-Disease	1215
)	O	1215
is	O	1215
the	O	1215
most	O	1215
common	O	1215
inherited	B-Disease	1215
ataxia	I-Disease	1215
.	O	1215

G130V	O	1220
,	O	1220
when	O	1220
present	O	1220
with	O	1220
an	O	1220
expanded	O	1220
GAA	O	1220
repeat	O	1220
on	O	1220
the	O	1220
other	O	1220
allele	O	1220
,	O	1220
is	O	1220
associated	O	1220
with	O	1220
an	O	1220
atypical	O	1220
FRDA	B-Disease	1220
phenotype	O	1220
.	O	1220

Most	O	1226
fragile	B-Disease	1226
X	I-Disease	1226
syndrome	I-Disease	1226
patients	O	1226
have	O	1226
expansion	O	1226
of	O	1226
a	O	1226
(	O	1226
CGG	O	1226
)	O	1226
(	O	1226
n	O	1226
)	O	1226
sequence	O	1226
with	O	1226
>	O	1226
200	O	1226
repeats	O	1226
(	O	1226
full	O	1226
mutation	O	1226
)	O	1226
in	O	1226
the	O	1226
FMR1	O	1226
gene	O	1226
responsible	O	1226
for	O	1226
this	O	1226
condition	O	1226
.	O	1226

Constitutional	O	1233
von	B-Disease	1233
Hippel	I-Disease	1233
-	I-Disease	1233
Lindau	I-Disease	1233
(	O	1233
VHL	B-Disease	1233
)	O	1233
gene	O	1233
deletions	O	1233
detected	O	1233
in	O	1233
VHL	B-Disease	1233
families	O	1233
by	O	1233
fluorescence	O	1233
in	O	1233
situ	O	1233
hybridization	O	1233
.	O	1233

von	B-Disease	1234
Hippel	I-Disease	1234
-	I-Disease	1234
Lindau	I-Disease	1234
(	I-Disease	1234
VHL	I-Disease	1234
)	I-Disease	1234
disease	I-Disease	1234
is	O	1234
an	O	1234
autosomal	B-Disease	1234
dominantly	I-Disease	1234
inherited	I-Disease	1234
cancer	I-Disease	1234
syndrome	I-Disease	1234
predisposing	O	1234
to	O	1234
a	O	1234
variety	O	1234
of	O	1234
tumor	B-Disease	1234
types	O	1234
that	O	1234
include	O	1234
retinal	O	1234
hemangioblastomas	B-Disease	1234
,	O	1234
hemangioblastomas	B-Disease	1234
of	O	1234
the	O	1234
central	O	1234
nervous	O	1234
system	O	1234
,	O	1234
renal	B-Disease	1234
cell	I-Disease	1234
carcinomas	I-Disease	1234
,	O	1234
pancreatic	B-Disease	1234
cysts	I-Disease	1234
and	I-Disease	1234
tumors	I-Disease	1234
,	O	1234
pheochromocytomas	B-Disease	1234
,	O	1234
endolymphatic	B-Disease	1234
sac	I-Disease	1234
tumors	I-Disease	1234
,	O	1234
and	O	1234
epididymal	B-Disease	1234
cystadenomas	I-Disease	1234
[	O	1234
W	O	1234
.	O	1234

The	O	1255
VHL	B-Disease	1255
gene	O	1255
was	O	1255
localized	O	1255
to	O	1255
chromosome	O	1255
3p25	O	1255
-	O	1255
26	O	1255
and	O	1255
cloned	O	1255
[	O	1255
F	O	1255
.	O	1255

Germline	O	1258
mutations	O	1258
in	O	1258
the	O	1258
VHL	B-Disease	1258
gene	O	1258
have	O	1258
been	O	1258
detected	O	1258
in	O	1258
the	O	1258
majority	O	1258
of	O	1258
VHL	B-Disease	1258
kindreds	O	1258
.	O	1258

The	O	1259
reported	O	1259
frequency	O	1259
of	O	1259
detection	O	1259
of	O	1259
VHL	B-Disease	1259
germline	O	1259
mutations	O	1259
has	O	1259
varied	O	1259
from	O	1259
39	O	1259
to	O	1259
80	O	1259
%	O	1259
(	O	1259
J	O	1259
.	O	1259

In	O	1287
the	O	1287
present	O	1287
study	O	1287
,	O	1287
we	O	1287
report	O	1287
the	O	1287
use	O	1287
of	O	1287
fluorescence	O	1287
in	O	1287
situ	O	1287
hybridization	O	1287
(	O	1287
FISH	O	1287
)	O	1287
as	O	1287
a	O	1287
method	O	1287
to	O	1287
detect	O	1287
and	O	1287
characterize	O	1287
VHL	B-Disease	1287
germline	O	1287
deletions	O	1287
.	O	1287

We	O	1288
reexamined	O	1288
a	O	1288
group	O	1288
of	O	1288
VHL	B-Disease	1288
patients	O	1288
shown	O	1288
previously	O	1288
by	O	1288
single	O	1288
-	O	1288
strand	O	1288
conformation	O	1288
and	O	1288
sequencing	O	1288
analysis	O	1288
not	O	1288
to	O	1288
harbor	O	1288
point	O	1288
mutations	O	1288
in	O	1288
the	O	1288
VHL	B-Disease	1288
locus	O	1288
.	O	1288

We	O	1289
found	O	1289
constitutional	O	1289
deletions	O	1289
in	O	1289
29	O	1289
of	O	1289
30	O	1289
VHL	B-Disease	1289
patients	O	1289
in	O	1289
this	O	1289
group	O	1289
using	O	1289
cosmid	O	1289
and	O	1289
P1	O	1289
probes	O	1289
that	O	1289
cover	O	1289
the	O	1289
VHL	B-Disease	1289
locus	O	1289
.	O	1289

We	O	1290
then	O	1290
tested	O	1290
six	O	1290
phenotypically	O	1290
normal	O	1290
offspring	O	1290
from	O	1290
four	O	1290
of	O	1290
these	O	1290
VHL	B-Disease	1290
families	O	1290
two	O	1290
were	O	1290
found	O	1290
to	O	1290
carry	O	1290
the	O	1290
deletion	O	1290
and	O	1290
the	O	1290
other	O	1290
four	O	1290
were	O	1290
deletion	O	1290
-	O	1290
free	O	1290
.	O	1290

In	O	1291
addition	O	1291
,	O	1291
germline	O	1291
mosaicism	O	1291
of	O	1291
the	O	1291
VHL	B-Disease	1291
gene	O	1291
was	O	1291
identified	O	1291
in	O	1291
one	O	1291
family	O	1291
.	O	1291

In	O	1292
sum	O	1292
,	O	1292
FISH	O	1292
was	O	1292
found	O	1292
to	O	1292
be	O	1292
a	O	1292
simple	O	1292
and	O	1292
reliable	O	1292
method	O	1292
to	O	1292
detect	O	1292
VHL	B-Disease	1292
germline	O	1292
deletions	O	1292
and	O	1292
practically	O	1292
useful	O	1292
in	O	1292
cases	O	1292
where	O	1292
other	O	1292
methods	O	1292
of	O	1292
screening	O	1292
have	O	1292
failed	O	1292
to	O	1292
detect	O	1292
a	O	1292
VHL	B-Disease	1292
gene	I-Disease	1292
abnormality	I-Disease	1292
Spectrum	O	1292
of	O	1292
hSNF5	O	1292
/	O	1292
INI1	O	1292
somatic	O	1292
mutations	O	1292
in	O	1292
human	O	1292
cancer	B-Disease	1292
and	O	1292
genotype	O	1292
-	O	1292
phenotype	O	1292
correlations	O	1292
.	O	1292

The	O	1293
hSNF5	O	1293
/	O	1293
INI1	O	1293
gene	O	1293
which	O	1293
encodes	O	1293
a	O	1293
member	O	1293
of	O	1293
the	O	1293
SWI	O	1293
/	O	1293
SNF	O	1293
chromatin	O	1293
ATP	O	1293
-	O	1293
dependent	O	1293
remodeling	O	1293
complex	O	1293
,	O	1293
is	O	1293
a	O	1293
new	O	1293
tumor	B-Disease	1293
suppressor	O	1293
gene	O	1293
localized	O	1293
on	O	1293
chromosome	O	1293
22q11	O	1293
.	O	1293

2	O	1294
and	O	1294
recently	O	1294
shown	O	1294
to	O	1294
be	O	1294
mutated	O	1294
in	O	1294
malignant	B-Disease	1294
rhabdoid	I-Disease	1294
tumors	I-Disease	1294
.	O	1294

We	O	1295
have	O	1295
searched	O	1295
for	O	1295
hSNF5	O	1295
/	O	1295
INI1	O	1295
mutations	O	1295
in	O	1295
229	O	1295
tumors	B-Disease	1295
of	O	1295
various	O	1295
origins	O	1295
using	O	1295
a	O	1295
screening	O	1295
method	O	1295
based	O	1295
on	O	1295
denaturing	O	1295
high	O	1295
-	O	1295
performance	O	1295
liquid	O	1295
chromatography	O	1295
.	O	1295

Mutations	O	1298
were	O	1298
retrieved	O	1298
in	O	1298
most	O	1298
rhabdoid	B-Disease	1298
tumors	I-Disease	1298
,	O	1298
whatever	O	1298
their	O	1298
sites	O	1298
of	O	1298
occurrence	O	1298
,	O	1298
indicating	O	1298
the	O	1298
common	O	1298
pathogenetic	O	1298
origin	O	1298
of	O	1298
these	O	1298
tumors	B-Disease	1298
.	O	1298

Recurrent	O	1299
hSNF5	O	1299
/	O	1299
INI1	O	1299
alterations	O	1299
were	O	1299
also	O	1299
observed	O	1299
in	O	1299
choroid	B-Disease	1299
plexus	I-Disease	1299
carcinomas	I-Disease	1299
and	O	1299
in	O	1299
a	O	1299
subset	O	1299
of	O	1299
central	O	1299
primitive	O	1299
neuroectodermal	B-Disease	1299
tumors	I-Disease	1299
(	O	1299
cPNETs	O	1299
)	O	1299
and	O	1299
medulloblastomas	B-Disease	1299
.	O	1299

In	O	1300
contrast	O	1300
,	O	1300
hSNF5	O	1300
/	O	1300
INI1	O	1300
point	O	1300
mutations	O	1300
were	O	1300
not	O	1300
detected	O	1300
in	O	1300
breast	B-Disease	1300
cancers	I-Disease	1300
,	O	1300
Wilms	B-Disease	1300
tumors	I-Disease	1300
,	O	1300
gliomas	B-Disease	1300
,	O	1300
ependymomas	B-Disease	1300
,	O	1300
sarcomas	B-Disease	1300
and	O	1300
other	O	1300
tumor	B-Disease	1300
types	O	1300
,	O	1300
even	O	1300
though	O	1300
most	O	1300
analyzed	O	1300
cases	O	1300
harbored	O	1300
loss	O	1300
of	O	1300
heterozygosity	O	1300
at	O	1300
22q11	O	1300
.	O	1300

These	O	1302
results	O	1302
suggest	O	1302
that	O	1302
rhabdoid	B-Disease	1302
tumors	I-Disease	1302
,	O	1302
choroid	B-Disease	1302
plexus	I-Disease	1302
carcinomas	I-Disease	1302
and	O	1302
a	O	1302
subset	O	1302
of	O	1302
medulloblastomas	B-Disease	1302
and	O	1302
cPNETs	O	1302
share	O	1302
common	O	1302
pathways	O	1302
of	O	1302
oncogenesis	O	1302
related	O	1302
to	O	1302
hSNF5	O	1302
/	O	1302
INI1	O	1302
alteration	O	1302
and	O	1302
that	O	1302
hSNF5	O	1302
/	O	1302
INI1	O	1302
mutations	O	1302
define	O	1302
a	O	1302
genetically	O	1302
homogeneous	O	1302
family	O	1302
of	O	1302
highly	O	1302
aggressive	O	1302
cancers	B-Disease	1302
mainly	O	1302
occurring	O	1302
in	O	1302
young	O	1302
children	O	1302
and	O	1302
frequently	O	1302
,	O	1302
but	O	1302
not	O	1302
always	O	1302
,	O	1302
exhibiting	O	1302
a	O	1302
rhabdoid	B-Disease	1302
phenotype	O	1302
Ataxin	O	1302
-	O	1302
3	O	1302
with	O	1302
an	O	1302
altered	O	1302
conformation	O	1302
that	O	1302
exposes	O	1302
the	O	1302
polyglutamine	O	1302
domain	O	1302
is	O	1302
associated	O	1302
with	O	1302
the	O	1302
nuclear	O	1302
matrix	O	1302
.	O	1302

Spinocerebellar	B-Disease	1303
ataxia	I-Disease	1303
type	I-Disease	1303
-	I-Disease	1303
3	I-Disease	1303
or	O	1303
Machado	B-Disease	1303
-	I-Disease	1303
Joseph	I-Disease	1303
disease	I-Disease	1303
(	O	1303
SCA3	B-Disease	1303
/	O	1303
MJD	B-Disease	1303
)	O	1303
is	O	1303
a	O	1303
member	O	1303
of	O	1303
the	O	1303
CAG	B-Disease	1303
/	I-Disease	1303
polyglutamine	I-Disease	1303
repeat	I-Disease	1303
disease	I-Disease	1303
family	O	1303
.	O	1303

Experimental	O	1305
models	O	1305
of	O	1305
polyglutamine	B-Disease	1305
disease	I-Disease	1305
implicate	O	1305
the	O	1305
nucleus	O	1305
in	O	1305
pathogenesis	O	1305
;	O	1305
however	O	1305
,	O	1305
the	O	1305
link	O	1305
between	O	1305
intranuclear	O	1305
expression	O	1305
of	O	1305
expanded	O	1305
polyglutamine	O	1305
and	O	1305
neuronal	B-Disease	1305
dysfunction	I-Disease	1305
remains	O	1305
unclear	O	1305
.	O	1305

Here	O	1306
we	O	1306
demonstrate	O	1306
that	O	1306
ataxin	O	1306
-	O	1306
3	O	1306
,	O	1306
the	O	1306
disease	O	1306
protein	O	1306
in	O	1306
SCA3	B-Disease	1306
/	O	1306
MJD	B-Disease	1306
,	O	1306
adopts	O	1306
a	O	1306
unique	O	1306
conformation	O	1306
when	O	1306
expressed	O	1306
within	O	1306
the	O	1306
nucleus	O	1306
of	O	1306
transfected	O	1306
cells	O	1306
.	O	1306

These	O	1312
data	O	1312
suggest	O	1312
that	O	1312
an	O	1312
early	O	1312
event	O	1312
in	O	1312
the	O	1312
pathogenesis	O	1312
of	O	1312
SCA3	B-Disease	1312
/	O	1312
MJD	B-Disease	1312
may	O	1312
be	O	1312
an	O	1312
altered	O	1312
conformation	O	1312
of	O	1312
ataxin	O	1312
-	O	1312
3	O	1312
within	O	1312
the	O	1312
nucleus	O	1312
that	O	1312
exposes	O	1312
the	O	1312
polyglutamine	O	1312
domain	O	1312
.	O	1312

The	O	1314
human	O	1314
MAGEL2	O	1314
gene	O	1314
and	O	1314
its	O	1314
mouse	O	1314
homologue	O	1314
are	O	1314
paternally	O	1314
expressed	O	1314
and	O	1314
mapped	O	1314
to	O	1314
the	O	1314
Prader	B-Disease	1314
-	I-Disease	1314
Willi	I-Disease	1314
region	O	1314
.	O	1314

Prader	B-Disease	1315
-	I-Disease	1315
Willi	I-Disease	1315
syndrome	I-Disease	1315
(	O	1315
PWS	B-Disease	1315
)	O	1315
is	O	1315
a	O	1315
complex	O	1315
neurogenetic	B-Disease	1315
disorder	I-Disease	1315
.	O	1315

The	O	1316
phenotype	O	1316
is	O	1316
likely	O	1316
to	O	1316
be	O	1316
a	O	1316
contiguous	B-Disease	1316
gene	I-Disease	1316
syndrome	I-Disease	1316
involving	O	1316
genes	O	1316
which	O	1316
are	O	1316
paternally	O	1316
expressed	O	1316
only	O	1316
,	O	1316
located	O	1316
in	O	1316
the	O	1316
human	O	1316
15q11	O	1316
-	O	1316
q13	O	1316
region	O	1316
.	O	1316

Four	O	1317
mouse	O	1317
models	O	1317
of	O	1317
PWS	B-Disease	1317
have	O	1317
been	O	1317
reported	O	1317
but	O	1317
these	O	1317
do	O	1317
not	O	1317
definitively	O	1317
allow	O	1317
the	O	1317
delineation	O	1317
of	O	1317
the	O	1317
critical	O	1317
region	O	1317
and	O	1317
the	O	1317
associated	O	1317
genes	O	1317
involved	O	1317
in	O	1317
the	O	1317
aetiology	O	1317
of	O	1317
PWS	B-Disease	1317
.	O	1317

Moreover	O	1318
,	O	1318
targeted	O	1318
mutagenesis	O	1318
of	O	1318
mouse	O	1318
homologues	O	1318
of	O	1318
the	O	1318
human	O	1318
candidate	O	1318
PWS	B-Disease	1318
genes	O	1318
does	O	1318
not	O	1318
appear	O	1318
to	O	1318
result	O	1318
in	O	1318
any	O	1318
of	O	1318
the	O	1318
features	O	1318
of	O	1318
PWS	B-Disease	1318
.	O	1318

Therefore	O	1319
,	O	1319
the	O	1319
isolation	O	1319
of	O	1319
new	O	1319
genes	O	1319
in	O	1319
this	O	1319
region	O	1319
remains	O	1319
crucial	O	1319
for	O	1319
a	O	1319
better	O	1319
understanding	O	1319
of	O	1319
the	O	1319
molecular	O	1319
basis	O	1319
of	O	1319
PWS	B-Disease	1319
.	O	1319

Moreover	O	1325
,	O	1325
MAGEL2	O	1325
/	O	1325
Magel2	O	1325
are	O	1325
expressed	O	1325
only	O	1325
from	O	1325
the	O	1325
paternal	O	1325
allele	O	1325
in	O	1325
brain	O	1325
,	O	1325
suggesting	O	1325
a	O	1325
potential	O	1325
role	O	1325
in	O	1325
the	O	1325
aetiology	O	1325
of	O	1325
PWS	B-Disease	1325
and	O	1325
its	O	1325
mouse	O	1325
model	O	1325
,	O	1325
respectively	O	1325
.	O	1325

Alveolar	B-Disease	1328
rhabdomyosarcoma	I-Disease	1328
is	O	1328
an	O	1328
aggressive	O	1328
pediatric	B-Disease	1328
cancer	I-Disease	1328
of	I-Disease	1328
striated	I-Disease	1328
muscle	I-Disease	1328
characterized	O	1328
in	O	1328
60	O	1328
%	O	1328
of	O	1328
cases	O	1328
by	O	1328
a	O	1328
t	O	1328
(	O	1328
2	O	1328
;	O	1328
13	O	1328
)	O	1328
(	O	1328
q35	O	1328
;	O	1328
q14	O	1328
)	O	1328
.	O	1328

Relevance	O	1334
of	O	1334
this	O	1334
model	O	1334
was	O	1334
suggested	O	1334
by	O	1334
verification	O	1334
that	O	1334
three	O	1334
of	O	1334
these	O	1334
genes	O	1334
(	O	1334
IGFBP5	O	1334
,	O	1334
HSIX1	O	1334
,	O	1334
and	O	1334
Slug	O	1334
)	O	1334
were	O	1334
also	O	1334
expressed	O	1334
in	O	1334
alveolar	B-Disease	1334
rhabdomyosarcoma	I-Disease	1334
cell	O	1334
lines	O	1334
.	O	1334

Experimental	O	1337
hemochromatosis	B-Disease	1337
due	O	1337
to	O	1337
MHC	O	1337
class	O	1337
I	O	1337
HFE	B-Disease	1337
deficiency	I-Disease	1337
:	O	1337
immune	O	1337
status	O	1337
and	O	1337
iron	O	1337
metabolism	O	1337
.	O	1337

The	O	1338
puzzling	O	1338
linkage	O	1338
between	O	1338
genetic	O	1338
hemochromatosis	B-Disease	1338
and	O	1338
histocompatibility	O	1338
loci	O	1338
became	O	1338
even	O	1338
more	O	1338
so	O	1338
when	O	1338
the	O	1338
gene	O	1338
involved	O	1338
,	O	1338
HFE	O	1338
,	O	1338
was	O	1338
identified	O	1338
.	O	1338

HFE	B-Disease	1342
-	I-Disease	1342
deficient	I-Disease	1342
animals	O	1342
were	O	1342
analyzed	O	1342
for	O	1342
a	O	1342
comprehensive	O	1342
set	O	1342
of	O	1342
metabolic	O	1342
and	O	1342
immune	O	1342
parameters	O	1342
.	O	1342

Faithfully	O	1343
mimicking	O	1343
human	O	1343
hemochromatosis	B-Disease	1343
,	O	1343
mice	O	1343
homozygous	O	1343
for	O	1343
this	O	1343
deletion	O	1343
develop	O	1343
iron	O	1343
overload	O	1343
,	O	1343
characterized	O	1343
by	O	1343
a	O	1343
higher	O	1343
plasma	O	1343
iron	O	1343
content	O	1343
and	O	1343
a	O	1343
raised	O	1343
transferrin	O	1343
saturation	O	1343
as	O	1343
well	O	1343
as	O	1343
an	O	1343
elevated	O	1343
hepatic	O	1343
iron	O	1343
load	O	1343
.	O	1343

Ataxia	B-Disease	1349
-	I-Disease	1349
telangiectasia	I-Disease	1349
is	O	1349
a	O	1349
rare	O	1349
genetic	B-Disease	1349
disorder	I-Disease	1349
associated	O	1349
with	O	1349
immune	B-Disease	1349
deficiency	I-Disease	1349
,	O	1349
chromosome	B-Disease	1349
instability	I-Disease	1349
,	O	1349
and	O	1349
a	O	1349
predisposition	O	1349
to	O	1349
lymphoid	B-Disease	1349
malignancy	I-Disease	1349
.	O	1349

These	O	1353
findings	O	1353
as	O	1353
well	O	1353
as	O	1353
data	O	1353
obtained	O	1353
by	O	1353
others	O	1353
for	O	1353
patients	O	1353
with	O	1353
ataxia	B-Disease	1353
-	I-Disease	1353
telangiectasia	I-Disease	1353
suggest	O	1353
that	O	1353
structural	O	1353
rearrangement	O	1353
of	O	1353
14q	O	1353
is	O	1353
the	O	1353
initial	O	1353
chromosomal	O	1353
change	O	1353
in	O	1353
lymphocyte	O	1353
clones	O	1353
of	O	1353
patients	O	1353
with	O	1353
this	O	1353
disorder	O	1353
.	O	1353

Chromosomes	O	1354
of	O	1354
lymphocytes	O	1354
from	O	1354
one	O	1354
of	O	1354
the	O	1354
patients	O	1354
were	O	1354
studied	O	1354
before	O	1354
and	O	1354
after	O	1354
the	O	1354
onset	O	1354
of	O	1354
chronic	B-Disease	1354
lymphocytic	I-Disease	1354
leukemia	I-Disease	1354
.	O	1354

Before	O	1355
leukemia	B-Disease	1355
was	O	1355
diagnosed	O	1355
,	O	1355
the	O	1355
patient	O	1355
had	O	1355
a	O	1355
lymphocyte	O	1355
clone	O	1355
with	O	1355
a	O	1355
14q	O	1355
translocation	O	1355
.	O	1355

This	O	1356
clone	O	1356
appears	O	1356
to	O	1356
have	O	1356
given	O	1356
rise	O	1356
to	O	1356
the	O	1356
leukemic	B-Disease	1356
cells	O	1356
.	O	1356

We	O	1357
hypothesize	O	1357
that	O	1357
structural	O	1357
rearrangement	O	1357
of	O	1357
14q	O	1357
is	O	1357
directly	O	1357
related	O	1357
to	O	1357
abnormal	O	1357
growth	O	1357
of	O	1357
lymphocytes	O	1357
and	O	1357
that	O	1357
it	O	1357
may	O	1357
be	O	1357
a	O	1357
step	O	1357
toward	O	1357
the	O	1357
development	O	1357
of	O	1357
lymphoid	B-Disease	1357
malignancies	I-Disease	1357
.	O	1357

Increasing	O	1358
evidence	O	1358
,	O	1358
provided	O	1358
by	O	1358
others	O	1358
,	O	1358
for	O	1358
the	O	1358
nonrandom	O	1358
involvement	O	1358
of	O	1358
14q	O	1358
in	O	1358
African	O	1358
-	O	1358
type	O	1358
Burkitts	B-Disease	1358
lymphoma	I-Disease	1358
and	O	1358
other	O	1358
lymphoid	B-Disease	1358
neoplasms	I-Disease	1358
further	O	1358
strengthens	O	1358
this	O	1358
hypothesis	O	1358
.	O	1358

Exon	O	1360
9	O	1360
mutations	O	1360
in	O	1360
the	O	1360
WT1	O	1360
gene	O	1360
,	O	1360
without	O	1360
influencing	O	1360
KTS	O	1360
splice	O	1360
isoforms	O	1360
,	O	1360
are	O	1360
also	O	1360
responsible	O	1360
for	O	1360
Frasier	B-Disease	1360
syndrome	I-Disease	1360
.	O	1360

We	O	1361
report	O	1361
new	O	1361
mutations	O	1361
in	O	1361
exon	O	1361
9	O	1361
of	O	1361
the	O	1361
WT1	O	1361
gene	O	1361
that	O	1361
did	O	1361
not	O	1361
alter	O	1361
the	O	1361
ratio	O	1361
of	O	1361
+	O	1361
/	O	1361
-	O	1361
KTS	O	1361
splice	O	1361
isoforms	O	1361
in	O	1361
two	O	1361
unrelated	O	1361
patients	O	1361
with	O	1361
Frasier	B-Disease	1361
syndrome	I-Disease	1361
(	O	1361
FS	B-Disease	1361
)	O	1361
.	O	1361

The	O	1363
mutations	O	1363
found	O	1363
in	O	1363
our	O	1363
cases	O	1363
occurred	O	1363
in	O	1363
the	O	1363
same	O	1363
exon	O	1363
of	O	1363
the	O	1363
WT1	O	1363
gene	O	1363
as	O	1363
detected	O	1363
in	O	1363
Denys	B-Disease	1363
-	I-Disease	1363
Drash	I-Disease	1363
syndrome	I-Disease	1363
(	O	1363
DDS	B-Disease	1363
)	O	1363
and	O	1363
could	O	1363
not	O	1363
be	O	1363
explained	O	1363
by	O	1363
the	O	1363
previously	O	1363
proposed	O	1363
mechanism	O	1363
.	O	1363

The	O	1364
results	O	1364
suggest	O	1364
that	O	1364
the	O	1364
two	O	1364
syndromes	O	1364
originate	O	1364
from	O	1364
the	O	1364
same	O	1364
WT1	B-Disease	1364
gene	I-Disease	1364
abnormality	I-Disease	1364
.	O	1364

From	O	1365
a	O	1365
molecular	O	1365
biological	O	1365
point	O	1365
of	O	1365
view	O	1365
,	O	1365
we	O	1365
concluded	O	1365
that	O	1365
the	O	1365
two	O	1365
diseases	O	1365
were	O	1365
not	O	1365
separable	O	1365
,	O	1365
and	O	1365
that	O	1365
FS	B-Disease	1365
should	O	1365
be	O	1365
included	O	1365
as	O	1365
an	O	1365
atypical	O	1365
form	O	1365
of	O	1365
DDS	B-Disease	1365
.	O	1365

Splice	O	1367
-	O	1367
site	O	1367
mutation	O	1367
in	O	1367
the	O	1367
PDS	B-Disease	1367
gene	O	1367
may	O	1367
result	O	1367
in	O	1367
intrafamilial	O	1367
variability	O	1367
for	O	1367
deafness	B-Disease	1367
in	O	1367
Pendred	B-Disease	1367
syndrome	I-Disease	1367
.	O	1367

Pendred	B-Disease	1368
syndrome	I-Disease	1368
is	O	1368
a	O	1368
recessive	B-Disease	1368
inherited	I-Disease	1368
disorder	I-Disease	1368
that	O	1368
consists	O	1368
of	O	1368
developmental	B-Disease	1368
abnormalities	I-Disease	1368
of	I-Disease	1368
the	I-Disease	1368
cochlea	I-Disease	1368
,	O	1368
sensorineural	B-Disease	1368
hearing	I-Disease	1368
loss	I-Disease	1368
,	O	1368
and	O	1368
diffuse	B-Disease	1368
thyroid	I-Disease	1368
enlargement	I-Disease	1368
(	O	1368
goiter	B-Disease	1368
)	O	1368
.	O	1368

This	O	1369
disorder	O	1369
may	O	1369
account	O	1369
for	O	1369
up	O	1369
to	O	1369
10	O	1369
%	O	1369
of	O	1369
cases	O	1369
of	O	1369
hereditary	B-Disease	1369
deafness	I-Disease	1369
.	O	1369

The	O	1370
disease	O	1370
gene	O	1370
(	O	1370
PDS	B-Disease	1370
)	O	1370
has	O	1370
been	O	1370
mapped	O	1370
to	O	1370
chromosome	O	1370
7q22	O	1370
-	O	1370
q31	O	1370
,	O	1370
and	O	1370
encodes	O	1370
a	O	1370
chloride	O	1370
-	O	1370
iodide	O	1370
transport	O	1370
protein	O	1370
.	O	1370

We	O	1371
performed	O	1371
mutation	O	1371
analysis	O	1371
of	O	1371
individual	O	1371
exons	O	1371
of	O	1371
the	O	1371
PDS	B-Disease	1371
gene	O	1371
in	O	1371
one	O	1371
Spanish	O	1371
family	O	1371
that	O	1371
shows	O	1371
intrafamilial	O	1371
variability	O	1371
of	O	1371
the	O	1371
deafness	B-Disease	1371
phenotype	O	1371
(	O	1371
two	O	1371
patients	O	1371
with	O	1371
profound	O	1371
and	O	1371
one	O	1371
with	O	1371
moderate	O	1371
-	O	1371
severe	O	1371
deafness	B-Disease	1371
)	O	1371
.	O	1371

We	O	1372
identified	O	1372
a	O	1372
new	O	1372
splice	O	1372
-	O	1372
site	O	1372
mutation	O	1372
affecting	O	1372
intron	O	1372
4	O	1372
of	O	1372
the	O	1372
PDS	B-Disease	1372
gene	O	1372
,	O	1372
at	O	1372
nucleotide	O	1372
position	O	1372
639	O	1372
+	O	1372
7	O	1372
.	O	1372

Since	O	1374
the	O	1374
newly	O	1374
created	O	1374
donor	O	1374
splice	O	1374
site	O	1374
is	O	1374
likely	O	1374
to	O	1374
compete	O	1374
with	O	1374
the	O	1374
normal	O	1374
one	O	1374
,	O	1374
variations	O	1374
of	O	1374
the	O	1374
levels	O	1374
of	O	1374
normal	O	1374
and	O	1374
aberrant	O	1374
transcripts	O	1374
of	O	1374
the	O	1374
PDS	B-Disease	1374
gene	O	1374
in	O	1374
the	O	1374
cochlea	O	1374
may	O	1374
explain	O	1374
the	O	1374
variability	O	1374
in	O	1374
the	O	1374
deafness	B-Disease	1374
presentation	O	1374
.	O	1374

The	O	1376
molecular	O	1376
basis	O	1376
of	O	1376
Sjogren	B-Disease	1376
-	I-Disease	1376
Larsson	I-Disease	1376
syndrome	I-Disease	1376
:	O	1376
mutation	O	1376
analysis	O	1376
of	O	1376
the	O	1376
fatty	O	1376
aldehyde	O	1376
dehydrogenase	O	1376
gene	O	1376
.	O	1376

Sjogren	B-Disease	1377
-	I-Disease	1377
Larsson	I-Disease	1377
syndrome	I-Disease	1377
(	O	1377
SLS	B-Disease	1377
)	O	1377
is	O	1377
an	O	1377
autosomal	B-Disease	1377
recessive	I-Disease	1377
disorder	I-Disease	1377
characterized	O	1377
by	O	1377
ichthyosis	B-Disease	1377
,	O	1377
mental	B-Disease	1377
retardation	I-Disease	1377
,	O	1377
spasticity	B-Disease	1377
,	O	1377
and	O	1377
deficient	B-Disease	1377
activity	I-Disease	1377
of	I-Disease	1377
fatty	I-Disease	1377
aldehyde	I-Disease	1377
dehydrogenase	I-Disease	1377
(	O	1377
FALDH	O	1377
)	O	1377
.	O	1377

To	O	1378
define	O	1378
the	O	1378
molecular	O	1378
defects	O	1378
causing	O	1378
SLS	B-Disease	1378
,	O	1378
we	O	1378
performed	O	1378
mutation	O	1378
analysis	O	1378
of	O	1378
the	O	1378
FALDH	O	1378
gene	O	1378
in	O	1378
probands	O	1378
from	O	1378
63	O	1378
kindreds	O	1378
with	O	1378
SLS	B-Disease	1378
.	O	1378

All	O	1380
of	O	1380
the	O	1380
patients	O	1380
with	O	1380
SLS	B-Disease	1380
were	O	1380
found	O	1380
to	O	1380
carry	O	1380
mutations	O	1380
.	O	1380

At	O	1385
least	O	1385
four	O	1385
of	O	1385
the	O	1385
common	O	1385
mutations	O	1385
(	O	1385
551C	O	1385
-	O	1385
-	O	1385
>	O	1385
T	O	1385
,	O	1385
682C	O	1385
-	O	1385
-	O	1385
>	O	1385
T	O	1385
,	O	1385
733G	O	1385
-	O	1385
-	O	1385
>	O	1385
A	O	1385
,	O	1385
and	O	1385
798	O	1385
+	O	1385
1delG	O	1385
)	O	1385
were	O	1385
associated	O	1385
with	O	1385
multiple	O	1385
SNP	O	1385
haplotypes	O	1385
,	O	1385
suggesting	O	1385
that	O	1385
these	O	1385
mutations	O	1385
originated	O	1385
independently	O	1385
on	O	1385
more	O	1385
than	O	1385
one	O	1385
occasion	O	1385
or	O	1385
were	O	1385
ancient	O	1385
SLS	B-Disease	1385
genes	O	1385
that	O	1385
had	O	1385
undergone	O	1385
intragenic	O	1385
recombination	O	1385
.	O	1385

Our	O	1386
results	O	1386
demonstrate	O	1386
that	O	1386
SLS	B-Disease	1386
is	O	1386
caused	O	1386
by	O	1386
a	O	1386
strikingly	O	1386
heterogeneous	O	1386
group	O	1386
of	O	1386
mutations	O	1386
in	O	1386
the	O	1386
FALDH	O	1386
gene	O	1386
and	O	1386
provide	O	1386
a	O	1386
framework	O	1386
for	O	1386
understanding	O	1386
the	O	1386
genetic	O	1386
basis	O	1386
of	O	1386
SLS	B-Disease	1386
and	O	1386
the	O	1386
development	O	1386
of	O	1386
DNA	O	1386
-	O	1386
based	O	1386
diagnostic	O	1386
tests	O	1386
.	O	1386

Loss	O	1388
-	O	1388
of	O	1388
-	O	1388
function	O	1388
mutations	O	1388
in	O	1388
the	O	1388
cathepsin	O	1388
C	O	1388
gene	O	1388
result	O	1388
in	O	1388
periodontal	B-Disease	1388
disease	I-Disease	1388
and	O	1388
palmoplantar	B-Disease	1388
keratosis	I-Disease	1388
.	O	1388

Papillon	B-Disease	1389
-	I-Disease	1389
Lefevre	I-Disease	1389
syndrome	I-Disease	1389
,	O	1389
or	O	1389
keratosis	B-Disease	1389
palmoplantaris	I-Disease	1389
with	O	1389
periodontopathia	B-Disease	1389
(	O	1389
PLS	B-Disease	1389
,	O	1389
MIM	O	1389
245000	O	1389
)	O	1389
,	O	1389
is	O	1389
an	O	1389
autosomal	B-Disease	1389
recessive	I-Disease	1389
disorder	I-Disease	1389
that	O	1389
is	O	1389
mainly	O	1389
ascertained	O	1389
by	O	1389
dentists	O	1389
because	O	1389
of	O	1389
the	O	1389
severe	O	1389
periodontitis	B-Disease	1389
that	O	1389
afflicts	O	1389
patients	O	1389
.	O	1389

Both	O	1390
the	O	1390
deciduous	O	1390
and	O	1390
permanent	O	1390
dentitions	O	1390
are	O	1390
affected	O	1390
,	O	1390
resulting	O	1390
in	O	1390
premature	O	1390
tooth	B-Disease	1390
loss	I-Disease	1390
.	O	1390

Palmoplantar	B-Disease	1391
keratosis	I-Disease	1391
,	O	1391
varying	O	1391
from	O	1391
mild	O	1391
psoriasiform	O	1391
scaly	O	1391
skin	O	1391
to	O	1391
overt	O	1391
hyperkeratosis	B-Disease	1391
,	O	1391
typically	O	1391
develops	O	1391
within	O	1391
the	O	1391
first	O	1391
three	O	1391
years	O	1391
of	O	1391
life	O	1391
.	O	1391

Keratosis	B-Disease	1392
also	O	1392
affects	O	1392
other	O	1392
sites	O	1392
such	O	1392
as	O	1392
elbows	O	1392
and	O	1392
knees	O	1392
.	O	1392

Most	O	1393
PLS	B-Disease	1393
patients	O	1393
display	O	1393
both	O	1393
periodontitis	B-Disease	1393
and	O	1393
hyperkeratosis	B-Disease	1393
.	O	1393

Some	O	1394
patients	O	1394
have	O	1394
only	O	1394
palmoplantar	B-Disease	1394
keratosis	I-Disease	1394
or	O	1394
periodontitis	B-Disease	1394
,	O	1394
and	O	1394
in	O	1394
rare	O	1394
individuals	O	1394
the	O	1394
periodontitis	B-Disease	1394
is	O	1394
mild	O	1394
and	O	1394
of	O	1394
late	O	1394
onset	O	1394
.	O	1394

In	O	1400
two	O	1400
of	O	1400
these	O	1400
families	O	1400
we	O	1400
used	O	1400
a	O	1400
functional	O	1400
assay	O	1400
to	O	1400
demonstrate	O	1400
an	O	1400
almost	O	1400
total	O	1400
loss	O	1400
of	O	1400
cathepsin	O	1400
C	O	1400
activity	O	1400
in	O	1400
PLS	B-Disease	1400
patients	O	1400
and	O	1400
reduced	O	1400
activity	O	1400
in	O	1400
obligate	O	1400
carriers	O	1400
.	O	1400

Confirmation	O	1401
of	O	1401
linkage	O	1401
of	O	1401
Van	B-Disease	1401
der	I-Disease	1401
Woude	I-Disease	1401
syndrome	I-Disease	1401
to	O	1401
chromosome	O	1401
1q32	O	1401
:	O	1401
evidence	O	1401
of	O	1401
association	O	1401
with	O	1401
STR	O	1401
alleles	O	1401
suggests	O	1401
possible	O	1401
unique	O	1401
origin	O	1401
of	O	1401
the	O	1401
disease	O	1401
mutation	O	1401
.	O	1401

Van	B-Disease	1402
der	I-Disease	1402
Woude	I-Disease	1402
syndrome	I-Disease	1402
(	O	1402
VWS	B-Disease	1402
)	O	1402
is	O	1402
an	O	1402
autosomal	B-Disease	1402
dominant	I-Disease	1402
craniofacial	I-Disease	1402
disorder	I-Disease	1402
with	O	1402
high	O	1402
penetrance	O	1402
and	O	1402
variable	O	1402
expression	O	1402
.	O	1402

Its	O	1403
clinical	O	1403
features	O	1403
are	O	1403
variably	O	1403
expressed	O	1403
,	O	1403
but	O	1403
include	O	1403
cleft	B-Disease	1403
lip	I-Disease	1403
and	O	1403
/	O	1403
or	O	1403
cleft	B-Disease	1403
palate	I-Disease	1403
,	O	1403
lip	B-Disease	1403
pits	I-Disease	1403
and	O	1403
hypodontia	B-Disease	1403
.	O	1403

All	O	1404
VWS	B-Disease	1404
families	O	1404
studied	O	1404
to	O	1404
date	O	1404
map	O	1404
the	O	1404
disease	O	1404
gene	O	1404
to	O	1404
a	O	1404
<	O	1404
2	O	1404
cM	O	1404
region	O	1404
of	O	1404
chromosome	O	1404
1q32	O	1404
,	O	1404
with	O	1404
no	O	1404
evidence	O	1404
of	O	1404
locus	O	1404
heterogeneity	O	1404
.	O	1404

The	O	1405
aim	O	1405
of	O	1405
this	O	1405
study	O	1405
is	O	1405
to	O	1405
refine	O	1405
the	O	1405
localization	O	1405
of	O	1405
the	O	1405
VWS	B-Disease	1405
gene	O	1405
and	O	1405
to	O	1405
further	O	1405
assess	O	1405
possible	O	1405
heterogeneity	O	1405
.	O	1405

We	O	1406
analyzed	O	1406
four	O	1406
multiplex	O	1406
VWS	B-Disease	1406
families	O	1406
.	O	1406

All	O	1407
available	O	1407
members	O	1407
were	O	1407
clinically	O	1407
assessed	O	1407
and	O	1407
genotyped	O	1407
for	O	1407
19	O	1407
short	O	1407
tandem	O	1407
repeat	O	1407
markers	O	1407
on	O	1407
chromosome	O	1407
1	O	1407
in	O	1407
the	O	1407
VWS	B-Disease	1407
candidate	O	1407
gene	O	1407
region	O	1407
.	O	1407

Our	O	1412
assay	O	1412
method	O	1412
for	O	1412
short	O	1412
tandem	O	1412
repeat	O	1412
(	O	1412
STR	O	1412
)	O	1412
markers	O	1412
provided	O	1412
highly	O	1412
accurate	O	1412
size	O	1412
estimation	O	1412
of	O	1412
marker	O	1412
allele	O	1412
fragment	O	1412
sizes	O	1412
,	O	1412
and	O	1412
therefore	O	1412
enabled	O	1412
us	O	1412
to	O	1412
determine	O	1412
the	O	1412
specific	O	1412
alleles	O	1412
segregating	O	1412
with	O	1412
the	O	1412
VWS	B-Disease	1412
gene	O	1412
in	O	1412
each	O	1412
of	O	1412
our	O	1412
four	O	1412
families	O	1412
.	O	1412

We	O	1413
observed	O	1413
a	O	1413
striking	O	1413
pattern	O	1413
of	O	1413
STR	O	1413
allele	O	1413
sharing	O	1413
at	O	1413
several	O	1413
closely	O	1413
linked	O	1413
loci	O	1413
among	O	1413
our	O	1413
four	O	1413
Caucasian	O	1413
VWS	B-Disease	1413
families	O	1413
recruited	O	1413
at	O	1413
three	O	1413
different	O	1413
locations	O	1413
in	O	1413
the	O	1413
US	O	1413
.	O	1413

These	O	1414
results	O	1414
suggest	O	1414
the	O	1414
possibility	O	1414
of	O	1414
a	O	1414
unique	O	1414
origin	O	1414
for	O	1414
a	O	1414
mutation	O	1414
responsible	O	1414
for	O	1414
many	O	1414
or	O	1414
most	O	1414
cases	O	1414
of	O	1414
VWS	B-Disease	1414
.	O	1414

A	O	1416
new	O	1416
platelet	O	1416
-	O	1416
specific	O	1416
alloantigen	O	1416
,	O	1416
termed	O	1416
Sit	O	1416
(	O	1416
a	O	1416
)	O	1416
,	O	1416
was	O	1416
identified	O	1416
in	O	1416
a	O	1416
severe	O	1416
case	O	1416
of	O	1416
neonatal	B-Disease	1416
alloimmune	I-Disease	1416
thrombocytopenia	I-Disease	1416
.	O	1416

Platelet	O	1430
aggregation	O	1430
responses	O	1430
of	O	1430
Sit	O	1430
(	O	1430
a	O	1430
)	O	1430
(	O	1430
+	O	1430
)	O	1430
individuals	O	1430
were	O	1430
diminished	O	1430
in	O	1430
response	O	1430
to	O	1430
collagen	O	1430
,	O	1430
indicating	O	1430
that	O	1430
the	O	1430
Thr	O	1430
(	O	1430
799	O	1430
)	O	1430
Met	O	1430
mutation	O	1430
affects	O	1430
the	O	1430
function	O	1430
of	O	1430
the	O	1430
GPIa	O	1430
/	O	1430
IIa	O	1430
complex	O	1430
Mutations	O	1430
of	O	1430
the	O	1430
cathepsin	O	1430
C	O	1430
gene	O	1430
are	O	1430
responsible	O	1430
for	O	1430
Papillon	B-Disease	1430
-	I-Disease	1430
Lefevre	I-Disease	1430
syndrome	I-Disease	1430
.	O	1430

Papillon	B-Disease	1431
-	I-Disease	1431
Lefevre	I-Disease	1431
syndrome	I-Disease	1431
(	O	1431
PLS	B-Disease	1431
)	O	1431
is	O	1431
an	O	1431
autosomal	B-Disease	1431
recessive	I-Disease	1431
disorder	I-Disease	1431
characterised	O	1431
by	O	1431
palmoplantar	B-Disease	1431
hyperkeratosis	I-Disease	1431
and	O	1431
severe	O	1431
early	O	1431
onset	O	1431
periodontitis	B-Disease	1431
that	O	1431
results	O	1431
in	O	1431
the	O	1431
premature	O	1431
loss	O	1431
of	O	1431
the	O	1431
primary	O	1431
and	O	1431
secondary	O	1431
dentitions	O	1431
.	O	1431

A	O	1432
major	O	1432
gene	O	1432
locus	O	1432
for	O	1432
PLS	B-Disease	1432
has	O	1432
been	O	1432
mapped	O	1432
to	O	1432
a	O	1432
2	O	1432
.	O	1432

By	O	1436
RT	O	1436
-	O	1436
PCR	O	1436
,	O	1436
we	O	1436
found	O	1436
CTSC	O	1436
is	O	1436
also	O	1436
expressed	O	1436
in	O	1436
epithelial	O	1436
regions	O	1436
commonly	O	1436
affected	O	1436
by	O	1436
PLS	B-Disease	1436
,	O	1436
including	O	1436
the	O	1436
palms	O	1436
,	O	1436
soles	O	1436
,	O	1436
knees	O	1436
,	O	1436
and	O	1436
oral	O	1436
keratinised	O	1436
gingiva	O	1436
.	O	1436

Sequence	O	1439
analysis	O	1439
of	O	1439
CTSC	O	1439
from	O	1439
subjects	O	1439
affected	O	1439
with	O	1439
PLS	B-Disease	1439
from	O	1439
five	O	1439
consanguineous	O	1439
Turkish	O	1439
families	O	1439
identified	O	1439
four	O	1439
different	O	1439
mutations	O	1439
.	O	1439

All	O	1442
PLS	B-Disease	1442
patients	O	1442
were	O	1442
homozygous	O	1442
for	O	1442
cathepsin	O	1442
C	O	1442
mutations	O	1442
inherited	O	1442
from	O	1442
a	O	1442
common	O	1442
ancestor	O	1442
.	O	1442

Parents	O	1443
and	O	1443
sibs	O	1443
heterozygous	O	1443
for	O	1443
cathepsin	O	1443
C	O	1443
mutations	O	1443
do	O	1443
not	O	1443
show	O	1443
either	O	1443
the	O	1443
palmoplantar	B-Disease	1443
hyperkeratosis	I-Disease	1443
or	O	1443
severe	O	1443
early	O	1443
onset	O	1443
periodontitis	B-Disease	1443
characteristic	O	1443
of	O	1443
PLS	B-Disease	1443
.	O	1443

A	O	1444
more	O	1444
complete	O	1444
understanding	O	1444
of	O	1444
the	O	1444
functional	O	1444
physiology	O	1444
of	O	1444
cathepsin	O	1444
C	O	1444
carries	O	1444
significant	O	1444
implications	O	1444
for	O	1444
understanding	O	1444
normal	O	1444
and	O	1444
abnormal	O	1444
skin	O	1444
development	O	1444
and	O	1444
periodontal	B-Disease	1444
disease	I-Disease	1444
susceptibility	O	1444
Mutational	O	1444
analysis	O	1444
of	O	1444
the	O	1444
HGO	O	1444
gene	O	1444
in	O	1444
Finnish	O	1444
alkaptonuria	B-Disease	1444
patients	O	1444
.	O	1444

Alkaptonuria	B-Disease	1445
(	O	1445
AKU	B-Disease	1445
)	O	1445
,	O	1445
the	O	1445
prototypic	O	1445
inborn	B-Disease	1445
error	I-Disease	1445
of	I-Disease	1445
metabolism	I-Disease	1445
,	O	1445
has	O	1445
recently	O	1445
been	O	1445
shown	O	1445
to	O	1445
be	O	1445
caused	O	1445
by	O	1445
loss	O	1445
of	O	1445
function	O	1445
mutations	O	1445
in	O	1445
the	O	1445
homogentisate	O	1445
-	O	1445
1	O	1445
,	O	1445
2	O	1445
-	O	1445
dioxygenase	O	1445
gene	O	1445
(	O	1445
HGO	O	1445
)	O	1445
.	O	1445

So	O	1446
far	O	1446
17	O	1446
mutations	O	1446
have	O	1446
been	O	1446
characterised	O	1446
in	O	1446
AKU	B-Disease	1446
patients	O	1446
of	O	1446
different	O	1446
ethnic	O	1446
origin	O	1446
.	O	1446

We	O	1447
describe	O	1447
three	O	1447
novel	O	1447
mutations	O	1447
(	O	1447
R58fs	O	1447
,	O	1447
R330S	O	1447
,	O	1447
and	O	1447
H371R	O	1447
)	O	1447
and	O	1447
one	O	1447
common	O	1447
AKU	B-Disease	1447
mutation	O	1447
(	O	1447
M368V	O	1447
)	O	1447
,	O	1447
detected	O	1447
by	O	1447
mutational	O	1447
and	O	1447
polymorphism	O	1447
analysis	O	1447
of	O	1447
the	O	1447
HGO	O	1447
gene	O	1447
in	O	1447
five	O	1447
Finnish	O	1447
AKU	B-Disease	1447
pedigrees	O	1447
.	O	1447

The	O	1448
three	O	1448
novel	O	1448
AKU	B-Disease	1448
mutations	O	1448
are	O	1448
most	O	1448
likely	O	1448
specific	O	1448
for	O	1448
the	O	1448
Finnish	O	1448
population	O	1448
and	O	1448
have	O	1448
originated	O	1448
recently	O	1448
.	O	1448

The	O	1450
identical	O	1450
5	O	1450
'	O	1450
splice	O	1450
-	O	1450
site	O	1450
acceptor	O	1450
mutation	O	1450
in	O	1450
five	O	1450
attenuated	B-Disease	1450
APC	I-Disease	1450
families	O	1450
from	O	1450
Newfoundland	O	1450
demonstrates	O	1450
a	O	1450
founder	O	1450
effect	O	1450
.	O	1450

Inherited	O	1451
mutations	O	1451
of	O	1451
the	O	1451
APC	B-Disease	1451
gene	O	1451
predispose	O	1451
carriers	O	1451
to	O	1451
multiple	O	1451
adenomatous	B-Disease	1451
polyps	I-Disease	1451
of	I-Disease	1451
the	I-Disease	1451
colon	I-Disease	1451
and	I-Disease	1451
rectum	I-Disease	1451
and	O	1451
to	O	1451
colorectal	B-Disease	1451
cancer	I-Disease	1451
.	O	1451

Mutations	O	1452
located	O	1452
at	O	1452
the	O	1452
extreme	O	1452
5	O	1452
end	O	1452
of	O	1452
the	O	1452
APC	B-Disease	1452
gene	O	1452
,	O	1452
however	O	1452
,	O	1452
are	O	1452
associated	O	1452
with	O	1452
a	O	1452
less	O	1452
severe	O	1452
disease	O	1452
known	O	1452
as	O	1452
attenuated	B-Disease	1452
adenomatous	I-Disease	1452
polyposis	I-Disease	1452
coli	I-Disease	1452
(	O	1452
AAPC	B-Disease	1452
)	O	1452
.	O	1452

Many	O	1453
individuals	O	1453
with	O	1453
AAPC	B-Disease	1453
develop	O	1453
relatively	O	1453
few	O	1453
colorectal	B-Disease	1453
polyps	I-Disease	1453
but	O	1453
are	O	1453
still	O	1453
at	O	1453
high	O	1453
risk	O	1453
for	O	1453
colorectal	B-Disease	1453
cancer	I-Disease	1453
.	O	1453

We	O	1454
report	O	1454
here	O	1454
the	O	1454
identification	O	1454
of	O	1454
a	O	1454
5	O	1454
APC	B-Disease	1454
germline	O	1454
mutation	O	1454
in	O	1454
five	O	1454
separately	O	1454
ascertained	O	1454
AAPC	B-Disease	1454
families	O	1454
from	O	1454
Newfoundland	O	1454
,	O	1454
Canada	O	1454
.	O	1454

This	O	1455
disease	O	1455
-	O	1455
causing	O	1455
mutation	O	1455
is	O	1455
a	O	1455
single	O	1455
basepair	O	1455
change	O	1455
(	O	1455
G	O	1455
to	O	1455
A	O	1455
)	O	1455
in	O	1455
the	O	1455
splice	O	1455
-	O	1455
acceptor	O	1455
region	O	1455
of	O	1455
APC	B-Disease	1455
intron	O	1455
3	O	1455
that	O	1455
creates	O	1455
a	O	1455
mutant	O	1455
RNA	O	1455
without	O	1455
exon	O	1455
4	O	1455
of	O	1455
APC	O	1455
.	O	1455

The	O	1456
observation	O	1456
of	O	1456
the	O	1456
same	O	1456
APC	B-Disease	1456
mutation	O	1456
in	O	1456
five	O	1456
families	O	1456
from	O	1456
the	O	1456
same	O	1456
geographic	O	1456
area	O	1456
demonstrates	O	1456
a	O	1456
founder	O	1456
effect	O	1456
.	O	1456

Furthermore	O	1457
,	O	1457
the	O	1457
identification	O	1457
of	O	1457
this	O	1457
germline	O	1457
mutation	O	1457
strengthens	O	1457
the	O	1457
correlation	O	1457
between	O	1457
the	O	1457
5	O	1457
location	O	1457
of	O	1457
an	O	1457
APC	B-Disease	1457
disease	O	1457
-	O	1457
causing	O	1457
mutation	O	1457
and	O	1457
the	O	1457
attenuated	B-Disease	1457
polyposis	I-Disease	1457
phenotype	O	1457
.	O	1457

Alstrom	B-Disease	1459
syndrome	I-Disease	1459
:	O	1459
further	O	1459
evidence	O	1459
for	O	1459
linkage	O	1459
to	O	1459
human	O	1459
chromosome	O	1459
2p13	O	1459
.	O	1459

Alstrom	B-Disease	1460
syndrome	I-Disease	1460
is	O	1460
a	O	1460
rare	O	1460
autosomal	B-Disease	1460
recessive	I-Disease	1460
disorder	I-Disease	1460
characterized	O	1460
by	O	1460
retinal	B-Disease	1460
degeneration	I-Disease	1460
,	O	1460
sensorineural	B-Disease	1460
hearing	I-Disease	1460
loss	I-Disease	1460
,	O	1460
early	O	1460
-	O	1460
onset	O	1460
obesity	B-Disease	1460
,	O	1460
and	O	1460
non	B-Disease	1460
-	I-Disease	1460
insulin	I-Disease	1460
-	I-Disease	1460
dependent	I-Disease	1460
diabetes	I-Disease	1460
mellitus	I-Disease	1460
.	O	1460

The	O	1461
gene	O	1461
for	O	1461
Alstrom	B-Disease	1461
syndrome	I-Disease	1461
(	O	1461
ALMS1	O	1461
)	O	1461
has	O	1461
been	O	1461
previously	O	1461
localized	O	1461
to	O	1461
human	O	1461
chromosome	O	1461
2p13	O	1461
by	O	1461
homozygosity	O	1461
mapping	O	1461
in	O	1461
two	O	1461
distinct	O	1461
isolated	O	1461
populations	O	1461
-	O	1461
French	O	1461
Acadian	O	1461
and	O	1461
North	O	1461
African	O	1461
.	O	1461

To	O	1465
confirm	O	1465
these	O	1465
findings	O	1465
,	O	1465
a	O	1465
large	O	1465
linkage	O	1465
study	O	1465
was	O	1465
performed	O	1465
in	O	1465
twelve	O	1465
additional	O	1465
families	O	1465
segregating	O	1465
for	O	1465
Alstrom	B-Disease	1465
syndrome	I-Disease	1465
.	O	1465

Pendred	B-Disease	1474
syndrome	I-Disease	1474
:	O	1474
phenotypic	O	1474
variability	O	1474
in	O	1474
two	O	1474
families	O	1474
carrying	O	1474
the	O	1474
same	O	1474
PDS	B-Disease	1474
missense	O	1474
mutation	O	1474
.	O	1474

Pendred	B-Disease	1475
syndrome	I-Disease	1475
comprises	O	1475
congenital	B-Disease	1475
sensorineural	I-Disease	1475
hearing	I-Disease	1475
loss	I-Disease	1475
,	O	1475
thyroid	B-Disease	1475
goiter	I-Disease	1475
,	O	1475
and	O	1475
positive	O	1475
perchlorate	O	1475
discharge	O	1475
test	O	1475
.	O	1475

Recently	O	1476
,	O	1476
this	O	1476
autosomal	B-Disease	1476
recessive	I-Disease	1476
disorder	I-Disease	1476
was	O	1476
shown	O	1476
to	O	1476
be	O	1476
caused	O	1476
by	O	1476
mutations	O	1476
in	O	1476
the	O	1476
PDS	B-Disease	1476
gene	O	1476
,	O	1476
which	O	1476
encodes	O	1476
an	O	1476
anion	O	1476
transporter	O	1476
called	O	1476
pendrin	O	1476
.	O	1476

Molecular	O	1477
analysis	O	1477
of	O	1477
the	O	1477
PDS	B-Disease	1477
gene	O	1477
was	O	1477
performed	O	1477
in	O	1477
two	O	1477
consanguineous	O	1477
large	O	1477
families	O	1477
from	O	1477
Southern	O	1477
Tunisia	O	1477
comprising	O	1477
a	O	1477
total	O	1477
of	O	1477
23	O	1477
individuals	O	1477
affected	O	1477
with	O	1477
profound	O	1477
congenital	B-Disease	1477
deafness	I-Disease	1477
;	O	1477
the	O	1477
same	O	1477
missense	O	1477
mutation	O	1477
,	O	1477
L445W	O	1477
,	O	1477
was	O	1477
identified	O	1477
in	O	1477
all	O	1477
affected	O	1477
individuals	O	1477
.	O	1477

A	O	1478
widened	B-Disease	1478
vestibular	I-Disease	1478
aqueduct	I-Disease	1478
was	O	1478
found	O	1478
in	O	1478
all	O	1478
patients	O	1478
who	O	1478
underwent	O	1478
computed	O	1478
tomography	O	1478
(	O	1478
CT	O	1478
)	O	1478
scan	O	1478
exploration	O	1478
of	O	1478
the	O	1478
inner	O	1478
ear	O	1478
.	O	1478

In	O	1479
contrast	O	1479
,	O	1479
goiter	B-Disease	1479
was	O	1479
present	O	1479
in	O	1479
only	O	1479
11	O	1479
affected	O	1479
individuals	O	1479
,	O	1479
who	O	1479
interestingly	O	1479
had	O	1479
a	O	1479
normal	O	1479
result	O	1479
of	O	1479
the	O	1479
perchlorate	O	1479
discharge	O	1479
test	O	1479
whenever	O	1479
performed	O	1479
.	O	1479

The	O	1480
present	O	1480
results	O	1480
question	O	1480
the	O	1480
sensitivity	O	1480
of	O	1480
the	O	1480
perchlorate	O	1480
test	O	1480
for	O	1480
the	O	1480
diagnosis	O	1480
of	O	1480
Pendred	B-Disease	1480
syndrome	I-Disease	1480
and	O	1480
support	O	1480
the	O	1480
use	O	1480
of	O	1480
a	O	1480
molecular	O	1480
analysis	O	1480
of	O	1480
the	O	1480
PDS	B-Disease	1480
gene	O	1480
in	O	1480
the	O	1480
assessment	O	1480
of	O	1480
individuals	O	1480
with	O	1480
severe	O	1480
to	O	1480
profound	O	1480
congenital	B-Disease	1480
hearing	I-Disease	1480
loss	I-Disease	1480
associated	O	1480
with	O	1480
inner	B-Disease	1480
ear	I-Disease	1480
morphological	I-Disease	1480
anomaly	I-Disease	1480
even	O	1480
in	O	1480
the	O	1480
absence	O	1480
of	O	1480
a	O	1480
thyroid	B-Disease	1480
goiter	I-Disease	1480
.	O	1480

Knobloch	B-Disease	1482
syndrome	I-Disease	1482
involving	O	1482
midline	B-Disease	1482
scalp	I-Disease	1482
defect	I-Disease	1482
of	I-Disease	1482
the	I-Disease	1482
frontal	I-Disease	1482
region	I-Disease	1482
.	O	1482

We	O	1483
report	O	1483
on	O	1483
a	O	1483
4	O	1483
-	O	1483
year	O	1483
-	O	1483
old	O	1483
boy	O	1483
with	O	1483
Knobloch	B-Disease	1483
syndrome	I-Disease	1483
.	O	1483

He	O	1484
has	O	1484
vitreoretinal	B-Disease	1484
degeneration	I-Disease	1484
,	O	1484
high	B-Disease	1484
myopia	I-Disease	1484
,	O	1484
cataract	B-Disease	1484
,	O	1484
telecanthus	B-Disease	1484
,	O	1484
hypertelorism	B-Disease	1484
,	O	1484
and	O	1484
a	O	1484
high	B-Disease	1484
-	I-Disease	1484
arched	I-Disease	1484
palate	I-Disease	1484
.	O	1484

He	O	1485
also	O	1485
has	O	1485
a	O	1485
defect	B-Disease	1485
of	I-Disease	1485
the	I-Disease	1485
anterior	I-Disease	1485
midline	I-Disease	1485
scalp	I-Disease	1485
with	O	1485
involvement	O	1485
of	O	1485
the	O	1485
frontal	O	1485
bone	O	1485
as	O	1485
documented	O	1485
by	O	1485
a	O	1485
computed	O	1485
tomography	O	1485
(	O	1485
CT	O	1485
)	O	1485
scan	O	1485
.	O	1485

Our	O	1488
patient	O	1488
illustrates	O	1488
the	O	1488
importance	O	1488
of	O	1488
investigating	O	1488
for	O	1488
underlying	O	1488
ocular	O	1488
and	O	1488
central	O	1488
nervous	O	1488
system	O	1488
pathology	O	1488
whenever	O	1488
midline	B-Disease	1488
scalp	I-Disease	1488
defects	I-Disease	1488
are	O	1488
present	O	1488
.	O	1488

The	O	1490
DNA	O	1490
double	O	1490
-	O	1490
strand	O	1490
break	O	1490
repair	O	1490
gene	O	1490
hMRE11	O	1490
is	O	1490
mutated	O	1490
in	O	1490
individuals	O	1490
with	O	1490
an	O	1490
ataxia	B-Disease	1490
-	I-Disease	1490
telangiectasia	I-Disease	1490
-	I-Disease	1490
like	I-Disease	1490
disorder	I-Disease	1490
.	O	1490

We	O	1491
show	O	1491
that	O	1491
hypomorphic	O	1491
mutations	O	1491
in	O	1491
hMRE11	O	1491
,	O	1491
but	O	1491
not	O	1491
in	O	1491
ATM	O	1491
,	O	1491
are	O	1491
present	O	1491
in	O	1491
certain	O	1491
individuals	O	1491
with	O	1491
an	O	1491
ataxia	B-Disease	1491
-	I-Disease	1491
telangiectasia	I-Disease	1491
-	I-Disease	1491
like	I-Disease	1491
disorder	I-Disease	1491
(	O	1491
ATLD	B-Disease	1491
)	O	1491
.	O	1491

The	O	1492
cellular	O	1492
features	O	1492
resulting	O	1492
from	O	1492
these	O	1492
hMRE11	O	1492
mutations	O	1492
are	O	1492
similar	O	1492
to	O	1492
those	O	1492
seen	O	1492
in	O	1492
A	B-Disease	1492
-	I-Disease	1492
T	I-Disease	1492
as	O	1492
well	O	1492
as	O	1492
NBS	B-Disease	1492
and	O	1492
include	O	1492
hypersensitivity	B-Disease	1492
to	I-Disease	1492
ionizing	I-Disease	1492
radiation	I-Disease	1492
,	O	1492
radioresistant	O	1492
DNA	O	1492
synthesis	O	1492
,	O	1492
and	O	1492
abrogation	O	1492
of	O	1492
ATM	O	1492
-	O	1492
dependent	O	1492
events	O	1492
,	O	1492
such	O	1492
as	O	1492
the	O	1492
activation	O	1492
of	O	1492
Jun	O	1492
kinase	O	1492
following	O	1492
exposure	O	1492
to	O	1492
gamma	O	1492
irradiation	O	1492
.	O	1492

These	O	1494
data	O	1494
demonstrate	O	1494
that	O	1494
ATM	O	1494
and	O	1494
the	O	1494
hMre11	O	1494
/	O	1494
hRad50	O	1494
/	O	1494
Nbs1	O	1494
protein	O	1494
complex	O	1494
act	O	1494
in	O	1494
the	O	1494
same	O	1494
DNA	O	1494
damage	O	1494
response	O	1494
pathway	O	1494
and	O	1494
link	O	1494
hMre11	O	1494
to	O	1494
the	O	1494
complex	O	1494
pathology	O	1494
of	O	1494
A	B-Disease	1494
-	I-Disease	1494
T	I-Disease	1494
.	O	1494

Mutations	O	1496
in	O	1496
TNFRSF11A	O	1496
,	O	1496
affecting	O	1496
the	O	1496
signal	O	1496
peptide	O	1496
of	O	1496
RANK	O	1496
,	O	1496
cause	O	1496
familial	B-Disease	1496
expansile	I-Disease	1496
osteolysis	I-Disease	1496
.	O	1496

Familial	B-Disease	1497
expansile	I-Disease	1497
osteolysis	I-Disease	1497
(	O	1497
FEO	B-Disease	1497
,	O	1497
MIM	O	1497
174810	O	1497
)	O	1497
is	O	1497
a	O	1497
rare	O	1497
,	O	1497
autosomal	B-Disease	1497
dominant	I-Disease	1497
bone	I-Disease	1497
disorder	I-Disease	1497
characterized	O	1497
by	O	1497
focal	O	1497
areas	O	1497
of	O	1497
increased	B-Disease	1497
bone	I-Disease	1497
remodelling	I-Disease	1497
.	O	1497

The	O	1498
osteolytic	B-Disease	1498
lesions	I-Disease	1498
,	O	1498
which	O	1498
develop	O	1498
usually	O	1498
in	O	1498
the	O	1498
long	O	1498
bones	O	1498
during	O	1498
early	O	1498
adulthood	O	1498
,	O	1498
show	O	1498
increased	O	1498
osteoblast	O	1498
and	O	1498
osteoclast	O	1498
activity	O	1498
.	O	1498

Our	O	1499
previous	O	1499
linkage	O	1499
studies	O	1499
mapped	O	1499
the	O	1499
gene	O	1499
responsible	O	1499
for	O	1499
FEO	B-Disease	1499
to	O	1499
an	O	1499
interval	O	1499
of	O	1499
less	O	1499
than	O	1499
5	O	1499
cM	O	1499
between	O	1499
D18S64	O	1499
and	O	1499
D18S51	O	1499
on	O	1499
chromosome	O	1499
18q21	O	1499
.	O	1499

We	O	1505
identified	O	1505
two	O	1505
heterozygous	O	1505
insertion	O	1505
mutations	O	1505
in	O	1505
exon	O	1505
1	O	1505
of	O	1505
TNFRSF11A	O	1505
in	O	1505
affected	O	1505
members	O	1505
of	O	1505
four	O	1505
families	O	1505
with	O	1505
FEO	B-Disease	1505
or	O	1505
familial	B-Disease	1505
Paget	I-Disease	1505
disease	I-Disease	1505
of	I-Disease	1505
bone	I-Disease	1505
(	O	1505
PDB	B-Disease	1505
)	O	1505
.	O	1505

Cardiac	O	1509
Na	O	1509
(	O	1509
+	O	1509
)	O	1509
channel	O	1509
dysfunction	O	1509
in	O	1509
Brugada	B-Disease	1509
syndrome	I-Disease	1509
is	O	1509
aggravated	O	1509
by	O	1509
beta	O	1509
(	O	1509
1	O	1509
)	O	1509
-	O	1509
subunit	O	1509
.	O	1509

BACKGROUND	O	1510
Mutations	O	1510
in	O	1510
the	O	1510
gene	O	1510
encoding	O	1510
the	O	1510
human	O	1510
cardiac	O	1510
Na	O	1510
(	O	1510
+	O	1510
)	O	1510
channel	O	1510
alpha	O	1510
-	O	1510
subunit	O	1510
(	O	1510
hH1	O	1510
)	O	1510
are	O	1510
responsible	O	1510
for	O	1510
chromosome	O	1510
3	O	1510
-	O	1510
linked	O	1510
congenital	B-Disease	1510
long	I-Disease	1510
-	I-Disease	1510
QT	I-Disease	1510
syndrome	I-Disease	1510
(	O	1510
LQT3	B-Disease	1510
)	O	1510
and	O	1510
idiopathic	B-Disease	1510
ventricular	I-Disease	1510
fibrillation	I-Disease	1510
(	O	1510
IVF	B-Disease	1510
)	O	1510
.	O	1510

Here	O	1512
,	O	1512
we	O	1512
characterize	O	1512
the	O	1512
altered	O	1512
effects	O	1512
of	O	1512
a	O	1512
human	O	1512
beta	O	1512
(	O	1512
1	O	1512
)	O	1512
-	O	1512
subunit	O	1512
(	O	1512
hbeta	O	1512
(	O	1512
1	O	1512
)	O	1512
)	O	1512
on	O	1512
the	O	1512
heterologously	O	1512
expressed	O	1512
hH1	O	1512
mutation	O	1512
(	O	1512
T1620M	O	1512
)	O	1512
previously	O	1512
associated	O	1512
with	O	1512
IVF	B-Disease	1512
.	O	1512

METHODS	O	1513
AND	O	1513
RESULTS	O	1513
When	O	1513
expressed	O	1513
alone	O	1513
in	O	1513
Xenopus	O	1513
oocytes	O	1513
,	O	1513
T1620M	O	1513
exhibited	O	1513
no	O	1513
persistent	O	1513
currents	O	1513
,	O	1513
in	O	1513
contrast	O	1513
to	O	1513
the	O	1513
LQT3	B-Disease	1513
mutant	O	1513
channels	O	1513
,	O	1513
but	O	1513
the	O	1513
midpoint	O	1513
of	O	1513
steady	O	1513
-	O	1513
state	O	1513
inactivation	O	1513
(	O	1513
V	O	1513
(	O	1513
1	O	1513
/	O	1513
2	O	1513
)	O	1513
)	O	1513
was	O	1513
significantly	O	1513
shifted	O	1513
toward	O	1513
more	O	1513
positive	O	1513
potentials	O	1513
than	O	1513
for	O	1513
wild	O	1513
-	O	1513
type	O	1513
hH1	O	1513
.	O	1513

CONCLUSIONS	O	1516
It	O	1516
is	O	1516
suggested	O	1516
that	O	1516
coexpression	O	1516
of	O	1516
hbeta	O	1516
(	O	1516
1	O	1516
)	O	1516
exposes	O	1516
a	O	1516
more	O	1516
severe	O	1516
functional	O	1516
defect	O	1516
that	O	1516
results	O	1516
in	O	1516
a	O	1516
greater	O	1516
overlap	O	1516
in	O	1516
the	O	1516
relationship	O	1516
between	O	1516
channel	O	1516
inactivation	O	1516
and	O	1516
activation	O	1516
(	O	1516
window	O	1516
current	O	1516
)	O	1516
in	O	1516
T1620M	O	1516
,	O	1516
which	O	1516
is	O	1516
proposed	O	1516
to	O	1516
be	O	1516
a	O	1516
potential	O	1516
pathophysiological	O	1516
mechanism	O	1516
of	O	1516
IVF	B-Disease	1516
in	O	1516
vivo	O	1516
.	O	1516

Meiotic	O	1519
segregation	O	1519
analysis	O	1519
of	O	1519
RB1	O	1519
alleles	O	1519
in	O	1519
retinoblastoma	B-Disease	1519
pedigrees	O	1519
by	O	1519
use	O	1519
of	O	1519
single	O	1519
-	O	1519
sperm	O	1519
typing	O	1519
.	O	1519

In	O	1520
hereditary	B-Disease	1520
retinoblastoma	I-Disease	1520
,	O	1520
different	O	1520
epidemiological	O	1520
studies	O	1520
have	O	1520
indicated	O	1520
a	O	1520
preferential	O	1520
paternal	O	1520
transmission	O	1520
of	O	1520
mutant	O	1520
retinoblastoma	B-Disease	1520
alleles	O	1520
to	O	1520
offspring	O	1520
,	O	1520
suggesting	O	1520
the	O	1520
occurrence	O	1520
of	O	1520
a	O	1520
meiotic	O	1520
drive	O	1520
.	O	1520

To	O	1521
investigate	O	1521
this	O	1521
mechanism	O	1521
,	O	1521
we	O	1521
analyzed	O	1521
sperm	O	1521
samples	O	1521
from	O	1521
six	O	1521
individuals	O	1521
from	O	1521
five	O	1521
unrelated	O	1521
families	O	1521
affected	O	1521
with	O	1521
hereditary	B-Disease	1521
retinoblastoma	I-Disease	1521
.	O	1521

Single	O	1522
-	O	1522
sperm	O	1522
typing	O	1522
techniques	O	1522
were	O	1522
performed	O	1522
for	O	1522
each	O	1522
sample	O	1522
by	O	1522
study	O	1522
of	O	1522
two	O	1522
informative	O	1522
short	O	1522
tandem	O	1522
repeats	O	1522
located	O	1522
either	O	1522
in	O	1522
or	O	1522
close	O	1522
to	O	1522
the	O	1522
retinoblastoma	B-Disease	1522
gene	O	1522
(	O	1522
RB1	O	1522
)	O	1522
.	O	1522

Friedreich	B-Disease	1530
ataxia	I-Disease	1530
:	O	1530
an	O	1530
overview	O	1530
.	O	1530

Friedreich	B-Disease	1531
ataxia	I-Disease	1531
,	O	1531
an	O	1531
autosomal	B-Disease	1531
recessive	I-Disease	1531
neurodegenerative	I-Disease	1531
disease	I-Disease	1531
,	O	1531
is	O	1531
the	O	1531
most	O	1531
common	O	1531
of	O	1531
the	O	1531
inherited	B-Disease	1531
ataxias	I-Disease	1531
.	O	1531

The	O	1532
recent	O	1532
discovery	O	1532
of	O	1532
the	O	1532
gene	O	1532
that	O	1532
is	O	1532
mutated	O	1532
in	O	1532
this	O	1532
condition	O	1532
,	O	1532
FRDA	O	1532
,	O	1532
has	O	1532
led	O	1532
to	O	1532
rapid	O	1532
advances	O	1532
in	O	1532
the	O	1532
understanding	O	1532
of	O	1532
the	O	1532
pathogenesis	O	1532
of	O	1532
Friedreich	B-Disease	1532
ataxia	I-Disease	1532
.	O	1532

There	O	1535
is	O	1535
mounting	O	1535
evidence	O	1535
to	O	1535
suggest	O	1535
that	O	1535
Friedreich	B-Disease	1535
ataxia	I-Disease	1535
is	O	1535
the	O	1535
result	O	1535
of	O	1535
accumulation	O	1535
of	O	1535
iron	O	1535
in	O	1535
mitochondria	O	1535
leading	O	1535
to	O	1535
excess	O	1535
production	O	1535
of	O	1535
free	O	1535
radicals	O	1535
,	O	1535
which	O	1535
then	O	1535
results	O	1535
in	O	1535
cellular	O	1535
damage	O	1535
and	O	1535
death	O	1535
.	O	1535

The	O	1537
discovery	O	1537
of	O	1537
the	O	1537
FRDA	B-Disease	1537
gene	O	1537
and	O	1537
its	O	1537
possible	O	1537
function	O	1537
has	O	1537
raised	O	1537
hope	O	1537
that	O	1537
rational	O	1537
therapeutic	O	1537
strategies	O	1537
will	O	1537
be	O	1537
developed	O	1537
.	O	1537

X	B-Disease	1539
-	I-Disease	1539
linked	I-Disease	1539
retinoschisis	I-Disease	1539
with	O	1539
point	O	1539
mutations	O	1539
in	O	1539
the	O	1539
XLRS1	O	1539
gene	O	1539
.	O	1539

BACKGROUND	O	1540
X	B-Disease	1540
-	I-Disease	1540
linked	I-Disease	1540
retinoschisis	I-Disease	1540
(	O	1540
XLRS	B-Disease	1540
)	O	1540
is	O	1540
a	O	1540
relatively	O	1540
rare	O	1540
vitreoretinal	B-Disease	1540
dystrophy	I-Disease	1540
that	O	1540
causes	O	1540
visual	B-Disease	1540
loss	I-Disease	1540
in	O	1540
young	O	1540
men	O	1540
.	O	1540

OBJECTIVE	O	1542
To	O	1542
analyze	O	1542
Japanese	O	1542
patients	O	1542
clinically	O	1542
diagnosed	O	1542
as	O	1542
having	O	1542
XLRS	B-Disease	1542
formutational	O	1542
changes	O	1542
in	O	1542
the	O	1542
XLRS1	O	1542
gene	O	1542
.	O	1542

METHODS	O	1543
Ten	O	1543
patients	O	1543
with	O	1543
XLRS	B-Disease	1543
underwent	O	1543
full	O	1543
ophthalmologic	O	1543
examination	O	1543
,	O	1543
including	O	1543
slitlamp	O	1543
biomicroscopy	O	1543
and	O	1543
dilated	O	1543
funduscopy	O	1543
.	O	1543

CONCLUSIONS	O	1549
The	O	1549
discovery	O	1549
of	O	1549
new	O	1549
point	O	1549
mutations	O	1549
in	O	1549
this	O	1549
study	O	1549
increases	O	1549
the	O	1549
available	O	1549
information	O	1549
regarding	O	1549
the	O	1549
spectrum	O	1549
of	O	1549
genetic	B-Disease	1549
abnormalities	I-Disease	1549
and	O	1549
clinical	O	1549
manifestations	O	1549
of	O	1549
XLRS	B-Disease	1549
.	O	1549

CLINICAL	O	1551
RELEVANCE	O	1551
Identification	O	1551
of	O	1551
mutations	O	1551
in	O	1551
the	O	1551
XLRS1	O	1551
gene	O	1551
and	O	1551
expanded	O	1551
information	O	1551
on	O	1551
clinical	O	1551
manifestations	O	1551
will	O	1551
facilitate	O	1551
early	O	1551
diagnosis	O	1551
,	O	1551
appropriate	O	1551
early	O	1551
therapy	O	1551
,	O	1551
and	O	1551
genetic	O	1551
counseling	O	1551
regarding	O	1551
the	O	1551
prognosis	O	1551
of	O	1551
XLRS	B-Disease	1551
.	O	1551

Ataxia	B-Disease	1554
-	I-Disease	1554
telangiectasia	I-Disease	1554
is	O	1554
a	O	1554
hereditary	B-Disease	1554
multisystemic	I-Disease	1554
disease	I-Disease	1554
resulting	O	1554
from	O	1554
mutations	O	1554
of	O	1554
ataxia	B-Disease	1554
telangiectasia	I-Disease	1554
,	O	1554
mutated	O	1554
(	O	1554
ATM	O	1554
)	O	1554
and	O	1554
is	O	1554
characterized	O	1554
by	O	1554
neurodegeneration	B-Disease	1554
,	O	1554
cancer	B-Disease	1554
,	O	1554
immune	B-Disease	1554
defects	I-Disease	1554
,	O	1554
and	O	1554
hypersensitivity	B-Disease	1554
to	I-Disease	1554
ionizing	I-Disease	1554
radiation	I-Disease	1554
.	O	1554

The	O	1555
molecular	O	1555
details	O	1555
of	O	1555
ATM	O	1555
function	O	1555
in	O	1555
the	O	1555
nervous	O	1555
system	O	1555
are	O	1555
unclear	O	1555
,	O	1555
although	O	1555
the	O	1555
neurological	B-Disease	1555
lesion	I-Disease	1555
in	O	1555
ataxia	B-Disease	1555
-	I-Disease	1555
telangiectasia	I-Disease	1555
becomes	O	1555
apparent	O	1555
early	O	1555
in	O	1555
life	O	1555
,	O	1555
suggesting	O	1555
a	O	1555
developmental	O	1555
origin	O	1555
.	O	1555

Haim	B-Disease	1563
-	I-Disease	1563
Munk	I-Disease	1563
syndrome	I-Disease	1563
and	O	1563
Papillon	B-Disease	1563
-	I-Disease	1563
Lefevre	I-Disease	1563
syndrome	I-Disease	1563
are	O	1563
allelic	O	1563
mutations	O	1563
in	O	1563
cathepsin	O	1563
C	O	1563
.	O	1563

Of	O	1564
the	O	1564
many	O	1564
palmoplantar	B-Disease	1564
keratoderma	I-Disease	1564
(	I-Disease	1564
PPK	I-Disease	1564
)	I-Disease	1564
conditions	I-Disease	1564
,	O	1564
only	O	1564
Papillon	B-Disease	1564
-	I-Disease	1564
Lefevre	I-Disease	1564
syndrome	I-Disease	1564
(	O	1564
PLS	B-Disease	1564
)	O	1564
and	O	1564
Haim	B-Disease	1564
-	I-Disease	1564
Munk	I-Disease	1564
syndrome	I-Disease	1564
(	O	1564
HMS	B-Disease	1564
)	O	1564
are	O	1564
associated	O	1564
with	O	1564
premature	O	1564
periodontal	O	1564
destruction	O	1564
.	O	1564

Although	O	1565
both	O	1565
PLS	B-Disease	1565
and	O	1565
HMS	B-Disease	1565
share	O	1565
the	O	1565
cardinal	O	1565
features	O	1565
of	O	1565
PPK	B-Disease	1565
and	O	1565
severe	O	1565
periodontitis	B-Disease	1565
,	O	1565
a	O	1565
number	O	1565
of	O	1565
additional	O	1565
findings	O	1565
are	O	1565
reported	O	1565
in	O	1565
HMS	B-Disease	1565
including	O	1565
arachnodactyly	B-Disease	1565
,	O	1565
acro	B-Disease	1565
-	I-Disease	1565
osteolysis	I-Disease	1565
,	O	1565
atrophic	B-Disease	1565
changes	I-Disease	1565
of	I-Disease	1565
the	I-Disease	1565
nails	I-Disease	1565
,	O	1565
and	O	1565
a	O	1565
radiographic	B-Disease	1565
deformity	I-Disease	1565
of	I-Disease	1565
the	I-Disease	1565
fingers	I-Disease	1565
.	O	1565

While	O	1566
PLS	B-Disease	1566
cases	O	1566
have	O	1566
been	O	1566
identified	O	1566
throughout	O	1566
the	O	1566
world	O	1566
,	O	1566
HMS	B-Disease	1566
has	O	1566
only	O	1566
been	O	1566
described	O	1566
among	O	1566
descendants	O	1566
of	O	1566
a	O	1566
religious	O	1566
isolate	O	1566
originally	O	1566
from	O	1566
Cochin	O	1566
,	O	1566
India	O	1566
.	O	1566

Although	O	1568
autosomal	O	1568
recessive	O	1568
transmission	O	1568
of	O	1568
PLS	B-Disease	1568
is	O	1568
evident	O	1568
,	O	1568
a	O	1568
more	O	1568
autosomal	O	1570
recessive	O	1570
pattern	O	1570
of	O	1570
inheritance	O	1570
with	O	1570
phenotypic	O	1570
influences	O	1570
from	O	1570
a	O	1570
closely	O	1570
linked	O	1570
modifying	O	1570
locus	O	1570
has	O	1570
been	O	1570
hypothesised	O	1570
for	O	1570
HMS	B-Disease	1570
.	O	1570

Recently	O	1571
,	O	1571
mutations	O	1571
of	O	1571
the	O	1571
cathepsin	O	1571
C	O	1571
gene	O	1571
have	O	1571
been	O	1571
identified	O	1571
as	O	1571
the	O	1571
underlying	O	1571
genetic	B-Disease	1571
defect	I-Disease	1571
in	O	1571
PLS	B-Disease	1571
.	O	1571

To	O	1572
determine	O	1572
if	O	1572
a	O	1572
cathepsin	O	1572
C	O	1572
mutation	O	1572
is	O	1572
also	O	1572
responsible	O	1572
for	O	1572
HMS	B-Disease	1572
,	O	1572
we	O	1572
sequenced	O	1572
the	O	1572
gene	O	1572
in	O	1572
affected	O	1572
and	O	1572
unaffected	O	1572
subjects	O	1572
from	O	1572
the	O	1572
Cochin	O	1572
isolate	O	1572
in	O	1572
which	O	1572
both	O	1572
the	O	1572
PLS	B-Disease	1572
and	O	1572
HMS	B-Disease	1572
phenotypes	O	1572
appear	O	1572
.	O	1572

This	O	1574
mutation	O	1574
segregates	O	1574
with	O	1574
HMS	B-Disease	1574
in	O	1574
four	O	1574
nuclear	O	1574
families	O	1574
.	O	1574

This	O	1578
finding	O	1578
supports	O	1578
simple	O	1578
autosomal	O	1578
recessive	O	1578
inheritance	O	1578
for	O	1578
HMS	B-Disease	1578
in	O	1578
these	O	1578
families	O	1578
.	O	1578

We	O	1579
also	O	1579
report	O	1579
a	O	1579
mutation	O	1579
of	O	1579
the	O	1579
same	O	1579
exon	O	1579
6	O	1579
CTSC	O	1579
codon	O	1579
(	O	1579
2126C	O	1579
-	O	1579
-	O	1579
>	O	1579
T	O	1579
)	O	1579
in	O	1579
a	O	1579
Turkish	O	1579
family	O	1579
with	O	1579
classical	O	1579
PLS	B-Disease	1579
.	O	1579

These	O	1580
findings	O	1580
provide	O	1580
evidence	O	1580
that	O	1580
PLS	B-Disease	1580
and	O	1580
HMS	B-Disease	1580
are	O	1580
allelic	O	1580
variants	O	1580
of	O	1580
cathepsin	O	1580
C	O	1580
gene	O	1580
mutations	O	1580
.	O	1580

ATM	O	1582
-	O	1582
heterozygous	O	1582
germline	O	1582
mutations	O	1582
contribute	O	1582
to	O	1582
breast	B-Disease	1582
cancer	I-Disease	1582
-	O	1582
susceptibility	O	1582
.	O	1582

Mutations	O	1585
in	O	1585
the	O	1585
ATM	O	1585
gene	O	1585
are	O	1585
responsible	O	1585
for	O	1585
the	O	1585
autosomal	B-Disease	1585
recessive	I-Disease	1585
disorder	I-Disease	1585
ataxia	B-Disease	1585
-	I-Disease	1585
telangiectasia	I-Disease	1585
(	O	1585
A	B-Disease	1585
-	I-Disease	1585
T	I-Disease	1585
)	O	1585
(	O	1585
MIM	O	1585
208900	O	1585
)	O	1585
.	O	1585

The	O	1586
finding	O	1586
that	O	1586
ATM	O	1586
-	O	1586
heterozygotes	O	1586
have	O	1586
an	O	1586
increased	O	1586
relative	O	1586
risk	O	1586
for	O	1586
breast	B-Disease	1586
cancer	I-Disease	1586
was	O	1586
supported	O	1586
by	O	1586
some	O	1586
studies	O	1586
but	O	1586
not	O	1586
confirmed	O	1586
by	O	1586
others	O	1586
.	O	1586

In	O	1587
view	O	1587
of	O	1587
this	O	1587
discrepancy	O	1587
,	O	1587
we	O	1587
examined	O	1587
the	O	1587
frequency	O	1587
of	O	1587
ATM	O	1587
germline	O	1587
mutations	O	1587
in	O	1587
a	O	1587
selected	O	1587
group	O	1587
of	O	1587
Dutch	O	1587
patients	O	1587
with	O	1587
breast	B-Disease	1587
cancer	I-Disease	1587
.	O	1587

A	O	1589
high	O	1589
percentage	O	1589
of	O	1589
ATM	O	1589
germline	O	1589
mutations	O	1589
was	O	1589
demonstrated	O	1589
among	O	1589
patients	O	1589
with	O	1589
sporadic	B-Disease	1589
breast	I-Disease	1589
cancer	I-Disease	1589
.	O	1589

The	O	1590
82	O	1590
patients	O	1590
included	O	1590
in	O	1590
this	O	1590
study	O	1590
had	O	1590
developed	O	1590
breast	B-Disease	1590
cancer	I-Disease	1590
at	O	1590
age	O	1590
<	O	1590
45	O	1590
and	O	1590
had	O	1590
survived	O	1590
>	O	1590
/	O	1590
=	O	1590
5	O	1590
years	O	1590
(	O	1590
mean	O	1590
15	O	1590
years	O	1590
)	O	1590
,	O	1590
and	O	1590
in	O	1590
33	O	1590
(	O	1590
40	O	1590
%	O	1590
)	O	1590
of	O	1590
the	O	1590
patients	O	1590
a	O	1590
contralateral	O	1590
breast	O	1590
tumor	O	1590
had	O	1590
been	O	1590
diagnosed	O	1590
.	O	1590

Inherited	O	1602
G6PD	B-Disease	1602
deficiency	I-Disease	1602
is	O	1602
associated	O	1602
with	O	1602
either	O	1602
episodic	B-Disease	1602
hemolytic	I-Disease	1602
anemia	I-Disease	1602
(	O	1602
triggered	O	1602
by	O	1602
fava	O	1602
beans	O	1602
or	O	1602
other	O	1602
agents	O	1602
)	O	1602
or	O	1602
life	B-Disease	1602
-	I-Disease	1602
long	I-Disease	1602
hemolytic	I-Disease	1602
anemia	I-Disease	1602
.	O	1602

From	O	1604
the	O	1604
alignment	O	1604
of	O	1604
the	O	1604
amino	O	1604
acid	O	1604
(	O	1604
aa	O	1604
)	O	1604
sequence	O	1604
of	O	1604
52	O	1604
glucose	O	1604
6	O	1604
-	O	1604
phosphate	O	1604
dehydrogenase	O	1604
(	O	1604
G6PD	O	1604
)	O	1604
species	O	1604
from	O	1604
42	O	1604
different	O	1604
organisms	O	1604
,	O	1604
we	O	1604
found	O	1604
a	O	1604
striking	O	1604
correlation	O	1604
between	O	1604
the	O	1604
aa	O	1604
replacements	O	1604
that	O	1604
cause	O	1604
G6PD	B-Disease	1604
deficiency	I-Disease	1604
in	O	1604
humans	O	1604
and	O	1604
the	O	1604
sequence	O	1604
conservation	O	1604
of	O	1604
G6PD	O	1604
two	O	1604
-	O	1604
thirds	O	1604
of	O	1604
such	O	1604
replacements	O	1604
are	O	1604
in	O	1604
highly	O	1604
and	O	1604
moderately	O	1604
conserved	O	1604
(	O	1604
50	O	1604
-	O	1604
99	O	1604
%	O	1604
)	O	1604
aa	O	1604
;	O	1604
relatively	O	1604
few	O	1604
are	O	1604
in	O	1604
fully	O	1604
conserved	O	1604
aa	O	1604
(	O	1604
where	O	1604
they	O	1604
might	O	1604
be	O	1604
lethal	O	1604
)	O	1604
or	O	1604
in	O	1604
poorly	O	1604
conserved	O	1604
aa	O	1604
,	O	1604
where	O	1604
presumably	O	1604
they	O	1604
simply	O	1604
would	O	1604
not	O	1604
cause	O	1604
G6PD	B-Disease	1604
deficiency	I-Disease	1604
.	O	1604

Constitutive	O	1609
and	O	1609
regulated	O	1609
modes	O	1609
of	O	1609
splicing	O	1609
produce	O	1609
six	O	1609
major	O	1609
myotonic	B-Disease	1609
dystrophy	I-Disease	1609
protein	O	1609
kinase	O	1609
(	O	1609
DMPK	O	1609
)	O	1609
isoforms	O	1609
with	O	1609
distinct	O	1609
properties	O	1609
.	O	1609

Myotonic	B-Disease	1610
dystrophy	I-Disease	1610
(	O	1610
DM	B-Disease	1610
)	O	1610
is	O	1610
the	O	1610
most	O	1610
prevalent	O	1610
inherited	B-Disease	1610
neuromuscular	I-Disease	1610
disease	I-Disease	1610
in	O	1610
adults	O	1610
.	O	1610

The	O	1611
genetic	B-Disease	1611
defect	I-Disease	1611
is	O	1611
a	O	1611
CTG	O	1611
triplet	O	1611
repeat	O	1611
expansion	O	1611
in	O	1611
the	O	1611
3	O	1611
-	O	1611
untranslated	O	1611
region	O	1611
of	O	1611
the	O	1611
myotonic	B-Disease	1611
dystrophy	I-Disease	1611
protein	O	1611
kinase	O	1611
(	O	1611
DMPK	O	1611
)	O	1611
gene	O	1611
,	O	1611
consisting	O	1611
of	O	1611
15	O	1611
exons	O	1611
.	O	1611

Information	O	1616
on	O	1616
DMPK	O	1616
mRNA	O	1616
and	O	1616
protein	O	1616
isoform	O	1616
expression	O	1616
patterns	O	1616
will	O	1616
be	O	1616
useful	O	1616
for	O	1616
recognizing	O	1616
differential	O	1616
effects	O	1616
of	O	1616
(	O	1616
CTG	O	1616
)	O	1616
(	O	1616
n	O	1616
)	O	1616
expansion	O	1616
in	O	1616
DM	B-Disease	1616
manifestation	O	1616
.	O	1616

Genetic	O	1618
analysis	O	1618
,	O	1618
phenotypic	O	1618
diagnosis	O	1618
,	O	1618
and	O	1618
risk	O	1618
of	O	1618
venous	B-Disease	1618
thrombosis	I-Disease	1618
in	O	1618
families	O	1618
with	O	1618
inherited	O	1618
deficiencies	B-Disease	1618
of	I-Disease	1618
protein	I-Disease	1618
S	I-Disease	1618
.	O	1618

Protein	B-Disease	1619
S	I-Disease	1619
deficiency	I-Disease	1619
is	O	1619
a	O	1619
recognized	O	1619
risk	O	1619
factor	O	1619
for	O	1619
venous	B-Disease	1619
thrombosis	I-Disease	1619
.	O	1619

Of	O	1620
all	O	1620
the	O	1620
inherited	O	1620
thrombophilic	B-Disease	1620
conditions	I-Disease	1620
,	O	1620
it	O	1620
remains	O	1620
the	O	1620
most	O	1620
difficult	O	1620
to	O	1620
diagnose	O	1620
because	O	1620
of	O	1620
phenotypic	O	1620
variability	O	1620
,	O	1620
which	O	1620
can	O	1620
lead	O	1620
to	O	1620
inconclusive	O	1620
results	O	1620
.	O	1620

Twenty	O	1622
-	O	1622
eight	O	1622
index	O	1622
patients	O	1622
with	O	1622
protein	B-Disease	1622
S	I-Disease	1622
deficiency	I-Disease	1622
and	O	1622
a	O	1622
PROS1	B-Disease	1622
gene	I-Disease	1622
defect	I-Disease	1622
were	O	1622
studied	O	1622
,	O	1622
together	O	1622
with	O	1622
109	O	1622
first	O	1622
-	O	1622
degree	O	1622
relatives	O	1622
.	O	1622

In	O	1624
this	O	1624
group	O	1624
of	O	1624
relatives	O	1624
,	O	1624
a	O	1624
low	O	1624
free	O	1624
protein	O	1624
S	O	1624
level	O	1624
was	O	1624
the	O	1624
most	O	1624
reliable	O	1624
predictor	O	1624
of	O	1624
a	O	1624
PROS1	B-Disease	1624
gene	I-Disease	1624
defect	I-Disease	1624
(	O	1624
sensitivity	O	1624
97	O	1624
.	O	1624

First	O	1626
-	O	1626
degree	O	1626
relatives	O	1626
with	O	1626
a	O	1626
PROS1	B-Disease	1626
gene	I-Disease	1626
defect	I-Disease	1626
had	O	1626
a	O	1626
5	O	1626
.	O	1626

0	O	1627
-	O	1627
fold	O	1627
higher	O	1627
risk	O	1627
of	O	1627
thrombosis	B-Disease	1627
(	O	1627
95	O	1627
%	O	1627
confidence	O	1627
interval	O	1627
,	O	1627
1	O	1627
.	O	1627

8	O	1629
)	O	1629
than	O	1629
those	O	1629
with	O	1629
a	O	1629
normal	O	1629
PROS1	O	1629
gene	O	1629
and	O	1629
no	O	1629
other	O	1629
recognized	O	1629
thrombophilic	B-Disease	1629
defect	I-Disease	1629
.	O	1629

Although	O	1630
pregnancy	O	1630
/	O	1630
puerperium	O	1630
and	O	1630
immobility	O	1630
/	O	1630
trauma	B-Disease	1630
were	O	1630
important	O	1630
precipitating	O	1630
factors	O	1630
for	O	1630
thrombosis	B-Disease	1630
,	O	1630
almost	O	1630
half	O	1630
of	O	1630
the	O	1630
events	O	1630
were	O	1630
spontaneous	O	1630
.	O	1630

Relatives	O	1631
with	O	1631
splice	O	1631
-	O	1631
site	O	1631
or	O	1631
major	O	1631
structural	O	1631
defects	B-Disease	1631
in	I-Disease	1631
the	I-Disease	1631
PROS1	I-Disease	1631
gene	I-Disease	1631
were	O	1631
more	O	1631
likely	O	1631
to	O	1631
have	O	1631
had	O	1631
a	O	1631
thrombotic	O	1631
event	O	1631
and	O	1631
had	O	1631
significantly	O	1631
lower	O	1631
total	O	1631
and	O	1631
free	O	1631
protein	O	1631
S	O	1631
levels	O	1631
than	O	1631
those	O	1631
relatives	O	1631
having	O	1631
missense	O	1631
mutations	O	1631
.	O	1631

We	O	1632
conclude	O	1632
that	O	1632
persons	O	1632
with	O	1632
PROS1	B-Disease	1632
gene	I-Disease	1632
defects	I-Disease	1632
and	O	1632
protein	B-Disease	1632
S	I-Disease	1632
deficiency	I-Disease	1632
are	O	1632
at	O	1632
increased	O	1632
risk	O	1632
of	O	1632
thrombosis	B-Disease	1632
and	O	1632
that	O	1632
free	O	1632
protein	O	1632
S	O	1632
estimation	O	1632
offers	O	1632
the	O	1632
most	O	1632
reliable	O	1632
way	O	1632
of	O	1632
diagnosing	O	1632
the	O	1632
deficiency	O	1632
.	O	1632

Autoimmune	B-Disease	1635
lymphoproliferative	I-Disease	1635
syndrome	I-Disease	1635
(	O	1635
ALPS	B-Disease	1635
)	O	1635
in	O	1635
a	O	1635
child	O	1635
from	O	1635
consanguineous	O	1635
parents	O	1635
:	O	1635
a	O	1635
dominant	O	1635
or	O	1635
recessive	O	1635
disease	O	1635
?	O	1635
Autoimmune	B-Disease	1635
lymphoproliferative	I-Disease	1635
syndrome	I-Disease	1635
(	O	1635
ALPS	B-Disease	1635
)	O	1635
is	O	1635
characterized	O	1635
by	O	1635
autoimmune	O	1635
features	O	1635
and	O	1635
lymphoproliferations	O	1635
and	O	1635
is	O	1635
generally	O	1635
caused	O	1635
by	O	1635
defective	O	1635
Fas	O	1635
-	O	1635
mediated	O	1635
apoptosis	O	1635
.	O	1635

This	O	1636
report	O	1636
describes	O	1636
a	O	1636
child	O	1636
with	O	1636
clinical	O	1636
features	O	1636
of	O	1636
ALPS	B-Disease	1636
without	O	1636
detectable	O	1636
Fas	O	1636
expression	O	1636
on	O	1636
freshly	O	1636
isolated	O	1636
blood	O	1636
leukocytes	O	1636
.	O	1636

The	O	1640
patient	O	1640
reported	O	1640
here	O	1640
is	O	1640
a	O	1640
human	O	1640
homologue	O	1640
of	O	1640
the	O	1640
Fas	O	1640
-	O	1640
nan	O	1640
mouse	O	1640
,	O	1640
inasmuch	O	1640
as	O	1640
she	O	1640
carries	O	1640
an	O	1640
autosomal	O	1640
homozygous	O	1640
mutation	O	1640
in	O	1640
the	O	1640
FAS	O	1640
gene	O	1640
and	O	1640
she	O	1640
shows	O	1640
the	O	1640
severe	O	1640
and	O	1640
accelerated	O	1640
ALPS	B-Disease	1640
phenotype	O	1640
.	O	1640

The	O	1641
heterozygous	O	1641
family	O	1641
members	O	1641
did	O	1641
not	O	1641
have	O	1641
the	O	1641
ALPS	B-Disease	1641
phenotype	O	1641
,	O	1641
indicating	O	1641
that	O	1641
the	O	1641
disease	O	1641
-	O	1641
causing	O	1641
FAS	O	1641
mutation	O	1641
in	O	1641
this	O	1641
family	O	1641
is	O	1641
autosomal	O	1641
recessive	O	1641
.	O	1641

Identification	O	1643
of	O	1643
novel	O	1643
imprinted	O	1643
transcripts	O	1643
in	O	1643
the	O	1643
Prader	B-Disease	1643
-	I-Disease	1643
Willi	I-Disease	1643
syndrome	I-Disease	1643
and	O	1643
Angelman	B-Disease	1643
syndrome	I-Disease	1643
deletion	O	1643
region	O	1643
:	O	1643
further	O	1643
evidence	O	1643
for	O	1643
regional	O	1643
imprinting	O	1643
control	O	1643
.	O	1643

Deletions	O	1644
and	O	1644
other	O	1644
abnormalities	O	1644
of	O	1644
human	O	1644
chromosome	O	1644
15q11	O	1644
-	O	1644
q13	O	1644
are	O	1644
associated	O	1644
with	O	1644
two	O	1644
developmental	O	1644
disorders	O	1644
,	O	1644
Prader	B-Disease	1644
-	I-Disease	1644
Willi	I-Disease	1644
syndrome	I-Disease	1644
(	O	1644
PWS	B-Disease	1644
)	O	1644
and	O	1644
Angelman	B-Disease	1644
syndrome	I-Disease	1644
(	O	1644
AS	B-Disease	1644
)	O	1644
.	O	1644

Loss	O	1645
of	O	1645
expression	O	1645
of	O	1645
imprinted	O	1645
,	O	1645
paternally	O	1645
expressed	O	1645
genes	O	1645
has	O	1645
been	O	1645
implicated	O	1645
in	O	1645
PWS	B-Disease	1645
.	O	1645

However	O	1646
,	O	1646
the	O	1646
number	O	1646
of	O	1646
imprinted	O	1646
genes	O	1646
that	O	1646
contribute	O	1646
to	O	1646
PWS	B-Disease	1646
,	O	1646
and	O	1646
the	O	1646
range	O	1646
over	O	1646
which	O	1646
the	O	1646
imprinting	O	1646
signal	O	1646
acts	O	1646
to	O	1646
silence	O	1646
one	O	1646
copy	O	1646
of	O	1646
the	O	1646
gene	O	1646
in	O	1646
a	O	1646
parent	O	1646
-	O	1646
of	O	1646
-	O	1646
origin	O	1646
-	O	1646
specific	O	1646
manner	O	1646
,	O	1646
are	O	1646
unknown	O	1646
.	O	1646

To	O	1647
identify	O	1647
additional	O	1647
imprinted	O	1647
genes	O	1647
that	O	1647
could	O	1647
contribute	O	1647
to	O	1647
the	O	1647
PWS	B-Disease	1647
phenotype	O	1647
and	O	1647
to	O	1647
understand	O	1647
the	O	1647
regional	O	1647
control	O	1647
of	O	1647
imprinting	O	1647
in	O	1647
15q11	O	1647
-	O	1647
q13	O	1647
,	O	1647
we	O	1647
have	O	1647
constructed	O	1647
an	O	1647
imprinted	O	1647
transcript	O	1647
map	O	1647
of	O	1647
the	O	1647
PWS	O	1647
-	O	1647
AS	O	1647
deletion	O	1647
interval	O	1647
.	O	1647

Combined	O	1654
analysis	O	1654
of	O	1654
hereditary	B-Disease	1654
prostate	I-Disease	1654
cancer	I-Disease	1654
linkage	O	1654
to	O	1654
1q24	O	1654
-	O	1654
25	O	1654
:	O	1654
results	O	1654
from	O	1654
772	O	1654
hereditary	B-Disease	1654
prostate	I-Disease	1654
cancer	I-Disease	1654
families	O	1654
from	O	1654
the	O	1654
International	O	1654
Consortium	O	1654
for	O	1654
Prostate	B-Disease	1654
Cancer	I-Disease	1654
Genetics	O	1654
.	O	1654

A	O	1655
previous	O	1655
linkage	O	1655
study	O	1655
provided	O	1655
evidence	O	1655
for	O	1655
a	O	1655
prostate	B-Disease	1655
cancer	I-Disease	1655
-	O	1655
susceptibility	O	1655
locus	O	1655
at	O	1655
1q24	O	1655
-	O	1655
25	O	1655
.	O	1655

In	O	1657
addition	O	1657
,	O	1657
evidence	O	1657
for	O	1657
locus	O	1657
heterogeneity	O	1657
has	O	1657
been	O	1657
provided	O	1657
by	O	1657
the	O	1657
identification	O	1657
of	O	1657
other	O	1657
putative	O	1657
hereditary	B-Disease	1657
prostate	I-Disease	1657
cancer	I-Disease	1657
loci	O	1657
on	O	1657
Xq27	O	1657
-	O	1657
28	O	1657
,	O	1657
1q42	O	1657
-	O	1657
43	O	1657
,	O	1657
and	O	1657
1p36	O	1657
.	O	1657

The	O	1658
present	O	1658
study	O	1658
describes	O	1658
a	O	1658
combined	O	1658
analysis	O	1658
for	O	1658
six	O	1658
markers	O	1658
in	O	1658
the	O	1658
1q24	O	1658
-	O	1658
25	O	1658
region	O	1658
in	O	1658
772	O	1658
families	O	1658
affected	O	1658
by	O	1658
hereditary	B-Disease	1658
prostate	I-Disease	1658
cancer	I-Disease	1658
and	O	1658
ascertained	O	1658
by	O	1658
the	O	1658
members	O	1658
of	O	1658
the	O	1658
International	O	1658
Consortium	O	1658
for	O	1658
Prostate	B-Disease	1658
Cancer	I-Disease	1658
Genetics	O	1658
(	O	1658
ICPCG	O	1658
)	O	1658
from	O	1658
North	O	1658
America	O	1658
,	O	1658
Australia	O	1658
,	O	1658
Finland	O	1658
,	O	1658
Norway	O	1658
,	O	1658
Sweden	O	1658
,	O	1658
and	O	1658
the	O	1658
United	O	1658
Kingdom	O	1658
.	O	1658

These	O	1688
results	O	1688
support	O	1688
the	O	1688
finding	O	1688
of	O	1688
a	O	1688
prostate	B-Disease	1688
cancer	I-Disease	1688
-	O	1688
susceptibility	O	1688
gene	O	1688
linked	O	1688
to	O	1688
1q24	O	1688
-	O	1688
25	O	1688
,	O	1688
albeit	O	1688
in	O	1688
a	O	1688
defined	O	1688
subset	O	1688
of	O	1688
prostate	B-Disease	1688
cancer	I-Disease	1688
families	O	1688
.	O	1688

Although	O	1689
HPC1	O	1689
accounts	O	1689
for	O	1689
only	O	1689
a	O	1689
small	O	1689
proportion	O	1689
of	O	1689
all	O	1689
families	O	1689
affected	O	1689
by	O	1689
hereditary	B-Disease	1689
prostate	I-Disease	1689
cancer	I-Disease	1689
,	O	1689
it	O	1689
appears	O	1689
to	O	1689
play	O	1689
a	O	1689
more	O	1689
prominent	O	1689
role	O	1689
in	O	1689
the	O	1689
subset	O	1689
of	O	1689
families	O	1689
with	O	1689
several	O	1689
members	O	1689
affected	O	1689
at	O	1689
an	O	1689
early	O	1689
age	O	1689
and	O	1689
with	O	1689
male	O	1689
-	O	1689
to	O	1689
-	O	1689
male	O	1689
disease	O	1689
transmission	O	1689
.	O	1689

A	O	1690
recurrent	O	1690
expansion	O	1690
of	O	1690
a	O	1690
maternal	O	1690
allele	O	1690
with	O	1690
36	O	1690
CAG	O	1690
repeats	O	1690
causes	O	1690
Huntington	B-Disease	1690
disease	I-Disease	1690
in	O	1690
two	O	1690
sisters	O	1690
.	O	1690

Large	O	1691
intergenerational	O	1691
repeat	O	1691
expansions	O	1691
of	O	1691
the	O	1691
CAG	O	1691
trinucleotide	O	1691
repeat	O	1691
in	O	1691
the	O	1691
HD	B-Disease	1691
gene	O	1691
have	O	1691
been	O	1691
well	O	1691
documented	O	1691
for	O	1691
the	O	1691
male	O	1691
germline	O	1691
.	O	1691

We	O	1692
describe	O	1692
a	O	1692
recurrent	O	1692
large	O	1692
expansion	O	1692
of	O	1692
a	O	1692
maternal	O	1692
allele	O	1692
with	O	1692
36	O	1692
CAG	O	1692
repeats	O	1692
(	O	1692
to	O	1692
66	O	1692
and	O	1692
57	O	1692
repeats	O	1692
,	O	1692
respectively	O	1692
,	O	1692
in	O	1692
two	O	1692
daughters	O	1692
)	O	1692
associated	O	1692
with	O	1692
onset	O	1692
of	O	1692
Huntington	B-Disease	1692
disease	I-Disease	1692
(	O	1692
HD	B-Disease	1692
)	O	1692
in	O	1692
the	O	1692
second	O	1692
and	O	1692
third	O	1692
decade	O	1692
in	O	1692
a	O	1692
family	O	1692
without	O	1692
history	O	1692
of	O	1692
HD	B-Disease	1692
.	O	1692

Motor	B-Disease	1697
incoordination	I-Disease	1697
,	O	1697
immune	B-Disease	1697
deficiencies	I-Disease	1697
,	O	1697
and	O	1697
an	O	1697
increased	O	1697
risk	O	1697
of	O	1697
cancer	B-Disease	1697
are	O	1697
the	O	1697
characteristic	O	1697
features	O	1697
of	O	1697
the	O	1697
hereditary	B-Disease	1697
disease	I-Disease	1697
ataxia	B-Disease	1697
-	I-Disease	1697
telangiectasia	I-Disease	1697
(	O	1697
A	B-Disease	1697
-	I-Disease	1697
T	I-Disease	1697
)	O	1697
,	O	1697
which	O	1697
is	O	1697
caused	O	1697
by	O	1697
mutations	O	1697
in	O	1697
the	O	1697
ATM	O	1697
gene	O	1697
.	O	1697

In	O	1699
contrast	O	1699
to	O	1699
other	O	1699
Atm	O	1699
mutant	O	1699
mice	O	1699
,	O	1699
Atm	O	1699
(	O	1699
y	O	1699
/	O	1699
y	O	1699
)	O	1699
mice	O	1699
show	O	1699
a	O	1699
lower	O	1699
incidence	O	1699
of	O	1699
thymic	B-Disease	1699
lymphoma	I-Disease	1699
and	O	1699
survive	O	1699
beyond	O	1699
a	O	1699
few	O	1699
months	O	1699
of	O	1699
age	O	1699
.	O	1699

Atm	O	1700
(	O	1700
y	O	1700
/	O	1700
y	O	1700
)	O	1700
mice	O	1700
exhibit	O	1700
deficits	O	1700
in	O	1700
motor	O	1700
learning	O	1700
indicative	O	1700
of	O	1700
cerebellar	B-Disease	1700
dysfunction	I-Disease	1700
.	O	1700

Even	O	1701
though	O	1701
we	O	1701
found	O	1701
no	O	1701
gross	O	1701
cerebellar	B-Disease	1701
degeneration	I-Disease	1701
in	O	1701
older	O	1701
Atm	O	1701
(	O	1701
y	O	1701
/	O	1701
y	O	1701
)	O	1701
animals	O	1701
,	O	1701
ectopic	O	1701
and	O	1701
abnormally	O	1701
differentiated	O	1701
Purkinje	O	1701
cells	O	1701
were	O	1701
apparent	O	1701
in	O	1701
mutant	O	1701
mice	O	1701
of	O	1701
all	O	1701
ages	O	1701
.	O	1701

These	O	1702
findings	O	1702
establish	O	1702
that	O	1702
some	O	1702
neuropathological	B-Disease	1702
abnormalities	I-Disease	1702
seen	O	1702
in	O	1702
A	B-Disease	1702
-	I-Disease	1702
T	I-Disease	1702
patients	O	1702
also	O	1702
are	O	1702
present	O	1702
in	O	1702
Atm	O	1702
mutant	O	1702
mice	O	1702
.	O	1702

In	O	1703
addition	O	1703
,	O	1703
we	O	1703
report	O	1703
a	O	1703
previously	O	1703
unrecognized	O	1703
effect	O	1703
of	O	1703
Atm	B-Disease	1703
deficiency	I-Disease	1703
on	O	1703
development	O	1703
or	O	1703
maintenance	O	1703
of	O	1703
CD4	O	1703
(	O	1703
+	O	1703
)	O	1703
8	O	1703
(	O	1703
+	O	1703
)	O	1703
thymocytes	O	1703
.	O	1703

We	O	1704
discuss	O	1704
these	O	1704
findings	O	1704
in	O	1704
the	O	1704
context	O	1704
of	O	1704
the	O	1704
hypothesis	O	1704
that	O	1704
abnormal	O	1704
development	O	1704
of	O	1704
Purkinje	O	1704
cells	O	1704
and	O	1704
lymphocytes	O	1704
contributes	O	1704
to	O	1704
the	O	1704
pathogenesis	O	1704
of	O	1704
A	B-Disease	1704
-	I-Disease	1704
T	I-Disease	1704
.	O	1704

Novel	O	1706
mutations	O	1706
of	O	1706
the	O	1706
ATP7B	O	1706
gene	O	1706
in	O	1706
Japanese	O	1706
patients	O	1706
with	O	1706
Wilson	B-Disease	1706
disease	I-Disease	1706
.	O	1706

Wilson	B-Disease	1707
disease	I-Disease	1707
(	O	1707
WD	B-Disease	1707
)	O	1707
is	O	1707
an	O	1707
autosomal	B-Disease	1707
recessive	I-Disease	1707
disorder	I-Disease	1707
characterized	O	1707
by	O	1707
copper	O	1707
accumulation	O	1707
in	O	1707
the	O	1707
liver	O	1707
,	O	1707
brain	O	1707
,	O	1707
kidneys	O	1707
,	O	1707
and	O	1707
corneas	O	1707
,	O	1707
and	O	1707
culminating	O	1707
in	O	1707
copper	O	1707
toxication	O	1707
in	O	1707
these	O	1707
organs	O	1707
.	O	1707

In	O	1708
this	O	1708
study	O	1708
,	O	1708
we	O	1708
analyzed	O	1708
mutations	O	1708
of	O	1708
the	O	1708
responsible	O	1708
gene	O	1708
,	O	1708
ATP7B	O	1708
,	O	1708
in	O	1708
four	O	1708
Japanese	O	1708
patients	O	1708
with	O	1708
WD	B-Disease	1708
.	O	1708

Therefore	O	1715
,	O	1715
the	O	1715
accumulation	O	1715
of	O	1715
the	O	1715
types	O	1715
of	O	1715
mutations	O	1715
in	O	1715
Japanese	O	1715
patients	O	1715
with	O	1715
WD	B-Disease	1715
will	O	1715
facilitate	O	1715
the	O	1715
fast	O	1715
and	O	1715
effective	O	1715
genetic	O	1715
diagnosis	O	1715
of	O	1715
WD	B-Disease	1715
in	O	1715
Japanese	O	1715
patients	O	1715
.	O	1715

Autoinhibition	O	1717
and	O	1717
activation	O	1717
mechanisms	O	1717
of	O	1717
the	O	1717
Wiskott	B-Disease	1717
-	I-Disease	1717
Aldrich	I-Disease	1717
syndrome	I-Disease	1717
protein	O	1717
.	O	1717

The	O	1718
Rho	O	1718
-	O	1718
family	O	1718
GTPase	O	1718
,	O	1718
Cdc42	O	1718
,	O	1718
can	O	1718
regulate	O	1718
the	O	1718
actin	O	1718
cytoskeleton	O	1718
through	O	1718
activation	O	1718
of	O	1718
Wiskott	B-Disease	1718
-	I-Disease	1718
Aldrich	I-Disease	1718
syndrome	I-Disease	1718
protein	O	1718
(	O	1718
WASP	O	1718
)	O	1718
family	O	1718
members	O	1718
.	O	1718

1	O	1727
)	O	1727
tumour	B-Disease	1727
suppressor	O	1727
gene	O	1727
are	O	1727
found	O	1727
in	O	1727
almost	O	1727
all	O	1727
of	O	1727
the	O	1727
families	O	1727
with	O	1727
inherited	B-Disease	1727
breast	I-Disease	1727
and	I-Disease	1727
ovarian	I-Disease	1727
cancers	I-Disease	1727
and	O	1727
about	O	1727
half	O	1727
of	O	1727
the	O	1727
families	O	1727
with	O	1727
only	O	1727
breast	B-Disease	1727
cancer	I-Disease	1727
.	O	1727

Machado	B-Disease	1738
-	I-Disease	1738
Joseph	I-Disease	1738
disease	I-Disease	1738
(	O	1738
MJD	B-Disease	1738
)	O	1738
belongs	O	1738
to	O	1738
a	O	1738
group	O	1738
of	O	1738
clinically	O	1738
and	O	1738
genetically	O	1738
heterogeneous	O	1738
neurodegenerative	B-Disease	1738
disorders	I-Disease	1738
characterized	O	1738
by	O	1738
progressive	B-Disease	1738
cerebellar	I-Disease	1738
ataxia	I-Disease	1738
.	O	1738

In	O	1740
Caucasians	O	1740
,	O	1740
repeat	O	1740
expansions	O	1740
in	O	1740
the	O	1740
MJD1	O	1740
gene	O	1740
have	O	1740
also	O	1740
been	O	1740
found	O	1740
in	O	1740
patients	O	1740
with	O	1740
the	O	1740
clinically	O	1740
distinct	O	1740
autosomal	O	1740
dominant	O	1740
spinocerebellar	B-Disease	1740
ataxia	I-Disease	1740
type	I-Disease	1740
3	I-Disease	1740
(	O	1740
SCA3	B-Disease	1740
)	O	1740
.	O	1740

Analyzing	O	1750
the	O	1750
expression	O	1750
level	O	1750
of	O	1750
the	O	1750
SCA3	O	1750
gene	O	1750
in	O	1750
several	O	1750
human	O	1750
brain	O	1750
sections	O	1750
revealed	O	1750
no	O	1750
significant	O	1750
higher	O	1750
mRNA	O	1750
level	O	1750
in	O	1750
regions	O	1750
predominantly	O	1750
affected	O	1750
in	O	1750
MJD	B-Disease	1750
.	O	1750

Thus	O	1751
additional	O	1751
molecules	O	1751
and	O	1751
/	O	1751
or	O	1751
regulatory	O	1751
events	O	1751
are	O	1751
necessary	O	1751
to	O	1751
explain	O	1751
the	O	1751
exclusive	O	1751
degeneration	B-Disease	1751
of	I-Disease	1751
certain	I-Disease	1751
brain	I-Disease	1751
areas	I-Disease	1751
.	O	1751

Emerin	B-Disease	1752
,	I-Disease	1752
deficiency	I-Disease	1752
of	O	1752
which	O	1752
causes	O	1752
Emery	B-Disease	1752
-	I-Disease	1752
Dreifuss	I-Disease	1752
muscular	I-Disease	1752
dystrophy	I-Disease	1752
,	O	1752
is	O	1752
localized	O	1752
at	O	1752
the	O	1752
inner	O	1752
nuclear	O	1752
membrane	O	1752
.	O	1752

X	B-Disease	1753
-	I-Disease	1753
linked	I-Disease	1753
recessive	I-Disease	1753
Emery	I-Disease	1753
-	I-Disease	1753
Dreifuss	I-Disease	1753
muscular	I-Disease	1753
dystrophy	I-Disease	1753
(	O	1753
EDMD	B-Disease	1753
)	O	1753
is	O	1753
an	O	1753
inherited	B-Disease	1753
muscle	I-Disease	1753
disorder	I-Disease	1753
characterized	O	1753
by	O	1753
the	O	1753
clinical	O	1753
triad	O	1753
of	O	1753
progressive	O	1753
wasting	B-Disease	1753
of	I-Disease	1753
humero	I-Disease	1753
-	I-Disease	1753
peroneal	I-Disease	1753
muscles	I-Disease	1753
,	O	1753
early	O	1753
contractures	B-Disease	1753
of	I-Disease	1753
the	I-Disease	1753
elbows	I-Disease	1753
,	I-Disease	1753
Achilles	I-Disease	1753
tendons	I-Disease	1753
and	I-Disease	1753
postcervical	I-Disease	1753
muscles	I-Disease	1753
,	O	1753
and	O	1753
cardiac	B-Disease	1753
conduction	I-Disease	1753
block	I-Disease	1753
with	O	1753
a	O	1753
high	O	1753
risk	O	1753
of	O	1753
sudden	B-Disease	1753
death	I-Disease	1753
.	O	1753

The	O	1754
gene	O	1754
for	O	1754
EDMD	B-Disease	1754
on	O	1754
Xq28	O	1754
encodes	O	1754
a	O	1754
novel	O	1754
protein	O	1754
named	O	1754
emerin	O	1754
that	O	1754
localizes	O	1754
at	O	1754
the	O	1754
nuclear	O	1754
membrane	O	1754
of	O	1754
skeletal	O	1754
,	O	1754
cardiac	O	1754
and	O	1754
smooth	O	1754
muscles	O	1754
and	O	1754
some	O	1754
other	O	1754
non	O	1754
-	O	1754
muscle	O	1754
tissues	O	1754
.	O	1754

Locus	O	1761
heterogeneity	O	1761
in	O	1761
Friedreich	B-Disease	1761
ataxia	I-Disease	1761
.	O	1761

Friedreich	B-Disease	1762
ataxia	I-Disease	1762
(	O	1762
FRDA	B-Disease	1762
)	O	1762
is	O	1762
the	O	1762
most	O	1762
common	O	1762
form	O	1762
of	O	1762
autosomal	B-Disease	1762
recessive	I-Disease	1762
ataxia	I-Disease	1762
.	O	1762

To	O	1764
date	O	1764
most	O	1764
data	O	1764
suggest	O	1764
locus	O	1764
homogeneity	O	1764
in	O	1764
FRDA	B-Disease	1764
.	O	1764

We	O	1765
now	O	1765
provide	O	1765
strong	O	1765
evidence	O	1765
of	O	1765
a	O	1765
second	O	1765
FRDA	B-Disease	1765
locus	O	1765
.	O	1765

Studying	O	1766
two	O	1766
siblings	O	1766
with	O	1766
FRDA	B-Disease	1766
from	O	1766
two	O	1766
families	O	1766
we	O	1766
did	O	1766
not	O	1766
detect	O	1766
a	O	1766
mutation	O	1766
in	O	1766
STM7	O	1766
/	O	1766
X25	O	1766
.	O	1766

Although	O	1768
the	O	1768
patients	O	1768
studied	O	1768
had	O	1768
typical	O	1768
FRDA	B-Disease	1768
,	O	1768
one	O	1768
sibpair	O	1768
had	O	1768
the	O	1768
uncommon	O	1768
symptom	O	1768
of	O	1768
retained	O	1768
tendon	O	1768
reflexes	O	1768
.	O	1768

In	O	1769
order	O	1769
to	O	1769
investigate	O	1769
whether	O	1769
retained	O	1769
tendon	O	1769
reflexes	O	1769
are	O	1769
characteristic	O	1769
of	O	1769
FRDA	B-Disease	1769
caused	O	1769
by	O	1769
the	O	1769
second	O	1769
locus	O	1769
,	O	1769
FRDA2	O	1769
,	O	1769
we	O	1769
studied	O	1769
an	O	1769
unrelated	O	1769
FRDA	B-Disease	1769
patient	O	1769
with	O	1769
retained	O	1769
tendon	O	1769
reflexes	O	1769
.	O	1769

The	O	1770
observation	O	1770
of	O	1770
typical	O	1770
mutations	O	1770
in	O	1770
STM7	O	1770
/	O	1770
X25	O	1770
(	O	1770
GAA	O	1770
expansions	O	1770
)	O	1770
in	O	1770
this	O	1770
patient	O	1770
demonstrates	O	1770
that	O	1770
the	O	1770
two	O	1770
genetically	O	1770
different	O	1770
forms	O	1770
of	O	1770
FRDA	B-Disease	1770
cannot	O	1770
be	O	1770
distinguished	O	1770
clinically	O	1770
.	O	1770

Glycerol	O	1772
as	O	1772
a	O	1772
correlate	O	1772
of	O	1772
impaired	B-Disease	1772
glucose	I-Disease	1772
tolerance	I-Disease	1772
:	O	1772
dissection	O	1772
of	O	1772
a	O	1772
complex	O	1772
system	O	1772
by	O	1772
use	O	1772
of	O	1772
a	O	1772
simple	O	1772
genetic	O	1772
trait	O	1772
.	O	1772

Impaired	B-Disease	1774
glucose	I-Disease	1774
tolerance	I-Disease	1774
(	O	1774
IGT	B-Disease	1774
)	O	1774
and	O	1774
hypertriglyceridemia	B-Disease	1774
are	O	1774
associated	O	1774
with	O	1774
an	O	1774
increased	O	1774
risk	O	1774
of	O	1774
diabetes	B-Disease	1774
mellitus	I-Disease	1774
and	O	1774
cardiovascular	B-Disease	1774
disease	I-Disease	1774
.	O	1774

The	O	1775
relationship	O	1775
between	O	1775
glycerol	O	1775
and	O	1775
the	O	1775
risk	O	1775
of	O	1775
IGT	B-Disease	1775
,	O	1775
however	O	1775
,	O	1775
is	O	1775
poorly	O	1775
understood	O	1775
.	O	1775

Family	O	1777
screening	O	1777
in	O	1777
the	O	1777
initial	O	1777
cohort	O	1777
identified	O	1777
18	O	1777
men	O	1777
from	O	1777
five	O	1777
families	O	1777
with	O	1777
severe	O	1777
hyperglycerolemia	B-Disease	1777
(	O	1777
values	O	1777
above	O	1777
2	O	1777
.	O	1777

Clinical	O	1787
and	O	1787
molecular	O	1787
genetics	O	1787
of	O	1787
primary	B-Disease	1787
dystonias	I-Disease	1787
.	O	1787

Primary	B-Disease	1788
dystonias	I-Disease	1788
are	O	1788
movement	B-Disease	1788
disorders	I-Disease	1788
with	O	1788
dystonia	B-Disease	1788
as	O	1788
a	O	1788
major	O	1788
symptom	O	1788
.	O	1788

,	O	1795
in	O	1795
idiopathic	B-Disease	1795
torsion	I-Disease	1795
dystonia	I-Disease	1795
(	O	1795
9q34	O	1795
)	O	1795
,	O	1795
focal	B-Disease	1795
dystonia	I-Disease	1795
(	O	1795
18p	O	1795
)	O	1795
,	O	1795
adult	O	1795
-	O	1795
onset	O	1795
idiopathic	B-Disease	1795
torsion	I-Disease	1795
dystonia	I-Disease	1795
of	O	1795
mixed	O	1795
type	O	1795
(	O	1795
8p21	O	1795
-	O	1795
q22	O	1795
)	O	1795
,	O	1795
dopa	B-Disease	1795
-	I-Disease	1795
responsive	I-Disease	1795
dystonia	I-Disease	1795
(	O	1795
14q22	O	1795
.	O	1795

2	O	1797
)	O	1797
,	O	1797
and	O	1797
paroxysmal	B-Disease	1797
dystonic	I-Disease	1797
choreoathetosis	I-Disease	1797
(	O	1797
2q25	O	1797
-	O	1797
q33	O	1797
;	O	1797
1p21	O	1797
-	O	1797
p13	O	1797
.	O	1797

1	O	1800
in	O	1800
the	O	1800
X	B-Disease	1800
-	I-Disease	1800
linked	I-Disease	1800
dystonia	I-Disease	1800
parkinsonism	I-Disease	1800
syndrome	I-Disease	1800
and	O	1800
to	O	1800
Xq22	O	1800
in	O	1800
X	B-Disease	1800
-	I-Disease	1800
linked	I-Disease	1800
sensorineural	I-Disease	1800
deafness	I-Disease	1800
,	O	1800
dystonia	B-Disease	1800
,	O	1800
and	O	1800
mental	B-Disease	1800
retardation	I-Disease	1800
.	O	1800

Mutations	O	1802
in	O	1802
a	O	1802
gene	O	1802
coding	O	1802
for	O	1802
an	O	1802
ATP	O	1802
-	O	1802
binding	O	1802
protein	O	1802
were	O	1802
detected	O	1802
in	O	1802
idiopathic	B-Disease	1802
torsion	I-Disease	1802
dystonia	I-Disease	1802
(	O	1802
DYT1	O	1802
)	O	1802
,	O	1802
and	O	1802
the	O	1802
GTP	O	1802
cyclohydrolase	O	1802
1	O	1802
gene	O	1802
is	O	1802
mutated	O	1802
in	O	1802
dopa	B-Disease	1802
-	I-Disease	1802
responsive	I-Disease	1802
dystonia	I-Disease	1802
(	O	1802
DYT5	O	1802
)	O	1802
.	O	1802

In	O	1803
sensorineural	B-Disease	1803
deafness	I-Disease	1803
,	O	1803
dystonia	B-Disease	1803
,	O	1803
and	O	1803
mental	B-Disease	1803
retardation	I-Disease	1803
,	O	1803
mutations	O	1803
were	O	1803
found	O	1803
in	O	1803
the	O	1803
gene	O	1803
DDP	O	1803
coding	O	1803
for	O	1803
a	O	1803
polypeptide	O	1803
of	O	1803
unknown	O	1803
function	O	1803
.	O	1803

This	O	1804
article	O	1804
reviews	O	1804
the	O	1804
clinical	O	1804
and	O	1804
molecular	O	1804
genetics	O	1804
of	O	1804
primary	B-Disease	1804
dystonias	I-Disease	1804
,	O	1804
critically	O	1804
discusses	O	1804
present	O	1804
findings	O	1804
,	O	1804
and	O	1804
proposes	O	1804
referring	O	1804
to	O	1804
the	O	1804
known	O	1804
forms	O	1804
,	O	1804
most	O	1804
of	O	1804
which	O	1804
can	O	1804
be	O	1804
distinguished	O	1804
by	O	1804
genetic	O	1804
criteria	O	1804
,	O	1804
as	O	1804
dystonias	B-Disease	1804
1	I-Disease	1804
-	I-Disease	1804
12	I-Disease	1804
.	O	1804

Determination	O	1805
of	O	1805
30	O	1805
X	B-Disease	1805
-	I-Disease	1805
linked	I-Disease	1805
adrenoleukodystrophy	I-Disease	1805
mutations	O	1805
,	O	1805
including	O	1805
15	O	1805
not	O	1805
previously	O	1805
described	O	1805
.	O	1805

X	B-Disease	1806
-	I-Disease	1806
linked	I-Disease	1806
Adrenoleukodystrophy	I-Disease	1806
(	O	1806
X	B-Disease	1806
-	I-Disease	1806
ALD	I-Disease	1806
)	O	1806
is	O	1806
the	O	1806
most	O	1806
frequent	O	1806
peroxisomal	B-Disease	1806
disease	I-Disease	1806
.	O	1806

Of	O	1814
particular	O	1814
concern	O	1814
are	O	1814
female	O	1814
members	O	1814
of	O	1814
kindreds	O	1814
segregating	O	1814
X	B-Disease	1814
-	I-Disease	1814
ALD	I-Disease	1814
mutations	O	1814
,	O	1814
because	O	1814
normal	O	1814
VLCFA	O	1814
levels	O	1814
do	O	1814
not	O	1814
guarantee	O	1814
lack	O	1814
of	O	1814
carrier	O	1814
status	O	1814
.	O	1814

We	O	1815
describe	O	1815
a	O	1815
fast	O	1815
method	O	1815
for	O	1815
detection	O	1815
of	O	1815
X	B-Disease	1815
-	I-Disease	1815
ALD	I-Disease	1815
mutations	O	1815
.	O	1815

Using	O	1817
this	O	1817
methodology	O	1817
we	O	1817
have	O	1817
found	O	1817
X	B-Disease	1817
-	I-Disease	1817
ALD	I-Disease	1817
mutations	O	1817
in	O	1817
30	O	1817
kindreds	O	1817
,	O	1817
including	O	1817
15	O	1817
not	O	1817
previously	O	1817
reported	O	1817
.	O	1817

beta	O	1818
-	O	1818
galactosidase	O	1818
gene	O	1818
mutations	O	1818
affecting	O	1818
the	O	1818
lysosomal	O	1818
enzyme	O	1818
and	O	1818
the	O	1818
elastin	O	1818
-	O	1818
binding	O	1818
protein	O	1818
in	O	1818
GM1	B-Disease	1818
-	I-Disease	1818
gangliosidosis	I-Disease	1818
patients	O	1818
with	O	1818
cardiac	B-Disease	1818
involvement	I-Disease	1818
.	O	1818

GM1	B-Disease	1819
-	I-Disease	1819
gangliosidosis	I-Disease	1819
is	O	1819
a	O	1819
lysosomal	B-Disease	1819
storage	I-Disease	1819
disorder	I-Disease	1819
caused	O	1819
by	O	1819
deficiency	B-Disease	1819
of	I-Disease	1819
acid	I-Disease	1819
beta	I-Disease	1819
-	I-Disease	1819
galactosidase	I-Disease	1819
(	O	1819
GLB1	O	1819
)	O	1819
.	O	1819

Six	O	1821
of	O	1821
the	O	1821
eight	O	1821
patients	O	1821
with	O	1821
the	O	1821
infantile	O	1821
,	O	1821
severe	O	1821
form	O	1821
of	O	1821
the	O	1821
disease	O	1821
presented	O	1821
cardiac	B-Disease	1821
involvement	I-Disease	1821
,	O	1821
a	O	1821
feature	O	1821
rarely	O	1821
associated	O	1821
with	O	1821
GM1	B-Disease	1821
-	I-Disease	1821
gangliosidosis	I-Disease	1821
.	O	1821

Interestingly	O	1823
,	O	1823
all	O	1823
patients	O	1823
with	O	1823
cardiac	B-Disease	1823
involvement	I-Disease	1823
were	O	1823
homozygous	O	1823
for	O	1823
one	O	1823
of	O	1823
these	O	1823
mutations	O	1823
R59H	O	1823
,	O	1823
Y591C	O	1823
,	O	1823
Y591N	O	1823
,	O	1823
or	O	1823
IVS14	O	1823
-	O	1823
2A	O	1823
>	O	1823
G	O	1823
.	O	1823

Although	O	1825
we	O	1825
could	O	1825
not	O	1825
directly	O	1825
correlate	O	1825
the	O	1825
presence	O	1825
of	O	1825
cardiac	B-Disease	1825
abnormalities	I-Disease	1825
with	O	1825
specific	O	1825
genetic	B-Disease	1825
lesions	I-Disease	1825
,	O	1825
the	O	1825
mutations	O	1825
identified	O	1825
in	O	1825
patients	O	1825
with	O	1825
cardiomyopathy	B-Disease	1825
fell	O	1825
in	O	1825
the	O	1825
GLB1	O	1825
cDNA	O	1825
region	O	1825
common	O	1825
to	O	1825
the	O	1825
lysosomal	O	1825
enzyme	O	1825
and	O	1825
the	O	1825
Hbeta	O	1825
-	O	1825
Gal	O	1825
-	O	1825
related	O	1825
protein	O	1825
,	O	1825
also	O	1825
known	O	1825
as	O	1825
the	O	1825
elastin	O	1825
binding	O	1825
protein	O	1825
(	O	1825
EBP	O	1825
)	O	1825
.	O	1825

In	O	1828
vivo	O	1828
modulation	O	1828
of	O	1828
Hmgic	O	1828
reduces	O	1828
obesity	B-Disease	1828
.	O	1828

It	O	1831
is	O	1831
disrupted	O	1831
and	O	1831
misexpressed	O	1831
in	O	1831
a	O	1831
number	O	1831
of	O	1831
mesenchymal	B-Disease	1831
tumour	I-Disease	1831
cell	O	1831
types	O	1831
,	O	1831
including	O	1831
fat	B-Disease	1831
-	I-Disease	1831
cell	I-Disease	1831
tumours	I-Disease	1831
(	O	1831
lipomas	B-Disease	1831
)	O	1831
.	O	1831

To	O	1833
study	O	1833
its	O	1833
role	O	1833
in	O	1833
adipogenesis	O	1833
and	O	1833
obesity	B-Disease	1833
,	O	1833
we	O	1833
examined	O	1833
Hmgic	O	1833
expression	O	1833
in	O	1833
the	O	1833
adipose	O	1833
tissue	O	1833
of	O	1833
adult	O	1833
,	O	1833
obese	B-Disease	1833
mice	O	1833
.	O	1833

Mice	O	1834
with	O	1834
a	O	1834
partial	B-Disease	1834
or	I-Disease	1834
complete	I-Disease	1834
deficiency	I-Disease	1834
of	I-Disease	1834
Hmgic	I-Disease	1834
resisted	O	1834
diet	O	1834
-	O	1834
induced	O	1834
obesity	B-Disease	1834
.	O	1834

Disruption	O	1835
of	O	1835
Hmgic	O	1835
caused	O	1835
a	O	1835
reduction	O	1835
in	O	1835
the	O	1835
obesity	B-Disease	1835
induced	O	1835
by	O	1835
leptin	B-Disease	1835
deficiency	I-Disease	1835
(	O	1835
Lepob	O	1835
/	O	1835
Lepob	O	1835
)	O	1835
in	O	1835
a	O	1835
gene	O	1835
-	O	1835
dose	O	1835
-	O	1835
dependent	O	1835
manner	O	1835
.	O	1835

Our	O	1836
studies	O	1836
implicate	O	1836
a	O	1836
role	O	1836
for	O	1836
HMGIC	O	1836
in	O	1836
fat	O	1836
-	O	1836
cell	O	1836
proliferation	O	1836
,	O	1836
indicating	O	1836
that	O	1836
it	O	1836
may	O	1836
be	O	1836
an	O	1836
adipose	O	1836
-	O	1836
specific	O	1836
target	O	1836
for	O	1836
the	O	1836
treatment	O	1836
of	O	1836
obesity	B-Disease	1836
.	O	1836

Molecular	O	1838
analysis	O	1838
of	O	1838
the	O	1838
genotype	O	1838
-	O	1838
phenotype	O	1838
relationship	O	1838
in	O	1838
factor	B-Disease	1838
X	I-Disease	1838
deficiency	I-Disease	1838
.	O	1838

Factor	B-Disease	1839
X	I-Disease	1839
deficiency	I-Disease	1839
is	O	1839
a	O	1839
rare	O	1839
haemorrhagic	B-Disease	1839
condition	I-Disease	1839
,	O	1839
normally	O	1839
inherited	O	1839
as	O	1839
an	O	1839
autosomal	O	1839
recessive	O	1839
trait	O	1839
,	O	1839
in	O	1839
which	O	1839
a	O	1839
variable	O	1839
clinical	O	1839
presentation	O	1839
correlates	O	1839
poorly	O	1839
with	O	1839
laboratory	O	1839
phenotype	O	1839
.	O	1839

The	O	1840
factor	O	1840
X	O	1840
(	O	1840
F10	O	1840
)	O	1840
genes	O	1840
of	O	1840
14	O	1840
unrelated	O	1840
individuals	O	1840
with	O	1840
factor	B-Disease	1840
X	I-Disease	1840
deficiency	I-Disease	1840
(	O	1840
12	O	1840
familial	O	1840
and	O	1840
two	O	1840
sporadic	O	1840
cases	O	1840
)	O	1840
were	O	1840
sequenced	O	1840
yielding	O	1840
a	O	1840
total	O	1840
of	O	1840
13	O	1840
novel	O	1840
mutations	O	1840
.	O	1840

Transgenic	O	1849
mice	O	1849
expressing	O	1849
a	O	1849
truncated	O	1849
form	O	1849
of	O	1849
the	O	1849
high	O	1849
mobility	O	1849
group	O	1849
I	O	1849
-	O	1849
C	O	1849
protein	O	1849
develop	O	1849
adiposity	O	1849
and	O	1849
an	O	1849
abnormally	O	1849
high	O	1849
prevalence	O	1849
of	O	1849
lipomas	B-Disease	1849
.	O	1849

Chromosomal	O	1850
translocations	O	1850
in	O	1850
human	O	1850
lipomas	B-Disease	1850
frequently	O	1850
create	O	1850
fusion	O	1850
transcripts	O	1850
encoding	O	1850
high	O	1850
mobility	O	1850
group	O	1850
(	O	1850
HMG	O	1850
)	O	1850
I	O	1850
-	O	1850
C	O	1850
DNA	O	1850
-	O	1850
binding	O	1850
domains	O	1850
and	O	1850
C	O	1850
-	O	1850
terminal	O	1850
sequences	O	1850
from	O	1850
different	O	1850
presumed	O	1850
transcription	O	1850
factors	O	1850
,	O	1850
suggesting	O	1850
a	O	1850
potential	O	1850
role	O	1850
for	O	1850
HMG	O	1850
I	O	1850
-	O	1850
C	O	1850
in	O	1850
the	O	1850
development	O	1850
of	O	1850
lipomas	B-Disease	1850
.	O	1850

Despite	O	1852
the	O	1852
ubiquitous	O	1852
expression	O	1852
of	O	1852
the	O	1852
truncated	O	1852
HMG	O	1852
I	O	1852
-	O	1852
C	O	1852
protein	O	1852
,	O	1852
the	O	1852
transgenic	O	1852
mice	O	1852
develop	O	1852
a	O	1852
selective	O	1852
abundance	O	1852
of	O	1852
fat	O	1852
tissue	O	1852
early	O	1852
in	O	1852
life	O	1852
,	O	1852
show	O	1852
marked	O	1852
adipose	B-Disease	1852
tissue	I-Disease	1852
inflammation	I-Disease	1852
,	O	1852
and	O	1852
have	O	1852
an	O	1852
abnormally	O	1852
high	O	1852
incidence	O	1852
of	O	1852
lipomas	B-Disease	1852
.	O	1852

These	O	1853
findings	O	1853
demonstrate	O	1853
that	O	1853
the	O	1853
DNA	O	1853
-	O	1853
binding	O	1853
domains	O	1853
of	O	1853
HMG	O	1853
I	O	1853
-	O	1853
C	O	1853
,	O	1853
in	O	1853
the	O	1853
absence	O	1853
of	O	1853
a	O	1853
C	O	1853
-	O	1853
terminal	O	1853
fusion	O	1853
partner	O	1853
,	O	1853
are	O	1853
sufficient	O	1853
to	O	1853
perturb	O	1853
adipogenesis	O	1853
and	O	1853
predispose	O	1853
to	O	1853
lipomas	B-Disease	1853
.	O	1853

We	O	1854
provide	O	1854
data	O	1854
supporting	O	1854
the	O	1854
central	O	1854
utility	O	1854
of	O	1854
this	O	1854
animal	O	1854
model	O	1854
as	O	1854
a	O	1854
tool	O	1854
to	O	1854
understand	O	1854
the	O	1854
molecular	O	1854
mechanisms	O	1854
underlying	O	1854
the	O	1854
development	O	1854
of	O	1854
one	O	1854
of	O	1854
the	O	1854
most	O	1854
common	O	1854
kind	O	1854
of	O	1854
human	O	1854
benign	B-Disease	1854
tumors	I-Disease	1854
.	O	1854

The	O	1857
rare	B-Disease	1857
diseases	I-Disease	1857
ataxia	B-Disease	1857
-	I-Disease	1857
telangiectasia	I-Disease	1857
(	O	1857
AT	B-Disease	1857
)	O	1857
,	O	1857
caused	O	1857
by	O	1857
mutations	O	1857
in	O	1857
the	O	1857
ATM	O	1857
gene	O	1857
,	O	1857
and	O	1857
Nijmegen	B-Disease	1857
breakage	I-Disease	1857
syndrome	I-Disease	1857
(	O	1857
NBS	B-Disease	1857
)	O	1857
,	O	1857
with	O	1857
mutations	O	1857
in	O	1857
the	O	1857
p95	O	1857
/	O	1857
nbs1	O	1857
gene	O	1857
,	O	1857
share	O	1857
a	O	1857
variety	O	1857
of	O	1857
phenotypic	B-Disease	1857
abnormalities	I-Disease	1857
such	O	1857
as	O	1857
chromosomal	B-Disease	1857
instability	I-Disease	1857
,	O	1857
radiation	O	1857
sensitivity	O	1857
and	O	1857
defects	O	1857
in	O	1857
cell	O	1857
-	O	1857
cycle	O	1857
checkpoints	O	1857
in	O	1857
response	O	1857
to	O	1857
ionizing	O	1857
radiation	O	1857
.	O	1857

Here	O	1859
,	O	1859
because	O	1859
of	O	1859
the	O	1859
similarities	O	1859
between	O	1859
AT	B-Disease	1859
and	O	1859
NBS	B-Disease	1859
,	O	1859
we	O	1859
evaluated	O	1859
the	O	1859
functional	O	1859
interactions	O	1859
between	O	1859
ATM	O	1859
and	O	1859
p95	O	1859
/	O	1859
nbs1	O	1859
.	O	1859

Activation	O	1860
of	O	1860
the	O	1860
ATM	O	1860
kinase	O	1860
by	O	1860
ionizing	O	1860
radiation	O	1860
and	O	1860
induction	O	1860
of	O	1860
ATM	O	1860
-	O	1860
dependent	O	1860
responses	O	1860
in	O	1860
NBS	B-Disease	1860
cells	O	1860
indicated	O	1860
that	O	1860
p95	O	1860
/	O	1860
nbs1	O	1860
may	O	1860
not	O	1860
be	O	1860
required	O	1860
for	O	1860
signalling	O	1860
to	O	1860
ATM	O	1860
after	O	1860
ionizing	O	1860
radiation	O	1860
.	O	1860

A	O	1862
p95	O	1862
/	O	1862
nbs1	O	1862
construct	O	1862
mutated	O	1862
at	O	1862
the	O	1862
ATM	O	1862
phosphorylation	O	1862
site	O	1862
abrogated	O	1862
an	O	1862
S	O	1862
-	O	1862
phase	O	1862
checkpoint	O	1862
induced	O	1862
by	O	1862
ionizing	O	1862
radiation	O	1862
in	O	1862
normal	O	1862
cells	O	1862
and	O	1862
failed	O	1862
to	O	1862
compensate	O	1862
for	O	1862
this	O	1862
functional	O	1862
deficiency	O	1862
in	O	1862
NBS	B-Disease	1862
cells	O	1862
.	O	1862

Understanding	O	1865
the	O	1865
molecular	O	1865
basis	O	1865
of	O	1865
fragile	B-Disease	1865
X	I-Disease	1865
syndrome	I-Disease	1865
.	O	1865

Fragile	B-Disease	1866
X	I-Disease	1866
syndrome	I-Disease	1866
,	O	1866
a	O	1866
common	O	1866
form	O	1866
of	O	1866
inherited	B-Disease	1866
mental	I-Disease	1866
retardation	I-Disease	1866
,	O	1866
is	O	1866
mainly	O	1866
caused	O	1866
by	O	1866
massive	O	1866
expansion	O	1866
of	O	1866
CGG	O	1866
triplet	O	1866
repeats	O	1866
located	O	1866
in	O	1866
the	O	1866
5	O	1866
-	O	1866
untranslated	O	1866
region	O	1866
of	O	1866
the	O	1866
fragile	B-Disease	1866
X	I-Disease	1866
mental	I-Disease	1866
retardation	I-Disease	1866
-	O	1866
1	O	1866
(	O	1866
FMR1	O	1866
)	O	1866
gene	O	1866
.	O	1866

In	O	1867
patients	O	1867
with	O	1867
fragile	B-Disease	1867
X	I-Disease	1867
syndrome	I-Disease	1867
,	O	1867
the	O	1867
expanded	O	1867
CGG	O	1867
triplet	O	1867
repeats	O	1867
are	O	1867
hypermethylated	O	1867
and	O	1867
the	O	1867
expression	O	1867
of	O	1867
the	O	1867
FMR1	O	1867
gene	O	1867
is	O	1867
repressed	O	1867
,	O	1867
which	O	1867
leads	O	1867
to	O	1867
the	O	1867
absence	O	1867
of	O	1867
FMR1	O	1867
protein	O	1867
(	O	1867
FMRP	O	1867
)	O	1867
and	O	1867
subsequent	O	1867
mental	B-Disease	1867
retardation	I-Disease	1867
.	O	1867

Haploinsufficiency	B-Disease	1873
of	I-Disease	1873
the	I-Disease	1873
transcription	I-Disease	1873
factors	I-Disease	1873
FOXC1	I-Disease	1873
and	I-Disease	1873
FOXC2	I-Disease	1873
results	O	1873
in	O	1873
aberrant	O	1873
ocular	O	1873
development	O	1873
.	O	1873

Anterior	B-Disease	1874
segment	I-Disease	1874
developmental	I-Disease	1874
disorders	I-Disease	1874
,	O	1874
including	O	1874
Axenfeld	B-Disease	1874
-	I-Disease	1874
Rieger	I-Disease	1874
anomaly	I-Disease	1874
(	O	1874
ARA	B-Disease	1874
)	O	1874
,	O	1874
variably	O	1874
associate	O	1874
with	O	1874
harmfully	O	1874
elevated	O	1874
intraocular	O	1874
pressure	O	1874
(	O	1874
IOP	O	1874
)	O	1874
,	O	1874
which	O	1874
causes	O	1874
glaucoma	B-Disease	1874
.	O	1874

Clinically	O	1875
observed	O	1875
dysgenesis	O	1875
does	O	1875
not	O	1875
correlate	O	1875
with	O	1875
IOP	O	1875
,	O	1875
however	O	1875
,	O	1875
and	O	1875
the	O	1875
etiology	O	1875
of	O	1875
glaucoma	B-Disease	1875
development	O	1875
is	O	1875
not	O	1875
understood	O	1875
.	O	1875

Mutations	O	1877
in	O	1877
the	O	1877
human	O	1877
homolog	O	1877
of	O	1877
Foxc1	O	1877
,	O	1877
FKHL7	O	1877
,	O	1877
cause	O	1877
dominant	O	1877
anterior	B-Disease	1877
segment	I-Disease	1877
defects	I-Disease	1877
and	O	1877
glaucoma	B-Disease	1877
in	O	1877
various	O	1877
families	O	1877
.	O	1877

We	O	1878
show	O	1878
that	O	1878
Foxc1	O	1878
(	O	1878
+	O	1878
/	O	1878
-	O	1878
)	O	1878
mice	O	1878
have	O	1878
anterior	B-Disease	1878
segment	I-Disease	1878
abnormalities	I-Disease	1878
similar	O	1878
to	O	1878
those	O	1878
reported	O	1878
in	O	1878
human	O	1878
patients	O	1878
.	O	1878

These	O	1879
abnormalities	O	1879
include	O	1879
small	O	1879
or	O	1879
absent	O	1879
Schlemms	O	1879
canal	O	1879
,	O	1879
aberrantly	O	1879
developed	O	1879
trabecular	O	1879
meshwork	O	1879
,	O	1879
iris	B-Disease	1879
hypoplasia	I-Disease	1879
,	O	1879
severely	O	1879
eccentric	O	1879
pupils	O	1879
and	O	1879
displaced	O	1879
Schwalbes	O	1879
line	O	1879
.	O	1879

Similar	O	1884
abnormalities	O	1884
were	O	1884
found	O	1884
in	O	1884
Foxc2	O	1884
(	O	1884
+	O	1884
/	O	1884
-	O	1884
)	O	1884
mice	O	1884
,	O	1884
but	O	1884
no	O	1884
disease	O	1884
-	O	1884
associated	O	1884
mutations	O	1884
were	O	1884
identified	O	1884
in	O	1884
the	O	1884
human	O	1884
homolog	O	1884
FKHL14	O	1884
in	O	1884
32	O	1884
ARA	B-Disease	1884
patients	O	1884
.	O	1884

Foxc1	O	1885
(	O	1885
+	O	1885
/	O	1885
-	O	1885
)	O	1885
and	O	1885
Foxc2	O	1885
(	O	1885
+	O	1885
/	O	1885
-	O	1885
)	O	1885
mice	O	1885
are	O	1885
useful	O	1885
models	O	1885
for	O	1885
studying	O	1885
anterior	O	1885
segment	O	1885
development	O	1885
and	O	1885
its	O	1885
anomalies	O	1885
,	O	1885
and	O	1885
may	O	1885
allow	O	1885
identification	O	1885
of	O	1885
genes	O	1885
that	O	1885
interact	O	1885
with	O	1885
Foxc1	O	1885
and	O	1885
Foxc2	O	1885
(	O	1885
or	O	1885
FKHL7	O	1885
and	O	1885
FKHL14	O	1885
)	O	1885
to	O	1885
produce	O	1885
a	O	1885
phenotype	O	1885
with	O	1885
elevated	O	1885
IOP	O	1885
and	O	1885
glaucoma	B-Disease	1885
.	O	1885

(	O	1887
Over	O	1887
)	O	1887
correction	O	1887
of	O	1887
FMR1	B-Disease	1887
deficiency	I-Disease	1887
with	O	1887
YAC	O	1887
transgenics	O	1887
:	O	1887
behavioral	O	1887
and	O	1887
physical	O	1887
features	O	1887
.	O	1887

Fragile	B-Disease	1888
X	I-Disease	1888
syndrome	I-Disease	1888
is	O	1888
a	O	1888
common	O	1888
cause	O	1888
of	O	1888
mental	B-Disease	1888
retardation	I-Disease	1888
involving	O	1888
loss	O	1888
of	O	1888
expression	O	1888
of	O	1888
the	O	1888
FMR1	O	1888
gene	O	1888
.	O	1888

Fmr1	O	1890
knockout	O	1890
mice	O	1890
exhibit	O	1890
a	O	1890
phenotype	O	1890
with	O	1890
some	O	1890
similarities	O	1890
to	O	1890
humans	O	1890
,	O	1890
such	O	1890
as	O	1890
macroorchidism	B-Disease	1890
and	O	1890
behavioral	O	1890
abnormalities	O	1890
.	O	1890

As	O	1891
a	O	1891
step	O	1891
toward	O	1891
understanding	O	1891
the	O	1891
function	O	1891
of	O	1891
FMR1	O	1891
and	O	1891
the	O	1891
determination	O	1891
of	O	1891
the	O	1891
potential	O	1891
for	O	1891
therapeutic	O	1891
approaches	O	1891
to	O	1891
fragile	B-Disease	1891
X	I-Disease	1891
syndrome	I-Disease	1891
,	O	1891
yeast	O	1891
artificial	O	1891
chromosome	O	1891
(	O	1891
YAC	O	1891
)	O	1891
transgenic	O	1891
mice	O	1891
were	O	1891
generated	O	1891
in	O	1891
order	O	1891
to	O	1891
determine	O	1891
whether	O	1891
the	O	1891
Fmr1	O	1891
knockout	O	1891
mouse	O	1891
phenotype	O	1891
could	O	1891
be	O	1891
rescued	O	1891
.	O	1891

Given	O	1895
the	O	1895
complex	O	1895
behavioral	O	1895
phenotype	O	1895
in	O	1895
fragile	B-Disease	1895
X	I-Disease	1895
patients	O	1895
and	O	1895
the	O	1895
mild	O	1895
phenotype	O	1895
previously	O	1895
reported	O	1895
for	O	1895
the	O	1895
Fmr1	O	1895
knockout	O	1895
mouse	O	1895
,	O	1895
we	O	1895
performed	O	1895
a	O	1895
more	O	1895
thorough	O	1895
evaluation	O	1895
of	O	1895
the	O	1895
Fmr1	O	1895
knockout	O	1895
phenotype	O	1895
using	O	1895
additional	O	1895
behavioral	O	1895
assays	O	1895
that	O	1895
had	O	1895
not	O	1895
previously	O	1895
been	O	1895
reported	O	1895
for	O	1895
this	O	1895
animal	O	1895
model	O	1895
.	O	1895

The	O	1896
mouse	O	1896
displayed	O	1896
reduced	O	1896
anxiety	B-Disease	1896
-	O	1896
related	O	1896
responses	O	1896
with	O	1896
increased	O	1896
exploratory	O	1896
behavior	O	1896
.	O	1896

These	O	1898
findings	O	1898
have	O	1898
significant	O	1898
implications	O	1898
for	O	1898
gene	O	1898
therapy	O	1898
for	O	1898
fragile	B-Disease	1898
X	I-Disease	1898
syndrome	I-Disease	1898
since	O	1898
overexpression	O	1898
of	O	1898
the	O	1898
gene	O	1898
may	O	1898
harbor	O	1898
its	O	1898
own	O	1898
phenotype	O	1898
.	O	1898

Transgenic	O	1900
mice	O	1900
carrying	O	1900
large	O	1900
human	O	1900
genomic	O	1900
sequences	O	1900
with	O	1900
expanded	O	1900
CTG	O	1900
repeat	O	1900
mimic	O	1900
closely	O	1900
the	O	1900
DM	B-Disease	1900
CTG	O	1900
repeat	O	1900
intergenerational	O	1900
and	O	1900
somatic	O	1900
instability	O	1900
.	O	1900

Myotonic	B-Disease	1901
dystrophy	I-Disease	1901
(	O	1901
DM	B-Disease	1901
)	O	1901
is	O	1901
caused	O	1901
by	O	1901
a	O	1901
CTG	O	1901
repeat	O	1901
expansion	O	1901
in	O	1901
the	O	1901
3UTR	O	1901
of	O	1901
the	O	1901
DM	B-Disease	1901
protein	O	1901
kinase	O	1901
(	O	1901
DMPK	O	1901
)	O	1901
gene	O	1901
.	O	1901

Furthermore	O	1903
,	O	1903
tissues	O	1903
from	O	1903
DM	B-Disease	1903
patients	O	1903
exhibit	O	1903
somatic	O	1903
mosaicism	O	1903
that	O	1903
increases	O	1903
with	O	1903
age	O	1903
.	O	1903

We	O	1904
generated	O	1904
transgenic	O	1904
mice	O	1904
carrying	O	1904
large	O	1904
human	O	1904
genomic	O	1904
sequences	O	1904
with	O	1904
20	O	1904
,	O	1904
55	O	1904
or	O	1904
>	O	1904
300	O	1904
CTG	O	1904
,	O	1904
cloned	O	1904
from	O	1904
patients	O	1904
from	O	1904
the	O	1904
same	O	1904
affected	O	1904
DM	B-Disease	1904
family	O	1904
.	O	1904

Although	O	1907
we	O	1907
did	O	1907
not	O	1907
observe	O	1907
dramatic	O	1907
expansions	O	1907
(	O	1907
or	O	1907
big	O	1907
jumps	O	1907
over	O	1907
several	O	1907
hundred	O	1907
CTG	O	1907
repeats	O	1907
)	O	1907
as	O	1907
in	O	1907
congenital	O	1907
forms	O	1907
of	O	1907
DM	B-Disease	1907
,	O	1907
our	O	1907
model	O	1907
carrying	O	1907
>	O	1907
300	O	1907
CTG	O	1907
is	O	1907
the	O	1907
first	O	1907
to	O	1907
show	O	1907
instability	O	1907
so	O	1907
close	O	1907
to	O	1907
the	O	1907
human	O	1907
DM	B-Disease	1907
situation	O	1907
.	O	1907

Inactivation	O	1910
of	O	1910
the	O	1910
Friedreich	B-Disease	1910
ataxia	I-Disease	1910
mouse	O	1910
gene	O	1910
leads	O	1910
to	O	1910
early	O	1910
embryonic	B-Disease	1910
lethality	I-Disease	1910
without	O	1910
iron	O	1910
accumulation	O	1910
.	O	1910

Friedreich	B-Disease	1911
ataxia	I-Disease	1911
(	O	1911
FRDA	B-Disease	1911
)	O	1911
,	O	1911
the	O	1911
most	O	1911
common	O	1911
autosomal	B-Disease	1911
recessive	I-Disease	1911
ataxia	I-Disease	1911
,	O	1911
is	O	1911
caused	O	1911
in	O	1911
almost	O	1911
all	O	1911
cases	O	1911
by	O	1911
homozygous	O	1911
intronic	O	1911
expansions	O	1911
resulting	O	1911
in	O	1911
the	O	1911
loss	O	1911
of	O	1911
frataxin	O	1911
,	O	1911
a	O	1911
mitochondrial	O	1911
protein	O	1911
conserved	O	1911
through	O	1911
evolution	O	1911
,	O	1911
and	O	1911
involved	O	1911
in	O	1911
mitochondrial	O	1911
iron	O	1911
homeostasis	O	1911
.	O	1911

Yeast	O	1912
knockout	O	1912
models	O	1912
,	O	1912
and	O	1912
histological	O	1912
and	O	1912
biochemical	O	1912
data	O	1912
from	O	1912
patient	O	1912
heart	O	1912
biopsies	O	1912
or	O	1912
autopsies	O	1912
indicate	O	1912
that	O	1912
the	O	1912
frataxin	O	1912
defect	O	1912
causes	O	1912
a	O	1912
specific	O	1912
iron	B-Disease	1912
-	I-Disease	1912
sulfur	I-Disease	1912
protein	I-Disease	1912
deficiency	I-Disease	1912
and	O	1912
mitochondrial	O	1912
iron	O	1912
accumulation	O	1912
leading	O	1912
to	O	1912
the	O	1912
pathological	O	1912
changes	O	1912
.	O	1912

To	O	1914
study	O	1914
the	O	1914
mechanism	O	1914
of	O	1914
the	O	1914
disease	O	1914
,	O	1914
we	O	1914
generated	O	1914
a	O	1914
mouse	O	1914
model	O	1914
by	O	1914
deletion	O	1914
of	O	1914
exon	O	1914
4	O	1914
leading	O	1914
to	O	1914
inactivation	O	1914
of	O	1914
the	O	1914
Frda	B-Disease	1914
gene	O	1914
product	O	1914
.	O	1914

We	O	1915
show	O	1915
that	O	1915
homozygous	O	1915
deletions	O	1915
cause	O	1915
embryonic	B-Disease	1915
lethality	I-Disease	1915
a	O	1915
few	O	1915
days	O	1915
after	O	1915
implantation	O	1915
,	O	1915
demonstrating	O	1915
an	O	1915
important	O	1915
role	O	1915
for	O	1915
frataxin	O	1915
during	O	1915
early	O	1915
development	O	1915
.	O	1915

Gaucher	B-Disease	1919
disease	I-Disease	1919
:	O	1919
the	O	1919
origins	O	1919
of	O	1919
the	O	1919
Ashkenazi	O	1919
Jewish	O	1919
N370S	O	1919
and	O	1919
84GG	O	1919
acid	O	1919
beta	O	1919
-	O	1919
glucosidase	O	1919
mutations	O	1919
.	O	1919

Type	O	1920
1	O	1920
Gaucher	B-Disease	1920
disease	I-Disease	1920
(	O	1920
GD	B-Disease	1920
)	O	1920
,	O	1920
a	O	1920
non	O	1920
-	O	1920
neuronopathic	O	1920
lysosomal	B-Disease	1920
storage	I-Disease	1920
disorder	I-Disease	1920
,	O	1920
results	O	1920
from	O	1920
the	O	1920
deficient	O	1920
activity	O	1920
of	O	1920
acid	O	1920
beta	O	1920
-	O	1920
glucosidase	O	1920
(	O	1920
GBA	O	1920
)	O	1920
.	O	1920

HLA	O	1935
B27	O	1935
and	O	1935
the	O	1935
genetics	O	1935
of	O	1935
ankylosing	B-Disease	1935
spondylitis	I-Disease	1935
.	O	1935

One	O	1936
hundred	O	1936
and	O	1936
twenty	O	1936
-	O	1936
eight	O	1936
of	O	1936
145	O	1936
patients	O	1936
with	O	1936
ankylosing	B-Disease	1936
spondylitis	I-Disease	1936
(	O	1936
AS	B-Disease	1936
)	O	1936
were	O	1936
found	O	1936
to	O	1936
be	O	1936
HLA	O	1936
B27	O	1936
positive	O	1936
.	O	1936

Five	O	1937
patients	O	1937
had	O	1937
evidence	O	1937
of	O	1937
a	O	1937
sero	O	1937
-	O	1937
negative	O	1937
peripheral	B-Disease	1937
arthritis	I-Disease	1937
resembling	O	1937
peripheral	B-Disease	1937
psoriatic	I-Disease	1937
arthritis	I-Disease	1937
and	O	1937
3	O	1937
of	O	1937
these	O	1937
were	O	1937
B27	O	1937
negative	O	1937
.	O	1937

One	O	1938
further	O	1938
B27	O	1938
negative	O	1938
patients	O	1938
had	O	1938
a	O	1938
sister	O	1938
with	O	1938
ankylosing	B-Disease	1938
spondylitis	I-Disease	1938
and	O	1938
ulcerative	B-Disease	1938
colitis	I-Disease	1938
and	O	1938
a	O	1938
mother	O	1938
with	O	1938
ulcerative	B-Disease	1938
colitis	I-Disease	1938
.	O	1938

These	O	1940
findings	O	1940
are	O	1940
interpreted	O	1940
as	O	1940
suggesting	O	1940
some	O	1940
degree	O	1940
of	O	1940
clinical	O	1940
and	O	1940
genetic	O	1940
heterogeneity	O	1940
in	O	1940
ankylosing	B-Disease	1940
spondylitis	I-Disease	1940
with	O	1940
genes	O	1940
for	O	1940
psoriasis	B-Disease	1940
and	O	1940
inflammatory	B-Disease	1940
bowel	I-Disease	1940
disease	I-Disease	1940
being	O	1940
important	O	1940
in	O	1940
some	O	1940
individuals	O	1940
,	O	1940
particularly	O	1940
those	O	1940
who	O	1940
are	O	1940
B27	O	1940
negative	O	1940
.	O	1940

Twenty	O	1941
-	O	1941
five	O	1941
first	O	1941
-	O	1941
degree	O	1941
relatives	O	1941
with	O	1941
ankylosing	B-Disease	1941
spondylitis	I-Disease	1941
were	O	1941
all	O	1941
B27	O	1941
positive	O	1941
.	O	1941

The	O	1942
only	O	1942
instance	O	1942
of	O	1942
disassociation	O	1942
of	O	1942
B27	O	1942
and	O	1942
spondylitis	B-Disease	1942
in	O	1942
a	O	1942
family	O	1942
was	O	1942
where	O	1942
the	O	1942
proband	O	1942
had	O	1942
ulcerative	B-Disease	1942
colitis	I-Disease	1942
as	O	1942
well	O	1942
as	O	1942
spondylitis	B-Disease	1942
.	O	1942

Of	O	1943
13	O	1943
B27	O	1943
positive	O	1943
fathers	O	1943
3	O	1943
could	O	1943
be	O	1943
diagnosed	O	1943
as	O	1943
having	O	1943
definite	O	1943
ankylosing	B-Disease	1943
spondylitis	I-Disease	1943
(	O	1943
23	O	1943
%	O	1943
)	O	1943
.	O	1943

These	O	1944
findings	O	1944
are	O	1944
thought	O	1944
to	O	1944
provide	O	1944
evidence	O	1944
against	O	1944
the	O	1944
concept	O	1944
that	O	1944
the	O	1944
gene	O	1944
for	O	1944
ankylosing	B-Disease	1944
spondylitis	I-Disease	1944
is	O	1944
not	O	1944
B27	O	1944
but	O	1944
a	O	1944
closely	O	1944
linked	O	1944
gene	O	1944
and	O	1944
favour	O	1944
the	O	1944
occurrence	O	1944
of	O	1944
an	O	1944
environmental	O	1944
event	O	1944
affecting	O	1944
approximately	O	1944
one	O	1944
-	O	1944
fifth	O	1944
of	O	1944
B27	O	1944
positive	O	1944
males	O	1944
to	O	1944
result	O	1944
in	O	1944
disease	O	1944
.	O	1944

Founder	O	1946
mutations	O	1946
in	O	1946
the	O	1946
BRCA1	O	1946
gene	O	1946
in	O	1946
Polish	O	1946
families	O	1946
with	O	1946
breast	B-Disease	1946
-	I-Disease	1946
ovarian	I-Disease	1946
cancer	I-Disease	1946
.	O	1946

The	O	1948
study	O	1948
group	O	1948
consisted	O	1948
of	O	1948
66	O	1948
Polish	O	1948
families	O	1948
with	O	1948
cancer	B-Disease	1948
who	O	1948
have	O	1948
at	O	1948
least	O	1948
three	O	1948
related	O	1948
females	O	1948
affected	O	1948
with	O	1948
breast	B-Disease	1948
or	I-Disease	1948
ovarian	I-Disease	1948
cancer	I-Disease	1948
and	O	1948
who	O	1948
had	O	1948
cancer	B-Disease	1948
diagnosed	O	1948
,	O	1948
in	O	1948
at	O	1948
least	O	1948
one	O	1948
of	O	1948
the	O	1948
three	O	1948
affected	O	1948
females	O	1948
,	O	1948
at	O	1948
age	O	1948
<	O	1948
50	O	1948
years	O	1948
.	O	1948

A	O	1949
total	O	1949
of	O	1949
26	O	1949
families	O	1949
had	O	1949
both	O	1949
breast	B-Disease	1949
and	I-Disease	1949
ovarian	I-Disease	1949
cancers	I-Disease	1949
,	O	1949
4	O	1949
families	O	1949
had	O	1949
ovarian	B-Disease	1949
cancers	I-Disease	1949
only	O	1949
,	O	1949
and	O	1949
36	O	1949
families	O	1949
had	O	1949
breast	B-Disease	1949
cancers	I-Disease	1949
only	O	1949
.	O	1949

BRCA1	B-Disease	1954
abnormalities	I-Disease	1954
were	O	1954
identified	O	1954
in	O	1954
all	O	1954
four	O	1954
families	O	1954
with	O	1954
ovarian	B-Disease	1954
cancer	I-Disease	1954
only	O	1954
,	O	1954
in	O	1954
67	O	1954
%	O	1954
of	O	1954
27	O	1954
families	O	1954
with	O	1954
both	O	1954
breast	B-Disease	1954
and	I-Disease	1954
ovarian	I-Disease	1954
cancer	I-Disease	1954
,	O	1954
and	O	1954
in	O	1954
34	O	1954
%	O	1954
of	O	1954
35	O	1954
families	O	1954
with	O	1954
breast	B-Disease	1954
cancer	I-Disease	1954
only	O	1954
.	O	1954

The	O	1955
single	O	1955
family	O	1955
with	O	1955
a	O	1955
BRCA2	O	1955
mutation	O	1955
had	O	1955
the	O	1955
breast	B-Disease	1955
-	I-Disease	1955
ovarian	I-Disease	1955
cancer	I-Disease	1955
syndrome	I-Disease	1955
.	O	1955

Three	O	1958
BRCA1	B-Disease	1958
abnormalities	I-Disease	1958
-	O	1958
5382insC	O	1958
,	O	1958
C61G	O	1958
,	O	1958
and	O	1958
4153delA	O	1958
-	O	1958
accounted	O	1958
for	O	1958
51	O	1958
%	O	1958
,	O	1958
20	O	1958
%	O	1958
,	O	1958
and	O	1958
11	O	1958
%	O	1958
of	O	1958
the	O	1958
identified	O	1958
mutations	O	1958
,	O	1958
respectively	O	1958
.	O	1958

Molecular	O	1960
basis	O	1960
of	O	1960
very	B-Disease	1960
long	I-Disease	1960
chain	I-Disease	1960
acyl	I-Disease	1960
-	I-Disease	1960
CoA	I-Disease	1960
dehydrogenase	I-Disease	1960
deficiency	I-Disease	1960
in	O	1960
three	O	1960
Israeli	O	1960
patients	O	1960
:	O	1960
identification	O	1960
of	O	1960
a	O	1960
complex	O	1960
mutant	O	1960
allele	O	1960
with	O	1960
P65L	O	1960
and	O	1960
K247Q	O	1960
mutations	O	1960
,	O	1960
the	O	1960
former	O	1960
being	O	1960
an	O	1960
exonic	O	1960
mutation	O	1960
causing	O	1960
exon	O	1960
3	O	1960
skipping	O	1960
.	O	1960

Very	B-Disease	1961
long	I-Disease	1961
chain	I-Disease	1961
acyl	I-Disease	1961
-	I-Disease	1961
CoA	I-Disease	1961
dehydrogenase	I-Disease	1961
(	I-Disease	1961
VLCAD	I-Disease	1961
)	I-Disease	1961
deficiency	I-Disease	1961
is	O	1961
a	O	1961
life	O	1961
-	O	1961
threatening	O	1961
disorder	O	1961
of	O	1961
mitochondrial	O	1961
fatty	O	1961
acid	O	1961
beta	O	1961
-	O	1961
oxidation	O	1961
.	O	1961

All	O	1963
patients	O	1963
had	O	1963
the	O	1963
severe	O	1963
childhood	O	1963
form	O	1963
of	O	1963
VLCAD	B-Disease	1963
deficiency	I-Disease	1963
with	O	1963
early	O	1963
onset	O	1963
and	O	1963
high	O	1963
mortality	O	1963
.	O	1963

Submicroscopic	O	1972
deletion	O	1972
in	O	1972
cousins	O	1972
with	O	1972
Prader	B-Disease	1972
-	I-Disease	1972
Willi	I-Disease	1972
syndrome	I-Disease	1972
causes	O	1972
a	O	1972
grandmatrilineal	O	1972
inheritance	O	1972
pattern	O	1972
:	O	1972
effects	O	1972
of	O	1972
imprinting	O	1972
.	O	1972

The	O	1973
Prader	B-Disease	1973
-	I-Disease	1973
Willi	I-Disease	1973
syndrome	I-Disease	1973
(	O	1973
PWS	B-Disease	1973
)	O	1973
critical	O	1973
region	O	1973
on	O	1973
15q11	O	1973
-	O	1973
q13	O	1973
is	O	1973
subject	O	1973
to	O	1973
imprinting	O	1973
.	O	1973

PWS	B-Disease	1974
becomes	O	1974
apparent	O	1974
when	O	1974
genes	O	1974
on	O	1974
the	O	1974
paternally	O	1974
inherited	O	1974
chromosome	O	1974
are	O	1974
not	O	1974
expressed	O	1974
.	O	1974

Familial	B-Disease	1975
PWS	I-Disease	1975
is	O	1975
rare	O	1975
.	O	1975

We	O	1976
report	O	1976
on	O	1976
a	O	1976
family	O	1976
in	O	1976
which	O	1976
a	O	1976
male	O	1976
and	O	1976
a	O	1976
female	O	1976
paternal	O	1976
first	O	1976
cousin	O	1976
both	O	1976
have	O	1976
PWS	B-Disease	1976
with	O	1976
cytogenetically	O	1976
normal	O	1976
karyotypes	O	1976
.	O	1976

DNA	O	1980
methylation	O	1980
analysis	O	1980
of	O	1980
D15S63	O	1980
is	O	1980
consistent	O	1980
with	O	1980
an	O	1980
abnormality	O	1980
of	O	1980
the	O	1980
imprinting	O	1980
center	O	1980
associated	O	1980
with	O	1980
PWS	B-Disease	1980
.	O	1980

In	O	1984
this	O	1984
case	O	1984
,	O	1984
PWS	B-Disease	1984
does	O	1984
not	O	1984
become	O	1984
evident	O	1984
as	O	1984
long	O	1984
as	O	1984
the	O	1984
deletion	O	1984
is	O	1984
passed	O	1984
through	O	1984
the	O	1984
matrilineal	O	1984
line	O	1984
.	O	1984

Human	O	1987
glycine	O	1987
decarboxylase	O	1987
gene	O	1987
(	O	1987
GLDC	O	1987
)	O	1987
and	O	1987
its	O	1987
highly	O	1987
conserved	O	1987
processed	O	1987
pseudogene	O	1987
(	O	1987
psiGLDC	O	1987
)	O	1987
:	O	1987
their	O	1987
structure	O	1987
and	O	1987
expression	O	1987
,	O	1987
and	O	1987
the	O	1987
identification	O	1987
of	O	1987
a	O	1987
large	O	1987
deletion	O	1987
in	O	1987
a	O	1987
family	O	1987
with	O	1987
nonketotic	B-Disease	1987
hyperglycinemia	I-Disease	1987
.	O	1987

Mutations	O	1988
in	O	1988
the	O	1988
glycine	O	1988
decarboxylase	O	1988
gene	O	1988
(	O	1988
GLDC	O	1988
)	O	1988
cause	O	1988
nonketotic	B-Disease	1988
hyperglycinemia	I-Disease	1988
(	O	1988
NKH	B-Disease	1988
)	O	1988
,	O	1988
an	O	1988
in	B-Disease	1988
-	I-Disease	1988
born	I-Disease	1988
error	I-Disease	1988
of	I-Disease	1988
metabolism	I-Disease	1988
characterized	O	1988
by	O	1988
severe	O	1988
neurological	B-Disease	1988
disturbance	I-Disease	1988
.	O	1988

We	O	1989
have	O	1989
determined	O	1989
the	O	1989
structure	O	1989
of	O	1989
GLDC	O	1989
and	O	1989
of	O	1989
its	O	1989
pseudogene	O	1989
(	O	1989
psiGLDC	O	1989
)	O	1989
and	O	1989
studied	O	1989
their	O	1989
expression	O	1989
for	O	1989
a	O	1989
molecular	O	1989
analysis	O	1989
of	O	1989
NKH	B-Disease	1989
.	O	1989

We	O	1996
have	O	1996
also	O	1996
examined	O	1996
a	O	1996
patient	O	1996
with	O	1996
NKH	B-Disease	1996
with	O	1996
no	O	1996
detectable	O	1996
GLDC	O	1996
mRNA	O	1996
in	O	1996
his	O	1996
lymphoblasts	O	1996
.	O	1996

Structural	O	2000
information	O	2000
of	O	2000
GLDC	O	2000
and	O	2000
psiGLDC	O	2000
should	O	2000
facilitate	O	2000
the	O	2000
molecular	O	2000
analysis	O	2000
of	O	2000
NKH	B-Disease	2000
.	O	2000

Prader	B-Disease	2002
-	I-Disease	2002
Willi	I-Disease	2002
syndrome	I-Disease	2002
(	O	2002
PWS	B-Disease	2002
)	O	2002
is	O	2002
a	O	2002
neurogenetic	B-Disease	2002
disease	I-Disease	2002
characterized	O	2002
by	O	2002
infantile	B-Disease	2002
hypotonia	I-Disease	2002
,	O	2002
gonadal	B-Disease	2002
hypoplasia	I-Disease	2002
,	O	2002
obsessive	O	2002
behaviour	O	2002
and	O	2002
neonatal	O	2002
feeding	O	2002
difficulties	O	2002
followed	O	2002
by	O	2002
hyperphagia	B-Disease	2002
,	O	2002
leading	O	2002
to	O	2002
profound	O	2002
obesity	B-Disease	2002
.	O	2002

PWS	B-Disease	2003
is	O	2003
due	O	2003
to	O	2003
a	O	2003
lack	O	2003
of	O	2003
paternal	O	2003
genetic	O	2003
information	O	2003
at	O	2003
15q11	O	2003
-	O	2003
q13	O	2003
(	O	2003
ref	O	2003
.	O	2003

Five	O	2005
imprinted	O	2005
,	O	2005
paternally	O	2005
expressed	O	2005
genes	O	2005
map	O	2005
to	O	2005
the	O	2005
PWS	B-Disease	2005
region	O	2005
,	O	2005
MKRN3	O	2005
(	O	2005
ref	O	2005
.	O	2005

Deletion	O	2012
of	O	2012
the	O	2012
SNRPN	O	2012
promoter	O	2012
/	O	2012
exon	O	2012
1	O	2012
region	O	2012
(	O	2012
the	O	2012
PWS	B-Disease	2012
IC	O	2012
element	O	2012
)	O	2012
appears	O	2012
to	O	2012
impair	O	2012
the	O	2012
establishment	O	2012
of	O	2012
the	O	2012
paternal	O	2012
imprint	O	2012
in	O	2012
the	O	2012
male	O	2012
germ	O	2012
line	O	2012
and	O	2012
leads	O	2012
to	O	2012
PWS	B-Disease	2012
.	O	2012

Here	O	2013
we	O	2013
report	O	2013
a	O	2013
PWS	B-Disease	2013
family	O	2013
in	O	2013
which	O	2013
the	O	2013
father	O	2013
is	O	2013
mosaic	O	2013
for	O	2013
an	O	2013
IC	O	2013
deletion	O	2013
on	O	2013
his	O	2013
paternal	O	2013
chromosome	O	2013
.	O	2013

Our	O	2016
studies	O	2016
demonstrate	O	2016
that	O	2016
the	O	2016
PWS	B-Disease	2016
IC	O	2016
element	O	2016
is	O	2016
not	O	2016
only	O	2016
required	O	2016
for	O	2016
the	O	2016
establishment	O	2016
of	O	2016
the	O	2016
paternal	O	2016
imprint	O	2016
,	O	2016
but	O	2016
also	O	2016
for	O	2016
its	O	2016
postzygotic	O	2016
maintenance	O	2016
.	O	2016

Mice	O	2018
deficient	B-Disease	2018
in	I-Disease	2018
Six5	I-Disease	2018
develop	O	2018
cataracts	B-Disease	2018
:	O	2018
implications	O	2018
for	O	2018
myotonic	B-Disease	2018
dystrophy	I-Disease	2018
.	O	2018

Expansion	O	2019
of	O	2019
a	O	2019
CTG	O	2019
trinucleotide	O	2019
repeat	O	2019
in	O	2019
the	O	2019
3	O	2019
UTR	O	2019
of	O	2019
the	O	2019
gene	O	2019
DMPK	O	2019
at	O	2019
the	O	2019
DM1	O	2019
locus	O	2019
on	O	2019
chromosome	O	2019
19	O	2019
causes	O	2019
myotonic	B-Disease	2019
dystrophy	I-Disease	2019
,	O	2019
a	O	2019
dominantly	B-Disease	2019
inherited	I-Disease	2019
disease	I-Disease	2019
characterized	O	2019
by	O	2019
skeletal	O	2019
muscle	B-Disease	2019
dystrophy	I-Disease	2019
and	O	2019
myotonia	B-Disease	2019
,	O	2019
cataracts	B-Disease	2019
and	O	2019
cardiac	B-Disease	2019
conduction	I-Disease	2019
defects	I-Disease	2019
.	O	2019

Targeted	O	2020
deletion	O	2020
of	O	2020
Dm15	O	2020
,	O	2020
the	O	2020
mouse	O	2020
orthologue	O	2020
of	O	2020
human	O	2020
DMPK	O	2020
,	O	2020
produced	O	2020
mice	O	2020
with	O	2020
a	O	2020
mild	O	2020
myopathy	B-Disease	2020
and	O	2020
cardiac	B-Disease	2020
conduction	I-Disease	2020
abnormalities	I-Disease	2020
,	O	2020
but	O	2020
without	O	2020
other	O	2020
features	O	2020
of	O	2020
myotonic	B-Disease	2020
dystrophy	I-Disease	2020
,	O	2020
such	O	2020
as	O	2020
myotonia	B-Disease	2020
and	O	2020
cataracts	B-Disease	2020
.	O	2020

To	O	2022
determine	O	2022
whether	O	2022
SIX5	B-Disease	2022
deficiency	I-Disease	2022
contributes	O	2022
to	O	2022
the	O	2022
myotonic	B-Disease	2022
dystrophy	I-Disease	2022
phenotype	O	2022
,	O	2022
we	O	2022
disrupted	O	2022
mouse	O	2022
Six5	O	2022
by	O	2022
replacing	O	2022
the	O	2022
first	O	2022
exon	O	2022
with	O	2022
a	O	2022
beta	O	2022
-	O	2022
galactosidase	O	2022
reporter	O	2022
.	O	2022

Homozygous	O	2024
mutant	O	2024
mice	O	2024
had	O	2024
no	O	2024
apparent	O	2024
abnormalities	B-Disease	2024
of	I-Disease	2024
skeletal	I-Disease	2024
muscle	I-Disease	2024
function	I-Disease	2024
,	O	2024
but	O	2024
developed	O	2024
lenticular	B-Disease	2024
opacities	I-Disease	2024
at	O	2024
a	O	2024
higher	O	2024
rate	O	2024
than	O	2024
controls	O	2024
.	O	2024

Our	O	2025
results	O	2025
suggest	O	2025
that	O	2025
SIX5	B-Disease	2025
deficiency	I-Disease	2025
contributes	O	2025
to	O	2025
the	O	2025
cataract	B-Disease	2025
phenotype	O	2025
in	O	2025
myotonic	B-Disease	2025
dystrophy	I-Disease	2025
,	O	2025
and	O	2025
that	O	2025
myotonic	B-Disease	2025
dystrophy	I-Disease	2025
represents	O	2025
a	O	2025
multigenic	B-Disease	2025
disorder	I-Disease	2025
.	O	2025

Heterozygous	O	2027
loss	O	2027
of	O	2027
Six5	O	2027
in	O	2027
mice	O	2027
is	O	2027
sufficient	O	2027
to	O	2027
cause	O	2027
ocular	O	2027
cataracts	B-Disease	2027
.	O	2027

Myotonic	B-Disease	2028
dystrophy	I-Disease	2028
(	O	2028
DM	B-Disease	2028
)	O	2028
is	O	2028
an	O	2028
autosomal	B-Disease	2028
dominant	I-Disease	2028
disorder	I-Disease	2028
characterized	O	2028
by	O	2028
skeletal	O	2028
muscle	B-Disease	2028
wasting	I-Disease	2028
,	O	2028
myotonia	B-Disease	2028
,	O	2028
cardiac	B-Disease	2028
arrhythmia	I-Disease	2028
,	O	2028
hyperinsulinaemia	B-Disease	2028
,	O	2028
mental	B-Disease	2028
retardation	I-Disease	2028
and	O	2028
ocular	O	2028
cataracts	B-Disease	2028
.	O	2028

The	O	2029
genetic	B-Disease	2029
defect	I-Disease	2029
in	O	2029
DM	B-Disease	2029
is	O	2029
a	O	2029
CTG	O	2029
repeat	O	2029
expansion	O	2029
located	O	2029
in	O	2029
the	O	2029
3	O	2029
untranslated	O	2029
region	O	2029
of	O	2029
DMPK	O	2029
and	O	2029
5	O	2029
of	O	2029
a	O	2029
homeodomain	O	2029
-	O	2029
encoding	O	2029
gene	O	2029
,	O	2029
SIX5	O	2029
(	O	2029
formerly	O	2029
DMAHP	O	2029
;	O	2029
refs	O	2029
2	O	2029
-	O	2029
5	O	2029
)	O	2029
.	O	2029

There	O	2030
are	O	2030
three	O	2030
mechanisms	O	2030
by	O	2030
which	O	2030
CTG	O	2030
expansion	O	2030
can	O	2030
result	O	2030
in	O	2030
DM	B-Disease	2030
.	O	2030

Previous	O	2034
studies	O	2034
have	O	2034
demonstrated	O	2034
that	O	2034
a	O	2034
dose	O	2034
-	O	2034
dependent	O	2034
loss	O	2034
of	O	2034
Dm15	O	2034
(	O	2034
the	O	2034
mouse	O	2034
DMPK	O	2034
homologue	O	2034
)	O	2034
in	O	2034
mice	O	2034
produces	O	2034
a	O	2034
partial	O	2034
DM	B-Disease	2034
phenotype	O	2034
characterized	O	2034
by	O	2034
decreased	O	2034
development	O	2034
of	O	2034
skeletal	O	2034
muscle	O	2034
force	O	2034
and	O	2034
cardiac	B-Disease	2034
conduction	I-Disease	2034
disorders	I-Disease	2034
.	O	2034

To	O	2035
test	O	2035
the	O	2035
role	O	2035
of	O	2035
Six5	O	2035
loss	O	2035
in	O	2035
DM	B-Disease	2035
,	O	2035
we	O	2035
have	O	2035
analysed	O	2035
a	O	2035
strain	O	2035
of	O	2035
mice	O	2035
in	O	2035
which	O	2035
Six5	O	2035
was	O	2035
deleted	O	2035
.	O	2035

Our	O	2036
results	O	2036
demonstrate	O	2036
that	O	2036
the	O	2036
rate	O	2036
and	O	2036
severity	O	2036
of	O	2036
cataract	B-Disease	2036
formation	O	2036
is	O	2036
inversely	O	2036
related	O	2036
to	O	2036
Six5	O	2036
dosage	O	2036
and	O	2036
is	O	2036
temporally	O	2036
progressive	O	2036
.	O	2036

Thus	O	2038
,	O	2038
altered	O	2038
ion	O	2038
homeostasis	O	2038
within	O	2038
the	O	2038
lens	O	2038
may	O	2038
contribute	O	2038
to	O	2038
cataract	B-Disease	2038
formation	O	2038
.	O	2038

As	O	2039
ocular	O	2039
cataracts	B-Disease	2039
are	O	2039
a	O	2039
characteristic	O	2039
feature	O	2039
of	O	2039
DM	B-Disease	2039
,	O	2039
these	O	2039
results	O	2039
demonstrate	O	2039
that	O	2039
decreased	O	2039
SIX5	O	2039
transcription	O	2039
is	O	2039
important	O	2039
in	O	2039
the	O	2039
aetiology	O	2039
of	O	2039
DM	B-Disease	2039
.	O	2039

Our	O	2040
data	O	2040
support	O	2040
the	O	2040
hypothesis	O	2040
that	O	2040
DM	B-Disease	2040
is	O	2040
a	O	2040
contiguous	O	2040
gene	O	2040
syndrome	O	2040
associated	O	2040
with	O	2040
the	O	2040
partial	O	2040
loss	O	2040
of	O	2040
both	O	2040
DMPK	O	2040
and	O	2040
SIX5	O	2040
.	O	2040

Mutations	O	2043
in	O	2043
the	O	2043
gene	O	2043
ATM	O	2043
are	O	2043
responsible	O	2043
for	O	2043
the	O	2043
genetic	B-Disease	2043
disorder	I-Disease	2043
ataxia	B-Disease	2043
-	I-Disease	2043
telangiectasia	I-Disease	2043
(	O	2043
A	B-Disease	2043
-	I-Disease	2043
T	I-Disease	2043
)	O	2043
,	O	2043
which	O	2043
is	O	2043
characterized	O	2043
by	O	2043
cerebellar	B-Disease	2043
dysfunction	I-Disease	2043
,	O	2043
radiosensitivity	O	2043
,	O	2043
chromosomal	O	2043
instability	O	2043
and	O	2043
cancer	B-Disease	2043
predisposition	O	2043
.	O	2043

Both	O	2044
the	O	2044
A	B-Disease	2044
-	I-Disease	2044
T	I-Disease	2044
phenotype	O	2044
and	O	2044
the	O	2044
similarity	O	2044
of	O	2044
the	O	2044
ATM	O	2044
protein	O	2044
to	O	2044
other	O	2044
DNA	O	2044
-	O	2044
damage	O	2044
sensors	O	2044
suggests	O	2044
a	O	2044
role	O	2044
for	O	2044
ATM	O	2044
in	O	2044
biochemical	O	2044
pathways	O	2044
involved	O	2044
in	O	2044
the	O	2044
recognition	O	2044
,	O	2044
signalling	O	2044
and	O	2044
repair	O	2044
of	O	2044
DNA	O	2044
double	O	2044
-	O	2044
strand	O	2044
breaks	O	2044
(	O	2044
DSBs	O	2044
)	O	2044
.	O	2044

There	O	2045
are	O	2045
strong	O	2045
parallels	O	2045
between	O	2045
the	O	2045
pattern	O	2045
of	O	2045
radiosensitivity	O	2045
,	O	2045
chromosomal	O	2045
instability	O	2045
and	O	2045
cancer	B-Disease	2045
predisposition	O	2045
in	O	2045
A	B-Disease	2045
-	I-Disease	2045
T	I-Disease	2045
patients	O	2045
and	O	2045
that	O	2045
in	O	2045
patients	O	2045
with	O	2045
Nijmegen	B-Disease	2045
breakage	I-Disease	2045
syndrome	I-Disease	2045
(	O	2045
NBS	B-Disease	2045
)	O	2045
.	O	2045

The	O	2046
protein	O	2046
defective	O	2046
in	O	2046
NBS	B-Disease	2046
,	O	2046
nibrin	O	2046
(	O	2046
encoded	O	2046
by	O	2046
NBS1	O	2046
)	O	2046
,	O	2046
forms	O	2046
a	O	2046
complex	O	2046
with	O	2046
MRE11	O	2046
and	O	2046
RAD50	O	2046
(	O	2046
refs	O	2046
1	O	2046
,	O	2046
2	O	2046
)	O	2046
.	O	2046

The	O	2048
overlap	O	2048
between	O	2048
clinical	O	2048
and	O	2048
cellular	O	2048
phenotypes	O	2048
in	O	2048
A	B-Disease	2048
-	I-Disease	2048
T	I-Disease	2048
and	O	2048
NBS	B-Disease	2048
suggests	O	2048
that	O	2048
ATM	O	2048
and	O	2048
nibrin	O	2048
may	O	2048
function	O	2048
in	O	2048
the	O	2048
same	O	2048
biochemical	O	2048
pathway	O	2048
.	O	2048

This	O	2050
response	O	2050
is	O	2050
abrogated	O	2050
in	O	2050
A	B-Disease	2050
-	I-Disease	2050
T	I-Disease	2050
cells	O	2050
that	O	2050
either	O	2050
do	O	2050
not	O	2050
express	O	2050
ATM	O	2050
protein	O	2050
or	O	2050
express	O	2050
near	O	2050
full	O	2050
-	O	2050
length	O	2050
mutant	O	2050
protein	O	2050
.	O	2050

Phosphorylation	O	2052
of	O	2052
this	O	2052
site	O	2052
appears	O	2052
to	O	2052
be	O	2052
functionally	O	2052
important	O	2052
because	O	2052
mutated	O	2052
nibrin	O	2052
(	O	2052
S343A	O	2052
)	O	2052
does	O	2052
not	O	2052
completely	O	2052
complement	O	2052
radiosensitivity	O	2052
in	O	2052
NBS	B-Disease	2052
cells	O	2052
.	O	2052

Our	O	2054
data	O	2054
provide	O	2054
a	O	2054
biochemical	O	2054
explanation	O	2054
for	O	2054
the	O	2054
similarity	O	2054
in	O	2054
phenotype	O	2054
between	O	2054
A	B-Disease	2054
-	I-Disease	2054
T	I-Disease	2054
and	O	2054
NBS	B-Disease	2054
.	O	2054

Clinicopathologic	O	2056
features	O	2056
of	O	2056
BRCA	B-Disease	2056
-	I-Disease	2056
linked	I-Disease	2056
and	I-Disease	2056
sporadic	I-Disease	2056
ovarian	I-Disease	2056
cancer	I-Disease	2056
.	O	2056

CONTEXT	O	2057
Most	O	2057
hereditary	B-Disease	2057
ovarian	I-Disease	2057
cancers	I-Disease	2057
are	O	2057
associated	O	2057
with	O	2057
germline	O	2057
mutations	O	2057
in	O	2057
BRCA1	O	2057
or	O	2057
BRCA2	O	2057
.	O	2057

Attempts	O	2058
to	O	2058
define	O	2058
the	O	2058
clinical	O	2058
significance	O	2058
of	O	2058
BRCA	O	2058
mutation	O	2058
status	O	2058
in	O	2058
ovarian	B-Disease	2058
cancer	I-Disease	2058
have	O	2058
produced	O	2058
conflicting	O	2058
results	O	2058
,	O	2058
especially	O	2058
regarding	O	2058
survival	O	2058
.	O	2058

OBJECTIVE	O	2059
To	O	2059
determine	O	2059
whether	O	2059
hereditary	B-Disease	2059
ovarian	I-Disease	2059
cancers	I-Disease	2059
have	O	2059
distinct	O	2059
clinical	O	2059
and	O	2059
pathological	O	2059
features	O	2059
compared	O	2059
with	O	2059
sporadic	B-Disease	2059
(	I-Disease	2059
nonhereditary	I-Disease	2059
)	I-Disease	2059
ovarian	I-Disease	2059
cancers	I-Disease	2059
.	O	2059

DESIGN	O	2060
AND	O	2060
SETTING	O	2060
Retrospective	O	2060
cohort	O	2060
study	O	2060
of	O	2060
a	O	2060
consecutive	O	2060
series	O	2060
of	O	2060
933	O	2060
ovarian	B-Disease	2060
cancers	I-Disease	2060
diagnosed	O	2060
and	O	2060
treated	O	2060
at	O	2060
our	O	2060
institution	O	2060
,	O	2060
which	O	2060
is	O	2060
a	O	2060
comprehensive	O	2060
cancer	B-Disease	2060
center	O	2060
as	O	2060
designated	O	2060
by	O	2060
the	O	2060
National	O	2060
Cancer	B-Disease	2060
Institute	O	2060
,	O	2060
over	O	2060
a	O	2060
12	O	2060
-	O	2060
year	O	2060
period	O	2060
(	O	2060
December	O	2060
1986	O	2060
to	O	2060
August	O	2060
1998	O	2060
)	O	2060
.	O	2060

The	O	2063
remaining	O	2063
101	O	2063
cases	O	2063
from	O	2063
the	O	2063
same	O	2063
series	O	2063
not	O	2063
associated	O	2063
with	O	2063
a	O	2063
BRCA	O	2063
mutation	O	2063
and	O	2063
2	O	2063
additional	O	2063
groups	O	2063
(	O	2063
Gynecologic	O	2063
Oncology	O	2063
Group	O	2063
protocols	O	2063
52	O	2063
and	O	2063
111	O	2063
)	O	2063
with	O	2063
ovarian	B-Disease	2063
cancer	I-Disease	2063
from	O	2063
clinical	O	2063
trials	O	2063
(	O	2063
for	O	2063
the	O	2063
survival	O	2063
analysis	O	2063
)	O	2063
were	O	2063
included	O	2063
for	O	2063
comparison	O	2063
.	O	2063

RESULTS	O	2065
Hereditary	B-Disease	2065
cancers	I-Disease	2065
were	O	2065
rarely	O	2065
diagnosed	O	2065
before	O	2065
age	O	2065
40	O	2065
years	O	2065
and	O	2065
were	O	2065
common	O	2065
after	O	2065
age	O	2065
60	O	2065
years	O	2065
,	O	2065
with	O	2065
mean	O	2065
age	O	2065
at	O	2065
diagnosis	O	2065
being	O	2065
significantly	O	2065
younger	O	2065
for	O	2065
BRCA1	O	2065
-	O	2065
vs	O	2065
BRCA2	O	2065
-	O	2065
linked	O	2065
patients	O	2065
(	O	2065
54	O	2065
vs	O	2065
62	O	2065
years	O	2065
;	O	2065
P	O	2065
=	O	2065
.	O	2065

Those	O	2070
with	O	2070
hereditary	B-Disease	2070
cancers	I-Disease	2070
had	O	2070
improved	O	2070
survival	O	2070
compared	O	2070
with	O	2070
the	O	2070
nonhereditary	O	2070
group	O	2070
(	O	2070
P	O	2070
=	O	2070
.	O	2070

For	O	2072
stage	B-Disease	2072
III	I-Disease	2072
cancers	I-Disease	2072
,	O	2072
BRCA	O	2072
mutation	O	2072
status	O	2072
was	O	2072
an	O	2072
independent	O	2072
prognostic	O	2072
variable	O	2072
(	O	2072
P	O	2072
=	O	2072
.	O	2072

CONCLUSIONS	O	2074
Although	O	2074
BRCA	B-Disease	2074
-	I-Disease	2074
associated	I-Disease	2074
hereditary	I-Disease	2074
ovarian	I-Disease	2074
cancers	I-Disease	2074
in	O	2074
this	O	2074
population	O	2074
have	O	2074
surgical	O	2074
and	O	2074
pathological	O	2074
characteristics	O	2074
similar	O	2074
to	O	2074
those	O	2074
of	O	2074
sporadic	B-Disease	2074
cancers	I-Disease	2074
,	O	2074
advanced	B-Disease	2074
-	I-Disease	2074
stage	I-Disease	2074
hereditary	I-Disease	2074
cancer	I-Disease	2074
patients	O	2074
survive	O	2074
longer	O	2074
than	O	2074
nonhereditary	B-Disease	2074
cancer	I-Disease	2074
patients	O	2074
.	O	2074

Age	O	2075
penetrance	O	2075
is	O	2075
greater	O	2075
for	O	2075
BRCA1	B-Disease	2075
-	I-Disease	2075
linked	I-Disease	2075
than	I-Disease	2075
for	I-Disease	2075
BRCA2	I-Disease	2075
-	I-Disease	2075
linked	I-Disease	2075
cancers	I-Disease	2075
in	O	2075
this	O	2075
population	O	2075
.	O	2075

The	O	2076
gene	O	2076
for	O	2076
familial	B-Disease	2076
Mediterranean	I-Disease	2076
fever	I-Disease	2076
,	O	2076
MEFV	O	2076
,	O	2076
is	O	2076
expressed	O	2076
in	O	2076
early	O	2076
leukocyte	O	2076
development	O	2076
and	O	2076
is	O	2076
regulated	O	2076
in	O	2076
response	O	2076
to	O	2076
inflammatory	O	2076
mediators	O	2076
.	O	2076

Familial	B-Disease	2077
Mediterranean	I-Disease	2077
fever	I-Disease	2077
(	O	2077
FMF	B-Disease	2077
)	O	2077
is	O	2077
a	O	2077
recessive	B-Disease	2077
disorder	I-Disease	2077
characterized	O	2077
by	O	2077
episodes	O	2077
of	O	2077
fever	B-Disease	2077
and	O	2077
neutrophil	B-Disease	2077
-	I-Disease	2077
mediated	I-Disease	2077
serosal	I-Disease	2077
inflammation	I-Disease	2077
.	O	2077

We	O	2078
recently	O	2078
identified	O	2078
the	O	2078
gene	O	2078
causing	O	2078
FMF	B-Disease	2078
,	O	2078
designated	O	2078
MEFV	O	2078
,	O	2078
and	O	2078
found	O	2078
it	O	2078
to	O	2078
be	O	2078
expressed	O	2078
in	O	2078
mature	O	2078
neutrophils	O	2078
,	O	2078
suggesting	O	2078
that	O	2078
it	O	2078
functions	O	2078
as	O	2078
an	O	2078
inflammatory	O	2078
regulator	O	2078
.	O	2078

In	O	2086
vitro	O	2086
stimulation	O	2086
of	O	2086
monocytes	O	2086
with	O	2086
the	O	2086
proinflammatory	O	2086
agents	O	2086
interferon	O	2086
(	O	2086
IFN	O	2086
)	O	2086
gamma	O	2086
,	O	2086
tumor	B-Disease	2086
necrosis	O	2086
factor	O	2086
,	O	2086
and	O	2086
lipopolysaccharide	O	2086
induced	O	2086
MEFV	O	2086
expression	O	2086
,	O	2086
whereas	O	2086
the	O	2086
antiinflammatory	O	2086
cytokines	O	2086
interleukin	O	2086
(	O	2086
IL	O	2086
)	O	2086
4	O	2086
,	O	2086
IL	O	2086
-	O	2086
10	O	2086
,	O	2086
and	O	2086
transforming	O	2086
growth	O	2086
factor	O	2086
beta	O	2086
inhibited	O	2086
such	O	2086
expression	O	2086
.	O	2086

Biochemical	O	2092
and	O	2092
structural	O	2092
analysis	O	2092
of	O	2092
missense	O	2092
mutations	O	2092
in	O	2092
N	O	2092
-	O	2092
acetylgalactosamine	O	2092
-	O	2092
6	O	2092
-	O	2092
sulfate	O	2092
sulfatase	O	2092
causing	O	2092
mucopolysaccharidosis	B-Disease	2092
IVA	I-Disease	2092
phenotypes	O	2092
.	O	2092

Mucopolysaccharidosis	B-Disease	2093
IVA	I-Disease	2093
(	O	2093
MPS	B-Disease	2093
IVA	I-Disease	2093
;	O	2093
OMIM	O	2093
#	O	2093
253000	O	2093
)	O	2093
,	O	2093
a	O	2093
lysosomal	B-Disease	2093
storage	I-Disease	2093
disorder	I-Disease	2093
caused	O	2093
by	O	2093
a	O	2093
deficiency	B-Disease	2093
of	I-Disease	2093
N	I-Disease	2093
-	I-Disease	2093
acetylgalactosamine	I-Disease	2093
-	I-Disease	2093
6	I-Disease	2093
-	I-Disease	2093
sulfate	I-Disease	2093
sulfatase	I-Disease	2093
(	O	2093
GALNS	O	2093
)	O	2093
,	O	2093
has	O	2093
variable	O	2093
clinical	O	2093
phenotypes	O	2093
.	O	2093

To	O	2094
date	O	2094
we	O	2094
have	O	2094
identified	O	2094
65	O	2094
missense	O	2094
mutations	O	2094
in	O	2094
the	O	2094
GALNS	O	2094
gene	O	2094
from	O	2094
MPS	B-Disease	2094
IVA	I-Disease	2094
patients	O	2094
,	O	2094
but	O	2094
the	O	2094
correlation	O	2094
between	O	2094
genotype	O	2094
and	O	2094
phenotype	O	2094
has	O	2094
remained	O	2094
unclear	O	2094
.	O	2094

These	O	2106
studies	O	2106
shed	O	2106
further	O	2106
light	O	2106
on	O	2106
the	O	2106
genotype	O	2106
-	O	2106
phenotype	O	2106
correlation	O	2106
of	O	2106
MPS	B-Disease	2106
IVA	I-Disease	2106
and	O	2106
structure	O	2106
-	O	2106
function	O	2106
relationship	O	2106
in	O	2106
the	O	2106
sulfatase	O	2106
family	O	2106
.	O	2106

Mutations	O	2107
at	O	2107
the	O	2107
ataxia	B-Disease	2107
-	I-Disease	2107
telangiectasia	I-Disease	2107
locus	O	2107
and	O	2107
clinical	O	2107
phenotypes	O	2107
of	O	2107
A	B-Disease	2107
-	I-Disease	2107
T	I-Disease	2107
patients	O	2107
.	O	2107

Mutations	O	2108
at	O	2108
the	O	2108
ataxia	B-Disease	2108
-	I-Disease	2108
telangiectasia	I-Disease	2108
(	O	2108
A	B-Disease	2108
-	I-Disease	2108
T	I-Disease	2108
)	O	2108
locus	O	2108
on	O	2108
chromosome	O	2108
band	O	2108
11q22	O	2108
cause	O	2108
a	O	2108
distinctive	O	2108
autosomal	B-Disease	2108
recessive	I-Disease	2108
syndrome	I-Disease	2108
in	O	2108
homozygotes	O	2108
and	O	2108
predispose	O	2108
heterozygotes	O	2108
to	O	2108
cancer	B-Disease	2108
,	O	2108
ischemic	B-Disease	2108
heart	I-Disease	2108
disease	I-Disease	2108
,	O	2108
and	O	2108
early	O	2108
mortality	O	2108
.	O	2108

PCR	O	2109
amplification	O	2109
from	O	2109
genomic	O	2109
DNA	O	2109
and	O	2109
automated	O	2109
sequencing	O	2109
of	O	2109
the	O	2109
entire	O	2109
coding	O	2109
region	O	2109
(	O	2109
66	O	2109
exons	O	2109
)	O	2109
and	O	2109
splice	O	2109
junctions	O	2109
detected	O	2109
77	O	2109
mutations	O	2109
(	O	2109
85	O	2109
%	O	2109
)	O	2109
in	O	2109
90	O	2109
A	B-Disease	2109
-	I-Disease	2109
T	I-Disease	2109
chromosomes	O	2109
.	O	2109

Heteroduplex	O	2110
analysis	O	2110
detected	O	2110
another	O	2110
42	O	2110
mutations	O	2110
at	O	2110
the	O	2110
A	B-Disease	2110
-	I-Disease	2110
T	I-Disease	2110
locus	O	2110
.	O	2110

Most	O	2112
(	O	2112
58	O	2112
/	O	2112
71	O	2112
,	O	2112
82	O	2112
%	O	2112
)	O	2112
mutations	O	2112
were	O	2112
frameshift	O	2112
and	O	2112
nonsense	O	2112
mutations	O	2112
that	O	2112
are	O	2112
predicted	O	2112
to	O	2112
cause	O	2112
truncation	O	2112
of	O	2112
the	O	2112
A	B-Disease	2112
-	I-Disease	2112
T	I-Disease	2112
protein	O	2112
;	O	2112
the	O	2112
less	O	2112
common	O	2112
mutation	O	2112
types	O	2112
were	O	2112
missense	O	2112
(	O	2112
9	O	2112
/	O	2112
71	O	2112
,	O	2112
13	O	2112
%	O	2112
)	O	2112
,	O	2112
splicing	O	2112
(	O	2112
3	O	2112
/	O	2112
71	O	2112
,	O	2112
4	O	2112
%	O	2112
)	O	2112
and	O	2112
one	O	2112
in	O	2112
-	O	2112
frame	O	2112
deletion	O	2112
,	O	2112
2546	O	2112
3	O	2112
(	O	2112
1	O	2112
/	O	2112
71	O	2112
,	O	2112
1	O	2112
%	O	2112
)	O	2112
.	O	2112

The	O	2113
mean	O	2113
survival	O	2113
and	O	2113
height	O	2113
distribution	O	2113
of	O	2113
134	O	2113
A	B-Disease	2113
-	I-Disease	2113
T	I-Disease	2113
patients	O	2113
correlated	O	2113
significantly	O	2113
with	O	2113
the	O	2113
specific	O	2113
mutations	O	2113
present	O	2113
in	O	2113
the	O	2113
patients	O	2113
.	O	2113

Alterations	O	2115
of	O	2115
the	O	2115
length	O	2115
or	O	2115
amino	O	2115
acid	O	2115
composition	O	2115
of	O	2115
the	O	2115
A	B-Disease	2115
-	I-Disease	2115
T	I-Disease	2115
gene	O	2115
product	O	2115
affect	O	2115
the	O	2115
A	B-Disease	2115
-	I-Disease	2115
T	I-Disease	2115
clinical	O	2115
phenotype	O	2115
in	O	2115
different	O	2115
ways	O	2115
.	O	2115

Mutation	O	2116
analysis	O	2116
at	O	2116
the	O	2116
A	B-Disease	2116
-	I-Disease	2116
T	I-Disease	2116
locus	O	2116
may	O	2116
help	O	2116
estimate	O	2116
the	O	2116
prognosis	O	2116
of	O	2116
A	B-Disease	2116
-	I-Disease	2116
T	I-Disease	2116
patients	O	2116
.	O	2116

Isolation	O	2118
,	O	2118
genomic	O	2118
organization	O	2118
,	O	2118
and	O	2118
expression	O	2118
analysis	O	2118
of	O	2118
the	O	2118
mouse	O	2118
and	O	2118
rat	O	2118
homologs	O	2118
of	O	2118
MEFV	O	2118
,	O	2118
the	O	2118
gene	O	2118
for	O	2118
familial	B-Disease	2118
mediterranean	I-Disease	2118
fever	I-Disease	2118
.	O	2118

Familial	B-Disease	2119
Mediterranean	I-Disease	2119
fever	I-Disease	2119
(	O	2119
FMF	B-Disease	2119
)	O	2119
is	O	2119
a	O	2119
recessive	B-Disease	2119
disorder	I-Disease	2119
characterized	O	2119
by	O	2119
episodes	O	2119
of	O	2119
fever	B-Disease	2119
with	O	2119
serositis	B-Disease	2119
or	O	2119
synovitis	B-Disease	2119
.	O	2119

Recently	O	2120
the	O	2120
FMF	B-Disease	2120
gene	O	2120
(	O	2120
MEFV	O	2120
)	O	2120
was	O	2120
cloned	O	2120
;	O	2120
the	O	2120
protein	O	2120
product	O	2120
,	O	2120
pyrin	O	2120
/	O	2120
marenostrin	O	2120
,	O	2120
is	O	2120
thought	O	2120
to	O	2120
regulate	O	2120
inflammation	O	2120
in	O	2120
myeloid	O	2120
cells	O	2120
.	O	2120

2	O	2130
domain	O	2130
,	O	2130
in	O	2130
which	O	2130
most	O	2130
FMF	B-Disease	2130
-	O	2130
associated	O	2130
mutations	O	2130
have	O	2130
been	O	2130
found	O	2130
in	O	2130
human	O	2130
MEFV	O	2130
.	O	2130

Additional	O	2136
copies	O	2136
of	O	2136
the	O	2136
proteolipid	O	2136
protein	O	2136
gene	O	2136
causing	O	2136
Pelizaeus	B-Disease	2136
-	I-Disease	2136
Merzbacher	I-Disease	2136
disease	I-Disease	2136
arise	O	2136
by	O	2136
separate	O	2136
integration	O	2136
into	O	2136
the	O	2136
X	O	2136
chromosome	O	2136
.	O	2136

Mutations	O	2138
and	O	2138
duplications	O	2138
of	O	2138
this	O	2138
gene	O	2138
are	O	2138
associated	O	2138
with	O	2138
Pelizaeus	B-Disease	2138
-	I-Disease	2138
Merzbacher	I-Disease	2138
disease	I-Disease	2138
(	O	2138
PMD	B-Disease	2138
)	O	2138
.	O	2138

Here	O	2139
we	O	2139
describe	O	2139
two	O	2139
new	O	2139
families	O	2139
in	O	2139
which	O	2139
males	O	2139
affected	O	2139
with	O	2139
PMD	B-Disease	2139
were	O	2139
found	O	2139
to	O	2139
have	O	2139
a	O	2139
copy	O	2139
of	O	2139
PLP	O	2139
on	O	2139
the	O	2139
short	O	2139
arm	O	2139
of	O	2139
the	O	2139
X	O	2139
chromosome	O	2139
,	O	2139
in	O	2139
addition	O	2139
to	O	2139
a	O	2139
normal	O	2139
copy	O	2139
on	O	2139
Xq22	O	2139
.	O	2139

In	O	2144
a	O	2144
second	O	2144
unrelated	O	2144
family	O	2144
with	O	2144
signs	O	2144
of	O	2144
PMD	B-Disease	2144
,	O	2144
cytogenetic	O	2144
analysis	O	2144
showed	O	2144
a	O	2144
pericentric	O	2144
inversion	O	2144
of	O	2144
the	O	2144
X	O	2144
chromosome	O	2144
.	O	2144

The	O	2148
identification	O	2148
of	O	2148
three	O	2148
separate	O	2148
families	O	2148
in	O	2148
which	O	2148
PLP	O	2148
is	O	2148
duplicated	O	2148
at	O	2148
a	O	2148
noncontiguous	O	2148
site	O	2148
suggests	O	2148
that	O	2148
such	O	2148
duplications	O	2148
could	O	2148
be	O	2148
a	O	2148
relatively	O	2148
common	O	2148
but	O	2148
previously	O	2148
undetected	O	2148
cause	O	2148
of	O	2148
genetic	B-Disease	2148
disorders	I-Disease	2148
.	O	2148

To	O	2155
do	O	2155
this	O	2155
,	O	2155
a	O	2155
collaborative	O	2155
screening	O	2155
study	O	2155
was	O	2155
set	O	2155
up	O	2155
that	O	2155
involved	O	2155
39	O	2155
institutions	O	2155
from	O	2155
19	O	2155
countries	O	2155
and	O	2155
included	O	2155
3	O	2155
,	O	2155
580	O	2155
unrelated	O	2155
individuals	O	2155
with	O	2155
a	O	2155
family	O	2155
history	O	2155
of	O	2155
the	O	2155
disease	O	2155
and	O	2155
934	O	2155
early	O	2155
-	O	2155
onset	O	2155
breast	B-Disease	2155
and	I-Disease	2155
/	I-Disease	2155
or	I-Disease	2155
ovarian	I-Disease	2155
cancer	I-Disease	2155
cases	O	2155
.	O	2155

Genotype	O	2159
-	O	2159
phenotype	O	2159
correlations	O	2159
in	O	2159
families	O	2159
with	O	2159
deletions	O	2159
in	O	2159
the	O	2159
von	B-Disease	2159
Hippel	I-Disease	2159
-	I-Disease	2159
Lindau	I-Disease	2159
(	O	2159
VHL	B-Disease	2159
)	O	2159
gene	O	2159
.	O	2159

Von	B-Disease	2160
Hippel	I-Disease	2160
-	I-Disease	2160
Lindau	I-Disease	2160
(	I-Disease	2160
VHL	I-Disease	2160
)	I-Disease	2160
disease	I-Disease	2160
is	O	2160
a	O	2160
hereditary	B-Disease	2160
tumor	I-Disease	2160
syndrome	I-Disease	2160
characterized	O	2160
by	O	2160
predisposition	O	2160
for	O	2160
bilateral	B-Disease	2160
and	I-Disease	2160
multi	I-Disease	2160
-	I-Disease	2160
centric	I-Disease	2160
hemangioblastoma	I-Disease	2160
in	O	2160
the	O	2160
retina	O	2160
and	O	2160
central	O	2160
nervous	O	2160
system	O	2160
,	O	2160
pheochromocytoma	B-Disease	2160
,	O	2160
renal	B-Disease	2160
cell	I-Disease	2160
carcinoma	I-Disease	2160
,	O	2160
and	O	2160
cysts	B-Disease	2160
in	I-Disease	2160
the	I-Disease	2160
kidney	I-Disease	2160
,	I-Disease	2160
pancreas	I-Disease	2160
,	I-Disease	2160
and	I-Disease	2160
epididymis	I-Disease	2160
.	O	2160

We	O	2161
describe	O	2161
five	O	2161
families	O	2161
for	O	2161
which	O	2161
direct	O	2161
sequencing	O	2161
of	O	2161
the	O	2161
coding	O	2161
region	O	2161
of	O	2161
the	O	2161
VHL	B-Disease	2161
gene	O	2161
had	O	2161
failed	O	2161
to	O	2161
identify	O	2161
the	O	2161
family	O	2161
-	O	2161
specific	O	2161
mutation	O	2161
.	O	2161

Further	O	2162
molecular	O	2162
analysis	O	2162
revealed	O	2162
deletions	O	2162
involving	O	2162
the	O	2162
VHL	B-Disease	2162
gene	O	2162
in	O	2162
each	O	2162
of	O	2162
these	O	2162
families	O	2162
.	O	2162

In	O	2164
the	O	2164
fifth	O	2164
family	O	2164
,	O	2164
FISH	O	2164
analysis	O	2164
demonstrated	O	2164
the	O	2164
deletion	O	2164
of	O	2164
the	O	2164
entire	O	2164
VHL	B-Disease	2164
gene	O	2164
.	O	2164

Our	O	2165
results	O	2165
show	O	2165
that	O	2165
(	O	2165
quantitative	O	2165
)	O	2165
Southern	O	2165
blot	O	2165
analysis	O	2165
is	O	2165
a	O	2165
sensitive	O	2165
method	O	2165
for	O	2165
detecting	O	2165
germline	O	2165
deletions	O	2165
of	O	2165
the	O	2165
VHL	B-Disease	2165
gene	O	2165
and	O	2165
should	O	2165
be	O	2165
implemented	O	2165
in	O	2165
routine	O	2165
DNA	O	2165
diagnosis	O	2165
for	O	2165
VHL	B-Disease	2165
disease	I-Disease	2165
.	O	2165

Our	O	2166
data	O	2166
support	O	2166
the	O	2166
previously	O	2166
established	O	2166
observation	O	2166
that	O	2166
families	O	2166
with	O	2166
a	O	2166
germline	O	2166
deletion	O	2166
have	O	2166
a	O	2166
low	O	2166
risk	O	2166
for	O	2166
pheochromocytoma	B-Disease	2166
.	O	2166

Further	O	2167
unraveling	O	2167
of	O	2167
genotype	O	2167
-	O	2167
phenotype	O	2167
correlations	O	2167
in	O	2167
VHL	B-Disease	2167
disease	I-Disease	2167
has	O	2167
revealed	O	2167
that	O	2167
families	O	2167
with	O	2167
a	O	2167
full	O	2167
or	O	2167
partial	O	2167
deletion	O	2167
of	O	2167
the	O	2167
VHL	B-Disease	2167
gene	O	2167
exhibit	O	2167
a	O	2167
phenotype	O	2167
with	O	2167
a	O	2167
preponderance	O	2167
of	O	2167
central	B-Disease	2167
nervous	I-Disease	2167
system	I-Disease	2167
hemangioblastoma	I-Disease	2167
.	O	2167

Age	O	2169
of	O	2169
the	O	2169
intronic	O	2169
GAA	O	2169
triplet	O	2169
repeat	O	2169
expansion	O	2169
mutation	O	2169
in	O	2169
Friedreich	B-Disease	2169
ataxia	I-Disease	2169
.	O	2169

Friedreich	B-Disease	2170
ataxia	I-Disease	2170
(	O	2170
FRDA	B-Disease	2170
)	O	2170
,	O	2170
the	O	2170
most	O	2170
frequently	O	2170
inherited	B-Disease	2170
ataxia	I-Disease	2170
,	O	2170
is	O	2170
due	O	2170
in	O	2170
the	O	2170
vast	O	2170
majority	O	2170
of	O	2170
cases	O	2170
to	O	2170
a	O	2170
large	O	2170
expansion	O	2170
of	O	2170
an	O	2170
intronic	O	2170
GAA	O	2170
repeat	O	2170
.	O	2170

Using	O	2171
linkage	O	2171
disequilibrium	O	2171
analysis	O	2171
based	O	2171
on	O	2171
haplotype	O	2171
data	O	2171
of	O	2171
seven	O	2171
polymorphic	O	2171
markers	O	2171
close	O	2171
to	O	2171
the	O	2171
frataxin	O	2171
gene	O	2171
,	O	2171
the	O	2171
age	O	2171
of	O	2171
FRDA	B-Disease	2171
founding	O	2171
mutational	O	2171
event	O	2171
(	O	2171
s	O	2171
)	O	2171
is	O	2171
estimated	O	2171
to	O	2171
be	O	2171
at	O	2171
least	O	2171
682	O	2171
+	O	2171
/	O	2171
-	O	2171
203	O	2171
generations	O	2171
(	O	2171
95	O	2171
%	O	2171
confidence	O	2171
interval	O	2171
564	O	2171
-	O	2171
801	O	2171
g	O	2171
)	O	2171
,	O	2171
a	O	2171
dating	O	2171
which	O	2171
is	O	2171
consistent	O	2171
with	O	2171
little	O	2171
or	O	2171
no	O	2171
negative	O	2171
selection	O	2171
and	O	2171
provides	O	2171
further	O	2171
evidence	O	2171
for	O	2171
an	O	2171
ancient	O	2171
spread	O	2171
of	O	2171
a	O	2171
pre	O	2171
-	O	2171
mutation	O	2171
(	O	2171
at	O	2171
-	O	2171
risk	O	2171
alleles	O	2171
)	O	2171
in	O	2171
western	O	2171
Europe	O	2171
.	O	2171

Functional	O	2173
link	O	2173
between	O	2173
ataxia	B-Disease	2173
-	I-Disease	2173
telangiectasia	I-Disease	2173
and	O	2173
Nijmegen	B-Disease	2173
breakage	I-Disease	2173
syndrome	I-Disease	2173
gene	O	2173
products	O	2173
.	O	2173

Ataxia	B-Disease	2174
-	I-Disease	2174
telangiectasia	I-Disease	2174
(	O	2174
A	B-Disease	2174
-	I-Disease	2174
T	I-Disease	2174
)	O	2174
and	O	2174
Nijmegen	B-Disease	2174
breakage	I-Disease	2174
syndrome	I-Disease	2174
(	O	2174
NBS	B-Disease	2174
)	O	2174
are	O	2174
recessive	B-Disease	2174
genetic	I-Disease	2174
disorders	I-Disease	2174
with	O	2174
susceptibility	O	2174
to	O	2174
cancer	B-Disease	2174
and	O	2174
similar	O	2174
cellular	O	2174
phenotypes	O	2174
.	O	2174

The	O	2175
protein	O	2175
product	O	2175
of	O	2175
the	O	2175
gene	O	2175
responsible	O	2175
for	O	2175
A	B-Disease	2175
-	I-Disease	2175
T	I-Disease	2175
,	O	2175
designated	O	2175
ATM	O	2175
,	O	2175
is	O	2175
a	O	2175
member	O	2175
of	O	2175
a	O	2175
family	O	2175
of	O	2175
kinases	O	2175
characterized	O	2175
by	O	2175
a	O	2175
carboxy	O	2175
-	O	2175
terminal	O	2175
phosphatidylinositol	O	2175
3	O	2175
-	O	2175
kinase	O	2175
-	O	2175
like	O	2175
domain	O	2175
.	O	2175

The	O	2176
NBS1	O	2176
protein	O	2176
is	O	2176
specifically	O	2176
mutated	O	2176
in	O	2176
patients	O	2176
with	O	2176
Nijmegen	B-Disease	2176
breakage	I-Disease	2176
syndrome	I-Disease	2176
and	O	2176
forms	O	2176
a	O	2176
complex	O	2176
with	O	2176
the	O	2176
DNA	O	2176
repair	O	2176
proteins	O	2176
Rad50	O	2176
and	O	2176
Mrel1	O	2176
.	O	2176

This	O	2180
response	O	2180
includes	O	2180
S	O	2180
-	O	2180
phase	O	2180
checkpoint	O	2180
activation	O	2180
,	O	2180
formation	O	2180
of	O	2180
the	O	2180
NBS1	O	2180
/	O	2180
Mrel1	O	2180
/	O	2180
Rad50	O	2180
nuclear	O	2180
foci	O	2180
and	O	2180
rescue	O	2180
of	O	2180
hypersensitivity	B-Disease	2180
to	I-Disease	2180
ionizing	I-Disease	2180
radiation	I-Disease	2180
.	O	2180

Together	O	2181
,	O	2181
these	O	2181
results	O	2181
demonstrate	O	2181
a	O	2181
biochemical	O	2181
link	O	2181
between	O	2181
cell	O	2181
-	O	2181
cycle	O	2181
checkpoints	O	2181
activated	O	2181
by	O	2181
DNA	O	2181
damage	O	2181
and	O	2181
DNA	O	2181
repair	O	2181
in	O	2181
two	O	2181
genetic	B-Disease	2181
diseases	I-Disease	2181
with	O	2181
overlapping	O	2181
phenotypes	O	2181
.	O	2181

Homozygosity	O	2183
mapping	O	2183
in	O	2183
a	O	2183
family	O	2183
with	O	2183
microcephaly	B-Disease	2183
,	O	2183
mental	B-Disease	2183
retardation	I-Disease	2183
,	O	2183
and	O	2183
short	B-Disease	2183
stature	I-Disease	2183
to	O	2183
a	O	2183
Cohen	B-Disease	2183
syndrome	I-Disease	2183
region	O	2183
on	O	2183
8q21	O	2183
.	O	2183

A	O	2186
syndrome	O	2186
of	O	2186
microcephaly	B-Disease	2186
,	O	2186
progressive	O	2186
postnatal	B-Disease	2186
growth	I-Disease	2186
deficiency	I-Disease	2186
,	O	2186
and	O	2186
mental	B-Disease	2186
retardation	I-Disease	2186
was	O	2186
observed	O	2186
in	O	2186
two	O	2186
brothers	O	2186
and	O	2186
their	O	2186
cousin	O	2186
from	O	2186
a	O	2186
multiply	O	2186
consanguineous	O	2186
kindred	O	2186
of	O	2186
Lebanese	O	2186
descent	O	2186
.	O	2186

Hypotonia	B-Disease	2187
,	O	2187
chorioretinal	B-Disease	2187
dystrophy	I-Disease	2187
,	O	2187
and	O	2187
myopia	B-Disease	2187
were	O	2187
also	O	2187
identified	O	2187
.	O	2187

Because	O	2189
of	O	2189
absence	O	2189
of	O	2189
a	O	2189
distinctive	O	2189
facial	O	2189
appearance	O	2189
,	O	2189
the	O	2189
degree	O	2189
of	O	2189
mental	B-Disease	2189
retardation	I-Disease	2189
,	O	2189
and	O	2189
short	B-Disease	2189
stature	I-Disease	2189
,	O	2189
the	O	2189
initially	O	2189
considered	O	2189
clinical	O	2189
diagnosis	O	2189
of	O	2189
Cohen	B-Disease	2189
syndrome	I-Disease	2189
was	O	2189
withdrawn	O	2189
and	O	2189
a	O	2189
novel	O	2189
genetic	O	2189
entity	O	2189
was	O	2189
assumed	O	2189
.	O	2189

Intriguingly	O	2198
enough	O	2198
,	O	2198
the	O	2198
identified	O	2198
gene	O	2198
region	O	2198
overlaps	O	2198
the	O	2198
refined	O	2198
gene	O	2198
region	O	2198
for	O	2198
Cohen	B-Disease	2198
syndrome	I-Disease	2198
(	O	2198
COH1	O	2198
)	O	2198
[	O	2198
Kolehmainen	O	2198
et	O	2198
al	O	2198
.	O	2198

This	O	2200
fact	O	2200
encourages	O	2200
the	O	2200
hypothesis	O	2200
that	O	2200
the	O	2200
described	O	2200
kindred	O	2200
segregates	O	2200
for	O	2200
a	O	2200
variant	O	2200
of	O	2200
Cohen	B-Disease	2200
syndrome	I-Disease	2200
and	O	2200
suggests	O	2200
a	O	2200
redefinition	O	2200
of	O	2200
its	O	2200
phenotype	O	2200
Polymorphisms	O	2200
of	O	2200
the	O	2200
CYP2D6	O	2200
gene	O	2200
increase	O	2200
susceptibility	O	2200
to	O	2200
ankylosing	B-Disease	2200
spondylitis	I-Disease	2200
.	O	2200

Ankylosing	B-Disease	2201
spondylitis	I-Disease	2201
(	O	2201
AS	B-Disease	2201
)	O	2201
is	O	2201
a	O	2201
common	O	2201
and	O	2201
highly	O	2201
familial	O	2201
rheumatic	B-Disease	2201
disorder	I-Disease	2201
.	O	2201

Previous	O	2204
linkage	O	2204
and	O	2204
association	O	2204
studies	O	2204
have	O	2204
suggested	O	2204
the	O	2204
presence	O	2204
of	O	2204
a	O	2204
susceptibility	O	2204
gene	O	2204
for	O	2204
AS	B-Disease	2204
close	O	2204
to	O	2204
,	O	2204
or	O	2204
within	O	2204
,	O	2204
the	O	2204
cytochrome	O	2204
P450	O	2204
2D6	O	2204
gene	O	2204
(	O	2204
CYP2D6	O	2204
,	O	2204
debrisoquine	O	2204
hydroxylase	O	2204
)	O	2204
located	O	2204
at	O	2204
chromosome	O	2204
22q13	O	2204
.	O	2204

We	O	2206
performed	O	2206
a	O	2206
linkage	O	2206
study	O	2206
of	O	2206
chromosome	O	2206
22	O	2206
in	O	2206
200	O	2206
families	O	2206
with	O	2206
AS	B-Disease	2206
affected	O	2206
sibling	O	2206
-	O	2206
pairs	O	2206
.	O	2206

For	O	2208
case	O	2208
-	O	2208
control	O	2208
studies	O	2208
,	O	2208
617	O	2208
unrelated	O	2208
individuals	O	2208
with	O	2208
AS	B-Disease	2208
(	O	2208
361	O	2208
probands	O	2208
from	O	2208
sibling	O	2208
-	O	2208
pair	O	2208
and	O	2208
parent	O	2208
-	O	2208
case	O	2208
trio	O	2208
families	O	2208
and	O	2208
256	O	2208
unrelated	O	2208
non	O	2208
-	O	2208
familial	O	2208
sporadic	O	2208
cases	O	2208
)	O	2208
and	O	2208
402	O	2208
healthy	O	2208
ethnically	O	2208
matched	O	2208
controls	O	2208
were	O	2208
employed	O	2208
.	O	2208

Homozygosity	O	2210
for	O	2210
poor	O	2210
metabolizer	O	2210
alleles	O	2210
was	O	2210
found	O	2210
to	O	2210
be	O	2210
associated	O	2210
with	O	2210
AS	B-Disease	2210
.	O	2210

Heterozygosity	O	2211
for	O	2211
the	O	2211
most	O	2211
frequent	O	2211
poor	O	2211
metabolizer	O	2211
allele	O	2211
(	O	2211
CYP2D6	O	2211
*	O	2211
4	O	2211
)	O	2211
was	O	2211
not	O	2211
associated	O	2211
with	O	2211
increased	O	2211
susceptibility	O	2211
to	O	2211
AS	B-Disease	2211
.	O	2211

Significant	O	2212
within	O	2212
-	O	2212
family	O	2212
association	O	2212
of	O	2212
CYP2D6	O	2212
*	O	2212
4	O	2212
alleles	O	2212
and	O	2212
AS	B-Disease	2212
was	O	2212
demonstrated	O	2212
.	O	2212

Weak	O	2213
linkage	O	2213
was	O	2213
also	O	2213
demonstrated	O	2213
between	O	2213
CYP2D6	O	2213
and	O	2213
AS	B-Disease	2213
.	O	2213

We	O	2214
postulate	O	2214
that	O	2214
altered	O	2214
metabolism	O	2214
of	O	2214
a	O	2214
natural	O	2214
toxin	O	2214
or	O	2214
antigen	O	2214
by	O	2214
the	O	2214
CYP2D6	O	2214
gene	O	2214
may	O	2214
increase	O	2214
susceptibility	O	2214
to	O	2214
AS	B-Disease	2214
.	O	2214

Functional	O	2215
differences	O	2215
of	O	2215
the	O	2215
PDS	B-Disease	2215
gene	O	2215
product	O	2215
are	O	2215
associated	O	2215
with	O	2215
phenotypic	O	2215
variation	O	2215
in	O	2215
patients	O	2215
with	O	2215
Pendred	B-Disease	2215
syndrome	I-Disease	2215
and	O	2215
non	B-Disease	2215
-	I-Disease	2215
syndromic	I-Disease	2215
hearing	I-Disease	2215
loss	I-Disease	2215
(	O	2215
DFNB4	B-Disease	2215
)	O	2215
.	O	2215

The	O	2216
PDS	B-Disease	2216
gene	O	2216
encodes	O	2216
a	O	2216
transmembrane	O	2216
protein	O	2216
,	O	2216
known	O	2216
as	O	2216
pendrin	O	2216
,	O	2216
which	O	2216
functions	O	2216
as	O	2216
a	O	2216
transporter	O	2216
of	O	2216
iodide	O	2216
and	O	2216
chloride	O	2216
.	O	2216

Mutations	O	2217
in	O	2217
this	O	2217
gene	O	2217
are	O	2217
responsible	O	2217
for	O	2217
Pendred	B-Disease	2217
syndrome	I-Disease	2217
and	O	2217
autosomal	B-Disease	2217
recessive	I-Disease	2217
non	I-Disease	2217
-	I-Disease	2217
syndromic	I-Disease	2217
hearing	I-Disease	2217
loss	I-Disease	2217
at	O	2217
the	O	2217
DFNB4	B-Disease	2217
locus	O	2217
on	O	2217
chromosome	O	2217
7q31	O	2217
.	O	2217

A	O	2218
screen	O	2218
of	O	2218
20	O	2218
individuals	O	2218
from	O	2218
the	O	2218
midwestern	O	2218
USA	O	2218
with	O	2218
non	B-Disease	2218
-	I-Disease	2218
syndromic	I-Disease	2218
hearing	I-Disease	2218
loss	I-Disease	2218
and	O	2218
dilated	O	2218
vestibular	O	2218
aqueducts	O	2218
identified	O	2218
three	O	2218
people	O	2218
(	O	2218
15	O	2218
%	O	2218
)	O	2218
with	O	2218
PDS	B-Disease	2218
mutations	O	2218
.	O	2218

To	O	2219
determine	O	2219
whether	O	2219
PDS	B-Disease	2219
mutations	O	2219
in	O	2219
individuals	O	2219
with	O	2219
Pendred	B-Disease	2219
syndrome	I-Disease	2219
differ	O	2219
functionally	O	2219
from	O	2219
PDS	B-Disease	2219
mutations	O	2219
in	O	2219
individuals	O	2219
with	O	2219
non	B-Disease	2219
-	I-Disease	2219
syndromic	I-Disease	2219
hearing	I-Disease	2219
loss	I-Disease	2219
,	O	2219
we	O	2219
compared	O	2219
three	O	2219
common	O	2219
Pendred	B-Disease	2219
syndrome	I-Disease	2219
allele	O	2219
variants	O	2219
(	O	2219
L236P	O	2219
,	O	2219
T416P	O	2219
and	O	2219
E384G	O	2219
)	O	2219
,	O	2219
with	O	2219
three	O	2219
PDS	B-Disease	2219
mutations	O	2219
reported	O	2219
only	O	2219
in	O	2219
individuals	O	2219
with	O	2219
non	B-Disease	2219
-	I-Disease	2219
syndromic	I-Disease	2219
hearing	I-Disease	2219
loss	I-Disease	2219
(	O	2219
V480D	O	2219
,	O	2219
V653A	O	2219
and	O	2219
I490L	O	2219
/	O	2219
G497S	O	2219
)	O	2219
.	O	2219

The	O	2220
mutations	O	2220
associated	O	2220
with	O	2220
Pendred	B-Disease	2220
syndrome	I-Disease	2220
have	O	2220
complete	O	2220
loss	O	2220
of	O	2220
pendrin	O	2220
-	O	2220
induced	O	2220
chloride	O	2220
and	O	2220
iodide	O	2220
transport	O	2220
,	O	2220
while	O	2220
alleles	O	2220
unique	O	2220
to	O	2220
people	O	2220
with	O	2220
DFNB4	B-Disease	2220
are	O	2220
able	O	2220
to	O	2220
transport	O	2220
both	O	2220
iodide	O	2220
and	O	2220
chloride	O	2220
,	O	2220
albeit	O	2220
at	O	2220
a	O	2220
much	O	2220
lower	O	2220
level	O	2220
than	O	2220
wild	O	2220
-	O	2220
type	O	2220
pendrin	O	2220
.	O	2220

We	O	2221
hypothesize	O	2221
that	O	2221
this	O	2221
residual	O	2221
level	O	2221
of	O	2221
anion	O	2221
transport	O	2221
is	O	2221
sufficient	O	2221
to	O	2221
eliminate	O	2221
or	O	2221
postpone	O	2221
the	O	2221
onset	O	2221
of	O	2221
goiter	B-Disease	2221
in	O	2221
individuals	O	2221
with	O	2221
DFNB4	B-Disease	2221
.	O	2221

Germline	O	2225
mutations	O	2225
are	O	2225
the	O	2225
major	O	2225
source	O	2225
of	O	2225
genetic	O	2225
variation	O	2225
that	O	2225
allows	O	2225
a	O	2225
species	O	2225
to	O	2225
evolve	O	2225
over	O	2225
time	O	2225
but	O	2225
at	O	2225
the	O	2225
cost	O	2225
of	O	2225
Mendelian	B-Disease	2225
disease	I-Disease	2225
and	O	2225
genetic	O	2225
predisposition	O	2225
to	O	2225
multifactorial	B-Disease	2225
diseases	I-Disease	2225
.	O	2225

Here	O	2227
,	O	2227
we	O	2227
compare	O	2227
the	O	2227
pattern	O	2227
of	O	2227
germline	O	2227
mutation	O	2227
in	O	2227
a	O	2227
population	O	2227
of	O	2227
hemophilia	B-Disease	2227
B	I-Disease	2227
patients	O	2227
from	O	2227
Mainland	O	2227
China	O	2227
(	O	2227
n	O	2227
=	O	2227
66	O	2227
)	O	2227
to	O	2227
that	O	2227
in	O	2227
U	O	2227
.	O	2227

Heterozygous	O	2232
mutations	O	2232
encoding	O	2232
abnormal	O	2232
forms	O	2232
of	O	2232
the	O	2232
death	O	2232
receptor	O	2232
Fas	O	2232
dominantly	O	2232
interfere	O	2232
with	O	2232
Fas	O	2232
-	O	2232
induced	O	2232
lymphocyte	O	2232
apoptosis	O	2232
in	O	2232
human	O	2232
autoimmune	B-Disease	2232
lymphoproliferative	I-Disease	2232
syndrome	I-Disease	2232
.	O	2232

Determination	O	2237
of	O	2237
carrier	O	2237
status	O	2237
for	O	2237
the	O	2237
Wiskott	B-Disease	2237
-	I-Disease	2237
Aldrich	I-Disease	2237
syndrome	I-Disease	2237
by	O	2237
flow	O	2237
cytometric	O	2237
analysis	O	2237
of	O	2237
Wiskott	B-Disease	2237
-	I-Disease	2237
Aldrich	I-Disease	2237
syndrome	I-Disease	2237
protein	O	2237
expression	O	2237
in	O	2237
peripheral	O	2237
blood	O	2237
mononuclear	O	2237
cells	O	2237
.	O	2237

The	O	2238
Wiskott	B-Disease	2238
-	I-Disease	2238
Aldrich	I-Disease	2238
syndrome	I-Disease	2238
(	O	2238
WAS	B-Disease	2238
)	O	2238
is	O	2238
caused	O	2238
by	O	2238
defects	O	2238
in	O	2238
the	O	2238
WAS	B-Disease	2238
protein	O	2238
(	O	2238
WASP	O	2238
)	O	2238
gene	O	2238
on	O	2238
the	O	2238
X	O	2238
chromosome	O	2238
.	O	2238

Previous	O	2239
study	O	2239
disclosed	O	2239
that	O	2239
flow	O	2239
cytometric	O	2239
analysis	O	2239
of	O	2239
intracellular	O	2239
WASP	O	2239
expression	O	2239
(	O	2239
FCM	O	2239
-	O	2239
WASP	O	2239
analysis	O	2239
)	O	2239
in	O	2239
lymphocytes	O	2239
was	O	2239
useful	O	2239
for	O	2239
the	O	2239
diagnosis	O	2239
of	O	2239
WAS	B-Disease	2239
patients	O	2239
.	O	2239

Lymphocytes	O	2240
from	O	2240
all	O	2240
WAS	B-Disease	2240
patients	O	2240
showed	O	2240
WASPdim	O	2240
instead	O	2240
of	O	2240
WASPbright	O	2240
.	O	2240

Here	O	2241
we	O	2241
report	O	2241
that	O	2241
FCM	O	2241
-	O	2241
WASP	O	2241
analysis	O	2241
in	O	2241
monocytes	O	2241
could	O	2241
be	O	2241
a	O	2241
useful	O	2241
tool	O	2241
for	O	2241
the	O	2241
WAS	B-Disease	2241
carrier	O	2241
diagnosis	O	2241
.	O	2241

Monocytes	O	2242
from	O	2242
all	O	2242
nine	O	2242
WAS	B-Disease	2242
carriers	O	2242
showed	O	2242
varied	O	2242
population	O	2242
of	O	2242
WASPdim	O	2242
together	O	2242
with	O	2242
WASPbright	O	2242
.	O	2242

The	O	2245
difference	O	2245
of	O	2245
the	O	2245
WASPdim	O	2245
population	O	2245
in	O	2245
monocytes	O	2245
and	O	2245
lymphocytes	O	2245
observed	O	2245
in	O	2245
WAS	B-Disease	2245
carriers	O	2245
suggests	O	2245
that	O	2245
WASP	O	2245
plays	O	2245
a	O	2245
more	O	2245
critical	O	2245
role	O	2245
in	O	2245
the	O	2245
development	O	2245
of	O	2245
lymphocytes	O	2245
than	O	2245
in	O	2245
that	O	2245
of	O	2245
monocytes	O	2245
.	O	2245

The	O	2246
present	O	2246
studies	O	2246
suggest	O	2246
that	O	2246
a	O	2246
skewed	O	2246
X	O	2246
-	O	2246
chromosomal	O	2246
inactivation	O	2246
pattern	O	2246
observed	O	2246
in	O	2246
WAS	B-Disease	2246
carrier	O	2246
peripheral	O	2246
blood	O	2246
cells	O	2246
is	O	2246
not	O	2246
fixed	O	2246
at	O	2246
the	O	2246
hemopoietic	O	2246
stem	O	2246
cell	O	2246
level	O	2246
but	O	2246
progresses	O	2246
after	O	2246
the	O	2246
lineage	O	2246
commitment	O	2246
.	O	2246

Restoration	O	2248
of	O	2248
photoreceptor	O	2248
ultrastructure	O	2248
and	O	2248
function	O	2248
in	O	2248
retinal	B-Disease	2248
degeneration	I-Disease	2248
slow	O	2248
mice	O	2248
by	O	2248
gene	O	2248
therapy	O	2248
.	O	2248

Mutations	O	2252
in	O	2252
Prph2	O	2252
have	O	2252
been	O	2252
shown	O	2252
to	O	2252
result	O	2252
in	O	2252
a	O	2252
variety	O	2252
of	O	2252
photoreceptor	B-Disease	2252
dystrophies	I-Disease	2252
,	O	2252
including	O	2252
autosomal	B-Disease	2252
dominant	I-Disease	2252
retinitis	I-Disease	2252
pigmentosa	I-Disease	2252
and	O	2252
macular	B-Disease	2252
dystrophy	I-Disease	2252
.	O	2252

A	O	2253
common	O	2253
feature	O	2253
of	O	2253
these	O	2253
diseases	O	2253
is	O	2253
the	O	2253
loss	O	2253
of	O	2253
photoreceptor	O	2253
function	O	2253
,	O	2253
also	O	2253
seen	O	2253
in	O	2253
the	O	2253
retinal	B-Disease	2253
degeneration	I-Disease	2253
slow	O	2253
(	O	2253
rds	O	2253
or	O	2253
Prph2	O	2253
Rd2	O	2253
/	O	2253
Rd2	O	2253
)	O	2253
mouse	O	2253
,	O	2253
which	O	2253
is	O	2253
homozygous	O	2253
for	O	2253
a	O	2253
nan	O	2253
mutation	O	2253
in	O	2253
Prph2	O	2253
.	O	2253

Mutations	O	2260
in	O	2260
the	O	2260
fibrinogen	O	2260
aalpha	O	2260
gene	O	2260
account	O	2260
for	O	2260
the	O	2260
majority	O	2260
of	O	2260
cases	O	2260
of	O	2260
congenital	B-Disease	2260
afibrinogenemia	I-Disease	2260
.	O	2260

Congenital	B-Disease	2261
afibrinogenemia	I-Disease	2261
is	O	2261
a	O	2261
rare	O	2261
,	O	2261
autosomal	B-Disease	2261
,	I-Disease	2261
recessive	I-Disease	2261
disorder	I-Disease	2261
characterized	O	2261
by	O	2261
the	O	2261
complete	O	2261
absence	O	2261
of	O	2261
detectable	O	2261
fibrinogen	O	2261
.	O	2261

Consequently	O	2269
,	O	2269
86	O	2269
%	O	2269
of	O	2269
afibrinogenemia	B-Disease	2269
alleles	O	2269
analyzed	O	2269
to	O	2269
date	O	2269
have	O	2269
truncating	O	2269
mutations	O	2269
of	O	2269
FGA	O	2269
,	O	2269
though	O	2269
mutations	O	2269
in	O	2269
all	O	2269
3	O	2269
fibrinogen	O	2269
genes	O	2269
,	O	2269
FGG	O	2269
,	O	2269
FGA	O	2269
,	O	2269
and	O	2269
FGB	O	2269
,	O	2269
might	O	2269
be	O	2269
predicted	O	2269
to	O	2269
cause	O	2269
congenital	B-Disease	2269
afibrinogenemia	I-Disease	2269
.	O	2269

Myotonic	B-Disease	2271
dystrophy	I-Disease	2271
:	O	2271
the	O	2271
role	O	2271
of	O	2271
the	O	2271
CUG	O	2271
triplet	O	2271
repeats	O	2271
in	O	2271
splicing	O	2271
of	O	2271
a	O	2271
novel	O	2271
DMPK	O	2271
exon	O	2271
and	O	2271
altered	O	2271
cytoplasmic	O	2271
DMPK	O	2271
mRNA	O	2271
isoform	O	2271
ratios	O	2271
.	O	2271

The	O	2272
mechanism	O	2272
by	O	2272
which	O	2272
(	O	2272
CTG	O	2272
)	O	2272
n	O	2272
expansion	O	2272
in	O	2272
the	O	2272
3	O	2272
UTR	O	2272
of	O	2272
the	O	2272
DMPK	O	2272
gene	O	2272
causes	O	2272
myotonic	B-Disease	2272
dystrophy	I-Disease	2272
(	O	2272
DM	B-Disease	2272
)	O	2272
is	O	2272
unknown	O	2272
.	O	2272

In	O	2275
contrast	O	2275
to	O	2275
(	O	2275
CUG	O	2275
)	O	2275
n	O	2275
containing	O	2275
mRNAs	O	2275
,	O	2275
the	O	2275
novel	O	2275
isoform	O	2275
is	O	2275
not	O	2275
retained	O	2275
in	O	2275
the	O	2275
nucleus	O	2275
in	O	2275
DM	B-Disease	2275
cells	O	2275
,	O	2275
resulting	O	2275
in	O	2275
imbalances	O	2275
in	O	2275
relative	O	2275
levels	O	2275
of	O	2275
cytoplasmic	O	2275
DMPK	O	2275
mRNA	O	2275
isoforms	O	2275
and	O	2275
a	O	2275
new	O	2275
dominant	O	2275
effect	O	2275
of	O	2275
the	O	2275
mutation	O	2275
on	O	2275
DMPK	O	2275
.	O	2275

Expression	O	2277
and	O	2277
imprinting	O	2277
of	O	2277
MAGEL2	O	2277
suggest	O	2277
a	O	2277
role	O	2277
in	O	2277
Prader	B-Disease	2277
-	I-Disease	2277
willi	I-Disease	2277
syndrome	I-Disease	2277
and	O	2277
the	O	2277
homologous	O	2277
murine	O	2277
imprinting	O	2277
phenotype	O	2277
.	O	2277

Prader	B-Disease	2278
-	I-Disease	2278
Willi	I-Disease	2278
syndrome	I-Disease	2278
(	O	2278
PWS	B-Disease	2278
)	O	2278
is	O	2278
caused	O	2278
by	O	2278
the	O	2278
loss	O	2278
of	O	2278
expression	O	2278
of	O	2278
imprinted	O	2278
genes	O	2278
in	O	2278
chromosome	O	2278
15q11	O	2278
-	O	2278
q13	O	2278
.	O	2278

Affected	O	2279
individuals	O	2279
exhibit	O	2279
neonatal	B-Disease	2279
hypotonia	I-Disease	2279
,	O	2279
developmental	B-Disease	2279
delay	I-Disease	2279
and	O	2279
childhood	B-Disease	2279
-	I-Disease	2279
onset	I-Disease	2279
obesity	I-Disease	2279
.	O	2279

Necdin	O	2280
,	O	2280
a	O	2280
protein	O	2280
implicated	O	2280
in	O	2280
the	O	2280
terminal	O	2280
differentiation	O	2280
of	O	2280
neurons	O	2280
,	O	2280
is	O	2280
the	O	2280
only	O	2280
PWS	B-Disease	2280
candidate	O	2280
gene	O	2280
to	O	2280
reduce	O	2280
viability	O	2280
when	O	2280
disrupted	O	2280
in	O	2280
a	O	2280
mouse	O	2280
model	O	2280
.	O	2280

In	O	2281
this	O	2281
study	O	2281
,	O	2281
we	O	2281
have	O	2281
characterized	O	2281
MAGEL2	O	2281
(	O	2281
also	O	2281
known	O	2281
as	O	2281
NDNL1	O	2281
)	O	2281
,	O	2281
a	O	2281
gene	O	2281
with	O	2281
51	O	2281
%	O	2281
amino	O	2281
acid	O	2281
sequence	O	2281
similarity	O	2281
to	O	2281
necdin	O	2281
and	O	2281
located	O	2281
41	O	2281
kb	O	2281
distal	O	2281
to	O	2281
NDN	O	2281
in	O	2281
the	O	2281
PWS	B-Disease	2281
deletion	O	2281
region	O	2281
.	O	2281

MAGEL2	O	2282
is	O	2282
expressed	O	2282
predominantly	O	2282
in	O	2282
brain	O	2282
,	O	2282
the	O	2282
primary	O	2282
tissue	O	2282
affected	O	2282
in	O	2282
PWS	B-Disease	2282
and	O	2282
in	O	2282
several	O	2282
fetal	O	2282
tissues	O	2282
as	O	2282
shown	O	2282
by	O	2282
northern	O	2282
blot	O	2282
analysis	O	2282
.	O	2282

MAGEL2	O	2283
is	O	2283
imprinted	O	2283
with	O	2283
monoallelic	O	2283
expression	O	2283
in	O	2283
control	O	2283
brain	O	2283
,	O	2283
and	O	2283
paternal	O	2283
-	O	2283
only	O	2283
expression	O	2283
in	O	2283
the	O	2283
central	O	2283
nervous	O	2283
system	O	2283
as	O	2283
demonstrated	O	2283
by	O	2283
its	O	2283
lack	O	2283
of	O	2283
expression	O	2283
in	O	2283
brain	O	2283
from	O	2283
a	O	2283
PWS	B-Disease	2283
-	O	2283
affected	O	2283
individual	O	2283
.	O	2283

We	O	2286
hypothesize	O	2286
that	O	2286
,	O	2286
although	O	2286
loss	O	2286
of	O	2286
necdin	O	2286
expression	O	2286
may	O	2286
be	O	2286
important	O	2286
in	O	2286
the	O	2286
neonatal	O	2286
presentation	O	2286
of	O	2286
PWS	B-Disease	2286
,	O	2286
loss	O	2286
of	O	2286
MAGEL2	O	2286
may	O	2286
be	O	2286
critical	O	2286
to	O	2286
abnormalities	B-Disease	2286
in	I-Disease	2286
brain	I-Disease	2286
development	I-Disease	2286
and	O	2286
dysmorphic	B-Disease	2286
features	I-Disease	2286
in	O	2286
individuals	O	2286
with	O	2286
PWS	B-Disease	2286
.	O	2286

Retinoschisin	O	2288
,	O	2288
the	O	2288
X	B-Disease	2288
-	I-Disease	2288
linked	I-Disease	2288
retinoschisis	I-Disease	2288
protein	O	2288
,	O	2288
is	O	2288
a	O	2288
secreted	O	2288
photoreceptor	O	2288
protein	O	2288
,	O	2288
and	O	2288
is	O	2288
expressed	O	2288
and	O	2288
released	O	2288
by	O	2288
Weri	O	2288
-	O	2288
Rb1	O	2288
cells	O	2288
.	O	2288

X	B-Disease	2289
-	I-Disease	2289
linked	I-Disease	2289
retinoschisis	I-Disease	2289
is	O	2289
characterized	O	2289
by	O	2289
microcystic	O	2289
-	O	2289
like	O	2289
changes	O	2289
of	O	2289
the	O	2289
macular	O	2289
region	O	2289
and	O	2289
schisis	O	2289
within	O	2289
the	O	2289
inner	O	2289
retinal	O	2289
layers	O	2289
,	O	2289
leading	O	2289
to	O	2289
visual	B-Disease	2289
deterioration	I-Disease	2289
in	O	2289
males	O	2289
.	O	2289

Furthermore	O	2296
,	O	2296
differentiated	O	2296
retinoblastoma	B-Disease	2296
cells	O	2296
(	O	2296
Weri	O	2296
-	O	2296
Rb1	O	2296
cells	O	2296
)	O	2296
were	O	2296
found	O	2296
to	O	2296
express	O	2296
RS1	O	2296
mRNA	O	2296
and	O	2296
to	O	2296
release	O	2296
retinoschisin	O	2296
.	O	2296

Thus	O	2298
,	O	2298
X	B-Disease	2298
-	I-Disease	2298
linked	I-Disease	2298
retinoschisis	I-Disease	2298
is	O	2298
caused	O	2298
by	O	2298
abnormalities	O	2298
in	O	2298
a	O	2298
putative	O	2298
secreted	O	2298
photoreceptor	O	2298
protein	O	2298
and	O	2298
is	O	2298
the	O	2298
first	O	2298
example	O	2298
of	O	2298
a	O	2298
secreted	O	2298
photo	O	2298
-	O	2298
receptor	O	2298
protein	O	2298
associated	O	2298
with	O	2298
a	O	2298
retinal	B-Disease	2298
dystrophy	I-Disease	2298
.	O	2298

Study	O	2300
of	O	2300
the	O	2300
voltage	O	2300
-	O	2300
gated	O	2300
sodium	O	2300
channel	O	2300
beta	O	2300
1	O	2300
subunit	O	2300
gene	O	2300
(	O	2300
SCN1B	O	2300
)	O	2300
in	O	2300
the	O	2300
benign	B-Disease	2300
familial	I-Disease	2300
infantile	I-Disease	2300
convulsions	I-Disease	2300
syndrome	I-Disease	2300
(	O	2300
BFIC	B-Disease	2300
)	O	2300
.	O	2300

Benign	B-Disease	2301
familial	I-Disease	2301
infantile	I-Disease	2301
convulsions	I-Disease	2301
(	O	2301
BFIC	B-Disease	2301
)	O	2301
is	O	2301
a	O	2301
rare	O	2301
autosomal	B-Disease	2301
dominant	I-Disease	2301
epilepsy	I-Disease	2301
syndrome	I-Disease	2301
.	O	2301

The	O	2304
seizures	O	2304
usually	O	2304
spontaneously	O	2304
cease	O	2304
after	O	2304
one	O	2304
year	O	2304
without	O	2304
treatment	O	2304
,	O	2304
leaving	O	2304
no	O	2304
neurological	B-Disease	2304
abnormalities	I-Disease	2304
.	O	2304

We	O	2305
have	O	2305
mapped	O	2305
BFIC	B-Disease	2305
to	O	2305
chromosome	O	2305
19q	O	2305
in	O	2305
five	O	2305
Italian	O	2305
pedigrees	O	2305
.	O	2305

The	O	2306
sodium	O	2306
channel	O	2306
beta1	O	2306
subunit	O	2306
gene	O	2306
(	O	2306
SCN1B	O	2306
)	O	2306
maps	O	2306
to	O	2306
this	O	2306
candidate	O	2306
region	O	2306
and	O	2306
has	O	2306
been	O	2306
shown	O	2306
to	O	2306
be	O	2306
involved	O	2306
in	O	2306
one	O	2306
Australian	O	2306
pedigree	O	2306
with	O	2306
generalized	B-Disease	2306
epilepsy	I-Disease	2306
and	I-Disease	2306
febrile	I-Disease	2306
seizures	I-Disease	2306
plus	I-Disease	2307
BFIC	B-Disease	2310
and	O	2310
GEFS	O	2310
+	O	2310
have	O	2310
clinical	O	2310
features	O	2310
in	O	2310
common	O	2310
,	O	2310
therefore	O	2310
SCN1B	O	2310
is	O	2310
a	O	2310
candidate	O	2310
gene	O	2310
for	O	2310
BFIC	B-Disease	2310
.	O	2310

We	O	2311
studied	O	2311
SCN1B	O	2311
exons	O	2311
1	O	2311
,	O	2311
2	O	2311
,	O	2311
3	O	2311
,	O	2311
4	O	2311
,	O	2311
and	O	2311
5	O	2311
,	O	2311
using	O	2311
four	O	2311
SSCP	O	2311
methods	O	2311
in	O	2311
10	O	2311
Caucasian	O	2311
BFIC	B-Disease	2311
probands	O	2311
of	O	2311
Western	O	2311
Europe	O	2311
.	O	2311

One	O	2313
variant	O	2313
was	O	2313
identified	O	2313
in	O	2313
intron	O	2313
5	O	2313
(	O	2313
IVS5	O	2313
-	O	2313
10C	O	2313
>	O	2313
G	O	2313
)	O	2313
,	O	2313
which	O	2313
did	O	2313
not	O	2313
segregate	O	2313
with	O	2313
BFIC	B-Disease	2313
and	O	2313
was	O	2313
observed	O	2313
in	O	2313
9	O	2313
.	O	2313

It	O	2316
was	O	2316
rare	O	2316
,	O	2316
as	O	2316
not	O	2316
observed	O	2316
in	O	2316
controls	O	2316
,	O	2316
but	O	2316
not	O	2316
segregating	O	2316
with	O	2316
the	O	2316
BFIC	B-Disease	2316
phenotype	O	2316
.	O	2316

Inactivation	O	2317
of	O	2317
germline	O	2317
mutant	O	2317
APC	B-Disease	2317
alleles	O	2317
by	O	2317
attenuated	O	2317
somatic	O	2317
mutations	O	2317
:	O	2317
a	O	2317
molecular	O	2317
genetic	O	2317
mechanism	O	2317
for	O	2317
attenuated	B-Disease	2317
familial	I-Disease	2317
adenomatous	I-Disease	2317
polyposis	I-Disease	2317
.	O	2317

Germline	O	2318
mutations	O	2318
of	O	2318
the	O	2318
adenomatous	B-Disease	2318
polyposis	I-Disease	2318
coli	I-Disease	2318
(	I-Disease	2318
APC	I-Disease	2318
)	I-Disease	2318
tumor	I-Disease	2318
-	O	2318
suppressor	O	2318
gene	O	2318
result	O	2318
in	O	2318
familial	B-Disease	2318
adenomatous	I-Disease	2318
polyposis	I-Disease	2318
(	O	2318
FAP	B-Disease	2318
)	O	2318
.	O	2318

Patients	O	2319
with	O	2319
FAP	B-Disease	2319
typically	O	2319
develop	O	2319
hundreds	O	2319
to	O	2319
thousands	O	2319
of	O	2319
benign	B-Disease	2319
colorectal	I-Disease	2319
tumors	I-Disease	2319
and	O	2319
early	O	2319
-	O	2319
onset	O	2319
colorectal	B-Disease	2319
cancer	I-Disease	2319
.	O	2319

A	O	2320
subset	O	2320
of	O	2320
germline	O	2320
APC	B-Disease	2320
mutations	O	2320
results	O	2320
in	O	2320
an	O	2320
attenuated	B-Disease	2320
FAP	I-Disease	2320
(	O	2320
AFAP	B-Disease	2320
)	O	2320
phenotype	O	2320
,	O	2320
in	O	2320
which	O	2320
patients	O	2320
develop	O	2320
fewer	O	2320
tumors	B-Disease	2320
and	O	2320
develop	O	2320
them	O	2320
at	O	2320
an	O	2320
older	O	2320
age	O	2320
.	O	2320

Although	O	2321
a	O	2321
genotype	O	2321
-	O	2321
phenotype	O	2321
correlation	O	2321
between	O	2321
the	O	2321
locations	O	2321
of	O	2321
APC	B-Disease	2321
germline	O	2321
mutations	O	2321
and	O	2321
the	O	2321
development	O	2321
of	O	2321
AFAP	B-Disease	2321
has	O	2321
been	O	2321
well	O	2321
documented	O	2321
,	O	2321
the	O	2321
mechanism	O	2321
for	O	2321
AFAP	B-Disease	2321
has	O	2321
not	O	2321
been	O	2321
well	O	2321
defined	O	2321
.	O	2321

We	O	2322
investigated	O	2322
the	O	2322
mechanism	O	2322
for	O	2322
AFAP	B-Disease	2322
in	O	2322
patients	O	2322
carrying	O	2322
a	O	2322
mutant	O	2322
APC	B-Disease	2322
allele	O	2322
(	O	2322
APC	O	2322
(	O	2322
AS9	O	2322
)	O	2322
)	O	2322
that	O	2322
has	O	2322
a	O	2322
mutation	O	2322
in	O	2322
the	O	2322
alternatively	O	2322
spliced	O	2322
region	O	2322
of	O	2322
exon	O	2322
9	O	2322
.	O	2322

APC	O	2323
(	O	2323
AS9	O	2323
)	O	2323
was	O	2323
found	O	2323
to	O	2323
down	O	2323
-	O	2323
regulate	O	2323
beta	O	2323
-	O	2323
catenin	O	2323
-	O	2323
regulated	O	2323
transcription	O	2323
,	O	2323
the	O	2323
major	O	2323
tumor	B-Disease	2323
-	O	2323
suppressor	O	2323
function	O	2323
of	O	2323
APC	O	2323
,	O	2323
as	O	2323
did	O	2323
the	O	2323
wild	O	2323
-	O	2323
type	O	2323
APC	O	2323
.	O	2323

Mutation	O	2324
analysis	O	2324
showed	O	2324
that	O	2324
both	O	2324
APC	O	2324
(	O	2324
AS9	O	2324
)	O	2324
and	O	2324
the	O	2324
wild	O	2324
-	O	2324
type	O	2324
APC	B-Disease	2324
alleles	O	2324
were	O	2324
somatically	O	2324
mutated	O	2324
in	O	2324
most	O	2324
colorectal	B-Disease	2324
tumors	I-Disease	2324
from	O	2324
these	O	2324
patients	O	2324
.	O	2324

Functional	O	2325
analysis	O	2325
showed	O	2325
that	O	2325
4666insA	O	2325
,	O	2325
a	O	2325
common	O	2325
somatic	O	2325
mutation	O	2325
in	O	2325
APC	O	2325
(	O	2325
AS9	O	2325
)	O	2325
in	O	2325
these	O	2325
tumors	B-Disease	2325
,	O	2325
did	O	2325
not	O	2325
inactivate	O	2325
the	O	2325
wild	O	2325
-	O	2325
type	O	2325
APC	O	2325
.	O	2325

Our	O	2326
results	O	2326
indicate	O	2326
that	O	2326
carriers	O	2326
of	O	2326
APC	O	2326
(	O	2326
AS9	O	2326
)	O	2326
develop	O	2326
fewer	O	2326
colorectal	B-Disease	2326
tumors	I-Disease	2326
than	O	2326
do	O	2326
typical	O	2326
patients	O	2326
with	O	2326
FAP	B-Disease	2326
because	O	2326
somatic	O	2326
inactivation	O	2326
of	O	2326
both	O	2326
APC	B-Disease	2326
alleles	O	2326
is	O	2326
necessary	O	2326
for	O	2326
colorectal	O	2326
tumorigenesis	O	2326
.	O	2326

However	O	2327
,	O	2327
these	O	2327
patients	O	2327
develop	O	2327
colorectal	B-Disease	2327
tumors	I-Disease	2327
more	O	2327
frequently	O	2327
than	O	2327
does	O	2327
the	O	2327
general	O	2327
population	O	2327
because	O	2327
APC	O	2327
(	O	2327
AS9	O	2327
)	O	2327
is	O	2327
inactivated	O	2327
by	O	2327
mutations	O	2327
that	O	2327
do	O	2327
not	O	2327
inactivate	O	2327
the	O	2327
wild	O	2327
-	O	2327
type	O	2327
APC	O	2327
.	O	2327

Iron	O	2329
-	O	2329
dependent	O	2329
self	O	2329
-	O	2329
assembly	O	2329
of	O	2329
recombinant	O	2329
yeast	O	2329
frataxin	O	2329
:	O	2329
implications	O	2329
for	O	2329
Friedreich	B-Disease	2329
ataxia	I-Disease	2329
.	O	2329

Frataxin	B-Disease	2330
deficiency	I-Disease	2330
is	O	2330
the	O	2330
primary	O	2330
cause	O	2330
of	O	2330
Friedreich	B-Disease	2330
ataxia	I-Disease	2330
(	O	2330
FRDA	B-Disease	2330
)	O	2330
,	O	2330
an	O	2330
autosomal	B-Disease	2330
recessive	I-Disease	2330
cardiodegenerative	I-Disease	2330
and	I-Disease	2330
neurodegenerative	I-Disease	2330
disease	I-Disease	2330
.	O	2330

Genetic	O	2332
inactivation	O	2332
of	O	2332
the	O	2332
yeast	O	2332
frataxin	O	2332
homologue	O	2332
(	O	2332
Yfh1p	O	2332
)	O	2332
results	O	2332
in	O	2332
mitochondrial	B-Disease	2332
iron	I-Disease	2332
accumulation	I-Disease	2332
and	O	2332
hypersensitivity	B-Disease	2332
to	I-Disease	2332
oxidative	I-Disease	2332
stress	I-Disease	2332
.	O	2332

Increased	O	2333
iron	O	2333
deposition	O	2333
and	O	2333
evidence	O	2333
of	O	2333
oxidative	O	2333
damage	O	2333
have	O	2333
also	O	2333
been	O	2333
observed	O	2333
in	O	2333
cardiac	O	2333
tissue	O	2333
and	O	2333
cultured	O	2333
fibroblasts	O	2333
from	O	2333
patients	O	2333
with	O	2333
FRDA	B-Disease	2333
.	O	2333

A	O	2347
mutation	O	2347
in	O	2347
the	O	2347
pleckstrin	O	2347
homology	O	2347
(	O	2347
PH	O	2347
)	O	2347
domain	O	2347
of	O	2347
the	O	2347
FGD1	O	2347
gene	O	2347
in	O	2347
an	O	2347
Italian	O	2347
family	O	2347
with	O	2347
faciogenital	B-Disease	2347
dysplasia	I-Disease	2347
(	O	2347
Aarskog	B-Disease	2347
-	I-Disease	2347
Scott	I-Disease	2347
syndrome	I-Disease	2347
)	O	2347
.	O	2347

Aarskog	B-Disease	2348
-	I-Disease	2348
Scott	I-Disease	2348
Syndrome	I-Disease	2348
(	O	2348
AAS	B-Disease	2348
)	O	2348
is	O	2348
an	O	2348
X	B-Disease	2348
-	I-Disease	2348
linked	I-Disease	2348
disorder	I-Disease	2348
characterised	O	2348
by	O	2348
short	B-Disease	2348
stature	I-Disease	2348
and	O	2348
multiple	O	2348
facial	B-Disease	2348
,	I-Disease	2348
limb	I-Disease	2348
and	I-Disease	2348
genital	I-Disease	2348
abnormalities	I-Disease	2348
.	O	2348

A	O	2349
gene	O	2349
,	O	2349
FGD1	O	2349
,	O	2349
altered	O	2349
in	O	2349
a	O	2349
patient	O	2349
with	O	2349
AAS	B-Disease	2349
phenotype	O	2349
,	O	2349
has	O	2349
been	O	2349
identified	O	2349
and	O	2349
found	O	2349
to	O	2349
encode	O	2349
a	O	2349
protein	O	2349
with	O	2349
homology	O	2349
to	O	2349
Rho	O	2349
/	O	2349
Rac	O	2349
guanine	O	2349
nucleotide	O	2349
exchange	O	2349
factors	O	2349
(	O	2349
Rho	O	2349
/	O	2349
Rac	O	2349
GEF	O	2349
)	O	2349
.	O	2349

However	O	2350
,	O	2350
since	O	2350
this	O	2350
original	O	2350
report	O	2350
on	O	2350
identification	O	2350
of	O	2350
a	O	2350
mutated	O	2350
FGD1	O	2350
gene	O	2350
in	O	2350
an	O	2350
AAS	B-Disease	2350
patient	O	2350
,	O	2350
no	O	2350
additional	O	2350
mutations	O	2350
in	O	2350
the	O	2350
FGD1	O	2350
gene	O	2350
have	O	2350
been	O	2350
described	O	2350
.	O	2350

We	O	2351
analysed	O	2351
13	O	2351
independent	O	2351
patients	O	2351
with	O	2351
clinical	O	2351
diagnosis	O	2351
of	O	2351
AAS	B-Disease	2351
.	O	2351

The	O	2353
mutation	O	2353
was	O	2353
found	O	2353
to	O	2353
segregate	O	2353
with	O	2353
the	O	2353
AAS	B-Disease	2353
phenotype	O	2353
in	O	2353
affected	O	2353
males	O	2353
and	O	2353
carrier	O	2353
females	O	2353
in	O	2353
the	O	2353
family	O	2353
of	O	2353
this	O	2353
patient	O	2353
.	O	2353

The	O	2355
same	O	2355
residue	O	2355
is	O	2355
often	O	2355
mutated	O	2355
in	O	2355
the	O	2355
Brutons	O	2355
tyrosine	O	2355
kinase	O	2355
(	O	2355
Btk	O	2355
)	O	2355
gene	O	2355
in	O	2355
patients	O	2355
with	O	2355
an	O	2355
X	B-Disease	2355
-	I-Disease	2355
linked	I-Disease	2355
agammaglobulinemia	I-Disease	2355
.	O	2355

Huntington	B-Disease	2359
disease	I-Disease	2359
(	O	2359
HD	B-Disease	2359
)	O	2359
is	O	2359
caused	O	2359
by	O	2359
expansion	O	2359
of	O	2359
a	O	2359
glutamine	O	2359
repeat	O	2359
in	O	2359
the	O	2359
amino	O	2359
-	O	2359
terminal	O	2359
region	O	2359
of	O	2359
huntingtin	O	2359
.	O	2359

Here	O	2361
we	O	2361
report	O	2361
that	O	2361
,	O	2361
in	O	2361
mutant	O	2361
mice	O	2361
expressing	O	2361
HD	B-Disease	2361
repeats	O	2361
,	O	2361
the	O	2361
production	O	2361
and	O	2361
aggregation	O	2361
of	O	2361
N	O	2361
-	O	2361
terminal	O	2361
huntingtin	O	2361
fragments	O	2361
preferentially	O	2361
occur	O	2361
in	O	2361
HD	B-Disease	2361
-	O	2361
affected	O	2361
neurons	O	2361
and	O	2361
their	O	2361
processes	O	2361
and	O	2361
axonal	O	2361
terminals	O	2361
.	O	2361

N	O	2362
-	O	2362
terminal	O	2362
fragments	O	2362
of	O	2362
mutant	O	2362
huntingtin	O	2362
form	O	2362
aggregates	O	2362
and	O	2362
induce	O	2362
neuritic	B-Disease	2362
degeneration	I-Disease	2362
in	O	2362
cultured	O	2362
striatal	O	2362
neurons	O	2362
.	O	2362

The	O	2364
specific	O	2364
processing	O	2364
and	O	2364
accumulation	O	2364
of	O	2364
toxic	O	2364
fragments	O	2364
of	O	2364
N	O	2364
-	O	2364
terminal	O	2364
huntingtin	O	2364
in	O	2364
HD	B-Disease	2364
-	O	2364
affected	O	2364
striatal	O	2364
neurons	O	2364
,	O	2364
especially	O	2364
in	O	2364
their	O	2364
neuronal	O	2364
processes	O	2364
and	O	2364
axonal	O	2364
terminals	O	2364
,	O	2364
may	O	2364
contribute	O	2364
to	O	2364
the	O	2364
selective	O	2364
neuropathology	O	2364
of	O	2364
HD	B-Disease	2364
.	O	2364

BRCA1	O	2366
is	O	2366
associated	O	2366
with	O	2366
a	O	2366
human	O	2366
SWI	O	2366
/	O	2366
SNF	O	2366
-	O	2366
related	O	2366
complex	O	2366
:	O	2366
linking	O	2366
chromatin	O	2366
remodeling	O	2366
to	O	2366
breast	B-Disease	2366
cancer	I-Disease	2366
.	O	2366

Germline	O	2367
mutations	O	2367
in	O	2367
the	O	2367
tumor	B-Disease	2367
suppressor	O	2367
gene	O	2367
,	O	2367
BRCA1	O	2367
,	O	2367
predispose	O	2367
individuals	O	2367
to	O	2367
breast	B-Disease	2367
and	I-Disease	2367
ovarian	I-Disease	2367
cancers	I-Disease	2367
.	O	2367

Moreover	O	2371
,	O	2371
p53	O	2371
-	O	2371
mediated	O	2371
stimulation	O	2371
of	O	2371
transcription	O	2371
by	O	2371
BRCA1	O	2371
was	O	2371
completely	O	2371
abrogated	O	2371
by	O	2371
either	O	2371
a	O	2371
dominant	O	2371
-	O	2371
negative	O	2371
mutant	O	2371
of	O	2371
BRG1	O	2371
or	O	2371
the	O	2371
cancer	B-Disease	2371
-	O	2371
causing	O	2371
deletion	O	2371
in	O	2371
exon	O	2371
11	O	2371
of	O	2371
BRCA1	O	2371
.	O	2371

Asef	O	2374
,	O	2374
a	O	2374
link	O	2374
between	O	2374
the	O	2374
tumor	B-Disease	2374
suppressor	O	2374
APC	O	2374
and	O	2374
G	O	2374
-	O	2374
protein	O	2374
signaling	O	2374
.	O	2374

The	O	2375
adenomatous	B-Disease	2375
polyposis	I-Disease	2375
coli	I-Disease	2375
gene	O	2375
(	O	2375
APC	O	2375
)	O	2375
is	O	2375
mutated	O	2375
in	O	2375
familial	B-Disease	2375
adenomatous	I-Disease	2375
polyposis	I-Disease	2375
and	O	2375
in	O	2375
sporadic	O	2375
colorectal	B-Disease	2375
tumors	I-Disease	2375
.	O	2375

Here	O	2376
the	O	2376
APC	B-Disease	2376
gene	O	2376
product	O	2376
is	O	2376
shown	O	2376
to	O	2376
bind	O	2376
through	O	2376
its	O	2376
armadillo	O	2376
repeat	O	2376
domain	O	2376
to	O	2376
a	O	2376
Rac	O	2376
-	O	2376
specific	O	2376
guanine	O	2376
nucleotide	O	2376
exchange	O	2376
factor	O	2376
(	O	2376
GEF	O	2376
)	O	2376
,	O	2376
termed	O	2376
Asef	O	2376
.	O	2376

The	O	2382
axonal	O	2382
chemoattractant	O	2382
netrin	O	2382
-	O	2382
1	O	2382
guides	O	2382
spinal	O	2382
commissural	O	2382
axons	O	2382
by	O	2382
activating	O	2382
its	O	2382
receptor	O	2382
DCC	O	2382
(	O	2382
Deleted	O	2382
in	O	2382
Colorectal	B-Disease	2382
Cancer	I-Disease	2382
)	O	2382
.	O	2382

Myotonic	B-Disease	2387
dystrophy	I-Disease	2387
in	O	2387
transgenic	O	2387
mice	O	2387
expressing	O	2387
an	O	2387
expanded	O	2387
CUG	O	2387
repeat	O	2387
.	O	2387

Myotonic	B-Disease	2388
dystrophy	I-Disease	2388
(	O	2388
DM	B-Disease	2388
)	O	2388
,	O	2388
the	O	2388
most	O	2388
common	O	2388
form	O	2388
of	O	2388
muscular	B-Disease	2388
dystrophy	I-Disease	2388
in	O	2388
adult	O	2388
humans	O	2388
,	O	2388
results	O	2388
from	O	2388
expansion	O	2388
of	O	2388
a	O	2388
CTG	O	2388
repeat	O	2388
in	O	2388
the	O	2388
3	O	2388
untranslated	O	2388
region	O	2388
of	O	2388
the	O	2388
DMPK	O	2388
gene	O	2388
.	O	2388

Mice	O	2391
that	O	2391
expressed	O	2391
expanded	O	2391
CUG	O	2391
repeats	O	2391
developed	O	2391
myotonia	B-Disease	2391
and	O	2391
myopathy	B-Disease	2391
,	O	2391
whereas	O	2391
mice	O	2391
expressing	O	2391
a	O	2391
nonexpanded	O	2391
repeat	O	2391
did	O	2391
not	O	2391
.	O	2391

Thus	O	2392
,	O	2392
transcripts	O	2392
with	O	2392
expanded	O	2392
CUG	O	2392
repeats	O	2392
are	O	2392
sufficient	O	2392
to	O	2392
generate	O	2392
a	O	2392
DM	B-Disease	2392
phenotype	O	2392
.	O	2392

Genomic	O	2395
rearrangements	O	2395
of	O	2395
the	O	2395
APC	B-Disease	2395
tumor	I-Disease	2395
-	O	2395
suppressor	O	2395
gene	O	2395
in	O	2395
familial	B-Disease	2395
adenomatous	I-Disease	2395
polyposis	I-Disease	2395
.	O	2395

Germline	O	2396
mutations	O	2396
of	O	2396
the	O	2396
adenomatous	B-Disease	2396
polyposis	I-Disease	2396
coli	I-Disease	2396
(	I-Disease	2396
APC	I-Disease	2396
)	I-Disease	2396
tumor	I-Disease	2396
-	O	2396
suppressor	O	2396
gene	O	2396
result	O	2396
in	O	2396
the	O	2396
hereditary	B-Disease	2396
colorectal	I-Disease	2396
cancer	I-Disease	2396
syndrome	I-Disease	2396
familial	B-Disease	2396
adenomatous	I-Disease	2396
polyposis	I-Disease	2396
(	O	2396
FAP	B-Disease	2396
)	O	2396
.	O	2396

Almost	O	2397
all	O	2397
APC	B-Disease	2397
mutations	O	2397
that	O	2397
have	O	2397
been	O	2397
identified	O	2397
are	O	2397
single	O	2397
-	O	2397
nucleotide	O	2397
alterations	O	2397
,	O	2397
small	O	2397
insertions	O	2397
,	O	2397
or	O	2397
small	O	2397
deletions	O	2397
that	O	2397
would	O	2397
truncate	O	2397
the	O	2397
protein	O	2397
product	O	2397
of	O	2397
the	O	2397
gene	O	2397
.	O	2397

No	O	2398
well	O	2398
-	O	2398
characterized	O	2398
intragenic	O	2398
rearrangement	O	2398
of	O	2398
APC	O	2398
has	O	2398
been	O	2398
described	O	2398
,	O	2398
and	O	2398
the	O	2398
prevalence	O	2398
of	O	2398
this	O	2398
type	O	2398
of	O	2398
mutation	O	2398
in	O	2398
FAP	B-Disease	2398
patients	O	2398
is	O	2398
not	O	2398
clear	O	2398
.	O	2398

We	O	2399
screened	O	2399
49	O	2399
potential	O	2399
FAP	B-Disease	2399
families	O	2399
and	O	2399
identified	O	2399
26	O	2399
different	O	2399
germline	O	2399
APC	B-Disease	2399
mutations	O	2399
in	O	2399
30	O	2399
families	O	2399
.	O	2399

The	O	2407
identification	O	2407
of	O	2407
four	O	2407
genomic	O	2407
rearrangements	O	2407
among	O	2407
30	O	2407
mutations	O	2407
suggests	O	2407
that	O	2407
genomic	O	2407
rearrangements	O	2407
are	O	2407
frequent	O	2407
germline	O	2407
APC	B-Disease	2407
mutations	O	2407
.	O	2407

Detection	O	2409
of	O	2409
a	O	2409
novel	O	2409
missense	O	2409
mutation	O	2409
and	O	2409
second	O	2409
recurrent	O	2409
mutation	O	2409
in	O	2409
the	O	2409
CACNA1A	O	2409
gene	O	2409
in	O	2409
individuals	O	2409
with	O	2409
EA	B-Disease	2409
-	I-Disease	2409
2	I-Disease	2409
and	O	2409
FHM	B-Disease	2409
.	O	2409

episodic	B-Disease	2411
ataxia	I-Disease	2411
type	I-Disease	2411
2	I-Disease	2411
(	O	2411
EA	B-Disease	2411
-	I-Disease	2411
2	I-Disease	2411
)	O	2411
,	O	2411
familial	B-Disease	2411
hemiplegic	I-Disease	2411
migraine	I-Disease	2411
(	O	2411
FHM	B-Disease	2411
)	O	2411
and	O	2411
spinocerebellar	B-Disease	2411
ataxia	I-Disease	2411
6	I-Disease	2411
(	O	2411
SCA6	B-Disease	2411
)	O	2411
.	O	2411

For	O	2412
individuals	O	2412
with	O	2412
EA	B-Disease	2412
-	I-Disease	2412
2	I-Disease	2412
,	O	2412
the	O	2412
mutations	O	2412
described	O	2412
thus	O	2412
far	O	2412
are	O	2412
presumed	O	2412
to	O	2412
result	O	2412
in	O	2412
a	O	2412
truncated	O	2412
protein	O	2412
product	O	2412
.	O	2412

Several	O	2413
different	O	2413
missense	O	2413
mutations	O	2413
have	O	2413
been	O	2413
identified	O	2413
in	O	2413
patients	O	2413
with	O	2413
FHM	B-Disease	2413
.	O	2413

We	O	2416
have	O	2416
characterised	O	2416
a	O	2416
novel	O	2416
missense	O	2416
mutation	O	2416
,	O	2416
G5260A	O	2416
,	O	2416
in	O	2416
exon	O	2416
32	O	2416
in	O	2416
a	O	2416
family	O	2416
segregating	O	2416
for	O	2416
EA	B-Disease	2416
-	I-Disease	2416
2	I-Disease	2416
.	O	2416

Furthermore	O	2419
,	O	2419
this	O	2419
mutation	O	2419
has	O	2419
been	O	2419
detected	O	2419
in	O	2419
a	O	2419
family	O	2419
member	O	2419
with	O	2419
mild	O	2419
clinical	O	2419
signs	O	2419
including	O	2419
only	O	2419
migraine	B-Disease	2419
.	O	2419

Additionally	O	2420
,	O	2420
a	O	2420
second	O	2420
previously	O	2420
identified	O	2420
recurrent	O	2420
muta	O	2420
tion	O	2420
,	O	2420
C2272T	O	2420
,	O	2420
in	O	2420
exon	O	2420
16	O	2420
has	O	2420
been	O	2420
discovered	O	2420
in	O	2420
a	O	2420
patient	O	2420
with	O	2420
FHM	B-Disease	2420
.	O	2420

Analbuminemia	B-Disease	2422
in	O	2422
a	O	2422
neonate	O	2422
.	O	2422

A	O	2423
small	O	2423
-	O	2423
for	O	2423
-	O	2423
gestational	O	2423
-	O	2423
age	O	2423
infant	O	2423
,	O	2423
found	O	2423
to	O	2423
have	O	2423
analbuminemia	B-Disease	2423
in	O	2423
the	O	2423
neonatal	O	2423
period	O	2423
,	O	2423
is	O	2423
reported	O	2423
and	O	2423
the	O	2423
twelve	O	2423
cases	O	2423
recorded	O	2423
in	O	2423
the	O	2423
world	O	2423
literature	O	2423
are	O	2423
reviewed	O	2423
.	O	2423

Patients	O	2424
lacking	O	2424
this	O	2424
serum	O	2424
protein	O	2424
are	O	2424
essentially	O	2424
asymptomatic	O	2424
,	O	2424
apart	O	2424
from	O	2424
minimal	O	2424
ankle	B-Disease	2424
edema	I-Disease	2424
and	O	2424
ease	B-Disease	2424
of	I-Disease	2424
fatigue	I-Disease	2424
.	O	2424

Apparent	O	2425
compensatory	O	2425
mechanisms	O	2425
which	O	2425
come	O	2425
into	O	2425
play	O	2425
when	O	2425
serum	O	2425
albumin	O	2425
is	O	2425
low	O	2425
include	O	2425
prolonged	O	2425
half	O	2425
-	O	2425
life	O	2425
of	O	2425
albumin	O	2425
and	O	2425
transferrin	O	2425
,	O	2425
an	O	2425
increase	O	2425
in	O	2425
serum	O	2425
globulins	O	2425
,	O	2425
beta	O	2425
lipoprotein	O	2425
,	O	2425
and	O	2425
glycoproteins	O	2425
,	O	2425
arterial	B-Disease	2425
hypotension	I-Disease	2425
with	O	2425
reduced	O	2425
capillary	O	2425
hydrostatic	O	2425
pressure	O	2425
,	O	2425
and	O	2425
the	O	2425
ability	O	2425
to	O	2425
respond	O	2425
with	O	2425
rapid	O	2425
sodium	O	2425
and	O	2425
chloride	O	2425
diuresis	O	2425
in	O	2425
response	O	2425
to	O	2425
small	O	2425
volume	O	2425
changes	O	2425
.	O	2425

Histidinemia	B-Disease	2428
.	O	2428

Two	O	2430
brothers	O	2430
,	O	2430
6	O	2430
and	O	2430
13	O	2430
years	O	2430
old	O	2430
,	O	2430
had	O	2430
histidinemia	B-Disease	2430
.	O	2430

Carrier	O	2434
detection	O	2434
of	O	2434
pyruvate	B-Disease	2434
carboxylase	I-Disease	2434
deficiency	I-Disease	2434
in	O	2434
fibroblasts	O	2434
and	O	2434
lymphocytes	O	2434
.	O	2434

1	O	2440
)	O	2440
activity	O	2440
was	O	2440
determined	O	2440
in	O	2440
the	O	2440
circulating	O	2440
peripheral	O	2440
lymphocytes	O	2440
and	O	2440
cultured	O	2440
skin	O	2440
fibroblasts	O	2440
from	O	2440
the	O	2440
family	O	2440
of	O	2440
a	O	2440
patient	O	2440
with	O	2440
hepatic	O	2440
,	O	2440
cerebral	O	2440
,	O	2440
renal	O	2440
cortical	O	2440
,	O	2440
leukocyte	O	2440
,	O	2440
and	O	2440
fibroblast	O	2440
pyruvate	B-Disease	2440
carboxylase	I-Disease	2440
deficiency	I-Disease	2440
(	O	2440
PC	B-Disease	2440
Portland	I-Disease	2440
deficiency	I-Disease	2440
)	O	2440
.	O	2440

Glucose	O	2445
-	O	2445
6	O	2445
-	O	2445
phosphate	O	2445
dehydrogenase	O	2445
variants	O	2445
from	O	2445
Italian	O	2445
subjects	O	2445
associated	O	2445
with	O	2445
severe	B-Disease	2445
neonatal	I-Disease	2445
jaundice	I-Disease	2445
.	O	2445

Screening	O	2446
for	O	2446
the	O	2446
G6PD	B-Disease	2446
deficiency	I-Disease	2446
was	O	2446
carried	O	2446
out	O	2446
at	O	2446
the	O	2446
Maternity	O	2446
Division	O	2446
of	O	2446
the	O	2446
Galliera	O	2446
Hospital	O	2446
in	O	2446
Genoa	O	2446
,	O	2446
Italy	O	2446
.	O	2446

Two	O	2447
groups	O	2447
of	O	2447
subjects	O	2447
with	O	2447
hyperbilirubinaemia	B-Disease	2447
of	O	2447
non	O	2447
-	O	2447
immunological	O	2447
origin	O	2447
were	O	2447
examined	O	2447
(	O	2447
a	O	2447
)	O	2447
302	O	2447
newborn	O	2447
babies	O	2447
of	O	2447
Sardinian	O	2447
extraction	O	2447
(	O	2447
on	O	2447
cord	O	2447
blood	O	2447
)	O	2447
and	O	2447
(	O	2447
b	O	2447
)	O	2447
201	O	2447
newborn	O	2447
babies	O	2447
of	O	2447
south	O	2447
Italian	O	2447
ancestry	O	2447
(	O	2447
on	O	2447
peripheral	O	2447
blood	O	2447
)	O	2447
.	O	2447

In	O	2451
the	O	2451
present	O	2451
work	O	2451
these	O	2451
three	O	2451
cases	O	2451
,	O	2451
each	O	2451
with	O	2451
severe	B-Disease	2451
neonatal	I-Disease	2451
jaundice	I-Disease	2451
,	O	2451
are	O	2451
reported	O	2451
.	O	2451

Cytogenetic	O	2455
investigations	O	2455
in	O	2455
families	O	2455
with	O	2455
ataxia	B-Disease	2455
-	I-Disease	2455
telangiectasia	I-Disease	2455
.	O	2455

Chromosomal	O	2456
studies	O	2456
were	O	2456
performed	O	2456
on	O	2456
peripheral	O	2456
blood	O	2456
lymphocytes	O	2456
and	O	2456
cultured	O	2456
skin	O	2456
fibroblasts	O	2456
from	O	2456
five	O	2456
Israeli	O	2456
-	O	2456
Moroccan	O	2456
families	O	2456
with	O	2456
ataxia	B-Disease	2456
-	I-Disease	2456
telangiectasia	I-Disease	2456
.	O	2456

Prenatal	O	2463
diagnosis	O	2463
of	O	2463
Wolman	B-Disease	2463
disease	I-Disease	2463
.	O	2463

Two	O	2464
pregnancies	O	2464
at	O	2464
risk	O	2464
for	O	2464
Wolman	B-Disease	2464
disease	I-Disease	2464
were	O	2464
monitored	O	2464
by	O	2464
assay	O	2464
and	O	2464
electrophoresis	O	2464
of	O	2464
acid	O	2464
lipase	O	2464
in	O	2464
cultured	O	2464
amniotic	O	2464
-	O	2464
fluid	O	2464
cells	O	2464
.	O	2464

Electrophoresis	O	2466
of	O	2466
cell	O	2466
extracts	O	2466
revealed	O	2466
the	O	2466
absence	O	2466
of	O	2466
the	O	2466
A	O	2466
form	O	2466
of	O	2466
acid	O	2466
lipase	O	2466
,	O	2466
consistent	O	2466
with	O	2466
the	O	2466
diagnosis	O	2466
of	O	2466
Wolman	B-Disease	2466
disease	I-Disease	2466
.	O	2466

The	O	2471
results	O	2471
suggest	O	2471
that	O	2471
the	O	2471
prenatal	O	2471
diagnosis	O	2471
of	O	2471
Wolman	B-Disease	2471
disease	I-Disease	2471
be	O	2471
made	O	2471
using	O	2471
the	O	2471
radioassay	O	2471
of	O	2471
acid	O	2471
lipase	O	2471
and	O	2471
/	O	2471
or	O	2471
electrophoresis	O	2471
.	O	2471

Malignant	B-Disease	2473
neoplasms	I-Disease	2473
in	O	2473
the	O	2473
families	O	2473
of	O	2473
patients	O	2473
with	O	2473
ataxia	B-Disease	2473
-	I-Disease	2473
telangiectasia	I-Disease	2473
.	O	2473

Ataxia	B-Disease	2474
-	I-Disease	2474
telangiectasia	I-Disease	2474
(	O	2474
A	B-Disease	2474
-	I-Disease	2474
T	I-Disease	2474
)	O	2474
is	O	2474
an	O	2474
autosomal	B-Disease	2474
recessive	I-Disease	2474
syndrome	I-Disease	2474
associated	O	2474
with	O	2474
a	O	2474
greatly	O	2474
increased	O	2474
incidence	O	2474
of	O	2474
malignant	B-Disease	2474
neoplasms	I-Disease	2474
in	O	2474
homozygous	O	2474
affected	O	2474
individuals	O	2474
.	O	2474

Heterozygotes	O	2475
for	O	2475
the	O	2475
gene	O	2475
for	O	2475
A	B-Disease	2475
-	I-Disease	2475
T	I-Disease	2475
are	O	2475
thought	O	2475
to	O	2475
comprise	O	2475
about	O	2475
1	O	2475
%	O	2475
of	O	2475
the	O	2475
general	O	2475
population	O	2475
and	O	2475
,	O	2475
therefore	O	2475
,	O	2475
it	O	2475
is	O	2475
important	O	2475
to	O	2475
know	O	2475
whether	O	2475
this	O	2475
gene	O	2475
also	O	2475
predisposes	O	2475
the	O	2475
heterozygous	O	2475
carrier	O	2475
to	O	2475
cancers	B-Disease	2475
.	O	2475

Heterozygous	O	2476
carriers	O	2476
of	O	2476
this	O	2476
gene	O	2476
are	O	2476
common	O	2476
among	O	2476
the	O	2476
close	O	2476
relatives	O	2476
of	O	2476
patients	O	2476
with	O	2476
A	B-Disease	2476
-	I-Disease	2476
T	I-Disease	2476
,	O	2476
although	O	2476
individual	O	2476
carriers	O	2476
cannot	O	2476
be	O	2476
identified	O	2476
by	O	2476
any	O	2476
clinical	O	2476
criterion	O	2476
or	O	2476
laboratory	O	2476
test	O	2476
.	O	2476

For	O	2477
this	O	2477
reason	O	2477
,	O	2477
we	O	2477
compared	O	2477
the	O	2477
incidence	O	2477
of	O	2477
death	O	2477
from	O	2477
malignant	B-Disease	2477
neoplasms	I-Disease	2477
in	O	2477
2	O	2477
families	O	2477
of	O	2477
patients	O	2477
with	O	2477
A	B-Disease	2477
-	I-Disease	2477
T	I-Disease	2477
to	O	2477
that	O	2477
expected	O	2477
in	O	2477
a	O	2477
random	O	2477
sample	O	2477
of	O	2477
the	O	2477
general	O	2477
population	O	2477
.	O	2477

There	O	2478
were	O	2478
59	O	2478
deaths	O	2478
from	O	2478
malignant	B-Disease	2478
neoplasms	I-Disease	2478
in	O	2478
relatives	O	2478
dying	O	2478
before	O	2478
age	O	2478
75	O	2478
,	O	2478
compared	O	2478
to	O	2478
42	O	2478
.	O	2478

For	O	2481
A	B-Disease	2481
-	I-Disease	2481
T	I-Disease	2481
heterozygotes	O	2481
younger	O	2481
than	O	2481
age	O	2481
45	O	2481
,	O	2481
the	O	2481
risk	O	2481
of	O	2481
dying	O	2481
from	O	2481
a	O	2481
malignant	B-Disease	2481
neoplasm	I-Disease	2481
was	O	2481
estimated	O	2481
to	O	2481
be	O	2481
greater	O	2481
than	O	2481
5	O	2481
times	O	2481
the	O	2481
risk	O	2481
for	O	2481
the	O	2481
general	O	2481
population	O	2481
.	O	2481

A	B-Disease	2482
-	I-Disease	2482
T	I-Disease	2482
heterozygotes	O	2482
may	O	2482
comprise	O	2482
more	O	2482
than	O	2482
5	O	2482
%	O	2482
of	O	2482
all	O	2482
persons	O	2482
dying	O	2482
from	O	2482
a	O	2482
cancer	B-Disease	2482
before	O	2482
age	O	2482
45	O	2482
.	O	2482

The	O	2483
incidence	O	2483
of	O	2483
ovarian	B-Disease	2483
,	I-Disease	2483
gastric	I-Disease	2483
,	I-Disease	2483
and	I-Disease	2483
biliary	I-Disease	2483
system	I-Disease	2483
carcinomas	I-Disease	2483
and	O	2483
of	O	2483
leukemia	B-Disease	2483
and	O	2483
lymphoma	B-Disease	2483
was	O	2483
increased	O	2483
in	O	2483
these	O	2483
A	B-Disease	2483
-	I-Disease	2483
T	I-Disease	2483
families	O	2483
.	O	2483

Other	O	2484
neoplasms	B-Disease	2484
that	O	2484
may	O	2484
be	O	2484
associated	O	2484
with	O	2484
this	O	2484
gene	O	2484
in	O	2484
heterozygotes	O	2484
include	O	2484
pancreatic	B-Disease	2484
,	I-Disease	2484
basal	I-Disease	2484
cell	I-Disease	2484
,	I-Disease	2484
colonic	I-Disease	2484
,	I-Disease	2484
breast	I-Disease	2484
,	I-Disease	2484
and	I-Disease	2484
cervical	I-Disease	2484
carcinomas	I-Disease	2484
.	O	2484

Striking	O	2485
prevalence	O	2485
of	O	2485
ankylosing	B-Disease	2485
spondylitis	I-Disease	2485
in	O	2485
Ankylosing	B-Disease	2488
spondylitis	I-Disease	2488
is	O	2488
diagnosed	O	2488
once	O	2488
or	O	2488
twice	O	2488
in	O	2488
each	O	2488
1000	O	2488
males	O	2488
and	O	2488
one	O	2488
tenth	O	2488
as	O	2488
frequently	O	2488
in	O	2488
females	O	2488
,	O	2488
but	O	2488
the	O	2488
true	O	2488
prevalence	O	2488
is	O	2488
unknown	O	2488
.	O	2488

Evaluation	O	2492
by	O	2492
postal	O	2492
questionnaires	O	2492
,	O	2492
and	O	2492
pelvic	O	2492
radiography	O	2492
of	O	2492
78	O	2492
HL	O	2492
-	O	2492
A	O	2492
27W	O	2492
-	O	2492
positive	O	2492
blood	O	2492
donors	O	2492
selected	O	2492
from	O	2492
a	O	2492
group	O	2492
of	O	2492
apparently	O	2492
healthy	O	2492
subjects	O	2492
revealed	O	2492
14	O	2492
who	O	2492
satisfied	O	2492
the	O	2492
criteria	O	2492
for	O	2492
definite	O	2492
ankylosing	B-Disease	2492
spondylitis	I-Disease	2492
.	O	2492

For	O	2495
a	O	2495
person	O	2495
of	O	2495
either	O	2495
sex	O	2495
with	O	2495
HL	O	2495
-	O	2495
A	O	2495
W27	O	2495
,	O	2495
there	O	2495
appears	O	2495
to	O	2495
be	O	2495
about	O	2495
a	O	2495
20	O	2495
per	O	2495
cent	O	2495
chance	O	2495
that	O	2495
ankylosing	B-Disease	2495
spondylitis	I-Disease	2495
will	O	2495
develop	O	2495
,	O	2495
suggesting	O	2495
a	O	2495
prevalence	O	2495
of	O	2495
10	O	2495
to	O	2495
15	O	2495
per	O	2495
thousand	O	2495
.	O	2495

Analbuminemia	B-Disease	2498
in	O	2498
an	O	2498
American	O	2498
Indian	O	2498
girl	O	2498
.	O	2498

Analbuminemia	B-Disease	2499
was	O	2499
fortuitously	O	2499
detected	O	2499
in	O	2499
a	O	2499
nonedematous	O	2499
12	O	2499
-	O	2499
year	O	2499
-	O	2499
old	O	2499
American	O	2499
Indian	O	2499
girl	O	2499
with	O	2499
atopic	B-Disease	2499
dermatitis	I-Disease	2499
,	O	2499
mild	O	2499
bronchial	B-Disease	2499
asthma	I-Disease	2499
,	O	2499
a	O	2499
mild	O	2499
seizure	B-Disease	2499
disorder	I-Disease	2499
,	O	2499
and	O	2499
hyperlipoproteinemia	B-Disease	2499
with	O	2499
a	O	2499
corneal	B-Disease	2499
arcus	I-Disease	2499
.	O	2499

The	O	2502
pedigree	O	2502
and	O	2502
clinical	O	2502
findings	O	2502
were	O	2502
compatible	O	2502
with	O	2502
autosomal	O	2502
recessive	O	2502
transmission	O	2502
of	O	2502
analbuminemia	B-Disease	2502
.	O	2502

Gc	O	2505
-	O	2505
protein	O	2505
levels	O	2505
were	O	2505
normal	O	2505
in	O	2505
the	O	2505
patient	O	2505
and	O	2505
together	O	2505
with	O	2505
normal	O	2505
chromosomal	O	2505
banding	O	2505
studies	O	2505
make	O	2505
it	O	2505
unlikely	O	2505
that	O	2505
a	O	2505
chromosomal	O	2505
deletion	O	2505
caused	O	2505
analbuminemia	B-Disease	2505
.	O	2505

Gc	O	2506
-	O	2506
types	O	2506
in	O	2506
the	O	2506
family	O	2506
were	O	2506
compatible	O	2506
with	O	2506
,	O	2506
but	O	2506
did	O	2506
not	O	2506
prove	O	2506
,	O	2506
linkage	O	2506
of	O	2506
analbuminemia	B-Disease	2506
to	O	2506
the	O	2506
Gc	O	2506
-	O	2506
locus	O	2506
.	O	2506

thalassemia	B-Disease	2508
Deletion	O	2511
of	O	2511
the	O	2511
KIT	O	2511
and	O	2511
PDGFRA	O	2511
genes	O	2511
in	O	2511
a	O	2511
patient	O	2511
with	O	2511
piebaldism	B-Disease	2511
.	O	2511

We	O	2512
have	O	2512
previously	O	2512
shown	O	2512
that	O	2512
human	O	2512
piebaldism	B-Disease	2512
results	O	2512
from	O	2512
mutations	O	2512
of	O	2512
the	O	2512
KIT	O	2512
gene	O	2512
,	O	2512
which	O	2512
encodes	O	2512
the	O	2512
receptor	O	2512
for	O	2512
the	O	2512
mast	O	2512
/	O	2512
stem	O	2512
cell	O	2512
growth	O	2512
factor	O	2512
and	O	2512
is	O	2512
located	O	2512
in	O	2512
chromosome	O	2512
segment	O	2512
4q12	O	2512
.	O	2512

Using	O	2513
DNA	O	2513
of	O	2513
a	O	2513
patient	O	2513
with	O	2513
piebaldism	B-Disease	2513
,	O	2513
mental	B-Disease	2513
retardation	I-Disease	2513
,	O	2513
and	O	2513
multiple	B-Disease	2513
congenital	I-Disease	2513
anomalies	I-Disease	2513
associated	O	2513
with	O	2513
a	O	2513
46	O	2513
,	O	2513
XY	O	2513
,	O	2513
del	O	2513
(	O	2513
4	O	2513
)	O	2513
(	O	2513
q12q21	O	2513
.	O	2513

Therefore	O	2516
,	O	2516
deletion	O	2516
of	O	2516
the	O	2516
KIT	O	2516
and	O	2516
PDGFRA	O	2516
genes	O	2516
may	O	2516
account	O	2516
for	O	2516
the	O	2516
piebald	B-Disease	2516
phenotype	O	2516
in	O	2516
this	O	2516
patient	O	2516
.	O	2516

A	O	2517
germ	O	2517
line	O	2517
mutation	O	2517
within	O	2517
the	O	2517
coding	O	2517
sequence	O	2517
for	O	2517
the	O	2517
putative	O	2517
5	O	2517
-	O	2517
phosphoribosyl	O	2517
-	O	2517
1	O	2517
-	O	2517
pyrophosphate	O	2517
binding	O	2517
site	O	2517
of	O	2517
hypoxanthine	O	2517
-	O	2517
guanine	O	2517
phosphoribosyltransferase	O	2517
(	O	2517
HPRT	O	2517
)	O	2517
in	O	2517
a	O	2517
Lesch	B-Disease	2517
-	I-Disease	2517
Nyhan	I-Disease	2517
patient	O	2517
:	O	2517
missense	O	2517
mutations	O	2517
within	O	2517
a	O	2517
functionally	O	2517
important	O	2517
region	O	2517
probably	O	2517
cause	O	2517
disease	O	2517
.	O	2517

Lesch	B-Disease	2518
-	I-Disease	2518
Nyhan	I-Disease	2518
syndrome	I-Disease	2518
caused	O	2518
by	O	2518
a	O	2518
complete	B-Disease	2518
deficiency	I-Disease	2518
of	I-Disease	2518
hypoxanthine	I-Disease	2518
guanine	I-Disease	2518
phosphoribosyltransferase	I-Disease	2518
(	O	2518
HPRT	O	2518
)	O	2518
is	O	2518
the	O	2518
result	O	2518
of	O	2518
a	O	2518
heterogeneous	O	2518
group	O	2518
of	O	2518
germ	O	2518
line	O	2518
mutations	O	2518
.	O	2518

We	O	2520
report	O	2520
here	O	2520
a	O	2520
newly	O	2520
identified	O	2520
HPRT	O	2520
mutation	O	2520
in	O	2520
a	O	2520
Japanese	O	2520
patient	O	2520
with	O	2520
Lesch	B-Disease	2520
-	I-Disease	2520
Nyhan	I-Disease	2520
syndrome	I-Disease	2520
.	O	2520

Missense	O	2524
mutations	O	2524
in	O	2524
human	O	2524
HPRT	B-Disease	2524
deficient	I-Disease	2524
patients	O	2524
thus	O	2524
far	O	2524
reported	O	2524
tend	O	2524
to	O	2524
accumulate	O	2524
in	O	2524
this	O	2524
functionally	O	2524
active	O	2524
region	O	2524
.	O	2524

Characterisation	O	2528
of	O	2528
a	O	2528
new	O	2528
rare	O	2528
fragile	O	2528
site	O	2528
easily	O	2528
confused	O	2528
with	O	2528
the	O	2528
fragile	B-Disease	2528
X	I-Disease	2528
.	O	2528

The	O	2531
fragile	O	2531
site	O	2531
is	O	2531
not	O	2531
associated	O	2531
with	O	2531
mental	B-Disease	2531
retardation	I-Disease	2531
,	O	2531
it	O	2531
does	O	2531
not	O	2531
give	O	2531
abnormal	O	2531
results	O	2531
when	O	2531
subjected	O	2531
to	O	2531
Southern	O	2531
analysis	O	2531
with	O	2531
probe	O	2531
pfxa3	O	2531
which	O	2531
detects	O	2531
the	O	2531
unstable	O	2531
DNA	O	2531
sequence	O	2531
characteristic	O	2531
of	O	2531
fragile	B-Disease	2531
X	I-Disease	2531
syndrome	I-Disease	2531
.	O	2531

The	O	2533
distinction	O	2533
between	O	2533
the	O	2533
two	O	2533
fragile	O	2533
sites	O	2533
is	O	2533
important	O	2533
clinically	O	2533
since	O	2533
cytogenetic	O	2533
detection	O	2533
of	O	2533
FRAXE	O	2533
,	O	2533
without	O	2533
molecular	O	2533
analysis	O	2533
,	O	2533
could	O	2533
result	O	2533
in	O	2533
misdiagnosis	O	2533
of	O	2533
fragile	B-Disease	2533
X	I-Disease	2533
syndrome	I-Disease	2533
.	O	2533

The	O	2535
Norrie	B-Disease	2535
disease	I-Disease	2535
gene	O	2535
maps	O	2535
to	O	2535
a	O	2535
150	O	2535
kb	O	2535
region	O	2535
on	O	2535
chromosome	O	2535
Xp11	O	2535
.	O	2535

Norrie	B-Disease	2537
disease	I-Disease	2537
is	O	2537
a	O	2537
human	O	2537
X	B-Disease	2537
-	I-Disease	2537
linked	I-Disease	2537
recessive	I-Disease	2537
disorder	I-Disease	2537
of	O	2537
unknown	O	2537
etiology	O	2537
characterized	O	2537
by	O	2537
congenital	B-Disease	2537
blindness	I-Disease	2537
,	O	2537
sensory	B-Disease	2537
neural	I-Disease	2537
deafness	I-Disease	2537
and	O	2537
mental	B-Disease	2537
retardation	I-Disease	2537
.	O	2537

We	O	2541
report	O	2541
here	O	2541
fine	O	2541
physical	O	2541
mapping	O	2541
of	O	2541
the	O	2541
obligate	O	2541
region	O	2541
containing	O	2541
the	O	2541
Norrie	B-Disease	2541
disease	I-Disease	2541
gene	O	2541
(	O	2541
NDP	O	2541
)	O	2541
defined	O	2541
by	O	2541
a	O	2541
recombination	O	2541
and	O	2541
by	O	2541
the	O	2541
smallest	O	2541
submicroscopic	O	2541
chromosomal	O	2541
deletion	O	2541
associated	O	2541
with	O	2541
Norrie	B-Disease	2541
disease	I-Disease	2541
identified	O	2541
to	O	2541
date	O	2541
.	O	2541

Molecular	O	2553
basis	O	2553
of	O	2553
phenylketonuria	B-Disease	2553
and	O	2553
related	O	2553
hyperphenylalaninemias	B-Disease	2553
:	O	2553
mutations	O	2553
and	O	2553
polymorphisms	O	2553
in	O	2553
the	O	2553
human	O	2553
phenylalanine	O	2553
hydroxylase	O	2553
gene	O	2553
.	O	2553

Mutations	O	2554
in	O	2554
the	O	2554
human	O	2554
phenylalanine	O	2554
hydroxylase	O	2554
gene	O	2554
producing	O	2554
phenylketonuria	B-Disease	2554
or	O	2554
hyperphenylalaninemia	B-Disease	2554
have	O	2554
now	O	2554
been	O	2554
identified	O	2554
in	O	2554
many	O	2554
patients	O	2554
from	O	2554
various	O	2554
ethnic	O	2554
groups	O	2554
.	O	2554

A	O	2564
glycine250	O	2564
-	O	2564
-	O	2564
>	O	2564
aspartate	O	2564
substitution	O	2564
in	O	2564
the	O	2564
alpha	O	2564
-	O	2564
subunit	O	2564
of	O	2564
hexosaminidase	O	2564
A	O	2564
causes	O	2564
juvenile	O	2564
-	O	2564
onset	O	2564
Tay	B-Disease	2564
-	I-Disease	2564
Sachs	I-Disease	2564
disease	I-Disease	2564
in	O	2564
a	O	2564
Lebanese	O	2564
-	O	2564
Canadian	O	2564
family	O	2564
.	O	2564

The	O	2565
mutation	O	2565
causing	O	2565
juvenile	O	2565
Tay	B-Disease	2565
-	I-Disease	2565
Sachs	I-Disease	2565
disease	I-Disease	2565
(	O	2565
TSD	B-Disease	2565
)	O	2565
in	O	2565
two	O	2565
sibs	O	2565
of	O	2565
Lebanese	O	2565
-	O	2565
Maronite	O	2565
origin	O	2565
is	O	2565
described	O	2565
.	O	2565

The	O	2573
predicted	O	2573
protein	O	2573
environment	O	2573
in	O	2573
which	O	2573
the	O	2573
mutation	O	2573
occurs	O	2573
is	O	2573
compared	O	2573
to	O	2573
that	O	2573
of	O	2573
the	O	2573
adult	O	2573
-	O	2573
onset	O	2573
Tay	B-Disease	2573
-	I-Disease	2573
Sachs	I-Disease	2573
disease	I-Disease	2573
mutation	O	2573
caused	O	2573
by	O	2573
a	O	2573
Gly269	O	2573
-	O	2573
-	O	2573
>	O	2573
Ser	O	2573
substitution	O	2573
in	O	2573
exon	O	2573
7	O	2573
.	O	2573

Novel	O	2575
Tay	B-Disease	2575
-	I-Disease	2575
Sachs	I-Disease	2575
disease	I-Disease	2575
mutations	O	2575
from	O	2575
China	O	2575
.	O	2575

We	O	2576
describe	O	2576
three	O	2576
HEXA	O	2576
mutations	O	2576
associated	O	2576
with	O	2576
infantile	O	2576
Tay	B-Disease	2576
-	I-Disease	2576
Sachs	I-Disease	2576
disease	I-Disease	2576
(	O	2576
TSD	B-Disease	2576
)	O	2576
in	O	2576
three	O	2576
unrelated	O	2576
nonconsanguineous	O	2576
Chinese	O	2576
families	O	2576
.	O	2576

It	O	2589
has	O	2589
been	O	2589
reported	O	2589
in	O	2589
an	O	2589
Italian	O	2589
TSD	B-Disease	2589
proband	O	2589
and	O	2589
causes	O	2589
defective	O	2589
intracellular	O	2589
transport	O	2589
of	O	2589
the	O	2589
alpha	O	2589
-	O	2589
subunit	O	2589
from	O	2589
the	O	2589
rough	O	2589
endoplasmic	O	2589
reticulum	O	2589
to	O	2589
the	O	2589
Golgi	O	2589
apparatus	O	2589
.	O	2589

Two	O	2590
missense	O	2590
mutations	O	2590
causing	O	2590
mild	O	2590
hyperphenylalaninemia	B-Disease	2590
associated	O	2590
with	O	2590
DNA	O	2590
haplotype	O	2590
12	O	2590
.	O	2590

The	O	2591
genetic	B-Disease	2591
defects	I-Disease	2591
responsible	O	2591
for	O	2591
most	O	2591
phenylketonuria	B-Disease	2591
(	O	2591
PKU	B-Disease	2591
)	O	2591
and	O	2591
hyperphenylalaninemia	B-Disease	2591
(	O	2591
HPA	B-Disease	2591
)	O	2591
cases	O	2591
are	O	2591
located	O	2591
in	O	2591
the	O	2591
phenylalanine	O	2591
hydroxylase	O	2591
(	O	2591
PAH	O	2591
)	O	2591
gene	O	2591
.	O	2591

We	O	2594
hypothesized	O	2594
that	O	2594
there	O	2594
is	O	2594
at	O	2594
least	O	2594
one	O	2594
mild	O	2594
mutation	O	2594
linked	O	2594
to	O	2594
haplotype	O	2594
12	O	2594
in	O	2594
the	O	2594
Swedish	O	2594
PKU	B-Disease	2594
/	O	2594
HPA	B-Disease	2594
population	O	2594
,	O	2594
since	O	2594
7	O	2594
of	O	2594
8	O	2594
patients	O	2594
carrying	O	2594
haplotype	O	2594
12	O	2594
had	O	2594
mild	O	2594
HPA	B-Disease	2594
.	O	2594

Mutations	O	2602
at	O	2602
the	O	2602
phenylalanine	O	2602
hydroxylase	O	2602
(	O	2602
PAH	O	2602
)	O	2602
locus	O	2602
are	O	2602
the	O	2602
major	O	2602
cause	O	2602
of	O	2602
hyperphenylalaninemia	B-Disease	2602
.	O	2602

Here	O	2604
we	O	2604
report	O	2604
(	O	2604
1	O	2604
)	O	2604
identification	O	2604
of	O	2604
another	O	2604
mutation	O	2604
,	O	2604
on	O	2604
a	O	2604
haplotype	O	2604
9	O	2604
chromosome	O	2604
,	O	2604
which	O	2604
converts	O	2604
codon	O	2604
65	O	2604
from	O	2604
isoleucine	O	2604
(	O	2604
ATT	O	2604
)	O	2604
to	O	2604
threonine	O	2604
(	O	2604
ACT	O	2604
)	O	2604
,	O	2604
(	O	2604
2	O	2604
)	O	2604
expression	O	2604
analysis	O	2604
of	O	2604
the	O	2604
I65T	O	2604
mutation	O	2604
in	O	2604
COS	O	2604
cells	O	2604
demonstrating	O	2604
75	O	2604
%	O	2604
loss	O	2604
of	O	2604
both	O	2604
immunoreactive	O	2604
protein	O	2604
and	O	2604
enzyme	O	2604
activity	O	2604
,	O	2604
and	O	2604
(	O	2604
3	O	2604
)	O	2604
expression	O	2604
analysis	O	2604
of	O	2604
the	O	2604
most	O	2604
prevalent	O	2604
PKU	B-Disease	2604
allele	O	2604
(	O	2604
M1V	O	2604
)	O	2604
in	O	2604
eastern	O	2604
Quebec	O	2604
,	O	2604
showing	O	2604
nondetectable	O	2604
levels	O	2604
of	O	2604
PAH	O	2604
protein	O	2604
and	O	2604
activity	O	2604
,	O	2604
a	O	2604
finding	O	2604
compatible	O	2604
with	O	2604
a	O	2604
mutation	O	2604
in	O	2604
the	O	2604
translation	O	2604
initiation	O	2604
codon	O	2604
.	O	2604

Homozygosity	O	2605
for	O	2605
M1V	O	2605
and	O	2605
codominant	O	2605
inheritance	O	2605
of	O	2605
I65T	O	2605
/	O	2605
R408W	O	2605
were	O	2605
both	O	2605
associated	O	2605
with	O	2605
classical	B-Disease	2605
phenylketonuria	I-Disease	2605
.	O	2605

Molecular	O	2607
basis	O	2607
of	O	2607
hexosaminidase	B-Disease	2607
A	I-Disease	2607
deficiency	I-Disease	2607
and	O	2607
pseudodeficiency	O	2607
in	O	2607
the	O	2607
Berks	O	2607
County	O	2607
Pennsylvania	O	2607
Dutch	O	2607
.	O	2607

Following	O	2608
the	O	2608
birth	O	2608
of	O	2608
two	O	2608
infants	O	2608
with	O	2608
Tay	B-Disease	2608
-	I-Disease	2608
Sachs	I-Disease	2608
disease	I-Disease	2608
(	O	2608
TSD	B-Disease	2608
)	O	2608
,	O	2608
a	O	2608
non	O	2608
-	O	2608
Jewish	O	2608
,	O	2608
Pennsylvania	O	2608
Dutch	O	2608
kindred	O	2608
was	O	2608
screened	O	2608
for	O	2608
TSD	B-Disease	2608
carriers	O	2608
using	O	2608
the	O	2608
biochemical	O	2608
assay	O	2608
.	O	2608

A	O	2609
high	O	2609
frequency	O	2609
of	O	2609
individuals	O	2609
who	O	2609
appeared	O	2609
to	O	2609
be	O	2609
TSD	B-Disease	2609
heterozygotes	O	2609
was	O	2609
detected	O	2609
(	O	2609
Kelly	O	2609
et	O	2609
al	O	2609
.	O	2609

One	O	2613
allele	O	2613
,	O	2613
reported	O	2613
originally	O	2613
in	O	2613
a	O	2613
French	O	2613
TSD	B-Disease	2613
patient	O	2613
(	O	2613
Akli	O	2613
et	O	2613
al	O	2613
.	O	2613

A	O	2620
mutation	O	2620
common	O	2620
in	O	2620
non	O	2620
-	O	2620
Jewish	O	2620
Tay	B-Disease	2620
-	I-Disease	2620
Sachs	I-Disease	2620
disease	I-Disease	2620
:	O	2620
frequency	O	2620
and	O	2620
RNA	O	2620
studies	O	2620
.	O	2620

Tay	B-Disease	2621
-	I-Disease	2621
Sachs	I-Disease	2621
disease	I-Disease	2621
(	O	2621
TSD	B-Disease	2621
)	O	2621
is	O	2621
an	O	2621
autosomal	B-Disease	2621
recessive	I-Disease	2621
genetic	I-Disease	2621
disorder	I-Disease	2621
resulting	O	2621
from	O	2621
mutation	O	2621
of	O	2621
the	O	2621
HEXA	O	2621
gene	O	2621
encoding	O	2621
the	O	2621
alpha	O	2621
-	O	2621
subunit	O	2621
of	O	2621
the	O	2621
lysosomal	O	2621
enzyme	O	2621
,	O	2621
beta	O	2621
-	O	2621
N	O	2621
-	O	2621
acetylhexosaminidase	O	2621
A	O	2621
(	O	2621
Hex	O	2621
A	O	2621
)	O	2621
.	O	2621

We	O	2622
have	O	2622
discovered	O	2622
that	O	2622
a	O	2622
Tay	B-Disease	2622
-	I-Disease	2622
Sachs	I-Disease	2622
mutation	O	2622
,	O	2622
IVS	O	2622
-	O	2622
9	O	2622
+	O	2622
1	O	2622
G	O	2622
-	O	2622
-	O	2622
>	O	2622
A	O	2622
,	O	2622
first	O	2622
detected	O	2622
by	O	2622
Akli	O	2622
et	O	2622
al	O	2622
.	O	2622

It	O	2626
was	O	2626
not	O	2626
identified	O	2626
among	O	2626
12	O	2626
Black	O	2626
American	O	2626
TSD	B-Disease	2626
alleles	O	2626
or	O	2626
in	O	2626
any	O	2626
of	O	2626
18	O	2626
Ashkenazi	O	2626
Jewish	O	2626
,	O	2626
enzyme	O	2626
-	O	2626
defined	O	2626
carriers	O	2626
who	O	2626
did	O	2626
not	O	2626
carry	O	2626
any	O	2626
of	O	2626
the	O	2626
mutations	O	2626
common	O	2626
to	O	2626
this	O	2626
population	O	2626
.	O	2626

Am	O	2631
J	O	2631
Hum	O	2631
Genet	O	2631
,	O	2631
1992	O	2631
)	O	2631
,	O	2631
these	O	2631
two	O	2631
alleles	O	2631
accounted	O	2631
for	O	2631
almost	O	2631
50	O	2631
%	O	2631
(	O	2631
29	O	2631
/	O	2631
64	O	2631
)	O	2631
of	O	2631
TSD	B-Disease	2631
or	O	2631
carrier	O	2631
alleles	O	2631
ascertained	O	2631
by	O	2631
enzyme	O	2631
screening	O	2631
tests	O	2631
in	O	2631
non	O	2631
-	O	2631
Jewish	O	2631
Caucasians	O	2631
.	O	2631

Aberrant	O	2633
splicing	O	2633
of	O	2633
the	O	2633
CHM	B-Disease	2633
gene	O	2633
is	O	2633
a	O	2633
significant	O	2633
cause	O	2633
of	O	2633
choroideremia	B-Disease	2633
.	O	2633

Choroideremia	B-Disease	2634
(	O	2634
CHM	B-Disease	2634
)	O	2634
is	O	2634
an	O	2634
X	B-Disease	2634
-	I-Disease	2634
linked	I-Disease	2634
progressive	I-Disease	2634
degeneration	I-Disease	2634
of	I-Disease	2634
the	I-Disease	2634
choroid	I-Disease	2634
and	I-Disease	2634
retina	I-Disease	2634
.	O	2634

12	O	2635
%	O	2635
of	O	2635
unrelated	O	2635
male	O	2635
patients	O	2635
carry	O	2635
deletions	O	2635
of	O	2635
the	O	2635
partially	O	2635
cloned	O	2635
CHM	B-Disease	2635
gene	O	2635
.	O	2635

In	O	2636
Finland	O	2636
,	O	2636
there	O	2636
are	O	2636
more	O	2636
than	O	2636
120	O	2636
living	O	2636
CHM	B-Disease	2636
patients	O	2636
belonging	O	2636
to	O	2636
eight	O	2636
apparently	O	2636
unrelated	O	2636
pedigrees	O	2636
.	O	2636

Molecular	O	2637
deletions	O	2637
involving	O	2637
the	O	2637
CHM	B-Disease	2637
gene	O	2637
have	O	2637
been	O	2637
detected	O	2637
in	O	2637
three	O	2637
families	O	2637
.	O	2637

Our	O	2641
findings	O	2641
provide	O	2641
additional	O	2641
evidence	O	2641
for	O	2641
the	O	2641
pathogenetic	O	2641
role	O	2641
of	O	2641
CHM	B-Disease	2641
mutations	O	2641
and	O	2641
provide	O	2641
a	O	2641
diagnostic	O	2641
tool	O	2641
for	O	2641
one	O	2641
fifth	O	2641
of	O	2641
the	O	2641
worlds	O	2641
known	O	2641
CHM	B-Disease	2641
patients	O	2641
.	O	2641

Germline	O	2643
intronic	O	2643
and	O	2643
exonic	O	2643
mutations	O	2643
in	O	2643
the	O	2643
Wilms	B-Disease	2643
'	I-Disease	2643
tumour	I-Disease	2643
gene	O	2643
(	O	2643
WT1	O	2643
)	O	2643
affecting	O	2643
urogenital	O	2643
development	O	2643
.	O	2643

Denys	B-Disease	2644
-	I-Disease	2644
Drash	I-Disease	2644
syndrome	I-Disease	2644
is	O	2644
a	O	2644
rare	O	2644
human	O	2644
developmental	B-Disease	2644
disorder	I-Disease	2644
affecting	O	2644
the	O	2644
urogenital	O	2644
system	O	2644
and	O	2644
leading	O	2644
to	O	2644
renal	B-Disease	2644
failure	I-Disease	2644
,	O	2644
intersex	B-Disease	2644
disorders	I-Disease	2644
and	O	2644
Wilms	B-Disease	2644
tumour	I-Disease	2644
.	O	2644

In	O	2645
this	O	2645
report	O	2645
,	O	2645
four	O	2645
individuals	O	2645
with	O	2645
this	O	2645
syndrome	O	2645
are	O	2645
described	O	2645
carrying	O	2645
germline	O	2645
point	O	2645
mutations	O	2645
in	O	2645
the	O	2645
Wilms	B-Disease	2645
tumour	I-Disease	2645
suppressor	O	2645
gene	O	2645
,	O	2645
WT1	O	2645
.	O	2645

Characterization	O	2650
of	O	2650
the	O	2650
myotonic	B-Disease	2650
dystrophy	I-Disease	2650
region	O	2650
predicts	O	2650
multiple	O	2650
protein	O	2650
isoform	O	2650
-	O	2650
encoding	O	2650
mRNAs	O	2650
.	O	2650

The	O	2651
mutation	O	2651
underlying	O	2651
myotonic	B-Disease	2651
dystrophy	I-Disease	2651
(	O	2651
DM	B-Disease	2651
)	O	2651
has	O	2651
been	O	2651
identified	O	2651
as	O	2651
an	O	2651
expansion	O	2651
of	O	2651
a	O	2651
polymorphic	O	2651
CTG	O	2651
-	O	2651
repeat	O	2651
in	O	2651
a	O	2651
gene	O	2651
encoding	O	2651
protein	O	2651
kinase	O	2651
activity	O	2651
.	O	2651

Characterization	O	2654
of	O	2654
the	O	2654
DM	B-Disease	2654
region	O	2654
of	O	2654
both	O	2654
species	O	2654
reveals	O	2654
another	O	2654
active	O	2654
gene	O	2654
(	O	2654
DMR	O	2654
-	O	2654
N9	O	2654
)	O	2654
in	O	2654
close	O	2654
proximity	O	2654
to	O	2654
the	O	2654
kinase	O	2654
gene	O	2654
.	O	2654

Clinical	O	2656
manifestation	O	2656
of	O	2656
DM	B-Disease	2656
may	O	2656
be	O	2656
caused	O	2656
by	O	2656
the	O	2656
expanded	O	2656
CTG	O	2656
-	O	2656
repeat	O	2656
compromising	O	2656
the	O	2656
(	O	2656
alternative	O	2656
)	O	2656
expression	O	2656
of	O	2656
DM	O	2656
-	O	2656
kinase	O	2656
or	O	2656
DMR	O	2656
-	O	2656
N9	O	2656
proteins	O	2656
.	O	2656

Fragile	B-Disease	2658
X	I-Disease	2658
syndrome	I-Disease	2658
without	O	2658
CCG	O	2658
amplification	O	2658
has	O	2658
an	O	2658
FMR1	O	2658
deletion	O	2658
.	O	2658

We	O	2659
describe	O	2659
a	O	2659
patient	O	2659
with	O	2659
typical	O	2659
clinical	O	2659
features	O	2659
of	O	2659
the	O	2659
fragile	B-Disease	2659
X	I-Disease	2659
syndrome	I-Disease	2659
,	O	2659
but	O	2659
without	O	2659
cytogenetic	O	2659
expression	O	2659
of	O	2659
the	O	2659
fragile	B-Disease	2659
X	I-Disease	2659
or	O	2659
an	O	2659
amplified	O	2659
CCG	O	2659
trinucleotide	O	2659
repeat	O	2659
fragment	O	2659
.	O	2659

This	O	2662
finding	O	2662
confirms	O	2662
that	O	2662
the	O	2662
fragile	B-Disease	2662
X	I-Disease	2662
phenotype	O	2662
can	O	2662
exist	O	2662
,	O	2662
without	O	2662
amplification	O	2662
of	O	2662
the	O	2662
CCG	O	2662
repeat	O	2662
or	O	2662
cytogenetic	O	2662
expression	O	2662
of	O	2662
the	O	2662
fragile	B-Disease	2662
X	I-Disease	2662
,	O	2662
and	O	2662
that	O	2662
fragile	B-Disease	2662
X	I-Disease	2662
syndrome	I-Disease	2662
is	O	2662
a	O	2662
genetically	O	2662
homogeneous	O	2662
disorder	O	2662
involving	O	2662
FMR1	O	2662
.	O	2662

Cloning	O	2664
of	O	2664
the	O	2664
Huntington	B-Disease	2664
disease	I-Disease	2664
region	O	2664
in	O	2664
yeast	O	2664
artificial	O	2664
chromosomes	O	2664
.	O	2664

The	O	2665
gene	O	2665
responsible	O	2665
for	O	2665
Huntington	B-Disease	2665
disease	I-Disease	2665
has	O	2665
been	O	2665
localized	O	2665
to	O	2665
a	O	2665
2	O	2665
.	O	2665

As	O	2667
part	O	2667
of	O	2667
a	O	2667
strategy	O	2667
to	O	2667
clone	O	2667
the	O	2667
HD	B-Disease	2667
gene	O	2667
on	O	2667
the	O	2667
basis	O	2667
of	O	2667
its	O	2667
chromosomal	O	2667
location	O	2667
,	O	2667
we	O	2667
isolated	O	2667
genomic	O	2667
DNA	O	2667
from	O	2667
the	O	2667
HD	B-Disease	2667
region	O	2667
as	O	2667
a	O	2667
set	O	2667
of	O	2667
overlapping	O	2667
yeast	O	2667
artificial	O	2667
chromosome	O	2667
(	O	2667
YAC	O	2667
)	O	2667
clones	O	2667
.	O	2667

We	O	2669
assembled	O	2669
the	O	2669
YAC	O	2669
clones	O	2669
into	O	2669
overlapping	O	2669
sets	O	2669
by	O	2669
hybridizing	O	2669
them	O	2669
to	O	2669
a	O	2669
large	O	2669
number	O	2669
of	O	2669
DNA	O	2669
probes	O	2669
from	O	2669
the	O	2669
HD	B-Disease	2669
region	O	2669
,	O	2669
including	O	2669
the	O	2669
STSs	O	2669
.	O	2669

2	O	2672
Mb	O	2672
of	O	2672
the	O	2672
HD	B-Disease	2672
region	O	2672
in	O	2672
YACs	O	2672
,	O	2672
including	O	2672
one	O	2672
continuous	O	2672
segment	O	2672
of	O	2672
2	O	2672
.	O	2672

0	O	2673
Mb	O	2673
covering	O	2673
the	O	2673
region	O	2673
that	O	2673
most	O	2673
likely	O	2673
contains	O	2673
the	O	2673
HD	B-Disease	2673
gene	O	2673
.	O	2673

These	O	2676
clones	O	2676
provide	O	2676
reagents	O	2676
for	O	2676
the	O	2676
complete	O	2676
characterization	O	2676
of	O	2676
this	O	2676
region	O	2676
of	O	2676
the	O	2676
genome	O	2676
and	O	2676
for	O	2676
the	O	2676
eventual	O	2676
isolation	O	2676
of	O	2676
the	O	2676
HD	B-Disease	2676
gene	O	2676
.	O	2676

Characterization	O	2677
of	O	2677
a	O	2677
YAC	O	2677
containing	O	2677
part	O	2677
or	O	2677
all	O	2677
of	O	2677
the	O	2677
Norrie	B-Disease	2677
disease	I-Disease	2677
locus	O	2677
.	O	2677

A	O	2684
series	O	2684
of	O	2684
subclones	O	2684
prepared	O	2684
from	O	2684
a	O	2684
phage	O	2684
library	O	2684
(	O	2684
lambda	O	2684
DASH	O	2684
II	O	2684
)	O	2684
of	O	2684
the	O	2684
YAC	O	2684
have	O	2684
been	O	2684
characterised	O	2684
and	O	2684
have	O	2684
been	O	2684
employed	O	2684
to	O	2684
determine	O	2684
the	O	2684
end	O	2684
point	O	2684
of	O	2684
the	O	2684
deletion	O	2684
of	O	2684
a	O	2684
Norrie	B-Disease	2684
disease	I-Disease	2684
(	O	2684
NDP	B-Disease	2684
)	O	2684
patient	O	2684
who	O	2684
has	O	2684
been	O	2684
shown	O	2684
to	O	2684
lack	O	2684
both	O	2684
DXS7	O	2684
and	O	2684
MAO	O	2684
coding	O	2684
sequences	O	2684
.	O	2684

Both	O	2687
mutations	O	2687
in	O	2687
G6PD	O	2687
A	O	2687
-	O	2687
are	O	2687
necessary	O	2687
to	O	2687
produce	O	2687
the	O	2687
G6PD	B-Disease	2687
deficient	I-Disease	2687
phenotype	O	2687
.	O	2687

The	O	2688
high	O	2688
prevalence	O	2688
of	O	2688
glucose	B-Disease	2688
6	I-Disease	2688
-	I-Disease	2688
phosphate	I-Disease	2688
dehydrogenase	I-Disease	2688
(	I-Disease	2688
G6PD	I-Disease	2688
)	I-Disease	2688
deficiency	I-Disease	2688
in	O	2688
African	O	2688
populations	O	2688
is	O	2688
due	O	2688
almost	O	2688
entirely	O	2688
to	O	2688
the	O	2688
enzyme	O	2688
variant	O	2688
A	O	2688
-	O	2688
,	O	2688
which	O	2688
differs	O	2688
from	O	2688
the	O	2688
wild	O	2688
-	O	2688
type	O	2688
G6PD	O	2688
B	O	2688
by	O	2688
two	O	2688
amino	O	2688
acid	O	2688
replacements	O	2688
,	O	2688
68	O	2688
Val	O	2688
-	O	2688
-	O	2688
>	O	2688
Met	O	2688
and	O	2688
126	O	2688
Asn	O	2688
-	O	2688
-	O	2688
>	O	2688
Asp	O	2688
.	O	2688

This	O	2693
could	O	2693
be	O	2693
because	O	2693
the	O	2693
68	O	2693
Val	O	2693
-	O	2693
-	O	2693
>	O	2693
Met	O	2693
mutation	O	2693
happened	O	2693
to	O	2693
arise	O	2693
in	O	2693
an	O	2693
A	O	2693
gene	O	2693
in	O	2693
the	O	2693
first	O	2693
instance	O	2693
,	O	2693
or	O	2693
because	O	2693
the	O	2693
68	O	2693
Val	O	2693
-	O	2693
-	O	2693
>	O	2693
Met	O	2693
mutation	O	2693
alone	O	2693
is	O	2693
not	O	2693
sufficient	O	2693
to	O	2693
cause	O	2693
G6PD	B-Disease	2693
deficiency	I-Disease	2693
.	O	2693

We	O	2699
infer	O	2699
that	O	2699
the	O	2699
coexistence	O	2699
of	O	2699
the	O	2699
two	O	2699
mutations	O	2699
is	O	2699
responsible	O	2699
for	O	2699
enzyme	B-Disease	2699
deficiency	I-Disease	2699
in	I-Disease	2699
G6PD	I-Disease	2699
A	O	2699
-	O	2699
because	O	2699
they	O	2699
act	O	2699
synergistically	O	2699
in	O	2699
causing	O	2699
instability	O	2699
of	O	2699
the	O	2699
enzyme	O	2699
.	O	2699

Small	O	2700
nuclear	O	2700
ribonucleoprotein	O	2700
polypeptide	O	2700
N	O	2700
(	O	2700
SNRPN	O	2700
)	O	2700
,	O	2700
an	O	2700
expressed	O	2700
gene	O	2700
in	O	2700
the	O	2700
Prader	B-Disease	2700
-	I-Disease	2700
Willi	I-Disease	2700
syndrome	I-Disease	2700
critical	O	2700
region	O	2700
.	O	2700

Prader	B-Disease	2701
-	I-Disease	2701
Willi	I-Disease	2701
syndrome	I-Disease	2701
(	O	2701
PWS	B-Disease	2701
)	O	2701
is	O	2701
associated	O	2701
with	O	2701
paternally	O	2701
derived	O	2701
chromosomal	O	2701
deletions	O	2701
in	O	2701
region	O	2701
15q11	O	2701
-	O	2701
13	O	2701
or	O	2701
with	O	2701
maternal	B-Disease	2701
disomy	I-Disease	2701
for	I-Disease	2701
chromosome	I-Disease	2701
15	I-Disease	2701
.	O	2701

Therefore	O	2702
,	O	2702
loss	O	2702
of	O	2702
the	O	2702
expressed	O	2702
paternal	O	2702
alleles	O	2702
of	O	2702
maternally	O	2702
imprinted	O	2702
genes	O	2702
must	O	2702
be	O	2702
responsible	O	2702
for	O	2702
the	O	2702
PWS	B-Disease	2702
phenotype	O	2702
.	O	2702

Furthermore	O	2704
,	O	2704
SNRPN	O	2704
was	O	2704
mapped	O	2704
to	O	2704
the	O	2704
minimal	O	2704
deletion	O	2704
interval	O	2704
that	O	2704
is	O	2704
critical	O	2704
for	O	2704
PWS	B-Disease	2704
.	O	2704

The	O	2705
fact	O	2705
that	O	2705
the	O	2705
mouse	O	2705
Snrpn	O	2705
gene	O	2705
is	O	2705
maternally	O	2705
imprinted	O	2705
in	O	2705
brain	O	2705
suggests	O	2705
that	O	2705
loss	O	2705
of	O	2705
the	O	2705
paternally	O	2705
derived	O	2705
SNRPN	O	2705
allele	O	2705
may	O	2705
be	O	2705
involved	O	2705
in	O	2705
the	O	2705
PWS	B-Disease	2705
phenotype	O	2705
.	O	2705

The	O	2707
presence	O	2707
of	O	2707
two	O	2707
different	O	2707
infantile	O	2707
Tay	B-Disease	2707
-	I-Disease	2707
Sachs	I-Disease	2707
disease	I-Disease	2707
mutations	O	2707
in	O	2707
a	O	2707
Cajun	O	2707
population	O	2707
.	O	2707

A	O	2708
study	O	2708
was	O	2708
undertaken	O	2708
to	O	2708
characterize	O	2708
the	O	2708
mutation	O	2708
(	O	2708
s	O	2708
)	O	2708
responsible	O	2708
for	O	2708
Tay	B-Disease	2708
-	I-Disease	2708
Sachs	I-Disease	2708
disease	I-Disease	2708
(	O	2708
TSD	B-Disease	2708
)	O	2708
in	O	2708
a	O	2708
Cajun	O	2708
population	O	2708
in	O	2708
southwest	O	2708
Louisiana	O	2708
and	O	2708
to	O	2708
identify	O	2708
the	O	2708
origins	O	2708
of	O	2708
these	O	2708
mutations	O	2708
.	O	2708

Eleven	O	2709
of	O	2709
12	O	2709
infantile	O	2709
TSD	B-Disease	2709
alleles	O	2709
examined	O	2709
in	O	2709
six	O	2709
families	O	2709
had	O	2709
the	O	2709
beta	O	2709
-	O	2709
hexosaminidase	O	2709
A	O	2709
(	O	2709
Hex	O	2709
A	O	2709
)	O	2709
alpha	O	2709
-	O	2709
subunit	O	2709
exon	O	2709
11	O	2709
insertion	O	2709
mutation	O	2709
that	O	2709
is	O	2709
present	O	2709
in	O	2709
approximately	O	2709
70	O	2709
%	O	2709
of	O	2709
Ashkenazi	O	2709
Jewish	O	2709
TSD	B-Disease	2709
heterozygotes	O	2709
.	O	2709

To	O	2711
determine	O	2711
the	O	2711
origins	O	2711
of	O	2711
these	O	2711
two	O	2711
mutations	O	2711
in	O	2711
the	O	2711
Cajun	O	2711
population	O	2711
,	O	2711
the	O	2711
TSD	B-Disease	2711
carrier	O	2711
status	O	2711
was	O	2711
enzymatically	O	2711
determined	O	2711
for	O	2711
90	O	2711
members	O	2711
of	O	2711
four	O	2711
of	O	2711
the	O	2711
six	O	2711
families	O	2711
,	O	2711
and	O	2711
extensive	O	2711
pedigrees	O	2711
were	O	2711
constructed	O	2711
for	O	2711
all	O	2711
carriers	O	2711
.	O	2711

Mutations	O	2716
in	O	2716
the	O	2716
candidate	O	2716
gene	O	2716
for	O	2716
Norrie	B-Disease	2716
disease	I-Disease	2716
.	O	2716

Recently	O	2717
,	O	2717
we	O	2717
and	O	2717
others	O	2717
have	O	2717
isolated	O	2717
a	O	2717
candidate	O	2717
gene	O	2717
for	O	2717
X	B-Disease	2717
linked	I-Disease	2717
Norrie	I-Disease	2717
disease	I-Disease	2717
(	O	2717
ND	B-Disease	2717
)	O	2717
which	O	2717
was	O	2717
found	O	2717
to	O	2717
be	O	2717
deleted	O	2717
or	O	2717
disrupted	O	2717
in	O	2717
several	O	2717
patients	O	2717
.	O	2717

As	O	2718
a	O	2718
prerequisite	O	2718
for	O	2718
the	O	2718
identification	O	2718
of	O	2718
point	O	2718
mutations	O	2718
in	O	2718
the	O	2718
ND	B-Disease	2718
gene	O	2718
we	O	2718
have	O	2718
established	O	2718
the	O	2718
exon	O	2718
-	O	2718
intron	O	2718
structure	O	2718
of	O	2718
this	O	2718
gene	O	2718
.	O	2718

These	O	2722
findings	O	2722
,	O	2722
and	O	2722
the	O	2722
absence	O	2722
of	O	2722
functionally	O	2722
relevant	O	2722
base	O	2722
changes	O	2722
in	O	2722
healthy	O	2722
controls	O	2722
,	O	2722
emphasize	O	2722
the	O	2722
causal	O	2722
role	O	2722
of	O	2722
this	O	2722
candidate	O	2722
gene	O	2722
in	O	2722
Norrie	B-Disease	2722
disease	I-Disease	2722
and	O	2722
pave	O	2722
the	O	2722
way	O	2722
for	O	2722
reliable	O	2722
diagnosis	O	2722
and	O	2722
carrier	O	2722
detection	O	2722
.	O	2722

Co	O	2726
-	O	2726
amplification	O	2726
of	O	2726
11	O	2726
exons	O	2726
from	O	2726
genomic	O	2726
DNA	O	2726
of	O	2726
Duchenne	B-Disease	2726
and	I-Disease	2726
Becker	I-Disease	2726
muscular	I-Disease	2726
dystrophy	I-Disease	2726
(	O	2726
DMD	B-Disease	2726
/	O	2726
BMD	B-Disease	2726
)	O	2726
patients	O	2726
with	O	2726
no	O	2726
deletion	O	2726
or	O	2726
duplication	O	2726
was	O	2726
performed	O	2726
and	O	2726
the	O	2726
samples	O	2726
subjected	O	2726
to	O	2726
multiple	O	2726
SSCP	O	2726
analysis	O	2726
.	O	2726

We	O	2727
report	O	2727
the	O	2727
case	O	2727
of	O	2727
a	O	2727
nonsense	O	2727
mutation	O	2727
in	O	2727
a	O	2727
Duchenne	B-Disease	2727
patient	O	2727
identified	O	2727
by	O	2727
this	O	2727
approach	O	2727
.	O	2727

High	O	2734
level	O	2734
expression	O	2734
of	O	2734
the	O	2734
nm23	O	2734
-	O	2734
H1	O	2734
gene	O	2734
,	O	2734
which	O	2734
encodes	O	2734
for	O	2734
a	O	2734
nucleoside	O	2734
diphosphate	O	2734
kinase	O	2734
,	O	2734
has	O	2734
been	O	2734
found	O	2734
to	O	2734
correlate	O	2734
with	O	2734
diminished	O	2734
metastasis	O	2734
in	O	2734
some	O	2734
tumors	B-Disease	2734
but	O	2734
not	O	2734
in	O	2734
others	O	2734
.	O	2734

In	O	2736
neuroblastoma	B-Disease	2736
,	O	2736
higher	O	2736
levels	O	2736
of	O	2736
p19	O	2736
/	O	2736
nm23	O	2736
,	O	2736
which	O	2736
are	O	2736
associated	O	2736
with	O	2736
amplification	O	2736
of	O	2736
the	O	2736
N	O	2736
-	O	2736
myc	O	2736
oncogene	O	2736
,	O	2736
large	O	2736
tumor	B-Disease	2736
mass	O	2736
,	O	2736
and	O	2736
metastasis	O	2736
,	O	2736
were	O	2736
observed	O	2736
in	O	2736
advanced	O	2736
stage	O	2736
tumors	B-Disease	2736
compared	O	2736
with	O	2736
limited	O	2736
stage	O	2736
disease	O	2736
.	O	2736

Because	O	2737
of	O	2737
the	O	2737
variable	O	2737
expression	O	2737
of	O	2737
nm23	O	2737
-	O	2737
H1	O	2737
in	O	2737
different	O	2737
tumors	B-Disease	2737
,	O	2737
we	O	2737
have	O	2737
investigated	O	2737
the	O	2737
relationship	O	2737
between	O	2737
amounts	O	2737
of	O	2737
the	O	2737
protein	O	2737
and	O	2737
cell	O	2737
proliferation	O	2737
.	O	2737

The	O	2738
levels	O	2738
of	O	2738
p19	O	2738
/	O	2738
nm23	O	2738
were	O	2738
compared	O	2738
between	O	2738
resting	O	2738
and	O	2738
mitotically	O	2738
stimulated	O	2738
normal	O	2738
human	O	2738
PBLs	O	2738
and	O	2738
in	O	2738
leukemia	B-Disease	2738
cells	O	2738
.	O	2738

In	O	2740
leukemia	B-Disease	2740
cells	O	2740
obtained	O	2740
from	O	2740
patients	O	2740
with	O	2740
different	O	2740
subtypes	O	2740
of	O	2740
acute	B-Disease	2740
leukemia	I-Disease	2740
,	O	2740
p19	O	2740
/	O	2740
nm23	O	2740
levels	O	2740
were	O	2740
also	O	2740
increased	O	2740
relative	O	2740
to	O	2740
resting	O	2740
normal	O	2740
lymphocytes	O	2740
.	O	2740

Treatment	O	2741
of	O	2741
mitotically	O	2741
stimulated	O	2741
lymphocytes	O	2741
with	O	2741
cyclosporin	O	2741
,	O	2741
which	O	2741
inhibits	O	2741
proliferation	O	2741
,	O	2741
blocked	O	2741
the	O	2741
increase	O	2741
in	O	2741
p19	O	2741
/	O	2741
nm23	O	2741
;	O	2741
treatment	O	2741
of	O	2741
the	O	2741
leukemia	B-Disease	2741
cell	O	2741
line	O	2741
HL	O	2741
-	O	2741
60	O	2741
with	O	2741
dimethylsulfoxide	O	2741
,	O	2741
which	O	2741
induces	O	2741
terminal	O	2741
differentiation	O	2741
,	O	2741
resulted	O	2741
in	O	2741
diminished	O	2741
levels	O	2741
of	O	2741
p19	O	2741
/	O	2741
nm23	O	2741
.	O	2741

An	O	2744
intrachromosomal	O	2744
insertion	O	2744
causing	O	2744
5q22	O	2744
deletion	O	2744
and	O	2744
familial	B-Disease	2744
adenomatous	I-Disease	2744
polyposis	I-Disease	2744
coli	I-Disease	2744
in	O	2744
two	O	2744
generations	O	2744
.	O	2744

We	O	2745
report	O	2745
familial	B-Disease	2745
adenomatous	I-Disease	2745
polyposis	I-Disease	2745
coli	I-Disease	2745
(	O	2745
FAPC	B-Disease	2745
)	O	2745
with	O	2745
epidermoid	B-Disease	2745
cysts	I-Disease	2745
,	O	2745
osteomata	B-Disease	2745
,	O	2745
and	O	2745
areas	O	2745
of	O	2745
congenital	B-Disease	2745
hypertrophy	I-Disease	2745
of	I-Disease	2745
the	I-Disease	2745
retinal	I-Disease	2745
pigment	I-Disease	2745
epithelium	I-Disease	2745
(	O	2745
CHRPEs	B-Disease	2745
)	O	2745
in	O	2745
a	O	2745
male	O	2745
patient	O	2745
and	O	2745
his	O	2745
maternal	O	2745
aunt	O	2745
,	O	2745
both	O	2745
of	O	2745
whom	O	2745
suffered	O	2745
a	O	2745
mild	O	2745
to	O	2745
moderate	O	2745
degree	O	2745
of	O	2745
mental	B-Disease	2745
handicap	I-Disease	2745
.	O	2745

As	O	2754
expected	O	2754
,	O	2754
the	O	2754
molecular	O	2754
analyses	O	2754
indicate	O	2754
loss	O	2754
of	O	2754
one	O	2754
allele	O	2754
at	O	2754
the	O	2754
MCC	O	2754
and	O	2754
APC	B-Disease	2754
loci	O	2754
.	O	2754

The	O	2755
APC	B-Disease	2755
gene	O	2755
is	O	2755
located	O	2755
within	O	2755
band	O	2755
5q22	O	2755
.	O	2755

Chromosome	O	2757
mapping	O	2757
of	O	2757
the	O	2757
rod	O	2757
photoreceptor	O	2757
cGMP	O	2757
phosphodiesterase	O	2757
beta	O	2757
-	O	2757
subunit	O	2757
gene	O	2757
in	O	2757
mouse	O	2757
and	O	2757
human	O	2757
:	O	2757
tight	O	2757
linkage	O	2757
to	O	2757
the	O	2757
Huntington	B-Disease	2757
disease	I-Disease	2757
region	O	2757
(	O	2757
4p16	O	2757
.	O	2757

The	O	2759
retinal	B-Disease	2759
degeneration	I-Disease	2759
mouse	O	2759
(	O	2759
gene	O	2759
symbol	O	2759
,	O	2759
rd	O	2759
)	O	2759
is	O	2759
an	O	2759
animal	O	2759
model	O	2759
for	O	2759
certain	O	2759
forms	O	2759
of	O	2759
human	O	2759
hereditary	B-Disease	2759
retinopathies	I-Disease	2759
.	O	2759

3	O	2765
,	O	2765
very	O	2765
close	O	2765
to	O	2765
the	O	2765
Huntington	B-Disease	2765
disease	I-Disease	2765
(	O	2765
HD	B-Disease	2765
)	O	2765
region	O	2765
.	O	2765

Analysis	O	2766
of	O	2766
the	O	2766
comparative	O	2766
map	O	2766
for	O	2766
mice	O	2766
and	O	2766
humans	O	2766
shows	O	2766
that	O	2766
the	O	2766
mouse	O	2766
homologue	O	2766
of	O	2766
the	O	2766
HD	B-Disease	2766
gene	O	2766
will	O	2766
reside	O	2766
on	O	2766
chromosome	O	2766
5	O	2766
.	O	2766

3	O	2768
region	O	2768
is	O	2768
maintained	O	2768
but	O	2768
gene	O	2768
order	O	2768
is	O	2768
not	O	2768
,	O	2768
suggesting	O	2768
at	O	2768
least	O	2768
three	O	2768
possible	O	2768
sites	O	2768
for	O	2768
the	O	2768
corresponding	O	2768
mouse	O	2768
HD	B-Disease	2768
gene	O	2768
.	O	2768

Coincident	O	2769
Kaposi	B-Disease	2769
sarcoma	I-Disease	2769
and	O	2769
T	B-Disease	2769
-	I-Disease	2769
cell	I-Disease	2769
lymphoma	I-Disease	2769
in	O	2769
a	O	2769
patient	O	2769
with	O	2769
the	O	2769
Wiskott	B-Disease	2769
-	I-Disease	2769
Aldrich	I-Disease	2769
syndrome	I-Disease	2769
.	O	2769

A	O	2770
24	O	2770
year	O	2770
old	O	2770
male	O	2770
with	O	2770
a	O	2770
history	O	2770
of	O	2770
eczema	B-Disease	2770
,	O	2770
recurrent	O	2770
mild	O	2770
infections	O	2770
,	O	2770
and	O	2770
thrombocytopenia	B-Disease	2770
consistent	O	2770
with	O	2770
the	O	2770
Wiskott	B-Disease	2770
-	I-Disease	2770
Aldrich	I-Disease	2770
syndrome	I-Disease	2770
(	O	2770
WAS	B-Disease	2770
)	O	2770
presented	O	2770
with	O	2770
a	O	2770
mediastinal	O	2770
mass	O	2770
,	O	2770
generalized	O	2770
lymphadenopathy	B-Disease	2770
,	O	2770
splenomegaly	B-Disease	2770
,	O	2770
and	O	2770
severe	O	2770
thrombocytopenia	B-Disease	2770
.	O	2770

However	O	2773
,	O	2773
their	O	2773
proliferative	O	2773
responses	O	2773
to	O	2773
anti	O	2773
-	O	2773
CD43	O	2773
antibody	O	2773
and	O	2773
periodate	O	2773
were	O	2773
diminished	O	2773
,	O	2773
consistent	O	2773
with	O	2773
the	O	2773
clinical	O	2773
diagnosis	O	2773
of	O	2773
WAS	B-Disease	2773
.	O	2773

An	O	2774
initial	O	2774
inguinal	O	2774
lymph	O	2774
node	O	2774
biopsy	O	2774
surprisingly	O	2774
revealed	O	2774
Kaposi	B-Disease	2774
sarcoma	I-Disease	2774
.	O	2774

However	O	2775
,	O	2775
following	O	2775
splenectomy	O	2775
to	O	2775
increase	O	2775
the	O	2775
platelet	O	2775
count	O	2775
,	O	2775
biopsy	O	2775
of	O	2775
the	O	2775
mediastinal	O	2775
mass	O	2775
revealed	O	2775
T	B-Disease	2775
-	I-Disease	2775
cell	I-Disease	2775
large	I-Disease	2775
cell	I-Disease	2775
lymphoma	I-Disease	2775
.	O	2775

Studies	O	2776
of	O	2776
biopsied	O	2776
tissue	O	2776
for	O	2776
the	O	2776
presence	O	2776
of	O	2776
Epstein	B-Disease	2776
-	I-Disease	2776
Barr	I-Disease	2776
virus	I-Disease	2776
and	O	2776
cytomegalovirus	B-Disease	2776
were	O	2776
negative	O	2776
,	O	2776
as	O	2776
were	O	2776
studies	O	2776
of	O	2776
blood	O	2776
,	O	2776
including	O	2776
the	O	2776
polymerase	O	2776
chain	O	2776
reaction	O	2776
,	O	2776
for	O	2776
the	O	2776
presence	O	2776
of	O	2776
the	O	2776
human	B-Disease	2776
immunodeficiency	I-Disease	2776
virus	I-Disease	2776
(	O	2776
HIV	B-Disease	2776
)	O	2776
.	O	2776

This	O	2777
is	O	2777
the	O	2777
first	O	2777
report	O	2777
of	O	2777
Kaposi	B-Disease	2777
sarcoma	I-Disease	2777
arising	O	2777
in	O	2777
a	O	2777
patient	O	2777
with	O	2777
a	O	2777
congenital	B-Disease	2777
immunodeficiency	I-Disease	2777
syndrome	I-Disease	2777
.	O	2777

Although	O	2778
Kaposi	B-Disease	2778
sarcoma	I-Disease	2778
can	O	2778
arise	O	2778
in	O	2778
the	O	2778
face	O	2778
of	O	2778
the	O	2778
severe	O	2778
immunosuppression	O	2778
that	O	2778
follows	O	2778
allograft	O	2778
transplantation	O	2778
and	O	2778
in	O	2778
patients	O	2778
infected	O	2778
with	O	2778
HIV	B-Disease	2778
,	O	2778
we	O	2778
postulate	O	2778
that	O	2778
longevity	O	2778
in	O	2778
the	O	2778
face	O	2778
of	O	2778
mild	O	2778
immunosuppression	O	2778
was	O	2778
the	O	2778
major	O	2778
factor	O	2778
in	O	2778
the	O	2778
development	O	2778
of	O	2778
Kaposi	B-Disease	2778
sarcoma	I-Disease	2778
in	O	2778
this	O	2778
patient	O	2778
.	O	2778

The	O	2780
APC	B-Disease	2780
gene	O	2780
,	O	2780
responsible	O	2780
for	O	2780
familial	B-Disease	2780
adenomatous	I-Disease	2780
polyposis	I-Disease	2780
,	O	2780
is	O	2780
mutated	O	2780
in	O	2780
human	O	2780
gastric	B-Disease	2780
cancer	I-Disease	2780
.	O	2780

Although	O	2781
gastric	B-Disease	2781
cancer	I-Disease	2781
is	O	2781
the	O	2781
most	O	2781
common	O	2781
cancer	B-Disease	2781
in	O	2781
the	O	2781
world	O	2781
,	O	2781
genetic	O	2781
changes	O	2781
during	O	2781
its	O	2781
carcinogenesis	O	2781
are	O	2781
not	O	2781
well	O	2781
understood	O	2781
.	O	2781

Since	O	2782
some	O	2782
gastric	B-Disease	2782
cancers	I-Disease	2782
are	O	2782
considered	O	2782
to	O	2782
originate	O	2782
from	O	2782
the	O	2782
intestinal	O	2782
metaplasia	O	2782
,	O	2782
it	O	2782
is	O	2782
likely	O	2782
that	O	2782
the	O	2782
adenomatous	B-Disease	2782
polyposis	I-Disease	2782
coli	I-Disease	2782
(	O	2782
APC	B-Disease	2782
)	O	2782
gene	O	2782
,	O	2782
the	O	2782
mutation	O	2782
of	O	2782
which	O	2782
causes	O	2782
adenomatous	B-Disease	2782
polyps	I-Disease	2782
in	I-Disease	2782
the	I-Disease	2782
colon	I-Disease	2782
,	O	2782
is	O	2782
associated	O	2782
with	O	2782
carcinogenesis	O	2782
of	O	2782
gastric	B-Disease	2782
cancer	I-Disease	2782
.	O	2782

Based	O	2783
on	O	2783
this	O	2783
idea	O	2783
,	O	2783
DNAs	O	2783
isolated	O	2783
from	O	2783
gastric	B-Disease	2783
cancers	I-Disease	2783
were	O	2783
examined	O	2783
by	O	2783
means	O	2783
of	O	2783
a	O	2783
RNase	O	2783
protection	O	2783
analysis	O	2783
coupled	O	2783
with	O	2783
polymerase	O	2783
chain	O	2783
reaction	O	2783
followed	O	2783
by	O	2783
sequencing	O	2783
of	O	2783
the	O	2783
polymerase	O	2783
chain	O	2783
reaction	O	2783
products	O	2783
.	O	2783

By	O	2784
screening	O	2784
nearly	O	2784
one	O	2784
-	O	2784
half	O	2784
of	O	2784
the	O	2784
coding	O	2784
region	O	2784
of	O	2784
the	O	2784
APC	B-Disease	2784
gene	O	2784
in	O	2784
44	O	2784
tumors	B-Disease	2784
,	O	2784
somatic	O	2784
mutations	O	2784
were	O	2784
detected	O	2784
in	O	2784
three	O	2784
tumors	B-Disease	2784
a	O	2784
missense	O	2784
mutation	O	2784
,	O	2784
a	O	2784
nonsense	O	2784
mutation	O	2784
,	O	2784
and	O	2784
a	O	2784
5	O	2784
-	O	2784
base	O	2784
pair	O	2784
deletion	O	2784
resulting	O	2784
in	O	2784
a	O	2784
frame	O	2784
shift	O	2784
which	O	2784
causes	O	2784
truncation	O	2784
of	O	2784
the	O	2784
gene	O	2784
product	O	2784
.	O	2784

These	O	2785
results	O	2785
suggest	O	2785
that	O	2785
the	O	2785
mutation	O	2785
of	O	2785
the	O	2785
APC	B-Disease	2785
gene	O	2785
also	O	2785
plays	O	2785
an	O	2785
important	O	2785
role	O	2785
during	O	2785
the	O	2785
carcinogenesis	O	2785
of	O	2785
at	O	2785
least	O	2785
some	O	2785
gastric	B-Disease	2785
cancers	I-Disease	2785
.	O	2785

A	O	2787
71	O	2787
-	O	2787
kilodalton	O	2787
protein	O	2787
is	O	2787
a	O	2787
major	O	2787
product	O	2787
of	O	2787
the	O	2787
Duchenne	B-Disease	2787
muscular	I-Disease	2787
dystrophy	I-Disease	2787
gene	O	2787
in	O	2787
brain	O	2787
and	O	2787
other	O	2787
nonmuscle	O	2787
tissues	O	2787
.	O	2787

The	O	2788
known	O	2788
Duchenne	B-Disease	2788
muscular	I-Disease	2788
dystrophy	I-Disease	2788
(	O	2788
DMD	B-Disease	2788
)	O	2788
gene	O	2788
products	O	2788
,	O	2788
the	O	2788
muscle	O	2788
-	O	2788
and	O	2788
brain	O	2788
-	O	2788
type	O	2788
dystrophin	O	2788
isoforms	O	2788
,	O	2788
are	O	2788
427	O	2788
-	O	2788
kDa	O	2788
proteins	O	2788
translated	O	2788
from	O	2788
14	O	2788
-	O	2788
kilobase	O	2788
(	O	2788
kb	O	2788
)	O	2788
mRNAs	O	2788
.	O	2788

5	O	2790
-	O	2790
kb	O	2790
mRNA	O	2790
that	O	2790
also	O	2790
is	O	2790
transcribed	O	2790
from	O	2790
the	O	2790
DMD	B-Disease	2790
gene	O	2790
.	O	2790

8	O	2793
-	O	2793
kDa	O	2793
protein	O	2793
that	O	2793
is	O	2793
a	O	2793
major	O	2793
product	O	2793
of	O	2793
the	O	2793
DMD	B-Disease	2793
gene	O	2793
.	O	2793

This	O	2796
protein	O	2796
is	O	2796
the	O	2796
major	O	2796
DMD	B-Disease	2796
gene	O	2796
product	O	2796
in	O	2796
brain	O	2796
and	O	2796
other	O	2796
nonmuscle	O	2796
tissues	O	2796
but	O	2796
is	O	2796
undetectable	O	2796
in	O	2796
skeletal	O	2796
muscle	O	2796
extracts	O	2796
.	O	2796

Correlation	O	2797
between	O	2797
the	O	2797
location	O	2797
of	O	2797
germ	O	2797
-	O	2797
line	O	2797
mutations	O	2797
in	O	2797
the	O	2797
APC	B-Disease	2797
gene	O	2797
and	O	2797
the	O	2797
number	O	2797
of	O	2797
colorectal	B-Disease	2797
polyps	I-Disease	2797
in	O	2797
familial	B-Disease	2797
adenomatous	I-Disease	2797
polyposis	I-Disease	2797
patients	O	2797
.	O	2797

Recently	O	2798
we	O	2798
have	O	2798
isolated	O	2798
the	O	2798
adenomatous	B-Disease	2798
polyposis	I-Disease	2798
coli	I-Disease	2798
(	O	2798
APC	B-Disease	2798
)	O	2798
gene	O	2798
which	O	2798
causes	O	2798
familial	B-Disease	2798
adenomatous	I-Disease	2798
polyposis	I-Disease	2798
(	O	2798
FAP	B-Disease	2798
)	O	2798
,	O	2798
and	O	2798
its	O	2798
germ	O	2798
-	O	2798
line	O	2798
mutations	O	2798
in	O	2798
a	O	2798
substantial	O	2798
number	O	2798
of	O	2798
FAP	B-Disease	2798
patients	O	2798
have	O	2798
been	O	2798
identified	O	2798
.	O	2798

On	O	2799
the	O	2799
basis	O	2799
of	O	2799
this	O	2799
information	O	2799
,	O	2799
we	O	2799
compared	O	2799
the	O	2799
location	O	2799
of	O	2799
germ	O	2799
-	O	2799
line	O	2799
mutations	O	2799
in	O	2799
the	O	2799
APC	B-Disease	2799
gene	O	2799
in	O	2799
22	O	2799
unrelated	O	2799
patients	O	2799
(	O	2799
12	O	2799
of	O	2799
whom	O	2799
have	O	2799
been	O	2799
reported	O	2799
previously	O	2799
)	O	2799
with	O	2799
the	O	2799
number	O	2799
of	O	2799
colorectal	B-Disease	2799
polyps	I-Disease	2799
developed	O	2799
in	O	2799
FAP	B-Disease	2799
patients	O	2799
;	O	2799
17	O	2799
were	O	2799
sparse	O	2799
types	O	2799
and	O	2799
five	O	2799
were	O	2799
profuse	O	2799
types	O	2799
.	O	2799

The	O	2801
location	O	2801
of	O	2801
the	O	2801
germ	O	2801
-	O	2801
line	O	2801
mutations	O	2801
seems	O	2801
to	O	2801
correlate	O	2801
with	O	2801
the	O	2801
two	O	2801
clinical	O	2801
types	O	2801
;	O	2801
germ	O	2801
-	O	2801
line	O	2801
mutations	O	2801
in	O	2801
five	O	2801
FAP	B-Disease	2801
patients	O	2801
with	O	2801
profuse	O	2801
polyps	B-Disease	2801
were	O	2801
observed	O	2801
between	O	2801
codon	O	2801
1250	O	2801
and	O	2801
codon	O	2801
1464	O	2801
,	O	2801
whereas	O	2801
mutations	O	2801
in	O	2801
17	O	2801
FAP	B-Disease	2801
patients	O	2801
with	O	2801
fewer	O	2801
polyps	B-Disease	2801
were	O	2801
observed	O	2801
in	O	2801
the	O	2801
other	O	2801
regions	O	2801
of	O	2801
the	O	2801
APC	B-Disease	2801
gene	O	2801
.	O	2801

The	O	2802
result	O	2802
suggests	O	2802
that	O	2802
the	O	2802
number	O	2802
of	O	2802
colorectal	B-Disease	2802
polyps	I-Disease	2802
in	O	2802
FAP	B-Disease	2802
patients	O	2802
may	O	2802
be	O	2802
associated	O	2802
with	O	2802
a	O	2802
difference	O	2802
in	O	2802
the	O	2802
stability	O	2802
or	O	2802
biological	O	2802
function	O	2802
of	O	2802
the	O	2802
truncated	O	2802
APC	B-Disease	2802
protein	O	2802
.	O	2802

Identification	O	2804
and	O	2804
rapid	O	2804
detection	O	2804
of	O	2804
three	O	2804
Tay	B-Disease	2804
-	I-Disease	2804
Sachs	I-Disease	2804
mutations	O	2804
in	O	2804
the	O	2804
Moroccan	O	2804
Jewish	O	2804
population	O	2804
.	O	2804

Infantile	O	2805
Tay	B-Disease	2805
-	I-Disease	2805
Sachs	I-Disease	2805
disease	I-Disease	2805
(	O	2805
TSD	B-Disease	2805
)	O	2805
is	O	2805
caused	O	2805
by	O	2805
mutations	O	2805
in	O	2805
the	O	2805
HEXA	O	2805
gene	O	2805
that	O	2805
result	O	2805
in	O	2805
the	O	2805
complete	O	2805
absence	O	2805
of	O	2805
beta	O	2805
-	O	2805
hexosaminidase	O	2805
A	O	2805
activity	O	2805
.	O	2805

It	O	2806
is	O	2806
well	O	2806
known	O	2806
that	O	2806
an	O	2806
elevated	O	2806
frequency	O	2806
of	O	2806
TSD	B-Disease	2806
mutations	O	2806
exists	O	2806
among	O	2806
Ashkenazi	O	2806
Jews	O	2806
.	O	2806

More	O	2807
recently	O	2807
it	O	2807
has	O	2807
become	O	2807
apparent	O	2807
that	O	2807
elevated	O	2807
carrier	O	2807
frequencies	O	2807
for	O	2807
TSD	B-Disease	2807
also	O	2807
occur	O	2807
in	O	2807
several	O	2807
other	O	2807
ethnic	O	2807
groups	O	2807
,	O	2807
including	O	2807
Moroccan	O	2807
Jews	O	2807
,	O	2807
a	O	2807
subgroup	O	2807
of	O	2807
Sephardic	O	2807
Jews	O	2807
.	O	2807

Elsewhere	O	2808
we	O	2808
reported	O	2808
an	O	2808
in	O	2808
-	O	2808
frame	O	2808
deletion	O	2808
of	O	2808
one	O	2808
of	O	2808
the	O	2808
two	O	2808
adjacent	O	2808
phenylalanine	O	2808
codons	O	2808
at	O	2808
position	O	2808
304	O	2808
or	O	2808
305	O	2808
(	O	2808
delta	O	2808
F304	O	2808
/	O	2808
305	O	2808
)	O	2808
in	O	2808
one	O	2808
HEXA	O	2808
allele	O	2808
of	O	2808
a	O	2808
Moroccan	O	2808
Jewish	O	2808
TSD	B-Disease	2808
patient	O	2808
and	O	2808
in	O	2808
three	O	2808
obligate	O	2808
carriers	O	2808
from	O	2808
six	O	2808
unrelated	O	2808
Moroccan	O	2808
Jewish	O	2808
families	O	2808
.	O	2808

We	O	2809
have	O	2809
now	O	2809
identified	O	2809
two	O	2809
additional	O	2809
mutations	O	2809
within	O	2809
exon	O	2809
5	O	2809
of	O	2809
the	O	2809
HEXA	O	2809
gene	O	2809
that	O	2809
account	O	2809
for	O	2809
the	O	2809
remaining	O	2809
TSD	B-Disease	2809
alleles	O	2809
in	O	2809
the	O	2809
patient	O	2809
and	O	2809
carriers	O	2809
.	O	2809

This	O	2812
mutation	O	2812
is	O	2812
at	O	2812
a	O	2812
CpG	O	2812
site	O	2812
in	O	2812
a	O	2812
Japanese	O	2812
infant	O	2812
with	O	2812
Tay	B-Disease	2812
-	I-Disease	2812
Sachs	I-Disease	2812
disease	I-Disease	2812
and	O	2812
was	O	2812
described	O	2812
elsewhere	O	2812
.	O	2812

Molecular	O	2816
characterization	O	2816
of	O	2816
glucose	B-Disease	2816
-	I-Disease	2816
6	I-Disease	2816
-	I-Disease	2816
phosphate	I-Disease	2816
dehydrogenase	I-Disease	2816
(	I-Disease	2816
G6PD	I-Disease	2816
)	I-Disease	2816
deficiency	I-Disease	2816
by	O	2816
natural	O	2816
and	O	2816
amplification	O	2816
created	O	2816
restriction	O	2816
sites	O	2816
:	O	2816
five	O	2816
mutations	O	2816
account	O	2816
for	O	2816
most	O	2816
G6PD	B-Disease	2816
deficiency	I-Disease	2816
cases	O	2816
in	O	2816
Taiwan	O	2816
.	O	2816

We	O	2817
have	O	2817
developed	O	2817
a	O	2817
rapid	O	2817
and	O	2817
simple	O	2817
method	O	2817
to	O	2817
diagnose	O	2817
the	O	2817
molecular	O	2817
defects	O	2817
of	O	2817
glucose	B-Disease	2817
-	I-Disease	2817
6	I-Disease	2817
-	I-Disease	2817
phosphate	I-Disease	2817
dehydrogenase	I-Disease	2817
(	I-Disease	2817
G6PD	I-Disease	2817
)	I-Disease	2817
deficiency	I-Disease	2817
in	O	2817
Chinese	O	2817
in	O	2817
Taiwan	O	2817
.	O	2817

Ninety	O	2819
-	O	2819
four	O	2819
Chinese	O	2819
males	O	2819
with	O	2819
G6PD	B-Disease	2819
deficiency	I-Disease	2819
were	O	2819
studied	O	2819
.	O	2819

These	O	2827
results	O	2827
show	O	2827
that	O	2827
the	O	2827
former	O	2827
five	O	2827
mutations	O	2827
account	O	2827
for	O	2827
more	O	2827
than	O	2827
90	O	2827
%	O	2827
of	O	2827
G6PD	B-Disease	2827
deficiency	I-Disease	2827
cases	O	2827
in	O	2827
Taiwan	O	2827
.	O	2827

Eight	O	2830
novel	O	2830
inactivating	O	2830
germ	O	2830
line	O	2830
mutations	O	2830
at	O	2830
the	O	2830
APC	B-Disease	2830
gene	O	2830
identified	O	2830
by	O	2830
denaturing	O	2830
gradient	O	2830
gel	O	2830
electrophoresis	O	2830
.	O	2830

Familial	B-Disease	2831
adenomatous	I-Disease	2831
polyposis	I-Disease	2831
(	O	2831
FAP	B-Disease	2831
)	O	2831
is	O	2831
a	O	2831
dominantly	O	2831
inherited	O	2831
condition	O	2831
predisposing	O	2831
to	O	2831
colorectal	B-Disease	2831
cancer	I-Disease	2831
.	O	2831

The	O	2832
recent	O	2832
isolation	O	2832
of	O	2832
the	O	2832
responsible	O	2832
gene	O	2832
(	O	2832
adenomatous	B-Disease	2832
polyposis	I-Disease	2832
coli	I-Disease	2832
or	O	2832
APC	B-Disease	2832
)	O	2832
has	O	2832
facilitated	O	2832
the	O	2832
search	O	2832
for	O	2832
germ	O	2832
line	O	2832
mutations	O	2832
in	O	2832
affected	O	2832
individuals	O	2832
.	O	2832

DGGE	O	2835
analysis	O	2835
of	O	2835
10	O	2835
APC	B-Disease	2835
exons	O	2835
(	O	2835
4	O	2835
,	O	2835
5	O	2835
,	O	2835
7	O	2835
,	O	2835
8	O	2835
,	O	2835
9	O	2835
,	O	2835
10	O	2835
,	O	2835
12	O	2835
,	O	2835
13	O	2835
,	O	2835
14	O	2835
,	O	2835
and	O	2835
part	O	2835
of	O	2835
15	O	2835
)	O	2835
in	O	2835
33	O	2835
unrelated	O	2835
Dutch	O	2835
FAP	B-Disease	2835
patients	O	2835
has	O	2835
led	O	2835
to	O	2835
the	O	2835
identification	O	2835
of	O	2835
eight	O	2835
novel	O	2835
germ	O	2835
line	O	2835
mutations	O	2835
resulting	O	2835
in	O	2835
stop	O	2835
codons	O	2835
or	O	2835
frameshifts	O	2835
.	O	2835

The	O	2836
results	O	2836
reported	O	2836
here	O	2836
indicate	O	2836
that	O	2836
(	O	2836
1	O	2836
)	O	2836
familial	B-Disease	2836
adenomatous	I-Disease	2836
polyposis	I-Disease	2836
is	O	2836
caused	O	2836
by	O	2836
an	O	2836
extremely	O	2836
heterogeneous	O	2836
spectrum	O	2836
of	O	2836
point	O	2836
mutations	O	2836
;	O	2836
(	O	2836
2	O	2836
)	O	2836
all	O	2836
the	O	2836
mutations	O	2836
found	O	2836
in	O	2836
this	O	2836
study	O	2836
are	O	2836
chain	O	2836
terminating	O	2836
;	O	2836
and	O	2836
(	O	2836
3	O	2836
)	O	2836
DGGE	O	2836
represents	O	2836
a	O	2836
rapid	O	2836
and	O	2836
sensitive	O	2836
technique	O	2836
for	O	2836
the	O	2836
detection	O	2836
of	O	2836
mutations	O	2836
in	O	2836
the	O	2836
unusually	O	2836
large	O	2836
APC	B-Disease	2836
gene	O	2836
.	O	2836

On	O	2838
the	O	2838
other	O	2838
hand	O	2838
,	O	2838
the	O	2838
occurrence	O	2838
of	O	2838
an	O	2838
extremely	O	2838
heterogeneous	O	2838
spectrum	O	2838
of	O	2838
mutations	O	2838
spread	O	2838
throughout	O	2838
the	O	2838
entire	O	2838
length	O	2838
of	O	2838
the	O	2838
large	O	2838
APC	B-Disease	2838
gene	O	2838
among	O	2838
the	O	2838
FAP	B-Disease	2838
patients	O	2838
indicates	O	2838
that	O	2838
this	O	2838
approach	O	2838
may	O	2838
not	O	2838
be	O	2838
useful	O	2838
as	O	2838
a	O	2838
rapid	O	2838
presymptomatic	O	2838
diagnostic	O	2838
procedure	O	2838
in	O	2838
a	O	2838
routine	O	2838
laboratory	O	2838
.	O	2838

Such	O	2840
intragenic	O	2840
polymorphisms	O	2840
offer	O	2840
a	O	2840
practical	O	2840
approach	O	2840
to	O	2840
a	O	2840
more	O	2840
rapid	O	2840
procedure	O	2840
for	O	2840
presymptomatic	O	2840
diagnosis	O	2840
of	O	2840
FAP	B-Disease	2840
by	O	2840
linkage	O	2840
analysis	O	2840
in	O	2840
informative	O	2840
families	O	2840
.	O	2840

Yeast	O	2842
artificial	O	2842
chromosomes	O	2842
for	O	2842
the	O	2842
molecular	O	2842
analysis	O	2842
of	O	2842
the	O	2842
familial	B-Disease	2842
polyposis	I-Disease	2842
APC	I-Disease	2842
gene	O	2842
region	O	2842
.	O	2842

1	O	2844
megabase	O	2844
pairs	O	2844
of	O	2844
DNA	O	2844
around	O	2844
the	O	2844
MCC	O	2844
(	O	2844
for	O	2844
mutated	O	2844
in	O	2844
colorectal	B-Disease	2844
carcinoma	I-Disease	2844
)	O	2844
and	O	2844
APC	B-Disease	2844
(	O	2844
for	O	2844
adenomatous	B-Disease	2844
polyposis	I-Disease	2844
coli	I-Disease	2844
)	O	2844
genes	O	2844
at	O	2844
5q21	O	2844
have	O	2844
been	O	2844
isolated	O	2844
and	O	2844
characterized	O	2844
.	O	2844

Starting	O	2845
from	O	2845
the	O	2845
MCC	O	2845
gene	O	2845
,	O	2845
a	O	2845
strategy	O	2845
was	O	2845
undertaken	O	2845
to	O	2845
identify	O	2845
constitutional	O	2845
submicroscopic	O	2845
deletions	O	2845
in	O	2845
familial	B-Disease	2845
adenomatous	I-Disease	2845
polyposis	I-Disease	2845
patients	O	2845
that	O	2845
might	O	2845
considerably	O	2845
narrow	O	2845
down	O	2845
the	O	2845
position	O	2845
of	O	2845
the	O	2845
APC	B-Disease	2845
gene	O	2845
.	O	2845

This	O	2848
screening	O	2848
approach	O	2848
led	O	2848
to	O	2848
the	O	2848
confirmation	O	2848
of	O	2848
a	O	2848
small	O	2848
heterozygous	O	2848
deletion	O	2848
in	O	2848
a	O	2848
polyposis	B-Disease	2848
patient	O	2848
that	O	2848
overlaps	O	2848
one	O	2848
of	O	2848
the	O	2848
two	O	2848
isolated	O	2848
YACs	O	2848
.	O	2848

This	O	2849
YAC	O	2849
has	O	2849
been	O	2849
shown	O	2849
to	O	2849
contain	O	2849
the	O	2849
entire	O	2849
APC	B-Disease	2849
gene	O	2849
,	O	2849
in	O	2849
addition	O	2849
to	O	2849
a	O	2849
significant	O	2849
portion	O	2849
of	O	2849
DNA	O	2849
flanking	O	2849
the	O	2849
5	O	2849
end	O	2849
of	O	2849
the	O	2849
gene	O	2849
,	O	2849
and	O	2849
should	O	2849
therefore	O	2849
prove	O	2849
a	O	2849
valuable	O	2849
resource	O	2849
for	O	2849
functional	O	2849
studies	O	2849
by	O	2849
transfer	O	2849
to	O	2849
colorectal	B-Disease	2849
tumor	I-Disease	2849
-	O	2849
derived	O	2849
cell	O	2849
lines	O	2849
.	O	2849

Inherited	O	2850
WT1	O	2850
mutation	O	2850
in	O	2850
Denys	B-Disease	2850
-	I-Disease	2850
Drash	I-Disease	2850
syndrome	I-Disease	2850
.	O	2850

Patients	O	2851
with	O	2851
the	O	2851
Denys	B-Disease	2851
-	I-Disease	2851
Drash	I-Disease	2851
syndrome	I-Disease	2851
(	O	2851
Wilms	B-Disease	2851
tumor	I-Disease	2851
,	O	2851
genital	B-Disease	2851
anomalies	I-Disease	2851
,	O	2851
and	O	2851
nephropathy	B-Disease	2851
)	O	2851
have	O	2851
been	O	2851
demonstrated	O	2851
to	O	2851
carry	O	2851
de	O	2851
novo	O	2851
constitutional	O	2851
mutations	O	2851
in	O	2851
WT1	O	2851
,	O	2851
the	O	2851
Wilms	B-Disease	2851
tumor	I-Disease	2851
gene	O	2851
at	O	2851
chromosome	O	2851
11p13	O	2851
.	O	2851

This	O	2854
observation	O	2854
indicates	O	2854
that	O	2854
the	O	2854
WT1	O	2854
exon	O	2854
9	O	2854
mutation	O	2854
affecting	O	2854
394Arg	O	2854
demonstrated	O	2854
in	O	2854
over	O	2854
one	O	2854
-	O	2854
half	O	2854
of	O	2854
the	O	2854
patients	O	2854
with	O	2854
the	O	2854
Denys	B-Disease	2854
-	I-Disease	2854
Drash	I-Disease	2854
syndrome	I-Disease	2854
may	O	2854
exhibit	O	2854
incomplete	O	2854
penetrance	O	2854
.	O	2854

Submicroscopic	O	2857
deletions	O	2857
at	O	2857
the	O	2857
WAGR	B-Disease	2857
locus	O	2857
,	O	2857
revealed	O	2857
by	O	2857
nonradioactive	O	2857
in	O	2857
situ	O	2857
hybridization	O	2857
.	O	2857

Fluorescence	O	2858
in	O	2858
situ	O	2858
hybridization	O	2858
(	O	2858
FISH	O	2858
)	O	2858
with	O	2858
biotin	O	2858
-	O	2858
labeled	O	2858
probes	O	2858
mapping	O	2858
to	O	2858
11p13	O	2858
has	O	2858
been	O	2858
used	O	2858
for	O	2858
the	O	2858
molecular	O	2858
analysis	O	2858
of	O	2858
deletions	O	2858
of	O	2858
the	O	2858
WAGR	B-Disease	2858
(	O	2858
Wilms	B-Disease	2858
tumor	I-Disease	2858
,	O	2858
aniridia	B-Disease	2858
,	O	2858
genitourinary	B-Disease	2858
abnormalities	I-Disease	2858
,	O	2858
and	O	2858
mental	B-Disease	2858
retardation	I-Disease	2858
)	O	2858
locus	O	2858
.	O	2858

We	O	2859
have	O	2859
detected	O	2859
a	O	2859
submicroscopic	O	2859
11p13	O	2859
deletion	O	2859
in	O	2859
a	O	2859
child	O	2859
with	O	2859
inherited	O	2859
aniridia	B-Disease	2859
who	O	2859
subsequently	O	2859
presented	O	2859
with	O	2859
Wilms	B-Disease	2859
tumor	I-Disease	2859
in	O	2859
a	O	2859
horseshoe	O	2859
kidney	O	2859
,	O	2859
only	O	2859
revealed	O	2859
at	O	2859
surgery	O	2859
.	O	2859

The	O	2860
mother	O	2860
,	O	2860
who	O	2860
has	O	2860
aniridia	B-Disease	2860
,	O	2860
was	O	2860
also	O	2860
found	O	2860
to	O	2860
carry	O	2860
a	O	2860
deletion	O	2860
including	O	2860
both	O	2860
the	O	2860
aniridia	B-Disease	2860
candidate	O	2860
gene	O	2860
(	O	2860
AN2	O	2860
)	O	2860
and	O	2860
the	O	2860
Wilms	B-Disease	2860
tumor	I-Disease	2860
predisposition	O	2860
gene	O	2860
(	O	2860
WT1	O	2860
)	O	2860
.	O	2860

This	O	2861
is	O	2861
therefore	O	2861
a	O	2861
rare	O	2861
case	O	2861
of	O	2861
an	O	2861
inherited	O	2861
WAGR	B-Disease	2861
deletion	O	2861
.	O	2861

Wilms	B-Disease	2862
tumor	I-Disease	2862
has	O	2862
so	O	2862
far	O	2862
only	O	2862
been	O	2862
associated	O	2862
with	O	2862
sporadic	O	2862
de	O	2862
novo	O	2862
aniridia	B-Disease	2862
cases	O	2862
.	O	2862

We	O	2863
have	O	2863
shown	O	2863
that	O	2863
a	O	2863
cosmid	O	2863
probe	O	2863
for	O	2863
a	O	2863
candidate	O	2863
aniridia	B-Disease	2863
gene	O	2863
,	O	2863
homologous	O	2863
to	O	2863
the	O	2863
mouse	O	2863
Pax	O	2863
-	O	2863
6	O	2863
gene	O	2863
,	O	2863
is	O	2863
deleted	O	2863
in	O	2863
cell	O	2863
lines	O	2863
from	O	2863
aniridia	B-Disease	2863
patients	O	2863
with	O	2863
previously	O	2863
characterized	O	2863
deletions	O	2863
at	O	2863
11p13	O	2863
,	O	2863
while	O	2863
another	O	2863
cosmid	O	2863
marker	O	2863
mapping	O	2863
between	O	2863
two	O	2863
aniridia	B-Disease	2863
-	O	2863
associated	O	2863
translocation	O	2863
breakpoints	O	2863
(	O	2863
and	O	2863
hence	O	2863
a	O	2863
second	O	2863
candidate	O	2863
marker	O	2863
)	O	2863
is	O	2863
present	O	2863
on	O	2863
both	O	2863
chromosomes	O	2863
.	O	2863

Linkage	O	2868
of	O	2868
gene	O	2868
for	O	2868
C2	B-Disease	2868
deficiency	I-Disease	2868
and	O	2868
the	O	2868
major	O	2868
histocompatibility	O	2868
complex	O	2868
MHC	O	2868
in	O	2868
man	O	2868
.	O	2868

Close	O	2870
linkage	O	2870
between	O	2870
HL	O	2870
-	O	2870
A	O	2870
and	O	2870
C2	B-Disease	2870
deficiency	I-Disease	2870
was	O	2870
first	O	2870
reported	O	2870
by	O	2870
FU	O	2870
and	O	2870
co	O	2870
-	O	2870
workers	O	2870
in	O	2870
1974	O	2870
.	O	2870

We	O	2871
present	O	2871
here	O	2871
a	O	2871
pedigree	O	2871
of	O	2871
a	O	2871
31	O	2871
-	O	2871
year	O	2871
-	O	2871
old	O	2871
C2	B-Disease	2871
-	I-Disease	2871
deficient	I-Disease	2871
individual	O	2871
with	O	2871
clinical	O	2871
manifestations	O	2871
of	O	2871
Hodgkins	B-Disease	2871
disease	I-Disease	2871
.	O	2871

In	O	2873
addition	O	2873
to	O	2873
close	O	2873
linkage	O	2873
between	O	2873
HL	O	2873
-	O	2873
A	O	2873
and	O	2873
C2	B-Disease	2873
deficiency	I-Disease	2873
,	O	2873
both	O	2873
parents	O	2873
were	O	2873
heterozygous	O	2873
for	O	2873
Bf	O	2873
(	O	2873
HL	O	2873
-	O	2873
A	O	2873
linked	O	2873
,	O	2873
electrophoretic	O	2873
variation	O	2873
of	O	2873
B	O	2873
)	O	2873
.	O	2873

The	O	2874
two	O	2874
HL	O	2874
-	O	2874
A	O	2874
haplotypes	O	2874
closely	O	2874
linked	O	2874
to	O	2874
C2	B-Disease	2874
deficiency	I-Disease	2874
are	O	2874
different	O	2874
2	O	2874
,	O	2874
W18	O	2874
and	O	2874
W24	O	2874
,	O	2874
W18	O	2874
.	O	2874

Screening	O	2877
for	O	2877
germ	O	2877
-	O	2877
line	O	2877
mutations	O	2877
in	O	2877
familial	B-Disease	2877
adenomatous	I-Disease	2877
polyposis	I-Disease	2877
patients	O	2877
:	O	2877
61	O	2877
new	O	2877
patients	O	2877
and	O	2877
a	O	2877
summary	O	2877
of	O	2877
150	O	2877
unrelated	O	2877
patients	O	2877
.	O	2877

We	O	2878
report	O	2878
here	O	2878
the	O	2878
result	O	2878
of	O	2878
a	O	2878
screening	O	2878
for	O	2878
germ	O	2878
-	O	2878
line	O	2878
mutations	O	2878
in	O	2878
the	O	2878
adenomatous	B-Disease	2878
polyposis	I-Disease	2878
coli	I-Disease	2878
(	O	2878
APC	B-Disease	2878
)	O	2878
gene	O	2878
in	O	2878
61	O	2878
new	O	2878
familial	B-Disease	2878
adenomatous	I-Disease	2878
polyposis	I-Disease	2878
(	O	2878
FAP	B-Disease	2878
)	O	2878
patients	O	2878
as	O	2878
well	O	2878
as	O	2878
a	O	2878
summary	O	2878
of	O	2878
the	O	2878
results	O	2878
of	O	2878
150	O	2878
patients	O	2878
.	O	2878

Examination	O	2879
of	O	2879
the	O	2879
entire	O	2879
coding	O	2879
region	O	2879
of	O	2879
the	O	2879
APC	B-Disease	2879
gene	O	2879
,	O	2879
based	O	2879
on	O	2879
a	O	2879
ribonuclease	O	2879
protection	O	2879
assay	O	2879
coupled	O	2879
with	O	2879
the	O	2879
polymerase	O	2879
chain	O	2879
reaction	O	2879
(	O	2879
PCR	O	2879
)	O	2879
,	O	2879
disclosed	O	2879
mutations	O	2879
that	O	2879
were	O	2879
considered	O	2879
to	O	2879
cause	O	2879
significant	O	2879
defects	O	2879
in	O	2879
the	O	2879
APC	B-Disease	2879
product	O	2879
in	O	2879
97	O	2879
of	O	2879
150	O	2879
unrelated	O	2879
FAP	B-Disease	2879
patients	O	2879
.	O	2879

Our	O	2880
findings	O	2880
revealed	O	2880
the	O	2880
following	O	2880
characteristics	O	2880
of	O	2880
the	O	2880
germ	O	2880
-	O	2880
line	O	2880
mutations	O	2880
of	O	2880
APC	O	2880
1	O	2880
)	O	2880
the	O	2880
great	O	2880
majority	O	2880
of	O	2880
the	O	2880
mutations	O	2880
were	O	2880
found	O	2880
to	O	2880
truncate	O	2880
the	O	2880
APC	B-Disease	2880
product	O	2880
;	O	2880
2	O	2880
)	O	2880
almost	O	2880
all	O	2880
of	O	2880
the	O	2880
mutations	O	2880
were	O	2880
located	O	2880
within	O	2880
the	O	2880
first	O	2880
half	O	2880
of	O	2880
the	O	2880
coding	O	2880
region	O	2880
;	O	2880
3	O	2880
)	O	2880
no	O	2880
correlation	O	2880
was	O	2880
observed	O	2880
between	O	2880
the	O	2880
locations	O	2880
of	O	2880
germ	O	2880
-	O	2880
line	O	2880
mutations	O	2880
and	O	2880
extracolonic	O	2880
manifestations	O	2880
in	O	2880
FAP	B-Disease	2880
patients	O	2880
;	O	2880
4	O	2880
)	O	2880
more	O	2880
than	O	2880
80	O	2880
%	O	2880
of	O	2880
base	O	2880
substitutions	O	2880
in	O	2880
the	O	2880
APC	B-Disease	2880
gene	O	2880
were	O	2880
from	O	2880
cytosine	O	2880
to	O	2880
other	O	2880
nucleotides	O	2880
,	O	2880
nearly	O	2880
one	O	2880
-	O	2880
third	O	2880
of	O	2880
which	O	2880
occurred	O	2880
at	O	2880
the	O	2880
GpG	O	2880
site	O	2880
.	O	2880

Our	O	2881
results	O	2881
provide	O	2881
information	O	2881
helpful	O	2881
to	O	2881
an	O	2881
understanding	O	2881
of	O	2881
the	O	2881
APC	B-Disease	2881
gene	O	2881
and	O	2881
will	O	2881
also	O	2881
contribute	O	2881
to	O	2881
presymptomatic	O	2881
diagnosis	O	2881
of	O	2881
members	O	2881
in	O	2881
FAP	B-Disease	2881
families	O	2881
.	O	2881

Somatic	O	2883
mutations	O	2883
of	O	2883
the	O	2883
APC	B-Disease	2883
gene	O	2883
in	O	2883
colorectal	B-Disease	2883
tumors	I-Disease	2883
:	O	2883
mutation	O	2883
cluster	O	2883
region	O	2883
in	O	2883
the	O	2883
APC	B-Disease	2883
gene	O	2883
.	O	2883

We	O	2884
examined	O	2884
somatic	O	2884
mutations	O	2884
of	O	2884
the	O	2884
adenomatous	B-Disease	2884
polyposis	I-Disease	2884
coli	I-Disease	2884
(	O	2884
APC	B-Disease	2884
)	O	2884
gene	O	2884
in	O	2884
63	O	2884
colorectal	B-Disease	2884
tumors	I-Disease	2884
(	O	2884
16	O	2884
adenomas	B-Disease	2884
and	O	2884
47	O	2884
carcinomas	B-Disease	2884
)	O	2884
developed	O	2884
in	O	2884
familial	B-Disease	2884
adenomatous	I-Disease	2884
polyposis	I-Disease	2884
(	O	2884
FAP	B-Disease	2884
)	O	2884
and	O	2884
non	O	2884
-	O	2884
FAP	O	2884
patients	O	2884
.	O	2884

In	O	2885
addition	O	2885
to	O	2885
loss	O	2885
of	O	2885
heterozygosity	O	2885
(	O	2885
LOH	O	2885
)	O	2885
at	O	2885
the	O	2885
APC	B-Disease	2885
locus	O	2885
in	O	2885
30	O	2885
tumors	B-Disease	2885
,	O	2885
43	O	2885
other	O	2885
somatic	O	2885
mutations	O	2885
were	O	2885
detected	O	2885
.	O	2885

Twenty	O	2887
-	O	2887
two	O	2887
tumors	B-Disease	2887
had	O	2887
frameshift	O	2887
mutations	O	2887
due	O	2887
to	O	2887
deletion	O	2887
or	O	2887
insertion	O	2887
;	O	2887
nineteen	O	2887
of	O	2887
them	O	2887
were	O	2887
deletions	O	2887
of	O	2887
one	O	2887
to	O	2887
31	O	2887
bp	O	2887
and	O	2887
three	O	2887
were	O	2887
a	O	2887
1	O	2887
-	O	2887
bp	O	2887
insertion	O	2887
.	O	2887

One	O	2888
tumor	B-Disease	2888
had	O	2888
a	O	2888
1	O	2888
-	O	2888
bp	O	2888
deletion	O	2888
in	O	2888
an	O	2888
intron	O	2888
near	O	2888
the	O	2888
splicing	O	2888
site	O	2888
.	O	2888

Hence	O	2889
,	O	2889
41	O	2889
(	O	2889
95	O	2889
%	O	2889
)	O	2889
of	O	2889
43	O	2889
mutations	O	2889
resulted	O	2889
in	O	2889
truncation	O	2889
of	O	2889
the	O	2889
APC	B-Disease	2889
protein	O	2889
.	O	2889

Over	O	2890
60	O	2890
%	O	2890
of	O	2890
the	O	2890
somatic	O	2890
mutations	O	2890
in	O	2890
the	O	2890
APC	B-Disease	2890
gene	O	2890
were	O	2890
clustered	O	2890
within	O	2890
a	O	2890
small	O	2890
region	O	2890
of	O	2890
exon	O	2890
15	O	2890
,	O	2890
designated	O	2890
as	O	2890
MCR	O	2890
(	O	2890
mutation	O	2890
cluster	O	2890
region	O	2890
)	O	2890
,	O	2890
which	O	2890
accounted	O	2890
for	O	2890
less	O	2890
than	O	2890
10	O	2890
%	O	2890
of	O	2890
the	O	2890
coding	O	2890
region	O	2890
.	O	2890

Combining	O	2891
these	O	2891
data	O	2891
and	O	2891
the	O	2891
results	O	2891
of	O	2891
LOH	O	2891
,	O	2891
more	O	2891
than	O	2891
80	O	2891
%	O	2891
of	O	2891
tumors	B-Disease	2891
(	O	2891
14	O	2891
adenomas	B-Disease	2891
and	O	2891
39	O	2891
carcinomas	B-Disease	2891
)	O	2891
had	O	2891
at	O	2891
least	O	2891
one	O	2891
mutation	O	2891
in	O	2891
the	O	2891
APC	B-Disease	2891
gene	O	2891
,	O	2891
of	O	2891
which	O	2891
more	O	2891
than	O	2891
60	O	2891
%	O	2891
(	O	2891
9	O	2891
adenomas	B-Disease	2891
and	O	2891
23	O	2891
carcinomas	B-Disease	2891
)	O	2891
had	O	2891
two	O	2891
mutations	O	2891
.	O	2891

These	O	2892
results	O	2892
strongly	O	2892
suggest	O	2892
that	O	2892
somatic	O	2892
mutations	O	2892
of	O	2892
the	O	2892
APC	B-Disease	2892
gene	O	2892
are	O	2892
associated	O	2892
with	O	2892
development	O	2892
of	O	2892
a	O	2892
great	O	2892
majority	O	2892
of	O	2892
colorectal	B-Disease	2892
tumors	I-Disease	2892
.	O	2892

Constitutional	O	2894
mutations	O	2894
in	O	2894
the	O	2894
WT1	O	2894
gene	O	2894
in	O	2894
patients	O	2894
with	O	2894
Denys	B-Disease	2894
-	I-Disease	2894
Drash	I-Disease	2894
syndrome	I-Disease	2894
.	O	2894

The	O	2895
Denys	B-Disease	2895
-	I-Disease	2895
Drash	I-Disease	2895
syndrome	I-Disease	2895
is	O	2895
characterised	O	2895
by	O	2895
a	O	2895
typical	O	2895
nephropathy	B-Disease	2895
,	O	2895
genital	B-Disease	2895
abnormalities	I-Disease	2895
and	O	2895
also	O	2895
predisposes	O	2895
to	O	2895
the	O	2895
development	O	2895
of	O	2895
Wilms	B-Disease	2895
tumor	I-Disease	2895
.	O	2895

These	O	2896
patients	O	2896
eventually	O	2896
go	O	2896
into	O	2896
end	O	2896
stage	O	2896
renal	B-Disease	2896
failure	I-Disease	2896
.	O	2896

A	O	2897
candidate	O	2897
Wilms	B-Disease	2897
tumor	I-Disease	2897
gene	O	2897
,	O	2897
WT1	O	2897
,	O	2897
from	O	2897
the	O	2897
11p13	O	2897
chromosome	O	2897
region	O	2897
has	O	2897
recently	O	2897
been	O	2897
cloned	O	2897
.	O	2897

Linkage	O	2909
disequilibrium	O	2909
mapping	O	2909
in	O	2909
isolated	O	2909
founder	O	2909
populations	O	2909
:	O	2909
diastrophic	B-Disease	2909
dysplasia	I-Disease	2909
in	O	2909
Finland	O	2909
.	O	2909

Using	O	2912
these	O	2912
methods	O	2912
,	O	2912
we	O	2912
report	O	2912
striking	O	2912
linkage	O	2912
disequilibrium	O	2912
for	O	2912
diastrophic	B-Disease	2912
dysplasia	I-Disease	2912
(	O	2912
DTD	B-Disease	2912
)	O	2912
in	O	2912
Finland	O	2912
indicating	O	2912
that	O	2912
the	O	2912
DTD	B-Disease	2912
gene	O	2912
should	O	2912
lie	O	2912
within	O	2912
0	O	2912
.	O	2912

The	O	2915
Wiskott	B-Disease	2915
-	I-Disease	2915
Aldrich	I-Disease	2915
syndrome	I-Disease	2915
:	O	2915
refinement	O	2915
of	O	2915
the	O	2915
localization	O	2915
on	O	2915
Xp	O	2915
and	O	2915
identification	O	2915
of	O	2915
another	O	2915
closely	O	2915
linked	O	2915
marker	O	2915
locus	O	2915
,	O	2915
OATL1	O	2915
.	O	2915

The	O	2916
Wiskott	B-Disease	2916
-	I-Disease	2916
Aldrich	I-Disease	2916
syndrome	I-Disease	2916
(	O	2916
WAS	B-Disease	2916
)	O	2916
has	O	2916
previously	O	2916
been	O	2916
mapped	O	2916
to	O	2916
the	O	2916
proximal	O	2916
short	O	2916
arm	O	2916
of	O	2916
the	O	2916
X	O	2916
chromosome	O	2916
between	O	2916
the	O	2916
DXS14	O	2916
and	O	2916
DXS7	O	2916
loci	O	2916
.	O	2916

In	O	2917
this	O	2917
study	O	2917
,	O	2917
further	O	2917
segregation	O	2917
analysis	O	2917
has	O	2917
been	O	2917
performed	O	2917
using	O	2917
a	O	2917
newly	O	2917
identified	O	2917
WAS	B-Disease	2917
family	O	2917
as	O	2917
well	O	2917
as	O	2917
an	O	2917
additional	O	2917
marker	O	2917
probe	O	2917
,	O	2917
HOATL1	O	2917
.	O	2917

The	O	2918
results	O	2918
indicate	O	2918
close	O	2918
linkage	O	2918
between	O	2918
the	O	2918
WAS	B-Disease	2918
and	O	2918
OATL1	O	2918
loci	O	2918
(	O	2918
Z	O	2918
=	O	2918
6	O	2918
.	O	2918

00	O	2920
)	O	2920
and	O	2920
localize	O	2920
the	O	2920
TIMP	O	2920
,	O	2920
OATL1	O	2920
,	O	2920
DXS255	O	2920
,	O	2920
and	O	2920
WAS	B-Disease	2920
loci	O	2920
distal	O	2920
to	O	2920
DXS146	O	2920
and	O	2920
the	O	2920
OATL1	O	2920
and	O	2920
WAS	B-Disease	2920
loci	O	2920
proximal	O	2920
to	O	2920
TIMP	O	2920
.	O	2920

These	O	2921
linkage	O	2921
data	O	2921
narrow	O	2921
the	O	2921
boundaries	O	2921
within	O	2921
which	O	2921
the	O	2921
WAS	B-Disease	2921
locus	O	2921
maps	O	2921
to	O	2921
the	O	2921
chromosomal	O	2921
region	O	2921
bracketed	O	2921
by	O	2921
TIMP	O	2921
and	O	2921
DXS146	O	2921
and	O	2921
support	O	2921
the	O	2921
loci	O	2921
order	O	2921
Xpter	O	2921
-	O	2921
DXS7	O	2921
-	O	2921
TIMP	O	2921
-	O	2921
(	O	2921
OATL1	O	2921
,	O	2921
WAS	O	2921
,	O	2921
DXS255	O	2921
)	O	2921
-	O	2921
DXS146	O	2921
.	O	2921

Detection	O	2922
of	O	2922
an	O	2922
unstable	O	2922
fragment	O	2922
of	O	2922
DNA	O	2922
specific	O	2922
to	O	2922
individuals	O	2922
with	O	2922
myotonic	B-Disease	2922
dystrophy	I-Disease	2922
.	O	2922

Myotonic	B-Disease	2923
dystrophy	I-Disease	2923
(	O	2923
DM	B-Disease	2923
)	O	2923
is	O	2923
the	O	2923
most	O	2923
common	O	2923
form	O	2923
of	O	2923
adult	O	2923
muscular	B-Disease	2923
dystrophy	I-Disease	2923
,	O	2923
with	O	2923
a	O	2923
prevalence	O	2923
of	O	2923
2	O	2923
-	O	2923
14	O	2923
per	O	2923
100	O	2923
,	O	2923
000	O	2923
individuals	O	2923
.	O	2923

The	O	2924
disease	O	2924
is	O	2924
characterized	O	2924
by	O	2924
progressive	O	2924
muscle	B-Disease	2924
weakness	I-Disease	2924
and	O	2924
sustained	B-Disease	2924
muscle	I-Disease	2924
contraction	I-Disease	2924
,	O	2924
often	O	2924
with	O	2924
a	O	2924
wide	O	2924
range	O	2924
of	O	2924
accompanying	O	2924
symptoms	O	2924
.	O	2924

It	O	2928
is	O	2928
flanked	O	2928
by	O	2928
the	O	2928
tightly	O	2928
linked	O	2928
genetic	O	2928
markers	O	2928
ERCC1	O	2928
proximally	O	2928
and	O	2928
D19S51	O	2928
distally	O	2928
;	O	2928
these	O	2928
define	O	2928
the	O	2928
DM	B-Disease	2928
critical	O	2928
region	O	2928
.	O	2928

We	O	2931
postulate	O	2931
that	O	2931
this	O	2931
unstable	O	2931
DNA	O	2931
sequence	O	2931
is	O	2931
the	O	2931
molecular	O	2931
feature	O	2931
that	O	2931
underlies	O	2931
DM	B-Disease	2931
.	O	2931

22	O	2936
)	O	2936
,	O	2936
present	O	2936
in	O	2936
a	O	2936
girl	O	2936
with	O	2936
Duchenne	B-Disease	2936
muscular	I-Disease	2936
dystrophy	I-Disease	2936
(	O	2936
DMD	B-Disease	2936
)	O	2936
.	O	2936

Physical	O	2937
mapping	O	2937
of	O	2937
the	O	2937
derivative	O	2937
chromosomes	O	2937
,	O	2937
after	O	2937
their	O	2937
separation	O	2937
in	O	2937
somatic	O	2937
cell	O	2937
hybrids	O	2937
,	O	2937
reveals	O	2937
that	O	2937
the	O	2937
translocation	O	2937
disrupts	O	2937
the	O	2937
DMD	B-Disease	2937
gene	O	2937
in	O	2937
Xp21	O	2937
within	O	2937
the	O	2937
18	O	2937
-	O	2937
kb	O	2937
intron	O	2937
16	O	2937
.	O	2937

A	O	2944
genetic	O	2944
etiology	O	2944
for	O	2944
DiGeorge	B-Disease	2944
syndrome	I-Disease	2944
:	O	2944
consistent	O	2944
deletions	O	2944
and	O	2944
microdeletions	O	2944
of	O	2944
22q11	O	2944
.	O	2944

DiGeorge	B-Disease	2945
syndrome	I-Disease	2945
(	O	2945
DGS	B-Disease	2945
)	O	2945
,	O	2945
a	O	2945
developmental	O	2945
field	O	2945
defect	O	2945
of	O	2945
the	O	2945
third	O	2945
and	O	2945
fourth	O	2945
pharyngeal	O	2945
pouches	O	2945
,	O	2945
is	O	2945
characterized	O	2945
by	O	2945
aplasia	B-Disease	2945
or	I-Disease	2945
hypoplasia	I-Disease	2945
of	I-Disease	2945
the	I-Disease	2945
thymus	I-Disease	2945
and	I-Disease	2945
parathyroid	I-Disease	2945
glands	I-Disease	2945
and	O	2945
by	O	2945
conotruncal	B-Disease	2945
cardiac	I-Disease	2945
malformations	I-Disease	2945
.	O	2945

Cytogenetic	O	2946
studies	O	2946
support	O	2946
the	O	2946
presence	O	2946
of	O	2946
a	O	2946
DGS	B-Disease	2946
critical	O	2946
region	O	2946
in	O	2946
band	O	2946
22q11	O	2946
.	O	2946

In	O	2947
the	O	2947
present	O	2947
study	O	2947
,	O	2947
we	O	2947
report	O	2947
the	O	2947
results	O	2947
of	O	2947
clinical	O	2947
,	O	2947
cytogenetic	O	2947
,	O	2947
and	O	2947
molecular	O	2947
studies	O	2947
of	O	2947
14	O	2947
patients	O	2947
with	O	2947
DGS	B-Disease	2947
.	O	2947

A	O	2952
third	O	2952
locus	O	2952
,	O	2952
D22S66	O	2952
,	O	2952
is	O	2952
deleted	O	2952
in	O	2952
the	O	2952
eight	O	2952
DGS	B-Disease	2952
probands	O	2952
tested	O	2952
.	O	2952

On	O	2956
the	O	2956
basis	O	2956
of	O	2956
these	O	2956
families	O	2956
,	O	2956
and	O	2956
of	O	2956
six	O	2956
maternally	O	2956
and	O	2956
five	O	2956
paternally	O	2956
derived	O	2956
unbalanced	O	2956
-	O	2956
translocation	O	2956
DGS	B-Disease	2956
probands	O	2956
in	O	2956
the	O	2956
literature	O	2956
,	O	2956
parent	O	2956
of	O	2956
origin	O	2956
or	O	2956
imprinting	O	2956
does	O	2956
not	O	2956
appear	O	2956
to	O	2956
play	O	2956
an	O	2956
important	O	2956
role	O	2956
in	O	2956
the	O	2956
pathogenesis	O	2956
of	O	2956
DGS	B-Disease	2956
.	O	2956

Deletion	O	2957
of	O	2957
the	O	2957
same	O	2957
three	O	2957
loci	O	2957
in	O	2957
all	O	2957
14	O	2957
DGS	B-Disease	2957
probands	O	2957
begins	O	2957
to	O	2957
delineate	O	2957
the	O	2957
region	O	2957
of	O	2957
chromosome	O	2957
22	O	2957
critical	O	2957
for	O	2957
DGS	B-Disease	2957
and	O	2957
confirms	O	2957
the	O	2957
hypothesis	O	2957
that	O	2957
submicroscopic	O	2957
deletions	O	2957
of	O	2957
22q11	O	2957
are	O	2957
etiologic	O	2957
in	O	2957
the	O	2957
vast	O	2957
majority	O	2957
of	O	2957
cases	O	2957
.	O	2957

Loss	O	2959
of	O	2959
normal	O	2959
allele	O	2959
of	O	2959
the	O	2959
APC	B-Disease	2959
gene	O	2959
in	O	2959
an	O	2959
adrenocortical	B-Disease	2959
carcinoma	I-Disease	2959
from	O	2959
a	O	2959
patient	O	2959
with	O	2959
familial	B-Disease	2959
adenomatous	I-Disease	2959
polyposis	I-Disease	2959
.	O	2959

Endocrine	B-Disease	2960
neoplasms	I-Disease	2960
have	O	2960
been	O	2960
reported	O	2960
occasionally	O	2960
in	O	2960
patients	O	2960
with	O	2960
familial	B-Disease	2960
adenomatous	I-Disease	2960
polyposis	I-Disease	2960
(	O	2960
FAP	B-Disease	2960
)	O	2960
.	O	2960

An	O	2961
adrenocorotical	B-Disease	2961
carcinoma	I-Disease	2961
was	O	2961
studied	O	2961
in	O	2961
a	O	2961
patient	O	2961
with	O	2961
a	O	2961
family	O	2961
history	O	2961
of	O	2961
FAP	B-Disease	2961
.	O	2961

Loss	O	2962
of	O	2962
heterozygosity	O	2962
(	O	2962
LOH	O	2962
)	O	2962
in	O	2962
the	O	2962
region	O	2962
close	O	2962
to	O	2962
the	O	2962
adenomatous	B-Disease	2962
polyposis	I-Disease	2962
coli	I-Disease	2962
(	O	2962
APC	B-Disease	2962
)	O	2962
gene	O	2962
was	O	2962
detected	O	2962
in	O	2962
this	O	2962
carcinoma	B-Disease	2962
,	O	2962
and	O	2962
evidence	O	2962
was	O	2962
obtained	O	2962
that	O	2962
there	O	2962
was	O	2962
a	O	2962
loss	O	2962
of	O	2962
the	O	2962
normal	O	2962
allele	O	2962
of	O	2962
the	O	2962
APC	B-Disease	2962
gene	O	2962
.	O	2962

This	O	2963
is	O	2963
the	O	2963
first	O	2963
demonstration	O	2963
of	O	2963
LOH	O	2963
at	O	2963
the	O	2963
APC	B-Disease	2963
locus	O	2963
in	O	2963
adrenocortical	B-Disease	2963
tumors	I-Disease	2963
.	O	2963

The	O	2964
present	O	2964
results	O	2964
and	O	2964
our	O	2964
previous	O	2964
data	O	2964
on	O	2964
LOH	O	2964
in	O	2964
a	O	2964
recurring	O	2964
desmoid	B-Disease	2964
tumor	I-Disease	2964
suggest	O	2964
that	O	2964
the	O	2964
heterozygous	O	2964
mutant	O	2964
/	O	2964
wild	O	2964
-	O	2964
type	O	2964
condition	O	2964
of	O	2964
the	O	2964
APC	B-Disease	2964
gene	O	2964
may	O	2964
give	O	2964
rise	O	2964
to	O	2964
benign	B-Disease	2964
tumors	I-Disease	2964
,	O	2964
and	O	2964
that	O	2964
functional	O	2964
loss	O	2964
of	O	2964
this	O	2964
gene	O	2964
leads	O	2964
to	O	2964
development	O	2964
of	O	2964
tumors	B-Disease	2964
not	O	2964
only	O	2964
in	O	2964
the	O	2964
colon	O	2964
but	O	2964
also	O	2964
in	O	2964
other	O	2964
various	O	2964
parts	O	2964
of	O	2964
the	O	2964
body	O	2964
in	O	2964
FAP	B-Disease	2964
patients	O	2964
.	O	2964

Oncogenic	O	2966
point	O	2966
mutations	O	2966
in	O	2966
exon	O	2966
20	O	2966
of	O	2966
the	O	2966
RB1	O	2966
gene	O	2966
in	O	2966
families	O	2966
showing	O	2966
incomplete	O	2966
penetrance	O	2966
and	O	2966
mild	O	2966
expression	O	2966
of	O	2966
the	O	2966
retinoblastoma	B-Disease	2966
phenotype	O	2966
.	O	2966

The	O	2967
retinoblastoma	B-Disease	2967
-	O	2967
predisposition	O	2967
gene	O	2967
,	O	2967
RB1	O	2967
,	O	2967
segregates	O	2967
as	O	2967
an	O	2967
autosomal	O	2967
dominant	O	2967
trait	O	2967
with	O	2967
high	O	2967
(	O	2967
90	O	2967
%	O	2967
)	O	2967
penetrance	O	2967
.	O	2967

Certain	O	2968
families	O	2968
,	O	2968
however	O	2968
,	O	2968
show	O	2968
an	O	2968
unusual	O	2968
low	O	2968
-	O	2968
penetrance	O	2968
phenotype	O	2968
with	O	2968
many	O	2968
individuals	O	2968
being	O	2968
unaffected	O	2968
,	O	2968
unilaterally	O	2968
affected	O	2968
,	O	2968
or	O	2968
with	O	2968
evidence	O	2968
of	O	2968
spontaneously	O	2968
regressed	O	2968
tumors	B-Disease	2968
.	O	2968

Late	O	2976
-	O	2976
onset	O	2976
metachromatic	B-Disease	2976
leukodystrophy	I-Disease	2976
:	O	2976
molecular	O	2976
pathology	O	2976
in	O	2976
two	O	2976
siblings	O	2976
.	O	2976

We	O	2977
report	O	2977
on	O	2977
a	O	2977
new	O	2977
allele	O	2977
at	O	2977
the	O	2977
arylsulfatase	O	2977
A	O	2977
(	O	2977
ARSA	O	2977
)	O	2977
locus	O	2977
causing	O	2977
late	O	2977
-	O	2977
onset	O	2977
metachromatic	B-Disease	2977
leukodystrophy	I-Disease	2977
(	O	2977
MLD	B-Disease	2977
)	O	2977
.	O	2977

In	O	2979
contrast	O	2979
to	O	2979
alleles	O	2979
that	O	2979
cause	O	2979
early	O	2979
-	O	2979
onset	O	2979
MLD	B-Disease	2979
,	O	2979
the	O	2979
arginine84	O	2979
to	O	2979
glutamine	O	2979
substitution	O	2979
is	O	2979
associated	O	2979
with	O	2979
some	O	2979
residual	O	2979
ARSA	O	2979
activity	O	2979
.	O	2979

A	O	2980
comparison	O	2980
of	O	2980
genotypes	O	2980
,	O	2980
ARSA	O	2980
activities	O	2980
,	O	2980
and	O	2980
clinical	O	2980
data	O	2980
on	O	2980
4	O	2980
individuals	O	2980
carrying	O	2980
the	O	2980
allele	O	2980
of	O	2980
81	O	2980
patients	O	2980
with	O	2980
MLD	B-Disease	2980
examined	O	2980
,	O	2980
further	O	2980
validates	O	2980
the	O	2980
concept	O	2980
that	O	2980
different	O	2980
degrees	O	2980
of	O	2980
residual	O	2980
ARSA	O	2980
activity	O	2980
are	O	2980
the	O	2980
basis	O	2980
of	O	2980
phenotypical	O	2980
variation	O	2980
in	O	2980
MLD	B-Disease	2980
.	O	2980

Trisomy	B-Disease	2982
15	I-Disease	2982
with	O	2982
loss	O	2982
of	O	2982
the	O	2982
paternal	O	2982
15	O	2982
as	O	2982
a	O	2982
cause	O	2982
of	O	2982
Prader	B-Disease	2982
-	I-Disease	2982
Willi	I-Disease	2982
syndrome	I-Disease	2982
due	O	2982
to	O	2982
maternal	B-Disease	2982
disomy	I-Disease	2982
.	O	2982

Uniparental	B-Disease	2983
disomy	I-Disease	2983
has	O	2983
recently	O	2983
been	O	2983
recognized	O	2983
to	O	2983
cause	O	2983
human	O	2983
disorders	O	2983
,	O	2983
including	O	2983
Prader	B-Disease	2983
-	I-Disease	2983
Willi	I-Disease	2983
syndrome	I-Disease	2983
(	O	2983
PWS	B-Disease	2983
)	O	2983
.	O	2983

We	O	2984
describe	O	2984
a	O	2984
particularly	O	2984
instructive	O	2984
case	O	2984
which	O	2984
raises	O	2984
important	O	2984
issues	O	2984
concerning	O	2984
the	O	2984
mechanisms	O	2984
producing	O	2984
uniparental	B-Disease	2984
disomy	I-Disease	2984
and	O	2984
whose	O	2984
evaluation	O	2984
provides	O	2984
evidence	O	2984
that	O	2984
trisomy	O	2984
may	O	2984
precede	O	2984
uniparental	B-Disease	2984
disomy	I-Disease	2984
in	O	2984
a	O	2984
fetus	O	2984
.	O	2984

Chorionic	O	2985
villus	O	2985
sampling	O	2985
performed	O	2985
for	O	2985
advanced	O	2985
maternal	O	2985
age	O	2985
revealed	O	2985
trisomy	B-Disease	2985
15	I-Disease	2985
in	O	2985
all	O	2985
direct	O	2985
and	O	2985
cultured	O	2985
cells	O	2985
,	O	2985
though	O	2985
the	O	2985
fetus	O	2985
appeared	O	2985
normal	O	2985
.	O	2985

The	O	2987
child	O	2987
was	O	2987
hypotonic	B-Disease	2987
at	O	2987
birth	O	2987
,	O	2987
and	O	2987
high	O	2987
-	O	2987
resolution	O	2987
banding	O	2987
failed	O	2987
to	O	2987
reveal	O	2987
the	O	2987
deletion	O	2987
of	O	2987
15q11	O	2987
-	O	2987
13	O	2987
,	O	2987
a	O	2987
deletion	O	2987
which	O	2987
is	O	2987
found	O	2987
in	O	2987
50	O	2987
%	O	2987
-	O	2987
70	O	2987
%	O	2987
of	O	2987
patients	O	2987
with	O	2987
PWS	B-Disease	2987
.	O	2987

Over	O	2988
time	O	2988
,	O	2988
typical	O	2988
features	O	2988
of	O	2988
PWS	B-Disease	2988
developed	O	2988
.	O	2988

Maternal	O	2990
nondisjunction	O	2990
with	O	2990
fertilization	O	2990
of	O	2990
a	O	2990
disomic	O	2990
egg	O	2990
by	O	2990
a	O	2990
normal	O	2990
sperm	O	2990
,	O	2990
followed	O	2990
by	O	2990
loss	O	2990
of	O	2990
the	O	2990
paternal	O	2990
15	O	2990
,	O	2990
is	O	2990
a	O	2990
likely	O	2990
cause	O	2990
of	O	2990
confined	O	2990
placental	O	2990
mosaicism	O	2990
and	O	2990
uniparental	B-Disease	2990
disomy	I-Disease	2990
in	O	2990
this	O	2990
case	O	2990
of	O	2990
PWS	B-Disease	2990
,	O	2990
and	O	2990
advanced	O	2990
maternal	O	2990
age	O	2990
may	O	2990
be	O	2990
a	O	2990
predisposing	O	2990
factor	O	2990
.	O	2990

Genetic	O	2992
heterogeneity	O	2992
in	O	2992
X	B-Disease	2992
-	I-Disease	2992
linked	I-Disease	2992
amelogenesis	I-Disease	2992
imperfecta	I-Disease	2992
.	O	2992

3	O	2995
encodes	O	2995
for	O	2995
the	O	2995
enamel	O	2995
protein	O	2995
amelogenin	O	2995
and	O	2995
has	O	2995
been	O	2995
implicated	O	2995
as	O	2995
the	O	2995
gene	O	2995
responsible	O	2995
for	O	2995
the	O	2995
inherited	B-Disease	2995
dental	I-Disease	2995
abnormality	I-Disease	2995
X	B-Disease	2995
-	I-Disease	2995
linked	I-Disease	2995
amelogenesis	I-Disease	2995
imperfecta	I-Disease	2995
(	O	2995
XAI	B-Disease	2995
)	O	2995
.	O	2995

Three	O	2996
families	O	2996
with	O	2996
XAI	B-Disease	2996
have	O	2996
been	O	2996
investigated	O	2996
using	O	2996
polymorphic	O	2996
DNA	O	2996
markers	O	2996
flanking	O	2996
the	O	2996
position	O	2996
of	O	2996
AMELX	O	2996
.	O	2996

Using	O	2997
two	O	2997
-	O	2997
point	O	2997
linkage	O	2997
analysis	O	2997
,	O	2997
linkage	O	2997
was	O	2997
established	O	2997
between	O	2997
XAI	B-Disease	2997
and	O	2997
several	O	2997
of	O	2997
these	O	2997
markers	O	2997
in	O	2997
two	O	2997
families	O	2997
,	O	2997
with	O	2997
a	O	2997
combined	O	2997
lod	O	2997
score	O	2997
of	O	2997
6	O	2997
.	O	2997

This	O	3000
supports	O	3000
the	O	3000
involvement	O	3000
of	O	3000
AMELX	O	3000
,	O	3000
located	O	3000
close	O	3000
to	O	3000
DXS16	O	3000
,	O	3000
in	O	3000
the	O	3000
XAI	B-Disease	3000
disease	I-Disease	3000
process	O	3000
(	O	3000
AIH1	O	3000
)	O	3000
in	O	3000
those	O	3000
families	O	3000
.	O	3000

There	O	3005
was	O	3005
significant	O	3005
evidence	O	3005
against	O	3005
linkage	O	3005
to	O	3005
this	O	3005
region	O	3005
in	O	3005
the	O	3005
third	O	3005
family	O	3005
,	O	3005
indicating	O	3005
locus	O	3005
heterogeneity	O	3005
in	O	3005
XAI	B-Disease	3005
.	O	3005

Multiple	O	3012
origins	O	3012
for	O	3012
phenylketonuria	B-Disease	3012
in	O	3012
Europe	O	3012
.	O	3012

Phenylketonuria	B-Disease	3013
(	O	3013
PKU	B-Disease	3013
)	O	3013
,	O	3013
a	O	3013
disorder	B-Disease	3013
of	I-Disease	3013
amino	I-Disease	3013
acid	I-Disease	3013
metabolism	I-Disease	3013
prevalent	O	3013
among	O	3013
Caucasians	O	3013
and	O	3013
other	O	3013
ethnic	O	3013
groups	O	3013
,	O	3013
is	O	3013
caused	O	3013
primarily	O	3013
by	O	3013
a	O	3013
deficiency	B-Disease	3013
of	I-Disease	3013
the	I-Disease	3013
hepatic	I-Disease	3013
enzyme	I-Disease	3013
phenylalanine	I-Disease	3013
hydroxylase	I-Disease	3013
(	O	3013
PAH	O	3013
)	O	3013
.	O	3013

PKU	B-Disease	3014
is	O	3014
a	O	3014
highly	O	3014
heterogeneous	O	3014
disorder	O	3014
,	O	3014
with	O	3014
more	O	3014
than	O	3014
60	O	3014
molecular	O	3014
lesions	O	3014
identified	O	3014
in	O	3014
the	O	3014
PAH	O	3014
gene	O	3014
.	O	3014

The	O	3015
haplotype	O	3015
associations	O	3015
,	O	3015
relative	O	3015
frequencies	O	3015
,	O	3015
and	O	3015
distributions	O	3015
of	O	3015
five	O	3015
prevalent	O	3015
PAH	O	3015
mutations	O	3015
(	O	3015
R158Q	O	3015
,	O	3015
R261Q	O	3015
,	O	3015
IVS10nt546	O	3015
,	O	3015
R408W	O	3015
,	O	3015
and	O	3015
IVS12n1	O	3015
)	O	3015
were	O	3015
established	O	3015
in	O	3015
a	O	3015
comprehensive	O	3015
European	O	3015
sample	O	3015
population	O	3015
and	O	3015
subsequently	O	3015
were	O	3015
examined	O	3015
to	O	3015
determine	O	3015
the	O	3015
potential	O	3015
roles	O	3015
of	O	3015
several	O	3015
genetic	O	3015
mechanisms	O	3015
in	O	3015
explaining	O	3015
the	O	3015
present	O	3015
distribution	O	3015
of	O	3015
the	O	3015
major	O	3015
PKU	B-Disease	3015
alleles	O	3015
.	O	3015

Together	O	3019
,	O	3019
these	O	3019
data	O	3019
suggest	O	3019
that	O	3019
there	O	3019
were	O	3019
multiple	O	3019
,	O	3019
geographically	O	3019
and	O	3019
ethnically	O	3019
distinct	O	3019
origins	O	3019
for	O	3019
PKU	B-Disease	3019
within	O	3019
the	O	3019
European	O	3019
population	O	3019
.	O	3019

Complement	B-Disease	3021
factor	I-Disease	3021
2	I-Disease	3021
deficiency	I-Disease	3021
:	O	3021
a	O	3021
clinical	O	3021
and	O	3021
serological	O	3021
family	O	3021
study	O	3021
.	O	3021

Inherited	B-Disease	3022
complement	I-Disease	3022
deficiencies	I-Disease	3022
are	O	3022
associated	O	3022
with	O	3022
a	O	3022
variety	O	3022
of	O	3022
connective	O	3022
tissue	O	3022
diseases	O	3022
.	O	3022

A	O	3023
family	O	3023
with	O	3023
inherited	B-Disease	3023
deficiency	I-Disease	3023
of	I-Disease	3023
complement	I-Disease	3023
factor	I-Disease	3023
2	I-Disease	3023
(	O	3023
C2	O	3023
)	O	3023
is	O	3023
described	O	3023
in	O	3023
which	O	3023
two	O	3023
family	O	3023
members	O	3023
with	O	3023
homozygous	O	3023
C2	B-Disease	3023
deficiency	I-Disease	3023
developed	O	3023
cutaneous	B-Disease	3023
vasculitis	I-Disease	3023
and	O	3023
sicca	B-Disease	3023
syndrome	I-Disease	3023
.	O	3023

The	O	3024
other	O	3024
family	O	3024
members	O	3024
had	O	3024
heterozygous	O	3024
C2	B-Disease	3024
deficiency	I-Disease	3024
and	O	3024
each	O	3024
member	O	3024
had	O	3024
the	O	3024
HLA	O	3024
-	O	3024
A25	O	3024
,	O	3024
B18	O	3024
,	O	3024
DR2	O	3024
(	O	3024
w15	O	3024
)	O	3024
haplotype	O	3024
.	O	3024

The	O	3025
mother	O	3025
had	O	3025
seropositive	B-Disease	3025
rheumatoid	I-Disease	3025
arthritis	I-Disease	3025
.	O	3025

New	O	3028
variant	O	3028
in	O	3028
exon	O	3028
3	O	3028
of	O	3028
the	O	3028
proteolipid	O	3028
protein	O	3028
(	O	3028
PLP	O	3028
)	O	3028
gene	O	3028
in	O	3028
a	O	3028
family	O	3028
with	O	3028
Pelizaeus	B-Disease	3028
-	I-Disease	3028
Merzbacher	I-Disease	3028
disease	I-Disease	3028
.	O	3028

A	O	3029
C	O	3029
-	O	3029
-	O	3029
greater	O	3029
than	O	3029
G	O	3029
transversion	O	3029
has	O	3029
been	O	3029
found	O	3029
in	O	3029
exon	O	3029
3	O	3029
of	O	3029
the	O	3029
PLP	O	3029
gene	O	3029
of	O	3029
affected	O	3029
males	O	3029
and	O	3029
their	O	3029
mother	O	3029
in	O	3029
a	O	3029
single	O	3029
sibship	O	3029
with	O	3029
Pelizaeus	B-Disease	3029
-	I-Disease	3029
merzbacher	I-Disease	3029
disease	I-Disease	3029
(	O	3029
PMD	B-Disease	3029
)	O	3029
.	O	3029

The	O	3034
cause	O	3034
of	O	3034
disease	O	3034
in	O	3034
this	O	3034
family	O	3034
remains	O	3034
unknown	O	3034
,	O	3034
but	O	3034
the	O	3034
association	O	3034
between	O	3034
this	O	3034
rare	O	3034
mutation	O	3034
and	O	3034
PMD	B-Disease	3034
is	O	3034
intriguing	O	3034
.	O	3034

Uncoupling	O	3037
of	O	3037
hypomyelination	B-Disease	3037
and	O	3037
glial	B-Disease	3037
cell	I-Disease	3037
death	I-Disease	3037
by	O	3037
a	O	3037
mutation	O	3037
in	O	3037
the	O	3037
proteolipid	O	3037
protein	O	3037
gene	O	3037
.	O	3037

Neurological	O	3039
mutant	O	3039
mice	O	3039
can	O	3039
often	O	3039
provide	O	3039
model	O	3039
systems	O	3039
for	O	3039
human	O	3039
genetic	B-Disease	3039
disorders	I-Disease	3039
.	O	3039

Mutations	O	3040
of	O	3040
the	O	3040
X	O	3040
-	O	3040
chromosome	O	3040
-	O	3040
linked	O	3040
PLP	O	3040
gene	O	3040
are	O	3040
lethal	O	3040
,	O	3040
identified	O	3040
first	O	3040
in	O	3040
the	O	3040
jimpy	O	3040
mouse	O	3040
and	O	3040
subsequently	O	3040
in	O	3040
patients	O	3040
with	O	3040
Pelizaeus	B-Disease	3040
-	I-Disease	3040
Merzbacher	I-Disease	3040
disease	I-Disease	3040
.	O	3040

The	O	3041
unexplained	O	3041
phenotype	O	3041
of	O	3041
these	O	3041
mutations	O	3041
includes	O	3041
degeneration	B-Disease	3041
and	I-Disease	3041
premature	I-Disease	3041
cell	I-Disease	3041
death	I-Disease	3041
of	I-Disease	3041
oligodendrocytes	I-Disease	3041
with	O	3041
associated	O	3041
hypomyelination	B-Disease	3041
.	O	3041

Surprisingly	O	3043
,	O	3043
rumpshaker	O	3043
mice	O	3043
,	O	3043
although	O	3043
myelin	B-Disease	3043
-	I-Disease	3043
deficient	I-Disease	3043
,	O	3043
have	O	3043
normal	O	3043
longevity	O	3043
and	O	3043
a	O	3043
full	O	3043
complement	O	3043
of	O	3043
morphologically	O	3043
normal	O	3043
oligodendrocytes	O	3043
.	O	3043

Hypomyelination	B-Disease	3044
can	O	3044
thus	O	3044
be	O	3044
genetically	O	3044
separated	O	3044
from	O	3044
the	O	3044
PLP	O	3044
-	O	3044
dependent	O	3044
oligodendrocyte	B-Disease	3044
degeneration	I-Disease	3044
.	O	3044

We	O	3045
suggest	O	3045
that	O	3045
PLP	O	3045
has	O	3045
a	O	3045
vital	O	3045
function	O	3045
in	O	3045
glial	O	3045
cell	O	3045
development	O	3045
,	O	3045
distinct	O	3045
from	O	3045
its	O	3045
later	O	3045
role	O	3045
in	O	3045
myelin	O	3045
assembly	O	3045
,	O	3045
and	O	3045
that	O	3045
this	O	3045
dichotomy	O	3045
of	O	3045
action	O	3045
may	O	3045
explain	O	3045
the	O	3045
clinical	O	3045
spectrum	O	3045
of	O	3045
Pelizaeus	B-Disease	3045
-	I-Disease	3045
Merzbacher	I-Disease	3045
disease	I-Disease	3045
.	O	3045

A	O	3047
pseudodeficiency	O	3047
allele	O	3047
common	O	3047
in	O	3047
non	O	3047
-	O	3047
Jewish	O	3047
Tay	B-Disease	3047
-	I-Disease	3047
Sachs	I-Disease	3047
carriers	O	3047
:	O	3047
implications	O	3047
for	O	3047
carrier	O	3047
screening	O	3047
.	O	3047

Deficiency	B-Disease	3048
of	I-Disease	3048
beta	I-Disease	3048
-	I-Disease	3048
hexosaminidase	I-Disease	3048
A	I-Disease	3048
(	O	3048
Hex	O	3048
A	O	3048
)	O	3048
activity	O	3048
typically	O	3048
results	O	3048
in	O	3048
Tay	B-Disease	3048
-	I-Disease	3048
Sachs	I-Disease	3048
disease	I-Disease	3048
.	O	3048

However	O	3049
,	O	3049
healthy	O	3049
subjects	O	3049
found	O	3049
to	O	3049
be	O	3049
deficient	B-Disease	3049
in	I-Disease	3049
Hex	I-Disease	3049
A	I-Disease	3049
activity	O	3049
(	O	3049
i	O	3049
.	O	3049

We	O	3052
analyzed	O	3052
the	O	3052
HEXA	O	3052
gene	O	3052
of	O	3052
one	O	3052
pseudodeficient	O	3052
subject	O	3052
and	O	3052
identified	O	3052
both	O	3052
a	O	3052
C739	O	3052
-	O	3052
to	O	3052
-	O	3052
T	O	3052
substitution	O	3052
that	O	3052
changes	O	3052
Arg247	O	3052
-	O	3052
-	O	3052
-	O	3052
-	O	3052
Trp	O	3052
on	O	3052
one	O	3052
allele	O	3052
and	O	3052
a	O	3052
previously	O	3052
identified	O	3052
Tay	B-Disease	3052
-	I-Disease	3052
Sachs	I-Disease	3052
disease	I-Disease	3052
mutation	O	3052
on	O	3052
the	O	3052
second	O	3052
allele	O	3052
.	O	3052

This	O	3054
allele	O	3054
accounted	O	3054
for	O	3054
32	O	3054
%	O	3054
(	O	3054
20	O	3054
/	O	3054
62	O	3054
)	O	3054
of	O	3054
non	O	3054
-	O	3054
Jewish	O	3054
enzyme	O	3054
-	O	3054
defined	O	3054
Tay	B-Disease	3054
-	I-Disease	3054
Sachs	I-Disease	3054
disease	I-Disease	3054
carriers	O	3054
but	O	3054
for	O	3054
none	O	3054
of	O	3054
36	O	3054
Jewish	O	3054
enzyme	O	3054
-	O	3054
defined	O	3054
carriers	O	3054
who	O	3054
did	O	3054
not	O	3054
have	O	3054
one	O	3054
of	O	3054
three	O	3054
known	O	3054
mutations	O	3054
common	O	3054
to	O	3054
this	O	3054
group	O	3054
.	O	3054

Tay	B-Disease	3057
-	I-Disease	3057
Sachs	I-Disease	3057
disease	I-Disease	3057
allele	O	3057
,	O	3057
causes	O	3057
Hex	O	3057
A	O	3057
pseudodeficiency	O	3057
.	O	3057

Given	O	3058
both	O	3058
the	O	3058
large	O	3058
proportion	O	3058
of	O	3058
non	O	3058
-	O	3058
Jewish	O	3058
carriers	O	3058
with	O	3058
this	O	3058
allele	O	3058
and	O	3058
that	O	3058
standard	O	3058
biochemical	O	3058
screening	O	3058
cannot	O	3058
differentiate	O	3058
between	O	3058
heterozygotes	O	3058
for	O	3058
the	O	3058
C739	O	3058
-	O	3058
to	O	3058
-	O	3058
T	O	3058
mutations	O	3058
and	O	3058
Tay	B-Disease	3058
-	I-Disease	3058
Sachs	I-Disease	3058
disease	I-Disease	3058
carriers	O	3058
,	O	3058
DNA	O	3058
testing	O	3058
for	O	3058
this	O	3058
mutation	O	3058
in	O	3058
at	O	3058
-	O	3058
risk	O	3058
couples	O	3058
is	O	3058
essential	O	3058
.	O	3058

Pelizaeus	B-Disease	3059
-	I-Disease	3059
Merzbacher	I-Disease	3059
disease	I-Disease	3059
:	O	3059
detection	O	3059
of	O	3059
mutations	O	3059
Thr181	O	3059
-	O	3059
-	O	3059
-	O	3059
-	O	3059
Pro	O	3059
and	O	3059
Leu223	O	3059
-	O	3059
-	O	3059
-	O	3059
-	O	3059
Pro	O	3059
in	O	3059
the	O	3059
proteolipid	O	3059
protein	O	3059
gene	O	3059
,	O	3059
and	O	3059
prenatal	O	3059
diagnosis	O	3059
.	O	3059

A	O	3060
family	O	3060
with	O	3060
an	O	3060
apparent	O	3060
history	O	3060
of	O	3060
X	O	3060
-	O	3060
linked	O	3060
Pelizaeus	B-Disease	3060
-	I-Disease	3060
Merzbacher	I-Disease	3060
disease	I-Disease	3060
presented	O	3060
for	O	3060
genetic	O	3060
counseling	O	3060
,	O	3060
requesting	O	3060
carrier	O	3060
detection	O	3060
and	O	3060
prenatal	O	3060
diagnosis	O	3060
.	O	3060

These	O	3068
results	O	3068
provide	O	3068
further	O	3068
examples	O	3068
of	O	3068
mutations	O	3068
in	O	3068
PLP	O	3068
that	O	3068
cause	O	3068
Pelizaeus	B-Disease	3068
-	I-Disease	3068
Merzbacher	I-Disease	3068
disease	I-Disease	3068
and	O	3068
illustrate	O	3068
the	O	3068
value	O	3068
of	O	3068
SSCP	O	3068
in	O	3068
genetic	O	3068
analysis	O	3068
.	O	3068

von	B-Disease	3070
Willebrand	I-Disease	3070
disease	I-Disease	3070
type	I-Disease	3070
B	I-Disease	3070
:	O	3070
a	O	3070
missense	O	3070
mutation	O	3070
selectively	O	3070
abolishes	O	3070
ristocetin	O	3070
-	O	3070
induced	O	3070
von	B-Disease	3070
Willebrand	I-Disease	3070
factor	O	3070
binding	O	3070
to	O	3070
platelet	O	3070
glycoprotein	O	3070
Ib	O	3070
.	O	3070

von	B-Disease	3071
Willebrand	I-Disease	3071
factor	O	3071
(	O	3071
vWF	O	3071
)	O	3071
is	O	3071
a	O	3071
multimeric	O	3071
glycoprotein	O	3071
that	O	3071
mediates	O	3071
the	O	3071
adhesion	O	3071
of	O	3071
platelets	O	3071
to	O	3071
the	O	3071
subendothelium	O	3071
by	O	3071
binding	O	3071
to	O	3071
platelet	O	3071
glycoprotein	O	3071
Ib	O	3071
.	O	3071

A	O	3073
missense	O	3073
mutation	O	3073
,	O	3073
Gly	O	3073
-	O	3073
561	O	3073
-	O	3073
-	O	3073
>	O	3073
Ser	O	3073
,	O	3073
was	O	3073
identified	O	3073
within	O	3073
the	O	3073
proposed	O	3073
glycoprotein	O	3073
Ib	O	3073
binding	O	3073
domain	O	3073
of	O	3073
vWF	O	3073
in	O	3073
the	O	3073
proband	O	3073
with	O	3073
von	B-Disease	3073
Willebrand	I-Disease	3073
disease	I-Disease	3073
type	I-Disease	3073
B	I-Disease	3073
,	O	3073
a	O	3073
unique	O	3073
variant	O	3073
characterized	O	3073
by	O	3073
no	O	3073
ristocetin	O	3073
-	O	3073
induced	O	3073
,	O	3073
but	O	3073
normal	O	3073
botrocetin	O	3073
-	O	3073
induced	O	3073
,	O	3073
binding	O	3073
to	O	3073
glycoprotein	O	3073
Ib	O	3073
.	O	3073

The	O	3074
corresponding	O	3074
mutant	O	3074
recombinant	O	3074
protein	O	3074
,	O	3074
rvWF	O	3074
(	O	3074
G561S	O	3074
)	O	3074
,	O	3074
formed	O	3074
normal	O	3074
multimers	O	3074
and	O	3074
exhibited	O	3074
the	O	3074
same	O	3074
functional	O	3074
defect	O	3074
as	O	3074
the	O	3074
patients	O	3074
plasma	O	3074
vWF	O	3074
,	O	3074
confirming	O	3074
that	O	3074
this	O	3074
mutation	O	3074
causes	O	3074
von	B-Disease	3074
Willebrand	I-Disease	3074
disease	I-Disease	3074
type	I-Disease	3074
B	I-Disease	3074
.	O	3074

The	O	3076
normal	O	3076
botrocetin	O	3076
-	O	3076
induced	O	3076
binding	O	3076
and	O	3076
the	O	3076
defective	O	3076
ristocetin	O	3076
-	O	3076
induced	O	3076
binding	O	3076
of	O	3076
rvWF	O	3076
(	O	3076
G561S	O	3076
)	O	3076
suggest	O	3076
that	O	3076
the	O	3076
primary	O	3076
defect	O	3076
in	O	3076
von	B-Disease	3076
Willebrand	I-Disease	3076
disease	I-Disease	3076
type	I-Disease	3076
B	I-Disease	3076
may	O	3076
be	O	3076
a	O	3076
failure	O	3076
of	O	3076
normal	O	3076
allosteric	O	3076
regulation	O	3076
of	O	3076
the	O	3076
glycoprotein	O	3076
Ib	O	3076
binding	O	3076
function	O	3076
of	O	3076
vWF	O	3076
.	O	3076

Typical	O	3078
and	O	3078
partial	O	3078
cat	B-Disease	3078
eye	I-Disease	3078
syndrome	I-Disease	3078
:	O	3078
identification	O	3078
of	O	3078
the	O	3078
marker	O	3078
chromosome	O	3078
by	O	3078
FISH	O	3078
.	O	3078

Three	O	3079
children	O	3079
are	O	3079
reported	O	3079
with	O	3079
typical	O	3079
cat	B-Disease	3079
eye	I-Disease	3079
syndrome	I-Disease	3079
(	O	3079
CES	B-Disease	3079
)	O	3079
and	O	3079
three	O	3079
more	O	3079
children	O	3079
with	O	3079
partial	O	3079
CES	B-Disease	3079
because	O	3079
of	O	3079
absence	O	3079
of	O	3079
coloboma	O	3079
,	O	3079
in	O	3079
which	O	3079
the	O	3079
supernumerary	O	3079
marker	O	3079
chromosome	O	3079
was	O	3079
studied	O	3079
by	O	3079
FISH	O	3079
.	O	3079

Using	O	3080
a	O	3080
genomic	O	3080
library	O	3080
,	O	3080
and	O	3080
also	O	3080
a	O	3080
centromeric	O	3080
and	O	3080
particularly	O	3080
a	O	3080
cosmid	O	3080
probe	O	3080
of	O	3080
22q11	O	3080
,	O	3080
partial	O	3080
tetrasomy	B-Disease	3080
was	O	3080
shown	O	3080
in	O	3080
all	O	3080
cases	O	3080
.	O	3080

[	O	3082
Genetic	O	3082
heterogeneity	O	3082
of	O	3082
G6PD	B-Disease	3082
deficiency	I-Disease	3082
:	O	3082
mutant	O	3082
alleles	O	3082
of	O	3082
G6PD	O	3082
in	O	3082
the	O	3082
Shekii	O	3082
district	O	3082
of	O	3082
Azerbaijan	O	3082
]	O	3082
Examination	O	3082
on	O	3082
G6PD	B-Disease	3082
deficiency	I-Disease	3082
in	O	3082
349	O	3082
patients	O	3082
of	O	3082
Shekii	O	3082
district	O	3082
hospital	O	3082
(	O	3082
Azerbaijan	O	3082
)	O	3082
revealed	O	3082
16	O	3082
hemi	O	3082
-	O	3082
,	O	3082
4	O	3082
homo	O	3082
-	O	3082
and	O	3082
9	O	3082
heterozygotic	O	3082
carriers	O	3082
of	O	3082
the	O	3082
defect	O	3082
.	O	3082

Carriers	O	3085
of	O	3085
G6PD	B-Disease	3085
deficiency	I-Disease	3085
are	O	3085
residents	O	3085
of	O	3085
11	O	3085
villages	O	3085
located	O	3085
in	O	3085
Alasani	O	3085
-	O	3085
Aphtalan	O	3085
valley	O	3085
,	O	3085
highly	O	3085
endemic	O	3085
with	O	3085
malaria	B-Disease	3085
in	O	3085
the	O	3085
past	O	3085
;	O	3085
nearly	O	3085
all	O	3085
marriages	O	3085
are	O	3085
endogamic	O	3085
.	O	3085

Craniofrontonasal	B-Disease	3088
dysplasia	I-Disease	3088
.	O	3088

We	O	3089
report	O	3089
on	O	3089
nine	O	3089
patients	O	3089
with	O	3089
craniofrontonasal	B-Disease	3089
dysplasia	I-Disease	3089
(	O	3089
CFND	B-Disease	3089
)	O	3089
.	O	3089

Seven	O	3090
classical	O	3090
cases	O	3090
had	O	3090
facial	O	3090
features	O	3090
suggestive	O	3090
of	O	3090
frontonasal	B-Disease	3090
dysplasia	I-Disease	3090
and	O	3090
coronal	B-Disease	3090
craniosynostosis	I-Disease	3090
.	O	3090

Extracranial	B-Disease	3091
abnormalities	I-Disease	3091
such	O	3091
as	O	3091
brittle	B-Disease	3091
nails	I-Disease	3091
with	I-Disease	3091
prominent	I-Disease	3091
longitudinal	I-Disease	3091
grooves	I-Disease	3091
or	O	3091
syndactyly	B-Disease	3091
of	I-Disease	3091
fingers	I-Disease	3091
and	I-Disease	3091
toes	I-Disease	3091
were	O	3091
observed	O	3091
in	O	3091
individual	O	3091
patients	O	3091
.	O	3091

Hypotonia	B-Disease	3094
and	O	3094
laxity	B-Disease	3094
of	I-Disease	3094
joints	I-Disease	3094
are	O	3094
common	O	3094
and	O	3094
may	O	3094
necessitate	O	3094
supportive	O	3094
measures	O	3094
.	O	3094

Mild	O	3095
developmental	B-Disease	3095
delay	I-Disease	3095
was	O	3095
noted	O	3095
in	O	3095
three	O	3095
out	O	3095
of	O	3095
six	O	3095
classical	O	3095
cases	O	3095
studied	O	3095
in	O	3095
detail	O	3095
.	O	3095

Unlike	O	3096
almost	O	3096
all	O	3096
other	O	3096
X	B-Disease	3096
-	I-Disease	3096
linked	I-Disease	3096
disorders	I-Disease	3096
,	O	3096
clinical	O	3096
expression	O	3096
in	O	3096
CFND	B-Disease	3096
is	O	3096
generally	O	3096
much	O	3096
more	O	3096
severe	O	3096
in	O	3096
females	O	3096
than	O	3096
in	O	3096
males	O	3096
.	O	3096

The	O	3099
intron	O	3099
7	O	3099
donor	O	3099
splice	O	3099
site	O	3099
transition	O	3099
:	O	3099
a	O	3099
second	O	3099
Tay	B-Disease	3099
-	I-Disease	3099
Sachs	I-Disease	3099
disease	I-Disease	3099
mutation	O	3099
in	O	3099
French	O	3099
Canada	O	3099
.	O	3099

Mutations	O	3100
at	O	3100
the	O	3100
hexosaminidase	O	3100
A	O	3100
(	O	3100
HEXA	O	3100
)	O	3100
gene	O	3100
which	O	3100
cause	O	3100
Tay	B-Disease	3100
-	I-Disease	3100
Sachs	I-Disease	3100
disease	I-Disease	3100
(	O	3100
TSD	B-Disease	3100
)	O	3100
have	O	3100
elevated	O	3100
frequency	O	3100
in	O	3100
the	O	3100
Ashkenazi	O	3100
Jewish	O	3100
and	O	3100
French	O	3100
-	O	3100
Canadian	O	3100
populations	O	3100
.	O	3100

We	O	3101
report	O	3101
a	O	3101
novel	O	3101
TSD	B-Disease	3101
allele	O	3101
in	O	3101
the	O	3101
French	O	3101
-	O	3101
Canadian	O	3101
population	O	3101
associated	O	3101
with	O	3101
the	O	3101
infantile	O	3101
form	O	3101
of	O	3101
the	O	3101
disease	O	3101
.	O	3101

The	O	3104
intron	O	3104
7	O	3104
+	O	3104
1	O	3104
mutation	O	3104
occurs	O	3104
in	O	3104
the	O	3104
base	O	3104
adjacent	O	3104
to	O	3104
the	O	3104
site	O	3104
of	O	3104
the	O	3104
adult	O	3104
-	O	3104
onset	O	3104
TSD	B-Disease	3104
mutation	O	3104
(	O	3104
G805A	O	3104
)	O	3104
.	O	3104

This	O	3110
mutation	O	3110
thus	O	3110
has	O	3110
a	O	3110
different	O	3110
geographic	O	3110
centre	O	3110
of	O	3110
diffusion	O	3110
and	O	3110
is	O	3110
probably	O	3110
less	O	3110
common	O	3110
than	O	3110
the	O	3110
exon	O	3110
1	O	3110
deletion	O	3110
TSD	B-Disease	3110
mutation	O	3110
in	O	3110
French	O	3110
Canadians	O	3110
.	O	3110

Aspartylglucosaminuria	B-Disease	3114
(	O	3114
AGU	B-Disease	3114
)	O	3114
is	O	3114
a	O	3114
recessive	O	3114
autosomally	O	3114
inherited	O	3114
lysosomal	B-Disease	3114
storage	I-Disease	3114
disorder	I-Disease	3114
due	O	3114
to	O	3114
deficiency	B-Disease	3114
of	I-Disease	3114
the	I-Disease	3114
enzyme	I-Disease	3114
aspartylglucosaminidase	I-Disease	3114
(	O	3114
AGA	O	3114
)	O	3114
.	O	3114

Resolution	O	3119
of	O	3119
the	O	3119
two	O	3119
loci	O	3119
for	O	3119
autosomal	O	3119
dominant	O	3119
aniridia	B-Disease	3119
,	O	3119
AN1	O	3119
and	O	3119
AN2	O	3119
,	O	3119
to	O	3119
a	O	3119
single	O	3119
locus	O	3119
on	O	3119
chromosome	O	3119
11p13	O	3119
.	O	3119

Two	O	3120
distinct	O	3120
loci	O	3120
have	O	3120
been	O	3120
proposed	O	3120
for	O	3120
aniridia	B-Disease	3120
;	O	3120
AN1	O	3120
for	O	3120
autosomal	O	3120
dominant	O	3120
aniridia	B-Disease	3120
on	O	3120
chromosome	O	3120
2p	O	3120
and	O	3120
AN2	O	3120
for	O	3120
the	O	3120
aniridia	B-Disease	3120
in	O	3120
the	O	3120
WAGR	B-Disease	3120
contiguous	I-Disease	3120
gene	I-Disease	3120
syndrome	I-Disease	3120
on	O	3120
chromosome	O	3120
11p13	O	3120
.	O	3120

In	O	3121
this	O	3121
report	O	3121
,	O	3121
the	O	3121
kindred	O	3121
segregating	O	3121
for	O	3121
autosomal	O	3121
dominant	O	3121
aniridia	B-Disease	3121
,	O	3121
which	O	3121
suggested	O	3121
linkage	O	3121
to	O	3121
acid	O	3121
phosphatase	O	3121
-	O	3121
1	O	3121
(	O	3121
ACP1	O	3121
)	O	3121
and	O	3121
led	O	3121
to	O	3121
the	O	3121
assignment	O	3121
of	O	3121
the	O	3121
AN1	O	3121
locus	O	3121
on	O	3121
chromosome	O	3121
2p	O	3121
,	O	3121
has	O	3121
been	O	3121
updated	O	3121
and	O	3121
expanded	O	3121
.	O	3121

Linkage	O	3122
analysis	O	3122
between	O	3122
the	O	3122
aniridia	B-Disease	3122
phenotype	O	3122
and	O	3122
ACP1	O	3122
does	O	3122
not	O	3122
support	O	3122
the	O	3122
original	O	3122
linkage	O	3122
results	O	3122
,	O	3122
excluding	O	3122
linkage	O	3122
up	O	3122
to	O	3122
theta	O	3122
=	O	3122
0	O	3122
.	O	3122

APOB	O	3125
,	O	3125
D2S71	O	3125
,	O	3125
D2S5	O	3125
,	O	3125
and	O	3125
D2S1	O	3125
,	O	3125
also	O	3125
excluded	O	3125
linkage	O	3125
to	O	3125
aniridia	B-Disease	3125
.	O	3125

Markers	O	3126
that	O	3126
have	O	3126
been	O	3126
isolated	O	3126
from	O	3126
the	O	3126
chromosome	O	3126
11p13	O	3126
region	O	3126
were	O	3126
then	O	3126
analyzed	O	3126
in	O	3126
this	O	3126
aniridia	B-Disease	3126
family	O	3126
.	O	3126

These	O	3139
data	O	3139
suggest	O	3139
that	O	3139
a	O	3139
locus	O	3139
for	O	3139
aniridia	B-Disease	3139
(	O	3139
AN1	O	3139
)	O	3139
on	O	3139
chromosome	O	3139
2p	O	3139
has	O	3139
been	O	3139
misassigned	O	3139
and	O	3139
that	O	3139
this	O	3139
autosomal	O	3139
dominant	O	3139
aniridia	B-Disease	3139
family	O	3139
is	O	3139
segregating	O	3139
for	O	3139
an	O	3139
aniridia	B-Disease	3139
mutation	O	3139
linked	O	3139
to	O	3139
markers	O	3139
in	O	3139
the	O	3139
11p13	O	3139
region	O	3139
.	O	3139

Fatal	O	3140
pyoderma	B-Disease	3140
gangrenosum	I-Disease	3140
in	O	3140
association	O	3140
with	O	3140
C7	B-Disease	3140
deficiency	I-Disease	3140
.	O	3140

Although	O	3141
pyoderma	B-Disease	3141
gangrenosum	I-Disease	3141
(	O	3141
PG	B-Disease	3141
)	O	3141
is	O	3141
often	O	3141
associated	O	3141
with	O	3141
systemic	B-Disease	3141
diseases	I-Disease	3141
,	O	3141
it	O	3141
has	O	3141
not	O	3141
been	O	3141
reported	O	3141
in	O	3141
association	O	3141
with	O	3141
congenital	B-Disease	3141
complement	I-Disease	3141
deficiencies	I-Disease	3141
.	O	3141

We	O	3142
describe	O	3142
an	O	3142
aggressive	O	3142
and	O	3142
ultimately	O	3142
fatal	O	3142
case	O	3142
of	O	3142
PG	B-Disease	3142
in	O	3142
a	O	3142
patient	O	3142
with	O	3142
a	O	3142
congenital	O	3142
C7	B-Disease	3142
deficiency	I-Disease	3142
.	O	3142

Deficiencies	B-Disease	3143
of	I-Disease	3143
C7	I-Disease	3143
can	O	3143
be	O	3143
associated	O	3143
with	O	3143
decreased	O	3143
neutrophil	O	3143
chemotaxis	O	3143
,	O	3143
phagocytosis	O	3143
,	O	3143
and	O	3143
opsonization	O	3143
,	O	3143
similar	O	3143
to	O	3143
the	O	3143
immunologic	B-Disease	3143
abnormalities	I-Disease	3143
described	O	3143
in	O	3143
patients	O	3143
with	O	3143
PG	B-Disease	3143
.	O	3143

Our	O	3144
patients	O	3144
decreased	O	3144
complement	O	3144
level	O	3144
,	O	3144
if	O	3144
not	O	3144
directly	O	3144
related	O	3144
to	O	3144
the	O	3144
development	O	3144
of	O	3144
PG	B-Disease	3144
,	O	3144
may	O	3144
have	O	3144
contributed	O	3144
to	O	3144
the	O	3144
aggressive	O	3144
nature	O	3144
of	O	3144
her	O	3144
disease	O	3144
.	O	3144

Glucose	B-Disease	3147
-	I-Disease	3147
6	I-Disease	3147
-	I-Disease	3147
PHOSPHATE	I-Disease	3147
dehydrogenase	I-Disease	3147
(	I-Disease	3147
G6PD	I-Disease	3147
;	I-Disease	3147
EC	I-Disease	3147
1	I-Disease	3147
.	I-Disease	3147

1	I-Disease	3148
.	I-Disease	3148

1	I-Disease	3149
.	I-Disease	3149

49	I-Disease	3150
)	I-Disease	3150
deficiency	I-Disease	3150
is	O	3150
the	O	3150
most	O	3150
common	O	3150
human	O	3150
enzymopathy	B-Disease	3150
,	O	3150
affecting	O	3150
more	O	3150
than	O	3150
200	O	3150
million	O	3150
people	O	3150
worldwide	O	3150
.	O	3150

Although	O	3151
greater	O	3151
than	O	3151
400	O	3151
variants	O	3151
have	O	3151
been	O	3151
described	O	3151
based	O	3151
on	O	3151
clinical	O	3151
and	O	3151
biochemical	O	3151
criteria	O	3151
,	O	3151
little	O	3151
is	O	3151
known	O	3151
about	O	3151
the	O	3151
molecular	O	3151
basis	O	3151
of	O	3151
these	O	3151
G6PD	B-Disease	3151
deficiencies	I-Disease	3151
.	O	3151

The	O	3164
1376	O	3164
G	O	3164
-	O	3164
-	O	3164
-	O	3164
-	O	3164
T	O	3164
mutation	O	3164
seems	O	3164
to	O	3164
be	O	3164
the	O	3164
dominant	O	3164
allele	O	3164
that	O	3164
causes	O	3164
G6PD	B-Disease	3164
deficiency	I-Disease	3164
in	O	3164
Taiwan	O	3164
.	O	3164

Our	O	3167
studies	O	3167
provide	O	3167
the	O	3167
direct	O	3167
proof	O	3167
of	O	3167
the	O	3167
genetic	O	3167
heterogeneity	O	3167
of	O	3167
G6PD	B-Disease	3167
deficiency	I-Disease	3167
in	O	3167
the	O	3167
Chinese	O	3167
populations	O	3167
of	O	3167
Taiwan	O	3167
and	O	3167
the	O	3167
PCR	O	3167
/	O	3167
RE	O	3167
digestion	O	3167
method	O	3167
is	O	3167
suitable	O	3167
for	O	3167
simultaneous	O	3167
detection	O	3167
of	O	3167
the	O	3167
487	O	3167
G	O	3167
-	O	3167
-	O	3167
-	O	3167
-	O	3167
A	O	3167
and	O	3167
493	O	3167
A	O	3167
-	O	3167
-	O	3167
-	O	3167
-	O	3167
G	O	3167
mutations	O	3167
.	O	3167

An	O	3168
error	O	3168
in	O	3168
dystrophin	O	3168
mRNA	O	3168
processing	O	3168
in	O	3168
golden	B-Disease	3168
retriever	I-Disease	3168
muscular	I-Disease	3168
dystrophy	I-Disease	3168
,	O	3168
an	O	3168
animal	O	3168
homologue	O	3168
of	O	3168
Duchenne	B-Disease	3168
muscular	I-Disease	3168
dystrophy	I-Disease	3168
.	O	3168

Golden	B-Disease	3169
retriever	I-Disease	3169
muscular	I-Disease	3169
dystrophy	I-Disease	3169
(	O	3169
GRMD	B-Disease	3169
)	O	3169
is	O	3169
a	O	3169
spontaneous	O	3169
,	O	3169
X	O	3169
-	O	3169
linked	O	3169
,	O	3169
progressively	O	3169
fatal	O	3169
disease	O	3169
of	O	3169
dogs	O	3169
and	O	3169
is	O	3169
also	O	3169
a	O	3169
homologue	O	3169
of	O	3169
Duchenne	B-Disease	3169
muscular	I-Disease	3169
dystrophy	I-Disease	3169
(	O	3169
DMD	B-Disease	3169
)	O	3169
.	O	3169

Two	O	3170
-	O	3170
thirds	O	3170
of	O	3170
DMD	B-Disease	3170
patients	O	3170
carry	O	3170
detectable	O	3170
deletions	O	3170
in	O	3170
their	O	3170
dystrophin	O	3170
gene	O	3170
.	O	3170

The	O	3171
defect	O	3171
underlying	O	3171
the	O	3171
remaining	O	3171
one	O	3171
-	O	3171
third	O	3171
of	O	3171
DMD	B-Disease	3171
patients	O	3171
is	O	3171
undetermined	O	3171
.	O	3171

Analysis	O	3172
of	O	3172
the	O	3172
canine	O	3172
dystrophin	O	3172
gene	O	3172
in	O	3172
normal	O	3172
and	O	3172
GRMD	B-Disease	3172
dogs	O	3172
has	O	3172
failed	O	3172
to	O	3172
demonstrate	O	3172
any	O	3172
detectable	O	3172
loss	O	3172
of	O	3172
exons	O	3172
.	O	3172

Here	O	3173
,	O	3173
we	O	3173
have	O	3173
demonstrated	O	3173
a	O	3173
RNA	O	3173
processing	O	3173
error	O	3173
in	O	3173
GRMD	B-Disease	3173
that	O	3173
results	O	3173
from	O	3173
a	O	3173
single	O	3173
base	O	3173
change	O	3173
in	O	3173
the	O	3173
3	O	3173
consensus	O	3173
splice	O	3173
site	O	3173
of	O	3173
intron	O	3173
6	O	3173
.	O	3173

This	O	3175
is	O	3175
the	O	3175
first	O	3175
example	O	3175
of	O	3175
dystrophin	B-Disease	3175
deficiency	I-Disease	3175
caused	O	3175
by	O	3175
a	O	3175
splice	O	3175
-	O	3175
site	O	3175
mutation	O	3175
.	O	3175

Type	B-Disease	3177
I	I-Disease	3177
human	I-Disease	3177
complement	I-Disease	3177
C2	I-Disease	3177
deficiency	I-Disease	3177
.	O	3177

Two	O	3179
variants	O	3179
of	O	3179
a	O	3179
genetic	O	3179
deficiency	B-Disease	3179
of	I-Disease	3179
complement	I-Disease	3179
protein	I-Disease	3179
C2	I-Disease	3179
(	O	3179
C2D	O	3179
)	O	3179
have	O	3179
been	O	3179
previously	O	3179
identified	O	3179
.	O	3179

Type	B-Disease	3181
I	I-Disease	3181
C2	I-Disease	3181
deficiency	I-Disease	3181
was	O	3181
described	O	3181
in	O	3181
a	O	3181
family	O	3181
in	O	3181
which	O	3181
the	O	3181
C2	O	3181
nan	O	3181
allele	O	3181
(	O	3181
C2Q0	O	3181
)	O	3181
is	O	3181
associated	O	3181
with	O	3181
the	O	3181
major	O	3181
histocompatibility	O	3181
haplotype	O	3181
/	O	3181
complotype	O	3181
HLA	O	3181
-	O	3181
A25	O	3181
,	O	3181
B18	O	3181
,	O	3181
C2Q0	O	3181
,	O	3181
BfS	O	3181
,	O	3181
C4A4	O	3181
,	O	3181
C4B2	O	3181
,	O	3181
Drw2	O	3181
;	O	3181
this	O	3181
extended	O	3181
haplotype	O	3181
occurs	O	3181
in	O	3181
over	O	3181
90	O	3181
%	O	3181
of	O	3181
C2	B-Disease	3181
-	I-Disease	3181
deficient	I-Disease	3181
individuals	O	3181
(	O	3181
common	O	3181
complotype	O	3181
/	O	3181
haplotype	O	3181
)	O	3181
.	O	3181

To	O	3182
determine	O	3182
the	O	3182
molecular	O	3182
basis	O	3182
of	O	3182
type	B-Disease	3182
I	I-Disease	3182
C2	I-Disease	3182
deficiency	I-Disease	3182
,	O	3182
the	O	3182
C2	O	3182
gene	O	3182
and	O	3182
cDNA	O	3182
were	O	3182
characterized	O	3182
from	O	3182
a	O	3182
homozygous	O	3182
type	B-Disease	3182
I	I-Disease	3182
C2	I-Disease	3182
-	I-Disease	3182
deficient	I-Disease	3182
individual	O	3182
with	O	3182
the	O	3182
common	O	3182
associated	O	3182
haplotype	O	3182
/	O	3182
complotype	O	3182
.	O	3182

In	O	3184
studies	O	3184
of	O	3184
eight	O	3184
kindred	O	3184
,	O	3184
the	O	3184
28	O	3184
-	O	3184
base	O	3184
pair	O	3184
deletion	O	3184
was	O	3184
observed	O	3184
in	O	3184
all	O	3184
C2Q0	O	3184
alleles	O	3184
associated	O	3184
with	O	3184
the	O	3184
common	O	3184
type	O	3184
I	O	3184
deficient	O	3184
complotype	O	3184
/	O	3184
haplotype	O	3184
;	O	3184
this	O	3184
deletion	O	3184
was	O	3184
not	O	3184
present	O	3184
in	O	3184
normal	O	3184
C2	O	3184
nor	O	3184
in	O	3184
type	B-Disease	3184
II	I-Disease	3184
C2	I-Disease	3184
-	I-Disease	3184
deficient	I-Disease	3184
genes	O	3184
.	O	3184

These	O	3185
data	O	3185
demonstrate	O	3185
that	O	3185
1	O	3185
)	O	3185
type	B-Disease	3185
I	I-Disease	3185
human	I-Disease	3185
complement	I-Disease	3185
C2	I-Disease	3185
deficiency	I-Disease	3185
is	O	3185
caused	O	3185
by	O	3185
a	O	3185
28	O	3185
-	O	3185
base	O	3185
pair	O	3185
genomic	O	3185
deletion	O	3185
that	O	3185
causes	O	3185
skipping	O	3185
of	O	3185
exon	O	3185
6	O	3185
during	O	3185
RNA	O	3185
splicing	O	3185
,	O	3185
resulting	O	3185
in	O	3185
generation	O	3185
of	O	3185
a	O	3185
premature	O	3185
termination	O	3185
codon	O	3185
,	O	3185
2	O	3185
)	O	3185
the	O	3185
28	O	3185
-	O	3185
base	O	3185
pair	O	3185
deletion	O	3185
in	O	3185
the	O	3185
type	O	3185
I	O	3185
C2Q0	O	3185
gene	O	3185
is	O	3185
strongly	O	3185
associated	O	3185
with	O	3185
the	O	3185
HLA	O	3185
haplotype	O	3185
/	O	3185
complotype	O	3185
A25	O	3185
,	O	3185
B18	O	3185
,	O	3185
C2Q0	O	3185
,	O	3185
BfS	O	3185
,	O	3185
C4A4	O	3185
,	O	3185
C4B2	O	3185
,	O	3185
Drw2	O	3185
,	O	3185
suggesting	O	3185
that	O	3185
all	O	3185
C2	B-Disease	3185
-	I-Disease	3185
deficient	I-Disease	3185
individuals	O	3185
with	O	3185
this	O	3185
haplotype	O	3185
/	O	3185
complotype	O	3185
will	O	3185
harbor	O	3185
the	O	3185
28	O	3185
-	O	3185
base	O	3185
pair	O	3185
C2	O	3185
gene	O	3185
deletion	O	3185
,	O	3185
and	O	3185
3	O	3185
)	O	3185
type	B-Disease	3185
II	I-Disease	3185
C2	I-Disease	3185
deficiency	I-Disease	3185
is	O	3185
caused	O	3185
by	O	3185
a	O	3185
different	O	3185
,	O	3185
as	O	3185
yet	O	3185
uncharacterized	O	3185
,	O	3185
molecular	O	3185
genetic	B-Disease	3185
defect	I-Disease	3185
.	O	3185

Molecular	O	3187
characterization	O	3187
of	O	3187
two	O	3187
galactosemia	B-Disease	3187
mutations	O	3187
and	O	3187
one	O	3187
polymorphism	O	3187
:	O	3187
implications	O	3187
for	O	3187
structure	O	3187
-	O	3187
function	O	3187
analysis	O	3187
of	O	3187
human	O	3187
galactose	O	3187
-	O	3187
1	O	3187
-	O	3187
phosphate	O	3187
uridyltransferase	O	3187
.	O	3187

We	O	3188
report	O	3188
here	O	3188
the	O	3188
molecular	O	3188
characterization	O	3188
of	O	3188
two	O	3188
galactosemia	B-Disease	3188
mutations	O	3188
,	O	3188
L74P	O	3188
and	O	3188
F171S	O	3188
,	O	3188
and	O	3188
one	O	3188
polymorphism	O	3188
,	O	3188
S135L	O	3188
,	O	3188
in	O	3188
human	O	3188
galactose	O	3188
-	O	3188
1	O	3188
-	O	3188
phosphate	O	3188
uridyltransferase	O	3188
(	O	3188
GALT	O	3188
)	O	3188
.	O	3188

Both	O	3189
galactosemia	B-Disease	3189
mutations	O	3189
result	O	3189
in	O	3189
reduced	O	3189
enzymatic	O	3189
activity	O	3189
when	O	3189
reconstructed	O	3189
in	O	3189
the	O	3189
cDNA	O	3189
and	O	3189
overexpressed	O	3189
.	O	3189

Our	O	3193
data	O	3193
further	O	3193
support	O	3193
the	O	3193
notion	O	3193
of	O	3193
molecular	O	3193
heterogeneity	O	3193
of	O	3193
galactosemia	B-Disease	3193
and	O	3193
suggest	O	3193
that	O	3193
galactosemia	B-Disease	3193
mutations	O	3193
and	O	3193
GALT	O	3193
polymorphisms	O	3193
may	O	3193
be	O	3193
useful	O	3193
tools	O	3193
in	O	3193
highlighting	O	3193
different	O	3193
functional	O	3193
domains	O	3193
in	O	3193
human	O	3193
GALT	O	3193
.	O	3193

Linkage	O	3195
relationship	O	3195
of	O	3195
C2	B-Disease	3195
deficiency	I-Disease	3195
,	O	3195
HLA	O	3195
and	O	3195
glyoxalase	O	3195
I	O	3195
loci	O	3195
.	O	3195

Immunogenetic	O	3196
analysis	O	3196
of	O	3196
a	O	3196
homozygous	O	3196
C2	B-Disease	3196
-	I-Disease	3196
deficient	I-Disease	3196
individual	O	3196
and	O	3196
family	O	3196
members	O	3196
demonstrated	O	3196
linkage	O	3196
of	O	3196
HLA	O	3196
-	O	3196
A25	O	3196
,	O	3196
B18	O	3196
and	O	3196
C2o	O	3196
.	O	3196

HLA	O	3197
-	O	3197
D	O	3197
typing	O	3197
showed	O	3197
that	O	3197
5	O	3197
members	O	3197
typed	O	3197
with	O	3197
homozygous	O	3197
Dw2	O	3197
typing	O	3197
cells	O	3197
from	O	3197
an	O	3197
individual	O	3197
with	O	3197
C2	B-Disease	3197
deficiency	I-Disease	3197
but	O	3197
not	O	3197
with	O	3197
Dw2	O	3197
typing	O	3197
cells	O	3197
from	O	3197
2	O	3197
individuals	O	3197
with	O	3197
normal	O	3197
C2	O	3197
.	O	3197

The	O	3198
homozygous	O	3198
C2	B-Disease	3198
-	I-Disease	3198
deficient	I-Disease	3198
propositus	O	3198
and	O	3198
brother	O	3198
were	O	3198
HLA	O	3198
-	O	3198
A	O	3198
and	O	3198
B	O	3198
homozygous	O	3198
but	O	3198
heterozygous	O	3198
at	O	3198
the	O	3198
HLA	O	3198
-	O	3198
D	O	3198
and	O	3198
glyoxalase	O	3198
I	O	3198
loci	O	3198
.	O	3198

Germline	O	3203
mutations	O	3203
in	O	3203
the	O	3203
Wilms	B-Disease	3203
'	I-Disease	3203
tumor	I-Disease	3203
suppressor	O	3203
gene	O	3203
are	O	3203
associated	O	3203
with	O	3203
abnormal	O	3203
urogenital	O	3203
development	O	3203
in	O	3203
Denys	B-Disease	3203
-	I-Disease	3203
Drash	I-Disease	3203
syndrome	I-Disease	3203
.	O	3203

Denys	B-Disease	3204
-	I-Disease	3204
Drash	I-Disease	3204
syndrome	I-Disease	3204
is	O	3204
a	O	3204
rare	O	3204
human	O	3204
condition	O	3204
in	O	3204
which	O	3204
severe	O	3204
urogenital	B-Disease	3204
aberrations	I-Disease	3204
result	O	3204
in	O	3204
renal	B-Disease	3204
failure	I-Disease	3204
,	O	3204
pseudohermaphroditism	B-Disease	3204
,	O	3204
and	O	3204
Wilms	B-Disease	3204
tumor	I-Disease	3204
(	O	3204
nephroblastoma	B-Disease	3204
)	O	3204
.	O	3204

To	O	3205
investigate	O	3205
its	O	3205
possible	O	3205
role	O	3205
,	O	3205
we	O	3205
have	O	3205
analyzed	O	3205
the	O	3205
coding	O	3205
exons	O	3205
of	O	3205
the	O	3205
Wilms	B-Disease	3205
tumor	I-Disease	3205
suppressor	O	3205
gene	O	3205
(	O	3205
WT1	O	3205
)	O	3205
for	O	3205
germline	O	3205
mutations	O	3205
.	O	3205

In	O	3206
ten	O	3206
independent	O	3206
cases	O	3206
of	O	3206
Denys	B-Disease	3206
-	I-Disease	3206
Drash	I-Disease	3206
syndrome	I-Disease	3206
,	O	3206
point	O	3206
mutations	O	3206
in	O	3206
the	O	3206
zinc	O	3206
finger	O	3206
domains	O	3206
of	O	3206
one	O	3206
WT1	O	3206
gene	O	3206
copy	O	3206
were	O	3206
found	O	3206
.	O	3206

Wilms	B-Disease	3210
tumors	I-Disease	3210
from	O	3210
three	O	3210
individuals	O	3210
and	O	3210
one	O	3210
juvenile	O	3210
granulosa	O	3210
cell	O	3210
tumor	B-Disease	3210
demonstrate	O	3210
reduction	O	3210
to	O	3210
homozygosity	O	3210
for	O	3210
the	O	3210
mutated	O	3210
WT1	O	3210
allele	O	3210
.	O	3210

Our	O	3211
results	O	3211
provide	O	3211
evidence	O	3211
of	O	3211
a	O	3211
direct	O	3211
role	O	3211
for	O	3211
WT1	O	3211
in	O	3211
Denys	B-Disease	3211
-	I-Disease	3211
Drash	I-Disease	3211
syndrome	I-Disease	3211
and	O	3211
thus	O	3211
urogenital	O	3211
system	O	3211
development	O	3211
.	O	3211

Linkage	O	3213
analysis	O	3213
in	O	3213
X	B-Disease	3213
-	I-Disease	3213
linked	I-Disease	3213
adrenoleukodystrophy	I-Disease	3213
and	O	3213
application	O	3213
in	O	3213
post	O	3213
-	O	3213
and	O	3213
prenatal	O	3213
diagnosis	O	3213
.	O	3213

We	O	3214
have	O	3214
performed	O	3214
linkage	O	3214
analysis	O	3214
with	O	3214
the	O	3214
DNA	O	3214
markers	O	3214
DXS52	O	3214
and	O	3214
the	O	3214
clotting	O	3214
factor	O	3214
VIII	O	3214
gene	O	3214
(	O	3214
F8C	O	3214
)	O	3214
,	O	3214
in	O	3214
several	O	3214
large	O	3214
families	O	3214
with	O	3214
X	B-Disease	3214
-	I-Disease	3214
linked	I-Disease	3214
adrenoleukodystrophy	I-Disease	3214
(	O	3214
ALD	B-Disease	3214
)	O	3214
.	O	3214

F8C	O	3217
was	O	3217
also	O	3217
tightly	O	3217
linked	O	3217
to	O	3217
ALD	B-Disease	3217
with	O	3217
a	O	3217
maximal	O	3217
LOD	O	3217
score	O	3217
of	O	3217
7	O	3217
.	O	3217

Multipoint	O	3219
linkage	O	3219
analysis	O	3219
with	O	3219
the	O	3219
markers	O	3219
DXS304	O	3219
,	O	3219
DXS52	O	3219
,	O	3219
and	O	3219
F8C	O	3219
indicated	O	3219
that	O	3219
both	O	3219
the	O	3219
gene	O	3219
for	O	3219
ALD	B-Disease	3219
and	O	3219
for	O	3219
F8C	O	3219
are	O	3219
distal	O	3219
to	O	3219
DXS52	O	3219
.	O	3219

In	O	3220
four	O	3220
patients	O	3220
with	O	3220
ALD	B-Disease	3220
,	O	3220
no	O	3220
major	O	3220
structural	O	3220
rearrangement	O	3220
in	O	3220
the	O	3220
Xqter	O	3220
region	O	3220
was	O	3220
observed	O	3220
;	O	3220
in	O	3220
particular	O	3220
,	O	3220
there	O	3220
were	O	3220
no	O	3220
abnormalities	B-Disease	3220
in	I-Disease	3220
the	I-Disease	3220
vision	I-Disease	3220
blindness	I-Disease	3220
genes	I-Disease	3220
.	O	3220

Two	O	3222
distinct	O	3222
mutations	O	3222
at	O	3222
a	O	3222
single	O	3222
BamHI	O	3222
site	O	3222
in	O	3222
phenylketonuria	B-Disease	3222
.	O	3222

Classical	B-Disease	3223
phenylketonuria	I-Disease	3223
is	O	3223
an	O	3223
autosomal	B-Disease	3223
recessive	I-Disease	3223
disease	I-Disease	3223
caused	O	3223
by	O	3223
a	O	3223
deficiency	B-Disease	3223
of	I-Disease	3223
hepatic	I-Disease	3223
phenylalanine	I-Disease	3223
hydroxylase	I-Disease	3223
(	O	3223
PAH	O	3223
)	O	3223
.	O	3223

The	O	3226
present	O	3226
study	O	3226
supports	O	3226
the	O	3226
view	O	3226
that	O	3226
the	O	3226
clinical	O	3226
heterogeneity	O	3226
in	O	3226
PKU	B-Disease	3226
is	O	3226
accounted	O	3226
for	O	3226
by	O	3226
the	O	3226
large	O	3226
variety	O	3226
of	O	3226
mutant	O	3226
genotypes	O	3226
associated	O	3226
with	O	3226
PAH	B-Disease	3226
deficiencies	I-Disease	3226
.	O	3226

A	O	3235
detailed	O	3235
10	O	3235
-	O	3235
point	O	3235
map	O	3235
of	O	3235
the	O	3235
4p16	O	3235
region	O	3235
constructed	O	3235
from	O	3235
the	O	3235
CEPH	O	3235
panel	O	3235
provides	O	3235
evidence	O	3235
for	O	3235
heterogeneity	O	3235
in	O	3235
the	O	3235
linkage	O	3235
maps	O	3235
constructed	O	3235
from	O	3235
families	O	3235
segregating	O	3235
for	O	3235
Huntington	B-Disease	3235
disease	I-Disease	3235
(	O	3235
HD	B-Disease	3235
)	O	3235
.	O	3235

Carrier	O	3238
detection	O	3238
and	O	3238
prenatal	O	3238
diagnosis	O	3238
of	O	3238
Pelizaeus	B-Disease	3238
-	I-Disease	3238
Merzbacher	I-Disease	3238
disease	I-Disease	3238
using	O	3238
a	O	3238
combination	O	3238
of	O	3238
anonymous	O	3238
DNA	O	3238
polymorphisms	O	3238
and	O	3238
the	O	3238
proteolipid	O	3238
protein	O	3238
(	O	3238
PLP	O	3238
)	O	3238
gene	O	3238
cDNA	O	3238
.	O	3238

We	O	3239
report	O	3239
carrier	O	3239
identification	O	3239
and	O	3239
a	O	3239
prenatal	O	3239
diagnosis	O	3239
using	O	3239
DNA	O	3239
polymorphisms	O	3239
in	O	3239
2	O	3239
families	O	3239
with	O	3239
X	B-Disease	3239
-	I-Disease	3239
linked	I-Disease	3239
Pelizaeus	I-Disease	3239
-	I-Disease	3239
Merzbacher	I-Disease	3239
disease	I-Disease	3239
(	O	3239
PMD	B-Disease	3239
)	O	3239
.	O	3239

In	O	3242
the	O	3242
case	O	3242
of	O	3242
the	O	3242
prenatal	O	3242
diagnosis	O	3242
,	O	3242
the	O	3242
fetus	O	3242
was	O	3242
shown	O	3242
by	O	3242
cytogenetic	O	3242
analysis	O	3242
to	O	3242
be	O	3242
a	O	3242
female	O	3242
,	O	3242
who	O	3242
we	O	3242
predict	O	3242
will	O	3242
be	O	3242
a	O	3242
noncarrier	O	3242
of	O	3242
PMD	B-Disease	3242
based	O	3242
on	O	3242
her	O	3242
genotype	O	3242
with	O	3242
the	O	3242
PLP	O	3242
intragenic	O	3242
polymorphism	O	3242
.	O	3242

Identification	O	3244
of	O	3244
deletion	O	3244
mutations	O	3244
and	O	3244
three	O	3244
new	O	3244
genes	O	3244
at	O	3244
the	O	3244
familial	B-Disease	3244
polyposis	I-Disease	3244
locus	O	3244
.	O	3244

Small	O	3245
(	O	3245
100	O	3245
-	O	3245
260	O	3245
kb	O	3245
)	O	3245
,	O	3245
nested	O	3245
deletions	O	3245
were	O	3245
characterized	O	3245
in	O	3245
DNA	O	3245
from	O	3245
two	O	3245
unrelated	O	3245
patients	O	3245
with	O	3245
familial	B-Disease	3245
adenomatous	I-Disease	3245
polyposis	I-Disease	3245
coli	I-Disease	3245
(	O	3245
APC	B-Disease	3245
)	O	3245
.	O	3245

Exclusion	O	3251
of	O	3251
linkage	O	3251
between	O	3251
familial	B-Disease	3251
Mediterranean	I-Disease	3251
fever	I-Disease	3251
and	O	3251
the	O	3251
human	O	3251
serum	O	3251
amyloid	O	3251
A	O	3251
(	O	3251
SAA	O	3251
)	O	3251
gene	O	3251
cluster	O	3251
.	O	3251

We	O	3252
studied	O	3252
the	O	3252
relationship	O	3252
between	O	3252
the	O	3252
autosomal	O	3252
recessive	O	3252
trait	O	3252
familial	B-Disease	3252
Mediterranean	I-Disease	3252
fever	I-Disease	3252
(	O	3252
FMF	B-Disease	3252
)	O	3252
and	O	3252
the	O	3252
serum	O	3252
amyloid	O	3252
A	O	3252
(	O	3252
SAA	O	3252
)	O	3252
genes	O	3252
by	O	3252
comparing	O	3252
alleles	O	3252
of	O	3252
a	O	3252
highly	O	3252
polymorphic	O	3252
dinucleotide	O	3252
repeat	O	3252
and	O	3252
a	O	3252
conventional	O	3252
restriction	O	3252
fragment	O	3252
length	O	3252
polymorphism	O	3252
(	O	3252
RFLP	O	3252
)	O	3252
in	O	3252
the	O	3252
SAA	O	3252
gene	O	3252
cluster	O	3252
in	O	3252
Israeli	O	3252
FMF	B-Disease	3252
kindreds	O	3252
.	O	3252

By	O	3253
haplotype	O	3253
analysis	O	3253
,	O	3253
our	O	3253
data	O	3253
indicate	O	3253
a	O	3253
minimum	O	3253
crossover	O	3253
frequency	O	3253
of	O	3253
22	O	3253
%	O	3253
between	O	3253
the	O	3253
SAA	O	3253
gene	O	3253
marker	O	3253
and	O	3253
FMF	B-Disease	3253
.	O	3253

4	O	3255
cM	O	3255
including	O	3255
and	O	3255
surrounding	O	3255
the	O	3255
SAA	O	3255
gene	O	3255
cluster	O	3255
as	O	3255
the	O	3255
site	O	3255
of	O	3255
the	O	3255
FMF	B-Disease	3255
mutation	O	3255
although	O	3255
SAA	O	3255
proteins	O	3255
are	O	3255
prominent	O	3255
physiologic	O	3255
markers	O	3255
of	O	3255
the	O	3255
acute	O	3255
attacks	O	3255
.	O	3255

PRAD1	O	3256
,	O	3256
a	O	3256
candidate	O	3256
BCL1	O	3256
oncogene	O	3256
:	O	3256
mapping	O	3256
and	O	3256
expression	O	3256
in	O	3256
centrocytic	B-Disease	3256
lymphoma	I-Disease	3256
.	O	3256

Rearrangement	O	3257
of	O	3257
the	O	3257
BCL1	O	3257
(	O	3257
B	O	3257
-	O	3257
cell	O	3257
lymphoma	O	3257
1	O	3257
)	O	3257
region	O	3257
on	O	3257
chromosome	O	3257
11q13	O	3257
appears	O	3257
to	O	3257
be	O	3257
highly	O	3257
characteristic	O	3257
of	O	3257
centrocytic	B-Disease	3257
lymphoma	I-Disease	3257
and	O	3257
also	O	3257
is	O	3257
found	O	3257
infrequently	O	3257
in	O	3257
other	O	3257
B	B-Disease	3257
-	I-Disease	3257
cell	I-Disease	3257
neoplasms	I-Disease	3257
.	O	3257

PRAD1	O	3259
,	O	3259
previously	O	3259
designated	O	3259
D11S287E	O	3259
,	O	3259
was	O	3259
identified	O	3259
on	O	3259
11q13	O	3259
as	O	3259
a	O	3259
chromosomal	O	3259
breakpoint	O	3259
region	O	3259
rearranged	O	3259
with	O	3259
the	O	3259
parathyroid	O	3259
hormone	O	3259
gene	O	3259
in	O	3259
a	O	3259
subset	O	3259
of	O	3259
parathyroid	B-Disease	3259
adenomas	I-Disease	3259
;	O	3259
this	O	3259
highly	O	3259
conserved	O	3259
putative	O	3259
oncogene	O	3259
,	O	3259
which	O	3259
encodes	O	3259
a	O	3259
novel	O	3259
cyclin	O	3259
,	O	3259
has	O	3259
been	O	3259
linked	O	3259
to	O	3259
BCL1	O	3259
and	O	3259
implicated	O	3259
also	O	3259
in	O	3259
subsets	O	3259
of	O	3259
breast	B-Disease	3259
and	I-Disease	3259
squamous	I-Disease	3259
cell	I-Disease	3259
neoplasms	I-Disease	3259
with	O	3259
11q13	O	3259
amplification	O	3259
.	O	3259

PRAD1	O	3261
mRNA	O	3261
is	O	3261
abundantly	O	3261
expressed	O	3261
in	O	3261
seven	O	3261
of	O	3261
seven	O	3261
centrocytic	B-Disease	3261
lymphomas	I-Disease	3261
(	O	3261
Kiel	O	3261
classification	O	3261
)	O	3261
,	O	3261
in	O	3261
contrast	O	3261
to	O	3261
13	O	3261
closely	O	3261
related	O	3261
but	O	3261
noncentrocytic	B-Disease	3261
lymphomas	I-Disease	3261
.	O	3261

Three	O	3262
of	O	3262
the	O	3262
seven	O	3262
centrocytic	B-Disease	3262
lymphomas	I-Disease	3262
had	O	3262
detectable	O	3262
BCL1	O	3262
DNA	O	3262
rearrangement	O	3262
.	O	3262

Its	O	3268
overexpression	O	3268
may	O	3268
be	O	3268
a	O	3268
key	O	3268
consequence	O	3268
of	O	3268
rearrangement	O	3268
of	O	3268
the	O	3268
BCL1	O	3268
vicinity	O	3268
in	O	3268
B	B-Disease	3268
-	I-Disease	3268
cell	I-Disease	3268
neoplasms	I-Disease	3268
and	O	3268
a	O	3268
unifying	O	3268
pathogenetic	O	3268
feature	O	3268
in	O	3268
centrocytic	B-Disease	3268
lymphoma	I-Disease	3268
.	O	3268

Two	O	3269
new	O	3269
arylsulfatase	O	3269
A	O	3269
(	O	3269
ARSA	O	3269
)	O	3269
mutations	O	3269
in	O	3269
a	O	3269
juvenile	O	3269
metachromatic	B-Disease	3269
leukodystrophy	I-Disease	3269
(	O	3269
MLD	B-Disease	3269
)	O	3269
patient	O	3269
.	O	3269

Fragments	O	3270
of	O	3270
the	O	3270
arylsulfatase	O	3270
A	O	3270
(	O	3270
ARSA	O	3270
)	O	3270
gene	O	3270
from	O	3270
a	O	3270
patient	O	3270
with	O	3270
juvenile	O	3270
-	O	3270
onset	O	3270
metachromatic	B-Disease	3270
leukodystrophy	I-Disease	3270
(	O	3270
MLD	B-Disease	3270
)	O	3270
were	O	3270
amplified	O	3270
by	O	3270
PCR	O	3270
and	O	3270
ligated	O	3270
into	O	3270
MP13	O	3270
cloning	O	3270
vectors	O	3270
.	O	3270

A	O	3279
collection	O	3279
of	O	3279
DNA	O	3279
samples	O	3279
from	O	3279
known	O	3279
or	O	3279
suspected	O	3279
MLD	B-Disease	3279
patients	O	3279
,	O	3279
members	O	3279
of	O	3279
their	O	3279
families	O	3279
,	O	3279
and	O	3279
normal	O	3279
controls	O	3279
was	O	3279
screened	O	3279
for	O	3279
these	O	3279
mutations	O	3279
.	O	3279

Four	O	3280
additional	O	3280
individuals	O	3280
carrying	O	3280
each	O	3280
of	O	3280
the	O	3280
mutations	O	3280
were	O	3280
found	O	3280
among	O	3280
the	O	3280
nearly	O	3280
100	O	3280
MLD	B-Disease	3280
patients	O	3280
in	O	3280
the	O	3280
sample	O	3280
.	O	3280

However	O	3283
,	O	3283
combinations	O	3283
with	O	3283
other	O	3283
MLD	B-Disease	3283
mutations	O	3283
suggest	O	3283
that	O	3283
the	O	3283
point	O	3283
mutation	O	3283
in	O	3283
exon	O	3283
3	O	3283
does	O	3283
result	O	3283
in	O	3283
some	O	3283
residual	O	3283
enzyme	O	3283
activity	O	3283
and	O	3283
is	O	3283
associated	O	3283
with	O	3283
late	O	3283
-	O	3283
onset	O	3283
forms	O	3283
of	O	3283
the	O	3283
disease	O	3283
.	O	3283

The	O	3284
splice	O	3284
-	O	3284
site	O	3284
mutation	O	3284
following	O	3284
exon	O	3284
7	O	3284
produces	O	3284
late	O	3284
-	O	3284
infantile	O	3284
MLD	B-Disease	3284
when	O	3284
combined	O	3284
with	O	3284
other	O	3284
enzyme	O	3284
-	O	3284
nan	O	3284
mutations	O	3284
,	O	3284
implying	O	3284
that	O	3284
it	O	3284
is	O	3284
completely	O	3284
silent	O	3284
enzymatically	O	3284
.	O	3284

Analysis	O	3286
of	O	3286
X	O	3286
-	O	3286
chromosome	O	3286
inactivation	O	3286
and	O	3286
presumptive	O	3286
expression	O	3286
of	O	3286
the	O	3286
Wiskott	B-Disease	3286
-	I-Disease	3286
Aldrich	I-Disease	3286
syndrome	I-Disease	3286
(	O	3286
WAS	B-Disease	3286
)	O	3286
gene	O	3286
in	O	3286
hematopoietic	O	3286
cell	O	3286
lineages	O	3286
of	O	3286
a	O	3286
thrombocytopenic	O	3286
carrier	O	3286
female	O	3286
of	O	3286
WAS	B-Disease	3286
.	O	3286

We	O	3287
report	O	3287
on	O	3287
a	O	3287
thrombocytopenic	B-Disease	3287
female	O	3287
belonging	O	3287
to	O	3287
a	O	3287
pedigree	O	3287
with	O	3287
the	O	3287
Wiskott	B-Disease	3287
-	I-Disease	3287
Aldrich	I-Disease	3287
syndrome	I-Disease	3287
(	O	3287
WAS	B-Disease	3287
)	O	3287
.	O	3287

Restriction	O	3288
fragment	O	3288
length	O	3288
polymorphism	O	3288
(	O	3288
RFLP	O	3288
)	O	3288
analysis	O	3288
with	O	3288
probe	O	3288
M27	O	3288
beta	O	3288
,	O	3288
closely	O	3288
linked	O	3288
to	O	3288
the	O	3288
WAS	B-Disease	3288
gene	O	3288
,	O	3288
demonstrated	O	3288
that	O	3288
she	O	3288
is	O	3288
a	O	3288
carrier	O	3288
of	O	3288
WAS	B-Disease	3288
.	O	3288

Both	O	3289
small	O	3289
-	O	3289
sized	O	3289
and	O	3289
normal	O	3289
-	O	3289
sized	O	3289
platelets	O	3289
were	O	3289
present	O	3289
,	O	3289
suggesting	O	3289
that	O	3289
,	O	3289
unlike	O	3289
the	O	3289
vast	O	3289
majority	O	3289
of	O	3289
WAS	B-Disease	3289
carriers	O	3289
,	O	3289
she	O	3289
does	O	3289
not	O	3289
manifest	O	3289
nonrandom	O	3289
X	O	3289
-	O	3289
chromosome	O	3289
inactivation	O	3289
in	O	3289
the	O	3289
thrombopoietic	O	3289
cell	O	3289
lineage	O	3289
.	O	3289

While	O	3291
this	O	3291
is	O	3291
the	O	3291
first	O	3291
complete	O	3291
report	O	3291
on	O	3291
the	O	3291
occurrence	O	3291
of	O	3291
thrombocytopenia	B-Disease	3291
in	O	3291
a	O	3291
carrier	O	3291
female	O	3291
of	O	3291
WAS	B-Disease	3291
as	O	3291
the	O	3291
result	O	3291
of	O	3291
atypical	O	3291
lyonization	O	3291
,	O	3291
it	O	3291
also	O	3291
suggests	O	3291
that	O	3291
expression	O	3291
of	O	3291
the	O	3291
WAS	B-Disease	3291
gene	O	3291
occurs	O	3291
at	O	3291
(	O	3291
or	O	3291
extends	O	3291
up	O	3291
to	O	3291
)	O	3291
a	O	3291
later	O	3291
stage	O	3291
than	O	3291
the	O	3291
multipotent	O	3291
stem	O	3291
cell	O	3291
along	O	3291
the	O	3291
hematopoietic	O	3291
differentiation	O	3291
pathway	O	3291
.	O	3291

A	O	3293
new	O	3293
mutation	O	3293
in	O	3293
the	O	3293
proteolipid	O	3293
protein	O	3293
(	O	3293
PLP	O	3293
)	O	3293
gene	O	3293
in	O	3293
a	O	3293
German	O	3293
family	O	3293
with	O	3293
Pelizaeus	B-Disease	3293
-	I-Disease	3293
Merzbacher	I-Disease	3293
disease	I-Disease	3293
.	O	3293

A	O	3294
C	O	3294
-	O	3294
to	O	3294
-	O	3294
T	O	3294
transition	O	3294
in	O	3294
exon	O	3294
4	O	3294
of	O	3294
the	O	3294
PLP	O	3294
gene	O	3294
was	O	3294
found	O	3294
in	O	3294
2	O	3294
affected	O	3294
males	O	3294
and	O	3294
two	O	3294
obligate	O	3294
carriers	O	3294
in	O	3294
a	O	3294
German	O	3294
family	O	3294
with	O	3294
Pelizaeus	B-Disease	3294
-	I-Disease	3294
Merzbacher	I-Disease	3294
disease	I-Disease	3294
.	O	3294

A	O	3298
3	O	3298
-	O	3298
base	O	3298
pair	O	3298
in	O	3298
-	O	3298
frame	O	3298
deletion	O	3298
of	O	3298
the	O	3298
phenylalanine	O	3298
hydroxylase	O	3298
gene	O	3298
results	O	3298
in	O	3298
a	O	3298
kinetic	O	3298
variant	O	3298
of	O	3298
phenylketonuria	B-Disease	3298
.	O	3298

Phenylketonuria	B-Disease	3299
(	O	3299
PKU	B-Disease	3299
)	O	3299
is	O	3299
an	O	3299
autosomal	B-Disease	3299
recessive	I-Disease	3299
disease	I-Disease	3299
due	O	3299
to	O	3299
deficiency	B-Disease	3299
of	I-Disease	3299
a	I-Disease	3299
hepatic	I-Disease	3299
enzyme	I-Disease	3299
,	I-Disease	3299
phenylalanine	I-Disease	3299
hydroxylase	I-Disease	3299
(	O	3299
PAH	O	3299
)	O	3299
.	O	3299

The	O	3300
absence	O	3300
of	O	3300
PAH	O	3300
activity	O	3300
results	O	3300
in	O	3300
typical	O	3300
PKU	B-Disease	3300
while	O	3300
persistence	O	3300
of	O	3300
a	O	3300
residual	O	3300
enzyme	O	3300
activity	O	3300
gives	O	3300
rise	O	3300
to	O	3300
variant	O	3300
forms	O	3300
of	O	3300
the	O	3300
disease	O	3300
.	O	3300

Finally	O	3303
,	O	3303
since	O	3303
none	O	3303
of	O	3303
the	O	3303
98	O	3303
PKU	B-Disease	3303
patients	O	3303
tested	O	3303
were	O	3303
found	O	3303
to	O	3303
carry	O	3303
this	O	3303
particular	O	3303
deletion	O	3303
,	O	3303
our	O	3303
study	O	3303
suggests	O	3303
that	O	3303
this	O	3303
molecular	O	3303
event	O	3303
probably	O	3303
occurred	O	3303
recently	O	3303
on	O	3303
the	O	3303
background	O	3303
of	O	3303
a	O	3303
haplotype	O	3303
2	O	3303
gene	O	3303
in	O	3303
Portugal	O	3303
.	O	3303

Mutation	O	3305
of	O	3305
the	O	3305
KIT	O	3305
(	O	3305
mast	O	3305
/	O	3305
stem	O	3305
cell	O	3305
growth	O	3305
factor	O	3305
receptor	O	3305
)	O	3305
protooncogene	O	3305
in	O	3305
human	O	3305
piebaldism	B-Disease	3305
.	O	3305

Piebaldism	B-Disease	3306
is	O	3306
an	O	3306
autosomal	B-Disease	3306
dominant	I-Disease	3306
genetic	I-Disease	3306
disorder	I-Disease	3306
characterized	O	3306
by	O	3306
cogenital	O	3306
patches	O	3306
of	O	3306
skin	O	3306
and	O	3306
hair	O	3306
from	O	3306
which	O	3306
melanocytes	O	3306
are	O	3306
completely	O	3306
absent	O	3306
.	O	3306

We	O	3308
identified	O	3308
a	O	3308
KIT	O	3308
gene	O	3308
mutation	O	3308
in	O	3308
a	O	3308
proband	O	3308
with	O	3308
classic	O	3308
autosomal	O	3308
dominant	O	3308
piebaldism	B-Disease	3308
.	O	3308

This	O	3310
substitution	O	3310
was	O	3310
not	O	3310
seen	O	3310
in	O	3310
any	O	3310
normal	O	3310
individuals	O	3310
and	O	3310
was	O	3310
completely	O	3310
linked	O	3310
to	O	3310
the	O	3310
piebald	B-Disease	3310
phenotype	O	3310
in	O	3310
the	O	3310
probands	O	3310
family	O	3310
.	O	3310

Piebaldism	B-Disease	3311
in	O	3311
this	O	3311
family	O	3311
thus	O	3311
appears	O	3311
to	O	3311
be	O	3311
the	O	3311
human	O	3311
homologue	O	3311
to	O	3311
dominant	O	3311
white	O	3311
spotting	O	3311
(	O	3311
W	O	3311
)	O	3311
of	O	3311
the	O	3311
mouse	O	3311
.	O	3311

Genetic	O	3313
analysis	O	3313
of	O	3313
a	O	3313
Japanese	O	3313
family	O	3313
with	O	3313
normotriglyceridemic	B-Disease	3313
abetalipoproteinemia	I-Disease	3313
indicates	O	3313
a	O	3313
lack	O	3313
of	O	3313
linkage	O	3313
to	O	3313
the	O	3313
apolipoprotein	O	3313
B	O	3313
gene	O	3313
.	O	3313

Normotriglyceridemic	B-Disease	3314
abetalipoproteinemia	I-Disease	3314
is	O	3314
a	O	3314
rare	O	3314
familial	B-Disease	3314
disorder	I-Disease	3314
characterized	O	3314
by	O	3314
an	O	3314
isolated	O	3314
deficiency	B-Disease	3314
of	I-Disease	3314
apoB	I-Disease	3314
-	I-Disease	3314
100	I-Disease	3314
.	O	3314

To	O	3316
elucidate	O	3316
the	O	3316
genetic	B-Disease	3316
abnormalities	I-Disease	3316
in	O	3316
this	O	3316
family	O	3316
,	O	3316
we	O	3316
studied	O	3316
the	O	3316
linkage	O	3316
of	O	3316
apoB	O	3316
gene	O	3316
using	O	3316
three	O	3316
genetic	O	3316
markers	O	3316
.	O	3316

Localisation	O	3321
of	O	3321
the	O	3321
gene	O	3321
for	O	3321
Norrie	B-Disease	3321
disease	I-Disease	3321
to	O	3321
between	O	3321
DXS7	O	3321
and	O	3321
DXS426	O	3321
on	O	3321
Xp	O	3321
.	O	3321

23	O	3324
,	O	3324
has	O	3324
been	O	3324
used	O	3324
to	O	3324
refine	O	3324
further	O	3324
the	O	3324
localisation	O	3324
of	O	3324
the	O	3324
gene	O	3324
for	O	3324
Norrie	B-Disease	3324
disease	I-Disease	3324
(	O	3324
NDP	B-Disease	3324
)	O	3324
.	O	3324

The	O	3325
results	O	3325
from	O	3325
a	O	3325
multiply	O	3325
informative	O	3325
crossover	O	3325
localize	O	3325
the	O	3325
NDP	B-Disease	3325
gene	O	3325
proximal	O	3325
to	O	3325
DXS7	O	3325
.	O	3325

In	O	3326
conjunction	O	3326
with	O	3326
information	O	3326
from	O	3326
2	O	3326
NDP	B-Disease	3326
patients	O	3326
who	O	3326
have	O	3326
a	O	3326
deletion	O	3326
for	O	3326
DXS7	O	3326
but	O	3326
not	O	3326
for	O	3326
DSX426	O	3326
,	O	3326
our	O	3326
data	O	3326
indicate	O	3326
that	O	3326
the	O	3326
NDP	B-Disease	3326
gene	O	3326
lies	O	3326
between	O	3326
DXS7	O	3326
and	O	3326
DXS426	O	3326
on	O	3326
proximal	O	3326
Xp	O	3326
.	O	3326

Aberrant	O	3327
splicing	O	3327
of	O	3327
phenylalanine	O	3327
hydroxylase	O	3327
mRNA	O	3327
:	O	3327
the	O	3327
major	O	3327
cause	O	3327
for	O	3327
phenylketonuria	B-Disease	3327
in	O	3327
parts	O	3327
of	O	3327
southern	O	3327
Europe	O	3327
.	O	3327

Because	O	3329
of	O	3329
the	O	3329
high	O	3329
frequency	O	3329
of	O	3329
these	O	3329
particular	O	3329
haplotypes	O	3329
in	O	3329
Bulgaria	O	3329
,	O	3329
Italy	O	3329
,	O	3329
and	O	3329
Turkey	O	3329
,	O	3329
it	O	3329
appears	O	3329
to	O	3329
be	O	3329
one	O	3329
of	O	3329
the	O	3329
more	O	3329
frequent	O	3329
defects	O	3329
in	O	3329
the	O	3329
PAH	O	3329
gene	O	3329
causing	O	3329
classical	O	3329
phenylketonuria	B-Disease	3329
in	O	3329
this	O	3329
part	O	3329
of	O	3329
Europe	O	3329
.	O	3329

Gardner	B-Disease	3335
syndrome	I-Disease	3335
in	O	3335
a	O	3335
boy	O	3335
with	O	3335
interstitial	O	3335
deletion	O	3335
of	O	3335
the	O	3335
long	O	3335
arm	O	3335
of	O	3335
chromosome	O	3335
5	O	3335
.	O	3335

We	O	3336
described	O	3336
a	O	3336
15	O	3336
-	O	3336
year	O	3336
-	O	3336
old	O	3336
boy	O	3336
with	O	3336
Gardner	B-Disease	3336
syndrome	I-Disease	3336
(	O	3336
GS	B-Disease	3336
)	O	3336
,	O	3336
mental	B-Disease	3336
retardation	I-Disease	3336
,	O	3336
and	O	3336
craniofacial	B-Disease	3336
abnormalities	I-Disease	3336
.	O	3336

The	O	3340
breakpoints	O	3340
in	O	3340
the	O	3340
present	O	3340
case	O	3340
and	O	3340
in	O	3340
3	O	3340
previously	O	3340
reported	O	3340
5q	O	3340
-	O	3340
patients	O	3340
with	O	3340
adenomatous	B-Disease	3340
polyposis	I-Disease	3340
coli	I-Disease	3340
suggest	O	3340
that	O	3340
the	O	3340
gene	O	3340
responsible	O	3340
for	O	3340
GS	B-Disease	3340
/	O	3340
or	O	3340
familial	B-Disease	3340
polyposis	I-Disease	3340
coli	I-Disease	3340
(	O	3340
FPC	B-Disease	3340
)	O	3340
is	O	3340
in	O	3340
the	O	3340
5q22	O	3340
region	O	3340
,	O	3340
a	O	3340
result	O	3340
consistent	O	3340
with	O	3340
the	O	3340
findings	O	3340
of	O	3340
linkage	O	3340
studies	O	3340
Huntington	B-Disease	3340
disease	I-Disease	3340
and	O	3340
childhood	O	3340
-	O	3340
onset	O	3340
Tourette	B-Disease	3340
syndrome	I-Disease	3340
.	O	3340

A	O	3341
40	O	3341
-	O	3341
year	O	3341
-	O	3341
old	O	3341
man	O	3341
with	O	3341
childhood	O	3341
-	O	3341
onset	O	3341
Tourette	B-Disease	3341
syndrome	I-Disease	3341
(	O	3341
TS	B-Disease	3341
)	O	3341
developed	O	3341
Huntington	B-Disease	3341
disease	I-Disease	3341
(	O	3341
HD	B-Disease	3341
)	O	3341
.	O	3341

We	O	3342
believe	O	3342
this	O	3342
to	O	3342
be	O	3342
the	O	3342
first	O	3342
reported	O	3342
case	O	3342
of	O	3342
childhood	O	3342
-	O	3342
onset	O	3342
TS	B-Disease	3342
with	O	3342
adult	O	3342
onset	O	3342
HD	B-Disease	3342
.	O	3342

Sequence	O	3345
of	O	3345
DNA	O	3345
flanking	O	3345
the	O	3345
exons	O	3345
of	O	3345
the	O	3345
HEXA	O	3345
gene	O	3345
,	O	3345
and	O	3345
identification	O	3345
of	O	3345
mutations	O	3345
in	O	3345
Tay	B-Disease	3345
-	I-Disease	3345
Sachs	I-Disease	3345
disease	I-Disease	3345
.	O	3345

The	O	3346
rapid	O	3346
identification	O	3346
of	O	3346
mutations	O	3346
causing	O	3346
Tay	B-Disease	3346
-	I-Disease	3346
Sachs	I-Disease	3346
disease	I-Disease	3346
requires	O	3346
the	O	3346
capacity	O	3346
to	O	3346
readily	O	3346
screen	O	3346
the	O	3346
regions	O	3346
of	O	3346
the	O	3346
HEXA	O	3346
gene	O	3346
most	O	3346
likely	O	3346
to	O	3346
be	O	3346
affected	O	3346
by	O	3346
mutation	O	3346
.	O	3346

Five	O	3349
novel	O	3349
mutations	O	3349
from	O	3349
Tay	B-Disease	3349
-	I-Disease	3349
Sachs	I-Disease	3349
disease	I-Disease	3349
patients	O	3349
were	O	3349
detected	O	3349
a	O	3349
5	O	3349
-	O	3349
bp	O	3349
deletion	O	3349
of	O	3349
TCTCC	O	3349
in	O	3349
IVS	O	3349
-	O	3349
9	O	3349
;	O	3349
a	O	3349
2	O	3349
-	O	3349
bp	O	3349
deletion	O	3349
of	O	3349
TG	O	3349
in	O	3349
exon	O	3349
5	O	3349
;	O	3349
G78	O	3349
to	O	3349
A	O	3349
,	O	3349
giving	O	3349
a	O	3349
stop	O	3349
codon	O	3349
in	O	3349
exon	O	3349
1	O	3349
;	O	3349
G533	O	3349
to	O	3349
T	O	3349
in	O	3349
exon	O	3349
5	O	3349
,	O	3349
producing	O	3349
the	O	3349
third	O	3349
amino	O	3349
acid	O	3349
substitution	O	3349
detected	O	3349
at	O	3349
this	O	3349
site	O	3349
;	O	3349
and	O	3349
G	O	3349
to	O	3349
C	O	3349
at	O	3349
position	O	3349
1	O	3349
of	O	3349
IVS	O	3349
-	O	3349
2	O	3349
,	O	3349
expected	O	3349
to	O	3349
produce	O	3349
abnormal	O	3349
splicing	O	3349
.	O	3349

Molecular	O	3352
characterization	O	3352
of	O	3352
two	O	3352
galactosemia	B-Disease	3352
mutations	O	3352
:	O	3352
correlation	O	3352
of	O	3352
mutations	O	3352
with	O	3352
highly	O	3352
conserved	O	3352
domains	O	3352
in	O	3352
galactose	O	3352
-	O	3352
1	O	3352
-	O	3352
phosphate	O	3352
uridyl	O	3352
transferase	O	3352
.	O	3352

Galactosemia	B-Disease	3353
is	O	3353
an	O	3353
autosomal	B-Disease	3353
recessive	I-Disease	3353
disorder	I-Disease	3353
of	I-Disease	3353
human	I-Disease	3353
galactose	I-Disease	3353
metabolism	I-Disease	3353
caused	O	3353
by	O	3353
deficiency	B-Disease	3353
of	I-Disease	3353
the	I-Disease	3353
enzyme	I-Disease	3353
galactose	I-Disease	3353
-	I-Disease	3353
1	I-Disease	3353
-	I-Disease	3353
phosphate	I-Disease	3353
uridyl	I-Disease	3353
transferase	I-Disease	3353
(	O	3353
GALT	O	3353
)	O	3353
.	O	3353

The	O	3358
arginine	O	3358
188	O	3358
mutation	O	3358
is	O	3358
the	O	3358
most	O	3358
common	O	3358
galactosemia	B-Disease	3358
mutation	O	3358
characterized	O	3358
to	O	3358
date	O	3358
.	O	3358

It	O	3359
accounts	O	3359
for	O	3359
one	O	3359
-	O	3359
fourth	O	3359
of	O	3359
the	O	3359
galactosemia	B-Disease	3359
alleles	O	3359
studied	O	3359
.	O	3359

Our	O	3364
data	O	3364
provide	O	3364
further	O	3364
evidence	O	3364
for	O	3364
the	O	3364
heterogeneity	O	3364
of	O	3364
galactosemia	B-Disease	3364
at	O	3364
the	O	3364
molecular	O	3364
level	O	3364
,	O	3364
heterogeneity	O	3364
which	O	3364
might	O	3364
be	O	3364
related	O	3364
to	O	3364
the	O	3364
variable	O	3364
clinical	O	3364
outcome	O	3364
observed	O	3364
in	O	3364
this	O	3364
disorder	O	3364
.	O	3364

Hypoxanthine	B-Disease	3366
-	I-Disease	3366
guanine	I-Disease	3366
phosphoribosyltransferase	I-Disease	3366
deficiency	I-Disease	3366
:	O	3366
analysis	O	3366
of	O	3366
HPRT	O	3366
mutations	O	3366
by	O	3366
direct	O	3366
sequencing	O	3366
and	O	3366
allele	O	3366
-	O	3366
specific	O	3366
amplification	O	3366
.	O	3366

The	O	3367
Lesch	B-Disease	3367
-	I-Disease	3367
Nyhan	I-Disease	3367
syndrome	I-Disease	3367
is	O	3367
a	O	3367
severe	O	3367
X	B-Disease	3367
chromosome	I-Disease	3367
-	I-Disease	3367
linked	I-Disease	3367
human	I-Disease	3367
disease	I-Disease	3367
caused	O	3367
by	O	3367
a	O	3367
virtual	O	3367
absence	B-Disease	3367
of	I-Disease	3367
hypoxanthine	I-Disease	3367
-	I-Disease	3367
guanine	I-Disease	3367
phosphoribosyltransferase	I-Disease	3367
(	I-Disease	3367
HPRT	I-Disease	3367
)	I-Disease	3367
activity	I-Disease	3367
.	O	3367

A	O	3368
partial	O	3368
deficiency	O	3368
in	O	3368
the	O	3368
activity	O	3368
of	O	3368
this	O	3368
enzyme	O	3368
can	O	3368
result	O	3368
in	O	3368
gouty	B-Disease	3368
arthritis	I-Disease	3368
.	O	3368

To	O	3369
determine	O	3369
the	O	3369
genetic	O	3369
basis	O	3369
for	O	3369
reduction	O	3369
or	O	3369
loss	O	3369
of	O	3369
enzyme	O	3369
activity	O	3369
,	O	3369
we	O	3369
have	O	3369
amplified	O	3369
and	O	3369
sequenced	O	3369
the	O	3369
coding	O	3369
region	O	3369
of	O	3369
HPRT	O	3369
cDNA	O	3369
from	O	3369
four	O	3369
patients	O	3369
one	O	3369
with	O	3369
Lesch	B-Disease	3369
-	I-Disease	3369
Nyhan	I-Disease	3369
syndrome	I-Disease	3369
(	O	3369
HPRTPerth	O	3369
)	O	3369
and	O	3369
three	O	3369
with	O	3369
partial	B-Disease	3369
deficiencies	I-Disease	3369
of	I-Disease	3369
HPRT	I-Disease	3369
activity	I-Disease	3369
,	O	3369
which	O	3369
have	O	3369
been	O	3369
designated	O	3369
HPRTUrangan	O	3369
,	O	3369
HPRTSwan	O	3369
and	O	3369
HPRTToowong	O	3369
.	O	3369

Molecular	O	3375
and	O	3375
metabolic	O	3375
basis	O	3375
for	O	3375
the	O	3375
metabolic	B-Disease	3375
disorder	I-Disease	3375
normotriglyceridemic	B-Disease	3375
abetalipoproteinemia	I-Disease	3375
.	O	3375

We	O	3376
have	O	3376
previously	O	3376
described	O	3376
a	O	3376
disorder	O	3376
,	O	3376
normotriglyceridemic	B-Disease	3376
abetalipoproteinemia	I-Disease	3376
,	O	3376
that	O	3376
is	O	3376
characterized	O	3376
by	O	3376
the	O	3376
virtual	O	3376
absence	O	3376
of	O	3376
plasma	O	3376
low	O	3376
density	O	3376
lipoproteins	O	3376
and	O	3376
complete	O	3376
absence	O	3376
of	O	3376
apoB	O	3376
-	O	3376
100	O	3376
,	O	3376
but	O	3376
with	O	3376
apparently	O	3376
normal	O	3376
secretion	O	3376
of	O	3376
triglyceride	O	3376
-	O	3376
rich	O	3376
lipoproteins	O	3376
containing	O	3376
apoB	O	3376
-	O	3376
48	O	3376
.	O	3376

Thus	O	3379
,	O	3379
this	O	3379
is	O	3379
a	O	3379
rare	O	3379
example	O	3379
of	O	3379
homozygous	B-Disease	3379
hypobetalipoproteinemia	I-Disease	3379
.	O	3379

A	O	3388
single	O	3388
origin	O	3388
of	O	3388
phenylketonuria	B-Disease	3388
in	O	3388
Yemenite	O	3388
Jews	O	3388
.	O	3388

Phenylketonuria	B-Disease	3389
(	O	3389
PKU	B-Disease	3389
)	O	3389
is	O	3389
a	O	3389
metabolic	B-Disease	3389
disease	I-Disease	3389
caused	O	3389
by	O	3389
recessive	O	3389
mutations	O	3389
of	O	3389
the	O	3389
gene	O	3389
encoding	O	3389
the	O	3389
hepatic	O	3389
enzyme	O	3389
phenylalanine	O	3389
hydroxylase	O	3389
(	O	3389
PAH	O	3389
)	O	3389
.	O	3389

The	O	3390
incidence	O	3390
of	O	3390
PKU	B-Disease	3390
varies	O	3390
widely	O	3390
across	O	3390
different	O	3390
geographic	O	3390
areas	O	3390
,	O	3390
and	O	3390
is	O	3390
highest	O	3390
(	O	3390
about	O	3390
1	O	3390
in	O	3390
5	O	3390
,	O	3390
000	O	3390
live	O	3390
births	O	3390
)	O	3390
in	O	3390
Ireland	O	3390
and	O	3390
western	O	3390
Scotland	O	3390
,	O	3390
and	O	3390
among	O	3390
Yemenite	O	3390
Jews	O	3390
.	O	3390

A	O	3391
limited	O	3391
number	O	3391
of	O	3391
point	O	3391
mutations	O	3391
account	O	3391
for	O	3391
most	O	3391
of	O	3391
the	O	3391
PKU	B-Disease	3391
cases	O	3391
in	O	3391
the	O	3391
European	O	3391
population	O	3391
.	O	3391

Here	O	3392
we	O	3392
report	O	3392
that	O	3392
a	O	3392
single	O	3392
molecular	O	3392
defect	O	3392
-	O	3392
-	O	3392
a	O	3392
deletion	O	3392
spanning	O	3392
the	O	3392
third	O	3392
exon	O	3392
of	O	3392
the	O	3392
PAH	O	3392
gene	O	3392
-	O	3392
-	O	3392
is	O	3392
responsible	O	3392
for	O	3392
all	O	3392
the	O	3392
PKU	B-Disease	3392
cases	O	3392
among	O	3392
the	O	3392
Yemenite	O	3392
Jews	O	3392
.	O	3392

Although	O	3394
the	O	3394
deleted	O	3394
PAH	O	3394
gene	O	3394
was	O	3394
traced	O	3394
to	O	3394
25	O	3394
different	O	3394
locations	O	3394
throughout	O	3394
Yemen	O	3394
,	O	3394
family	O	3394
histories	O	3394
and	O	3394
official	O	3394
documents	O	3394
of	O	3394
the	O	3394
Yemenite	O	3394
Jewish	O	3394
community	O	3394
showed	O	3394
that	O	3394
the	O	3394
common	O	3394
ancestor	O	3394
of	O	3394
all	O	3394
the	O	3394
carriers	O	3394
of	O	3394
this	O	3394
genetic	B-Disease	3394
defect	I-Disease	3394
lived	O	3394
in	O	3394
Sana	O	3394
,	O	3394
the	O	3394
capital	O	3394
of	O	3394
Yemen	O	3394
,	O	3394
before	O	3394
the	O	3394
eighteenth	O	3394
century	O	3394
.	O	3394

Linkage	O	3396
of	O	3396
aspartylglucosaminuria	B-Disease	3396
(	O	3396
AGU	B-Disease	3396
)	O	3396
to	O	3396
marker	O	3396
loci	O	3396
on	O	3396
the	O	3396
long	O	3396
arm	O	3396
of	O	3396
chromosome	O	3396
4	O	3396
.	O	3396

Aspartylglucosaminuria	B-Disease	3397
(	O	3397
AGU	B-Disease	3397
)	O	3397
is	O	3397
caused	O	3397
by	O	3397
deficient	O	3397
activity	O	3397
of	O	3397
the	O	3397
enzyme	O	3397
aspartylglucosaminidase	O	3397
(	O	3397
AGA	O	3397
)	O	3397
.	O	3397

Restriction	O	3400
fragment	O	3400
length	O	3400
polymorphism	O	3400
alleles	O	3400
for	O	3400
the	O	3400
ADH2	O	3400
,	O	3400
ADH3	O	3400
,	O	3400
EGF	O	3400
,	O	3400
FG	O	3400
alpha	O	3400
and	O	3400
FG	O	3400
beta	O	3400
loci	O	3400
and	O	3400
blood	O	3400
group	O	3400
antigens	O	3400
for	O	3400
the	O	3400
MNS	O	3400
locus	O	3400
were	O	3400
determined	O	3400
in	O	3400
a	O	3400
panel	O	3400
of	O	3400
12	O	3400
Finnish	O	3400
AGU	B-Disease	3400
families	O	3400
.	O	3400

Loose	O	3403
linkage	O	3403
of	O	3403
the	O	3403
AGU	B-Disease	3403
locus	O	3403
to	O	3403
the	O	3403
FG	O	3403
and	O	3403
MNS	O	3403
loci	O	3403
was	O	3403
observed	O	3403
(	O	3403
z	O	3403
=	O	3403
1	O	3403
.	O	3403

Linkage	O	3414
relationships	O	3414
of	O	3414
the	O	3414
apolipoprotein	O	3414
C1	O	3414
gene	O	3414
and	O	3414
a	O	3414
cytochrome	O	3414
P450	O	3414
gene	O	3414
(	O	3414
CYP2A	O	3414
)	O	3414
to	O	3414
myotonic	B-Disease	3414
dystrophy	I-Disease	3414
.	O	3414

We	O	3415
have	O	3415
studied	O	3415
the	O	3415
genetic	O	3415
linkage	O	3415
of	O	3415
two	O	3415
markers	O	3415
,	O	3415
the	O	3415
apolipoprotein	O	3415
C1	O	3415
(	O	3415
APOC1	O	3415
)	O	3415
gene	O	3415
and	O	3415
a	O	3415
cytochrome	O	3415
P450	O	3415
(	O	3415
CYP2A	O	3415
)	O	3415
gene	O	3415
,	O	3415
in	O	3415
relation	O	3415
to	O	3415
the	O	3415
gene	O	3415
for	O	3415
myotonic	B-Disease	3415
dystrophy	I-Disease	3415
(	O	3415
DM	B-Disease	3415
)	O	3415
.	O	3415

Genetic	O	3425
linkage	O	3425
map	O	3425
of	O	3425
six	O	3425
polymorphic	O	3425
DNA	O	3425
markers	O	3425
around	O	3425
the	O	3425
gene	O	3425
for	O	3425
familial	B-Disease	3425
adenomatous	I-Disease	3425
polyposis	I-Disease	3425
on	O	3425
chromosome	O	3425
5	O	3425
.	O	3425

A	O	3426
genetic	O	3426
linkage	O	3426
map	O	3426
of	O	3426
six	O	3426
polymorphic	O	3426
DNA	O	3426
markers	O	3426
close	O	3426
to	O	3426
the	O	3426
gene	O	3426
(	O	3426
APC	O	3426
)	O	3426
for	O	3426
familial	B-Disease	3426
adenomatous	I-Disease	3426
polyposis	I-Disease	3426
(	O	3426
FAP	B-Disease	3426
)	O	3426
on	O	3426
chromosome	O	3426
5q	O	3426
is	O	3426
reported	O	3426
.	O	3426

One	O	3427
hundred	O	3427
fifty	O	3427
-	O	3427
five	O	3427
typed	O	3427
members	O	3427
of	O	3427
nine	O	3427
FAP	B-Disease	3427
kindred	O	3427
provided	O	3427
more	O	3427
than	O	3427
90	O	3427
meioses	O	3427
for	O	3427
linkage	O	3427
analysis	O	3427
.	O	3427

48	O	3439
,	O	3439
but	O	3439
published	O	3439
deletion	O	3439
mapping	O	3439
in	O	3439
colorectal	B-Disease	3439
carcinomas	I-Disease	3439
and	O	3439
linkage	O	3439
analysis	O	3439
in	O	3439
FAP	B-Disease	3439
suggest	O	3439
that	O	3439
YN5	O	3439
.	O	3439

44	O	3444
locus	O	3444
lies	O	3444
very	O	3444
close	O	3444
to	O	3444
the	O	3444
APC	B-Disease	3444
gene	O	3444
.	O	3444

These	O	3445
data	O	3445
not	O	3445
only	O	3445
allow	O	3445
use	O	3445
of	O	3445
flanking	O	3445
markers	O	3445
for	O	3445
presymptomatic	O	3445
diagnosis	O	3445
of	O	3445
FAP	B-Disease	3445
but	O	3445
also	O	3445
provide	O	3445
a	O	3445
high	O	3445
-	O	3445
density	O	3445
map	O	3445
of	O	3445
the	O	3445
region	O	3445
for	O	3445
isolation	O	3445
of	O	3445
the	O	3445
APC	B-Disease	3445
gene	O	3445
itself	O	3445
and	O	3445
for	O	3445
further	O	3445
assessment	O	3445
of	O	3445
the	O	3445
role	O	3445
of	O	3445
chromosome	O	3445
5	O	3445
deletions	O	3445
in	O	3445
the	O	3445
biology	O	3445
of	O	3445
sporadic	O	3445
colorectal	B-Disease	3445
cancer	I-Disease	3445
.	O	3445

Serum	O	3446
amyloid	O	3446
A	O	3446
and	O	3446
P	O	3446
protein	O	3446
genes	O	3446
in	O	3446
familial	B-Disease	3446
Mediterranean	I-Disease	3446
fever	I-Disease	3446
.	O	3446

Two	O	3447
recent	O	3447
studies	O	3447
have	O	3447
suggested	O	3447
the	O	3447
involvement	O	3447
of	O	3447
serum	O	3447
amyloid	O	3447
A	O	3447
(	O	3447
SAA	O	3447
)	O	3447
and	O	3447
P	O	3447
(	O	3447
APCS	O	3447
)	O	3447
genes	O	3447
in	O	3447
familial	B-Disease	3447
Mediterranean	I-Disease	3447
fever	I-Disease	3447
(	O	3447
MEF	B-Disease	3447
)	O	3447
.	O	3447

To	O	3448
test	O	3448
the	O	3448
role	O	3448
of	O	3448
SAA	O	3448
and	O	3448
APCS	O	3448
in	O	3448
MEF	B-Disease	3448
and	O	3448
MEF	B-Disease	3448
-	I-Disease	3448
amyloidosis	I-Disease	3448
,	O	3448
we	O	3448
studied	O	3448
17	O	3448
informative	O	3448
families	O	3448
(	O	3448
15	O	3448
Armenians	O	3448
,	O	3448
2	O	3448
non	O	3448
-	O	3448
Ashkenazi	O	3448
Jews	O	3448
)	O	3448
and	O	3448
8	O	3448
MEF	B-Disease	3448
patients	O	3448
with	O	3448
amyloidosis	B-Disease	3448
using	O	3448
a	O	3448
candidate	O	3448
gene	O	3448
approach	O	3448
.	O	3448

No	O	3449
evidence	O	3449
for	O	3449
any	O	3449
MEF	B-Disease	3449
-	O	3449
associated	O	3449
polymorphism	O	3449
was	O	3449
found	O	3449
in	O	3449
any	O	3449
of	O	3449
the	O	3449
41	O	3449
Armenian	O	3449
and	O	3449
Jewish	O	3449
MEF	B-Disease	3449
patients	O	3449
tested	O	3449
.	O	3449

Our	O	3450
family	O	3450
studies	O	3450
allowed	O	3450
us	O	3450
to	O	3450
rule	O	3450
out	O	3450
tight	O	3450
linkage	O	3450
between	O	3450
SAA	O	3450
and	O	3450
MEF	B-Disease	3450
(	O	3450
lod	O	3450
score	O	3450
=	O	3450
-	O	3450
2	O	3450
.	O	3450

For	O	3453
APCS	O	3453
we	O	3453
found	O	3453
that	O	3453
the	O	3453
allele	O	3453
frequency	O	3453
in	O	3453
the	O	3453
MEF	B-Disease	3453
-	I-Disease	3453
amyloidosis	I-Disease	3453
patients	O	3453
was	O	3453
similar	O	3453
to	O	3453
that	O	3453
in	O	3453
18	O	3453
unrelated	O	3453
MEF	B-Disease	3453
patients	O	3453
without	O	3453
amyloidosis	B-Disease	3453
and	O	3453
their	O	3453
33	O	3453
healthy	O	3453
parents	O	3453
.	O	3453

Glucose	B-Disease	3455
-	I-Disease	3455
6	I-Disease	3455
-	I-Disease	3455
phosphate	I-Disease	3455
dehydrogenase	I-Disease	3455
(	I-Disease	3455
G6PD	I-Disease	3455
)	I-Disease	3455
deficiency	I-Disease	3455
appears	O	3455
to	O	3455
be	O	3455
fairly	O	3455
common	O	3455
in	O	3455
Mexico	O	3455
.	O	3455

Two	O	3458
other	O	3458
Mexican	O	3458
males	O	3458
with	O	3458
G6PD	B-Disease	3458
deficiency	I-Disease	3458
were	O	3458
found	O	3458
to	O	3458
have	O	3458
the	O	3458
same	O	3458
mutation	O	3458
.	O	3458

Hereditary	O	3462
deficiency	B-Disease	3462
of	I-Disease	3462
C5	I-Disease	3462
in	O	3462
association	O	3462
with	O	3462
discoid	B-Disease	3462
lupus	I-Disease	3462
erythematosus	I-Disease	3462
.	O	3462

A	O	3463
29	O	3463
-	O	3463
year	O	3463
-	O	3463
old	O	3463
woman	O	3463
with	O	3463
discoid	B-Disease	3463
lupus	I-Disease	3463
erythematosus	I-Disease	3463
had	O	3463
undetectable	O	3463
classic	O	3463
pathway	O	3463
complement	O	3463
activity	O	3463
.	O	3463

Hypocomplementemia	B-Disease	3464
was	O	3464
due	O	3464
to	O	3464
selective	O	3464
deficiency	B-Disease	3464
of	I-Disease	3464
C5	I-Disease	3464
.	O	3464

To	O	3466
our	O	3466
knowledge	O	3466
this	O	3466
is	O	3466
the	O	3466
first	O	3466
documented	O	3466
case	O	3466
of	O	3466
an	O	3466
association	O	3466
between	O	3466
discoid	B-Disease	3466
lupus	I-Disease	3466
erythematosus	I-Disease	3466
and	O	3466
C5	B-Disease	3466
deficiency	I-Disease	3466
.	O	3466

Founder	O	3468
effect	O	3468
of	O	3468
a	O	3468
prevalent	O	3468
phenylketonuria	B-Disease	3468
mutation	O	3468
in	O	3468
the	O	3468
Oriental	O	3468
population	O	3468
.	O	3468

1	O	3472
]	O	3472
gene	O	3472
in	O	3472
a	O	3472
Chinese	O	3472
patient	O	3472
with	O	3472
classic	O	3472
phenylketonuria	B-Disease	3472
(	O	3472
PKU	B-Disease	3472
)	O	3472
.	O	3472

This	O	3474
mutation	O	3474
(	O	3474
R413P	O	3474
)	O	3474
results	O	3474
in	O	3474
negligible	O	3474
enzymatic	O	3474
activity	O	3474
when	O	3474
expressed	O	3474
in	O	3474
heterologous	O	3474
mammalian	O	3474
cells	O	3474
and	O	3474
is	O	3474
compatible	O	3474
with	O	3474
a	O	3474
classic	O	3474
PKU	B-Disease	3474
phenotype	O	3474
in	O	3474
the	O	3474
patient	O	3474
.	O	3474

8	O	3477
%	O	3477
of	O	3477
northern	O	3477
Chinese	O	3477
and	O	3477
27	O	3477
%	O	3477
of	O	3477
Japanese	O	3477
PKU	B-Disease	3477
alleles	O	3477
,	O	3477
but	O	3477
it	O	3477
is	O	3477
rare	O	3477
in	O	3477
southern	O	3477
Chinese	O	3477
(	O	3477
2	O	3477
.	O	3477

Our	O	3483
results	O	3483
are	O	3483
compatible	O	3483
with	O	3483
this	O	3483
hypothesis	O	3483
in	O	3483
that	O	3483
the	O	3483
PKU	B-Disease	3483
mutation	O	3483
might	O	3483
have	O	3483
occurred	O	3483
in	O	3483
northern	O	3483
Mongoloids	O	3483
and	O	3483
subsequently	O	3483
spread	O	3483
to	O	3483
the	O	3483
Chinese	O	3483
and	O	3483
Japanese	O	3483
populations	O	3483
.	O	3483

Glucose	B-Disease	3484
/	I-Disease	3484
galactose	I-Disease	3484
malabsorption	I-Disease	3484
caused	O	3484
by	O	3484
a	O	3484
defect	O	3484
in	O	3484
the	O	3484
Na	O	3484
+	O	3484
/	O	3484
glucose	O	3484
cotransporter	O	3484
.	O	3484

Glucose	B-Disease	3485
/	I-Disease	3485
galactose	I-Disease	3485
malabsorption	I-Disease	3485
(	O	3485
GGM	B-Disease	3485
)	O	3485
is	O	3485
an	O	3485
autosomal	B-Disease	3485
recessive	I-Disease	3485
disease	I-Disease	3485
manifesting	O	3485
within	O	3485
the	O	3485
first	O	3485
weeks	O	3485
of	O	3485
life	O	3485
and	O	3485
characterized	O	3485
by	O	3485
a	O	3485
selective	O	3485
failure	O	3485
to	O	3485
absorb	O	3485
dietary	O	3485
glucose	O	3485
and	O	3485
galactose	O	3485
from	O	3485
the	O	3485
intestine	O	3485
.	O	3485

The	O	3486
consequent	O	3486
severe	O	3486
diarrhoea	B-Disease	3486
and	O	3486
dehydration	B-Disease	3486
are	O	3486
usually	O	3486
fatal	O	3486
unless	O	3486
these	O	3486
sugars	O	3486
are	O	3486
eliminated	O	3486
from	O	3486
the	O	3486
diet	O	3486
.	O	3486

Intestinal	O	3487
biopsies	O	3487
of	O	3487
GGM	B-Disease	3487
patients	O	3487
have	O	3487
revealed	O	3487
a	O	3487
specific	O	3487
defect	O	3487
in	O	3487
Na	O	3487
(	O	3487
+	O	3487
)	O	3487
-	O	3487
dependent	O	3487
absorption	O	3487
of	O	3487
glucose	O	3487
in	O	3487
the	O	3487
brush	O	3487
border	O	3487
.	O	3487

We	O	3491
have	O	3491
now	O	3491
amplified	O	3491
SGLT1	O	3491
complementary	O	3491
DNA	O	3491
and	O	3491
genomic	O	3491
DNA	O	3491
from	O	3491
members	O	3491
of	O	3491
a	O	3491
family	O	3491
affected	O	3491
with	O	3491
GGM	B-Disease	3491
by	O	3491
the	O	3491
polymerase	O	3491
chain	O	3491
reaction	O	3491
.	O	3491

Sequence	O	3492
analysis	O	3492
of	O	3492
the	O	3492
amplified	O	3492
products	O	3492
has	O	3492
revealed	O	3492
a	O	3492
single	O	3492
missense	O	3492
mutation	O	3492
in	O	3492
SGLT1	O	3492
which	O	3492
cosegregates	O	3492
with	O	3492
the	O	3492
GGM	B-Disease	3492
phenotype	O	3492
and	O	3492
results	O	3492
in	O	3492
a	O	3492
complete	O	3492
loss	O	3492
of	O	3492
Na	O	3492
(	O	3492
+	O	3492
)	O	3492
-	O	3492
dependent	O	3492
glucose	O	3492
transport	O	3492
in	O	3492
Xenopus	O	3492
oocytes	O	3492
injected	O	3492
with	O	3492
this	O	3492
complementary	O	3492
RNA	O	3492
.	O	3492

A	O	3494
de	O	3494
novo	O	3494
unbalanced	O	3494
reciprocal	O	3494
translocation	O	3494
identified	O	3494
as	O	3494
paternal	O	3494
in	O	3494
origin	O	3494
in	O	3494
the	O	3494
Prader	B-Disease	3494
-	I-Disease	3494
Willi	I-Disease	3494
syndrome	I-Disease	3494
.	O	3494

Interstitial	O	3495
cytogenetic	O	3495
deletions	O	3495
involving	O	3495
the	O	3495
paternally	O	3495
derived	O	3495
chromosome	O	3495
15q11	O	3495
-	O	3495
13	O	3495
have	O	3495
been	O	3495
described	O	3495
in	O	3495
patients	O	3495
with	O	3495
the	O	3495
Prader	B-Disease	3495
-	I-Disease	3495
Willi	I-Disease	3495
syndrome	I-Disease	3495
(	O	3495
PWS	B-Disease	3495
)	O	3495
.	O	3495

We	O	3496
report	O	3496
a	O	3496
child	O	3496
with	O	3496
PWS	B-Disease	3496
and	O	3496
a	O	3496
de	O	3496
novo	O	3496
unbalanced	O	3496
karyotype	O	3496
-	O	3496
45	O	3496
,	O	3496
XY	O	3496
,	O	3496
-	O	3496
9	O	3496
,	O	3496
-	O	3496
15	O	3496
,	O	3496
+	O	3496
der	O	3496
(	O	3496
9	O	3496
)	O	3496
t	O	3496
(	O	3496
9	O	3496
;	O	3496
15	O	3496
)	O	3496
(	O	3496
q34	O	3496
;	O	3496
q13	O	3496
)	O	3496
.	O	3496

Molecular	O	3497
studies	O	3497
with	O	3497
the	O	3497
DNA	O	3497
probe	O	3497
pML34	O	3497
confirmed	O	3497
that	O	3497
only	O	3497
a	O	3497
single	O	3497
Prader	B-Disease	3497
Willi	I-Disease	3497
critical	O	3497
region	O	3497
(	O	3497
PWCR	O	3497
15q11	O	3497
.	O	3497

Localisation	O	3501
of	O	3501
the	O	3501
myotonic	B-Disease	3501
dystrophy	I-Disease	3501
locus	O	3501
to	O	3501
19q13	O	3501
.	O	3501

We	O	3505
report	O	3505
here	O	3505
the	O	3505
linkage	O	3505
relationship	O	3505
of	O	3505
the	O	3505
myotonic	B-Disease	3505
dystrophy	I-Disease	3505
(	O	3505
DM	B-Disease	3505
)	O	3505
locus	O	3505
to	O	3505
twelve	O	3505
of	O	3505
these	O	3505
markers	O	3505
as	O	3505
studied	O	3505
in	O	3505
45	O	3505
families	O	3505
with	O	3505
DM	B-Disease	3505
.	O	3505

Ten	O	3507
of	O	3507
the	O	3507
twelve	O	3507
markers	O	3507
have	O	3507
been	O	3507
shown	O	3507
to	O	3507
be	O	3507
proximal	O	3507
to	O	3507
the	O	3507
DM	B-Disease	3507
gene	O	3507
and	O	3507
two	O	3507
,	O	3507
PRKCG	O	3507
and	O	3507
D19S22	O	3507
,	O	3507
distal	O	3507
but	O	3507
at	O	3507
distances	O	3507
of	O	3507
approximately	O	3507
25	O	3507
cM	O	3507
and	O	3507
15	O	3507
cM	O	3507
,	O	3507
respectively	O	3507
.	O	3507

The	O	3508
closest	O	3508
proximal	O	3508
markers	O	3508
are	O	3508
APOC2	O	3508
(	O	3508
apolipoprotein	O	3508
C	O	3508
-	O	3508
II	O	3508
)	O	3508
and	O	3508
CKM	O	3508
(	O	3508
creatine	O	3508
kinase	O	3508
,	O	3508
muscle	O	3508
)	O	3508
approximately	O	3508
3	O	3508
cM	O	3508
and	O	3508
2	O	3508
cM	O	3508
from	O	3508
the	O	3508
DM	B-Disease	3508
gene	O	3508
respectively	O	3508
,	O	3508
in	O	3508
the	O	3508
order	O	3508
APOC2	O	3508
-	O	3508
CKM	O	3508
-	O	3508
DM	O	3508
.	O	3508

The	O	3509
distance	O	3509
between	O	3509
APOC2	O	3509
,	O	3509
CKM	O	3509
and	O	3509
DM	B-Disease	3509
(	O	3509
of	O	3509
the	O	3509
order	O	3509
of	O	3509
2	O	3509
million	O	3509
base	O	3509
pairs	O	3509
)	O	3509
and	O	3509
their	O	3509
known	O	3509
orientation	O	3509
should	O	3509
permit	O	3509
directional	O	3509
chromosome	O	3509
walking	O	3509
and	O	3509
jumping	O	3509
.	O	3509

The	O	3510
data	O	3510
presented	O	3510
here	O	3510
should	O	3510
enable	O	3510
us	O	3510
to	O	3510
determine	O	3510
whether	O	3510
or	O	3510
not	O	3510
new	O	3510
markers	O	3510
are	O	3510
distal	O	3510
to	O	3510
APOC2	O	3510
/	O	3510
CKM	O	3510
and	O	3510
thus	O	3510
potentially	O	3510
flank	O	3510
the	O	3510
DM	B-Disease	3510
gene	O	3510
.	O	3510

The	O	3514
human	O	3514
gene	O	3514
for	O	3514
histidase	O	3514
(	O	3514
histidine	O	3514
ammonia	O	3514
-	O	3514
lyase	O	3514
;	O	3514
HAL	O	3514
)	O	3514
,	O	3514
the	O	3514
enzyme	O	3514
deficient	O	3514
in	O	3514
histidinemia	B-Disease	3514
,	O	3514
was	O	3514
assigned	O	3514
to	O	3514
human	O	3514
chromosome	O	3514
12	O	3514
by	O	3514
Southern	O	3514
blot	O	3514
analysis	O	3514
of	O	3514
human	O	3514
X	O	3514
mouse	O	3514
somatic	O	3514
cell	O	3514
hybrid	O	3514
DNA	O	3514
.	O	3514

Determination	O	3521
of	O	3521
the	O	3521
mutations	O	3521
responsible	O	3521
for	O	3521
the	O	3521
Lesch	B-Disease	3521
-	I-Disease	3521
Nyhan	I-Disease	3521
syndrome	I-Disease	3521
in	O	3521
17	O	3521
subjects	O	3521
.	O	3521

The	O	3525
direct	O	3525
sequencing	O	3525
of	O	3525
the	O	3525
polymerase	O	3525
chain	O	3525
reaction	O	3525
-	O	3525
amplified	O	3525
product	O	3525
of	O	3525
reverse	O	3525
-	O	3525
transcribed	O	3525
HPRT	O	3525
mRNA	O	3525
enabled	O	3525
the	O	3525
rapid	O	3525
identification	O	3525
of	O	3525
the	O	3525
mutations	O	3525
found	O	3525
in	O	3525
17	O	3525
previously	O	3525
uncharacterized	O	3525
cell	O	3525
lines	O	3525
derived	O	3525
from	O	3525
patients	O	3525
with	O	3525
the	O	3525
Lesch	B-Disease	3525
-	I-Disease	3525
Nyhan	I-Disease	3525
syndrome	I-Disease	3525
.	O	3525

Linkage	O	3527
of	O	3527
DNA	O	3527
markers	O	3527
at	O	3527
Xq28	O	3527
to	O	3527
adrenoleukodystrophy	B-Disease	3527
and	O	3527
adrenomyeloneuropathy	B-Disease	3527
present	O	3527
within	O	3527
the	O	3527
same	O	3527
family	O	3527
.	O	3527

We	O	3528
present	O	3528
a	O	3528
large	O	3528
kindred	O	3528
that	O	3528
contained	O	3528
patients	O	3528
with	O	3528
either	O	3528
adrenoleukodystrophy	B-Disease	3528
(	O	3528
ALD	B-Disease	3528
)	O	3528
or	O	3528
adrenomyeloneuropathy	B-Disease	3528
(	O	3528
AMN	B-Disease	3528
)	O	3528
.	O	3528

The	O	3529
pedigree	O	3529
clearly	O	3529
supported	O	3529
the	O	3529
X	O	3529
-	O	3529
linked	O	3529
mode	O	3529
of	O	3529
inheritance	O	3529
of	O	3529
the	O	3529
nonneonatal	O	3529
form	O	3529
of	O	3529
ALD	B-Disease	3529
/	O	3529
AMN	B-Disease	3529
.	O	3529

Analysis	O	3530
with	O	3530
DNA	O	3530
markers	O	3530
at	O	3530
Xq28	O	3530
suggested	O	3530
segregation	O	3530
of	O	3530
both	O	3530
ALD	B-Disease	3530
and	O	3530
AMN	B-Disease	3530
with	O	3530
an	O	3530
identical	O	3530
haplotype	O	3530
.	O	3530

This	O	3531
indicated	O	3531
that	O	3531
nonneonatal	O	3531
ALD	B-Disease	3531
and	O	3531
AMN	B-Disease	3531
are	O	3531
caused	O	3531
by	O	3531
a	O	3531
mutation	O	3531
in	O	3531
the	O	3531
same	O	3531
gene	O	3531
at	O	3531
Xq28	O	3531
.	O	3531

It	O	3532
showed	O	3532
,	O	3532
furthermore	O	3532
,	O	3532
that	O	3532
phenotypic	O	3532
differences	O	3532
between	O	3532
ALD	B-Disease	3532
and	O	3532
AMN	B-Disease	3532
are	O	3532
not	O	3532
necessarily	O	3532
the	O	3532
consequence	O	3532
of	O	3532
allelic	O	3532
heterogeneity	O	3532
due	O	3532
to	O	3532
different	O	3532
mutations	O	3532
within	O	3532
the	O	3532
same	O	3532
gene	O	3532
.	O	3532

The	O	3533
maximal	O	3533
lod	O	3533
score	O	3533
for	O	3533
linkage	O	3533
of	O	3533
the	O	3533
ALD	B-Disease	3533
/	O	3533
AMN	B-Disease	3533
gene	O	3533
and	O	3533
the	O	3533
multiallelic	O	3533
anonymous	O	3533
DNA	O	3533
marker	O	3533
at	O	3533
DXS52	O	3533
was	O	3533
3	O	3533
.	O	3533

Skewed	O	3537
X	O	3537
inactivation	O	3537
in	O	3537
a	O	3537
female	O	3537
MZ	O	3537
twin	O	3537
results	O	3537
in	O	3537
Duchenne	B-Disease	3537
muscular	I-Disease	3537
dystrophy	I-Disease	3537
.	O	3537

One	O	3538
of	O	3538
female	O	3538
MZ	O	3538
twins	O	3538
presented	O	3538
with	O	3538
muscular	B-Disease	3538
dystrophy	I-Disease	3538
.	O	3538

Physical	O	3539
examination	O	3539
,	O	3539
creatine	O	3539
phosphokinase	O	3539
levels	O	3539
,	O	3539
and	O	3539
muscle	O	3539
biopsy	O	3539
were	O	3539
consistent	O	3539
with	O	3539
Duchenne	B-Disease	3539
muscular	I-Disease	3539
dystrophy	I-Disease	3539
(	O	3539
DMD	B-Disease	3539
)	O	3539
.	O	3539

However	O	3540
,	O	3540
because	O	3540
of	O	3540
her	O	3540
sex	O	3540
she	O	3540
was	O	3540
diagnosed	O	3540
as	O	3540
having	O	3540
limb	B-Disease	3540
-	I-Disease	3540
girdle	I-Disease	3540
muscular	I-Disease	3540
dystrophy	I-Disease	3540
.	O	3540

With	O	3541
cDNA	O	3541
probes	O	3541
to	O	3541
the	O	3541
DMD	B-Disease	3541
gene	O	3541
,	O	3541
a	O	3541
gene	O	3541
deletion	O	3541
was	O	3541
detected	O	3541
in	O	3541
the	O	3541
twins	O	3541
and	O	3541
their	O	3541
mother	O	3541
.	O	3541

These	O	3546
data	O	3546
indicate	O	3546
that	O	3546
the	O	3546
affected	O	3546
twin	O	3546
is	O	3546
a	O	3546
manifesting	O	3546
carrier	O	3546
of	O	3546
an	O	3546
abnormal	O	3546
DMD	B-Disease	3546
gene	O	3546
,	O	3546
her	O	3546
myopathy	B-Disease	3546
being	O	3546
a	O	3546
direct	O	3546
result	O	3546
of	O	3546
underexpression	O	3546
of	O	3546
dystrophin	O	3546
.	O	3546

Cytogenetic	O	3547
analysis	O	3547
revealed	O	3547
normal	O	3547
karyotypes	O	3547
,	O	3547
eliminating	O	3547
the	O	3547
possibility	O	3547
of	O	3547
a	O	3547
translocation	O	3547
affecting	O	3547
DMD	B-Disease	3547
gene	O	3547
function	O	3547
.	O	3547

Both	O	3548
linkage	O	3548
analysis	O	3548
and	O	3548
DNA	O	3548
fingerprint	O	3548
analysis	O	3548
revealed	O	3548
that	O	3548
each	O	3548
twin	O	3548
has	O	3548
two	O	3548
different	O	3548
X	O	3548
chromosomes	O	3548
,	O	3548
eliminating	O	3548
the	O	3548
possibility	O	3548
of	O	3548
uniparental	B-Disease	3548
disomy	I-Disease	3548
as	O	3548
a	O	3548
mechanism	O	3548
for	O	3548
DMD	B-Disease	3548
expression	O	3548
.	O	3548

Adrenoleukodystrophy	B-Disease	3551
and	O	3551
adrenomyeloneuropathy	B-Disease	3551
associated	O	3551
with	O	3551
partial	O	3551
adrenal	B-Disease	3551
insufficiency	I-Disease	3551
in	O	3551
three	O	3551
generations	O	3551
of	O	3551
a	O	3551
kindred	O	3551
.	O	3551

Four	O	3552
cases	O	3552
of	O	3552
adrenoleukodystrophy	B-Disease	3552
(	O	3552
ALD	B-Disease	3552
)	O	3552
and	O	3552
one	O	3552
case	O	3552
of	O	3552
adrenomyeloneuropathy	B-Disease	3552
(	O	3552
AMN	B-Disease	3552
)	O	3552
have	O	3552
developed	O	3552
in	O	3552
a	O	3552
kindred	O	3552
over	O	3552
three	O	3552
generations	O	3552
demonstrating	O	3552
that	O	3552
AMN	B-Disease	3552
is	O	3552
a	O	3552
clinical	O	3552
variant	O	3552
of	O	3552
ALD	B-Disease	3552
.	O	3552

Pituitary	O	3553
-	O	3553
adrenal	O	3553
function	O	3553
studies	O	3553
were	O	3553
performed	O	3553
in	O	3553
10	O	3553
family	O	3553
members	O	3553
,	O	3553
including	O	3553
two	O	3553
affected	O	3553
males	O	3553
and	O	3553
four	O	3553
females	O	3553
identified	O	3553
as	O	3553
carriers	O	3553
of	O	3553
ALD	B-Disease	3553
/	O	3553
AMN	B-Disease	3553
.	O	3553

No	O	3554
pituitary	B-Disease	3554
-	I-Disease	3554
adrenal	I-Disease	3554
abnormality	I-Disease	3554
was	O	3554
found	O	3554
in	O	3554
the	O	3554
carriers	O	3554
.	O	3554

However	O	3555
,	O	3555
basal	O	3555
morning	O	3555
plasma	O	3555
adrenocorticotropic	O	3555
hormone	O	3555
(	O	3555
ACTH	O	3555
)	O	3555
levels	O	3555
were	O	3555
markedly	O	3555
elevated	O	3555
in	O	3555
the	O	3555
two	O	3555
males	O	3555
with	O	3555
ALD	B-Disease	3555
and	O	3555
AMN	B-Disease	3555
,	O	3555
despite	O	3555
the	O	3555
fact	O	3555
that	O	3555
they	O	3555
had	O	3555
no	O	3555
clinical	O	3555
signs	O	3555
of	O	3555
adrenal	B-Disease	3555
insufficiency	I-Disease	3555
and	O	3555
that	O	3555
morning	O	3555
plasma	O	3555
cortisol	O	3555
levels	O	3555
and	O	3555
their	O	3555
response	O	3555
to	O	3555
maximal	O	3555
exogenous	O	3555
ACTH	O	3555
stimulation	O	3555
appeared	O	3555
to	O	3555
be	O	3555
normal	O	3555
.	O	3555

Thus	O	3557
,	O	3557
people	O	3557
with	O	3557
ALD	B-Disease	3557
and	O	3557
AMN	B-Disease	3557
may	O	3557
have	O	3557
subclinical	O	3557
partial	O	3557
adrenocrotical	B-Disease	3557
insufficiency	I-Disease	3557
.	O	3557

No	O	3558
other	O	3558
endocrinologic	B-Disease	3558
dysfunction	I-Disease	3558
was	O	3558
identified	O	3558
.	O	3558

Regional	O	3560
localisation	O	3560
of	O	3560
the	O	3560
Friedreich	B-Disease	3560
ataxia	I-Disease	3560
locus	O	3560
to	O	3560
human	O	3560
chromosome	O	3560
9q13	O	3560
-	O	3560
-	O	3560
-	O	3560
-	O	3560
q21	O	3560
.	O	3560

We	O	3562
have	O	3562
previously	O	3562
assigned	O	3562
the	O	3562
Friedreich	B-Disease	3562
ataxia	I-Disease	3562
locus	O	3562
(	O	3562
FRDA	O	3562
)	O	3562
to	O	3562
chromosome	O	3562
9	O	3562
;	O	3562
the	O	3562
current	O	3562
maximal	O	3562
lod	O	3562
score	O	3562
between	O	3562
FRDA	O	3562
and	O	3562
MCT112	O	3562
(	O	3562
D9S15	O	3562
)	O	3562
is	O	3562
greater	O	3562
than	O	3562
50	O	3562
at	O	3562
a	O	3562
recombination	O	3562
fraction	O	3562
of	O	3562
theta	O	3562
=	O	3562
0	O	3562
.	O	3562

We	O	3571
recently	O	3571
described	O	3571
a	O	3571
Japanese	O	3571
family	O	3571
with	O	3571
increased	O	3571
HDL	O	3571
levels	O	3571
and	O	3571
CETP	B-Disease	3571
deficiency	I-Disease	3571
due	O	3571
to	O	3571
a	O	3571
splicing	O	3571
defect	O	3571
of	O	3571
the	O	3571
CETP	O	3571
gene	O	3571
.	O	3571

Family	O	3576
members	O	3576
homozygous	O	3576
for	O	3576
CETP	B-Disease	3576
deficiency	I-Disease	3576
(	O	3576
n	O	3576
=	O	3576
10	O	3576
)	O	3576
had	O	3576
moderate	O	3576
hypercholesterolemia	B-Disease	3576
(	O	3576
mean	O	3576
total	O	3576
cholesterol	O	3576
level	O	3576
[	O	3576
+	O	3576
/	O	3576
-	O	3576
SD	O	3576
]	O	3576
,	O	3576
7	O	3576
.	O	3576

CETP	B-Disease	3589
deficiency	I-Disease	3589
was	O	3589
not	O	3589
found	O	3589
in	O	3589
six	O	3589
unrelated	O	3589
subjects	O	3589
with	O	3589
elevated	O	3589
HDL	O	3589
cholesterol	O	3589
levels	O	3589
who	O	3589
were	O	3589
from	O	3589
different	O	3589
parts	O	3589
of	O	3589
the	O	3589
United	O	3589
States	O	3589
.	O	3589

CETP	B-Disease	3591
deficiency	I-Disease	3591
appears	O	3591
to	O	3591
be	O	3591
a	O	3591
frequent	O	3591
cause	O	3591
of	O	3591
increased	O	3591
HDL	O	3591
levels	O	3591
in	O	3591
the	O	3591
population	O	3591
of	O	3591
Japan	O	3591
,	O	3591
possibly	O	3591
because	O	3591
of	O	3591
a	O	3591
founder	O	3591
effect	O	3591
.	O	3591

There	O	3593
was	O	3593
no	O	3593
evidence	O	3593
of	O	3593
premature	B-Disease	3593
atherosclerosis	I-Disease	3593
in	O	3593
the	O	3593
families	O	3593
with	O	3593
CETP	B-Disease	3593
deficiency	I-Disease	3593
.	O	3593

In	O	3594
fact	O	3594
,	O	3594
the	O	3594
lipoprotein	O	3594
profile	O	3594
of	O	3594
persons	O	3594
with	O	3594
CETP	B-Disease	3594
deficiency	I-Disease	3594
is	O	3594
potentially	O	3594
antiatherogenic	O	3594
and	O	3594
may	O	3594
be	O	3594
associated	O	3594
with	O	3594
an	O	3594
increased	O	3594
life	O	3594
span	O	3594
.	O	3594

Further	O	3595
mapping	O	3595
of	O	3595
an	O	3595
ataxia	B-Disease	3595
-	I-Disease	3595
telangiectasia	I-Disease	3595
locus	O	3595
to	O	3595
the	O	3595
chromosome	O	3595
11q23	O	3595
region	O	3595
.	O	3595

We	O	3596
recently	O	3596
mapped	O	3596
the	O	3596
gene	O	3596
for	O	3596
ataxia	B-Disease	3596
-	I-Disease	3596
telangiectasia	I-Disease	3596
group	O	3596
A	O	3596
(	O	3596
ATA	O	3596
)	O	3596
to	O	3596
chromosome	O	3596
11q22	O	3596
-	O	3596
23	O	3596
by	O	3596
linkage	O	3596
analysis	O	3596
,	O	3596
using	O	3596
the	O	3596
genetic	O	3596
markers	O	3596
THY1	O	3596
and	O	3596
pYNB3	O	3596
.	O	3596

The	O	3599
present	O	3599
paper	O	3599
describes	O	3599
further	O	3599
mapping	O	3599
of	O	3599
the	O	3599
AT	B-Disease	3599
locus	O	3599
by	O	3599
means	O	3599
of	O	3599
a	O	3599
panel	O	3599
of	O	3599
10	O	3599
markers	O	3599
that	O	3599
span	O	3599
approximately	O	3599
60	O	3599
cM	O	3599
in	O	3599
the	O	3599
11q22	O	3599
-	O	3599
23	O	3599
region	O	3599
centered	O	3599
around	O	3599
S144	O	3599
and	O	3599
THY1	O	3599
.	O	3599

Location	O	3600
scores	O	3600
indicate	O	3600
that	O	3600
three	O	3600
contiguous	O	3600
subsegments	O	3600
within	O	3600
the	O	3600
[	O	3600
S144	O	3600
-	O	3600
THY1	O	3600
]	O	3600
segment	O	3600
,	O	3600
as	O	3600
well	O	3600
as	O	3600
three	O	3600
contiguous	O	3600
segments	O	3600
telomeric	O	3600
to	O	3600
THY1	O	3600
,	O	3600
are	O	3600
each	O	3600
unlikely	O	3600
to	O	3600
contain	O	3600
the	O	3600
AT	B-Disease	3600
locus	O	3600
,	O	3600
while	O	3600
the	O	3600
more	O	3600
centromeric	O	3600
[	O	3600
STMY	O	3600
-	O	3600
S144	O	3600
]	O	3600
segment	O	3600
is	O	3600
most	O	3600
likely	O	3600
to	O	3600
contain	O	3600
the	O	3600
AT	B-Disease	3600
locus	O	3600
.	O	3600

These	O	3601
data	O	3601
,	O	3601
together	O	3601
with	O	3601
recent	O	3601
refinements	O	3601
in	O	3601
the	O	3601
linkage	O	3601
and	O	3601
physical	O	3601
maps	O	3601
of	O	3601
11q22	O	3601
-	O	3601
23	O	3601
,	O	3601
place	O	3601
the	O	3601
AT	B-Disease	3601
locus	O	3601
at	O	3601
11q23	O	3601
.	O	3601

Recurrent	O	3602
meningitis	B-Disease	3602
in	O	3602
a	O	3602
patient	O	3602
with	O	3602
congenital	B-Disease	3602
deficiency	I-Disease	3602
of	I-Disease	3602
the	I-Disease	3602
C9	I-Disease	3602
component	I-Disease	3602
of	I-Disease	3602
complement	I-Disease	3602
.	O	3602

First	O	3603
case	O	3603
of	O	3603
C9	B-Disease	3603
deficiency	I-Disease	3603
in	O	3603
Europe	O	3603
.	O	3603

We	O	3604
describe	O	3604
the	O	3604
first	O	3604
cases	O	3604
,	O	3604
to	O	3604
our	O	3604
knowledge	O	3604
,	O	3604
of	O	3604
C9	B-Disease	3604
deficiency	I-Disease	3604
in	O	3604
Europe	O	3604
that	O	3604
were	O	3604
detected	O	3604
in	O	3604
a	O	3604
Swiss	O	3604
family	O	3604
,	O	3604
of	O	3604
which	O	3604
two	O	3604
members	O	3604
-	O	3604
-	O	3604
one	O	3604
with	O	3604
a	O	3604
complete	O	3604
deficiency	O	3604
and	O	3604
the	O	3604
other	O	3604
with	O	3604
approximately	O	3604
half	O	3604
-	O	3604
normal	O	3604
C9	O	3604
levels	O	3604
-	O	3604
-	O	3604
experienced	O	3604
bacterial	B-Disease	3604
meningitis	I-Disease	3604
.	O	3604

The	O	3605
index	O	3605
patient	O	3605
,	O	3605
a	O	3605
56	O	3605
-	O	3605
year	O	3605
-	O	3605
old	O	3605
white	O	3605
man	O	3605
with	O	3605
a	O	3605
history	O	3605
of	O	3605
purulent	B-Disease	3605
meningitis	I-Disease	3605
at	O	3605
the	O	3605
age	O	3605
of	O	3605
23	O	3605
years	O	3605
,	O	3605
presented	O	3605
with	O	3605
an	O	3605
acute	B-Disease	3605
meningococcal	I-Disease	3605
meningitis	I-Disease	3605
.	O	3605

No	O	3606
impairment	B-Disease	3606
of	I-Disease	3606
cellular	I-Disease	3606
immunity	I-Disease	3606
or	O	3606
immunoglobulin	B-Disease	3606
deficiency	I-Disease	3606
could	O	3606
be	O	3606
found	O	3606
.	O	3606

Complement	O	3607
assays	O	3607
showed	O	3607
a	O	3607
complete	B-Disease	3607
deficiency	I-Disease	3607
of	I-Disease	3607
the	I-Disease	3607
C9	I-Disease	3607
component	I-Disease	3607
,	O	3607
while	O	3607
the	O	3607
other	O	3607
individual	O	3607
component	O	3607
levels	O	3607
were	O	3607
normal	O	3607
and	O	3607
the	O	3607
hemolytic	O	3607
activity	O	3607
(	O	3607
measured	O	3607
using	O	3607
the	O	3607
CH50	O	3607
assay	O	3607
)	O	3607
was	O	3607
only	O	3607
slightly	O	3607
reduced	O	3607
.	O	3607

A	O	3608
family	O	3608
study	O	3608
revealed	O	3608
complete	B-Disease	3608
C9	I-Disease	3608
deficiency	I-Disease	3608
in	O	3608
the	O	3608
patients	O	3608
healthy	O	3608
brother	O	3608
and	O	3608
half	O	3608
-	O	3608
normal	O	3608
C9	O	3608
concentrations	O	3608
in	O	3608
his	O	3608
sister	O	3608
,	O	3608
his	O	3608
son	O	3608
(	O	3608
who	O	3608
also	O	3608
had	O	3608
experienced	O	3608
an	O	3608
episode	O	3608
of	O	3608
bacterial	B-Disease	3608
meningitis	I-Disease	3608
)	O	3608
,	O	3608
and	O	3608
his	O	3608
niece	O	3608
,	O	3608
consistent	O	3608
with	O	3608
an	O	3608
inherited	O	3608
C9	B-Disease	3608
deficiency	I-Disease	3608
.	O	3608

This	O	3609
first	O	3609
case	O	3609
of	O	3609
recurrent	B-Disease	3609
meningitis	I-Disease	3609
in	O	3609
a	O	3609
white	O	3609
patient	O	3609
with	O	3609
complete	B-Disease	3609
C9	I-Disease	3609
deficiency	I-Disease	3609
suggests	O	3609
that	O	3609
this	O	3609
complement	B-Disease	3609
defect	I-Disease	3609
may	O	3609
also	O	3609
be	O	3609
a	O	3609
risk	O	3609
factor	O	3609
for	O	3609
bacterial	B-Disease	3609
,	I-Disease	3609
especially	I-Disease	3609
neisserial	I-Disease	3609
,	I-Disease	3609
infections	I-Disease	3609
.	O	3609

Detection	O	3611
of	O	3611
98	O	3611
%	O	3611
of	O	3611
DMD	B-Disease	3611
/	O	3611
BMD	B-Disease	3611
gene	O	3611
deletions	O	3611
by	O	3611
polymerase	O	3611
chain	O	3611
reaction	O	3611
.	O	3611

When	O	3613
used	O	3613
in	O	3613
conjunction	O	3613
with	O	3613
an	O	3613
existing	O	3613
primer	O	3613
set	O	3613
,	O	3613
these	O	3613
two	O	3613
multiplex	O	3613
reactions	O	3613
detect	O	3613
about	O	3613
98	O	3613
%	O	3613
of	O	3613
deletions	O	3613
in	O	3613
patients	O	3613
with	O	3613
Duchenne	B-Disease	3613
or	I-Disease	3613
Becker	I-Disease	3613
muscular	I-Disease	3613
dystrophy	I-Disease	3613
(	O	3613
DMD	B-Disease	3613
,	O	3613
BMD	B-Disease	3613
)	O	3613
.	O	3613

Thus	O	3617
,	O	3617
use	O	3617
of	O	3617
these	O	3617
PCR	O	3617
-	O	3617
based	O	3617
assays	O	3617
will	O	3617
allow	O	3617
deletion	O	3617
detection	O	3617
and	O	3617
prenatal	O	3617
diagnosis	O	3617
for	O	3617
most	O	3617
DMD	B-Disease	3617
/	O	3617
BMD	B-Disease	3617
patients	O	3617
in	O	3617
a	O	3617
fraction	O	3617
of	O	3617
the	O	3617
time	O	3617
required	O	3617
for	O	3617
Southern	O	3617
blot	O	3617
analysis	O	3617
.	O	3617

Of	O	3622
these	O	3622
,	O	3622
31	O	3622
had	O	3622
severe	O	3622
G6PD	B-Disease	3622
deficiency	I-Disease	3622
,	O	3622
nine	O	3622
had	O	3622
mild	O	3622
to	O	3622
moderate	O	3622
deficiency	O	3622
,	O	3622
and	O	3622
three	O	3622
had	O	3622
a	O	3622
non	O	3622
-	O	3622
deficient	O	3622
electrophoretic	O	3622
variant	O	3622
.	O	3622

The	O	3623
overall	O	3623
rate	O	3623
of	O	3623
G6PD	B-Disease	3623
deficiency	I-Disease	3623
was	O	3623
2	O	3623
.	O	3623

The	O	3625
frequency	O	3625
of	O	3625
G6PD	B-Disease	3625
deficiency	I-Disease	3625
,	O	3625
ranging	O	3625
from	O	3625
7	O	3625
.	O	3625

Biochemical	O	3627
characterization	O	3627
has	O	3627
shown	O	3627
that	O	3627
most	O	3627
of	O	3627
the	O	3627
G6PD	B-Disease	3627
deficiency	I-Disease	3627
in	O	3627
this	O	3627
population	O	3627
is	O	3627
accounted	O	3627
for	O	3627
by	O	3627
G6PD	O	3627
Mediterranean	O	3627
.	O	3627

These	O	3629
data	O	3629
provide	O	3629
further	O	3629
evidence	O	3629
for	O	3629
the	O	3629
marked	O	3629
genetic	O	3629
heterogeneity	O	3629
of	O	3629
G6PD	B-Disease	3629
deficiency	I-Disease	3629
within	O	3629
a	O	3629
relatively	O	3629
narrow	O	3629
geographic	O	3629
area	O	3629
and	O	3629
they	O	3629
prove	O	3629
the	O	3629
presence	O	3629
in	O	3629
the	O	3629
Italian	O	3629
peninsula	O	3629
of	O	3629
a	O	3629
gene	O	3629
(	O	3629
GdA	O	3629
-	O	3629
)	O	3629
regarded	O	3629
as	O	3629
characteristically	O	3629
African	O	3629
.	O	3629

Deficiency	B-Disease	3630
of	I-Disease	3630
the	I-Disease	3630
murine	I-Disease	3630
fifth	I-Disease	3630
complement	I-Disease	3630
component	I-Disease	3630
(	I-Disease	3630
C5	I-Disease	3630
)	I-Disease	3630
.	O	3630

To	O	3632
ascertain	O	3632
the	O	3632
molecular	O	3632
mechanism	O	3632
that	O	3632
causes	O	3632
murine	O	3632
C5	B-Disease	3632
deficiency	I-Disease	3632
,	O	3632
genomic	O	3632
and	O	3632
cDNA	O	3632
libraries	O	3632
were	O	3632
constructed	O	3632
from	O	3632
mouse	O	3632
liver	O	3632
DNA	O	3632
and	O	3632
mRNA	O	3632
employing	O	3632
the	O	3632
congenic	O	3632
strains	O	3632
B10	O	3632
.	O	3632

D2	O	3634
/	O	3634
oSnJ	O	3634
that	O	3634
are	O	3634
sufficient	O	3634
and	O	3634
deficient	B-Disease	3634
for	I-Disease	3634
C5	I-Disease	3634
,	O	3634
respectively	O	3634
.	O	3634

Genomic	O	3635
fragments	O	3635
were	O	3635
isolated	O	3635
which	O	3635
correspond	O	3635
to	O	3635
PvuII	O	3635
and	O	3635
HindIII	O	3635
restriction	O	3635
fragment	O	3635
length	O	3635
polymorphisms	O	3635
associated	O	3635
with	O	3635
C5	B-Disease	3635
deficiency	I-Disease	3635
.	O	3635

Sequence	O	3636
analyses	O	3636
demonstrated	O	3636
that	O	3636
each	O	3636
of	O	3636
these	O	3636
polymorphisms	O	3636
resulted	O	3636
from	O	3636
single	O	3636
base	O	3636
pair	O	3636
substitutions	O	3636
and	O	3636
that	O	3636
neither	O	3636
substitution	O	3636
would	O	3636
probably	O	3636
cause	O	3636
or	O	3636
contribute	O	3636
to	O	3636
the	O	3636
C5	B-Disease	3636
deficiency	I-Disease	3636
.	O	3636

Six	O	3643
C5	B-Disease	3643
-	I-Disease	3643
deficient	I-Disease	3643
strains	O	3643
,	O	3643
A	O	3643
/	O	3643
HeJ	O	3643
,	O	3643
AKR	O	3643
/	O	3643
J	O	3643
,	O	3643
DBA	O	3643
/	O	3643
2J	O	3643
,	O	3643
NZB	O	3643
/	O	3643
B1NJ	O	3643
,	O	3643
SWR	O	3643
/	O	3643
J	O	3643
,	O	3643
and	O	3643
B10	O	3643
.	O	3643

These	O	3647
data	O	3647
demonstrate	O	3647
that	O	3647
1	O	3647
)	O	3647
there	O	3647
is	O	3647
an	O	3647
identical	O	3647
2	O	3647
-	O	3647
base	O	3647
pair	O	3647
deletion	O	3647
in	O	3647
an	O	3647
exon	O	3647
of	O	3647
the	O	3647
C5	O	3647
gene	O	3647
in	O	3647
several	O	3647
different	O	3647
C5	B-Disease	3647
-	I-Disease	3647
deficient	I-Disease	3647
mouse	O	3647
strains	O	3647
;	O	3647
2	O	3647
)	O	3647
the	O	3647
mRNA	O	3647
transcribed	O	3647
from	O	3647
the	O	3647
C5D	O	3647
gene	O	3647
retains	O	3647
this	O	3647
deletion	O	3647
;	O	3647
and	O	3647
3	O	3647
)	O	3647
this	O	3647
mutation	O	3647
should	O	3647
result	O	3647
in	O	3647
C5	B-Disease	3647
protein	I-Disease	3647
deficiency	I-Disease	3647
.	O	3647

Molecular	O	3648
genetics	O	3648
of	O	3648
PKU	B-Disease	3648
in	O	3648
eastern	O	3648
Europe	O	3648
:	O	3648
a	O	3648
nonsense	O	3648
mutation	O	3648
associated	O	3648
with	O	3648
haplotype	O	3648
4	O	3648
of	O	3648
the	O	3648
phenylalanine	O	3648
hydroxylase	O	3648
gene	O	3648
.	O	3648

Phenylketonuria	B-Disease	3649
(	O	3649
PKU	B-Disease	3649
)	O	3649
is	O	3649
a	O	3649
genetic	B-Disease	3649
disorder	I-Disease	3649
secondary	O	3649
to	O	3649
a	O	3649
deficiency	B-Disease	3649
of	I-Disease	3649
hepatic	I-Disease	3649
phenylalanine	I-Disease	3649
hydroxylase	I-Disease	3649
(	O	3649
PAH	O	3649
)	O	3649
.	O	3649

A	O	3651
new	O	3651
molecular	B-Disease	3651
lesion	I-Disease	3651
has	O	3651
been	O	3651
identified	O	3651
in	O	3651
exon	O	3651
7	O	3651
of	O	3651
the	O	3651
PAH	O	3651
gene	O	3651
in	O	3651
a	O	3651
Hungarian	O	3651
PKU	B-Disease	3651
patient	O	3651
by	O	3651
direct	O	3651
sequencing	O	3651
of	O	3651
PCR	O	3651
-	O	3651
amplified	O	3651
DNA	O	3651
.	O	3651

The	O	3656
red	O	3656
-	O	3656
green	O	3656
visual	O	3656
pigment	O	3656
gene	O	3656
region	O	3656
in	O	3656
adrenoleukodystrophy	B-Disease	3656
.	O	3656

Although	O	3657
recent	O	3657
data	O	3657
established	O	3657
that	O	3657
a	O	3657
specific	O	3657
very	O	3657
-	O	3657
long	O	3657
-	O	3657
chain	O	3657
fatty	O	3657
acyl	O	3657
-	O	3657
CoA	O	3657
synthetase	O	3657
is	O	3657
defective	O	3657
in	O	3657
X	B-Disease	3657
-	I-Disease	3657
linked	I-Disease	3657
adrenoleukodystrophy	I-Disease	3657
(	O	3657
ALD	B-Disease	3657
)	O	3657
,	O	3657
the	O	3657
ALD	B-Disease	3657
gene	O	3657
is	O	3657
still	O	3657
unidentified	O	3657
.	O	3657

The	O	3658
ALD	B-Disease	3658
locus	O	3658
has	O	3658
been	O	3658
mapped	O	3658
to	O	3658
Xq28	O	3658
,	O	3658
like	O	3658
the	O	3658
red	O	3658
and	O	3658
green	O	3658
color	O	3658
pigment	O	3658
genes	O	3658
.	O	3658

Abnormal	B-Disease	3659
color	I-Disease	3659
vision	I-Disease	3659
has	O	3659
been	O	3659
observed	O	3659
in	O	3659
12	O	3659
of	O	3659
27	O	3659
patients	O	3659
with	O	3659
adrenomyeloneuropathy	B-Disease	3659
(	O	3659
AMN	B-Disease	3659
)	O	3659
,	O	3659
a	O	3659
milder	O	3659
form	O	3659
of	O	3659
ALD	B-Disease	3659
.	O	3659

Furthermore	O	3660
,	O	3660
rearrangements	O	3660
of	O	3660
the	O	3660
color	O	3660
vision	O	3660
gene	O	3660
cluster	O	3660
were	O	3660
found	O	3660
in	O	3660
four	O	3660
of	O	3660
eight	O	3660
ALD	B-Disease	3660
kindreds	O	3660
.	O	3660

This	O	3661
led	O	3661
us	O	3661
to	O	3661
propose	O	3661
that	O	3661
a	O	3661
single	O	3661
DNA	O	3661
rearrangement	O	3661
could	O	3661
underlie	O	3661
both	O	3661
ALD	B-Disease	3661
and	O	3661
abnormal	B-Disease	3661
color	I-Disease	3661
vision	I-Disease	3661
in	O	3661
these	O	3661
patients	O	3661
.	O	3661

Study	O	3662
of	O	3662
34	O	3662
French	O	3662
ALD	B-Disease	3662
patients	O	3662
failed	O	3662
to	O	3662
reveal	O	3662
a	O	3662
higher	O	3662
than	O	3662
expected	O	3662
frequency	O	3662
of	O	3662
green	O	3662
/	O	3662
red	O	3662
visual	O	3662
pigment	O	3662
rearrangements	O	3662
3	O	3662
to	O	3662
the	O	3662
red	O	3662
/	O	3662
green	O	3662
color	O	3662
vision	O	3662
gene	O	3662
complex	O	3662
.	O	3662

color	O	3665
vision	O	3665
arrays	O	3665
on	O	3665
molecular	O	3665
analysis	O	3665
was	O	3665
twice	O	3665
as	O	3665
high	O	3665
as	O	3665
expected	O	3665
on	O	3665
the	O	3665
basis	O	3665
of	O	3665
the	O	3665
frequency	O	3665
of	O	3665
phenotypic	B-Disease	3665
color	I-Disease	3665
vision	I-Disease	3665
defects	I-Disease	3665
.	O	3665

The	O	3667
R	O	3667
/	O	3667
GCP	O	3667
region	O	3667
was	O	3667
also	O	3667
analyzed	O	3667
in	O	3667
29	O	3667
French	O	3667
and	O	3667
seven	O	3667
North	O	3667
American	O	3667
ALD	B-Disease	3667
patients	O	3667
by	O	3667
using	O	3667
six	O	3667
genomic	O	3667
DNA	O	3667
probes	O	3667
,	O	3667
isolated	O	3667
from	O	3667
a	O	3667
cosmid	O	3667
walk	O	3667
,	O	3667
that	O	3667
flank	O	3667
the	O	3667
color	O	3667
vision	O	3667
genes	O	3667
.	O	3667

One	O	3669
of	O	3669
the	O	3669
eight	O	3669
previously	O	3669
reported	O	3669
ALD	B-Disease	3669
individuals	O	3669
has	O	3669
a	O	3669
long	O	3669
deletion	O	3669
5	O	3669
of	O	3669
the	O	3669
red	O	3669
pigment	O	3669
gene	O	3669
,	O	3669
a	O	3669
deletion	O	3669
causing	O	3669
blue	O	3669
cone	O	3669
monochromacy	O	3669
.	O	3669

This	O	3670
finding	O	3670
and	O	3670
the	O	3670
previous	O	3670
findings	O	3670
of	O	3670
a	O	3670
45	O	3670
%	O	3670
frequency	O	3670
of	O	3670
phenotypic	O	3670
color	O	3670
vision	O	3670
defects	O	3670
in	O	3670
patients	O	3670
with	O	3670
AMN	B-Disease	3670
may	O	3670
suggest	O	3670
that	O	3670
the	O	3670
ALD	B-Disease	3670
/	O	3670
AMN	B-Disease	3670
gene	O	3670
lies	O	3670
5	O	3670
to	O	3670
the	O	3670
red	O	3670
pigment	O	3670
gene	O	3670
and	O	3670
that	O	3670
the	O	3670
frequent	O	3670
phenotypic	O	3670
color	B-Disease	3670
vision	I-Disease	3670
anomalies	I-Disease	3670
owe	O	3670
their	O	3670
origin	O	3670
to	O	3670
deleted	O	3670
DNA	O	3670
that	O	3670
includes	O	3670
regulatory	O	3670
genes	O	3670
for	O	3670
color	O	3670
vision	O	3670
.	O	3670

It	O	3671
is	O	3671
possible	O	3671
,	O	3671
however	O	3671
,	O	3671
that	O	3671
phenotypic	O	3671
color	B-Disease	3671
vision	I-Disease	3671
anomalies	I-Disease	3671
in	O	3671
AMN	B-Disease	3671
may	O	3671
be	O	3671
phenocopies	O	3671
secondary	O	3671
to	O	3671
retinal	O	3671
or	O	3671
neural	O	3671
involvement	O	3671
by	O	3671
the	O	3671
disease	O	3671
.	O	3671

Paroxysmal	B-Disease	3674
nocturnal	I-Disease	3674
haemoglobinuria	I-Disease	3674
with	O	3674
coexisting	O	3674
deficiency	B-Disease	3674
of	I-Disease	3674
the	I-Disease	3674
ninth	I-Disease	3674
component	I-Disease	3674
of	I-Disease	3674
complement	I-Disease	3674
:	O	3674
lack	O	3674
of	O	3674
massive	O	3674
haemolytic	B-Disease	3674
attack	I-Disease	3674
.	O	3674

A	O	3675
47	O	3675
-	O	3675
year	O	3675
-	O	3675
old	O	3675
woman	O	3675
with	O	3675
paroxysmal	B-Disease	3675
nocturnal	I-Disease	3675
haemoglobinuria	I-Disease	3675
(	O	3675
PNH	B-Disease	3675
)	O	3675
was	O	3675
found	O	3675
to	O	3675
have	O	3675
an	O	3675
inherited	B-Disease	3675
deficiency	I-Disease	3675
in	I-Disease	3675
the	I-Disease	3675
ninth	I-Disease	3675
complement	I-Disease	3675
component	I-Disease	3675
(	O	3675
C9	O	3675
)	O	3675
.	O	3675

Surprisingly	O	3678
,	O	3678
she	O	3678
has	O	3678
suffered	O	3678
only	O	3678
mild	O	3678
haemolysis	B-Disease	3678
and	O	3678
has	O	3678
never	O	3678
experienced	O	3678
massive	O	3678
spontaneous	O	3678
haemolysis	B-Disease	3678
.	O	3678

Gross	O	3679
haemoglobinuria	B-Disease	3679
and	O	3679
jaundice	B-Disease	3679
occurred	O	3679
only	O	3679
after	O	3679
receiving	O	3679
postoperative	O	3679
transfusion	O	3679
of	O	3679
whole	O	3679
blood	O	3679
.	O	3679

These	O	3684
observations	O	3684
indicated	O	3684
that	O	3684
C9	O	3684
may	O	3684
play	O	3684
a	O	3684
critical	O	3684
role	O	3684
in	O	3684
haemolytic	B-Disease	3684
attacks	I-Disease	3684
in	O	3684
patients	O	3684
with	O	3684
PNH	B-Disease	3684
and	O	3684
that	O	3684
characteristic	O	3684
haemolysis	B-Disease	3684
in	O	3684
PNH	B-Disease	3684
may	O	3684
be	O	3684
tempered	O	3684
by	O	3684
coexisting	O	3684
C9	B-Disease	3684
deficiency	I-Disease	3684
.	O	3684

Duplicational	O	3686
mutation	O	3686
at	O	3686
the	O	3686
Duchenne	B-Disease	3686
muscular	I-Disease	3686
dystrophy	I-Disease	3686
locus	O	3686
:	O	3686
its	O	3686
frequency	O	3686
,	O	3686
distribution	O	3686
,	O	3686
origin	O	3686
,	O	3686
and	O	3686
phenotypegenotype	O	3686
correlation	O	3686
.	O	3686

Partial	O	3687
gene	O	3687
deletion	O	3687
is	O	3687
the	O	3687
major	O	3687
cause	O	3687
of	O	3687
mutation	O	3687
leading	O	3687
to	O	3687
Duchenne	B-Disease	3687
muscular	I-Disease	3687
dystrophy	I-Disease	3687
(	O	3687
DMD	B-Disease	3687
)	O	3687
and	O	3687
Becker	B-Disease	3687
muscular	I-Disease	3687
dystrophy	I-Disease	3687
(	O	3687
BMD	B-Disease	3687
)	O	3687
.	O	3687

We	O	3689
have	O	3689
conducted	O	3689
a	O	3689
survey	O	3689
for	O	3689
duplication	O	3689
in	O	3689
72	O	3689
unrelated	O	3689
nondeletion	O	3689
patients	O	3689
,	O	3689
analyzed	O	3689
by	O	3689
Southern	O	3689
blot	O	3689
hybridization	O	3689
with	O	3689
clones	O	3689
representing	O	3689
the	O	3689
entire	O	3689
DMD	B-Disease	3689
cDNA	O	3689
.	O	3689

A	O	3693
shift	O	3693
of	O	3693
the	O	3693
reading	O	3693
frame	O	3693
was	O	3693
predicted	O	3693
in	O	3693
four	O	3693
of	O	3693
the	O	3693
six	O	3693
DMD	B-Disease	3693
cases	O	3693
and	O	3693
in	O	3693
one	O	3693
of	O	3693
the	O	3693
two	O	3693
intermediate	O	3693
cases	O	3693
,	O	3693
while	O	3693
the	O	3693
reading	O	3693
frame	O	3693
remained	O	3693
uninterrupted	O	3693
in	O	3693
both	O	3693
BMD	B-Disease	3693
cases	O	3693
.	O	3693

Glucose	O	3698
6	O	3698
-	O	3698
phosphate	O	3698
dehydrogenase	O	3698
variants	O	3698
:	O	3698
Gd	O	3698
(	O	3698
+	O	3698
)	O	3698
Alexandra	O	3698
associated	O	3698
with	O	3698
neonatal	B-Disease	3698
jaundice	I-Disease	3698
and	O	3698
Gd	O	3698
(	O	3698
-	O	3698
)	O	3698
Camperdown	O	3698
in	O	3698
a	O	3698
young	O	3698
man	O	3698
with	O	3698
lamellar	B-Disease	3698
cataracts	I-Disease	3698
.	O	3698

The	O	3700
first	O	3700
,	O	3700
of	O	3700
Italian	O	3700
extraction	O	3700
,	O	3700
suffered	O	3700
from	O	3700
severe	O	3700
neonatal	B-Disease	3700
jaundice	I-Disease	3700
following	O	3700
maternal	O	3700
ingestion	O	3700
of	O	3700
fresh	O	3700
broad	O	3700
beans	O	3700
(	O	3700
Vicia	O	3700
fava	O	3700
)	O	3700
both	O	3700
prenatally	O	3700
and	O	3700
postnatally	O	3700
the	O	3700
expression	O	3700
of	O	3700
the	O	3700
enzymatic	O	3700
defect	O	3700
was	O	3700
much	O	3700
more	O	3700
severe	O	3700
in	O	3700
the	O	3700
neonatal	O	3700
period	O	3700
than	O	3700
on	O	3700
retesting	O	3700
in	O	3700
adolescence	O	3700
,	O	3700
when	O	3700
biochemical	O	3700
characterization	O	3700
showed	O	3700
unique	O	3700
features	O	3700
which	O	3700
justify	O	3700
designation	O	3700
as	O	3700
a	O	3700
new	O	3700
variant	O	3700
Gd	O	3700
(	O	3700
+	O	3700
)	O	3700
Alexandra	O	3700
.	O	3700

The	O	3701
second	O	3701
patient	O	3701
,	O	3701
a	O	3701
boy	O	3701
of	O	3701
Maltese	O	3701
extraction	O	3701
who	O	3701
was	O	3701
found	O	3701
to	O	3701
have	O	3701
bilateral	B-Disease	3701
lamellar	I-Disease	3701
cataracts	I-Disease	3701
at	O	3701
the	O	3701
age	O	3701
of	O	3701
4	O	3701
years	O	3701
,	O	3701
was	O	3701
identified	O	3701
as	O	3701
G6PD	B-Disease	3701
deficient	I-Disease	3701
only	O	3701
as	O	3701
a	O	3701
result	O	3701
of	O	3701
a	O	3701
survey	O	3701
of	O	3701
children	O	3701
of	O	3701
Mediterranean	O	3701
origin	O	3701
with	O	3701
unexplained	O	3701
cataract	B-Disease	3701
formation	O	3701
;	O	3701
he	O	3701
has	O	3701
approximately	O	3701
15	O	3701
%	O	3701
of	O	3701
normal	O	3701
enzyme	O	3701
activity	O	3701
,	O	3701
with	O	3701
another	O	3701
unique	O	3701
combination	O	3701
of	O	3701
biochemical	O	3701
characteristics	O	3701
which	O	3701
has	O	3701
led	O	3701
to	O	3701
its	O	3701
designation	O	3701
as	O	3701
Gd	O	3701
(	O	3701
-	O	3701
)	O	3701
Camperdown	O	3701
.	O	3701

Although	O	3702
this	O	3702
association	O	3702
may	O	3702
be	O	3702
coincidental	O	3702
,	O	3702
it	O	3702
prompts	O	3702
further	O	3702
attention	O	3702
to	O	3702
the	O	3702
possibility	O	3702
that	O	3702
under	O	3702
certain	O	3702
circumstances	O	3702
G6PD	B-Disease	3702
deficiency	I-Disease	3702
may	O	3702
favor	O	3702
cataract	B-Disease	3702
formation	O	3702
.	O	3702

Statistical	O	3705
analysis	O	3705
of	O	3705
the	O	3705
two	O	3705
stage	O	3705
mutation	O	3705
model	O	3705
in	O	3705
von	B-Disease	3705
Hippel	I-Disease	3705
-	I-Disease	3705
Lindau	I-Disease	3705
disease	I-Disease	3705
,	O	3705
and	O	3705
in	O	3705
sporadic	B-Disease	3705
cerebellar	I-Disease	3705
haemangioblastoma	I-Disease	3705
and	O	3705
renal	B-Disease	3705
cell	I-Disease	3705
carcinoma	I-Disease	3705
.	O	3705

Analysis	O	3706
of	O	3706
the	O	3706
age	O	3706
incidence	O	3706
curves	O	3706
for	O	3706
unilateral	B-Disease	3706
and	I-Disease	3706
bilateral	I-Disease	3706
retinoblastoma	I-Disease	3706
led	O	3706
Knudson	O	3706
to	O	3706
propose	O	3706
that	O	3706
hereditary	B-Disease	3706
tumours	I-Disease	3706
may	O	3706
arise	O	3706
by	O	3706
a	O	3706
single	O	3706
event	O	3706
and	O	3706
sporadic	B-Disease	3706
tumours	I-Disease	3706
by	O	3706
a	O	3706
two	O	3706
stage	O	3706
mutation	O	3706
process	O	3706
.	O	3706

It	O	3707
has	O	3707
been	O	3707
suggested	O	3707
recently	O	3707
that	O	3707
sporadic	B-Disease	3707
renal	I-Disease	3707
cell	I-Disease	3707
carcinoma	I-Disease	3707
may	O	3707
arise	O	3707
from	O	3707
a	O	3707
two	O	3707
stage	O	3707
mutation	O	3707
process	O	3707
.	O	3707

We	O	3708
analysed	O	3708
the	O	3708
age	O	3708
incidence	O	3708
curves	O	3708
for	O	3708
symptomatic	O	3708
renal	B-Disease	3708
cell	I-Disease	3708
carcinoma	I-Disease	3708
(	O	3708
n	O	3708
=	O	3708
26	O	3708
)	O	3708
and	O	3708
cerebellar	B-Disease	3708
haemangioblastoma	I-Disease	3708
(	O	3708
n	O	3708
=	O	3708
68	O	3708
)	O	3708
in	O	3708
109	O	3708
patients	O	3708
with	O	3708
von	B-Disease	3708
Hippel	I-Disease	3708
-	I-Disease	3708
Lindau	I-Disease	3708
(	I-Disease	3708
VHL	I-Disease	3708
)	I-Disease	3708
disease	I-Disease	3708
,	O	3708
and	O	3708
compared	O	3708
them	O	3708
to	O	3708
104	O	3708
patients	O	3708
with	O	3708
sporadic	B-Disease	3708
renal	I-Disease	3708
cell	I-Disease	3708
carcinoma	I-Disease	3708
and	O	3708
43	O	3708
patients	O	3708
with	O	3708
sporadic	B-Disease	3708
cerebellar	I-Disease	3708
haemangioblastoma	I-Disease	3708
.	O	3708

The	O	3709
age	O	3709
incidence	O	3709
curves	O	3709
for	O	3709
renal	B-Disease	3709
cell	I-Disease	3709
carcinoma	I-Disease	3709
and	O	3709
cerebellar	B-Disease	3709
haemangioblastoma	I-Disease	3709
in	O	3709
VHL	B-Disease	3709
disease	I-Disease	3709
were	O	3709
compatible	O	3709
with	O	3709
a	O	3709
single	O	3709
mutation	O	3709
model	O	3709
,	O	3709
whereas	O	3709
the	O	3709
age	O	3709
incidence	O	3709
curves	O	3709
for	O	3709
sporadic	B-Disease	3709
renal	I-Disease	3709
cell	I-Disease	3709
carcinoma	I-Disease	3709
and	O	3709
cerebellar	B-Disease	3709
haemangioblastoma	I-Disease	3709
suggested	O	3709
a	O	3709
two	O	3709
stage	O	3709
mutation	O	3709
process	O	3709
.	O	3709

These	O	3710
data	O	3710
are	O	3710
compatible	O	3710
with	O	3710
the	O	3710
VHL	B-Disease	3710
gene	O	3710
functioning	O	3710
as	O	3710
a	O	3710
recessive	O	3710
tumour	B-Disease	3710
suppressor	O	3710
gene	O	3710
.	O	3710

Sporadic	B-Disease	3711
cerebellar	I-Disease	3711
haemangioblastoma	I-Disease	3711
and	O	3711
some	O	3711
renal	B-Disease	3711
cell	I-Disease	3711
carcinoma	I-Disease	3711
may	O	3711
arise	O	3711
from	O	3711
somatic	O	3711
mutations	O	3711
inactivating	O	3711
both	O	3711
alleles	O	3711
at	O	3711
the	O	3711
VHL	B-Disease	3711
locus	O	3711
.	O	3711

Screening	O	3713
for	O	3713
carriers	O	3713
of	O	3713
Tay	B-Disease	3713
-	I-Disease	3713
Sachs	I-Disease	3713
disease	I-Disease	3713
among	O	3713
Ashkenazi	O	3713
Jews	O	3713
.	O	3713

The	O	3716
prevention	O	3716
of	O	3716
Tay	B-Disease	3716
-	I-Disease	3716
Sachs	I-Disease	3716
disease	I-Disease	3716
(	O	3716
GM2	B-Disease	3716
gangliosidosis	I-Disease	3716
,	I-Disease	3716
type	I-Disease	3716
1	I-Disease	3716
)	O	3716
depends	O	3716
on	O	3716
the	O	3716
identification	O	3716
of	O	3716
carriers	O	3716
of	O	3716
the	O	3716
gene	O	3716
for	O	3716
this	O	3716
autosomal	B-Disease	3716
recessive	I-Disease	3716
disorder	I-Disease	3716
.	O	3716

We	O	3717
compared	O	3717
the	O	3717
enzyme	O	3717
-	O	3717
based	O	3717
test	O	3717
widely	O	3717
used	O	3717
in	O	3717
screening	O	3717
for	O	3717
Tay	B-Disease	3717
-	I-Disease	3717
Sachs	I-Disease	3717
disease	I-Disease	3717
with	O	3717
a	O	3717
test	O	3717
based	O	3717
on	O	3717
analysis	O	3717
of	O	3717
DNA	O	3717
.	O	3717

We	O	3718
developed	O	3718
methods	O	3718
to	O	3718
detect	O	3718
the	O	3718
three	O	3718
mutations	O	3718
in	O	3718
the	O	3718
HEXA	O	3718
gene	O	3718
that	O	3718
occur	O	3718
with	O	3718
high	O	3718
frequency	O	3718
among	O	3718
Ashkenazi	O	3718
Jews	O	3718
two	O	3718
mutations	O	3718
cause	O	3718
infantile	O	3718
Tay	B-Disease	3718
-	I-Disease	3718
Sachs	I-Disease	3718
disease	I-Disease	3718
,	O	3718
and	O	3718
the	O	3718
third	O	3718
causes	O	3718
the	O	3718
adult	O	3718
-	O	3718
onset	O	3718
form	O	3718
of	O	3718
the	O	3718
disease	O	3718
.	O	3718

Among	O	3721
62	O	3721
Ashkenazi	O	3721
obligate	O	3721
carriers	O	3721
of	O	3721
Tay	B-Disease	3721
-	I-Disease	3721
Sachs	I-Disease	3721
disease	I-Disease	3721
,	O	3721
the	O	3721
three	O	3721
specific	O	3721
mutations	O	3721
accounted	O	3721
for	O	3721
all	O	3721
but	O	3721
one	O	3721
of	O	3721
the	O	3721
mutant	O	3721
alleles	O	3721
(	O	3721
98	O	3721
percent	O	3721
)	O	3721
.	O	3721

The	O	3729
increased	O	3729
specificity	O	3729
and	O	3729
predictive	O	3729
value	O	3729
of	O	3729
the	O	3729
DNA	O	3729
-	O	3729
based	O	3729
test	O	3729
make	O	3729
it	O	3729
a	O	3729
useful	O	3729
adjunct	O	3729
to	O	3729
the	O	3729
diagnostic	O	3729
tests	O	3729
currently	O	3729
used	O	3729
to	O	3729
screen	O	3729
for	O	3729
carriers	O	3729
of	O	3729
Tay	B-Disease	3729
-	I-Disease	3729
Sachs	I-Disease	3729
disease	I-Disease	3729
.	O	3729

Total	B-Disease	3730
deficiency	I-Disease	3730
of	I-Disease	3730
plasma	I-Disease	3730
cholesteryl	I-Disease	3730
ester	I-Disease	3730
transfer	I-Disease	3730
protein	I-Disease	3730
in	O	3730
subjects	O	3730
homozygous	O	3730
and	O	3730
heterozygous	O	3730
for	O	3730
the	O	3730
intron	O	3730
14	O	3730
splicing	O	3730
defect	O	3730
.	O	3730

The	O	3731
molecular	O	3731
basis	O	3731
of	O	3731
cholesteryl	B-Disease	3731
ester	I-Disease	3731
transfer	I-Disease	3731
protein	I-Disease	3731
(	I-Disease	3731
CETP	I-Disease	3731
)	I-Disease	3731
deficiency	I-Disease	3731
was	O	3731
investigated	O	3731
in	O	3731
4	O	3731
unrelated	O	3731
CETP	B-Disease	3731
-	I-Disease	3731
deficient	I-Disease	3731
families	O	3731
.	O	3731

Thus	O	3739
,	O	3739
other	O	3739
genetic	B-Disease	3739
defects	I-Disease	3739
or	O	3739
metabolic	O	3739
factors	O	3739
influencing	O	3739
CETP	O	3739
expression	O	3739
are	O	3739
implicated	O	3739
.	O	3739

The	O	3740
data	O	3740
suggest	O	3740
that	O	3740
the	O	3740
G	O	3740
-	O	3740
to	O	3740
-	O	3740
A	O	3740
mutation	O	3740
may	O	3740
be	O	3740
common	O	3740
in	O	3740
human	O	3740
plasma	O	3740
CETP	B-Disease	3740
deficiency	I-Disease	3740
.	O	3740

Glucose	B-Disease	3744
-	I-Disease	3744
6	I-Disease	3744
-	I-Disease	3744
phosphate	I-Disease	3744
dehydrogenase	I-Disease	3744
(	I-Disease	3744
G6PD	I-Disease	3744
;	I-Disease	3744
E	I-Disease	3744
.	I-Disease	3744

C	I-Disease	3745
.	I-Disease	3745

1	I-Disease	3746
.	I-Disease	3746

1	I-Disease	3747
.	I-Disease	3747

1	I-Disease	3748
.	I-Disease	3748

49	I-Disease	3749
)	I-Disease	3749
deficiency	I-Disease	3749
is	O	3749
the	O	3749
most	O	3749
common	O	3749
human	O	3749
enzymopathy	B-Disease	3749
;	O	3749
more	O	3749
than	O	3749
300	O	3749
different	O	3749
biochemical	O	3749
variants	O	3749
of	O	3749
the	O	3749
enzyme	O	3749
have	O	3749
been	O	3749
described	O	3749
.	O	3749

In	O	3750
many	O	3750
parts	O	3750
of	O	3750
the	O	3750
world	O	3750
the	O	3750
Mediterranean	O	3750
type	O	3750
of	O	3750
G6PD	B-Disease	3750
deficiency	I-Disease	3750
is	O	3750
prevalent	O	3750
.	O	3750

A	O	3760
normal	O	3760
male	O	3760
with	O	3760
an	O	3760
inherited	O	3760
deletion	O	3760
of	O	3760
one	O	3760
exon	O	3760
within	O	3760
the	O	3760
DMD	B-Disease	3760
gene	O	3760
.	O	3760

We	O	3761
describe	O	3761
two	O	3761
brothers	O	3761
with	O	3761
identical	O	3761
inherited	O	3761
deletions	O	3761
of	O	3761
one	O	3761
single	O	3761
exon	O	3761
within	O	3761
the	O	3761
middle	O	3761
of	O	3761
the	O	3761
DMD	B-Disease	3761
gene	O	3761
;	O	3761
one	O	3761
brother	O	3761
has	O	3761
Becker	B-Disease	3761
muscular	I-Disease	3761
dystrophy	I-Disease	3761
diagnosed	O	3761
at	O	3761
11	O	3761
years	O	3761
of	O	3761
age	O	3761
,	O	3761
whereas	O	3761
the	O	3761
older	O	3761
brother	O	3761
is	O	3761
normal	O	3761
at	O	3761
18	O	3761
.	O	3761

These	O	3762
results	O	3762
have	O	3762
implications	O	3762
for	O	3762
genetic	O	3762
counselling	O	3762
and	O	3762
prenatal	O	3762
diagnosis	O	3762
in	O	3762
families	O	3762
with	O	3762
Becker	B-Disease	3762
muscular	I-Disease	3762
dystrophy	I-Disease	3762
.	O	3762

Duchenne	B-Disease	3764
muscular	I-Disease	3764
dystrophy	I-Disease	3764
gene	O	3764
expression	O	3764
in	O	3764
normal	O	3764
and	O	3764
diseased	O	3764
human	O	3764
muscle	O	3764
.	O	3764

A	O	3765
probe	O	3765
for	O	3765
the	O	3765
5	O	3765
end	O	3765
of	O	3765
the	O	3765
Duchenne	B-Disease	3765
muscular	I-Disease	3765
dystrophy	I-Disease	3765
(	O	3765
DMD	B-Disease	3765
)	O	3765
gene	O	3765
was	O	3765
used	O	3765
to	O	3765
study	O	3765
expression	O	3765
of	O	3765
the	O	3765
gene	O	3765
in	O	3765
normal	O	3765
human	O	3765
muscle	O	3765
,	O	3765
myogenic	O	3765
cell	O	3765
cultures	O	3765
,	O	3765
and	O	3765
muscle	O	3765
from	O	3765
patients	O	3765
with	O	3765
DMD	B-Disease	3765
.	O	3765

In	O	3767
DMD	B-Disease	3767
muscle	O	3767
,	O	3767
expression	O	3767
of	O	3767
this	O	3767
portion	O	3767
of	O	3767
the	O	3767
gene	O	3767
was	O	3767
also	O	3767
revealed	O	3767
by	O	3767
in	O	3767
situ	O	3767
RNA	O	3767
hybridization	O	3767
,	O	3767
particularly	O	3767
in	O	3767
regenerating	O	3767
muscle	O	3767
fibers	O	3767
.	O	3767

Molecular	O	3769
and	O	3769
phenotypic	O	3769
analysis	O	3769
of	O	3769
patients	O	3769
with	O	3769
deletions	O	3769
within	O	3769
the	O	3769
deletion	O	3769
-	O	3769
rich	O	3769
region	O	3769
of	O	3769
the	O	3769
Duchenne	B-Disease	3769
muscular	I-Disease	3769
dystrophy	I-Disease	3769
(	O	3769
DMD	B-Disease	3769
)	O	3769
gene	O	3769
.	O	3769

Eighty	O	3770
unrelated	O	3770
individuals	O	3770
with	O	3770
Duchenne	B-Disease	3770
muscular	I-Disease	3770
dystrophy	I-Disease	3770
(	O	3770
DMD	B-Disease	3770
)	O	3770
or	O	3770
Becker	B-Disease	3770
muscular	I-Disease	3770
dystrophy	I-Disease	3770
(	O	3770
BMD	B-Disease	3770
)	O	3770
were	O	3770
found	O	3770
to	O	3770
have	O	3770
deletions	O	3770
in	O	3770
the	O	3770
major	O	3770
deletion	O	3770
-	O	3770
rich	O	3770
region	O	3770
of	O	3770
the	O	3770
DMD	B-Disease	3770
locus	O	3770
.	O	3770

Thirty	O	3776
-	O	3776
eight	O	3776
independent	O	3776
patients	O	3776
were	O	3776
old	O	3776
enough	O	3776
to	O	3776
be	O	3776
classified	O	3776
as	O	3776
DMD	B-Disease	3776
,	O	3776
BMD	B-Disease	3776
,	O	3776
or	O	3776
intermediate	O	3776
phenotype	O	3776
and	O	3776
had	O	3776
deletions	O	3776
of	O	3776
exons	O	3776
with	O	3776
sequenced	O	3776
intron	O	3776
/	O	3776
exon	O	3776
boundaries	O	3776
.	O	3776

Of	O	3777
these	O	3777
,	O	3777
eight	O	3777
BMD	B-Disease	3777
patients	O	3777
and	O	3777
one	O	3777
intermediate	O	3777
patient	O	3777
had	O	3777
gene	O	3777
deletions	O	3777
predicted	O	3777
to	O	3777
leave	O	3777
the	O	3777
reading	O	3777
frame	O	3777
intact	O	3777
,	O	3777
while	O	3777
21	O	3777
DMD	B-Disease	3777
patients	O	3777
,	O	3777
7	O	3777
intermediate	O	3777
patients	O	3777
,	O	3777
and	O	3777
1	O	3777
BMD	B-Disease	3777
patient	O	3777
had	O	3777
gene	O	3777
deletions	O	3777
predicted	O	3777
to	O	3777
disrupt	O	3777
the	O	3777
reading	O	3777
frame	O	3777
.	O	3777

Chromosome	O	3784
translocations	O	3784
involving	O	3784
11p13	O	3784
have	O	3784
been	O	3784
associated	O	3784
with	O	3784
familial	B-Disease	3784
aniridia	I-Disease	3784
in	O	3784
two	O	3784
kindreds	O	3784
highlighting	O	3784
the	O	3784
chromosomal	O	3784
localization	O	3784
of	O	3784
the	O	3784
AN2	O	3784
locus	O	3784
.	O	3784

This	O	3785
locus	O	3785
is	O	3785
also	O	3785
part	O	3785
of	O	3785
the	O	3785
WAGR	B-Disease	3785
complex	O	3785
(	O	3785
Wilms	B-Disease	3785
tumor	I-Disease	3785
,	O	3785
aniridia	B-Disease	3785
,	O	3785
genitourinary	B-Disease	3785
abnormalities	I-Disease	3785
,	O	3785
and	O	3785
mental	B-Disease	3785
retardation	I-Disease	3785
)	O	3785
.	O	3785

Linkage	O	3790
analysis	O	3790
of	O	3790
the	O	3790
apolipoprotein	O	3790
C2	O	3790
gene	O	3790
and	O	3790
myotonic	B-Disease	3790
dystrophy	I-Disease	3790
on	O	3790
human	O	3790
chromosome	O	3790
19	O	3790
reveals	O	3790
linkage	O	3790
disequilibrium	O	3790
in	O	3790
a	O	3790
French	O	3790
-	O	3790
Canadian	O	3790
population	O	3790
.	O	3790

The	O	3791
gene	O	3791
for	O	3791
human	O	3791
apolipoprotein	O	3791
C2	O	3791
(	O	3791
APOC2	O	3791
)	O	3791
,	O	3791
situated	O	3791
on	O	3791
the	O	3791
proximal	O	3791
long	O	3791
arm	O	3791
of	O	3791
chromosome	O	3791
19	O	3791
,	O	3791
is	O	3791
closely	O	3791
linked	O	3791
to	O	3791
the	O	3791
gene	O	3791
for	O	3791
the	O	3791
most	O	3791
common	O	3791
form	O	3791
of	O	3791
adult	O	3791
muscular	B-Disease	3791
dystrophy	I-Disease	3791
,	O	3791
myotonic	B-Disease	3791
dystrophy	I-Disease	3791
(	O	3791
DM	B-Disease	3791
)	O	3791
.	O	3791

We	O	3793
have	O	3793
conducted	O	3793
a	O	3793
comprehensive	O	3793
DM	B-Disease	3793
linkage	O	3793
study	O	3793
utilizing	O	3793
all	O	3793
six	O	3793
RFLPs	O	3793
and	O	3793
involving	O	3793
50	O	3793
families	O	3793
and	O	3793
372	O	3793
individuals	O	3793
.	O	3793

This	O	3816
represents	O	3816
the	O	3816
first	O	3816
evidence	O	3816
of	O	3816
linkage	O	3816
disequilibrium	O	3816
between	O	3816
APOC2	O	3816
and	O	3816
the	O	3816
DM	B-Disease	3816
locus	O	3816
.	O	3816

Phenylalanine	O	3817
hydroxylase	O	3817
gene	O	3817
haplotypes	O	3817
in	O	3817
Polynesians	O	3817
:	O	3817
evolutionary	O	3817
origins	O	3817
and	O	3817
absence	O	3817
of	O	3817
alleles	O	3817
associated	O	3817
with	O	3817
severe	O	3817
phenylketonuria	B-Disease	3817
.	O	3817

The	O	3822
absence	O	3822
of	O	3822
severe	O	3822
phenylketonuria	B-Disease	3822
(	O	3822
PKU	B-Disease	3822
)	O	3822
in	O	3822
both	O	3822
Polynesians	O	3822
and	O	3822
Southeast	O	3822
Asians	O	3822
is	O	3822
consistent	O	3822
with	O	3822
the	O	3822
lack	O	3822
of	O	3822
PAH	O	3822
haplotypes	O	3822
2	O	3822
and	O	3822
3	O	3822
,	O	3822
on	O	3822
which	O	3822
the	O	3822
severe	O	3822
PKU	B-Disease	3822
mutants	O	3822
have	O	3822
arisen	O	3822
among	O	3822
Caucasians	O	3822
.	O	3822

Preferential	O	3824
germline	O	3824
mutation	O	3824
of	O	3824
the	O	3824
paternal	O	3824
allele	O	3824
in	O	3824
retinoblastoma	B-Disease	3824
.	O	3824

The	O	3825
event	O	3825
triggering	O	3825
malignant	O	3825
proliferation	O	3825
in	O	3825
70	O	3825
%	O	3825
of	O	3825
retinoblastoma	B-Disease	3825
tumours	I-Disease	3825
is	O	3825
loss	O	3825
of	O	3825
heterozygosity	O	3825
for	O	3825
chromosome	O	3825
13q14	O	3825
,	O	3825
whereby	O	3825
the	O	3825
normal	O	3825
retinoblastoma	B-Disease	3825
gene	O	3825
(	O	3825
RB1	O	3825
)	O	3825
allele	O	3825
is	O	3825
lost	O	3825
and	O	3825
an	O	3825
already	O	3825
mutated	O	3825
RB1	O	3825
allele	O	3825
remains	O	3825
in	O	3825
the	O	3825
tumour	B-Disease	3825
.	O	3825

Most	O	3827
bilateral	O	3827
patients	O	3827
have	O	3827
no	O	3827
family	O	3827
history	O	3827
of	O	3827
retinoblastoma	B-Disease	3827
and	O	3827
are	O	3827
presumed	O	3827
to	O	3827
have	O	3827
new	O	3827
germline	O	3827
mutations	O	3827
which	O	3827
arose	O	3827
in	O	3827
the	O	3827
egg	O	3827
,	O	3827
sperm	O	3827
or	O	3827
early	O	3827
embryo	O	3827
.	O	3827

We	O	3828
have	O	3828
determined	O	3828
the	O	3828
parental	O	3828
origin	O	3828
of	O	3828
the	O	3828
retained	O	3828
allele	O	3828
in	O	3828
nine	O	3828
retinoblastoma	B-Disease	3828
tumours	I-Disease	3828
from	O	3828
eight	O	3828
unrelated	O	3828
non	O	3828
-	O	3828
familial	O	3828
cases	O	3828
by	O	3828
using	O	3828
RB1	O	3828
-	O	3828
linked	O	3828
genetic	O	3828
markers	O	3828
.	O	3828

Six	O	3829
tumours	B-Disease	3829
retained	O	3829
the	O	3829
paternal	O	3829
allele	O	3829
and	O	3829
three	O	3829
retained	O	3829
the	O	3829
maternal	O	3829
allele	O	3829
.	O	3829

Of	O	3830
the	O	3830
three	O	3830
unilateral	B-Disease	3830
tumours	I-Disease	3830
,	O	3830
only	O	3830
one	O	3830
retained	O	3830
the	O	3830
paternal	O	3830
RB1	O	3830
allele	O	3830
.	O	3830

Thus	O	3831
,	O	3831
there	O	3831
is	O	3831
no	O	3831
evidence	O	3831
that	O	3831
the	O	3831
paternal	O	3831
RB1	O	3831
allele	O	3831
is	O	3831
preferentially	O	3831
retained	O	3831
in	O	3831
retinoblastoma	B-Disease	3831
,	O	3831
as	O	3831
has	O	3831
been	O	3831
suggested	O	3831
to	O	3831
be	O	3831
the	O	3831
case	O	3831
in	O	3831
osteosarcoma	B-Disease	3831
.	O	3831

By	O	3832
contrast	O	3832
,	O	3832
tumours	B-Disease	3832
from	O	3832
four	O	3832
of	O	3832
the	O	3832
five	O	3832
bilateral	O	3832
patients	O	3832
retained	O	3832
the	O	3832
paternal	O	3832
RB1	O	3832
allele	O	3832
.	O	3832

Haplotype	O	3835
analysis	O	3835
of	O	3835
the	O	3835
phenylalanine	O	3835
hydroxylase	O	3835
gene	O	3835
in	O	3835
Turkish	O	3835
phenylketonuria	B-Disease	3835
families	O	3835
.	O	3835

We	O	3836
have	O	3836
estimated	O	3836
the	O	3836
haplotype	O	3836
distribution	O	3836
of	O	3836
mutant	O	3836
and	O	3836
normal	O	3836
phenylalanine	O	3836
hydroxylase	O	3836
(	O	3836
PAH	O	3836
)	O	3836
alleles	O	3836
for	O	3836
17	O	3836
Turkish	O	3836
phenylketonuria	B-Disease	3836
(	O	3836
PKU	B-Disease	3836
)	O	3836
families	O	3836
20	O	3836
normal	O	3836
and	O	3836
27	O	3836
mutated	O	3836
PAH	O	3836
alleles	O	3836
could	O	3836
be	O	3836
identified	O	3836
.	O	3836

Two	O	3843
of	O	3843
the	O	3843
eight	O	3843
polymorphic	O	3843
sites	O	3843
were	O	3843
in	O	3843
association	O	3843
with	O	3843
PKU	B-Disease	3843
.	O	3843

Huntington	B-Disease	3845
disease	I-Disease	3845
:	O	3845
no	O	3845
evidence	O	3845
for	O	3845
locus	O	3845
heterogeneity	O	3845
.	O	3845

A	O	3846
total	O	3846
of	O	3846
63	O	3846
families	O	3846
with	O	3846
Huntington	B-Disease	3846
disease	I-Disease	3846
(	O	3846
HD	B-Disease	3846
)	O	3846
were	O	3846
examined	O	3846
for	O	3846
linkage	O	3846
between	O	3846
HD	B-Disease	3846
and	O	3846
G8	O	3846
(	O	3846
D4S10	O	3846
)	O	3846
.	O	3846

These	O	3860
data	O	3860
suggest	O	3860
that	O	3860
there	O	3860
is	O	3860
only	O	3860
one	O	3860
HD	B-Disease	3860
locus	O	3860
,	O	3860
although	O	3860
a	O	3860
second	O	3860
rare	O	3860
locus	O	3860
cannot	O	3860
be	O	3860
ruled	O	3860
out	O	3860
.	O	3860

Haplotype	O	3861
and	O	3861
multipoint	O	3861
linkage	O	3861
analysis	O	3861
in	O	3861
Finnish	O	3861
choroideremia	B-Disease	3861
families	O	3861
.	O	3861

Multipoint	O	3862
linkage	O	3862
analysis	O	3862
of	O	3862
choroideremia	B-Disease	3862
(	O	3862
TCD	B-Disease	3862
)	O	3862
and	O	3862
seven	O	3862
X	O	3862
chromosomal	O	3862
restriction	O	3862
fragment	O	3862
length	O	3862
polymorphisms	O	3862
(	O	3862
RFLPs	O	3862
)	O	3862
was	O	3862
carried	O	3862
out	O	3862
in	O	3862
18	O	3862
Finnish	O	3862
TCD	B-Disease	3862
families	O	3862
.	O	3862

The	O	3863
data	O	3863
place	O	3863
TCD	B-Disease	3863
distal	O	3863
to	O	3863
PGK	O	3863
and	O	3863
DXS72	O	3863
,	O	3863
very	O	3863
close	O	3863
to	O	3863
DXYS1	O	3863
and	O	3863
DXYS5	O	3863
(	O	3863
Zmax	O	3863
=	O	3863
24	O	3863
at	O	3863
theta	O	3863
=	O	3863
0	O	3863
)	O	3863
and	O	3863
proximal	O	3863
to	O	3863
DXYS4	O	3863
and	O	3863
DXYS12	O	3863
.	O	3863

All	O	3865
the	O	3865
TCD	B-Disease	3865
males	O	3865
and	O	3865
carrier	O	3865
females	O	3865
studied	O	3865
have	O	3865
the	O	3865
same	O	3865
DXYS1	O	3865
allele	O	3865
in	O	3865
coupling	O	3865
with	O	3865
TCD	B-Disease	3865
.	O	3865

In	O	3866
Northeastern	O	3866
Finland	O	3866
,	O	3866
66	O	3866
/	O	3866
69	O	3866
chromosomes	O	3866
carrying	O	3866
TCD	B-Disease	3866
had	O	3866
the	O	3866
same	O	3866
haplotype	O	3866
at	O	3866
loci	O	3866
DXS72	O	3866
,	O	3866
DXYS1	O	3866
,	O	3866
DXYS4	O	3866
,	O	3866
and	O	3866
DXYS12	O	3866
.	O	3866

The	O	3867
same	O	3867
haplotype	O	3867
is	O	3867
seen	O	3867
in	O	3867
only	O	3867
15	O	3867
/	O	3867
99	O	3867
chromosomes	O	3867
not	O	3867
carrying	O	3867
TCD	B-Disease	3867
.	O	3867

Moreover	O	3868
,	O	3868
in	O	3868
71	O	3868
/	O	3868
104	O	3868
non	O	3868
-	O	3868
TCD	O	3868
chromosomes	O	3868
,	O	3868
the	O	3868
haplotype	O	3868
at	O	3868
six	O	3868
marker	O	3868
loci	O	3868
is	O	3868
different	O	3868
from	O	3868
those	O	3868
seen	O	3868
in	O	3868
any	O	3868
of	O	3868
the	O	3868
76	O	3868
TCD	B-Disease	3868
chromosomes	O	3868
.	O	3868

This	O	3869
supports	O	3869
the	O	3869
previously	O	3869
described	O	3869
hypothesis	O	3869
that	O	3869
the	O	3869
large	O	3869
Northern	O	3869
Finnish	O	3869
choroideremia	B-Disease	3869
pedigrees	O	3869
,	O	3869
comprising	O	3869
a	O	3869
total	O	3869
of	O	3869
over	O	3869
80	O	3869
living	O	3869
patients	O	3869
representing	O	3869
more	O	3869
than	O	3869
a	O	3869
fifth	O	3869
of	O	3869
all	O	3869
TCD	B-Disease	3869
patients	O	3869
described	O	3869
worldwide	O	3869
,	O	3869
carry	O	3869
the	O	3869
same	O	3869
mutation	O	3869
.	O	3869

Autosomal	O	3872
dominant	O	3872
aniridia	B-Disease	3872
linked	O	3872
to	O	3872
the	O	3872
chromosome	O	3872
11p13	O	3872
markers	O	3872
catalase	O	3872
and	O	3872
D11S151	O	3872
in	O	3872
a	O	3872
large	O	3872
Dutch	O	3872
family	O	3872
.	O	3872

In	O	3873
a	O	3873
large	O	3873
pedigree	O	3873
with	O	3873
autosomal	O	3873
dominant	O	3873
aniridia	B-Disease	3873
,	O	3873
we	O	3873
found	O	3873
close	O	3873
linkage	O	3873
between	O	3873
the	O	3873
aniridia	B-Disease	3873
locus	O	3873
AN2	O	3873
and	O	3873
the	O	3873
markers	O	3873
catalase	O	3873
(	O	3873
CAT	O	3873
)	O	3873
(	O	3873
zeta	O	3873
=	O	3873
7	O	3873
.	O	3873

We	O	3879
conclude	O	3879
that	O	3879
the	O	3879
autosomal	O	3879
dominant	O	3879
aniridia	B-Disease	3879
in	O	3879
this	O	3879
family	O	3879
is	O	3879
due	O	3879
to	O	3879
a	O	3879
mutation	O	3879
at	O	3879
the	O	3879
AN2	O	3879
locus	O	3879
on	O	3879
11p13	O	3879
.	O	3879

18	O	3881
)	O	3881
between	O	3881
the	O	3881
aniridia	B-Disease	3881
and	O	3881
the	O	3881
chromosome	O	3881
2p25	O	3881
marker	O	3881
D2S1	O	3881
(	O	3881
linked	O	3881
to	O	3881
ACP1	O	3881
)	O	3881
.	O	3881

Recombination	O	3882
events	O	3882
that	O	3882
locate	O	3882
myotonic	B-Disease	3882
dystrophy	I-Disease	3882
distal	O	3882
to	O	3882
APOC2	O	3882
on	O	3882
19q	O	3882
.	O	3882

We	O	3883
previously	O	3883
reported	O	3883
a	O	3883
recombination	O	3883
in	O	3883
an	O	3883
individual	O	3883
with	O	3883
myotonic	B-Disease	3883
dystrophy	I-Disease	3883
(	O	3883
DM	B-Disease	3883
)	O	3883
which	O	3883
placed	O	3883
the	O	3883
markers	O	3883
D19S19	O	3883
and	O	3883
APOC2	O	3883
on	O	3883
the	O	3883
same	O	3883
side	O	3883
of	O	3883
the	O	3883
DM	B-Disease	3883
locus	O	3883
.	O	3883

Haplotyping	O	3884
of	O	3884
this	O	3884
family	O	3884
with	O	3884
more	O	3884
recently	O	3884
characterized	O	3884
probes	O	3884
which	O	3884
are	O	3884
either	O	3884
tightly	O	3884
linked	O	3884
to	O	3884
DM	B-Disease	3884
or	O	3884
distal	O	3884
to	O	3884
the	O	3884
linkage	O	3884
group	O	3884
at	O	3884
q13	O	3884
.	O	3884

2	O	3885
shows	O	3885
that	O	3885
the	O	3885
DM	B-Disease	3885
locus	O	3885
is	O	3885
distal	O	3885
to	O	3885
APOC2	O	3885
.	O	3885

This	O	3886
is	O	3886
confirmed	O	3886
by	O	3886
other	O	3886
recombinants	O	3886
where	O	3886
DM	B-Disease	3886
segregates	O	3886
with	O	3886
distal	O	3886
probes	O	3886
.	O	3886

Additional	O	3887
marker	O	3887
to	O	3887
marker	O	3887
recombinations	O	3887
in	O	3887
unaffected	O	3887
individuals	O	3887
are	O	3887
reported	O	3887
and	O	3887
support	O	3887
the	O	3887
order	O	3887
and	O	3887
orientation	O	3887
of	O	3887
the	O	3887
DM	B-Disease	3887
linkage	O	3887
group	O	3887
as	O	3887
pter	O	3887
-	O	3887
(	O	3887
INSR	O	3887
,	O	3887
LDLR	O	3887
,	O	3887
S9	O	3887
)	O	3887
-	O	3887
(	O	3887
S19	O	3887
,	O	3887
BCL3	O	3887
,	O	3887
APOC2	O	3887
)	O	3887
-	O	3887
(	O	3887
CKMM	O	3887
,	O	3887
DM	O	3887
)	O	3887
-	O	3887
(	O	3887
S22	O	3887
,	O	3887
+	O	3887
+	O	3887
+	O	3887
PRKCG	O	3887
)	O	3887
-	O	3887
qter	O	3887
.	O	3887

The	O	3888
data	O	3888
presented	O	3888
here	O	3888
cannot	O	3888
determine	O	3888
whether	O	3888
DM	B-Disease	3888
is	O	3888
proximal	O	3888
or	O	3888
distal	O	3888
to	O	3888
CKMM	O	3888
.	O	3888

The	O	3889
consequences	O	3889
of	O	3889
this	O	3889
probe	O	3889
order	O	3889
for	O	3889
antenatal	O	3889
diagnosis	O	3889
and	O	3889
future	O	3889
research	O	3889
aiming	O	3889
to	O	3889
isolate	O	3889
the	O	3889
gene	O	3889
which	O	3889
is	O	3889
affected	O	3889
in	O	3889
DM	B-Disease	3889
are	O	3889
discussed	O	3889
.	O	3889

Inactivation	O	3891
of	O	3891
both	O	3891
alleles	O	3891
of	O	3891
the	O	3891
RB1	O	3891
gene	O	3891
during	O	3891
normal	O	3891
retinal	O	3891
development	O	3891
initiates	O	3891
the	O	3891
formation	O	3891
of	O	3891
a	O	3891
retinoblastoma	B-Disease	3891
(	I-Disease	3891
RB	I-Disease	3891
)	I-Disease	3891
tumor	I-Disease	3891
.	O	3891

To	O	3892
identify	O	3892
the	O	3892
mutations	O	3892
which	O	3892
inactivate	O	3892
RB1	O	3892
,	O	3892
21	O	3892
RB	B-Disease	3892
tumors	I-Disease	3892
isolated	O	3892
from	O	3892
19	O	3892
patients	O	3892
were	O	3892
analyzed	O	3892
with	O	3892
the	O	3892
polymerase	O	3892
chain	O	3892
reaction	O	3892
or	O	3892
an	O	3892
RNase	O	3892
protection	O	3892
assay	O	3892
or	O	3892
both	O	3892
.	O	3892

Mutations	O	3893
were	O	3893
identified	O	3893
in	O	3893
13	O	3893
of	O	3893
21	O	3893
RB	B-Disease	3893
tumors	I-Disease	3893
;	O	3893
in	O	3893
8	O	3893
tumors	B-Disease	3893
,	O	3893
the	O	3893
precise	O	3893
errors	O	3893
in	O	3893
nucleotide	O	3893
sequence	O	3893
were	O	3893
characterized	O	3893
.	O	3893

We	O	3895
were	O	3895
unable	O	3895
to	O	3895
detect	O	3895
expression	O	3895
of	O	3895
the	O	3895
mutant	O	3895
allele	O	3895
in	O	3895
lymphoblasts	O	3895
of	O	3895
three	O	3895
bilaterally	O	3895
affected	O	3895
patients	O	3895
,	O	3895
although	O	3895
the	O	3895
mutation	O	3895
was	O	3895
present	O	3895
in	O	3895
the	O	3895
genomic	O	3895
DNA	O	3895
and	O	3895
transcripts	O	3895
containing	O	3895
the	O	3895
mutations	O	3895
were	O	3895
obvious	O	3895
in	O	3895
the	O	3895
RB	B-Disease	3895
tumors	I-Disease	3895
in	O	3895
the	O	3895
absence	O	3895
of	O	3895
a	O	3895
normal	O	3895
RB1	O	3895
allele	O	3895
.	O	3895

Partial	O	3898
deletion	O	3898
8q	O	3898
without	O	3898
Langer	B-Disease	3898
-	I-Disease	3898
Giedion	I-Disease	3898
syndrome	I-Disease	3898
:	O	3898
a	O	3898
recognisable	O	3898
syndrome	O	3898
.	O	3898

The	O	3902
clinical	O	3902
features	O	3902
were	O	3902
similar	O	3902
and	O	3902
there	O	3902
were	O	3902
no	O	3902
obvious	O	3902
stigmata	O	3902
of	O	3902
Langer	B-Disease	3902
-	I-Disease	3902
Giedion	I-Disease	3902
syndrome	I-Disease	3902
(	O	3902
LGS	B-Disease	3902
)	O	3902
.	O	3902

There	O	3903
are	O	3903
three	O	3903
other	O	3903
cases	O	3903
reported	O	3903
with	O	3903
a	O	3903
deletion	O	3903
of	O	3903
chromosome	O	3903
8	O	3903
at	O	3903
approximately	O	3903
the	O	3903
same	O	3903
breakpoint	O	3903
,	O	3903
one	O	3903
without	O	3903
LGS	B-Disease	3903
and	O	3903
some	O	3903
similarities	O	3903
to	O	3903
our	O	3903
cases	O	3903
,	O	3903
the	O	3903
other	O	3903
two	O	3903
with	O	3903
LGS	B-Disease	3903
.	O	3903

Our	O	3904
findings	O	3904
would	O	3904
support	O	3904
the	O	3904
observation	O	3904
that	O	3904
the	O	3904
critical	O	3904
segment	O	3904
for	O	3904
the	O	3904
assignment	O	3904
of	O	3904
LGS	B-Disease	3904
is	O	3904
proximal	O	3904
to	O	3904
or	O	3904
involves	O	3904
the	O	3904
proximal	O	3904
part	O	3904
of	O	3904
8q24	O	3904
.	O	3904

1	O	3905
,	O	3905
but	O	3905
a	O	3905
review	O	3905
of	O	3905
published	O	3905
reports	O	3905
suggests	O	3905
that	O	3905
the	O	3905
aetiology	O	3905
of	O	3905
LGS	B-Disease	3905
may	O	3905
be	O	3905
a	O	3905
more	O	3905
complex	O	3905
issue	O	3905
Myotonic	B-Disease	3905
dystrophy	I-Disease	3905
is	O	3905
closely	O	3905
linked	O	3905
to	O	3905
the	O	3905
gene	O	3905
for	O	3905
muscle	O	3905
-	O	3905
type	O	3905
creatine	O	3905
kinase	O	3905
(	O	3905
CKMM	O	3905
)	O	3905
.	O	3905

We	O	3906
have	O	3906
studied	O	3906
genetic	O	3906
linkage	O	3906
between	O	3906
the	O	3906
gene	O	3906
for	O	3906
creatine	O	3906
kinase	O	3906
muscle	O	3906
type	O	3906
(	O	3906
CKMM	O	3906
)	O	3906
and	O	3906
the	O	3906
gene	O	3906
for	O	3906
myotonic	B-Disease	3906
dystrophy	I-Disease	3906
(	O	3906
DM	B-Disease	3906
)	O	3906
.	O	3906

In	O	3907
a	O	3907
panel	O	3907
of	O	3907
65	O	3907
myotonic	B-Disease	3907
dystrophy	I-Disease	3907
families	O	3907
from	O	3907
Canada	O	3907
and	O	3907
the	O	3907
Netherlands	O	3907
,	O	3907
a	O	3907
maximum	O	3907
lod	O	3907
score	O	3907
(	O	3907
Zmax	O	3907
)	O	3907
of	O	3907
22	O	3907
.	O	3907

This	O	3911
establishes	O	3911
CKMM	O	3911
as	O	3911
a	O	3911
useful	O	3911
marker	O	3911
for	O	3911
myotonic	B-Disease	3911
dystrophy	I-Disease	3911
Color	B-Disease	3911
vision	I-Disease	3911
defects	I-Disease	3911
in	O	3911
adrenomyeloneuropathy	B-Disease	3911
.	O	3911

The	O	3912
relationship	O	3912
between	O	3912
abnormal	B-Disease	3912
color	I-Disease	3912
vision	I-Disease	3912
and	O	3912
adrenomyeloneuropathy	B-Disease	3912
(	O	3912
AMN	B-Disease	3912
)	O	3912
was	O	3912
investigated	O	3912
in	O	3912
27	O	3912
AMN	B-Disease	3912
patients	O	3912
and	O	3912
31	O	3912
age	O	3912
-	O	3912
matched	O	3912
controls	O	3912
by	O	3912
using	O	3912
the	O	3912
Farnsworth	O	3912
-	O	3912
Munsell	O	3912
100	O	3912
Hue	O	3912
test	O	3912
.	O	3912

The	O	3914
axes	O	3914
of	O	3914
bipolarity	O	3914
determined	O	3914
by	O	3914
the	O	3914
testing	O	3914
differed	O	3914
widely	O	3914
between	O	3914
the	O	3914
patients	O	3914
with	O	3914
abnormal	O	3914
scores	O	3914
,	O	3914
compatible	O	3914
with	O	3914
the	O	3914
notion	O	3914
that	O	3914
different	O	3914
alterations	O	3914
in	O	3914
visual	O	3914
pigment	O	3914
genes	O	3914
occur	O	3914
in	O	3914
different	O	3914
AMN	B-Disease	3914
kindreds	O	3914
.	O	3914

These	O	3915
observations	O	3915
confirm	O	3915
our	O	3915
earlier	O	3915
impression	O	3915
that	O	3915
the	O	3915
frequency	O	3915
of	O	3915
abnormal	B-Disease	3915
color	I-Disease	3915
vision	I-Disease	3915
is	O	3915
increased	O	3915
in	O	3915
these	O	3915
kindreds	O	3915
,	O	3915
and	O	3915
it	O	3915
supports	O	3915
our	O	3915
contentions	O	3915
that	O	3915
(	O	3915
1	O	3915
)	O	3915
AMN	B-Disease	3915
(	O	3915
and	O	3915
its	O	3915
companion	O	3915
,	O	3915
adrenoleukodystrophy	B-Disease	3915
)	O	3915
are	O	3915
very	O	3915
closely	O	3915
linked	O	3915
to	O	3915
the	O	3915
visual	O	3915
pigment	O	3915
loci	O	3915
at	O	3915
Xq28	O	3915
and	O	3915
(	O	3915
2	O	3915
)	O	3915
this	O	3915
proximity	O	3915
might	O	3915
provide	O	3915
the	O	3915
opportunity	O	3915
to	O	3915
observe	O	3915
contiguous	B-Disease	3915
gene	I-Disease	3915
defects	I-Disease	3915
.	O	3915

Molecular	O	3917
analysis	O	3917
of	O	3917
a	O	3917
female	O	3917
Lesch	B-Disease	3917
-	I-Disease	3917
Nyhan	I-Disease	3917
patient	O	3917
.	O	3917

We	O	3918
report	O	3918
the	O	3918
identification	O	3918
of	O	3918
a	O	3918
female	O	3918
patient	O	3918
with	O	3918
the	O	3918
X	O	3918
-	O	3918
linked	O	3918
recessive	O	3918
Lesch	B-Disease	3918
-	I-Disease	3918
Nyhan	I-Disease	3918
syndrome	I-Disease	3918
(	O	3918
hypoxanthine	B-Disease	3918
phosphoribosyltransferase	I-Disease	3918
[	I-Disease	3918
HPRT	I-Disease	3918
]	I-Disease	3918
deficiency	I-Disease	3918
)	O	3918
.	O	3918

Pelizaeus	B-Disease	3925
-	I-Disease	3925
Merzbacher	I-Disease	3925
disease	I-Disease	3925
:	O	3925
an	O	3925
X	B-Disease	3925
-	I-Disease	3925
linked	I-Disease	3925
neurologic	I-Disease	3925
disorder	I-Disease	3925
of	I-Disease	3925
myelin	I-Disease	3925
metabolism	I-Disease	3925
with	O	3925
a	O	3925
novel	O	3925
mutation	O	3925
in	O	3925
the	O	3925
gene	O	3925
encoding	O	3925
proteolipid	O	3925
protein	O	3925
.	O	3925

The	O	3926
nosology	O	3926
of	O	3926
the	O	3926
inborn	B-Disease	3926
errors	I-Disease	3926
of	I-Disease	3926
myelin	I-Disease	3926
metabolism	I-Disease	3926
has	O	3926
been	O	3926
stymied	O	3926
by	O	3926
the	O	3926
lack	O	3926
of	O	3926
molecular	O	3926
genetic	O	3926
analysis	O	3926
.	O	3926

Historically	O	3927
,	O	3927
Pelizaeus	B-Disease	3927
-	I-Disease	3927
Merzbacher	I-Disease	3927
disease	I-Disease	3927
has	O	3927
encompassed	O	3927
a	O	3927
host	O	3927
of	O	3927
neurologic	B-Disease	3927
disorders	I-Disease	3927
that	O	3927
present	O	3927
with	O	3927
a	O	3927
deficit	B-Disease	3927
of	I-Disease	3927
myelin	I-Disease	3927
,	O	3927
the	O	3927
membrane	O	3927
elaborated	O	3927
by	O	3927
glial	O	3927
cells	O	3927
that	O	3927
encircles	O	3927
and	O	3927
successively	O	3927
enwraps	O	3927
axons	O	3927
.	O	3927

We	O	3928
describe	O	3928
here	O	3928
a	O	3928
Pelizaeus	B-Disease	3928
-	I-Disease	3928
Merzbacher	I-Disease	3928
pedigree	O	3928
of	O	3928
the	O	3928
classical	O	3928
type	O	3928
,	O	3928
with	O	3928
X	O	3928
-	O	3928
linked	O	3928
inheritance	O	3928
,	O	3928
a	O	3928
typical	O	3928
clinical	O	3928
progression	O	3928
,	O	3928
and	O	3928
a	O	3928
pathologic	O	3928
loss	O	3928
of	O	3928
myelinating	O	3928
cells	O	3928
and	O	3928
myelin	O	3928
in	O	3928
the	O	3928
central	O	3928
nervous	O	3928
system	O	3928
.	O	3928

To	O	3929
discriminate	O	3929
variants	O	3929
of	O	3929
Pelizaeus	B-Disease	3929
-	I-Disease	3929
Merzbacher	I-Disease	3929
disease	I-Disease	3929
,	O	3929
a	O	3929
set	O	3929
of	O	3929
oligonucleotide	O	3929
primers	O	3929
was	O	3929
constructed	O	3929
to	O	3929
polymerase	O	3929
-	O	3929
chain	O	3929
-	O	3929
reaction	O	3929
(	O	3929
PCR	O	3929
)	O	3929
amplify	O	3929
and	O	3929
sequence	O	3929
the	O	3929
gene	O	3929
encoding	O	3929
proteolipid	O	3929
protein	O	3929
(	O	3929
PLP	O	3929
)	O	3929
,	O	3929
a	O	3929
structural	O	3929
protein	O	3929
that	O	3929
comprises	O	3929
half	O	3929
of	O	3929
the	O	3929
protein	O	3929
of	O	3929
the	O	3929
myelin	O	3929
sheath	O	3929
.	O	3929

Our	O	3931
results	O	3931
delineate	O	3931
the	O	3931
clinical	O	3931
features	O	3931
of	O	3931
Pelizaeus	B-Disease	3931
-	I-Disease	3931
Merzbacher	I-Disease	3931
disease	I-Disease	3931
,	O	3931
define	O	3931
the	O	3931
possible	O	3931
molecular	O	3931
pathology	O	3931
of	O	3931
this	O	3931
dysmyelinating	B-Disease	3931
disorder	I-Disease	3931
,	O	3931
and	O	3931
address	O	3931
the	O	3931
molecular	O	3931
classification	O	3931
of	O	3931
inborn	B-Disease	3931
errors	I-Disease	3931
of	I-Disease	3931
myelin	I-Disease	3931
metabolism	I-Disease	3931
.	O	3931

Patients	O	3932
with	O	3932
the	O	3932
classical	O	3932
form	O	3932
(	O	3932
type	O	3932
I	O	3932
)	O	3932
and	O	3932
the	O	3932
more	O	3932
severely	O	3932
affected	O	3932
,	O	3932
connatal	O	3932
variant	O	3932
of	O	3932
Pelizaeus	B-Disease	3932
-	I-Disease	3932
Merzbacher	I-Disease	3932
disease	I-Disease	3932
(	I-Disease	3932
type	I-Disease	3932
II	I-Disease	3932
)	I-Disease	3932
would	O	3932
be	O	3932
predicted	O	3932
to	O	3932
display	O	3932
mutation	O	3932
at	O	3932
the	O	3932
PLP	O	3932
locus	O	3932
.	O	3932

The	O	3933
other	O	3933
variants	O	3933
(	O	3933
types	O	3933
III	O	3933
-	O	3933
VI	O	3933
)	O	3933
,	O	3933
which	O	3933
have	O	3933
sometimes	O	3933
been	O	3933
categorized	O	3933
as	O	3933
Pelizaeus	B-Disease	3933
-	I-Disease	3933
Merzbacher	I-Disease	3933
disease	I-Disease	3933
,	O	3933
may	O	3933
represent	O	3933
mutations	O	3933
in	O	3933
genes	O	3933
encoding	O	3933
other	O	3933
structural	O	3933
myelin	O	3933
proteins	O	3933
or	O	3933
proteins	O	3933
critical	O	3933
to	O	3933
myelination	O	3933
.	O	3933

Molecular	O	3935
basis	O	3935
of	O	3935
human	O	3935
von	B-Disease	3935
Willebrand	I-Disease	3935
disease	I-Disease	3935
:	O	3935
analysis	O	3935
of	O	3935
platelet	O	3935
von	B-Disease	3935
Willebrand	I-Disease	3935
factor	O	3935
mRNA	O	3935
.	O	3935

von	B-Disease	3936
Willebrand	I-Disease	3936
disease	I-Disease	3936
(	O	3936
vWD	B-Disease	3936
)	O	3936
,	O	3936
the	O	3936
most	O	3936
common	O	3936
inherited	B-Disease	3936
bleeding	I-Disease	3936
disorder	I-Disease	3936
in	O	3936
humans	O	3936
,	O	3936
can	O	3936
result	O	3936
from	O	3936
either	O	3936
a	O	3936
quantitative	O	3936
or	O	3936
a	O	3936
qualitative	O	3936
defect	O	3936
in	O	3936
the	O	3936
adhesive	O	3936
glycoprotein	O	3936
,	O	3936
von	B-Disease	3936
Willebrand	I-Disease	3936
factor	O	3936
(	O	3936
vWF	O	3936
)	O	3936
.	O	3936

Molecular	O	3937
studies	O	3937
of	O	3937
vWD	B-Disease	3937
have	O	3937
been	O	3937
limited	O	3937
by	O	3937
the	O	3937
large	O	3937
size	O	3937
of	O	3937
the	O	3937
vWF	O	3937
gene	O	3937
and	O	3937
difficulty	O	3937
in	O	3937
obtaining	O	3937
the	O	3937
vWF	O	3937
mRNA	O	3937
from	O	3937
patients	O	3937
.	O	3937

In	O	3940
two	O	3940
type	B-Disease	3940
IIA	I-Disease	3940
vWD	I-Disease	3940
patients	O	3940
,	O	3940
two	O	3940
different	O	3940
but	O	3940
adjacent	O	3940
missense	O	3940
mutations	O	3940
were	O	3940
identified	O	3940
,	O	3940
the	O	3940
locations	O	3940
of	O	3940
which	O	3940
may	O	3940
identify	O	3940
an	O	3940
important	O	3940
vWF	O	3940
functional	O	3940
domain	O	3940
.	O	3940

Expression	O	3941
in	O	3941
heterologous	O	3941
cells	O	3941
of	O	3941
recombinant	O	3941
vWF	O	3941
containing	O	3941
one	O	3941
of	O	3941
these	O	3941
latter	O	3941
mutations	O	3941
reproduced	O	3941
the	O	3941
characteristic	O	3941
structural	O	3941
abnormality	O	3941
seen	O	3941
in	O	3941
type	B-Disease	3941
IIA	I-Disease	3941
vWD	I-Disease	3941
plasma	O	3941
.	O	3941

Familial	B-Disease	3943
deficiency	I-Disease	3943
of	I-Disease	3943
the	I-Disease	3943
seventh	I-Disease	3943
component	I-Disease	3943
of	I-Disease	3943
complement	I-Disease	3943
associated	O	3943
with	O	3943
recurrent	O	3943
meningococcal	B-Disease	3943
infections	I-Disease	3943
.	O	3943

We	O	3944
describe	O	3944
an	O	3944
11	O	3944
-	O	3944
year	O	3944
-	O	3944
old	O	3944
girl	O	3944
suffering	O	3944
from	O	3944
recurrent	B-Disease	3944
meningitis	I-Disease	3944
with	O	3944
a	O	3944
complete	O	3944
absence	B-Disease	3944
of	I-Disease	3944
the	I-Disease	3944
seventh	I-Disease	3944
component	I-Disease	3944
of	I-Disease	3944
complement	I-Disease	3944
(	O	3944
C7	O	3944
)	O	3944
.	O	3944

The	O	3948
relatives	O	3948
(	O	3948
parents	O	3948
and	O	3948
one	O	3948
sister	O	3948
)	O	3948
had	O	3948
half	O	3948
-	O	3948
normal	O	3948
levels	O	3948
of	O	3948
both	O	3948
immunochemically	O	3948
and	O	3948
functionally	O	3948
determined	O	3948
C7	O	3948
,	O	3948
indicating	O	3948
a	O	3948
heterozygous	O	3948
state	O	3948
for	O	3948
C7	B-Disease	3948
deficiency	I-Disease	3948
.	O	3948

1	O	3951
;	O	3951
p13	O	3951
)	O	3951
associated	O	3951
with	O	3951
familial	O	3951
isolated	B-Disease	3951
aniridia	I-Disease	3951
.	O	3951

A	O	3952
father	O	3952
and	O	3952
daughter	O	3952
with	O	3952
isolated	B-Disease	3952
aniridia	I-Disease	3952
were	O	3952
observed	O	3952
to	O	3952
have	O	3952
an	O	3952
apparently	O	3952
balanced	O	3952
,	O	3952
reciprocal	O	3952
translocation	O	3952
involving	O	3952
chromosomes	O	3952
5	O	3952
and	O	3952
11	O	3952
[	O	3952
t	O	3952
(	O	3952
5	O	3952
;	O	3952
11	O	3952
)	O	3952
(	O	3952
q13	O	3952
.	O	3952

This	O	3955
finding	O	3955
,	O	3955
in	O	3955
association	O	3955
with	O	3955
3	O	3955
other	O	3955
instances	O	3955
of	O	3955
single	O	3955
breaks	O	3955
at	O	3955
11p13	O	3955
and	O	3955
aniridia	B-Disease	3955
,	O	3955
supports	O	3955
the	O	3955
assignment	O	3955
of	O	3955
AN2	O	3955
to	O	3955
11p13	O	3955
.	O	3955

Homozygous	B-Disease	3956
hypobetalipoproteinemia	I-Disease	3956
:	O	3956
a	O	3956
disease	O	3956
distinct	O	3956
from	O	3956
abetalipoproproteinemia	B-Disease	3956
at	O	3956
the	O	3956
molecular	O	3956
level	O	3956
.	O	3956

apoB	O	3957
DNA	O	3957
,	O	3957
RNA	O	3957
,	O	3957
and	O	3957
protein	O	3957
from	O	3957
two	O	3957
patients	O	3957
with	O	3957
homozygous	B-Disease	3957
hypobetalipoproteinemia	I-Disease	3957
(	O	3957
HBL	B-Disease	3957
)	O	3957
were	O	3957
evaluated	O	3957
and	O	3957
compared	O	3957
with	O	3957
normal	O	3957
individuals	O	3957
.	O	3957

Northern	O	3959
and	O	3959
slot	O	3959
blot	O	3959
analyses	O	3959
of	O	3959
total	O	3959
liver	O	3959
mRNA	O	3959
from	O	3959
HBL	B-Disease	3959
patients	O	3959
documented	O	3959
a	O	3959
normal	O	3959
size	O	3959
apoB	O	3959
mRNA	O	3959
that	O	3959
was	O	3959
present	O	3959
in	O	3959
greatly	O	3959
reduced	O	3959
quantities	O	3959
.	O	3959

ApoB	O	3960
protein	O	3960
was	O	3960
detected	O	3960
within	O	3960
HBL	B-Disease	3960
hepatocytes	O	3960
utilizing	O	3960
immunohistochemical	O	3960
techniques	O	3960
;	O	3960
however	O	3960
,	O	3960
it	O	3960
was	O	3960
markedly	O	3960
reduced	O	3960
in	O	3960
quantity	O	3960
when	O	3960
compared	O	3960
with	O	3960
control	O	3960
samples	O	3960
.	O	3960

No	O	3961
apoB	O	3961
was	O	3961
detectable	O	3961
in	O	3961
the	O	3961
plasma	O	3961
of	O	3961
HBL	B-Disease	3961
individuals	O	3961
with	O	3961
an	O	3961
ELISA	O	3961
assay	O	3961
.	O	3961

These	O	3962
data	O	3962
are	O	3962
most	O	3962
consistent	O	3962
with	O	3962
a	O	3962
mutation	O	3962
in	O	3962
the	O	3962
coding	O	3962
portion	O	3962
of	O	3962
the	O	3962
apoB	O	3962
gene	O	3962
in	O	3962
HBL	B-Disease	3962
patients	O	3962
,	O	3962
leading	O	3962
to	O	3962
an	O	3962
abnormal	O	3962
apoB	O	3962
protein	O	3962
and	O	3962
apoB	O	3962
mRNA	O	3962
instability	O	3962
.	O	3962

These	O	3963
results	O	3963
are	O	3963
distinct	O	3963
from	O	3963
those	O	3963
previously	O	3963
noted	O	3963
in	O	3963
abetalipoproteinemia	B-Disease	3963
,	O	3963
which	O	3963
was	O	3963
characterized	O	3963
by	O	3963
an	O	3963
elevated	O	3963
level	O	3963
of	O	3963
hepatic	O	3963
apoB	O	3963
mRNA	O	3963
and	O	3963
accumulation	O	3963
of	O	3963
intracellular	O	3963
hepatic	O	3963
apoB	O	3963
protein	O	3963
.	O	3963

Spontaneous	O	3965
reversion	O	3965
of	O	3965
novel	O	3965
Lesch	B-Disease	3965
-	I-Disease	3965
Nyhan	I-Disease	3965
mutation	O	3965
by	O	3965
HPRT	O	3965
gene	O	3965
rearrangement	O	3965
.	O	3965

Molecular	O	3966
analysis	O	3966
of	O	3966
an	O	3966
unusual	O	3966
patient	O	3966
with	O	3966
the	O	3966
Lesch	B-Disease	3966
-	I-Disease	3966
Nyhan	I-Disease	3966
syndrome	I-Disease	3966
has	O	3966
suggested	O	3966
that	O	3966
the	O	3966
mutation	O	3966
is	O	3966
due	O	3966
to	O	3966
a	O	3966
partial	O	3966
HPRT	O	3966
gene	O	3966
duplication	O	3966
.	O	3966

Growth	O	3970
of	O	3970
Epstein	B-Disease	3970
-	I-Disease	3970
Barr	I-Disease	3970
virus	O	3970
-	O	3970
transformed	O	3970
lymphoblasts	O	3970
from	O	3970
this	O	3970
patient	O	3970
in	O	3970
selective	O	3970
medium	O	3970
has	O	3970
permitted	O	3970
isolation	O	3970
of	O	3970
spontaneous	O	3970
HPRT	O	3970
+	O	3970
revertants	O	3970
of	O	3970
this	O	3970
mutation	O	3970
.	O	3970

This	O	3973
may	O	3973
explain	O	3973
the	O	3973
relatively	O	3973
mild	O	3973
symptoms	O	3973
of	O	3973
the	O	3973
Lesch	B-Disease	3973
-	I-Disease	3973
Nyhan	I-Disease	3973
syndrome	I-Disease	3973
exhibited	O	3973
by	O	3973
this	O	3973
patient	O	3973
.	O	3973

Complex	B-Disease	3975
glycerol	I-Disease	3975
kinase	I-Disease	3975
deficiency	I-Disease	3975
:	O	3975
molecular	O	3975
-	O	3975
genetic	O	3975
,	O	3975
cytogenetic	O	3975
,	O	3975
and	O	3975
clinical	O	3975
studies	O	3975
of	O	3975
five	O	3975
Japanese	O	3975
patients	O	3975
.	O	3975

Five	O	3976
male	O	3976
Japanese	O	3976
patients	O	3976
with	O	3976
complex	B-Disease	3976
glycerol	I-Disease	3976
kinase	I-Disease	3976
deficiency	I-Disease	3976
(	O	3976
CGKD	B-Disease	3976
)	O	3976
and	O	3976
their	O	3976
relatives	O	3976
were	O	3976
studied	O	3976
clinically	O	3976
,	O	3976
cytogenetically	O	3976
,	O	3976
and	O	3976
molecular	O	3976
-	O	3976
genetically	O	3976
.	O	3976

All	O	3977
patients	O	3977
had	O	3977
muscular	B-Disease	3977
dystrophy	I-Disease	3977
or	O	3977
muscle	B-Disease	3977
weakness	I-Disease	3977
,	O	3977
mental	B-Disease	3977
retardation	I-Disease	3977
,	O	3977
congenital	B-Disease	3977
adrenal	I-Disease	3977
hypoplasia	I-Disease	3977
,	O	3977
and	O	3977
glycerol	B-Disease	3977
kinase	I-Disease	3977
deficiency	I-Disease	3977
.	O	3977

A	O	3984
comparison	O	3984
of	O	3984
the	O	3984
clinical	O	3984
manifestations	O	3984
of	O	3984
the	O	3984
present	O	3984
five	O	3984
patients	O	3984
and	O	3984
reported	O	3984
CGKD	B-Disease	3984
or	O	3984
Duchenne	B-Disease	3984
muscular	I-Disease	3984
dystrophy	I-Disease	3984
(	O	3984
DMD	B-Disease	3984
)	O	3984
patients	O	3984
with	O	3984
DNA	O	3984
deletion	O	3984
suggests	O	3984
the	O	3984
existence	O	3984
of	O	3984
a	O	3984
certain	O	3984
gene	O	3984
responsible	O	3984
for	O	3984
gonadotropin	B-Disease	3984
deficiency	I-Disease	3984
(	O	3984
GTD	B-Disease	3984
)	O	3984
.	O	3984

The	O	3985
result	O	3985
of	O	3985
the	O	3985
present	O	3985
study	O	3985
and	O	3985
results	O	3985
of	O	3985
previous	O	3985
studies	O	3985
suggest	O	3985
that	O	3985
genes	O	3985
for	O	3985
ornithine	O	3985
transcarbamylase	O	3985
(	O	3985
OTC	O	3985
)	O	3985
,	O	3985
DMD	B-Disease	3985
,	O	3985
and	O	3985
GK	O	3985
and	O	3985
putative	O	3985
genes	O	3985
responsible	O	3985
for	O	3985
congenital	B-Disease	3985
adrenal	I-Disease	3985
hypoplasia	I-Disease	3985
(	O	3985
AHC	B-Disease	3985
)	O	3985
and	O	3985
GTD	B-Disease	3985
are	O	3985
arranged	O	3985
from	O	3985
telomere	O	3985
to	O	3985
centromere	O	3985
as	O	3985
pter	O	3985
-	O	3985
-	O	3985
GTD	O	3985
-	O	3985
-	O	3985
AHC	O	3985
-	O	3985
-	O	3985
GK	O	3985
-	O	3985
-	O	3985
DMD	O	3985
-	O	3985
-	O	3985
OTC	O	3985
-	O	3985
-	O	3985
cen	O	3985
Genetically	O	3985
determined	O	3985
low	O	3985
C4	O	3985
:	O	3985
a	O	3985
predisposing	O	3985
factor	O	3985
to	O	3985
autoimmune	B-Disease	3985
chronic	I-Disease	3985
active	I-Disease	3985
hepatitis	I-Disease	3985
.	O	3985

Of	O	3986
26	O	3986
patients	O	3986
with	O	3986
autoimmune	B-Disease	3986
chronic	I-Disease	3986
active	I-Disease	3986
hepatitis	I-Disease	3986
(	O	3986
CAH	B-Disease	3986
)	O	3986
starting	O	3986
in	O	3986
childhood	O	3986
18	O	3986
(	O	3986
69	O	3986
%	O	3986
)	O	3986
had	O	3986
low	O	3986
C4	O	3986
and	O	3986
5	O	3986
(	O	3986
19	O	3986
%	O	3986
)	O	3986
had	O	3986
low	O	3986
C3	O	3986
serum	O	3986
levels	O	3986
.	O	3986

These	O	3991
results	O	3991
suggest	O	3991
that	O	3991
low	O	3991
C4	O	3991
levels	O	3991
in	O	3991
CAH	B-Disease	3991
are	O	3991
genetically	O	3991
determined	O	3991
.	O	3991

C4	O	3992
phenotyping	O	3992
in	O	3992
20	O	3992
patients	O	3992
and	O	3992
in	O	3992
26	O	3992
parents	O	3992
showed	O	3992
that	O	3992
90	O	3992
%	O	3992
and	O	3992
81	O	3992
%	O	3992
,	O	3992
respectively	O	3992
,	O	3992
had	O	3992
nan	O	3992
allotypes	O	3992
at	O	3992
either	O	3992
the	O	3992
C4A	O	3992
or	O	3992
C4B	O	3992
locus	O	3992
compared	O	3992
with	O	3992
59	O	3992
%	O	3992
in	O	3992
controls	O	3992
,	O	3992
indicating	O	3992
that	O	3992
defective	O	3992
expression	O	3992
of	O	3992
structural	O	3992
genes	O	3992
may	O	3992
contribute	O	3992
to	O	3992
the	O	3992
observed	O	3992
C4	B-Disease	3992
deficiency	I-Disease	3992
.	O	3992

An	O	3994
amino	O	3994
-	O	3994
acid	O	3994
substitution	O	3994
involved	O	3994
in	O	3994
phenylketonuria	B-Disease	3994
is	O	3994
in	O	3994
linkage	O	3994
disequilibrium	O	3994
with	O	3994
DNA	O	3994
haplotype	O	3994
2	O	3994
.	O	3994

Phenylketonuria	B-Disease	3995
(	O	3995
PKU	B-Disease	3995
)	O	3995
is	O	3995
an	O	3995
autosomal	B-Disease	3995
recessive	I-Disease	3995
human	I-Disease	3995
genetic	I-Disease	3995
disorder	I-Disease	3995
caused	O	3995
by	O	3995
a	O	3995
deficiency	B-Disease	3995
of	I-Disease	3995
hepatic	I-Disease	3995
phenylalanine	I-Disease	3995
hydroxylase	I-Disease	3995
(	O	3995
PAH	O	3995
,	O	3995
phenylalanine	O	3995
4	O	3995
-	O	3995
monooxygenase	O	3995
,	O	3995
EC	O	3995
1	O	3995
.	O	3995

PKU	B-Disease	3999
is	O	3999
a	O	3999
common	O	3999
inborn	B-Disease	3999
error	I-Disease	3999
of	I-Disease	3999
amino	I-Disease	3999
-	I-Disease	3999
acid	I-Disease	3999
metabolism	I-Disease	3999
in	O	3999
caucasian	O	3999
populations	O	3999
and	O	3999
approximately	O	3999
1	O	3999
in	O	3999
50	O	3999
individuals	O	3999
are	O	3999
carriers	O	3999
of	O	3999
a	O	3999
PKU	B-Disease	3999
allele	O	3999
.	O	3999

To	O	4000
define	O	4000
the	O	4000
molecular	O	4000
basis	O	4000
of	O	4000
PKU	B-Disease	4000
,	O	4000
we	O	4000
characterized	O	4000
twelve	O	4000
restriction	O	4000
fragment	O	4000
-	O	4000
length	O	4000
polymorphism	O	4000
(	O	4000
RFLP	O	4000
)	O	4000
haplotypes	O	4000
of	O	4000
the	O	4000
PAH	O	4000
locus	O	4000
in	O	4000
the	O	4000
northern	O	4000
European	O	4000
population	O	4000
and	O	4000
observed	O	4000
that	O	4000
90	O	4000
%	O	4000
of	O	4000
the	O	4000
PKU	B-Disease	4000
alleles	O	4000
in	O	4000
this	O	4000
population	O	4000
are	O	4000
confined	O	4000
to	O	4000
four	O	4000
common	O	4000
RFLP	O	4000
haplotypes	O	4000
.	O	4000

We	O	4002
now	O	4002
report	O	4002
the	O	4002
molecular	B-Disease	4002
lesion	I-Disease	4002
associated	O	4002
with	O	4002
the	O	4002
RFLP	O	4002
haplotype	O	4002
2	O	4002
mutant	O	4002
allele	O	4002
.	O	4002

Direct	O	4004
hybridization	O	4004
analysis	O	4004
of	O	4004
the	O	4004
point	O	4004
mutation	O	4004
using	O	4004
a	O	4004
specific	O	4004
oligonucleotide	O	4004
probe	O	4004
demonstrated	O	4004
that	O	4004
this	O	4004
mutation	O	4004
is	O	4004
also	O	4004
in	O	4004
linkage	O	4004
disequilibrium	O	4004
with	O	4004
RFLP	O	4004
haplotype	O	4004
2	O	4004
alleles	O	4004
that	O	4004
make	O	4004
up	O	4004
about	O	4004
20	O	4004
%	O	4004
of	O	4004
mutant	O	4004
PAH	O	4004
genes	O	4004
Choroideremia	B-Disease	4004
:	O	4004
close	O	4004
linkage	O	4004
to	O	4004
DXYS1	O	4004
and	O	4004
DXYS12	O	4004
demonstrated	O	4004
by	O	4004
segregation	O	4004
analysis	O	4004
and	O	4004
historical	O	4004
-	O	4004
genealogical	O	4004
evidence	O	4004
.	O	4004

Linkage	O	4005
studies	O	4005
using	O	4005
restriction	O	4005
fragment	O	4005
length	O	4005
polymorphisms	O	4005
were	O	4005
conducted	O	4005
in	O	4005
the	O	4005
X	B-Disease	4005
-	I-Disease	4005
linked	I-Disease	4005
disorder	I-Disease	4005
,	O	4005
choroideremia	B-Disease	4005
,	O	4005
designated	O	4005
TCD	B-Disease	4005
for	O	4005
Progressive	B-Disease	4005
Tapeto	I-Disease	4005
-	I-Disease	4005
Choroidal	I-Disease	4005
Dystrophy	I-Disease	4005
.	O	4005

In	O	4008
addition	O	4008
,	O	4008
locus	O	4008
DXYS12	O	4008
was	O	4008
found	O	4008
to	O	4008
be	O	4008
closely	O	4008
linked	O	4008
with	O	4008
TCD	B-Disease	4008
(	O	4008
lod	O	4008
3	O	4008
.	O	4008

All	O	4012
36	O	4012
patients	O	4012
and	O	4012
48	O	4012
carriers	O	4012
tested	O	4012
from	O	4012
the	O	4012
three	O	4012
kindreds	O	4012
had	O	4012
the	O	4012
same	O	4012
haplotype	O	4012
(	O	4012
TCD	B-Disease	4012
/	O	4012
DXYS1	O	4012
,	O	4012
11kb	O	4012
/	O	4012
DXYS12	O	4012
,	O	4012
1	O	4012
.	O	4012

Given	O	4014
that	O	4014
at	O	4014
least	O	4014
105	O	4014
female	O	4014
meioses	O	4014
transmitting	O	4014
TCD	B-Disease	4014
have	O	4014
occurred	O	4014
since	O	4014
1650	O	4014
in	O	4014
these	O	4014
kindreds	O	4014
,	O	4014
extremely	O	4014
close	O	4014
linkage	O	4014
between	O	4014
TCD	B-Disease	4014
,	O	4014
DXYS1	O	4014
and	O	4014
DXYS12	O	4014
is	O	4014
suggested	O	4014
.	O	4014

The	O	4015
above	O	4015
haplotype	O	4015
is	O	4015
a	O	4015
very	O	4015
useful	O	4015
diagnostic	O	4015
tool	O	4015
in	O	4015
these	O	4015
TCD	B-Disease	4015
families	O	4015
.	O	4015

We	O	4016
suggest	O	4016
that	O	4016
our	O	4016
historical	O	4016
-	O	4016
genealogical	O	4016
approach	O	4016
to	O	4016
linkage	O	4016
analysis	O	4016
may	O	4016
be	O	4016
possible	O	4016
elsewhere	O	4016
in	O	4016
similar	O	4016
isolated	O	4016
populations	O	4016
Von	B-Disease	4016
Hippel	I-Disease	4016
-	I-Disease	4016
Lindau	I-Disease	4016
disease	I-Disease	4016
maps	O	4016
to	O	4016
the	O	4016
region	O	4016
of	O	4016
chromosome	O	4016
3	O	4016
associated	O	4016
with	O	4016
renal	B-Disease	4016
cell	I-Disease	4016
carcinoma	I-Disease	4016
.	O	4016

Von	B-Disease	4017
Hippel	I-Disease	4017
-	I-Disease	4017
Lindau	I-Disease	4017
disease	I-Disease	4017
(	O	4017
VHL	B-Disease	4017
)	O	4017
is	O	4017
an	O	4017
autosomal	B-Disease	4017
dominant	I-Disease	4017
disorder	I-Disease	4017
with	O	4017
inherited	O	4017
susceptibility	O	4017
to	O	4017
various	O	4017
forms	O	4017
of	O	4017
cancer	B-Disease	4017
,	O	4017
including	O	4017
hemangioblastomas	B-Disease	4017
of	O	4017
the	O	4017
central	O	4017
nervous	O	4017
system	O	4017
,	O	4017
phaeochromocytomas	B-Disease	4017
,	O	4017
pancreatic	B-Disease	4017
malignancies	I-Disease	4017
,	O	4017
and	O	4017
renal	B-Disease	4017
cell	I-Disease	4017
carcinomas	I-Disease	4017
.	O	4017

Renal	B-Disease	4018
cell	I-Disease	4018
carcinomas	I-Disease	4018
constitute	O	4018
a	O	4018
particularly	O	4018
frequent	O	4018
cause	O	4018
of	O	4018
death	O	4018
in	O	4018
this	O	4018
disorder	O	4018
,	O	4018
occurring	O	4018
as	O	4018
bilateral	B-Disease	4018
and	I-Disease	4018
multifocal	I-Disease	4018
tumours	I-Disease	4018
,	O	4018
and	O	4018
presenting	O	4018
at	O	4018
an	O	4018
earlier	O	4018
age	O	4018
than	O	4018
in	O	4018
sporadic	O	4018
,	O	4018
non	O	4018
-	O	4018
familial	O	4018
cases	O	4018
of	O	4018
this	O	4018
tumour	B-Disease	4018
type	O	4018
.	O	4018

We	O	4019
report	O	4019
here	O	4019
that	O	4019
the	O	4019
VHL	B-Disease	4019
gene	O	4019
is	O	4019
linked	O	4019
to	O	4019
the	O	4019
locus	O	4019
encoding	O	4019
the	O	4019
human	O	4019
homologoue	O	4019
of	O	4019
the	O	4019
RAF1	O	4019
oncogene	O	4019
,	O	4019
which	O	4019
maps	O	4019
to	O	4019
chromosome	O	4019
3p25	O	4019
(	O	4019
ref	O	4019
.	O	4019

Crossovers	O	4021
with	O	4021
the	O	4021
VHL	B-Disease	4021
locus	O	4021
suggest	O	4021
that	O	4021
the	O	4021
defect	O	4021
responsible	O	4021
for	O	4021
the	O	4021
VHL	B-Disease	4021
phenotype	O	4021
is	O	4021
not	O	4021
a	O	4021
mutation	O	4021
in	O	4021
the	O	4021
RAF1	O	4021
gene	O	4021
itself	O	4021
.	O	4021

An	O	4022
alternative	O	4022
or	O	4022
prior	O	4022
event	O	4022
to	O	4022
oncogene	O	4022
activation	O	4022
in	O	4022
tumour	B-Disease	4022
formation	O	4022
may	O	4022
be	O	4022
the	O	4022
inactivation	O	4022
of	O	4022
a	O	4022
putative	O	4022
tumour	B-Disease	4022
suppressor	O	4022
which	O	4022
can	O	4022
be	O	4022
associated	O	4022
with	O	4022
both	O	4022
the	O	4022
inherited	B-Disease	4022
and	I-Disease	4022
sporadic	I-Disease	4022
forms	I-Disease	4022
of	I-Disease	4022
the	I-Disease	4022
cancer	I-Disease	4022
.	O	4022

Sporadic	B-Disease	4023
renal	I-Disease	4023
cell	I-Disease	4023
carcinomas	I-Disease	4023
have	O	4023
previously	O	4023
been	O	4023
associated	O	4023
with	O	4023
the	O	4023
loss	O	4023
of	O	4023
regions	O	4023
on	O	4023
chromosome	O	4023
3p	O	4023
(	O	4023
refs	O	4023
5	O	4023
,	O	4023
6	O	4023
)	O	4023
.	O	4023

Consequently	O	4024
,	O	4024
sporadic	O	4024
and	O	4024
VHL	O	4024
-	O	4024
associated	O	4024
forms	O	4024
of	O	4024
renal	B-Disease	4024
cell	I-Disease	4024
carcinoma	I-Disease	4024
might	O	4024
both	O	4024
result	O	4024
from	O	4024
alterations	O	4024
causing	O	4024
loss	O	4024
of	O	4024
function	O	4024
of	O	4024
the	O	4024
same	O	4024
tumour	B-Disease	4024
suppressor	O	4024
gene	O	4024
on	O	4024
this	O	4024
chromosome	O	4024
.	O	4024

Tightly	O	4026
linked	O	4026
flanking	O	4026
markers	O	4026
for	O	4026
the	O	4026
Lowe	B-Disease	4026
oculocerebrorenal	I-Disease	4026
syndrome	I-Disease	4026
,	O	4026
with	O	4026
application	O	4026
to	O	4026
carrier	O	4026
assessment	O	4026
.	O	4026

The	O	4027
Lowe	B-Disease	4027
oculocerebrorenal	I-Disease	4027
syndrome	I-Disease	4027
(	O	4027
OCRL	B-Disease	4027
)	O	4027
is	O	4027
characterized	O	4027
by	O	4027
congenital	O	4027
cataract	B-Disease	4027
,	O	4027
mental	B-Disease	4027
retardation	I-Disease	4027
,	O	4027
and	O	4027
defective	B-Disease	4027
renal	I-Disease	4027
tubular	I-Disease	4027
function	I-Disease	4027
.	O	4027

A	O	4028
map	O	4028
assignment	O	4028
of	O	4028
OCRL	B-Disease	4028
to	O	4028
Xq24	O	4028
-	O	4028
q26	O	4028
has	O	4028
been	O	4028
made	O	4028
previously	O	4028
by	O	4028
linkage	O	4028
analysis	O	4028
with	O	4028
DXS42	O	4028
at	O	4028
Xq24	O	4028
-	O	4028
q26	O	4028
(	O	4028
theta	O	4028
=	O	4028
0	O	4028
,	O	4028
z	O	4028
=	O	4028
5	O	4028
.	O	4028

With	O	4032
additional	O	4032
OCRL	B-Disease	4032
families	O	4032
made	O	4032
informative	O	4032
for	O	4032
DXS42	O	4032
,	O	4032
theta	O	4032
remained	O	4032
0	O	4032
with	O	4032
z	O	4032
=	O	4032
6	O	4032
.	O	4032

Evidence	O	4036
for	O	4036
placing	O	4036
OCRL	O	4036
at	O	4036
Xq25	O	4036
also	O	4036
comes	O	4036
from	O	4036
a	O	4036
female	O	4036
with	O	4036
Lowe	B-Disease	4036
syndrome	I-Disease	4036
and	O	4036
an	O	4036
X	O	4036
;	O	4036
3	O	4036
translocation	O	4036
.	O	4036

The	O	4040
markers	O	4040
DXS10	O	4040
and	O	4040
DXS42	O	4040
therefore	O	4040
show	O	4040
tight	O	4040
linkage	O	4040
with	O	4040
OCRL	B-Disease	4040
in	O	4040
six	O	4040
families	O	4040
and	O	4040
flank	O	4040
the	O	4040
Xq25	O	4040
breakpoint	O	4040
in	O	4040
a	O	4040
female	O	4040
patient	O	4040
with	O	4040
an	O	4040
X	O	4040
;	O	4040
3	O	4040
translocation	O	4040
.	O	4040

Linkage	O	4041
analysis	O	4041
with	O	4041
flanking	O	4041
markers	O	4041
was	O	4041
used	O	4041
to	O	4041
assess	O	4041
OCRL	B-Disease	4041
carrier	O	4041
status	O	4041
in	O	4041
women	O	4041
at	O	4041
risk	O	4041
.	O	4041

Results	O	4042
,	O	4042
when	O	4042
compared	O	4042
with	O	4042
carrier	O	4042
determination	O	4042
by	O	4042
ophthalmologic	O	4042
examination	O	4042
,	O	4042
indicated	O	4042
that	O	4042
the	O	4042
slit	O	4042
-	O	4042
lamp	O	4042
exam	O	4042
can	O	4042
be	O	4042
a	O	4042
sensitive	O	4042
and	O	4042
specific	O	4042
method	O	4042
of	O	4042
carrier	O	4042
determination	O	4042
in	O	4042
many	O	4042
cases	O	4042
Identification	O	4042
of	O	4042
a	O	4042
single	O	4042
nucleotide	O	4042
change	O	4042
in	O	4042
the	O	4042
hypoxanthine	O	4042
-	O	4042
guanine	O	4042
phosphoribosyltransferase	O	4042
gene	O	4042
(	O	4042
HPRTYale	O	4042
)	O	4042
responsible	O	4042
for	O	4042
Lesch	B-Disease	4042
-	I-Disease	4042
Nyhan	I-Disease	4042
syndrome	I-Disease	4042
.	O	4042

Complete	O	4043
deficiency	B-Disease	4043
of	I-Disease	4043
hypoxanthine	I-Disease	4043
-	I-Disease	4043
guanine	I-Disease	4043
phosphoribosyltransferase	I-Disease	4043
(	O	4043
HPRT	O	4043
)	O	4043
causes	O	4043
the	O	4043
Lesch	B-Disease	4043
-	I-Disease	4043
Nyhan	I-Disease	4043
syndrome	I-Disease	4043
.	O	4043

Previous	O	4044
characterization	O	4044
of	O	4044
a	O	4044
mutant	O	4044
form	O	4044
of	O	4044
HPRT	O	4044
,	O	4044
HPRTYale	O	4044
,	O	4044
from	O	4044
a	O	4044
subject	O	4044
with	O	4044
the	O	4044
Lesch	B-Disease	4044
-	I-Disease	4044
Nyhan	I-Disease	4044
syndrome	I-Disease	4044
revealed	O	4044
normal	O	4044
mRNA	O	4044
and	O	4044
protein	O	4044
concentrations	O	4044
,	O	4044
no	O	4044
residual	O	4044
catalytic	O	4044
activity	O	4044
,	O	4044
and	O	4044
cathodal	O	4044
migration	O	4044
upon	O	4044
PAGE	O	4044
.	O	4044

G6PD	B-Disease	4054
deficiency	I-Disease	4054
in	O	4054
different	O	4054
geographical	O	4054
areas	O	4054
appears	O	4054
to	O	4054
have	O	4054
arisen	O	4054
through	O	4054
independent	O	4054
mutational	O	4054
events	O	4054
,	O	4054
but	O	4054
within	O	4054
the	O	4054
same	O	4054
population	O	4054
it	O	4054
may	O	4054
also	O	4054
be	O	4054
heterogeneous	O	4054
.	O	4054

We	O	4056
cloned	O	4056
and	O	4056
sequenced	O	4056
the	O	4056
four	O	4056
G6PD	O	4056
variants	O	4056
from	O	4056
Sardinia	O	4056
and	O	4056
found	O	4056
that	O	4056
only	O	4056
two	O	4056
mutations	O	4056
are	O	4056
responsible	O	4056
for	O	4056
G6PD	B-Disease	4056
deficiency	I-Disease	4056
in	O	4056
this	O	4056
area	O	4056
one	O	4056
mutation	O	4056
is	O	4056
the	O	4056
cause	O	4056
of	O	4056
the	O	4056
G6PD	B-Disease	4056
Seattle	I-Disease	4056
-	I-Disease	4056
like	I-Disease	4056
phenotype	I-Disease	4056
,	O	4056
a	O	4056
milder	O	4056
form	O	4056
of	O	4056
G6PD	B-Disease	4056
deficiency	I-Disease	4056
;	O	4056
the	O	4056
other	O	4056
mutation	O	4056
is	O	4056
responsible	O	4056
for	O	4056
all	O	4056
forms	O	4056
of	O	4056
very	O	4056
severe	O	4056
G6PD	B-Disease	4056
deficiency	I-Disease	4056
in	O	4056
Sardinia	O	4056
and	O	4056
,	O	4056
possibly	O	4056
,	O	4056
in	O	4056
the	O	4056
Mediterranean	O	4056
.	O	4056

Chronic	B-Disease	4058
nonspherocytic	I-Disease	4058
hemolytic	I-Disease	4058
anemia	I-Disease	4058
(	O	4058
CNSHA	B-Disease	4058
)	O	4058
and	O	4058
glucose	B-Disease	4058
6	I-Disease	4058
phosphate	I-Disease	4058
dehydrogenase	I-Disease	4058
(	I-Disease	4058
G6PD	I-Disease	4058
)	I-Disease	4058
deficiency	I-Disease	4058
in	O	4058
a	O	4058
patient	O	4058
with	O	4058
familial	B-Disease	4058
amyloidotic	I-Disease	4058
polyneuropathy	I-Disease	4058
(	O	4058
FAP	B-Disease	4058
)	O	4058
.	O	4058

A	O	4060
new	O	4060
glucose	O	4060
-	O	4060
6	O	4060
-	O	4060
phosphate	O	4060
dehydrogenase	O	4060
(	O	4060
G6PD	O	4060
)	O	4060
variant	O	4060
with	O	4060
severe	O	4060
erythrocytic	B-Disease	4060
G6PD	I-Disease	4060
deficiency	I-Disease	4060
and	O	4060
a	O	4060
unique	O	4060
pH	O	4060
optimum	O	4060
is	O	4060
described	O	4060
in	O	4060
a	O	4060
young	O	4060
patient	O	4060
with	O	4060
chronic	B-Disease	4060
nonspherocytic	I-Disease	4060
hemolytic	I-Disease	4060
anemia	I-Disease	4060
(	O	4060
CNSHA	B-Disease	4060
)	O	4060
and	O	4060
familial	B-Disease	4060
amyloidotic	I-Disease	4060
polyneuropathy	I-Disease	4060
(	O	4060
FAP	B-Disease	4060
)	O	4060
.	O	4060

Chronic	B-Disease	4061
hemolysis	I-Disease	4061
was	O	4061
present	O	4061
in	O	4061
the	O	4061
absence	O	4061
of	O	4061
infections	O	4061
,	O	4061
oxidant	O	4061
drugs	O	4061
or	O	4061
ingestion	O	4061
of	O	4061
faba	O	4061
beans	O	4061
.	O	4061

Therefore	O	4070
the	O	4070
present	O	4070
variant	O	4070
has	O	4070
been	O	4070
designated	O	4070
G6PD	O	4070
Clinic	O	4070
to	O	4070
distinguish	O	4070
it	O	4070
from	O	4070
other	O	4070
G6PD	O	4070
variants	O	4070
previously	O	4070
described	O	4070
Molecular	O	4070
detection	O	4070
of	O	4070
chromosomal	O	4070
translocations	O	4070
that	O	4070
disrupt	O	4070
the	O	4070
putative	O	4070
retinoblastoma	B-Disease	4070
susceptibility	O	4070
locus	O	4070
.	O	4070

A	O	4071
candidate	O	4071
DNA	O	4071
sequence	O	4071
with	O	4071
many	O	4071
of	O	4071
the	O	4071
properties	O	4071
predicted	O	4071
for	O	4071
the	O	4071
retinoblastoma	B-Disease	4071
susceptibility	O	4071
(	O	4071
RB1	O	4071
)	O	4071
locus	O	4071
has	O	4071
been	O	4071
cloned	O	4071
(	O	4071
S	O	4071
.	O	4071

Here	O	4091
we	O	4091
used	O	4091
field	O	4091
inversion	O	4091
gel	O	4091
electrophoresis	O	4091
(	O	4091
FIGE	O	4091
)	O	4091
to	O	4091
construct	O	4091
a	O	4091
restriction	O	4091
map	O	4091
of	O	4091
approximately	O	4091
1	O	4091
,	O	4091
000	O	4091
kb	O	4091
of	O	4091
DNA	O	4091
surrounding	O	4091
the	O	4091
RB1	O	4091
locus	O	4091
and	O	4091
to	O	4091
detect	O	4091
the	O	4091
translocation	O	4091
breakpoints	O	4091
in	O	4091
three	O	4091
retinoblastoma	B-Disease	4091
patients	O	4091
.	O	4091

The	O	4096
detection	O	4096
and	O	4096
mapping	O	4096
of	O	4096
the	O	4096
translocation	O	4096
breakpoints	O	4096
of	O	4096
all	O	4096
three	O	4096
retinoblastoma	B-Disease	4096
patients	O	4096
to	O	4096
within	O	4096
the	O	4096
putative	O	4096
RB1	O	4096
gene	O	4096
substantiated	O	4096
the	O	4096
authenticity	O	4096
of	O	4096
this	O	4096
candidate	O	4096
sequence	O	4096
and	O	4096
demonstrated	O	4096
the	O	4096
utility	O	4096
of	O	4096
FIGE	O	4096
in	O	4096
detecting	O	4096
chromosomal	O	4096
rearrangements	O	4096
affecting	O	4096
this	O	4096
locus	O	4096
.	O	4096

Inherited	O	4097
C3	B-Disease	4097
deficiency	I-Disease	4097
with	O	4097
recurrent	O	4097
infections	O	4097
and	O	4097
glomerulonephritis	B-Disease	4097
.	O	4097

A	O	4098
10	O	4098
-	O	4098
year	O	4098
-	O	4098
old	O	4098
Laotian	O	4098
boy	O	4098
had	O	4098
homozygous	O	4098
deficiency	B-Disease	4098
of	I-Disease	4098
the	I-Disease	4098
third	I-Disease	4098
component	I-Disease	4098
of	I-Disease	4098
complement	I-Disease	4098
and	O	4098
recurrent	O	4098
bacterial	B-Disease	4098
infections	I-Disease	4098
beginning	O	4098
at	O	4098
age	O	4098
5	O	4098
months	O	4098
.	O	4098

In	O	4101
vitro	O	4101
addition	O	4101
of	O	4101
purified	O	4101
C3	O	4101
to	O	4101
patient	O	4101
serum	O	4101
restored	O	4101
hemolytic	O	4101
complement	O	4101
to	O	4101
normal	O	4101
levels	O	4101
,	O	4101
and	O	4101
plasma	O	4101
infusion	O	4101
during	O	4101
each	O	4101
of	O	4101
four	O	4101
episodes	O	4101
of	O	4101
pneumonia	B-Disease	4101
significantly	O	4101
enhanced	O	4101
serum	O	4101
opsonic	O	4101
activity	O	4101
for	O	4101
as	O	4101
long	O	4101
as	O	4101
36	O	4101
hours	O	4101
.	O	4101

A	O	4102
renal	O	4102
biopsy	O	4102
specimen	O	4102
revealed	O	4102
mesangiopathic	B-Disease	4102
glomerulonephritis	I-Disease	4102
,	O	4102
although	O	4102
significant	O	4102
levels	O	4102
of	O	4102
circulating	O	4102
IgG	O	4102
immune	O	4102
complexes	O	4102
were	O	4102
not	O	4102
detected	O	4102
.	O	4102

These	O	4103
findings	O	4103
further	O	4103
support	O	4103
the	O	4103
association	O	4103
of	O	4103
C3	B-Disease	4103
deficiency	I-Disease	4103
with	O	4103
immune	B-Disease	4103
-	I-Disease	4103
complex	I-Disease	4103
disease	I-Disease	4103
and	O	4103
suggest	O	4103
that	O	4103
plasma	O	4103
infusion	O	4103
may	O	4103
be	O	4103
an	O	4103
adjunct	O	4103
to	O	4103
antibiotic	O	4103
therapy	O	4103
in	O	4103
the	O	4103
management	O	4103
of	O	4103
severe	O	4103
pyogenic	B-Disease	4103
infections	I-Disease	4103
in	O	4103
patients	O	4103
with	O	4103
C3	B-Disease	4103
deficiency	I-Disease	4103
.	O	4103

A	O	4109
deficiency	B-Disease	4109
of	I-Disease	4109
AAT	I-Disease	4109
in	O	4109
individuals	O	4109
homozygous	O	4109
for	O	4109
the	O	4109
PI	O	4109
Z	O	4109
allele	O	4109
occurs	O	4109
in	O	4109
about	O	4109
1	O	4109
in	O	4109
2	O	4109
,	O	4109
000	O	4109
-	O	4109
8	O	4109
,	O	4109
000	O	4109
caucasians	O	4109
and	O	4109
is	O	4109
associated	O	4109
with	O	4109
an	O	4109
increased	O	4109
risk	O	4109
of	O	4109
early	O	4109
adult	O	4109
onset	O	4109
emphysema	B-Disease	4109
and	O	4109
liver	B-Disease	4109
disease	I-Disease	4109
in	O	4109
childhood	O	4109
.	O	4109

3	O	4115
in	O	4115
Duchenne	B-Disease	4115
and	I-Disease	4115
Becker	I-Disease	4115
muscular	I-Disease	4115
dystrophy	I-Disease	4115
families	O	4115
.	O	4115

3	O	4118
,	O	4118
has	O	4118
been	O	4118
studied	O	4118
in	O	4118
kindreds	O	4118
segregating	O	4118
for	O	4118
Duchenne	B-Disease	4118
muscular	I-Disease	4118
dystrophy	I-Disease	4118
(	O	4118
DMD	B-Disease	4118
)	O	4118
and	O	4118
Becker	B-Disease	4118
muscular	I-Disease	4118
dystrophy	I-Disease	4118
(	O	4118
BMD	B-Disease	4118
)	O	4118
.	O	4118

In	O	4119
DMD	B-Disease	4119
families	O	4119
four	O	4119
crossovers	O	4119
were	O	4119
observed	O	4119
in	O	4119
38	O	4119
informative	O	4119
meioses	O	4119
between	O	4119
C7	O	4119
and	O	4119
the	O	4119
DMD	B-Disease	4119
locus	O	4119
(	O	4119
theta	O	4119
=	O	4119
0	O	4119
.	O	4119

In	O	4122
BMD	B-Disease	4122
families	O	4122
no	O	4122
recombinants	O	4122
were	O	4122
observed	O	4122
in	O	4122
the	O	4122
16	O	4122
informative	O	4122
meioses	O	4122
studied	O	4122
.	O	4122

C7	O	4128
and	O	4128
754	O	4128
thus	O	4128
provide	O	4128
good	O	4128
bridging	O	4128
markers	O	4128
for	O	4128
the	O	4128
diagnosis	O	4128
of	O	4128
DMD	B-Disease	4128
and	O	4128
BMD	B-Disease	4128
Isolation	O	4128
of	O	4128
molecular	O	4128
probes	O	4128
associated	O	4128
with	O	4128
the	O	4128
chromosome	O	4128
15	O	4128
instability	O	4128
in	O	4128
the	O	4128
Prader	B-Disease	4128
-	I-Disease	4128
Willi	I-Disease	4128
syndrome	I-Disease	4128
.	O	4128

Flow	O	4129
cytometry	O	4129
and	O	4129
recombinant	O	4129
DNA	O	4129
techniques	O	4129
have	O	4129
been	O	4129
used	O	4129
to	O	4129
obtain	O	4129
reagents	O	4129
for	O	4129
a	O	4129
molecular	O	4129
analysis	O	4129
of	O	4129
the	O	4129
Prader	B-Disease	4129
-	I-Disease	4129
Willi	I-Disease	4129
syndrome	I-Disease	4129
(	O	4129
PWS	B-Disease	4129
)	O	4129
.	O	4129

2	O	4135
and	O	4135
are	O	4135
shown	O	4135
to	O	4135
be	O	4135
deleted	O	4135
in	O	4135
DNA	O	4135
of	O	4135
one	O	4135
of	O	4135
two	O	4135
patients	O	4135
examined	O	4135
with	O	4135
the	O	4135
PWS	B-Disease	4135
.	O	4135

2	O	4139
may	O	4139
elucidate	O	4139
the	O	4139
molecular	O	4139
basis	O	4139
for	O	4139
the	O	4139
instability	O	4139
of	O	4139
this	O	4139
chromosomal	O	4139
region	O	4139
in	O	4139
patients	O	4139
with	O	4139
the	O	4139
PWS	B-Disease	4139
or	O	4139
other	O	4139
diseases	O	4139
associated	O	4139
with	O	4139
chromosomal	B-Disease	4139
abnormalities	I-Disease	4139
in	O	4139
the	O	4139
proximal	O	4139
long	O	4139
arm	O	4139
of	O	4139
human	O	4139
chromosome	O	4139
15	O	4139
Analysis	O	4139
of	O	4139
deletions	O	4139
in	O	4139
DNA	O	4139
from	O	4139
patients	O	4139
with	O	4139
Becker	B-Disease	4139
and	I-Disease	4139
Duchenne	I-Disease	4139
muscular	I-Disease	4139
dystrophy	I-Disease	4139
.	O	4139

Duchenne	B-Disease	4140
muscular	I-Disease	4140
dystrophy	I-Disease	4140
(	O	4140
DMD	B-Disease	4140
)	O	4140
is	O	4140
an	O	4140
X	B-Disease	4140
-	I-Disease	4140
linked	I-Disease	4140
recessive	I-Disease	4140
genetic	I-Disease	4140
disorder	I-Disease	4140
for	O	4140
which	O	4140
the	O	4140
biochemical	O	4140
defect	O	4140
is	O	4140
as	O	4140
yet	O	4140
unknown	O	4140
.	O	4140

Both	O	4142
of	O	4142
these	O	4142
cloned	O	4142
segments	O	4142
were	O	4142
described	O	4142
as	O	4142
tightly	O	4142
linked	O	4142
to	O	4142
the	O	4142
locus	O	4142
and	O	4142
were	O	4142
capable	O	4142
of	O	4142
detecting	O	4142
deletions	O	4142
in	O	4142
the	O	4142
DNA	O	4142
of	O	4142
boys	O	4142
affected	O	4142
with	O	4142
DMD	B-Disease	4142
.	O	4142

In	O	4143
an	O	4143
attempt	O	4143
to	O	4143
determine	O	4143
more	O	4143
precisely	O	4143
the	O	4143
occurrence	O	4143
of	O	4143
these	O	4143
deletions	O	4143
within	O	4143
a	O	4143
large	O	4143
population	O	4143
of	O	4143
DMD	B-Disease	4143
patients	O	4143
and	O	4143
the	O	4143
accuracy	O	4143
of	O	4143
one	O	4143
of	O	4143
the	O	4143
segments	O	4143
,	O	4143
DXS164	O	4143
(	O	4143
pERT87	O	4143
)	O	4143
,	O	4143
in	O	4143
determining	O	4143
the	O	4143
inheritance	O	4143
of	O	4143
the	O	4143
DMD	B-Disease	4143
X	O	4143
chromosome	O	4143
,	O	4143
the	O	4143
subclones	O	4143
1	O	4143
,	O	4143
8	O	4143
and	O	4143
15	O	4143
were	O	4143
made	O	4143
available	O	4143
to	O	4143
many	O	4143
investigators	O	4143
throughout	O	4143
the	O	4143
world	O	4143
.	O	4143

Here	O	4144
we	O	4144
describe	O	4144
the	O	4144
combined	O	4144
results	O	4144
of	O	4144
more	O	4144
than	O	4144
20	O	4144
research	O	4144
laboratories	O	4144
with	O	4144
respect	O	4144
to	O	4144
the	O	4144
occurrence	O	4144
of	O	4144
deletions	O	4144
at	O	4144
the	O	4144
DXS164	O	4144
locus	O	4144
in	O	4144
DNA	O	4144
samples	O	4144
isolated	O	4144
from	O	4144
patients	O	4144
with	O	4144
DMD	B-Disease	4144
and	O	4144
Becker	B-Disease	4144
muscular	I-Disease	4144
dystrophy	I-Disease	4144
(	O	4144
BMD	B-Disease	4144
)	O	4144
.	O	4144

The	O	4145
results	O	4145
indicate	O	4145
that	O	4145
the	O	4145
DXS164	O	4145
locus	O	4145
apparently	O	4145
recombines	O	4145
with	O	4145
DMD	B-Disease	4145
5	O	4145
%	O	4145
of	O	4145
the	O	4145
time	O	4145
,	O	4145
but	O	4145
is	O	4145
probably	O	4145
located	O	4145
between	O	4145
independent	O	4145
sites	O	4145
of	O	4145
mutation	O	4145
which	O	4145
yield	O	4145
DMD	B-Disease	4145
.	O	4145

The	O	4146
breakpoints	O	4146
of	O	4146
some	O	4146
deletions	O	4146
are	O	4146
delineated	O	4146
within	O	4146
the	O	4146
DXS164	O	4146
locus	O	4146
,	O	4146
and	O	4146
it	O	4146
is	O	4146
evident	O	4146
that	O	4146
the	O	4146
deletions	O	4146
at	O	4146
the	O	4146
DMD	B-Disease	4146
locus	O	4146
are	O	4146
frequent	O	4146
and	O	4146
extremely	O	4146
large	O	4146
.	O	4146

A	O	4148
potential	O	4148
animal	O	4148
model	O	4148
for	O	4148
Lesch	B-Disease	4148
-	I-Disease	4148
Nyhan	I-Disease	4148
syndrome	I-Disease	4148
through	O	4148
introduction	O	4148
of	O	4148
HPRT	O	4148
mutations	O	4148
into	O	4148
mice	O	4148
.	O	4148

The	O	4149
human	O	4149
Lesch	B-Disease	4149
-	I-Disease	4149
Nyhan	I-Disease	4149
syndrome	I-Disease	4149
is	O	4149
a	O	4149
rare	O	4149
neurological	B-Disease	4149
and	I-Disease	4149
behavioural	I-Disease	4149
disorder	I-Disease	4149
,	O	4149
affecting	O	4149
only	O	4149
males	O	4149
,	O	4149
which	O	4149
is	O	4149
caused	O	4149
by	O	4149
an	O	4149
inherited	B-Disease	4149
deficiency	I-Disease	4149
in	O	4149
the	O	4149
level	O	4149
of	O	4149
activity	O	4149
of	O	4149
the	O	4149
purine	O	4149
salvage	O	4149
enzyme	O	4149
hypoxanthine	O	4149
-	O	4149
guanosine	O	4149
phosphoribosyl	O	4149
transferase	O	4149
(	O	4149
HPRT	O	4149
)	O	4149
.	O	4149

How	O	4150
the	O	4150
resulting	O	4150
alterations	O	4150
in	O	4150
purine	O	4150
metabolism	O	4150
lead	O	4150
to	O	4150
the	O	4150
severe	O	4150
symptoms	O	4150
characteristic	O	4150
of	O	4150
Lesch	B-Disease	4150
-	I-Disease	4150
Nyhan	I-Disease	4150
patients	O	4150
is	O	4150
still	O	4150
not	O	4150
understood	O	4150
.	O	4150

To	O	4152
derive	O	4152
an	O	4152
animal	O	4152
model	O	4152
for	O	4152
the	O	4152
Lesch	B-Disease	4152
-	I-Disease	4152
Nyhan	I-Disease	4152
syndrome	I-Disease	4152
,	O	4152
we	O	4152
have	O	4152
used	O	4152
cultured	O	4152
mouse	O	4152
embryonic	O	4152
stem	O	4152
cells	O	4152
,	O	4152
mutagenized	O	4152
by	O	4152
retroviral	O	4152
insertion	O	4152
and	O	4152
selected	O	4152
for	O	4152
loss	O	4152
of	O	4152
HPRT	O	4152
activity	O	4152
,	O	4152
to	O	4152
construct	O	4152
chimaeric	O	4152
mice	O	4152
.	O	4152

Two	O	4153
clonal	O	4153
lines	O	4153
carrying	O	4153
different	O	4153
mutant	O	4153
Hprt	O	4153
alleles	O	4153
have	O	4153
given	O	4153
rise	O	4153
to	O	4153
germ	O	4153
cells	O	4153
in	O	4153
chimaeras	O	4153
,	O	4153
allowing	O	4153
the	O	4153
derivation	O	4153
of	O	4153
strains	O	4153
of	O	4153
mutant	O	4153
mice	O	4153
having	O	4153
the	O	4153
same	O	4153
biochemical	O	4153
defect	O	4153
as	O	4153
Lesch	B-Disease	4153
-	I-Disease	4153
Nyhan	I-Disease	4153
patients	O	4153
.	O	4153

Re	O	4156
-	O	4156
evaluation	O	4156
of	O	4156
the	O	4156
sublocalization	O	4156
of	O	4156
esterase	O	4156
D	O	4156
and	O	4156
its	O	4156
relation	O	4156
to	O	4156
the	O	4156
retinoblastoma	B-Disease	4156
locus	O	4156
by	O	4156
in	O	4156
situ	O	4156
hybridization	O	4156
.	O	4156

A	O	4163
deletion	O	4163
in	O	4163
an	O	4163
individual	O	4163
with	O	4163
retinoblastoma	B-Disease	4163
was	O	4163
reported	O	4163
to	O	4163
separate	O	4163
the	O	4163
closely	O	4163
linked	O	4163
ESD	O	4163
and	O	4163
retinoblastoma	B-Disease	4163
(	O	4163
RB1	O	4163
)	O	4163
loci	O	4163
,	O	4163
placing	O	4163
ESD	O	4163
proximal	O	4163
to	O	4163
RB1	O	4163
.	O	4163

Hereditary	B-Disease	4167
C2	I-Disease	4167
deficiency	I-Disease	4167
associated	O	4167
with	O	4167
common	O	4167
variable	O	4167
immunodeficiency	B-Disease	4167
.	O	4167

Homozygous	O	4168
C2	B-Disease	4168
deficiency	I-Disease	4168
in	O	4168
a	O	4168
19	O	4168
-	O	4168
year	O	4168
-	O	4168
old	O	4168
boy	O	4168
was	O	4168
associated	O	4168
with	O	4168
variable	O	4168
immunodeficiency	B-Disease	4168
manifested	O	4168
by	O	4168
marked	O	4168
hypoimmunoglobulinemia	B-Disease	4168
and	O	4168
impaired	O	4168
antibody	O	4168
responses	O	4168
,	O	4168
normal	O	4168
circulating	O	4168
B	O	4168
lymphocytes	O	4168
,	O	4168
and	O	4168
subnormal	O	4168
T	O	4168
-	O	4168
cell	O	4168
functions	O	4168
.	O	4168

Neither	O	4169
antilymphocytic	O	4169
autoantibodies	O	4169
nor	O	4169
chromosomal	B-Disease	4169
abnormalities	I-Disease	4169
were	O	4169
found	O	4169
.	O	4169

Serum	O	4170
immunoglobulin	O	4170
levels	O	4170
were	O	4170
within	O	4170
normal	O	4170
limits	O	4170
in	O	4170
his	O	4170
parents	O	4170
and	O	4170
brother	O	4170
who	O	4170
were	O	4170
heterozygous	O	4170
for	O	4170
C2	B-Disease	4170
deficiency	I-Disease	4170
.	O	4170

Mild	O	4173
and	O	4173
severe	O	4173
muscular	B-Disease	4173
dystrophy	I-Disease	4173
associated	O	4173
with	O	4173
deletions	O	4173
in	O	4173
Xp21	O	4173
of	O	4173
the	O	4173
human	O	4173
X	O	4173
chromosome	O	4173
.	O	4173

We	O	4174
have	O	4174
analysed	O	4174
over	O	4174
300	O	4174
patients	O	4174
suffering	O	4174
from	O	4174
Duchenne	B-Disease	4174
or	I-Disease	4174
Becker	I-Disease	4174
muscular	I-Disease	4174
dystrophy	I-Disease	4174
(	O	4174
DMD	B-Disease	4174
or	O	4174
BMD	B-Disease	4174
)	O	4174
.	O	4174

These	O	4177
loci	O	4177
have	O	4177
been	O	4177
shown	O	4177
to	O	4177
lie	O	4177
within	O	4177
the	O	4177
DMD	B-Disease	4177
region	O	4177
covering	O	4177
several	O	4177
hundred	O	4177
kilobases	O	4177
(	O	4177
kb	O	4177
)	O	4177
of	O	4177
DNA	O	4177
.	O	4177

One	O	4178
mildly	O	4178
affected	O	4178
BMD	B-Disease	4178
patient	O	4178
possesses	O	4178
a	O	4178
deletion	O	4178
of	O	4178
at	O	4178
least	O	4178
110	O	4178
kb	O	4178
including	O	4178
exons	O	4178
of	O	4178
the	O	4178
DMD	B-Disease	4178
gene	O	4178
.	O	4178

Other	O	4179
patients	O	4179
with	O	4179
similar	O	4179
exon	O	4179
deletions	O	4179
,	O	4179
or	O	4179
smaller	O	4179
deletions	O	4179
,	O	4179
show	O	4179
the	O	4179
more	O	4179
severe	O	4179
phenotype	O	4179
typical	O	4179
of	O	4179
DMD	B-Disease	4179
.	O	4179

Patterns	O	4182
of	O	4182
exon	O	4182
deletions	O	4182
in	O	4182
Duchenne	B-Disease	4182
and	I-Disease	4182
Becker	I-Disease	4182
muscular	I-Disease	4182
dystrophy	I-Disease	4182
.	O	4182

A	O	4183
panel	O	4183
of	O	4183
patients	O	4183
with	O	4183
Duchenne	B-Disease	4183
and	I-Disease	4183
Becker	I-Disease	4183
muscular	I-Disease	4183
dystrophy	I-Disease	4183
(	O	4183
DMD	B-Disease	4183
and	O	4183
BMD	B-Disease	4183
)	O	4183
has	O	4183
been	O	4183
screened	O	4183
with	O	4183
the	O	4183
cDNA	O	4183
probes	O	4183
Cf56a	O	4183
and	O	4183
Cf23a	O	4183
,	O	4183
which	O	4183
detect	O	4183
exons	O	4183
in	O	4183
the	O	4183
central	O	4183
part	O	4183
of	O	4183
the	O	4183
DMD	B-Disease	4183
gene	O	4183
.	O	4183

The	O	4185
deletions	O	4185
were	O	4185
mapped	O	4185
and	O	4185
prove	O	4185
to	O	4185
be	O	4185
heterogeneous	O	4185
in	O	4185
size	O	4185
and	O	4185
extent	O	4185
,	O	4185
particularly	O	4185
in	O	4185
DMD	B-Disease	4185
.	O	4185

Deletions	O	4186
specific	O	4186
to	O	4186
DMD	B-Disease	4186
and	O	4186
to	O	4186
BMD	B-Disease	4186
are	O	4186
described	O	4186
.	O	4186

Half	O	4187
of	O	4187
all	O	4187
BMD	B-Disease	4187
patients	O	4187
have	O	4187
a	O	4187
deletion	O	4187
of	O	4187
one	O	4187
particular	O	4187
small	O	4187
group	O	4187
of	O	4187
exons	O	4187
;	O	4187
smaller	O	4187
deletions	O	4187
within	O	4187
this	O	4187
same	O	4187
group	O	4187
produce	O	4187
the	O	4187
more	O	4187
severe	O	4187
DMD	B-Disease	4187
.	O	4187

Hereditary	B-Disease	4189
deficiency	I-Disease	4189
of	I-Disease	4189
the	I-Disease	4189
third	I-Disease	4189
component	I-Disease	4189
of	I-Disease	4189
complement	I-Disease	4189
in	O	4189
a	O	4189
child	O	4189
with	O	4189
fever	B-Disease	4189
,	O	4189
skin	B-Disease	4189
rash	I-Disease	4189
,	O	4189
and	O	4189
arthralgias	B-Disease	4189
:	O	4189
response	O	4189
to	O	4189
transfusion	O	4189
of	O	4189
whole	O	4189
blood	O	4189
.	O	4189

A	O	4190
previously	O	4190
well	O	4190
34	O	4190
-	O	4190
month	O	4190
-	O	4190
old	O	4190
male	O	4190
presenting	O	4190
with	O	4190
fever	B-Disease	4190
,	O	4190
skin	B-Disease	4190
rash	I-Disease	4190
,	O	4190
and	O	4190
arthralgias	B-Disease	4190
was	O	4190
found	O	4190
to	O	4190
lack	O	4190
C3	O	4190
by	O	4190
immunochemical	O	4190
(	O	4190
undetectable	O	4190
)	O	4190
and	O	4190
hemolytic	O	4190
(	O	4190
1	O	4190
%	O	4190
normal	O	4190
)	O	4190
assays	O	4190
.	O	4190

A	O	4197
transfusion	O	4197
of	O	4197
320	O	4197
ml	O	4197
1	O	4197
-	O	4197
hour	O	4197
-	O	4197
old	O	4197
normal	O	4197
whole	O	4197
blood	O	4197
on	O	4197
the	O	4197
fifty	O	4197
-	O	4197
second	O	4197
day	O	4197
resulted	O	4197
in	O	4197
transitory	O	4197
elevation	O	4197
of	O	4197
the	O	4197
C3	O	4197
level	O	4197
to	O	4197
25	O	4197
mg	O	4197
/	O	4197
dl	O	4197
with	O	4197
a	O	4197
fall	O	4197
-	O	4197
off	O	4197
(	O	4197
approximately	O	4197
2	O	4197
1	O	4197
/	O	4197
2	O	4197
%	O	4197
per	O	4197
hour	O	4197
)	O	4197
to	O	4197
undetectable	O	4197
levels	O	4197
by	O	4197
69	O	4197
hours	O	4197
;	O	4197
it	O	4197
was	O	4197
followed	O	4197
by	O	4197
disappearance	O	4197
of	O	4197
the	O	4197
skin	B-Disease	4197
rash	I-Disease	4197
and	O	4197
arthralgias	B-Disease	4197
and	O	4197
return	O	4197
to	O	4197
normal	O	4197
of	O	4197
the	O	4197
previously	O	4197
elevated	O	4197
temperature	O	4197
and	O	4197
CRP	O	4197
levels	O	4197
.	O	4197

C3	O	4198
levels	O	4198
in	O	4198
family	O	4198
members	O	4198
(	O	4198
seven	O	4198
of	O	4198
24	O	4198
half	O	4198
-	O	4198
normal	O	4198
)	O	4198
,	O	4198
lack	O	4198
of	O	4198
anti	O	4198
-	O	4198
C3	O	4198
activity	O	4198
,	O	4198
normal	O	4198
C3b	O	4198
-	O	4198
INA	O	4198
levels	O	4198
and	O	4198
a	O	4198
normal	O	4198
rate	O	4198
of	O	4198
catabolism	O	4198
of	O	4198
transfused	O	4198
C3	O	4198
indicated	O	4198
that	O	4198
the	O	4198
deficiency	O	4198
was	O	4198
inherited	O	4198
with	O	4198
autosomal	O	4198
codominance	O	4198
and	O	4198
involved	O	4198
decreased	B-Disease	4198
synthesis	I-Disease	4198
of	I-Disease	4198
C3	I-Disease	4198
.	O	4198

Thus	O	4199
,	O	4199
this	O	4199
child	O	4199
is	O	4199
a	O	4199
unique	O	4199
individual	O	4199
with	O	4199
inherited	B-Disease	4199
C3	I-Disease	4199
deficiency	I-Disease	4199
presenting	O	4199
with	O	4199
absence	O	4199
of	O	4199
repeated	O	4199
infections	O	4199
,	O	4199
whose	O	4199
symptoms	O	4199
of	O	4199
fever	B-Disease	4199
,	O	4199
skin	B-Disease	4199
rash	I-Disease	4199
,	O	4199
and	O	4199
arthralgia	B-Disease	4199
were	O	4199
abated	O	4199
by	O	4199
whole	O	4199
blood	O	4199
transfusion	O	4199
.	O	4199

Erythrocyte	O	4202
glucose	O	4202
-	O	4202
6	O	4202
-	O	4202
phosphate	O	4202
dehydrogenase	O	4202
(	O	4202
G6PD	O	4202
)	O	4202
was	O	4202
characterized	O	4202
in	O	4202
blood	O	4202
samples	O	4202
obtained	O	4202
from	O	4202
97	O	4202
randomly	O	4202
selected	O	4202
males	O	4202
with	O	4202
enzyme	B-Disease	4202
deficiency	I-Disease	4202
from	O	4202
various	O	4202
regions	O	4202
of	O	4202
Guangdong	O	4202
Province	O	4202
,	O	4202
China	O	4202
.	O	4202

The	O	4206
results	O	4206
demonstrated	O	4206
that	O	4206
the	O	4206
genetic	O	4206
heterogeneity	O	4206
of	O	4206
G6PD	B-Disease	4206
deficiency	I-Disease	4206
was	O	4206
high	O	4206
in	O	4206
this	O	4206
area	O	4206
.	O	4206

Homozygous	O	4208
and	O	4208
heterozygous	O	4208
deletions	O	4208
of	O	4208
the	O	4208
von	B-Disease	4208
Willebrand	I-Disease	4208
factor	O	4208
gene	O	4208
in	O	4208
patients	O	4208
and	O	4208
carriers	O	4208
of	O	4208
severe	B-Disease	4208
von	I-Disease	4208
Willebrand	I-Disease	4208
disease	I-Disease	4208
.	O	4208

Severe	B-Disease	4209
von	I-Disease	4209
Willebrand	I-Disease	4209
disease	I-Disease	4209
is	O	4209
characterized	O	4209
by	O	4209
undetectable	O	4209
or	O	4209
trace	O	4209
quantities	O	4209
of	O	4209
von	B-Disease	4209
Willebrand	I-Disease	4209
factor	O	4209
in	O	4209
plasma	O	4209
and	O	4209
tissue	O	4209
stores	O	4209
.	O	4209

The	O	4215
second	O	4215
group	O	4215
was	O	4215
comprised	O	4215
of	O	4215
a	O	4215
family	O	4215
in	O	4215
which	O	4215
there	O	4215
was	O	4215
a	O	4215
complete	O	4215
heterozygous	O	4215
deletion	O	4215
of	O	4215
the	O	4215
vWF	O	4215
gene	O	4215
in	O	4215
the	O	4215
proband	O	4215
and	O	4215
one	O	4215
asymptomatic	O	4215
parent	O	4215
,	O	4215
suggesting	O	4215
that	O	4215
a	O	4215
different	O	4215
type	O	4215
of	O	4215
genetic	B-Disease	4215
abnormality	I-Disease	4215
was	O	4215
inherited	O	4215
from	O	4215
the	O	4215
other	O	4215
parent	O	4215
.	O	4215

Thus	O	4216
,	O	4216
the	O	4216
patient	O	4216
appeared	O	4216
to	O	4216
be	O	4216
doubly	O	4216
heterozygous	O	4216
for	O	4216
interacting	O	4216
genetic	B-Disease	4216
abnormalities	I-Disease	4216
affecting	O	4216
vWF	O	4216
expression	O	4216
.	O	4216

These	O	4219
techniques	O	4219
should	O	4219
prove	O	4219
useful	O	4219
in	O	4219
identifying	O	4219
carriers	O	4219
of	O	4219
severe	B-Disease	4219
von	I-Disease	4219
Willebrand	I-Disease	4219
disease	I-Disease	4219
and	O	4219
also	O	4219
in	O	4219
defining	O	4219
patients	O	4219
predictably	O	4219
at	O	4219
risk	O	4219
of	O	4219
developing	O	4219
alloantibodies	O	4219
to	O	4219
vWF	O	4219
.	O	4219

Sjogren	B-Disease	4220
-	I-Disease	4220
Larsson	I-Disease	4220
syndrome	I-Disease	4220
.	O	4220

Lipid	O	4222
metabolism	O	4222
was	O	4222
studied	O	4222
in	O	4222
cultured	O	4222
skin	O	4222
fibroblasts	O	4222
from	O	4222
patients	O	4222
with	O	4222
the	O	4222
inherited	B-Disease	4222
disorder	I-Disease	4222
,	O	4222
Sjogren	B-Disease	4222
-	I-Disease	4222
Larsson	I-Disease	4222
syndrome	I-Disease	4222
(	O	4222
SLS	B-Disease	4222
)	O	4222
.	O	4222

Intact	O	4223
SLS	B-Disease	4223
fibroblasts	O	4223
incubated	O	4223
in	O	4223
the	O	4223
presence	O	4223
of	O	4223
[	O	4223
1	O	4223
-	O	4223
14C	O	4223
]	O	4223
palmitate	O	4223
accumulated	O	4223
more	O	4223
radioactive	O	4223
hexadecanol	O	4223
than	O	4223
did	O	4223
normal	O	4223
cells	O	4223
,	O	4223
whereas	O	4223
incorporation	O	4223
of	O	4223
radioactivity	O	4223
into	O	4223
other	O	4223
cellular	O	4223
lipids	O	4223
was	O	4223
unaltered	O	4223
.	O	4223

The	O	4224
hexadecanol	O	4224
content	O	4224
of	O	4224
SLS	B-Disease	4224
fibroblasts	O	4224
was	O	4224
abnormally	O	4224
elevated	O	4224
.	O	4224

The	O	4226
half	O	4226
-	O	4226
life	O	4226
of	O	4226
intracellular	O	4226
hexadecanol	O	4226
loaded	O	4226
into	O	4226
SLS	B-Disease	4226
fibroblasts	O	4226
was	O	4226
increased	O	4226
(	O	4226
70	O	4226
min	O	4226
)	O	4226
compared	O	4226
with	O	4226
normal	O	4226
(	O	4226
15	O	4226
min	O	4226
)	O	4226
,	O	4226
and	O	4226
intact	O	4226
SLS	B-Disease	4226
fibroblasts	O	4226
showed	O	4226
impaired	O	4226
oxidation	O	4226
of	O	4226
[	O	4226
14C	O	4226
]	O	4226
-	O	4226
hexadecanol	O	4226
to	O	4226
fatty	O	4226
acid	O	4226
.	O	4226

Fatty	O	4227
alcohol	O	4227
NAD	O	4227
+	O	4227
oxidoreductase	O	4227
,	O	4227
the	O	4227
enzyme	O	4227
catalyzing	O	4227
this	O	4227
reaction	O	4227
,	O	4227
was	O	4227
deficient	O	4227
in	O	4227
SLS	B-Disease	4227
fibroblasts	O	4227
.	O	4227

Mean	O	4228
total	O	4228
activity	O	4228
in	O	4228
SLS	B-Disease	4228
fibroblasts	O	4228
(	O	4228
n	O	4228
=	O	4228
5	O	4228
)	O	4228
was	O	4228
13	O	4228
%	O	4228
of	O	4228
that	O	4228
in	O	4228
normal	O	4228
fibroblasts	O	4228
,	O	4228
and	O	4228
palmitoyl	O	4228
CoA	O	4228
-	O	4228
inhibitable	O	4228
activity	O	4228
was	O	4228
1	O	4228
%	O	4228
of	O	4228
normal	O	4228
.	O	4228

Fibroblasts	O	4229
from	O	4229
two	O	4229
obligate	O	4229
SLS	B-Disease	4229
heterozygotes	O	4229
had	O	4229
enzyme	O	4229
activities	O	4229
intermediate	O	4229
between	O	4229
that	O	4229
in	O	4229
normal	O	4229
fibroblasts	O	4229
and	O	4229
individuals	O	4229
with	O	4229
SLS	B-Disease	4229
.	O	4229

These	O	4230
results	O	4230
suggest	O	4230
that	O	4230
the	O	4230
primary	O	4230
defect	O	4230
in	O	4230
SLS	B-Disease	4230
is	O	4230
deficiency	B-Disease	4230
of	I-Disease	4230
fatty	I-Disease	4230
alcohol	I-Disease	4230
NAD	I-Disease	4230
+	I-Disease	4230
oxidoreductase	I-Disease	4230
.	O	4230

SLS	B-Disease	4231
represents	O	4231
the	O	4231
first	O	4231
inherited	B-Disease	4231
disorder	I-Disease	4231
in	O	4231
man	O	4231
associated	O	4231
with	O	4231
an	O	4231
isolated	O	4231
abnormality	B-Disease	4231
in	I-Disease	4231
fatty	I-Disease	4231
alcohol	I-Disease	4231
metabolism	I-Disease	4231
.	O	4231

Germinal	O	4233
mosaicism	O	4233
in	O	4233
Duchenne	B-Disease	4233
muscular	I-Disease	4233
dystrophy	I-Disease	4233
.	O	4233

We	O	4234
have	O	4234
identified	O	4234
a	O	4234
Duchenne	B-Disease	4234
muscular	I-Disease	4234
dystrophy	I-Disease	4234
(	O	4234
DMD	B-Disease	4234
)	O	4234
pedigree	O	4234
where	O	4234
the	O	4234
disease	O	4234
is	O	4234
associated	O	4234
with	O	4234
a	O	4234
molecular	O	4234
deletion	O	4234
within	O	4234
the	O	4234
DMD	B-Disease	4234
locus	O	4234
.	O	4234

Nebulin	O	4239
seen	O	4239
in	O	4239
DMD	B-Disease	4239
males	O	4239
including	O	4239
one	O	4239
patient	O	4239
with	O	4239
a	O	4239
large	O	4239
DNA	O	4239
deletion	O	4239
encompassing	O	4239
the	O	4239
DMD	B-Disease	4239
gene	O	4239
.	O	4239

The	O	4240
presence	O	4240
of	O	4240
nebulin	O	4240
in	O	4240
a	O	4240
muscle	O	4240
specimen	O	4240
from	O	4240
a	O	4240
patient	O	4240
with	O	4240
Duchenne	B-Disease	4240
muscular	I-Disease	4240
dystrophy	I-Disease	4240
(	O	4240
DMD	B-Disease	4240
)	O	4240
due	O	4240
to	O	4240
a	O	4240
large	O	4240
deletion	O	4240
precludes	O	4240
the	O	4240
possibility	O	4240
that	O	4240
this	O	4240
protein	O	4240
is	O	4240
the	O	4240
DMD	B-Disease	4240
gene	O	4240
product	O	4240
.	O	4240

Expression	O	4242
of	O	4242
the	O	4242
murine	O	4242
Duchenne	B-Disease	4242
muscular	I-Disease	4242
dystrophy	I-Disease	4242
gene	O	4242
in	O	4242
muscle	O	4242
and	O	4242
brain	O	4242
.	O	4242

5	O	4244
kilobases	O	4244
of	O	4244
the	O	4244
murine	O	4244
Duchenne	B-Disease	4244
muscular	I-Disease	4244
dystrophy	I-Disease	4244
(	O	4244
Dmd	O	4244
)	O	4244
messenger	O	4244
RNA	O	4244
(	O	4244
mRNA	O	4244
)	O	4244
.	O	4244

Dmd	O	4246
mRNA	O	4246
is	O	4246
also	O	4246
present	O	4246
,	O	4246
but	O	4246
at	O	4246
much	O	4246
lower	O	4246
than	O	4246
normal	O	4246
levels	O	4246
,	O	4246
in	O	4246
both	O	4246
the	O	4246
muscle	O	4246
and	O	4246
brain	O	4246
of	O	4246
three	O	4246
different	O	4246
strains	O	4246
of	O	4246
dystrophic	B-Disease	4246
mdx	O	4246
mice	O	4246
.	O	4246

The	O	4247
identification	O	4247
of	O	4247
Dmd	O	4247
mRNA	O	4247
in	O	4247
brain	O	4247
raises	O	4247
the	O	4247
possibility	O	4247
of	O	4247
a	O	4247
relation	O	4247
between	O	4247
human	O	4247
Duchenne	B-Disease	4247
muscular	I-Disease	4247
dystrophy	I-Disease	4247
(	O	4247
DMD	B-Disease	4247
)	O	4247
gene	O	4247
expression	O	4247
and	O	4247
the	O	4247
mental	B-Disease	4247
retardation	I-Disease	4247
found	O	4247
in	O	4247
some	O	4247
DMD	B-Disease	4247
males	O	4247
.	O	4247

Glucose	B-Disease	4249
6	I-Disease	4249
-	I-Disease	4249
phosphate	I-Disease	4249
dehydrogenase	I-Disease	4249
deficiency	I-Disease	4249
and	O	4249
incidence	O	4249
of	O	4249
hematologic	B-Disease	4249
malignancy	I-Disease	4249
.	O	4249

We	O	4250
have	O	4250
evaluated	O	4250
the	O	4250
hypothesis	O	4250
of	O	4250
a	O	4250
negative	O	4250
association	O	4250
between	O	4250
glucose	B-Disease	4250
6	I-Disease	4250
-	I-Disease	4250
phosphate	I-Disease	4250
dehydrogenase	I-Disease	4250
(	I-Disease	4250
G6PD	I-Disease	4250
)	I-Disease	4250
deficiency	I-Disease	4250
and	O	4250
cancer	B-Disease	4250
in	O	4250
a	O	4250
cohort	O	4250
of	O	4250
481	O	4250
Sardinian	O	4250
males	O	4250
with	O	4250
hematological	B-Disease	4250
malignancies	I-Disease	4250
.	O	4250

The	O	4251
frequency	O	4251
of	O	4251
G6PD	B-Disease	4251
deficiency	I-Disease	4251
in	O	4251
the	O	4251
patients	O	4251
was	O	4251
not	O	4251
different	O	4251
from	O	4251
the	O	4251
incidence	O	4251
in	O	4251
a	O	4251
group	O	4251
of	O	4251
16	O	4251
,	O	4251
219	O	4251
controls	O	4251
.	O	4251

The	O	4252
same	O	4252
conclusion	O	4252
resulted	O	4252
from	O	4252
the	O	4252
comparison	O	4252
of	O	4252
the	O	4252
frequency	O	4252
of	O	4252
expression	O	4252
of	O	4252
the	O	4252
GdB	O	4252
gene	O	4252
in	O	4252
23	O	4252
heterozygous	O	4252
women	O	4252
having	O	4252
a	O	4252
clonal	O	4252
hematologic	B-Disease	4252
disease	I-Disease	4252
and	O	4252
a	O	4252
control	O	4252
group	O	4252
of	O	4252
37	O	4252
healthy	O	4252
heterozygotes	O	4252
.	O	4252

Therefore	O	4253
at	O	4253
present	O	4253
there	O	4253
is	O	4253
no	O	4253
evidence	O	4253
that	O	4253
G6PD	B-Disease	4253
deficiency	I-Disease	4253
has	O	4253
a	O	4253
protective	O	4253
effect	O	4253
against	O	4253
development	O	4253
of	O	4253
hematologic	B-Disease	4253
neoplasms	I-Disease	4253
.	O	4253

Hepatoblastoma	B-Disease	4255
,	O	4255
pigmented	B-Disease	4255
ocular	I-Disease	4255
fundus	I-Disease	4255
lesions	I-Disease	4255
and	O	4255
jaw	B-Disease	4255
lesions	I-Disease	4255
in	O	4255
Gardner	B-Disease	4255
syndrome	I-Disease	4255
.	O	4255

Hepatoblastoma	B-Disease	4256
is	O	4256
a	O	4256
rare	O	4256
neoplasm	B-Disease	4256
of	O	4256
infants	O	4256
and	O	4256
children	O	4256
only	O	4256
recently	O	4256
documented	O	4256
in	O	4256
association	O	4256
with	O	4256
hereditary	B-Disease	4256
adenomatous	I-Disease	4256
polyposis	I-Disease	4256
of	I-Disease	4256
the	I-Disease	4256
colon	I-Disease	4256
[	O	4256
Kingston	O	4256
et	O	4256
al	O	4256
.	O	4256

We	O	4258
report	O	4258
four	O	4258
children	O	4258
with	O	4258
hepatoblastoma	B-Disease	4258
from	O	4258
four	O	4258
unrelated	O	4258
families	O	4258
with	O	4258
Gardner	B-Disease	4258
syndrome	I-Disease	4258
(	O	4258
GS	B-Disease	4258
)	O	4258
.	O	4258

One	O	4259
child	O	4259
,	O	4259
now	O	4259
19	O	4259
years	O	4259
old	O	4259
,	O	4259
survived	O	4259
after	O	4259
a	O	4259
resection	O	4259
of	O	4259
a	O	4259
hepatoblastoma	B-Disease	4259
in	O	4259
infancy	O	4259
and	O	4259
recently	O	4259
was	O	4259
found	O	4259
to	O	4259
have	O	4259
GS	B-Disease	4259
.	O	4259

He	O	4260
has	O	4260
an	O	4260
associated	O	4260
odontoma	B-Disease	4260
and	O	4260
pigmented	B-Disease	4260
ocular	I-Disease	4260
fundus	I-Disease	4260
lesions	I-Disease	4260
,	O	4260
both	O	4260
of	O	4260
which	O	4260
have	O	4260
been	O	4260
shown	O	4260
to	O	4260
be	O	4260
clinical	O	4260
markers	O	4260
of	O	4260
GS	B-Disease	4260
.	O	4260

Many	O	4261
individuals	O	4261
in	O	4261
these	O	4261
four	O	4261
GS	B-Disease	4261
families	O	4261
,	O	4261
both	O	4261
affected	O	4261
and	O	4261
at	O	4261
risk	O	4261
,	O	4261
have	O	4261
osteomatous	B-Disease	4261
jaw	I-Disease	4261
lesions	I-Disease	4261
and	O	4261
pigmented	B-Disease	4261
ocular	I-Disease	4261
fundus	I-Disease	4261
lesions	I-Disease	4261
.	O	4261

A	O	4262
search	O	4262
for	O	4262
colonic	B-Disease	4262
polyps	I-Disease	4262
should	O	4262
be	O	4262
made	O	4262
in	O	4262
families	O	4262
of	O	4262
infants	O	4262
and	O	4262
children	O	4262
with	O	4262
hepatoblastoma	B-Disease	4262
.	O	4262

If	O	4263
the	O	4263
child	O	4263
survives	O	4263
,	O	4263
he	O	4263
or	O	4263
she	O	4263
should	O	4263
be	O	4263
monitored	O	4263
for	O	4263
the	O	4263
later	O	4263
appearance	O	4263
of	O	4263
colonic	B-Disease	4263
polyps	I-Disease	4263
.	O	4263

The	O	4264
finding	O	4264
of	O	4264
jaw	B-Disease	4264
lesions	I-Disease	4264
and	O	4264
/	O	4264
or	O	4264
pigmented	B-Disease	4264
ocular	I-Disease	4264
fundus	I-Disease	4264
lesions	I-Disease	4264
in	O	4264
relatives	O	4264
at	O	4264
risk	O	4264
are	O	4264
indications	O	4264
of	O	4264
the	O	4264
possible	O	4264
presence	O	4264
of	O	4264
the	O	4264
GS	B-Disease	4264
gene	O	4264
.	O	4264

Identification	O	4265
of	O	4265
an	O	4265
altered	O	4265
splice	O	4265
site	O	4265
in	O	4265
Ashkenazi	O	4265
Tay	B-Disease	4265
-	I-Disease	4265
Sachs	I-Disease	4265
disease	I-Disease	4265
.	O	4265

Tay	B-Disease	4266
-	I-Disease	4266
Sachs	I-Disease	4266
disease	I-Disease	4266
is	O	4266
an	O	4266
autosomal	B-Disease	4266
recessive	I-Disease	4266
genetic	I-Disease	4266
disorder	I-Disease	4266
resulting	O	4266
from	O	4266
mutation	O	4266
of	O	4266
the	O	4266
HEXA	O	4266
gene	O	4266
encoding	O	4266
the	O	4266
alpha	O	4266
-	O	4266
subunit	O	4266
of	O	4266
the	O	4266
lysosomal	O	4266
enzyme	O	4266
,	O	4266
beta	O	4266
-	O	4266
N	O	4266
-	O	4266
acetylhexosaminidase	O	4266
A	O	4266
(	O	4266
ref	O	4266
.	O	4266

A	O	4271
test	O	4271
for	O	4271
the	O	4271
mutant	O	4271
allele	O	4271
based	O	4271
on	O	4271
amplification	O	4271
of	O	4271
DNA	O	4271
by	O	4271
the	O	4271
polymerase	O	4271
chain	O	4271
rection	O	4271
and	O	4271
cleavage	O	4271
of	O	4271
a	O	4271
DdeI	O	4271
restriction	O	4271
site	O	4271
generated	O	4271
by	O	4271
the	O	4271
mutation	O	4271
revealed	O	4271
that	O	4271
this	O	4271
case	O	4271
and	O	4271
two	O	4271
other	O	4271
cases	O	4271
of	O	4271
the	O	4271
Ashkenazi	O	4271
,	O	4271
infantile	O	4271
form	O	4271
of	O	4271
Tay	B-Disease	4271
-	I-Disease	4271
Sachs	I-Disease	4271
disease	I-Disease	4271
are	O	4271
heterozygous	O	4271
for	O	4271
two	O	4271
different	O	4271
mutations	O	4271
.	O	4271

X	B-Disease	4274
-	I-Disease	4274
linked	I-Disease	4274
glucose	I-Disease	4274
-	I-Disease	4274
6	I-Disease	4274
-	I-Disease	4274
phosphate	I-Disease	4274
dehydrogenase	I-Disease	4274
deficiency	I-Disease	4274
in	O	4274
Mus	O	4274
musculus	O	4274
.	O	4274

A	O	4275
mouse	O	4275
with	O	4275
X	B-Disease	4275
-	I-Disease	4275
linked	I-Disease	4275
glucose	I-Disease	4275
-	I-Disease	4275
6	I-Disease	4275
-	I-Disease	4275
phosphate	I-Disease	4275
dehydrogenase	I-Disease	4275
(	I-Disease	4275
G6PD	I-Disease	4275
)	I-Disease	4275
deficiency	I-Disease	4275
has	O	4275
been	O	4275
recovered	O	4275
in	O	4275
offspring	O	4275
of	O	4275
1	O	4275
-	O	4275
ethyl	O	4275
-	O	4275
1	O	4275
-	O	4275
nitrosourea	O	4275
-	O	4275
treated	O	4275
male	O	4275
mice	O	4275
.	O	4275

This	O	4281
is	O	4281
presently	O	4281
the	O	4281
only	O	4281
animal	O	4281
model	O	4281
for	O	4281
X	B-Disease	4281
-	I-Disease	4281
linked	I-Disease	4281
G6PD	I-Disease	4281
deficiency	I-Disease	4281
in	O	4281
humans	O	4281
.	O	4281

Diverse	O	4283
point	O	4283
mutations	O	4283
in	O	4283
the	O	4283
human	O	4283
glucose	O	4283
-	O	4283
6	O	4283
-	O	4283
phosphate	O	4283
dehydrogenase	O	4283
gene	O	4283
cause	O	4283
enzyme	B-Disease	4283
deficiency	I-Disease	4283
and	O	4283
mild	O	4283
or	O	4283
severe	O	4283
hemolytic	B-Disease	4283
anemia	I-Disease	4283
.	O	4283

Glucose	B-Disease	4284
-	I-Disease	4284
6	I-Disease	4284
-	I-Disease	4284
phosphate	I-Disease	4284
dehydrogenase	I-Disease	4284
(	I-Disease	4284
G6PD	I-Disease	4284
;	I-Disease	4284
EC	I-Disease	4284
1	I-Disease	4284
.	I-Disease	4284

1	I-Disease	4285
.	I-Disease	4285

1	I-Disease	4286
.	I-Disease	4286

49	I-Disease	4287
)	I-Disease	4287
deficiency	I-Disease	4287
is	O	4287
a	O	4287
common	O	4287
genetic	B-Disease	4287
abnormality	I-Disease	4287
affecting	O	4287
an	O	4287
estimated	O	4287
400	O	4287
million	O	4287
people	O	4287
worldwide	O	4287
.	O	4287

The	O	4292
other	O	4292
six	O	4292
mutants	O	4292
investigated	O	4292
were	O	4292
all	O	4292
associated	O	4292
with	O	4292
enzyme	B-Disease	4292
deficiency	I-Disease	4292
.	O	4292

In	O	4293
one	O	4293
of	O	4293
the	O	4293
commonest	O	4293
,	O	4293
G6PD	O	4293
Mediterranean	O	4293
,	O	4293
which	O	4293
is	O	4293
associated	O	4293
with	O	4293
favism	B-Disease	4293
among	O	4293
other	O	4293
clinical	O	4293
manifestations	O	4293
,	O	4293
a	O	4293
single	O	4293
amino	O	4293
acid	O	4293
replacement	O	4293
was	O	4293
found	O	4293
(	O	4293
serine	O	4293
-	O	4293
-	O	4293
-	O	4293
-	O	4293
phenylalanine	O	4293
)	O	4293
it	O	4293
must	O	4293
be	O	4293
responsible	O	4293
for	O	4293
the	O	4293
decreased	O	4293
stability	O	4293
and	O	4293
the	O	4293
reduced	O	4293
catalytic	O	4293
efficiency	O	4293
of	O	4293
this	O	4293
enzyme	O	4293
.	O	4293

Single	O	4294
point	O	4294
mutations	O	4294
were	O	4294
also	O	4294
found	O	4294
in	O	4294
G6PD	O	4294
Metaponto	O	4294
(	O	4294
Southern	O	4294
Italy	O	4294
)	O	4294
and	O	4294
in	O	4294
G6PD	O	4294
Ilesha	O	4294
(	O	4294
Nigeria	O	4294
)	O	4294
,	O	4294
which	O	4294
are	O	4294
asymptomatic	O	4294
,	O	4294
and	O	4294
in	O	4294
G6PD	O	4294
Chatham	O	4294
,	O	4294
which	O	4294
was	O	4294
observed	O	4294
in	O	4294
an	O	4294
Indian	O	4294
boy	O	4294
with	O	4294
neonatal	B-Disease	4294
jaundice	I-Disease	4294
.	O	4294

In	O	4298
G6PD	O	4298
Santiago	O	4298
,	O	4298
a	O	4298
de	O	4298
novo	O	4298
mutation	O	4298
(	O	4298
glycine	O	4298
-	O	4298
-	O	4298
-	O	4298
-	O	4298
arginine	O	4298
)	O	4298
is	O	4298
associated	O	4298
with	O	4298
severe	O	4298
chronic	O	4298
hemolytic	B-Disease	4298
anemia	I-Disease	4298
.	O	4298

Thus	O	4300
,	O	4300
diverse	O	4300
point	O	4300
mutations	O	4300
may	O	4300
account	O	4300
largely	O	4300
for	O	4300
the	O	4300
phenotypic	O	4300
heterogeneity	O	4300
of	O	4300
G6PD	B-Disease	4300
deficiency	I-Disease	4300
.	O	4300

Tight	O	4301
linkage	O	4301
between	O	4301
myotonic	B-Disease	4301
dystrophy	I-Disease	4301
and	O	4301
apolipoprotein	O	4301
E	O	4301
genes	O	4301
revealed	O	4301
with	O	4301
allele	O	4301
-	O	4301
specific	O	4301
oligonucleotides	O	4301
.	O	4301

In	O	4302
16	O	4302
families	O	4302
with	O	4302
myotonic	B-Disease	4302
dystrophy	I-Disease	4302
(	O	4302
DM	B-Disease	4302
)	O	4302
a	O	4302
novel	O	4302
approach	O	4302
based	O	4302
on	O	4302
use	O	4302
of	O	4302
allele	O	4302
-	O	4302
specific	O	4302
oligonucleotides	O	4302
has	O	4302
been	O	4302
employed	O	4302
to	O	4302
study	O	4302
the	O	4302
linkage	O	4302
relationship	O	4302
between	O	4302
the	O	4302
apolipoprotein	O	4302
E	O	4302
(	O	4302
APOE	O	4302
)	O	4302
gene	O	4302
and	O	4302
DM	B-Disease	4302
.	O	4302

These	O	4311
results	O	4311
suggest	O	4311
that	O	4311
,	O	4311
in	O	4311
addition	O	4311
to	O	4311
APOC2	O	4311
,	O	4311
APOE	O	4311
is	O	4311
a	O	4311
useful	O	4311
marker	O	4311
for	O	4311
presymptomatic	O	4311
DM	B-Disease	4311
diagnosis	O	4311
.	O	4311

Regional	O	4312
localization	O	4312
of	O	4312
polymorphic	O	4312
DNA	O	4312
loci	O	4312
on	O	4312
the	O	4312
proximal	O	4312
long	O	4312
arm	O	4312
of	O	4312
the	O	4312
X	O	4312
chromosome	O	4312
using	O	4312
deletions	O	4312
associated	O	4312
with	O	4312
choroideremia	B-Disease	4312
.	O	4312

In	O	4313
two	O	4313
unrelated	O	4313
families	O	4313
,	O	4313
males	O	4313
have	O	4313
been	O	4313
identified	O	4313
who	O	4313
suffer	O	4313
from	O	4313
choroideremia	B-Disease	4313
and	O	4313
at	O	4313
the	O	4313
same	O	4313
time	O	4313
have	O	4313
an	O	4313
interstitial	O	4313
deletion	O	4313
on	O	4313
the	O	4313
proximal	O	4313
long	O	4313
arm	O	4313
of	O	4313
the	O	4313
X	O	4313
chromosome	O	4313
.	O	4313

By	O	4319
Southern	O	4319
blot	O	4319
analysis	O	4319
we	O	4319
have	O	4319
mapped	O	4319
ten	O	4319
different	O	4319
polymorphic	O	4319
DNA	O	4319
loci	O	4319
relative	O	4319
to	O	4319
the	O	4319
position	O	4319
of	O	4319
the	O	4319
deletion	O	4319
and	O	4319
the	O	4319
choroideremia	B-Disease	4319
locus	O	4319
TCD	O	4319
.	O	4319

Retroviral	O	4322
-	O	4322
mediated	O	4322
gene	O	4322
transfer	O	4322
of	O	4322
human	O	4322
phenylalanine	O	4322
hydroxylase	O	4322
into	O	4322
NIH	O	4322
3T3	O	4322
and	O	4322
hepatoma	B-Disease	4322
cells	O	4322
.	O	4322

Phenylketonuria	B-Disease	4323
(	O	4323
PKU	B-Disease	4323
)	O	4323
is	O	4323
caused	O	4323
by	O	4323
deficiency	B-Disease	4323
of	I-Disease	4323
the	I-Disease	4323
hepatic	I-Disease	4323
enzyme	I-Disease	4323
phenylalanine	I-Disease	4323
hydroxylase	I-Disease	4323
(	O	4323
PAH	O	4323
)	O	4323
.	O	4323

The	O	4328
recombinant	O	4328
virus	O	4328
is	O	4328
also	O	4328
capable	O	4328
of	O	4328
infecting	O	4328
a	O	4328
mouse	O	4328
hepatoma	B-Disease	4328
cell	O	4328
line	O	4328
that	O	4328
does	O	4328
not	O	4328
normally	O	4328
synthesize	O	4328
PAH	O	4328
.	O	4328

PAH	O	4329
activity	O	4329
is	O	4329
present	O	4329
in	O	4329
the	O	4329
cellular	O	4329
extracts	O	4329
and	O	4329
the	O	4329
entire	O	4329
hydroxylation	O	4329
system	O	4329
is	O	4329
reconstituted	O	4329
in	O	4329
the	O	4329
hepatoma	B-Disease	4329
cells	O	4329
infected	O	4329
with	O	4329
the	O	4329
recombinant	O	4329
viruses	O	4329
.	O	4329

Thus	O	4330
,	O	4330
recombinant	O	4330
viruses	O	4330
containing	O	4330
human	O	4330
PAH	O	4330
cDNA	O	4330
provide	O	4330
a	O	4330
means	O	4330
for	O	4330
introducing	O	4330
functional	O	4330
PAH	O	4330
into	O	4330
mammalian	O	4330
cells	O	4330
of	O	4330
hepatic	O	4330
origin	O	4330
and	O	4330
can	O	4330
potentially	O	4330
be	O	4330
introduced	O	4330
into	O	4330
whole	O	4330
animals	O	4330
as	O	4330
a	O	4330
model	O	4330
for	O	4330
somatic	O	4330
gene	O	4330
therapy	O	4330
for	O	4330
PKU	B-Disease	4330
.	O	4330

Estimation	O	4332
of	O	4332
the	O	4332
male	O	4332
to	O	4332
female	O	4332
ratio	O	4332
of	O	4332
mutation	O	4332
rates	O	4332
from	O	4332
the	O	4332
segregation	O	4332
of	O	4332
X	O	4332
-	O	4332
chromosomal	O	4332
DNA	O	4332
haplotypes	O	4332
in	O	4332
Duchenne	B-Disease	4332
muscular	I-Disease	4332
dystrophy	I-Disease	4332
families	O	4332
.	O	4332

A	O	4333
novel	O	4333
procedure	O	4333
is	O	4333
presented	O	4333
to	O	4333
estimate	O	4333
the	O	4333
ratio	O	4333
of	O	4333
male	O	4333
to	O	4333
female	O	4333
mutation	O	4333
rates	O	4333
for	O	4333
Duchenne	B-Disease	4333
muscular	I-Disease	4333
dystrophy	I-Disease	4333
(	O	4333
DMD	B-Disease	4333
)	O	4333
.	O	4333

X	O	4334
-	O	4334
specific	O	4334
restriction	O	4334
fragment	O	4334
length	O	4334
polymorphisms	O	4334
are	O	4334
used	O	4334
to	O	4334
establish	O	4334
DNA	O	4334
haplotypes	O	4334
in	O	4334
three	O	4334
-	O	4334
generation	O	4334
DMD	B-Disease	4334
families	O	4334
.	O	4334

From	O	4335
the	O	4335
proportion	O	4335
of	O	4335
DMD	B-Disease	4335
patients	O	4335
who	O	4335
have	O	4335
inherited	O	4335
their	O	4335
maternal	O	4335
grandfathers	O	4335
X	O	4335
chromosome	O	4335
,	O	4335
the	O	4335
ratio	O	4335
of	O	4335
mutation	O	4335
rates	O	4335
can	O	4335
be	O	4335
calculated	O	4335
.	O	4335

Deletions	O	4338
of	O	4338
a	O	4338
DNA	O	4338
sequence	O	4338
in	O	4338
retinoblastomas	B-Disease	4338
and	O	4338
mesenchymal	B-Disease	4338
tumors	I-Disease	4338
:	O	4338
organization	O	4338
of	O	4338
the	O	4338
sequence	O	4338
and	O	4338
its	O	4338
encoded	O	4338
protein	O	4338
.	O	4338

Retinoblastoma	B-Disease	4339
is	O	4339
a	O	4339
childhood	B-Disease	4339
tumor	I-Disease	4339
that	O	4339
can	O	4339
arise	O	4339
because	O	4339
of	O	4339
mutant	O	4339
alleles	O	4339
acquired	O	4339
as	O	4339
somatic	O	4339
or	O	4339
germinal	O	4339
mutations	O	4339
.	O	4339

We	O	4342
have	O	4342
reported	O	4342
isolation	O	4342
of	O	4342
a	O	4342
cDNA	O	4342
fragment	O	4342
that	O	4342
recognizes	O	4342
chromosomal	O	4342
sequences	O	4342
possessing	O	4342
many	O	4342
of	O	4342
the	O	4342
attributes	O	4342
of	O	4342
the	O	4342
retinoblastoma	B-Disease	4342
gene	O	4342
associated	O	4342
with	O	4342
the	O	4342
RB1	O	4342
locus	O	4342
.	O	4342

We	O	4343
now	O	4343
report	O	4343
that	O	4343
this	O	4343
segment	O	4343
is	O	4343
additionally	O	4343
the	O	4343
target	O	4343
of	O	4343
somatic	O	4343
mutations	O	4343
in	O	4343
mesenchymal	B-Disease	4343
tumors	I-Disease	4343
among	O	4343
patients	O	4343
having	O	4343
no	O	4343
apparent	O	4343
predisposition	O	4343
to	O	4343
retinoblastoma	B-Disease	4343
and	O	4343
no	O	4343
previous	O	4343
evidence	O	4343
of	O	4343
retinoblastoma	B-Disease	4343
.	O	4343

These	O	4344
tumors	B-Disease	4344
provide	O	4344
additional	O	4344
evidence	O	4344
that	O	4344
the	O	4344
cloned	O	4344
sequences	O	4344
are	O	4344
representative	O	4344
of	O	4344
a	O	4344
gene	O	4344
that	O	4344
is	O	4344
a	O	4344
frequent	O	4344
target	O	4344
of	O	4344
inactivation	O	4344
during	O	4344
tumorigenesis	O	4344
.	O	4344

Treatment	O	4347
of	O	4347
Duchenne	B-Disease	4347
muscular	I-Disease	4347
dystrophy	I-Disease	4347
with	O	4347
growth	O	4347
hormone	O	4347
inhibitors	O	4347
.	O	4347

A	O	4348
controlled	O	4348
,	O	4348
double	O	4348
-	O	4348
blind	O	4348
therapeutic	O	4348
trial	O	4348
with	O	4348
the	O	4348
drug	O	4348
mazindol	O	4348
,	O	4348
a	O	4348
growth	O	4348
hormone	O	4348
inhibitor	O	4348
,	O	4348
was	O	4348
performed	O	4348
in	O	4348
a	O	4348
pair	O	4348
of	O	4348
7	O	4348
1	O	4348
/	O	4348
2	O	4348
year	O	4348
-	O	4348
old	O	4348
monozygotic	O	4348
twins	O	4348
,	O	4348
with	O	4348
Duchenne	B-Disease	4348
muscular	I-Disease	4348
dystrophy	I-Disease	4348
(	O	4348
DMD	B-Disease	4348
)	O	4348
.	O	4348

The	O	4349
rationale	O	4349
for	O	4349
this	O	4349
trial	O	4349
was	O	4349
based	O	4349
on	O	4349
a	O	4349
patient	O	4349
(	O	4349
reported	O	4349
previously	O	4349
)	O	4349
affected	O	4349
simultaneously	O	4349
with	O	4349
DMD	B-Disease	4349
and	O	4349
growth	B-Disease	4349
hormone	I-Disease	4349
(	I-Disease	4349
GH	I-Disease	4349
)	I-Disease	4349
deficiency	I-Disease	4349
,	O	4349
who	O	4349
is	O	4349
showing	O	4349
a	O	4349
benign	O	4349
course	O	4349
of	O	4349
the	O	4349
dystrophic	B-Disease	4349
process	I-Disease	4349
and	O	4349
is	O	4349
still	O	4349
walking	O	4349
at	O	4349
18	O	4349
years	O	4349
.	O	4349

These	O	4353
results	O	4353
strongly	O	4353
suggest	O	4353
that	O	4353
treatment	O	4353
with	O	4353
a	O	4353
GH	O	4353
inhibitor	O	4353
is	O	4353
beneficial	O	4353
for	O	4353
DMD	B-Disease	4353
patients	O	4353
.	O	4353

Identification	O	4355
and	O	4355
localization	O	4355
of	O	4355
mutations	O	4355
at	O	4355
the	O	4355
Lesch	B-Disease	4355
-	I-Disease	4355
Nyhan	I-Disease	4355
locus	O	4355
by	O	4355
ribonuclease	O	4355
A	O	4355
cleavage	O	4355
.	O	4355

The	O	4358
recently	O	4358
described	O	4358
ribonuclease	O	4358
A	O	4358
cleavage	O	4358
procedure	O	4358
,	O	4358
with	O	4358
a	O	4358
polyuridylic	O	4358
acid	O	4358
-	O	4358
paper	O	4358
affinity	O	4358
chromatography	O	4358
step	O	4358
,	O	4358
has	O	4358
been	O	4358
used	O	4358
to	O	4358
identify	O	4358
the	O	4358
mutational	O	4358
lesions	O	4358
in	O	4358
the	O	4358
hypoxanthine	O	4358
phosphoribosyltransferase	O	4358
(	O	4358
HPRT	O	4358
)	O	4358
messenger	O	4358
RNAs	O	4358
of	O	4358
patients	O	4358
with	O	4358
Lesch	B-Disease	4358
-	I-Disease	4358
Nyhan	I-Disease	4358
syndrome	I-Disease	4358
.	O	4358

Distinctive	O	4359
ribonuclease	O	4359
A	O	4359
cleavage	O	4359
patterns	O	4359
were	O	4359
identified	O	4359
in	O	4359
messenger	O	4359
RNA	O	4359
from	O	4359
5	O	4359
of	O	4359
14	O	4359
Lesch	B-Disease	4359
-	I-Disease	4359
Nyhan	I-Disease	4359
patients	O	4359
who	O	4359
were	O	4359
chosen	O	4359
because	O	4359
no	O	4359
HPRT	O	4359
Southern	O	4359
or	O	4359
Northern	O	4359
blotting	O	4359
pattern	O	4359
changes	O	4359
had	O	4359
been	O	4359
found	O	4359
.	O	4359

This	O	4360
approach	O	4360
now	O	4360
allows	O	4360
HPRT	O	4360
mutation	O	4360
detection	O	4360
in	O	4360
50	O	4360
percent	O	4360
of	O	4360
the	O	4360
cases	O	4360
of	O	4360
Lesch	B-Disease	4360
-	I-Disease	4360
Nyhan	I-Disease	4360
syndrome	I-Disease	4360
.	O	4360

Two	O	4363
new	O	4363
variants	O	4363
of	O	4363
glucose	O	4363
-	O	4363
6	O	4363
-	O	4363
phosphate	O	4363
dehydrogenase	O	4363
associated	O	4363
with	O	4363
hereditary	B-Disease	4363
non	I-Disease	4363
-	I-Disease	4363
spherocytic	I-Disease	4363
hemolytic	I-Disease	4363
anemia	I-Disease	4363
:	O	4363
G6PD	O	4363
Wayne	O	4363
and	O	4363
G6PD	O	4363
Huron	O	4363
.	O	4363

Two	O	4364
new	O	4364
deficient	O	4364
variants	O	4364
of	O	4364
glucose	O	4364
-	O	4364
6	O	4364
-	O	4364
phosphate	O	4364
dehydrogenase	O	4364
(	O	4364
G6PD	O	4364
)	O	4364
causing	O	4364
hereditary	B-Disease	4364
nonspherocytic	I-Disease	4364
hemolytic	I-Disease	4364
anemia	I-Disease	4364
(	O	4364
HNSHA	B-Disease	4364
)	O	4364
are	O	4364
described	O	4364
.	O	4364

The	O	4367
patients	O	4367
with	O	4367
G6PD	O	4367
Huron	O	4367
were	O	4367
under	O	4367
medical	O	4367
observation	O	4367
for	O	4367
a	O	4367
considerable	O	4367
period	O	4367
of	O	4367
time	O	4367
without	O	4367
the	O	4367
diagnosis	O	4367
of	O	4367
G6PD	B-Disease	4367
deficiency	I-Disease	4367
being	O	4367
entertained	O	4367
because	O	4367
the	O	4367
family	O	4367
was	O	4367
of	O	4367
Northern	O	4367
European	O	4367
origin	O	4367
.	O	4367

Since	O	4368
sporadic	O	4368
variants	O	4368
of	O	4368
G6PD	O	4368
causing	O	4368
HNSHA	B-Disease	4368
show	O	4368
no	O	4368
special	O	4368
racial	O	4368
predilection	O	4368
,	O	4368
the	O	4368
diagnosis	O	4368
of	O	4368
G6PD	B-Disease	4368
deficiency	I-Disease	4368
should	O	4368
always	O	4368
be	O	4368
considered	O	4368
in	O	4368
patients	O	4368
with	O	4368
this	O	4368
syndrome	O	4368
.	O	4368

Sialophorin	O	4370
,	O	4370
a	O	4370
surface	O	4370
sialoglycoprotein	O	4370
defective	O	4370
in	O	4370
the	O	4370
Wiskott	B-Disease	4370
-	I-Disease	4370
Aldrich	I-Disease	4370
syndrome	I-Disease	4370
,	O	4370
is	O	4370
involved	O	4370
in	O	4370
human	O	4370
T	O	4370
lymphocyte	O	4370
proliferation	O	4370
.	O	4370

The	O	4371
mAb	O	4371
L10	O	4371
was	O	4371
used	O	4371
to	O	4371
determine	O	4371
the	O	4371
distribution	O	4371
and	O	4371
the	O	4371
function	O	4371
of	O	4371
sialophorin	O	4371
,	O	4371
the	O	4371
heavily	O	4371
glycosylated	O	4371
surface	O	4371
molecule	O	4371
that	O	4371
is	O	4371
deficient	O	4371
/	O	4371
defective	O	4371
in	O	4371
lymphocytes	O	4371
of	O	4371
patients	O	4371
with	O	4371
the	O	4371
X	B-Disease	4371
-	I-Disease	4371
linked	I-Disease	4371
immunodeficiency	I-Disease	4371
Wiskott	I-Disease	4371
-	I-Disease	4371
Aldrich	I-Disease	4371
syndrome	I-Disease	4371
.	O	4371

Hypopigmentation	B-Disease	4379
in	O	4379
the	O	4379
Prader	B-Disease	4379
-	I-Disease	4379
Willi	I-Disease	4379
syndrome	I-Disease	4379
.	O	4379

Cutaneous	B-Disease	4380
and	I-Disease	4380
ocular	I-Disease	4380
pigmentation	I-Disease	4380
were	O	4380
evaluated	O	4380
in	O	4380
29	O	4380
individuals	O	4380
with	O	4380
the	O	4380
Prader	B-Disease	4380
-	I-Disease	4380
Willi	I-Disease	4380
syndrome	I-Disease	4380
(	O	4380
PWS	B-Disease	4380
)	O	4380
.	O	4380

Criteria	O	4381
for	O	4381
hypopigmentation	B-Disease	4381
included	O	4381
the	O	4381
presence	O	4381
of	O	4381
type	O	4381
I	O	4381
or	O	4381
II	O	4381
skin	O	4381
,	O	4381
the	O	4381
lightest	O	4381
skin	O	4381
type	O	4381
in	O	4381
the	O	4381
family	O	4381
by	O	4381
history	O	4381
,	O	4381
and	O	4381
iris	O	4381
translucency	O	4381
on	O	4381
globe	O	4381
transillumination	O	4381
.	O	4381

On	O	4382
the	O	4382
basis	O	4382
of	O	4382
these	O	4382
criteria	O	4382
,	O	4382
48	O	4382
%	O	4382
of	O	4382
the	O	4382
PWS	B-Disease	4382
individuals	O	4382
were	O	4382
hypopigmented	B-Disease	4382
.	O	4382

The	O	4383
presence	O	4383
of	O	4383
hypopigmentation	B-Disease	4383
correlated	O	4383
with	O	4383
a	O	4383
small	O	4383
interstitial	O	4383
deletion	O	4383
on	O	4383
the	O	4383
proximal	O	4383
long	O	4383
arm	O	4383
of	O	4383
chromosome	O	4383
15	O	4383
;	O	4383
however	O	4383
,	O	4383
this	O	4383
deletion	O	4383
was	O	4383
also	O	4383
found	O	4383
in	O	4383
individuals	O	4383
who	O	4383
did	O	4383
not	O	4383
meet	O	4383
the	O	4383
full	O	4383
criteria	O	4383
for	O	4383
hypopigmentation	B-Disease	4383
.	O	4383

Hairbulb	O	4384
tyrosinase	O	4384
activity	O	4384
and	O	4384
glutathione	O	4384
content	O	4384
,	O	4384
as	O	4384
well	O	4384
as	O	4384
urine	O	4384
cysteinyldopa	O	4384
excretion	O	4384
,	O	4384
were	O	4384
low	O	4384
in	O	4384
PWS	B-Disease	4384
individuals	O	4384
with	O	4384
and	O	4384
without	O	4384
hypopigmentation	B-Disease	4384
and	O	4384
did	O	4384
not	O	4384
separate	O	4384
these	O	4384
two	O	4384
groups	O	4384
.	O	4384

We	O	4385
conclude	O	4385
that	O	4385
hypopigmentation	B-Disease	4385
is	O	4385
found	O	4385
in	O	4385
a	O	4385
significant	O	4385
proportion	O	4385
of	O	4385
individuals	O	4385
with	O	4385
PWS	B-Disease	4385
and	O	4385
that	O	4385
the	O	4385
hypopigmentation	B-Disease	4385
may	O	4385
be	O	4385
associated	O	4385
with	O	4385
a	O	4385
deletion	O	4385
of	O	4385
the	O	4385
long	O	4385
arm	O	4385
of	O	4385
chromosome	O	4385
15	O	4385
.	O	4385

The	O	4386
mechanism	O	4386
for	O	4386
the	O	4386
hypopigmentation	B-Disease	4386
is	O	4386
unknown	O	4386
.	O	4386

Phenotype	O	4388
heterogeneity	O	4388
among	O	4388
hemizygotes	O	4388
in	O	4388
a	O	4388
family	O	4388
biochemically	O	4388
screened	O	4388
for	O	4388
adrenoleukodystrophy	B-Disease	4388
.	O	4388

We	O	4389
report	O	4389
on	O	4389
two	O	4389
clinically	O	4389
,	O	4389
neurologically	O	4389
normal	O	4389
relatives	O	4389
of	O	4389
a	O	4389
boy	O	4389
affected	O	4389
by	O	4389
adrenoleukodystrophy	B-Disease	4389
(	O	4389
ALD	B-Disease	4389
)	O	4389
;	O	4389
they	O	4389
were	O	4389
found	O	4389
repeatedly	O	4389
to	O	4389
have	O	4389
the	O	4389
biochemical	O	4389
defect	O	4389
of	O	4389
an	O	4389
ALD	B-Disease	4389
hemizygote	O	4389
.	O	4389

While	O	4391
no	O	4391
evidence	O	4391
of	O	4391
neurologic	B-Disease	4391
disease	I-Disease	4391
(	O	4391
leukodystrophy	B-Disease	4391
or	O	4391
myeloneuropathy	B-Disease	4391
)	O	4391
was	O	4391
present	O	4391
in	O	4391
these	O	4391
hemizygotes	O	4391
,	O	4391
adrenocortical	B-Disease	4391
insufficiency	I-Disease	4391
provoking	O	4391
compensatory	O	4391
high	O	4391
ACTH	O	4391
release	O	4391
was	O	4391
found	O	4391
in	O	4391
both	O	4391
.	O	4391

These	O	4392
findings	O	4392
should	O	4392
be	O	4392
taken	O	4392
into	O	4392
consideration	O	4392
when	O	4392
counseling	O	4392
families	O	4392
in	O	4392
which	O	4392
cases	O	4392
with	O	4392
clinically	O	4392
expressed	O	4392
ALD	B-Disease	4392
are	O	4392
represented	O	4392
in	O	4392
several	O	4392
generations	O	4392
.	O	4392

The	O	4394
mapping	O	4394
of	O	4394
a	O	4394
cDNA	O	4394
from	O	4394
the	O	4394
human	O	4394
X	B-Disease	4394
-	I-Disease	4394
linked	I-Disease	4394
Duchenne	I-Disease	4394
muscular	I-Disease	4394
dystrophy	I-Disease	4394
gene	O	4394
to	O	4394
the	O	4394
mouse	O	4394
X	O	4394
chromosome	O	4394
.	O	4394

The	O	4395
recent	O	4395
discovery	O	4395
of	O	4395
sequences	O	4395
at	O	4395
the	O	4395
site	O	4395
of	O	4395
the	O	4395
Duchenne	B-Disease	4395
muscular	I-Disease	4395
dystrophy	I-Disease	4395
(	O	4395
DMD	B-Disease	4395
)	O	4395
gene	O	4395
in	O	4395
humans	O	4395
has	O	4395
opened	O	4395
up	O	4395
the	O	4395
possibility	O	4395
of	O	4395
a	O	4395
detailed	O	4395
molecular	O	4395
analysis	O	4395
of	O	4395
the	O	4395
genes	O	4395
in	O	4395
humans	O	4395
and	O	4395
in	O	4395
related	O	4395
mammalian	O	4395
species	O	4395
.	O	4395

Until	O	4396
relatively	O	4396
recently	O	4396
,	O	4396
there	O	4396
was	O	4396
no	O	4396
obvious	O	4396
mouse	O	4396
model	O	4396
of	O	4396
this	O	4396
genetic	B-Disease	4396
disease	I-Disease	4396
for	O	4396
the	O	4396
development	O	4396
of	O	4396
therapeutic	O	4396
strategies	O	4396
.	O	4396

The	O	4397
identification	O	4397
of	O	4397
a	O	4397
mouse	O	4397
X	O	4397
-	O	4397
linked	O	4397
mutant	O	4397
showing	O	4397
muscular	B-Disease	4397
dystrophy	I-Disease	4397
,	O	4397
mdx	O	4397
,	O	4397
has	O	4397
provided	O	4397
a	O	4397
candidate	O	4397
mouse	O	4397
genetic	O	4397
homologue	O	4397
to	O	4397
the	O	4397
DMD	B-Disease	4397
locus	O	4397
;	O	4397
the	O	4397
relatively	O	4397
mild	O	4397
pathological	O	4397
features	O	4397
of	O	4397
mdx	O	4397
suggest	O	4397
it	O	4397
may	O	4397
have	O	4397
more	O	4397
in	O	4397
common	O	4397
with	O	4397
mutations	O	4397
of	O	4397
the	O	4397
Becker	B-Disease	4397
muscular	I-Disease	4397
dystrophy	I-Disease	4397
type	O	4397
at	O	4397
the	O	4397
same	O	4397
human	O	4397
locus	O	4397
,	O	4397
however	O	4397
.	O	4397

But	O	4398
the	O	4398
close	O	4398
genetic	O	4398
linkage	O	4398
of	O	4398
mdx	O	4398
to	O	4398
G6PD	O	4398
and	O	4398
Hprt	O	4398
on	O	4398
the	O	4398
mouse	O	4398
X	O	4398
chromosome	O	4398
,	O	4398
coupled	O	4398
with	O	4398
its	O	4398
comparatively	O	4398
mild	O	4398
pathology	O	4398
,	O	4398
have	O	4398
suggested	O	4398
that	O	4398
the	O	4398
mdx	O	4398
mutation	O	4398
may	O	4398
instead	O	4398
correspond	O	4398
to	O	4398
Emery	B-Disease	4398
Dreifuss	I-Disease	4398
muscular	I-Disease	4398
dystrophy	I-Disease	4398
which	O	4398
itself	O	4398
is	O	4398
closely	O	4398
linked	O	4398
to	O	4398
DNA	O	4398
markers	O	4398
at	O	4398
Xq28	O	4398
-	O	4398
qter	O	4398
in	O	4398
the	O	4398
region	O	4398
of	O	4398
G6PD	O	4398
on	O	4398
the	O	4398
human	O	4398
X	O	4398
chromosome	O	4398
.	O	4398

Using	O	4399
an	O	4399
interspecific	O	4399
mouse	O	4399
domesticus	O	4399
/	O	4399
spretus	O	4399
cross	O	4399
,	O	4399
segregating	O	4399
for	O	4399
a	O	4399
variety	O	4399
of	O	4399
markers	O	4399
on	O	4399
the	O	4399
mouse	O	4399
X	O	4399
chromosome	O	4399
,	O	4399
we	O	4399
have	O	4399
positioned	O	4399
on	O	4399
the	O	4399
mouse	O	4399
X	O	4399
chromosome	O	4399
sequences	O	4399
homologous	O	4399
to	O	4399
a	O	4399
DMD	B-Disease	4399
cDNA	O	4399
clone	O	4399
.	O	4399

These	O	4400
sequences	O	4400
map	O	4400
provocatively	O	4400
close	O	4400
to	O	4400
the	O	4400
mdx	O	4400
mutation	O	4400
and	O	4400
unexpectedly	O	4400
distant	O	4400
from	O	4400
sparse	O	4400
fur	O	4400
,	O	4400
spf	O	4400
,	O	4400
the	O	4400
mouse	O	4400
homologue	O	4400
of	O	4400
OTC	O	4400
(	O	4400
ornithine	O	4400
transcarbamylase	O	4400
)	O	4400
which	O	4400
is	O	4400
closely	O	4400
linked	O	4400
to	O	4400
DMD	B-Disease	4400
on	O	4400
the	O	4400
human	O	4400
X	O	4400
chromosome	O	4400
.	O	4400

Localization	O	4402
of	O	4402
the	O	4402
region	O	4402
homologous	O	4402
to	O	4402
the	O	4402
Duchenne	B-Disease	4402
muscular	I-Disease	4402
dystrophy	I-Disease	4402
locus	O	4402
on	O	4402
the	O	4402
mouse	O	4402
X	O	4402
chromosome	O	4402
.	O	4402

Recent	O	4403
progress	O	4403
has	O	4403
resulted	O	4403
in	O	4403
part	O	4403
of	O	4403
the	O	4403
gene	O	4403
mutated	O	4403
in	O	4403
Duchenne	B-Disease	4403
and	I-Disease	4403
the	I-Disease	4403
milder	I-Disease	4403
Becker	I-Disease	4403
muscular	I-Disease	4403
dystrophies	I-Disease	4403
being	O	4403
cloned	O	4403
and	O	4403
has	O	4403
suggested	O	4403
that	O	4403
the	O	4403
gene	O	4403
itself	O	4403
extends	O	4403
over	O	4403
1	O	4403
,	O	4403
000	O	4403
to	O	4403
2	O	4403
,	O	4403
000	O	4403
kilobases	O	4403
(	O	4403
kb	O	4403
)	O	4403
.	O	4403

The	O	4405
mouse	O	4405
mdx	O	4405
mutation	O	4405
affects	O	4405
muscle	O	4405
and	O	4405
confers	O	4405
a	O	4405
mild	O	4405
dystrophic	B-Disease	4405
syndrome	I-Disease	4405
,	O	4405
but	O	4405
it	O	4405
is	O	4405
not	O	4405
clear	O	4405
whether	O	4405
this	O	4405
mutation	O	4405
is	O	4405
equivalent	O	4405
to	O	4405
Duchenne	B-Disease	4405
/	I-Disease	4405
Becker	I-Disease	4405
muscular	I-Disease	4405
dystrophy	I-Disease	4405
in	O	4405
man	O	4405
.	O	4405

Here	O	4406
we	O	4406
describe	O	4406
the	O	4406
use	O	4406
of	O	4406
two	O	4406
sequences	O	4406
from	O	4406
the	O	4406
human	O	4406
Duchenne	B-Disease	4406
muscular	I-Disease	4406
dystrophy	I-Disease	4406
(	O	4406
DMD	B-Disease	4406
)	O	4406
gene	O	4406
that	O	4406
cross	O	4406
-	O	4406
hybridize	O	4406
to	O	4406
mouse	O	4406
X	O	4406
-	O	4406
linked	O	4406
sequences	O	4406
to	O	4406
localize	O	4406
the	O	4406
gene	O	4406
homologous	O	4406
to	O	4406
DMD	B-Disease	4406
in	O	4406
the	O	4406
mouse	O	4406
.	O	4406

By	O	4408
analogy	O	4408
with	O	4408
the	O	4408
human	O	4408
X	O	4408
-	O	4408
chromosome	O	4408
,	O	4408
we	O	4408
conclude	O	4408
that	O	4408
the	O	4408
region	O	4408
in	O	4408
the	O	4408
mouse	O	4408
around	O	4408
the	O	4408
G6pd	O	4408
and	O	4408
St14	O	4408
-	O	4408
1	O	4408
loci	O	4408
may	O	4408
contain	O	4408
two	O	4408
genes	O	4408
corresponding	O	4408
to	O	4408
distinct	O	4408
human	O	4408
myopathies	B-Disease	4408
Emery	B-Disease	4408
Dreifuss	I-Disease	4408
muscular	I-Disease	4408
dystrophy	I-Disease	4408
which	O	4408
is	O	4408
known	O	4408
to	O	4408
be	O	4408
closely	O	4408
linked	O	4408
to	O	4408
St14	O	4408
-	O	4408
1	O	4408
in	O	4408
man	O	4408
and	O	4408
the	O	4408
DMD	B-Disease	4408
homologue	O	4408
described	O	4408
here	O	4408
.	O	4408

GT	O	4410
to	O	4410
AT	O	4410
transition	O	4410
at	O	4410
a	O	4410
splice	O	4410
donor	O	4410
site	O	4410
causes	O	4410
skipping	O	4410
of	O	4410
the	O	4410
preceding	O	4410
exon	O	4410
in	O	4410
phenylketonuria	B-Disease	4410
.	O	4410

Classical	B-Disease	4411
Phenylketonuria	I-Disease	4411
(	O	4411
PKU	B-Disease	4411
)	O	4411
is	O	4411
an	O	4411
autosomal	B-Disease	4411
recessive	I-Disease	4411
human	I-Disease	4411
genetic	I-Disease	4411
disorder	I-Disease	4411
caused	O	4411
by	O	4411
a	O	4411
deficiency	B-Disease	4411
of	I-Disease	4411
hepatic	I-Disease	4411
phenylalanine	I-Disease	4411
hydroxylase	I-Disease	4411
(	O	4411
PAH	O	4411
)	O	4411
.	O	4411

We	O	4412
isolated	O	4412
several	O	4412
mutant	O	4412
PAH	O	4412
cDNA	O	4412
clones	O	4412
from	O	4412
a	O	4412
PKU	B-Disease	4412
carrier	O	4412
individual	O	4412
and	O	4412
showed	O	4412
that	O	4412
they	O	4412
contained	O	4412
an	O	4412
internal	O	4412
116	O	4412
base	O	4412
pair	O	4412
deletion	O	4412
,	O	4412
corresponding	O	4412
precisely	O	4412
to	O	4412
exon	O	4412
12	O	4412
of	O	4412
the	O	4412
human	O	4412
chromosomal	O	4412
PAH	O	4412
gene	O	4412
.	O	4412

Conservation	O	4418
of	O	4418
the	O	4418
Duchenne	B-Disease	4418
muscular	I-Disease	4418
dystrophy	I-Disease	4418
gene	O	4418
in	O	4418
mice	O	4418
and	O	4418
humans	O	4418
.	O	4418

A	O	4419
portion	O	4419
of	O	4419
the	O	4419
Duchenne	B-Disease	4419
muscular	I-Disease	4419
dystrophy	I-Disease	4419
(	O	4419
DMD	B-Disease	4419
)	O	4419
gene	O	4419
transcript	O	4419
from	O	4419
human	O	4419
fetal	O	4419
skeletal	O	4419
muscle	O	4419
and	O	4419
mouse	O	4419
adult	O	4419
heart	O	4419
was	O	4419
sequenced	O	4419
,	O	4419
representing	O	4419
approximately	O	4419
25	O	4419
percent	O	4419
of	O	4419
the	O	4419
total	O	4419
,	O	4419
14	O	4419
-	O	4419
kb	O	4419
DMD	B-Disease	4419
transcript	O	4419
.	O	4419

The	O	4421
amino	O	4421
acid	O	4421
sequence	O	4421
that	O	4421
is	O	4421
predicted	O	4421
from	O	4421
this	O	4421
portion	O	4421
of	O	4421
the	O	4421
DMD	B-Disease	4421
gene	O	4421
indicates	O	4421
that	O	4421
the	O	4421
protein	O	4421
product	O	4421
might	O	4421
serve	O	4421
a	O	4421
structural	O	4421
role	O	4421
in	O	4421
muscle	O	4421
,	O	4421
but	O	4421
the	O	4421
abundance	O	4421
and	O	4421
tissue	O	4421
distribution	O	4421
of	O	4421
the	O	4421
messenger	O	4421
RNA	O	4421
suggests	O	4421
that	O	4421
the	O	4421
DMD	B-Disease	4421
protein	O	4421
is	O	4421
not	O	4421
nebulin	O	4421
.	O	4421

Familial	O	4423
Prader	B-Disease	4423
-	I-Disease	4423
Willi	I-Disease	4423
syndrome	I-Disease	4423
with	O	4423
apparently	O	4423
normal	O	4423
chromosomes	O	4423
.	O	4423

We	O	4424
report	O	4424
on	O	4424
4	O	4424
sibs	O	4424
(	O	4424
2F	O	4424
,	O	4424
2M	O	4424
)	O	4424
with	O	4424
Prader	B-Disease	4424
-	I-Disease	4424
Willi	I-Disease	4424
syndrome	I-Disease	4424
(	O	4424
PWS	B-Disease	4424
)	O	4424
.	O	4424

The	O	4426
other	O	4426
child	O	4426
had	O	4426
died	O	4426
at	O	4426
age	O	4426
10	O	4426
months	O	4426
with	O	4426
a	O	4426
history	O	4426
and	O	4426
clinical	O	4426
findings	O	4426
typical	O	4426
of	O	4426
first	O	4426
phase	O	4426
of	O	4426
PWS	B-Disease	4426
.	O	4426

The	O	4428
implications	O	4428
of	O	4428
this	O	4428
unusual	O	4428
familial	O	4428
occurrence	O	4428
for	O	4428
our	O	4428
understanding	O	4428
of	O	4428
PWS	B-Disease	4428
are	O	4428
discussed	O	4428
.	O	4428

Nebulin	O	4430
and	O	4430
titin	O	4430
expression	O	4430
in	O	4430
Duchenne	B-Disease	4430
muscular	I-Disease	4430
dystrophy	I-Disease	4430
appears	O	4430
normal	O	4430
.	O	4430

Monoclonal	O	4431
antibodies	O	4431
which	O	4431
recognize	O	4431
different	O	4431
epitopes	O	4431
on	O	4431
either	O	4431
titin	O	4431
or	O	4431
nebulin	O	4431
show	O	4431
normal	O	4431
staining	O	4431
patterns	O	4431
on	O	4431
frozen	O	4431
sections	O	4431
of	O	4431
three	O	4431
muscle	O	4431
biopsies	O	4431
of	O	4431
Duchenne	B-Disease	4431
muscular	I-Disease	4431
dystrophy	I-Disease	4431
(	O	4431
DMD	B-Disease	4431
)	O	4431
.	O	4431

Since	O	4433
the	O	4433
donor	O	4433
of	O	4433
one	O	4433
of	O	4433
these	O	4433
biopsies	O	4433
has	O	4433
a	O	4433
large	O	4433
deletion	O	4433
of	O	4433
the	O	4433
5	O	4433
-	O	4433
region	O	4433
of	O	4433
the	O	4433
DMD	B-Disease	4433
gene	O	4433
,	O	4433
our	O	4433
results	O	4433
argue	O	4433
against	O	4433
the	O	4433
recent	O	4433
proposal	O	4433
that	O	4433
nebulin	O	4433
is	O	4433
the	O	4433
gene	O	4433
mutated	O	4433
in	O	4433
DMD	B-Disease	4433
.	O	4433

Heterozygous	B-Disease	4435
C2	I-Disease	4435
deficiency	I-Disease	4435
associated	O	4435
with	O	4435
angioedema	B-Disease	4435
,	O	4435
myasthenia	B-Disease	4435
gravis	I-Disease	4435
,	O	4435
and	O	4435
systemic	B-Disease	4435
lupus	I-Disease	4435
erythematosus	I-Disease	4435
.	O	4435

We	O	4436
describe	O	4436
a	O	4436
patient	O	4436
with	O	4436
myasthenia	B-Disease	4436
gravis	I-Disease	4436
,	O	4436
systemic	B-Disease	4436
lupus	I-Disease	4436
erythematosus	I-Disease	4436
,	O	4436
and	O	4436
angioedema	B-Disease	4436
associated	O	4436
with	O	4436
heterozygous	O	4436
complement	B-Disease	4436
factor	I-Disease	4436
2	I-Disease	4436
(	I-Disease	4436
C2	I-Disease	4436
)	I-Disease	4436
deficiency	I-Disease	4436
.	O	4436

The	O	4437
significance	O	4437
of	O	4437
this	O	4437
association	O	4437
is	O	4437
controversial	O	4437
,	O	4437
though	O	4437
the	O	4437
association	O	4437
of	O	4437
C2	B-Disease	4437
deficiency	I-Disease	4437
with	O	4437
certain	O	4437
histocompatibility	O	4437
antigens	O	4437
suggests	O	4437
possible	O	4437
linkage	O	4437
to	O	4437
immune	O	4437
response	O	4437
genes	O	4437
.	O	4437

To	O	4438
our	O	4438
knowledge	O	4438
this	O	4438
is	O	4438
the	O	4438
first	O	4438
report	O	4438
of	O	4438
heterozygous	O	4438
C2	B-Disease	4438
deficiency	I-Disease	4438
in	O	4438
association	O	4438
with	O	4438
this	O	4438
combination	O	4438
of	O	4438
autoimmune	B-Disease	4438
disorders	I-Disease	4438
,	O	4438
and	O	4438
we	O	4438
discuss	O	4438
the	O	4438
aetiological	O	4438
implications	O	4438
.	O	4438

Genetic	O	4440
analysis	O	4440
of	O	4440
an	O	4440
inherited	O	4440
deficiency	B-Disease	4440
of	I-Disease	4440
the	I-Disease	4440
third	I-Disease	4440
component	I-Disease	4440
of	I-Disease	4440
complement	I-Disease	4440
in	O	4440
Brittany	O	4440
spaniel	O	4440
dogs	O	4440
.	O	4440

Genetically	O	4441
determined	O	4441
C3	B-Disease	4441
deficiency	I-Disease	4441
in	O	4441
Brittany	O	4441
spaniel	O	4441
dogs	O	4441
shares	O	4441
a	O	4441
number	O	4441
of	O	4441
biochemical	O	4441
and	O	4441
clinical	O	4441
characteristics	O	4441
with	O	4441
the	O	4441
human	O	4441
disorder	O	4441
.	O	4441

In	O	4442
humans	O	4442
,	O	4442
the	O	4442
gene	O	4442
for	O	4442
C3	B-Disease	4442
deficiency	I-Disease	4442
is	O	4442
a	O	4442
nan	O	4442
gene	O	4442
that	O	4442
is	O	4442
allelic	O	4442
to	O	4442
the	O	4442
structural	O	4442
gene	O	4442
for	O	4442
C3	O	4442
and	O	4442
is	O	4442
not	O	4442
linked	O	4442
to	O	4442
the	O	4442
major	O	4442
histocompatibility	O	4442
locus	O	4442
.	O	4442

The	O	4443
current	O	4443
study	O	4443
used	O	4443
allotype	O	4443
analysis	O	4443
of	O	4443
canine	O	4443
C3	O	4443
in	O	4443
order	O	4443
to	O	4443
demonstrate	O	4443
that	O	4443
the	O	4443
gene	O	4443
for	O	4443
C3	B-Disease	4443
deficiency	I-Disease	4443
in	O	4443
these	O	4443
dogs	O	4443
is	O	4443
also	O	4443
a	O	4443
nan	O	4443
gene	O	4443
allelic	O	4443
to	O	4443
the	O	4443
structural	O	4443
gene	O	4443
for	O	4443
C3	O	4443
.	O	4443

In	O	4444
addition	O	4444
,	O	4444
preliminary	O	4444
pedigree	O	4444
analysis	O	4444
suggests	O	4444
that	O	4444
the	O	4444
gene	O	4444
for	O	4444
canine	O	4444
C3	B-Disease	4444
deficiency	I-Disease	4444
is	O	4444
apparently	O	4444
not	O	4444
closely	O	4444
linked	O	4444
to	O	4444
the	O	4444
major	O	4444
histocompatibility	O	4444
complex	O	4444
of	O	4444
the	O	4444
dog	O	4444
.	O	4444

Thus	O	4445
,	O	4445
it	O	4445
appears	O	4445
that	O	4445
C3	B-Disease	4445
deficiency	I-Disease	4445
in	O	4445
Brittany	O	4445
spaniel	O	4445
dogs	O	4445
not	O	4445
only	O	4445
shares	O	4445
biochemical	O	4445
and	O	4445
clinical	O	4445
features	O	4445
with	O	4445
C3	B-Disease	4445
deficiency	I-Disease	4445
in	O	4445
humans	O	4445
,	O	4445
but	O	4445
also	O	4445
shares	O	4445
some	O	4445
genetic	O	4445
characteristics	O	4445
with	O	4445
the	O	4445
human	O	4445
disorder	O	4445
.	O	4445

Phenylketonuria	B-Disease	4448
(	O	4448
PKU	B-Disease	4448
)	O	4448
is	O	4448
caused	O	4448
by	O	4448
a	O	4448
genetic	O	4448
deficiency	B-Disease	4448
of	I-Disease	4448
the	I-Disease	4448
enzyme	I-Disease	4448
phenylalanine	I-Disease	4448
hydroxylase	I-Disease	4448
(	O	4448
PAH	O	4448
)	O	4448
.	O	4448

These	O	4451
results	O	4451
support	O	4451
the	O	4451
use	O	4451
of	O	4451
the	O	4451
human	O	4451
PAH	O	4451
probe	O	4451
in	O	4451
prenatal	O	4451
diagnosis	O	4451
and	O	4451
detection	O	4451
of	O	4451
carriers	O	4451
,	O	4451
to	O	4451
provide	O	4451
new	O	4451
opportunities	O	4451
for	O	4451
the	O	4451
biochemical	O	4451
characterization	O	4451
of	O	4451
normal	O	4451
and	O	4451
mutant	O	4451
enzymes	O	4451
,	O	4451
and	O	4451
in	O	4451
the	O	4451
investigation	O	4451
of	O	4451
alternative	O	4451
genetic	O	4451
therapies	O	4451
for	O	4451
PKU	B-Disease	4451
.	O	4451

Regional	O	4453
mapping	O	4453
of	O	4453
the	O	4453
phenylalanine	O	4453
hydroxylase	O	4453
gene	O	4453
and	O	4453
the	O	4453
phenylketonuria	B-Disease	4453
locus	O	4453
in	O	4453
the	O	4453
human	O	4453
genome	O	4453
.	O	4453

Phenylketonuria	B-Disease	4454
(	O	4454
PKU	B-Disease	4454
)	O	4454
is	O	4454
an	O	4454
autosomal	B-Disease	4454
recessive	I-Disease	4454
disorder	I-Disease	4454
of	O	4454
amino	O	4454
acid	O	4454
metabolism	O	4454
caused	O	4454
by	O	4454
a	O	4454
deficiency	B-Disease	4454
of	I-Disease	4454
the	I-Disease	4454
hepatic	I-Disease	4454
enzyme	I-Disease	4454
phenylalanine	I-Disease	4454
hydroxylase	I-Disease	4454
(	O	4454
PAH	O	4454
;	O	4454
phenylalanine	O	4454
4	O	4454
-	O	4454
monooxygenase	O	4454
,	O	4454
EC	O	4454
1	O	4454
.	O	4454

Results	O	4463
of	O	4463
these	O	4463
experiments	O	4463
demonstrated	O	4463
that	O	4463
the	O	4463
region	O	4463
on	O	4463
chromosome	O	4463
12	O	4463
containing	O	4463
the	O	4463
PAH	O	4463
gene	O	4463
and	O	4463
the	O	4463
PKU	B-Disease	4463
locus	O	4463
in	O	4463
man	O	4463
is	O	4463
12q22	O	4463
-	O	4463
-	O	4463
-	O	4463
-	O	4463
12q24	O	4463
.	O	4463

These	O	4465
results	O	4465
not	O	4465
only	O	4465
provide	O	4465
a	O	4465
regionalized	O	4465
map	O	4465
position	O	4465
for	O	4465
a	O	4465
major	O	4465
human	O	4465
disease	O	4465
locus	O	4465
but	O	4465
also	O	4465
can	O	4465
serve	O	4465
as	O	4465
a	O	4465
reference	O	4465
point	O	4465
for	O	4465
linkage	O	4465
analysis	O	4465
with	O	4465
other	O	4465
DNA	O	4465
markers	O	4465
on	O	4465
human	O	4465
chromosome	O	4465
12	O	4465
Heterogeneity	O	4465
of	O	4465
type	B-Disease	4465
I	I-Disease	4465
von	I-Disease	4465
Willebrand	I-Disease	4465
disease	I-Disease	4465
:	O	4465
evidence	O	4465
for	O	4465
a	O	4465
subgroup	O	4465
with	O	4465
an	O	4465
abnormal	O	4465
von	B-Disease	4465
Willebrand	I-Disease	4465
factor	O	4465
.	O	4465

Type	B-Disease	4466
I	I-Disease	4466
von	I-Disease	4466
Willebrand	I-Disease	4466
disease	I-Disease	4466
(	O	4466
vWD	B-Disease	4466
)	O	4466
is	O	4466
characterized	O	4466
by	O	4466
equally	O	4466
low	O	4466
plasma	O	4466
concentrations	O	4466
of	O	4466
von	B-Disease	4466
Willebrand	I-Disease	4466
factor	O	4466
antigen	O	4466
(	O	4466
vWF	O	4466
Ag	O	4466
)	O	4466
and	O	4466
ristocetin	O	4466
cofactor	O	4466
(	O	4466
RiCof	O	4466
)	O	4466
and	O	4466
by	O	4466
the	O	4466
presence	O	4466
of	O	4466
all	O	4466
vWF	O	4466
multimers	O	4466
in	O	4466
sodium	O	4466
dodecyl	O	4466
sulfate	O	4466
(	O	4466
SDS	O	4466
)	O	4466
-	O	4466
agarose	O	4466
gel	O	4466
electrophoresis	O	4466
.	O	4466

These	O	4474
findings	O	4474
demonstrated	O	4474
that	O	4474
there	O	4474
can	O	4474
be	O	4474
an	O	4474
abnormal	O	4474
vWF	O	4474
(	O	4474
RiCof	O	4474
less	O	4474
than	O	4474
vWF	O	4474
Ag	O	4474
)	O	4474
even	O	4474
in	O	4474
type	B-Disease	4474
I	I-Disease	4474
vWD	I-Disease	4474
,	O	4474
coexisting	O	4474
with	O	4474
a	O	4474
complete	O	4474
set	O	4474
of	O	4474
vWF	O	4474
multimers	O	4474
(	O	4474
platelet	O	4474
discordant	O	4474
)	O	4474
;	O	4474
that	O	4474
the	O	4474
abnormal	O	4474
vWF	O	4474
can	O	4474
be	O	4474
shown	O	4474
more	O	4474
clearly	O	4474
in	O	4474
platelets	O	4474
than	O	4474
in	O	4474
plasma	O	4474
or	O	4474
else	O	4474
in	O	4474
plasma	O	4474
after	O	4474
DDAVP	O	4474
infusion	O	4474
;	O	4474
and	O	4474
that	O	4474
DDAVP	O	4474
normalizes	O	4474
the	O	4474
BT	O	4474
only	O	4474
in	O	4474
those	O	4474
patients	O	4474
with	O	4474
normal	O	4474
platelet	O	4474
levels	O	4474
of	O	4474
both	O	4474
vWF	O	4474
Ag	O	4474
and	O	4474
RiCof	O	4474
(	O	4474
platelet	O	4474
normal	O	4474
)	O	4474
.	O	4474

Genetic	O	4476
analysis	O	4476
in	O	4476
families	O	4476
with	O	4476
van	B-Disease	4476
der	I-Disease	4476
Woude	I-Disease	4476
syndrome	I-Disease	4476
.	O	4476

We	O	4477
have	O	4477
brought	O	4477
together	O	4477
information	O	4477
on	O	4477
864	O	4477
affected	O	4477
individuals	O	4477
in	O	4477
164	O	4477
families	O	4477
(	O	4477
including	O	4477
three	O	4477
new	O	4477
pedigrees	O	4477
)	O	4477
reported	O	4477
in	O	4477
the	O	4477
137	O	4477
year	O	4477
period	O	4477
since	O	4477
1845	O	4477
when	O	4477
Demarquay	O	4477
first	O	4477
described	O	4477
a	O	4477
family	O	4477
with	O	4477
what	O	4477
was	O	4477
later	O	4477
called	O	4477
van	B-Disease	4477
der	I-Disease	4477
Woude	I-Disease	4477
syndrome	I-Disease	4477
(	O	4477
VWS	B-Disease	4477
)	O	4477
.	O	4477

Both	O	4478
types	O	4478
of	O	4478
oral	B-Disease	4478
cleft	I-Disease	4478
,	O	4478
cleft	B-Disease	4478
palate	I-Disease	4478
(	O	4478
CP	B-Disease	4478
)	O	4478
and	O	4478
cleft	B-Disease	4478
lip	I-Disease	4478
with	O	4478
or	O	4478
without	O	4478
CP	B-Disease	4478
(	O	4478
CLP	B-Disease	4478
)	O	4478
,	O	4478
segregate	O	4478
in	O	4478
these	O	4478
families	O	4478
together	O	4478
with	O	4478
lower	O	4478
lip	B-Disease	4478
pits	I-Disease	4478
or	O	4478
fistulae	B-Disease	4478
in	O	4478
an	O	4478
autosomal	O	4478
dominant	O	4478
mode	O	4478
with	O	4478
high	O	4478
penetrance	O	4478
estimated	O	4478
to	O	4478
be	O	4478
K	O	4478
=	O	4478
.	O	4478

Cleft	O	4481
types	O	4481
(	O	4481
CLP	B-Disease	4481
and	O	4481
CP	B-Disease	4481
)	O	4481
occur	O	4481
in	O	4481
VWS	B-Disease	4481
in	O	4481
the	O	4481
same	O	4481
proportions	O	4481
as	O	4481
in	O	4481
the	O	4481
general	O	4481
non	O	4481
-	O	4481
VWS	O	4481
population	O	4481
,	O	4481
ie	O	4481
,	O	4481
about	O	4481
twice	O	4481
as	O	4481
many	O	4481
cleft	O	4481
-	O	4481
bearing	O	4481
individuals	O	4481
have	O	4481
CLP	B-Disease	4481
as	O	4481
have	O	4481
CP	B-Disease	4481
.	O	4481

On	O	4482
the	O	4482
other	O	4482
hand	O	4482
,	O	4482
we	O	4482
do	O	4482
not	O	4482
find	O	4482
the	O	4482
usually	O	4482
observed	O	4482
excess	O	4482
of	O	4482
females	O	4482
with	O	4482
CP	B-Disease	4482
and	O	4482
excess	O	4482
of	O	4482
males	O	4482
with	O	4482
CLP	B-Disease	4482
;	O	4482
in	O	4482
VWS	B-Disease	4482
the	O	4482
sex	O	4482
ratios	O	4482
are	O	4482
more	O	4482
nearly	O	4482
equal	O	4482
.	O	4482

Lip	B-Disease	4483
pits	I-Disease	4483
also	O	4483
are	O	4483
equally	O	4483
distributed	O	4483
between	O	4483
the	O	4483
sexes	O	4483
.	O	4483

Affected	O	4484
males	O	4484
and	O	4484
females	O	4484
are	O	4484
equally	O	4484
likely	O	4484
to	O	4484
transmit	O	4484
VWS	B-Disease	4484
.	O	4484

The	O	4486
expression	O	4486
of	O	4486
VWS	B-Disease	4486
is	O	4486
significantly	O	4486
modified	O	4486
by	O	4486
the	O	4486
genetic	O	4486
background	O	4486
More	O	4486
extreme	O	4486
phenotypes	O	4486
in	O	4486
parents	O	4486
tend	O	4486
to	O	4486
produce	O	4486
more	O	4486
extreme	O	4486
expression	O	4486
in	O	4486
their	O	4486
children	O	4486
.	O	4486

For	O	4487
a	O	4487
VWS	B-Disease	4487
gene	O	4487
carrier	O	4487
the	O	4487
relative	O	4487
risk	O	4487
of	O	4487
transmitting	O	4487
a	O	4487
cleft	O	4487
is	O	4487
26	O	4487
.	O	4487

45	O	4488
%	O	4488
;	O	4488
that	O	4488
of	O	4488
transmitting	O	4488
lower	O	4488
lip	B-Disease	4488
pits	I-Disease	4488
is	O	4488
23	O	4488
.	O	4488

Three	O	4490
pedigrees	O	4490
of	O	4490
lip	B-Disease	4490
pits	I-Disease	4490
in	O	4490
the	O	4490
literature	O	4490
show	O	4490
no	O	4490
clefts	O	4490
among	O	4490
a	O	4490
significant	O	4490
number	O	4490
of	O	4490
affected	O	4490
individuals	O	4490
.	O	4490

Control	O	4491
of	O	4491
gene	O	4491
expression	O	4491
in	O	4491
VWS	B-Disease	4491
in	O	4491
the	O	4491
three	O	4491
target	O	4491
tissues	O	4491
appears	O	4491
to	O	4491
be	O	4491
independent	O	4491
and	O	4491
separately	O	4491
designated	O	4491
.	O	4491

Mutation	O	4492
rate	O	4492
of	O	4492
the	O	4492
VWS	B-Disease	4492
gene	O	4492
is	O	4492
calculated	O	4492
to	O	4492
be	O	4492
1	O	4492
.	O	4492

8	O	4493
X	O	4493
10	O	4493
(	O	4493
-	O	4493
5	O	4493
)	O	4493
Hereditary	B-Disease	4493
C7	I-Disease	4493
deficiency	I-Disease	4493
.	O	4493

The	O	4495
serum	O	4495
of	O	4495
a	O	4495
44	O	4495
-	O	4495
yr	O	4495
-	O	4495
old	O	4495
woman	O	4495
of	O	4495
French	O	4495
-	O	4495
Canadian	O	4495
descent	O	4495
having	O	4495
a	O	4495
B	O	4495
-	O	4495
27	O	4495
positive	O	4495
ankylosing	B-Disease	4495
spondylitis	I-Disease	4495
was	O	4495
deficient	B-Disease	4495
in	I-Disease	4495
the	I-Disease	4495
seventh	I-Disease	4495
component	I-Disease	4495
of	I-Disease	4495
complement	I-Disease	4495
(	O	4495
C7	O	4495
)	O	4495
as	O	4495
determined	O	4495
by	O	4495
hemolytic	O	4495
and	O	4495
immunochemical	O	4495
methods	O	4495
.	O	4495

The	O	4499
seven	O	4499
other	O	4499
siblings	O	4499
were	O	4499
heterozygous	O	4499
for	O	4499
C7	B-Disease	4499
deficiency	I-Disease	4499
,	O	4499
while	O	4499
the	O	4499
paternal	O	4499
aunt	O	4499
had	O	4499
a	O	4499
normal	O	4499
C7	O	4499
level	O	4499
.	O	4499

Studies	O	4501
of	O	4501
the	O	4501
HLA	O	4501
antigens	O	4501
in	O	4501
all	O	4501
the	O	4501
22	O	4501
subjects	O	4501
and	O	4501
in	O	4501
three	O	4501
spouses	O	4501
indicated	O	4501
no	O	4501
close	O	4501
linkage	O	4501
between	O	4501
the	O	4501
CM	B-Disease	4501
deficienty	I-Disease	4501
and	O	4501
the	O	4501
HLA	O	4501
system	O	4501
.	O	4501

In	O	4502
addition	O	4502
,	O	4502
the	O	4502
simultaneous	O	4502
occurrence	O	4502
of	O	4502
two	O	4502
hereditary	O	4502
complement	B-Disease	4502
deficiencies	I-Disease	4502
(	I-Disease	4502
C2	I-Disease	4502
and	I-Disease	4502
C7	I-Disease	4502
)	I-Disease	4502
was	O	4502
discovered	O	4502
in	O	4502
one	O	4502
family	O	4502
of	O	4502
this	O	4502
remarkable	O	4502
kindred	O	4502
.	O	4502

Genetic	O	4504
defect	B-Disease	4504
in	I-Disease	4504
secretion	I-Disease	4504
of	I-Disease	4504
complement	I-Disease	4504
C5	I-Disease	4504
in	O	4504
mice	O	4504
.	O	4504

A	O	4505
genetic	O	4505
deficiency	B-Disease	4505
of	I-Disease	4505
the	I-Disease	4505
fifth	I-Disease	4505
(	I-Disease	4505
C5	I-Disease	4505
)	I-Disease	4505
component	I-Disease	4505
of	I-Disease	4505
complement1	I-Disease	4505
-	I-Disease	4505
3	I-Disease	4505
,	O	4505
a	O	4505
serum	O	4505
glycoprotein	O	4505
of	O	4505
molecular	O	4505
weight	O	4505
(	O	4505
MW	O	4505
)	O	4505
220	O	4505
,	O	4505
000	O	4505
(	O	4505
ref	O	4505
.	O	4505

Using	O	4517
similar	O	4517
methods	O	4517
,	O	4517
we	O	4517
now	O	4517
find	O	4517
that	O	4517
C5	B-Disease	4517
deficiency	I-Disease	4517
in	O	4517
each	O	4517
of	O	4517
five	O	4517
different	O	4517
mouse	O	4517
strains	O	4517
(	O	4517
AKR	O	4517
,	O	4517
SWR	O	4517
,	O	4517
DBA	O	4517
/	O	4517
2J8	O	4517
A	O	4517
/	O	4517
HeJ	O	4517
and	O	4517
B10	O	4517
.	O	4517

D2	O	4518
/	O	4518
old	O	4518
line	O	4518
)	O	4518
is	O	4518
due	O	4518
to	O	4518
a	O	4518
failure	O	4518
in	O	4518
secretion	O	4518
of	O	4518
C5	O	4518
protein	O	4518
and	O	4518
not	O	4518
to	O	4518
a	O	4518
failure	O	4518
in	O	4518
biosynthesis	O	4518
of	O	4518
pro	O	4518
-	O	4518
C5	O	4518
Recurrent	O	4518
meningococcal	B-Disease	4518
meningitis	I-Disease	4518
with	O	4518
absence	B-Disease	4518
of	I-Disease	4518
the	I-Disease	4518
sixth	I-Disease	4518
component	I-Disease	4518
of	I-Disease	4518
complement	I-Disease	4518
:	O	4518
an	O	4518
evaluation	O	4518
of	O	4518
underlying	O	4518
immunologic	O	4518
mechanisms	O	4518
.	O	4518

A	O	4519
51	O	4519
/	O	4519
2	O	4519
-	O	4519
year	O	4519
-	O	4519
old	O	4519
black	O	4519
girl	O	4519
with	O	4519
recurrent	O	4519
meningococcal	B-Disease	4519
meningitis	I-Disease	4519
and	O	4519
absence	B-Disease	4519
of	I-Disease	4519
the	I-Disease	4519
sixth	I-Disease	4519
component	I-Disease	4519
of	I-Disease	4519
complement	I-Disease	4519
(	O	4519
C6	O	4519
)	O	4519
is	O	4519
reported	O	4519
.	O	4519

To	O	4520
explore	O	4520
the	O	4520
pathogenesis	O	4520
of	O	4520
recurrent	O	4520
neisserial	B-Disease	4520
infections	I-Disease	4520
in	O	4520
C6	B-Disease	4520
deficiency	I-Disease	4520
,	O	4520
a	O	4520
detailed	O	4520
analysis	O	4520
of	O	4520
her	O	4520
immune	O	4520
competence	O	4520
was	O	4520
conducted	O	4520
.	O	4520

In	O	4522
addition	O	4522
,	O	4522
her	O	4522
C6	B-Disease	4522
-	I-Disease	4522
deficient	I-Disease	4522
serum	O	4522
was	O	4522
indistinguishable	O	4522
from	O	4522
normal	O	4522
serum	O	4522
in	O	4522
a	O	4522
complement	O	4522
-	O	4522
dependent	O	4522
assay	O	4522
of	O	4522
phagocyte	O	4522
bactericidal	O	4522
activity	O	4522
.	O	4522

Absent	O	4523
bacteriolysis	O	4523
remains	O	4523
the	O	4523
only	O	4523
consistent	O	4523
defect	O	4523
associated	O	4523
with	O	4523
recurrent	O	4523
neisserial	B-Disease	4523
infections	I-Disease	4523
and	O	4523
absence	O	4523
of	O	4523
one	O	4523
of	O	4523
the	O	4523
late	O	4523
-	O	4523
acting	O	4523
complement	O	4523
components	O	4523
.	O	4523

Deficiency	B-Disease	4525
of	I-Disease	4525
the	I-Disease	4525
fifth	I-Disease	4525
component	I-Disease	4525
of	I-Disease	4525
complement	I-Disease	4525
in	O	4525
human	O	4525
subjects	O	4525
.	O	4525

The	O	4527
discovery	O	4527
of	O	4527
a	O	4527
large	O	4527
kindred	O	4527
with	O	4527
a	O	4527
heritable	O	4527
deficiency	B-Disease	4527
of	I-Disease	4527
the	I-Disease	4527
fifth	I-Disease	4527
component	I-Disease	4527
of	I-Disease	4527
complement	I-Disease	4527
(	O	4527
C5	O	4527
)	O	4527
has	O	4527
permitted	O	4527
the	O	4527
accumulation	O	4527
of	O	4527
new	O	4527
clinical	O	4527
,	O	4527
genetic	O	4527
and	O	4527
immunologic	O	4527
data	O	4527
concerning	O	4527
the	O	4527
role	O	4527
of	O	4527
C5	O	4527
in	O	4527
human	O	4527
subjects	O	4527
.	O	4527

The	O	4528
proband	O	4528
,	O	4528
who	O	4528
has	O	4528
had	O	4528
nine	O	4528
episodes	O	4528
of	O	4528
disseminated	O	4528
gonococcal	B-Disease	4528
infection	I-Disease	4528
,	O	4528
has	O	4528
a	O	4528
hemolytic	O	4528
C5	O	4528
level	O	4528
of	O	4528
approximately	O	4528
0	O	4528
.	O	4528

No	O	4534
chemotactic	O	4534
activity	O	4534
for	O	4534
polymorphonuclear	O	4534
leukocytes	O	4534
could	O	4534
be	O	4534
generated	O	4534
in	O	4534
the	O	4534
C5	B-Disease	4534
-	I-Disease	4534
deficient	I-Disease	4534
serums	O	4534
upon	O	4534
activation	O	4534
of	O	4534
either	O	4534
the	O	4534
classic	O	4534
or	O	4534
alternative	O	4534
pathways	O	4534
,	O	4534
again	O	4534
demonstrating	O	4534
the	O	4534
importance	O	4534
of	O	4534
C5	O	4534
in	O	4534
human	O	4534
subjects	O	4534
for	O	4534
the	O	4534
production	O	4534
of	O	4534
chemotactic	O	4534
factors	O	4534
.	O	4534

No	O	4538
linkage	O	4538
for	O	4538
C5	B-Disease	4538
deficiency	I-Disease	4538
and	O	4538
the	O	4538
A	O	4538
or	O	4538
B	O	4538
loci	O	4538
of	O	4538
the	O	4538
major	O	4538
histocompatibility	O	4538
complex	O	4538
could	O	4538
be	O	4538
found	O	4538
.	O	4538

These	O	4539
data	O	4539
suggest	O	4539
an	O	4539
autosomal	O	4539
codominant	O	4539
mode	O	4539
of	O	4539
inheritance	O	4539
of	O	4539
C5	B-Disease	4539
deficiency	I-Disease	4539
.	O	4539

Deficiency	B-Disease	4540
of	I-Disease	4540
C5	I-Disease	4540
is	O	4540
compatible	O	4540
with	O	4540
good	O	4540
health	O	4540
,	O	4540
but	O	4540
it	O	4540
can	O	4540
be	O	4540
associated	O	4540
with	O	4540
repeated	O	4540
disseminated	O	4540
gonococcal	B-Disease	4540
infection	I-Disease	4540
Incidence	O	4540
and	O	4540
characteristics	O	4540
of	O	4540
glucose	O	4540
-	O	4540
6	O	4540
-	O	4540
phosphate	O	4540
dehydrogenase	O	4540
variants	O	4540
in	O	4540
Japan	O	4540
.	O	4540

A	O	4541
total	O	4541
of	O	4541
3000	O	4541
men	O	4541
living	O	4541
in	O	4541
Yamaguchi	O	4541
were	O	4541
screened	O	4541
for	O	4541
glucose	B-Disease	4541
-	I-Disease	4541
6	I-Disease	4541
-	I-Disease	4541
phosphate	I-Disease	4541
dehydrogenase	I-Disease	4541
(	I-Disease	4541
G6PD	I-Disease	4541
)	I-Disease	4541
deficiency	I-Disease	4541
using	O	4541
Beutlers	O	4541
spot	O	4541
test	O	4541
and	O	4541
three	O	4541
types	O	4541
of	O	4541
starch	O	4541
gel	O	4541
electrophoresis	O	4541
.	O	4541

Fifteen	O	4546
G6PD	B-Disease	4546
-	I-Disease	4546
deficient	I-Disease	4546
variants	O	4546
were	O	4546
found	O	4546
at	O	4546
the	O	4546
rate	O	4546
of	O	4546
0	O	4546
.	O	4546

These	O	4549
three	O	4549
variants	O	4549
had	O	4549
a	O	4549
mild	O	4549
to	O	4549
moderate	O	4549
G6PD	B-Disease	4549
deficiency	I-Disease	4549
and	O	4549
were	O	4549
not	O	4549
associated	O	4549
with	O	4549
any	O	4549
clinical	O	4549
signs	O	4549
.	O	4549

One	O	4554
boy	O	4554
with	O	4554
G6PD	O	4554
Ube	O	4554
was	O	4554
Korean	O	4554
Utilization	O	4554
of	O	4554
purines	O	4554
by	O	4554
an	O	4554
HPRT	O	4554
variant	O	4554
in	O	4554
an	O	4554
intelligent	O	4554
,	O	4554
nonmutilative	O	4554
patient	O	4554
with	O	4554
features	O	4554
of	O	4554
the	O	4554
Lesch	B-Disease	4554
-	I-Disease	4554
Nyhan	I-Disease	4554
syndrome	I-Disease	4554
.	O	4554

,	O	4558
was	O	4558
among	O	4558
the	O	4558
first	O	4558
reported	O	4558
with	O	4558
hyperuricemia	B-Disease	4558
and	O	4558
central	B-Disease	4558
nervous	I-Disease	4558
system	I-Disease	4558
symptoms	I-Disease	4558
.	O	4558

8	O	4564
)	O	4564
distinct	O	4564
from	O	4564
the	O	4564
enzyme	O	4564
present	O	4564
in	O	4564
patients	O	4564
with	O	4564
the	O	4564
Lesch	B-Disease	4564
-	I-Disease	4564
Nyhan	I-Disease	4564
syndrome	I-Disease	4564
.	O	4564

The	O	4565
patient	O	4565
had	O	4565
chroeoathetosis	B-Disease	4565
,	O	4565
spasticity	B-Disease	4565
,	O	4565
dysarthric	B-Disease	4565
speech	I-Disease	4565
,	O	4565
and	O	4565
hyperuricemia	B-Disease	4565
.	O	4565

In	O	4569
contrast	O	4569
,	O	4569
cells	O	4569
from	O	4569
patients	O	4569
with	O	4569
the	O	4569
Lesch	B-Disease	4569
-	I-Disease	4569
Nyhan	I-Disease	4569
syndrome	I-Disease	4569
were	O	4569
virtually	O	4569
completely	O	4569
unable	O	4569
to	O	4569
convert	O	4569
hypoxanthine	O	4569
to	O	4569
nucleotides	O	4569
.	O	4569

The	O	4571
growth	O	4571
of	O	4571
the	O	4571
cultured	O	4571
fibroblasts	O	4571
of	O	4571
this	O	4571
patient	O	4571
was	O	4571
intermediate	O	4571
in	O	4571
media	O	4571
containing	O	4571
hypoxanthine	O	4571
aminopterin	O	4571
thymidine	O	4571
(	O	4571
HAT	O	4571
)	O	4571
,	O	4571
whereas	O	4571
the	O	4571
growth	O	4571
of	O	4571
Lesch	B-Disease	4571
-	I-Disease	4571
Nyhan	I-Disease	4571
cells	O	4571
was	O	4571
inhibited	O	4571
and	O	4571
normal	O	4571
cells	O	4571
grew	O	4571
normally	O	4571
.	O	4571

Similarly	O	4572
in	O	4572
8	O	4572
-	O	4572
azaguanine	O	4572
,	O	4572
6	O	4572
-	O	4572
thioguanine	O	4572
,	O	4572
and	O	4572
8	O	4572
-	O	4572
azahypoxanthine	O	4572
,	O	4572
the	O	4572
growth	O	4572
of	O	4572
the	O	4572
patients	O	4572
cells	O	4572
was	O	4572
intermediate	O	4572
between	O	4572
normal	O	4572
and	O	4572
Lesch	B-Disease	4572
-	I-Disease	4572
Nyhan	I-Disease	4572
cells	O	4572
.	O	4572

They	O	4574
document	O	4574
that	O	4574
this	O	4574
famous	O	4574
patient	O	4574
did	O	4574
not	O	4574
have	O	4574
the	O	4574
Lesch	B-Disease	4574
-	I-Disease	4574
Nyhan	I-Disease	4574
syndrome	I-Disease	4574
Localisation	O	4574
of	O	4574
the	O	4574
Becker	B-Disease	4574
muscular	I-Disease	4574
dystrophy	I-Disease	4574
gene	O	4574
on	O	4574
the	O	4574
short	O	4574
arm	O	4574
of	O	4574
the	O	4574
X	O	4574
chromosome	O	4574
by	O	4574
linkage	O	4574
to	O	4574
cloned	O	4574
DNA	O	4574
sequences	O	4574
.	O	4574

A	O	4575
linkage	O	4575
study	O	4575
in	O	4575
30	O	4575
Becker	B-Disease	4575
muscular	I-Disease	4575
dystrophy	I-Disease	4575
(	O	4575
BMD	B-Disease	4575
)	O	4575
kindreds	O	4575
using	O	4575
three	O	4575
cloned	O	4575
DNA	O	4575
sequences	O	4575
from	O	4575
the	O	4575
X	O	4575
chromosome	O	4575
which	O	4575
demonstrate	O	4575
restriction	O	4575
fragment	O	4575
length	O	4575
polymorphisms	O	4575
(	O	4575
RFLPs	O	4575
)	O	4575
,	O	4575
suggests	O	4575
that	O	4575
the	O	4575
BMD	B-Disease	4575
gene	O	4575
is	O	4575
located	O	4575
on	O	4575
the	O	4575
short	O	4575
arm	O	4575
of	O	4575
the	O	4575
X	O	4575
chromosome	O	4575
,	O	4575
in	O	4575
the	O	4575
p21	O	4575
region	O	4575
.	O	4575

The	O	4576
genes	O	4576
for	O	4576
Becker	B-Disease	4576
and	I-Disease	4576
Duchenne	I-Disease	4576
dystrophies	I-Disease	4576
must	O	4576
therefore	O	4576
be	O	4576
closely	O	4576
linked	O	4576
,	O	4576
if	O	4576
not	O	4576
allelic	O	4576
,	O	4576
and	O	4576
any	O	4576
future	O	4576
DNA	O	4576
probes	O	4576
found	O	4576
to	O	4576
be	O	4576
of	O	4576
practical	O	4576
use	O	4576
in	O	4576
one	O	4576
disorder	O	4576
should	O	4576
be	O	4576
equally	O	4576
applicable	O	4576
to	O	4576
the	O	4576
other	O	4576
.	O	4576

Molecular	O	4579
evidence	O	4579
for	O	4579
new	O	4579
mutation	O	4579
at	O	4579
the	O	4579
hprt	O	4579
locus	O	4579
in	O	4579
Lesch	B-Disease	4579
-	I-Disease	4579
Nyhan	I-Disease	4579
patients	O	4579
.	O	4579

Partial	O	4584
HPRT	B-Disease	4584
deficiencies	I-Disease	4584
are	O	4584
associated	O	4584
with	O	4584
gouty	B-Disease	4584
arthritis	I-Disease	4584
,	O	4584
while	O	4584
absence	O	4584
of	O	4584
activity	O	4584
results	O	4584
in	O	4584
Lesch	B-Disease	4584
-	I-Disease	4584
Nyhan	I-Disease	4584
syndrome	I-Disease	4584
(	O	4584
L	B-Disease	4584
-	I-Disease	4584
N	I-Disease	4584
)	O	4584
.	O	4584

L	B-Disease	4585
-	I-Disease	4585
N	I-Disease	4585
patients	O	4585
fail	O	4585
to	O	4585
reproduce	O	4585
and	O	4585
the	O	4585
heterozygous	O	4585
state	O	4585
appears	O	4585
to	O	4585
confer	O	4585
no	O	4585
selective	O	4585
advantage	O	4585
.	O	4585

Thus	O	4586
,	O	4586
Haldanes	O	4586
principle	O	4586
predicts	O	4586
that	O	4586
new	O	4586
mutations	O	4586
at	O	4586
the	O	4586
hprt	O	4586
locus	O	4586
must	O	4586
occur	O	4586
frequently	O	4586
in	O	4586
order	O	4586
for	O	4586
L	B-Disease	4586
-	I-Disease	4586
N	I-Disease	4586
syndrome	I-Disease	4586
to	O	4586
be	O	4586
maintained	O	4586
in	O	4586
the	O	4586
population	O	4586
.	O	4586

This	O	4587
constant	O	4587
introduction	O	4587
of	O	4587
new	O	4587
mutations	O	4587
would	O	4587
be	O	4587
expected	O	4587
to	O	4587
result	O	4587
in	O	4587
a	O	4587
heterogeneous	O	4587
collection	O	4587
of	O	4587
genetic	B-Disease	4587
lesions	I-Disease	4587
,	O	4587
some	O	4587
of	O	4587
which	O	4587
may	O	4587
be	O	4587
novel	O	4587
.	O	4587

As	O	4588
we	O	4588
report	O	4588
here	O	4588
,	O	4588
the	O	4588
mutations	O	4588
in	O	4588
the	O	4588
hprt	O	4588
gene	O	4588
of	O	4588
seven	O	4588
L	B-Disease	4588
-	I-Disease	4588
N	I-Disease	4588
patients	O	4588
,	O	4588
selected	O	4588
from	O	4588
an	O	4588
initial	O	4588
survey	O	4588
of	O	4588
28	O	4588
patients	O	4588
,	O	4588
have	O	4588
been	O	4588
characterized	O	4588
and	O	4588
all	O	4588
were	O	4588
found	O	4588
to	O	4588
be	O	4588
distinctly	O	4588
different	O	4588
,	O	4588
as	O	4588
predicted	O	4588
.	O	4588

Further	O	4590
molecular	O	4590
analysis	O	4590
of	O	4590
the	O	4590
origin	O	4590
of	O	4590
new	O	4590
mutations	O	4590
at	O	4590
the	O	4590
hprt	O	4590
locus	O	4590
should	O	4590
aid	O	4590
in	O	4590
resolving	O	4590
the	O	4590
issue	O	4590
of	O	4590
an	O	4590
apparent	O	4590
difference	O	4590
in	O	4590
the	O	4590
frequency	O	4590
of	O	4590
hprt	O	4590
mutations	O	4590
in	O	4590
males	O	4590
and	O	4590
females	O	4590
Allelic	O	4590
exclusion	O	4590
of	O	4590
glucose	O	4590
-	O	4590
6	O	4590
-	O	4590
phosphate	O	4590
dehydrogenase	O	4590
in	O	4590
platelets	O	4590
and	O	4590
T	O	4590
lymphocytes	O	4590
from	O	4590
a	O	4590
Wiskott	B-Disease	4590
-	I-Disease	4590
Aldrich	I-Disease	4590
syndrome	I-Disease	4590
carrier	O	4590
.	O	4590

An	O	4591
obligate	O	4591
carrier	O	4591
of	O	4591
the	O	4591
Wiskott	B-Disease	4591
-	I-Disease	4591
Aldrich	I-Disease	4591
syndrome	I-Disease	4591
(	O	4591
WAS	B-Disease	4591
)	O	4591
who	O	4591
was	O	4591
also	O	4591
heterozygous	O	4591
for	O	4591
the	O	4591
A	O	4591
and	O	4591
B	O	4591
types	O	4591
of	O	4591
X	O	4591
-	O	4591
linked	O	4591
glucose	O	4591
-	O	4591
6	O	4591
-	O	4591
phosphate	O	4591
dehydrogenase	O	4591
was	O	4591
found	O	4591
.	O	4591

With	O	4592
her	O	4592
it	O	4592
became	O	4592
possible	O	4592
to	O	4592
determine	O	4592
whether	O	4592
allelic	O	4592
exclusion	O	4592
occurs	O	4592
in	O	4592
particular	O	4592
cell	O	4592
-	O	4592
types	O	4592
of	O	4592
the	O	4592
WAS	B-Disease	4592
carrier	O	4592
.	O	4592

These	O	4595
findings	O	4595
suggest	O	4595
that	O	4595
selection	O	4595
against	O	4595
the	O	4595
WAS	B-Disease	4595
gene	O	4595
occurs	O	4595
in	O	4595
platelets	O	4595
and	O	4595
thymus	O	4595
-	O	4595
derived	O	4595
T	O	4595
lymphocytes	O	4595
and	O	4595
that	O	4595
the	O	4595
defects	O	4595
associated	O	4595
with	O	4595
WAS	B-Disease	4595
expressed	O	4595
in	O	4595
these	O	4595
cell	O	4595
-	O	4595
types	O	4595
may	O	4595
be	O	4595
implicated	O	4595
in	O	4595
the	O	4595
genesis	O	4595
of	O	4595
the	O	4595
Wiskott	B-Disease	4595
-	I-Disease	4595
Aldrich	I-Disease	4595
syndrome	I-Disease	4595
.	O	4595

Complement	B-Disease	4597
deficiency	I-Disease	4597
and	O	4597
nephritis	B-Disease	4597
.	O	4597

A	O	4599
family	O	4599
is	O	4599
described	O	4599
in	O	4599
which	O	4599
three	O	4599
children	O	4599
had	O	4599
homozygous	O	4599
deficiency	B-Disease	4599
of	I-Disease	4599
C3	I-Disease	4599
and	O	4599
in	O	4599
which	O	4599
both	O	4599
parents	O	4599
and	O	4599
two	O	4599
other	O	4599
children	O	4599
were	O	4599
heterozygous	O	4599
for	O	4599
the	O	4599
C3	O	4599
nan	O	4599
gene	O	4599
.	O	4599

One	O	4600
child	O	4600
with	O	4600
heterozygous	O	4600
C3	B-Disease	4600
deficiency	I-Disease	4600
was	O	4600
found	O	4600
to	O	4600
have	O	4600
membranoproliferative	O	4600
glomerulonephritis	B-Disease	4600
;	O	4600
proteinuria	B-Disease	4600
and	O	4600
/	O	4600
or	O	4600
microscopical	O	4600
haematuria	B-Disease	4600
was	O	4600
present	O	4600
in	O	4600
all	O	4600
three	O	4600
homozygous	O	4600
C3	B-Disease	4600
-	I-Disease	4600
deficient	I-Disease	4600
children	O	4600
.	O	4600

All	O	4601
children	O	4601
with	O	4601
homozygous	O	4601
or	O	4601
heterozygous	O	4601
C3	B-Disease	4601
deficiency	I-Disease	4601
were	O	4601
,	O	4601
to	O	4601
a	O	4601
varying	O	4601
degree	O	4601
,	O	4601
susceptible	O	4601
to	O	4601
infection	O	4601
.	O	4601

The	O	4602
only	O	4602
child	O	4602
of	O	4602
the	O	4602
family	O	4602
with	O	4602
normal	O	4602
complement	O	4602
had	O	4602
no	O	4602
increased	O	4602
risk	O	4602
of	O	4602
infection	O	4602
and	O	4602
no	O	4602
renal	B-Disease	4602
disease	I-Disease	4602
.	O	4602

This	O	4603
family	O	4603
study	O	4603
provides	O	4603
further	O	4603
support	O	4603
for	O	4603
the	O	4603
proposal	O	4603
that	O	4603
C3	B-Disease	4603
deficiency	I-Disease	4603
predisposes	O	4603
to	O	4603
nephritis	B-Disease	4603
.	O	4603

Heterogeneity	O	4605
of	O	4605
glucose	B-Disease	4605
-	I-Disease	4605
6	I-Disease	4605
-	I-Disease	4605
phosphate	I-Disease	4605
dehydrogenase	I-Disease	4605
deficiency	I-Disease	4605
in	O	4605
Algeria	O	4605
.	O	4605

Glucose	B-Disease	4607
-	I-Disease	4607
6	I-Disease	4607
-	I-Disease	4607
phosphate	I-Disease	4607
dehydrogenase	I-Disease	4607
(	I-Disease	4607
G6PD	I-Disease	4607
)	I-Disease	4607
deficiency	I-Disease	4607
was	O	4607
found	O	4607
in	O	4607
3	O	4607
.	O	4607

G6PD	B-Disease	4615
deficiency	I-Disease	4615
is	O	4615
heterogeneous	O	4615
in	O	4615
northern	O	4615
Algeria	O	4615
where	O	4615
autochtonous	O	4615
variants	O	4615
seem	O	4615
to	O	4615
prevail	O	4615
.	O	4615

Glucose	B-Disease	4617
-	I-Disease	4617
6	I-Disease	4617
-	I-Disease	4617
phosphate	I-Disease	4617
dehydrogenase	I-Disease	4617
deficiency	I-Disease	4617
inhibits	O	4617
in	O	4617
vitro	O	4617
growth	O	4617
of	O	4617
Plasmodium	O	4617
falciparum	O	4617
.	O	4617

Glucose	B-Disease	4618
-	I-Disease	4618
6	I-Disease	4618
-	I-Disease	4618
phosphate	I-Disease	4618
dehydrogenase	I-Disease	4618
(	I-Disease	4618
G6PD	I-Disease	4618
;	I-Disease	4618
EC	I-Disease	4618
1	I-Disease	4618
.	I-Disease	4618

1	I-Disease	4619
.	I-Disease	4619

1	I-Disease	4620
.	I-Disease	4620

49	I-Disease	4621
)	I-Disease	4621
-	I-Disease	4621
deficient	I-Disease	4621
red	O	4621
blood	O	4621
cells	O	4621
from	O	4621
male	O	4621
hemizygotes	O	4621
and	O	4621
female	O	4621
heterozygotes	O	4621
from	O	4621
the	O	4621
island	O	4621
of	O	4621
Sardinia	O	4621
were	O	4621
studied	O	4621
for	O	4621
their	O	4621
ability	O	4621
to	O	4621
support	O	4621
growth	O	4621
in	O	4621
vitro	O	4621
of	O	4621
the	O	4621
malaria	B-Disease	4621
-	O	4621
causing	O	4621
organism	O	4621
Plasmodium	O	4621
falciparum	O	4621
.	O	4621

Parasite	O	4622
growth	O	4622
was	O	4622
approximately	O	4622
one	O	4622
-	O	4622
third	O	4622
of	O	4622
normal	O	4622
in	O	4622
both	O	4622
hemi	O	4622
-	O	4622
and	O	4622
heterozygotes	O	4622
for	O	4622
G6PD	B-Disease	4622
deficiency	I-Disease	4622
.	O	4622

In	O	4623
Sardinians	O	4623
with	O	4623
the	O	4623
beta	O	4623
0	O	4623
-	O	4623
thalassemia	O	4623
trait	O	4623
,	O	4623
parasite	O	4623
growth	O	4623
was	O	4623
normal	O	4623
except	O	4623
when	O	4623
G6PD	B-Disease	4623
deficiency	I-Disease	4623
occurred	O	4623
together	O	4623
with	O	4623
the	O	4623
thalassemia	B-Disease	4623
trait	O	4623
.	O	4623

The	O	4624
data	O	4624
support	O	4624
the	O	4624
hypothesis	O	4624
that	O	4624
G6PD	B-Disease	4624
deficiency	I-Disease	4624
may	O	4624
confer	O	4624
a	O	4624
selective	O	4624
advantage	O	4624
in	O	4624
a	O	4624
malarious	B-Disease	4624
area	O	4624
;	O	4624
the	O	4624
female	O	4624
heterozygote	O	4624
may	O	4624
be	O	4624
at	O	4624
a	O	4624
particular	O	4624
advantage	O	4624
because	O	4624
resistance	O	4624
to	O	4624
malaria	B-Disease	4624
equals	O	4624
that	O	4624
of	O	4624
male	O	4624
hemizygotes	O	4624
,	O	4624
but	O	4624
the	O	4624
risk	O	4624
of	O	4624
fatal	B-Disease	4624
hemolysis	I-Disease	4624
may	O	4624
be	O	4624
less	O	4624
.	O	4624

Bone	O	4627
marrow	O	4627
transplant	O	4627
in	O	4627
adrenoleukodystrophy	B-Disease	4627
.	O	4627

An	O	4628
allogeneic	O	4628
bone	O	4628
marrow	O	4628
transplant	O	4628
(	O	4628
BMT	O	4628
)	O	4628
from	O	4628
a	O	4628
normal	O	4628
HLA	O	4628
identical	O	4628
sibling	O	4628
donor	O	4628
was	O	4628
performed	O	4628
in	O	4628
a	O	4628
13	O	4628
-	O	4628
year	O	4628
-	O	4628
old	O	4628
boy	O	4628
with	O	4628
rapidly	O	4628
progressive	O	4628
adrenoleukodystrophy	B-Disease	4628
(	O	4628
ALD	B-Disease	4628
)	O	4628
.	O	4628

Engraftment	O	4629
and	O	4629
complete	O	4629
hematologic	O	4629
recovery	O	4629
occurred	O	4629
within	O	4629
4	O	4629
weeks	O	4629
,	O	4629
but	O	4629
neurologic	B-Disease	4629
deterioration	I-Disease	4629
continued	O	4629
.	O	4629

The	O	4630
patient	O	4630
died	O	4630
of	O	4630
an	O	4630
adenovirus	B-Disease	4630
infection	I-Disease	4630
141	O	4630
days	O	4630
after	O	4630
BMT	O	4630
.	O	4630

ALD	B-Disease	4631
is	O	4631
characterized	O	4631
by	O	4631
abnormally	O	4631
high	O	4631
plasma	O	4631
levels	O	4631
of	O	4631
very	O	4631
long	O	4631
chain	O	4631
fatty	O	4631
acids	O	4631
(	O	4631
VLCFA	O	4631
)	O	4631
as	O	4631
a	O	4631
result	O	4631
of	O	4631
impaired	O	4631
capacity	O	4631
to	O	4631
degrade	O	4631
them	O	4631
.	O	4631

The	O	4636
identification	O	4636
of	O	4636
mutant	O	4636
forms	O	4636
of	O	4636
glucose	O	4636
-	O	4636
6	O	4636
-	O	4636
phosphate	O	4636
dehydrogenase	O	4636
]	O	4636
In	O	4636
28	O	4636
families	O	4636
with	O	4636
G6PD	B-Disease	4636
deficiency	I-Disease	4636
living	O	4636
in	O	4636
3	O	4636
settlements	O	4636
of	O	4636
Shekii	O	4636
district	O	4636
of	O	4636
Azerbaijan	O	4636
11	O	4636
G6PD	O	4636
variants	O	4636
of	O	4636
II	O	4636
and	O	4636
III	O	4636
classes	O	4636
differing	O	4636
by	O	4636
kinetic	O	4636
properties	O	4636
were	O	4636
identified	O	4636
according	O	4636
WHO	O	4636
program	O	4636
.	O	4636

Adrenoleukodystrophy	B-Disease	4642
:	O	4642
survey	O	4642
of	O	4642
303	O	4642
cases	O	4642
:	O	4642
biochemistry	O	4642
,	O	4642
diagnosis	O	4642
,	O	4642
and	O	4642
therapy	O	4642
.	O	4642

Adrenoleukodystrophy	B-Disease	4643
(	O	4643
ALD	B-Disease	4643
)	O	4643
is	O	4643
a	O	4643
genetically	O	4643
determined	O	4643
disorder	O	4643
associated	O	4643
with	O	4643
progressive	B-Disease	4643
central	I-Disease	4643
demyelination	I-Disease	4643
and	O	4643
adrenal	B-Disease	4643
cortical	I-Disease	4643
insufficiency	I-Disease	4643
.	O	4643

This	O	4645
degradation	O	4645
normally	O	4645
takes	O	4645
place	O	4645
in	O	4645
a	O	4645
subcellular	O	4645
organelle	O	4645
called	O	4645
the	O	4645
peroxisome	O	4645
,	O	4645
and	O	4645
ALD	B-Disease	4645
,	O	4645
together	O	4645
with	O	4645
Zellwegers	B-Disease	4645
cerebrohepatorenal	I-Disease	4645
syndrome	I-Disease	4645
,	O	4645
is	O	4645
now	O	4645
considered	O	4645
to	O	4645
belong	O	4645
to	O	4645
the	O	4645
newly	O	4645
formed	O	4645
category	O	4645
of	O	4645
peroxisomal	B-Disease	4645
disorders	I-Disease	4645
.	O	4645

We	O	4647
have	O	4647
identified	O	4647
303	O	4647
patients	O	4647
with	O	4647
ALD	B-Disease	4647
in	O	4647
217	O	4647
kindreds	O	4647
.	O	4647

Sixty	O	4649
percent	O	4649
of	O	4649
patients	O	4649
had	O	4649
childhood	O	4649
ALD	B-Disease	4649
and	O	4649
17	O	4649
%	O	4649
adrenomyeloneuropathy	B-Disease	4649
,	O	4649
both	O	4649
of	O	4649
which	O	4649
are	O	4649
X	O	4649
-	O	4649
linked	O	4649
,	O	4649
with	O	4649
the	O	4649
gene	O	4649
mapped	O	4649
to	O	4649
Xq28	O	4649
.	O	4649

Neonatal	B-Disease	4650
ALD	I-Disease	4650
,	O	4650
a	O	4650
distinct	O	4650
entity	O	4650
with	O	4650
autosomal	O	4650
recessive	O	4650
inheritance	O	4650
and	O	4650
points	O	4650
of	O	4650
resemblance	O	4650
to	O	4650
Zellwegers	B-Disease	4650
syndrome	I-Disease	4650
,	O	4650
accounted	O	4650
for	O	4650
7	O	4650
%	O	4650
of	O	4650
the	O	4650
cases	O	4650
.	O	4650

Although	O	4651
excess	O	4651
C26	O	4651
0	O	4651
in	O	4651
the	O	4651
brain	O	4651
of	O	4651
patients	O	4651
with	O	4651
ALD	B-Disease	4651
is	O	4651
partially	O	4651
of	O	4651
dietary	O	4651
origin	O	4651
,	O	4651
dietary	O	4651
C26	O	4651
0	O	4651
restriction	O	4651
did	O	4651
not	O	4651
produce	O	4651
clear	O	4651
benefit	O	4651
.	O	4651

Considerable	O	4655
genetic	O	4655
heterogeneity	O	4655
in	O	4655
G6PD	O	4655
was	O	4655
found	O	4655
in	O	4655
the	O	4655
Bulgarian	O	4655
population	O	4655
-	O	4655
14	O	4655
G6PD	O	4655
variants	O	4655
isolated	O	4655
from	O	4655
117	O	4655
hemizygous	O	4655
carriers	O	4655
of	O	4655
G6PD	B-Disease	4655
deficiency	I-Disease	4655
.	O	4655

Clinical	O	4660
use	O	4660
of	O	4660
DNA	O	4660
markers	O	4660
linked	O	4660
to	O	4660
the	O	4660
gene	O	4660
for	O	4660
Duchenne	B-Disease	4660
muscular	I-Disease	4660
dystrophy	I-Disease	4660
.	O	4660

Seventy	O	4661
families	O	4661
with	O	4661
Duchenne	B-Disease	4661
muscular	I-Disease	4661
dystrophy	I-Disease	4661
(	O	4661
DMD	B-Disease	4661
)	O	4661
known	O	4661
to	O	4661
the	O	4661
Institute	O	4661
of	O	4661
Child	O	4661
Health	O	4661
fall	O	4661
into	O	4661
three	O	4661
categories	O	4661
with	O	4661
respect	O	4661
to	O	4661
potential	O	4661
linkage	O	4661
analysis	O	4661
with	O	4661
the	O	4661
X	O	4661
chromosome	O	4661
DNA	O	4661
markers	O	4661
RC8	O	4661
and	O	4661
L1	O	4661
.	O	4661

28	O	4662
that	O	4662
bridge	O	4662
the	O	4662
DMD	B-Disease	4662
gene	O	4662
.	O	4662

Here	O	4664
prediction	O	4664
and	O	4664
exclusion	O	4664
of	O	4664
DMD	B-Disease	4664
gene	O	4664
transmission	O	4664
may	O	4664
be	O	4664
possible	O	4664
,	O	4664
the	O	4664
accuracy	O	4664
being	O	4664
dependent	O	4664
on	O	4664
the	O	4664
closeness	O	4664
of	O	4664
the	O	4664
linkage	O	4664
of	O	4664
the	O	4664
DNA	O	4664
marker	O	4664
(	O	4664
s	O	4664
)	O	4664
to	O	4664
the	O	4664
DMD	B-Disease	4664
gene	O	4664
;	O	4664
an	O	4664
illustrative	O	4664
case	O	4664
is	O	4664
reported	O	4664
.	O	4664

Given	O	4666
an	O	4666
informative	O	4666
restriction	O	4666
fragment	O	4666
length	O	4666
polymorphism	O	4666
(	O	4666
RFLP	O	4666
)	O	4666
,	O	4666
the	O	4666
probability	O	4666
that	O	4666
the	O	4666
boy	O	4666
represents	O	4666
a	O	4666
new	O	4666
mutation	O	4666
can	O	4666
be	O	4666
reassessed	O	4666
;	O	4666
it	O	4666
is	O	4666
also	O	4666
possible	O	4666
to	O	4666
exclude	O	4666
the	O	4666
DMD	B-Disease	4666
gene	O	4666
in	O	4666
a	O	4666
sister	O	4666
.	O	4666

Here	O	4668
exclusion	O	4668
of	O	4668
the	O	4668
DMD	B-Disease	4668
gene	O	4668
in	O	4668
a	O	4668
sister	O	4668
may	O	4668
be	O	4668
possible	O	4668
.	O	4668

The	O	4670
linkage	O	4670
analysis	O	4670
required	O	4670
is	O	4670
described	O	4670
,	O	4670
and	O	4670
the	O	4670
need	O	4670
to	O	4670
check	O	4670
DMD	B-Disease	4670
families	O	4670
for	O	4670
informative	O	4670
RFLPs	O	4670
is	O	4670
stressed	O	4670
.	O	4670

Family	O	4671
studies	O	4671
in	O	4671
Bechterew	B-Disease	4671
'	I-Disease	4671
s	I-Disease	4671
syndrome	I-Disease	4671
(	O	4671
ankylosing	B-Disease	4671
spondylitis	I-Disease	4671
)	O	4671
III	O	4671
.	O	4671

The	O	4673
results	O	4673
of	O	4673
segregation	O	4673
analyses	O	4673
in	O	4673
75	O	4673
families	O	4673
where	O	4673
the	O	4673
proband	O	4673
had	O	4673
ankylosing	B-Disease	4673
spondylitis	I-Disease	4673
,	O	4673
are	O	4673
presented	O	4673
.	O	4673

The	O	4676
results	O	4676
were	O	4676
in	O	4676
agreement	O	4676
with	O	4676
our	O	4676
hypothesis	O	4676
that	O	4676
ankylosing	B-Disease	4676
spondylitis	I-Disease	4676
is	O	4676
part	O	4676
of	O	4676
a	O	4676
syndrome	O	4676
where	O	4676
different	O	4676
genetic	O	4676
factors	O	4676
interact	O	4676
.	O	4676

Such	O	4677
known	O	4677
factors	O	4677
are	O	4677
HLA	O	4677
B27	O	4677
associated	O	4677
disease	O	4677
susceptibility	O	4677
,	O	4677
susceptibility	O	4677
to	O	4677
psoriatic	B-Disease	4677
arthropathy	I-Disease	4677
and	O	4677
susceptibility	O	4677
to	O	4677
entero	B-Disease	4677
-	I-Disease	4677
arthropathy	I-Disease	4677
.	O	4677

Radiographical	O	4678
sacro	B-Disease	4678
-	I-Disease	4678
iliitis	I-Disease	4678
was	O	4678
restricted	O	4678
to	O	4678
HLA	O	4678
B27	O	4678
positive	O	4678
relatives	O	4678
,	O	4678
and	O	4678
was	O	4678
more	O	4678
frequently	O	4678
found	O	4678
in	O	4678
relatives	O	4678
to	O	4678
probands	O	4678
with	O	4678
psoriasis	B-Disease	4678
than	O	4678
in	O	4678
relatives	O	4678
to	O	4678
probands	O	4678
without	O	4678
psoriasis	B-Disease	4678
.	O	4678

The	O	4681
phenotypic	O	4681
expressions	O	4681
of	O	4681
the	O	4681
different	O	4681
genetic	O	4681
predispositions	O	4681
involved	O	4681
,	O	4681
include	O	4681
sacro	B-Disease	4681
-	I-Disease	4681
iliitis	I-Disease	4681
,	O	4681
psoriasis	B-Disease	4681
,	O	4681
acute	B-Disease	4681
anterior	I-Disease	4681
uveitis	I-Disease	4681
,	O	4681
peripheral	O	4681
arthropathy	B-Disease	4681
and	O	4681
inflammatory	B-Disease	4681
bowel	I-Disease	4681
disease	I-Disease	4681
.	O	4681

We	O	4682
suggest	O	4682
the	O	4682
descriptive	O	4682
name	O	4682
HEREDITARY	B-Disease	4682
MULTIFOCAL	I-Disease	4682
RELAPSING	I-Disease	4682
INFLAMMATION	I-Disease	4682
(	O	4682
HEMRI	B-Disease	4682
)	O	4682
for	O	4682
this	O	4682
syndrome	O	4682
.	O	4682

Ankylosing	B-Disease	4683
spondylitis	I-Disease	4683
,	O	4683
psoriatic	B-Disease	4683
arthropathy	I-Disease	4683
and	O	4683
entero	B-Disease	4683
-	I-Disease	4683
arthropathy	I-Disease	4683
may	O	4683
be	O	4683
regarded	O	4683
as	O	4683
clinical	O	4683
sub	O	4683
-	O	4683
types	O	4683
of	O	4683
the	O	4683
syndrome	O	4683
.	O	4683

Prader	B-Disease	4685
-	I-Disease	4685
Willi	I-Disease	4685
syndrome	I-Disease	4685
and	O	4685
chromosome	O	4685
15	O	4685
.	O	4685

A	O	4687
chromosome	B-Disease	4687
15	I-Disease	4687
anomaly	I-Disease	4687
was	O	4687
observed	O	4687
in	O	4687
12	O	4687
of	O	4687
20	O	4687
patients	O	4687
,	O	4687
17	O	4687
of	O	4687
whom	O	4687
were	O	4687
clinically	O	4687
suspected	O	4687
of	O	4687
having	O	4687
Prader	B-Disease	4687
-	I-Disease	4687
Willi	I-Disease	4687
syndrome	I-Disease	4687
(	O	4687
PWS	B-Disease	4687
)	O	4687
.	O	4687

The	O	4688
clinical	O	4688
features	O	4688
of	O	4688
eight	O	4688
cases	O	4688
with	O	4688
15q11	O	4688
-	O	4688
12	O	4688
deletion	O	4688
were	O	4688
very	O	4688
similar	O	4688
to	O	4688
those	O	4688
originally	O	4688
described	O	4688
in	O	4688
PWS	B-Disease	4688
.	O	4688

On	O	4689
the	O	4689
other	O	4689
hand	O	4689
,	O	4689
the	O	4689
group	O	4689
of	O	4689
normal	O	4689
karyotype	O	4689
patients	O	4689
is	O	4689
heterogeneous	O	4689
,	O	4689
and	O	4689
their	O	4689
features	O	4689
do	O	4689
not	O	4689
strictly	O	4689
correspond	O	4689
to	O	4689
the	O	4689
clinical	O	4689
definition	O	4689
of	O	4689
PWS	B-Disease	4689
.	O	4689

However	O	4690
,	O	4690
the	O	4690
hypothesis	O	4690
that	O	4690
PWS	B-Disease	4690
is	O	4690
associated	O	4690
with	O	4690
deletion	O	4690
of	O	4690
15q11	O	4690
-	O	4690
12	O	4690
can	O	4690
neither	O	4690
explain	O	4690
the	O	4690
apparently	O	4690
balanced	O	4690
translocations	O	4690
of	O	4690
chromosome	O	4690
15	O	4690
nor	O	4690
account	O	4690
for	O	4690
the	O	4690
small	O	4690
supernumerary	O	4690
metacentric	O	4690
chromosomes	O	4690
corresponding	O	4690
to	O	4690
an	O	4690
isochromosome	O	4690
15	O	4690
for	O	4690
band	O	4690
15q11	O	4690
observed	O	4690
in	O	4690
some	O	4690
cases	O	4690
.	O	4690

The	O	4692
Tay	B-Disease	4692
-	I-Disease	4692
Sachs	I-Disease	4692
disease	I-Disease	4692
gene	O	4692
in	O	4692
North	O	4692
American	O	4692
Jewish	O	4692
populations	O	4692
:	O	4692
geographic	O	4692
variations	O	4692
and	O	4692
origin	O	4692
.	O	4692

From	O	4693
data	O	4693
collected	O	4693
in	O	4693
a	O	4693
North	O	4693
American	O	4693
Tay	B-Disease	4693
-	I-Disease	4693
Sachs	I-Disease	4693
disease	I-Disease	4693
(	O	4693
TSD	B-Disease	4693
)	O	4693
heterozygote	O	4693
screening	O	4693
program	O	4693
,	O	4693
the	O	4693
TSD	B-Disease	4693
carrier	O	4693
frequency	O	4693
among	O	4693
46	O	4693
,	O	4693
304	O	4693
Jewish	O	4693
individuals	O	4693
was	O	4693
found	O	4693
to	O	4693
be	O	4693
.	O	4693

This	O	4695
frequency	O	4695
is	O	4695
consistent	O	4695
with	O	4695
earlier	O	4695
estimates	O	4695
based	O	4695
on	O	4695
TSD	B-Disease	4695
incidence	O	4695
data	O	4695
.	O	4695

TSD	B-Disease	4696
carrier	O	4696
frequencies	O	4696
were	O	4696
then	O	4696
examined	O	4696
by	O	4696
single	O	4696
country	O	4696
and	O	4696
single	O	4696
region	O	4696
of	O	4696
origin	O	4696
in	O	4696
28	O	4696
,	O	4696
029	O	4696
Jews	O	4696
within	O	4696
this	O	4696
sample	O	4696
for	O	4696
whom	O	4696
such	O	4696
data	O	4696
were	O	4696
available	O	4696
for	O	4696
analysis	O	4696
.	O	4696

Jews	O	4697
with	O	4697
Polish	O	4697
and	O	4697
/	O	4697
or	O	4697
Russian	O	4697
ancestry	O	4697
constituted	O	4697
88	O	4697
%	O	4697
of	O	4697
this	O	4697
sample	O	4697
and	O	4697
had	O	4697
a	O	4697
TSD	B-Disease	4697
carrier	O	4697
frequency	O	4697
of	O	4697
.	O	4697

No	O	4699
TSD	B-Disease	4699
carriers	O	4699
were	O	4699
observed	O	4699
among	O	4699
the	O	4699
166	O	4699
Jews	O	4699
of	O	4699
Near	O	4699
Eastern	O	4699
origins	O	4699
.	O	4699

Relative	O	4700
to	O	4700
Jews	O	4700
of	O	4700
Polish	O	4700
and	O	4700
Russian	O	4700
origins	O	4700
,	O	4700
there	O	4700
was	O	4700
at	O	4700
least	O	4700
a	O	4700
twofold	O	4700
increase	O	4700
in	O	4700
the	O	4700
TSD	B-Disease	4700
carrier	O	4700
frequency	O	4700
in	O	4700
Jews	O	4700
of	O	4700
Austrian	O	4700
,	O	4700
Hungarian	O	4700
,	O	4700
and	O	4700
Czechoslovakian	O	4700
origins	O	4700
(	O	4700
P	O	4700
less	O	4700
than	O	4700
.	O	4700

These	O	4702
findings	O	4702
suggest	O	4702
that	O	4702
the	O	4702
TSD	B-Disease	4702
gene	O	4702
proliferated	O	4702
among	O	4702
the	O	4702
antecedents	O	4702
of	O	4702
modern	O	4702
Ashkenazi	O	4702
Jewry	O	4702
after	O	4702
the	O	4702
Second	O	4702
Diaspora	O	4702
(	O	4702
70	O	4702
A	O	4702
.	O	4702

Human	O	4707
deficiency	B-Disease	4707
of	I-Disease	4707
the	I-Disease	4707
sixth	I-Disease	4707
component	I-Disease	4707
of	I-Disease	4707
complement	I-Disease	4707
in	O	4707
a	O	4707
patient	O	4707
with	O	4707
meningococcal	B-Disease	4707
meningitis	I-Disease	4707
and	O	4707
no	O	4707
haemostasis	B-Disease	4707
abnormality	I-Disease	4707
.	O	4707

A	O	4708
case	O	4708
of	O	4708
human	O	4708
complete	O	4708
C6	B-Disease	4708
deficiency	I-Disease	4708
is	O	4708
reported	O	4708
.	O	4708

The	O	4709
patient	O	4709
,	O	4709
a	O	4709
31	O	4709
year	O	4709
old	O	4709
white	O	4709
male	O	4709
,	O	4709
was	O	4709
seen	O	4709
on	O	4709
the	O	4709
occasion	O	4709
of	O	4709
an	O	4709
isolated	O	4709
episode	O	4709
of	O	4709
meningococcal	B-Disease	4709
meningitis	I-Disease	4709
.	O	4709

No	O	4711
hemostatic	B-Disease	4711
abnormalities	I-Disease	4711
were	O	4711
observed	O	4711
.	O	4711

Absence	B-Disease	4713
of	I-Disease	4713
the	I-Disease	4713
seventh	I-Disease	4713
component	I-Disease	4713
of	I-Disease	4713
complement	I-Disease	4713
in	O	4713
a	O	4713
patient	O	4713
with	O	4713
chronic	B-Disease	4713
meningococcemia	I-Disease	4713
presenting	O	4713
as	O	4713
vasculitis	B-Disease	4713
.	O	4713

A	O	4714
previously	O	4714
healthy	O	4714
40	O	4714
-	O	4714
year	O	4714
-	O	4714
old	O	4714
man	O	4714
presenting	O	4714
with	O	4714
fever	B-Disease	4714
,	O	4714
arthritis	B-Disease	4714
,	O	4714
and	O	4714
cutaneous	B-Disease	4714
vasculitis	I-Disease	4714
was	O	4714
found	O	4714
to	O	4714
have	O	4714
chronic	B-Disease	4714
meningococcemia	I-Disease	4714
.	O	4714

Evaluation	O	4715
of	O	4715
his	O	4715
complement	O	4715
system	O	4715
showed	O	4715
an	O	4715
absence	O	4715
of	O	4715
functional	O	4715
and	O	4715
antigenic	O	4715
C7	O	4715
,	O	4715
compatible	O	4715
with	O	4715
a	O	4715
complete	O	4715
deficiency	B-Disease	4715
of	I-Disease	4715
the	I-Disease	4715
seventh	I-Disease	4715
component	I-Disease	4715
of	I-Disease	4715
complement	I-Disease	4715
.	O	4715

Study	O	4716
of	O	4716
the	O	4716
patients	O	4716
family	O	4716
spanning	O	4716
four	O	4716
generations	O	4716
showed	O	4716
heterozygous	O	4716
deficiency	B-Disease	4716
of	I-Disease	4716
C7	I-Disease	4716
in	O	4716
five	O	4716
members	O	4716
.	O	4716

Chronic	B-Disease	4717
neisserial	I-Disease	4717
infection	I-Disease	4717
can	O	4717
be	O	4717
associated	O	4717
with	O	4717
C7	B-Disease	4717
deficiency	I-Disease	4717
and	O	4717
must	O	4717
be	O	4717
distinguished	O	4717
from	O	4717
other	O	4717
causes	O	4717
of	O	4717
cutaneous	B-Disease	4717
vasculitis	I-Disease	4717
.	O	4717

Familial	B-Disease	4719
discoid	I-Disease	4719
lupus	I-Disease	4719
erythematosus	I-Disease	4719
associated	O	4719
with	O	4719
heterozygote	O	4719
C2	B-Disease	4719
deficiency	I-Disease	4719
.	O	4719

Two	O	4720
siblings	O	4720
with	O	4720
chronic	B-Disease	4720
discoid	I-Disease	4720
lupus	I-Disease	4720
erythematosus	I-Disease	4720
and	O	4720
several	O	4720
family	O	4720
members	O	4720
were	O	4720
found	O	4720
with	O	4720
heterozygous	O	4720
C2	B-Disease	4720
deficiency	I-Disease	4720
.	O	4720

Linkage	O	4722
studies	O	4722
in	O	4722
this	O	4722
family	O	4722
suggested	O	4722
a	O	4722
close	O	4722
linkage	O	4722
between	O	4722
the	O	4722
C2	B-Disease	4722
deficiency	I-Disease	4722
gene	O	4722
and	O	4722
genes	O	4722
coding	O	4722
for	O	4722
B18	O	4722
,	O	4722
Dw2	O	4722
,	O	4722
and	O	4722
BfS	O	4722
antigens	O	4722
.	O	4722

Severe	B-Disease	4725
-	I-Disease	4725
glucose	I-Disease	4725
-	I-Disease	4725
6	I-Disease	4725
-	I-Disease	4725
phosphate	I-Disease	4725
dehydrogenase	I-Disease	4725
(	I-Disease	4725
G6PD	I-Disease	4725
)	I-Disease	4725
deficiency	I-Disease	4725
associated	O	4725
with	O	4725
chronic	O	4725
hemolytic	B-Disease	4725
anemia	I-Disease	4725
,	O	4725
granulocyte	B-Disease	4725
dysfunction	I-Disease	4725
,	O	4725
and	O	4725
increased	O	4725
susceptibility	O	4725
to	O	4725
infections	O	4725
:	O	4725
description	O	4725
of	O	4725
a	O	4725
new	O	4725
molecular	O	4725
variant	O	4725
(	O	4725
G6PD	O	4725
Barcelona	O	4725
)	O	4725
.	O	4725

Molecular	O	4726
,	O	4726
kinetic	O	4726
,	O	4726
and	O	4726
functional	O	4726
studies	O	4726
were	O	4726
carried	O	4726
out	O	4726
on	O	4726
erythrocytes	O	4726
and	O	4726
leukocytes	O	4726
in	O	4726
a	O	4726
Spanish	O	4726
male	O	4726
with	O	4726
G6PD	B-Disease	4726
deficiency	I-Disease	4726
,	O	4726
congenital	B-Disease	4726
nonspherocytic	I-Disease	4726
hemolytic	I-Disease	4726
anemia	I-Disease	4726
(	O	4726
CNSHA	B-Disease	4726
)	O	4726
,	O	4726
and	O	4726
increased	O	4726
susceptibility	O	4726
to	O	4726
infections	O	4726
.	O	4726

The	O	4732
molecular	O	4732
characteristics	O	4732
of	O	4732
G6PD	O	4732
in	O	4732
the	O	4732
patient	O	4732
differed	O	4732
from	O	4732
those	O	4732
of	O	4732
all	O	4732
previously	O	4732
reported	O	4732
variants	O	4732
associated	O	4732
with	O	4732
CNSHA	B-Disease	4732
,	O	4732
so	O	4732
the	O	4732
present	O	4732
variant	O	4732
was	O	4732
provisionally	O	4732
called	O	4732
G6PD	O	4732
Barcelona	O	4732
to	O	4732
distinguish	O	4732
it	O	4732
from	O	4732
other	O	4732
G6PD	O	4732
variants	O	4732
previously	O	4732
described	O	4732
.	O	4732

Possible	O	4733
mechanisms	O	4733
for	O	4733
the	O	4733
severe	O	4733
deficiency	B-Disease	4733
of	I-Disease	4733
G6PD	I-Disease	4733
in	O	4733
erythrocytes	O	4733
and	O	4733
granulocytes	O	4733
was	O	4733
investigated	O	4733
by	O	4733
studies	O	4733
on	O	4733
the	O	4733
immunologic	O	4733
specific	O	4733
activity	O	4733
of	O	4733
the	O	4733
mutant	O	4733
enzyme	O	4733
.	O	4733

Glucose	B-Disease	4734
-	I-Disease	4734
6	I-Disease	4734
-	I-Disease	4734
phosphate	I-Disease	4734
dehydrogenase	I-Disease	4734
deficiency	I-Disease	4734
in	O	4734
Papua	O	4734
New	O	4734
Guinea	O	4734
.	O	4734

Twenty	O	4737
-	O	4737
six	O	4737
G6PD	B-Disease	4737
deficient	I-Disease	4737
individuals	O	4737
were	O	4737
identified	O	4737
.	O	4737

This	O	4739
study	O	4739
illustrates	O	4739
the	O	4739
extreme	O	4739
heterogeneity	O	4739
of	O	4739
G6PD	B-Disease	4739
deficiency	I-Disease	4739
among	O	4739
the	O	4739
people	O	4739
of	O	4739
Papua	O	4739
New	O	4739
Guinea	O	4739
.	O	4739

glucose	B-Disease	4743
-	I-Disease	4743
6	I-Disease	4743
-	I-Disease	4743
phosphate	I-Disease	4743
dehydrogenase	I-Disease	4743
(	I-Disease	4743
G6PD	I-Disease	4743
)	I-Disease	4743
deficiency	I-Disease	4743
in	O	4743
Spain	O	4743
and	O	4743
description	O	4743
of	O	4743
two	O	4743
new	O	4743
variants	O	4743
associated	O	4743
with	O	4743
favism	B-Disease	4743
.	O	4743

Subjects	O	4748
were	O	4748
from	O	4748
multiple	O	4748
geographic	O	4748
regions	O	4748
within	O	4748
Spain	O	4748
,	O	4748
and	O	4748
all	O	4748
suffered	O	4748
from	O	4748
hemolytic	B-Disease	4748
anemia	I-Disease	4748
,	O	4748
either	O	4748
acute	O	4748
(	O	4748
34	O	4748
cases	O	4748
)	O	4748
or	O	4748
chronic	O	4748
nonspherocytic	O	4748
(	O	4748
2	O	4748
cases	O	4748
)	O	4748
.	O	4748

The	O	4753
present	O	4753
study	O	4753
constitutes	O	4753
the	O	4753
first	O	4753
attempt	O	4753
to	O	4753
characterize	O	4753
the	O	4753
deficient	B-Disease	4753
G6PD	I-Disease	4753
variants	O	4753
found	O	4753
in	O	4753
Spain	O	4753
and	O	4753
supplies	O	4753
new	O	4753
data	O	4753
on	O	4753
the	O	4753
relationship	O	4753
between	O	4753
molecular	O	4753
characteristics	O	4753
of	O	4753
deficient	O	4753
variants	O	4753
and	O	4753
their	O	4753
clinical	O	4753
manifestations	O	4753
.	O	4753

The	O	4754
most	O	4754
important	O	4754
findings	O	4754
can	O	4754
be	O	4754
summarized	O	4754
as	O	4754
follows	O	4754
(	O	4754
1	O	4754
)	O	4754
The	O	4754
Spanish	O	4754
population	O	4754
is	O	4754
characterized	O	4754
by	O	4754
an	O	4754
important	O	4754
heterogeneity	O	4754
in	O	4754
G6PD	B-Disease	4754
deficiency	I-Disease	4754
.	O	4754

(	O	4756
3	O	4756
)	O	4756
Favism	B-Disease	4756
has	O	4756
been	O	4756
observed	O	4756
associated	O	4756
with	O	4756
all	O	4756
kinds	O	4756
of	O	4756
variants	O	4756
described	O	4756
here	O	4756
.	O	4756

(	O	4757
4	O	4757
)	O	4757
G6PD	O	4757
Betica	O	4757
,	O	4757
which	O	4757
is	O	4757
the	O	4757
most	O	4757
frequent	O	4757
variant	O	4757
found	O	4757
in	O	4757
subjects	O	4757
of	O	4757
Southern	O	4757
Spanish	O	4757
origin	O	4757
,	O	4757
has	O	4757
been	O	4757
observed	O	4757
associated	O	4757
with	O	4757
favism	B-Disease	4757
in	O	4757
all	O	4757
cases	O	4757
except	O	4757
one	O	4757
.	O	4757

A	O	4758
new	O	4758
glucose	O	4758
-	O	4758
6	O	4758
-	O	4758
phosphate	O	4758
dehydrogenase	O	4758
variant	O	4758
(	O	4758
G6PD	O	4758
Nagano	O	4758
)	O	4758
associated	O	4758
with	O	4758
congenital	B-Disease	4758
hemolytic	I-Disease	4758
anemia	I-Disease	4758
.	O	4758

A	O	4759
new	O	4759
glucose	O	4759
-	O	4759
6	O	4759
-	O	4759
phosphate	O	4759
dehydrogenase	O	4759
(	O	4759
G6PD	O	4759
)	O	4759
variant	O	4759
associated	O	4759
with	O	4759
chronic	B-Disease	4759
nonspherocytic	I-Disease	4759
hemolytic	I-Disease	4759
anemia	I-Disease	4759
was	O	4759
reported	O	4759
.	O	4759

The	O	4760
patient	O	4760
,	O	4760
a	O	4760
6	O	4760
-	O	4760
year	O	4760
-	O	4760
old	O	4760
Japanese	O	4760
male	O	4760
,	O	4760
was	O	4760
noticed	O	4760
to	O	4760
have	O	4760
hemolytic	B-Disease	4760
anemia	I-Disease	4760
soon	O	4760
after	O	4760
birth	O	4760
,	O	4760
and	O	4760
a	O	4760
diagnosis	O	4760
of	O	4760
G6PD	B-Disease	4760
deficiency	I-Disease	4760
was	O	4760
made	O	4760
at	O	4760
the	O	4760
age	O	4760
of	O	4760
2	O	4760
.	O	4760

He	O	4761
had	O	4761
episodes	O	4761
of	O	4761
hemolytic	B-Disease	4761
crisis	I-Disease	4761
several	O	4761
times	O	4761
after	O	4761
upper	B-Disease	4761
respiratory	I-Disease	4761
infection	I-Disease	4761
.	O	4761

Infection	O	4766
-	O	4766
induced	O	4766
hemolysis	B-Disease	4766
and	O	4766
chronic	B-Disease	4766
hemolytic	I-Disease	4766
anemia	I-Disease	4766
seem	O	4766
to	O	4766
be	O	4766
due	O	4766
to	O	4766
markedly	O	4766
impaired	O	4766
enzyme	O	4766
activity	O	4766
and	O	4766
thermal	O	4766
instability	O	4766
.	O	4766

Heterozygous	O	4767
C2	B-Disease	4767
-	I-Disease	4767
deficiency	I-Disease	4767
and	O	4767
myasthenia	B-Disease	4767
gravis	I-Disease	4767
.	O	4767

Complement	B-Disease	4768
deficiency	I-Disease	4768
states	O	4768
in	O	4768
myasthenia	B-Disease	4768
gravis	I-Disease	4768
(	O	4768
MG	B-Disease	4768
)	O	4768
have	O	4768
not	O	4768
been	O	4768
reported	O	4768
previously	O	4768
.	O	4768

We	O	4769
describe	O	4769
a	O	4769
19	O	4769
-	O	4769
year	O	4769
-	O	4769
old	O	4769
woman	O	4769
with	O	4769
typical	O	4769
MG	B-Disease	4769
and	O	4769
heterozygous	O	4769
C2	B-Disease	4769
deficiency	I-Disease	4769
,	O	4769
along	O	4769
with	O	4769
HLA	O	4769
typing	O	4769
of	O	4769
the	O	4769
patient	O	4769
and	O	4769
her	O	4769
immediate	O	4769
family	O	4769
.	O	4769

Adrenoleukodystrophy	B-Disease	4771
:	O	4771
increased	O	4771
plasma	O	4771
content	O	4771
of	O	4771
saturated	O	4771
very	O	4771
long	O	4771
chain	O	4771
fatty	O	4771
acids	O	4771
.	O	4771

With	O	4772
a	O	4772
new	O	4772
method	O	4772
we	O	4772
measured	O	4772
the	O	4772
saturated	O	4772
very	O	4772
long	O	4772
chain	O	4772
fatty	O	4772
acids	O	4772
in	O	4772
the	O	4772
plasma	O	4772
of	O	4772
adrenoleukodystrophy	B-Disease	4772
(	O	4772
ALD	B-Disease	4772
)	O	4772
hemizygotes	O	4772
,	O	4772
ALD	B-Disease	4772
heterozygotes	O	4772
,	O	4772
and	O	4772
controls	O	4772
.	O	4772

ALD	B-Disease	4773
hemizygotes	O	4773
showed	O	4773
increased	O	4773
levels	O	4773
of	O	4773
hexacosanoate	O	4773
(	O	4773
C26	O	4773
fatty	O	4773
acid	O	4773
)	O	4773
which	O	4773
represented	O	4773
0	O	4773
.	O	4773

C26	O	4779
levels	O	4779
were	O	4779
also	O	4779
increased	O	4779
in	O	4779
most	O	4779
ALD	B-Disease	4779
heterozygotes	O	4779
,	O	4779
with	O	4779
a	O	4779
mean	O	4779
level	O	4779
0	O	4779
.	O	4779

Abnormal	O	4783
high	O	4783
density	O	4783
lipoproteins	O	4783
in	O	4783
cerebrotendinous	B-Disease	4783
xanthomatosis	I-Disease	4783
.	O	4783

The	O	4784
plasma	O	4784
lipoprotein	O	4784
profiles	O	4784
and	O	4784
high	O	4784
density	O	4784
lipoproteins	O	4784
(	O	4784
HDL	O	4784
)	O	4784
were	O	4784
characterized	O	4784
in	O	4784
patients	O	4784
with	O	4784
the	O	4784
genetic	B-Disease	4784
disease	I-Disease	4784
cerebrotendinous	B-Disease	4784
xanthomatosis	I-Disease	4784
(	O	4784
CTX	B-Disease	4784
)	O	4784
.	O	4784

Abnormalities	B-Disease	4785
in	I-Disease	4785
the	I-Disease	4785
HDL	I-Disease	4785
may	O	4785
contribute	O	4785
to	O	4785
their	O	4785
increased	O	4785
atherogenesis	O	4785
and	O	4785
excessive	O	4785
deposits	O	4785
of	O	4785
tissue	O	4785
sterols	O	4785
in	O	4785
the	O	4785
presence	O	4785
of	O	4785
low	O	4785
or	O	4785
low	O	4785
-	O	4785
normal	O	4785
concentrations	O	4785
of	O	4785
plasma	O	4785
cholesterol	O	4785
(	O	4785
165	O	4785
+	O	4785
/	O	4785
-	O	4785
25	O	4785
mg	O	4785
/	O	4785
dl	O	4785
)	O	4785
and	O	4785
low	O	4785
density	O	4785
lipoproteins	O	4785
(	O	4785
LDL	O	4785
)	O	4785
.	O	4785

The	O	4786
mean	O	4786
HDL	O	4786
-	O	4786
cholesterol	O	4786
concentration	O	4786
in	O	4786
the	O	4786
CTX	B-Disease	4786
plasmas	O	4786
was	O	4786
14	O	4786
.	O	4786

The	O	4791
ratio	O	4791
of	O	4791
apoprotein	O	4791
(	O	4791
apo	O	4791
)	O	4791
to	O	4791
total	O	4791
cholesterol	O	4791
in	O	4791
the	O	4791
HDL	O	4791
of	O	4791
CTX	B-Disease	4791
was	O	4791
two	O	4791
to	O	4791
three	O	4791
times	O	4791
greater	O	4791
than	O	4791
normal	O	4791
.	O	4791

In	O	4792
the	O	4792
CTX	B-Disease	4792
HDL	O	4792
,	O	4792
the	O	4792
ratio	O	4792
of	O	4792
apoAI	O	4792
to	O	4792
apoAII	O	4792
was	O	4792
high	O	4792
,	O	4792
the	O	4792
proportion	O	4792
of	O	4792
apoC	O	4792
low	O	4792
,	O	4792
and	O	4792
a	O	4792
normally	O	4792
minor	O	4792
form	O	4792
of	O	4792
apoAI	O	4792
increased	O	4792
relative	O	4792
to	O	4792
other	O	4792
forms	O	4792
.	O	4792

The	O	4794
abnormalities	O	4794
in	O	4794
lipoprotein	O	4794
distribution	O	4794
profile	O	4794
and	O	4794
composition	O	4794
of	O	4794
the	O	4794
plasma	O	4794
HDL	O	4794
result	O	4794
from	O	4794
metabolic	O	4794
defects	O	4794
that	O	4794
are	O	4794
not	O	4794
understood	O	4794
but	O	4794
may	O	4794
be	O	4794
linked	O	4794
to	O	4794
the	O	4794
genetic	B-Disease	4794
defect	I-Disease	4794
in	O	4794
bile	O	4794
acid	O	4794
synthesis	O	4794
in	O	4794
CTX	B-Disease	4794
.	O	4794

Genetics	O	4796
of	O	4796
cerebrotendinous	B-Disease	4796
xanthomatosis	I-Disease	4796
(	O	4796
CTX	B-Disease	4796
)	O	4796
:	O	4796
an	O	4796
autosomal	O	4796
recessive	O	4796
trait	O	4796
with	O	4796
high	O	4796
gene	O	4796
frequency	O	4796
in	O	4796
Sephardim	O	4796
of	O	4796
Moroccan	O	4796
origin	O	4796
.	O	4796

We	O	4797
described	O	4797
6	O	4797
patients	O	4797
(	O	4797
from	O	4797
3	O	4797
families	O	4797
)	O	4797
affected	O	4797
with	O	4797
cerebrotendinous	B-Disease	4797
xanthomatosis	I-Disease	4797
(	O	4797
CTX	B-Disease	4797
)	O	4797
.	O	4797

In	O	4799
view	O	4799
of	O	4799
the	O	4799
small	O	4799
number	O	4799
of	O	4799
CTX	B-Disease	4799
patients	O	4799
diagnosed	O	4799
in	O	4799
the	O	4799
world	O	4799
(	O	4799
a	O	4799
total	O	4799
of	O	4799
50	O	4799
including	O	4799
our	O	4799
6	O	4799
patients	O	4799
)	O	4799
,	O	4799
we	O	4799
are	O	4799
probably	O	4799
dealing	O	4799
with	O	4799
an	O	4799
ethnic	O	4799
subgroup	O	4799
with	O	4799
a	O	4799
high	O	4799
CTX	O	4799
gene	O	4799
frequency	O	4799
,	O	4799
which	O	4799
we	O	4799
have	O	4799
estimated	O	4799
to	O	4799
be	O	4799
1	O	4799
/	O	4799
108	O	4799
.	O	4799

Since	O	4800
there	O	4800
are	O	4800
differences	O	4800
in	O	4800
expression	O	4800
in	O	4800
this	O	4800
disease	O	4800
,	O	4800
we	O	4800
recommend	O	4800
cholestanol	O	4800
study	O	4800
in	O	4800
cases	O	4800
of	O	4800
undiagnosed	O	4800
cataract	B-Disease	4800
or	O	4800
tendinous	B-Disease	4800
xanthomas	I-Disease	4800
in	O	4800
childhood	O	4800
or	O	4800
early	O	4800
adolescence	O	4800
.	O	4800

The	O	4801
diagnosis	O	4801
in	O	4801
CTX	B-Disease	4801
is	O	4801
important	O	4801
not	O	4801
only	O	4801
for	O	4801
genetic	O	4801
counseling	O	4801
,	O	4801
but	O	4801
also	O	4801
in	O	4801
veiw	O	4801
of	O	4801
possible	O	4801
treatment	O	4801
.	O	4801

All	O	4805
of	O	4805
them	O	4805
were	O	4805
found	O	4805
in	O	4805
Italian	O	4805
males	O	4805
and	O	4805
all	O	4805
were	O	4805
associated	O	4805
with	O	4805
enzyme	B-Disease	4805
deficiency	I-Disease	4805
,	O	4805
but	O	4805
only	O	4805
two	O	4805
with	O	4805
signs	O	4805
of	O	4805
haemolysis	B-Disease	4805
.	O	4805

These	O	4806
and	O	4806
other	O	4806
variants	O	4806
reported	O	4806
in	O	4806
the	O	4806
literature	O	4806
,	O	4806
which	O	4806
must	O	4806
thus	O	4806
far	O	4806
be	O	4806
regarded	O	4806
as	O	4806
sporadic	O	4806
,	O	4806
are	O	4806
found	O	4806
to	O	4806
map	O	4806
in	O	4806
parts	O	4806
of	O	4806
Italy	O	4806
where	O	4806
common	O	4806
types	O	4806
of	O	4806
G6PD	B-Disease	4806
deficiency	I-Disease	4806
are	O	4806
also	O	4806
prevalent	O	4806
.	O	4806

Ten	O	4809
variants	O	4809
of	O	4809
erythrocyte	O	4809
glucose	O	4809
-	O	4809
6	O	4809
-	O	4809
phosphate	O	4809
dehydrogenase	O	4809
were	O	4809
identified	O	4809
in	O	4809
22	O	4809
patients	O	4809
with	O	4809
G6PD	B-Disease	4809
deficiency	I-Disease	4809
from	O	4809
three	O	4809
districts	O	4809
of	O	4809
Bulgaria	O	4809
.	O	4809

Nephropathy	B-Disease	4813
in	O	4813
the	O	4813
Wiskott	B-Disease	4813
-	I-Disease	4813
Aldrich	I-Disease	4813
syndrome	I-Disease	4813
.	O	4813

Nephropathy	B-Disease	4814
was	O	4814
detected	O	4814
in	O	4814
five	O	4814
of	O	4814
32	O	4814
patients	O	4814
with	O	4814
the	O	4814
Wiskott	B-Disease	4814
-	I-Disease	4814
Aldrich	I-Disease	4814
syndrome	I-Disease	4814
who	O	4814
were	O	4814
participating	O	4814
in	O	4814
a	O	4814
study	O	4814
of	O	4814
transfer	O	4814
factor	O	4814
(	O	4814
TF	O	4814
)	O	4814
therapy	O	4814
.	O	4814

In	O	4815
two	O	4815
patients	O	4815
,	O	4815
nephropathy	B-Disease	4815
was	O	4815
present	O	4815
before	O	4815
TF	O	4815
and	O	4815
did	O	4815
not	O	4815
appear	O	4815
changed	O	4815
by	O	4815
TF	O	4815
therapy	O	4815
.	O	4815

One	O	4816
of	O	4816
these	O	4816
patients	O	4816
subsequently	O	4816
developed	O	4816
progressive	O	4816
renal	B-Disease	4816
failure	I-Disease	4816
requiring	O	4816
dialysis	O	4816
beginning	O	4816
5	O	4816
1	O	4816
/	O	4816
2	O	4816
years	O	4816
after	O	4816
TF	O	4816
therapy	O	4816
.	O	4816

An	O	4819
additional	O	4819
patient	O	4819
was	O	4819
identified	O	4819
who	O	4819
died	O	4819
with	O	4819
renal	B-Disease	4819
failure	I-Disease	4819
without	O	4819
having	O	4819
received	O	4819
TF	O	4819
.	O	4819

The	O	4820
results	O	4820
suggest	O	4820
that	O	4820
renal	B-Disease	4820
failure	I-Disease	4820
occurs	O	4820
in	O	4820
the	O	4820
Wiskott	B-Disease	4820
-	I-Disease	4820
Aldrich	I-Disease	4820
syndrome	I-Disease	4820
more	O	4820
frequently	O	4820
than	O	4820
generally	O	4820
recognized	O	4820
and	O	4820
that	O	4820
administration	O	4820
of	O	4820
TF	O	4820
may	O	4820
precipitate	O	4820
or	O	4820
accelerate	O	4820
the	O	4820
renal	B-Disease	4820
disease	I-Disease	4820
in	O	4820
patients	O	4820
with	O	4820
this	O	4820
syndrome	O	4820
.	O	4820

Wiskott	B-Disease	4822
-	I-Disease	4822
Aldrich	I-Disease	4822
syndrome	I-Disease	4822
:	O	4822
cellular	O	4822
impairments	O	4822
and	O	4822
their	O	4822
implication	O	4822
for	O	4822
carrier	O	4822
detection	O	4822
.	O	4822

A	O	4823
family	O	4823
in	O	4823
which	O	4823
two	O	4823
male	O	4823
siblings	O	4823
were	O	4823
affected	O	4823
with	O	4823
Wiskott	B-Disease	4823
-	I-Disease	4823
Aldrich	I-Disease	4823
syndrome	I-Disease	4823
(	O	4823
WAS	B-Disease	4823
)	O	4823
was	O	4823
studied	O	4823
using	O	4823
G	O	4823
-	O	4823
6	O	4823
-	O	4823
PD	O	4823
isoenzymes	O	4823
as	O	4823
an	O	4823
X	O	4823
-	O	4823
linked	O	4823
marker	O	4823
in	O	4823
order	O	4823
to	O	4823
investigate	O	4823
the	O	4823
nature	O	4823
of	O	4823
cellular	O	4823
abnormalities	O	4823
.	O	4823

Isolated	O	4824
peripheral	O	4824
blood	O	4824
cell	O	4824
types	O	4824
from	O	4824
the	O	4824
doubly	O	4824
heterozygous	O	4824
mother	O	4824
of	O	4824
the	O	4824
affected	O	4824
males	O	4824
seemingly	O	4824
failed	O	4824
to	O	4824
express	O	4824
the	O	4824
G	O	4824
-	O	4824
6	O	4824
-	O	4824
PD	O	4824
allele	O	4824
in	O	4824
cis	O	4824
position	O	4824
with	O	4824
the	O	4824
WAS	B-Disease	4824
allele	O	4824
while	O	4824
her	O	4824
cultured	O	4824
skin	O	4824
fibroblasts	O	4824
expressed	O	4824
both	O	4824
G	O	4824
-	O	4824
6	O	4824
-	O	4824
PD	O	4824
alleles	O	4824
.	O	4824

In	O	4826
vitro	O	4826
culture	O	4826
of	O	4826
hemopoietic	O	4826
progenitor	O	4826
cells	O	4826
of	O	4826
the	O	4826
heterozygous	O	4826
mother	O	4826
showed	O	4826
that	O	4826
the	O	4826
majority	O	4826
of	O	4826
progenitor	O	4826
cells	O	4826
did	O	4826
not	O	4826
express	O	4826
the	O	4826
WAS	B-Disease	4826
allele	O	4826
.	O	4826

However	O	4827
,	O	4827
a	O	4827
small	O	4827
number	O	4827
of	O	4827
cells	O	4827
expressing	O	4827
the	O	4827
G	O	4827
-	O	4827
6	O	4827
-	O	4827
PD	O	4827
type	O	4827
linked	O	4827
with	O	4827
the	O	4827
WAS	B-Disease	4827
allele	O	4827
were	O	4827
detected	O	4827
.	O	4827

This	O	4829
observation	O	4829
suggests	O	4829
that	O	4829
selection	O	4829
against	O	4829
cells	O	4829
expressing	O	4829
the	O	4829
Wiskott	B-Disease	4829
-	I-Disease	4829
Aldrich	I-Disease	4829
defect	I-Disease	4829
takes	O	4829
place	O	4829
in	O	4829
the	O	4829
hemopoietic	O	4829
system	O	4829
of	O	4829
the	O	4829
heterozygous	O	4829
female	O	4829
and	O	4829
offers	O	4829
a	O	4829
possible	O	4829
means	O	4829
of	O	4829
carrier	O	4829
detection	O	4829
in	O	4829
some	O	4829
women	O	4829
.	O	4829

Linkage	O	4830
studies	O	4830
in	O	4830
this	O	4830
family	O	4830
revealed	O	4830
one	O	4830
example	O	4830
of	O	4830
probable	O	4830
recombination	O	4830
between	O	4830
the	O	4830
loci	O	4830
for	O	4830
WAS	B-Disease	4830
and	O	4830
G	O	4830
-	O	4830
6	O	4830
-	O	4830
PD	O	4830
among	O	4830
three	O	4830
informative	O	4830
subjects	O	4830
,	O	4830
suggesting	O	4830
that	O	4830
these	O	4830
two	O	4830
loci	O	4830
may	O	4830
not	O	4830
be	O	4830
closely	O	4830
linked	O	4830
on	O	4830
the	O	4830
X	O	4830
-	O	4830
chromosome	O	4830
.	O	4830

A	O	4832
new	O	4832
CT	O	4832
pattern	O	4832
in	O	4832
adrenoleukodystrophy	B-Disease	4832
.	O	4832

A	O	4833
new	O	4833
CT	O	4833
pattern	O	4833
was	O	4833
observed	O	4833
in	O	4833
2	O	4833
patients	O	4833
with	O	4833
adrenoleukodystrophy	B-Disease	4833
(	O	4833
ALD	B-Disease	4833
)	O	4833
.	O	4833

This	O	4835
is	O	4835
different	O	4835
from	O	4835
numerous	O	4835
previous	O	4835
descriptions	O	4835
of	O	4835
the	O	4835
CT	O	4835
pattern	O	4835
in	O	4835
ALD	B-Disease	4835
.	O	4835

Type	B-Disease	4836
II	I-Disease	4836
ALD	I-Disease	4836
does	O	4836
not	O	4836
appear	O	4836
to	O	4836
have	O	4836
been	O	4836
seen	O	4836
in	O	4836
any	O	4836
other	O	4836
leukoencephalopathy	B-Disease	4836
and	O	4836
is	O	4836
probably	O	4836
specific	O	4836
for	O	4836
a	O	4836
phenotypic	O	4836
variant	O	4836
or	O	4836
an	O	4836
evolving	O	4836
stage	O	4836
of	O	4836
ALD	B-Disease	4836
.	O	4836

Further	O	4838
evidence	O	4838
for	O	4838
heterogeneity	O	4838
of	O	4838
glucose	B-Disease	4838
-	I-Disease	4838
6	I-Disease	4838
-	I-Disease	4838
phosphate	I-Disease	4838
dehydrogenase	I-Disease	4838
deficiency	I-Disease	4838
in	O	4838
Papua	O	4838
New	O	4838
Guinea	O	4838
.	O	4838

Th	O	4841
data	O	4841
presented	O	4841
here	O	4841
together	O	4841
with	O	4841
those	O	4841
of	O	4841
previously	O	4841
published	O	4841
studies	O	4841
demonstrate	O	4841
a	O	4841
degree	O	4841
of	O	4841
heterogeneity	O	4841
of	O	4841
G6PD	B-Disease	4841
deficiency	I-Disease	4841
that	O	4841
is	O	4841
much	O	4841
higher	O	4841
than	O	4841
that	O	4841
in	O	4841
other	O	4841
regions	O	4841
of	O	4841
the	O	4841
world	O	4841
where	O	4841
G6PD	B-Disease	4841
deficiency	I-Disease	4841
is	O	4841
common	O	4841
.	O	4841

Increased	O	4843
incidence	O	4843
of	O	4843
cataracts	B-Disease	4843
in	O	4843
male	O	4843
subjects	O	4843
deficient	B-Disease	4843
in	I-Disease	4843
glucose	I-Disease	4843
-	I-Disease	4843
6	I-Disease	4843
-	I-Disease	4843
phosphate	I-Disease	4843
dehydrogenase	I-Disease	4843
.	O	4843

Glucose	B-Disease	4844
-	I-Disease	4844
6	I-Disease	4844
-	I-Disease	4844
phosphate	I-Disease	4844
dehydrogenase	I-Disease	4844
(	I-Disease	4844
G6PD	I-Disease	4844
)	I-Disease	4844
deficiency	I-Disease	4844
in	O	4844
RBCs	O	4844
was	O	4844
found	O	4844
significantly	O	4844
more	O	4844
frequently	O	4844
in	O	4844
210	O	4844
male	O	4844
cataractous	B-Disease	4844
patients	O	4844
than	O	4844
in	O	4844
672	O	4844
control	O	4844
subjects	O	4844
of	O	4844
Sardinian	O	4844
origin	O	4844
.	O	4844

The	O	4845
frequency	O	4845
of	O	4845
the	O	4845
deficiency	O	4845
was	O	4845
increasingly	O	4845
higher	O	4845
in	O	4845
presenile	O	4845
cataracts	B-Disease	4845
.	O	4845

In	O	4846
the	O	4846
G6PD	B-Disease	4846
-	I-Disease	4846
deficient	I-Disease	4846
group	O	4846
,	O	4846
the	O	4846
incidence	O	4846
of	O	4846
cortical	B-Disease	4846
and	I-Disease	4846
total	I-Disease	4846
cataracts	I-Disease	4846
was	O	4846
also	O	4846
increased	O	4846
.	O	4846

Moreover	O	4848
,	O	4848
G6PD	B-Disease	4848
deficiency	I-Disease	4848
should	O	4848
be	O	4848
added	O	4848
to	O	4848
other	O	4848
conditions	O	4848
,	O	4848
such	O	4848
as	O	4848
the	O	4848
galactosemic	B-Disease	4848
states	O	4848
and	O	4848
riboflavin	B-Disease	4848
deficiency	I-Disease	4848
,	O	4848
where	O	4848
cataracts	B-Disease	4848
represent	O	4848
a	O	4848
sensitive	O	4848
indicator	O	4848
of	O	4848
metabolic	B-Disease	4848
abnormalities	I-Disease	4848
of	O	4848
the	O	4848
RBC	O	4848
.	O	4848

Molecular	O	4850
basis	O	4850
of	O	4850
human	O	4850
mitochondrial	O	4850
very	B-Disease	4850
-	I-Disease	4850
long	I-Disease	4850
-	I-Disease	4850
chain	I-Disease	4850
acyl	I-Disease	4850
-	I-Disease	4850
CoA	I-Disease	4850
dehydrogenase	I-Disease	4850
deficiency	I-Disease	4850
causing	O	4850
cardiomyopathy	B-Disease	4850
and	O	4850
sudden	B-Disease	4850
death	I-Disease	4850
in	O	4850
childhood	O	4850
.	O	4850

Defects	O	4852
in	O	4852
enzymes	O	4852
of	O	4852
the	O	4852
beta	O	4852
-	O	4852
oxidation	O	4852
pathway	O	4852
cause	O	4852
sudden	B-Disease	4852
,	I-Disease	4852
unexplained	I-Disease	4852
death	I-Disease	4852
in	O	4852
childhood	O	4852
,	O	4852
acute	O	4852
hepatic	B-Disease	4852
encephalopathy	I-Disease	4852
or	O	4852
liver	B-Disease	4852
failure	I-Disease	4852
,	O	4852
skeletal	B-Disease	4852
myopathy	I-Disease	4852
,	O	4852
and	O	4852
cardiomyopathy	B-Disease	4852
.	O	4852

Polymerase	O	4858
chain	O	4858
reaction	O	4858
amplification	O	4858
of	O	4858
VLCAD	O	4858
mRNA	O	4858
and	O	4858
genomic	O	4858
exons	O	4858
defined	O	4858
the	O	4858
molecular	O	4858
defects	O	4858
in	O	4858
two	O	4858
patients	O	4858
with	O	4858
VLCAD	B-Disease	4858
deficiency	I-Disease	4858
who	O	4858
presented	O	4858
with	O	4858
unexplained	O	4858
cardiac	B-Disease	4858
arrest	I-Disease	4858
and	O	4858
cardiomyopathy	B-Disease	4858
.	O	4858

This	O	4861
initial	O	4861
delineation	O	4861
of	O	4861
human	O	4861
mutations	O	4861
in	O	4861
VLCAD	O	4861
suggests	O	4861
that	O	4861
VLCAD	B-Disease	4861
deficiency	I-Disease	4861
reduces	O	4861
myocardial	O	4861
fatty	O	4861
acid	O	4861
beta	O	4861
-	O	4861
oxidation	O	4861
and	O	4861
energy	O	4861
production	O	4861
and	O	4861
is	O	4861
associated	O	4861
with	O	4861
cardiomyopathy	B-Disease	4861
and	O	4861
sudden	B-Disease	4861
death	I-Disease	4861
in	O	4861
childhood	O	4861
.	O	4861

Aberrant	O	4862
subcellular	O	4862
localization	O	4862
of	O	4862
BRCA1	O	4862
in	O	4862
breast	B-Disease	4862
cancer	I-Disease	4862
.	O	4862

The	O	4863
BRCA1	O	4863
gene	O	4863
product	O	4863
was	O	4863
identified	O	4863
as	O	4863
a	O	4863
220	O	4863
-	O	4863
kilodalton	O	4863
nuclear	O	4863
phosphoprotein	O	4863
in	O	4863
normal	O	4863
cells	O	4863
,	O	4863
including	O	4863
breast	O	4863
ductal	O	4863
epithelial	O	4863
cells	O	4863
,	O	4863
and	O	4863
in	O	4863
18	O	4863
of	O	4863
20	O	4863
tumor	B-Disease	4863
cell	O	4863
lines	O	4863
derived	O	4863
from	O	4863
tissues	O	4863
other	O	4863
than	O	4863
breast	O	4863
and	O	4863
ovary	O	4863
.	O	4863

In	O	4864
16	O	4864
of	O	4864
17	O	4864
breast	B-Disease	4864
and	I-Disease	4864
ovarian	I-Disease	4864
cancer	I-Disease	4864
lines	O	4864
and	O	4864
17	O	4864
of	O	4864
17	O	4864
samples	O	4864
of	O	4864
cells	O	4864
obtained	O	4864
from	O	4864
malignant	O	4864
effusions	O	4864
,	O	4864
however	O	4864
,	O	4864
BRCA1	O	4864
localized	O	4864
mainly	O	4864
in	O	4864
cytoplasm	O	4864
.	O	4864

Absence	O	4865
of	O	4865
BRCA1	O	4865
or	O	4865
aberrant	O	4865
subcellular	O	4865
location	O	4865
was	O	4865
also	O	4865
observed	O	4865
to	O	4865
a	O	4865
variable	O	4865
extent	O	4865
in	O	4865
histological	O	4865
sections	O	4865
of	O	4865
many	O	4865
breast	B-Disease	4865
cancer	I-Disease	4865
biopsies	O	4865
.	O	4865

These	O	4866
findings	O	4866
suggest	O	4866
that	O	4866
BRCA1	B-Disease	4866
abnormalities	I-Disease	4866
may	O	4866
be	O	4866
involved	O	4866
in	O	4866
the	O	4866
pathogenesis	O	4866
of	O	4866
many	O	4866
breast	B-Disease	4866
cancers	I-Disease	4866
,	O	4866
sporadic	O	4866
as	O	4866
well	O	4866
as	O	4866
familial	O	4866
.	O	4866

Mapping	O	4868
of	O	4868
the	O	4868
mouse	O	4868
homologue	O	4868
of	O	4868
the	O	4868
Wilson	B-Disease	4868
disease	I-Disease	4868
gene	O	4868
to	O	4868
mouse	O	4868
chromosome	O	4868
8	O	4868
.	O	4868

ATP7B	O	4869
,	O	4869
the	O	4869
gene	O	4869
altered	O	4869
in	O	4869
Wilson	B-Disease	4869
disease	I-Disease	4869
(	O	4869
WD	B-Disease	4869
)	O	4869
patients	O	4869
,	O	4869
lies	O	4869
in	O	4869
a	O	4869
block	O	4869
of	O	4869
homology	O	4869
shared	O	4869
between	O	4869
human	O	4869
chromosome	O	4869
13q14	O	4869
and	O	4869
the	O	4869
central	O	4869
region	O	4869
of	O	4869
mouse	O	4869
chromosome	O	4869
14	O	4869
.	O	4869

This	O	4874
assignment	O	4874
suggests	O	4874
a	O	4874
possible	O	4874
location	O	4874
for	O	4874
the	O	4874
toxic	O	4874
milk	O	4874
mutation	O	4874
in	O	4874
the	O	4874
mouse	O	4874
,	O	4874
which	O	4874
has	O	4874
been	O	4874
proposed	O	4874
as	O	4874
a	O	4874
homologue	O	4874
of	O	4874
WD	B-Disease	4874
.	O	4874

Germline	O	4876
mutations	O	4876
of	O	4876
the	O	4876
BRCA1	O	4876
gene	O	4876
in	O	4876
breast	B-Disease	4876
and	I-Disease	4876
ovarian	I-Disease	4876
cancer	I-Disease	4876
families	O	4876
provide	O	4876
evidence	O	4876
for	O	4876
a	O	4876
genotype	O	4876
-	O	4876
phenotype	O	4876
correlation	O	4876
.	O	4876

Mutations	O	4877
in	O	4877
the	O	4877
BRCA1	O	4877
gene	O	4877
,	O	4877
discovered	O	4877
in	O	4877
1994	O	4877
,	O	4877
are	O	4877
associated	O	4877
with	O	4877
an	O	4877
80	O	4877
-	O	4877
90	O	4877
%	O	4877
lifetime	O	4877
risk	O	4877
of	O	4877
breast	B-Disease	4877
cancer	I-Disease	4877
.	O	4877

We	O	4878
have	O	4878
analysed	O	4878
60	O	4878
families	O	4878
with	O	4878
a	O	4878
history	O	4878
of	O	4878
breast	B-Disease	4878
and	I-Disease	4878
/	I-Disease	4878
or	I-Disease	4878
ovarian	I-Disease	4878
cancer	I-Disease	4878
for	O	4878
germline	O	4878
mutations	O	4878
in	O	4878
BRCA1	O	4878
.	O	4878

We	O	4880
observed	O	4880
a	O	4880
significant	O	4880
correlation	O	4880
between	O	4880
the	O	4880
location	O	4880
of	O	4880
the	O	4880
mutation	O	4880
in	O	4880
the	O	4880
gene	O	4880
and	O	4880
the	O	4880
ratio	O	4880
of	O	4880
breast	B-Disease	4880
to	I-Disease	4880
ovarian	I-Disease	4880
cancer	I-Disease	4880
incidence	O	4880
within	O	4880
each	O	4880
family	O	4880
.	O	4880

Our	O	4881
data	O	4881
suggest	O	4881
a	O	4881
transition	O	4881
in	O	4881
risk	O	4881
such	O	4881
that	O	4881
mutations	O	4881
in	O	4881
the	O	4881
3	O	4881
third	O	4881
of	O	4881
the	O	4881
gene	O	4881
are	O	4881
associated	O	4881
with	O	4881
a	O	4881
lower	O	4881
proportion	O	4881
of	O	4881
ovarian	B-Disease	4881
cancer	I-Disease	4881
.	O	4881

Hereditary	O	4884
deficiency	B-Disease	4884
of	I-Disease	4884
the	I-Disease	4884
seventh	I-Disease	4884
component	I-Disease	4884
of	I-Disease	4884
complement	I-Disease	4884
and	O	4884
recurrent	O	4884
meningococcal	B-Disease	4884
infection	I-Disease	4884
:	O	4884
investigations	O	4884
of	O	4884
an	O	4884
Irish	O	4884
family	O	4884
using	O	4884
a	O	4884
novel	O	4884
haemolytic	O	4884
screening	O	4884
assay	O	4884
for	O	4884
complement	O	4884
activity	O	4884
and	O	4884
C7	O	4884
M	O	4884
/	O	4884
N	O	4884
allotyping	O	4884
.	O	4884

Terminal	B-Disease	4885
complement	I-Disease	4885
component	I-Disease	4885
deficiency	I-Disease	4885
predisposes	O	4885
to	O	4885
meningococcal	B-Disease	4885
infection	I-Disease	4885
and	O	4885
is	O	4885
inherited	O	4885
in	O	4885
an	O	4885
autosomal	O	4885
co	O	4885
-	O	4885
dominant	O	4885
manner	O	4885
.	O	4885

An	O	4886
Irish	O	4886
family	O	4886
is	O	4886
described	O	4886
,	O	4886
in	O	4886
which	O	4886
2	O	4886
of	O	4886
3	O	4886
brothers	O	4886
had	O	4886
recurrent	O	4886
meningococcal	B-Disease	4886
infection	I-Disease	4886
.	O	4886

A	O	4887
novel	O	4887
screening	O	4887
assay	O	4887
was	O	4887
used	O	4887
to	O	4887
investigate	O	4887
for	O	4887
terminal	B-Disease	4887
complement	I-Disease	4887
deficiency	I-Disease	4887
and	O	4887
the	O	4887
2	O	4887
affected	O	4887
brothers	O	4887
were	O	4887
found	O	4887
to	O	4887
be	O	4887
completely	B-Disease	4887
deficient	I-Disease	4887
in	I-Disease	4887
the	I-Disease	4887
seventh	I-Disease	4887
component	I-Disease	4887
of	I-Disease	4887
complement	I-Disease	4887
(	O	4887
C7	O	4887
)	O	4887
.	O	4887

C7	O	4889
M	O	4889
/	O	4889
N	O	4889
protein	O	4889
polymorphism	O	4889
allotyping	O	4889
,	O	4889
used	O	4889
to	O	4889
investigate	O	4889
the	O	4889
segregation	O	4889
of	O	4889
the	O	4889
C7	B-Disease	4889
deficiency	I-Disease	4889
genes	O	4889
,	O	4889
showed	O	4889
that	O	4889
the	O	4889
apparently	O	4889
complement	O	4889
sufficient	O	4889
brother	O	4889
was	O	4889
heterozygous	O	4889
C7	B-Disease	4889
deficient	I-Disease	4889
and	O	4889
a	O	4889
carrier	O	4889
of	O	4889
one	O	4889
of	O	4889
the	O	4889
deficiency	O	4889
genes	O	4889
.	O	4889

Complement	O	4890
screening	O	4890
should	O	4890
be	O	4890
carried	O	4890
out	O	4890
in	O	4890
any	O	4890
individual	O	4890
suffering	O	4890
recurrent	O	4890
meningococcal	B-Disease	4890
infection	I-Disease	4890
or	O	4890
infection	O	4890
with	O	4890
an	O	4890
uncommon	O	4890
meningococcal	B-Disease	4890
serogroup	O	4890
.	O	4890

Identification	O	4891
of	O	4891
complement	B-Disease	4891
deficient	I-Disease	4891
patients	O	4891
allows	O	4891
the	O	4891
implementation	O	4891
of	O	4891
strategies	O	4891
to	O	4891
prevent	O	4891
recurrent	O	4891
infection	O	4891
.	O	4891

Molecular	O	4893
basis	O	4893
of	O	4893
subtotal	B-Disease	4893
complement	I-Disease	4893
C6	I-Disease	4893
deficiency	I-Disease	4893
.	O	4893

Individuals	O	4895
with	O	4895
subtotal	B-Disease	4895
complement	I-Disease	4895
C6	I-Disease	4895
deficiency	I-Disease	4895
possess	O	4895
a	O	4895
C6	O	4895
molecule	O	4895
that	O	4895
is	O	4895
14	O	4895
%	O	4895
shorter	O	4895
than	O	4895
normal	O	4895
C6	O	4895
and	O	4895
present	O	4895
in	O	4895
low	O	4895
but	O	4895
detectable	O	4895
concentrations	O	4895
(	O	4895
1	O	4895
-	O	4895
2	O	4895
%	O	4895
of	O	4895
the	O	4895
normal	O	4895
mean	O	4895
)	O	4895
.	O	4895

Interestingly	O	4903
,	O	4903
all	O	4903
three	O	4903
subjects	O	4903
were	O	4903
probably	O	4903
heterozygous	O	4903
for	O	4903
both	O	4903
subtotal	B-Disease	4903
C6	I-Disease	4903
and	I-Disease	4903
complete	I-Disease	4903
C6	I-Disease	4903
deficiency	I-Disease	4903
.	O	4903

Myotonic	B-Disease	4904
dystrophy	I-Disease	4904
:	O	4904
evidence	O	4904
for	O	4904
a	O	4904
possible	O	4904
dominant	O	4904
-	O	4904
negative	O	4904
RNA	O	4904
mutation	O	4904
.	O	4904

The	O	4905
trinucleotide	O	4905
expansion	O	4905
mutation	O	4905
causing	O	4905
myotonic	B-Disease	4905
dystrophy	I-Disease	4905
is	O	4905
in	O	4905
the	O	4905
3	O	4905
untranslated	O	4905
region	O	4905
of	O	4905
a	O	4905
protein	O	4905
kinase	O	4905
gene	O	4905
.	O	4905

The	O	4906
molecular	O	4906
mechanisms	O	4906
by	O	4906
which	O	4906
the	O	4906
expanded	O	4906
repeat	O	4906
causes	O	4906
the	O	4906
clinically	O	4906
variable	O	4906
and	O	4906
multisystemic	B-Disease	4906
disease	I-Disease	4906
,	O	4906
myotonic	B-Disease	4906
dystrophy	I-Disease	4906
,	O	4906
are	O	4906
not	O	4906
understood	O	4906
.	O	4906

Here	O	4908
we	O	4908
use	O	4908
muscle	O	4908
biopsies	O	4908
from	O	4908
classical	O	4908
adult	O	4908
-	O	4908
onset	O	4908
myotonic	B-Disease	4908
dystrophy	I-Disease	4908
patients	O	4908
to	O	4908
study	O	4908
the	O	4908
accumulation	O	4908
of	O	4908
transcripts	O	4908
from	O	4908
both	O	4908
the	O	4908
normal	O	4908
and	O	4908
expanded	O	4908
DM	B-Disease	4908
kinase	O	4908
genes	O	4908
in	O	4908
patient	O	4908
muscle	O	4908
,	O	4908
and	O	4908
compare	O	4908
the	O	4908
results	O	4908
to	O	4908
normal	O	4908
and	O	4908
myopathic	B-Disease	4908
controls	O	4908
.	O	4908

We	O	4909
found	O	4909
relatively	O	4909
small	O	4909
decreases	O	4909
of	O	4909
DM	B-Disease	4909
kinase	O	4909
RNA	O	4909
in	O	4909
the	O	4909
total	O	4909
RNA	O	4909
pool	O	4909
from	O	4909
muscle	O	4909
;	O	4909
however	O	4909
,	O	4909
these	O	4909
reductions	O	4909
were	O	4909
not	O	4909
disease	O	4909
specific	O	4909
.	O	4909

Analysis	O	4910
of	O	4910
poly	O	4910
(	O	4910
A	O	4910
)	O	4910
+	O	4910
RNA	O	4910
showed	O	4910
dramatic	O	4910
decreases	O	4910
of	O	4910
both	O	4910
the	O	4910
mutant	O	4910
and	O	4910
normal	O	4910
DM	B-Disease	4910
kinase	O	4910
RNAs	O	4910
,	O	4910
and	O	4910
these	O	4910
changes	O	4910
were	O	4910
disease	O	4910
-	O	4910
specific	O	4910
.	O	4910

Our	O	4911
findings	O	4911
are	O	4911
consistent	O	4911
with	O	4911
a	O	4911
novel	O	4911
molecular	O	4911
pathogenetic	O	4911
mechanism	O	4911
for	O	4911
myotonic	B-Disease	4911
dystrophy	I-Disease	4911
both	O	4911
the	O	4911
normal	O	4911
and	O	4911
expanded	O	4911
DM	B-Disease	4911
kinase	O	4911
genes	O	4911
are	O	4911
transcribed	O	4911
in	O	4911
patient	O	4911
muscle	O	4911
,	O	4911
but	O	4911
the	O	4911
abnormal	O	4911
expansion	O	4911
-	O	4911
containing	O	4911
RNA	O	4911
has	O	4911
a	O	4911
dominant	O	4911
effect	O	4911
on	O	4911
RNA	O	4911
metabolism	O	4911
by	O	4911
preventing	O	4911
the	O	4911
accumulation	O	4911
of	O	4911
poly	O	4911
(	O	4911
A	O	4911
)	O	4911
+	O	4911
RNA	O	4911
.	O	4911

The	O	4912
ability	O	4912
of	O	4912
the	O	4912
expansion	O	4912
mutation	O	4912
to	O	4912
alter	O	4912
accumulation	O	4912
of	O	4912
poly	O	4912
(	O	4912
A	O	4912
)	O	4912
+	O	4912
RNA	O	4912
in	O	4912
trans	O	4912
suggests	O	4912
that	O	4912
myotonic	B-Disease	4912
dystrophy	I-Disease	4912
may	O	4912
be	O	4912
the	O	4912
first	O	4912
example	O	4912
of	O	4912
a	O	4912
dominant	O	4912
-	O	4912
negative	O	4912
mutation	O	4912
manifested	O	4912
at	O	4912
the	O	4912
RNA	O	4912
level	O	4912
.	O	4912

A	O	4914
strong	O	4914
candidate	O	4914
for	O	4914
the	O	4914
breast	B-Disease	4914
and	I-Disease	4914
ovarian	I-Disease	4914
cancer	I-Disease	4914
susceptibility	O	4914
gene	O	4914
BRCA1	O	4914
.	O	4914

A	O	4915
strong	O	4915
candidate	O	4915
for	O	4915
the	O	4915
17q	O	4915
-	O	4915
linked	O	4915
BRCA1	O	4915
gene	O	4915
,	O	4915
which	O	4915
influences	O	4915
susceptibility	O	4915
to	O	4915
breast	B-Disease	4915
and	I-Disease	4915
ovarian	I-Disease	4915
cancer	I-Disease	4915
,	O	4915
has	O	4915
been	O	4915
identified	O	4915
by	O	4915
positional	O	4915
cloning	O	4915
methods	O	4915
.	O	4915

Identification	O	4920
of	O	4920
BRCA1	O	4920
should	O	4920
facilitate	O	4920
early	O	4920
diagnosis	O	4920
of	O	4920
breast	B-Disease	4920
and	I-Disease	4920
ovarian	I-Disease	4920
cancer	I-Disease	4920
susceptibility	O	4920
in	O	4920
some	O	4920
individuals	O	4920
as	O	4920
well	O	4920
as	O	4920
a	O	4920
better	O	4920
understanding	O	4920
of	O	4920
breast	B-Disease	4920
cancer	I-Disease	4920
biology	O	4920
.	O	4920

Molecular	O	4922
characterization	O	4922
of	O	4922
galactosemia	B-Disease	4922
(	O	4922
type	O	4922
1	O	4922
)	O	4922
mutations	O	4922
in	O	4922
Japanese	O	4922
.	O	4922

We	O	4923
characterized	O	4923
two	O	4923
novel	O	4923
mutations	O	4923
of	O	4923
the	O	4923
galactose	O	4923
-	O	4923
1	O	4923
-	O	4923
phosphate	O	4923
uridyltransferase	O	4923
(	O	4923
GALT	O	4923
)	O	4923
gene	O	4923
in	O	4923
two	O	4923
Japanese	O	4923
patients	O	4923
with	O	4923
GALT	B-Disease	4923
deficiency	I-Disease	4923
and	O	4923
identified	O	4923
N314D	O	4923
and	O	4923
R333W	O	4923
mutations	O	4923
,	O	4923
previously	O	4923
found	O	4923
in	O	4923
Caucasians	O	4923
.	O	4923

In	O	4927
seven	O	4927
Japanese	O	4927
families	O	4927
(	O	4927
14	O	4927
alleles	O	4927
for	O	4927
classic	O	4927
form	O	4927
and	O	4927
one	O	4927
allele	O	4927
for	O	4927
Duarte	O	4927
variant	O	4927
)	O	4927
with	O	4927
GALT	B-Disease	4927
deficiency	I-Disease	4927
,	O	4927
the	O	4927
R231H	O	4927
and	O	4927
318A	O	4927
-	O	4927
-	O	4927
>	O	4927
G	O	4927
mutations	O	4927
were	O	4927
found	O	4927
only	O	4927
on	O	4927
both	O	4927
alleles	O	4927
of	O	4927
the	O	4927
proband	O	4927
.	O	4927

We	O	4931
speculate	O	4931
that	O	4931
classic	B-Disease	4931
galactosemia	I-Disease	4931
mutations	O	4931
appear	O	4931
to	O	4931
differ	O	4931
between	O	4931
Japanese	O	4931
and	O	4931
Caucasian	O	4931
patients	O	4931
.	O	4931

Our	O	4932
limited	O	4932
data	O	4932
set	O	4932
on	O	4932
galactosemia	B-Disease	4932
mutations	O	4932
in	O	4932
Japanese	O	4932
suggests	O	4932
that	O	4932
the	O	4932
N314D	O	4932
GALT	O	4932
mutation	O	4932
encoding	O	4932
the	O	4932
Duarte	O	4932
variant	O	4932
arose	O	4932
before	O	4932
Asian	O	4932
and	O	4932
Caucasian	O	4932
people	O	4932
diverged	O	4932
and	O	4932
that	O	4932
classic	B-Disease	4932
galactosemia	I-Disease	4932
mutations	O	4932
arose	O	4932
and	O	4932
/	O	4932
or	O	4932
accumulated	O	4932
after	O	4932
the	O	4932
divergence	O	4932
of	O	4932
Asian	O	4932
and	O	4932
Caucasian	O	4932
populations	O	4932
.	O	4932

Three	O	4934
novel	O	4934
aniridia	B-Disease	4934
mutations	O	4934
in	O	4934
the	O	4934
human	O	4934
PAX6	O	4934
gene	O	4934
.	O	4934

Aniridia	B-Disease	4935
(	O	4935
iris	B-Disease	4935
hypoplasia	I-Disease	4935
)	O	4935
is	O	4935
an	O	4935
autosomal	B-Disease	4935
dominant	I-Disease	4935
congenital	I-Disease	4935
disorder	I-Disease	4935
of	I-Disease	4935
the	I-Disease	4935
eye	I-Disease	4935
.	O	4935

Mutations	O	4936
in	O	4936
the	O	4936
human	O	4936
aniridia	B-Disease	4936
(	O	4936
PAX6	O	4936
)	O	4936
gene	O	4936
have	O	4936
now	O	4936
been	O	4936
identified	O	4936
in	O	4936
many	O	4936
patients	O	4936
from	O	4936
various	O	4936
ethnic	O	4936
groups	O	4936
.	O	4936

In	O	4937
the	O	4937
study	O	4937
reported	O	4937
here	O	4937
we	O	4937
describe	O	4937
PAX6	O	4937
mutations	O	4937
in	O	4937
one	O	4937
sporadic	O	4937
and	O	4937
five	O	4937
familial	O	4937
cases	O	4937
with	O	4937
aniridia	B-Disease	4937
.	O	4937

One	O	4939
PAX6	O	4939
mutation	O	4939
found	O	4939
in	O	4939
the	O	4939
PST	O	4939
region	O	4939
was	O	4939
associated	O	4939
with	O	4939
cataracts	B-Disease	4939
in	O	4939
an	O	4939
aniridia	B-Disease	4939
family	O	4939
.	O	4939

Another	O	4940
splice	O	4940
mutation	O	4940
in	O	4940
the	O	4940
PST	O	4940
domain	O	4940
occurred	O	4940
in	O	4940
an	O	4940
aniridia	B-Disease	4940
patient	O	4940
with	O	4940
anosmia	B-Disease	4940
(	O	4940
inability	O	4940
to	O	4940
smell	O	4940
)	O	4940
.	O	4940

The	O	4941
six	O	4941
new	O	4941
aniridia	B-Disease	4941
cases	O	4941
reported	O	4941
here	O	4941
have	O	4941
mutations	O	4941
predicted	O	4941
to	O	4941
generate	O	4941
incomplete	O	4941
PAX6	O	4941
proteins	O	4941
.	O	4941

These	O	4942
results	O	4942
support	O	4942
the	O	4942
theory	O	4942
that	O	4942
human	O	4942
aniridia	B-Disease	4942
is	O	4942
caused	O	4942
by	O	4942
haploinsufficiency	B-Disease	4942
of	I-Disease	4942
PAX6	I-Disease	4942
.	O	4942

Since	O	4945
BRCA1	O	4945
,	O	4945
the	O	4945
first	O	4945
major	O	4945
gene	O	4945
responsible	O	4945
for	O	4945
inherited	B-Disease	4945
breast	I-Disease	4945
cancer	I-Disease	4945
,	O	4945
was	O	4945
cloned	O	4945
,	O	4945
more	O	4945
than	O	4945
50	O	4945
unique	O	4945
mutations	O	4945
have	O	4945
been	O	4945
detected	O	4945
in	O	4945
the	O	4945
germline	O	4945
of	O	4945
individuals	O	4945
with	O	4945
breast	B-Disease	4945
and	I-Disease	4945
ovarian	I-Disease	4945
cancer	I-Disease	4945
.	O	4945

In	O	4946
high	O	4946
-	O	4946
risk	O	4946
pedigrees	O	4946
,	O	4946
female	O	4946
carriers	O	4946
of	O	4946
BRCA1	O	4946
mutations	O	4946
have	O	4946
an	O	4946
80	O	4946
-	O	4946
90	O	4946
%	O	4946
lifetime	O	4946
risk	O	4946
of	O	4946
breast	B-Disease	4946
cancer	I-Disease	4946
,	O	4946
and	O	4946
a	O	4946
40	O	4946
-	O	4946
50	O	4946
%	O	4946
risk	O	4946
of	O	4946
ovarian	B-Disease	4946
cancer	I-Disease	4946
.	O	4946

However	O	4947
,	O	4947
the	O	4947
mutation	O	4947
stats	O	4947
of	O	4947
individuals	O	4947
unselected	O	4947
for	O	4947
breast	B-Disease	4947
or	I-Disease	4947
ovarian	I-Disease	4947
cancer	I-Disease	4947
has	O	4947
not	O	4947
been	O	4947
determined	O	4947
,	O	4947
and	O	4947
it	O	4947
is	O	4947
not	O	4947
known	O	4947
whether	O	4947
mutations	O	4947
in	O	4947
such	O	4947
individuals	O	4947
confer	O	4947
the	O	4947
same	O	4947
risk	O	4947
of	O	4947
cancer	B-Disease	4947
as	O	4947
in	O	4947
individuals	O	4947
from	O	4947
the	O	4947
high	O	4947
-	O	4947
risk	O	4947
families	O	4947
studied	O	4947
so	O	4947
far	O	4947
.	O	4947

Following	O	4948
the	O	4948
finding	O	4948
of	O	4948
a	O	4948
185delAG	O	4948
frameshift	O	4948
mutation	O	4948
in	O	4948
several	O	4948
Ashkenazi	O	4948
Jewish	O	4948
breast	O	4948
/	O	4948
ovarian	O	4948
families	O	4948
,	O	4948
we	O	4948
have	O	4948
determined	O	4948
the	O	4948
frequency	O	4948
of	O	4948
this	O	4948
mutation	O	4948
in	O	4948
858	O	4948
Ashkenazim	O	4948
seeking	O	4948
genetic	O	4948
testing	O	4948
for	O	4948
conditions	O	4948
unrelated	O	4948
to	O	4948
cancer	B-Disease	4948
,	O	4948
and	O	4948
in	O	4948
815	O	4948
reference	O	4948
individuals	O	4948
not	O	4948
selected	O	4948
for	O	4948
ethnic	O	4948
origin	O	4948
.	O	4948

Our	O	4953
results	O	4953
suggest	O	4953
that	O	4953
one	O	4953
in	O	4953
a	O	4953
hundred	O	4953
women	O	4953
of	O	4953
Ashkenazi	O	4953
descent	O	4953
may	O	4953
be	O	4953
at	O	4953
especially	O	4953
high	O	4953
risk	O	4953
of	O	4953
developing	O	4953
breast	B-Disease	4953
and	I-Disease	4953
/	I-Disease	4953
or	I-Disease	4953
ovarian	I-Disease	4953
cancer	I-Disease	4953
.	O	4953

The	O	4955
Huntington	B-Disease	4955
disease	I-Disease	4955
(	O	4955
HD	B-Disease	4955
)	O	4955
phenotype	O	4955
is	O	4955
associated	O	4955
with	O	4955
expansion	O	4955
of	O	4955
a	O	4955
trinucleotide	O	4955
repeat	O	4955
in	O	4955
the	O	4955
IT15	O	4955
gene	O	4955
,	O	4955
which	O	4955
is	O	4955
predicted	O	4955
to	O	4955
encode	O	4955
a	O	4955
348	O	4955
-	O	4955
kDa	O	4955
protein	O	4955
named	O	4955
huntington	O	4955
.	O	4955

In	O	4958
lymphoblastoid	O	4958
cell	O	4958
lines	O	4958
from	O	4958
juvenile	O	4958
-	O	4958
onset	O	4958
heterozygote	O	4958
HD	B-Disease	4958
cases	O	4958
,	O	4958
both	O	4958
normal	O	4958
and	O	4958
mutant	O	4958
huntingtin	O	4958
are	O	4958
expressed	O	4958
,	O	4958
and	O	4958
increasing	O	4958
repeat	O	4958
expansion	O	4958
leads	O	4958
to	O	4958
lower	O	4958
levels	O	4958
of	O	4958
the	O	4958
mutant	O	4958
protein	O	4958
.	O	4958

In	O	4960
the	O	4960
human	O	4960
striatum	O	4960
,	O	4960
huntingtin	O	4960
is	O	4960
enriched	O	4960
in	O	4960
a	O	4960
patch	O	4960
-	O	4960
like	O	4960
distribution	O	4960
,	O	4960
potentially	O	4960
corresponding	O	4960
to	O	4960
the	O	4960
first	O	4960
areas	O	4960
affected	O	4960
in	O	4960
HD	B-Disease	4960
.	O	4960

Marked	O	4965
phenotypic	O	4965
heterogeneity	O	4965
associated	O	4965
with	O	4965
expansion	O	4965
of	O	4965
a	O	4965
CAG	O	4965
repeat	O	4965
sequence	O	4965
at	O	4965
the	O	4965
spinocerebellar	B-Disease	4965
ataxia	I-Disease	4965
3	I-Disease	4965
/	I-Disease	4965
Machado	I-Disease	4965
-	I-Disease	4965
Joseph	I-Disease	4965
disease	I-Disease	4965
locus	O	4965
.	O	4965

The	O	4966
spinocerebellar	B-Disease	4966
ataxia	I-Disease	4966
3	I-Disease	4966
locus	O	4966
(	O	4966
SCA3	B-Disease	4966
)	O	4966
for	O	4966
type	B-Disease	4966
I	I-Disease	4966
autosomal	I-Disease	4966
dominant	I-Disease	4966
cerebellar	I-Disease	4966
ataxia	I-Disease	4966
(	O	4966
ADCA	B-Disease	4966
type	I-Disease	4966
I	I-Disease	4966
)	O	4966
,	O	4966
a	O	4966
clinically	O	4966
and	O	4966
genetically	O	4966
heterogeneous	O	4966
group	O	4966
of	O	4966
neurodegenerative	B-Disease	4966
disorders	I-Disease	4966
,	O	4966
has	O	4966
been	O	4966
mapped	O	4966
to	O	4966
chromosome	O	4966
14q32	O	4966
.	O	4966

ADCA	B-Disease	4968
type	I-Disease	4968
I	I-Disease	4968
patients	O	4968
from	O	4968
families	O	4968
segregating	O	4968
SCA3	B-Disease	4968
share	O	4968
clinical	O	4968
features	O	4968
in	O	4968
common	O	4968
with	O	4968
those	O	4968
with	O	4968
Machado	B-Disease	4968
-	I-Disease	4968
Joseph	I-Disease	4968
disease	I-Disease	4968
(	O	4968
MJD	B-Disease	4968
)	O	4968
,	O	4968
the	O	4968
gene	O	4968
of	O	4968
which	O	4968
maps	O	4968
to	O	4968
the	O	4968
same	O	4968
region	O	4968
.	O	4968

We	O	4969
show	O	4969
here	O	4969
that	O	4969
the	O	4969
disease	O	4969
gene	O	4969
segregating	O	4969
in	O	4969
each	O	4969
of	O	4969
three	O	4969
French	O	4969
ADCA	B-Disease	4969
type	I-Disease	4969
I	I-Disease	4969
kindreds	O	4969
and	O	4969
in	O	4969
a	O	4969
French	O	4969
family	O	4969
with	O	4969
neuropathological	O	4969
findings	O	4969
suggesting	O	4969
the	O	4969
ataxochoreic	O	4969
form	O	4969
of	O	4969
dentatorubropallidoluysian	B-Disease	4969
atrophy	I-Disease	4969
carries	O	4969
an	O	4969
expanded	O	4969
CAG	O	4969
repeat	O	4969
sequence	O	4969
located	O	4969
at	O	4969
the	O	4969
same	O	4969
locus	O	4969
as	O	4969
that	O	4969
for	O	4969
MJD	B-Disease	4969
.	O	4969

Overexpression	O	4973
of	O	4973
DM20	O	4973
messenger	O	4973
RNA	O	4973
in	O	4973
two	O	4973
brothers	O	4973
with	O	4973
Pelizaeus	B-Disease	4973
-	I-Disease	4973
Merzbacher	I-Disease	4973
disease	I-Disease	4973
.	O	4973

Pelizaeus	B-Disease	4974
-	I-Disease	4974
Merzbacher	I-Disease	4974
disease	I-Disease	4974
is	O	4974
a	O	4974
rare	B-Disease	4974
,	I-Disease	4974
sex	I-Disease	4974
-	I-Disease	4974
linked	I-Disease	4974
recessive	I-Disease	4974
,	I-Disease	4974
dysmyelinating	I-Disease	4974
disease	I-Disease	4974
of	I-Disease	4974
the	I-Disease	4974
central	I-Disease	4974
nervous	I-Disease	4974
system	I-Disease	4974
that	O	4974
has	O	4974
been	O	4974
associated	O	4974
with	O	4974
mutations	O	4974
in	O	4974
the	O	4974
myelin	O	4974
proteolipid	O	4974
protein	O	4974
(	O	4974
PLP	O	4974
)	O	4974
gene	O	4974
.	O	4974

Only	O	4975
25	O	4975
%	O	4975
of	O	4975
patients	O	4975
studied	O	4975
with	O	4975
Pelizaeus	B-Disease	4975
-	I-Disease	4975
Merzbacher	I-Disease	4975
disease	I-Disease	4975
have	O	4975
exonic	O	4975
mutations	O	4975
in	O	4975
this	O	4975
gene	O	4975
,	O	4975
the	O	4975
underlying	O	4975
cause	O	4975
of	O	4975
the	O	4975
disease	O	4975
in	O	4975
the	O	4975
remaining	O	4975
patients	O	4975
is	O	4975
unknown	O	4975
.	O	4975

We	O	4978
studied	O	4978
cultured	O	4978
skin	O	4978
fibroblasts	O	4978
from	O	4978
2	O	4978
brothers	O	4978
with	O	4978
Pelizaeus	B-Disease	4978
-	I-Disease	4978
Merzbacher	I-Disease	4978
disease	I-Disease	4978
who	O	4978
exhibited	O	4978
no	O	4978
detectable	O	4978
exonic	O	4978
mutation	O	4978
of	O	4978
the	O	4978
PLP	O	4978
gene	O	4978
.	O	4978

Our	O	4981
findings	O	4981
suggest	O	4981
that	O	4981
in	O	4981
some	O	4981
patients	O	4981
,	O	4981
Pelizaeus	B-Disease	4981
-	I-Disease	4981
Merzbacher	I-Disease	4981
disease	I-Disease	4981
is	O	4981
caused	O	4981
by	O	4981
overexpression	O	4981
of	O	4981
PLP	O	4981
gene	O	4981
transcripts	O	4981
,	O	4981
and	O	4981
that	O	4981
in	O	4981
these	O	4981
families	O	4981
a	O	4981
50	O	4981
%	O	4981
increase	O	4981
of	O	4981
DM20	O	4981
messenger	O	4981
RNA	O	4981
in	O	4981
females	O	4981
,	O	4981
relative	O	4981
to	O	4981
the	O	4981
increase	O	4981
in	O	4981
affected	O	4981
males	O	4981
,	O	4981
can	O	4981
identify	O	4981
a	O	4981
female	O	4981
carrier	O	4981
.	O	4981

The	O	4983
Wiskott	B-Disease	4983
-	I-Disease	4983
Aldrich	I-Disease	4983
syndrome	I-Disease	4983
and	O	4983
X	B-Disease	4983
-	I-Disease	4983
linked	I-Disease	4983
congenital	I-Disease	4983
thrombocytopenia	I-Disease	4983
are	O	4983
caused	O	4983
by	O	4983
mutations	O	4983
of	O	4983
the	O	4983
same	O	4983
gene	O	4983
.	O	4983

The	O	4984
Wiskott	B-Disease	4984
-	I-Disease	4984
Aldrich	I-Disease	4984
syndrome	I-Disease	4984
(	O	4984
WAS	B-Disease	4984
)	O	4984
is	O	4984
an	O	4984
X	B-Disease	4984
-	I-Disease	4984
linked	I-Disease	4984
recessive	I-Disease	4984
disorder	I-Disease	4984
characterized	O	4984
by	O	4984
thrombocytopenia	B-Disease	4984
,	O	4984
small	O	4984
platelets	O	4984
,	O	4984
eczema	B-Disease	4984
,	O	4984
recurrent	O	4984
infections	O	4984
,	O	4984
and	O	4984
immunodeficiency	B-Disease	4984
.	O	4984

Besides	O	4985
the	O	4985
classic	O	4985
WAS	B-Disease	4985
phenotype	O	4985
,	O	4985
there	O	4985
is	O	4985
a	O	4985
group	O	4985
of	O	4985
patients	O	4985
with	O	4985
congenital	B-Disease	4985
X	I-Disease	4985
-	I-Disease	4985
linked	I-Disease	4985
thrombocytopenia	I-Disease	4985
(	O	4985
XLT	B-Disease	4985
)	O	4985
who	O	4985
have	O	4985
small	O	4985
platelets	O	4985
but	O	4985
only	O	4985
transient	O	4985
eczema	B-Disease	4985
,	O	4985
if	O	4985
any	O	4985
,	O	4985
and	O	4985
minimal	O	4985
immune	B-Disease	4985
deficiency	I-Disease	4985
.	O	4985

Because	O	4986
the	O	4986
gene	O	4986
responsible	O	4986
for	O	4986
WAS	B-Disease	4986
has	O	4986
been	O	4986
sequenced	O	4986
,	O	4986
it	O	4986
was	O	4986
possible	O	4986
to	O	4986
correlate	O	4986
the	O	4986
WAS	B-Disease	4986
phenotypes	O	4986
with	O	4986
WAS	B-Disease	4986
gene	O	4986
mutations	O	4986
.	O	4986

Using	O	4987
a	O	4987
fingerprinting	O	4987
screening	O	4987
technique	O	4987
,	O	4987
we	O	4987
determined	O	4987
the	O	4987
approximate	O	4987
location	O	4987
of	O	4987
the	O	4987
mutation	O	4987
in	O	4987
13	O	4987
unrelated	O	4987
WAS	B-Disease	4987
patients	O	4987
with	O	4987
mild	O	4987
to	O	4987
severe	O	4987
clinical	O	4987
symptoms	O	4987
.	O	4987

Direct	O	4988
sequence	O	4988
analysis	O	4988
of	O	4988
cDNA	O	4988
and	O	4988
genomic	O	4988
DNA	O	4988
obtained	O	4988
from	O	4988
patient	O	4988
-	O	4988
derived	O	4988
cell	O	4988
lines	O	4988
showed	O	4988
12	O	4988
unique	O	4988
mutations	O	4988
distributed	O	4988
throughout	O	4988
the	O	4988
WAS	B-Disease	4988
gene	O	4988
,	O	4988
including	O	4988
insertions	O	4988
,	O	4988
deletions	O	4988
,	O	4988
and	O	4988
point	O	4988
mutations	O	4988
resulting	O	4988
in	O	4988
amino	O	4988
acid	O	4988
substitutions	O	4988
,	O	4988
termination	O	4988
,	O	4988
exon	O	4988
skipping	O	4988
,	O	4988
or	O	4988
splicing	O	4988
defects	O	4988
.	O	4988

Of	O	4989
4	O	4989
unrelated	O	4989
patients	O	4989
with	O	4989
the	O	4989
XLT	B-Disease	4989
phenotype	O	4989
,	O	4989
3	O	4989
had	O	4989
missense	O	4989
mutations	O	4989
affecting	O	4989
exon	O	4989
2	O	4989
and	O	4989
1	O	4989
had	O	4989
a	O	4989
splice	O	4989
-	O	4989
site	O	4989
mutation	O	4989
affecting	O	4989
exon	O	4989
9	O	4989
.	O	4989

Patients	O	4990
with	O	4990
classic	O	4990
WAS	B-Disease	4990
had	O	4990
more	O	4990
complex	O	4990
mutations	O	4990
,	O	4990
resulting	O	4990
in	O	4990
termination	O	4990
codons	O	4990
,	O	4990
frameshift	O	4990
,	O	4990
and	O	4990
early	O	4990
termination	O	4990
.	O	4990

These	O	4991
findings	O	4991
provide	O	4991
direct	O	4991
evidence	O	4991
that	O	4991
XLT	B-Disease	4991
and	O	4991
WAS	B-Disease	4991
are	O	4991
caused	O	4991
by	O	4991
mutations	O	4991
of	O	4991
the	O	4991
same	O	4991
gene	O	4991
and	O	4991
suggest	O	4991
that	O	4991
severe	O	4991
clinical	O	4991
phenotypes	O	4991
are	O	4991
associated	O	4991
with	O	4991
complex	O	4991
mutations	O	4991
.	O	4991

Myotonia	B-Disease	4993
levior	I-Disease	4993
is	O	4993
a	O	4993
chloride	B-Disease	4993
channel	I-Disease	4993
disorder	I-Disease	4993
.	O	4993

The	O	4994
group	O	4994
of	O	4994
dominant	B-Disease	4994
non	I-Disease	4994
-	I-Disease	4994
dystrophic	I-Disease	4994
myotonias	I-Disease	4994
,	O	4994
comprising	O	4994
disorders	O	4994
characterized	O	4994
by	O	4994
clinically	O	4994
similar	O	4994
forms	O	4994
of	O	4994
myogenic	O	4994
muscle	O	4994
stiffness	O	4994
,	O	4994
is	O	4994
genetically	O	4994
inhomogeneous	O	4994
.	O	4994

Dominant	B-Disease	4995
myotonia	I-Disease	4995
congenita	I-Disease	4995
(	O	4995
Thomsens	B-Disease	4995
disease	I-Disease	4995
)	O	4995
is	O	4995
linked	O	4995
to	O	4995
CLCN1	O	4995
,	O	4995
the	O	4995
gene	O	4995
encoding	O	4995
the	O	4995
major	O	4995
muscle	O	4995
chloride	O	4995
channel	O	4995
,	O	4995
localized	O	4995
on	O	4995
chromosome	O	4995
7q35	O	4995
.	O	4995

In	O	4996
contrast	O	4996
,	O	4996
dominant	B-Disease	4996
myotonias	I-Disease	4996
sensitive	O	4996
to	O	4996
potassium	O	4996
are	O	4996
caused	O	4996
by	O	4996
point	O	4996
mutations	O	4996
in	O	4996
SCN4A	O	4996
on	O	4996
chromosome	O	4996
17q	O	4996
,	O	4996
the	O	4996
gene	O	4996
for	O	4996
the	O	4996
alpha	O	4996
subunit	O	4996
of	O	4996
the	O	4996
adult	O	4996
skeletal	O	4996
muscle	O	4996
sodium	O	4996
channel	O	4996
.	O	4996

No	O	4997
linkage	O	4997
or	O	4997
molecular	O	4997
genetic	O	4997
data	O	4997
are	O	4997
as	O	4997
yet	O	4997
available	O	4997
on	O	4997
myotonia	B-Disease	4997
levior	I-Disease	4997
characterized	O	4997
by	O	4997
milder	O	4997
symptoms	O	4997
and	O	4997
later	O	4997
onset	O	4997
of	O	4997
myotonia	B-Disease	4997
than	O	4997
in	O	4997
Thomsens	B-Disease	4997
disease	I-Disease	4997
,	O	4997
and	O	4997
absence	O	4997
of	O	4997
muscle	B-Disease	4997
hypertrophy	I-Disease	4997
.	O	4997

We	O	4998
report	O	4998
a	O	4998
CLCN1	O	4998
Gln	O	4998
-	O	4998
552	O	4998
-	O	4998
Arg	O	4998
substitution	O	4998
for	O	4998
a	O	4998
family	O	4998
with	O	4998
dominant	O	4998
inheritance	O	4998
previously	O	4998
diagnosed	O	4998
to	O	4998
have	O	4998
myotonia	B-Disease	4998
levior	I-Disease	4998
.	O	4998

Thus	O	4999
,	O	4999
this	O	4999
disorder	O	4999
appears	O	4999
as	O	4999
a	O	4999
variant	O	4999
of	O	4999
Thomsens	B-Disease	4999
disease	I-Disease	4999
due	O	4999
to	O	4999
mutations	O	4999
leading	O	4999
to	O	4999
low	O	4999
clinical	O	4999
expressivity	O	4999
.	O	4999

In	O	5001
another	O	5001
family	O	5001
previously	O	5001
diagnosed	O	5001
as	O	5001
having	O	5001
Thomsens	B-Disease	5001
disease	I-Disease	5001
,	O	5001
we	O	5001
unexpectedly	O	5001
found	O	5001
a	O	5001
CLCN1	O	5001
14	O	5001
bp	O	5001
deletion	O	5001
known	O	5001
to	O	5001
cause	O	5001
recessive	B-Disease	5001
myotonia	I-Disease	5001
,	O	5001
and	O	5001
a	O	5001
rare	O	5001
Trp	O	5001
-	O	5001
118	O	5001
-	O	5001
Gly	O	5001
polymorphism	O	5001
.	O	5001

Southern	O	5003
analysis	O	5003
reveals	O	5003
a	O	5003
large	O	5003
deletion	O	5003
at	O	5003
the	O	5003
hypoxanthine	O	5003
phosphoribosyltransferase	O	5003
locus	O	5003
in	O	5003
a	O	5003
patient	O	5003
with	O	5003
Lesch	B-Disease	5003
-	I-Disease	5003
Nyhan	I-Disease	5003
syndrome	I-Disease	5003
.	O	5003

Whole	O	5004
genomic	O	5004
hprt	O	5004
clones	O	5004
were	O	5004
used	O	5004
in	O	5004
Southern	O	5004
analysis	O	5004
to	O	5004
screen	O	5004
the	O	5004
integrity	O	5004
of	O	5004
the	O	5004
hprt	O	5004
gene	O	5004
in	O	5004
a	O	5004
family	O	5004
that	O	5004
includes	O	5004
a	O	5004
patient	O	5004
with	O	5004
HPRT	B-Disease	5004
enzyme	I-Disease	5004
deficiency	I-Disease	5004
causal	O	5004
to	O	5004
Lesch	B-Disease	5004
-	I-Disease	5004
Nyhan	I-Disease	5004
syndrome	I-Disease	5004
.	O	5004

Characterisation	O	5008
of	O	5008
molecular	O	5008
defects	O	5008
in	O	5008
X	B-Disease	5008
-	I-Disease	5008
linked	I-Disease	5008
amelogenesis	I-Disease	5008
imperfecta	I-Disease	5008
(	O	5008
AIH1	O	5008
)	O	5008
.	O	5008

Disturbances	O	5010
of	O	5010
enamel	O	5010
formation	O	5010
occur	O	5010
in	O	5010
amelogenesis	B-Disease	5010
imperfecta	I-Disease	5010
,	O	5010
a	O	5010
clinically	O	5010
heterogenous	O	5010
group	O	5010
of	O	5010
inherited	B-Disease	5010
disorders	I-Disease	5010
characterised	O	5010
by	O	5010
defective	O	5010
enamel	O	5010
biomineralisation	O	5010
.	O	5010

3	O	5013
)	O	5013
and	O	5013
has	O	5013
been	O	5013
implicated	O	5013
in	O	5013
the	O	5013
molecular	O	5013
pathology	O	5013
of	O	5013
X	B-Disease	5013
-	I-Disease	5013
linked	I-Disease	5013
amelogenesis	I-Disease	5013
imperfecta	I-Disease	5013
(	O	5013
AIH1	B-Disease	5013
)	O	5013
.	O	5013

We	O	5014
have	O	5014
identified	O	5014
three	O	5014
families	O	5014
exhibiting	O	5014
AIH1	B-Disease	5014
and	O	5014
screened	O	5014
the	O	5014
AMGX	O	5014
gene	O	5014
for	O	5014
mutations	O	5014
using	O	5014
single	O	5014
-	O	5014
strand	O	5014
conformational	O	5014
polymorphism	O	5014
analysis	O	5014
and	O	5014
DNA	O	5014
sequencing	O	5014
.	O	5014

Frequency	O	5017
of	O	5017
exon	O	5017
15	O	5017
missense	O	5017
mutation	O	5017
(	O	5017
442D	O	5017
:	O	5017
G	O	5017
)	O	5017
in	O	5017
cholesteryl	O	5017
ester	O	5017
transfer	O	5017
protein	O	5017
gene	O	5017
in	O	5017
hyperalphalipoproteinemic	B-Disease	5017
Japanese	O	5017
subjects	O	5017
.	O	5017

The	O	5019
hyperalphalipoproteinemia	B-Disease	5019
caused	O	5019
by	O	5019
CETP	B-Disease	5019
deficiency	I-Disease	5019
is	O	5019
fairly	O	5019
common	O	5019
in	O	5019
Japan	O	5019
and	O	5019
one	O	5019
of	O	5019
the	O	5019
most	O	5019
common	O	5019
mutations	O	5019
in	O	5019
the	O	5019
CETP	O	5019
gene	O	5019
is	O	5019
the	O	5019
splicing	O	5019
defect	O	5019
of	O	5019
the	O	5019
intron	O	5019
14	O	5019
,	O	5019
the	O	5019
allelic	O	5019
frequency	O	5019
of	O	5019
which	O	5019
has	O	5019
been	O	5019
shown	O	5019
to	O	5019
be	O	5019
0	O	5019
.	O	5019

In	O	5022
the	O	5022
current	O	5022
study	O	5022
,	O	5022
we	O	5022
determined	O	5022
the	O	5022
frequency	O	5022
of	O	5022
this	O	5022
new	O	5022
mutation	O	5022
in	O	5022
Japanese	O	5022
hyperalphalipoproteinemic	B-Disease	5022
(	O	5022
HDL	O	5022
-	O	5022
cholesterol	O	5022
>	O	5022
or	O	5022
=	O	5022
100	O	5022
mg	O	5022
/	O	5022
dl	O	5022
)	O	5022
subjects	O	5022
.	O	5022

Among	O	5024
117	O	5024
Japanese	O	5024
hyperalphalipoproteinemic	B-Disease	5024
subjects	O	5024
(	O	5024
HDL	O	5024
-	O	5024
cholesterol	O	5024
;	O	5024
116	O	5024
.	O	5024

One	O	5033
of	O	5033
the	O	5033
homozygotes	O	5033
for	O	5033
the	O	5033
442D	O	5033
G	O	5033
mutation	O	5033
was	O	5033
the	O	5033
patient	O	5033
previously	O	5033
described	O	5033
by	O	5033
us	O	5033
as	O	5033
having	O	5033
hyperalphalipoproteinemia	B-Disease	5033
with	O	5033
corneal	B-Disease	5033
opacity	I-Disease	5033
and	O	5033
coronary	B-Disease	5033
heart	I-Disease	5033
disease	I-Disease	5033
.	O	5033

This	O	5034
was	O	5034
the	O	5034
first	O	5034
reported	O	5034
subject	O	5034
homozygous	O	5034
for	O	5034
the	O	5034
CETP	B-Disease	5034
deficiency	I-Disease	5034
who	O	5034
also	O	5034
demonstrated	O	5034
atherosclerotic	B-Disease	5034
symptoms	I-Disease	5034
.	O	5034

(	O	5036
ABSTRACT	O	5036
TRUNCATED	O	5036
AT	O	5036
250	O	5036
WORDS	O	5036
)	O	5036
Mucopolysaccharidosis	B-Disease	5036
type	I-Disease	5036
IVA	I-Disease	5036
:	O	5036
common	O	5036
double	O	5036
deletion	O	5036
in	O	5036
the	O	5036
N	O	5036
-	O	5036
acetylgalactosamine	O	5036
-	O	5036
6	O	5036
-	O	5036
sulfatase	O	5036
gene	O	5036
(	O	5036
GALNS	O	5036
)	O	5036
.	O	5036

Mucopolysaccharidosis	B-Disease	5037
IVA	I-Disease	5037
(	O	5037
MPS	B-Disease	5037
IVA	I-Disease	5037
)	O	5037
is	O	5037
an	O	5037
autosomal	B-Disease	5037
recessive	I-Disease	5037
disorder	I-Disease	5037
caused	O	5037
by	O	5037
a	O	5037
deficiency	B-Disease	5037
in	I-Disease	5037
N	I-Disease	5037
-	I-Disease	5037
acetylgalactosamine	I-Disease	5037
-	I-Disease	5037
6	I-Disease	5037
-	I-Disease	5037
sulfatase	I-Disease	5037
(	O	5037
GALNS	O	5037
)	O	5037
.	O	5037

Detection	O	5047
of	O	5047
eight	O	5047
BRCA1	O	5047
mutations	O	5047
in	O	5047
10	O	5047
breast	B-Disease	5047
/	I-Disease	5047
ovarian	I-Disease	5047
cancer	I-Disease	5047
families	O	5047
,	O	5047
including	O	5047
1	O	5047
family	O	5047
with	O	5047
male	B-Disease	5047
breast	I-Disease	5047
cancer	I-Disease	5047
.	O	5047

Genetic	O	5048
epidemiological	O	5048
evidence	O	5048
suggests	O	5048
that	O	5048
mutations	O	5048
in	O	5048
BRCA1	O	5048
may	O	5048
be	O	5048
responsible	O	5048
for	O	5048
approximately	O	5048
one	O	5048
half	O	5048
of	O	5048
early	O	5048
onset	O	5048
familial	B-Disease	5048
breast	I-Disease	5048
cancer	I-Disease	5048
and	O	5048
the	O	5048
majority	O	5048
of	O	5048
familial	B-Disease	5048
breast	I-Disease	5048
/	I-Disease	5048
ovarian	I-Disease	5048
cancer	I-Disease	5048
.	O	5048

The	O	5049
recent	O	5049
cloning	O	5049
of	O	5049
BRCA1	O	5049
allows	O	5049
for	O	5049
the	O	5049
direct	O	5049
detection	O	5049
of	O	5049
mutations	O	5049
,	O	5049
but	O	5049
the	O	5049
feasibility	O	5049
of	O	5049
presymptomatic	O	5049
screening	O	5049
for	O	5049
cancer	B-Disease	5049
susceptibility	O	5049
is	O	5049
unknown	O	5049
.	O	5049

We	O	5050
analyzed	O	5050
genomic	O	5050
DNA	O	5050
from	O	5050
one	O	5050
affected	O	5050
individual	O	5050
from	O	5050
each	O	5050
of	O	5050
24	O	5050
families	O	5050
with	O	5050
at	O	5050
least	O	5050
three	O	5050
cases	O	5050
of	O	5050
ovarian	B-Disease	5050
or	I-Disease	5050
breast	I-Disease	5050
cancer	I-Disease	5050
,	O	5050
using	O	5050
SSCP	O	5050
assays	O	5050
.	O	5050

A	O	5054
frameshift	O	5054
mutation	O	5054
was	O	5054
detected	O	5054
in	O	5054
a	O	5054
male	O	5054
proband	O	5054
affected	O	5054
with	O	5054
both	O	5054
breast	B-Disease	5054
and	I-Disease	5054
prostate	I-Disease	5054
cancer	I-Disease	5054
.	O	5054

A	O	5055
40	O	5055
-	O	5055
bp	O	5055
deletion	O	5055
was	O	5055
detected	O	5055
in	O	5055
a	O	5055
patient	O	5055
who	O	5055
developed	O	5055
intra	B-Disease	5055
-	I-Disease	5055
abdominal	I-Disease	5055
carcinomatosis	I-Disease	5055
1	O	5055
year	O	5055
after	O	5055
prophylactic	O	5055
oophorectomy	O	5055
.	O	5055

These	O	5057
results	O	5057
provide	O	5057
further	O	5057
evidence	O	5057
that	O	5057
inherited	B-Disease	5057
breast	I-Disease	5057
and	I-Disease	5057
ovarian	I-Disease	5057
cancer	I-Disease	5057
can	O	5057
occur	O	5057
as	O	5057
a	O	5057
consequence	O	5057
of	O	5057
a	O	5057
wide	O	5057
array	O	5057
of	O	5057
BRCA1	O	5057
mutations	O	5057
.	O	5057

The	O	5059
finding	O	5059
of	O	5059
a	O	5059
mutation	O	5059
in	O	5059
a	O	5059
family	O	5059
with	O	5059
male	B-Disease	5059
breast	I-Disease	5059
cancer	I-Disease	5059
,	O	5059
not	O	5059
previously	O	5059
thought	O	5059
to	O	5059
be	O	5059
related	O	5059
to	O	5059
BRCA1	O	5059
,	O	5059
also	O	5059
illustrates	O	5059
the	O	5059
potential	O	5059
difficulties	O	5059
of	O	5059
genetic	O	5059
counseling	O	5059
for	O	5059
individuals	O	5059
known	O	5059
to	O	5059
carry	O	5059
mutations	O	5059
.	O	5059

Natural	O	5061
selection	O	5061
of	O	5061
hemi	O	5061
-	O	5061
and	O	5061
heterozygotes	O	5061
for	O	5061
G6PD	B-Disease	5061
deficiency	I-Disease	5061
in	O	5061
Africa	O	5061
by	O	5061
resistance	O	5061
to	O	5061
severe	O	5061
malaria	B-Disease	5061
.	O	5061

Glucose	B-Disease	5062
-	I-Disease	5062
6	I-Disease	5062
-	I-Disease	5062
phosphate	I-Disease	5062
dehydrogenase	I-Disease	5062
(	I-Disease	5062
G6PD	I-Disease	5062
)	I-Disease	5062
deficiency	I-Disease	5062
,	O	5062
the	O	5062
most	O	5062
common	O	5062
enzymopathy	B-Disease	5062
of	O	5062
humans	O	5062
,	O	5062
affects	O	5062
over	O	5062
400	O	5062
million	O	5062
people	O	5062
.	O	5062

The	O	5063
geographical	O	5063
correlation	O	5063
of	O	5063
its	O	5063
distribution	O	5063
with	O	5063
the	O	5063
historical	O	5063
endemicity	O	5063
of	O	5063
malaria	B-Disease	5063
suggests	O	5063
that	O	5063
this	O	5063
disorder	O	5063
has	O	5063
risen	O	5063
in	O	5063
frequency	O	5063
through	O	5063
natural	O	5063
selection	O	5063
by	O	5063
malaria	B-Disease	5063
.	O	5063

However	O	5064
,	O	5064
attempts	O	5064
to	O	5064
confirm	O	5064
that	O	5064
G6PD	B-Disease	5064
deficiency	I-Disease	5064
is	O	5064
protective	O	5064
in	O	5064
case	O	5064
-	O	5064
control	O	5064
studies	O	5064
of	O	5064
malaria	B-Disease	5064
have	O	5064
yielded	O	5064
conflicting	O	5064
results	O	5064
.	O	5064

Hence	O	5065
,	O	5065
for	O	5065
this	O	5065
X	B-Disease	5065
-	I-Disease	5065
linked	I-Disease	5065
disorder	I-Disease	5065
,	O	5065
it	O	5065
is	O	5065
unclear	O	5065
whether	O	5065
both	O	5065
male	O	5065
hemizygotes	O	5065
and	O	5065
female	O	5065
heterozygotes	O	5065
are	O	5065
protected	O	5065
or	O	5065
,	O	5065
as	O	5065
frequently	O	5065
suggested	O	5065
,	O	5065
only	O	5065
females	O	5065
.	O	5065

Here	O	5067
we	O	5067
report	O	5067
that	O	5067
,	O	5067
in	O	5067
two	O	5067
large	O	5067
case	O	5067
-	O	5067
control	O	5067
studies	O	5067
of	O	5067
over	O	5067
2	O	5067
,	O	5067
000	O	5067
African	O	5067
children	O	5067
,	O	5067
the	O	5067
common	O	5067
African	O	5067
form	O	5067
of	O	5067
G6PD	B-Disease	5067
deficiency	I-Disease	5067
(	O	5067
G6PD	B-Disease	5067
A	I-Disease	5067
-	I-Disease	5067
)	O	5067
is	O	5067
associated	O	5067
with	O	5067
a	O	5067
46	O	5067
-	O	5067
58	O	5067
%	O	5067
reduction	O	5067
in	O	5067
risk	O	5067
of	O	5067
severe	O	5067
malaria	B-Disease	5067
for	O	5067
both	O	5067
female	O	5067
heterozygotes	O	5067
and	O	5067
male	O	5067
hemizygotes	O	5067
.	O	5067

A	O	5068
mathematical	O	5068
model	O	5068
incorporating	O	5068
the	O	5068
measured	O	5068
selective	O	5068
advantage	O	5068
against	O	5068
malaria	B-Disease	5068
suggests	O	5068
that	O	5068
a	O	5068
counterbalancing	O	5068
selective	O	5068
disadvantage	O	5068
,	O	5068
associated	O	5068
with	O	5068
this	O	5068
enzyme	B-Disease	5068
deficiency	I-Disease	5068
,	O	5068
has	O	5068
retarded	O	5068
its	O	5068
rise	O	5068
in	O	5068
frequency	O	5068
in	O	5068
malaria	B-Disease	5068
-	O	5068
endemic	O	5068
regions	O	5068
.	O	5068

Although	O	5069
G6PD	B-Disease	5069
deficiency	I-Disease	5069
is	O	5069
now	O	5069
regarded	O	5069
as	O	5069
a	O	5069
generally	O	5069
benign	O	5069
disorder	O	5069
,	O	5069
in	O	5069
earlier	O	5069
environmental	O	5069
conditions	O	5069
it	O	5069
could	O	5069
have	O	5069
been	O	5069
significantly	O	5069
disadvantageous	O	5069
.	O	5069

The	O	5071
alveolar	B-Disease	5071
rhabdomyosarcoma	I-Disease	5071
PAX3	O	5071
/	O	5071
FKHR	O	5071
fusion	O	5071
protein	O	5071
is	O	5071
a	O	5071
transcriptional	O	5071
activator	O	5071
.	O	5071

Chimeric	O	5072
transcription	O	5072
factors	O	5072
,	O	5072
created	O	5072
by	O	5072
gene	O	5072
fusions	O	5072
as	O	5072
the	O	5072
result	O	5072
of	O	5072
chromosomal	O	5072
translocations	O	5072
,	O	5072
have	O	5072
been	O	5072
implicated	O	5072
in	O	5072
the	O	5072
pathogenesis	O	5072
of	O	5072
several	O	5072
pathologically	O	5072
disparate	O	5072
solid	B-Disease	5072
tumors	I-Disease	5072
.	O	5072

The	O	5073
PAX3	O	5073
/	O	5073
FKHR	O	5073
fusion	O	5073
gene	O	5073
,	O	5073
formed	O	5073
by	O	5073
a	O	5073
t	O	5073
(	O	5073
2	O	5073
;	O	5073
13	O	5073
)	O	5073
(	O	5073
q35	O	5073
;	O	5073
q14	O	5073
)	O	5073
in	O	5073
alveolar	B-Disease	5073
rhabdomyosarcoma	I-Disease	5073
,	O	5073
encodes	O	5073
a	O	5073
hybrid	O	5073
protein	O	5073
that	O	5073
contains	O	5073
both	O	5073
PAX3	O	5073
DNA	O	5073
binding	O	5073
domains	O	5073
,	O	5073
the	O	5073
paired	O	5073
box	O	5073
and	O	5073
homeodomain	O	5073
,	O	5073
linked	O	5073
to	O	5073
the	O	5073
bisected	O	5073
DNA	O	5073
binding	O	5073
domain	O	5073
of	O	5073
FKHR	O	5073
,	O	5073
a	O	5073
member	O	5073
of	O	5073
the	O	5073
forkhead	O	5073
family	O	5073
of	O	5073
transcription	O	5073
factors	O	5073
.	O	5073

We	O	5076
show	O	5076
that	O	5076
the	O	5076
native	O	5076
PAX3	O	5076
/	O	5076
FKHR	O	5076
protein	O	5076
present	O	5076
in	O	5076
tumor	B-Disease	5076
cells	O	5076
with	O	5076
this	O	5076
translocation	O	5076
has	O	5076
transcriptional	O	5076
characteristics	O	5076
similar	O	5076
to	O	5076
the	O	5076
in	O	5076
vitro	O	5076
expressed	O	5076
protein	O	5076
.	O	5076

A	O	5079
p16INK4a	O	5079
-	O	5079
insensitive	O	5079
CDK4	O	5079
mutant	O	5079
targeted	O	5079
by	O	5079
cytolytic	O	5079
T	O	5079
lymphocytes	O	5079
in	O	5079
a	O	5079
human	O	5079
melanoma	B-Disease	5079
.	O	5079

A	O	5080
mutated	O	5080
cyclin	O	5080
-	O	5080
dependent	O	5080
kinase	O	5080
4	O	5080
(	O	5080
CDK4	O	5080
)	O	5080
was	O	5080
identified	O	5080
as	O	5080
a	O	5080
tumor	B-Disease	5080
-	O	5080
specific	O	5080
antigen	O	5080
recognized	O	5080
by	O	5080
HLA	O	5080
-	O	5080
A2	O	5080
.	O	5080

1	O	5081
-	O	5081
restricted	O	5081
autologous	O	5081
cytolytic	O	5081
T	O	5081
lymphocytes	O	5081
(	O	5081
CTLs	O	5081
)	O	5081
in	O	5081
a	O	5081
human	O	5081
melanoma	B-Disease	5081
.	O	5081

The	O	5082
mutated	O	5082
CDK4	O	5082
allele	O	5082
was	O	5082
present	O	5082
in	O	5082
autologous	O	5082
cultured	O	5082
melanoma	B-Disease	5082
cells	O	5082
and	O	5082
metastasis	O	5082
tissue	O	5082
,	O	5082
but	O	5082
not	O	5082
in	O	5082
the	O	5082
patients	O	5082
lymphocytes	O	5082
.	O	5082

The	O	5084
same	O	5084
mutation	O	5084
was	O	5084
found	O	5084
in	O	5084
one	O	5084
additional	O	5084
melanoma	B-Disease	5084
among	O	5084
28	O	5084
melanomas	B-Disease	5084
analyzed	O	5084
.	O	5084

These	O	5085
results	O	5085
suggest	O	5085
that	O	5085
mutation	O	5085
of	O	5085
CDK4	O	5085
can	O	5085
create	O	5085
a	O	5085
tumor	B-Disease	5085
-	O	5085
specific	O	5085
antigen	O	5085
and	O	5085
can	O	5085
disrupt	O	5085
the	O	5085
cell	O	5085
-	O	5085
cycle	O	5085
regulation	O	5085
exerted	O	5085
by	O	5085
the	O	5085
tumor	B-Disease	5085
suppressor	O	5085
p16INK4a	O	5085
.	O	5085

More	O	5088
than	O	5088
75	O	5088
%	O	5088
of	O	5088
the	O	5088
reported	O	5088
mutations	O	5088
in	O	5088
the	O	5088
hereditary	B-Disease	5088
breast	I-Disease	5088
and	I-Disease	5088
ovarian	I-Disease	5088
cancer	I-Disease	5088
gene	O	5088
,	O	5088
BRCA1	O	5088
,	O	5088
result	O	5088
in	O	5088
truncated	O	5088
proteins	O	5088
.	O	5088

In	O	5090
45	O	5090
patients	O	5090
from	O	5090
breast	B-Disease	5090
and	I-Disease	5090
/	I-Disease	5090
or	I-Disease	5090
ovarian	I-Disease	5090
cancer	I-Disease	5090
families	O	5090
we	O	5090
found	O	5090
six	O	5090
novel	O	5090
mutations	O	5090
two	O	5090
single	O	5090
nucleotide	O	5090
insertions	O	5090
,	O	5090
three	O	5090
small	O	5090
deletions	O	5090
(	O	5090
1	O	5090
-	O	5090
5	O	5090
bp	O	5090
)	O	5090
and	O	5090
a	O	5090
nonsense	O	5090
mutation	O	5090
identified	O	5090
two	O	5090
unrelated	O	5090
families	O	5090
.	O	5090

PCR	O	5098
-	O	5098
amplified	O	5098
VLCAD	O	5098
cDNAs	O	5098
were	O	5098
sequenced	O	5098
in	O	5098
cultured	O	5098
fibroblasts	O	5098
from	O	5098
two	O	5098
VLCAD	B-Disease	5098
-	I-Disease	5098
deficient	I-Disease	5098
patients	O	5098
.	O	5098

This	O	5101
is	O	5101
the	O	5101
first	O	5101
demonstration	O	5101
of	O	5101
a	O	5101
mutation	O	5101
causing	O	5101
VLCAD	B-Disease	5101
deficiency	I-Disease	5101
.	O	5101

Quantitative	O	5102
cDNA	O	5102
expression	O	5102
of	O	5102
normal	O	5102
human	O	5102
VLCAD	O	5102
was	O	5102
performed	O	5102
in	O	5102
the	O	5102
patients	O	5102
fibroblasts	O	5102
,	O	5102
using	O	5102
vaccinia	O	5102
viral	O	5102
system	O	5102
,	O	5102
which	O	5102
demonstrated	O	5102
that	O	5102
the	O	5102
deficiency	B-Disease	5102
of	I-Disease	5102
the	I-Disease	5102
normal	I-Disease	5102
VLCAD	I-Disease	5102
protein	I-Disease	5102
causes	O	5102
impaired	O	5102
long	O	5102
-	O	5102
chain	O	5102
fatty	O	5102
acid	O	5102
beta	O	5102
-	O	5102
oxidation	O	5102
activity	O	5102
in	O	5102
the	O	5102
patients	O	5102
fibroblasts	O	5102
.	O	5102

In	O	5103
patient	O	5103
fibroblasts	O	5103
,	O	5103
raising	O	5103
VLCAD	O	5103
activity	O	5103
to	O	5103
approximately	O	5103
20	O	5103
%	O	5103
of	O	5103
normal	O	5103
control	O	5103
fibroblast	O	5103
activity	O	5103
raised	O	5103
palmitic	O	5103
acid	O	5103
beta	O	5103
-	O	5103
oxidation	O	5103
flux	O	5103
to	O	5103
the	O	5103
level	O	5103
found	O	5103
in	O	5103
control	O	5103
fibroblasts	O	5103
,	O	5103
which	O	5103
may	O	5103
offer	O	5103
important	O	5103
information	O	5103
for	O	5103
the	O	5103
rational	O	5103
design	O	5103
of	O	5103
future	O	5103
somatic	O	5103
gene	O	5103
therapy	O	5103
for	O	5103
VLCAD	B-Disease	5103
deficiency	I-Disease	5103
.	O	5103

Brain	B-Disease	5105
disease	I-Disease	5105
and	O	5105
molecular	O	5105
analysis	O	5105
in	O	5105
myotonic	B-Disease	5105
dystrophy	I-Disease	5105
.	O	5105

Abnormal	O	5106
amplification	O	5106
of	O	5106
a	O	5106
CTG	O	5106
repeat	O	5106
on	O	5106
chromosome	O	5106
19	O	5106
is	O	5106
the	O	5106
molecular	O	5106
basis	O	5106
of	O	5106
myotonic	B-Disease	5106
dystrophy	I-Disease	5106
(	O	5106
DM	B-Disease	5106
)	O	5106
.	O	5106

We	O	5108
performed	O	5108
extensive	O	5108
cognitive	O	5108
testing	O	5108
,	O	5108
cerebral	O	5108
magnetic	O	5108
resonance	O	5108
imaging	O	5108
(	O	5108
MRI	O	5108
)	O	5108
and	O	5108
a	O	5108
molecular	O	5108
analysis	O	5108
in	O	5108
28	O	5108
cases	O	5108
of	O	5108
DM	B-Disease	5108
to	O	5108
determine	O	5108
the	O	5108
relationship	O	5108
between	O	5108
the	O	5108
molecular	O	5108
defect	O	5108
and	O	5108
brain	B-Disease	5108
disease	I-Disease	5108
.	O	5108

Fourteen	O	5110
patients	O	5110
had	O	5110
subcortical	O	5110
white	B-Disease	5110
matter	I-Disease	5110
lesions	I-Disease	5110
on	O	5110
MRI	O	5110
,	O	5110
14	O	5110
had	O	5110
cerebral	B-Disease	5110
atrophy	I-Disease	5110
.	O	5110

Disease	O	5113
duration	O	5113
influenced	O	5113
the	O	5113
appearance	O	5113
and	O	5113
amount	O	5113
of	O	5113
white	B-Disease	5113
matter	I-Disease	5113
lesions	I-Disease	5113
on	O	5113
MRI	O	5113
.	O	5113

Quantification	O	5114
of	O	5114
CTG	O	5114
repeat	O	5114
size	O	5114
may	O	5114
allow	O	5114
an	O	5114
early	O	5114
estimate	O	5114
on	O	5114
the	O	5114
probability	O	5114
of	O	5114
brain	O	5114
involvement	O	5114
in	O	5114
DM	B-Disease	5114
;	O	5114
cognitive	B-Disease	5114
dysfunction	I-Disease	5114
is	O	5114
associated	O	5114
with	O	5114
white	B-Disease	5114
matter	I-Disease	5114
lesions	I-Disease	5114
and	O	5114
cerebral	B-Disease	5114
atrophy	I-Disease	5114
later	O	5114
on	O	5114
in	O	5114
the	O	5114
course	O	5114
.	O	5114

Mutations	O	5116
in	O	5116
the	O	5116
gene	O	5116
for	O	5116
X	B-Disease	5116
-	I-Disease	5116
linked	I-Disease	5116
adrenoleukodystrophy	I-Disease	5116
in	O	5116
patients	O	5116
with	O	5116
different	O	5116
clinical	O	5116
phenotypes	O	5116
.	O	5116

Recently	O	5117
,	O	5117
the	O	5117
gene	O	5117
for	O	5117
the	O	5117
most	O	5117
common	O	5117
peroxisomal	B-Disease	5117
disorder	I-Disease	5117
,	O	5117
X	B-Disease	5117
-	I-Disease	5117
linked	I-Disease	5117
adrenoleukodystrophy	I-Disease	5117
(	O	5117
X	B-Disease	5117
-	I-Disease	5117
ALD	I-Disease	5117
)	O	5117
,	O	5117
has	O	5117
been	O	5117
described	O	5117
encoding	O	5117
a	O	5117
peroxisomal	O	5117
membrane	O	5117
transporter	O	5117
protein	O	5117
.	O	5117

We	O	5118
analyzed	O	5118
the	O	5118
entire	O	5118
protein	O	5118
-	O	5118
coding	O	5118
sequence	O	5118
of	O	5118
this	O	5118
gene	O	5118
by	O	5118
reverse	O	5118
-	O	5118
transcription	O	5118
PCR	O	5118
,	O	5118
SSCP	O	5118
,	O	5118
and	O	5118
DNA	O	5118
sequencing	O	5118
in	O	5118
five	O	5118
patients	O	5118
with	O	5118
different	O	5118
clinical	O	5118
expression	O	5118
of	O	5118
X	B-Disease	5118
-	I-Disease	5118
ALD	I-Disease	5118
and	O	5118
in	O	5118
their	O	5118
female	O	5118
relatives	O	5118
;	O	5118
these	O	5118
clinical	O	5118
expressions	O	5118
were	O	5118
cerebral	O	5118
childhood	O	5118
ALD	B-Disease	5118
,	O	5118
adrenomyeloneuropathy	B-Disease	5118
(	O	5118
AMN	B-Disease	5118
)	O	5118
,	O	5118
and	O	5118
Addison	B-Disease	5119
disease	I-Disease	5119
only	I-Disease	5119
(	O	5120
ADO	B-Disease	5120
)	O	5120
phenotype	O	5120
.	O	5120

In	O	5121
the	O	5121
three	O	5121
patients	O	5121
exhibiting	O	5121
the	O	5121
classical	O	5121
picture	O	5121
of	O	5121
severe	O	5121
childhood	O	5121
ALD	B-Disease	5121
we	O	5121
identified	O	5121
in	O	5121
the	O	5121
5	O	5121
portion	O	5121
of	O	5121
the	O	5121
X	B-Disease	5121
-	I-Disease	5121
ALD	I-Disease	5121
gene	O	5121
a	O	5121
38	O	5121
-	O	5121
bp	O	5121
deletion	O	5121
that	O	5121
causes	O	5121
a	O	5121
frameshift	O	5121
mutation	O	5121
,	O	5121
a	O	5121
3	O	5121
-	O	5121
bp	O	5121
deletion	O	5121
leading	O	5121
to	O	5121
a	O	5121
deletion	O	5121
of	O	5121
an	O	5121
amino	O	5121
acid	O	5121
in	O	5121
the	O	5121
ATP	O	5121
-	O	5121
binding	O	5121
domain	O	5121
of	O	5121
the	O	5121
ALD	B-Disease	5121
protein	O	5121
,	O	5121
and	O	5121
a	O	5121
missense	O	5121
mutation	O	5121
.	O	5121

In	O	5122
the	O	5122
patient	O	5122
with	O	5122
the	O	5122
clinical	O	5122
phenotype	O	5122
of	O	5122
AMN	B-Disease	5122
,	O	5122
a	O	5122
nonsense	O	5122
mutation	O	5122
in	O	5122
codon	O	5122
212	O	5122
,	O	5122
along	O	5122
with	O	5122
a	O	5122
second	O	5122
site	O	5122
mutation	O	5122
at	O	5122
codon	O	5122
178	O	5122
,	O	5122
was	O	5122
observed	O	5122
.	O	5122

Analysis	O	5123
of	O	5123
the	O	5123
patient	O	5123
with	O	5123
the	O	5123
ADO	B-Disease	5123
phenotype	O	5123
revealed	O	5123
a	O	5123
further	O	5123
missense	O	5123
mutation	O	5123
at	O	5123
a	O	5123
highly	O	5123
conserved	O	5123
position	O	5123
in	O	5123
the	O	5123
ALDP	O	5123
/	O	5123
PMP70	O	5123
comparison	O	5123
.	O	5123

,	O	5126
the	O	5126
frameshift	O	5126
and	O	5126
the	O	5126
nonsense	O	5126
mutation	O	5126
)	O	5126
in	O	5126
patients	O	5126
with	O	5126
biochemically	O	5126
proved	O	5126
childhood	O	5126
ALD	B-Disease	5126
and	O	5126
AMN	B-Disease	5126
further	O	5126
strongly	O	5126
supports	O	5126
the	O	5126
hypothesis	O	5126
that	O	5126
alterations	O	5126
in	O	5126
this	O	5126
gene	O	5126
play	O	5126
a	O	5126
crucial	O	5126
role	O	5126
in	O	5126
the	O	5126
pathogenesis	O	5126
of	O	5126
X	B-Disease	5126
-	I-Disease	5126
ALD	I-Disease	5126
.	O	5126

Since	O	5127
the	O	5127
current	O	5127
biochemical	O	5127
techniques	O	5127
for	O	5127
X	B-Disease	5127
-	I-Disease	5127
ALD	I-Disease	5127
carrier	O	5127
detection	O	5127
in	O	5127
affected	O	5127
families	O	5127
lack	O	5127
sufficient	O	5127
reliability	O	5127
,	O	5127
our	O	5127
procedure	O	5127
described	O	5127
for	O	5127
systematic	O	5127
mutation	O	5127
scanning	O	5127
is	O	5127
also	O	5127
capable	O	5127
of	O	5127
improving	O	5127
genetic	O	5127
counseling	O	5127
and	O	5127
prenatal	O	5127
diagnosis	O	5127
Duchenne	B-Disease	5127
muscular	I-Disease	5127
dystrophy	I-Disease	5127
and	O	5127
myotonic	B-Disease	5127
dystrophy	I-Disease	5127
in	O	5127
the	O	5127
same	O	5127
patient	O	5127
.	O	5127

We	O	5128
report	O	5128
on	O	5128
the	O	5128
first	O	5128
patient	O	5128
identified	O	5128
with	O	5128
myotonic	B-Disease	5128
dystrophy	I-Disease	5128
and	O	5128
Duchenne	B-Disease	5128
muscular	I-Disease	5128
dystrophy	I-Disease	5128
(	O	5128
DMD	B-Disease	5128
)	O	5128
.	O	5128

The	O	5129
family	O	5129
of	O	5129
the	O	5129
propositus	O	5129
had	O	5129
a	O	5129
strong	O	5129
history	O	5129
of	O	5129
myotonic	B-Disease	5129
dystrophy	I-Disease	5129
,	O	5129
and	O	5129
there	O	5129
was	O	5129
an	O	5129
intrafamilial	O	5129
pathological	O	5129
expansion	O	5129
of	O	5129
the	O	5129
responsible	O	5129
CTG	O	5129
repeat	O	5129
between	O	5129
the	O	5129
mildly	O	5129
affected	O	5129
mother	O	5129
(	O	5129
160	O	5129
repeats	O	5129
;	O	5129
normal	O	5129
27	O	5129
repeats	O	5129
)	O	5129
and	O	5129
her	O	5129
more	O	5129
severely	O	5129
affected	O	5129
son	O	5129
(	O	5129
650	O	5129
repeats	O	5129
)	O	5129
,	O	5129
and	O	5129
his	O	5129
sister	O	5129
(	O	5129
650	O	5129
repeats	O	5129
)	O	5129
.	O	5129

The	O	5130
propositus	O	5130
was	O	5130
an	O	5130
isolated	O	5130
case	O	5130
of	O	5130
Duchenne	B-Disease	5130
muscular	I-Disease	5130
dystrophy	I-Disease	5130
with	O	5130
marked	O	5130
dystrophin	B-Disease	5130
deficiency	I-Disease	5130
in	O	5130
muscle	O	5130
biopsy	O	5130
.	O	5130

Myotonic	B-Disease	5132
dystrophy	I-Disease	5132
could	O	5132
interfere	O	5132
to	O	5132
some	O	5132
extent	O	5132
with	O	5132
the	O	5132
progression	O	5132
of	O	5132
Duchenne	B-Disease	5132
dystrophy	I-Disease	5132
.	O	5132

Twelve	O	5134
percent	O	5134
of	O	5134
dystrophin	O	5134
revertant	O	5134
fibers	O	5134
as	O	5134
observed	O	5134
by	O	5134
immunohistochemistry	O	5134
could	O	5134
be	O	5134
sufficient	O	5134
to	O	5134
ameliorate	O	5134
typical	O	5134
DMD	B-Disease	5134
clinical	O	5134
severity	O	5134
,	O	5134
or	O	5134
the	O	5134
patient	O	5134
may	O	5134
present	O	5134
a	O	5134
somatic	O	5134
mosaic	O	5134
.	O	5134

Age	O	5137
at	O	5137
diagnosis	O	5137
as	O	5137
an	O	5137
indicator	O	5137
of	O	5137
eligibility	O	5137
for	O	5137
BRCA1	O	5137
DNA	O	5137
testing	O	5137
in	O	5137
familial	B-Disease	5137
breast	I-Disease	5137
cancer	I-Disease	5137
.	O	5137

We	O	5138
searched	O	5138
for	O	5138
criteria	O	5138
that	O	5138
could	O	5138
indicate	O	5138
breast	B-Disease	5138
cancer	I-Disease	5138
families	O	5138
with	O	5138
a	O	5138
high	O	5138
prior	O	5138
probability	O	5138
of	O	5138
being	O	5138
caused	O	5138
by	O	5138
the	O	5138
breast	B-Disease	5138
/	I-Disease	5138
ovarian	I-Disease	5138
cancer	I-Disease	5138
susceptibility	O	5138
locus	O	5138
BRCA1	O	5138
on	O	5138
chromosome	O	5138
17	O	5138
.	O	5138

To	O	5139
this	O	5139
end	O	5139
,	O	5139
we	O	5139
performed	O	5139
a	O	5139
linkage	O	5139
study	O	5139
with	O	5139
59	O	5139
consecutively	O	5139
collected	O	5139
Dutch	O	5139
breast	B-Disease	5139
cancer	I-Disease	5139
families	O	5139
,	O	5139
including	O	5139
16	O	5139
with	O	5139
at	O	5139
least	O	5139
one	O	5139
case	O	5139
of	O	5139
ovarian	B-Disease	5139
cancer	I-Disease	5139
.	O	5139

We	O	5140
used	O	5140
an	O	5140
intake	O	5140
cut	O	5140
-	O	5140
off	O	5140
of	O	5140
at	O	5140
least	O	5140
three	O	5140
first	O	5140
-	O	5140
degree	O	5140
relatives	O	5140
with	O	5140
breast	B-Disease	5140
and	I-Disease	5140
/	I-Disease	5140
or	I-Disease	5140
ovarian	I-Disease	5140
cancer	I-Disease	5140
at	O	5140
any	O	5140
age	O	5140
.	O	5140

Significant	O	5141
evidence	O	5141
for	O	5141
linkage	O	5141
was	O	5141
found	O	5141
only	O	5141
among	O	5141
the	O	5141
13	O	5141
breast	B-Disease	5141
cancer	I-Disease	5141
families	O	5141
with	O	5141
a	O	5141
mean	O	5141
age	O	5141
at	O	5141
diagnosis	O	5141
of	O	5141
less	O	5141
than	O	5141
45	O	5141
years	O	5141
.	O	5141

An	O	5142
unexpectedly	O	5142
low	O	5142
proportion	O	5142
of	O	5142
the	O	5142
breast	B-Disease	5142
-	I-Disease	5142
ovarian	I-Disease	5142
cancer	I-Disease	5142
families	O	5142
were	O	5142
estimated	O	5142
to	O	5142
be	O	5142
linked	O	5142
to	O	5142
BRCA1	O	5142
,	O	5142
which	O	5142
could	O	5142
be	O	5142
due	O	5142
to	O	5142
a	O	5142
founder	O	5142
effect	O	5142
in	O	5142
the	O	5142
Dutch	O	5142
population	O	5142
.	O	5142

Given	O	5143
the	O	5143
expected	O	5143
logistical	O	5143
problems	O	5143
in	O	5143
clinical	O	5143
management	O	5143
now	O	5143
that	O	5143
BRCA1	O	5143
has	O	5143
been	O	5143
identified	O	5143
,	O	5143
we	O	5143
propose	O	5143
an	O	5143
interim	O	5143
period	O	5143
in	O	5143
which	O	5143
only	O	5143
families	O	5143
with	O	5143
a	O	5143
strong	O	5143
positive	O	5143
family	O	5143
history	O	5143
for	O	5143
early	O	5143
onset	O	5143
breast	B-Disease	5143
and	I-Disease	5143
/	I-Disease	5143
or	I-Disease	5143
ovarian	I-Disease	5143
cancer	I-Disease	5143
will	O	5143
be	O	5143
offered	O	5143
BRCA1	O	5143
mutation	O	5143
testing	O	5143
.	O	5143

Linkage	O	5145
analysis	O	5145
of	O	5145
26	O	5145
Canadian	O	5145
breast	B-Disease	5145
and	I-Disease	5145
breast	I-Disease	5145
-	I-Disease	5145
ovarian	I-Disease	5145
cancer	I-Disease	5145
families	O	5145
.	O	5145

We	O	5146
have	O	5146
examined	O	5146
26	O	5146
Canadian	O	5146
families	O	5146
with	O	5146
hereditary	B-Disease	5146
breast	I-Disease	5146
or	I-Disease	5146
ovarian	I-Disease	5146
cancer	I-Disease	5146
for	O	5146
linkage	O	5146
to	O	5146
markers	O	5146
flanking	O	5146
the	O	5146
BRCA1	O	5146
gene	O	5146
on	O	5146
chromosome	O	5146
17q12	O	5146
-	O	5146
q21	O	5146
.	O	5146

Of	O	5147
the	O	5147
15	O	5147
families	O	5147
that	O	5147
contain	O	5147
cases	O	5147
of	O	5147
ovarian	B-Disease	5147
cancer	I-Disease	5147
,	O	5147
94	O	5147
%	O	5147
were	O	5147
estimated	O	5147
to	O	5147
be	O	5147
linked	O	5147
to	O	5147
BRCA1	O	5147
.	O	5147

In	O	5148
contrast	O	5148
,	O	5148
there	O	5148
was	O	5148
no	O	5148
overall	O	5148
evidence	O	5148
of	O	5148
linkage	O	5148
in	O	5148
the	O	5148
group	O	5148
of	O	5148
10	O	5148
families	O	5148
with	O	5148
breast	B-Disease	5148
cancer	I-Disease	5148
without	O	5148
ovarian	B-Disease	5148
cancer	I-Disease	5148
.	O	5148

A	O	5149
genetic	O	5149
recombinant	O	5149
in	O	5149
a	O	5149
breast	B-Disease	5149
-	I-Disease	5149
ovarian	I-Disease	5149
cancer	I-Disease	5149
family	O	5149
indicates	O	5149
a	O	5149
placement	O	5149
of	O	5149
BRCA1	O	5149
telomeric	O	5149
to	O	5149
D17S776	O	5149
,	O	5149
and	O	5149
helps	O	5149
to	O	5149
define	O	5149
the	O	5149
region	O	5149
of	O	5149
assignment	O	5149
of	O	5149
the	O	5149
cancer	B-Disease	5149
susceptibility	O	5149
gene	O	5149
.	O	5149

Other	O	5150
cancers	B-Disease	5150
of	O	5150
interest	O	5150
that	O	5150
appeared	O	5150
in	O	5150
the	O	5150
BRCA1	O	5150
-	O	5150
linked	O	5150
families	O	5150
included	O	5150
primary	B-Disease	5150
peritoneal	I-Disease	5150
cancer	I-Disease	5150
,	O	5150
cancer	B-Disease	5150
of	I-Disease	5150
the	I-Disease	5150
fallopian	I-Disease	5150
tube	I-Disease	5150
,	O	5150
and	O	5150
malignant	B-Disease	5150
melanoma	I-Disease	5150
.	O	5150

Structural	O	5152
analysis	O	5152
of	O	5152
the	O	5152
5	O	5152
'	O	5152
region	O	5152
of	O	5152
mouse	O	5152
and	O	5152
human	O	5152
Huntington	B-Disease	5152
disease	I-Disease	5152
genes	O	5152
reveals	O	5152
conservation	O	5152
of	O	5152
putative	O	5152
promoter	O	5152
region	O	5152
and	O	5152
di	O	5152
-	O	5152
and	O	5152
trinucleotide	O	5152
polymorphisms	O	5152
.	O	5152

We	O	5153
have	O	5153
previously	O	5153
cloned	O	5153
and	O	5153
characterized	O	5153
the	O	5153
murine	O	5153
homologue	O	5153
of	O	5153
the	O	5153
Huntington	B-Disease	5153
disease	I-Disease	5153
(	O	5153
HD	B-Disease	5153
)	O	5153
gene	O	5153
and	O	5153
shown	O	5153
that	O	5153
it	O	5153
maps	O	5153
to	O	5153
mouse	O	5153
chromosome	O	5153
5	O	5153
within	O	5153
a	O	5153
region	O	5153
of	O	5153
conserved	O	5153
synteny	O	5153
with	O	5153
human	O	5153
chromosome	O	5153
4p16	O	5153
.	O	5153

Here	O	5155
we	O	5155
present	O	5155
a	O	5155
detailed	O	5155
comparison	O	5155
of	O	5155
the	O	5155
sequence	O	5155
of	O	5155
the	O	5155
putative	O	5155
promoter	O	5155
and	O	5155
the	O	5155
organization	O	5155
of	O	5155
the	O	5155
5	O	5155
genomic	O	5155
region	O	5155
of	O	5155
the	O	5155
murine	O	5155
(	O	5155
Hdh	O	5155
)	O	5155
and	O	5155
human	O	5155
HD	B-Disease	5155
genes	O	5155
encompassing	O	5155
the	O	5155
first	O	5155
five	O	5155
exons	O	5155
.	O	5155

Two	O	5157
dinucleotide	O	5157
(	O	5157
CT	O	5157
)	O	5157
and	O	5157
one	O	5157
trinucleotide	O	5157
intronic	O	5157
polymorphism	O	5157
in	O	5157
Hdh	O	5157
and	O	5157
an	O	5157
intronic	O	5157
CA	O	5157
polymorphism	O	5157
in	O	5157
the	O	5157
HD	B-Disease	5157
gene	O	5157
were	O	5157
identified	O	5157
.	O	5157

8	O	5159
%	O	5159
nucleotide	O	5159
identity	O	5159
)	O	5159
between	O	5159
Hdh	O	5159
and	O	5159
the	O	5159
HD	B-Disease	5159
gene	O	5159
from	O	5159
nucleotide	O	5159
-	O	5159
56	O	5159
to	O	5159
-	O	5159
206	O	5159
(	O	5159
of	O	5159
Hdh	O	5159
)	O	5159
.	O	5159

Neither	O	5160
Hdh	O	5160
nor	O	5160
the	O	5160
HD	B-Disease	5160
gene	O	5160
have	O	5160
typical	O	5160
TATA	O	5160
or	O	5160
CCAAT	O	5160
elements	O	5160
,	O	5160
but	O	5160
both	O	5160
show	O	5160
one	O	5160
putative	O	5160
AP2	O	5160
binding	O	5160
site	O	5160
and	O	5160
numerous	O	5160
potential	O	5160
Sp1	O	5160
binding	O	5160
sites	O	5160
.	O	5160

The	O	5161
high	O	5161
sequence	O	5161
identity	O	5161
between	O	5161
Hdh	O	5161
and	O	5161
the	O	5161
HD	B-Disease	5161
gene	O	5161
for	O	5161
approximately	O	5161
200	O	5161
bp	O	5161
5	O	5161
to	O	5161
the	O	5161
putative	O	5161
translation	O	5161
start	O	5161
site	O	5161
indicates	O	5161
that	O	5161
these	O	5161
sequences	O	5161
may	O	5161
play	O	5161
a	O	5161
role	O	5161
in	O	5161
regulating	O	5161
expression	O	5161
of	O	5161
the	O	5161
Huntington	B-Disease	5161
disease	I-Disease	5161
gene	O	5161
The	O	5161
protein	O	5161
deficient	O	5161
in	O	5161
Lowe	B-Disease	5161
syndrome	I-Disease	5161
is	O	5161
a	O	5161
phosphatidylinositol	O	5161
-	O	5161
4	O	5161
,	O	5161
5	O	5161
-	O	5161
bisphosphate	O	5161
5	O	5161
-	O	5161
phosphatase	O	5161
.	O	5161

Lowe	B-Disease	5162
syndrome	I-Disease	5162
,	O	5162
also	O	5162
known	O	5162
as	O	5162
oculocerebrorenal	B-Disease	5162
syndrome	I-Disease	5162
,	O	5162
is	O	5162
caused	O	5162
by	O	5162
mutations	O	5162
in	O	5162
the	O	5162
X	O	5162
chromosome	O	5162
-	O	5162
encoded	O	5162
OCRL	O	5162
gene	O	5162
.	O	5162

Deficiency	O	5173
of	O	5173
this	O	5173
enzyme	O	5173
apparently	O	5173
causes	O	5173
the	O	5173
protean	O	5173
manifestations	O	5173
of	O	5173
Lowe	B-Disease	5173
syndrome	I-Disease	5173
.	O	5173

New	O	5175
founder	O	5175
haplotypes	O	5175
at	O	5175
the	O	5175
myotonic	B-Disease	5175
dystrophy	I-Disease	5175
locus	O	5175
in	O	5175
southern	O	5175
Africa	O	5175
.	O	5175

The	O	5176
association	O	5176
between	O	5176
normal	O	5176
alleles	O	5176
at	O	5176
the	O	5176
CTG	O	5176
repeat	O	5176
and	O	5176
two	O	5176
nearby	O	5176
polymorphisms	O	5176
in	O	5176
the	O	5176
myotonin	O	5176
protein	O	5176
kinase	O	5176
gene	O	5176
,	O	5176
the	O	5176
Alu	O	5176
insertion	O	5176
/	O	5176
deletion	O	5176
polymorphism	O	5176
and	O	5176
the	O	5176
myotonic	B-Disease	5176
dystrophy	I-Disease	5176
kinase	O	5176
(	O	5176
DMK	O	5176
)	O	5176
(	O	5176
G	O	5176
/	O	5176
T	O	5176
)	O	5176
intron	O	5176
9	O	5176
/	O	5176
HinfI	O	5176
polymorphism	O	5176
,	O	5176
has	O	5176
been	O	5176
analyzed	O	5176
in	O	5176
South	O	5176
African	O	5176
Negroids	O	5176
,	O	5176
a	O	5176
population	O	5176
in	O	5176
which	O	5176
myotonic	B-Disease	5176
dystrophy	I-Disease	5176
(	O	5176
DM	B-Disease	5176
)	O	5176
has	O	5176
not	O	5176
been	O	5176
described	O	5176
.	O	5176

model	O	5185
for	O	5185
the	O	5185
origin	O	5185
of	O	5185
modern	O	5185
humans	O	5185
and	O	5185
suggest	O	5185
that	O	5185
the	O	5185
rare	O	5185
ancestral	O	5185
DM	B-Disease	5185
mutation	O	5185
event	O	5185
may	O	5185
have	O	5185
occurred	O	5185
after	O	5185
the	O	5185
migration	O	5185
from	O	5185
Africa	O	5185
,	O	5185
hence	O	5185
the	O	5185
absence	O	5185
of	O	5185
DM	B-Disease	5185
in	O	5185
sub	O	5185
-	O	5185
Saharan	O	5185
Negroid	O	5185
peoples	O	5185
.	O	5185

Discordant	O	5187
clinical	O	5187
outcome	O	5187
in	O	5187
myotonic	B-Disease	5187
dystrophy	I-Disease	5187
relatives	O	5187
showing	O	5187
(	O	5187
CTG	O	5187
)	O	5187
n	O	5187
>	O	5187
700	O	5187
repeats	O	5187
.	O	5187

A	O	5188
myotonic	B-Disease	5188
dystrophy	I-Disease	5188
(	O	5188
DM	B-Disease	5188
)	O	5188
family	O	5188
is	O	5188
described	O	5188
in	O	5188
which	O	5188
discordant	O	5188
DM	B-Disease	5188
phenotypes	O	5188
were	O	5188
found	O	5188
in	O	5188
the	O	5188
children	O	5188
of	O	5188
two	O	5188
affected	O	5188
sisters	O	5188
with	O	5188
similar	O	5188
CTG	O	5188
expansion	O	5188
and	O	5188
clinical	O	5188
manifestations	O	5188
.	O	5188

In	O	5189
this	O	5189
family	O	5189
,	O	5189
congenital	O	5189
as	O	5189
well	O	5189
as	O	5189
early	O	5189
severe	O	5189
childhood	O	5189
and	O	5189
later	O	5189
childhood	O	5189
onset	O	5189
DM	B-Disease	5189
coexist	O	5189
.	O	5189

This	O	5190
observation	O	5190
strengthens	O	5190
the	O	5190
limited	O	5190
ability	O	5190
of	O	5190
lymphocytes	O	5190
CTG	O	5190
repeat	O	5190
number	O	5190
analysis	O	5190
in	O	5190
predicting	O	5190
genotype	O	5190
-	O	5190
phenotype	O	5190
correlations	O	5190
in	O	5190
DM	B-Disease	5190
patients	O	5190
.	O	5190

The	O	5197
seven	O	5197
deficient	O	5197
fibroblast	O	5197
lines	O	5197
were	O	5197
characterized	O	5197
by	O	5197
measuring	O	5197
acyl	O	5197
-	O	5197
coenzyme	O	5197
A	O	5197
dehydrogenation	O	5197
activities	O	5197
,	O	5197
overall	O	5197
palmitic	O	5197
acid	O	5197
oxidation	O	5197
,	O	5197
and	O	5197
VLCAD	O	5197
protein	O	5197
synthesis	O	5197
using	O	5197
pulse	O	5197
-	O	5197
chase	O	5197
,	O	5197
further	O	5197
confirming	O	5197
the	O	5197
diagnosis	O	5197
of	O	5197
VLCAD	B-Disease	5197
deficiency	I-Disease	5197
.	O	5197

Clinically	O	5199
,	O	5199
all	O	5199
patients	O	5199
with	O	5199
VLCAD	B-Disease	5199
deficiency	I-Disease	5199
exhibited	O	5199
cardiac	B-Disease	5199
disease	I-Disease	5199
.	O	5199

At	O	5200
least	O	5200
four	O	5200
of	O	5200
them	O	5200
presented	O	5200
with	O	5200
hypertrophic	B-Disease	5200
cardiomyopathy	I-Disease	5200
.	O	5200

This	O	5201
frequency	O	5201
(	O	5201
>	O	5201
57	O	5201
%	O	5201
)	O	5201
was	O	5201
much	O	5201
higher	O	5201
than	O	5201
that	O	5201
observed	O	5201
in	O	5201
patients	O	5201
with	O	5201
other	O	5201
disorders	O	5201
of	O	5201
mitochondrial	O	5201
long	O	5201
-	O	5201
chain	O	5201
fatty	O	5201
acid	O	5201
oxidation	O	5201
that	O	5201
may	O	5201
be	O	5201
accompanied	O	5201
by	O	5201
cardiac	B-Disease	5201
disease	I-Disease	5201
in	O	5201
infants	O	5201
.	O	5201

Hereditary	B-Disease	5203
deficiency	I-Disease	5203
of	I-Disease	5203
the	I-Disease	5203
fifth	I-Disease	5203
component	I-Disease	5203
of	I-Disease	5203
complement	I-Disease	5203
in	O	5203
man	O	5203
.	O	5203

Biological	O	5205
properties	O	5205
of	O	5205
C5	B-Disease	5205
-	I-Disease	5205
deficient	I-Disease	5205
human	O	5205
serum	O	5205
.	O	5205

The	O	5206
first	O	5206
known	O	5206
human	O	5206
kindred	O	5206
with	O	5206
hereditary	B-Disease	5206
deficiency	I-Disease	5206
of	I-Disease	5206
the	I-Disease	5206
fifth	I-Disease	5206
component	I-Disease	5206
of	I-Disease	5206
complement	I-Disease	5206
(	O	5206
C5	O	5206
)	O	5206
was	O	5206
documented	O	5206
in	O	5206
the	O	5206
accompanying	O	5206
report	O	5206
.	O	5206

This	O	5207
study	O	5207
examines	O	5207
several	O	5207
biological	O	5207
properties	O	5207
of	O	5207
C5	B-Disease	5207
-	I-Disease	5207
deficient	I-Disease	5207
(	O	5207
C5D	B-Disease	5207
)	O	5207
human	O	5207
serum	O	5207
,	O	5207
particularly	O	5207
sera	O	5207
obtained	O	5207
from	O	5207
two	O	5207
C5D	B-Disease	5207
homozygotes	O	5207
.	O	5207

The	O	5208
proband	O	5208
,	O	5208
who	O	5208
has	O	5208
inactive	O	5208
systemic	B-Disease	5208
lupus	I-Disease	5208
erythematosus	I-Disease	5208
is	O	5208
completely	O	5208
lacking	O	5208
C5	O	5208
,	O	5208
while	O	5208
her	O	5208
healthy	O	5208
half	O	5208
-	O	5208
sister	O	5208
has	O	5208
1	O	5208
-	O	5208
2	O	5208
%	O	5208
of	O	5208
normal	O	5208
levels	O	5208
.	O	5208

Sera	O	5211
from	O	5211
eight	O	5211
family	O	5211
members	O	5211
who	O	5211
were	O	5211
apparently	O	5211
heterozygous	O	5211
for	O	5211
C5	B-Disease	5211
deficiency	I-Disease	5211
gave	O	5211
normal	O	5211
chemotactic	O	5211
scores	O	5211
.	O	5211

The	O	5212
ability	O	5212
of	O	5212
C5D	B-Disease	5212
serum	O	5212
to	O	5212
opsonize	O	5212
Saccharomyces	O	5212
cerevisiae	O	5212
(	O	5212
bakers	O	5212
yeast	O	5212
)	O	5212
or	O	5212
Candida	O	5212
albicans	O	5212
for	O	5212
ingestion	O	5212
by	O	5212
normal	O	5212
neutrophils	O	5212
was	O	5212
completely	O	5212
normal	O	5212
.	O	5212

In	O	5213
addition	O	5213
,	O	5213
C5D	B-Disease	5213
serum	O	5213
was	O	5213
capable	O	5213
of	O	5213
promoting	O	5213
normal	O	5213
phagocytosis	O	5213
and	O	5213
intracellular	O	5213
killing	O	5213
of	O	5213
Staphylococcus	O	5213
aureus	O	5213
.	O	5213

The	O	5214
probands	O	5214
serum	O	5214
was	O	5214
incapable	O	5214
of	O	5214
mediating	O	5214
lysis	O	5214
of	O	5214
erythrocytes	O	5214
from	O	5214
a	O	5214
patient	O	5214
with	O	5214
paroxysmal	B-Disease	5214
nocturnal	I-Disease	5214
hemoglobinuria	I-Disease	5214
in	O	5214
both	O	5214
the	O	5214
sucrose	O	5214
hemolysia	O	5214
and	O	5214
acid	O	5214
hemolysis	O	5214
tests	O	5214
,	O	5214
and	O	5214
also	O	5214
lacked	O	5214
bactericidal	O	5214
activity	O	5214
against	O	5214
sensitized	O	5214
or	O	5214
unsensitized	O	5214
Salmonella	O	5214
typhi	O	5214
.	O	5214

Human	O	5219
peroxisomal	O	5219
targeting	O	5219
signal	O	5219
-	O	5219
1	O	5219
receptor	O	5219
restores	O	5219
peroxisomal	O	5219
protein	O	5219
import	O	5219
in	O	5219
cells	O	5219
from	O	5219
patients	O	5219
with	O	5219
fatal	O	5219
peroxisomal	B-Disease	5219
disorders	I-Disease	5219
.	O	5219

Human	O	5221
patients	O	5221
with	O	5221
fatal	O	5221
generalized	O	5221
peroxisomal	B-Disease	5221
deficiency	I-Disease	5221
disorders	I-Disease	5221
fall	O	5221
into	O	5221
at	O	5221
least	O	5221
nine	O	5221
genetic	O	5221
complementation	O	5221
groups	O	5221
.	O	5221

The	O	5239
PTS1R	O	5239
cDNA	O	5239
also	O	5239
complements	O	5239
the	O	5239
PTS1	B-Disease	5239
protein	I-Disease	5239
-	I-Disease	5239
import	I-Disease	5239
defect	I-Disease	5239
in	O	5239
skin	O	5239
fibroblasts	O	5239
from	O	5239
patients	O	5239
-	O	5239
-	O	5239
belonging	O	5239
to	O	5239
complementation	O	5239
group	O	5239
two	O	5239
-	O	5239
-	O	5239
diagnosed	O	5239
as	O	5239
having	O	5239
neonatal	B-Disease	5239
adrenoleukodystrophy	I-Disease	5239
or	O	5239
Zellweger	B-Disease	5239
syndrome	I-Disease	5239
.	O	5239

The	O	5240
PTS1R	O	5240
gene	O	5240
has	O	5240
been	O	5240
localized	O	5240
to	O	5240
a	O	5240
chromosomal	O	5240
location	O	5240
where	O	5240
no	O	5240
other	O	5240
peroxisomal	B-Disease	5240
disorder	I-Disease	5240
genes	O	5240
are	O	5240
known	O	5240
to	O	5240
map	O	5240
.	O	5240

Our	O	5241
findings	O	5241
represent	O	5241
the	O	5241
only	O	5241
case	O	5241
in	O	5241
which	O	5241
the	O	5241
molecular	O	5241
basis	O	5241
of	O	5241
the	O	5241
protein	B-Disease	5241
-	I-Disease	5241
import	I-Disease	5241
deficiency	I-Disease	5241
in	O	5241
human	O	5241
peroxisomal	B-Disease	5241
disorders	I-Disease	5241
is	O	5241
understood	O	5241
.	O	5241

Spectrum	O	5242
of	O	5242
germline	O	5242
mutations	O	5242
in	O	5242
the	O	5242
RB1	O	5242
gene	O	5242
:	O	5242
a	O	5242
study	O	5242
of	O	5242
232	O	5242
patients	O	5242
with	O	5242
hereditary	B-Disease	5242
and	I-Disease	5242
non	I-Disease	5242
hereditary	I-Disease	5242
retinoblastoma	I-Disease	5242
.	O	5242

Germline	O	5243
mutations	O	5243
in	O	5243
the	O	5243
RB1	O	5243
gene	O	5243
confer	O	5243
hereditary	O	5243
predisposition	O	5243
to	O	5243
retinoblastoma	B-Disease	5243
.	O	5243

We	O	5244
have	O	5244
performed	O	5244
a	O	5244
mutation	O	5244
survey	O	5244
of	O	5244
the	O	5244
RB1	O	5244
gene	O	5244
in	O	5244
232	O	5244
patients	O	5244
with	O	5244
hereditary	B-Disease	5244
or	I-Disease	5244
non	I-Disease	5244
hereditary	I-Disease	5244
retinoblastoma	I-Disease	5244
.	O	5244

The	O	5249
spectrum	O	5249
of	O	5249
mutations	O	5249
presented	O	5249
here	O	5249
should	O	5249
help	O	5249
to	O	5249
improve	O	5249
the	O	5249
clinical	O	5249
management	O	5249
of	O	5249
retinoblastoma	B-Disease	5249
and	O	5249
to	O	5249
understand	O	5249
the	O	5249
molecular	O	5249
mechanisms	O	5249
leading	O	5249
to	O	5249
tumorigenesis	O	5249
.	O	5249

Aniridia	B-Disease	5251
-	O	5251
associated	O	5251
cytogenetic	O	5251
rearrangements	O	5251
suggest	O	5251
that	O	5251
a	O	5251
position	O	5251
effect	O	5251
may	O	5251
cause	O	5251
the	O	5251
mutant	O	5251
phenotype	O	5251
.	O	5251

Current	O	5252
evidence	O	5252
suggests	O	5252
that	O	5252
aniridia	B-Disease	5252
(	O	5252
absence	B-Disease	5252
of	I-Disease	5252
iris	I-Disease	5252
)	O	5252
is	O	5252
caused	O	5252
by	O	5252
loss	O	5252
of	O	5252
function	O	5252
of	O	5252
one	O	5252
copy	O	5252
of	O	5252
the	O	5252
PAX6	O	5252
gene	O	5252
,	O	5252
which	O	5252
maps	O	5252
to	O	5252
11p13	O	5252
.	O	5252

We	O	5253
present	O	5253
the	O	5253
further	O	5253
characterisation	O	5253
of	O	5253
two	O	5253
aniridia	B-Disease	5253
pedigrees	O	5253
in	O	5253
which	O	5253
the	O	5253
disease	O	5253
segregates	O	5253
with	O	5253
chromosomal	O	5253
rearrangements	O	5253
which	O	5253
involve	O	5253
11p13	O	5253
but	O	5253
do	O	5253
not	O	5253
disrupt	O	5253
the	O	5253
PAX6	O	5253
gene	O	5253
.	O	5253

Somatic	O	5258
mutations	O	5258
in	O	5258
the	O	5258
BRCA1	O	5258
gene	O	5258
in	O	5258
sporadic	B-Disease	5258
ovarian	I-Disease	5258
tumours	I-Disease	5258
.	O	5258

The	O	5259
BRCA1	O	5259
gene	O	5259
on	O	5259
chromosome	O	5259
17q21	O	5259
is	O	5259
responsible	O	5259
for	O	5259
an	O	5259
autosomal	B-Disease	5259
dominant	I-Disease	5259
syndrome	I-Disease	5259
of	O	5259
increased	O	5259
susceptibility	O	5259
to	O	5259
breast	B-Disease	5259
and	I-Disease	5259
ovarian	I-Disease	5259
cancer	I-Disease	5259
but	O	5259
no	O	5259
somatic	O	5259
mutations	O	5259
in	O	5259
tumours	B-Disease	5259
have	O	5259
yet	O	5259
been	O	5259
described	O	5259
.	O	5259

To	O	5260
study	O	5260
the	O	5260
potential	O	5260
role	O	5260
of	O	5260
BRCA1	O	5260
in	O	5260
sporadic	O	5260
carcinogenesis	O	5260
,	O	5260
we	O	5260
analysed	O	5260
the	O	5260
genomic	O	5260
DNA	O	5260
of	O	5260
tumour	B-Disease	5260
and	O	5260
normal	O	5260
fractions	O	5260
of	O	5260
47	O	5260
ovarian	B-Disease	5260
cancers	I-Disease	5260
for	O	5260
mutations	O	5260
in	O	5260
BRCA1	O	5260
using	O	5260
the	O	5260
single	O	5260
-	O	5260
strand	O	5260
conformation	O	5260
polymorphism	O	5260
technique	O	5260
.	O	5260

We	O	5261
now	O	5261
describe	O	5261
somatic	O	5261
mutations	O	5261
in	O	5261
the	O	5261
DNA	O	5261
of	O	5261
four	O	5261
tumours	B-Disease	5261
which	O	5261
also	O	5261
had	O	5261
loss	O	5261
of	O	5261
heterozygosity	O	5261
(	O	5261
LOH	O	5261
)	O	5261
at	O	5261
a	O	5261
BRCA1	O	5261
intragenic	O	5261
marker	O	5261
.	O	5261

Our	O	5262
data	O	5262
support	O	5262
a	O	5262
tumour	B-Disease	5262
suppressor	O	5262
mechanism	O	5262
for	O	5262
BRCA1	O	5262
;	O	5262
somatic	O	5262
mutations	O	5262
and	O	5262
LOH	O	5262
may	O	5262
result	O	5262
in	O	5262
inactivation	O	5262
of	O	5262
BRCA1	O	5262
in	O	5262
at	O	5262
least	O	5262
a	O	5262
small	O	5262
number	O	5262
of	O	5262
ovarian	B-Disease	5262
cancers	I-Disease	5262
.	O	5262

Decreased	O	5264
expression	O	5264
of	O	5264
BRCA1	O	5264
accelerates	O	5264
growth	O	5264
and	O	5264
is	O	5264
often	O	5264
present	O	5264
during	O	5264
sporadic	B-Disease	5264
breast	I-Disease	5264
cancer	I-Disease	5264
progression	O	5264
.	O	5264

We	O	5265
have	O	5265
characterized	O	5265
expression	O	5265
of	O	5265
the	O	5265
familial	B-Disease	5265
breast	I-Disease	5265
and	I-Disease	5265
ovarian	I-Disease	5265
cancer	I-Disease	5265
gene	O	5265
,	O	5265
BRCA1	O	5265
,	O	5265
in	O	5265
cases	O	5265
of	O	5265
non	B-Disease	5265
-	I-Disease	5265
hereditary	I-Disease	5265
(	I-Disease	5265
sporadic	I-Disease	5265
)	I-Disease	5265
breast	I-Disease	5265
cancer	I-Disease	5265
and	O	5265
analyzed	O	5265
the	O	5265
effect	O	5265
of	O	5265
antisense	O	5265
inhibition	O	5265
of	O	5265
BRCA1	O	5265
on	O	5265
the	O	5265
proliferative	O	5265
rate	O	5265
of	O	5265
mammary	O	5265
epithelial	O	5265
cells	O	5265
.	O	5265

BRCA1	O	5266
mRNA	O	5266
levels	O	5266
are	O	5266
markedly	O	5266
decreased	O	5266
during	O	5266
the	O	5266
transition	O	5266
from	O	5266
carcinoma	B-Disease	5266
in	I-Disease	5266
situ	I-Disease	5266
to	O	5266
invasive	B-Disease	5266
cancer	I-Disease	5266
.	O	5266

These	O	5268
studies	O	5268
suggest	O	5268
that	O	5268
BRCA1	O	5268
may	O	5268
normally	O	5268
serve	O	5268
as	O	5268
a	O	5268
negative	O	5268
regulator	O	5268
of	O	5268
mammary	O	5268
epithelial	O	5268
cell	O	5268
growth	O	5268
whose	O	5268
function	O	5268
is	O	5268
compromised	O	5268
in	O	5268
breast	B-Disease	5268
cancer	I-Disease	5268
either	O	5268
by	O	5268
direct	O	5268
mutation	O	5268
or	O	5268
alterations	O	5268
in	O	5268
gene	O	5268
expression	O	5268
.	O	5268

Additional	O	5270
case	O	5270
of	O	5270
female	O	5270
monozygotic	O	5270
twins	O	5270
discordant	O	5270
for	O	5270
the	O	5270
clinical	O	5270
manifestations	O	5270
of	O	5270
Duchenne	B-Disease	5270
muscular	I-Disease	5270
dystrophy	I-Disease	5270
due	O	5270
to	O	5270
opposite	O	5270
X	O	5270
-	O	5270
chromosome	O	5270
inactivation	O	5270
.	O	5270

A	O	5271
pair	O	5271
of	O	5271
female	O	5271
monozygotic	O	5271
(	O	5271
MZ	O	5271
)	O	5271
twins	O	5271
,	O	5271
heterozygous	O	5271
carriers	O	5271
for	O	5271
a	O	5271
deletion	O	5271
in	O	5271
the	O	5271
DMD	B-Disease	5271
gene	O	5271
and	O	5271
discordant	O	5271
for	O	5271
the	O	5271
clinical	O	5271
manifestations	O	5271
of	O	5271
Duchenne	B-Disease	5271
muscular	I-Disease	5271
dystrophy	I-Disease	5271
,	O	5271
were	O	5271
analyzed	O	5271
by	O	5271
molecular	O	5271
studies	O	5271
,	O	5271
in	O	5271
situ	O	5271
hybridization	O	5271
,	O	5271
and	O	5271
methylation	O	5271
pattern	O	5271
of	O	5271
X	O	5271
chromosomes	O	5271
to	O	5271
search	O	5271
for	O	5271
opposite	O	5271
X	O	5271
inactivation	O	5271
as	O	5271
an	O	5271
explanation	O	5271
of	O	5271
their	O	5271
clinical	O	5271
discordance	O	5271
.	O	5271

A	O	5273
review	O	5273
shows	O	5273
that	O	5273
MZ	O	5273
female	O	5273
twins	O	5273
discordant	O	5273
for	O	5273
X	B-Disease	5273
-	I-Disease	5273
linked	I-Disease	5273
diseases	I-Disease	5273
are	O	5273
not	O	5273
uncommon	O	5273
.	O	5273

X	B-Disease	5276
-	I-Disease	5276
linked	I-Disease	5276
adrenoleukodystrophy	I-Disease	5276
(	O	5276
ALD	B-Disease	5276
)	O	5276
:	O	5276
a	O	5276
novel	O	5276
mutation	O	5276
of	O	5276
the	O	5276
ALD	B-Disease	5276
gene	O	5276
in	O	5276
6	O	5276
members	O	5276
of	O	5276
a	O	5276
family	O	5276
presenting	O	5276
with	O	5276
5	O	5276
different	O	5276
phenotypes	O	5276
.	O	5276

Fragments	O	5277
of	O	5277
the	O	5277
adrenoleukodystrophy	B-Disease	5277
(	O	5277
ALD	B-Disease	5277
)	O	5277
cDNA	O	5277
from	O	5277
a	O	5277
patient	O	5277
with	O	5277
adolescent	B-Disease	5277
ALD	I-Disease	5277
were	O	5277
amplified	O	5277
by	O	5277
polymerase	O	5277
chain	O	5277
reaction	O	5277
and	O	5277
subcloned	O	5277
.	O	5277

Bidirectional	O	5278
sequencing	O	5278
of	O	5278
the	O	5278
entire	O	5278
coding	O	5278
ALD	B-Disease	5278
gene	O	5278
disclosed	O	5278
a	O	5278
cytosine	O	5278
to	O	5278
guanine	O	5278
transversion	O	5278
at	O	5278
nucleotide	O	5278
1451	O	5278
in	O	5278
exon	O	5278
five	O	5278
,	O	5278
resulting	O	5278
in	O	5278
substitution	O	5278
of	O	5278
proline	O	5278
484	O	5278
by	O	5278
arginine	O	5278
.	O	5278

Five	O	5279
of	O	5279
nine	O	5279
siblings	O	5279
of	O	5279
the	O	5279
patient	O	5279
,	O	5279
comprising	O	5279
two	O	5279
cerebral	B-Disease	5279
ALD	I-Disease	5279
,	O	5279
one	O	5279
adrenomyeloneuropathy	B-Disease	5279
,	O	5279
one	O	5279
Addison	B-Disease	5279
only	I-Disease	5279
as	O	5279
well	O	5279
as	O	5279
the	O	5279
symptomatic	O	5279
mother	O	5279
(	O	5279
all	O	5279
accumulating	O	5279
very	O	5279
long	O	5279
chain	O	5279
fatty	O	5279
acids	O	5279
)	O	5279
carried	O	5279
this	O	5279
mutation	O	5279
,	O	5279
which	O	5279
was	O	5279
not	O	5279
found	O	5279
in	O	5279
the	O	5279
unaffected	O	5279
persons	O	5279
,	O	5279
in	O	5279
five	O	5279
unrelated	O	5279
ALD	B-Disease	5279
patients	O	5279
,	O	5279
and	O	5279
in	O	5279
twenty	O	5279
controls	O	5279
.	O	5279

Novel	O	5282
mutation	O	5282
at	O	5282
the	O	5282
initiation	O	5282
codon	O	5282
in	O	5282
the	O	5282
Norrie	B-Disease	5282
disease	I-Disease	5282
gene	O	5282
in	O	5282
two	O	5282
Japanese	O	5282
families	O	5282
.	O	5282

We	O	5283
have	O	5283
identified	O	5283
a	O	5283
new	O	5283
mutation	O	5283
of	O	5283
Norrie	B-Disease	5283
disease	I-Disease	5283
(	O	5283
ND	B-Disease	5283
)	O	5283
gene	O	5283
in	O	5283
two	O	5283
Japanese	O	5283
males	O	5283
from	O	5283
unrelated	O	5283
families	O	5283
;	O	5283
they	O	5283
showed	O	5283
typical	O	5283
ocular	O	5283
features	O	5283
of	O	5283
ND	B-Disease	5283
but	O	5283
no	O	5283
mental	B-Disease	5283
retardation	I-Disease	5283
or	O	5283
hearing	B-Disease	5283
impairment	I-Disease	5283
.	O	5283

A	O	5284
mutation	O	5284
was	O	5284
found	O	5284
in	O	5284
both	O	5284
patients	O	5284
at	O	5284
the	O	5284
initiation	O	5284
codon	O	5284
of	O	5284
exon	O	5284
2	O	5284
of	O	5284
the	O	5284
ND	B-Disease	5284
gene	O	5284
(	O	5284
ATG	O	5284
to	O	5284
GTG	O	5284
)	O	5284
,	O	5284
with	O	5284
otherwise	O	5284
normal	O	5284
nucleotide	O	5284
sequences	O	5284
.	O	5284

The	O	5286
mutation	O	5286
of	O	5286
the	O	5286
initiation	O	5286
codon	O	5286
would	O	5286
cause	O	5286
the	O	5286
failure	O	5286
of	O	5286
ND	B-Disease	5286
gene	O	5286
expression	O	5286
or	O	5286
a	O	5286
defect	O	5286
in	O	5286
translation	O	5286
thereby	O	5286
truncating	O	5286
the	O	5286
amino	O	5286
terminus	O	5286
of	O	5286
ND	B-Disease	5286
protein	O	5286
.	O	5286

In	O	5287
view	O	5287
of	O	5287
the	O	5287
rarity	O	5287
and	O	5287
marked	O	5287
heterogeneity	O	5287
of	O	5287
mutations	O	5287
in	O	5287
the	O	5287
ND	B-Disease	5287
gene	O	5287
,	O	5287
the	O	5287
present	O	5287
apparently	O	5287
unrelated	O	5287
Japanese	O	5287
families	O	5287
who	O	5287
have	O	5287
lived	O	5287
in	O	5287
the	O	5287
same	O	5287
area	O	5287
for	O	5287
over	O	5287
two	O	5287
centuries	O	5287
presumably	O	5287
share	O	5287
the	O	5287
origin	O	5287
of	O	5287
the	O	5287
mutation	O	5287
.	O	5287

Anticipation	O	5289
resulting	O	5289
in	O	5289
elimination	O	5289
of	O	5289
the	O	5289
myotonic	B-Disease	5289
dystrophy	I-Disease	5289
gene	O	5289
:	O	5289
a	O	5289
follow	O	5289
up	O	5289
study	O	5289
of	O	5289
one	O	5289
extended	O	5289
family	O	5289
.	O	5289

We	O	5290
have	O	5290
re	O	5290
-	O	5290
examined	O	5290
an	O	5290
extended	O	5290
myotonic	B-Disease	5290
dystrophy	I-Disease	5290
(	O	5290
DM	B-Disease	5290
)	O	5290
family	O	5290
,	O	5290
previously	O	5290
described	O	5290
in	O	5290
1955	O	5290
,	O	5290
in	O	5290
order	O	5290
to	O	5290
study	O	5290
the	O	5290
long	O	5290
term	O	5290
effects	O	5290
of	O	5290
anticipation	O	5290
in	O	5290
DM	B-Disease	5290
and	O	5290
in	O	5290
particular	O	5290
the	O	5290
implications	O	5290
for	O	5290
families	O	5290
affected	O	5290
by	O	5290
this	O	5290
disease	O	5290
.	O	5290

Clinical	O	5292
anticipation	O	5292
,	O	5292
defined	O	5292
as	O	5292
the	O	5292
cascade	O	5292
of	O	5292
mild	O	5292
,	O	5292
adult	O	5292
,	O	5292
childhood	O	5292
,	O	5292
or	O	5292
congenital	B-Disease	5292
disease	I-Disease	5292
in	O	5292
subsequent	O	5292
generations	O	5292
,	O	5292
appeared	O	5292
to	O	5292
be	O	5292
a	O	5292
relentless	O	5292
process	O	5292
,	O	5292
occurring	O	5292
in	O	5292
all	O	5292
affected	O	5292
branches	O	5292
of	O	5292
the	O	5292
family	O	5292
.	O	5292

Gene	O	5297
loss	O	5297
in	O	5297
the	O	5297
patient	O	5297
group	O	5297
was	O	5297
complete	O	5297
,	O	5297
owing	O	5297
to	O	5297
infertility	B-Disease	5297
of	O	5297
the	O	5297
male	O	5297
patients	O	5297
with	O	5297
adult	O	5297
onset	O	5297
disease	O	5297
and	O	5297
the	O	5297
fact	O	5297
that	O	5297
mentally	B-Disease	5297
retarded	I-Disease	5297
patients	O	5297
did	O	5297
not	O	5297
procreate	O	5297
.	O	5297

Therefore	O	5301
it	O	5301
is	O	5301
highly	O	5301
probable	O	5301
that	O	5301
the	O	5301
DM	B-Disease	5301
gene	O	5301
will	O	5301
be	O	5301
eliminated	O	5301
from	O	5301
this	O	5301
pedigree	O	5301
within	O	5301
one	O	5301
generation	O	5301
.	O	5301

The	O	5302
high	O	5302
population	O	5302
frequency	O	5302
of	O	5302
DM	B-Disease	5302
can	O	5302
at	O	5302
present	O	5302
not	O	5302
be	O	5302
explained	O	5302
by	O	5302
the	O	5302
contribution	O	5302
of	O	5302
asymptomatic	O	5302
cases	O	5302
in	O	5302
the	O	5302
younger	O	5302
generations	O	5302
of	O	5302
known	O	5302
families	O	5302
,	O	5302
but	O	5302
is	O	5302
probably	O	5302
caused	O	5302
by	O	5302
the	O	5302
events	O	5302
in	O	5302
the	O	5302
ancestral	O	5302
generations	O	5302
.	O	5302

The	O	5304
gene	O	5304
for	O	5304
spinal	B-Disease	5304
cerebellar	I-Disease	5304
ataxia	I-Disease	5304
3	O	5304
(	O	5304
SCA3	O	5304
)	O	5304
is	O	5304
located	O	5304
in	O	5304
a	O	5304
region	O	5304
of	O	5304
approximately	O	5304
3	O	5304
cM	O	5304
on	O	5304
chromosome	O	5304
14q24	O	5304
.	O	5304

SCA3	O	5307
,	O	5307
the	O	5307
gene	O	5307
for	O	5307
spinal	B-Disease	5307
cerebellar	I-Disease	5307
ataxia	I-Disease	5307
3	O	5307
,	O	5307
was	O	5307
recently	O	5307
mapped	O	5307
to	O	5307
a	O	5307
15	O	5307
-	O	5307
cM	O	5307
interval	O	5307
between	O	5307
D14S67	O	5307
and	O	5307
D14S81	O	5307
on	O	5307
chromosome	O	5307
14q	O	5307
,	O	5307
by	O	5307
linkage	O	5307
analysis	O	5307
in	O	5307
two	O	5307
families	O	5307
of	O	5307
French	O	5307
ancestry	O	5307
.	O	5307

2	O	5318
containing	O	5318
the	O	5318
gene	O	5318
for	O	5318
the	O	5318
Machado	B-Disease	5318
-	I-Disease	5318
Joseph	I-Disease	5318
disease	I-Disease	5318
,	O	5318
which	O	5318
is	O	5318
clinically	O	5318
related	O	5318
to	O	5318
the	O	5318
phenotype	O	5318
determined	O	5318
by	O	5318
SCA3	O	5318
,	O	5318
but	O	5318
it	O	5318
cannot	O	5318
yet	O	5318
be	O	5318
concluded	O	5318
that	O	5318
both	O	5318
diseases	O	5318
result	O	5318
from	O	5318
alterations	O	5318
of	O	5318
the	O	5318
same	O	5318
gene	O	5318
An	O	5318
evaluation	O	5318
of	O	5318
genetic	O	5318
heterogeneity	O	5318
in	O	5318
145	O	5318
breast	B-Disease	5318
-	I-Disease	5318
ovarian	I-Disease	5318
cancer	I-Disease	5318
families	O	5318
.	O	5318

Breast	B-Disease	5319
Cancer	I-Disease	5319
Linkage	O	5319
Consortium	O	5319
.	O	5319

The	O	5320
breast	B-Disease	5320
-	I-Disease	5320
ovary	I-Disease	5320
cancer	I-Disease	5320
-	I-Disease	5320
family	I-Disease	5320
syndrome	I-Disease	5320
is	O	5320
a	O	5320
dominant	O	5320
predisposition	O	5320
to	O	5320
cancer	B-Disease	5320
of	I-Disease	5320
the	I-Disease	5320
breast	I-Disease	5320
and	I-Disease	5320
ovaries	I-Disease	5320
which	O	5320
has	O	5320
been	O	5320
mapped	O	5320
to	O	5320
chromosome	O	5320
region	O	5320
17q12	O	5320
-	O	5320
q21	O	5320
.	O	5320

The	O	5321
majority	O	5321
,	O	5321
but	O	5321
not	O	5321
all	O	5321
,	O	5321
of	O	5321
breast	B-Disease	5321
-	I-Disease	5321
ovary	I-Disease	5321
cancer	I-Disease	5321
families	O	5321
show	O	5321
linkage	O	5321
to	O	5321
this	O	5321
susceptibility	O	5321
locus	O	5321
,	O	5321
designated	O	5321
BRCA1	O	5321
.	O	5321

We	O	5322
report	O	5322
here	O	5322
the	O	5322
results	O	5322
of	O	5322
a	O	5322
linkage	O	5322
analysis	O	5322
of	O	5322
145	O	5322
families	O	5322
with	O	5322
both	O	5322
breast	B-Disease	5322
and	I-Disease	5322
ovarian	I-Disease	5322
cancer	I-Disease	5322
.	O	5322

These	O	5323
families	O	5323
contain	O	5323
either	O	5323
a	O	5323
total	O	5323
of	O	5323
three	O	5323
or	O	5323
more	O	5323
cases	O	5323
of	O	5323
early	O	5323
-	O	5323
onset	O	5323
(	O	5323
before	O	5323
age	O	5323
60	O	5323
years	O	5323
)	O	5323
breast	B-Disease	5323
cancer	I-Disease	5323
or	O	5323
ovarian	B-Disease	5323
cancer	I-Disease	5323
.	O	5323

All	O	5324
families	O	5324
contained	O	5324
at	O	5324
least	O	5324
one	O	5324
case	O	5324
of	O	5324
ovarian	B-Disease	5324
cancer	I-Disease	5324
.	O	5324

None	O	5326
of	O	5326
the	O	5326
13	O	5326
families	O	5326
with	O	5326
cases	O	5326
of	O	5326
male	B-Disease	5326
breast	I-Disease	5326
cancer	I-Disease	5326
appear	O	5326
to	O	5326
be	O	5326
linked	O	5326
,	O	5326
but	O	5326
it	O	5326
is	O	5326
estimated	O	5326
that	O	5326
92	O	5326
%	O	5326
(	O	5326
95	O	5326
%	O	5326
confidence	O	5326
interval	O	5326
76	O	5326
%	O	5326
-	O	5326
100	O	5326
%	O	5326
)	O	5326
of	O	5326
families	O	5326
with	O	5326
no	O	5326
male	B-Disease	5326
breast	I-Disease	5326
cancer	I-Disease	5326
and	O	5326
with	O	5326
two	O	5326
or	O	5326
more	O	5326
ovarian	B-Disease	5326
cancers	I-Disease	5326
are	O	5326
linked	O	5326
to	O	5326
BRCA1	O	5326
.	O	5326

These	O	5327
data	O	5327
suggest	O	5327
that	O	5327
the	O	5327
breast	B-Disease	5327
-	I-Disease	5327
ovarian	I-Disease	5327
cancer	I-Disease	5327
-	I-Disease	5327
family	I-Disease	5327
syndrome	I-Disease	5327
is	O	5327
genetically	O	5327
heterogeneous	O	5327
.	O	5327

However	O	5328
,	O	5328
the	O	5328
large	O	5328
majority	O	5328
of	O	5328
families	O	5328
with	O	5328
early	O	5328
-	O	5328
onset	O	5328
breast	B-Disease	5328
cancer	I-Disease	5328
and	O	5328
with	O	5328
two	O	5328
or	O	5328
more	O	5328
cases	O	5328
of	O	5328
ovarian	B-Disease	5328
cancer	I-Disease	5328
are	O	5328
likely	O	5328
to	O	5328
be	O	5328
due	O	5328
to	O	5328
BRCA1	O	5328
mutations	O	5328
.	O	5328

Molecular	O	5330
basis	O	5330
of	O	5330
essential	B-Disease	5330
fructosuria	I-Disease	5330
:	O	5330
molecular	O	5330
cloning	O	5330
and	O	5330
mutational	O	5330
analysis	O	5330
of	O	5330
human	O	5330
ketohexokinase	O	5330
(	O	5330
fructokinase	O	5330
)	O	5330
.	O	5330

Essential	B-Disease	5331
fructosuria	I-Disease	5331
is	O	5331
one	O	5331
of	O	5331
the	O	5331
oldest	O	5331
known	O	5331
inborn	B-Disease	5331
errors	I-Disease	5331
of	I-Disease	5331
metabolism	I-Disease	5331
.	O	5331

It	O	5332
is	O	5332
a	O	5332
benign	O	5332
condition	O	5332
which	O	5332
is	O	5332
believed	O	5332
to	O	5332
result	O	5332
from	O	5332
deficiency	B-Disease	5332
of	I-Disease	5332
hepatic	I-Disease	5332
fructokinase	I-Disease	5332
(	O	5332
ketohexokinase	O	5332
,	O	5332
KHK	O	5332
,	O	5332
E	O	5332
.	O	5332

Despite	O	5339
the	O	5339
early	O	5339
recognition	O	5339
of	O	5339
this	O	5339
disorder	O	5339
,	O	5339
the	O	5339
primary	O	5339
structure	O	5339
of	O	5339
human	O	5339
KHK	O	5339
and	O	5339
the	O	5339
molecular	O	5339
basis	O	5339
of	O	5339
essential	B-Disease	5339
fructosuria	I-Disease	5339
have	O	5339
not	O	5339
been	O	5339
previously	O	5339
defined	O	5339
.	O	5339

Direct	O	5343
evidence	O	5343
that	O	5343
mutation	O	5343
of	O	5343
the	O	5343
KHK	O	5343
structural	O	5343
gene	O	5343
is	O	5343
the	O	5343
cause	O	5343
of	O	5343
essential	B-Disease	5343
fructosuria	I-Disease	5343
was	O	5343
also	O	5343
obtained	O	5343
.	O	5343

In	O	5344
a	O	5344
well	O	5344
-	O	5344
characterized	O	5344
family	O	5344
,	O	5344
in	O	5344
which	O	5344
three	O	5344
of	O	5344
eight	O	5344
siblings	O	5344
have	O	5344
fructosuria	B-Disease	5344
,	O	5344
all	O	5344
affected	O	5344
individuals	O	5344
are	O	5344
compound	O	5344
heterozygotes	O	5344
for	O	5344
two	O	5344
mutations	O	5344
Gly40Arg	O	5344
and	O	5344
Ala43Thr	O	5344
.	O	5344

An	O	5347
additional	O	5347
conservative	O	5347
amino	O	5347
acid	O	5347
change	O	5347
(	O	5347
Val49IIe	O	5347
)	O	5347
was	O	5347
present	O	5347
on	O	5347
the	O	5347
KHK	O	5347
allele	O	5347
bearing	O	5347
Ala43Thr	O	5347
Homozygous	O	5347
presence	O	5347
of	O	5347
the	O	5347
crossover	O	5347
(	O	5347
fusion	O	5347
gene	O	5347
)	O	5347
mutation	O	5347
identified	O	5347
in	O	5347
a	O	5347
type	B-Disease	5347
II	I-Disease	5347
Gaucher	I-Disease	5347
disease	I-Disease	5347
fetus	O	5347
:	O	5347
is	O	5347
this	O	5347
analogous	O	5347
to	O	5347
the	O	5347
Gaucher	O	5347
knock	O	5347
-	O	5347
out	O	5347
mouse	O	5347
model	O	5347
?	O	5347
Gaucher	B-Disease	5347
disease	I-Disease	5347
(	O	5347
GD	B-Disease	5347
)	O	5347
is	O	5347
an	O	5347
inherited	O	5347
deficiency	B-Disease	5347
of	I-Disease	5347
beta	I-Disease	5347
-	I-Disease	5347
glucocerebrosidase	I-Disease	5347
(	O	5347
EC	O	5347
3	O	5347
.	O	5347

In	O	5351
type	B-Disease	5351
I	I-Disease	5351
GD	I-Disease	5351
,	O	5351
the	O	5351
CNS	O	5351
is	O	5351
not	O	5351
involved	O	5351
(	O	5351
nonneuronopathic	O	5351
)	O	5351
,	O	5351
whereas	O	5351
in	O	5351
type	B-Disease	5351
II	I-Disease	5351
GD	I-Disease	5351
(	O	5351
acute	O	5351
neuronopathic	O	5351
)	O	5351
CNS	O	5351
involvement	O	5351
is	O	5351
early	O	5351
and	O	5351
rapidly	O	5351
progressive	O	5351
,	O	5351
while	O	5351
in	O	5351
type	B-Disease	5351
III	I-Disease	5351
GD	I-Disease	5351
(	O	5351
subacute	O	5351
neuronopathic	O	5351
)	O	5351
CNS	O	5351
involvement	O	5351
occurs	O	5351
later	O	5351
and	O	5351
is	O	5351
slowly	O	5351
progressive	O	5351
.	O	5351

The	O	5352
T6433C	O	5352
(	O	5352
L444P	O	5352
)	O	5352
substitution	O	5352
is	O	5352
prevalent	O	5352
in	O	5352
type	B-Disease	5352
GD	I-Disease	5352
II	I-Disease	5352
.	O	5352

Using	O	5357
this	O	5357
procedure	O	5357
we	O	5357
demonstrated	O	5357
the	O	5357
fusion	O	5357
gene	O	5357
in	O	5357
homozygous	O	5357
form	O	5357
for	O	5357
the	O	5357
first	O	5357
time	O	5357
,	O	5357
in	O	5357
a	O	5357
Macedonian	O	5357
/	O	5357
Ashkenazi	O	5357
Jewish	O	5357
GD	B-Disease	5357
type	I-Disease	5357
II	I-Disease	5357
fetus	O	5357
.	O	5357

A	O	5360
previous	O	5360
conceptus	O	5360
in	O	5360
this	O	5360
family	O	5360
was	O	5360
stillborn	B-Disease	5360
at	O	5360
36	O	5360
weeks	O	5360
,	O	5360
with	O	5360
features	O	5360
of	O	5360
severe	O	5360
type	B-Disease	5360
II	I-Disease	5360
GD	I-Disease	5360
.	O	5360

(	O	5362
ABSTRACT	O	5362
TRUNCATED	O	5362
AT	O	5362
250	O	5362
WORDS	O	5362
)	O	5362
Late	O	5362
infantile	O	5362
metachromatic	B-Disease	5362
leukodystrophy	I-Disease	5362
in	O	5362
Israel	O	5362
.	O	5362

Metachromatic	B-Disease	5363
Leukodystrophy	I-Disease	5363
(	O	5363
MLD	B-Disease	5363
)	O	5363
is	O	5363
a	O	5363
neurodegenerative	B-Disease	5363
disease	I-Disease	5363
in	O	5363
which	O	5363
the	O	5363
lysosomal	O	5363
enzyme	O	5363
,	O	5363
Aryl	O	5363
sulfatase	O	5363
A	O	5363
(	O	5363
ARSA	O	5363
)	O	5363
is	O	5363
deficient	O	5363
.	O	5363

The	O	5365
gene	O	5365
of	O	5365
ARSA	O	5365
has	O	5365
been	O	5365
cloned	O	5365
and	O	5365
up	O	5365
to	O	5365
now	O	5365
eight	O	5365
mutations	O	5365
causing	O	5365
MLD	B-Disease	5365
have	O	5365
been	O	5365
reported	O	5365
.	O	5365

In	O	5368
Israel	O	5368
,	O	5368
late	O	5368
infantile	O	5368
MLD	B-Disease	5368
was	O	5368
found	O	5368
to	O	5368
be	O	5368
very	O	5368
frequent	O	5368
in	O	5368
a	O	5368
small	O	5368
Jewish	O	5368
isolate	O	5368
,	O	5368
the	O	5368
Habbanite	O	5368
Jews	O	5368
(	O	5368
1	O	5368
/	O	5368
75	O	5368
live	O	5368
births	O	5368
)	O	5368
.	O	5368

MLD	B-Disease	5371
is	O	5371
also	O	5371
frequent	O	5371
among	O	5371
Moslem	O	5371
Arabs	O	5371
in	O	5371
Jerusalem	O	5371
.	O	5371

This	O	5373
mutation	O	5373
has	O	5373
been	O	5373
reported	O	5373
in	O	5373
patients	O	5373
with	O	5373
the	O	5373
late	O	5373
infantile	O	5373
MLD	B-Disease	5373
from	O	5373
different	O	5373
ethnic	O	5373
groups	O	5373
.	O	5373

Knowledge	O	5375
of	O	5375
the	O	5375
different	O	5375
mutations	O	5375
causing	O	5375
MLD	B-Disease	5375
in	O	5375
these	O	5375
defined	O	5375
populations	O	5375
will	O	5375
allow	O	5375
a	O	5375
carrier	O	5375
screening	O	5375
program	O	5375
to	O	5375
be	O	5375
carried	O	5375
out	O	5375
and	O	5375
prevent	O	5375
the	O	5375
birth	O	5375
of	O	5375
additional	O	5375
affected	O	5375
children	O	5375
.	O	5375

A	O	5377
single	O	5377
amino	O	5377
acid	O	5377
substitution	O	5377
(	O	5377
G103D	O	5377
)	O	5377
in	O	5377
the	O	5377
type	O	5377
II	O	5377
collagen	O	5377
triple	O	5377
helix	O	5377
produces	O	5377
Kniest	B-Disease	5377
dysplasia	I-Disease	5377
.	O	5377

Kniest	B-Disease	5378
dysplasia	I-Disease	5378
is	O	5378
a	O	5378
moderately	O	5378
severe	O	5378
chondrodysplasia	B-Disease	5378
phenotype	O	5378
that	O	5378
results	O	5378
from	O	5378
mutations	O	5378
in	O	5378
the	O	5378
gene	O	5378
for	O	5378
type	O	5378
II	O	5378
collagen	O	5378
,	O	5378
COL2A1	O	5378
.	O	5378

Characteristics	O	5379
of	O	5379
the	O	5379
disorder	O	5379
include	O	5379
a	O	5379
short	B-Disease	5379
trunk	I-Disease	5379
and	I-Disease	5379
extremities	I-Disease	5379
,	O	5379
mid	B-Disease	5379
-	I-Disease	5379
face	I-Disease	5379
hypoplasia	I-Disease	5379
,	O	5379
cleft	B-Disease	5379
palate	I-Disease	5379
,	O	5379
myopia	B-Disease	5379
,	O	5379
retinal	B-Disease	5379
detachment	I-Disease	5379
,	O	5379
and	O	5379
hearing	B-Disease	5379
loss	I-Disease	5379
.	O	5379

Recently	O	5380
,	O	5380
deletions	O	5380
of	O	5380
all	O	5380
or	O	5380
part	O	5380
of	O	5380
exon	O	5380
12	O	5380
have	O	5380
been	O	5380
identified	O	5380
in	O	5380
individuals	O	5380
with	O	5380
Kniest	B-Disease	5380
dysplasia	I-Disease	5380
,	O	5380
suggesting	O	5380
that	O	5380
mutations	O	5380
within	O	5380
this	O	5380
region	O	5380
of	O	5380
the	O	5380
protein	O	5380
may	O	5380
primarily	O	5380
result	O	5380
in	O	5380
the	O	5380
Kniest	B-Disease	5380
dysplasia	I-Disease	5380
phenotype	O	5380
.	O	5380

We	O	5381
used	O	5381
SSCP	O	5381
to	O	5381
analyze	O	5381
an	O	5381
amplified	O	5381
genomic	O	5381
DNA	O	5381
fragment	O	5381
containing	O	5381
exon	O	5381
12	O	5381
from	O	5381
seven	O	5381
individuals	O	5381
with	O	5381
Kniest	B-Disease	5381
dysplasia	I-Disease	5381
.	O	5381

These	O	5386
data	O	5386
demonstrate	O	5386
that	O	5386
point	O	5386
mutations	O	5386
which	O	5386
result	O	5386
in	O	5386
single	O	5386
amino	O	5386
acid	O	5386
substitutions	O	5386
can	O	5386
produce	O	5386
Kniest	B-Disease	5386
dysplasia	I-Disease	5386
and	O	5386
further	O	5386
support	O	5386
the	O	5386
hypothesis	O	5386
that	O	5386
alteration	O	5386
of	O	5386
a	O	5386
domain	O	5386
,	O	5386
which	O	5386
includes	O	5386
the	O	5386
region	O	5386
encoded	O	5386
by	O	5386
exon	O	5386
12	O	5386
,	O	5386
in	O	5386
the	O	5386
type	O	5386
II	O	5386
collagen	O	5386
protein	O	5386
leads	O	5386
to	O	5386
this	O	5386
disorder	O	5386
.	O	5386

CAG	O	5388
expansions	O	5388
in	O	5388
a	O	5388
novel	O	5388
gene	O	5388
for	O	5388
Machado	B-Disease	5388
-	I-Disease	5388
Joseph	I-Disease	5388
disease	I-Disease	5388
at	O	5388
chromosome	O	5388
14q32	O	5388
.	O	5388

1	O	5391
,	O	5391
the	O	5391
genetic	O	5391
locus	O	5391
for	O	5391
Machado	B-Disease	5391
-	I-Disease	5391
Joseph	I-Disease	5391
disease	I-Disease	5391
(	O	5391
MJD	B-Disease	5391
)	O	5391
.	O	5391

In	O	5392
normal	O	5392
individuals	O	5392
the	O	5392
gene	O	5392
contains	O	5392
between	O	5392
13	O	5392
and	O	5392
36	O	5392
CAG	O	5392
repeats	O	5392
,	O	5392
whereas	O	5392
most	O	5392
of	O	5392
the	O	5392
clinically	O	5392
diagnosed	O	5392
patients	O	5392
and	O	5392
all	O	5392
of	O	5392
the	O	5392
affected	O	5392
members	O	5392
of	O	5392
a	O	5392
family	O	5392
with	O	5392
the	O	5392
clinical	O	5392
and	O	5392
pathological	O	5392
diagnosis	O	5392
of	O	5392
MJD	B-Disease	5392
show	O	5392
expansion	O	5392
of	O	5392
the	O	5392
repeat	O	5392
-	O	5392
number	O	5392
(	O	5392
from	O	5392
68	O	5392
-	O	5392
79	O	5392
)	O	5392
.	O	5392

These	O	5394
results	O	5394
raise	O	5394
the	O	5394
possibility	O	5394
that	O	5394
similar	O	5394
abnormalities	O	5394
in	O	5394
related	O	5394
genes	O	5394
may	O	5394
give	O	5394
rise	O	5394
to	O	5394
diseases	O	5394
similar	O	5394
to	O	5394
MJD	B-Disease	5394
.	O	5394

Mutations	O	5395
in	O	5395
the	O	5395
BRCA1	O	5395
gene	O	5395
in	O	5395
families	O	5395
with	O	5395
early	O	5395
-	O	5395
onset	O	5395
breast	B-Disease	5395
and	I-Disease	5395
ovarian	I-Disease	5395
cancer	I-Disease	5395
.	O	5395

We	O	5396
analysed	O	5396
50	O	5396
probands	O	5396
with	O	5396
a	O	5396
family	O	5396
history	O	5396
of	O	5396
breast	B-Disease	5396
and	I-Disease	5396
/	I-Disease	5396
or	I-Disease	5396
ovarian	I-Disease	5396
cancer	I-Disease	5396
for	O	5396
germline	O	5396
mutations	O	5396
in	O	5396
the	O	5396
coding	O	5396
region	O	5396
of	O	5396
the	O	5396
BRCA1	O	5396
candidate	O	5396
gene	O	5396
,	O	5396
using	O	5396
single	O	5396
-	O	5396
strand	O	5396
conformation	O	5396
polymorphism	O	5396
(	O	5396
SSCP	O	5396
)	O	5396
analysis	O	5396
on	O	5396
PCR	O	5396
-	O	5396
amplified	O	5396
genomic	O	5396
DNA	O	5396
.	O	5396

These	O	5399
data	O	5399
are	O	5399
consistent	O	5399
with	O	5399
a	O	5399
tumour	B-Disease	5399
suppressor	O	5399
model	O	5399
,	O	5399
and	O	5399
support	O	5399
the	O	5399
notion	O	5399
that	O	5399
this	O	5399
candidate	O	5399
gene	O	5399
is	O	5399
in	O	5399
fact	O	5399
BRCA1	O	5399
.	O	5399

Confirmation	O	5402
of	O	5402
BRCA1	O	5402
by	O	5402
analysis	O	5402
of	O	5402
germline	O	5402
mutations	O	5402
linked	O	5402
to	O	5402
breast	B-Disease	5402
and	I-Disease	5402
ovarian	I-Disease	5402
cancer	I-Disease	5402
in	O	5402
ten	O	5402
families	O	5402
.	O	5402

We	O	5403
provide	O	5403
genetic	O	5403
evidence	O	5403
supporting	O	5403
the	O	5403
identity	O	5403
of	O	5403
the	O	5403
candidate	O	5403
gene	O	5403
for	O	5403
BRCA1	O	5403
through	O	5403
the	O	5403
characterization	O	5403
of	O	5403
germline	O	5403
mutations	O	5403
in	O	5403
63	O	5403
breast	B-Disease	5403
cancer	I-Disease	5403
patients	O	5403
and	O	5403
10	O	5403
ovarian	B-Disease	5403
cancer	I-Disease	5403
patients	O	5403
in	O	5403
ten	O	5403
families	O	5403
with	O	5403
cancer	B-Disease	5403
linked	O	5403
to	O	5403
chromosome	O	5403
17q21	O	5403
.	O	5403

The	O	5408
four	O	5408
families	O	5408
with	O	5408
both	O	5408
breast	B-Disease	5408
and	I-Disease	5408
ovarian	I-Disease	5408
cancer	I-Disease	5408
had	O	5408
chain	O	5408
termination	O	5408
mutations	O	5408
in	O	5408
the	O	5408
N	O	5408
-	O	5408
terminal	O	5408
half	O	5408
of	O	5408
the	O	5408
protein	O	5408
.	O	5408

High	O	5410
resolution	O	5410
genetic	O	5410
analysis	O	5410
suggests	O	5410
one	O	5410
ancestral	O	5410
predisposing	O	5410
haplotype	O	5410
for	O	5410
the	O	5410
origin	O	5410
of	O	5410
the	O	5410
myotonic	B-Disease	5410
dystrophy	I-Disease	5410
mutation	O	5410
.	O	5410

The	O	5411
mutation	O	5411
causing	O	5411
myotonic	B-Disease	5411
dystrophy	I-Disease	5411
(	O	5411
DM	B-Disease	5411
)	O	5411
has	O	5411
been	O	5411
identified	O	5411
as	O	5411
an	O	5411
amplification	O	5411
of	O	5411
an	O	5411
unstable	O	5411
trinucleotide	O	5411
(	O	5411
CTG	O	5411
)	O	5411
n	O	5411
repeat	O	5411
in	O	5411
over	O	5411
99	O	5411
%	O	5411
of	O	5411
the	O	5411
global	O	5411
DM	B-Disease	5411
population	O	5411
.	O	5411

It	O	5412
is	O	5412
in	O	5412
complete	O	5412
linkage	O	5412
disequilibrium	O	5412
with	O	5412
an	O	5412
Alu	O	5412
element	O	5412
polymorphism	O	5412
within	O	5412
the	O	5412
DM	B-Disease	5412
kinase	O	5412
gene	O	5412
,	O	5412
suggesting	O	5412
that	O	5412
DM	B-Disease	5412
is	O	5412
a	O	5412
consequence	O	5412
of	O	5412
one	O	5412
or	O	5412
few	O	5412
ancestral	O	5412
mutations	O	5412
.	O	5412

A	O	5413
recent	O	5413
analysis	O	5413
utilizing	O	5413
this	O	5413
polymorphism	O	5413
as	O	5413
well	O	5413
as	O	5413
a	O	5413
flanking	O	5413
dinucleotide	O	5413
marker	O	5413
,	O	5413
suggested	O	5413
that	O	5413
similar	O	5413
to	O	5413
Fragile	B-Disease	5413
X	I-Disease	5413
syndrome	I-Disease	5413
,	O	5413
DM	B-Disease	5413
exhibited	O	5413
a	O	5413
founder	O	5413
effect	O	5413
(	O	5413
Imbert	O	5413
et	O	5413
al	O	5413
.	O	5413

In	O	5416
contrast	O	5416
,	O	5416
the	O	5416
low	O	5416
reproductive	O	5416
fitness	O	5416
of	O	5416
individuals	O	5416
with	O	5416
congenital	O	5416
DM	B-Disease	5416
(	O	5416
the	O	5416
endpoint	O	5416
of	O	5416
genetic	O	5416
anticipation	O	5416
in	O	5416
myotonic	B-Disease	5416
dystrophy	I-Disease	5416
)	O	5416
suggests	O	5416
a	O	5416
higher	O	5416
rate	O	5416
of	O	5416
new	O	5416
mutations	O	5416
.	O	5416

We	O	5417
present	O	5417
a	O	5417
high	O	5417
resolution	O	5417
genetic	O	5417
analysis	O	5417
of	O	5417
the	O	5417
DM	B-Disease	5417
locus	O	5417
using	O	5417
PCR	O	5417
based	O	5417
assays	O	5417
of	O	5417
nine	O	5417
polymorphisms	O	5417
,	O	5417
spanning	O	5417
a	O	5417
physical	O	5417
distance	O	5417
of	O	5417
30	O	5417
kb	O	5417
,	O	5417
within	O	5417
and	O	5417
immediately	O	5417
flanking	O	5417
the	O	5417
DM	B-Disease	5417
kinase	O	5417
gene	O	5417
.	O	5417

The	O	5418
persistent	O	5418
complete	O	5418
allelic	O	5418
association	O	5418
of	O	5418
the	O	5418
DM	B-Disease	5418
mutation	O	5418
with	O	5418
all	O	5418
these	O	5418
polymorphisms	O	5418
provides	O	5418
further	O	5418
support	O	5418
to	O	5418
previous	O	5418
observations	O	5418
and	O	5418
suggests	O	5418
more	O	5418
strongly	O	5418
that	O	5418
the	O	5418
DM	B-Disease	5418
mutation	O	5418
occurred	O	5418
on	O	5418
the	O	5418
background	O	5418
of	O	5418
a	O	5418
particular	O	5418
haplotype	O	5418
in	O	5418
which	O	5418
the	O	5418
(	O	5418
CTG	O	5418
)	O	5418
n	O	5418
repeat	O	5418
became	O	5418
inherently	O	5418
unstable	O	5418
and	O	5418
therefore	O	5418
predisposed	O	5418
to	O	5418
amplification	O	5418
.	O	5418

Genetic	O	5419
instability	O	5419
in	O	5419
human	O	5419
ovarian	B-Disease	5419
cancer	I-Disease	5419
cell	O	5419
lines	O	5419
.	O	5419

We	O	5420
have	O	5420
analyzed	O	5420
the	O	5420
stability	O	5420
of	O	5420
microsatellites	O	5420
in	O	5420
cell	O	5420
lines	O	5420
derived	O	5420
from	O	5420
human	O	5420
ovarian	B-Disease	5420
cancers	I-Disease	5420
and	O	5420
found	O	5420
that	O	5420
5	O	5420
out	O	5420
of	O	5420
10	O	5420
of	O	5420
the	O	5420
ovarian	B-Disease	5420
tumor	I-Disease	5420
cell	O	5420
lines	O	5420
are	O	5420
genetically	O	5420
unstable	O	5420
at	O	5420
the	O	5420
majority	O	5420
of	O	5420
the	O	5420
loci	O	5420
analyzed	O	5420
.	O	5420

In	O	5421
clones	O	5421
and	O	5421
subclones	O	5421
derived	O	5421
serially	O	5421
from	O	5421
one	O	5421
of	O	5421
these	O	5421
cell	O	5421
lines	O	5421
(	O	5421
2774	O	5421
;	O	5421
serous	B-Disease	5421
cystadenocarcinoma	I-Disease	5421
)	O	5421
,	O	5421
a	O	5421
very	O	5421
high	O	5421
proportion	O	5421
of	O	5421
microsatellites	O	5421
distributed	O	5421
in	O	5421
many	O	5421
different	O	5421
regions	O	5421
of	O	5421
the	O	5421
genome	O	5421
change	O	5421
their	O	5421
size	O	5421
in	O	5421
a	O	5421
mercurial	O	5421
fashion	O	5421
.	O	5421

We	O	5422
conclude	O	5422
that	O	5422
genomic	O	5422
instability	O	5422
in	O	5422
ovarian	B-Disease	5422
tumors	I-Disease	5422
is	O	5422
a	O	5422
dynamic	O	5422
and	O	5422
ongoing	O	5422
process	O	5422
whose	O	5422
high	O	5422
frequency	O	5422
may	O	5422
have	O	5422
been	O	5422
previously	O	5422
underestimated	O	5422
by	O	5422
PCR	O	5422
-	O	5422
based	O	5422
allelotyping	O	5422
of	O	5422
bulk	O	5422
tumor	B-Disease	5422
tissue	O	5422
.	O	5422

We	O	5423
have	O	5423
identified	O	5423
the	O	5423
source	O	5423
of	O	5423
the	O	5423
genetic	O	5423
instability	O	5423
in	O	5423
one	O	5423
ovarian	B-Disease	5423
tumor	I-Disease	5423
as	O	5423
a	O	5423
point	O	5423
mutation	O	5423
(	O	5423
R524P	O	5423
)	O	5423
in	O	5423
the	O	5423
human	O	5423
mismatch	O	5423
-	O	5423
repair	O	5423
gene	O	5423
MSH2	O	5423
(	O	5423
Salmonella	O	5423
MutS	O	5423
homologue	O	5423
)	O	5423
,	O	5423
which	O	5423
has	O	5423
recently	O	5423
been	O	5423
shown	O	5423
to	O	5423
be	O	5423
involved	O	5423
in	O	5423
hereditary	B-Disease	5423
nonpolyposis	I-Disease	5423
colorectal	I-Disease	5423
cancer	I-Disease	5423
.	O	5423

However	O	5425
the	O	5425
wild	O	5425
-	O	5425
type	O	5425
allele	O	5425
was	O	5425
lost	O	5425
at	O	5425
some	O	5425
point	O	5425
early	O	5425
during	O	5425
tumorigenesis	O	5425
so	O	5425
that	O	5425
DNA	O	5425
isolated	O	5425
either	O	5425
from	O	5425
the	O	5425
patients	O	5425
ovarian	B-Disease	5425
tumor	I-Disease	5425
or	O	5425
from	O	5425
the	O	5425
2774	O	5425
cell	O	5425
line	O	5425
carries	O	5425
only	O	5425
the	O	5425
mutant	O	5425
allele	O	5425
of	O	5425
the	O	5425
human	O	5425
MSH2	O	5425
gene	O	5425
.	O	5425

The	O	5426
genetic	O	5426
instability	O	5426
observed	O	5426
in	O	5426
the	O	5426
tumor	B-Disease	5426
and	O	5426
cell	O	5426
line	O	5426
DNA	O	5426
,	O	5426
together	O	5426
with	O	5426
the	O	5426
germ	O	5426
-	O	5426
line	O	5426
mutation	O	5426
in	O	5426
a	O	5426
mismatch	O	5426
-	O	5426
repair	O	5426
gene	O	5426
,	O	5426
suggest	O	5426
that	O	5426
the	O	5426
MSH2	O	5426
gene	O	5426
is	O	5426
involved	O	5426
in	O	5426
the	O	5426
onset	O	5426
and	O	5426
/	O	5426
or	O	5426
progression	O	5426
in	O	5426
a	O	5426
subset	O	5426
of	O	5426
ovarian	B-Disease	5426
cancer	I-Disease	5426
.	O	5426

BRCA1	O	5428
mutations	O	5428
in	O	5428
primary	O	5428
breast	B-Disease	5428
and	I-Disease	5428
ovarian	I-Disease	5428
carcinomas	I-Disease	5428
.	O	5428

Loss	O	5429
of	O	5429
heterozygosity	O	5429
data	O	5429
from	O	5429
familial	B-Disease	5429
tumors	I-Disease	5429
suggest	O	5429
that	O	5429
BRCA1	O	5429
,	O	5429
a	O	5429
gene	O	5429
that	O	5429
confers	O	5429
susceptibility	O	5429
to	O	5429
ovarian	B-Disease	5429
and	I-Disease	5429
early	I-Disease	5429
-	I-Disease	5429
onset	I-Disease	5429
breast	B-Disease	5429
cancer	I-Disease	5429
,	O	5429
encodes	O	5429
a	O	5429
tumor	B-Disease	5429
suppressor	O	5429
.	O	5429

The	O	5430
BRCA1	O	5430
region	O	5430
is	O	5430
also	O	5430
subject	O	5430
to	O	5430
allelic	O	5430
loss	O	5430
in	O	5430
sporadic	B-Disease	5430
breast	I-Disease	5430
and	I-Disease	5430
ovarian	I-Disease	5430
cancers	I-Disease	5430
,	O	5430
an	O	5430
indication	O	5430
that	O	5430
BRCA1	O	5430
mutations	O	5430
may	O	5430
occur	O	5430
somatically	O	5430
in	O	5430
these	O	5430
tumors	B-Disease	5430
.	O	5430

The	O	5431
BRCA1	O	5431
coding	O	5431
region	O	5431
was	O	5431
examined	O	5431
for	O	5431
mutations	O	5431
in	O	5431
primary	O	5431
breast	B-Disease	5431
and	I-Disease	5431
ovarian	I-Disease	5431
tumors	I-Disease	5431
that	O	5431
show	O	5431
allele	O	5431
loss	O	5431
at	O	5431
the	O	5431
BRCA1	O	5431
locus	O	5431
.	O	5431

Mutations	O	5432
were	O	5432
detected	O	5432
in	O	5432
3	O	5432
of	O	5432
32	O	5432
breast	O	5432
and	O	5432
1	O	5432
of	O	5432
12	O	5432
ovarian	B-Disease	5432
carcinomas	I-Disease	5432
;	O	5432
all	O	5432
four	O	5432
mutations	O	5432
were	O	5432
germline	O	5432
alterations	O	5432
and	O	5432
occurred	O	5432
in	O	5432
early	O	5432
-	O	5432
onset	O	5432
cancers	B-Disease	5432
.	O	5432

These	O	5433
results	O	5433
suggest	O	5433
that	O	5433
mutation	O	5433
of	O	5433
BRCA1	O	5433
may	O	5433
not	O	5433
be	O	5433
critical	O	5433
in	O	5433
the	O	5433
development	O	5433
of	O	5433
the	O	5433
majority	O	5433
of	O	5433
breast	B-Disease	5433
and	I-Disease	5433
ovarian	I-Disease	5433
cancers	I-Disease	5433
that	O	5433
arise	O	5433
in	O	5433
the	O	5433
absence	O	5433
of	O	5433
a	O	5433
mutant	O	5433
germline	O	5433
allele	O	5433
.	O	5433

PAX6	O	5435
gene	O	5435
dosage	O	5435
effect	O	5435
in	O	5435
a	O	5435
family	O	5435
with	O	5435
congenital	B-Disease	5435
cataracts	I-Disease	5435
,	O	5435
aniridia	B-Disease	5435
,	O	5435
anophthalmia	B-Disease	5435
and	O	5435
central	B-Disease	5435
nervous	I-Disease	5435
system	I-Disease	5435
defects	I-Disease	5435
.	O	5435

The	O	5436
human	O	5436
eye	O	5436
malformation	O	5436
aniridia	B-Disease	5436
results	O	5436
from	O	5436
haploinsufficiency	B-Disease	5436
of	I-Disease	5436
PAX6	I-Disease	5436
,	O	5436
a	O	5436
paired	O	5436
box	O	5436
DNA	O	5436
-	O	5436
binding	O	5436
protein	O	5436
.	O	5436

To	O	5437
study	O	5437
this	O	5437
dosage	O	5437
effect	O	5437
,	O	5437
we	O	5437
characterized	O	5437
two	O	5437
PAX6	O	5437
mutations	O	5437
in	O	5437
a	O	5437
family	O	5437
segregating	O	5437
aniridia	B-Disease	5437
and	O	5437
a	O	5437
milder	O	5437
syndrome	O	5437
consisting	O	5437
of	O	5437
congenital	B-Disease	5437
cataracts	I-Disease	5437
and	O	5437
late	O	5437
onset	O	5437
corneal	B-Disease	5437
dystrophy	I-Disease	5437
.	O	5437

A	O	5440
compound	O	5440
heterozygote	O	5440
had	O	5440
severe	O	5440
craniofacial	B-Disease	5440
and	I-Disease	5440
central	I-Disease	5440
nervous	I-Disease	5440
system	I-Disease	5440
defects	I-Disease	5440
and	O	5440
no	B-Disease	5440
eyes	I-Disease	5440
.	O	5440

We	O	5444
have	O	5444
constructed	O	5444
a	O	5444
physical	O	5444
map	O	5444
of	O	5444
a	O	5444
4	O	5444
cM	O	5444
region	O	5444
on	O	5444
chromosome	O	5444
17q12	O	5444
-	O	5444
21	O	5444
that	O	5444
contains	O	5444
the	O	5444
hereditary	B-Disease	5444
breast	I-Disease	5444
and	I-Disease	5444
ovarian	I-Disease	5444
cancer	I-Disease	5444
gene	O	5444
BRCA1	O	5444
.	O	5444

Two	O	5447
genes	O	5447
that	O	5447
lie	O	5447
within	O	5447
a	O	5447
narrow	O	5447
region	O	5447
defined	O	5447
by	O	5447
meiotic	O	5447
breakpoints	O	5447
in	O	5447
BRCA1	O	5447
patients	O	5447
have	O	5447
been	O	5447
sequenced	O	5447
in	O	5447
breast	B-Disease	5447
cancer	I-Disease	5447
patients	O	5447
without	O	5447
revealing	O	5447
any	O	5447
deleterious	O	5447
mutations	O	5447
.	O	5447

The	O	5450
LEC	O	5450
rat	O	5450
has	O	5450
a	O	5450
deletion	O	5450
in	O	5450
the	O	5450
copper	O	5450
transporting	O	5450
ATPase	O	5450
gene	O	5450
homologous	O	5450
to	O	5450
the	O	5450
Wilson	B-Disease	5450
disease	I-Disease	5450
gene	O	5450
.	O	5450

The	O	5451
Long	O	5451
-	O	5451
Evans	O	5451
Cinnamon	O	5451
(	O	5451
LEC	O	5451
)	O	5451
rat	O	5451
shows	O	5451
similarity	O	5451
to	O	5451
Wilson	B-Disease	5451
disease	I-Disease	5451
in	O	5451
many	O	5451
clinical	O	5451
and	O	5451
biochemical	O	5451
features	O	5451
.	O	5451

We	O	5452
have	O	5452
cloned	O	5452
cDNAs	O	5452
for	O	5452
the	O	5452
rat	O	5452
gene	O	5452
(	O	5452
Atp7b	O	5452
)	O	5452
homologous	O	5452
to	O	5452
the	O	5452
human	O	5452
Wilson	B-Disease	5452
disease	I-Disease	5452
gene	O	5452
(	O	5452
ATP7B	O	5452
)	O	5452
and	O	5452
have	O	5452
used	O	5452
them	O	5452
to	O	5452
identify	O	5452
a	O	5452
partial	O	5452
deletion	O	5452
in	O	5452
the	O	5452
Atp7b	O	5452
gene	O	5452
in	O	5452
the	O	5452
LEC	O	5452
rat	O	5452
.	O	5452

Our	O	5454
results	O	5454
provide	O	5454
convincing	O	5454
evidence	O	5454
for	O	5454
defining	O	5454
the	O	5454
LEC	O	5454
rat	O	5454
as	O	5454
an	O	5454
animal	O	5454
model	O	5454
for	O	5454
Wilson	B-Disease	5454
disease	I-Disease	5454
.	O	5454

This	O	5455
model	O	5455
will	O	5455
be	O	5455
important	O	5455
for	O	5455
studying	O	5455
liver	O	5455
pathophysiology	O	5455
,	O	5455
for	O	5455
developing	O	5455
therapy	O	5455
for	O	5455
Wilson	B-Disease	5455
disease	I-Disease	5455
and	O	5455
for	O	5455
studying	O	5455
the	O	5455
pathway	O	5455
of	O	5455
copper	O	5455
transport	O	5455
and	O	5455
its	O	5455
possible	O	5455
interaction	O	5455
with	O	5455
other	O	5455
heavy	O	5455
metals	O	5455
.	O	5455

Genomic	O	5457
organization	O	5457
of	O	5457
the	O	5457
adrenoleukodystrophy	B-Disease	5457
gene	O	5457
.	O	5457

Adrenoleukodystrophy	B-Disease	5458
(	O	5458
ALD	B-Disease	5458
)	O	5458
,	O	5458
the	O	5458
most	O	5458
frequent	O	5458
peroxisomal	B-Disease	5458
disorder	I-Disease	5458
,	O	5458
is	O	5458
a	O	5458
severe	O	5458
neurodegenerative	B-Disease	5458
disease	I-Disease	5458
associated	O	5458
with	O	5458
an	O	5458
impairment	B-Disease	5458
of	I-Disease	5458
very	I-Disease	5458
long	I-Disease	5458
chain	I-Disease	5458
fatty	I-Disease	5458
acids	I-Disease	5458
beta	I-Disease	5458
-	I-Disease	5458
oxidation	I-Disease	5458
.	O	5458

We	O	5459
have	O	5459
recently	O	5459
identified	O	5459
by	O	5459
positional	O	5459
cloning	O	5459
the	O	5459
gene	O	5459
responsible	O	5459
for	O	5459
ALD	B-Disease	5459
,	O	5459
located	O	5459
in	O	5459
Xq28	O	5459
.	O	5459

We	O	5463
report	O	5463
here	O	5463
a	O	5463
detailed	O	5463
characterization	O	5463
of	O	5463
the	O	5463
ALD	B-Disease	5463
gene	O	5463
structure	O	5463
.	O	5463

To	O	5465
facilitate	O	5465
the	O	5465
detection	O	5465
of	O	5465
mutations	O	5465
in	O	5465
ALD	B-Disease	5465
patients	O	5465
,	O	5465
we	O	5465
have	O	5465
determined	O	5465
the	O	5465
intronic	O	5465
sequences	O	5465
flanking	O	5465
the	O	5465
exons	O	5465
as	O	5465
well	O	5465
as	O	5465
the	O	5465
sequence	O	5465
of	O	5465
the	O	5465
3	O	5465
untranslated	O	5465
region	O	5465
and	O	5465
of	O	5465
the	O	5465
immediate	O	5465
5	O	5465
promoter	O	5465
region	O	5465
.	O	5465

The	O	5467
ALD	B-Disease	5467
gene	O	5467
has	O	5467
been	O	5467
positioned	O	5467
on	O	5467
a	O	5467
pulsed	O	5467
-	O	5467
field	O	5467
map	O	5467
between	O	5467
DXS15	O	5467
and	O	5467
the	O	5467
L1CAM	O	5467
gene	O	5467
,	O	5467
about	O	5467
650	O	5467
kb	O	5467
upstream	O	5467
from	O	5467
the	O	5467
color	O	5467
pigment	O	5467
genes	O	5467
.	O	5467

The	O	5468
frequent	O	5468
occurrence	O	5468
of	O	5468
color	O	5468
vision	O	5468
anomalies	O	5468
observed	O	5468
in	O	5468
patients	O	5468
with	O	5468
adrenomyeloneuropathy	B-Disease	5468
(	O	5468
the	O	5468
adult	O	5468
onset	O	5468
form	O	5468
of	O	5468
ALD	B-Disease	5468
)	O	5468
thus	O	5468
does	O	5468
not	O	5468
represent	O	5468
a	O	5468
contiguous	B-Disease	5468
gene	I-Disease	5468
syndrome	I-Disease	5468
but	O	5468
a	O	5468
secondary	O	5468
manifestation	O	5468
of	O	5468
ALD	B-Disease	5468
.	O	5468

The	O	5470
murine	O	5470
homologues	O	5470
of	O	5470
the	O	5470
Huntington	B-Disease	5470
disease	I-Disease	5470
gene	O	5470
(	O	5470
Hdh	O	5470
)	O	5470
and	O	5470
the	O	5470
alpha	O	5470
-	O	5470
adducin	O	5470
gene	O	5470
(	O	5470
Add1	O	5470
)	O	5470
map	O	5470
to	O	5470
mouse	O	5470
chromosome	O	5470
5	O	5470
within	O	5470
a	O	5470
region	O	5470
of	O	5470
conserved	O	5470
synteny	O	5470
with	O	5470
human	O	5470
chromosome	O	5470
4p16	O	5470
.	O	5470

Huntington	B-Disease	5472
disease	I-Disease	5472
(	O	5472
HD	B-Disease	5472
)	O	5472
is	O	5472
a	O	5472
severe	O	5472
autosomal	B-Disease	5472
dominant	I-Disease	5472
neurodegenerative	I-Disease	5472
disorder	I-Disease	5472
associated	O	5472
with	O	5472
a	O	5472
novel	O	5472
gene	O	5472
(	O	5472
IT15	O	5472
)	O	5472
.	O	5472

Genetic	O	5478
cholesteryl	B-Disease	5478
ester	I-Disease	5478
transfer	I-Disease	5478
protein	I-Disease	5478
deficiency	I-Disease	5478
caused	O	5478
by	O	5478
two	O	5478
prevalent	O	5478
mutations	O	5478
as	O	5478
a	O	5478
major	O	5478
determinant	O	5478
of	O	5478
increased	O	5478
levels	O	5478
of	O	5478
high	O	5478
density	O	5478
lipoprotein	O	5478
cholesterol	O	5478
.	O	5478

We	O	5480
previously	O	5480
described	O	5480
plasma	O	5480
cholesteryl	B-Disease	5480
ester	I-Disease	5480
transfer	I-Disease	5480
protein	I-Disease	5480
(	I-Disease	5480
CETP	I-Disease	5480
)	I-Disease	5480
deficiency	I-Disease	5480
due	O	5480
to	O	5480
an	O	5480
intron	O	5480
14	O	5480
G	O	5480
(	O	5480
+	O	5480
1	O	5480
)	O	5480
-	O	5480
to	O	5480
-	O	5480
A	O	5480
mutation	O	5480
(	O	5480
Int14	O	5480
A	O	5480
)	O	5480
in	O	5480
several	O	5480
families	O	5480
with	O	5480
very	O	5480
high	O	5480
HDL	O	5480
-	O	5480
C	O	5480
levels	O	5480
in	O	5480
Japan	O	5480
.	O	5480

CETP	B-Disease	5491
deficiency	I-Disease	5491
,	O	5491
reflecting	O	5491
two	O	5491
prevalent	O	5491
mutations	O	5491
(	O	5491
D442G	O	5491
and	O	5491
Int14	O	5491
A	O	5491
)	O	5491
,	O	5491
is	O	5491
the	O	5491
first	O	5491
example	O	5491
of	O	5491
a	O	5491
genetic	B-Disease	5491
deficiency	I-Disease	5491
state	O	5491
which	O	5491
is	O	5491
sufficiently	O	5491
common	O	5491
to	O	5491
explain	O	5491
a	O	5491
significant	O	5491
fraction	O	5491
of	O	5491
the	O	5491
variation	O	5491
in	O	5491
HDL	O	5491
-	O	5491
C	O	5491
in	O	5491
the	O	5491
general	O	5491
population	O	5491
.	O	5491

Treatment	O	5493
of	O	5493
cerebrotendinous	B-Disease	5493
xanthomatosis	I-Disease	5493
:	O	5493
effects	O	5493
of	O	5493
chenodeoxycholic	O	5493
acid	O	5493
,	O	5493
pravastatin	O	5493
,	O	5493
and	O	5493
combined	O	5493
use	O	5493
.	O	5493

Treatments	O	5494
by	O	5494
oral	O	5494
administration	O	5494
of	O	5494
chenodeoxycholic	O	5494
acid	O	5494
(	O	5494
CDCA	O	5494
)	O	5494
alone	O	5494
,	O	5494
3	O	5494
-	O	5494
hydroxy	O	5494
-	O	5494
3	O	5494
-	O	5494
methylglutaryl	O	5494
(	O	5494
HMG	O	5494
)	O	5494
CoA	O	5494
reductase	O	5494
inhibitor	O	5494
(	O	5494
pravastatin	O	5494
)	O	5494
alone	O	5494
,	O	5494
and	O	5494
combination	O	5494
of	O	5494
the	O	5494
two	O	5494
drugs	O	5494
were	O	5494
attempted	O	5494
for	O	5494
7	O	5494
patients	O	5494
with	O	5494
cerebrotendinous	B-Disease	5494
xanthomatosis	I-Disease	5494
(	O	5494
CTX	B-Disease	5494
)	O	5494
.	O	5494

The	O	5517
combination	O	5517
of	O	5517
CDCA	O	5517
and	O	5517
pravastatin	O	5517
was	O	5517
a	O	5517
good	O	5517
treatment	O	5517
for	O	5517
CTX	B-Disease	5517
,	O	5517
based	O	5517
on	O	5517
the	O	5517
improvement	O	5517
of	O	5517
serum	O	5517
lipoprotein	O	5517
metabolism	O	5517
,	O	5517
the	O	5517
suppression	O	5517
of	O	5517
cholesterol	O	5517
synthesis	O	5517
,	O	5517
and	O	5517
reductions	O	5517
of	O	5517
cholestanol	O	5517
and	O	5517
plant	O	5517
sterol	O	5517
levels	O	5517
.	O	5517

In	O	5518
all	O	5518
of	O	5518
7	O	5518
patients	O	5518
,	O	5518
the	O	5518
progression	O	5518
of	O	5518
disease	O	5518
was	O	5518
arrested	O	5518
,	O	5518
but	O	5518
dramatic	O	5518
effects	O	5518
on	O	5518
clinical	O	5518
manifestations	O	5518
,	O	5518
xanthoma	B-Disease	5518
,	O	5518
and	O	5518
electrophysiological	O	5518
findings	O	5518
could	O	5518
not	O	5518
be	O	5518
found	O	5518
after	O	5518
the	O	5518
treatment	O	5518
of	O	5518
these	O	5518
drugs	O	5518
Mutation	O	5518
spectrum	O	5518
in	O	5518
the	O	5518
CHM	B-Disease	5518
gene	O	5518
of	O	5518
Danish	O	5518
and	O	5518
Swedish	O	5518
choroideremia	B-Disease	5518
patients	O	5518
.	O	5518

The	O	5519
recent	O	5519
isolation	O	5519
of	O	5519
the	O	5519
complete	O	5519
open	O	5519
reading	O	5519
frame	O	5519
of	O	5519
the	O	5519
choroideremia	B-Disease	5519
(	O	5519
CHM	B-Disease	5519
)	O	5519
gene	O	5519
and	O	5519
the	O	5519
characterization	O	5519
of	O	5519
the	O	5519
exon	O	5519
-	O	5519
intron	O	5519
boundaries	O	5519
has	O	5519
paved	O	5519
the	O	5519
way	O	5519
to	O	5519
mutation	O	5519
detection	O	5519
in	O	5519
patients	O	5519
with	O	5519
classical	O	5519
choroideremia	B-Disease	5519
.	O	5519

Causative	O	5521
mutations	O	5521
in	O	5521
the	O	5521
CHM	B-Disease	5521
gene	O	5521
were	O	5521
detected	O	5521
in	O	5521
at	O	5521
least	O	5521
12	O	5521
families	O	5521
,	O	5521
indicating	O	5521
that	O	5521
a	O	5521
substantial	O	5521
part	O	5521
of	O	5521
the	O	5521
mutations	O	5521
can	O	5521
be	O	5521
identified	O	5521
by	O	5521
this	O	5521
approach	O	5521
.	O	5521

Thus	O	5523
,	O	5523
in	O	5523
one	O	5523
patient	O	5523
,	O	5523
the	O	5523
deletion	O	5523
resulted	O	5523
in	O	5523
the	O	5523
absence	O	5523
of	O	5523
only	O	5523
one	O	5523
exon	O	5523
,	O	5523
while	O	5523
in	O	5523
another	O	5523
the	O	5523
deletion	O	5523
comprised	O	5523
the	O	5523
entire	O	5523
CHM	B-Disease	5523
gene	O	5523
.	O	5523

Interestingly	O	5526
,	O	5526
all	O	5526
CHM	B-Disease	5526
gene	O	5526
mutations	O	5526
detected	O	5526
thus	O	5526
far	O	5526
in	O	5526
choroideremia	B-Disease	5526
patients	O	5526
give	O	5526
rise	O	5526
to	O	5526
the	O	5526
introduction	O	5526
of	O	5526
a	O	5526
premature	O	5526
stop	O	5526
codon	O	5526
.	O	5526

Predominance	O	5528
of	O	5528
the	O	5528
adrenomyeloneuropathy	B-Disease	5528
phenotype	O	5528
of	O	5528
X	B-Disease	5528
-	I-Disease	5528
linked	I-Disease	5528
adrenoleukodystrophy	I-Disease	5528
in	O	5528
The	O	5528
Netherlands	O	5528
:	O	5528
a	O	5528
survey	O	5528
of	O	5528
30	O	5528
kindreds	O	5528
.	O	5528

X	B-Disease	5529
-	I-Disease	5529
linked	I-Disease	5529
adrenoleukodystrophy	I-Disease	5529
(	O	5529
X	B-Disease	5529
-	I-Disease	5529
ALD	I-Disease	5529
)	O	5529
is	O	5529
an	O	5529
inherited	B-Disease	5529
disorder	I-Disease	5529
of	O	5529
peroxisomal	O	5529
beta	O	5529
-	O	5529
oxidation	O	5529
associated	O	5529
with	O	5529
accumulation	O	5529
of	O	5529
saturated	O	5529
very	O	5529
long	O	5529
-	O	5529
chain	O	5529
fatty	O	5529
acids	O	5529
,	O	5529
which	O	5529
results	O	5529
in	O	5529
central	O	5529
and	O	5529
peripheral	O	5529
demyelination	B-Disease	5529
and	O	5529
in	O	5529
impaired	B-Disease	5529
function	I-Disease	5529
of	I-Disease	5529
adrenal	I-Disease	5529
cortex	I-Disease	5529
and	I-Disease	5529
testes	I-Disease	5529
.	O	5529

The	O	5530
phenotypic	O	5530
expression	O	5530
is	O	5530
highly	O	5530
variable	O	5530
,	O	5530
childhood	B-Disease	5530
cerebral	I-Disease	5530
ALD	I-Disease	5530
(	O	5530
CCALD	B-Disease	5530
)	O	5530
and	O	5530
adrenomyeloneuropathy	B-Disease	5530
(	O	5530
AMN	B-Disease	5530
)	O	5530
being	O	5530
the	O	5530
main	O	5530
variants	O	5530
.	O	5530

We	O	5531
explored	O	5531
the	O	5531
30	O	5531
Dutch	O	5531
kindreds	O	5531
well	O	5531
known	O	5531
to	O	5531
the	O	5531
Dutch	O	5531
X	B-Disease	5531
-	I-Disease	5531
ALD	I-Disease	5531
/	O	5531
AMN	B-Disease	5531
Study	O	5531
Group	O	5531
and	O	5531
phenotyped	O	5531
77	O	5531
male	O	5531
patients	O	5531
35	O	5531
(	O	5531
46	O	5531
%	O	5531
)	O	5531
had	O	5531
AMN	B-Disease	5531
and	O	5531
24	O	5531
(	O	5531
31	O	5531
%	O	5531
)	O	5531
CCALD	B-Disease	5531
or	O	5531
adolescent	B-Disease	5531
cerebral	I-Disease	5531
ALD	I-Disease	5531
(	O	5531
AdolCALD	B-Disease	5531
)	O	5531
.	O	5531

These	O	5532
percentages	O	5532
differ	O	5532
significantly	O	5532
from	O	5532
previous	O	5532
reports	O	5532
,	O	5532
in	O	5532
which	O	5532
25	O	5532
to	O	5532
28	O	5532
%	O	5532
of	O	5532
the	O	5532
patients	O	5532
developed	O	5532
AMN	B-Disease	5532
and	O	5532
53	O	5532
to	O	5532
57	O	5532
%	O	5532
CCALD	B-Disease	5532
or	O	5532
AdolCALD	B-Disease	5532
.	O	5532

Our	O	5533
findings	O	5533
indicate	O	5533
that	O	5533
-	O	5533
-	O	5533
at	O	5533
least	O	5533
in	O	5533
the	O	5533
Netherlands	O	5533
-	O	5533
-	O	5533
AMN	B-Disease	5533
may	O	5533
be	O	5533
the	O	5533
most	O	5533
frequent	O	5533
phenotype	O	5533
of	O	5533
X	B-Disease	5533
-	I-Disease	5533
ALD	I-Disease	5533
.	O	5533

Adrenoleukodystrophy	B-Disease	5535
gene	O	5535
encodes	O	5535
an	O	5535
80	O	5535
kDa	O	5535
membrane	O	5535
protein	O	5535
.	O	5535

An	O	5536
antibody	O	5536
against	O	5536
the	O	5536
synthetic	O	5536
C	O	5536
-	O	5536
terminal	O	5536
peptides	O	5536
deduced	O	5536
from	O	5536
the	O	5536
cDNA	O	5536
of	O	5536
the	O	5536
gene	O	5536
responsible	O	5536
for	O	5536
X	B-Disease	5536
-	I-Disease	5536
linked	I-Disease	5536
adrenoleukodystrophy	I-Disease	5536
(	O	5536
ALD	B-Disease	5536
)	O	5536
was	O	5536
produced	O	5536
to	O	5536
characterize	O	5536
the	O	5536
product	O	5536
of	O	5536
the	O	5536
ALD	B-Disease	5536
gene	O	5536
.	O	5536

The	O	5537
antibody	O	5537
reacted	O	5537
with	O	5537
the	O	5537
80	O	5537
kDa	O	5537
band	O	5537
protein	O	5537
in	O	5537
control	O	5537
fibroblasts	O	5537
,	O	5537
while	O	5537
no	O	5537
bands	O	5537
were	O	5537
detected	O	5537
in	O	5537
the	O	5537
fibroblasts	O	5537
from	O	5537
a	O	5537
patient	O	5537
with	O	5537
ALD	B-Disease	5537
(	O	5537
#	O	5537
163	O	5537
)	O	5537
,	O	5537
in	O	5537
which	O	5537
mRNA	O	5537
of	O	5537
the	O	5537
ALD	B-Disease	5537
gene	O	5537
was	O	5537
undetectable	O	5537
based	O	5537
on	O	5537
Northern	O	5537
blot	O	5537
analysis	O	5537
.	O	5537

These	O	5541
data	O	5541
thus	O	5541
indicate	O	5541
that	O	5541
the	O	5541
ALD	B-Disease	5541
gene	O	5541
encodes	O	5541
an	O	5541
80	O	5541
kDa	O	5541
membrane	O	5541
protein	O	5541
.	O	5541

Isolation	O	5543
of	O	5543
the	O	5543
gene	O	5543
for	O	5543
McLeod	B-Disease	5543
syndrome	I-Disease	5543
that	O	5543
encodes	O	5543
a	O	5543
novel	O	5543
membrane	O	5543
transport	O	5543
protein	O	5543
.	O	5543

McLeod	B-Disease	5544
syndrome	I-Disease	5544
is	O	5544
an	O	5544
X	B-Disease	5544
-	I-Disease	5544
linked	I-Disease	5544
multisystem	I-Disease	5544
disorder	I-Disease	5544
characterized	O	5544
by	O	5544
abnormalities	O	5544
in	O	5544
the	O	5544
neuromuscular	O	5544
and	O	5544
hematopoietic	O	5544
systems	O	5544
.	O	5544

We	O	5545
have	O	5545
assembled	O	5545
a	O	5545
cosmid	O	5545
contig	O	5545
of	O	5545
360	O	5545
kb	O	5545
that	O	5545
encompasses	O	5545
the	O	5545
McLeod	B-Disease	5545
gene	O	5545
locus	O	5545
.	O	5545

The	O	5547
mRNA	O	5547
expression	O	5547
pattern	O	5547
of	O	5547
one	O	5547
of	O	5547
them	O	5547
,	O	5547
designated	O	5547
as	O	5547
XK	O	5547
,	O	5547
correlates	O	5547
closely	O	5547
to	O	5547
the	O	5547
McLeod	B-Disease	5547
phenotype	O	5547
.	O	5547

Nucleotide	O	5549
sequence	O	5549
analysis	O	5549
of	O	5549
XK	O	5549
from	O	5549
two	O	5549
unrelated	O	5549
McLeod	B-Disease	5549
patients	O	5549
has	O	5549
identified	O	5549
point	O	5549
mutations	O	5549
at	O	5549
conserved	O	5549
splice	O	5549
donor	O	5549
and	O	5549
acceptor	O	5549
sites	O	5549
.	O	5549

These	O	5550
findings	O	5550
provide	O	5550
direct	O	5550
evidence	O	5550
that	O	5550
XK	O	5550
is	O	5550
responsible	O	5550
for	O	5550
McLeod	B-Disease	5550
syndrome	I-Disease	5550
.	O	5550

X	B-Disease	5552
-	I-Disease	5552
linked	I-Disease	5552
spastic	I-Disease	5552
paraplegia	I-Disease	5552
and	O	5552
Pelizaeus	B-Disease	5552
-	I-Disease	5552
Merzbacher	I-Disease	5552
disease	I-Disease	5552
are	O	5552
allelic	B-Disease	5552
disorders	I-Disease	5552
at	O	5552
the	O	5552
proteolipid	O	5552
protein	O	5552
locus	O	5552
.	O	5552

Three	O	5553
forms	O	5553
of	O	5553
X	B-Disease	5553
-	I-Disease	5553
linked	I-Disease	5553
spastic	I-Disease	5553
paraplegia	I-Disease	5553
(	O	5553
SPG	B-Disease	5553
)	O	5553
have	O	5553
been	O	5553
defined	O	5553
.	O	5553

A	O	5555
rare	O	5555
X	B-Disease	5555
-	I-Disease	5555
linked	I-Disease	5555
dysmyelinating	I-Disease	5555
disorder	I-Disease	5555
of	O	5555
the	O	5555
central	O	5555
nervous	O	5555
system	O	5555
,	O	5555
Pelizaeus	B-Disease	5555
-	I-Disease	5555
Merzbacher	I-Disease	5555
disease	I-Disease	5555
(	O	5555
PMD	B-Disease	5555
)	O	5555
,	O	5555
has	O	5555
also	O	5555
been	O	5555
mapped	O	5555
to	O	5555
Xq21	O	5555
-	O	5555
q22	O	5555
,	O	5555
and	O	5555
is	O	5555
caused	O	5555
by	O	5555
mutations	O	5555
in	O	5555
the	O	5555
proteolipid	O	5555
protein	O	5555
gene	O	5555
(	O	5555
PLP	O	5555
)	O	5555
which	O	5555
encodes	O	5555
two	O	5555
myelin	O	5555
proteins	O	5555
,	O	5555
PLP	O	5555
and	O	5555
DM20	O	5555
.	O	5555

It	O	5560
appears	O	5560
,	O	5560
therefore	O	5560
,	O	5560
that	O	5560
SPG2	O	5560
and	O	5560
PMD	B-Disease	5560
are	O	5560
allelic	B-Disease	5560
disorders	I-Disease	5560
Canavan	B-Disease	5560
disease	I-Disease	5560
:	O	5560
mutations	O	5560
among	O	5560
Jewish	O	5560
and	O	5560
non	O	5560
-	O	5560
Jewish	O	5560
patients	O	5560
.	O	5560

Canavan	B-Disease	5561
disease	I-Disease	5561
is	O	5561
an	O	5561
autosomal	B-Disease	5561
recessive	I-Disease	5561
leukodystrophy	I-Disease	5561
caused	O	5561
by	O	5561
the	O	5561
deficiency	B-Disease	5561
of	I-Disease	5561
aspartoacylase	I-Disease	5561
(	O	5561
ASPA	O	5561
)	O	5561
.	O	5561

Of	O	5570
the	O	5570
128	O	5570
unrelated	O	5570
Canavan	B-Disease	5570
chromosomes	O	5570
analyzed	O	5570
,	O	5570
88	O	5570
were	O	5570
from	O	5570
probands	O	5570
of	O	5570
Ashkenazi	O	5570
Jewish	O	5570
descent	O	5570
.	O	5570

8	O	5576
%	O	5576
of	O	5576
the	O	5576
Canavan	B-Disease	5576
chromosomes	O	5576
of	O	5576
Ashkenazi	O	5576
Jewish	O	5576
origin	O	5576
.	O	5576

Predominant	O	5578
occurrence	O	5578
of	O	5578
certain	O	5578
mutations	O	5578
among	O	5578
Ashkenazi	O	5578
Jewish	O	5578
and	O	5578
non	O	5578
-	O	5578
Jewish	O	5578
patients	O	5578
with	O	5578
Canavan	B-Disease	5578
disease	I-Disease	5578
would	O	5578
suggest	O	5578
a	O	5578
founding	O	5578
-	O	5578
father	O	5578
effect	O	5578
in	O	5578
propagation	O	5578
of	O	5578
these	O	5578
mutant	O	5578
chromosomes	O	5578
Intelligence	O	5578
quotient	O	5578
profile	O	5578
in	O	5578
myotonic	B-Disease	5578
dystrophy	I-Disease	5578
,	O	5578
intergenerational	O	5578
deficit	O	5578
,	O	5578
and	O	5578
correlation	O	5578
with	O	5578
CTG	O	5578
amplification	O	5578
.	O	5578

An	O	5579
abbreviated	O	5579
Wechsler	O	5579
Adult	O	5579
Intelligence	O	5579
Scale	O	5579
Revised	O	5579
(	O	5579
WAIS	O	5579
-	O	5579
R	O	5579
)	O	5579
was	O	5579
used	O	5579
to	O	5579
assess	O	5579
verbal	O	5579
and	O	5579
arithmetical	O	5579
cognitive	O	5579
performance	O	5579
in	O	5579
55	O	5579
subjects	O	5579
with	O	5579
myotonic	B-Disease	5579
dystrophy	I-Disease	5579
(	O	5579
DM	B-Disease	5579
)	O	5579
,	O	5579
covering	O	5579
all	O	5579
grades	O	5579
of	O	5579
disease	O	5579
severity	O	5579
,	O	5579
and	O	5579
31	O	5579
controls	O	5579
at	O	5579
50	O	5579
%	O	5579
risk	O	5579
of	O	5579
inheriting	O	5579
DM	B-Disease	5579
.	O	5579

Significant	O	5581
IQ	O	5581
differences	O	5581
were	O	5581
found	O	5581
between	O	5581
(	O	5581
1	O	5581
)	O	5581
all	O	5581
55	O	5581
DM	B-Disease	5581
subjects	O	5581
(	O	5581
mean	O	5581
90	O	5581
.	O	5581

The	O	5596
correlation	O	5596
of	O	5596
IQ	O	5596
difference	O	5596
and	O	5596
CTG	O	5596
expansion	O	5596
difference	O	5596
in	O	5596
both	O	5596
the	O	5596
DM	B-Disease	5596
parent	O	5596
-	O	5596
child	O	5596
pairs	O	5596
and	O	5596
normal	O	5596
sib	O	5596
-	O	5596
affected	O	5596
sib	O	5596
pairs	O	5596
was	O	5596
poor	O	5596
,	O	5596
indicating	O	5596
that	O	5596
CTG	O	5596
expansion	O	5596
is	O	5596
not	O	5596
a	O	5596
reliable	O	5596
predictor	O	5596
of	O	5596
IQ	O	5596
either	O	5596
in	O	5596
individual	O	5596
persons	O	5596
or	O	5596
families	O	5596
.	O	5596

Further	O	5597
analysis	O	5597
of	O	5597
cognitive	O	5597
function	O	5597
in	O	5597
DM	B-Disease	5597
is	O	5597
required	O	5597
to	O	5597
clarify	O	5597
specific	O	5597
deficits	O	5597
characteristic	O	5597
of	O	5597
this	O	5597
patient	O	5597
group	O	5597
Adenomatous	B-Disease	5597
polyposis	I-Disease	5597
coli	I-Disease	5597
and	O	5597
a	O	5597
cytogenetic	O	5597
deletion	O	5597
of	O	5597
chromosome	O	5597
5	O	5597
resulting	O	5597
from	O	5597
a	O	5597
maternal	O	5597
intrachromosomal	O	5597
insertion	O	5597
.	O	5597

We	O	5598
present	O	5598
the	O	5598
clinical	O	5598
and	O	5598
laboratory	O	5598
findings	O	5598
in	O	5598
an	O	5598
institutionalised	O	5598
adult	O	5598
patient	O	5598
originally	O	5598
referred	O	5598
for	O	5598
autism	B-Disease	5598
.	O	5598

A	O	5599
high	O	5599
risk	O	5599
of	O	5599
colorectal	B-Disease	5599
cancer	I-Disease	5599
was	O	5599
predicted	O	5599
when	O	5599
an	O	5599
interstitial	O	5599
deletion	O	5599
of	O	5599
the	O	5599
long	O	5599
arm	O	5599
of	O	5599
chromosome	O	5599
5	O	5599
,	O	5599
del	O	5599
(	O	5599
5	O	5599
)	O	5599
(	O	5599
q15q22	O	5599
.	O	5599

3	O	5600
)	O	5600
,	O	5600
was	O	5600
detected	O	5600
in	O	5600
her	O	5600
lymphocytes	O	5600
and	O	5600
deletion	O	5600
of	O	5600
the	O	5600
MCC	O	5600
and	O	5600
APC	B-Disease	5600
genes	O	5600
confirmed	O	5600
by	O	5600
molecular	O	5600
analysis	O	5600
.	O	5600

Adenomatous	B-Disease	5601
polyposis	I-Disease	5601
coli	I-Disease	5601
and	O	5601
carcinoma	B-Disease	5601
of	I-Disease	5601
the	I-Disease	5601
rectum	I-Disease	5601
were	O	5601
subsequently	O	5601
diagnosed	O	5601
in	O	5601
the	O	5601
patient	O	5601
.	O	5601

She	O	5602
was	O	5602
profoundly	O	5602
mentally	B-Disease	5602
retarded	I-Disease	5602
,	O	5602
autistic	B-Disease	5602
,	O	5602
and	O	5602
had	O	5602
minor	O	5602
dysmorphic	B-Disease	5602
features	I-Disease	5602
consistent	O	5602
with	O	5602
those	O	5602
of	O	5602
previous	O	5602
patients	O	5602
with	O	5602
similar	O	5602
deletions	O	5602
.	O	5602

This	O	5606
family	O	5606
further	O	5606
confirms	O	5606
the	O	5606
cytogenetic	O	5606
mapping	O	5606
of	O	5606
both	O	5606
MCC	O	5606
and	O	5606
APC	B-Disease	5606
genes	O	5606
to	O	5606
5q22	O	5606
and	O	5606
comparison	O	5606
with	O	5606
other	O	5606
recent	O	5606
cases	O	5606
suggests	O	5606
that	O	5606
both	O	5606
genes	O	5606
and	O	5606
their	O	5606
closely	O	5606
linked	O	5606
markers	O	5606
lie	O	5606
within	O	5606
the	O	5606
5q22	O	5606
.	O	5606

1	O	5607
subband	O	5607
Familial	B-Disease	5607
male	I-Disease	5607
breast	I-Disease	5607
cancer	I-Disease	5607
is	O	5607
not	O	5607
linked	O	5607
to	O	5607
the	O	5607
BRCA1	O	5607
locus	O	5607
on	O	5607
chromosome	O	5607
17q	O	5607
.	O	5607

Breast	B-Disease	5608
cancer	I-Disease	5608
in	O	5608
men	O	5608
is	O	5608
about	O	5608
a	O	5608
hundredfold	O	5608
less	O	5608
common	O	5608
than	O	5608
in	O	5608
women	O	5608
and	O	5608
this	O	5608
has	O	5608
hindered	O	5608
research	O	5608
into	O	5608
its	O	5608
genetic	O	5608
basis	O	5608
.	O	5608

We	O	5609
have	O	5609
examined	O	5609
22	O	5609
families	O	5609
with	O	5609
at	O	5609
least	O	5609
one	O	5609
case	O	5609
of	O	5609
male	B-Disease	5609
breast	I-Disease	5609
cancer	I-Disease	5609
for	O	5609
linkage	O	5609
to	O	5609
the	O	5609
hereditary	B-Disease	5609
breast	I-Disease	5609
and	I-Disease	5609
ovarian	I-Disease	5609
cancer	I-Disease	5609
locus	O	5609
,	O	5609
BRCA1	O	5609
,	O	5609
on	O	5609
chromosome	O	5609
17q	O	5609
.	O	5609

Our	O	5612
results	O	5612
indicate	O	5612
that	O	5612
there	O	5612
is	O	5612
a	O	5612
gene	O	5612
(	O	5612
s	O	5612
)	O	5612
other	O	5612
than	O	5612
BRCA1	O	5612
which	O	5612
predisposes	O	5612
to	O	5612
early	O	5612
-	O	5612
onset	O	5612
breast	B-Disease	5612
cancer	I-Disease	5612
in	O	5612
women	O	5612
and	O	5612
which	O	5612
confers	O	5612
a	O	5612
higher	O	5612
risk	O	5612
of	O	5612
male	B-Disease	5612
breast	I-Disease	5612
cancer	I-Disease	5612
.	O	5612

Identification	O	5613
of	O	5613
additional	O	5613
pedigrees	O	5613
that	O	5613
include	O	5613
cases	O	5613
of	O	5613
male	B-Disease	5613
breast	I-Disease	5613
cancer	I-Disease	5613
may	O	5613
therefore	O	5613
facilitate	O	5613
the	O	5613
mapping	O	5613
and	O	5613
isolation	O	5613
of	O	5613
this	O	5613
gene	O	5613
.	O	5613

The	O	5614
EWS	O	5614
gene	O	5614
,	O	5614
involved	O	5614
in	O	5614
Ewing	B-Disease	5614
family	I-Disease	5614
of	I-Disease	5614
tumors	I-Disease	5614
,	O	5614
malignant	B-Disease	5614
melanoma	I-Disease	5614
of	I-Disease	5614
soft	I-Disease	5614
parts	I-Disease	5614
and	O	5614
desmoplastic	B-Disease	5614
small	I-Disease	5614
round	I-Disease	5614
cell	I-Disease	5614
tumors	I-Disease	5614
,	O	5614
codes	O	5614
for	O	5614
an	O	5614
RNA	O	5614
binding	O	5614
protein	O	5614
with	O	5614
novel	O	5614
regulatory	O	5614
domains	O	5614
.	O	5614

The	O	5615
EWS	O	5615
gene	O	5615
,	O	5615
which	O	5615
maps	O	5615
to	O	5615
band	O	5615
q12	O	5615
of	O	5615
human	O	5615
chromosome	O	5615
22	O	5615
,	O	5615
is	O	5615
involved	O	5615
in	O	5615
a	O	5615
wide	O	5615
variety	O	5615
of	O	5615
human	O	5615
solid	B-Disease	5615
tumors	I-Disease	5615
including	O	5615
Ewing	B-Disease	5615
sarcoma	I-Disease	5615
,	O	5615
related	O	5615
primitive	O	5615
neuroectodermal	B-Disease	5615
tumors	I-Disease	5615
,	O	5615
malignant	B-Disease	5615
melanoma	I-Disease	5615
of	I-Disease	5615
soft	I-Disease	5615
parts	I-Disease	5615
and	O	5615
desmoplastic	B-Disease	5615
small	I-Disease	5615
round	I-Disease	5615
cell	I-Disease	5615
tumors	I-Disease	5615
.	O	5615

In	O	5616
these	O	5616
tumors	B-Disease	5616
,	O	5616
the	O	5616
EWS	O	5616
is	O	5616
fused	O	5616
to	O	5616
genes	O	5616
encoding	O	5616
transcriptional	O	5616
activators	O	5616
/	O	5616
repressors	O	5616
,	O	5616
like	O	5616
Fli	O	5616
-	O	5616
1	O	5616
or	O	5616
erg	O	5616
or	O	5616
ATF	O	5616
1	O	5616
or	O	5616
wt1	O	5616
.	O	5616

An	O	5624
EWS	O	5624
-	O	5624
erg	O	5624
chimeric	O	5624
protein	O	5624
,	O	5624
which	O	5624
is	O	5624
found	O	5624
in	O	5624
Ewings	B-Disease	5624
sarcoma	I-Disease	5624
cells	O	5624
,	O	5624
functions	O	5624
as	O	5624
a	O	5624
transcriptional	O	5624
activator	O	5624
.	O	5624

Canavan	B-Disease	5627
disease	I-Disease	5627
:	O	5627
genomic	O	5627
organization	O	5627
and	O	5627
localization	O	5627
of	O	5627
human	O	5627
ASPA	O	5627
to	O	5627
17p13	O	5627
-	O	5627
ter	O	5627
and	O	5627
conservation	O	5627
of	O	5627
the	O	5627
ASPA	O	5627
gene	O	5627
during	O	5627
evolution	O	5627
.	O	5627

Canavan	B-Disease	5628
disease	I-Disease	5628
,	O	5628
or	O	5628
spongy	B-Disease	5628
degeneration	I-Disease	5628
of	I-Disease	5628
the	I-Disease	5628
brain	I-Disease	5628
,	O	5628
is	O	5628
a	O	5628
severe	O	5628
leukodystrophy	B-Disease	5628
caused	O	5628
by	O	5628
the	O	5628
deficiency	B-Disease	5628
of	I-Disease	5628
aspartoacylase	I-Disease	5628
(	O	5628
ASPA	O	5628
)	O	5628
.	O	5628

Recently	O	5629
,	O	5629
a	O	5629
missense	O	5629
mutation	O	5629
was	O	5629
identified	O	5629
in	O	5629
human	O	5629
ASPA	O	5629
coding	O	5629
sequence	O	5629
from	O	5629
patients	O	5629
with	O	5629
Canavan	B-Disease	5629
disease	I-Disease	5629
.	O	5629

It	O	5640
should	O	5640
now	O	5640
be	O	5640
possible	O	5640
to	O	5640
identify	O	5640
mutations	O	5640
in	O	5640
the	O	5640
noncoding	O	5640
genomic	O	5640
sequences	O	5640
that	O	5640
lead	O	5640
to	O	5640
Canavan	B-Disease	5640
disease	I-Disease	5640
and	O	5640
to	O	5640
study	O	5640
the	O	5640
regulation	O	5640
of	O	5640
ASPA	O	5640
.	O	5640

Myotonic	B-Disease	5642
dystrophy	I-Disease	5642
:	O	5642
size	O	5642
-	O	5642
and	O	5642
sex	O	5642
-	O	5642
dependent	O	5642
dynamics	O	5642
of	O	5642
CTG	O	5642
meiotic	O	5642
instability	O	5642
,	O	5642
and	O	5642
somatic	O	5642
mosaicism	O	5642
.	O	5642

Myotonic	B-Disease	5643
dystrophy	I-Disease	5643
(	O	5643
DM	B-Disease	5643
)	O	5643
is	O	5643
a	O	5643
progressive	O	5643
neuromuscular	B-Disease	5643
disorder	I-Disease	5643
which	O	5643
results	O	5643
from	O	5643
elongations	O	5643
of	O	5643
an	O	5643
unstable	O	5643
(	O	5643
CTG	O	5643
)	O	5643
n	O	5643
repeat	O	5643
,	O	5643
located	O	5643
in	O	5643
the	O	5643
3	O	5643
untranslated	O	5643
region	O	5643
of	O	5643
the	O	5643
DM	B-Disease	5643
gene	O	5643
.	O	5643

Our	O	5647
observation	O	5647
of	O	5647
differently	O	5647
sized	O	5647
repeats	O	5647
in	O	5647
various	O	5647
DM	B-Disease	5647
tissues	O	5647
from	O	5647
the	O	5647
same	O	5647
individual	O	5647
may	O	5647
explain	O	5647
why	O	5647
the	O	5647
size	O	5647
of	O	5647
the	O	5647
mutation	O	5647
observed	O	5647
in	O	5647
lymphocytes	O	5647
does	O	5647
not	O	5647
necessarily	O	5647
correlate	O	5647
with	O	5647
the	O	5647
severity	O	5647
and	O	5647
nature	O	5647
of	O	5647
symptoms	O	5647
.	O	5647

Through	O	5648
a	O	5648
molecular	O	5648
and	O	5648
genetic	O	5648
study	O	5648
of	O	5648
142	O	5648
families	O	5648
including	O	5648
418	O	5648
DM	B-Disease	5648
patients	O	5648
,	O	5648
we	O	5648
have	O	5648
investigated	O	5648
the	O	5648
dynamics	O	5648
of	O	5648
the	O	5648
CTG	O	5648
repeat	O	5648
meiotic	O	5648
instability	O	5648
.	O	5648

Finally	O	5656
,	O	5656
this	O	5656
analysis	O	5656
reveals	O	5656
a	O	5656
significant	O	5656
excess	O	5656
of	O	5656
transmitting	O	5656
grandfathers	O	5656
partially	O	5656
accounted	O	5656
for	O	5656
by	O	5656
increased	O	5656
fertility	O	5656
in	O	5656
affected	O	5656
males	O	5656
Illegitimate	O	5656
transcription	O	5656
of	O	5656
the	O	5656
phenylalanine	O	5656
hydroxylase	O	5656
gene	O	5656
in	O	5656
lymphocytes	O	5656
for	O	5656
identification	O	5656
of	O	5656
mutations	O	5656
in	O	5656
phenylketonuria	B-Disease	5656
.	O	5656

Taking	O	5657
advantage	O	5657
of	O	5657
the	O	5657
illegitimate	O	5657
transcription	O	5657
of	O	5657
the	O	5657
phenylalanine	O	5657
hydroxylase	O	5657
(	O	5657
PAH	O	5657
)	O	5657
gene	O	5657
,	O	5657
we	O	5657
have	O	5657
been	O	5657
able	O	5657
to	O	5657
analyse	O	5657
the	O	5657
PAH	O	5657
cDNA	O	5657
sequence	O	5657
of	O	5657
hyperphenylalaninemic	B-Disease	5657
children	O	5657
in	O	5657
circulating	O	5657
lymphocytes	O	5657
.	O	5657

The	O	5661
present	O	5661
study	O	5661
supports	O	5661
the	O	5661
view	O	5661
that	O	5661
circulating	O	5661
lymphocytes	O	5661
give	O	5661
easy	O	5661
access	O	5661
to	O	5661
PAH	O	5661
gene	O	5661
transcripts	O	5661
whose	O	5661
nucleotide	O	5661
sequence	O	5661
is	O	5661
identical	O	5661
to	O	5661
that	O	5661
reported	O	5661
in	O	5661
liver	O	5661
and	O	5661
therefore	O	5661
represent	O	5661
a	O	5661
useful	O	5661
tool	O	5661
for	O	5661
molecular	O	5661
genetic	O	5661
studies	O	5661
in	O	5661
phenylketonuria	B-Disease	5661
.	O	5661

High	O	5663
residual	O	5663
arylsulfatase	O	5663
A	O	5663
(	O	5663
ARSA	O	5663
)	O	5663
activity	O	5663
in	O	5663
a	O	5663
patient	O	5663
with	O	5663
late	B-Disease	5663
-	I-Disease	5663
infantile	I-Disease	5663
metachromatic	I-Disease	5663
leukodystrophy	I-Disease	5663
.	O	5663

We	O	5664
identified	O	5664
a	O	5664
patient	O	5664
suffering	O	5664
from	O	5664
late	B-Disease	5664
-	I-Disease	5664
infantile	I-Disease	5664
metachromatic	I-Disease	5664
leukodystrophy	I-Disease	5664
(	O	5664
MLD	B-Disease	5664
)	O	5664
who	O	5664
has	O	5664
a	O	5664
residual	O	5664
arylsulfatase	O	5664
A	O	5664
(	O	5664
ARSA	O	5664
)	O	5664
activity	O	5664
of	O	5664
about	O	5664
10	O	5664
%	O	5664
.	O	5664

Fibroblasts	O	5665
of	O	5665
the	O	5665
patient	O	5665
show	O	5665
significant	O	5665
sulfatide	O	5665
degradation	O	5665
activity	O	5665
exceeding	O	5665
that	O	5665
of	O	5665
adult	B-Disease	5665
MLD	I-Disease	5665
patients	O	5665
.	O	5665

These	O	5669
findings	O	5669
are	O	5669
in	O	5669
contrast	O	5669
to	O	5669
previous	O	5669
results	O	5669
showing	O	5669
that	O	5669
the	O	5669
late	B-Disease	5669
-	I-Disease	5669
infantile	I-Disease	5669
type	I-Disease	5669
of	I-Disease	5669
MLD	I-Disease	5669
is	O	5669
always	O	5669
associated	O	5669
with	O	5669
the	O	5669
complete	O	5669
absence	O	5669
of	O	5669
ARSA	O	5669
activity	O	5669
.	O	5669

An	O	5672
arylsulfatase	O	5672
A	O	5672
(	O	5672
ARSA	O	5672
)	O	5672
missense	O	5672
mutation	O	5672
(	O	5672
T274M	O	5672
)	O	5672
causing	O	5672
late	B-Disease	5672
-	I-Disease	5672
infantile	I-Disease	5672
metachromatic	I-Disease	5672
leukodystrophy	I-Disease	5672
.	O	5672

Metachromatic	B-Disease	5673
leukodystrophy	I-Disease	5673
(	O	5673
MLD	B-Disease	5673
)	O	5673
is	O	5673
an	O	5673
autosomal	B-Disease	5673
recessive	I-Disease	5673
lysosomal	I-Disease	5673
storage	I-Disease	5673
disorder	I-Disease	5673
caused	O	5673
by	O	5673
a	O	5673
deficiency	B-Disease	5673
of	I-Disease	5673
arylsulfatase	I-Disease	5673
A	I-Disease	5673
(	O	5673
ARSA	O	5673
;	O	5673
EC	O	5673
3	O	5673
.	O	5673

The	O	5677
8	O	5677
ARSA	O	5677
exons	O	5677
and	O	5677
adjacent	O	5677
intron	O	5677
boundaries	O	5677
from	O	5677
a	O	5677
patient	O	5677
with	O	5677
late	B-Disease	5677
-	I-Disease	5677
infantile	I-Disease	5677
metachromatic	I-Disease	5677
leukodystrophy	I-Disease	5677
were	O	5677
polymerase	O	5677
chain	O	5677
reaction	O	5677
(	O	5677
PCR	O	5677
)	O	5677
amplified	O	5677
in	O	5677
seven	O	5677
discrete	O	5677
reactions	O	5677
.	O	5677

Analysis	O	5680
of	O	5680
a	O	5680
further	O	5680
29	O	5680
MLD	B-Disease	5680
patients	O	5680
revealed	O	5680
the	O	5680
presence	O	5680
of	O	5680
five	O	5680
additional	O	5680
homozygotes	O	5680
for	O	5680
T274M	O	5680
.	O	5680

This	O	5683
is	O	5683
consistent	O	5683
with	O	5683
the	O	5683
very	O	5683
low	O	5683
ARSA	O	5683
activity	O	5683
measured	O	5683
in	O	5683
these	O	5683
patients	O	5683
and	O	5683
their	O	5683
uniformly	O	5683
severe	O	5683
clinical	O	5683
presentation	O	5683
Mutations	O	5683
in	O	5683
the	O	5683
PAX6	O	5683
gene	O	5683
in	O	5683
patients	O	5683
with	O	5683
hereditary	O	5683
aniridia	B-Disease	5683
.	O	5683

The	O	5684
14	O	5684
exons	O	5684
of	O	5684
the	O	5684
PAX6	O	5684
gene	O	5684
have	O	5684
been	O	5684
analysed	O	5684
exon	O	5684
-	O	5684
by	O	5684
-	O	5684
exon	O	5684
using	O	5684
SSCP	O	5684
in	O	5684
6	O	5684
aniridia	B-Disease	5684
families	O	5684
.	O	5684

This	O	5692
data	O	5692
strongly	O	5692
supports	O	5692
the	O	5692
candidature	O	5692
of	O	5692
PAX6	O	5692
as	O	5692
the	O	5692
gene	O	5692
responsible	O	5692
for	O	5692
hereditary	O	5692
aniridia	B-Disease	5692
.	O	5692

Three	O	5694
novel	O	5694
mutations	O	5694
in	O	5694
five	O	5694
unrelated	O	5694
subjects	O	5694
with	O	5694
hereditary	O	5694
protein	B-Disease	5694
S	I-Disease	5694
deficiency	I-Disease	5694
type	I-Disease	5694
I	I-Disease	5694
.	O	5694

A	O	5695
panel	O	5695
of	O	5695
eight	O	5695
unrelated	O	5695
subjects	O	5695
with	O	5695
inherited	O	5695
type	B-Disease	5695
I	I-Disease	5695
protein	I-Disease	5695
S	I-Disease	5695
deficiency	I-Disease	5695
was	O	5695
screened	O	5695
for	O	5695
mutations	O	5695
in	O	5695
the	O	5695
PROS1	O	5695
gene	O	5695
.	O	5695

The	O	5704
latter	O	5704
indicates	O	5704
that	O	5704
a	O	5704
mRNA	O	5704
based	O	5704
approach	O	5704
is	O	5704
not	O	5704
feasible	O	5704
for	O	5704
the	O	5704
genetic	O	5704
analysis	O	5704
of	O	5704
protein	B-Disease	5704
S	I-Disease	5704
deficiency	I-Disease	5704
type	I-Disease	5704
I	I-Disease	5704
.	O	5704

Characteristics	O	5706
of	O	5706
intergenerational	O	5706
contractions	O	5706
of	O	5706
the	O	5706
CTG	O	5706
repeat	O	5706
in	O	5706
myotonic	B-Disease	5706
dystrophy	I-Disease	5706
.	O	5706

In	O	5707
myotonic	B-Disease	5707
dystrophy	I-Disease	5707
(	O	5707
DM	B-Disease	5707
)	O	5707
,	O	5707
the	O	5707
size	O	5707
of	O	5707
a	O	5707
CTG	O	5707
repeat	O	5707
in	O	5707
the	O	5707
DM	B-Disease	5707
kinase	O	5707
gene	O	5707
generally	O	5707
increases	O	5707
in	O	5707
successive	O	5707
generations	O	5707
with	O	5707
clinical	O	5707
evidence	O	5707
of	O	5707
anticipation	O	5707
.	O	5707

We	O	5709
examined	O	5709
1	O	5709
,	O	5709
489	O	5709
DM	B-Disease	5709
parent	O	5709
-	O	5709
offspring	O	5709
pairs	O	5709
,	O	5709
of	O	5709
which	O	5709
95	O	5709
(	O	5709
6	O	5709
.	O	5709

It	O	5712
is	O	5712
surprising	O	5712
that	O	5712
anticipation	O	5712
occurred	O	5712
in	O	5712
27	O	5712
(	O	5712
48	O	5712
%	O	5712
)	O	5712
of	O	5712
these	O	5712
56	O	5712
pairs	O	5712
,	O	5712
while	O	5712
none	O	5712
clearly	O	5712
showed	O	5712
a	O	5712
later	O	5712
onset	O	5712
of	O	5712
DM	B-Disease	5712
in	O	5712
the	O	5712
symptomatic	O	5712
offspring	O	5712
.	O	5712

Sixteen	O	5722
DM	B-Disease	5722
parents	O	5722
had	O	5722
multiple	O	5722
DM	B-Disease	5722
offspring	O	5722
with	O	5722
the	O	5722
CTG	O	5722
repeat	O	5722
contractions	O	5722
.	O	5722

4	O	5724
%	O	5724
)	O	5724
and	O	5724
the	O	5724
size	O	5724
of	O	5724
DM	B-Disease	5724
sib	O	5724
population	O	5724
(	O	5724
1	O	5724
.	O	5724

54	O	5725
DM	B-Disease	5725
offspring	O	5725
per	O	5725
DM	B-Disease	5725
parent	O	5725
,	O	5725
in	O	5725
968	O	5725
DM	B-Disease	5725
parents	O	5725
)	O	5725
.	O	5725

We	O	5726
conclude	O	5726
that	O	5726
(	O	5726
1	O	5726
)	O	5726
intergenerational	O	5726
contractions	O	5726
of	O	5726
the	O	5726
CTG	O	5726
repeat	O	5726
in	O	5726
leukocyte	O	5726
DNA	O	5726
frequently	O	5726
accompanies	O	5726
apparent	O	5726
anticipation	O	5726
,	O	5726
especially	O	5726
when	O	5726
DM	B-Disease	5726
is	O	5726
maternally	O	5726
transmitted	O	5726
,	O	5726
and	O	5726
(	O	5726
2	O	5726
)	O	5726
the	O	5726
paternal	O	5726
origin	O	5726
of	O	5726
the	O	5726
repeat	O	5726
and	O	5726
the	O	5726
presence	O	5726
of	O	5726
the	O	5726
repeat	O	5726
contraction	O	5726
in	O	5726
a	O	5726
sibling	O	5726
increase	O	5726
the	O	5726
probability	O	5726
of	O	5726
the	O	5726
CTG	O	5726
repeat	O	5726
contraction	O	5726
Gonosomal	O	5726
mosaicism	O	5726
in	O	5726
myotonic	B-Disease	5726
dystrophy	I-Disease	5726
patients	O	5726
:	O	5726
involvement	O	5726
of	O	5726
mitotic	O	5726
events	O	5726
in	O	5726
(	O	5726
CTG	O	5726
)	O	5726
n	O	5726
repeat	O	5726
variation	O	5726
and	O	5726
selection	O	5726
against	O	5726
extreme	O	5726
expansion	O	5726
in	O	5726
sperm	O	5726
.	O	5726

Myotonic	B-Disease	5727
dystrophy	I-Disease	5727
(	O	5727
DM	B-Disease	5727
)	O	5727
is	O	5727
caused	O	5727
by	O	5727
abnormal	O	5727
expansion	O	5727
of	O	5727
a	O	5727
polymorphic	O	5727
(	O	5727
CTG	O	5727
)	O	5727
n	O	5727
repeat	O	5727
,	O	5727
located	O	5727
in	O	5727
the	O	5727
DM	B-Disease	5727
protein	O	5727
kinase	O	5727
gene	O	5727
.	O	5727

We	O	5728
determined	O	5728
the	O	5728
(	O	5728
CTG	O	5728
)	O	5728
n	O	5728
repeat	O	5728
lengths	O	5728
in	O	5728
a	O	5728
broad	O	5728
range	O	5728
of	O	5728
tissue	O	5728
DNAs	O	5728
from	O	5728
patients	O	5728
with	O	5728
mild	O	5728
,	O	5728
classical	O	5728
,	O	5728
or	O	5728
congenital	O	5728
manifestation	O	5728
of	O	5728
DM	B-Disease	5728
.	O	5728

Differences	O	5729
in	O	5729
the	O	5729
repeat	O	5729
length	O	5729
were	O	5729
seen	O	5729
in	O	5729
somatic	O	5729
tissues	O	5729
from	O	5729
single	O	5729
DM	B-Disease	5729
individuals	O	5729
and	O	5729
twins	O	5729
.	O	5729

We	O	5734
conclude	O	5734
that	O	5734
DM	B-Disease	5734
patients	O	5734
can	O	5734
be	O	5734
considered	O	5734
gonosomal	O	5734
mosaics	O	5734
,	O	5734
i	O	5734
.	O	5734

A	O	5740
model	O	5740
explaining	O	5740
mitotic	O	5740
instability	O	5740
and	O	5740
sex	O	5740
-	O	5740
dependent	O	5740
segregation	O	5740
phenomena	O	5740
in	O	5740
DM	B-Disease	5740
manifestation	O	5740
is	O	5740
discussed	O	5740
Regionally	O	5740
clustered	O	5740
APC	B-Disease	5740
mutations	O	5740
are	O	5740
associated	O	5740
with	O	5740
a	O	5740
severe	O	5740
phenotype	O	5740
and	O	5740
occur	O	5740
at	O	5740
a	O	5740
high	O	5740
frequency	O	5740
in	O	5740
new	O	5740
mutation	O	5740
cases	O	5740
of	O	5740
adenomatous	B-Disease	5740
polyposis	I-Disease	5740
coli	I-Disease	5740
.	O	5740

Germline	O	5741
mutation	O	5741
in	O	5741
APC	O	5741
at	O	5741
5q21	O	5741
-	O	5741
22	O	5741
results	O	5741
in	O	5741
the	O	5741
dominantly	O	5741
inherited	O	5741
syndrome	O	5741
adenomatous	B-Disease	5741
polyposis	I-Disease	5741
coli	I-Disease	5741
(	O	5741
APC	B-Disease	5741
)	O	5741
.	O	5741

Eighteen	O	5745
patients	O	5745
had	O	5745
no	O	5745
family	O	5745
history	O	5745
of	O	5745
the	O	5745
disease	O	5745
;	O	5745
of	O	5745
these	O	5745
11	O	5745
were	O	5745
classified	O	5745
as	O	5745
having	O	5745
a	O	5745
severe	O	5745
phenotype	O	5745
,	O	5745
based	O	5745
on	O	5745
an	O	5745
early	O	5745
age	O	5745
at	O	5745
presentation	O	5745
or	O	5745
cancer	B-Disease	5745
development	O	5745
.	O	5745

A	O	5747
5	O	5747
bp	O	5747
deletion	O	5747
at	O	5747
codon	O	5747
1309	O	5747
reported	O	5747
to	O	5747
occur	O	5747
in	O	5747
10	O	5747
-	O	5747
15	O	5747
%	O	5747
of	O	5747
unselected	O	5747
APC	B-Disease	5747
patients	O	5747
worldwide	O	5747
,	O	5747
was	O	5747
found	O	5747
in	O	5747
5	O	5747
of	O	5747
the	O	5747
18	O	5747
new	O	5747
mutation	O	5747
cases	O	5747
and	O	5747
4	O	5747
of	O	5747
the	O	5747
27	O	5747
familial	O	5747
cases	O	5747
all	O	5747
nine	O	5747
were	O	5747
classed	O	5747
as	O	5747
severe	O	5747
.	O	5747

In	O	5749
contrast	O	5749
all	O	5749
of	O	5749
the	O	5749
APC	B-Disease	5749
mutations	O	5749
detected	O	5749
in	O	5749
affected	O	5749
individuals	O	5749
with	O	5749
an	O	5749
average	O	5749
phenotype	O	5749
were	O	5749
located	O	5749
prior	O	5749
to	O	5749
codon	O	5749
1309	O	5749
.	O	5749

Mutations	O	5752
at	O	5752
the	O	5752
PAX6	O	5752
locus	O	5752
are	O	5752
found	O	5752
in	O	5752
heterogeneous	O	5752
anterior	B-Disease	5752
segment	I-Disease	5752
malformations	I-Disease	5752
including	O	5752
Peters	B-Disease	5752
'	I-Disease	5752
anomaly	I-Disease	5752
.	O	5752

Mutation	O	5753
or	O	5753
deletion	O	5753
of	O	5753
the	O	5753
PAX6	O	5753
gene	O	5753
underlies	O	5753
many	O	5753
cases	O	5753
of	O	5753
aniridia	B-Disease	5753
.	O	5753

Three	O	5754
lines	O	5754
of	O	5754
evidence	O	5754
now	O	5754
converge	O	5754
to	O	5754
implicate	O	5754
PAX6	O	5754
more	O	5754
widely	O	5754
in	O	5754
anterior	B-Disease	5754
segment	I-Disease	5754
malformations	I-Disease	5754
including	O	5754
Peters	B-Disease	5754
anomaly	I-Disease	5754
.	O	5754

First	O	5755
,	O	5755
a	O	5755
child	O	5755
with	O	5755
Peters	B-Disease	5755
anomaly	I-Disease	5755
is	O	5755
deleted	O	5755
for	O	5755
one	O	5755
copy	O	5755
of	O	5755
PAX6	O	5755
.	O	5755

Second	O	5756
,	O	5756
affected	O	5756
members	O	5756
of	O	5756
a	O	5756
family	O	5756
with	O	5756
dominantly	O	5756
inherited	O	5756
anterior	B-Disease	5756
segment	I-Disease	5756
malformations	I-Disease	5756
,	O	5756
including	O	5756
Peters	B-Disease	5756
anomaly	I-Disease	5756
are	O	5756
heterozygous	O	5756
for	O	5756
an	O	5756
R26G	O	5756
mutation	O	5756
in	O	5756
the	O	5756
PAX6	O	5756
paired	O	5756
box	O	5756
.	O	5756

Third	O	5757
,	O	5757
a	O	5757
proportion	O	5757
of	O	5757
Sey	O	5757
/	O	5757
+	O	5757
Smalleye	O	5757
mice	O	5757
,	O	5757
heterozygous	O	5757
for	O	5757
a	O	5757
nonsense	O	5757
mutation	O	5757
in	O	5757
murine	O	5757
Pax	O	5757
-	O	5757
6	O	5757
,	O	5757
have	O	5757
an	O	5757
ocular	O	5757
phenotype	O	5757
resembling	O	5757
Peters	B-Disease	5757
anomaly	I-Disease	5757
.	O	5757

We	O	5758
therefore	O	5758
propose	O	5758
that	O	5758
a	O	5758
variety	O	5758
of	O	5758
anterior	B-Disease	5758
segment	I-Disease	5758
anomalies	I-Disease	5758
may	O	5758
be	O	5758
associated	O	5758
with	O	5758
PAX6	O	5758
mutations	O	5758
.	O	5758

Huntington	B-Disease	5760
disease	I-Disease	5760
without	O	5760
CAG	O	5760
expansion	O	5760
:	O	5760
phenocopies	O	5760
or	O	5760
errors	O	5760
in	O	5760
assignment	O	5760
?	O	5760
Huntington	B-Disease	5760
disease	I-Disease	5760
(	O	5760
HD	B-Disease	5760
)	O	5760
has	O	5760
been	O	5760
shown	O	5760
to	O	5760
be	O	5760
associated	O	5760
with	O	5760
an	O	5760
expanded	O	5760
CAG	O	5760
repeat	O	5760
within	O	5760
a	O	5760
novel	O	5760
gene	O	5760
on	O	5760
4p16	O	5760
.	O	5760

The	O	5764
reasons	O	5764
for	O	5764
not	O	5764
observing	O	5764
expansion	O	5764
in	O	5764
affected	O	5764
individuals	O	5764
are	O	5764
important	O	5764
for	O	5764
determining	O	5764
the	O	5764
sensitivity	O	5764
of	O	5764
using	O	5764
repeat	O	5764
length	O	5764
both	O	5764
for	O	5764
diagnosis	O	5764
of	O	5764
affected	O	5764
patients	O	5764
and	O	5764
for	O	5764
predictive	O	5764
testing	O	5764
programs	O	5764
and	O	5764
may	O	5764
have	O	5764
biological	O	5764
relevance	O	5764
for	O	5764
the	O	5764
understanding	O	5764
of	O	5764
the	O	5764
molecular	O	5764
mechanism	O	5764
underlying	O	5764
HD	B-Disease	5764
.	O	5764

The	O	5766
remaining	O	5766
12	O	5766
patients	O	5766
represent	O	5766
possible	O	5766
phenocopies	O	5766
for	O	5766
HD	B-Disease	5766
.	O	5766

Mutations	O	5769
in	O	5769
the	O	5769
HD	B-Disease	5769
gene	O	5769
that	O	5769
are	O	5769
other	O	5769
than	O	5769
CAG	O	5769
expansion	O	5769
have	O	5769
not	O	5769
been	O	5769
excluded	O	5769
for	O	5769
the	O	5769
remaining	O	5769
eight	O	5769
cases	O	5769
;	O	5769
however	O	5769
,	O	5769
in	O	5769
as	O	5769
many	O	5769
as	O	5769
seven	O	5769
of	O	5769
these	O	5769
persons	O	5769
,	O	5769
retrospective	O	5769
review	O	5769
of	O	5769
these	O	5769
patients	O	5769
clinical	O	5769
features	O	5769
identified	O	5769
characteristics	O	5769
not	O	5769
typical	O	5769
for	O	5769
HD	B-Disease	5769
.	O	5769

This	O	5770
study	O	5770
shows	O	5770
that	O	5770
on	O	5770
rare	O	5770
occasions	O	5770
mutations	O	5770
in	O	5770
other	O	5770
,	O	5770
as	O	5770
-	O	5770
yet	O	5770
-	O	5770
undefined	O	5770
genes	O	5770
can	O	5770
present	O	5770
with	O	5770
a	O	5770
clinical	O	5770
phenotype	O	5770
very	O	5770
similar	O	5770
to	O	5770
that	O	5770
of	O	5770
HD	B-Disease	5770
Frequent	O	5770
detection	O	5770
of	O	5770
codon	O	5770
877	O	5770
mutation	O	5770
in	O	5770
the	O	5770
androgen	O	5770
receptor	O	5770
gene	O	5770
in	O	5770
advanced	B-Disease	5770
prostate	I-Disease	5770
cancers	I-Disease	5770
.	O	5770

Prostatic	O	5771
tissue	O	5771
specimens	O	5771
derived	O	5771
from	O	5771
transurethral	O	5771
resections	O	5771
of	O	5771
patients	O	5771
with	O	5771
metastatic	B-Disease	5771
prostate	I-Disease	5771
cancer	I-Disease	5771
were	O	5771
analyzed	O	5771
for	O	5771
genetic	O	5771
alterations	O	5771
in	O	5771
the	O	5771
hormone	O	5771
-	O	5771
binding	O	5771
domain	O	5771
of	O	5771
the	O	5771
androgen	O	5771
receptor	O	5771
(	O	5771
AR	O	5771
)	O	5771
gene	O	5771
.	O	5771

This	O	5773
same	O	5773
AR	O	5773
mutation	O	5773
has	O	5773
been	O	5773
reported	O	5773
previously	O	5773
in	O	5773
a	O	5773
metastatic	B-Disease	5773
prostate	I-Disease	5773
cancer	I-Disease	5773
cell	O	5773
line	O	5773
,	O	5773
LNCaP	O	5773
,	O	5773
where	O	5773
this	O	5773
mutation	O	5773
confers	O	5773
upon	O	5773
the	O	5773
AR	O	5773
an	O	5773
altered	O	5773
ligand	O	5773
-	O	5773
binding	O	5773
specificity	O	5773
which	O	5773
is	O	5773
stimulated	O	5773
by	O	5773
estrogens	O	5773
,	O	5773
progestagens	O	5773
,	O	5773
and	O	5773
antiandrogens	O	5773
.	O	5773

It	O	5774
is	O	5774
possible	O	5774
that	O	5774
analogous	O	5774
to	O	5774
an	O	5774
activated	O	5774
/	O	5774
altered	O	5774
growth	O	5774
factor	O	5774
receptor	O	5774
oncogene	O	5774
,	O	5774
codon	O	5774
877	O	5774
mutant	O	5774
AR	O	5774
with	O	5774
altered	O	5774
ligand	O	5774
binding	O	5774
may	O	5774
provide	O	5774
a	O	5774
selective	O	5774
growth	O	5774
advantage	O	5774
in	O	5774
the	O	5774
genesis	O	5774
of	O	5774
a	O	5774
subset	O	5774
of	O	5774
advanced	B-Disease	5774
prostate	I-Disease	5774
cancer	I-Disease	5774
.	O	5774

Although	O	5775
estrogens	O	5775
are	O	5775
used	O	5775
infrequently	O	5775
,	O	5775
antiandrogens	O	5775
are	O	5775
used	O	5775
increasingly	O	5775
in	O	5775
hormonal	O	5775
therapy	O	5775
for	O	5775
patients	O	5775
with	O	5775
advanced	B-Disease	5775
prostate	I-Disease	5775
cancer	I-Disease	5775
.	O	5775

The	O	5778
human	O	5778
gene	O	5778
for	O	5778
alkaptonuria	B-Disease	5778
(	O	5778
AKU	B-Disease	5778
)	O	5778
maps	O	5778
to	O	5778
chromosome	O	5778
3q	O	5778
.	O	5778

Alkaptonuria	B-Disease	5779
(	O	5779
AKU	B-Disease	5779
;	O	5779
McKusick	O	5779
no	O	5779
.	O	5779

203500	O	5780
)	O	5780
is	O	5780
a	O	5780
rare	O	5780
autosomal	B-Disease	5780
recessive	I-Disease	5780
disorder	I-Disease	5780
caused	O	5780
by	O	5780
the	O	5780
lack	O	5780
of	O	5780
homogentisic	O	5780
acid	O	5780
oxidase	O	5780
activity	O	5780
.	O	5780

Ochronosis	B-Disease	5782
is	O	5782
the	O	5782
predominant	O	5782
clinical	O	5782
complication	O	5782
of	O	5782
the	O	5782
disease	O	5782
leading	O	5782
to	O	5782
ochronotic	B-Disease	5782
arthropathy	I-Disease	5782
,	O	5782
dark	O	5782
urine	O	5782
,	O	5782
pigment	O	5782
changes	O	5782
of	O	5782
the	O	5782
skin	O	5782
,	O	5782
and	O	5782
other	O	5782
clinical	O	5782
features	O	5782
.	O	5782

A	O	5783
mutation	O	5783
causing	O	5783
alkaptonuria	B-Disease	5783
in	O	5783
the	O	5783
mouse	O	5783
has	O	5783
mapped	O	5783
to	O	5783
chromosome	O	5783
16	O	5783
.	O	5783

Considering	O	5784
conserved	O	5784
synteny	O	5784
,	O	5784
we	O	5784
were	O	5784
able	O	5784
to	O	5784
map	O	5784
the	O	5784
human	O	5784
gene	O	5784
to	O	5784
chromosome	O	5784
3q	O	5784
in	O	5784
six	O	5784
alkaptonuria	B-Disease	5784
pedigrees	O	5784
of	O	5784
Slovak	O	5784
origin	O	5784
.	O	5784

An	O	5788
SGLT1	O	5788
missense	O	5788
mutation	O	5788
underlies	O	5788
hereditary	B-Disease	5788
glucose	I-Disease	5788
/	I-Disease	5788
galactose	I-Disease	5788
malabsorption	I-Disease	5788
,	O	5788
characterized	O	5788
by	O	5788
potentially	O	5788
fatal	O	5788
diarrhea	B-Disease	5788
;	O	5788
conversely	O	5788
,	O	5788
oral	O	5788
rehydration	O	5788
therapy	O	5788
exploits	O	5788
normal	O	5788
transport	O	5788
to	O	5788
alleviate	O	5788
life	O	5788
-	O	5788
threatening	O	5788
diarrhea	B-Disease	5788
of	O	5788
infectious	O	5788
origin	O	5788
.	O	5788

A	O	5793
new	O	5793
missense	O	5793
mutation	O	5793
in	O	5793
exon	O	5793
1	O	5793
causing	O	5793
glucose	B-Disease	5793
/	I-Disease	5793
galactose	I-Disease	5793
malabsorption	I-Disease	5793
is	O	5793
also	O	5793
described	O	5793
.	O	5793

These	O	5795
data	O	5795
facilitate	O	5795
the	O	5795
search	O	5795
for	O	5795
new	O	5795
glucose	B-Disease	5795
/	I-Disease	5795
galactose	I-Disease	5795
malabsorption	I-Disease	5795
-	O	5795
related	O	5795
mutations	O	5795
in	O	5795
this	O	5795
important	O	5795
gene	O	5795
and	O	5795
provide	O	5795
a	O	5795
basis	O	5795
for	O	5795
future	O	5795
evolutionary	O	5795
comparisons	O	5795
with	O	5795
other	O	5795
Na	O	5795
(	O	5795
+	O	5795
)	O	5795
-	O	5795
dependent	O	5795
cotransporters	O	5795
.	O	5795

Four	O	5797
novel	O	5797
PEPD	O	5797
alleles	O	5797
causing	O	5797
prolidase	B-Disease	5797
deficiency	I-Disease	5797
.	O	5797

Mutations	O	5798
at	O	5798
the	O	5798
PEPD	O	5798
locus	O	5798
cause	O	5798
prolidase	B-Disease	5798
deficiency	I-Disease	5798
(	O	5798
McKusick	O	5798
170100	O	5798
)	O	5798
,	O	5798
a	O	5798
rare	O	5798
autosomal	B-Disease	5798
recessive	I-Disease	5798
disorder	I-Disease	5798
characterized	O	5798
by	O	5798
iminodipeptiduria	B-Disease	5798
,	O	5798
skin	B-Disease	5798
ulcers	I-Disease	5798
,	O	5798
mental	B-Disease	5798
retardation	I-Disease	5798
,	O	5798
and	O	5798
recurrent	O	5798
infections	O	5798
.	O	5798

Our	O	5806
results	O	5806
indicate	O	5806
that	O	5806
the	O	5806
severe	O	5806
form	O	5806
of	O	5806
prolidase	B-Disease	5806
deficiency	I-Disease	5806
is	O	5806
caused	O	5806
by	O	5806
multiple	O	5806
PEPD	O	5806
alleles	O	5806
.	O	5806

Recombinations	O	5809
in	O	5809
individuals	O	5809
homozygous	O	5809
by	O	5809
descent	O	5809
localize	O	5809
the	O	5809
Friedreich	B-Disease	5809
ataxia	I-Disease	5809
locus	O	5809
in	O	5809
a	O	5809
cloned	O	5809
450	O	5809
-	O	5809
kb	O	5809
interval	O	5809
.	O	5809

The	O	5810
locus	O	5810
for	O	5810
Friedreich	B-Disease	5810
ataxia	I-Disease	5810
(	O	5810
FRDA	B-Disease	5810
)	O	5810
,	O	5810
a	O	5810
severe	O	5810
neurodegenerative	B-Disease	5810
disease	I-Disease	5810
,	O	5810
is	O	5810
tightly	O	5810
linked	O	5810
to	O	5810
markers	O	5810
D9S5	O	5810
and	O	5810
D9S15	O	5810
,	O	5810
and	O	5810
analysis	O	5810
of	O	5810
rare	O	5810
recombination	O	5810
events	O	5810
has	O	5810
suggested	O	5810
the	O	5810
order	O	5810
cen	O	5810
-	O	5810
FRDA	O	5810
-	O	5810
D9S5	O	5810
-	O	5810
D9S15	O	5810
-	O	5810
qter	O	5810
.	O	5810

In	O	5812
order	O	5812
to	O	5812
map	O	5812
these	O	5812
markers	O	5812
with	O	5812
respect	O	5812
to	O	5812
the	O	5812
FRDA	B-Disease	5812
locus	O	5812
,	O	5812
all	O	5812
within	O	5812
a	O	5812
1	O	5812
-	O	5812
cM	O	5812
confidence	O	5812
interval	O	5812
,	O	5812
we	O	5812
sought	O	5812
to	O	5812
increase	O	5812
the	O	5812
genetic	O	5812
information	O	5812
of	O	5812
available	O	5812
FRDA	B-Disease	5812
families	O	5812
by	O	5812
considering	O	5812
homozygosity	O	5812
by	O	5812
descent	O	5812
and	O	5812
association	O	5812
with	O	5812
founder	O	5812
haplotypes	O	5812
in	O	5812
isolated	O	5812
populations	O	5812
.	O	5812

This	O	5813
approach	O	5813
allowed	O	5813
us	O	5813
to	O	5813
identify	O	5813
one	O	5813
phase	O	5813
-	O	5813
known	O	5813
recombination	O	5813
and	O	5813
one	O	5813
probable	O	5813
historic	O	5813
recombination	O	5813
on	O	5813
haplotypes	O	5813
from	O	5813
Reunion	O	5813
Island	O	5813
patients	O	5813
,	O	5813
both	O	5813
of	O	5813
which	O	5813
place	O	5813
three	O	5813
of	O	5813
the	O	5813
five	O	5813
markers	O	5813
proximal	O	5813
to	O	5813
FRDA	B-Disease	5813
.	O	5813

This	O	5814
represents	O	5814
the	O	5814
first	O	5814
identification	O	5814
of	O	5814
close	O	5814
FRDA	B-Disease	5814
flanking	O	5814
markers	O	5814
on	O	5814
the	O	5814
centromeric	O	5814
side	O	5814
.	O	5814

Taken	O	5816
together	O	5816
,	O	5816
the	O	5816
results	O	5816
place	O	5816
the	O	5816
FRDA	B-Disease	5816
locus	O	5816
in	O	5816
a	O	5816
450	O	5816
-	O	5816
kb	O	5816
interval	O	5816
,	O	5816
which	O	5816
is	O	5816
small	O	5816
enough	O	5816
for	O	5816
direct	O	5816
search	O	5816
of	O	5816
candidate	O	5816
genes	O	5816
.	O	5816

Investigation	O	5819
of	O	5819
thermoregulatory	O	5819
characteristics	O	5819
in	O	5819
patients	O	5819
with	O	5819
Prader	B-Disease	5819
-	I-Disease	5819
Willi	I-Disease	5819
syndrome	I-Disease	5819
.	O	5819

A	O	5820
survey	O	5820
instrument	O	5820
is	O	5820
used	O	5820
to	O	5820
assess	O	5820
temperature	O	5820
regulation	O	5820
characteristics	O	5820
in	O	5820
children	O	5820
with	O	5820
Prader	B-Disease	5820
-	I-Disease	5820
Willi	I-Disease	5820
syndrome	I-Disease	5820
(	O	5820
PWS	B-Disease	5820
)	O	5820
compared	O	5820
to	O	5820
3	O	5820
control	O	5820
groups	O	5820
sibs	O	5820
of	O	5820
PWS	B-Disease	5820
patients	O	5820
(	O	5820
SIB	O	5820
)	O	5820
,	O	5820
neurodevelopmentally	B-Disease	5820
handicapped	I-Disease	5820
children	O	5820
(	O	5820
ND	O	5820
)	O	5820
,	O	5820
and	O	5820
age	O	5820
and	O	5820
gender	O	5820
matched	O	5820
well	O	5820
children	O	5820
(	O	5820
WC	O	5820
)	O	5820
.	O	5820

Significant	O	5821
differences	O	5821
were	O	5821
found	O	5821
between	O	5821
PWS	B-Disease	5821
patients	O	5821
,	O	5821
SIB	O	5821
controls	O	5821
,	O	5821
and	O	5821
WC	O	5821
controls	O	5821
in	O	5821
the	O	5821
prevalence	O	5821
of	O	5821
febrile	O	5821
convulsions	O	5821
,	O	5821
fever	O	5821
-	O	5821
associated	O	5821
symptoms	O	5821
,	O	5821
and	O	5821
temperature	O	5821
less	O	5821
than	O	5821
94	O	5821
degrees	O	5821
F	O	5821
.	O	5821

No	O	5822
differences	O	5822
were	O	5822
noted	O	5822
in	O	5822
any	O	5822
variable	O	5822
between	O	5822
the	O	5822
PWS	B-Disease	5822
patients	O	5822
and	O	5822
the	O	5822
ND	O	5822
controls	O	5822
,	O	5822
suggesting	O	5822
that	O	5822
these	O	5822
abnormalities	O	5822
are	O	5822
not	O	5822
unique	O	5822
to	O	5822
PWS	B-Disease	5822
,	O	5822
but	O	5822
can	O	5822
occur	O	5822
in	O	5822
any	O	5822
neurodevelopmentally	B-Disease	5822
handicapped	I-Disease	5822
individual	O	5822
,	O	5822
further	O	5822
suggesting	O	5822
these	O	5822
do	O	5822
not	O	5822
necessarily	O	5822
reflect	O	5822
syndrome	O	5822
-	O	5822
specific	O	5822
hypothalamic	B-Disease	5822
abnormalities	I-Disease	5822
.	O	5822

Phenotypic	O	5824
variation	O	5824
including	O	5824
retinitis	B-Disease	5824
pigmentosa	I-Disease	5824
,	O	5824
pattern	B-Disease	5824
dystrophy	I-Disease	5824
,	O	5824
and	O	5824
fundus	B-Disease	5824
flavimaculatus	I-Disease	5824
in	O	5824
a	O	5824
single	O	5824
family	O	5824
with	O	5824
a	O	5824
deletion	O	5824
of	O	5824
codon	O	5824
153	O	5824
or	O	5824
154	O	5824
of	O	5824
the	O	5824
peripherin	O	5824
/	O	5824
RDS	O	5824
gene	O	5824
.	O	5824

BACKGROUND	O	5825
AND	O	5825
OBJECTIVES	O	5825
Mutations	O	5825
of	O	5825
the	O	5825
peripherin	O	5825
/	O	5825
RDS	O	5825
gene	O	5825
have	O	5825
been	O	5825
reported	O	5825
in	O	5825
autosomal	B-Disease	5825
dominant	I-Disease	5825
retinitis	I-Disease	5825
pigmentosa	I-Disease	5825
,	O	5825
pattern	O	5825
macular	B-Disease	5825
dystrophy	I-Disease	5825
,	O	5825
and	O	5825
retinitis	B-Disease	5825
punctata	I-Disease	5825
albescens	I-Disease	5825
.	O	5825

RESULTS	O	5830
The	O	5830
mother	O	5830
presented	O	5830
at	O	5830
age	O	5830
63	O	5830
years	O	5830
with	O	5830
a	O	5830
profoundly	O	5830
abnormal	O	5830
electroretinogram	O	5830
(	O	5830
ERG	O	5830
)	O	5830
and	O	5830
adult	O	5830
-	O	5830
onset	O	5830
retinitis	B-Disease	5830
pigmentosa	I-Disease	5830
that	O	5830
progressed	O	5830
dramatically	O	5830
over	O	5830
12	O	5830
years	O	5830
,	O	5830
with	O	5830
marked	O	5830
loss	O	5830
of	O	5830
peripheral	O	5830
visual	O	5830
field	O	5830
.	O	5830

One	O	5831
daughter	O	5831
developed	O	5831
pattern	B-Disease	5831
macular	I-Disease	5831
dystrophy	I-Disease	5831
at	O	5831
age	O	5831
31	O	5831
years	O	5831
.	O	5831

Another	O	5833
daughter	O	5833
presented	O	5833
at	O	5833
age	O	5833
42	O	5833
years	O	5833
with	O	5833
macular	B-Disease	5833
degeneration	I-Disease	5833
and	O	5833
over	O	5833
10	O	5833
years	O	5833
developed	O	5833
the	O	5833
clinical	O	5833
picture	O	5833
of	O	5833
fundus	B-Disease	5833
flavimaculatus	I-Disease	5833
.	O	5833

The	O	5835
son	O	5835
had	O	5835
onset	O	5835
of	O	5835
macular	B-Disease	5835
degeneration	I-Disease	5835
at	O	5835
age	O	5835
44	O	5835
years	O	5835
.	O	5835

Pericentral	B-Disease	5836
scotomas	I-Disease	5836
were	O	5836
present	O	5836
and	O	5836
the	O	5836
ERG	O	5836
was	O	5836
markedly	O	5836
abnormal	O	5836
.	O	5836

In	O	5845
two	O	5845
patients	O	5845
with	O	5845
the	O	5845
autosomal	B-Disease	5845
recessive	I-Disease	5845
disease	I-Disease	5845
glucose	I-Disease	5845
/	I-Disease	5845
galactose	I-Disease	5845
malabsorption	I-Disease	5845
,	O	5845
the	O	5845
underlying	O	5845
cause	O	5845
was	O	5845
found	O	5845
to	O	5845
be	O	5845
a	O	5845
missense	O	5845
mutation	O	5845
in	O	5845
SGLT1	O	5845
,	O	5845
and	O	5845
the	O	5845
Asp28	O	5845
-	O	5845
-	O	5845
>	O	5845
Asn	O	5845
change	O	5845
was	O	5845
demonstrated	O	5845
in	O	5845
vitro	O	5845
to	O	5845
eliminate	O	5845
SGLT1	O	5845
transport	O	5845
activity	O	5845
.	O	5845

1	O	5849
,	O	5849
and	O	5849
provide	O	5849
an	O	5849
example	O	5849
of	O	5849
the	O	5849
utility	O	5849
of	O	5849
the	O	5849
SGLT1	O	5849
probe	O	5849
as	O	5849
a	O	5849
diagnostic	O	5849
for	O	5849
genetic	B-Disease	5849
diseases	I-Disease	5849
associated	O	5849
with	O	5849
translocations	O	5849
of	O	5849
chromosome	O	5849
22	O	5849
.	O	5849

Restriction	O	5850
of	O	5850
ocular	O	5850
fundus	O	5850
lesions	O	5850
to	O	5850
a	O	5850
specific	O	5850
subgroup	O	5850
of	O	5850
APC	B-Disease	5850
mutations	O	5850
in	O	5850
adenomatous	B-Disease	5850
polyposis	I-Disease	5850
coli	I-Disease	5850
patients	O	5850
.	O	5850

In	O	5851
humans	O	5851
,	O	5851
alteration	O	5851
of	O	5851
the	O	5851
tumor	B-Disease	5851
suppressor	O	5851
gene	O	5851
,	O	5851
APC	B-Disease	5851
,	O	5851
causes	O	5851
adenomatous	B-Disease	5851
polyposis	I-Disease	5851
coli	I-Disease	5851
,	O	5851
a	O	5851
condition	O	5851
causing	O	5851
predisposition	O	5851
to	O	5851
colorectal	B-Disease	5851
cancer	I-Disease	5851
.	O	5851

The	O	5852
syndrome	O	5852
inconsistently	O	5852
associates	O	5852
characteristic	O	5852
patches	O	5852
of	O	5852
congenital	B-Disease	5852
hypertrophy	I-Disease	5852
of	I-Disease	5852
the	I-Disease	5852
retinal	I-Disease	5852
pigment	I-Disease	5852
epithelium	I-Disease	5852
(	O	5852
CHRPE	B-Disease	5852
)	O	5852
.	O	5852

Ocular	O	5853
examination	O	5853
revealed	O	5853
that	O	5853
patients	O	5853
expressing	O	5853
CHRPE	B-Disease	5853
tend	O	5853
to	O	5853
cluster	O	5853
within	O	5853
specific	O	5853
families	O	5853
.	O	5853

The	O	5854
exact	O	5854
APC	B-Disease	5854
mutation	O	5854
was	O	5854
identified	O	5854
in	O	5854
42	O	5854
unrelated	O	5854
patients	O	5854
.	O	5854

The	O	5856
extent	O	5856
of	O	5856
CHRPE	B-Disease	5856
was	O	5856
found	O	5856
to	O	5856
be	O	5856
dependent	O	5856
on	O	5856
the	O	5856
position	O	5856
of	O	5856
the	O	5856
mutation	O	5856
along	O	5856
the	O	5856
coding	O	5856
sequence	O	5856
.	O	5856

CHRPE	B-Disease	5857
lesions	O	5857
are	O	5857
almost	O	5857
always	O	5857
absent	O	5857
if	O	5857
the	O	5857
mutation	O	5857
occurs	O	5857
before	O	5857
exon	O	5857
9	O	5857
,	O	5857
but	O	5857
are	O	5857
systematically	O	5857
present	O	5857
if	O	5857
it	O	5857
occurs	O	5857
after	O	5857
this	O	5857
exon	O	5857
.	O	5857

Thus	O	5858
,	O	5858
the	O	5858
range	O	5858
of	O	5858
phenotypic	O	5858
expression	O	5858
observed	O	5858
among	O	5858
affected	O	5858
patients	O	5858
may	O	5858
result	O	5858
in	O	5858
part	O	5858
from	O	5858
different	O	5858
allelic	O	5858
manifestations	O	5858
of	O	5858
APC	B-Disease	5858
mutations	O	5858
.	O	5858

The	O	5862
authors	O	5862
earlier	O	5862
findings	O	5862
of	O	5862
a	O	5862
negative	O	5862
electroretinogram	O	5862
(	O	5862
ERG	O	5862
)	O	5862
in	O	5862
a	O	5862
boy	O	5862
with	O	5862
Duchenne	B-Disease	5862
muscular	I-Disease	5862
dystrophy	I-Disease	5862
(	O	5862
DMD	B-Disease	5862
)	O	5862
led	O	5862
them	O	5862
to	O	5862
investigate	O	5862
dystrophin	O	5862
gene	O	5862
deletions	O	5862
and	O	5862
ERGs	O	5862
in	O	5862
five	O	5862
boys	O	5862
with	O	5862
DMD	B-Disease	5862
.	O	5862

The	O	5863
authors	O	5863
wanted	O	5863
to	O	5863
determined	O	5863
whether	O	5863
there	O	5863
were	O	5863
similar	O	5863
ERG	O	5863
findings	O	5863
in	O	5863
an	O	5863
animal	O	5863
model	O	5863
for	O	5863
DMD	B-Disease	5863
,	O	5863
the	O	5863
mdx	O	5863
mouse	O	5863
.	O	5863

Ganzfeld	O	5865
ERGs	O	5865
were	O	5865
recorded	O	5865
in	O	5865
five	O	5865
boys	O	5865
with	O	5865
DMD	B-Disease	5865
after	O	5865
a	O	5865
complete	O	5865
ophthalmic	O	5865
examination	O	5865
.	O	5865

The	O	5873
authors	O	5873
believe	O	5873
the	O	5873
unique	O	5873
ERG	O	5873
recorded	O	5873
for	O	5873
the	O	5873
human	O	5873
subjects	O	5873
is	O	5873
a	O	5873
manifestation	O	5873
of	O	5873
DMD	B-Disease	5873
associated	O	5873
with	O	5873
defects	O	5873
at	O	5873
the	O	5873
dystrophin	O	5873
gene	O	5873
locus	O	5873
and	O	5873
represents	O	5873
a	O	5873
new	O	5873
clinical	O	5873
entity	O	5873
.	O	5873

The	O	5875
ERG	O	5875
shows	O	5875
promise	O	5875
of	O	5875
becoming	O	5875
a	O	5875
noninvasive	O	5875
diagnostic	O	5875
tool	O	5875
for	O	5875
DMD	B-Disease	5875
and	O	5875
its	O	5875
milder	O	5875
allelic	O	5875
forms	O	5875
.	O	5875

Association	O	5877
of	O	5877
the	O	5877
APC	B-Disease	5877
tumor	I-Disease	5877
suppressor	O	5877
protein	O	5877
with	O	5877
catenins	O	5877
.	O	5877

Mutations	O	5878
of	O	5878
APC	O	5878
appear	O	5878
to	O	5878
initiate	O	5878
sporadic	O	5878
and	O	5878
inherited	O	5878
forms	O	5878
of	O	5878
human	O	5878
colorectal	B-Disease	5878
cancer	I-Disease	5878
.	O	5878

Although	O	5879
these	O	5879
mutations	O	5879
have	O	5879
been	O	5879
well	O	5879
characterized	O	5879
,	O	5879
little	O	5879
is	O	5879
known	O	5879
about	O	5879
the	O	5879
function	O	5879
of	O	5879
the	O	5879
APC	B-Disease	5879
gene	O	5879
product	O	5879
.	O	5879

Two	O	5880
cellular	O	5880
proteins	O	5880
that	O	5880
associate	O	5880
with	O	5880
APC	B-Disease	5880
were	O	5880
identified	O	5880
by	O	5880
nucleotide	O	5880
sequence	O	5880
analysis	O	5880
and	O	5880
peptide	O	5880
mapping	O	5880
as	O	5880
the	O	5880
E	O	5880
-	O	5880
cadherin	O	5880
-	O	5880
associated	O	5880
proteins	O	5880
alpha	O	5880
-	O	5880
and	O	5880
beta	O	5880
-	O	5880
catenin	O	5880
.	O	5880

These	O	5882
results	O	5882
suggest	O	5882
an	O	5882
important	O	5882
link	O	5882
between	O	5882
tumor	B-Disease	5882
initiation	O	5882
and	O	5882
cell	O	5882
adhesion	O	5882
.	O	5882

Difference	O	5884
in	O	5884
methylation	O	5884
patterns	O	5884
within	O	5884
the	O	5884
D15S9	O	5884
region	O	5884
of	O	5884
chromosome	O	5884
15q11	O	5884
-	O	5884
13	O	5884
in	O	5884
first	O	5884
cousins	O	5884
with	O	5884
Angelman	B-Disease	5884
syndrome	I-Disease	5884
and	O	5884
Prader	B-Disease	5884
-	I-Disease	5884
Willi	I-Disease	5884
syndrome	I-Disease	5884
.	O	5884

Abnormalities	O	5885
of	O	5885
chromosome	O	5885
region	O	5885
15q11	O	5885
-	O	5885
13	O	5885
are	O	5885
associated	O	5885
with	O	5885
Angelman	B-Disease	5885
syndrome	I-Disease	5885
(	O	5885
AS	B-Disease	5885
)	O	5885
and	O	5885
Prader	B-Disease	5885
-	I-Disease	5885
Willi	I-Disease	5885
syndrome	I-Disease	5885
(	O	5885
PWS	B-Disease	5885
)	O	5885
.	O	5885

Differences	O	5886
between	O	5886
the	O	5886
methylation	O	5886
patterns	O	5886
of	O	5886
the	O	5886
region	O	5886
of	O	5886
chromosome	O	5886
15q11	O	5886
-	O	5886
13	O	5886
which	O	5886
hybridizes	O	5886
to	O	5886
the	O	5886
highly	O	5886
conserved	O	5886
DNA	O	5886
,	O	5886
DN34	O	5886
,	O	5886
in	O	5886
normal	O	5886
individuals	O	5886
and	O	5886
in	O	5886
patients	O	5886
with	O	5886
AS	B-Disease	5886
and	O	5886
PWS	B-Disease	5886
have	O	5886
been	O	5886
described	O	5886
.	O	5886

We	O	5887
report	O	5887
on	O	5887
a	O	5887
family	O	5887
in	O	5887
which	O	5887
first	O	5887
cousins	O	5887
are	O	5887
affected	O	5887
by	O	5887
AS	B-Disease	5887
and	O	5887
PWS	B-Disease	5887
as	O	5887
a	O	5887
result	O	5887
of	O	5887
a	O	5887
familial	O	5887
paracentric	O	5887
inversion	O	5887
of	O	5887
15q11	O	5887
-	O	5887
q13	O	5887
.	O	5887

Haplotype	O	5890
studies	O	5890
in	O	5890
Wilson	B-Disease	5890
disease	I-Disease	5890
.	O	5890

In	O	5891
51	O	5891
families	O	5891
with	O	5891
Wilson	B-Disease	5891
disease	I-Disease	5891
,	O	5891
we	O	5891
have	O	5891
studied	O	5891
DNA	O	5891
haplotypes	O	5891
of	O	5891
dinucleotide	O	5891
repeat	O	5891
polymorphisms	O	5891
(	O	5891
CA	O	5891
repeats	O	5891
)	O	5891
in	O	5891
the	O	5891
13q14	O	5891
.	O	5891

3	O	5892
region	O	5892
,	O	5892
to	O	5892
examine	O	5892
these	O	5892
markers	O	5892
for	O	5892
association	O	5892
with	O	5892
the	O	5892
Wilson	B-Disease	5892
disease	I-Disease	5892
gene	O	5892
(	O	5892
WND	B-Disease	5892
)	O	5892
.	O	5892

In	O	5893
addition	O	5893
to	O	5893
a	O	5893
marker	O	5893
(	O	5893
D13S133	O	5893
)	O	5893
described	O	5893
elsewhere	O	5893
,	O	5893
we	O	5893
have	O	5893
developed	O	5893
three	O	5893
new	O	5893
highly	O	5893
polymorphic	O	5893
markers	O	5893
(	O	5893
D13S314	O	5893
,	O	5893
D13S315	O	5893
,	O	5893
and	O	5893
D13S316	O	5893
)	O	5893
close	O	5893
to	O	5893
the	O	5893
WND	B-Disease	5893
locus	O	5893
.	O	5893

We	O	5894
have	O	5894
examined	O	5894
the	O	5894
distribution	O	5894
of	O	5894
marker	O	5894
alleles	O	5894
at	O	5894
the	O	5894
loci	O	5894
studied	O	5894
and	O	5894
have	O	5894
found	O	5894
that	O	5894
D13S314	O	5894
,	O	5894
D13S133	O	5894
,	O	5894
and	O	5894
D13S316	O	5894
each	O	5894
show	O	5894
nonrandom	O	5894
distribution	O	5894
on	O	5894
chromosomes	O	5894
carrying	O	5894
the	O	5894
WND	B-Disease	5894
mutation	O	5894
.	O	5894

We	O	5895
have	O	5895
studied	O	5895
haplotypes	O	5895
of	O	5895
these	O	5895
three	O	5895
markers	O	5895
and	O	5895
have	O	5895
found	O	5895
that	O	5895
there	O	5895
are	O	5895
highly	O	5895
significant	O	5895
differences	O	5895
between	O	5895
WND	B-Disease	5895
and	O	5895
normal	O	5895
haplotypes	O	5895
in	O	5895
northern	O	5895
European	O	5895
families	O	5895
.	O	5895

These	O	5896
findings	O	5896
have	O	5896
important	O	5896
implications	O	5896
for	O	5896
mutation	O	5896
detection	O	5896
and	O	5896
molecular	O	5896
diagnosis	O	5896
in	O	5896
families	O	5896
with	O	5896
Wilson	B-Disease	5896
disease	I-Disease	5896
.	O	5896

We	O	5898
have	O	5898
analyzed	O	5898
a	O	5898
single	O	5898
multi	O	5898
-	O	5898
affected	O	5898
breast	B-Disease	5898
/	I-Disease	5898
ovarian	I-Disease	5898
cancer	I-Disease	5898
pedigree	O	5898
(	O	5898
BOV3	O	5898
)	O	5898
and	O	5898
have	O	5898
shown	O	5898
consistent	O	5898
inheritance	O	5898
of	O	5898
markers	O	5898
on	O	5898
chromosome	O	5898
17q	O	5898
with	O	5898
the	O	5898
disease	O	5898
confirming	O	5898
that	O	5898
this	O	5898
family	O	5898
is	O	5898
due	O	5898
to	O	5898
the	O	5898
BRCA1	O	5898
gene	O	5898
.	O	5898

Analysis	O	5899
of	O	5899
17q	O	5899
haplotypes	O	5899
shows	O	5899
a	O	5899
recombination	O	5899
event	O	5899
in	O	5899
a	O	5899
bilateral	O	5899
breast	B-Disease	5899
cancer	I-Disease	5899
case	O	5899
which	O	5899
suggests	O	5899
that	O	5899
the	O	5899
BRCA1	O	5899
gene	O	5899
lies	O	5899
distal	O	5899
to	O	5899
D17S857	O	5899
;	O	5899
D17S857	O	5899
is	O	5899
thus	O	5899
the	O	5899
new	O	5899
proximal	O	5899
boundary	O	5899
for	O	5899
the	O	5899
region	O	5899
containing	O	5899
BRCA1	O	5899
.	O	5899

All	O	5902
seven	O	5902
breast	B-Disease	5902
tumour	I-Disease	5902
/	O	5902
blood	O	5902
pairs	O	5902
examined	O	5902
from	O	5902
this	O	5902
family	O	5902
show	O	5902
loss	O	5902
of	O	5902
heterozygosity	O	5902
in	O	5902
the	O	5902
tumours	B-Disease	5902
.	O	5902

The	O	5903
allel	O	5903
retained	O	5903
in	O	5903
each	O	5903
tumour	B-Disease	5903
was	O	5903
from	O	5903
the	O	5903
disease	O	5903
-	O	5903
bearing	O	5903
chromosome	O	5903
implicating	O	5903
BRCA1	O	5903
as	O	5903
a	O	5903
tumour	B-Disease	5903
suppressor	O	5903
gene	O	5903
.	O	5903

Myotonic	B-Disease	5906
dystrophy	I-Disease	5906
kinase	O	5906
is	O	5906
a	O	5906
component	O	5906
of	O	5906
neuromuscular	O	5906
junctions	O	5906
.	O	5906

The	O	5907
clinical	O	5907
manifestation	O	5907
of	O	5907
myotonic	B-Disease	5907
dystrophy	I-Disease	5907
(	O	5907
DM	B-Disease	5907
)	O	5907
is	O	5907
correlated	O	5907
to	O	5907
the	O	5907
extent	O	5907
of	O	5907
expansion	O	5907
of	O	5907
an	O	5907
unstable	O	5907
[	O	5907
CTG	O	5907
]	O	5907
n	O	5907
DNA	O	5907
motif	O	5907
.	O	5907

Recent	O	5908
studies	O	5908
have	O	5908
demonstrated	O	5908
that	O	5908
this	O	5908
trinucleotide	O	5908
motif	O	5908
forms	O	5908
part	O	5908
of	O	5908
the	O	5908
last	O	5908
,	O	5908
3	O	5908
untranslated	O	5908
exon	O	5908
of	O	5908
a	O	5908
gene	O	5908
which	O	5908
potentially	O	5908
encodes	O	5908
multiple	O	5908
protein	O	5908
isoforms	O	5908
of	O	5908
a	O	5908
serine	O	5908
/	O	5908
threonine	O	5908
protein	O	5908
kinase	O	5908
(	O	5908
myotonic	B-Disease	5908
dystrophy	I-Disease	5908
protein	O	5908
kinase	O	5908
,	O	5908
DM	O	5908
-	O	5908
PK	O	5908
)	O	5908
.	O	5908

Immunoreactive	O	5910
DM	O	5910
-	O	5910
kinase	O	5910
protein	O	5910
of	O	5910
53	O	5910
kD	O	5910
is	O	5910
present	O	5910
at	O	5910
low	O	5910
levels	O	5910
in	O	5910
skeletal	O	5910
and	O	5910
cardiac	O	5910
muscle	O	5910
extracts	O	5910
of	O	5910
DM	B-Disease	5910
patients	O	5910
and	O	5910
normal	O	5910
controls	O	5910
.	O	5910

Strikingly	O	5913
,	O	5913
presence	O	5913
of	O	5913
the	O	5913
protein	O	5913
can	O	5913
also	O	5913
be	O	5913
demonstrated	O	5913
for	O	5913
NMJs	O	5913
of	O	5913
muscular	O	5913
tissues	O	5913
of	O	5913
adult	O	5913
and	O	5913
congenital	O	5913
cases	O	5913
of	O	5913
DM	B-Disease	5913
,	O	5913
with	O	5913
no	O	5913
gross	O	5913
changes	O	5913
in	O	5913
structural	O	5913
organisation	O	5913
.	O	5913

Our	O	5914
findings	O	5914
provide	O	5914
a	O	5914
basis	O	5914
for	O	5914
further	O	5914
characterisation	O	5914
of	O	5914
the	O	5914
role	O	5914
of	O	5914
the	O	5914
kinase	O	5914
in	O	5914
protein	O	5914
assembly	O	5914
processes	O	5914
or	O	5914
signal	O	5914
mediation	O	5914
at	O	5914
synaptic	O	5914
sites	O	5914
and	O	5914
ultimately	O	5914
for	O	5914
the	O	5914
understanding	O	5914
of	O	5914
the	O	5914
complex	O	5914
pathophysiology	O	5914
of	O	5914
DM	B-Disease	5914
.	O	5914

Markedly	O	5916
accelerated	O	5916
catabolism	O	5916
of	O	5916
apolipoprotein	O	5916
A	O	5916
-	O	5916
II	O	5916
(	O	5916
ApoA	O	5916
-	O	5916
II	O	5916
)	O	5916
and	O	5916
high	O	5916
density	O	5916
lipoproteins	O	5916
containing	O	5916
ApoA	O	5916
-	O	5916
II	O	5916
in	O	5916
classic	O	5916
lecithin	O	5916
:	O	5916
cholesterol	B-Disease	5916
acyltransferase	I-Disease	5916
deficiency	I-Disease	5916
and	O	5916
fish	B-Disease	5916
-	I-Disease	5916
eye	I-Disease	5916
disease	I-Disease	5916
.	O	5916

Classic	B-Disease	5917
(	I-Disease	5917
complete	I-Disease	5917
)	I-Disease	5917
lecithin	I-Disease	5917
cholesterol	I-Disease	5917
acyltransferase	I-Disease	5917
(	I-Disease	5917
LCAT	I-Disease	5917
)	I-Disease	5917
deficiency	I-Disease	5917
and	O	5917
Fish	B-Disease	5917
-	I-Disease	5917
eye	I-Disease	5917
disease	I-Disease	5917
(	O	5917
partial	B-Disease	5917
LCAT	I-Disease	5917
deficiency	I-Disease	5917
)	O	5917
are	O	5917
genetic	O	5917
syndromes	O	5917
associated	O	5917
with	O	5917
markedly	O	5917
decreased	O	5917
plasma	O	5917
levels	O	5917
of	O	5917
high	O	5917
density	O	5917
lipoprotein	O	5917
(	O	5917
HDL	O	5917
)	O	5917
cholesterol	O	5917
but	O	5917
not	O	5917
with	O	5917
an	O	5917
increased	O	5917
risk	O	5917
of	O	5917
atherosclerotic	B-Disease	5917
cardiovascular	I-Disease	5917
disease	I-Disease	5917
.	O	5917

We	O	5918
investigated	O	5918
the	O	5918
metabolism	O	5918
of	O	5918
the	O	5918
HDL	O	5918
apolipoproteins	O	5918
(	O	5918
apo	O	5918
)	O	5918
apoA	O	5918
-	O	5918
I	O	5918
and	O	5918
apoA	O	5918
-	O	5918
II	O	5918
in	O	5918
a	O	5918
total	O	5918
of	O	5918
five	O	5918
patients	O	5918
with	O	5918
LCAT	B-Disease	5918
deficiency	I-Disease	5918
,	O	5918
one	O	5918
with	O	5918
classic	B-Disease	5918
LCAT	I-Disease	5918
deficiency	I-Disease	5918
and	O	5918
four	O	5918
with	O	5918
Fish	B-Disease	5918
-	I-Disease	5918
eye	I-Disease	5918
disease	I-Disease	5918
.	O	5918

In	O	5932
summary	O	5932
,	O	5932
genetic	O	5932
syndromes	O	5932
of	O	5932
either	O	5932
complete	B-Disease	5932
or	I-Disease	5932
partial	I-Disease	5932
LCAT	I-Disease	5932
deficiency	I-Disease	5932
result	O	5932
in	O	5932
low	O	5932
levels	O	5932
of	O	5932
HDL	O	5932
through	O	5932
preferential	O	5932
hypercatabolism	O	5932
of	O	5932
apoA	O	5932
-	O	5932
II	O	5932
and	O	5932
HDL	O	5932
particles	O	5932
containing	O	5932
apoA	O	5932
-	O	5932
II	O	5932
.	O	5932

Because	O	5933
LpA	O	5933
-	O	5933
I	O	5933
has	O	5933
been	O	5933
proposed	O	5933
to	O	5933
be	O	5933
more	O	5933
protective	O	5933
than	O	5933
LpA	O	5933
-	O	5933
I	O	5933
A	O	5933
-	O	5933
II	O	5933
against	O	5933
atherosclerosis	B-Disease	5933
,	O	5933
this	O	5933
selective	O	5933
effect	O	5933
on	O	5933
the	O	5933
metabolism	O	5933
of	O	5933
LpA	O	5933
-	O	5933
I	O	5933
A	O	5933
-	O	5933
II	O	5933
may	O	5933
provide	O	5933
a	O	5933
potential	O	5933
explanation	O	5933
why	O	5933
patients	O	5933
with	O	5933
classic	B-Disease	5933
LCAT	I-Disease	5933
deficiency	I-Disease	5933
and	O	5933
Fish	B-Disease	5933
-	I-Disease	5933
eye	I-Disease	5933
disease	I-Disease	5933
are	O	5933
not	O	5933
at	O	5933
increased	O	5933
risk	O	5933
for	O	5933
premature	O	5933
atherosclerosis	B-Disease	5933
despite	O	5933
markedly	O	5933
decreased	O	5933
levels	O	5933
of	O	5933
HDL	O	5933
cholesterol	O	5933
and	O	5933
apoA	O	5933
-	O	5933
I	O	5933
X	B-Disease	5933
linked	I-Disease	5933
recessive	I-Disease	5933
thrombocytopenia	I-Disease	5933
.	O	5933

A	O	5934
Saudi	O	5934
Arab	O	5934
boy	O	5934
presented	O	5934
in	O	5934
early	O	5934
childhood	O	5934
with	O	5934
thrombocytopenia	B-Disease	5934
,	O	5934
morphologically	O	5934
large	O	5934
and	O	5934
normal	O	5934
sized	O	5934
platelets	O	5934
,	O	5934
increased	O	5934
mean	O	5934
platelet	O	5934
volume	O	5934
,	O	5934
and	O	5934
a	O	5934
hypermegakaryocytic	O	5934
bone	O	5934
marrow	O	5934
.	O	5934

There	O	5935
was	O	5935
no	O	5935
clinical	O	5935
and	O	5935
laboratory	O	5935
evidence	O	5935
of	O	5935
any	O	5935
significant	O	5935
immunological	B-Disease	5935
abnormalities	I-Disease	5935
.	O	5935

Similar	O	5936
findings	O	5936
in	O	5936
two	O	5936
other	O	5936
brothers	O	5936
suggested	O	5936
strongly	O	5936
that	O	5936
they	O	5936
were	O	5936
all	O	5936
suffering	O	5936
from	O	5936
an	O	5936
X	B-Disease	5936
linked	I-Disease	5936
recessive	I-Disease	5936
thrombocytopenic	I-Disease	5936
disorder	I-Disease	5936
.	O	5936

Results	O	5937
of	O	5937
DNA	O	5937
analysis	O	5937
with	O	5937
the	O	5937
probe	O	5937
M27	O	5937
beta	O	5937
are	O	5937
consistent	O	5937
with	O	5937
X	O	5937
linkage	O	5937
and	O	5937
indicate	O	5937
also	O	5937
that	O	5937
the	O	5937
locus	O	5937
of	O	5937
the	O	5937
relevant	O	5937
gene	O	5937
lies	O	5937
close	O	5937
to	O	5937
or	O	5937
is	O	5937
identical	O	5937
to	O	5937
the	O	5937
locus	O	5937
of	O	5937
the	O	5937
gene	O	5937
for	O	5937
the	O	5937
Wiskott	B-Disease	5937
-	I-Disease	5937
Aldrich	I-Disease	5937
syndrome	I-Disease	5937
(	O	5937
WAS	B-Disease	5937
)	O	5937
.	O	5937

Because	O	5938
of	O	5938
various	O	5938
features	O	5938
which	O	5938
include	O	5938
the	O	5938
presence	O	5938
of	O	5938
large	O	5938
and	O	5938
normal	O	5938
sized	O	5938
platelets	O	5938
(	O	5938
rather	O	5938
than	O	5938
small	O	5938
platelets	O	5938
)	O	5938
and	O	5938
freedom	O	5938
from	O	5938
significant	O	5938
immune	B-Disease	5938
deficiencies	I-Disease	5938
,	O	5938
it	O	5938
is	O	5938
likely	O	5938
that	O	5938
the	O	5938
X	B-Disease	5938
linked	I-Disease	5938
recessive	I-Disease	5938
thrombocytopenia	I-Disease	5938
in	O	5938
this	O	5938
family	O	5938
is	O	5938
an	O	5938
isolated	O	5938
entity	O	5938
quite	O	5938
distinct	O	5938
from	O	5938
the	O	5938
classical	O	5938
WAS	B-Disease	5938
phenotype	O	5938
.	O	5938

However	O	5939
,	O	5939
a	O	5939
modified	O	5939
expression	O	5939
of	O	5939
the	O	5939
WAS	B-Disease	5939
gene	O	5939
producing	O	5939
a	O	5939
mild	O	5939
phenotypic	O	5939
variant	O	5939
cannot	O	5939
be	O	5939
excluded	O	5939
entirely	O	5939
.	O	5939

Macular	B-Disease	5941
dystrophy	I-Disease	5941
associated	O	5941
with	O	5941
mutations	O	5941
at	O	5941
codon	O	5941
172	O	5941
in	O	5941
the	O	5941
human	O	5941
retinal	B-Disease	5941
degeneration	I-Disease	5941
slow	O	5941
gene	O	5941
.	O	5941

BACKGROUND	O	5942
Recently	O	5942
,	O	5942
mutations	O	5942
in	O	5942
the	O	5942
retinal	B-Disease	5942
degeneration	I-Disease	5942
slow	O	5942
(	O	5942
rds	O	5942
)	O	5942
gene	O	5942
which	O	5942
codes	O	5942
for	O	5942
peripherin	O	5942
-	O	5942
rds	O	5942
have	O	5942
been	O	5942
implicated	O	5942
as	O	5942
a	O	5942
cause	O	5942
of	O	5942
autosomal	B-Disease	5942
dominant	I-Disease	5942
retinitis	I-Disease	5942
pigmentosa	I-Disease	5942
.	O	5942

Mutations	O	5944
at	O	5944
codon	O	5944
172	O	5944
of	O	5944
the	O	5944
rds	O	5944
gene	O	5944
have	O	5944
been	O	5944
identified	O	5944
in	O	5944
three	O	5944
families	O	5944
with	O	5944
autosomal	O	5944
dominantly	O	5944
inherited	O	5944
,	O	5944
progressive	O	5944
macular	B-Disease	5944
dystrophy	I-Disease	5944
.	O	5944

RESULTS	O	5946
In	O	5946
all	O	5946
but	O	5946
one	O	5946
affected	O	5946
member	O	5946
,	O	5946
symptoms	O	5946
of	O	5946
progressive	O	5946
central	O	5946
visual	B-Disease	5946
loss	I-Disease	5946
developed	O	5946
in	O	5946
the	O	5946
third	O	5946
or	O	5946
fourth	O	5946
decade	O	5946
of	O	5946
life	O	5946
accompanied	O	5946
by	O	5946
central	B-Disease	5946
scotoma	I-Disease	5946
and	O	5946
well	O	5946
-	O	5946
demarcated	O	5946
atrophy	B-Disease	5946
of	I-Disease	5946
the	I-Disease	5946
retinal	I-Disease	5946
pigment	I-Disease	5946
epithelium	I-Disease	5946
and	O	5946
choriocapillaris	B-Disease	5946
of	I-Disease	5946
the	I-Disease	5946
macula	I-Disease	5946
.	O	5946

CONCLUSION	O	5952
These	O	5952
results	O	5952
indicate	O	5952
that	O	5952
mutations	O	5952
in	O	5952
the	O	5952
rds	O	5952
gene	O	5952
can	O	5952
be	O	5952
expressed	O	5952
as	O	5952
a	O	5952
macular	B-Disease	5952
dystrophy	I-Disease	5952
,	O	5952
with	O	5952
evidence	O	5952
of	O	5952
primary	O	5952
cone	B-Disease	5952
dysfunction	I-Disease	5952
and	O	5952
preservation	O	5952
of	O	5952
peripheral	O	5952
rod	O	5952
function	O	5952
.	O	5952

Anonymous	O	5954
marker	O	5954
loci	O	5954
within	O	5954
400	O	5954
kb	O	5954
of	O	5954
HLA	O	5954
-	O	5954
A	O	5954
generate	O	5954
haplotypes	O	5954
in	O	5954
linkage	O	5954
disequilibrium	O	5954
with	O	5954
the	O	5954
hemochromatosis	B-Disease	5954
gene	O	5954
(	O	5954
HFE	O	5954
)	O	5954
The	O	5954
hemochromatosis	B-Disease	5954
gene	O	5954
(	O	5954
HFE	O	5954
)	O	5954
maps	O	5954
to	O	5954
6p21	O	5954
.	O	5954

The	O	5956
unambiguous	O	5956
identification	O	5956
of	O	5956
a	O	5956
crossover	O	5956
event	O	5956
within	O	5956
hemochromatosis	B-Disease	5956
families	O	5956
is	O	5956
very	O	5956
difficult	O	5956
;	O	5956
it	O	5956
is	O	5956
particularly	O	5956
hampered	O	5956
by	O	5956
the	O	5956
variability	O	5956
of	O	5956
the	O	5956
phenotypic	O	5956
expression	O	5956
as	O	5956
well	O	5956
as	O	5956
by	O	5956
the	O	5956
sex	O	5956
-	O	5956
and	O	5956
age	O	5956
-	O	5956
related	O	5956
penetrance	O	5956
of	O	5956
the	O	5956
disease	O	5956
.	O	5956

In	O	5959
the	O	5959
present	O	5959
report	O	5959
,	O	5959
66	O	5959
hemochromatosis	B-Disease	5959
families	O	5959
yielding	O	5959
151	O	5959
hemochromatosis	B-Disease	5959
chromosomes	O	5959
and	O	5959
182	O	5959
normal	O	5959
chromosomes	O	5959
were	O	5959
RFLP	O	5959
-	O	5959
typed	O	5959
with	O	5959
a	O	5959
battery	O	5959
of	O	5959
probes	O	5959
,	O	5959
including	O	5959
two	O	5959
newly	O	5959
derived	O	5959
polymorphic	O	5959
markers	O	5959
from	O	5959
the	O	5959
6	O	5959
.	O	5959

Additionally	O	5968
,	O	5968
hemochromatosis	B-Disease	5968
haplotypes	O	5968
possessing	O	5968
HLA	O	5968
-	O	5968
A11	O	5968
and	O	5968
the	O	5968
low	O	5968
-	O	5968
frequency	O	5968
HLA	O	5968
-	O	5968
F	O	5968
polymorphism	O	5968
(	O	5968
allele	O	5968
2	O	5968
)	O	5968
are	O	5968
supportive	O	5968
of	O	5968
a	O	5968
separate	O	5968
founder	O	5968
chromosome	O	5968
containing	O	5968
a	O	5968
second	O	5968
,	O	5968
independently	O	5968
arising	O	5968
mutant	O	5968
allele	O	5968
.	O	5968

hemochromatosis	B-Disease	5970
critical	O	5970
region	O	5970
centromeric	O	5971
boundary	O	5971
and	O	5971
the	O	5971
identification	O	5971
of	O	5971
a	O	5971
linkage	O	5971
-	O	5971
disequilibrium	O	5971
zone	O	5971
both	O	5971
significantly	O	5971
contribute	O	5971
to	O	5971
a	O	5971
reduction	O	5971
in	O	5971
the	O	5971
amount	O	5971
of	O	5971
DNA	O	5971
required	O	5971
to	O	5971
be	O	5971
searched	O	5971
for	O	5971
novel	O	5971
coding	O	5971
sequences	O	5971
constituting	O	5971
the	O	5971
HFE	B-Disease	5971
defect	I-Disease	5971
Genomic	O	5971
structure	O	5971
of	O	5971
the	O	5971
EWS	O	5971
gene	O	5971
and	O	5971
its	O	5971
relationship	O	5971
to	O	5971
EWSR1	O	5971
,	O	5971
a	O	5971
site	O	5971
of	O	5971
tumor	B-Disease	5971
-	O	5971
associated	O	5971
chromosome	O	5971
translocation	O	5971
.	O	5971

The	O	5972
EWS	O	5972
gene	O	5972
has	O	5972
been	O	5972
identified	O	5972
based	O	5972
on	O	5972
its	O	5972
location	O	5972
at	O	5972
the	O	5972
chromosome	O	5972
22	O	5972
breakpoint	O	5972
of	O	5972
the	O	5972
t	O	5972
(	O	5972
11	O	5972
;	O	5972
22	O	5972
)	O	5972
(	O	5972
q24	O	5972
;	O	5972
q12	O	5972
)	O	5972
translocation	O	5972
that	O	5972
characterizes	O	5972
Ewing	B-Disease	5972
sarcoma	I-Disease	5972
and	O	5972
related	O	5972
neuroectodermal	B-Disease	5972
tumors	I-Disease	5972
.	O	5972

Positions	O	5979
of	O	5979
the	O	5979
chromosome	O	5979
22	O	5979
breakpoints	O	5979
were	O	5979
determined	O	5979
for	O	5979
19	O	5979
Ewing	B-Disease	5979
tumors	I-Disease	5979
.	O	5979

Norrie	B-Disease	5982
disease	I-Disease	5982
gene	O	5982
:	O	5982
characterization	O	5982
of	O	5982
deletions	O	5982
and	O	5982
possible	O	5982
function	O	5982
.	O	5982

Positional	O	5983
cloning	O	5983
experiments	O	5983
have	O	5983
resulted	O	5983
recently	O	5983
in	O	5983
the	O	5983
isolation	O	5983
of	O	5983
a	O	5983
candidate	O	5983
gene	O	5983
for	O	5983
Norrie	B-Disease	5983
disease	I-Disease	5983
(	O	5983
pseudoglioma	B-Disease	5983
;	O	5983
NDP	B-Disease	5983
)	O	5983
,	O	5983
a	O	5983
severe	O	5983
X	B-Disease	5983
-	I-Disease	5983
linked	I-Disease	5983
neurodevelopmental	I-Disease	5983
disorder	I-Disease	5983
.	O	5983

Here	O	5984
we	O	5984
report	O	5984
the	O	5984
isolation	O	5984
and	O	5984
analysis	O	5984
of	O	5984
human	O	5984
genomic	O	5984
DNA	O	5984
clones	O	5984
encompassing	O	5984
the	O	5984
NDP	B-Disease	5984
gene	O	5984
.	O	5984

Detailed	O	5986
analysis	O	5986
of	O	5986
genomic	O	5986
deletions	O	5986
in	O	5986
Norrie	B-Disease	5986
patients	O	5986
shows	O	5986
that	O	5986
they	O	5986
are	O	5986
heterogeneous	O	5986
,	O	5986
both	O	5986
in	O	5986
size	O	5986
and	O	5986
in	O	5986
position	O	5986
.	O	5986

By	O	5987
PCR	O	5987
analysis	O	5987
,	O	5987
we	O	5987
found	O	5987
that	O	5987
expression	O	5987
of	O	5987
the	O	5987
NDP	B-Disease	5987
gene	O	5987
was	O	5987
not	O	5987
confined	O	5987
to	O	5987
the	O	5987
eye	O	5987
or	O	5987
to	O	5987
the	O	5987
brain	O	5987
.	O	5987

An	O	5988
extensive	O	5988
DNA	O	5988
and	O	5988
protein	O	5988
sequence	O	5988
comparison	O	5988
between	O	5988
the	O	5988
human	O	5988
NDP	B-Disease	5988
gene	O	5988
and	O	5988
related	O	5988
genes	O	5988
from	O	5988
the	O	5988
database	O	5988
revealed	O	5988
homology	O	5988
with	O	5988
cysteine	O	5988
-	O	5988
rich	O	5988
protein	O	5988
-	O	5988
binding	O	5988
domains	O	5988
of	O	5988
immediate	O	5988
-	O	5988
-	O	5988
early	O	5988
genes	O	5988
implicated	O	5988
in	O	5988
the	O	5988
regulation	O	5988
of	O	5988
cell	O	5988
proliferation	O	5988
.	O	5988

The	O	5991
normal	O	5991
Huntington	B-Disease	5991
disease	I-Disease	5991
(	O	5991
HD	B-Disease	5991
)	O	5991
allele	O	5991
,	O	5991
or	O	5991
a	O	5991
closely	O	5991
linked	O	5991
gene	O	5991
,	O	5991
influences	O	5991
age	O	5991
at	O	5991
onset	O	5991
of	O	5991
HD	B-Disease	5991
.	O	5991

We	O	5992
evaluated	O	5992
the	O	5992
hypothesis	O	5992
that	O	5992
Huntington	B-Disease	5992
disease	I-Disease	5992
(	O	5992
HD	B-Disease	5992
)	O	5992
is	O	5992
influenced	O	5992
by	O	5992
the	O	5992
normal	O	5992
HD	B-Disease	5992
allele	O	5992
by	O	5992
comparing	O	5992
transmission	O	5992
patterns	O	5992
of	O	5992
genetically	O	5992
linked	O	5992
markers	O	5992
at	O	5992
the	O	5992
D4S10	O	5992
locus	O	5992
in	O	5992
the	O	5992
normal	O	5992
parent	O	5992
against	O	5992
age	O	5992
at	O	5992
onset	O	5992
in	O	5992
the	O	5992
affected	O	5992
offspring	O	5992
.	O	5992

These	O	5995
findings	O	5995
suggest	O	5995
that	O	5995
the	O	5995
expression	O	5995
of	O	5995
HD	B-Disease	5995
is	O	5995
modulated	O	5995
by	O	5995
the	O	5995
normal	O	5995
HD	B-Disease	5995
allele	O	5995
or	O	5995
by	O	5995
a	O	5995
closely	O	5995
linked	O	5995
locus	O	5995
.	O	5995

Further	O	5997
investigation	O	5997
of	O	5997
the	O	5997
HEXA	O	5997
gene	O	5997
intron	O	5997
9	O	5997
donor	O	5997
splice	O	5997
site	O	5997
mutation	O	5997
frequently	O	5997
found	O	5997
in	O	5997
non	O	5997
-	O	5997
Jewish	O	5997
Tay	B-Disease	5997
-	I-Disease	5997
Sachs	I-Disease	5997
disease	I-Disease	5997
patients	O	5997
from	O	5997
the	O	5997
British	O	5997
Isles	O	5997
.	O	5997

In	O	5998
a	O	5998
previous	O	5998
study	O	5998
we	O	5998
found	O	5998
that	O	5998
a	O	5998
Tay	B-Disease	5998
-	I-Disease	5998
Sachs	I-Disease	5998
disease	I-Disease	5998
(	O	5998
TSD	B-Disease	5998
)	O	5998
causing	O	5998
mutation	O	5998
in	O	5998
the	O	5998
intron	O	5998
9	O	5998
donor	O	5998
splice	O	5998
site	O	5998
of	O	5998
the	O	5998
HEXA	O	5998
gene	O	5998
occurs	O	5998
at	O	5998
high	O	5998
frequency	O	5998
in	O	5998
non	O	5998
-	O	5998
Jewish	O	5998
patients	O	5998
and	O	5998
carriers	O	5998
from	O	5998
the	O	5998
British	O	5998
Isles	O	5998
.	O	5998

We	O	6000
have	O	6000
now	O	6000
tested	O	6000
,	O	6000
in	O	6000
a	O	6000
blind	O	6000
study	O	6000
,	O	6000
26	O	6000
American	O	6000
TSD	B-Disease	6000
carriers	O	6000
and	O	6000
28	O	6000
non	O	6000
-	O	6000
carriers	O	6000
who	O	6000
have	O	6000
British	O	6000
ancestry	O	6000
for	O	6000
the	O	6000
intron	O	6000
9	O	6000
splice	O	6000
site	O	6000
mutation	O	6000
.	O	6000

All	O	6002
six	O	6002
had	O	6002
Irish	O	6002
ancestry	O	6002
,	O	6002
compared	O	6002
with	O	6002
nine	O	6002
of	O	6002
the	O	6002
20	O	6002
other	O	6002
(	O	6002
intron	O	6002
9	O	6002
mutation	O	6002
negative	O	6002
)	O	6002
TSD	B-Disease	6002
carriers	O	6002
(	O	6002
p	O	6002
<	O	6002
0	O	6002
.	O	6002

These	O	6004
results	O	6004
confirm	O	6004
the	O	6004
previously	O	6004
found	O	6004
high	O	6004
frequency	O	6004
of	O	6004
the	O	6004
intron	O	6004
9	O	6004
mutation	O	6004
in	O	6004
non	O	6004
-	O	6004
Jewish	O	6004
TSD	B-Disease	6004
families	O	6004
of	O	6004
British	O	6004
Isles	O	6004
,	O	6004
particularly	O	6004
Irish	O	6004
,	O	6004
origin	O	6004
,	O	6004
and	O	6004
reinforce	O	6004
the	O	6004
need	O	6004
to	O	6004
screen	O	6004
such	O	6004
families	O	6004
for	O	6004
this	O	6004
mutation	O	6004
.	O	6004

Molecular	O	6005
mechanisms	O	6005
of	O	6005
oncogenic	O	6005
mutations	O	6005
in	O	6005
tumors	B-Disease	6005
from	O	6005
patients	O	6005
with	O	6005
bilateral	B-Disease	6005
and	I-Disease	6005
unilateral	I-Disease	6005
retinoblastoma	I-Disease	6005
.	O	6005

The	O	6006
RB1	O	6006
gene	O	6006
from	O	6006
12	O	6006
human	O	6006
retinoblastoma	B-Disease	6006
tumors	I-Disease	6006
has	O	6006
been	O	6006
analyzed	O	6006
exon	O	6006
-	O	6006
by	O	6006
-	O	6006
exon	O	6006
with	O	6006
the	O	6006
single	O	6006
-	O	6006
strand	O	6006
conformation	O	6006
polymorphism	O	6006
technique	O	6006
.	O	6006

Mutations	O	6007
were	O	6007
found	O	6007
in	O	6007
all	O	6007
tumors	B-Disease	6007
,	O	6007
and	O	6007
one	O	6007
-	O	6007
third	O	6007
of	O	6007
the	O	6007
tumors	B-Disease	6007
had	O	6007
independent	O	6007
mutations	O	6007
in	O	6007
both	O	6007
alleles	O	6007
neither	O	6007
of	O	6007
which	O	6007
were	O	6007
found	O	6007
in	O	6007
the	O	6007
germ	O	6007
line	O	6007
,	O	6007
confirming	O	6007
their	O	6007
true	O	6007
sporadic	O	6007
nature	O	6007
.	O	6007

In	O	6008
the	O	6008
remaining	O	6008
two	O	6008
-	O	6008
thirds	O	6008
of	O	6008
the	O	6008
tumors	B-Disease	6008
only	O	6008
one	O	6008
mutation	O	6008
was	O	6008
found	O	6008
,	O	6008
consistent	O	6008
with	O	6008
the	O	6008
loss	O	6008
-	O	6008
of	O	6008
-	O	6008
heterozygosity	O	6008
theory	O	6008
of	O	6008
tumorigenesis	O	6008
.	O	6008

PAX6	O	6015
mutations	O	6015
in	O	6015
aniridia	B-Disease	6015
.	O	6015

Aniridia	B-Disease	6016
is	O	6016
a	O	6016
congenital	B-Disease	6016
malformation	I-Disease	6016
of	I-Disease	6016
the	I-Disease	6016
eye	I-Disease	6016
,	O	6016
chiefly	O	6016
characterised	O	6016
by	O	6016
iris	B-Disease	6016
hypoplasia	I-Disease	6016
,	O	6016
which	O	6016
can	O	6016
cause	O	6016
blindness	B-Disease	6016
.	O	6016

The	O	6017
PAX6	O	6017
gene	O	6017
was	O	6017
isolated	O	6017
as	O	6017
a	O	6017
candidate	O	6017
aniridia	B-Disease	6017
gene	O	6017
by	O	6017
positional	O	6017
cloning	O	6017
from	O	6017
the	O	6017
smallest	O	6017
region	O	6017
of	O	6017
overlap	O	6017
of	O	6017
aniridia	B-Disease	6017
-	O	6017
associated	O	6017
deletions	O	6017
.	O	6017

Subsequently	O	6018
PAX6	O	6018
intragenic	O	6018
mutations	O	6018
were	O	6018
demonstrated	O	6018
in	O	6018
Smalleye	O	6018
,	O	6018
a	O	6018
mouse	O	6018
mutant	O	6018
which	O	6018
is	O	6018
an	O	6018
animal	O	6018
model	O	6018
for	O	6018
aniridia	B-Disease	6018
,	O	6018
and	O	6018
six	O	6018
human	O	6018
aniridia	B-Disease	6018
patients	O	6018
.	O	6018

In	O	6019
this	O	6019
paper	O	6019
we	O	6019
describe	O	6019
four	O	6019
additional	O	6019
PAX6	O	6019
point	O	6019
mutations	O	6019
in	O	6019
aniridia	B-Disease	6019
patients	O	6019
,	O	6019
both	O	6019
sporadic	O	6019
and	O	6019
familial	O	6019
.	O	6019

In	O	6021
addition	O	6021
,	O	6021
the	O	6021
frequency	O	6021
at	O	6021
which	O	6021
we	O	6021
have	O	6021
found	O	6021
PAX6	O	6021
mutations	O	6021
suggests	O	6021
that	O	6021
lesions	O	6021
in	O	6021
PAX6	O	6021
will	O	6021
account	O	6021
for	O	6021
most	O	6021
cases	O	6021
of	O	6021
aniridia	B-Disease	6021
.	O	6021

Autosomal	B-Disease	6024
dominant	I-Disease	6024
neurohypophyseal	I-Disease	6024
diabetes	I-Disease	6024
insipidus	I-Disease	6024
is	O	6024
a	O	6024
familial	O	6024
form	O	6024
of	O	6024
diabetes	B-Disease	6024
insipidus	I-Disease	6024
.	O	6024

This	O	6025
disorder	O	6025
is	O	6025
associated	O	6025
with	O	6025
variable	O	6025
levels	O	6025
of	O	6025
arginine	O	6025
vasopressin	O	6025
(	O	6025
AVP	O	6025
)	O	6025
and	O	6025
diabetes	B-Disease	6025
insipidus	I-Disease	6025
of	O	6025
varying	O	6025
severity	O	6025
,	O	6025
which	O	6025
responds	O	6025
to	O	6025
exogenous	O	6025
AVP	O	6025
.	O	6025

To	O	6026
determine	O	6026
the	O	6026
molecular	O	6026
basis	O	6026
of	O	6026
autosomal	B-Disease	6026
dominant	I-Disease	6026
neurohypophyseal	I-Disease	6026
diabetes	I-Disease	6026
insipidus	I-Disease	6026
,	O	6026
the	O	6026
AVP	O	6026
genes	O	6026
of	O	6026
members	O	6026
of	O	6026
a	O	6026
large	O	6026
kindred	O	6026
were	O	6026
analyzed	O	6026
.	O	6026

Germinal	O	6030
mosaicism	O	6030
in	O	6030
a	O	6030
Duchenne	B-Disease	6030
muscular	I-Disease	6030
dystrophy	I-Disease	6030
family	O	6030
:	O	6030
implications	O	6030
for	O	6030
genetic	O	6030
counselling	O	6030
.	O	6030

In	O	6031
this	O	6031
study	O	6031
we	O	6031
describe	O	6031
a	O	6031
three	O	6031
-	O	6031
generation	O	6031
family	O	6031
in	O	6031
which	O	6031
two	O	6031
siblings	O	6031
were	O	6031
affected	O	6031
by	O	6031
Duchenne	B-Disease	6031
muscular	I-Disease	6031
dystrophy	I-Disease	6031
(	O	6031
DMD	B-Disease	6031
)	O	6031
.	O	6031

Immunohistochemical	O	6032
analysis	O	6032
of	O	6032
muscle	O	6032
dystrophin	O	6032
and	O	6032
haplotype	O	6032
analysis	O	6032
of	O	6032
the	O	6032
DMD	B-Disease	6032
locus	O	6032
revealed	O	6032
that	O	6032
the	O	6032
X	O	6032
chromosome	O	6032
carrying	O	6032
the	O	6032
DMD	B-Disease	6032
gene	O	6032
was	O	6032
transmitted	O	6032
from	O	6032
the	O	6032
healthy	O	6032
maternal	O	6032
grandfather	O	6032
to	O	6032
his	O	6032
three	O	6032
daughters	O	6032
,	O	6032
including	O	6032
the	O	6032
probands	O	6032
mother	O	6032
.	O	6032

These	O	6033
findings	O	6033
indicate	O	6033
that	O	6033
the	O	6033
grandfather	O	6033
was	O	6033
a	O	6033
germinal	O	6033
mosaic	O	6033
for	O	6033
the	O	6033
DMD	B-Disease	6033
gene	O	6033
.	O	6033

Genetic	O	6037
mapping	O	6037
of	O	6037
the	O	6037
breast	B-Disease	6037
-	I-Disease	6037
ovarian	I-Disease	6037
cancer	I-Disease	6037
syndrome	I-Disease	6037
to	O	6037
a	O	6037
small	O	6037
interval	O	6037
on	O	6037
chromosome	O	6037
17q12	O	6037
-	O	6037
21	O	6037
:	O	6037
exclusion	O	6037
of	O	6037
candidate	O	6037
genes	O	6037
EDH17B2	O	6037
and	O	6037
RARA	O	6037
.	O	6037

A	O	6038
susceptibility	O	6038
gene	O	6038
for	O	6038
hereditary	B-Disease	6038
breast	I-Disease	6038
-	I-Disease	6038
ovarian	I-Disease	6038
cancer	I-Disease	6038
,	O	6038
BRCA1	O	6038
,	O	6038
has	O	6038
been	O	6038
assigned	O	6038
by	O	6038
linkage	O	6038
analysis	O	6038
to	O	6038
chromosome	O	6038
17q21	O	6038
.	O	6038

We	O	6040
have	O	6040
typed	O	6040
22	O	6040
breast	B-Disease	6040
and	I-Disease	6040
breast	I-Disease	6040
-	I-Disease	6040
ovarian	I-Disease	6040
cancer	I-Disease	6040
families	O	6040
with	O	6040
eight	O	6040
polymorphisms	O	6040
from	O	6040
the	O	6040
chromosome	O	6040
17q12	O	6040
-	O	6040
21	O	6040
region	O	6040
,	O	6040
including	O	6040
two	O	6040
in	O	6040
the	O	6040
EDH17B2	O	6040
gene	O	6040
.	O	6040

Genetic	O	6041
recombination	O	6041
with	O	6041
the	O	6041
breast	B-Disease	6041
cancer	I-Disease	6041
trait	O	6041
excludes	O	6041
RARA	O	6041
from	O	6041
further	O	6041
consideration	O	6041
as	O	6041
a	O	6041
candidate	O	6041
gene	O	6041
for	O	6041
BRCA1	O	6041
.	O	6041

Mutations	O	6044
in	O	6044
the	O	6044
EDH17B2	O	6044
gene	O	6044
,	O	6044
therefore	O	6044
do	O	6044
not	O	6044
appear	O	6044
to	O	6044
be	O	6044
responsible	O	6044
for	O	6044
the	O	6044
hereditary	B-Disease	6044
breast	I-Disease	6044
-	I-Disease	6044
ovarian	I-Disease	6044
cancer	I-Disease	6044
syndrome	I-Disease	6044
.	O	6044

Plasma	O	6048
HDL	O	6048
are	O	6048
a	O	6048
negative	O	6048
risk	O	6048
factor	O	6048
for	O	6048
atherosclerosis	B-Disease	6048
.	O	6048

Subjects	O	6050
with	O	6050
homozygous	O	6050
CETP	B-Disease	6050
deficiency	I-Disease	6050
caused	O	6050
by	O	6050
a	O	6050
gene	O	6050
splicing	O	6050
defect	O	6050
have	O	6050
markedly	O	6050
elevated	O	6050
HDL	O	6050
;	O	6050
however	O	6050
,	O	6050
heterozygotes	O	6050
have	O	6050
only	O	6050
mild	O	6050
increases	O	6050
in	O	6050
HDL	O	6050
.	O	6050

Familial	B-Disease	6057
Mediterranean	I-Disease	6057
fever	I-Disease	6057
in	O	6057
the	O	6057
colchicine	O	6057
era	O	6057
:	O	6057
the	O	6057
fate	O	6057
of	O	6057
one	O	6057
family	O	6057
.	O	6057

In	O	6058
order	O	6058
to	O	6058
demonstrate	O	6058
the	O	6058
effect	O	6058
of	O	6058
prophylactic	O	6058
colchicine	O	6058
treatment	O	6058
on	O	6058
the	O	6058
natural	O	6058
history	O	6058
of	O	6058
familial	B-Disease	6058
Mediterranean	I-Disease	6058
fever	I-Disease	6058
(	O	6058
FMF	B-Disease	6058
)	O	6058
,	O	6058
a	O	6058
family	O	6058
is	O	6058
presented	O	6058
with	O	6058
6	O	6058
out	O	6058
of	O	6058
9	O	6058
siblings	O	6058
affected	O	6058
by	O	6058
FMF	B-Disease	6058
.	O	6058

Each	O	6059
patient	O	6059
represents	O	6059
a	O	6059
different	O	6059
stage	O	6059
of	O	6059
the	O	6059
amyloidotic	B-Disease	6059
kidney	I-Disease	6059
disease	I-Disease	6059
of	O	6059
FMF	B-Disease	6059
and	O	6059
the	O	6059
effect	O	6059
of	O	6059
continuous	O	6059
colchicine	O	6059
treatment	O	6059
on	O	6059
its	O	6059
course	O	6059
.	O	6059

Detection	O	6062
of	O	6062
a	O	6062
new	O	6062
submicroscopic	O	6062
Norrie	B-Disease	6062
disease	I-Disease	6062
deletion	O	6062
interval	O	6062
with	O	6062
a	O	6062
novel	O	6062
DNA	O	6062
probe	O	6062
isolated	O	6062
by	O	6062
differential	O	6062
Alu	O	6062
PCR	O	6062
fingerprint	O	6062
cloning	O	6062
.	O	6062

This	O	6066
novel	O	6066
sequence	O	6066
,	O	6066
cpXr318	O	6066
(	O	6066
DXS742	O	6066
)	O	6066
,	O	6066
detects	O	6066
a	O	6066
new	O	6066
submicroscopic	O	6066
deletion	O	6066
interval	O	6066
at	O	6066
the	O	6066
Norrie	B-Disease	6066
disease	I-Disease	6066
locus	O	6066
(	O	6066
NDP	O	6066
)	O	6066
.	O	6066

Finally	O	6069
,	O	6069
DXS742	O	6069
,	O	6069
DSX7	O	6069
,	O	6069
DXS77	O	6069
,	O	6069
and	O	6069
MAOA	O	6069
were	O	6069
integrated	O	6069
into	O	6069
a	O	6069
physical	O	6069
map	O	6069
spanning	O	6069
the	O	6069
Norrie	B-Disease	6069
disease	I-Disease	6069
locus	O	6069
Putative	O	6069
X	B-Disease	6069
-	I-Disease	6069
linked	I-Disease	6069
adrenoleukodystrophy	I-Disease	6069
gene	O	6069
shares	O	6069
unexpected	O	6069
homology	O	6069
with	O	6069
ABC	O	6069
transporters	O	6069
.	O	6069

Adrenoleukodystrophy	B-Disease	6070
(	O	6070
ALD	B-Disease	6070
)	O	6070
is	O	6070
an	O	6070
X	B-Disease	6070
-	I-Disease	6070
linked	I-Disease	6070
disease	I-Disease	6070
affecting	O	6070
1	O	6070
/	O	6070
20	O	6070
,	O	6070
000	O	6070
males	O	6070
either	O	6070
as	O	6070
cerebral	B-Disease	6070
ALD	I-Disease	6070
in	O	6070
childhood	O	6070
or	O	6070
as	O	6070
adrenomyeloneuropathy	B-Disease	6070
(	O	6070
AMN	B-Disease	6070
)	O	6070
in	O	6070
adults	O	6070
.	O	6070

Childhood	O	6071
ALD	B-Disease	6071
is	O	6071
the	O	6071
more	O	6071
severe	O	6071
form	O	6071
,	O	6071
with	O	6071
onset	O	6071
of	O	6071
neurological	O	6071
symptoms	O	6071
between	O	6071
5	O	6071
-	O	6071
12	O	6071
years	O	6071
of	O	6071
age	O	6071
.	O	6071

Central	B-Disease	6072
nervous	I-Disease	6072
system	I-Disease	6072
demyelination	I-Disease	6072
progresses	O	6072
rapidly	O	6072
and	O	6072
death	O	6072
occurs	O	6072
within	O	6072
a	O	6072
few	O	6072
years	O	6072
.	O	6072

AMN	B-Disease	6073
is	O	6073
a	O	6073
milder	O	6073
form	O	6073
of	O	6073
the	O	6073
disease	O	6073
with	O	6073
onset	O	6073
at	O	6073
15	O	6073
-	O	6073
30	O	6073
years	O	6073
of	O	6073
age	O	6073
and	O	6073
a	O	6073
more	O	6073
progressive	O	6073
course	O	6073
.	O	6073

Adrenal	B-Disease	6074
insufficiency	I-Disease	6074
(	O	6074
Addisons	B-Disease	6074
disease	I-Disease	6074
)	O	6074
may	O	6074
remain	O	6074
the	O	6074
only	O	6074
clinical	O	6074
manifestation	O	6074
of	O	6074
ALD	B-Disease	6074
.	O	6074

The	O	6075
principal	O	6075
biochemical	O	6075
abnormality	O	6075
of	O	6075
ALD	B-Disease	6075
is	O	6075
the	O	6075
accumulation	O	6075
of	O	6075
very	O	6075
-	O	6075
long	O	6075
-	O	6075
chain	O	6075
fatty	O	6075
acids	O	6075
(	O	6075
VLCFA	O	6075
)	O	6075
because	O	6075
of	O	6075
impaired	O	6075
beta	O	6075
-	O	6075
oxidation	O	6075
in	O	6075
peroxisomes	O	6075
.	O	6075

The	O	6076
normal	O	6076
oxidation	O	6076
of	O	6076
VLCFA	O	6076
-	O	6076
CoA	O	6076
in	O	6076
patients	O	6076
fibroblasts	O	6076
suggested	O	6076
that	O	6076
the	O	6076
gene	O	6076
coding	O	6076
for	O	6076
the	O	6076
VLCFA	O	6076
-	O	6076
CoA	O	6076
synthetase	O	6076
could	O	6076
be	O	6076
a	O	6076
candidate	O	6076
gene	O	6076
for	O	6076
ALD	B-Disease	6076
.	O	6076

Here	O	6077
we	O	6077
use	O	6077
positional	O	6077
cloning	O	6077
to	O	6077
identify	O	6077
a	O	6077
gene	O	6077
partially	O	6077
deleted	O	6077
in	O	6077
6	O	6077
of	O	6077
85	O	6077
independent	O	6077
patients	O	6077
with	O	6077
ALD	B-Disease	6077
.	O	6077

An	O	6079
identical	O	6079
deletion	O	6079
was	O	6079
detected	O	6079
in	O	6079
two	O	6079
brothers	O	6079
presenting	O	6079
with	O	6079
different	O	6079
clinical	O	6079
ALD	B-Disease	6079
phenotypes	O	6079
.	O	6079

Targeted	O	6083
modification	O	6083
of	O	6083
the	O	6083
apolipoprotein	O	6083
B	O	6083
gene	O	6083
results	O	6083
in	O	6083
hypobetalipoproteinemia	B-Disease	6083
and	O	6083
developmental	B-Disease	6083
abnormalities	I-Disease	6083
in	O	6083
mice	O	6083
.	O	6083

Familial	B-Disease	6084
hypobetalipoproteinemia	I-Disease	6084
is	O	6084
an	O	6084
autosomal	B-Disease	6084
codominant	I-Disease	6084
disorder	I-Disease	6084
resulting	O	6084
in	O	6084
a	O	6084
dramatic	O	6084
reduction	O	6084
in	O	6084
plasma	O	6084
concentrations	O	6084
of	O	6084
apolipoprotein	O	6084
(	O	6084
apo	O	6084
)	O	6084
B	O	6084
,	O	6084
cholesterol	O	6084
,	O	6084
and	O	6084
beta	O	6084
-	O	6084
migrating	O	6084
lipoproteins	O	6084
.	O	6084

A	O	6085
benefit	O	6085
of	O	6085
hypobetalipoproteinemia	B-Disease	6085
is	O	6085
that	O	6085
mildly	O	6085
affected	O	6085
individuals	O	6085
may	O	6085
be	O	6085
protected	O	6085
from	O	6085
coronary	B-Disease	6085
vascular	I-Disease	6085
disease	I-Disease	6085
.	O	6085

Mice	O	6087
containing	O	6087
this	O	6087
allele	O	6087
display	O	6087
all	O	6087
of	O	6087
the	O	6087
hallmarks	O	6087
of	O	6087
human	O	6087
hypobetalipoproteinemia	B-Disease	6087
they	O	6087
produce	O	6087
a	O	6087
truncated	O	6087
apoB	O	6087
protein	O	6087
,	O	6087
apoB70	O	6087
,	O	6087
and	O	6087
have	O	6087
markedly	O	6087
decreased	O	6087
plasma	O	6087
concentrations	O	6087
of	O	6087
apoB	O	6087
,	O	6087
beta	O	6087
-	O	6087
lipoproteins	O	6087
,	O	6087
and	O	6087
total	O	6087
cholesterol	O	6087
.	O	6087

In	O	6088
addition	O	6088
,	O	6088
the	O	6088
mice	O	6088
manifest	O	6088
several	O	6088
characteristics	O	6088
that	O	6088
are	O	6088
occasionally	O	6088
observed	O	6088
in	O	6088
human	O	6088
hypobetalipoproteinemia	B-Disease	6088
,	O	6088
including	O	6088
reduced	O	6088
plasma	O	6088
triglyceride	O	6088
concentrations	O	6088
,	O	6088
fasting	O	6088
chylomicronemia	B-Disease	6088
,	O	6088
and	O	6088
reduced	O	6088
high	O	6088
density	O	6088
lipoprotein	O	6088
cholesterol	O	6088
.	O	6088

An	O	6089
unexpected	O	6089
finding	O	6089
is	O	6089
that	O	6089
the	O	6089
modified	O	6089
Apob	O	6089
allele	O	6089
is	O	6089
strongly	O	6089
associated	O	6089
with	O	6089
exencephalus	B-Disease	6089
and	O	6089
hydrocephalus	B-Disease	6089
.	O	6089

These	O	6090
mice	O	6090
should	O	6090
help	O	6090
increase	O	6090
our	O	6090
understanding	O	6090
of	O	6090
hypobetalipoproteinemia	B-Disease	6090
,	O	6090
atherogenesis	B-Disease	6090
,	O	6090
and	O	6090
the	O	6090
etiology	O	6090
of	O	6090
exencephalus	B-Disease	6090
and	O	6090
hydrocephalus	B-Disease	6090
.	O	6090

A	O	6092
novel	O	6092
disease	O	6092
with	O	6092
deficiency	B-Disease	6092
of	I-Disease	6092
mitochondrial	I-Disease	6092
very	I-Disease	6092
-	I-Disease	6092
long	I-Disease	6092
-	I-Disease	6092
chain	I-Disease	6092
acyl	I-Disease	6092
-	I-Disease	6092
CoA	I-Disease	6092
dehydrogenase	I-Disease	6092
.	O	6092

Two	O	6094
of	O	6094
the	O	6094
patients	O	6094
,	O	6094
4	O	6094
-	O	6094
5	O	6094
month	O	6094
old	O	6094
boys	O	6094
,	O	6094
were	O	6094
found	O	6094
to	O	6094
have	O	6094
a	O	6094
novel	O	6094
disease	O	6094
,	O	6094
VLCAD	B-Disease	6094
deficiency	I-Disease	6094
,	O	6094
as	O	6094
judged	O	6094
from	O	6094
the	O	6094
results	O	6094
of	O	6094
very	O	6094
low	O	6094
palmitoyl	O	6094
-	O	6094
CoA	O	6094
dehydrogenase	O	6094
activity	O	6094
and	O	6094
the	O	6094
lack	O	6094
of	O	6094
immunoreactivity	O	6094
toward	O	6094
antibody	O	6094
raised	O	6094
to	O	6094
purified	O	6094
VLCAD	O	6094
.	O	6094

Molecular	O	6096
characterization	O	6096
of	O	6096
glucose	B-Disease	6096
-	I-Disease	6096
6	I-Disease	6096
-	I-Disease	6096
phosphate	I-Disease	6096
dehydrogenase	I-Disease	6096
(	I-Disease	6096
G6PD	I-Disease	6096
)	I-Disease	6096
deficiency	I-Disease	6096
in	O	6096
patients	O	6096
of	O	6096
Chinese	O	6096
descent	O	6096
and	O	6096
identification	O	6096
of	O	6096
new	O	6096
base	O	6096
substitutions	O	6096
in	O	6096
the	O	6096
human	O	6096
G6PD	O	6096
gene	O	6096
.	O	6096

The	O	6097
underlying	O	6097
DNA	O	6097
changes	O	6097
associated	O	6097
with	O	6097
glucose	B-Disease	6097
-	I-Disease	6097
6	I-Disease	6097
-	I-Disease	6097
phosphate	I-Disease	6097
dehydrogenase	I-Disease	6097
(	I-Disease	6097
G6PD	I-Disease	6097
)	I-Disease	6097
-	I-Disease	6097
deficient	I-Disease	6097
Asians	O	6097
have	O	6097
not	O	6097
been	O	6097
extensively	O	6097
investigated	O	6097
.	O	6097

To	O	6098
fill	O	6098
this	O	6098
gap	O	6098
,	O	6098
we	O	6098
sequenced	O	6098
the	O	6098
G6PD	O	6098
gene	O	6098
of	O	6098
43	O	6098
G6PD	B-Disease	6098
-	I-Disease	6098
deficient	I-Disease	6098
Chinese	O	6098
whose	O	6098
G6PD	O	6098
was	O	6098
well	O	6098
characterized	O	6098
biochemically	O	6098
.	O	6098

These	O	6101
five	O	6101
nucleotide	O	6101
substitutions	O	6101
account	O	6101
for	O	6101
over	O	6101
83	O	6101
%	O	6101
of	O	6101
our	O	6101
43	O	6101
G6PD	B-Disease	6101
-	I-Disease	6101
deficient	I-Disease	6101
samples	O	6101
and	O	6101
these	O	6101
substitutions	O	6101
have	O	6101
not	O	6101
been	O	6101
reported	O	6101
in	O	6101
non	O	6101
-	O	6101
Asians	O	6101
.	O	6101

The	O	6103
substitutions	O	6103
at	O	6103
cDNA	O	6103
1376	O	6103
and	O	6103
1388	O	6103
account	O	6103
for	O	6103
over	O	6103
50	O	6103
%	O	6103
of	O	6103
the	O	6103
43	O	6103
samples	O	6103
examined	O	6103
indicating	O	6103
a	O	6103
high	O	6103
prevalence	O	6103
of	O	6103
these	O	6103
two	O	6103
alleles	O	6103
among	O	6103
G6PD	B-Disease	6103
-	I-Disease	6103
deficient	I-Disease	6103
Chinese	O	6103
.	O	6103

Our	O	6104
findings	O	6104
add	O	6104
support	O	6104
to	O	6104
the	O	6104
notion	O	6104
that	O	6104
diverse	O	6104
point	O	6104
mutations	O	6104
may	O	6104
account	O	6104
largely	O	6104
for	O	6104
much	O	6104
of	O	6104
the	O	6104
phenotypic	O	6104
heterogeneity	O	6104
of	O	6104
G6PD	B-Disease	6104
deficiency	I-Disease	6104
.	O	6104

Identification	O	6106
of	O	6106
mutations	O	6106
in	O	6106
Danish	O	6106
choroideremia	B-Disease	6106
families	O	6106
.	O	6106

We	O	6107
have	O	6107
searched	O	6107
for	O	6107
mutations	O	6107
in	O	6107
the	O	6107
choroideremia	B-Disease	6107
gene	O	6107
(	O	6107
CHM	B-Disease	6107
)	O	6107
in	O	6107
patients	O	6107
from	O	6107
12	O	6107
Danish	O	6107
families	O	6107
in	O	6107
which	O	6107
CHM	B-Disease	6107
is	O	6107
segregating	O	6107
.	O	6107

Structure	O	6111
and	O	6111
genomic	O	6111
sequence	O	6111
of	O	6111
the	O	6111
myotonic	B-Disease	6111
dystrophy	I-Disease	6111
(	O	6111
DM	B-Disease	6111
kinase	O	6111
)	O	6111
gene	O	6111
.	O	6111

The	O	6112
mutation	O	6112
causing	O	6112
myotonic	B-Disease	6112
dystrophy	I-Disease	6112
(	O	6112
DM	B-Disease	6112
)	O	6112
has	O	6112
recently	O	6112
been	O	6112
identified	O	6112
as	O	6112
an	O	6112
unstable	O	6112
CTG	O	6112
trinucleotide	O	6112
repeat	O	6112
located	O	6112
in	O	6112
the	O	6112
3	O	6112
untranslated	O	6112
region	O	6112
of	O	6112
a	O	6112
gene	O	6112
encoding	O	6112
for	O	6112
a	O	6112
protein	O	6112
with	O	6112
putative	O	6112
serine	O	6112
-	O	6112
threonine	O	6112
protein	O	6112
kinase	O	6112
activity	O	6112
.	O	6112

In	O	6113
this	O	6113
report	O	6113
we	O	6113
present	O	6113
the	O	6113
genomic	O	6113
sequences	O	6113
of	O	6113
the	O	6113
human	O	6113
and	O	6113
murine	O	6113
DM	B-Disease	6113
kinase	O	6113
gene	O	6113
.	O	6113

A	O	6114
comparison	O	6114
of	O	6114
these	O	6114
sequences	O	6114
with	O	6114
each	O	6114
other	O	6114
and	O	6114
with	O	6114
known	O	6114
cDNA	O	6114
sequences	O	6114
from	O	6114
both	O	6114
species	O	6114
,	O	6114
led	O	6114
us	O	6114
to	O	6114
predict	O	6114
a	O	6114
translation	O	6114
initiation	O	6114
codon	O	6114
,	O	6114
as	O	6114
well	O	6114
as	O	6114
determine	O	6114
the	O	6114
organization	O	6114
of	O	6114
the	O	6114
DM	B-Disease	6114
kinase	O	6114
gene	O	6114
.	O	6114

Several	O	6115
polymorphisms	O	6115
within	O	6115
the	O	6115
human	O	6115
DM	B-Disease	6115
kinase	O	6115
gene	O	6115
have	O	6115
been	O	6115
identified	O	6115
,	O	6115
and	O	6115
PCR	O	6115
assays	O	6115
to	O	6115
detect	O	6115
two	O	6115
of	O	6115
these	O	6115
are	O	6115
described	O	6115
.	O	6115

The	O	6116
complete	O	6116
sequence	O	6116
and	O	6116
characterization	O	6116
of	O	6116
the	O	6116
structure	O	6116
of	O	6116
the	O	6116
DM	B-Disease	6116
kinase	O	6116
gene	O	6116
,	O	6116
as	O	6116
well	O	6116
as	O	6116
the	O	6116
identification	O	6116
of	O	6116
novel	O	6116
polymorphisms	O	6116
within	O	6116
the	O	6116
gene	O	6116
,	O	6116
represent	O	6116
an	O	6116
important	O	6116
step	O	6116
in	O	6116
a	O	6116
further	O	6116
understanding	O	6116
of	O	6116
the	O	6116
genetics	O	6116
of	O	6116
myotonic	B-Disease	6116
dystrophy	I-Disease	6116
and	O	6116
the	O	6116
molecular	O	6116
biology	O	6116
of	O	6116
the	O	6116
gene	O	6116
.	O	6116

Autosomal	O	6118
recessive	O	6118
transmission	O	6118
of	O	6118
hemophilia	B-Disease	6118
A	I-Disease	6118
due	O	6118
to	O	6118
a	O	6118
von	B-Disease	6118
Willebrand	I-Disease	6118
factor	O	6118
mutation	O	6118
.	O	6118

The	O	6119
differential	O	6119
diagnosis	O	6119
of	O	6119
the	O	6119
genetic	B-Disease	6119
bleeding	I-Disease	6119
disorders	I-Disease	6119
,	O	6119
hemophilia	B-Disease	6119
A	I-Disease	6119
and	O	6119
von	B-Disease	6119
Willebrand	I-Disease	6119
disease	I-Disease	6119
,	O	6119
is	O	6119
occasionally	O	6119
confounded	O	6119
by	O	6119
the	O	6119
close	O	6119
molecular	O	6119
relationship	O	6119
of	O	6119
coagulation	O	6119
factor	O	6119
VIII	O	6119
and	O	6119
von	B-Disease	6119
Willebrand	I-Disease	6119
factor	O	6119
(	O	6119
vWF	O	6119
)	O	6119
.	O	6119

This	O	6120
report	O	6120
describes	O	6120
the	O	6120
autosomal	O	6120
inheritance	O	6120
of	O	6120
a	O	6120
hemophilia	B-Disease	6120
A	I-Disease	6120
phenotype	O	6120
due	O	6120
to	O	6120
a	O	6120
mutation	O	6120
of	O	6120
vWF	O	6120
that	O	6120
results	O	6120
in	O	6120
defective	O	6120
factor	O	6120
VIII	O	6120
binding	O	6120
.	O	6120

However	O	6127
,	O	6127
the	O	6127
mutant	O	6127
failed	O	6127
to	O	6127
bind	O	6127
factor	O	6127
VIII	O	6127
,	O	6127
demonstrating	O	6127
that	O	6127
the	O	6127
mutation	O	6127
was	O	6127
functionally	O	6127
related	O	6127
to	O	6127
the	O	6127
observed	O	6127
hemophilia	B-Disease	6127
phenotype	O	6127
.	O	6127

autosomal	O	6129
hemophilia	B-Disease	6129
.	O	6129

We	O	6132
conclude	O	6132
that	O	6132
vWF	O	6132
mutation	O	6132
may	O	6132
be	O	6132
an	O	6132
under	O	6132
recognized	O	6132
cause	O	6132
of	O	6132
hemophilia	B-Disease	6132
,	O	6132
especially	O	6132
in	O	6132
cases	O	6132
where	O	6132
the	O	6132
inheritance	O	6132
pattern	O	6132
is	O	6132
not	O	6132
consistent	O	6132
with	O	6132
X	O	6132
-	O	6132
linked	O	6132
transmission	O	6132
.	O	6132

Somatic	O	6133
von	B-Disease	6133
Hippel	I-Disease	6133
-	I-Disease	6133
Lindau	I-Disease	6133
mutation	O	6133
in	O	6133
clear	O	6133
cell	O	6133
papillary	B-Disease	6133
cystadenoma	I-Disease	6133
of	I-Disease	6133
the	I-Disease	6133
epididymis	I-Disease	6133
.	O	6133

Papillary	B-Disease	6134
cystadenoma	I-Disease	6134
of	I-Disease	6134
the	I-Disease	6134
epididymis	I-Disease	6134
is	O	6134
an	O	6134
uncommon	O	6134
benign	O	6134
lesion	O	6134
that	O	6134
may	O	6134
occur	O	6134
sporadically	O	6134
or	O	6134
as	O	6134
a	O	6134
manifestation	O	6134
of	O	6134
von	B-Disease	6134
Hippel	I-Disease	6134
-	I-Disease	6134
Lindau	I-Disease	6134
(	I-Disease	6134
VHL	I-Disease	6134
)	I-Disease	6134
disease	I-Disease	6134
.	O	6134

Neither	O	6135
immunohistochemical	O	6135
studies	O	6135
nor	O	6135
molecular	O	6135
genetic	O	6135
analyses	O	6135
of	O	6135
the	O	6135
VHL	B-Disease	6135
gene	O	6135
have	O	6135
been	O	6135
reported	O	6135
previously	O	6135
for	O	6135
this	O	6135
lesion	O	6135
.	O	6135

The	O	6136
authors	O	6136
describe	O	6136
two	O	6136
cases	O	6136
of	O	6136
clear	O	6136
cell	O	6136
papillary	B-Disease	6136
cystadenoma	I-Disease	6136
of	I-Disease	6136
the	I-Disease	6136
epididymis	I-Disease	6136
,	O	6136
both	O	6136
of	O	6136
which	O	6136
were	O	6136
initially	O	6136
confused	O	6136
with	O	6136
metastatic	B-Disease	6136
renal	I-Disease	6136
cell	I-Disease	6136
carcinoma	I-Disease	6136
.	O	6136

Because	O	6140
clear	O	6140
cell	O	6140
papillary	B-Disease	6140
cystadenoma	I-Disease	6140
is	O	6140
similar	O	6140
to	O	6140
renal	B-Disease	6140
cell	I-Disease	6140
carcinoma	I-Disease	6140
histologically	O	6140
,	O	6140
and	O	6140
because	O	6140
both	O	6140
occur	O	6140
as	O	6140
components	O	6140
of	O	6140
the	O	6140
von	B-Disease	6140
Hippel	I-Disease	6140
-	I-Disease	6140
Lindau	I-Disease	6140
disease	I-Disease	6140
complex	O	6140
,	O	6140
the	O	6140
authors	O	6140
analyzed	O	6140
both	O	6140
cases	O	6140
for	O	6140
the	O	6140
presence	O	6140
of	O	6140
mutations	O	6140
in	O	6140
the	O	6140
VHL	B-Disease	6140
gene	O	6140
.	O	6140

A	O	6141
somatic	O	6141
VHL	B-Disease	6141
gene	O	6141
mutation	O	6141
was	O	6141
detected	O	6141
in	O	6141
one	O	6141
of	O	6141
the	O	6141
two	O	6141
tumors	B-Disease	6141
by	O	6141
polymerase	O	6141
chain	O	6141
reaction	O	6141
followed	O	6141
by	O	6141
single	O	6141
-	O	6141
strand	O	6141
conformation	O	6141
polymorphism	O	6141
analysis	O	6141
.	O	6141

As	O	6143
the	O	6143
VHL	B-Disease	6143
gene	O	6143
is	O	6143
believed	O	6143
to	O	6143
function	O	6143
as	O	6143
a	O	6143
tumor	B-Disease	6143
suppressor	O	6143
gene	O	6143
,	O	6143
VHL	B-Disease	6143
gene	O	6143
mutations	O	6143
may	O	6143
play	O	6143
a	O	6143
role	O	6143
in	O	6143
the	O	6143
initiation	O	6143
of	O	6143
tumorigenesis	O	6143
in	O	6143
sporadic	O	6143
cystadenomas	B-Disease	6143
of	I-Disease	6143
the	I-Disease	6143
epididymis	I-Disease	6143
.	O	6143

Identification	O	6144
of	O	6144
WASP	O	6144
mutations	O	6144
in	O	6144
patients	O	6144
with	O	6144
Wiskott	B-Disease	6144
-	I-Disease	6144
Aldrich	I-Disease	6144
syndrome	I-Disease	6144
and	O	6144
isolated	B-Disease	6144
thrombocytopenia	I-Disease	6144
reveals	O	6144
allelic	O	6144
heterogeneity	O	6144
at	O	6144
the	O	6144
WAS	B-Disease	6144
locus	O	6144
.	O	6144

Mutation	O	6145
in	O	6145
the	O	6145
gene	O	6145
encoding	O	6145
the	O	6145
recently	O	6145
isolated	O	6145
WASP	O	6145
protein	O	6145
has	O	6145
now	O	6145
been	O	6145
identified	O	6145
as	O	6145
the	O	6145
genetic	B-Disease	6145
defect	I-Disease	6145
responsible	O	6145
for	O	6145
the	O	6145
X	B-Disease	6145
-	I-Disease	6145
linked	I-Disease	6145
Wiskott	I-Disease	6145
-	I-Disease	6145
Aldrich	I-Disease	6145
syndrome	I-Disease	6145
(	O	6145
WAS	B-Disease	6145
)	O	6145
,	O	6145
a	O	6145
primary	O	6145
immunodeficiency	B-Disease	6145
disease	I-Disease	6145
associated	O	6145
with	O	6145
extensive	O	6145
phenotypic	O	6145
variability	O	6145
.	O	6145

To	O	6146
elucidate	O	6146
the	O	6146
range	O	6146
of	O	6146
WASP	O	6146
mutations	O	6146
responsible	O	6146
for	O	6146
WAS	B-Disease	6146
,	O	6146
we	O	6146
used	O	6146
PCR	O	6146
-	O	6146
SSCP	O	6146
analysis	O	6146
to	O	6146
screen	O	6146
for	O	6146
WASP	O	6146
gene	O	6146
mutation	O	6146
in	O	6146
19	O	6146
unrelated	O	6146
boys	O	6146
with	O	6146
the	O	6146
diagnosis	O	6146
of	O	6146
classical	O	6146
or	O	6146
attenuated	O	6146
WAS	B-Disease	6146
or	O	6146
isolated	B-Disease	6146
thrombocytopenia	I-Disease	6146
.	O	6146

However	O	6148
,	O	6148
a	O	6148
missense	O	6148
mutation	O	6148
which	O	6148
results	O	6148
in	O	6148
substitution	O	6148
of	O	6148
the	O	6148
arginine	O	6148
at	O	6148
WAS	B-Disease	6148
codon	O	6148
86	O	6148
was	O	6148
identified	O	6148
in	O	6148
three	O	6148
boys	O	6148
with	O	6148
severe	O	6148
WAS	B-Disease	6148
as	O	6148
well	O	6148
as	O	6148
in	O	6148
one	O	6148
boy	O	6148
presenting	O	6148
with	O	6148
thrombocytopenia	B-Disease	6148
alone	O	6148
.	O	6148

While	O	6149
the	O	6149
three	O	6149
mutations	O	6149
found	O	6149
in	O	6149
the	O	6149
isolated	B-Disease	6149
thrombocytopenia	I-Disease	6149
patients	O	6149
leave	O	6149
the	O	6149
reading	O	6149
frame	O	6149
intact	O	6149
,	O	6149
about	O	6149
one	O	6149
-	O	6149
half	O	6149
of	O	6149
the	O	6149
gene	O	6149
alterations	O	6149
detected	O	6149
in	O	6149
both	O	6149
severe	O	6149
and	O	6149
attenuated	O	6149
WAS	B-Disease	6149
patients	O	6149
result	O	6149
in	O	6149
frameshifted	O	6149
transcript	O	6149
and	O	6149
premature	O	6149
translation	O	6149
termination	O	6149
.	O	6149

These	O	6150
findings	O	6150
therefore	O	6150
confirm	O	6150
the	O	6150
association	O	6150
of	O	6150
WAS	B-Disease	6150
with	O	6150
WASP	O	6150
mutation	O	6150
and	O	6150
identify	O	6150
WASP	O	6150
mutation	O	6150
as	O	6150
a	O	6150
cause	O	6150
for	O	6150
isolated	O	6150
congenital	B-Disease	6150
thrombocytopenia	I-Disease	6150
in	O	6150
males	O	6150
.	O	6150

While	O	6151
the	O	6151
WASP	O	6151
gene	O	6151
defects	O	6151
responsible	O	6151
for	O	6151
isolated	B-Disease	6151
thrombocytopenia	I-Disease	6151
and	O	6151
other	O	6151
mild	O	6151
presentations	O	6151
of	O	6151
WAS	B-Disease	6151
do	O	6151
not	O	6151
appear	O	6151
distinct	O	6151
from	O	6151
those	O	6151
resulting	O	6151
in	O	6151
severe	O	6151
WAS	B-Disease	6151
,	O	6151
these	O	6151
data	O	6151
indicate	O	6151
that	O	6151
analysis	O	6151
of	O	6151
WASP	O	6151
gene	O	6151
mutation	O	6151
provides	O	6151
a	O	6151
valuable	O	6151
tool	O	6151
for	O	6151
distinguishing	O	6151
the	O	6151
spectrum	O	6151
of	O	6151
WAS	B-Disease	6151
patients	O	6151
and	O	6151
the	O	6151
subset	O	6151
of	O	6151
males	O	6151
with	O	6151
isolated	B-Disease	6151
thrombocytopenia	I-Disease	6151
who	O	6151
represent	O	6151
mild	O	6151
cases	O	6151
of	O	6151
WAS	B-Disease	6151
.	O	6151

WASP	O	6153
gene	O	6153
mutations	O	6153
in	O	6153
Wiskott	B-Disease	6153
-	I-Disease	6153
Aldrich	I-Disease	6153
syndrome	I-Disease	6153
and	O	6153
X	B-Disease	6153
-	I-Disease	6153
linked	I-Disease	6153
thrombocytopenia	I-Disease	6153
.	O	6153

23	O	6155
and	O	6155
shown	O	6155
to	O	6155
be	O	6155
mutated	O	6155
in	O	6155
three	O	6155
patients	O	6155
with	O	6155
the	O	6155
Wiskott	B-Disease	6155
-	I-Disease	6155
Aldrich	I-Disease	6155
syndrome	I-Disease	6155
(	O	6155
WAS	B-Disease	6155
)	O	6155
.	O	6155

Four	O	6159
amino	O	6159
acid	O	6159
substitutions	O	6159
,	O	6159
Leu27Phe	O	6159
,	O	6159
Thr48Ile	O	6159
,	O	6159
Val75Met	O	6159
and	O	6159
Arg477Lys	O	6159
,	O	6159
were	O	6159
found	O	6159
in	O	6159
patients	O	6159
with	O	6159
congenital	B-Disease	6159
thrombocytopenia	I-Disease	6159
and	O	6159
no	O	6159
clinically	O	6159
evident	O	6159
immune	O	6159
defect	O	6159
indicating	O	6159
that	O	6159
the	O	6159
WASP	O	6159
gene	O	6159
is	O	6159
the	O	6159
site	O	6159
for	O	6159
mutations	O	6159
in	O	6159
X	B-Disease	6159
-	I-Disease	6159
linked	I-Disease	6159
thrombocytopenia	I-Disease	6159
as	O	6159
well	O	6159
as	O	6159
in	O	6159
WAS	B-Disease	6159
.	O	6159

A	O	6160
T	O	6160
-	O	6160
cell	O	6160
line	O	6160
from	O	6160
a	O	6160
WAS	B-Disease	6160
patient	O	6160
contained	O	6160
two	O	6160
independent	O	6160
DNA	O	6160
alterations	O	6160
,	O	6160
a	O	6160
constitutional	O	6160
frameshift	O	6160
mutation	O	6160
,	O	6160
also	O	6160
present	O	6160
in	O	6160
peripheral	O	6160
blood	O	6160
leukocytes	O	6160
from	O	6160
the	O	6160
patient	O	6160
,	O	6160
and	O	6160
compensatory	O	6160
splice	O	6160
site	O	6160
mutation	O	6160
unique	O	6160
to	O	6160
the	O	6160
cell	O	6160
line	O	6160
.	O	6160

Evidence	O	6162
for	O	6162
inter	O	6162
-	O	6162
generational	O	6162
instability	O	6162
in	O	6162
the	O	6162
CAG	O	6162
repeat	O	6162
in	O	6162
the	O	6162
MJD1	O	6162
gene	O	6162
and	O	6162
for	O	6162
conserved	O	6162
haplotypes	O	6162
at	O	6162
flanking	O	6162
markers	O	6162
amongst	O	6162
Japanese	O	6162
and	O	6162
Caucasian	O	6162
subjects	O	6162
with	O	6162
Machado	B-Disease	6162
-	I-Disease	6162
Joseph	I-Disease	6162
disease	I-Disease	6162
.	O	6162

The	O	6163
size	O	6163
of	O	6163
the	O	6163
(	O	6163
CAG	O	6163
)	O	6163
n	O	6163
repeat	O	6163
array	O	6163
in	O	6163
the	O	6163
3	O	6163
'	O	6163
end	O	6163
of	O	6163
the	O	6163
MJD1	O	6163
gene	O	6163
and	O	6163
the	O	6163
haplotype	O	6163
at	O	6163
a	O	6163
series	O	6163
of	O	6163
microsatellite	O	6163
markers	O	6163
surrounding	O	6163
the	O	6163
MJD1	O	6163
gene	O	6163
were	O	6163
examined	O	6163
in	O	6163
a	O	6163
large	O	6163
cohort	O	6163
of	O	6163
Japanese	O	6163
and	O	6163
Caucasian	O	6163
subjects	O	6163
affected	O	6163
with	O	6163
Machado	B-Disease	6163
-	I-Disease	6163
Joseph	I-Disease	6163
disease	I-Disease	6163
(	O	6163
MJD	B-Disease	6163
)	O	6163
.	O	6163

First	O	6165
,	O	6165
MJD	B-Disease	6165
is	O	6165
associated	O	6165
with	O	6165
expansion	O	6165
fo	O	6165
the	O	6165
array	O	6165
from	O	6165
the	O	6165
normal	O	6165
range	O	6165
of	O	6165
14	O	6165
-	O	6165
37	O	6165
repeats	O	6165
to	O	6165
68	O	6165
-	O	6165
84	O	6165
repeats	O	6165
in	O	6165
most	O	6165
Japanese	O	6165
and	O	6165
Caucasian	O	6165
subjects	O	6165
,	O	6165
but	O	6165
no	O	6165
subjects	O	6165
were	O	6165
observed	O	6165
with	O	6165
expansions	O	6165
intermediate	O	6165
in	O	6165
size	O	6165
between	O	6165
those	O	6165
of	O	6165
the	O	6165
normal	O	6165
and	O	6165
MJD	B-Disease	6165
affected	O	6165
groups	O	6165
.	O	6165

Second	O	6166
,	O	6166
the	O	6166
expanded	O	6166
allele	O	6166
associated	O	6166
with	O	6166
MJD	B-Disease	6166
displays	O	6166
inter	O	6166
-	O	6166
generational	O	6166
instability	O	6166
,	O	6166
particularly	O	6166
in	O	6166
male	O	6166
meioses	O	6166
,	O	6166
and	O	6166
this	O	6166
instability	O	6166
was	O	6166
associated	O	6166
with	O	6166
the	O	6166
clinical	O	6166
phenomenon	O	6166
of	O	6166
anticipation	O	6166
.	O	6166

Third	O	6167
,	O	6167
the	O	6167
size	O	6167
of	O	6167
the	O	6167
expanded	O	6167
allele	O	6167
is	O	6167
not	O	6167
only	O	6167
inversely	O	6167
correlated	O	6167
with	O	6167
the	O	6167
age	O	6167
-	O	6167
of	O	6167
-	O	6167
onset	O	6167
of	O	6167
MJD	B-Disease	6167
(	O	6167
r	O	6167
=	O	6167
-	O	6167
0	O	6167
.	O	6167

Fourth	O	6174
,	O	6174
the	O	6174
disease	O	6174
phenotype	O	6174
is	O	6174
significantly	O	6174
more	O	6174
severe	O	6174
and	O	6174
had	O	6174
an	O	6174
early	O	6174
age	O	6174
of	O	6174
onset	O	6174
(	O	6174
16	O	6174
years	O	6174
)	O	6174
in	O	6174
a	O	6174
subject	O	6174
homozygous	O	6174
for	O	6174
the	O	6174
expanded	O	6174
allele	O	6174
,	O	6174
which	O	6174
contrasts	O	6174
with	O	6174
Huntington	B-Disease	6174
disease	I-Disease	6174
and	O	6174
suggests	O	6174
that	O	6174
the	O	6174
expanded	O	6174
allele	O	6174
in	O	6174
the	O	6174
MJD1	O	6174
gene	O	6174
could	O	6174
exert	O	6174
its	O	6174
effect	O	6174
either	O	6174
by	O	6174
a	O	6174
dominant	O	6174
negative	O	6174
effect	O	6174
(	O	6174
putatively	O	6174
excluded	O	6174
in	O	6174
HD	B-Disease	6174
)	O	6174
or	O	6174
by	O	6174
a	O	6174
gain	O	6174
of	O	6174
function	O	6174
effect	O	6174
as	O	6174
proposed	O	6174
for	O	6174
HD	B-Disease	6174
.	O	6174

Finally	O	6175
,	O	6175
Japanese	O	6175
and	O	6175
Caucasian	O	6175
subjects	O	6175
affected	O	6175
with	O	6175
MJD	B-Disease	6175
share	O	6175
haplotypes	O	6175
at	O	6175
several	O	6175
markers	O	6175
surrounding	O	6175
the	O	6175
MJD1	O	6175
gene	O	6175
,	O	6175
which	O	6175
are	O	6175
uncommon	O	6175
in	O	6175
the	O	6175
normal	O	6175
Japanese	O	6175
and	O	6175
Caucasian	O	6175
population	O	6175
,	O	6175
and	O	6175
which	O	6175
suggests	O	6175
the	O	6175
existence	O	6175
either	O	6175
of	O	6175
common	O	6175
founders	O	6175
in	O	6175
these	O	6175
populations	O	6175
or	O	6175
of	O	6175
chromosomes	O	6175
susceptible	O	6175
to	O	6175
pathologic	O	6175
expansion	O	6175
of	O	6175
the	O	6175
CAG	O	6175
repeat	O	6175
in	O	6175
the	O	6175
MJD1	O	6175
gene	O	6175
.	O	6175

A	O	6176
4	O	6176
-	O	6176
megabase	O	6176
YAC	O	6176
contig	O	6176
that	O	6176
spans	O	6176
the	O	6176
Langer	B-Disease	6176
-	I-Disease	6176
Giedion	I-Disease	6176
syndrome	I-Disease	6176
region	O	6176
on	O	6176
human	O	6176
chromosome	O	6176
8q24	O	6176
.	O	6176

1	O	6177
:	O	6177
use	O	6177
in	O	6177
refining	O	6177
the	O	6177
location	O	6177
of	O	6177
the	O	6177
trichorhinophalangeal	B-Disease	6177
syndrome	I-Disease	6177
and	O	6177
multiple	O	6177
exostoses	O	6177
genes	O	6177
(	O	6177
TRPS1	O	6177
and	O	6177
EXT1	O	6177
)	O	6177
.	O	6177

1	O	6179
and	O	6179
used	O	6179
this	O	6179
map	O	6179
to	O	6179
refine	O	6179
the	O	6179
locations	O	6179
of	O	6179
the	O	6179
genes	O	6179
responsible	O	6179
for	O	6179
Langer	B-Disease	6179
-	I-Disease	6179
Giedion	I-Disease	6179
syndrome	I-Disease	6179
.	O	6179

The	O	6181
minimal	O	6181
region	O	6181
of	O	6181
overlap	O	6181
of	O	6181
Langer	B-Disease	6181
-	I-Disease	6181
Giedion	I-Disease	6181
syndrome	I-Disease	6181
deletions	O	6181
,	O	6181
previously	O	6181
identified	O	6181
by	O	6181
analysis	O	6181
of	O	6181
15	O	6181
patients	O	6181
,	O	6181
was	O	6181
placed	O	6181
on	O	6181
the	O	6181
map	O	6181
by	O	6181
analysis	O	6181
of	O	6181
2	O	6181
patients	O	6181
whose	O	6181
deletions	O	6181
define	O	6181
the	O	6181
endpoints	O	6181
.	O	6181

3	O	6184
)	O	6184
translocation	O	6184
from	O	6184
a	O	6184
patient	O	6184
with	O	6184
trichorhinophalangeal	B-Disease	6184
syndrome	I-Disease	6184
(	O	6184
TRPS	B-Disease	6184
I	O	6184
)	O	6184
was	O	6184
found	O	6184
to	O	6184
be	O	6184
located	O	6184
just	O	6184
within	O	6184
the	O	6184
proximal	O	6184
end	O	6184
of	O	6184
the	O	6184
minimal	O	6184
deletion	O	6184
region	O	6184
.	O	6184

3	O	6187
in	O	6187
a	O	6187
patient	O	6187
with	O	6187
multiple	O	6187
exostoses	O	6187
was	O	6187
found	O	6187
to	O	6187
overlap	O	6187
the	O	6187
distal	O	6187
end	O	6187
of	O	6187
the	O	6187
LGS	B-Disease	6187
deletion	O	6187
region	O	6187
,	O	6187
indicating	O	6187
that	O	6187
the	O	6187
EXT1	O	6187
gene	O	6187
is	O	6187
distal	O	6187
to	O	6187
the	O	6187
TRPS1	O	6187
gene	O	6187
and	O	6187
supporting	O	6187
the	O	6187
hypothesis	O	6187
that	O	6187
Langer	B-Disease	6187
-	I-Disease	6187
Giedion	I-Disease	6187
syndrome	I-Disease	6187
is	O	6187
due	O	6187
to	O	6187
loss	O	6187
of	O	6187
functional	O	6187
copies	O	6187
of	O	6187
both	O	6187
the	O	6187
TRPS1	O	6187
and	O	6187
the	O	6187
EXT1	O	6187
genes	O	6187
BRCA1	O	6187
mutations	O	6187
in	O	6187
a	O	6187
population	O	6187
-	O	6187
based	O	6187
sample	O	6187
of	O	6187
young	O	6187
women	O	6187
with	O	6187
breast	B-Disease	6187
cancer	I-Disease	6187
.	O	6187

Inherited	O	6189
mutations	O	6189
in	O	6189
the	O	6189
BRCA1	O	6189
gene	O	6189
are	O	6189
associated	O	6189
with	O	6189
a	O	6189
high	O	6189
risk	O	6189
of	O	6189
breast	B-Disease	6189
and	I-Disease	6189
ovarian	I-Disease	6189
cancer	I-Disease	6189
in	O	6189
some	O	6189
families	O	6189
.	O	6189

However	O	6190
,	O	6190
little	O	6190
is	O	6190
known	O	6190
about	O	6190
the	O	6190
contribution	O	6190
of	O	6190
BRCA1	O	6190
mutations	O	6190
to	O	6190
breast	B-Disease	6190
cancer	I-Disease	6190
in	O	6190
the	O	6190
general	O	6190
population	O	6190
.	O	6190

We	O	6191
analyzed	O	6191
DNA	O	6191
samples	O	6191
from	O	6191
women	O	6191
enrolled	O	6191
in	O	6191
a	O	6191
population	O	6191
-	O	6191
based	O	6191
study	O	6191
of	O	6191
early	O	6191
-	O	6191
onset	O	6191
breast	B-Disease	6191
cancer	I-Disease	6191
to	O	6191
assess	O	6191
the	O	6191
spectrum	O	6191
and	O	6191
frequency	O	6191
of	O	6191
germ	O	6191
-	O	6191
line	O	6191
BRCA1	O	6191
mutations	O	6191
in	O	6191
young	O	6191
women	O	6191
with	O	6191
breast	B-Disease	6191
cancer	I-Disease	6191
.	O	6191

We	O	6193
studied	O	6193
80	O	6193
women	O	6193
in	O	6193
whom	O	6193
breast	B-Disease	6193
cancer	I-Disease	6193
was	O	6193
diagnosed	O	6193
before	O	6193
the	O	6193
age	O	6193
of	O	6193
35	O	6193
,	O	6193
and	O	6193
who	O	6193
were	O	6193
not	O	6193
selected	O	6193
on	O	6193
the	O	6193
basis	O	6193
of	O	6193
family	O	6193
history	O	6193
.	O	6193

Two	O	6199
of	O	6199
the	O	6199
mutations	O	6199
and	O	6199
three	O	6199
of	O	6199
the	O	6199
rare	O	6199
sequence	O	6199
variants	O	6199
were	O	6199
found	O	6199
among	O	6199
the	O	6199
39	O	6199
women	O	6199
who	O	6199
reported	O	6199
no	O	6199
family	O	6199
history	O	6199
of	O	6199
breast	B-Disease	6199
or	I-Disease	6199
ovarian	I-Disease	6199
cancer	I-Disease	6199
.	O	6199

Alterations	O	6202
in	O	6202
BRCA1	O	6202
were	O	6202
identified	O	6202
in	O	6202
approximately	O	6202
10	O	6202
percent	O	6202
of	O	6202
this	O	6202
cohort	O	6202
of	O	6202
young	O	6202
women	O	6202
with	O	6202
breast	B-Disease	6202
cancer	I-Disease	6202
.	O	6202

The	O	6203
risk	O	6203
of	O	6203
harboring	O	6203
a	O	6203
mutation	O	6203
was	O	6203
not	O	6203
limited	O	6203
to	O	6203
women	O	6203
with	O	6203
family	O	6203
histories	O	6203
of	O	6203
breast	B-Disease	6203
or	I-Disease	6203
ovarian	I-Disease	6203
cancer	I-Disease	6203
.	O	6203

Thirty	O	6208
-	O	6208
seven	O	6208
families	O	6208
with	O	6208
four	O	6208
or	O	6208
more	O	6208
cases	O	6208
of	O	6208
breast	B-Disease	6208
cancer	I-Disease	6208
or	O	6208
breast	B-Disease	6208
and	I-Disease	6208
ovarian	I-Disease	6208
cancer	I-Disease	6208
were	O	6208
analyzed	O	6208
for	O	6208
mutations	O	6208
in	O	6208
BRCA1	O	6208
.	O	6208

Expressivity	O	6211
of	O	6211
185delAG	O	6211
in	O	6211
these	O	6211
families	O	6211
varied	O	6211
,	O	6211
from	O	6211
early	O	6211
-	O	6211
onset	O	6211
breast	B-Disease	6211
cancer	I-Disease	6211
without	O	6211
ovarian	B-Disease	6211
cancer	I-Disease	6211
.	O	6211

In	O	6213
one	O	6213
family	O	6213
,	O	6213
penetrance	O	6213
was	O	6213
complete	O	6213
,	O	6213
with	O	6213
females	O	6213
developing	O	6213
early	O	6213
-	O	6213
onset	O	6213
breast	B-Disease	6213
cancer	I-Disease	6213
or	O	6213
ovarian	B-Disease	6213
cancer	I-Disease	6213
and	O	6213
the	O	6213
male	O	6213
carrier	O	6213
developing	O	6213
prostatic	B-Disease	6213
cancer	I-Disease	6213
,	O	6213
whereas	O	6213
,	O	6213
in	O	6213
the	O	6213
other	O	6213
family	O	6213
,	O	6213
penetrance	O	6213
was	O	6213
incomplete	O	6213
and	O	6213
only	O	6213
breast	B-Disease	6213
cancer	I-Disease	6213
occurred	O	6213
,	O	6213
diagnosed	O	6213
at	O	6213
ages	O	6213
38	O	6213
-	O	6213
81	O	6213
years	O	6213
.	O	6213

Two	O	6214
novel	O	6214
nonsense	O	6214
mutations	O	6214
led	O	6214
to	O	6214
the	O	6214
loss	O	6214
of	O	6214
mutant	O	6214
BRCA1	O	6214
transcript	O	6214
in	O	6214
families	O	6214
with	O	6214
10	O	6214
and	O	6214
6	O	6214
cases	O	6214
of	O	6214
early	O	6214
-	O	6214
onset	O	6214
breast	B-Disease	6214
cancer	I-Disease	6214
and	O	6214
ovarian	B-Disease	6214
cancer	I-Disease	6214
.	O	6214

Overall	O	6217
in	O	6217
our	O	6217
series	O	6217
,	O	6217
BRCA1	O	6217
mutations	O	6217
have	O	6217
been	O	6217
detected	O	6217
in	O	6217
26	O	6217
families	O	6217
16	O	6217
with	O	6217
positive	O	6217
BRCA1	O	6217
lod	O	6217
scores	O	6217
,	O	6217
7	O	6217
with	O	6217
negative	O	6217
lod	O	6217
scores	O	6217
(	O	6217
reflecting	O	6217
multiple	O	6217
sporadic	O	6217
breast	B-Disease	6217
cancers	I-Disease	6217
)	O	6217
,	O	6217
and	O	6217
3	O	6217
not	O	6217
tested	O	6217
for	O	6217
linkage	O	6217
.	O	6217

Deficiency	B-Disease	6220
of	I-Disease	6220
glucose	I-Disease	6220
-	I-Disease	6220
6	I-Disease	6220
-	I-Disease	6220
phosphate	I-Disease	6220
dehydrogenase	I-Disease	6220
(	O	6220
G6PD	O	6220
)	O	6220
is	O	6220
usually	O	6220
found	O	6220
at	O	6220
high	O	6220
frequencies	O	6220
in	O	6220
areas	O	6220
of	O	6220
the	O	6220
world	O	6220
where	O	6220
malaria	B-Disease	6220
has	O	6220
been	O	6220
endemic	O	6220
.	O	6220

The	O	6221
frequency	O	6221
and	O	6221
genetic	O	6221
basis	O	6221
of	O	6221
G6PD	B-Disease	6221
deficiency	I-Disease	6221
have	O	6221
been	O	6221
studied	O	6221
in	O	6221
Africa	O	6221
,	O	6221
around	O	6221
the	O	6221
Mediterranean	O	6221
,	O	6221
and	O	6221
in	O	6221
the	O	6221
Far	O	6221
East	O	6221
,	O	6221
but	O	6221
little	O	6221
such	O	6221
information	O	6221
is	O	6221
available	O	6221
about	O	6221
the	O	6221
situation	O	6221
in	O	6221
India	O	6221
.	O	6221

To	O	6222
determine	O	6222
the	O	6222
extent	O	6222
of	O	6222
heterogeneity	O	6222
of	O	6222
G6PD	O	6222
,	O	6222
we	O	6222
have	O	6222
studied	O	6222
several	O	6222
different	O	6222
Indian	O	6222
populations	O	6222
by	O	6222
screening	O	6222
for	O	6222
G6PD	B-Disease	6222
deficiency	I-Disease	6222
,	O	6222
followed	O	6222
by	O	6222
molecular	O	6222
analysis	O	6222
of	O	6222
deficient	O	6222
alleles	O	6222
.	O	6222

The	O	6223
frequency	O	6223
of	O	6223
G6PD	B-Disease	6223
deficiency	I-Disease	6223
varies	O	6223
between	O	6223
3	O	6223
%	O	6223
and	O	6223
15	O	6223
%	O	6223
in	O	6223
different	O	6223
tribal	O	6223
and	O	6223
urban	O	6223
groups	O	6223
.	O	6223

Remarkably	O	6224
,	O	6224
a	O	6224
previously	O	6224
unreported	O	6224
deficient	O	6224
variant	O	6224
,	O	6224
G6PD	O	6224
Orissa	O	6224
(	O	6224
44	O	6224
Ala	O	6224
-	O	6224
-	O	6224
>	O	6224
Gly	O	6224
)	O	6224
,	O	6224
is	O	6224
responsible	O	6224
for	O	6224
most	O	6224
of	O	6224
the	O	6224
G6PD	B-Disease	6224
deficiency	I-Disease	6224
in	O	6224
tribal	O	6224
Indian	O	6224
populations	O	6224
but	O	6224
is	O	6224
not	O	6224
found	O	6224
in	O	6224
urban	O	6224
populations	O	6224
,	O	6224
where	O	6224
most	O	6224
of	O	6224
the	O	6224
G6PD	B-Disease	6224
deficiency	I-Disease	6224
is	O	6224
due	O	6224
to	O	6224
the	O	6224
G6PD	O	6224
Mediterranean	O	6224
(	O	6224
188	O	6224
Ser	O	6224
-	O	6224
-	O	6224
>	O	6224
Phe	O	6224
)	O	6224
variant	O	6224
.	O	6224

Evidence	O	6228
for	O	6228
linkage	O	6228
of	O	6228
bipolar	B-Disease	6228
disorder	I-Disease	6228
to	O	6228
chromosome	O	6228
18	O	6228
with	O	6228
a	O	6228
parent	O	6228
-	O	6228
of	O	6228
-	O	6228
origin	O	6228
effect	O	6228
.	O	6228

A	O	6229
susceptibility	O	6229
gene	O	6229
on	O	6229
chromosome	O	6229
18	O	6229
and	O	6229
a	O	6229
parent	O	6229
-	O	6229
of	O	6229
-	O	6229
origin	O	6229
effect	O	6229
have	O	6229
been	O	6229
suggested	O	6229
for	O	6229
bipolar	B-Disease	6229
affective	I-Disease	6229
disorder	I-Disease	6229
(	O	6229
BPAD	B-Disease	6229
)	O	6229
.	O	6229

We	O	6230
have	O	6230
studied	O	6230
28	O	6230
nuclear	O	6230
families	O	6230
selected	O	6230
for	O	6230
apparent	O	6230
unilineal	O	6230
transmission	O	6230
of	O	6230
the	O	6230
BPAD	B-Disease	6230
phenotype	O	6230
,	O	6230
by	O	6230
using	O	6230
31	O	6230
polymorphic	O	6230
markers	O	6230
spanning	O	6230
chromosome	O	6230
18	O	6230
.	O	6230

Our	O	6243
results	O	6243
provide	O	6243
further	O	6243
support	O	6243
for	O	6243
linkage	O	6243
of	O	6243
BPAD	B-Disease	6243
to	O	6243
chromosome	O	6243
18	O	6243
and	O	6243
the	O	6243
first	O	6243
molecular	O	6243
evidence	O	6243
for	O	6243
a	O	6243
parent	O	6243
-	O	6243
of	O	6243
-	O	6243
origin	O	6243
effect	O	6243
operating	O	6243
in	O	6243
this	O	6243
disorder	O	6243
.	O	6243

The	O	6244
number	O	6244
of	O	6244
loci	O	6244
involved	O	6244
,	O	6244
and	O	6244
their	O	6244
precise	O	6244
location	O	6244
,	O	6244
require	O	6244
further	O	6244
study	O	6244
A	O	6244
prevalent	O	6244
mutation	O	6244
for	O	6244
galactosemia	B-Disease	6244
among	O	6244
black	O	6244
Americans	O	6244
.	O	6244

OBJECTIVE	O	6245
To	O	6245
define	O	6245
the	O	6245
mutation	O	6245
causing	O	6245
galactosemia	B-Disease	6245
in	O	6245
patients	O	6245
of	O	6245
black	O	6245
American	O	6245
origin	O	6245
who	O	6245
have	O	6245
no	O	6245
galactose	O	6245
-	O	6245
1	O	6245
-	O	6245
phosphate	O	6245
uridyltransferase	O	6245
(	O	6245
GALT	O	6245
)	O	6245
activity	O	6245
in	O	6245
erythrocytes	O	6245
but	O	6245
good	O	6245
clinical	O	6245
outcome	O	6245
.	O	6245

RESULTS	O	6249
We	O	6249
found	O	6249
a	O	6249
48	O	6249
%	O	6249
prevalence	O	6249
of	O	6249
the	O	6249
S135L	O	6249
mutation	O	6249
among	O	6249
17	O	6249
black	O	6249
American	O	6249
patients	O	6249
with	O	6249
classic	B-Disease	6249
galactosemia	I-Disease	6249
and	O	6249
a	O	6249
1	O	6249
%	O	6249
prevalence	O	6249
in	O	6249
a	O	6249
population	O	6249
of	O	6249
50	O	6249
black	O	6249
Americans	O	6249
without	O	6249
galactosemia	B-Disease	6249
.	O	6249

The	O	6250
S135L	O	6250
mutation	O	6250
was	O	6250
not	O	6250
found	O	6250
in	O	6250
84	O	6250
white	O	6250
patients	O	6250
with	O	6250
G	O	6250
/	O	6250
G	O	6250
galactosemia	B-Disease	6250
nor	O	6250
in	O	6250
87	O	6250
white	O	6250
control	O	6250
subjects	O	6250
without	O	6250
galactosemia	B-Disease	6250
.	O	6250

CONCLUSIONS	O	6252
The	O	6252
S135L	O	6252
mutation	O	6252
in	O	6252
the	O	6252
GALT	O	6252
gene	O	6252
is	O	6252
a	O	6252
prevalent	O	6252
cause	O	6252
of	O	6252
galactosemia	B-Disease	6252
among	O	6252
black	O	6252
patients	O	6252
.	O	6252

A	O	6255
high	O	6255
incidence	O	6255
of	O	6255
BRCA1	O	6255
mutations	O	6255
in	O	6255
20	O	6255
breast	B-Disease	6255
-	I-Disease	6255
ovarian	I-Disease	6255
cancer	I-Disease	6255
families	O	6255
.	O	6255

We	O	6256
have	O	6256
analyzed	O	6256
20	O	6256
breast	B-Disease	6256
-	I-Disease	6256
ovarian	I-Disease	6256
cancer	I-Disease	6256
families	O	6256
,	O	6256
the	O	6256
majority	O	6256
of	O	6256
which	O	6256
show	O	6256
positive	O	6256
evidence	O	6256
of	O	6256
linkage	O	6256
to	O	6256
chromosome	O	6256
17q12	O	6256
for	O	6256
germ	O	6256
-	O	6256
line	O	6256
mutations	O	6256
in	O	6256
the	O	6256
BRCA1	O	6256
gene	O	6256
.	O	6256

BRCA1	O	6257
mutations	O	6257
cosegregating	O	6257
with	O	6257
breast	B-Disease	6257
and	I-Disease	6257
ovarian	I-Disease	6257
cancer	I-Disease	6257
susceptibility	O	6257
were	O	6257
identified	O	6257
in	O	6257
16	O	6257
families	O	6257
,	O	6257
including	O	6257
1	O	6257
family	O	6257
with	O	6257
a	O	6257
case	O	6257
of	O	6257
male	B-Disease	6257
breast	I-Disease	6257
cancer	I-Disease	6257
.	O	6257

It	O	6264
is	O	6264
expected	O	6264
that	O	6264
the	O	6264
majority	O	6264
of	O	6264
clear	O	6264
examples	O	6264
of	O	6264
the	O	6264
breast	B-Disease	6264
-	I-Disease	6264
ovarian	I-Disease	6264
syndrome	I-Disease	6264
will	O	6264
be	O	6264
associated	O	6264
with	O	6264
germ	O	6264
-	O	6264
line	O	6264
mutations	O	6264
in	O	6264
the	O	6264
coding	O	6264
region	O	6264
of	O	6264
BRCA1	O	6264
.	O	6264

Brca1	B-Disease	6266
deficiency	I-Disease	6266
results	O	6266
in	O	6266
early	O	6266
embryonic	B-Disease	6266
lethality	I-Disease	6266
characterized	O	6266
by	O	6266
neuroepithelial	B-Disease	6266
abnormalities	I-Disease	6266
.	O	6266

The	O	6267
breast	B-Disease	6267
and	I-Disease	6267
ovarian	I-Disease	6267
cancer	I-Disease	6267
susceptibility	O	6267
gene	O	6267
,	O	6267
BRCA1	O	6267
,	O	6267
has	O	6267
been	O	6267
cloned	O	6267
and	O	6267
shown	O	6267
to	O	6267
encode	O	6267
a	O	6267
zinc	O	6267
-	O	6267
finger	O	6267
protein	O	6267
of	O	6267
unknown	O	6267
function	O	6267
.	O	6267

Mutations	O	6268
in	O	6268
BRCA1	O	6268
account	O	6268
for	O	6268
at	O	6268
least	O	6268
80	O	6268
%	O	6268
of	O	6268
families	O	6268
with	O	6268
both	O	6268
breast	B-Disease	6268
and	I-Disease	6268
ovarian	I-Disease	6268
cancer	I-Disease	6268
,	O	6268
as	O	6268
well	O	6268
as	O	6268
some	O	6268
non	O	6268
-	O	6268
familial	O	6268
sporadic	O	6268
ovarian	B-Disease	6268
cancers	I-Disease	6268
.	O	6268

The	O	6269
loss	O	6269
of	O	6269
wild	O	6269
-	O	6269
type	O	6269
BRCA1	O	6269
in	O	6269
tumours	B-Disease	6269
of	O	6269
individuals	O	6269
carrying	O	6269
one	O	6269
nonfunctional	O	6269
BRCA1	O	6269
allele	O	6269
suggests	O	6269
that	O	6269
BRCA1	O	6269
encodes	O	6269
a	O	6269
tumour	B-Disease	6269
suppressor	O	6269
that	O	6269
may	O	6269
inhibit	O	6269
the	O	6269
proliferation	O	6269
of	O	6269
mammary	O	6269
epithelial	O	6269
cells	O	6269
.	O	6269

To	O	6270
examine	O	6270
the	O	6270
role	O	6270
of	O	6270
BRCA1	O	6270
in	O	6270
normal	O	6270
tissue	O	6270
growth	O	6270
and	O	6270
differentiation	O	6270
,	O	6270
and	O	6270
to	O	6270
generate	O	6270
a	O	6270
potential	O	6270
model	O	6270
for	O	6270
the	O	6270
cancer	B-Disease	6270
susceptibility	O	6270
associated	O	6270
with	O	6270
loss	O	6270
of	O	6270
BRCA1	O	6270
function	O	6270
,	O	6270
we	O	6270
have	O	6270
created	O	6270
a	O	6270
mouse	O	6270
line	O	6270
carrying	O	6270
a	O	6270
mutation	O	6270
in	O	6270
one	O	6270
Brca1	O	6270
allele	O	6270
.	O	6270

Abnormalities	O	6272
in	O	6272
Brca1	B-Disease	6272
-	I-Disease	6272
deficient	I-Disease	6272
embryos	O	6272
were	O	6272
most	O	6272
evident	O	6272
in	O	6272
the	O	6272
neural	O	6272
tube	O	6272
,	O	6272
with	O	6272
40	O	6272
%	O	6272
of	O	6272
the	O	6272
embryos	O	6272
presenting	O	6272
with	O	6272
varying	O	6272
degrees	O	6272
of	O	6272
spina	B-Disease	6272
bifida	I-Disease	6272
and	O	6272
anencephaly	B-Disease	6272
.	O	6272

In	O	6273
addition	O	6273
,	O	6273
the	O	6273
neuroepithelium	O	6273
in	O	6273
Brca1	B-Disease	6273
-	I-Disease	6273
deficient	I-Disease	6273
embryos	O	6273
appeared	O	6273
disorganized	O	6273
,	O	6273
with	O	6273
signs	O	6273
of	O	6273
both	O	6273
rapid	O	6273
proliferation	O	6273
and	O	6273
excessive	O	6273
cell	O	6273
death	O	6273
.	O	6273

Identification	O	6275
of	O	6275
mutations	O	6275
in	O	6275
the	O	6275
ALD	O	6275
-	O	6275
gene	O	6275
of	O	6275
20	O	6275
families	O	6275
with	O	6275
adrenoleukodystrophy	B-Disease	6275
/	O	6275
adrenomyeloneuropathy	B-Disease	6275
.	O	6275

Adrenoleukodystrophy	B-Disease	6276
(	O	6276
ALD	B-Disease	6276
)	O	6276
,	O	6276
an	O	6276
X	B-Disease	6276
-	I-Disease	6276
linked	I-Disease	6276
inherited	I-Disease	6276
metabolic	I-Disease	6276
disorder	I-Disease	6276
,	O	6276
is	O	6276
the	O	6276
most	O	6276
frequent	O	6276
inborn	B-Disease	6276
peroxisomal	I-Disease	6276
disease	I-Disease	6276
.	O	6276

It	O	6277
leads	O	6277
to	O	6277
demyelination	B-Disease	6277
in	I-Disease	6277
the	I-Disease	6277
central	I-Disease	6277
and	I-Disease	6277
peripheral	I-Disease	6277
nervous	I-Disease	6277
system	I-Disease	6277
.	O	6277

The	O	6279
ALD	B-Disease	6279
gene	O	6279
has	O	6279
been	O	6279
recently	O	6279
identified	O	6279
and	O	6279
encodes	O	6279
a	O	6279
745	O	6279
-	O	6279
amino	O	6279
-	O	6279
acid	O	6279
protein	O	6279
.	O	6279

We	O	6280
screened	O	6280
patients	O	6280
with	O	6280
adrenoleukodystrophy	B-Disease	6280
/	O	6280
adrenomyeloneuropathy	B-Disease	6280
(	O	6280
ALD	B-Disease	6280
/	O	6280
AMN	B-Disease	6280
)	O	6280
from	O	6280
20	O	6280
kindreds	O	6280
for	O	6280
mutations	O	6280
in	O	6280
the	O	6280
ALD	B-Disease	6280
gene	O	6280
.	O	6280

Eleven	O	6281
missense	O	6281
and	O	6281
two	O	6281
nonsense	O	6281
mutations	O	6281
,	O	6281
five	O	6281
deletions	O	6281
,	O	6281
and	O	6281
one	O	6281
insertion	O	6281
were	O	6281
detected	O	6281
by	O	6281
direct	O	6281
sequencing	O	6281
of	O	6281
eight	O	6281
reverse	O	6281
transcribed	O	6281
fragments	O	6281
of	O	6281
the	O	6281
ALD	B-Disease	6281
-	O	6281
gene	O	6281
mRNA	O	6281
.	O	6281

The	O	6285
mutations	O	6285
were	O	6285
not	O	6285
detected	O	6285
in	O	6285
the	O	6285
ALD	B-Disease	6285
gene	O	6285
of	O	6285
30	O	6285
healthy	O	6285
persons	O	6285
.	O	6285

The	O	6287
murine	O	6287
homolog	O	6287
of	O	6287
the	O	6287
human	O	6287
breast	B-Disease	6287
and	I-Disease	6287
ovarian	I-Disease	6287
cancer	I-Disease	6287
susceptibility	O	6287
gene	O	6287
Brca1	O	6287
maps	O	6287
to	O	6287
mouse	O	6287
chromosome	O	6287
11D	O	6287
.	O	6287

The	O	6288
recently	O	6288
cloned	O	6288
human	O	6288
breast	B-Disease	6288
and	I-Disease	6288
ovarian	I-Disease	6288
cancer	I-Disease	6288
susceptibility	O	6288
gene	O	6288
,	O	6288
BRCA1	O	6288
,	O	6288
is	O	6288
located	O	6288
on	O	6288
human	O	6288
chromosome	O	6288
17q21	O	6288
.	O	6288

Atelosteogenesis	B-Disease	6297
type	I-Disease	6297
II	I-Disease	6297
is	O	6297
caused	O	6297
by	O	6297
mutations	O	6297
in	O	6297
the	O	6297
diastrophic	B-Disease	6297
dysplasia	I-Disease	6297
sulfate	O	6297
-	O	6297
transporter	O	6297
gene	O	6297
(	O	6297
DTDST	O	6297
)	O	6297
:	O	6297
evidence	O	6297
for	O	6297
a	O	6297
phenotypic	O	6297
series	O	6297
involving	O	6297
three	O	6297
chondrodysplasias	B-Disease	6297
.	O	6297

Atelosteogenesis	B-Disease	6298
type	I-Disease	6298
II	I-Disease	6298
(	O	6298
AO	B-Disease	6298
II	I-Disease	6298
)	O	6298
is	O	6298
a	O	6298
neonatally	O	6298
lethal	O	6298
chondrodysplasia	B-Disease	6298
whose	O	6298
clinical	O	6298
and	O	6298
histological	O	6298
characteristics	O	6298
resemble	O	6298
those	O	6298
of	O	6298
another	O	6298
chondrodysplasia	B-Disease	6298
,	O	6298
the	O	6298
much	O	6298
less	O	6298
severe	O	6298
diastrophic	B-Disease	6298
dysplasia	I-Disease	6298
(	O	6298
DTD	B-Disease	6298
)	O	6298
.	O	6298

DTD	B-Disease	6300
is	O	6300
caused	O	6300
by	O	6300
mutations	O	6300
in	O	6300
the	O	6300
recently	O	6300
identified	O	6300
diastrophic	B-Disease	6300
dysplasia	I-Disease	6300
sulfate	O	6300
-	O	6300
transporter	O	6300
gene	O	6300
(	O	6300
DTDST	O	6300
)	O	6300
.	O	6300

Here	O	6301
,	O	6301
we	O	6301
report	O	6301
that	O	6301
AOII	B-Disease	6301
patients	O	6301
also	O	6301
have	O	6301
DTDST	O	6301
mutations	O	6301
,	O	6301
which	O	6301
lead	O	6301
to	O	6301
defective	O	6301
uptake	O	6301
of	O	6301
inorganic	O	6301
sulfate	O	6301
and	O	6301
insufficient	O	6301
sulfation	O	6301
of	O	6301
macromolecules	O	6301
by	O	6301
patient	O	6301
mesenchymal	O	6301
cells	O	6301
in	O	6301
vitro	O	6301
.	O	6301

Together	O	6302
with	O	6302
our	O	6302
recent	O	6302
observation	O	6302
that	O	6302
a	O	6302
third	O	6302
even	O	6302
more	O	6302
severe	O	6302
chondrodysplasia	B-Disease	6302
,	O	6302
achondrogenesis	O	6302
type	O	6302
IB	O	6302
,	O	6302
is	O	6302
also	O	6302
caused	O	6302
by	O	6302
mutations	O	6302
in	O	6302
DTDST	O	6302
,	O	6302
these	O	6302
results	O	6302
demonstrate	O	6302
a	O	6302
phenotypic	O	6302
series	O	6302
of	O	6302
three	O	6302
chondrodysplasias	B-Disease	6302
of	O	6302
increasing	O	6302
severity	O	6302
caused	O	6302
by	O	6302
lesions	O	6302
in	O	6302
a	O	6302
single	O	6302
sulfate	O	6302
-	O	6302
transporter	O	6302
gene	O	6302
.	O	6302

Several	O	6306
BRCA1	O	6306
mutations	O	6306
have	O	6306
now	O	6306
been	O	6306
found	O	6306
to	O	6306
occur	O	6306
in	O	6306
geographically	O	6306
diverse	O	6306
breast	B-Disease	6306
and	I-Disease	6306
ovarian	I-Disease	6306
cancer	I-Disease	6306
families	O	6306
.	O	6306

To	O	6307
investigate	O	6307
mutation	O	6307
origin	O	6307
and	O	6307
mutation	O	6307
-	O	6307
specific	O	6307
phenotypes	O	6307
due	O	6307
to	O	6307
BRCA1	O	6307
,	O	6307
we	O	6307
constructed	O	6307
a	O	6307
haplotype	O	6307
of	O	6307
nine	O	6307
polymorphic	O	6307
markers	O	6307
within	O	6307
or	O	6307
immediately	O	6307
flanking	O	6307
the	O	6307
BRCA1	O	6307
locus	O	6307
in	O	6307
a	O	6307
set	O	6307
of	O	6307
61	O	6307
breast	B-Disease	6307
/	I-Disease	6307
ovarian	I-Disease	6307
cancer	I-Disease	6307
families	O	6307
selected	O	6307
for	O	6307
having	O	6307
one	O	6307
of	O	6307
six	O	6307
recurrent	O	6307
BRCA1	O	6307
mutations	O	6307
.	O	6307

A	O	6309
comparison	O	6309
of	O	6309
the	O	6309
six	O	6309
mutations	O	6309
in	O	6309
the	O	6309
relative	O	6309
proportions	O	6309
of	O	6309
cases	O	6309
of	O	6309
breast	B-Disease	6309
and	I-Disease	6309
ovarian	I-Disease	6309
cancer	I-Disease	6309
was	O	6309
suggestive	O	6309
of	O	6309
an	O	6309
effect	O	6309
(	O	6309
P	O	6309
=	O	6309
.	O	6309

069	O	6310
)	O	6310
,	O	6310
with	O	6310
57	O	6310
%	O	6310
of	O	6310
women	O	6310
presumed	O	6310
affected	O	6310
because	O	6310
of	O	6310
the	O	6310
1294	O	6310
del	O	6310
40	O	6310
BRCA1	O	6310
mutation	O	6310
having	O	6310
ovarian	B-Disease	6310
cancer	I-Disease	6310
,	O	6310
compared	O	6310
with	O	6310
14	O	6310
%	O	6310
of	O	6310
affected	O	6310
women	O	6310
with	O	6310
the	O	6310
splice	O	6310
-	O	6310
site	O	6310
mutation	O	6310
in	O	6310
intron	O	6310
5	O	6310
of	O	6310
BRCA1	O	6310
.	O	6310

The	O	6315
BRCA1	O	6315
gene	O	6315
is	O	6315
in	O	6315
large	O	6315
part	O	6315
responsible	O	6315
for	O	6315
hereditary	B-Disease	6315
human	I-Disease	6315
breast	I-Disease	6315
and	I-Disease	6315
ovarian	I-Disease	6315
cancer	I-Disease	6315
.	O	6315

The	O	6322
isolation	O	6322
of	O	6322
the	O	6322
mouse	O	6322
Brca1	O	6322
homologue	O	6322
will	O	6322
facilitate	O	6322
the	O	6322
creation	O	6322
of	O	6322
mouse	O	6322
models	O	6322
for	O	6322
germline	O	6322
BRCA1	B-Disease	6322
defects	I-Disease	6322
.	O	6322

Emerin	B-Disease	6324
deficiency	I-Disease	6324
at	O	6324
the	O	6324
nuclear	O	6324
membrane	O	6324
in	O	6324
patients	O	6324
with	O	6324
Emery	B-Disease	6324
-	I-Disease	6324
Dreifuss	I-Disease	6324
muscular	I-Disease	6324
dystrophy	I-Disease	6324
.	O	6324

Mutations	O	6325
in	O	6325
the	O	6325
STA	O	6325
gene	O	6325
at	O	6325
the	O	6325
Xq28	O	6325
locus	O	6325
have	O	6325
been	O	6325
found	O	6325
in	O	6325
patients	O	6325
with	O	6325
X	B-Disease	6325
-	I-Disease	6325
linked	I-Disease	6325
Emery	I-Disease	6325
-	I-Disease	6325
Dreifuss	I-Disease	6325
muscular	I-Disease	6325
dystrophy	I-Disease	6325
(	O	6325
EDMD	B-Disease	6325
)	O	6325
.	O	6325

Using	O	6328
both	O	6328
antisera	O	6328
,	O	6328
we	O	6328
found	O	6328
positive	O	6328
nuclear	O	6328
membrane	O	6328
staining	O	6328
in	O	6328
skeletal	O	6328
,	O	6328
cardiac	O	6328
and	O	6328
smooth	O	6328
muscles	O	6328
in	O	6328
the	O	6328
normal	O	6328
controls	O	6328
and	O	6328
in	O	6328
patients	O	6328
with	O	6328
neuromuscular	B-Disease	6328
diseases	I-Disease	6328
other	O	6328
than	O	6328
EDMD	B-Disease	6328
.	O	6328

In	O	6329
contrast	O	6329
,	O	6329
a	O	6329
deficiency	O	6329
in	O	6329
immunofluorescent	O	6329
staining	O	6329
of	O	6329
skeletal	O	6329
and	O	6329
cardiac	O	6329
muscle	O	6329
from	O	6329
EDMD	B-Disease	6329
patients	O	6329
was	O	6329
observed	O	6329
.	O	6329

Together	O	6331
,	O	6331
our	O	6331
findings	O	6331
suggest	O	6331
the	O	6331
specific	O	6331
deficiency	B-Disease	6331
of	I-Disease	6331
emerin	I-Disease	6331
in	O	6331
the	O	6331
nuclear	O	6331
membrane	O	6331
of	O	6331
muscle	O	6331
cells	O	6331
in	O	6331
patients	O	6331
with	O	6331
EDMD	B-Disease	6331
.	O	6331

Growth	B-Disease	6333
retardation	I-Disease	6333
and	O	6333
tumour	B-Disease	6333
inhibition	O	6333
by	O	6333
BRCA1	O	6333
.	O	6333

Inherited	O	6334
mutations	O	6334
in	O	6334
BRCA1	O	6334
predispose	O	6334
to	O	6334
breast	B-Disease	6334
and	I-Disease	6334
ovarian	I-Disease	6334
cancer	I-Disease	6334
,	O	6334
but	O	6334
the	O	6334
role	O	6334
of	O	6334
BRCA1	O	6334
in	O	6334
sporadic	O	6334
breast	B-Disease	6334
and	I-Disease	6334
ovarian	I-Disease	6334
cancer	I-Disease	6334
has	O	6334
previously	O	6334
been	O	6334
elusive	O	6334
.	O	6334

Here	O	6335
,	O	6335
we	O	6335
show	O	6335
that	O	6335
retroviral	O	6335
transfer	O	6335
of	O	6335
the	O	6335
wild	O	6335
-	O	6335
type	O	6335
BRCA1	O	6335
gene	O	6335
inhibits	O	6335
growth	O	6335
in	O	6335
vitro	O	6335
of	O	6335
all	O	6335
breast	B-Disease	6335
and	I-Disease	6335
ovarian	I-Disease	6335
cancer	I-Disease	6335
cell	O	6335
lines	O	6335
tested	O	6335
,	O	6335
but	O	6335
not	O	6335
colon	B-Disease	6335
or	I-Disease	6335
lung	I-Disease	6335
cancer	I-Disease	6335
cells	O	6335
or	O	6335
fibroblasts	O	6335
.	O	6335

Mutant	O	6336
BRCA1	O	6336
has	O	6336
no	O	6336
effect	O	6336
on	O	6336
growth	O	6336
of	O	6336
breast	B-Disease	6336
cancer	I-Disease	6336
cells	O	6336
;	O	6336
ovarian	B-Disease	6336
cancer	I-Disease	6336
cell	O	6336
growth	O	6336
is	O	6336
not	O	6336
affected	O	6336
by	O	6336
BRCA1	O	6336
mutations	O	6336
in	O	6336
the	O	6336
5	O	6336
portion	O	6336
of	O	6336
the	O	6336
gene	O	6336
,	O	6336
but	O	6336
is	O	6336
inhibited	O	6336
by	O	6336
3	O	6336
BRCA1	O	6336
mutations	O	6336
.	O	6336

Development	O	6337
of	O	6337
MCF	B-Disease	6337
-	I-Disease	6337
7	I-Disease	6337
tumours	I-Disease	6337
in	O	6337
nude	O	6337
mice	O	6337
is	O	6337
inhibited	O	6337
when	O	6337
MCF	O	6337
-	O	6337
7	O	6337
cells	O	6337
are	O	6337
transfected	O	6337
with	O	6337
wild	O	6337
-	O	6337
type	O	6337
,	O	6337
but	O	6337
not	O	6337
mutant	O	6337
,	O	6337
BRCA1	O	6337
.	O	6337

Most	O	6338
importantly	O	6338
,	O	6338
among	O	6338
mice	O	6338
with	O	6338
established	O	6338
MCF	B-Disease	6338
-	I-Disease	6338
7	I-Disease	6338
tumours	I-Disease	6338
,	O	6338
peritoneal	O	6338
treatment	O	6338
with	O	6338
a	O	6338
retroviral	O	6338
vector	O	6338
expressing	O	6338
wild	O	6338
-	O	6338
type	O	6338
BRCA1	O	6338
significantly	O	6338
inhibits	O	6338
tumour	B-Disease	6338
growth	O	6338
and	O	6338
increased	O	6338
survival	O	6338
.	O	6338

Clustering	O	6339
of	O	6339
missense	O	6339
mutations	O	6339
in	O	6339
the	O	6339
ataxia	B-Disease	6339
-	I-Disease	6339
telangiectasia	I-Disease	6339
gene	O	6339
in	O	6339
a	O	6339
sporadic	B-Disease	6339
T	I-Disease	6339
-	I-Disease	6339
cell	I-Disease	6339
leukaemia	I-Disease	6339
.	O	6339

Ataxia	B-Disease	6340
-	I-Disease	6340
telangiectasia	I-Disease	6340
(	O	6340
A	B-Disease	6340
-	I-Disease	6340
T	I-Disease	6340
)	O	6340
is	O	6340
a	O	6340
recessive	B-Disease	6340
multi	I-Disease	6340
-	I-Disease	6340
system	I-Disease	6340
disorder	I-Disease	6340
caused	O	6340
by	O	6340
mutations	O	6340
in	O	6340
the	O	6340
ATM	O	6340
gene	O	6340
at	O	6340
11q22	O	6340
-	O	6340
q23	O	6340
(	O	6340
ref	O	6340
.	O	6340

The	O	6342
risk	O	6342
of	O	6342
cancer	B-Disease	6342
,	O	6342
especially	O	6342
lymphoid	B-Disease	6342
neoplasias	I-Disease	6342
,	O	6342
is	O	6342
substantially	O	6342
elevated	O	6342
in	O	6342
A	B-Disease	6342
-	I-Disease	6342
T	I-Disease	6342
patients	O	6342
and	O	6342
has	O	6342
long	O	6342
been	O	6342
associated	O	6342
with	O	6342
chromosomal	O	6342
instability	O	6342
.	O	6342

By	O	6343
analysing	O	6343
tumour	B-Disease	6343
DNA	O	6343
from	O	6343
patients	O	6343
with	O	6343
sporadic	B-Disease	6343
T	I-Disease	6343
-	I-Disease	6343
cell	I-Disease	6343
prolymphocytic	I-Disease	6343
leukaemia	I-Disease	6343
(	O	6343
T	B-Disease	6343
-	I-Disease	6343
PLL	I-Disease	6343
)	O	6343
,	O	6343
a	O	6343
rare	O	6343
clonal	B-Disease	6343
malignancy	I-Disease	6343
with	O	6343
similarities	O	6343
to	O	6343
a	O	6343
mature	B-Disease	6343
T	I-Disease	6343
-	I-Disease	6343
cell	I-Disease	6343
leukaemia	I-Disease	6343
seen	O	6343
in	O	6343
A	B-Disease	6343
-	I-Disease	6343
T	I-Disease	6343
,	O	6343
we	O	6343
demonstrate	O	6343
a	O	6343
high	O	6343
frequency	O	6343
of	O	6343
ATM	O	6343
mutations	O	6343
in	O	6343
T	B-Disease	6343
-	I-Disease	6343
PLL	I-Disease	6343
.	O	6343

In	O	6344
marked	O	6344
contrast	O	6344
to	O	6344
the	O	6344
ATM	O	6344
mutation	O	6344
pattern	O	6344
in	O	6344
A	B-Disease	6344
-	I-Disease	6344
T	I-Disease	6344
,	O	6344
the	O	6344
most	O	6344
frequent	O	6344
nucleotide	O	6344
changes	O	6344
in	O	6344
this	O	6344
leukaemia	B-Disease	6344
were	O	6344
missense	O	6344
mutations	O	6344
.	O	6344

Two	O	6347
of	O	6347
seventeen	O	6347
mutated	O	6347
T	B-Disease	6347
-	I-Disease	6347
PLL	I-Disease	6347
samples	O	6347
had	O	6347
a	O	6347
previously	O	6347
reported	O	6347
A	B-Disease	6347
-	I-Disease	6347
T	I-Disease	6347
allele	O	6347
.	O	6347

In	O	6348
contrast	O	6348
,	O	6348
no	O	6348
mutations	O	6348
were	O	6348
detected	O	6348
in	O	6348
the	O	6348
p53	O	6348
gene	O	6348
,	O	6348
suggesting	O	6348
that	O	6348
this	O	6348
tumour	B-Disease	6348
suppressor	O	6348
is	O	6348
not	O	6348
frequently	O	6348
altered	O	6348
in	O	6348
this	O	6348
leukaemia	B-Disease	6348
.	O	6348

Occasional	O	6349
missense	O	6349
mutations	O	6349
in	O	6349
ATM	O	6349
were	O	6349
also	O	6349
found	O	6349
in	O	6349
tumour	B-Disease	6349
DNA	O	6349
from	O	6349
patients	O	6349
with	O	6349
B	B-Disease	6349
-	I-Disease	6349
cell	I-Disease	6349
non	I-Disease	6349
-	I-Disease	6349
Hodgkins	I-Disease	6349
lymphomas	I-Disease	6349
(	O	6349
B	B-Disease	6349
-	I-Disease	6349
NHL	I-Disease	6349
)	O	6349
and	O	6349
a	O	6349
B	B-Disease	6349
-	I-Disease	6349
NHL	I-Disease	6349
cell	O	6349
line	O	6349
.	O	6349

The	O	6350
evidence	O	6350
of	O	6350
a	O	6350
significant	O	6350
proportion	O	6350
of	O	6350
loss	O	6350
-	O	6350
of	O	6350
-	O	6350
function	O	6350
mutations	O	6350
and	O	6350
a	O	6350
complete	O	6350
absence	O	6350
of	O	6350
the	O	6350
normal	O	6350
copy	O	6350
of	O	6350
ATM	O	6350
in	O	6350
the	O	6350
majority	O	6350
of	O	6350
mutated	O	6350
tumours	B-Disease	6350
establishes	O	6350
somatic	O	6350
inactivation	O	6350
of	O	6350
this	O	6350
gene	O	6350
in	O	6350
the	O	6350
pathogenesis	O	6350
of	O	6350
sporadic	B-Disease	6350
T	I-Disease	6350
-	I-Disease	6350
PLL	I-Disease	6350
and	O	6350
suggests	O	6350
that	O	6350
ATM	O	6350
acts	O	6350
as	O	6350
a	O	6350
tumour	B-Disease	6350
suppressor	O	6350
.	O	6350

As	O	6351
constitutional	O	6351
DNA	O	6351
was	O	6351
not	O	6351
available	O	6351
,	O	6351
a	O	6351
putative	O	6351
hereditary	O	6351
predisposition	O	6351
to	O	6351
T	B-Disease	6351
-	I-Disease	6351
PLL	I-Disease	6351
will	O	6351
require	O	6351
further	O	6351
investigation	O	6351
.	O	6351

Myotonic	B-Disease	6353
dystrophy	I-Disease	6353
protein	O	6353
kinase	O	6353
is	O	6353
involved	O	6353
in	O	6353
the	O	6353
modulation	O	6353
of	O	6353
the	O	6353
Ca2	O	6353
+	O	6353
homeostasis	O	6353
in	O	6353
skeletal	O	6353
muscle	O	6353
cells	O	6353
.	O	6353

Myotonic	B-Disease	6354
dystrophy	I-Disease	6354
(	O	6354
DM	B-Disease	6354
)	O	6354
,	O	6354
the	O	6354
most	O	6354
prevalent	O	6354
muscular	B-Disease	6354
disorder	I-Disease	6354
in	O	6354
adults	O	6354
,	O	6354
is	O	6354
caused	O	6354
by	O	6354
(	O	6354
CTG	O	6354
)	O	6354
n	O	6354
-	O	6354
repeat	O	6354
expansion	O	6354
in	O	6354
a	O	6354
gene	O	6354
encoding	O	6354
a	O	6354
protein	O	6354
kinase	O	6354
(	O	6354
DM	B-Disease	6354
protein	O	6354
kinase	O	6354
;	O	6354
DMPK	O	6354
)	O	6354
and	O	6354
involves	O	6354
changes	O	6354
in	O	6354
cytoarchitecture	O	6354
and	O	6354
ion	O	6354
homeostasis	O	6354
.	O	6354

Constitutional	O	6362
RB1	O	6362
-	O	6362
gene	O	6362
mutations	O	6362
in	O	6362
patients	O	6362
with	O	6362
isolated	O	6362
unilateral	B-Disease	6362
retinoblastoma	I-Disease	6362
.	O	6362

In	O	6363
most	O	6363
patients	O	6363
with	O	6363
isolated	O	6363
unilateral	B-Disease	6363
retinoblastoma	I-Disease	6363
,	O	6363
tumor	B-Disease	6363
development	O	6363
is	O	6363
initiated	O	6363
by	O	6363
somatic	O	6363
inactivation	O	6363
of	O	6363
both	O	6363
alleles	O	6363
of	O	6363
the	O	6363
RB1	O	6363
gene	O	6363
.	O	6363

However	O	6364
,	O	6364
some	O	6364
of	O	6364
these	O	6364
patients	O	6364
can	O	6364
transmit	O	6364
retinoblastoma	B-Disease	6364
predisposition	O	6364
to	O	6364
their	O	6364
offspring	O	6364
.	O	6364

To	O	6365
determine	O	6365
the	O	6365
frequency	O	6365
and	O	6365
nature	O	6365
of	O	6365
constitutional	O	6365
RB1	O	6365
-	O	6365
gene	O	6365
mutations	O	6365
in	O	6365
patients	O	6365
with	O	6365
isolated	O	6365
unilateral	B-Disease	6365
retinoblastoma	I-Disease	6365
,	O	6365
we	O	6365
analyzed	O	6365
DNA	O	6365
from	O	6365
peripheral	O	6365
blood	O	6365
and	O	6365
from	O	6365
tumor	B-Disease	6365
tissue	O	6365
.	O	6365

The	O	6366
analysis	O	6366
of	O	6366
tumors	B-Disease	6366
from	O	6366
54	O	6366
(	O	6366
71	O	6366
%	O	6366
)	O	6366
of	O	6366
76	O	6366
informative	O	6366
patients	O	6366
showed	O	6366
loss	O	6366
of	O	6366
constitutional	O	6366
heterozygosity	O	6366
(	O	6366
LOH	O	6366
)	O	6366
at	O	6366
intragenic	O	6366
loci	O	6366
.	O	6366

For	O	6368
39	O	6368
randomly	O	6368
selected	O	6368
tumors	B-Disease	6368
,	O	6368
SSCP	O	6368
,	O	6368
hetero	O	6368
-	O	6368
duplex	O	6368
analysis	O	6368
,	O	6368
sequencing	O	6368
,	O	6368
and	O	6368
Southern	O	6368
blot	O	6368
analysis	O	6368
were	O	6368
used	O	6368
to	O	6368
identify	O	6368
mutations	O	6368
.	O	6368

Mutations	O	6369
were	O	6369
detected	O	6369
in	O	6369
21	O	6369
(	O	6369
91	O	6369
%	O	6369
)	O	6369
of	O	6369
23	O	6369
tumors	B-Disease	6369
with	O	6369
LOH	O	6369
.	O	6369

In	O	6370
6	O	6370
(	O	6370
38	O	6370
%	O	6370
)	O	6370
of	O	6370
16	O	6370
tumors	B-Disease	6370
without	O	6370
LOH	O	6370
,	O	6370
one	O	6370
mutation	O	6370
was	O	6370
detected	O	6370
,	O	6370
and	O	6370
in	O	6370
9	O	6370
(	O	6370
56	O	6370
%	O	6370
)	O	6370
of	O	6370
the	O	6370
tumors	B-Disease	6370
without	O	6370
LOH	O	6370
,	O	6370
both	O	6370
mutations	O	6370
were	O	6370
found	O	6370
.	O	6370

Thus	O	6371
,	O	6371
a	O	6371
total	O	6371
of	O	6371
45	O	6371
mutations	O	6371
were	O	6371
identified	O	6371
in	O	6371
tumors	B-Disease	6371
of	O	6371
36	O	6371
patients	O	6371
.	O	6371

In	O	6376
2	O	6376
patients	O	6376
without	O	6376
a	O	6376
detectable	O	6376
mutation	O	6376
in	O	6376
peripheral	O	6376
blood	O	6376
,	O	6376
mosaicism	O	6376
was	O	6376
suggested	O	6376
because	O	6376
1	O	6376
of	O	6376
the	O	6376
patients	O	6376
showed	O	6376
multifocal	O	6376
tumors	B-Disease	6376
and	O	6376
the	O	6376
other	O	6376
later	O	6376
developed	O	6376
bilateral	B-Disease	6376
retinoblastoma	I-Disease	6376
.	O	6376

In	O	6377
conclusion	O	6377
,	O	6377
our	O	6377
results	O	6377
emphasize	O	6377
that	O	6377
the	O	6377
manifestation	O	6377
and	O	6377
transmissibility	O	6377
of	O	6377
retinoblastoma	B-Disease	6377
depend	O	6377
on	O	6377
the	O	6377
nature	O	6377
of	O	6377
the	O	6377
first	O	6377
mutation	O	6377
,	O	6377
its	O	6377
time	O	6377
in	O	6377
development	O	6377
,	O	6377
and	O	6377
the	O	6377
number	O	6377
and	O	6377
types	O	6377
of	O	6377
cells	O	6377
that	O	6377
are	O	6377
affected	O	6377
.	O	6377

Hereditary	B-Disease	6379
deficiency	I-Disease	6379
of	I-Disease	6379
the	I-Disease	6379
fifth	I-Disease	6379
component	I-Disease	6379
of	I-Disease	6379
complement	I-Disease	6379
in	O	6379
man	O	6379
.	O	6379

The	O	6382
first	O	6382
recognized	O	6382
human	O	6382
kindred	O	6382
with	O	6382
hereditary	B-Disease	6382
deficiency	I-Disease	6382
of	I-Disease	6382
the	I-Disease	6382
fifth	I-Disease	6382
component	I-Disease	6382
of	I-Disease	6382
complement	I-Disease	6382
(	O	6382
C5	O	6382
)	O	6382
is	O	6382
described	O	6382
.	O	6382

The	O	6383
proband	O	6383
,	O	6383
a	O	6383
20	O	6383
-	O	6383
year	O	6383
-	O	6383
old	O	6383
black	O	6383
female	O	6383
with	O	6383
systemic	B-Disease	6383
lupus	I-Disease	6383
erythematosus	I-Disease	6383
since	O	6383
age	O	6383
11	O	6383
,	O	6383
lacked	O	6383
serum	O	6383
hemolytic	O	6383
complement	O	6383
activity	O	6383
,	O	6383
even	O	6383
during	O	6383
remission	O	6383
.	O	6383

C5	O	6388
levels	O	6388
of	O	6388
other	O	6388
family	O	6388
members	O	6388
were	O	6388
either	O	6388
normal	O	6388
or	O	6388
approximately	O	6388
half	O	6388
-	O	6388
normal	O	6388
,	O	6388
consistent	O	6388
with	O	6388
autosomal	O	6388
codominant	O	6388
inheritance	O	6388
of	O	6388
the	O	6388
gene	O	6388
determining	O	6388
C5	B-Disease	6388
deficiency	I-Disease	6388
.	O	6388

Normal	O	6389
hemolytic	O	6389
titers	O	6389
were	O	6389
restored	O	6389
to	O	6389
both	O	6389
homozygous	O	6389
C5	B-Disease	6389
-	I-Disease	6389
deficient	I-Disease	6389
(	O	6389
C5D	B-Disease	6389
)	O	6389
sera	O	6389
by	O	6389
addition	O	6389
of	O	6389
highly	O	6389
purified	O	6389
human	O	6389
C5	O	6389
.	O	6389

In	O	6390
specific	O	6390
C5	O	6390
titrations	O	6390
,	O	6390
however	O	6390
,	O	6390
it	O	6390
was	O	6390
noted	O	6390
that	O	6390
when	O	6390
limited	O	6390
amounts	O	6390
of	O	6390
C5	O	6390
were	O	6390
assayed	O	6390
in	O	6390
the	O	6390
presence	O	6390
of	O	6390
low	O	6390
dilutions	O	6390
of	O	6390
either	O	6390
C5D	B-Disease	6390
serum	O	6390
,	O	6390
curving	O	6390
rather	O	6390
than	O	6390
linear	O	6390
dose	O	6390
-	O	6390
response	O	6390
plots	O	6390
were	O	6390
consistently	O	6390
obtained	O	6390
,	O	6390
suggesting	O	6390
some	O	6390
inhibitory	O	6390
effect	O	6390
.	O	6390

Further	O	6391
studies	O	6391
suggested	O	6391
that	O	6391
low	O	6391
dilutions	O	6391
of	O	6391
C5D	B-Disease	6391
serum	O	6391
contain	O	6391
a	O	6391
factor	O	6391
(	O	6391
or	O	6391
factors	O	6391
)	O	6391
interfering	O	6391
at	O	6391
some	O	6391
step	O	6391
in	O	6391
the	O	6391
hemolytic	O	6391
assay	O	6391
of	O	6391
C5	O	6391
,	O	6391
rather	O	6391
than	O	6391
a	O	6391
true	O	6391
C5	O	6391
inhibitor	O	6391
or	O	6391
inactivator	O	6391
.	O	6391

Of	O	6392
clinical	O	6392
interest	O	6392
are	O	6392
(	O	6392
a	O	6392
)	O	6392
the	O	6392
documentation	O	6392
of	O	6392
membranous	O	6392
glomerulonephritis	B-Disease	6392
,	O	6392
vasculitis	B-Disease	6392
,	O	6392
and	O	6392
arthritis	B-Disease	6392
in	O	6392
an	O	6392
individual	O	6392
lacking	O	6392
C5	O	6392
(	O	6392
and	O	6392
its	O	6392
biologic	O	6392
functions	O	6392
)	O	6392
,	O	6392
and	O	6392
(	O	6392
b	O	6392
)	O	6392
a	O	6392
remarkable	O	6392
propensity	O	6392
to	O	6392
bacterial	B-Disease	6392
infections	I-Disease	6392
in	O	6392
the	O	6392
proband	O	6392
,	O	6392
even	O	6392
during	O	6392
periods	O	6392
of	O	6392
low	O	6392
-	O	6392
dose	O	6392
or	O	6392
alternate	O	6392
-	O	6392
day	O	6392
corticosteroid	O	6392
therapy	O	6392
.	O	6392

Other	O	6393
observations	O	6393
indicate	O	6393
that	O	6393
the	O	6393
C5D	B-Disease	6393
state	O	6393
is	O	6393
compatible	O	6393
with	O	6393
normal	O	6393
coagulation	O	6393
function	O	6393
and	O	6393
the	O	6393
capacity	O	6393
to	O	6393
mount	O	6393
a	O	6393
neutrophilic	O	6393
leukocytosis	O	6393
during	O	6393
pyogenic	B-Disease	6393
infection	I-Disease	6393
.	O	6393

Susceptibility	O	6395
to	O	6395
ankylosing	B-Disease	6395
spondylitis	I-Disease	6395
in	O	6395
twins	O	6395
:	O	6395
the	O	6395
role	O	6395
of	O	6395
genes	O	6395
,	O	6395
HLA	O	6395
,	O	6395
and	O	6395
the	O	6395
environment	O	6395
.	O	6395

OBJECTIVE	O	6396
To	O	6396
determine	O	6396
the	O	6396
relative	O	6396
effects	O	6396
of	O	6396
genetic	O	6396
and	O	6396
environmental	O	6396
factors	O	6396
in	O	6396
susceptibility	O	6396
to	O	6396
ankylosing	B-Disease	6396
spondylitis	I-Disease	6396
(	O	6396
AS	B-Disease	6396
)	O	6396
.	O	6396

METHODS	O	6397
Twins	O	6397
with	O	6397
AS	B-Disease	6397
were	O	6397
identified	O	6397
from	O	6397
the	O	6397
Royal	O	6397
National	O	6397
Hospital	O	6397
for	O	6397
Rheumatic	B-Disease	6397
Diseases	I-Disease	6397
database	O	6397
.	O	6397

Genetic	O	6400
and	O	6400
environmental	O	6400
variance	O	6400
components	O	6400
were	O	6400
assessed	O	6400
with	O	6400
the	O	6400
program	O	6400
Mx	O	6400
,	O	6400
using	O	6400
data	O	6400
from	O	6400
this	O	6400
and	O	6400
previous	O	6400
studies	O	6400
of	O	6400
twins	O	6400
with	O	6400
AS	B-Disease	6400
.	O	6400

CONCLUSION	O	6406
Susceptibility	O	6406
to	O	6406
AS	B-Disease	6406
is	O	6406
largely	O	6406
genetically	O	6406
determined	O	6406
,	O	6406
and	O	6406
the	O	6406
environmental	O	6406
trigger	O	6406
for	O	6406
the	O	6406
disease	O	6406
is	O	6406
probably	O	6406
ubiquitous	O	6406
.	O	6406

HLA	O	6407
-	O	6407
B27	O	6407
accounts	O	6407
for	O	6407
a	O	6407
minority	O	6407
of	O	6407
the	O	6407
overall	O	6407
genetic	O	6407
susceptibility	O	6407
to	O	6407
AS	B-Disease	6407
.	O	6407

Germ	O	6409
-	O	6409
line	O	6409
mutations	O	6409
of	O	6409
the	O	6409
BRCA1	O	6409
gene	O	6409
predispose	O	6409
women	O	6409
to	O	6409
early	O	6409
-	O	6409
onset	O	6409
breast	B-Disease	6409
and	I-Disease	6409
ovarian	I-Disease	6409
cancer	I-Disease	6409
by	O	6409
compromising	O	6409
the	O	6409
genes	O	6409
presumptive	O	6409
function	O	6409
as	O	6409
a	O	6409
tumor	B-Disease	6409
suppressor	O	6409
.	O	6409

This	O	6421
cell	O	6421
cycle	O	6421
-	O	6421
dependent	O	6421
colocalization	O	6421
of	O	6421
BARD1	O	6421
and	O	6421
BRCA1	O	6421
indicates	O	6421
a	O	6421
role	O	6421
for	O	6421
BARD1	O	6421
in	O	6421
BRCA1	O	6421
-	O	6421
mediated	O	6421
tumor	B-Disease	6421
suppression	O	6421
.	O	6421

Recent	O	6423
studies	O	6423
have	O	6423
shown	O	6423
that	O	6423
hereditary	B-Disease	6423
hemochromatosis	I-Disease	6423
(	O	6423
HH	B-Disease	6423
)	O	6423
is	O	6423
likely	O	6423
to	O	6423
be	O	6423
caused	O	6423
by	O	6423
homozygosity	O	6423
for	O	6423
a	O	6423
Cys282Tyr	O	6423
mutation	O	6423
in	O	6423
the	O	6423
HFE	O	6423
gene	O	6423
located	O	6423
4	O	6423
.	O	6423

Comparisons	O	6432
with	O	6432
allele	O	6432
frequencies	O	6432
based	O	6432
on	O	6432
prevalence	O	6432
estimates	O	6432
of	O	6432
HH	B-Disease	6432
showed	O	6432
some	O	6432
disagreements	O	6432
with	O	6432
the	O	6432
RFLP	O	6432
data	O	6432
,	O	6432
particularly	O	6432
in	O	6432
Finns	O	6432
.	O	6432

The	O	6433
newly	O	6433
described	O	6433
HFE	O	6433
marker	O	6433
provides	O	6433
a	O	6433
new	O	6433
approach	O	6433
to	O	6433
the	O	6433
screening	O	6433
of	O	6433
HH	B-Disease	6433
as	O	6433
well	O	6433
as	O	6433
studies	O	6433
of	O	6433
the	O	6433
relationship	O	6433
between	O	6433
the	O	6433
HFE	O	6433
Tyr	O	6433
allele	O	6433
and	O	6433
different	O	6433
disorders	O	6433
including	O	6433
cancer	B-Disease	6433
Autosomal	B-Disease	6433
dominant	I-Disease	6433
neurohypophyseal	I-Disease	6433
diabetes	I-Disease	6433
insipidus	I-Disease	6433
associated	O	6433
with	O	6433
a	O	6433
missense	O	6433
mutation	O	6433
encoding	O	6433
Gly23	O	6433
-	O	6433
-	O	6433
>	O	6433
Val	O	6433
in	O	6433
neurophysin	O	6433
II	O	6433
.	O	6433

Autosomal	B-Disease	6434
dominant	I-Disease	6434
neurohypophyseal	I-Disease	6434
diabetes	I-Disease	6434
insipidus	I-Disease	6434
(	O	6434
ADNDI	B-Disease	6434
)	O	6434
is	O	6434
an	O	6434
inherited	B-Disease	6434
disease	I-Disease	6434
caused	O	6434
by	O	6434
progressive	O	6434
degeneration	O	6434
of	O	6434
the	O	6434
magnocellular	O	6434
neurons	O	6434
of	O	6434
the	O	6434
hypothalamus	O	6434
leading	O	6434
to	O	6434
decreased	O	6434
ability	O	6434
to	O	6434
produce	O	6434
the	O	6434
hormone	O	6434
arginine	O	6434
vasopressin	O	6434
(	O	6434
AVP	O	6434
)	O	6434
.	O	6434

Affected	O	6435
individuals	O	6435
are	O	6435
not	O	6435
symptomatic	O	6435
at	O	6435
birth	O	6435
,	O	6435
but	O	6435
usually	O	6435
develop	O	6435
diabetes	B-Disease	6435
insipidus	I-Disease	6435
at	O	6435
1	O	6435
-	O	6435
6	O	6435
yr	O	6435
of	O	6435
age	O	6435
.	O	6435

The	O	6436
genetic	O	6436
locus	O	6436
of	O	6436
the	O	6436
disease	O	6436
is	O	6436
the	O	6436
AVP	O	6436
-	O	6436
neurophysin	O	6436
II	O	6436
(	O	6436
NPII	O	6436
)	O	6436
gene	O	6436
,	O	6436
and	O	6436
mutations	O	6436
that	O	6436
cause	O	6436
ADNDI	B-Disease	6436
have	O	6436
been	O	6436
found	O	6436
in	O	6436
both	O	6436
the	O	6436
signal	O	6436
peptide	O	6436
of	O	6436
the	O	6436
prepro	O	6436
-	O	6436
AVP	O	6436
-	O	6436
NPII	O	6436
precursor	O	6436
and	O	6436
within	O	6436
NPII	O	6436
itself	O	6436
.	O	6436

This	O	6440
mutation	O	6440
may	O	6440
be	O	6440
valuable	O	6440
for	O	6440
developing	O	6440
models	O	6440
of	O	6440
dominantly	B-Disease	6440
inherited	I-Disease	6440
neurodegeneration	I-Disease	6440
,	O	6440
as	O	6440
the	O	6440
early	O	6440
age	O	6440
of	O	6440
onset	O	6440
of	O	6440
symptoms	O	6440
suggests	O	6440
that	O	6440
this	O	6440
mutation	O	6440
may	O	6440
be	O	6440
particularly	O	6440
deleterious	O	6440
to	O	6440
the	O	6440
magnocellular	O	6440
neuron	O	6440
.	O	6440

Frequent	O	6442
inactivation	O	6442
of	O	6442
PTEN	O	6442
/	O	6442
MMAC1	O	6442
in	O	6442
primary	O	6442
prostate	B-Disease	6442
cancer	I-Disease	6442
.	O	6442

Sporadic	B-Disease	6443
prostate	I-Disease	6443
carcinoma	I-Disease	6443
is	O	6443
the	O	6443
most	O	6443
common	O	6443
male	B-Disease	6443
cancer	I-Disease	6443
in	O	6443
the	O	6443
Western	O	6443
world	O	6443
,	O	6443
yet	O	6443
many	O	6443
of	O	6443
the	O	6443
major	O	6443
genetic	O	6443
events	O	6443
involved	O	6443
in	O	6443
the	O	6443
progression	O	6443
of	O	6443
this	O	6443
often	O	6443
fatal	O	6443
cancer	B-Disease	6443
remain	O	6443
to	O	6443
be	O	6443
elucidated	O	6443
.	O	6443

Numerous	O	6444
cytogenetic	O	6444
and	O	6444
allelotype	O	6444
studies	O	6444
have	O	6444
reported	O	6444
frequent	O	6444
loss	O	6444
of	O	6444
heterozygosity	O	6444
on	O	6444
chromosomal	O	6444
arm	O	6444
10q	O	6444
in	O	6444
sporadic	B-Disease	6444
prostate	I-Disease	6444
cancer	I-Disease	6444
.	O	6444

A	O	6446
new	O	6446
tumor	B-Disease	6446
suppressor	O	6446
gene	O	6446
,	O	6446
PTEN	O	6446
/	O	6446
MMAC1	O	6446
,	O	6446
was	O	6446
isolated	O	6446
recently	O	6446
at	O	6446
this	O	6446
region	O	6446
of	O	6446
chromosome	O	6446
10q23	O	6446
and	O	6446
found	O	6446
to	O	6446
be	O	6446
inactivated	O	6446
by	O	6446
mutation	O	6446
in	O	6446
three	O	6446
prostate	B-Disease	6446
cancer	I-Disease	6446
cell	O	6446
lines	O	6446
.	O	6446

We	O	6447
screened	O	6447
80	O	6447
prostate	B-Disease	6447
tumors	I-Disease	6447
by	O	6447
microsatellite	O	6447
analysis	O	6447
and	O	6447
found	O	6447
chromosome	O	6447
10q23	O	6447
to	O	6447
be	O	6447
deleted	O	6447
in	O	6447
23	O	6447
cases	O	6447
.	O	6447

The	O	6449
identification	O	6449
of	O	6449
the	O	6449
second	O	6449
mutational	O	6449
event	O	6449
in	O	6449
10	O	6449
(	O	6449
43	O	6449
%	O	6449
)	O	6449
tumors	B-Disease	6449
establishes	O	6449
PTEN	O	6449
/	O	6449
MMAC1	O	6449
as	O	6449
a	O	6449
main	O	6449
inactivation	O	6449
target	O	6449
of	O	6449
10q	O	6449
loss	O	6449
in	O	6449
sporadic	B-Disease	6449
prostate	I-Disease	6449
cancer	I-Disease	6449
.	O	6449

Risk	O	6451
reversals	O	6451
in	O	6451
predictive	O	6451
testing	O	6451
for	O	6451
Huntington	B-Disease	6451
disease	I-Disease	6451
.	O	6451

The	O	6452
first	O	6452
predictive	O	6452
testing	O	6452
for	O	6452
Huntington	B-Disease	6452
disease	I-Disease	6452
(	O	6452
HD	B-Disease	6452
)	O	6452
was	O	6452
based	O	6452
on	O	6452
analysis	O	6452
of	O	6452
linked	O	6452
polymorphic	O	6452
DNA	O	6452
markers	O	6452
to	O	6452
estimate	O	6452
the	O	6452
likelihood	O	6452
of	O	6452
inheriting	O	6452
the	O	6452
mutation	O	6452
for	O	6452
HD	B-Disease	6452
.	O	6452

With	O	6454
direct	O	6454
tests	O	6454
for	O	6454
the	O	6454
HD	B-Disease	6454
mutation	O	6454
,	O	6454
we	O	6454
have	O	6454
assessed	O	6454
the	O	6454
accuracy	O	6454
of	O	6454
results	O	6454
obtained	O	6454
by	O	6454
linkage	O	6454
approaches	O	6454
when	O	6454
requested	O	6454
to	O	6454
do	O	6454
so	O	6454
by	O	6454
the	O	6454
test	O	6454
individuals	O	6454
.	O	6454

A	O	6459
novel	O	6459
common	O	6459
missense	O	6459
mutation	O	6459
G301C	O	6459
in	O	6459
the	O	6459
N	O	6459
-	O	6459
acetylgalactosamine	O	6459
-	O	6459
6	O	6459
-	O	6459
sulfate	O	6459
sulfatase	O	6459
gene	O	6459
in	O	6459
mucopolysaccharidosis	B-Disease	6459
IVA	I-Disease	6459
.	O	6459

Mucopolysaccharidosis	B-Disease	6460
IVA	I-Disease	6460
(	O	6460
MPS	B-Disease	6460
IVA	I-Disease	6460
)	O	6460
is	O	6460
an	O	6460
autosomal	B-Disease	6460
recessive	I-Disease	6460
lysosomal	I-Disease	6460
storage	I-Disease	6460
disorder	I-Disease	6460
caused	O	6460
by	O	6460
a	O	6460
genetic	B-Disease	6460
defect	I-Disease	6460
in	O	6460
N	O	6460
-	O	6460
acetylgalactosamine	O	6460
-	O	6460
6	O	6460
-	O	6460
sulfate	O	6460
sulfatase	O	6460
(	O	6460
GALNS	O	6460
)	O	6460
.	O	6460

To	O	6462
characterize	O	6462
the	O	6462
mutational	O	6462
spectrum	O	6462
in	O	6462
various	O	6462
ethnic	O	6462
groups	O	6462
,	O	6462
mutations	O	6462
in	O	6462
the	O	6462
GALNS	O	6462
gene	O	6462
in	O	6462
Colombian	O	6462
MPS	B-Disease	6462
IVA	I-Disease	6462
patients	O	6462
were	O	6462
investigated	O	6462
,	O	6462
and	O	6462
genetic	O	6462
backgrounds	O	6462
were	O	6462
extensively	O	6462
analyzed	O	6462
to	O	6462
identify	O	6462
racial	O	6462
origin	O	6462
,	O	6462
based	O	6462
on	O	6462
mitochondrial	O	6462
DNA	O	6462
(	O	6462
mtDNA	O	6462
)	O	6462
lineages	O	6462
.	O	6462

Three	O	6463
novel	O	6463
missense	O	6463
mutations	O	6463
never	O	6463
identified	O	6463
previously	O	6463
in	O	6463
other	O	6463
populations	O	6463
and	O	6463
found	O	6463
in	O	6463
16	O	6463
out	O	6463
of	O	6463
19	O	6463
Colombian	O	6463
MPS	B-Disease	6463
IVA	I-Disease	6463
unrelated	O	6463
alleles	O	6463
account	O	6463
for	O	6463
84	O	6463
.	O	6463

Investigation	O	6469
of	O	6469
the	O	6469
genetic	O	6469
background	O	6469
by	O	6469
means	O	6469
of	O	6469
mtDNA	O	6469
lineages	O	6469
indicate	O	6469
that	O	6469
all	O	6469
our	O	6469
patients	O	6469
are	O	6469
probably	O	6469
of	O	6469
native	O	6469
American	O	6469
descent	O	6469
Low	O	6469
frequency	O	6469
of	O	6469
BRCA1	O	6469
germline	O	6469
mutations	O	6469
in	O	6469
45	O	6469
German	O	6469
breast	B-Disease	6469
/	I-Disease	6469
ovarian	I-Disease	6469
cancer	I-Disease	6469
families	O	6469
.	O	6469

In	O	6470
this	O	6470
study	O	6470
we	O	6470
investigated	O	6470
45	O	6470
German	O	6470
breast	B-Disease	6470
/	I-Disease	6470
ovarian	I-Disease	6470
cancer	I-Disease	6470
families	O	6470
for	O	6470
germline	O	6470
mutations	O	6470
in	O	6470
the	O	6470
BRCA1	O	6470
gene	O	6470
.	O	6470

We	O	6471
identified	O	6471
four	O	6471
germline	O	6471
mutations	O	6471
in	O	6471
three	O	6471
breast	B-Disease	6471
cancer	I-Disease	6471
families	O	6471
and	O	6471
in	O	6471
one	O	6471
breast	B-Disease	6471
-	I-Disease	6471
ovarian	I-Disease	6471
cancer	I-Disease	6471
family	O	6471
.	O	6471

These	O	6479
findings	O	6479
show	O	6479
that	O	6479
BRCA1	O	6479
is	O	6479
implicated	O	6479
in	O	6479
a	O	6479
small	O	6479
fraction	O	6479
of	O	6479
breast	B-Disease	6479
/	I-Disease	6479
ovarian	I-Disease	6479
cancer	I-Disease	6479
families	O	6479
suggesting	O	6479
the	O	6479
involvement	O	6479
of	O	6479
another	O	6479
susceptibility	O	6479
gene	O	6479
(	O	6479
s	O	6479
)	O	6479
Paternal	O	6479
transmission	O	6479
of	O	6479
congenital	B-Disease	6479
myotonic	I-Disease	6479
dystrophy	I-Disease	6479
.	O	6479

We	O	6480
report	O	6480
a	O	6480
rare	O	6480
case	O	6480
of	O	6480
paternally	O	6480
transmitted	O	6480
congenital	B-Disease	6480
myotonic	I-Disease	6480
dystrophy	I-Disease	6480
(	O	6480
DM	B-Disease	6480
)	O	6480
.	O	6480

The	O	6481
proband	O	6481
is	O	6481
a	O	6481
23	O	6481
year	O	6481
old	O	6481
,	O	6481
mentally	B-Disease	6481
retarded	I-Disease	6481
male	O	6481
who	O	6481
suffers	O	6481
severe	O	6481
muscular	B-Disease	6481
weakness	I-Disease	6481
.	O	6481

His	O	6483
two	O	6483
sibs	O	6483
suffer	O	6483
from	O	6483
childhood	O	6483
onset	O	6483
DM	B-Disease	6483
.	O	6483

Their	O	6484
late	O	6484
father	O	6484
had	O	6484
the	O	6484
adult	O	6484
type	O	6484
of	O	6484
DM	B-Disease	6484
,	O	6484
with	O	6484
onset	O	6484
around	O	6484
30	O	6484
years	O	6484
.	O	6484

Only	O	6485
six	O	6485
other	O	6485
cases	O	6485
of	O	6485
paternal	O	6485
transmission	O	6485
of	O	6485
congenital	B-Disease	6485
DM	I-Disease	6485
have	O	6485
been	O	6485
reported	O	6485
recently	O	6485
.	O	6485

We	O	6486
review	O	6486
the	O	6486
sex	O	6486
related	O	6486
effects	O	6486
on	O	6486
transmission	O	6486
of	O	6486
congenital	B-Disease	6486
DM	I-Disease	6486
.	O	6486

Decreased	O	6487
fertility	O	6487
of	O	6487
males	O	6487
with	O	6487
adult	O	6487
onset	O	6487
DM	B-Disease	6487
and	O	6487
contraction	O	6487
of	O	6487
the	O	6487
repeat	O	6487
upon	O	6487
male	O	6487
transmission	O	6487
contribute	O	6487
to	O	6487
the	O	6487
almost	O	6487
absent	O	6487
occurrence	O	6487
of	O	6487
paternal	O	6487
transmission	O	6487
of	O	6487
congenital	B-Disease	6487
DM	I-Disease	6487
.	O	6487

Also	O	6488
the	O	6488
fathers	O	6488
of	O	6488
the	O	6488
reported	O	6488
congenitally	O	6488
affected	O	6488
children	O	6488
showed	O	6488
,	O	6488
on	O	6488
average	O	6488
,	O	6488
shorter	O	6488
CTG	O	6488
repeat	O	6488
lengths	O	6488
and	O	6488
hence	O	6488
less	O	6488
severe	O	6488
clinical	O	6488
symptoms	O	6488
than	O	6488
the	O	6488
mothers	O	6488
of	O	6488
children	O	6488
with	O	6488
congenital	B-Disease	6488
DM	I-Disease	6488
.	O	6488

We	O	6489
conclude	O	6489
that	O	6489
paternal	O	6489
transmission	O	6489
of	O	6489
congenital	B-Disease	6489
DM	I-Disease	6489
is	O	6489
rare	O	6489
and	O	6489
preferentially	O	6489
occurs	O	6489
with	O	6489
onset	O	6489
of	O	6489
DM	B-Disease	6489
past	O	6489
30	O	6489
years	O	6489
in	O	6489
the	O	6489
father	O	6489
.	O	6489

The	O	6491
RB1	O	6491
gene	O	6491
mutation	O	6491
in	O	6491
a	O	6491
child	O	6491
with	O	6491
ectopic	B-Disease	6491
intracranial	I-Disease	6491
retinoblastoma	I-Disease	6491
.	O	6491

The	O	6492
RB1	O	6492
gene	O	6492
mutation	O	6492
was	O	6492
investigated	O	6492
in	O	6492
a	O	6492
child	O	6492
with	O	6492
ectopic	B-Disease	6492
intracranial	I-Disease	6492
retinoblastoma	I-Disease	6492
using	O	6492
DNA	O	6492
obtained	O	6492
from	O	6492
both	O	6492
the	O	6492
pineal	B-Disease	6492
and	I-Disease	6492
retinal	I-Disease	6492
tumours	I-Disease	6492
of	O	6492
the	O	6492
patient	O	6492
.	O	6492

A	O	6493
nonsense	O	6493
mutation	O	6493
in	O	6493
exon	O	6493
17	O	6493
(	O	6493
codon	O	6493
556	O	6493
)	O	6493
of	O	6493
the	O	6493
RB1	O	6493
gene	O	6493
was	O	6493
found	O	6493
to	O	6493
be	O	6493
present	O	6493
homozygously	O	6493
in	O	6493
both	O	6493
the	O	6493
retinal	B-Disease	6493
and	I-Disease	6493
the	I-Disease	6493
pineal	I-Disease	6493
tumours	I-Disease	6493
.	O	6493

The	O	6496
mutation	O	6496
is	O	6496
in	O	6496
an	O	6496
area	O	6496
of	O	6496
the	O	6496
gene	O	6496
that	O	6496
encodes	O	6496
the	O	6496
protein	O	6496
-	O	6496
binding	O	6496
region	O	6496
known	O	6496
as	O	6496
the	O	6496
pocket	O	6496
region	O	6496
and	O	6496
has	O	6496
been	O	6496
detected	O	6496
in	O	6496
other	O	6496
cases	O	6496
of	O	6496
retinoblastoma	B-Disease	6496
.	O	6496

Appreciable	O	6499
beta	O	6499
hexosaminidase	O	6499
A	O	6499
(	O	6499
hex	O	6499
A	O	6499
)	O	6499
activity	O	6499
has	O	6499
been	O	6499
detected	O	6499
in	O	6499
cultured	O	6499
skin	O	6499
fibroblasts	O	6499
and	O	6499
melanoma	B-Disease	6499
tissue	O	6499
from	O	6499
healthy	O	6499
individuals	O	6499
previously	O	6499
reported	O	6499
as	O	6499
having	O	6499
deficiency	B-Disease	6499
of	I-Disease	6499
hex	I-Disease	6499
A	I-Disease	6499
activity	O	6499
indistinguishable	O	6499
from	O	6499
that	O	6499
of	O	6499
patients	O	6499
with	O	6499
Tay	B-Disease	6499
-	I-Disease	6499
Sachs	I-Disease	6499
disease	I-Disease	6499
(	O	6499
TSD	B-Disease	6499
)	O	6499
.	O	6499

Previous	O	6503
family	O	6503
studies	O	6503
suggested	O	6503
that	O	6503
these	O	6503
individuals	O	6503
may	O	6503
be	O	6503
compound	O	6503
heterozygotes	O	6503
for	O	6503
the	O	6503
common	O	6503
mutant	O	6503
TSD	B-Disease	6503
gene	O	6503
and	O	6503
a	O	6503
rare	O	6503
(	O	6503
allelic	O	6503
)	O	6503
mutant	O	6503
gene	O	6503
.	O	6503

Heterozygotes	O	6505
for	O	6505
the	O	6505
rare	O	6505
mutant	O	6505
may	O	6505
be	O	6505
indistinguishable	O	6505
from	O	6505
heterozygotes	O	6505
for	O	6505
the	O	6505
common	O	6505
TSD	B-Disease	6505
mutant	O	6505
.	O	6505

However	O	6506
,	O	6506
direct	O	6506
visualization	O	6506
and	O	6506
quantitation	O	6506
of	O	6506
hex	O	6506
A	O	6506
by	O	6506
the	O	6506
methods	O	6506
described	O	6506
may	O	6506
prevent	O	6506
false	O	6506
-	O	6506
positive	O	6506
prenatal	O	6506
diagnosis	O	6506
of	O	6506
TSD	B-Disease	6506
in	O	6506
fetuses	O	6506
having	O	6506
the	O	6506
incomplete	O	6506
hex	B-Disease	6506
A	I-Disease	6506
deficiency	I-Disease	6506
of	O	6506
the	O	6506
type	O	6506
described	O	6506
in	O	6506
the	O	6506
four	O	6506
healthy	O	6506
individuals	O	6506
The	O	6506
tumor	B-Disease	6506
suppressor	O	6506
gene	O	6506
Smad4	O	6506
/	O	6506
Dpc4	O	6506
is	O	6506
required	O	6506
for	O	6506
gastrulation	O	6506
and	O	6506
later	O	6506
for	O	6506
anterior	O	6506
development	O	6506
of	O	6506
the	O	6506
mouse	O	6506
embryo	O	6506
.	O	6506

Mutations	O	6507
in	O	6507
the	O	6507
SMAD4	O	6507
/	O	6507
DPC4	O	6507
tumor	B-Disease	6507
suppressor	O	6507
gene	O	6507
,	O	6507
a	O	6507
key	O	6507
signal	O	6507
transducer	O	6507
in	O	6507
most	O	6507
TGFbeta	O	6507
-	O	6507
related	O	6507
pathways	O	6507
,	O	6507
are	O	6507
involved	O	6507
in	O	6507
50	O	6507
%	O	6507
of	O	6507
pancreatic	B-Disease	6507
cancers	I-Disease	6507
.	O	6507

Growth	B-Disease	6511
retardation	I-Disease	6511
of	O	6511
the	O	6511
Smad4	O	6511
-	O	6511
deficient	O	6511
embryos	O	6511
results	O	6511
from	O	6511
reduced	O	6511
cell	O	6511
proliferation	O	6511
rather	O	6511
than	O	6511
increased	O	6511
apoptosis	O	6511
.	O	6511

Aggregation	O	6512
of	O	6512
mutant	O	6512
Smad4	O	6512
ES	O	6512
cells	O	6512
with	O	6512
wild	O	6512
-	O	6512
type	O	6512
tetraploid	O	6512
morulae	O	6512
rescues	O	6512
the	O	6512
gastrulation	B-Disease	6512
defect	I-Disease	6512
.	O	6512

These	O	6513
results	O	6513
indicate	O	6513
that	O	6513
Smad4	O	6513
is	O	6513
initially	O	6513
required	O	6513
for	O	6513
the	O	6513
differentiation	O	6513
of	O	6513
the	O	6513
visceral	O	6513
endoderm	O	6513
and	O	6513
that	O	6513
the	O	6513
gastrulation	B-Disease	6513
defect	I-Disease	6513
in	O	6513
the	O	6513
epiblast	O	6513
is	O	6513
secondary	O	6513
and	O	6513
non	O	6513
-	O	6513
cell	O	6513
autonomous	O	6513
.	O	6513

Prevalence	O	6515
of	O	6515
p16	O	6515
and	O	6515
CDK4	O	6515
germline	O	6515
mutations	O	6515
in	O	6515
48	O	6515
melanoma	B-Disease	6515
-	O	6515
prone	O	6515
families	O	6515
in	O	6515
France	O	6515
.	O	6515

The	O	6516
French	O	6516
Familial	B-Disease	6516
Melanoma	I-Disease	6516
Study	O	6516
Group	O	6516
.	O	6516

Germline	O	6517
mutations	O	6517
in	O	6517
the	O	6517
p16	O	6517
and	O	6517
CDK4	O	6517
genes	O	6517
have	O	6517
been	O	6517
reported	O	6517
in	O	6517
a	O	6517
subset	O	6517
of	O	6517
melanoma	B-Disease	6517
pedigrees	O	6517
,	O	6517
but	O	6517
their	O	6517
prevalence	O	6517
is	O	6517
not	O	6517
well	O	6517
known	O	6517
.	O	6517

We	O	6518
searched	O	6518
for	O	6518
such	O	6518
germline	O	6518
mutations	O	6518
in	O	6518
48	O	6518
French	O	6518
melanoma	B-Disease	6518
-	O	6518
prone	O	6518
families	O	6518
selected	O	6518
according	O	6518
to	O	6518
two	O	6518
major	O	6518
criteria	O	6518
families	O	6518
with	O	6518
at	O	6518
least	O	6518
three	O	6518
affected	O	6518
members	O	6518
(	O	6518
n	O	6518
=	O	6518
20	O	6518
)	O	6518
or	O	6518
families	O	6518
with	O	6518
two	O	6518
affected	O	6518
members	O	6518
,	O	6518
one	O	6518
of	O	6518
them	O	6518
affected	O	6518
before	O	6518
the	O	6518
age	O	6518
of	O	6518
50	O	6518
(	O	6518
n	O	6518
=	O	6518
28	O	6518
)	O	6518
,	O	6518
and	O	6518
one	O	6518
additional	O	6518
minor	O	6518
criterion	O	6518
.	O	6518

In	O	6521
summary	O	6521
,	O	6521
our	O	6521
results	O	6521
show	O	6521
frequent	O	6521
involvement	O	6521
of	O	6521
the	O	6521
p16	O	6521
gene	O	6521
in	O	6521
familial	B-Disease	6521
melanoma	I-Disease	6521
and	O	6521
confirm	O	6521
the	O	6521
role	O	6521
of	O	6521
the	O	6521
CDK4	O	6521
gene	O	6521
as	O	6521
a	O	6521
melanoma	B-Disease	6521
-	O	6521
predisposing	O	6521
gene	O	6521
.	O	6521

Progression	O	6523
of	O	6523
somatic	O	6523
CTG	O	6523
repeat	O	6523
length	O	6523
heterogeneity	O	6523
in	O	6523
the	O	6523
blood	O	6523
cells	O	6523
of	O	6523
myotonic	B-Disease	6523
dystrophy	I-Disease	6523
patients	O	6523
.	O	6523

The	O	6524
genetic	O	6524
basis	O	6524
of	O	6524
myotonic	B-Disease	6524
dystrophy	I-Disease	6524
(	O	6524
DM	B-Disease	6524
)	O	6524
is	O	6524
the	O	6524
expansion	O	6524
of	O	6524
an	O	6524
unstable	O	6524
CTG	O	6524
repeat	O	6524
in	O	6524
the	O	6524
34	O	6524
UTR	O	6524
of	O	6524
the	O	6524
DM	B-Disease	6524
protein	O	6524
kinase	O	6524
gene	O	6524
on	O	6524
chromosome	O	6524
19	O	6524
.	O	6524

One	O	6525
of	O	6525
the	O	6525
principal	O	6525
features	O	6525
of	O	6525
the	O	6525
DM	B-Disease	6525
mutation	O	6525
is	O	6525
an	O	6525
extraordinarily	O	6525
high	O	6525
level	O	6525
of	O	6525
somatic	O	6525
mosaicism	O	6525
,	O	6525
due	O	6525
to	O	6525
an	O	6525
extremely	O	6525
high	O	6525
degree	O	6525
of	O	6525
somatic	O	6525
instability	O	6525
both	O	6525
within	O	6525
and	O	6525
between	O	6525
different	O	6525
tissues	O	6525
.	O	6525

In	O	6528
order	O	6528
to	O	6528
further	O	6528
characterize	O	6528
the	O	6528
dynamics	O	6528
of	O	6528
DM	B-Disease	6528
CTG	O	6528
repeat	O	6528
somatic	O	6528
instability	O	6528
,	O	6528
we	O	6528
have	O	6528
studied	O	6528
repeat	O	6528
length	O	6528
changes	O	6528
over	O	6528
time	O	6528
in	O	6528
111	O	6528
myotonic	B-Disease	6528
dystrophy	I-Disease	6528
patients	O	6528
with	O	6528
varying	O	6528
clinical	O	6528
severity	O	6528
and	O	6528
CTG	O	6528
repeat	O	6528
size	O	6528
over	O	6528
time	O	6528
intervals	O	6528
of	O	6528
1	O	6528
-	O	6528
7	O	6528
years	O	6528
.	O	6528

Aspartylglucosaminuria	B-Disease	6532
among	O	6532
Palestinian	O	6532
Arabs	O	6532
.	O	6532

Aspartylglucosaminuria	B-Disease	6533
(	O	6533
AGU	B-Disease	6533
)	O	6533
is	O	6533
a	O	6533
rare	O	6533
disorder	B-Disease	6533
of	I-Disease	6533
glycoprotein	I-Disease	6533
metabolism	I-Disease	6533
caused	O	6533
by	O	6533
the	O	6533
deficiency	B-Disease	6533
of	I-Disease	6533
the	I-Disease	6533
lysosomal	I-Disease	6533
enzyme	I-Disease	6533
aspartylglucosaminidase	I-Disease	6533
(	O	6533
AGA	O	6533
)	O	6533
.	O	6533

AGU	B-Disease	6534
is	O	6534
inherited	O	6534
as	O	6534
an	O	6534
autosomal	O	6534
recessive	O	6534
trait	O	6534
and	O	6534
occurs	O	6534
with	O	6534
a	O	6534
high	O	6534
frequency	O	6534
in	O	6534
Finland	O	6534
because	O	6534
of	O	6534
a	O	6534
founder	O	6534
effect	O	6534
.	O	6534

While	O	6535
very	O	6535
few	O	6535
patients	O	6535
with	O	6535
AGU	B-Disease	6535
have	O	6535
been	O	6535
reported	O	6535
from	O	6535
non	O	6535
-	O	6535
Finnish	O	6535
origin	O	6535
,	O	6535
we	O	6535
diagnosed	O	6535
the	O	6535
disorder	O	6535
in	O	6535
8	O	6535
patients	O	6535
originating	O	6535
from	O	6535
3	O	6535
unrelated	O	6535
families	O	6535
,	O	6535
all	O	6535
Palestinian	O	6535
Arabs	O	6535
from	O	6535
the	O	6535
region	O	6535
of	O	6535
Jerusalem	O	6535
.	O	6535

The	O	6536
clinical	O	6536
diagnosis	O	6536
of	O	6536
AGU	B-Disease	6536
is	O	6536
often	O	6536
difficult	O	6536
,	O	6536
in	O	6536
particular	O	6536
early	O	6536
in	O	6536
the	O	6536
course	O	6536
of	O	6536
the	O	6536
disease	O	6536
,	O	6536
and	O	6536
most	O	6536
of	O	6536
the	O	6536
patients	O	6536
are	O	6536
diagnosed	O	6536
after	O	6536
the	O	6536
age	O	6536
of	O	6536
5	O	6536
years	O	6536
.	O	6536

Detection	O	6539
of	O	6539
heterozygous	O	6539
carriers	O	6539
of	O	6539
the	O	6539
ataxia	B-Disease	6539
-	I-Disease	6539
telangiectasia	I-Disease	6539
(	O	6539
ATM	O	6539
)	O	6539
gene	O	6539
by	O	6539
G2	O	6539
phase	O	6539
chromosomal	O	6539
radiosensitivity	O	6539
of	O	6539
peripheral	O	6539
blood	O	6539
lymphocytes	O	6539
.	O	6539

In	O	6540
ataxia	B-Disease	6540
-	I-Disease	6540
telangiectasia	I-Disease	6540
(	O	6540
A	B-Disease	6540
-	I-Disease	6540
T	I-Disease	6540
)	O	6540
patients	O	6540
,	O	6540
mutations	O	6540
in	O	6540
a	O	6540
single	O	6540
gene	O	6540
,	O	6540
ATM	O	6540
,	O	6540
result	O	6540
in	O	6540
an	O	6540
autosomal	B-Disease	6540
recessive	I-Disease	6540
syndrome	I-Disease	6540
that	O	6540
embraces	O	6540
a	O	6540
variety	O	6540
of	O	6540
clinical	O	6540
features	O	6540
and	O	6540
manifests	O	6540
extreme	O	6540
radiosensitivity	O	6540
and	O	6540
a	O	6540
strong	O	6540
pre	O	6540
-	O	6540
disposition	O	6540
to	O	6540
malignancy	B-Disease	6540
.	O	6540

Heterozygotes	O	6541
for	O	6541
the	O	6541
ATM	O	6541
gene	O	6541
have	O	6541
no	O	6541
clinical	O	6541
expression	O	6541
of	O	6541
A	B-Disease	6541
-	I-Disease	6541
T	I-Disease	6541
but	O	6541
may	O	6541
be	O	6541
cancer	B-Disease	6541
prone	O	6541
with	O	6541
a	O	6541
moderate	O	6541
increase	O	6541
in	O	6541
in	O	6541
vitro	O	6541
radiosensitivity	O	6541
.	O	6541

We	O	6542
performed	O	6542
a	O	6542
blind	O	6542
chromosomal	O	6542
analysis	O	6542
on	O	6542
G2	O	6542
-	O	6542
phase	O	6542
lymphocytes	O	6542
from	O	6542
7	O	6542
unrelated	O	6542
A	B-Disease	6542
-	I-Disease	6542
T	I-Disease	6542
patients	O	6542
,	O	6542
13	O	6542
obligate	O	6542
A	B-Disease	6542
-	I-Disease	6542
T	I-Disease	6542
heterozygotes	O	6542
(	O	6542
parents	O	6542
of	O	6542
the	O	6542
patients	O	6542
)	O	6542
,	O	6542
and	O	6542
14	O	6542
normal	O	6542
controls	O	6542
following	O	6542
X	O	6542
-	O	6542
irradiation	O	6542
with	O	6542
1	O	6542
Gy	O	6542
in	O	6542
order	O	6542
to	O	6542
evaluate	O	6542
this	O	6542
cytogenetic	O	6542
method	O	6542
as	O	6542
a	O	6542
tool	O	6542
for	O	6542
detection	O	6542
of	O	6542
ATM	O	6542
carriers	O	6542
.	O	6542

Both	O	6543
A	B-Disease	6543
-	I-Disease	6543
T	I-Disease	6543
homozygotes	O	6543
and	O	6543
heterozygotes	O	6543
showed	O	6543
significantly	O	6543
increased	O	6543
levels	O	6543
of	O	6543
radiation	O	6543
-	O	6543
induced	O	6543
chromatid	O	6543
damage	O	6543
relative	O	6543
to	O	6543
that	O	6543
of	O	6543
normal	O	6543
controls	O	6543
.	O	6543

These	O	6544
results	O	6544
show	O	6544
that	O	6544
the	O	6544
G2	O	6544
-	O	6544
phase	O	6544
chromosomal	O	6544
radiosensitivity	O	6544
assay	O	6544
can	O	6544
be	O	6544
used	O	6544
for	O	6544
the	O	6544
detection	O	6544
of	O	6544
A	B-Disease	6544
-	I-Disease	6544
T	I-Disease	6544
heterozygotes	O	6544
.	O	6544

In	O	6545
combination	O	6545
with	O	6545
molecular	O	6545
genetic	O	6545
analyses	O	6545
,	O	6545
this	O	6545
test	O	6545
may	O	6545
be	O	6545
of	O	6545
value	O	6545
in	O	6545
studies	O	6545
of	O	6545
familial	B-Disease	6545
and	I-Disease	6545
sporadic	I-Disease	6545
cancers	I-Disease	6545
aimed	O	6545
at	O	6545
determination	O	6545
of	O	6545
the	O	6545
potential	O	6545
involvement	O	6545
of	O	6545
ATM	O	6545
mutations	O	6545
in	O	6545
tumor	B-Disease	6545
risk	O	6545
or	O	6545
development	O	6545
.	O	6545

Ataxia	B-Disease	6547
-	I-Disease	6547
telangiectasia	I-Disease	6547
:	O	6547
identification	O	6547
and	O	6547
detection	O	6547
of	O	6547
founder	O	6547
-	O	6547
effect	O	6547
mutations	O	6547
in	O	6547
the	O	6547
ATM	O	6547
gene	O	6547
in	O	6547
ethnic	O	6547
populations	O	6547
.	O	6547

To	O	6548
facilitate	O	6548
the	O	6548
evaluation	O	6548
of	O	6548
ATM	O	6548
heterozygotes	O	6548
for	O	6548
susceptibility	O	6548
to	O	6548
other	O	6548
diseases	O	6548
,	O	6548
such	O	6548
as	O	6548
breast	B-Disease	6548
cancer	I-Disease	6548
,	O	6548
we	O	6548
have	O	6548
attempted	O	6548
to	O	6548
define	O	6548
the	O	6548
most	O	6548
common	O	6548
mutations	O	6548
and	O	6548
their	O	6548
frequencies	O	6548
in	O	6548
ataxia	B-Disease	6548
-	I-Disease	6548
telangiectasia	I-Disease	6548
(	O	6548
A	B-Disease	6548
-	I-Disease	6548
T	I-Disease	6548
)	O	6548
homozygotes	O	6548
from	O	6548
10	O	6548
ethnic	O	6548
populations	O	6548
.	O	6548

These	O	6555
assays	O	6555
should	O	6555
facilitate	O	6555
screening	O	6555
for	O	6555
A	B-Disease	6555
-	I-Disease	6555
T	I-Disease	6555
heterozygotes	O	6555
in	O	6555
the	O	6555
populations	O	6555
studied	O	6555
.	O	6555

The	O	6557
von	B-Disease	6557
Hippel	I-Disease	6557
-	I-Disease	6557
Lindau	I-Disease	6557
tumor	I-Disease	6557
suppressor	O	6557
gene	O	6557
is	O	6557
required	O	6557
for	O	6557
cell	O	6557
cycle	O	6557
exit	O	6557
upon	O	6557
serum	O	6557
withdrawal	O	6557
.	O	6557

The	O	6558
inactivation	O	6558
of	O	6558
the	O	6558
von	B-Disease	6558
Hippel	I-Disease	6558
-	I-Disease	6558
Lindau	I-Disease	6558
(	I-Disease	6558
VHL	I-Disease	6558
)	I-Disease	6558
tumor	I-Disease	6558
suppressor	O	6558
gene	O	6558
predisposes	O	6558
affected	O	6558
individuals	O	6558
to	O	6558
the	O	6558
human	O	6558
VHL	B-Disease	6558
cancer	I-Disease	6558
syndrome	I-Disease	6558
and	O	6558
is	O	6558
associated	O	6558
with	O	6558
sporadic	B-Disease	6558
renal	I-Disease	6558
cell	I-Disease	6558
carcinomas	I-Disease	6558
(	O	6558
RCC	B-Disease	6558
)	O	6558
and	O	6558
brain	B-Disease	6558
hemangioblastomas	I-Disease	6558
.	O	6558

VHL	O	6559
-	O	6559
negative	O	6559
786	O	6559
-	O	6559
0	O	6559
RCC	B-Disease	6559
cells	O	6559
are	O	6559
tumorigenic	O	6559
in	O	6559
nude	O	6559
mice	O	6559
which	O	6559
is	O	6559
suppressed	O	6559
by	O	6559
the	O	6559
reintroduction	O	6559
of	O	6559
VHL	B-Disease	6559
.	O	6559

The	O	6561
786	O	6561
-	O	6561
0	O	6561
cell	O	6561
line	O	6561
,	O	6561
like	O	6561
many	O	6561
cancer	B-Disease	6561
cells	O	6561
,	O	6561
fails	O	6561
to	O	6561
exit	O	6561
the	O	6561
cell	O	6561
cycle	O	6561
upon	O	6561
serum	O	6561
withdrawal	O	6561
.	O	6561

Here	O	6562
,	O	6562
it	O	6562
is	O	6562
shown	O	6562
that	O	6562
reintroduction	O	6562
of	O	6562
the	O	6562
wild	O	6562
-	O	6562
type	O	6562
VHL	B-Disease	6562
gene	O	6562
restores	O	6562
the	O	6562
ability	O	6562
of	O	6562
VHL	O	6562
-	O	6562
negative	O	6562
RCC	B-Disease	6562
cancer	I-Disease	6562
cells	O	6562
to	O	6562
exit	O	6562
the	O	6562
cell	O	6562
cycle	O	6562
and	O	6562
enter	O	6562
G0	O	6562
/	O	6562
quiescence	O	6562
in	O	6562
low	O	6562
serum	O	6562
.	O	6562

Both	O	6563
VHL	O	6563
-	O	6563
positive	O	6563
and	O	6563
VHL	O	6563
-	O	6563
negative	O	6563
RCC	B-Disease	6563
cells	O	6563
exit	O	6563
the	O	6563
cell	O	6563
cycle	O	6563
by	O	6563
contact	O	6563
inhibition	O	6563
.	O	6563

The	O	6564
cyclin	O	6564
-	O	6564
dependent	O	6564
kinase	O	6564
inhibitor	O	6564
,	O	6564
p27	O	6564
,	O	6564
accumulates	O	6564
upon	O	6564
serum	O	6564
withdrawal	O	6564
,	O	6564
only	O	6564
in	O	6564
the	O	6564
presence	O	6564
of	O	6564
VHL	B-Disease	6564
,	O	6564
as	O	6564
a	O	6564
result	O	6564
of	O	6564
the	O	6564
stabilization	O	6564
of	O	6564
the	O	6564
protein	O	6564
.	O	6564

We	O	6565
propose	O	6565
that	O	6565
the	O	6565
loss	O	6565
of	O	6565
wild	O	6565
-	O	6565
type	O	6565
VHL	B-Disease	6565
gene	O	6565
results	O	6565
in	O	6565
a	O	6565
specific	O	6565
cellular	O	6565
defect	O	6565
in	O	6565
serum	O	6565
-	O	6565
dependent	O	6565
growth	O	6565
control	O	6565
,	O	6565
which	O	6565
may	O	6565
initiate	O	6565
tumor	B-Disease	6565
formation	O	6565
.	O	6565

This	O	6566
is	O	6566
corrected	O	6566
by	O	6566
the	O	6566
reintroduction	O	6566
of	O	6566
wild	O	6566
-	O	6566
type	O	6566
VHL	B-Disease	6566
,	O	6566
implicating	O	6566
VHL	B-Disease	6566
as	O	6566
the	O	6566
first	O	6566
tumor	B-Disease	6566
suppressor	O	6566
involved	O	6566
in	O	6566
the	O	6566
regulation	O	6566
of	O	6566
cell	O	6566
cycle	O	6566
exit	O	6566
,	O	6566
which	O	6566
is	O	6566
consistent	O	6566
with	O	6566
its	O	6566
gatekeeper	O	6566
function	O	6566
in	O	6566
the	O	6566
kidney	O	6566
.	O	6566

Piebaldism	B-Disease	6568
with	O	6568
deafness	B-Disease	6568
:	O	6568
molecular	O	6568
evidence	O	6568
for	O	6568
an	O	6568
expanded	O	6568
syndrome	O	6568
.	O	6568

In	O	6569
a	O	6569
South	O	6569
African	O	6569
girl	O	6569
of	O	6569
Xhosa	O	6569
stock	O	6569
with	O	6569
severe	O	6569
piebaldism	B-Disease	6569
and	O	6569
profound	O	6569
congenital	O	6569
sensorineural	B-Disease	6569
deafness	I-Disease	6569
we	O	6569
identified	O	6569
a	O	6569
novel	O	6569
missense	O	6569
substitution	O	6569
at	O	6569
a	O	6569
highly	O	6569
conserved	O	6569
residue	O	6569
in	O	6569
the	O	6569
intracellular	O	6569
kinase	O	6569
domain	O	6569
of	O	6569
the	O	6569
KIT	O	6569
proto	O	6569
-	O	6569
oncogene	O	6569
,	O	6569
R796G	O	6569
.	O	6569

Though	O	6570
auditory	B-Disease	6570
anomalies	I-Disease	6570
have	O	6570
been	O	6570
observed	O	6570
in	O	6570
mice	O	6570
with	O	6570
dominant	O	6570
white	O	6570
spotting	O	6570
(	O	6570
W	O	6570
)	O	6570
due	O	6570
to	O	6570
KIT	O	6570
mutations	O	6570
,	O	6570
deafness	B-Disease	6570
is	O	6570
not	O	6570
typical	O	6570
in	O	6570
human	O	6570
piebaldism	B-Disease	6570
.	O	6570

Thus	O	6571
,	O	6571
the	O	6571
occurrence	O	6571
of	O	6571
sensorineural	B-Disease	6571
deafness	I-Disease	6571
in	O	6571
this	O	6571
patient	O	6571
extends	O	6571
considerably	O	6571
the	O	6571
phenotypic	O	6571
range	O	6571
of	O	6571
piebaldism	B-Disease	6571
due	O	6571
to	O	6571
KIT	O	6571
gene	O	6571
mutation	O	6571
in	O	6571
humans	O	6571
and	O	6571
tightens	O	6571
the	O	6571
clinical	O	6571
similarity	O	6571
between	O	6571
piebaldism	B-Disease	6571
and	O	6571
the	O	6571
various	O	6571
forms	O	6571
of	O	6571
Waardenburg	B-Disease	6571
syndrome	I-Disease	6571
.	O	6571

Cycloheximide	O	6573
facilitates	O	6573
the	O	6573
identification	O	6573
of	O	6573
aberrant	O	6573
transcripts	O	6573
resulting	O	6573
from	O	6573
a	O	6573
novel	O	6573
splice	O	6573
-	O	6573
site	O	6573
mutation	O	6573
in	O	6573
COL17A1	O	6573
in	O	6573
a	O	6573
patient	O	6573
with	O	6573
generalized	O	6573
atrophic	B-Disease	6573
benign	I-Disease	6573
epidermolysis	I-Disease	6573
bullosa	I-Disease	6573
.	O	6573

Patients	O	6574
with	O	6574
generalized	O	6574
atrophic	B-Disease	6574
benign	I-Disease	6574
epidermolysis	I-Disease	6574
bullosa	I-Disease	6574
often	O	6574
show	O	6574
decreased	O	6574
expression	O	6574
of	O	6574
type	O	6574
XVII	O	6574
collagen	O	6574
,	O	6574
a	O	6574
transmembrane	O	6574
hemidesmosomal	O	6574
protein	O	6574
encoded	O	6574
by	O	6574
COL17A1	O	6574
.	O	6574

This	O	6575
report	O	6575
documents	O	6575
a	O	6575
novel	O	6575
splice	O	6575
-	O	6575
site	O	6575
mutation	O	6575
in	O	6575
COL17A1	O	6575
in	O	6575
a	O	6575
patient	O	6575
with	O	6575
generalized	O	6575
atrophic	B-Disease	6575
benign	I-Disease	6575
epidermolysis	I-Disease	6575
bullosa	I-Disease	6575
,	O	6575
and	O	6575
applies	O	6575
a	O	6575
new	O	6575
methodology	O	6575
to	O	6575
define	O	6575
and	O	6575
characterize	O	6575
the	O	6575
resulting	O	6575
mRNA	O	6575
splice	O	6575
variants	O	6575
.	O	6575

A	O	6583
deletion	O	6583
mutation	O	6583
in	O	6583
COL17A1	O	6583
in	O	6583
five	O	6583
Austrian	O	6583
families	O	6583
with	O	6583
generalized	O	6583
atrophic	B-Disease	6583
benign	I-Disease	6583
epidermolysis	I-Disease	6583
bullosa	I-Disease	6583
represents	O	6583
propagation	O	6583
of	O	6583
an	O	6583
ancestral	O	6583
allele	O	6583
.	O	6583

Patients	O	6584
with	O	6584
generalized	O	6584
atrophic	B-Disease	6584
benign	I-Disease	6584
epidermolysis	I-Disease	6584
bullosa	I-Disease	6584
,	O	6584
a	O	6584
usually	O	6584
nonlethal	O	6584
form	O	6584
of	O	6584
junctional	B-Disease	6584
epidermolysis	I-Disease	6584
bullosa	I-Disease	6584
,	O	6584
have	O	6584
generalized	O	6584
blistering	B-Disease	6584
,	O	6584
nail	B-Disease	6584
dystrophy	I-Disease	6584
,	O	6584
patchy	B-Disease	6584
alopecia	I-Disease	6584
,	O	6584
and	O	6584
dental	B-Disease	6584
abnormalities	I-Disease	6584
.	O	6584

Skin	B-Disease	6585
fragility	I-Disease	6585
in	O	6585
most	O	6585
cases	O	6585
is	O	6585
due	O	6585
to	O	6585
mutations	O	6585
in	O	6585
the	O	6585
gene	O	6585
encoding	O	6585
type	O	6585
XVII	O	6585
collagen	O	6585
(	O	6585
COL17A1	O	6585
)	O	6585
.	O	6585

Recently	O	6586
,	O	6586
we	O	6586
reported	O	6586
five	O	6586
Austrian	O	6586
families	O	6586
with	O	6586
generalized	O	6586
atrophic	B-Disease	6586
benign	I-Disease	6586
epidermolysis	I-Disease	6586
bullosa	I-Disease	6586
who	O	6586
share	O	6586
the	O	6586
same	O	6586
COL17A1	O	6586
mutation	O	6586
.	O	6586

The	O	6596
haptoglobin	O	6596
-	O	6596
gene	O	6596
deletion	O	6596
responsible	O	6596
for	O	6596
anhaptoglobinemia	B-Disease	6596
.	O	6596

We	O	6597
have	O	6597
found	O	6597
an	O	6597
allelic	O	6597
deletion	O	6597
of	O	6597
the	O	6597
haptoglobin	O	6597
(	O	6597
Hp	O	6597
)	O	6597
gene	O	6597
from	O	6597
an	O	6597
individual	O	6597
with	O	6597
anhaptoglobinemia	B-Disease	6597
.	O	6597

Southern	O	6599
blot	O	6599
and	O	6599
PCR	O	6599
analyses	O	6599
have	O	6599
indicated	O	6599
that	O	6599
the	O	6599
individual	O	6599
with	O	6599
anhaptoglobinemia	B-Disease	6599
was	O	6599
homozygous	O	6599
for	O	6599
the	O	6599
gene	O	6599
deletion	O	6599
and	O	6599
that	O	6599
the	O	6599
gene	O	6599
deletion	O	6599
was	O	6599
included	O	6599
at	O	6599
least	O	6599
from	O	6599
the	O	6599
promoter	O	6599
region	O	6599
of	O	6599
Hp	O	6599
to	O	6599
Hpr	O	6599
alpha	O	6599
but	O	6599
not	O	6599
to	O	6599
Hpr	O	6599
beta	O	6599
(	O	6599
Hpdel	O	6599
)	O	6599
.	O	6599

In	O	6600
addition	O	6600
,	O	6600
we	O	6600
found	O	6600
seven	O	6600
individuals	O	6600
with	O	6600
hypohaptoglobinemia	B-Disease	6600
in	O	6600
three	O	6600
families	O	6600
,	O	6600
and	O	6600
the	O	6600
genotypes	O	6600
of	O	6600
six	O	6600
of	O	6600
the	O	6600
seven	O	6600
individuals	O	6600
were	O	6600
found	O	6600
to	O	6600
be	O	6600
Hp2	O	6600
/	O	6600
Hpdel	O	6600
.	O	6600

The	O	6601
phenotypes	O	6601
and	O	6601
genotypes	O	6601
in	O	6601
one	O	6601
of	O	6601
these	O	6601
three	O	6601
families	O	6601
showed	O	6601
the	O	6601
father	O	6601
to	O	6601
be	O	6601
hypohaptoglobinemic	B-Disease	6601
(	O	6601
Hp2	O	6601
)	O	6601
and	O	6601
Hp2	O	6601
/	O	6601
Hpdel	O	6601
,	O	6601
the	O	6601
mother	O	6601
to	O	6601
be	O	6601
Hp2	O	6601
-	O	6601
1	O	6601
and	O	6601
Hp1	O	6601
/	O	6601
Hp2	O	6601
,	O	6601
one	O	6601
of	O	6601
the	O	6601
two	O	6601
children	O	6601
to	O	6601
be	O	6601
hypohaptoglobinemic	B-Disease	6601
(	O	6601
Hp2	O	6601
)	O	6601
and	O	6601
Hp2	O	6601
/	O	6601
Hpdel	O	6601
,	O	6601
and	O	6601
the	O	6601
other	O	6601
child	O	6601
to	O	6601
be	O	6601
Hp1	O	6601
and	O	6601
Hp1	O	6601
/	O	6601
Hpdel	O	6601
,	O	6601
showing	O	6601
an	O	6601
anomalous	O	6601
inheritance	O	6601
of	O	6601
Hp	O	6601
phenotypes	O	6601
in	O	6601
the	O	6601
child	O	6601
with	O	6601
Hp1	O	6601
.	O	6601

On	O	6611
the	O	6611
basis	O	6611
of	O	6611
the	O	6611
present	O	6611
study	O	6611
,	O	6611
the	O	6611
mechanism	O	6611
of	O	6611
anhaptoglobinemia	B-Disease	6611
and	O	6611
the	O	6611
mechanism	O	6611
of	O	6611
anomalous	O	6611
inheritance	O	6611
of	O	6611
Hp	O	6611
phenotypes	O	6611
were	O	6611
well	O	6611
explained	O	6611
.	O	6611

However	O	6612
,	O	6612
the	O	6612
mechanism	O	6612
of	O	6612
hypohaptoglobinemia	B-Disease	6612
remains	O	6612
unknown	O	6612
ATM	O	6612
mutations	O	6612
and	O	6612
phenotypes	O	6612
in	O	6612
ataxia	B-Disease	6612
-	I-Disease	6612
telangiectasia	I-Disease	6612
families	O	6612
in	O	6612
the	O	6612
British	O	6612
Isles	O	6612
:	O	6612
expression	O	6612
of	O	6612
mutant	O	6612
ATM	O	6612
and	O	6612
the	O	6612
risk	O	6612
of	O	6612
leukemia	B-Disease	6612
,	O	6612
lymphoma	B-Disease	6612
,	O	6612
and	O	6612
breast	B-Disease	6612
cancer	I-Disease	6612
.	O	6612

We	O	6613
report	O	6613
the	O	6613
spectrum	O	6613
of	O	6613
59	O	6613
ATM	O	6613
mutations	O	6613
observed	O	6613
in	O	6613
ataxia	B-Disease	6613
-	I-Disease	6613
telangiectasia	I-Disease	6613
(	O	6613
A	B-Disease	6613
-	I-Disease	6613
T	I-Disease	6613
)	O	6613
patients	O	6613
in	O	6613
the	O	6613
British	O	6613
Isles	O	6613
.	O	6613

Of	O	6614
51	O	6614
ATM	O	6614
mutations	O	6614
identified	O	6614
in	O	6614
families	O	6614
native	O	6614
to	O	6614
the	O	6614
British	O	6614
Isles	O	6614
,	O	6614
11	O	6614
were	O	6614
founder	O	6614
mutations	O	6614
,	O	6614
and	O	6614
2	O	6614
of	O	6614
these	O	6614
11	O	6614
conferred	O	6614
a	O	6614
milder	O	6614
clinical	O	6614
phenotype	O	6614
with	O	6614
respect	O	6614
to	O	6614
both	O	6614
cerebellar	B-Disease	6614
degeneration	I-Disease	6614
and	O	6614
cellular	O	6614
features	O	6614
.	O	6614

We	O	6615
report	O	6615
,	O	6615
in	O	6615
two	O	6615
A	B-Disease	6615
-	I-Disease	6615
T	I-Disease	6615
families	O	6615
,	O	6615
an	O	6615
ATM	O	6615
mutation	O	6615
(	O	6615
7271T	O	6615
-	O	6615
-	O	6615
>	O	6615
G	O	6615
)	O	6615
that	O	6615
may	O	6615
be	O	6615
associated	O	6615
with	O	6615
an	O	6615
increased	O	6615
risk	O	6615
of	O	6615
breast	B-Disease	6615
cancer	I-Disease	6615
in	O	6615
both	O	6615
homozygotes	O	6615
and	O	6615
heterozygotes	O	6615
(	O	6615
relative	O	6615
risk	O	6615
12	O	6615
.	O	6615

0025	O	6617
)	O	6617
,	O	6617
although	O	6617
there	O	6617
is	O	6617
a	O	6617
less	O	6617
severe	O	6617
A	B-Disease	6617
-	I-Disease	6617
T	I-Disease	6617
phenotype	O	6617
in	O	6617
terms	O	6617
of	O	6617
the	O	6617
degree	O	6617
of	O	6617
cerebellar	B-Disease	6617
degeneration	I-Disease	6617
.	O	6617

In	O	6619
addition	O	6619
,	O	6619
we	O	6619
have	O	6619
studied	O	6619
18	O	6619
A	B-Disease	6619
-	I-Disease	6619
T	I-Disease	6619
patients	O	6619
,	O	6619
in	O	6619
15	O	6619
families	O	6619
,	O	6619
who	O	6619
developed	O	6619
leukemia	B-Disease	6619
,	O	6619
lymphoma	B-Disease	6619
,	O	6619
preleukemic	O	6619
T	O	6619
-	O	6619
cell	O	6619
proliferation	O	6619
,	O	6619
or	O	6619
Hodgkin	B-Disease	6619
lymphoma	I-Disease	6619
,	O	6619
mostly	O	6619
in	O	6619
childhood	O	6619
.	O	6619

We	O	6621
also	O	6621
show	O	6621
that	O	6621
25	O	6621
%	O	6621
of	O	6621
all	O	6621
A	B-Disease	6621
-	I-Disease	6621
T	I-Disease	6621
patients	O	6621
carried	O	6621
in	O	6621
-	O	6621
frame	O	6621
deletions	O	6621
or	O	6621
missense	O	6621
mutations	O	6621
,	O	6621
many	O	6621
of	O	6621
which	O	6621
were	O	6621
also	O	6621
associated	O	6621
with	O	6621
expression	O	6621
of	O	6621
mutant	O	6621
ATM	O	6621
protein	O	6621
.	O	6621

The	O	6622
DMPK	O	6622
gene	O	6622
of	O	6622
severely	O	6622
affected	O	6622
myotonic	B-Disease	6622
dystrophy	I-Disease	6622
patients	O	6622
is	O	6622
hypermethylated	O	6622
proximal	O	6622
to	O	6622
the	O	6622
largely	O	6622
expanded	O	6622
CTG	O	6622
repeat	O	6622
.	O	6622

Using	O	6623
methylation	O	6623
-	O	6623
sensitive	O	6623
restriction	O	6623
enzymes	O	6623
,	O	6623
we	O	6623
characterized	O	6623
the	O	6623
methylation	O	6623
pattern	O	6623
on	O	6623
the	O	6623
5	O	6623
side	O	6623
of	O	6623
the	O	6623
CTG	O	6623
repeat	O	6623
in	O	6623
the	O	6623
DMPK	O	6623
gene	O	6623
of	O	6623
normal	O	6623
individuals	O	6623
and	O	6623
of	O	6623
patients	O	6623
affected	O	6623
with	O	6623
myotonic	B-Disease	6623
dystrophy	I-Disease	6623
,	O	6623
showing	O	6623
expansions	O	6623
of	O	6623
the	O	6623
repetitive	O	6623
sequence	O	6623
.	O	6623

The	O	6630
hemochromatosis	B-Disease	6630
gene	O	6630
product	O	6630
complexes	O	6630
with	O	6630
the	O	6630
transferrin	O	6630
receptor	O	6630
and	O	6630
lowers	O	6630
its	O	6630
affinity	O	6630
for	O	6630
ligand	O	6630
binding	O	6630
.	O	6630

We	O	6631
recently	O	6631
reported	O	6631
the	O	6631
positional	O	6631
cloning	O	6631
of	O	6631
a	O	6631
candidate	O	6631
gene	O	6631
for	O	6631
hereditary	B-Disease	6631
hemochromatosis	I-Disease	6631
called	O	6631
HFE	O	6631
.	O	6631

These	O	6642
results	O	6642
establish	O	6642
a	O	6642
molecular	O	6642
link	O	6642
between	O	6642
HFE	O	6642
and	O	6642
a	O	6642
key	O	6642
protein	O	6642
involved	O	6642
in	O	6642
iron	O	6642
transport	O	6642
,	O	6642
the	O	6642
TfR	O	6642
,	O	6642
and	O	6642
raise	O	6642
the	O	6642
possibility	O	6642
that	O	6642
alterations	O	6642
in	O	6642
this	O	6642
regulatory	O	6642
mechanism	O	6642
may	O	6642
play	O	6642
a	O	6642
role	O	6642
in	O	6642
the	O	6642
pathogenesis	O	6642
of	O	6642
hereditary	B-Disease	6642
hemochromatosis	I-Disease	6642
.	O	6642

The	O	6645
UBE3A	O	6645
gene	O	6645
encodes	O	6645
the	O	6645
E6	O	6645
-	O	6645
AP	O	6645
ubiquitin	O	6645
-	O	6645
protein	O	6645
ligase	O	6645
and	O	6645
has	O	6645
recently	O	6645
been	O	6645
shown	O	6645
to	O	6645
be	O	6645
mutated	O	6645
in	O	6645
Angelman	B-Disease	6645
syndrome	I-Disease	6645
patients	O	6645
who	O	6645
lack	O	6645
15q11	O	6645
-	O	6645
q13	O	6645
deletions	O	6645
or	O	6645
chromosome	O	6645
15	O	6645
paternal	O	6645
uniparental	B-Disease	6645
disomy	I-Disease	6645
.	O	6645

Mutation	O	6653
spectrum	O	6653
and	O	6653
genotype	O	6653
-	O	6653
phenotype	O	6653
analyses	O	6653
in	O	6653
Cowden	B-Disease	6653
disease	I-Disease	6653
and	O	6653
Bannayan	B-Disease	6653
-	I-Disease	6653
Zonana	I-Disease	6653
syndrome	I-Disease	6653
,	O	6653
two	O	6653
hamartoma	B-Disease	6653
syndromes	I-Disease	6653
with	O	6653
germline	O	6653
PTEN	O	6653
mutation	O	6653
.	O	6653

The	O	6654
tumour	B-Disease	6654
suppressor	O	6654
gene	O	6654
PTEN	O	6654
,	O	6654
which	O	6654
maps	O	6654
to	O	6654
10q23	O	6654
.	O	6654

3	O	6655
and	O	6655
encodes	O	6655
a	O	6655
403	O	6655
amino	O	6655
acid	O	6655
dual	O	6655
specificity	O	6655
phosphatase	O	6655
(	O	6655
protein	O	6655
tyrosine	O	6655
phosphatase	O	6655
;	O	6655
PTPase	O	6655
)	O	6655
,	O	6655
was	O	6655
shown	O	6655
recently	O	6655
to	O	6655
play	O	6655
a	O	6655
broad	O	6655
role	O	6655
in	O	6655
human	O	6655
malignancy	B-Disease	6655
.	O	6655

Somatic	O	6656
PTEN	O	6656
deletions	O	6656
and	O	6656
mutations	O	6656
were	O	6656
observed	O	6656
in	O	6656
sporadic	B-Disease	6656
breast	I-Disease	6656
,	I-Disease	6656
brain	I-Disease	6656
,	I-Disease	6656
prostate	I-Disease	6656
and	I-Disease	6656
kidney	I-Disease	6656
cancer	I-Disease	6656
cell	O	6656
lines	O	6656
and	O	6656
in	O	6656
several	O	6656
primary	O	6656
tumours	B-Disease	6656
such	O	6656
as	O	6656
endometrial	B-Disease	6656
carcinomas	I-Disease	6656
,	O	6656
malignant	B-Disease	6656
melanoma	I-Disease	6656
and	O	6656
thyroid	B-Disease	6656
tumours	I-Disease	6656
.	O	6656

In	O	6657
addition	O	6657
,	O	6657
PTEN	O	6657
was	O	6657
identified	O	6657
as	O	6657
the	O	6657
susceptibility	O	6657
gene	O	6657
for	O	6657
two	O	6657
hamartoma	B-Disease	6657
syndromes	I-Disease	6657
Cowden	B-Disease	6657
disease	I-Disease	6657
(	O	6657
CD	B-Disease	6657
;	O	6657
MIM	O	6657
158350	O	6657
)	O	6657
and	O	6657
Bannayan	B-Disease	6657
-	I-Disease	6657
Zonana	I-Disease	6657
(	I-Disease	6657
BZS	I-Disease	6657
)	I-Disease	6657
or	I-Disease	6657
Ruvalcaba	I-Disease	6657
-	I-Disease	6657
Riley	I-Disease	6657
-	I-Disease	6657
Smith	I-Disease	6657
syndrome	I-Disease	6657
(	O	6657
MIM	O	6657
153480	O	6657
)	O	6657
.	O	6657

Constitutive	O	6658
DNA	O	6658
from	O	6658
37	O	6658
CD	B-Disease	6658
families	O	6658
and	O	6658
seven	O	6658
BZS	B-Disease	6658
families	O	6658
was	O	6658
screened	O	6658
for	O	6658
germline	O	6658
PTEN	O	6658
mutations	O	6658
.	O	6658

PTEN	O	6659
mutations	O	6659
were	O	6659
identified	O	6659
in	O	6659
30	O	6659
of	O	6659
37	O	6659
(	O	6659
81	O	6659
%	O	6659
)	O	6659
CD	B-Disease	6659
families	O	6659
,	O	6659
including	O	6659
missense	O	6659
and	O	6659
nonsense	O	6659
point	O	6659
mutations	O	6659
,	O	6659
deletions	O	6659
,	O	6659
insertions	O	6659
,	O	6659
a	O	6659
deletion	O	6659
/	O	6659
insertion	O	6659
and	O	6659
splice	O	6659
site	O	6659
mutations	O	6659
.	O	6659

A	O	6661
hot	O	6661
spot	O	6661
for	O	6661
PTEN	O	6661
mutation	O	6661
in	O	6661
CD	B-Disease	6661
was	O	6661
identified	O	6661
in	O	6661
exon	O	6661
5	O	6661
that	O	6661
contains	O	6661
the	O	6661
PTPase	O	6661
core	O	6661
motif	O	6661
,	O	6661
with	O	6661
13	O	6661
of	O	6661
30	O	6661
(	O	6661
43	O	6661
%	O	6661
)	O	6661
CD	B-Disease	6661
mutations	O	6661
identified	O	6661
in	O	6661
this	O	6661
exon	O	6661
.	O	6661

Germline	O	6663
PTEN	O	6663
mutations	O	6663
were	O	6663
identified	O	6663
in	O	6663
four	O	6663
of	O	6663
seven	O	6663
(	O	6663
57	O	6663
%	O	6663
)	O	6663
BZS	B-Disease	6663
families	O	6663
studied	O	6663
.	O	6663

It	O	6665
is	O	6665
also	O	6665
worthy	O	6665
of	O	6665
note	O	6665
that	O	6665
a	O	6665
single	O	6665
nonsense	O	6665
point	O	6665
mutation	O	6665
,	O	6665
R233X	O	6665
,	O	6665
was	O	6665
observed	O	6665
in	O	6665
the	O	6665
germline	O	6665
DNA	O	6665
from	O	6665
two	O	6665
unrelated	O	6665
CD	B-Disease	6665
families	O	6665
and	O	6665
one	O	6665
BZS	B-Disease	6665
family	O	6665
.	O	6665

Genotype	O	6666
-	O	6666
phenotype	O	6666
studies	O	6666
were	O	6666
not	O	6666
performed	O	6666
on	O	6666
this	O	6666
small	O	6666
group	O	6666
of	O	6666
BZS	B-Disease	6666
families	O	6666
.	O	6666

However	O	6667
,	O	6667
genotype	O	6667
-	O	6667
phenotype	O	6667
analysis	O	6667
inthe	O	6667
group	O	6667
of	O	6667
CD	B-Disease	6667
families	O	6667
revealed	O	6667
two	O	6667
possible	O	6667
associations	O	6667
worthy	O	6667
of	O	6667
follow	O	6667
-	O	6667
up	O	6667
in	O	6667
independent	O	6667
analyses	O	6667
.	O	6667

The	O	6668
first	O	6668
was	O	6668
an	O	6668
association	O	6668
noted	O	6668
in	O	6668
the	O	6668
group	O	6668
of	O	6668
CD	B-Disease	6668
families	O	6668
with	O	6668
breast	B-Disease	6668
disease	I-Disease	6668
.	O	6668

Specifically	O	6670
and	O	6670
more	O	6670
directly	O	6670
,	O	6670
an	O	6670
association	O	6670
was	O	6670
also	O	6670
observed	O	6670
between	O	6670
the	O	6670
presence	O	6670
of	O	6670
a	O	6670
PTEN	O	6670
mutation	O	6670
and	O	6670
malignant	B-Disease	6670
breast	I-Disease	6670
disease	I-Disease	6670
.	O	6670

However	O	6672
,	O	6672
these	O	6672
observations	O	6672
would	O	6672
need	O	6672
to	O	6672
be	O	6672
confirmed	O	6672
by	O	6672
studying	O	6672
a	O	6672
larger	O	6672
number	O	6672
of	O	6672
CD	B-Disease	6672
families	O	6672
.	O	6672

Molecular	O	6673
defects	O	6673
leading	O	6673
to	O	6673
human	O	6673
complement	B-Disease	6673
component	I-Disease	6673
C6	I-Disease	6673
deficiency	I-Disease	6673
in	O	6673
an	O	6673
African	O	6673
-	O	6673
American	O	6673
family	O	6673
.	O	6673

Complement	B-Disease	6674
component	I-Disease	6674
C6	I-Disease	6674
deficiency	I-Disease	6674
(	O	6674
C6D	B-Disease	6674
)	O	6674
was	O	6674
diagnosed	O	6674
in	O	6674
a	O	6674
16	O	6674
-	O	6674
year	O	6674
-	O	6674
old	O	6674
African	O	6674
-	O	6674
American	O	6674
male	O	6674
with	O	6674
meningococcal	B-Disease	6674
meningitis	I-Disease	6674
.	O	6674

The	O	6675
patients	O	6675
father	O	6675
and	O	6675
two	O	6675
brothers	O	6675
also	O	6675
had	O	6675
C6D	B-Disease	6675
,	O	6675
but	O	6675
gave	O	6675
no	O	6675
history	O	6675
of	O	6675
meningitis	B-Disease	6675
or	O	6675
other	O	6675
neisserial	B-Disease	6675
infection	I-Disease	6675
.	O	6675

The	O	6677
first	O	6677
,	O	6677
1195delC	O	6677
located	O	6677
in	O	6677
exon	O	6677
7	O	6677
,	O	6677
is	O	6677
a	O	6677
novel	O	6677
mutation	O	6677
,	O	6677
while	O	6677
the	O	6677
second	O	6677
,	O	6677
1936delG	O	6677
in	O	6677
exon	O	6677
12	O	6677
,	O	6677
has	O	6677
been	O	6677
described	O	6677
before	O	6677
to	O	6677
cause	O	6677
C6D	B-Disease	6677
in	O	6677
an	O	6677
unrelated	O	6677
African	O	6677
-	O	6677
American	O	6677
individual	O	6677
.	O	6677

Mutations	O	6682
in	O	6682
PAX6	O	6682
are	O	6682
responsible	O	6682
for	O	6682
human	O	6682
aniridia	B-Disease	6682
and	O	6682
have	O	6682
also	O	6682
been	O	6682
found	O	6682
in	O	6682
patients	O	6682
with	O	6682
Peters	B-Disease	6682
anomaly	I-Disease	6682
,	O	6682
with	O	6682
congenital	B-Disease	6682
cataracts	I-Disease	6682
,	O	6682
with	O	6682
autosomal	B-Disease	6682
dominant	I-Disease	6682
keratitis	I-Disease	6682
,	O	6682
and	O	6682
with	O	6682
isolated	B-Disease	6682
foveal	I-Disease	6682
hypoplasia	I-Disease	6682
.	O	6682

No	O	6683
locus	O	6683
other	O	6683
than	O	6683
chromosome	O	6683
11p13	O	6683
has	O	6683
been	O	6683
implicated	O	6683
in	O	6683
aniridia	B-Disease	6683
,	O	6683
and	O	6683
PAX6	O	6683
is	O	6683
clearly	O	6683
the	O	6683
major	O	6683
,	O	6683
if	O	6683
not	O	6683
only	O	6683
,	O	6683
gene	O	6683
responsible	O	6683
.	O	6683

Genetic	O	6690
heterogeneity	O	6690
and	O	6690
penetrance	O	6690
analysis	O	6690
of	O	6690
the	O	6690
BRCA1	O	6690
and	O	6690
BRCA2	O	6690
genes	O	6690
in	O	6690
breast	B-Disease	6690
cancer	I-Disease	6690
families	O	6690
.	O	6690

The	O	6691
Breast	B-Disease	6691
Cancer	I-Disease	6691
Linkage	O	6691
Consortium	O	6691
.	O	6691

The	O	6692
contribution	O	6692
of	O	6692
BRCA1	O	6692
and	O	6692
BRCA2	O	6692
to	O	6692
inherited	B-Disease	6692
breast	I-Disease	6692
cancer	I-Disease	6692
was	O	6692
assessed	O	6692
by	O	6692
linkage	O	6692
and	O	6692
mutation	O	6692
analysis	O	6692
in	O	6692
237	O	6692
families	O	6692
,	O	6692
each	O	6692
with	O	6692
at	O	6692
least	O	6692
four	O	6692
cases	O	6692
of	O	6692
breast	B-Disease	6692
cancer	I-Disease	6692
,	O	6692
collected	O	6692
by	O	6692
the	O	6692
Breast	B-Disease	6692
Cancer	I-Disease	6692
Linkage	O	6692
Consortium	O	6692
.	O	6692

Families	O	6693
were	O	6693
included	O	6693
without	O	6693
regard	O	6693
to	O	6693
the	O	6693
occurrence	O	6693
of	O	6693
ovarian	B-Disease	6693
or	I-Disease	6693
other	I-Disease	6693
cancers	I-Disease	6693
.	O	6693

The	O	6695
majority	O	6695
(	O	6695
81	O	6695
%	O	6695
)	O	6695
of	O	6695
the	O	6695
breast	B-Disease	6695
-	I-Disease	6695
ovarian	I-Disease	6695
cancer	I-Disease	6695
families	O	6695
were	O	6695
due	O	6695
to	O	6695
BRCA1	O	6695
,	O	6695
with	O	6695
most	O	6695
others	O	6695
(	O	6695
14	O	6695
%	O	6695
)	O	6695
due	O	6695
to	O	6695
BRCA2	O	6695
.	O	6695

Conversely	O	6696
,	O	6696
the	O	6696
majority	O	6696
of	O	6696
families	O	6696
with	O	6696
male	B-Disease	6696
and	I-Disease	6696
female	I-Disease	6696
breast	I-Disease	6696
cancer	I-Disease	6696
were	O	6696
due	O	6696
to	O	6696
BRCA2	O	6696
(	O	6696
76	O	6696
%	O	6696
)	O	6696
.	O	6696

The	O	6697
largest	O	6697
proportion	O	6697
(	O	6697
67	O	6697
%	O	6697
)	O	6697
of	O	6697
families	O	6697
due	O	6697
to	O	6697
other	O	6697
genes	O	6697
was	O	6697
found	O	6697
in	O	6697
families	O	6697
with	O	6697
four	O	6697
or	O	6697
five	O	6697
cases	O	6697
of	O	6697
female	O	6697
breast	B-Disease	6697
cancer	I-Disease	6697
only	O	6697
.	O	6697

The	O	6702
estimated	O	6702
cumulative	O	6702
risk	O	6702
of	O	6702
breast	B-Disease	6702
cancer	I-Disease	6702
reached	O	6702
28	O	6702
%	O	6702
(	O	6702
95	O	6702
%	O	6702
CI	O	6702
9	O	6702
%	O	6702
-	O	6702
44	O	6702
%	O	6702
)	O	6702
by	O	6702
age	O	6702
50	O	6702
years	O	6702
and	O	6702
84	O	6702
%	O	6702
(	O	6702
95	O	6702
%	O	6702
CI	O	6702
43	O	6702
%	O	6702
-	O	6702
95	O	6702
%	O	6702
)	O	6702
by	O	6702
age	O	6702
70	O	6702
years	O	6702
.	O	6702

The	O	6703
corresponding	O	6703
ovarian	B-Disease	6703
cancer	I-Disease	6703
risks	O	6703
were	O	6703
0	O	6703
.	O	6703

The	O	6705
lifetime	O	6705
risk	O	6705
of	O	6705
breast	B-Disease	6705
cancer	I-Disease	6705
appears	O	6705
similar	O	6705
to	O	6705
the	O	6705
risk	O	6705
in	O	6705
BRCA1	O	6705
carriers	O	6705
,	O	6705
but	O	6705
there	O	6705
was	O	6705
some	O	6705
suggestion	O	6705
of	O	6705
a	O	6705
lower	O	6705
risk	O	6705
in	O	6705
BRCA2	O	6705
carriers	O	6705
<	O	6705
50	O	6705
years	O	6705
of	O	6705
age	O	6705
.	O	6705

Eye	B-Disease	6706
movement	I-Disease	6706
abnormalities	I-Disease	6706
correlate	O	6706
with	O	6706
genotype	O	6706
in	O	6706
autosomal	O	6706
dominant	O	6706
cerebellar	B-Disease	6706
ataxia	I-Disease	6706
type	I-Disease	6706
I	I-Disease	6706
.	O	6706

We	O	6707
compared	O	6707
horizontal	O	6707
eye	O	6707
movements	O	6707
(	O	6707
visually	O	6707
guided	O	6707
saccades	O	6707
,	O	6707
antisaccades	O	6707
,	O	6707
and	O	6707
smooth	O	6707
pursuit	O	6707
)	O	6707
in	O	6707
control	O	6707
subjects	O	6707
(	O	6707
n	O	6707
=	O	6707
14	O	6707
)	O	6707
and	O	6707
patients	O	6707
with	O	6707
three	O	6707
forms	O	6707
of	O	6707
autosomal	O	6707
dominant	O	6707
cerebellar	B-Disease	6707
ataxias	I-Disease	6707
type	I-Disease	6707
I	I-Disease	6707
spinocerebellar	B-Disease	6707
ataxias	I-Disease	6707
1	I-Disease	6707
and	I-Disease	6707
2	I-Disease	6707
(	O	6707
SCA1	B-Disease	6707
,	O	6707
n	O	6707
=	O	6707
11	O	6707
;	O	6707
SCA2	B-Disease	6707
,	O	6707
n	O	6707
=	O	6707
10	O	6707
)	O	6707
and	O	6707
SCA3	B-Disease	6707
/	O	6707
Machado	B-Disease	6707
-	I-Disease	6707
Joseph	I-Disease	6707
disease	I-Disease	6707
(	O	6707
MJD	B-Disease	6707
)	O	6707
(	O	6707
n	O	6707
=	O	6707
16	O	6707
)	O	6707
.	O	6707

In	O	6708
SCA1	B-Disease	6708
,	O	6708
saccade	O	6708
amplitude	O	6708
was	O	6708
significantly	O	6708
increased	O	6708
,	O	6708
resulting	O	6708
in	O	6708
hypermetria	B-Disease	6708
.	O	6708

In	O	6710
SCA2	B-Disease	6710
,	O	6710
saccade	O	6710
velocity	O	6710
was	O	6710
markedly	O	6710
decreased	O	6710
.	O	6710

In	O	6713
SCA3	B-Disease	6713
,	O	6713
gaze	B-Disease	6713
-	I-Disease	6713
evoked	I-Disease	6713
nystagmus	I-Disease	6713
was	O	6713
often	O	6713
present	O	6713
as	O	6713
was	O	6713
saccade	O	6713
hypometria	O	6713
and	O	6713
smooth	O	6713
pursuit	O	6713
gain	O	6713
was	O	6713
markedly	O	6713
decreased	O	6713
.	O	6713

Three	O	6714
major	O	6714
criteria	O	6714
,	O	6714
saccade	O	6714
amplitude	O	6714
,	O	6714
saccade	O	6714
velocity	O	6714
,	O	6714
and	O	6714
presence	O	6714
of	O	6714
gaze	B-Disease	6714
-	I-Disease	6714
evoked	I-Disease	6714
nystagmus	I-Disease	6714
,	O	6714
permitted	O	6714
the	O	6714
correct	O	6714
assignment	O	6714
of	O	6714
90	O	6714
%	O	6714
of	O	6714
the	O	6714
SCA1	B-Disease	6714
,	O	6714
90	O	6714
%	O	6714
of	O	6714
the	O	6714
SCA2	B-Disease	6714
,	O	6714
and	O	6714
93	O	6714
%	O	6714
of	O	6714
the	O	6714
patients	O	6714
with	O	6714
SCA3	B-Disease	6714
to	O	6714
their	O	6714
genetically	O	6714
confirmed	O	6714
patient	O	6714
group	O	6714
and	O	6714
,	O	6714
therefore	O	6714
,	O	6714
may	O	6714
help	O	6714
orient	O	6714
diagnoses	O	6714
of	O	6714
SCA1	B-Disease	6714
,	O	6714
SCA2	B-Disease	6714
,	O	6714
and	O	6714
SCA3	B-Disease	6714
at	O	6714
early	O	6714
clinical	O	6714
stages	O	6714
of	O	6714
the	O	6714
diseases	O	6714
.	O	6714

Genetic	O	6716
basis	O	6716
and	O	6716
molecular	O	6716
mechanism	O	6716
for	O	6716
idiopathic	B-Disease	6716
ventricular	I-Disease	6716
fibrillation	I-Disease	6716
.	O	6716

Ventricular	B-Disease	6717
fibrillation	I-Disease	6717
causes	O	6717
more	O	6717
than	O	6717
300	O	6717
,	O	6717
000	O	6717
sudden	O	6717
deaths	O	6717
each	O	6717
year	O	6717
in	O	6717
the	O	6717
USA	O	6717
alone	O	6717
.	O	6717

In	O	6718
approximately	O	6718
5	O	6718
-	O	6718
12	O	6718
%	O	6718
of	O	6718
these	O	6718
cases	O	6718
,	O	6718
there	O	6718
are	O	6718
no	O	6718
demonstrable	O	6718
cardiac	O	6718
or	O	6718
non	O	6718
-	O	6718
cardiac	O	6718
causes	O	6718
to	O	6718
account	O	6718
for	O	6718
the	O	6718
episode	O	6718
,	O	6718
which	O	6718
is	O	6718
therefore	O	6718
classified	O	6718
as	O	6718
idiopathic	B-Disease	6718
ventricular	I-Disease	6718
fibrillation	I-Disease	6718
(	O	6718
IVF	B-Disease	6718
)	O	6718
.	O	6718

A	O	6719
distinct	O	6719
group	O	6719
of	O	6719
IVF	B-Disease	6719
patients	O	6719
has	O	6719
been	O	6719
found	O	6719
to	O	6719
present	O	6719
with	O	6719
a	O	6719
characteristic	O	6719
electrocardiographic	O	6719
pattern	O	6719
.	O	6719

Because	O	6720
of	O	6720
the	O	6720
small	O	6720
size	O	6720
of	O	6720
most	O	6720
pedigrees	O	6720
and	O	6720
the	O	6720
high	O	6720
incidence	O	6720
of	O	6720
sudden	B-Disease	6720
death	I-Disease	6720
,	O	6720
however	O	6720
,	O	6720
molecular	O	6720
genetic	O	6720
studies	O	6720
of	O	6720
IVF	B-Disease	6720
have	O	6720
not	O	6720
yet	O	6720
been	O	6720
done	O	6720
.	O	6720

Because	O	6721
IVF	B-Disease	6721
causes	O	6721
cardiac	O	6721
rhythm	O	6721
disturbance	O	6721
,	O	6721
we	O	6721
investigated	O	6721
whether	O	6721
malfunction	O	6721
of	O	6721
ion	O	6721
channels	O	6721
could	O	6721
cause	O	6721
the	O	6721
disorder	O	6721
by	O	6721
studying	O	6721
mutations	O	6721
in	O	6721
the	O	6721
cardiac	O	6721
sodium	O	6721
channel	O	6721
gene	O	6721
SCN5A	O	6721
.	O	6721

We	O	6722
have	O	6722
now	O	6722
identified	O	6722
a	O	6722
missense	O	6722
mutation	O	6722
,	O	6722
a	O	6722
splice	O	6722
-	O	6722
donor	O	6722
mutation	O	6722
,	O	6722
and	O	6722
a	O	6722
frameshift	O	6722
mutation	O	6722
in	O	6722
the	O	6722
coding	O	6722
region	O	6722
of	O	6722
SCN5A	O	6722
in	O	6722
three	O	6722
IVF	B-Disease	6722
families	O	6722
.	O	6722

Our	O	6724
results	O	6724
indicate	O	6724
that	O	6724
mutations	O	6724
in	O	6724
cardiac	O	6724
ion	O	6724
-	O	6724
channel	O	6724
genes	O	6724
contribute	O	6724
to	O	6724
the	O	6724
risk	O	6724
of	O	6724
developing	O	6724
IVF	B-Disease	6724
.	O	6724

Molecular	O	6726
heterogeneity	O	6726
in	O	6726
mucopolysaccharidosis	B-Disease	6726
IVA	I-Disease	6726
in	O	6726
Australia	O	6726
and	O	6726
Northern	O	6726
Ireland	O	6726
:	O	6726
nine	O	6726
novel	O	6726
mutations	O	6726
including	O	6726
T312S	O	6726
,	O	6726
a	O	6726
common	O	6726
allele	O	6726
that	O	6726
confers	O	6726
a	O	6726
mild	O	6726
phenotype	O	6726
.	O	6726

Mucopolysaccharidosis	B-Disease	6727
IVA	I-Disease	6727
(	O	6727
MPS	B-Disease	6727
IVA	I-Disease	6727
)	O	6727
is	O	6727
an	O	6727
autosomal	B-Disease	6727
recessive	I-Disease	6727
lysosomal	I-Disease	6727
storage	I-Disease	6727
disorder	I-Disease	6727
caused	O	6727
by	O	6727
a	O	6727
genetic	B-Disease	6727
defect	I-Disease	6727
in	O	6727
N	O	6727
-	O	6727
acetylgalactosamine	O	6727
-	O	6727
6	O	6727
-	O	6727
sulfate	O	6727
sulfatase	O	6727
(	O	6727
GALNS	O	6727
)	O	6727
.	O	6727

Previous	O	6728
studies	O	6728
of	O	6728
patients	O	6728
from	O	6728
a	O	6728
British	O	6728
-	O	6728
Irish	O	6728
population	O	6728
showed	O	6728
that	O	6728
the	O	6728
I113F	O	6728
mutation	O	6728
is	O	6728
the	O	6728
most	O	6728
common	O	6728
single	O	6728
mutation	O	6728
among	O	6728
MPS	B-Disease	6728
IVA	I-Disease	6728
patients	O	6728
and	O	6728
produces	O	6728
a	O	6728
severe	O	6728
clinical	O	6728
phenotype	O	6728
.	O	6728

We	O	6729
studied	O	6729
mutations	O	6729
in	O	6729
the	O	6729
GALNS	O	6729
gene	O	6729
from	O	6729
23	O	6729
additional	O	6729
MPS	B-Disease	6729
IVA	I-Disease	6729
patients	O	6729
(	O	6729
15	O	6729
from	O	6729
Australia	O	6729
,	O	6729
8	O	6729
from	O	6729
Northern	O	6729
Ireland	O	6729
)	O	6729
,	O	6729
with	O	6729
various	O	6729
clinical	O	6729
phenotypes	O	6729
(	O	6729
severe	O	6729
,	O	6729
16	O	6729
cases	O	6729
;	O	6729
intermediate	O	6729
,	O	6729
4	O	6729
cases	O	6729
;	O	6729
mild	O	6729
,	O	6729
3	O	6729
cases	O	6729
)	O	6729
.	O	6729

These	O	6738
data	O	6738
provide	O	6738
further	O	6738
evidence	O	6738
for	O	6738
extensive	O	6738
allelic	O	6738
heterogeneity	O	6738
in	O	6738
MPS	B-Disease	6738
IVA	I-Disease	6738
in	O	6738
British	O	6738
-	O	6738
Irish	O	6738
patients	O	6738
and	O	6738
provide	O	6738
evidence	O	6738
for	O	6738
their	O	6738
transmission	O	6738
to	O	6738
Australia	O	6738
by	O	6738
British	O	6738
-	O	6738
Irish	O	6738
migrants	O	6738
.	O	6738

Identification	O	6740
of	O	6740
constitutional	O	6740
WT1	O	6740
mutations	O	6740
,	O	6740
in	O	6740
patients	O	6740
with	O	6740
isolated	O	6740
diffuse	B-Disease	6740
mesangial	I-Disease	6740
sclerosis	I-Disease	6740
,	O	6740
and	O	6740
analysis	O	6740
of	O	6740
genotype	O	6740
/	O	6740
phenotype	O	6740
correlations	O	6740
by	O	6740
use	O	6740
of	O	6740
a	O	6740
computerized	O	6740
mutation	O	6740
database	O	6740
.	O	6740

Constitutional	O	6741
mutations	O	6741
of	O	6741
the	O	6741
WT1	O	6741
gene	O	6741
,	O	6741
encoding	O	6741
a	O	6741
zinc	O	6741
-	O	6741
finger	O	6741
transcription	O	6741
factor	O	6741
involved	O	6741
in	O	6741
renal	O	6741
and	O	6741
gonadal	O	6741
development	O	6741
,	O	6741
are	O	6741
found	O	6741
in	O	6741
most	O	6741
patients	O	6741
with	O	6741
Denys	B-Disease	6741
-	I-Disease	6741
Drash	I-Disease	6741
syndrome	I-Disease	6741
(	O	6741
DDS	B-Disease	6741
)	O	6741
,	O	6741
or	O	6741
diffuse	B-Disease	6741
mesangial	I-Disease	6741
sclerosis	I-Disease	6741
(	O	6741
DMS	B-Disease	6741
)	O	6741
associated	O	6741
with	O	6741
pseudohermaphroditism	B-Disease	6741
and	O	6741
/	O	6741
or	O	6741
Wilms	B-Disease	6741
tumor	I-Disease	6741
(	O	6741
WT	B-Disease	6741
)	O	6741
.	O	6741

Most	O	6742
mutations	O	6742
in	O	6742
DDS	B-Disease	6742
patients	O	6742
lie	O	6742
in	O	6742
exon	O	6742
8	O	6742
or	O	6742
exon	O	6742
9	O	6742
,	O	6742
encoding	O	6742
zinc	O	6742
finger	O	6742
2	O	6742
or	O	6742
zinc	O	6742
finger	O	6742
3	O	6742
,	O	6742
respectively	O	6742
,	O	6742
with	O	6742
a	O	6742
hot	O	6742
spot	O	6742
(	O	6742
R394W	O	6742
)	O	6742
in	O	6742
exon	O	6742
9	O	6742
.	O	6742

We	O	6743
analyzed	O	6743
a	O	6743
series	O	6743
of	O	6743
24	O	6743
patients	O	6743
,	O	6743
10	O	6743
with	O	6743
isolated	B-Disease	6743
DMS	I-Disease	6743
(	O	6743
IDMS	B-Disease	6743
)	O	6743
,	O	6743
10	O	6743
with	O	6743
DDS	B-Disease	6743
,	O	6743
and	O	6743
4	O	6743
with	O	6743
urogenital	B-Disease	6743
abnormalities	I-Disease	6743
and	O	6743
/	O	6743
or	O	6743
WT	B-Disease	6743
.	O	6743

We	O	6744
report	O	6744
WT1	O	6744
heterozygous	O	6744
mutations	O	6744
in	O	6744
16	O	6744
patients	O	6744
,	O	6744
4	O	6744
of	O	6744
whom	O	6744
presented	O	6744
with	O	6744
IDMS	B-Disease	6744
.	O	6744

One	O	6745
male	O	6745
and	O	6745
two	O	6745
female	O	6745
IDMS	B-Disease	6745
patients	O	6745
with	O	6745
WT1	O	6745
mutations	O	6745
underwent	O	6745
normal	O	6745
puberty	O	6745
.	O	6745

Two	O	6746
mutations	O	6746
associated	O	6746
with	O	6746
IDMS	B-Disease	6746
are	O	6746
different	O	6746
from	O	6746
those	O	6746
described	O	6746
in	O	6746
DDS	B-Disease	6746
patients	O	6746
.	O	6746

No	O	6747
WT1	O	6747
mutations	O	6747
were	O	6747
detected	O	6747
in	O	6747
the	O	6747
six	O	6747
other	O	6747
IDMS	B-Disease	6747
patients	O	6747
,	O	6747
suggesting	O	6747
genetic	O	6747
heterogeneity	O	6747
of	O	6747
this	O	6747
disease	O	6747
.	O	6747

This	O	6749
demonstrated	O	6749
(	O	6749
1	O	6749
)	O	6749
the	O	6749
association	O	6749
between	O	6749
mutations	O	6749
in	O	6749
exons	O	6749
8	O	6749
and	O	6749
9	O	6749
and	O	6749
DMS	B-Disease	6749
;	O	6749
(	O	6749
2	O	6749
)	O	6749
among	O	6749
patients	O	6749
with	O	6749
DMS	B-Disease	6749
,	O	6749
a	O	6749
higher	O	6749
frequency	O	6749
of	O	6749
exon	O	6749
8	O	6749
mutations	O	6749
among	O	6749
46	O	6749
,	O	6749
XY	O	6749
patients	O	6749
with	O	6749
female	O	6749
phenotype	O	6749
than	O	6749
among	O	6749
46	O	6749
,	O	6749
XY	O	6749
patients	O	6749
with	O	6749
sexual	O	6749
ambiguity	O	6749
or	O	6749
male	O	6749
phenotype	O	6749
;	O	6749
and	O	6749
(	O	6749
3	O	6749
)	O	6749
statistically	O	6749
significant	O	6749
evidence	O	6749
that	O	6749
mutations	O	6749
in	O	6749
exons	O	6749
8	O	6749
and	O	6749
9	O	6749
preferentially	O	6749
affect	O	6749
amino	O	6749
acids	O	6749
with	O	6749
different	O	6749
functions	O	6749
.	O	6749

The	O	6752
185delAG	O	6752
mutation	O	6752
in	O	6752
BRCA1	O	6752
is	O	6752
detected	O	6752
in	O	6752
Ashkenazi	O	6752
Jews	O	6752
both	O	6752
in	O	6752
familial	B-Disease	6752
breast	I-Disease	6752
and	I-Disease	6752
ovarian	I-Disease	6752
cancer	I-Disease	6752
and	O	6752
in	O	6752
the	O	6752
general	O	6752
population	O	6752
.	O	6752

BRCA1	O	6759
allelic	O	6759
patterns	O	6759
were	O	6759
determined	O	6759
for	O	6759
four	O	6759
of	O	6759
these	O	6759
individuals	O	6759
and	O	6759
for	O	6759
12	O	6759
additional	O	6759
non	O	6759
-	O	6759
Ashkenazi	O	6759
185delAG	O	6759
mutation	O	6759
carriers	O	6759
who	O	6759
had	O	6759
breast	B-Disease	6759
/	I-Disease	6759
ovarian	I-Disease	6759
cancer	I-Disease	6759
.	O	6759

Crystal	O	6765
structure	O	6765
of	O	6765
the	O	6765
hemochromatosis	B-Disease	6765
protein	O	6765
HFE	O	6765
and	O	6765
characterization	O	6765
of	O	6765
its	O	6765
interaction	O	6765
with	O	6765
transferrin	O	6765
receptor	O	6765
.	O	6765

HFE	O	6766
is	O	6766
an	O	6766
MHC	O	6766
-	O	6766
related	O	6766
protein	O	6766
that	O	6766
is	O	6766
mutated	O	6766
in	O	6766
the	O	6766
iron	B-Disease	6766
-	I-Disease	6766
overload	I-Disease	6766
disease	I-Disease	6766
hereditary	B-Disease	6766
hemochromatosis	I-Disease	6766
.	O	6766

6	O	6769
A	O	6769
crystal	O	6769
structure	O	6769
of	O	6769
HFE	O	6769
reveals	O	6769
the	O	6769
locations	O	6769
of	O	6769
hemochromatosis	B-Disease	6769
mutations	O	6769
and	O	6769
a	O	6769
patch	O	6769
of	O	6769
histidines	O	6769
that	O	6769
could	O	6769
be	O	6769
involved	O	6769
in	O	6769
pH	O	6769
-	O	6769
dependent	O	6769
interactions	O	6769
.	O	6769

Identification	O	6772
of	O	6772
three	O	6772
novel	O	6772
mutations	O	6772
and	O	6772
a	O	6772
high	O	6772
frequency	O	6772
of	O	6772
the	O	6772
Arg778Leu	O	6772
mutation	O	6772
in	O	6772
Korean	O	6772
patients	O	6772
with	O	6772
Wilson	B-Disease	6772
disease	I-Disease	6772
.	O	6772

Four	O	6773
mutations	O	6773
-	O	6773
-	O	6773
R778L	O	6773
,	O	6773
A874V	O	6773
,	O	6773
L1083F	O	6773
,	O	6773
and	O	6773
2304delC	O	6773
-	O	6773
-	O	6773
in	O	6773
the	O	6773
copper	O	6773
-	O	6773
transporting	O	6773
enzyme	O	6773
,	O	6773
P	O	6773
-	O	6773
type	O	6773
ATPase	O	6773
(	O	6773
ATP7B	O	6773
)	O	6773
,	O	6773
were	O	6773
identified	O	6773
in	O	6773
Korean	O	6773
Patients	O	6773
with	O	6773
Wilson	B-Disease	6773
disease	I-Disease	6773
.	O	6773

Since	O	6777
a	O	6777
mutation	O	6777
at	O	6777
cDNA	O	6777
nucleotide	O	6777
2302	O	6777
(	O	6777
2302insC	O	6777
)	O	6777
had	O	6777
been	O	6777
previously	O	6777
described	O	6777
,	O	6777
this	O	6777
region	O	6777
of	O	6777
the	O	6777
ATP7B	O	6777
gene	O	6777
may	O	6777
be	O	6777
susceptible	O	6777
to	O	6777
gene	O	6777
rearrangements	O	6777
causing	O	6777
Wilson	B-Disease	6777
disease	I-Disease	6777
.	O	6777

Disruption	O	6778
of	O	6778
splicing	O	6778
regulated	O	6778
by	O	6778
a	O	6778
CUG	O	6778
-	O	6778
binding	O	6778
protein	O	6778
in	O	6778
myotonic	B-Disease	6778
dystrophy	I-Disease	6778
.	O	6778

Myotonic	B-Disease	6779
dystrophy	I-Disease	6779
(	O	6779
DM	B-Disease	6779
)	O	6779
is	O	6779
caused	O	6779
by	O	6779
a	O	6779
CTG	O	6779
expansion	O	6779
in	O	6779
the	O	6779
3	O	6779
untranslated	O	6779
region	O	6779
of	O	6779
the	O	6779
DM	B-Disease	6779
gene	O	6779
.	O	6779

One	O	6780
model	O	6780
of	O	6780
DM	B-Disease	6780
pathogenesis	O	6780
suggests	O	6780
that	O	6780
RNAs	O	6780
from	O	6780
the	O	6780
expanded	O	6780
allele	O	6780
create	O	6780
a	O	6780
gain	O	6780
-	O	6780
of	O	6780
-	O	6780
function	O	6780
mutation	O	6780
by	O	6780
the	O	6780
inappropriate	O	6780
binding	O	6780
of	O	6780
proteins	O	6780
to	O	6780
the	O	6780
CUG	O	6780
repeats	O	6780
.	O	6780

Splicing	O	6783
of	O	6783
cTNT	O	6783
was	O	6783
disrupted	O	6783
in	O	6783
DM	B-Disease	6783
striated	O	6783
muscle	O	6783
and	O	6783
in	O	6783
normal	O	6783
cells	O	6783
expressing	O	6783
transcripts	O	6783
that	O	6783
contain	O	6783
CUG	O	6783
repeats	O	6783
.	O	6783

Altered	O	6784
expression	O	6784
of	O	6784
genes	O	6784
regulated	O	6784
posttranscriptionally	O	6784
by	O	6784
CUG	O	6784
-	O	6784
BP	O	6784
therefore	O	6784
may	O	6784
contribute	O	6784
to	O	6784
DM	B-Disease	6784
pathogenesis	O	6784
.	O	6784

Identification	O	6786
of	O	6786
a	O	6786
novel	O	6786
nonsense	O	6786
mutation	O	6786
and	O	6786
a	O	6786
missense	O	6786
substitution	O	6786
in	O	6786
the	O	6786
vasopressin	O	6786
-	O	6786
neurophysin	O	6786
II	O	6786
gene	O	6786
in	O	6786
two	O	6786
Spanish	O	6786
kindreds	O	6786
with	O	6786
familial	B-Disease	6786
neurohypophyseal	I-Disease	6786
diabetes	I-Disease	6786
insipidus	I-Disease	6786
.	O	6786

Familial	B-Disease	6787
neurohypophyseal	I-Disease	6787
diabetes	I-Disease	6787
insipidus	I-Disease	6787
(	O	6787
FNDI	B-Disease	6787
)	O	6787
is	O	6787
an	O	6787
autosomal	B-Disease	6787
dominant	I-Disease	6787
disease	I-Disease	6787
caused	O	6787
by	O	6787
deficiency	O	6787
in	O	6787
the	O	6787
antidiuretic	O	6787
hormone	O	6787
arginine	O	6787
vasopressin	O	6787
(	O	6787
AVP	O	6787
)	O	6787
encoded	O	6787
by	O	6787
the	O	6787
AVP	O	6787
-	O	6787
neurophysin	O	6787
II	O	6787
(	O	6787
AVP	O	6787
-	O	6787
NPII	O	6787
)	O	6787
gene	O	6787
on	O	6787
chromosome	O	6787
20p13	O	6787
.	O	6787

In	O	6788
this	O	6788
study	O	6788
,	O	6788
we	O	6788
analyzed	O	6788
two	O	6788
families	O	6788
with	O	6788
FNDI	B-Disease	6788
using	O	6788
direct	O	6788
automated	O	6788
fluorescent	O	6788
,	O	6788
solid	O	6788
phase	O	6788
,	O	6788
single	O	6788
-	O	6788
stranded	O	6788
DNA	O	6788
sequencing	O	6788
of	O	6788
PCR	O	6788
-	O	6788
amplified	O	6788
AVP	O	6788
-	O	6788
NPII	O	6788
DNA	O	6788
.	O	6788

This	O	6792
missense	O	6792
mutation	O	6792
,	O	6792
which	O	6792
replaces	O	6792
Ala	O	6792
with	O	6792
Thr	O	6792
,	O	6792
is	O	6792
frequent	O	6792
among	O	6792
FNDI	B-Disease	6792
patients	O	6792
and	O	6792
is	O	6792
thought	O	6792
to	O	6792
reduce	O	6792
the	O	6792
efficiency	O	6792
of	O	6792
cleavage	O	6792
by	O	6792
signal	O	6792
peptidases	O	6792
.	O	6792

Genetic	O	6794
heterogeneity	O	6794
of	O	6794
Saethre	B-Disease	6794
-	I-Disease	6794
Chotzen	I-Disease	6794
syndrome	I-Disease	6794
,	O	6794
due	O	6794
to	O	6794
TWIST	O	6794
and	O	6794
FGFR	O	6794
mutations	O	6794
.	O	6794

Thirty	O	6795
-	O	6795
two	O	6795
unrelated	O	6795
patients	O	6795
with	O	6795
features	O	6795
of	O	6795
Saethre	B-Disease	6795
-	I-Disease	6795
Chotzen	I-Disease	6795
syndrome	I-Disease	6795
,	O	6795
a	O	6795
common	O	6795
autosomal	B-Disease	6795
dominant	I-Disease	6795
condition	I-Disease	6795
of	O	6795
craniosynostosis	B-Disease	6795
and	O	6795
limb	B-Disease	6795
anomalies	I-Disease	6795
,	O	6795
were	O	6795
screened	O	6795
for	O	6795
mutations	O	6795
in	O	6795
TWIST	O	6795
,	O	6795
FGFR2	O	6795
,	O	6795
and	O	6795
FGFR3	O	6795
.	O	6795

To	O	6798
date	O	6798
,	O	6798
our	O	6798
detection	O	6798
rate	O	6798
for	O	6798
TWIST	O	6798
or	O	6798
FGFR	O	6798
mutations	O	6798
is	O	6798
68	O	6798
%	O	6798
in	O	6798
our	O	6798
Saethre	B-Disease	6798
-	I-Disease	6798
Chotzen	I-Disease	6798
syndrome	I-Disease	6798
patients	O	6798
,	O	6798
including	O	6798
our	O	6798
five	O	6798
patients	O	6798
elsewhere	O	6798
reported	O	6798
with	O	6798
TWIST	O	6798
mutations	O	6798
.	O	6798

The	O	6800
most	O	6800
common	O	6800
phenotypic	O	6800
features	O	6800
,	O	6800
present	O	6800
in	O	6800
more	O	6800
than	O	6800
a	O	6800
third	O	6800
of	O	6800
our	O	6800
patients	O	6800
with	O	6800
TWIST	O	6800
mutations	O	6800
,	O	6800
are	O	6800
coronal	B-Disease	6800
synostosis	I-Disease	6800
,	O	6800
brachycephaly	B-Disease	6800
,	O	6800
low	B-Disease	6800
frontal	I-Disease	6800
hairline	I-Disease	6800
,	O	6800
facial	B-Disease	6800
asymmetry	I-Disease	6800
,	O	6800
ptosis	B-Disease	6800
,	O	6800
hypertelorism	B-Disease	6800
,	O	6800
broad	B-Disease	6800
great	I-Disease	6800
toes	I-Disease	6800
,	O	6800
and	O	6800
clinodactyly	B-Disease	6800
.	O	6800

The	O	6802
overlap	O	6802
in	O	6802
clinical	O	6802
features	O	6802
and	O	6802
the	O	6802
presence	O	6802
,	O	6802
in	O	6802
the	O	6802
same	O	6802
genes	O	6802
,	O	6802
of	O	6802
mutations	O	6802
for	O	6802
more	O	6802
than	O	6802
one	O	6802
craniosynostotic	B-Disease	6802
condition	I-Disease	6802
-	O	6802
such	O	6802
as	O	6802
Saethre	B-Disease	6802
-	I-Disease	6802
Chotzen	I-Disease	6802
,	I-Disease	6802
Crouzon	I-Disease	6802
,	I-Disease	6802
and	I-Disease	6802
Pfeiffer	I-Disease	6802
syndromes	I-Disease	6802
-	O	6802
support	O	6802
the	O	6802
hypothesis	O	6802
that	O	6802
TWIST	O	6802
and	O	6802
FGFRs	O	6802
are	O	6802
components	O	6802
of	O	6802
the	O	6802
same	O	6802
molecular	O	6802
pathway	O	6802
involved	O	6802
in	O	6802
the	O	6802
modulation	O	6802
of	O	6802
craniofacial	O	6802
and	O	6802
limb	O	6802
development	O	6802
in	O	6802
humans	O	6802
.	O	6802

Mutation	O	6804
analysis	O	6804
of	O	6804
UBE3A	O	6804
in	O	6804
Angelman	B-Disease	6804
syndrome	I-Disease	6804
patients	O	6804
.	O	6804

Angelman	B-Disease	6805
syndrome	I-Disease	6805
(	O	6805
AS	B-Disease	6805
)	O	6805
is	O	6805
caused	O	6805
by	O	6805
chromosome	O	6805
15q11	O	6805
-	O	6805
q13	O	6805
deletions	O	6805
of	O	6805
maternal	O	6805
origin	O	6805
,	O	6805
by	O	6805
paternal	O	6805
uniparental	B-Disease	6805
disomy	I-Disease	6805
(	O	6805
UPD	B-Disease	6805
)	O	6805
15	O	6805
,	O	6805
by	O	6805
imprinting	O	6805
defects	O	6805
,	O	6805
and	O	6805
by	O	6805
mutations	O	6805
in	O	6805
the	O	6805
UBE3A	O	6805
gene	O	6805
.	O	6805

Here	O	6807
we	O	6807
describe	O	6807
UBE3A	O	6807
coding	O	6807
-	O	6807
region	O	6807
mutations	O	6807
detected	O	6807
by	O	6807
SSCP	O	6807
analysis	O	6807
in	O	6807
13	O	6807
AS	B-Disease	6807
individuals	O	6807
or	O	6807
families	O	6807
.	O	6807

In	O	6811
two	O	6811
familial	O	6811
cases	O	6811
and	O	6811
one	O	6811
sporadic	O	6811
case	O	6811
,	O	6811
mosaicism	O	6811
for	O	6811
UBE3A	O	6811
mutations	O	6811
was	O	6811
detected	O	6811
in	O	6811
the	O	6811
mother	O	6811
of	O	6811
three	O	6811
AS	B-Disease	6811
sons	O	6811
,	O	6811
in	O	6811
the	O	6811
maternal	O	6811
grandfather	O	6811
of	O	6811
two	O	6811
AS	B-Disease	6811
first	O	6811
cousins	O	6811
,	O	6811
and	O	6811
in	O	6811
the	O	6811
mother	O	6811
of	O	6811
an	O	6811
AS	B-Disease	6811
daughter	O	6811
.	O	6811

The	O	6814
hemochromatosis	B-Disease	6814
845	O	6814
G	O	6814
-	O	6814
-	O	6814
>	O	6814
A	O	6814
and	O	6814
187	O	6814
C	O	6814
-	O	6814
-	O	6814
>	O	6814
G	O	6814
mutations	O	6814
:	O	6814
prevalence	O	6814
in	O	6814
non	O	6814
-	O	6814
Caucasian	O	6814
populations	O	6814
.	O	6814

Hemochromatosis	B-Disease	6815
,	O	6815
the	O	6815
inherited	B-Disease	6815
disorder	I-Disease	6815
of	I-Disease	6815
iron	I-Disease	6815
metabolism	I-Disease	6815
,	O	6815
leads	O	6815
,	O	6815
if	O	6815
untreated	O	6815
,	O	6815
to	O	6815
progressive	O	6815
iron	B-Disease	6815
overload	I-Disease	6815
and	O	6815
premature	B-Disease	6815
death	I-Disease	6815
.	O	6815

The	O	6816
hemochromatosis	B-Disease	6816
gene	O	6816
,	O	6816
HFE	O	6816
,	O	6816
recently	O	6816
has	O	6816
been	O	6816
identified	O	6816
,	O	6816
and	O	6816
characterization	O	6816
of	O	6816
this	O	6816
gene	O	6816
has	O	6816
shown	O	6816
that	O	6816
it	O	6816
contains	O	6816
two	O	6816
mutations	O	6816
that	O	6816
result	O	6816
in	O	6816
amino	O	6816
acid	O	6816
substitutions	O	6816
-	O	6816
cDNA	O	6816
nucleotides	O	6816
845	O	6816
G	O	6816
-	O	6816
-	O	6816
>	O	6816
A	O	6816
(	O	6816
C282Y	O	6816
)	O	6816
and	O	6816
187	O	6816
C	O	6816
-	O	6816
-	O	6816
>	O	6816
G	O	6816
(	O	6816
H63D	O	6816
)	O	6816
.	O	6816

Although	O	6817
hemochromatosis	B-Disease	6817
is	O	6817
common	O	6817
in	O	6817
Caucasians	O	6817
,	O	6817
affecting	O	6817
>	O	6817
=	O	6817
1	O	6817
/	O	6817
300	O	6817
individuals	O	6817
of	O	6817
northern	O	6817
European	O	6817
origin	O	6817
,	O	6817
it	O	6817
has	O	6817
not	O	6817
been	O	6817
recognized	O	6817
in	O	6817
other	O	6817
populations	O	6817
.	O	6817

Genotype	O	6825
-	O	6825
phenotype	O	6825
correlations	O	6825
in	O	6825
attenuated	B-Disease	6825
adenomatous	I-Disease	6825
polyposis	I-Disease	6825
coli	I-Disease	6825
.	O	6825

Germ	O	6826
-	O	6826
line	O	6826
mutations	O	6826
of	O	6826
the	O	6826
tumor	B-Disease	6826
suppressor	O	6826
APC	O	6826
are	O	6826
implicated	O	6826
in	O	6826
attenuated	B-Disease	6826
adenomatous	I-Disease	6826
polyposis	I-Disease	6826
coli	I-Disease	6826
(	O	6826
AAPC	B-Disease	6826
)	O	6826
,	O	6826
a	O	6826
variant	O	6826
of	O	6826
familial	B-Disease	6826
adenomatous	I-Disease	6826
polyposis	I-Disease	6826
(	O	6826
FAP	B-Disease	6826
)	O	6826
.	O	6826

AAPC	B-Disease	6827
is	O	6827
recognized	O	6827
by	O	6827
the	O	6827
occurrence	O	6827
of	O	6827
<	O	6827
100	O	6827
colonic	B-Disease	6827
adenomas	I-Disease	6827
and	O	6827
a	O	6827
later	O	6827
onset	O	6827
of	O	6827
colorectal	B-Disease	6827
cancer	I-Disease	6827
(	O	6827
age	O	6827
>	O	6827
40	O	6827
years	O	6827
)	O	6827
.	O	6827

The	O	6828
aim	O	6828
of	O	6828
this	O	6828
study	O	6828
was	O	6828
to	O	6828
assess	O	6828
genotype	O	6828
-	O	6828
phenotype	O	6828
correlations	O	6828
in	O	6828
AAPC	B-Disease	6828
families	O	6828
.	O	6828

By	O	6829
protein	O	6829
-	O	6829
truncation	O	6829
test	O	6829
(	O	6829
PTT	O	6829
)	O	6829
assay	O	6829
,	O	6829
the	O	6829
entire	O	6829
coding	O	6829
region	O	6829
of	O	6829
the	O	6829
APC	B-Disease	6829
gene	O	6829
was	O	6829
screened	O	6829
in	O	6829
affected	O	6829
individuals	O	6829
from	O	6829
11	O	6829
AAPC	B-Disease	6829
kindreds	O	6829
,	O	6829
and	O	6829
their	O	6829
phenotypic	O	6829
differences	O	6829
were	O	6829
examined	O	6829
.	O	6829

Five	O	6830
novel	O	6830
germ	O	6830
-	O	6830
line	O	6830
APC	B-Disease	6830
mutations	O	6830
were	O	6830
identified	O	6830
in	O	6830
seven	O	6830
kindreds	O	6830
.	O	6830

Mutations	O	6831
were	O	6831
located	O	6831
in	O	6831
three	O	6831
different	O	6831
regions	O	6831
of	O	6831
the	O	6831
APC	B-Disease	6831
gene	O	6831
(	O	6831
1	O	6831
)	O	6831
at	O	6831
the	O	6831
5	O	6831
end	O	6831
spanning	O	6831
exons	O	6831
4	O	6831
and	O	6831
5	O	6831
,	O	6831
(	O	6831
2	O	6831
)	O	6831
within	O	6831
exon	O	6831
9	O	6831
,	O	6831
and	O	6831
(	O	6831
3	O	6831
)	O	6831
at	O	6831
the	O	6831
3	O	6831
distal	O	6831
end	O	6831
of	O	6831
the	O	6831
gene	O	6831
.	O	6831

Variability	O	6832
in	O	6832
the	O	6832
number	O	6832
of	O	6832
colorectal	B-Disease	6832
adenomas	I-Disease	6832
was	O	6832
most	O	6832
apparent	O	6832
in	O	6832
individuals	O	6832
with	O	6832
mutations	O	6832
in	O	6832
region	O	6832
1	O	6832
,	O	6832
and	O	6832
upper	O	6832
-	O	6832
gastrointestinal	O	6832
manifestations	O	6832
were	O	6832
more	O	6832
severe	O	6832
in	O	6832
them	O	6832
.	O	6832

In	O	6833
individuals	O	6833
with	O	6833
mutations	O	6833
in	O	6833
either	O	6833
region	O	6833
2	O	6833
or	O	6833
region	O	6833
3	O	6833
,	O	6833
the	O	6833
average	O	6833
number	O	6833
of	O	6833
adenomas	B-Disease	6833
tended	O	6833
to	O	6833
be	O	6833
lower	O	6833
than	O	6833
those	O	6833
in	O	6833
individuals	O	6833
with	O	6833
mutations	O	6833
in	O	6833
region	O	6833
1	O	6833
,	O	6833
although	O	6833
age	O	6833
at	O	6833
diagnosis	O	6833
was	O	6833
similar	O	6833
.	O	6833

In	O	6834
all	O	6834
AAPC	B-Disease	6834
kindreds	O	6834
,	O	6834
a	O	6834
predominance	O	6834
of	O	6834
right	O	6834
-	O	6834
sided	O	6834
colorectal	B-Disease	6834
adenomas	I-Disease	6834
and	O	6834
rectal	B-Disease	6834
polyp	I-Disease	6834
sparing	O	6834
was	O	6834
observed	O	6834
.	O	6834

No	O	6835
desmoid	B-Disease	6835
tumors	I-Disease	6835
were	O	6835
found	O	6835
in	O	6835
these	O	6835
kindreds	O	6835
.	O	6835

Our	O	6836
data	O	6836
suggest	O	6836
that	O	6836
,	O	6836
in	O	6836
AAPC	B-Disease	6836
families	O	6836
,	O	6836
the	O	6836
location	O	6836
of	O	6836
the	O	6836
APC	B-Disease	6836
mutation	O	6836
may	O	6836
partially	O	6836
predict	O	6836
specific	O	6836
phenotypic	O	6836
expression	O	6836
.	O	6836

This	O	6837
should	O	6837
help	O	6837
in	O	6837
the	O	6837
design	O	6837
of	O	6837
tailored	O	6837
clinical	O	6837
-	O	6837
management	O	6837
protocols	O	6837
in	O	6837
this	O	6837
subset	O	6837
of	O	6837
FAP	B-Disease	6837
patients	O	6837
.	O	6837

Wilms	B-Disease	6839
'	I-Disease	6839
tumor	I-Disease	6839
1	O	6839
and	O	6839
Dax	O	6839
-	O	6839
1	O	6839
modulate	O	6839
the	O	6839
orphan	O	6839
nuclear	O	6839
receptor	O	6839
SF	O	6839
-	O	6839
1	O	6839
in	O	6839
sex	O	6839
-	O	6839
specific	O	6839
gene	O	6839
expression	O	6839
.	O	6839

Products	O	6840
of	O	6840
steroidogenic	O	6840
factor	O	6840
1	O	6840
(	O	6840
SF	O	6840
-	O	6840
1	O	6840
)	O	6840
and	O	6840
Wilms	B-Disease	6840
tumor	I-Disease	6840
1	O	6840
(	O	6840
WT1	O	6840
)	O	6840
genes	O	6840
are	O	6840
essential	O	6840
for	O	6840
mammalian	O	6840
gonadogenesis	O	6840
prior	O	6840
to	O	6840
sexual	O	6840
differentiation	O	6840
.	O	6840

In	O	6843
contrast	O	6843
,	O	6843
WT1	O	6843
missense	O	6843
mutations	O	6843
,	O	6843
associated	O	6843
with	O	6843
male	B-Disease	6843
pseudohermaphroditism	I-Disease	6843
in	O	6843
Denys	B-Disease	6843
-	I-Disease	6843
Drash	I-Disease	6843
syndrome	I-Disease	6843
,	O	6843
fail	O	6843
to	O	6843
synergize	O	6843
with	O	6843
SF	O	6843
-	O	6843
1	O	6843
.	O	6843

A	O	6847
mouse	O	6847
model	O	6847
for	O	6847
Prader	B-Disease	6847
-	I-Disease	6847
Willi	I-Disease	6847
syndrome	I-Disease	6847
imprinting	O	6847
-	O	6847
centre	O	6847
mutations	O	6847
.	O	6847

Deletion	O	6849
of	O	6849
this	O	6849
IC	O	6849
abolishes	O	6849
local	O	6849
paternally	O	6849
derived	O	6849
gene	O	6849
expression	O	6849
and	O	6849
results	O	6849
in	O	6849
Prader	B-Disease	6849
-	I-Disease	6849
Willi	I-Disease	6849
syndrome	I-Disease	6849
(	O	6849
PWS	B-Disease	6849
)	O	6849
.	O	6849

We	O	6850
have	O	6850
created	O	6850
two	O	6850
deletion	O	6850
mutations	O	6850
in	O	6850
mice	O	6850
to	O	6850
understand	O	6850
PWS	B-Disease	6850
and	O	6850
the	O	6850
mechanism	O	6850
of	O	6850
this	O	6850
IC	O	6850
.	O	6850

Mice	O	6851
harbouring	O	6851
an	O	6851
intragenic	O	6851
deletion	O	6851
in	O	6851
Snrpn	O	6851
are	O	6851
phenotypically	O	6851
normal	O	6851
,	O	6851
suggesting	O	6851
that	O	6851
mutations	O	6851
of	O	6851
SNRPN	O	6851
are	O	6851
not	O	6851
sufficient	O	6851
to	O	6851
induce	O	6851
PWS	B-Disease	6851
.	O	6851

Mice	O	6852
with	O	6852
a	O	6852
larger	O	6852
deletion	O	6852
involving	O	6852
both	O	6852
Snrpn	O	6852
and	O	6852
the	O	6852
putative	O	6852
PWS	O	6852
-	O	6852
IC	O	6852
lack	O	6852
expression	O	6852
of	O	6852
the	O	6852
imprinted	O	6852
genes	O	6852
Zfp127	O	6852
(	O	6852
mouse	O	6852
homologue	O	6852
of	O	6852
ZNF127	O	6852
)	O	6852
,	O	6852
Ndn	O	6852
and	O	6852
Ipw	O	6852
,	O	6852
and	O	6852
manifest	O	6852
several	O	6852
phenotypes	O	6852
common	O	6852
to	O	6852
PWS	B-Disease	6852
infants	O	6852
.	O	6852

Mutations	O	6855
of	O	6855
the	O	6855
ATM	O	6855
gene	O	6855
detected	O	6855
in	O	6855
Japanese	O	6855
ataxia	B-Disease	6855
-	I-Disease	6855
telangiectasia	I-Disease	6855
patients	O	6855
:	O	6855
possible	O	6855
preponderance	O	6855
of	O	6855
the	O	6855
two	O	6855
founder	O	6855
mutations	O	6855
4612del165	O	6855
and	O	6855
7883del5	O	6855
.	O	6855

3	O	6857
has	O	6857
recently	O	6857
been	O	6857
identified	O	6857
as	O	6857
the	O	6857
gene	O	6857
responsible	O	6857
for	O	6857
the	O	6857
human	O	6857
recessive	B-Disease	6857
disease	I-Disease	6857
ataxia	B-Disease	6857
-	I-Disease	6857
telangiectasia	I-Disease	6857
(	O	6857
A	B-Disease	6857
-	I-Disease	6857
T	I-Disease	6857
)	O	6857
.	O	6857

In	O	6858
order	O	6858
to	O	6858
define	O	6858
the	O	6858
types	O	6858
of	O	6858
disease	O	6858
-	O	6858
causing	O	6858
ATM	O	6858
mutations	O	6858
in	O	6858
Japanese	O	6858
A	B-Disease	6858
-	I-Disease	6858
T	I-Disease	6858
patients	O	6858
as	O	6858
well	O	6858
as	O	6858
to	O	6858
look	O	6858
for	O	6858
possible	O	6858
mutational	O	6858
hotspots	O	6858
,	O	6858
reverse	O	6858
-	O	6858
transcribed	O	6858
RNA	O	6858
derived	O	6858
from	O	6858
ten	O	6858
patients	O	6858
belonging	O	6858
to	O	6858
eight	O	6858
unrelated	O	6858
Japanese	O	6858
A	B-Disease	6858
-	I-Disease	6858
T	I-Disease	6858
families	O	6858
was	O	6858
analyzed	O	6858
for	O	6858
mutations	O	6858
by	O	6858
the	O	6858
restriction	O	6858
endonuclease	O	6858
fingerprinting	O	6858
method	O	6858
.	O	6858

W474C	O	6867
amino	O	6867
acid	O	6867
substitution	O	6867
affects	O	6867
early	O	6867
processing	O	6867
of	O	6867
the	O	6867
alpha	O	6867
-	O	6867
subunit	O	6867
of	O	6867
beta	O	6867
-	O	6867
hexosaminidase	O	6867
A	O	6867
and	O	6867
is	O	6867
associated	O	6867
with	O	6867
subacute	O	6867
G	B-Disease	6867
(	I-Disease	6867
M2	I-Disease	6867
)	I-Disease	6867
gangliosidosis	I-Disease	6867
.	O	6867

Mutations	O	6868
in	O	6868
the	O	6868
HEXA	O	6868
gene	O	6868
,	O	6868
encoding	O	6868
the	O	6868
alpha	O	6868
-	O	6868
subunit	O	6868
of	O	6868
beta	O	6868
-	O	6868
hexosaminidase	O	6868
A	O	6868
(	O	6868
Hex	O	6868
A	O	6868
)	O	6868
,	O	6868
that	O	6868
abolish	O	6868
Hex	O	6868
A	O	6868
enzyme	O	6868
activity	O	6868
cause	O	6868
Tay	B-Disease	6868
-	I-Disease	6868
Sachs	I-Disease	6868
disease	I-Disease	6868
(	O	6868
TSD	B-Disease	6868
)	O	6868
,	O	6868
the	O	6868
fatal	O	6868
infantile	B-Disease	6868
form	I-Disease	6868
of	I-Disease	6868
G	I-Disease	6868
(	I-Disease	6868
M2	I-Disease	6868
)	I-Disease	6868
gangliosidosis	I-Disease	6868
,	I-Disease	6868
Type	I-Disease	6868
1	I-Disease	6868
.	O	6868

We	O	6870
identified	O	6870
a	O	6870
1422	O	6870
G	O	6870
-	O	6870
-	O	6870
>	O	6870
C	O	6870
(	O	6870
amino	O	6870
acid	O	6870
W474C	O	6870
)	O	6870
substitution	O	6870
in	O	6870
the	O	6870
first	O	6870
position	O	6870
of	O	6870
exon	O	6870
13	O	6870
of	O	6870
HEXA	O	6870
of	O	6870
a	O	6870
non	O	6870
-	O	6870
Jewish	O	6870
proband	O	6870
who	O	6870
manifested	O	6870
a	O	6870
subacute	O	6870
variant	O	6870
of	O	6870
G	B-Disease	6870
(	I-Disease	6870
M2	I-Disease	6870
)	I-Disease	6870
gangliosidosis	I-Disease	6870
.	O	6870

When	O	6873
the	O	6873
W474C	O	6873
-	O	6873
containing	O	6873
alpha	O	6873
-	O	6873
subunit	O	6873
was	O	6873
transiently	O	6873
co	O	6873
-	O	6873
expressed	O	6873
with	O	6873
the	O	6873
beta	O	6873
-	O	6873
subunit	O	6873
to	O	6873
produce	O	6873
Hex	O	6873
A	O	6873
(	O	6873
alphabeta	O	6873
)	O	6873
in	O	6873
COS	O	6873
-	O	6873
7	O	6873
cells	O	6873
,	O	6873
the	O	6873
mature	O	6873
alpha	O	6873
-	O	6873
subunit	O	6873
was	O	6873
present	O	6873
,	O	6873
but	O	6873
its	O	6873
level	O	6873
was	O	6873
much	O	6873
lower	O	6873
than	O	6873
that	O	6873
from	O	6873
normal	O	6873
alpha	O	6873
-	O	6873
subunit	O	6873
transfections	O	6873
,	O	6873
although	O	6873
higher	O	6873
than	O	6873
in	O	6873
those	O	6873
cells	O	6873
transfected	O	6873
with	O	6873
an	O	6873
alpha	O	6873
-	O	6873
subunit	O	6873
associated	O	6873
with	O	6873
infantile	O	6873
TSD	B-Disease	6873
.	O	6873

We	O	6875
conclude	O	6875
that	O	6875
the	O	6875
1422	O	6875
G	O	6875
-	O	6875
-	O	6875
>	O	6875
C	O	6875
mutation	O	6875
is	O	6875
the	O	6875
cause	O	6875
of	O	6875
Hex	B-Disease	6875
A	I-Disease	6875
enzyme	I-Disease	6875
deficiency	I-Disease	6875
in	O	6875
the	O	6875
proband	O	6875
.	O	6875

The	O	6876
resulting	O	6876
W474C	O	6876
substitution	O	6876
clearly	O	6876
interferes	O	6876
with	O	6876
alpha	O	6876
-	O	6876
subunit	O	6876
processing	O	6876
,	O	6876
but	O	6876
because	O	6876
the	O	6876
base	O	6876
substitution	O	6876
falls	O	6876
at	O	6876
the	O	6876
first	O	6876
position	O	6876
of	O	6876
exon	O	6876
13	O	6876
,	O	6876
aberrant	O	6876
splicing	O	6876
may	O	6876
also	O	6876
contribute	O	6876
to	O	6876
Hex	B-Disease	6876
A	I-Disease	6876
deficiency	I-Disease	6876
in	O	6876
this	O	6876
proband	O	6876
.	O	6876

Two	O	6878
frequent	O	6878
missense	O	6878
mutations	O	6878
in	O	6878
Pendred	B-Disease	6878
syndrome	I-Disease	6878
.	O	6878

Pendred	B-Disease	6879
syndrome	I-Disease	6879
is	O	6879
an	O	6879
autosomal	B-Disease	6879
recessive	I-Disease	6879
disorder	I-Disease	6879
characterized	O	6879
by	O	6879
early	O	6879
childhood	O	6879
deafness	B-Disease	6879
and	O	6879
goiter	B-Disease	6879
.	O	6879

We	O	6882
performed	O	6882
mutation	O	6882
analysis	O	6882
of	O	6882
the	O	6882
PDS	B-Disease	6882
gene	O	6882
in	O	6882
patients	O	6882
from	O	6882
14	O	6882
Pendred	B-Disease	6882
families	O	6882
originating	O	6882
from	O	6882
seven	O	6882
countries	O	6882
and	O	6882
identified	O	6882
all	O	6882
mutations	O	6882
.	O	6882

Pendred	B-Disease	6886
patients	O	6886
in	O	6886
three	O	6886
non	O	6886
-	O	6886
consanguineous	O	6886
families	O	6886
were	O	6886
shown	O	6886
to	O	6886
be	O	6886
compound	O	6886
heterozygotes	O	6886
for	O	6886
L236P	O	6886
and	O	6886
T416P	O	6886
.	O	6886

The	O	6888
identification	O	6888
of	O	6888
two	O	6888
frequent	O	6888
PDS	B-Disease	6888
mutations	O	6888
will	O	6888
facilitate	O	6888
the	O	6888
molecular	O	6888
diagnosis	O	6888
of	O	6888
Pendred	B-Disease	6888
syndrome	I-Disease	6888
.	O	6888

Insertional	O	6889
mutation	O	6889
by	O	6889
transposable	O	6889
element	O	6889
,	O	6889
L1	O	6889
,	O	6889
in	O	6889
the	O	6889
DMD	B-Disease	6889
gene	O	6889
results	O	6889
in	O	6889
X	B-Disease	6889
-	I-Disease	6889
linked	I-Disease	6889
dilated	I-Disease	6889
cardiomyopathy	I-Disease	6889
.	O	6889

X	B-Disease	6890
-	I-Disease	6890
linked	I-Disease	6890
dilated	I-Disease	6890
cardiomyopathy	I-Disease	6890
(	O	6890
XLDCM	B-Disease	6890
)	O	6890
is	O	6890
a	O	6890
clinical	O	6890
phenotype	O	6890
of	O	6890
dystrophinopathy	B-Disease	6890
which	O	6890
is	O	6890
characterized	O	6890
by	O	6890
preferential	O	6890
myocardial	B-Disease	6890
involvement	I-Disease	6890
without	O	6890
any	O	6890
overt	O	6890
clinical	O	6890
signs	O	6890
of	O	6890
skeletal	B-Disease	6890
myopathy	I-Disease	6890
.	O	6890

To	O	6891
date	O	6891
,	O	6891
several	O	6891
mutations	O	6891
in	O	6891
the	O	6891
Duchenne	B-Disease	6891
muscular	I-Disease	6891
dystrophy	I-Disease	6891
gene	O	6891
,	O	6891
DMD	O	6891
,	O	6891
have	O	6891
been	O	6891
identified	O	6891
in	O	6891
patients	O	6891
with	O	6891
XLDCM	B-Disease	6891
,	O	6891
but	O	6891
a	O	6891
pathogenic	O	6891
correlation	O	6891
of	O	6891
these	O	6891
cardiospecific	O	6891
mutations	O	6891
in	O	6891
DMD	O	6891
with	O	6891
the	O	6891
XLDCM	B-Disease	6891
phenotype	O	6891
has	O	6891
remained	O	6891
to	O	6891
be	O	6891
elucidated	O	6891
.	O	6891

We	O	6892
report	O	6892
here	O	6892
the	O	6892
identification	O	6892
of	O	6892
a	O	6892
unique	O	6892
de	O	6892
novo	O	6892
L1	O	6892
insertion	O	6892
in	O	6892
the	O	6892
muscle	O	6892
exon	O	6892
1	O	6892
in	O	6892
DMD	O	6892
in	O	6892
three	O	6892
XLDCM	B-Disease	6892
patients	O	6892
from	O	6892
two	O	6892
unrelated	O	6892
Japanese	O	6892
families	O	6892
.	O	6892

We	O	6894
speculate	O	6894
that	O	6894
this	O	6894
insertion	O	6894
of	O	6894
an	O	6894
L1	O	6894
sequence	O	6894
in	O	6894
DMD	O	6894
is	O	6894
responsible	O	6894
for	O	6894
some	O	6894
of	O	6894
the	O	6894
population	O	6894
of	O	6894
Japanese	O	6894
patients	O	6894
with	O	6894
XLDCM	B-Disease	6894
.	O	6894

Severe	O	6896
early	O	6896
-	O	6896
onset	O	6896
obesity	B-Disease	6896
,	O	6896
adrenal	B-Disease	6896
insufficiency	I-Disease	6896
and	O	6896
red	O	6896
hair	O	6896
pigmentation	O	6896
caused	O	6896
by	O	6896
POMC	O	6896
mutations	O	6896
in	O	6896
humans	O	6896
.	O	6896

While	O	6898
a	O	6898
few	O	6898
cases	O	6898
of	O	6898
isolated	O	6898
ACTH	B-Disease	6898
deficiency	I-Disease	6898
have	O	6898
been	O	6898
reported	O	6898
(	O	6898
OMIM	O	6898
201400	O	6898
)	O	6898
,	O	6898
an	O	6898
inherited	O	6898
POMC	O	6898
defect	O	6898
has	O	6898
not	O	6898
been	O	6898
described	O	6898
so	O	6898
far	O	6898
.	O	6898

Recent	O	6899
studies	O	6899
in	O	6899
animal	O	6899
models	O	6899
elucidated	O	6899
a	O	6899
central	O	6899
role	O	6899
of	O	6899
alpha	O	6899
-	O	6899
MSH	O	6899
in	O	6899
the	O	6899
regulation	O	6899
of	O	6899
food	O	6899
intake	O	6899
by	O	6899
activation	O	6899
of	O	6899
the	O	6899
brain	O	6899
melanocortin	O	6899
-	O	6899
4	O	6899
-	O	6899
receptor	O	6899
(	O	6899
MC4	O	6899
-	O	6899
R	O	6899
;	O	6899
refs	O	6899
3	O	6899
-	O	6899
5	O	6899
)	O	6899
and	O	6899
the	O	6899
linkage	O	6899
of	O	6899
human	O	6899
obesity	B-Disease	6899
to	O	6899
chromosome	O	6899
2	O	6899
in	O	6899
close	O	6899
proximity	O	6899
to	O	6899
the	O	6899
POMC	O	6899
locus	O	6899
,	O	6899
led	O	6899
to	O	6899
the	O	6899
proposal	O	6899
of	O	6899
an	O	6899
association	O	6899
of	O	6899
POMC	O	6899
with	O	6899
human	O	6899
obesity	B-Disease	6899
.	O	6899

The	O	6900
dual	O	6900
role	O	6900
of	O	6900
alpha	O	6900
-	O	6900
MSH	O	6900
in	O	6900
regulating	O	6900
food	O	6900
intake	O	6900
and	O	6900
influencing	O	6900
hair	O	6900
pigmentation	O	6900
predicts	O	6900
that	O	6900
the	O	6900
phenotype	O	6900
associated	O	6900
with	O	6900
a	O	6900
defect	O	6900
in	O	6900
POMC	O	6900
function	O	6900
would	O	6900
include	O	6900
obesity	B-Disease	6900
,	O	6900
alteration	O	6900
in	O	6900
pigmentation	O	6900
and	O	6900
ACTH	B-Disease	6900
deficiency	I-Disease	6900
.	O	6900

These	O	6904
findings	O	6904
represent	O	6904
the	O	6904
first	O	6904
examples	O	6904
of	O	6904
a	O	6904
genetic	B-Disease	6904
defect	I-Disease	6904
within	O	6904
the	O	6904
POMC	O	6904
gene	O	6904
and	O	6904
define	O	6904
a	O	6904
new	O	6904
monogenic	B-Disease	6904
endocrine	I-Disease	6904
disorder	I-Disease	6904
resulting	O	6904
in	O	6904
early	O	6904
-	O	6904
onset	O	6904
obesity	B-Disease	6904
,	O	6904
adrenal	B-Disease	6904
insufficiency	I-Disease	6904
and	O	6904
red	O	6904
hair	O	6904
pigmentation	O	6904
.	O	6904

A	O	6906
European	O	6906
multicenter	O	6906
study	O	6906
of	O	6906
phenylalanine	B-Disease	6906
hydroxylase	I-Disease	6906
deficiency	I-Disease	6906
:	O	6906
classification	O	6906
of	O	6906
105	O	6906
mutations	O	6906
and	O	6906
a	O	6906
general	O	6906
system	O	6906
for	O	6906
genotype	O	6906
-	O	6906
based	O	6906
prediction	O	6906
of	O	6906
metabolic	O	6906
phenotype	O	6906
.	O	6906

Phenylketonuria	B-Disease	6907
(	O	6907
PKU	B-Disease	6907
)	O	6907
and	O	6907
mild	B-Disease	6907
hyperphenylalaninemia	I-Disease	6907
(	O	6907
MHP	B-Disease	6907
)	O	6907
are	O	6907
allelic	B-Disease	6907
disorders	I-Disease	6907
caused	O	6907
by	O	6907
mutations	O	6907
in	O	6907
the	O	6907
gene	O	6907
encoding	O	6907
phenylalanine	O	6907
hydroxylase	O	6907
(	O	6907
PAH	O	6907
)	O	6907
.	O	6907

Previous	O	6908
studies	O	6908
have	O	6908
suggested	O	6908
that	O	6908
the	O	6908
highly	O	6908
variable	O	6908
metabolic	O	6908
phenotypes	O	6908
of	O	6908
PAH	B-Disease	6908
deficiency	I-Disease	6908
correlate	O	6908
with	O	6908
PAH	O	6908
genotypes	O	6908
.	O	6908

Our	O	6915
data	O	6915
indicate	O	6915
that	O	6915
the	O	6915
PAH	O	6915
-	O	6915
mutation	O	6915
genotype	O	6915
is	O	6915
the	O	6915
main	O	6915
determinant	O	6915
of	O	6915
metabolic	O	6915
phenotype	O	6915
in	O	6915
most	O	6915
patients	O	6915
with	O	6915
PAH	B-Disease	6915
deficiency	I-Disease	6915
.	O	6915

In	O	6916
the	O	6916
present	O	6916
study	O	6916
,	O	6916
the	O	6916
classification	O	6916
of	O	6916
105	O	6916
PAH	O	6916
mutations	O	6916
may	O	6916
allow	O	6916
the	O	6916
prediction	O	6916
of	O	6916
the	O	6916
biochemical	O	6916
phenotype	O	6916
in	O	6916
>	O	6916
10	O	6916
,	O	6916
000	O	6916
genotypes	O	6916
,	O	6916
which	O	6916
may	O	6916
be	O	6916
useful	O	6916
for	O	6916
the	O	6916
management	O	6916
of	O	6916
hyperphenylalaninemia	B-Disease	6916
in	O	6916
newborns	O	6916
.	O	6916

Somatic	O	6917
instability	O	6917
of	O	6917
the	O	6917
CTG	O	6917
repeat	O	6917
in	O	6917
mice	O	6917
transgenic	O	6917
for	O	6917
the	O	6917
myotonic	B-Disease	6917
dystrophy	I-Disease	6917
region	O	6917
is	O	6917
age	O	6917
dependent	O	6917
but	O	6917
not	O	6917
correlated	O	6917
to	O	6917
the	O	6917
relative	O	6917
intertissue	O	6917
transcription	O	6917
levels	O	6917
and	O	6917
proliferative	O	6917
capacities	O	6917
.	O	6917

A	O	6918
(	O	6918
CTG	O	6918
)	O	6918
nexpansion	O	6918
in	O	6918
the	O	6918
3	O	6918
-	O	6918
untranslated	O	6918
region	O	6918
(	O	6918
UTR	O	6918
)	O	6918
of	O	6918
the	O	6918
DM	O	6918
protein	O	6918
kinase	O	6918
gene	O	6918
(	O	6918
DMPK	O	6918
)	O	6918
is	O	6918
responsible	O	6918
for	O	6918
causing	O	6918
myotonic	B-Disease	6918
dystrophy	I-Disease	6918
(	O	6918
DM	B-Disease	6918
)	O	6918
.	O	6918

The	O	6921
trinucleotide	O	6921
repeat	O	6921
instability	O	6921
mechanisms	O	6921
involved	O	6921
in	O	6921
DM	B-Disease	6921
and	O	6921
other	O	6921
human	O	6921
genetic	B-Disease	6921
diseases	I-Disease	6921
are	O	6921
unknown	O	6921
.	O	6921

We	O	6922
studied	O	6922
somatic	O	6922
instability	O	6922
by	O	6922
measuring	O	6922
the	O	6922
CTG	O	6922
repeat	O	6922
length	O	6922
at	O	6922
several	O	6922
ages	O	6922
in	O	6922
various	O	6922
tissues	O	6922
of	O	6922
transgenic	O	6922
mice	O	6922
carrying	O	6922
a	O	6922
(	O	6922
CTG	O	6922
)	O	6922
55expansion	O	6922
surrounded	O	6922
by	O	6922
45	O	6922
kb	O	6922
of	O	6922
the	O	6922
human	O	6922
DM	B-Disease	6922
region	O	6922
,	O	6922
using	O	6922
small	O	6922
-	O	6922
pool	O	6922
PCR	O	6922
.	O	6922

As	O	6924
observed	O	6924
in	O	6924
some	O	6924
of	O	6924
the	O	6924
tissues	O	6924
of	O	6924
DM	B-Disease	6924
patients	O	6924
,	O	6924
there	O	6924
is	O	6924
a	O	6924
tendency	O	6924
for	O	6924
repeat	O	6924
length	O	6924
and	O	6924
somatic	O	6924
mosaicism	O	6924
to	O	6924
increase	O	6924
with	O	6924
the	O	6924
age	O	6924
of	O	6924
the	O	6924
mouse	O	6924
.	O	6924

A	O	6928
novel	O	6928
missense	O	6928
mutation	O	6928
in	O	6928
patients	O	6928
from	O	6928
a	O	6928
retinoblastoma	B-Disease	6928
pedigree	O	6928
showing	O	6928
only	O	6928
mild	O	6928
expression	O	6928
of	O	6928
the	O	6928
tumor	B-Disease	6928
phenotype	O	6928
.	O	6928

We	O	6929
have	O	6929
used	O	6929
single	O	6929
strand	O	6929
conformation	O	6929
polymorphism	O	6929
analysis	O	6929
to	O	6929
study	O	6929
the	O	6929
27	O	6929
exons	O	6929
of	O	6929
the	O	6929
RB1	O	6929
gene	O	6929
in	O	6929
individuals	O	6929
from	O	6929
a	O	6929
family	O	6929
showing	O	6929
mild	O	6929
expression	O	6929
of	O	6929
the	O	6929
retinoblastoma	B-Disease	6929
phenotype	O	6929
.	O	6929

In	O	6930
this	O	6930
family	O	6930
affected	O	6930
individuals	O	6930
developed	O	6930
unilateral	B-Disease	6930
tumors	I-Disease	6930
and	O	6930
,	O	6930
as	O	6930
a	O	6930
result	O	6930
of	O	6930
linkage	O	6930
analysis	O	6930
,	O	6930
unaffected	O	6930
mutation	O	6930
carriers	O	6930
were	O	6930
also	O	6930
identified	O	6930
within	O	6930
the	O	6930
pedigree	O	6930
.	O	6930

Analysis	O	6933
of	O	6933
all	O	6933
family	O	6933
members	O	6933
demonstrated	O	6933
that	O	6933
the	O	6933
missense	O	6933
mutation	O	6933
co	O	6933
-	O	6933
segregated	O	6933
with	O	6933
patients	O	6933
with	O	6933
tumors	B-Disease	6933
or	O	6933
who	O	6933
,	O	6933
as	O	6933
a	O	6933
result	O	6933
of	O	6933
linkage	O	6933
analysis	O	6933
had	O	6933
been	O	6933
predicted	O	6933
to	O	6933
carry	O	6933
the	O	6933
predisposing	O	6933
mutation	O	6933
.	O	6933

Maternal	B-Disease	6936
disomy	I-Disease	6936
and	O	6936
Prader	B-Disease	6936
-	I-Disease	6936
Willi	I-Disease	6936
syndrome	I-Disease	6936
consistent	O	6936
with	O	6936
gamete	O	6936
complementation	O	6936
in	O	6936
a	O	6936
case	O	6936
of	O	6936
familial	O	6936
translocation	O	6936
(	O	6936
3	O	6936
;	O	6936
15	O	6936
)	O	6936
(	O	6936
p25	O	6936
;	O	6936
q11	O	6936
.	O	6936

Maternal	B-Disease	6938
uniparental	I-Disease	6938
disomy	I-Disease	6938
(	I-Disease	6938
UPD	I-Disease	6938
)	I-Disease	6938
for	I-Disease	6938
chromosome	I-Disease	6938
15	I-Disease	6938
is	O	6938
responsible	O	6938
for	O	6938
an	O	6938
estimated	O	6938
30	O	6938
%	O	6938
of	O	6938
cases	O	6938
of	O	6938
Prader	B-Disease	6938
-	I-Disease	6938
Willi	I-Disease	6938
syndrome	I-Disease	6938
(	O	6938
PWS	B-Disease	6938
)	O	6938
.	O	6938

We	O	6939
report	O	6939
on	O	6939
an	O	6939
unusual	O	6939
case	O	6939
of	O	6939
maternal	B-Disease	6939
disomy	I-Disease	6939
15	I-Disease	6939
in	O	6939
PWS	B-Disease	6939
that	O	6939
is	O	6939
most	O	6939
consistent	O	6939
with	O	6939
adjacent	O	6939
-	O	6939
1	O	6939
segregation	O	6939
of	O	6939
a	O	6939
paternal	O	6939
t	O	6939
(	O	6939
3	O	6939
;	O	6939
15	O	6939
)	O	6939
(	O	6939
p25	O	6939
;	O	6939
q11	O	6939
.	O	6939

)	O	6943
,	O	6943
a	O	6943
17	O	6943
-	O	6943
year	O	6943
-	O	6943
old	O	6943
white	O	6943
male	O	6943
with	O	6943
PWS	B-Disease	6943
,	O	6943
was	O	6943
found	O	6943
to	O	6943
have	O	6943
47	O	6943
chromosomes	O	6943
with	O	6943
a	O	6943
supernumerary	O	6943
,	O	6943
paternal	O	6943
der	O	6943
(	O	6943
15	O	6943
)	O	6943
consisting	O	6943
of	O	6943
the	O	6943
short	O	6943
arm	O	6943
and	O	6943
the	O	6943
proximal	O	6943
long	O	6943
arm	O	6943
of	O	6943
chromosome	O	6943
15	O	6943
,	O	6943
and	O	6943
distal	O	6943
chromosome	O	6943
arm	O	6943
3p	O	6943
.	O	6943

Fluorescent	O	6945
in	O	6945
situ	O	6945
hybridization	O	6945
analysis	O	6945
demonstrated	O	6945
that	O	6945
the	O	6945
PWS	B-Disease	6945
critical	O	6945
region	O	6945
resided	O	6945
on	O	6945
the	O	6945
derivative	O	6945
chromosome	O	6945
3	O	6945
and	O	6945
that	O	6945
there	O	6945
was	O	6945
no	O	6945
deletion	O	6945
of	O	6945
the	O	6945
PWS	B-Disease	6945
region	O	6945
on	O	6945
the	O	6945
normal	O	6945
pair	O	6945
of	O	6945
15s	O	6945
present	O	6945
in	O	6945
J	O	6945
.	O	6945

Maternal	B-Disease	6949
disomy	I-Disease	6949
was	O	6949
confirmed	O	6949
by	O	6949
polymerase	O	6949
chain	O	6949
reaction	O	6949
analysis	O	6949
of	O	6949
microsatellite	O	6949
repeats	O	6949
at	O	6949
the	O	6949
gamma	O	6949
-	O	6949
aminobutyric	O	6949
acid	O	6949
receptor	O	6949
beta3	O	6949
subunit	O	6949
(	O	6949
GABRB3	O	6949
)	O	6949
locus	O	6949
.	O	6949

Uniparental	B-Disease	6953
disomy	I-Disease	6953
associated	O	6953
with	O	6953
unbalanced	O	6953
segregation	O	6953
of	O	6953
non	O	6953
-	O	6953
Robertsonian	O	6953
translocations	O	6953
has	O	6953
been	O	6953
reported	O	6953
previously	O	6953
but	O	6953
has	O	6953
not	O	6953
,	O	6953
to	O	6953
our	O	6953
knowledge	O	6953
,	O	6953
been	O	6953
observed	O	6953
in	O	6953
a	O	6953
case	O	6953
of	O	6953
PWS	B-Disease	6953
.	O	6953

Furthermore	O	6954
,	O	6954
our	O	6954
findings	O	6954
are	O	6954
best	O	6954
interpreted	O	6954
as	O	6954
true	O	6954
gamete	O	6954
complementation	O	6954
resulting	O	6954
in	O	6954
maternal	B-Disease	6954
UPD	I-Disease	6954
15	I-Disease	6954
and	O	6954
PWS	B-Disease	6954
Schwartz	B-Disease	6954
-	I-Disease	6954
Jampel	I-Disease	6954
syndrome	I-Disease	6954
type	I-Disease	6954
2	I-Disease	6954
and	O	6954
Stuve	B-Disease	6954
-	I-Disease	6954
Wiedemann	I-Disease	6954
syndrome	I-Disease	6954
:	O	6954
a	O	6954
case	O	6954
for	O	6954
Recent	O	6957
studies	O	6957
demonstrated	O	6957
the	O	6957
existence	O	6957
of	O	6957
a	O	6957
genetically	O	6957
distinct	O	6957
,	O	6957
usually	O	6957
lethal	O	6957
form	O	6957
of	O	6957
the	O	6957
Schwartz	B-Disease	6957
-	I-Disease	6957
Jampel	I-Disease	6957
syndrome	I-Disease	6957
(	O	6957
SJS	B-Disease	6957
)	O	6957
of	O	6957
myotonia	B-Disease	6957
and	O	6957
skeletal	B-Disease	6957
dysplasia	I-Disease	6957
,	O	6957
which	O	6957
we	O	6957
called	O	6957
SJS	B-Disease	6957
type	I-Disease	6957
2	I-Disease	6957
.	O	6957

This	O	6958
disorder	O	6958
is	O	6958
reminiscent	O	6958
of	O	6958
another	O	6958
rare	O	6958
condition	O	6958
,	O	6958
the	O	6958
Stuve	B-Disease	6958
-	I-Disease	6958
Wiedemann	I-Disease	6958
syndrome	I-Disease	6958
(	O	6958
SWS	B-Disease	6958
)	O	6958
,	O	6958
which	O	6958
comprises	O	6958
campomelia	B-Disease	6958
at	O	6958
birth	O	6958
with	O	6958
skeletal	B-Disease	6958
dysplasia	I-Disease	6958
,	O	6958
contractures	B-Disease	6958
,	O	6958
and	O	6958
early	B-Disease	6958
death	I-Disease	6958
.	O	6958

To	O	6959
test	O	6959
for	O	6959
possible	O	6959
nosologic	O	6959
identity	O	6959
between	O	6959
these	O	6959
disorders	O	6959
,	O	6959
we	O	6959
reviewed	O	6959
the	O	6959
literature	O	6959
and	O	6959
obtained	O	6959
a	O	6959
follow	O	6959
-	O	6959
up	O	6959
of	O	6959
the	O	6959
only	O	6959
two	O	6959
surviving	O	6959
patients	O	6959
,	O	6959
one	O	6959
with	O	6959
SJS	B-Disease	6959
type	I-Disease	6959
2	I-Disease	6959
at	O	6959
age	O	6959
10	O	6959
years	O	6959
and	O	6959
another	O	6959
with	O	6959
SWS	B-Disease	6959
at	O	6959
age	O	6959
7	O	6959
years	O	6959
.	O	6959

Patients	O	6960
reported	O	6960
as	O	6960
having	O	6960
either	O	6960
neonatal	O	6960
SJS	B-Disease	6960
or	O	6960
SWS	B-Disease	6960
presented	O	6960
a	O	6960
combination	O	6960
of	O	6960
a	O	6960
severe	O	6960
,	O	6960
prenatal	O	6960
-	O	6960
onset	O	6960
neuromuscular	B-Disease	6960
disorder	I-Disease	6960
(	O	6960
with	O	6960
congenital	B-Disease	6960
joint	I-Disease	6960
contractures	I-Disease	6960
,	O	6960
respiratory	O	6960
and	O	6960
feeding	O	6960
difficulties	O	6960
,	O	6960
tendency	O	6960
to	O	6960
hyperthermia	B-Disease	6960
,	O	6960
and	O	6960
frequent	O	6960
death	O	6960
in	O	6960
infancy	O	6960
)	O	6960
with	O	6960
a	O	6960
distinct	O	6960
campomelic	B-Disease	6960
-	I-Disease	6960
metaphyseal	I-Disease	6960
skeletal	I-Disease	6960
dysplasia	I-Disease	6960
.	O	6960

The	O	6962
follow	O	6962
-	O	6962
up	O	6962
observation	O	6962
of	O	6962
an	O	6962
identical	O	6962
and	O	6962
unique	O	6962
pattern	O	6962
of	O	6962
progressive	O	6962
bone	B-Disease	6962
dysplasia	I-Disease	6962
in	O	6962
the	O	6962
two	O	6962
patients	O	6962
(	O	6962
one	O	6962
with	O	6962
SJS	B-Disease	6962
type	I-Disease	6962
2	I-Disease	6962
,	O	6962
one	O	6962
with	O	6962
SWS	B-Disease	6962
)	O	6962
surviving	O	6962
beyond	O	6962
infancy	O	6962
adds	O	6962
to	O	6962
the	O	6962
evidence	O	6962
in	O	6962
favor	O	6962
of	O	6962
identity	O	6962
.	O	6962

The	O	6963
hypothesis	O	6963
that	O	6963
SWS	B-Disease	6963
and	O	6963
SJS	B-Disease	6963
type	I-Disease	6963
2	I-Disease	6963
are	O	6963
the	O	6963
same	O	6963
disorder	O	6963
should	O	6963
be	O	6963
testable	O	6963
by	O	6963
molecular	O	6963
methods	O	6963
.	O	6963

A	O	6965
mouse	O	6965
model	O	6965
of	O	6965
severe	O	6965
von	B-Disease	6965
Willebrand	I-Disease	6965
disease	I-Disease	6965
:	O	6965
defects	O	6965
in	O	6965
hemostasis	O	6965
and	O	6965
thrombosis	B-Disease	6965
.	O	6965

von	B-Disease	6966
Willebrand	I-Disease	6966
factor	I-Disease	6966
(	I-Disease	6966
vWf	I-Disease	6966
)	I-Disease	6966
deficiency	I-Disease	6966
causes	O	6966
severe	O	6966
von	B-Disease	6966
Willebrand	I-Disease	6966
disease	I-Disease	6966
in	O	6966
humans	O	6966
.	O	6966

vWf	B-Disease	6968
-	I-Disease	6968
deficient	I-Disease	6968
mice	O	6968
appeared	O	6968
normal	O	6968
at	O	6968
birth	O	6968
;	O	6968
they	O	6968
were	O	6968
viable	O	6968
and	O	6968
fertile	O	6968
.	O	6968

Neither	O	6969
vWf	O	6969
nor	O	6969
vWf	O	6969
propolypeptide	O	6969
(	O	6969
von	B-Disease	6969
Willebrand	I-Disease	6969
antigen	O	6969
II	O	6969
)	O	6969
were	O	6969
detectable	O	6969
in	O	6969
plasma	O	6969
,	O	6969
platelets	O	6969
,	O	6969
or	O	6969
endothelial	O	6969
cells	O	6969
of	O	6969
the	O	6969
homozygous	O	6969
mutant	O	6969
mice	O	6969
.	O	6969

Defective	O	6972
thrombosis	B-Disease	6972
in	O	6972
mutant	O	6972
mice	O	6972
was	O	6972
also	O	6972
evident	O	6972
in	O	6972
an	O	6972
in	O	6972
vivo	O	6972
model	O	6972
of	O	6972
vascular	B-Disease	6972
injury	I-Disease	6972
.	O	6972

We	O	6974
conclude	O	6974
that	O	6974
these	O	6974
mice	O	6974
very	O	6974
closely	O	6974
mimic	O	6974
severe	O	6974
human	O	6974
von	B-Disease	6974
Willebrand	I-Disease	6974
disease	I-Disease	6974
and	O	6974
will	O	6974
be	O	6974
very	O	6974
useful	O	6974
for	O	6974
investigating	O	6974
the	O	6974
role	O	6974
of	O	6974
vWf	O	6974
in	O	6974
normal	O	6974
physiology	O	6974
and	O	6974
in	O	6974
disease	O	6974
models	O	6974
.	O	6974

Oral	O	6976
contraceptives	O	6976
and	O	6976
the	O	6976
risk	O	6976
of	O	6976
hereditary	B-Disease	6976
ovarian	I-Disease	6976
cancer	I-Disease	6976
.	O	6976

Hereditary	B-Disease	6977
Ovarian	I-Disease	6977
Cancer	I-Disease	6977
Clinical	O	6977
Study	O	6977
Group	O	6977
.	O	6977

BACKGROUND	O	6978
Women	O	6978
with	O	6978
mutations	O	6978
in	O	6978
either	O	6978
the	O	6978
BRCA1	O	6978
or	O	6978
the	O	6978
BRCA2	O	6978
gene	O	6978
have	O	6978
a	O	6978
high	O	6978
lifetime	O	6978
risk	O	6978
of	O	6978
ovarian	B-Disease	6978
cancer	I-Disease	6978
.	O	6978

Oral	O	6979
contraceptives	O	6979
protect	O	6979
against	O	6979
ovarian	B-Disease	6979
cancer	I-Disease	6979
in	O	6979
general	O	6979
,	O	6979
but	O	6979
it	O	6979
is	O	6979
not	O	6979
known	O	6979
whether	O	6979
they	O	6979
also	O	6979
protect	O	6979
against	O	6979
hereditary	B-Disease	6979
forms	I-Disease	6979
of	I-Disease	6979
ovarian	I-Disease	6979
cancer	I-Disease	6979
.	O	6979

METHODS	O	6980
We	O	6980
enrolled	O	6980
207	O	6980
women	O	6980
with	O	6980
hereditary	B-Disease	6980
ovarian	I-Disease	6980
cancer	I-Disease	6980
and	O	6980
161	O	6980
of	O	6980
their	O	6980
sisters	O	6980
as	O	6980
controls	O	6980
in	O	6980
a	O	6980
case	O	6980
-	O	6980
control	O	6980
study	O	6980
.	O	6980

RESULTS	O	6984
The	O	6984
adjusted	O	6984
odds	O	6984
ratio	O	6984
for	O	6984
ovarian	B-Disease	6984
cancer	I-Disease	6984
associated	O	6984
with	O	6984
any	O	6984
past	O	6984
use	O	6984
of	O	6984
oral	O	6984
contraceptives	O	6984
was	O	6984
0	O	6984
.	O	6984

Oral	O	6990
-	O	6990
contraceptive	O	6990
use	O	6990
protected	O	6990
against	O	6990
ovarian	B-Disease	6990
cancer	I-Disease	6990
both	O	6990
for	O	6990
carriers	O	6990
of	O	6990
the	O	6990
BRCA1	O	6990
mutation	O	6990
(	O	6990
odds	O	6990
ratio	O	6990
,	O	6990
0	O	6990
.	O	6990

CONCLUSIONS	O	6997
Oral	O	6997
-	O	6997
contraceptive	O	6997
use	O	6997
may	O	6997
reduce	O	6997
the	O	6997
risk	O	6997
of	O	6997
ovarian	B-Disease	6997
cancer	I-Disease	6997
in	O	6997
women	O	6997
with	O	6997
pathogenic	O	6997
mutations	O	6997
in	O	6997
the	O	6997
BRCA1	O	6997
or	O	6997
BRCA2	O	6997
gene	O	6997
A	O	6997
Japanese	O	6997
family	O	6997
with	O	6997
adrenoleukodystrophy	B-Disease	6997
with	O	6997
a	O	6997
codon	O	6997
291	O	6997
deletion	O	6997
:	O	6997
a	O	6997
clinical	O	6997
,	O	6997
biochemical	O	6997
,	O	6997
pathological	O	6997
,	O	6997
and	O	6997
genetic	O	6997
report	O	6997
.	O	6997

We	O	6998
report	O	6998
a	O	6998
Japanese	O	6998
family	O	6998
with	O	6998
adrenoleukodystrophy	B-Disease	6998
(	O	6998
ALD	B-Disease	6998
)	O	6998
with	O	6998
a	O	6998
three	O	6998
base	O	6998
pair	O	6998
deletion	O	6998
(	O	6998
delGAG	O	6998
291	O	6998
)	O	6998
in	O	6998
the	O	6998
ALD	B-Disease	6998
gene	O	6998
.	O	6998

While	O	7000
the	O	7000
proband	O	7000
(	O	7000
patient	O	7000
1	O	7000
)	O	7000
was	O	7000
classified	O	7000
as	O	7000
having	O	7000
a	O	7000
rare	O	7000
intermediate	O	7000
type	O	7000
of	O	7000
adult	O	7000
cerebral	O	7000
and	O	7000
cerebello	O	7000
-	O	7000
brain	O	7000
stem	O	7000
forms	O	7000
,	O	7000
his	O	7000
younger	O	7000
brother	O	7000
(	O	7000
patient	O	7000
2	O	7000
)	O	7000
and	O	7000
nephew	O	7000
(	O	7000
patient	O	7000
3	O	7000
)	O	7000
had	O	7000
a	O	7000
childhood	O	7000
ALD	B-Disease	7000
type	O	7000
.	O	7000

The	O	7002
tau	O	7002
level	O	7002
in	O	7002
the	O	7002
cerebrospinal	O	7002
fluid	O	7002
(	O	7002
CSF	O	7002
)	O	7002
in	O	7002
patient	O	7002
1	O	7002
was	O	7002
as	O	7002
high	O	7002
as	O	7002
that	O	7002
of	O	7002
patients	O	7002
with	O	7002
Alzheimers	B-Disease	7002
disease	I-Disease	7002
(	O	7002
AD	B-Disease	7002
)	O	7002
.	O	7002

His	O	7003
brain	O	7003
magnetic	O	7003
resonance	O	7003
image	O	7003
(	O	7003
MRI	O	7003
)	O	7003
showed	O	7003
abnormalities	B-Disease	7003
in	I-Disease	7003
the	I-Disease	7003
bilateral	I-Disease	7003
cerebellar	I-Disease	7003
hemispheres	I-Disease	7003
and	O	7003
brain	O	7003
stem	O	7003
,	O	7003
but	O	7003
not	O	7003
in	O	7003
the	O	7003
cerebral	O	7003
white	O	7003
matter	O	7003
,	O	7003
where	O	7003
marked	O	7003
reductions	O	7003
of	O	7003
the	O	7003
cerebral	O	7003
blood	O	7003
flow	O	7003
and	O	7003
oxygen	O	7003
metabolism	O	7003
were	O	7003
clearly	O	7003
demonstrated	O	7003
by	O	7003
positron	O	7003
emission	O	7003
tomography	O	7003
(	O	7003
PET	O	7003
)	O	7003
.	O	7003

In	O	7004
patients	O	7004
2	O	7004
and	O	7004
3	O	7004
,	O	7004
the	O	7004
autopsy	O	7004
findings	O	7004
showed	O	7004
massive	O	7004
demyelination	B-Disease	7004
of	I-Disease	7004
the	I-Disease	7004
cerebral	I-Disease	7004
white	I-Disease	7004
matter	I-Disease	7004
with	O	7004
sparing	O	7004
of	O	7004
the	O	7004
U	O	7004
-	O	7004
fibers	O	7004
,	O	7004
compatible	O	7004
with	O	7004
the	O	7004
findings	O	7004
of	O	7004
childhood	O	7004
ALD	B-Disease	7004
.	O	7004

The	O	7006
findings	O	7006
in	O	7006
this	O	7006
family	O	7006
suggest	O	7006
that	O	7006
delGAG291	O	7006
is	O	7006
part	O	7006
of	O	7006
the	O	7006
cause	O	7006
of	O	7006
Japanese	O	7006
ALD	B-Disease	7006
with	O	7006
phenotypic	O	7006
variations	O	7006
.	O	7006

Moreover	O	7007
,	O	7007
although	O	7007
the	O	7007
scale	O	7007
of	O	7007
the	O	7007
study	O	7007
is	O	7007
limited	O	7007
,	O	7007
there	O	7007
is	O	7007
a	O	7007
possibility	O	7007
that	O	7007
PET	O	7007
can	O	7007
detect	O	7007
an	O	7007
insidious	B-Disease	7007
lesion	I-Disease	7007
which	O	7007
is	O	7007
undetectable	O	7007
by	O	7007
computed	O	7007
tomogram	O	7007
(	O	7007
CT	O	7007
)	O	7007
or	O	7007
MRI	O	7007
analysis	O	7007
,	O	7007
and	O	7007
that	O	7007
the	O	7007
higher	O	7007
level	O	7007
of	O	7007
tau	O	7007
reflects	O	7007
the	O	7007
process	O	7007
of	O	7007
neuronal	B-Disease	7007
degeneration	I-Disease	7007
in	O	7007
ALD	B-Disease	7007
.	O	7007

Nonsense	O	7010
mutation	O	7010
in	O	7010
exon	O	7010
4	O	7010
of	O	7010
human	O	7010
complement	O	7010
C9	O	7010
gene	O	7010
is	O	7010
the	O	7010
major	O	7010
cause	O	7010
of	O	7010
Japanese	O	7010
complement	B-Disease	7010
C9	I-Disease	7010
deficiency	I-Disease	7010
.	O	7010

Deficiency	B-Disease	7011
of	I-Disease	7011
the	I-Disease	7011
ninth	I-Disease	7011
component	I-Disease	7011
of	I-Disease	7011
human	I-Disease	7011
complement	I-Disease	7011
(	O	7011
C9	O	7011
)	O	7011
is	O	7011
the	O	7011
most	O	7011
common	O	7011
complement	B-Disease	7011
deficiency	I-Disease	7011
in	O	7011
Japan	O	7011
but	O	7011
is	O	7011
rare	O	7011
in	O	7011
other	O	7011
countries	O	7011
.	O	7011

We	O	7012
studied	O	7012
the	O	7012
molecular	O	7012
basis	O	7012
of	O	7012
C9	B-Disease	7012
deficiency	I-Disease	7012
in	O	7012
four	O	7012
Japanese	O	7012
C9	B-Disease	7012
-	I-Disease	7012
deficient	I-Disease	7012
patients	O	7012
who	O	7012
had	O	7012
suffered	O	7012
from	O	7012
meningococcal	B-Disease	7012
meningitis	I-Disease	7012
.	O	7012

Direct	O	7013
sequencing	O	7013
of	O	7013
amplified	O	7013
C9	O	7013
cDNA	O	7013
and	O	7013
DNA	O	7013
revealed	O	7013
a	O	7013
nonsense	O	7013
substitution	O	7013
(	O	7013
CGA	O	7013
-	O	7013
-	O	7013
>	O	7013
TGA	O	7013
)	O	7013
at	O	7013
codon	O	7013
95	O	7013
in	O	7013
exon	O	7013
4	O	7013
in	O	7013
the	O	7013
four	O	7013
C9	B-Disease	7013
-	I-Disease	7013
deficient	I-Disease	7013
individuals	O	7013
.	O	7013

The	O	7015
common	O	7015
mutation	O	7015
at	O	7015
codon	O	7015
95	O	7015
in	O	7015
exon	O	7015
4	O	7015
might	O	7015
be	O	7015
responsible	O	7015
for	O	7015
most	O	7015
Japanese	O	7015
C9	B-Disease	7015
deficiency	I-Disease	7015
.	O	7015

The	O	7018
breast	B-Disease	7018
and	I-Disease	7018
ovarian	I-Disease	7018
cancer	I-Disease	7018
susceptibility	O	7018
gene	O	7018
BRCA1	O	7018
encodes	O	7018
a	O	7018
zinc	O	7018
finger	O	7018
protein	O	7018
of	O	7018
unknown	O	7018
function	O	7018
.	O	7018

Here	O	7020
,	O	7020
it	O	7020
is	O	7020
shown	O	7020
that	O	7020
mouse	O	7020
embryonic	O	7020
stem	O	7020
cells	O	7020
deficient	B-Disease	7020
in	I-Disease	7020
BRCA1	I-Disease	7020
are	O	7020
defective	O	7020
in	O	7020
the	O	7020
ability	O	7020
to	O	7020
carry	O	7020
out	O	7020
transcription	O	7020
-	O	7020
coupled	O	7020
repair	O	7020
of	O	7020
oxidative	O	7020
DNA	O	7020
damage	O	7020
,	O	7020
and	O	7020
are	O	7020
hypersensitive	O	7020
to	O	7020
ionizing	O	7020
radiation	O	7020
and	O	7020
hydrogen	O	7020
peroxide	O	7020
.	O	7020

Heterozygous	O	7026
mutations	O	7026
in	O	7026
the	O	7026
human	O	7026
PAX6	O	7026
gene	O	7026
result	O	7026
in	O	7026
various	O	7026
phenotypes	O	7026
,	O	7026
including	O	7026
aniridia	B-Disease	7026
,	O	7026
Peters	B-Disease	7026
anomaly	I-Disease	7026
,	O	7026
autosomal	B-Disease	7026
dominant	I-Disease	7026
keratitis	I-Disease	7026
,	O	7026
and	O	7026
familial	B-Disease	7026
foveal	I-Disease	7026
dysplasia	I-Disease	7026
.	O	7026

It	O	7027
is	O	7027
believed	O	7027
that	O	7027
the	O	7027
mutated	O	7027
allele	O	7027
of	O	7027
PAX6	O	7027
produces	O	7027
an	O	7027
inactive	O	7027
protein	O	7027
and	O	7027
aniridia	B-Disease	7027
is	O	7027
caused	O	7027
due	O	7027
to	O	7027
genetic	O	7027
haploinsufficiency	O	7027
.	O	7027

However	O	7028
,	O	7028
several	O	7028
truncation	O	7028
mutations	O	7028
have	O	7028
been	O	7028
found	O	7028
to	O	7028
occur	O	7028
in	O	7028
the	O	7028
C	O	7028
-	O	7028
terminal	O	7028
half	O	7028
of	O	7028
PAX6	O	7028
in	O	7028
patients	O	7028
with	O	7028
Aniridia	B-Disease	7028
resulting	O	7028
in	O	7028
mutant	O	7028
proteins	O	7028
that	O	7028
retain	O	7028
the	O	7028
DNA	O	7028
-	O	7028
binding	O	7028
domains	O	7028
but	O	7028
have	O	7028
lost	O	7028
most	O	7028
of	O	7028
the	O	7028
transactivation	O	7028
domain	O	7028
.	O	7028

These	O	7033
results	O	7033
provide	O	7033
a	O	7033
new	O	7033
insight	O	7033
into	O	7033
the	O	7033
role	O	7033
of	O	7033
mutant	O	7033
PAX6	O	7033
in	O	7033
causing	O	7033
aniridia	B-Disease	7033
.	O	7033

Reversal	O	7035
of	O	7035
severe	O	7035
hypertrophic	B-Disease	7035
cardiomyopathy	I-Disease	7035
and	O	7035
excellent	O	7035
neuropsychologic	O	7035
outcome	O	7035
in	O	7035
very	B-Disease	7035
-	I-Disease	7035
long	I-Disease	7035
-	I-Disease	7035
chain	I-Disease	7035
acyl	I-Disease	7035
-	I-Disease	7035
coenzyme	I-Disease	7035
A	I-Disease	7035
dehydrogenase	I-Disease	7035
deficiency	I-Disease	7035
.	O	7035

Very	B-Disease	7036
-	I-Disease	7036
long	I-Disease	7036
-	I-Disease	7036
chain	I-Disease	7036
acyl	I-Disease	7036
-	I-Disease	7036
coenzyme	I-Disease	7036
A	I-Disease	7036
dehydrogenase	I-Disease	7036
(	I-Disease	7036
VLCAD	I-Disease	7036
)	I-Disease	7036
deficiency	I-Disease	7036
is	O	7036
a	O	7036
disorder	O	7036
of	O	7036
fatty	O	7036
acid	O	7036
beta	O	7036
oxidation	O	7036
that	O	7036
reportedly	O	7036
has	O	7036
high	O	7036
rates	O	7036
of	O	7036
morbidity	O	7036
and	O	7036
mortality	O	7036
.	O	7036

We	O	7037
describe	O	7037
the	O	7037
outcome	O	7037
of	O	7037
a	O	7037
5	O	7037
-	O	7037
year	O	7037
-	O	7037
old	O	7037
girl	O	7037
with	O	7037
VLCAD	B-Disease	7037
deficiency	I-Disease	7037
who	O	7037
was	O	7037
first	O	7037
seen	O	7037
at	O	7037
5	O	7037
months	O	7037
of	O	7037
age	O	7037
with	O	7037
severe	O	7037
hypertrophic	B-Disease	7037
cardiomyopathy	I-Disease	7037
,	O	7037
hepatomegaly	B-Disease	7037
,	O	7037
encephalopathy	B-Disease	7037
,	O	7037
and	O	7037
hypotonia	B-Disease	7037
.	O	7037

Biochemical	O	7038
studies	O	7038
indicated	O	7038
VLCAD	B-Disease	7038
deficiency	I-Disease	7038
caused	O	7038
by	O	7038
a	O	7038
stable	O	7038
yet	O	7038
inactive	O	7038
enzyme	O	7038
.	O	7038

Clinical	O	7042
recognition	O	7042
of	O	7042
VLCAD	B-Disease	7042
deficiency	I-Disease	7042
is	O	7042
important	O	7042
because	O	7042
it	O	7042
is	O	7042
one	O	7042
of	O	7042
the	O	7042
few	O	7042
directly	O	7042
treatable	O	7042
causes	O	7042
of	O	7042
cardiomyopathy	B-Disease	7042
in	O	7042
children	O	7042
.	O	7042

A	O	7045
gene	O	7045
encoding	O	7045
a	O	7045
novel	O	7045
transmembrane	O	7045
protein	O	7045
was	O	7045
identified	O	7045
by	O	7045
DNA	O	7045
sequence	O	7045
analysis	O	7045
within	O	7045
the	O	7045
insulin	B-Disease	7045
-	I-Disease	7045
dependent	I-Disease	7045
diabetes	I-Disease	7045
mellitus	I-Disease	7045
(	O	7045
IDDM	B-Disease	7045
)	O	7045
locus	O	7045
IDDM4	O	7045
on	O	7045
chromosome	O	7045
11q13	O	7045
.	O	7045

Based	O	7046
on	O	7046
its	O	7046
chromosomal	O	7046
position	O	7046
,	O	7046
this	O	7046
gene	O	7046
is	O	7046
a	O	7046
candidate	O	7046
for	O	7046
conferring	O	7046
susceptibility	O	7046
to	O	7046
diabetes	B-Disease	7046
.	O	7046

The	O	7052
APC	B-Disease	7052
variants	O	7052
I1307K	O	7052
and	O	7052
E1317Q	O	7052
are	O	7052
associated	O	7052
with	O	7052
colorectal	B-Disease	7052
tumors	I-Disease	7052
,	O	7052
but	O	7052
not	O	7052
always	O	7052
with	O	7052
a	O	7052
family	O	7052
history	O	7052
.	O	7052

Classical	O	7053
familial	B-Disease	7053
adenomatous	I-Disease	7053
polyposis	I-Disease	7053
(	O	7053
FAP	B-Disease	7053
)	O	7053
is	O	7053
a	O	7053
high	O	7053
-	O	7053
penetrance	O	7053
autosomal	B-Disease	7053
dominant	I-Disease	7053
disease	I-Disease	7053
that	O	7053
predisposes	O	7053
to	O	7053
hundreds	O	7053
or	O	7053
thousands	O	7053
of	O	7053
colorectal	B-Disease	7053
adenomas	I-Disease	7053
and	I-Disease	7053
carcinoma	I-Disease	7053
and	O	7053
that	O	7053
results	O	7053
from	O	7053
truncating	O	7053
mutations	O	7053
in	O	7053
the	O	7053
APC	B-Disease	7053
gene	O	7053
.	O	7053

A	O	7054
variant	O	7054
of	O	7054
FAP	B-Disease	7054
is	O	7054
attenuated	B-Disease	7054
adenomatous	I-Disease	7054
polyposis	I-Disease	7054
coli	I-Disease	7054
,	O	7054
which	O	7054
results	O	7054
from	O	7054
germ	O	7054
-	O	7054
line	O	7054
mutations	O	7054
in	O	7054
the	O	7054
5	O	7054
and	O	7054
3	O	7054
regions	O	7054
of	O	7054
the	O	7054
APC	B-Disease	7054
gene	O	7054
.	O	7054

Attenuated	B-Disease	7055
adenomatous	I-Disease	7055
polyposis	I-Disease	7055
coli	I-Disease	7055
patients	O	7055
have	O	7055
colorectal	B-Disease	7057
adenomas	I-Disease	7057
(	O	7057
typically	O	7057
fewer	O	7057
than	O	7057
100	O	7057
)	O	7057
without	O	7057
the	O	7057
florid	O	7057
phenotype	O	7057
of	O	7057
classical	O	7057
FAP	B-Disease	7057
.	O	7057

Another	O	7058
group	O	7058
of	O	7058
patients	O	7058
with	O	7058
multiple	O	7058
adenomas	B-Disease	7058
has	O	7058
no	O	7058
mutations	O	7058
in	O	7058
the	O	7058
APC	B-Disease	7058
gene	O	7058
,	O	7058
and	O	7058
their	O	7058
phenotype	O	7058
probably	O	7058
results	O	7058
from	O	7058
variation	O	7058
at	O	7058
a	O	7058
locus	O	7058
,	O	7058
or	O	7058
loci	O	7058
,	O	7058
elsewhere	O	7058
in	O	7058
the	O	7058
genome	O	7058
.	O	7058

Recently	O	7059
,	O	7059
however	O	7059
,	O	7059
a	O	7059
missense	O	7059
variant	O	7059
of	O	7059
APC	B-Disease	7059
(	O	7059
I1307K	O	7059
)	O	7059
was	O	7059
described	O	7059
that	O	7059
confers	O	7059
an	O	7059
increased	O	7059
risk	O	7059
of	O	7059
colorectal	B-Disease	7059
tumors	I-Disease	7059
,	O	7059
including	O	7059
multiple	O	7059
adenomas	B-Disease	7059
,	O	7059
in	O	7059
Ashkenazim	O	7059
.	O	7059

We	O	7060
have	O	7060
studied	O	7060
a	O	7060
set	O	7060
of	O	7060
164	O	7060
patients	O	7060
with	O	7060
multiple	O	7060
colorectal	B-Disease	7060
adenomas	I-Disease	7060
and	I-Disease	7060
/	I-Disease	7060
or	I-Disease	7060
carcinoma	I-Disease	7060
and	O	7060
analyzed	O	7060
codons	O	7060
1263	O	7060
-	O	7060
1377	O	7060
(	O	7060
exon	O	7060
15G	O	7060
)	O	7060
of	O	7060
the	O	7060
APC	B-Disease	7060
gene	O	7060
for	O	7060
germ	O	7060
-	O	7060
line	O	7060
variants	O	7060
.	O	7060

Four	O	7062
patients	O	7062
had	O	7062
a	O	7062
germ	O	7062
-	O	7062
line	O	7062
E1317Q	O	7062
missense	O	7062
variant	O	7062
of	O	7062
APC	O	7062
that	O	7062
was	O	7062
not	O	7062
present	O	7062
in	O	7062
controls	O	7062
;	O	7062
one	O	7062
of	O	7062
these	O	7062
individuals	O	7062
had	O	7062
an	O	7062
unusually	O	7062
large	O	7062
number	O	7062
of	O	7062
metaplastic	B-Disease	7062
polyps	I-Disease	7062
of	I-Disease	7062
the	I-Disease	7062
colorectum	I-Disease	7062
.	O	7062

There	O	7063
is	O	7063
increasing	O	7063
evidence	O	7063
that	O	7063
there	O	7063
exist	O	7063
germ	O	7063
-	O	7063
line	O	7063
variants	O	7063
of	O	7063
the	O	7063
APC	B-Disease	7063
gene	O	7063
that	O	7063
predispose	O	7063
to	O	7063
the	O	7063
development	O	7063
of	O	7063
multiple	O	7063
colorectal	B-Disease	7063
adenomas	I-Disease	7063
and	I-Disease	7063
carcinoma	I-Disease	7063
,	O	7063
but	O	7063
without	O	7063
the	O	7063
florid	O	7063
phenotype	O	7063
of	O	7063
classical	O	7063
FAP	B-Disease	7063
,	O	7063
and	O	7063
possibly	O	7063
with	O	7063
importance	O	7063
for	O	7063
colorectal	B-Disease	7063
cancer	I-Disease	7063
risk	O	7063
in	O	7063
the	O	7063
general	O	7063
population	O	7063
.	O	7063

Genomic	O	7065
structure	O	7065
of	O	7065
the	O	7065
human	O	7065
congenital	B-Disease	7065
chloride	I-Disease	7065
diarrhea	I-Disease	7065
(	O	7065
CLD	B-Disease	7065
)	O	7065
gene	O	7065
.	O	7065

Congenital	B-Disease	7066
chloride	I-Disease	7066
diarrhea	I-Disease	7066
(	O	7066
CLD	B-Disease	7066
)	O	7066
is	O	7066
caused	O	7066
by	O	7066
mutations	O	7066
in	O	7066
a	O	7066
gene	O	7066
which	O	7066
encodes	O	7066
an	O	7066
intestinal	O	7066
anion	O	7066
transporter	O	7066
.	O	7066

We	O	7067
report	O	7067
here	O	7067
the	O	7067
complete	O	7067
genomic	O	7067
organization	O	7067
of	O	7067
the	O	7067
human	O	7067
CLD	B-Disease	7067
gene	O	7067
which	O	7067
spans	O	7067
approximately	O	7067
39kb	O	7067
,	O	7067
and	O	7067
comprises	O	7067
21	O	7067
exons	O	7067
.	O	7067

The	O	7070
genomic	O	7070
structure	O	7070
was	O	7070
determined	O	7070
using	O	7070
DNA	O	7070
from	O	7070
several	O	7070
sources	O	7070
including	O	7070
multiple	O	7070
large	O	7070
-	O	7070
insert	O	7070
libaries	O	7070
and	O	7070
genomic	O	7070
DNA	O	7070
from	O	7070
Finnish	O	7070
CLD	B-Disease	7070
patients	O	7070
and	O	7070
controls	O	7070
.	O	7070

Genomic	O	7072
sequencing	O	7072
of	O	7072
a	O	7072
BAC	O	7072
clone	O	7072
H	O	7072
_	O	7072
RG364P16	O	7072
revealed	O	7072
the	O	7072
presence	O	7072
of	O	7072
another	O	7072
,	O	7072
highly	O	7072
homologous	O	7072
gene	O	7072
3	O	7072
of	O	7072
the	O	7072
CLD	B-Disease	7072
gene	O	7072
,	O	7072
with	O	7072
a	O	7072
similar	O	7072
genomic	O	7072
structure	O	7072
,	O	7072
recently	O	7072
identified	O	7072
as	O	7072
the	O	7072
Pendred	B-Disease	7072
syndrome	I-Disease	7072
gene	O	7072
(	O	7072
PDS	B-Disease	7072
)	O	7072
.	O	7072

The	O	7074
APCI1307K	O	7074
allele	O	7074
and	O	7074
cancer	B-Disease	7074
risk	O	7074
in	O	7074
a	O	7074
community	O	7074
-	O	7074
based	O	7074
study	O	7074
of	O	7074
Ashkenazi	O	7074
Jews	O	7074
.	O	7074

Mutations	O	7075
in	O	7075
APC	O	7075
are	O	7075
classically	O	7075
associated	O	7075
with	O	7075
familial	B-Disease	7075
adenomatous	I-Disease	7075
polyposis	I-Disease	7075
(	O	7075
FAP	B-Disease	7075
)	O	7075
,	O	7075
a	O	7075
highly	O	7075
penetrant	O	7075
autosomal	B-Disease	7075
dominant	I-Disease	7075
disorder	I-Disease	7075
characterized	O	7075
by	O	7075
multiple	O	7075
intestinal	O	7075
polyps	B-Disease	7075
and	O	7075
,	O	7075
without	O	7075
surgical	O	7075
intervention	O	7075
,	O	7075
the	O	7075
development	O	7075
of	O	7075
colorectal	B-Disease	7075
cancer	I-Disease	7075
(	O	7075
CRC	B-Disease	7075
)	O	7075
.	O	7075

APC	B-Disease	7076
is	O	7076
a	O	7076
tumour	O	7076
-	O	7076
suppressor	O	7076
gene	O	7076
,	O	7076
and	O	7076
somatic	O	7076
loss	O	7076
occurs	O	7076
in	O	7076
tumours	B-Disease	7076
.	O	7076

1	O	7079
%	O	7079
of	O	7079
unselected	O	7079
Ashkenazi	O	7079
Jews	O	7079
and	O	7079
higher	O	7079
proportions	O	7079
of	O	7079
Ashkenazim	O	7079
with	O	7079
family	O	7079
or	O	7079
personal	O	7079
histories	O	7079
of	O	7079
CRC	B-Disease	7079
(	O	7079
ref	O	7079
.	O	7079

To	O	7081
evaluate	O	7081
the	O	7081
role	O	7081
of	O	7081
I1307K	O	7081
in	O	7081
cancer	B-Disease	7081
,	O	7081
we	O	7081
genotyped	O	7081
5	O	7081
,	O	7081
081	O	7081
Ashkenazi	O	7081
volunteers	O	7081
in	O	7081
a	O	7081
community	O	7081
survey	O	7081
.	O	7081

Risk	O	7082
of	O	7082
developing	O	7082
colorectal	B-Disease	7082
,	I-Disease	7082
breast	I-Disease	7082
and	I-Disease	7082
other	I-Disease	7082
cancers	I-Disease	7082
were	O	7082
compared	O	7082
between	O	7082
genotyped	O	7082
I1307K	O	7082
carriers	O	7082
and	O	7082
non	O	7082
-	O	7082
carriers	O	7082
and	O	7082
their	O	7082
first	O	7082
-	O	7082
degree	O	7082
relatives	O	7082
.	O	7082

Sperm	O	7083
DNA	O	7083
analysis	O	7083
in	O	7083
a	O	7083
Friedreich	B-Disease	7083
ataxia	I-Disease	7083
premutation	O	7083
carrier	O	7083
suggests	O	7083
both	O	7083
meiotic	O	7083
and	O	7083
mitotic	O	7083
expansion	O	7083
in	O	7083
the	O	7083
FRDA	B-Disease	7083
gene	O	7083
.	O	7083

Friedreich	B-Disease	7084
ataxia	I-Disease	7084
is	O	7084
usually	O	7084
caused	O	7084
by	O	7084
an	O	7084
expansion	O	7084
of	O	7084
a	O	7084
GAA	O	7084
trinucleotide	O	7084
repeat	O	7084
in	O	7084
intron	O	7084
1	O	7084
of	O	7084
the	O	7084
FRDA	B-Disease	7084
gene	O	7084
.	O	7084

The	O	7093
R496H	O	7093
mutation	O	7093
of	O	7093
arylsulfatase	O	7093
A	O	7093
does	O	7093
not	O	7093
cause	O	7093
metachromatic	B-Disease	7093
leukodystrophy	I-Disease	7093
.	O	7093

Deficiency	B-Disease	7094
of	I-Disease	7094
arylsulfatase	I-Disease	7094
A	I-Disease	7094
(	O	7094
ARSA	O	7094
)	O	7094
enzyme	O	7094
activity	O	7094
causes	O	7094
metachromatic	B-Disease	7094
leukodystrophy	I-Disease	7094
(	O	7094
MLD	B-Disease	7094
)	O	7094
.	O	7094

A	O	7095
number	O	7095
of	O	7095
ARSA	O	7095
gene	O	7095
mutations	O	7095
responsible	O	7095
for	O	7095
MLD	B-Disease	7095
have	O	7095
been	O	7095
identified	O	7095
.	O	7095

Recently	O	7096
,	O	7096
the	O	7096
R496H	O	7096
mutation	O	7096
of	O	7096
ARSA	O	7096
was	O	7096
proposed	O	7096
to	O	7096
be	O	7096
a	O	7096
cause	O	7096
of	O	7096
MLD	B-Disease	7096
(	O	7096
Draghia	O	7096
et	O	7096
al	O	7096
.	O	7096

It	O	7101
is	O	7101
therefore	O	7101
concluded	O	7101
that	O	7101
the	O	7101
R496H	O	7101
mutation	O	7101
of	O	7101
ARSA	O	7101
does	O	7101
not	O	7101
negatively	O	7101
influence	O	7101
the	O	7101
activity	O	7101
of	O	7101
ARSA	O	7101
and	O	7101
is	O	7101
not	O	7101
a	O	7101
cause	O	7101
of	O	7101
MLD	B-Disease	7101
Down	O	7101
-	O	7101
regulation	O	7101
of	O	7101
transmembrane	O	7101
carbonic	O	7101
anhydrases	O	7101
in	O	7101
renal	B-Disease	7101
cell	I-Disease	7101
carcinoma	I-Disease	7101
cell	O	7101
lines	O	7101
by	O	7101
wild	O	7101
-	O	7101
type	O	7101
von	B-Disease	7101
Hippel	I-Disease	7101
-	I-Disease	7101
Lindau	I-Disease	7101
transgenes	O	7101
.	O	7101

To	O	7102
discover	O	7102
genes	O	7102
involved	O	7102
in	O	7102
von	B-Disease	7102
Hippel	I-Disease	7102
-	I-Disease	7102
Lindau	I-Disease	7102
(	O	7102
VHL	B-Disease	7102
)	O	7102
-	O	7102
mediated	O	7102
carcinogenesis	O	7102
,	O	7102
we	O	7102
used	O	7102
renal	B-Disease	7102
cell	I-Disease	7102
carcinoma	I-Disease	7102
cell	O	7102
lines	O	7102
stably	O	7102
transfected	O	7102
with	O	7102
wild	O	7102
-	O	7102
type	O	7102
VHL	O	7102
-	O	7102
expressing	O	7102
transgenes	O	7102
.	O	7102

Reintroduced	O	7105
wild	O	7105
-	O	7105
type	O	7105
VHL	B-Disease	7105
strongly	O	7105
inhibited	O	7105
the	O	7105
overexpression	O	7105
of	O	7105
the	O	7105
CA12	O	7105
gene	O	7105
in	O	7105
the	O	7105
parental	O	7105
renal	B-Disease	7105
cell	I-Disease	7105
carcinoma	I-Disease	7105
cell	O	7105
lines	O	7105
.	O	7105

Although	O	7107
both	O	7107
domains	O	7107
of	O	7107
the	O	7107
VHL	B-Disease	7107
protein	O	7107
contribute	O	7107
to	O	7107
regulation	O	7107
of	O	7107
CA12	O	7107
expression	O	7107
,	O	7107
the	O	7107
elongin	O	7107
binding	O	7107
domain	O	7107
alone	O	7107
could	O	7107
effectively	O	7107
regulate	O	7107
CA9	O	7107
expression	O	7107
.	O	7107

2	O	7109
respectively	O	7109
,	O	7109
regions	O	7109
prone	O	7109
to	O	7109
amplification	O	7109
in	O	7109
some	O	7109
human	O	7109
cancers	B-Disease	7109
.	O	7109

Additional	O	7110
experiments	O	7110
are	O	7110
needed	O	7110
to	O	7110
define	O	7110
the	O	7110
role	O	7110
of	O	7110
CA	O	7110
IX	O	7110
and	O	7110
CA	O	7110
XII	O	7110
enzymes	O	7110
in	O	7110
the	O	7110
regulation	O	7110
of	O	7110
pH	O	7110
in	O	7110
the	O	7110
extracellular	O	7110
microenvironment	O	7110
and	O	7110
its	O	7110
potential	O	7110
impact	O	7110
on	O	7110
cancer	B-Disease	7110
cell	O	7110
growth	O	7110
.	O	7110

A	O	7111
gene	O	7111
encoding	O	7111
a	O	7111
transmembrane	O	7111
protein	O	7111
is	O	7111
mutated	O	7111
in	O	7111
patients	O	7111
with	O	7111
diabetes	B-Disease	7111
mellitus	I-Disease	7111
and	O	7111
optic	B-Disease	7111
atrophy	I-Disease	7111
(	O	7111
Wolfram	B-Disease	7111
syndrome	I-Disease	7111
)	O	7111
.	O	7111

Wolfram	B-Disease	7112
syndrome	I-Disease	7112
(	O	7112
WFS	B-Disease	7112
;	O	7112
OMIM	O	7112
222300	O	7112
)	O	7112
is	O	7112
an	O	7112
autosomal	B-Disease	7112
recessive	I-Disease	7112
neurodegenerative	I-Disease	7112
disorder	I-Disease	7112
defined	O	7112
by	O	7112
young	O	7112
-	O	7112
onset	O	7112
non	O	7112
-	O	7112
immune	O	7112
insulin	B-Disease	7112
-	I-Disease	7112
dependent	I-Disease	7112
diabetes	I-Disease	7112
mellitus	I-Disease	7112
and	O	7112
progressive	O	7112
optic	B-Disease	7112
atrophy	I-Disease	7112
.	O	7112

On	O	7114
the	O	7114
basis	O	7114
of	O	7114
meiotic	O	7114
recombinants	O	7114
and	O	7114
disease	O	7114
-	O	7114
associated	O	7114
haplotypes	O	7114
,	O	7114
the	O	7114
WFS	B-Disease	7114
gene	O	7114
was	O	7114
localized	O	7114
to	O	7114
a	O	7114
BAC	O	7114
/	O	7114
P1	O	7114
contig	O	7114
of	O	7114
less	O	7114
than	O	7114
250	O	7114
kb	O	7114
.	O	7114

Mutations	O	7115
in	O	7115
a	O	7115
novel	O	7115
gene	O	7115
(	O	7115
WFS1	O	7115
)	O	7115
encoding	O	7115
a	O	7115
putative	O	7115
transmembrane	O	7115
protein	O	7115
were	O	7115
found	O	7115
in	O	7115
all	O	7115
affected	O	7115
individuals	O	7115
in	O	7115
six	O	7115
WFS	B-Disease	7115
families	O	7115
,	O	7115
and	O	7115
these	O	7115
mutations	O	7115
were	O	7115
associated	O	7115
with	O	7115
the	O	7115
disease	O	7115
phenotype	O	7115
.	O	7115

Stable	O	7118
interaction	O	7118
between	O	7118
the	O	7118
products	O	7118
of	O	7118
the	O	7118
BRCA1	O	7118
and	O	7118
BRCA2	O	7118
tumor	B-Disease	7118
suppressor	O	7118
genes	O	7118
in	O	7118
mitotic	O	7118
and	O	7118
meiotic	O	7118
cells	O	7118
.	O	7118

BRCA1	O	7119
and	O	7119
BRCA2	O	7119
account	O	7119
for	O	7119
most	O	7119
cases	O	7119
of	O	7119
familial	O	7119
,	O	7119
early	O	7119
onset	O	7119
breast	B-Disease	7119
and	I-Disease	7119
/	I-Disease	7119
or	I-Disease	7119
ovarian	I-Disease	7119
cancer	I-Disease	7119
and	O	7119
encode	O	7119
products	O	7119
that	O	7119
each	O	7119
interact	O	7119
with	O	7119
hRAD51	O	7119
.	O	7119

Dysfunction	O	7123
of	O	7123
this	O	7123
pathway	O	7123
may	O	7123
be	O	7123
a	O	7123
general	O	7123
phenomenon	O	7123
in	O	7123
the	O	7123
majority	O	7123
of	O	7123
cases	O	7123
of	O	7123
hereditary	B-Disease	7123
breast	I-Disease	7123
and	I-Disease	7123
/	I-Disease	7123
or	I-Disease	7123
ovarian	I-Disease	7123
cancer	I-Disease	7123
.	O	7123

A	O	7126
novel	O	7126
C	O	7126
to	O	7126
A	O	7126
mutation	O	7126
in	O	7126
the	O	7126
sterol	O	7126
27	O	7126
-	O	7126
hydroxylase	O	7126
gene	O	7126
(	O	7126
CYP27	O	7126
)	O	7126
was	O	7126
identified	O	7126
by	O	7126
sequencing	O	7126
amplified	O	7126
CYP27	O	7126
gene	O	7126
products	O	7126
from	O	7126
a	O	7126
patient	O	7126
with	O	7126
cerebrotendinous	B-Disease	7126
xanthomatosis	I-Disease	7126
(	O	7126
CTX	B-Disease	7126
)	O	7126
.	O	7126

Our	O	7132
data	O	7132
suggest	O	7132
that	O	7132
the	O	7132
C	O	7132
to	O	7132
A	O	7132
mutation	O	7132
at	O	7132
the	O	7132
penultimate	O	7132
nucleotide	O	7132
of	O	7132
exon	O	7132
6	O	7132
of	O	7132
the	O	7132
CYP27	O	7132
gene	O	7132
not	O	7132
only	O	7132
causes	O	7132
the	O	7132
deficiency	B-Disease	7132
in	I-Disease	7132
the	I-Disease	7132
sterol	I-Disease	7132
27	I-Disease	7132
-	I-Disease	7132
hydroxylase	I-Disease	7132
activity	I-Disease	7132
,	O	7132
but	O	7132
also	O	7132
partially	O	7132
leads	O	7132
to	O	7132
alternative	O	7132
pre	O	7132
-	O	7132
mRNA	O	7132
splicing	O	7132
of	O	7132
the	O	7132
gene	O	7132
.	O	7132

ATM	O	7134
germline	O	7134
mutations	O	7134
in	O	7134
classical	O	7134
ataxia	B-Disease	7134
-	I-Disease	7134
telangiectasia	I-Disease	7134
patients	O	7134
in	O	7134
the	O	7134
Dutch	O	7134
population	O	7134
.	O	7134

Germline	O	7135
mutations	O	7135
in	O	7135
the	O	7135
ATM	O	7135
gene	O	7135
are	O	7135
responsible	O	7135
for	O	7135
the	O	7135
autosomal	B-Disease	7135
recessive	I-Disease	7135
disorder	I-Disease	7135
ataxia	B-Disease	7135
-	I-Disease	7135
telangiectasia	I-Disease	7135
(	O	7135
A	B-Disease	7135
-	I-Disease	7135
T	I-Disease	7135
)	O	7135
.	O	7135

In	O	7136
our	O	7136
study	O	7136
,	O	7136
we	O	7136
have	O	7136
determined	O	7136
the	O	7136
ATM	O	7136
mutation	O	7136
spectrum	O	7136
in	O	7136
19	O	7136
classical	O	7136
A	B-Disease	7136
-	I-Disease	7136
T	I-Disease	7136
patients	O	7136
,	O	7136
including	O	7136
some	O	7136
immigrant	O	7136
populations	O	7136
,	O	7136
as	O	7136
well	O	7136
as	O	7136
12	O	7136
of	O	7136
Dutch	O	7136
ethnic	O	7136
origin	O	7136
.	O	7136

The	O	7143
most	O	7143
frequently	O	7143
found	O	7143
mutation	O	7143
,	O	7143
identified	O	7143
in	O	7143
three	O	7143
unrelated	O	7143
Turkish	O	7143
A	B-Disease	7143
-	I-Disease	7143
T	I-Disease	7143
individuals	O	7143
,	O	7143
was	O	7143
previously	O	7143
described	O	7143
to	O	7143
be	O	7143
a	O	7143
Turkish	O	7143
A	B-Disease	7143
-	I-Disease	7143
T	I-Disease	7143
founder	O	7143
mutation	O	7143
.	O	7143

All	O	7147
patients	O	7147
manifested	O	7147
classical	O	7147
A	B-Disease	7147
-	I-Disease	7147
T	I-Disease	7147
and	O	7147
increased	O	7147
cellular	O	7147
radioresistant	O	7147
DNA	O	7147
synthesis	O	7147
.	O	7147

Determination	O	7148
of	O	7148
the	O	7148
genomic	O	7148
structure	O	7148
of	O	7148
the	O	7148
COL4A4	O	7148
gene	O	7148
and	O	7148
of	O	7148
novel	O	7148
mutations	O	7148
causing	O	7148
autosomal	B-Disease	7148
recessive	I-Disease	7148
Alport	I-Disease	7148
syndrome	I-Disease	7148
.	O	7148

Autosomal	B-Disease	7149
recessive	I-Disease	7149
Alport	I-Disease	7149
syndrome	I-Disease	7149
is	O	7149
a	O	7149
progressive	O	7149
hematuric	B-Disease	7149
glomerulonephritis	I-Disease	7149
characterized	O	7149
by	O	7149
glomerular	B-Disease	7149
basement	I-Disease	7149
membrane	I-Disease	7149
abnormalities	I-Disease	7149
and	O	7149
associated	O	7149
with	O	7149
mutations	O	7149
in	O	7149
either	O	7149
the	O	7149
COL4A3	O	7149
or	O	7149
the	O	7149
COL4A4	O	7149
gene	O	7149
,	O	7149
which	O	7149
encode	O	7149
the	O	7149
alpha3	O	7149
and	O	7149
alpha4	O	7149
type	O	7149
IV	O	7149
collagen	O	7149
chains	O	7149
,	O	7149
respectively	O	7149
.	O	7149

We	O	7151
report	O	7151
here	O	7151
the	O	7151
complete	O	7151
characterization	O	7151
of	O	7151
the	O	7151
48	O	7151
exons	O	7151
of	O	7151
the	O	7151
COL4A4	O	7151
gene	O	7151
,	O	7151
a	O	7151
comprehensive	O	7151
gene	O	7151
screen	O	7151
,	O	7151
and	O	7151
the	O	7151
subsequent	O	7151
detection	O	7151
of	O	7151
10	O	7151
novel	O	7151
mutations	O	7151
in	O	7151
eight	O	7151
patients	O	7151
diagnosed	O	7151
with	O	7151
autosomal	B-Disease	7151
recessive	I-Disease	7151
Alport	I-Disease	7151
syndrome	I-Disease	7151
.	O	7151

Founder	O	7155
BRCA1	O	7155
and	O	7155
BRCA2	O	7155
mutations	O	7155
in	O	7155
French	O	7155
Canadian	O	7155
breast	B-Disease	7155
and	I-Disease	7155
ovarian	I-Disease	7155
cancer	I-Disease	7155
families	O	7155
.	O	7155

We	O	7156
have	O	7156
identified	O	7156
four	O	7156
mutations	O	7156
in	O	7156
each	O	7156
of	O	7156
the	O	7156
breast	B-Disease	7156
cancer	I-Disease	7156
-	O	7156
susceptibility	O	7156
genes	O	7156
,	O	7156
BRCA1	O	7156
and	O	7156
BRCA2	O	7156
,	O	7156
in	O	7156
French	O	7156
Canadian	O	7156
breast	B-Disease	7156
cancer	I-Disease	7156
and	O	7156
breast	B-Disease	7156
/	I-Disease	7156
ovarian	I-Disease	7156
cancer	I-Disease	7156
families	O	7156
from	O	7156
Quebec	O	7156
.	O	7156

To	O	7157
identify	O	7157
founder	O	7157
effects	O	7157
,	O	7157
we	O	7157
examined	O	7157
independently	O	7157
ascertained	O	7157
French	O	7157
Canadian	O	7157
cancer	B-Disease	7157
families	O	7157
for	O	7157
the	O	7157
distribution	O	7157
of	O	7157
these	O	7157
eight	O	7157
mutations	O	7157
.	O	7157

7x	O	7163
greater	O	7163
if	O	7163
one	O	7163
or	O	7163
more	O	7163
cases	O	7163
of	O	7163
ovarian	B-Disease	7163
cancer	I-Disease	7163
were	O	7163
also	O	7163
present	O	7163
in	O	7163
the	O	7163
family	O	7163
.	O	7163

3x	O	7165
greater	O	7165
if	O	7165
there	O	7165
were	O	7165
at	O	7165
least	O	7165
five	O	7165
cases	O	7165
of	O	7165
breast	B-Disease	7165
cancer	I-Disease	7165
in	O	7165
the	O	7165
family	O	7165
.	O	7165

Interestingly	O	7166
,	O	7166
the	O	7166
presence	O	7166
of	O	7166
a	O	7166
breast	B-Disease	7166
cancer	I-Disease	7166
case	O	7166
<	O	7166
36	O	7166
years	O	7166
of	O	7166
age	O	7166
was	O	7166
strongly	O	7166
predictive	O	7166
of	O	7166
the	O	7166
presence	O	7166
of	O	7166
any	O	7166
of	O	7166
the	O	7166
eight	O	7166
mutations	O	7166
screened	O	7166
.	O	7166

The	O	7168
identification	O	7168
of	O	7168
common	O	7168
BRCA1	O	7168
and	O	7168
BRCA2	O	7168
mutations	O	7168
will	O	7168
facilitate	O	7168
carrier	O	7168
detection	O	7168
in	O	7168
French	O	7168
Canadian	O	7168
breast	B-Disease	7168
cancer	I-Disease	7168
and	O	7168
breast	B-Disease	7168
/	I-Disease	7168
ovarian	I-Disease	7168
cancer	I-Disease	7168
families	O	7168
.	O	7168

Are	O	7169
Dp71	O	7169
and	O	7169
Dp140	O	7169
brain	O	7169
dystrophin	O	7169
isoforms	O	7169
related	O	7169
to	O	7169
cognitive	B-Disease	7169
impairment	I-Disease	7169
in	O	7169
Duchenne	B-Disease	7169
muscular	I-Disease	7169
dystrophy	I-Disease	7169
?	O	7169
Molecular	O	7169
study	O	7169
and	O	7169
neuropsychological	O	7169
analysis	O	7169
were	O	7169
performed	O	7169
concurrently	O	7169
on	O	7169
49	O	7169
patients	O	7169
with	O	7169
Duchenne	B-Disease	7169
muscular	I-Disease	7169
dystrophy	I-Disease	7169
(	O	7169
DMD	B-Disease	7169
)	O	7169
in	O	7169
order	O	7169
to	O	7169
find	O	7169
a	O	7169
molecular	O	7169
explanation	O	7169
for	O	7169
the	O	7169
cognitive	B-Disease	7169
impairment	I-Disease	7169
observed	O	7169
in	O	7169
most	O	7169
DMD	B-Disease	7169
patients	O	7169
.	O	7169

Complete	O	7170
analysis	O	7170
of	O	7170
the	O	7170
dystrophin	O	7170
gene	O	7170
was	O	7170
performed	O	7170
to	O	7170
define	O	7170
the	O	7170
localization	O	7170
of	O	7170
deletions	O	7170
and	O	7170
duplications	O	7170
in	O	7170
relation	O	7170
to	O	7170
the	O	7170
different	O	7170
DMD	B-Disease	7170
promoters	O	7170
.	O	7170

Comparison	O	7173
of	O	7173
molecular	O	7173
and	O	7173
psychometric	O	7173
findings	O	7173
demonstrated	O	7173
that	O	7173
deletions	O	7173
and	O	7173
duplications	O	7173
that	O	7173
were	O	7173
localized	O	7173
in	O	7173
the	O	7173
distal	O	7173
part	O	7173
of	O	7173
the	O	7173
gene	O	7173
seemed	O	7173
to	O	7173
be	O	7173
preferentially	O	7173
associated	O	7173
with	O	7173
cognitive	B-Disease	7173
impairment	I-Disease	7173
.	O	7173

Two	O	7174
altered	O	7174
Dp71	O	7174
transcripts	O	7174
and	O	7174
two	O	7174
deleted	O	7174
Dp140	O	7174
DNA	O	7174
sequences	O	7174
were	O	7174
found	O	7174
in	O	7174
four	O	7174
patients	O	7174
with	O	7174
severe	O	7174
cerebral	B-Disease	7174
dysfunction	I-Disease	7174
.	O	7174

These	O	7175
findings	O	7175
suggest	O	7175
that	O	7175
some	O	7175
sequences	O	7175
located	O	7175
in	O	7175
the	O	7175
distal	O	7175
part	O	7175
of	O	7175
the	O	7175
gene	O	7175
and	O	7175
,	O	7175
in	O	7175
particular	O	7175
,	O	7175
some	O	7175
DMD	B-Disease	7175
isoforms	O	7175
expressed	O	7175
in	O	7175
the	O	7175
brain	O	7175
may	O	7175
be	O	7175
related	O	7175
to	O	7175
the	O	7175
cognitive	B-Disease	7175
impairment	I-Disease	7175
associated	O	7175
with	O	7175
DMD	B-Disease	7175
.	O	7175

I1307K	O	7177
APC	O	7177
and	O	7177
hMLH1	O	7177
mutations	O	7177
in	O	7177
a	O	7177
non	O	7177
-	O	7177
Jewish	O	7177
family	O	7177
with	O	7177
hereditary	B-Disease	7177
non	I-Disease	7177
-	I-Disease	7177
polyposis	I-Disease	7177
colorectal	I-Disease	7177
cancer	I-Disease	7177
.	O	7177

We	O	7178
describe	O	7178
a	O	7178
French	O	7178
Canadian	O	7178
hereditary	B-Disease	7178
non	I-Disease	7178
-	I-Disease	7178
polyposis	I-Disease	7178
colorectal	I-Disease	7178
cancer	I-Disease	7178
(	O	7178
HNPCC	B-Disease	7178
)	O	7178
kindred	O	7178
which	O	7178
carries	O	7178
a	O	7178
novel	O	7178
truncating	O	7178
mutation	O	7178
in	O	7178
hMLH1	O	7178
.	O	7178

Interestingly	O	7179
,	O	7179
the	O	7179
I1307K	O	7179
APC	O	7179
polymorphism	O	7179
,	O	7179
associated	O	7179
with	O	7179
an	O	7179
increased	O	7179
risk	O	7179
of	O	7179
colorectal	B-Disease	7179
cancer	I-Disease	7179
,	O	7179
is	O	7179
also	O	7179
present	O	7179
in	O	7179
this	O	7179
family	O	7179
.	O	7179

In	O	7181
addition	O	7181
,	O	7181
in	O	7181
this	O	7181
family	O	7181
,	O	7181
there	O	7181
appears	O	7181
to	O	7181
be	O	7181
no	O	7181
relationship	O	7181
between	O	7181
the	O	7181
I1307K	O	7181
polymorphism	O	7181
and	O	7181
the	O	7181
presence	O	7181
or	O	7181
absence	O	7181
of	O	7181
cancer	B-Disease	7181
.	O	7181

Identification	O	7183
of	O	7183
a	O	7183
novel	O	7183
mutation	O	7183
of	O	7183
the	O	7183
CPO	O	7183
gene	O	7183
in	O	7183
a	O	7183
Japanese	O	7183
hereditary	B-Disease	7183
coproporphyria	I-Disease	7183
family	O	7183
.	O	7183

Hereditary	B-Disease	7184
coproporphyria	I-Disease	7184
(	O	7184
HCP	B-Disease	7184
)	O	7184
is	O	7184
an	O	7184
autosomal	B-Disease	7184
dominant	I-Disease	7184
disease	I-Disease	7184
characterized	O	7184
by	O	7184
a	O	7184
deficiency	B-Disease	7184
of	I-Disease	7184
coproporphyrinogen	I-Disease	7184
oxidase	I-Disease	7184
(	O	7184
CPO	O	7184
)	O	7184
caused	O	7184
by	O	7184
a	O	7184
mutation	O	7184
in	O	7184
the	O	7184
CPO	O	7184
gene	O	7184
.	O	7184

Only	O	7185
11	O	7185
mutations	O	7185
of	O	7185
the	O	7185
gene	O	7185
have	O	7185
been	O	7185
reported	O	7185
in	O	7185
HCP	B-Disease	7185
patients	O	7185
.	O	7185

Human	B-Disease	7192
complement	I-Disease	7192
factor	I-Disease	7192
H	I-Disease	7192
deficiency	I-Disease	7192
associated	O	7192
with	O	7192
hemolytic	B-Disease	7192
uremic	I-Disease	7192
syndrome	I-Disease	7192
.	O	7192

This	O	7193
study	O	7193
reports	O	7193
on	O	7193
six	O	7193
cases	O	7193
of	O	7193
deficiency	B-Disease	7193
in	I-Disease	7193
the	I-Disease	7193
human	I-Disease	7193
complement	I-Disease	7193
regulatory	I-Disease	7193
protein	I-Disease	7193
Factor	I-Disease	7193
H	I-Disease	7193
(	O	7193
FH	O	7193
)	O	7193
in	O	7193
the	O	7193
context	O	7193
of	O	7193
an	O	7193
acute	B-Disease	7193
renal	I-Disease	7193
disease	I-Disease	7193
.	O	7193

Five	O	7194
of	O	7194
the	O	7194
cases	O	7194
were	O	7194
observed	O	7194
in	O	7194
children	O	7194
presenting	O	7194
with	O	7194
idiopathic	O	7194
hemolytic	B-Disease	7194
uremic	I-Disease	7194
syndrome	I-Disease	7194
(	O	7194
HUS	B-Disease	7194
)	O	7194
.	O	7194

Factor	B-Disease	7198
H	I-Disease	7198
deficiency	I-Disease	7198
is	O	7198
the	O	7198
only	O	7198
complement	B-Disease	7198
deficiency	I-Disease	7198
associated	O	7198
with	O	7198
HUS	B-Disease	7198
.	O	7198

These	O	7199
observations	O	7199
suggest	O	7199
a	O	7199
role	O	7199
for	O	7199
FH	O	7199
and	O	7199
/	O	7199
or	O	7199
FH	O	7199
receptors	O	7199
in	O	7199
the	O	7199
pathogenesis	O	7199
of	O	7199
idiopathic	O	7199
HUS	B-Disease	7199
.	O	7199

Further	O	7201
evidence	O	7201
for	O	7201
a	O	7201
major	O	7201
ancient	O	7201
mutation	O	7201
underlying	O	7201
myotonic	B-Disease	7201
dystrophy	I-Disease	7201
from	O	7201
linkage	O	7201
disequilibrium	O	7201
studies	O	7201
in	O	7201
the	O	7201
Japanese	O	7201
population	O	7201
.	O	7201

The	O	7202
myotonic	B-Disease	7202
dystrophy	I-Disease	7202
(	O	7202
DM	B-Disease	7202
)	O	7202
mutation	O	7202
is	O	7202
an	O	7202
unstable	O	7202
(	O	7202
CTG	O	7202
)	O	7202
n	O	7202
repeat	O	7202
,	O	7202
present	O	7202
at	O	7202
a	O	7202
copy	O	7202
number	O	7202
of	O	7202
5	O	7202
-	O	7202
37	O	7202
repeats	O	7202
on	O	7202
normal	O	7202
chromosomes	O	7202
but	O	7202
amplified	O	7202
to	O	7202
50	O	7202
-	O	7202
3000	O	7202
copies	O	7202
on	O	7202
DM	B-Disease	7202
chromosomes	O	7202
.	O	7202

Previous	O	7203
findings	O	7203
in	O	7203
Caucasian	O	7203
populations	O	7203
of	O	7203
a	O	7203
DM	B-Disease	7203
founder	O	7203
chromosome	O	7203
raise	O	7203
a	O	7203
question	O	7203
about	O	7203
the	O	7203
molecular	O	7203
events	O	7203
involved	O	7203
in	O	7203
the	O	7203
expansion	O	7203
mutation	O	7203
.	O	7203

To	O	7204
investigate	O	7204
whether	O	7204
a	O	7204
founder	O	7204
chromosome	O	7204
for	O	7204
the	O	7204
DM	B-Disease	7204
mutation	O	7204
exists	O	7204
in	O	7204
the	O	7204
Japanese	O	7204
population	O	7204
,	O	7204
we	O	7204
genotyped	O	7204
families	O	7204
using	O	7204
polymorphic	O	7204
markers	O	7204
near	O	7204
the	O	7204
(	O	7204
CTG	O	7204
)	O	7204
n	O	7204
repeat	O	7204
region	O	7204
and	O	7204
constructed	O	7204
haplotypes	O	7204
.	O	7204

Six	O	7205
different	O	7205
haplotypes	O	7205
were	O	7205
found	O	7205
and	O	7205
DM	B-Disease	7205
alleles	O	7205
were	O	7205
always	O	7205
haplotype	O	7205
A	O	7205
.	O	7205

To	O	7206
find	O	7206
an	O	7206
origin	O	7206
of	O	7206
the	O	7206
(	O	7206
CTG	O	7206
)	O	7206
n	O	7206
repeat	O	7206
mutation	O	7206
and	O	7206
to	O	7206
investigate	O	7206
the	O	7206
mechanism	O	7206
of	O	7206
the	O	7206
expansion	O	7206
mutation	O	7206
in	O	7206
the	O	7206
Japanese	O	7206
population	O	7206
we	O	7206
have	O	7206
studied	O	7206
90	O	7206
Japanese	O	7206
DM	B-Disease	7206
families	O	7206
comprising	O	7206
190	O	7206
affected	O	7206
and	O	7206
130	O	7206
unaffected	O	7206
members	O	7206
.	O	7206

These	O	7208
data	O	7208
support	O	7208
multistep	O	7208
models	O	7208
of	O	7208
triplet	O	7208
repeat	O	7208
expansion	O	7208
that	O	7208
have	O	7208
been	O	7208
proposed	O	7208
for	O	7208
both	O	7208
DM	B-Disease	7208
and	O	7208
Friedreichs	B-Disease	7208
ataxia	I-Disease	7208
.	O	7208

The	O	7210
molecular	O	7210
basis	O	7210
of	O	7210
C6	B-Disease	7210
deficiency	I-Disease	7210
in	O	7210
the	O	7210
western	O	7210
Cape	O	7210
,	O	7210
South	O	7210
Africa	O	7210
.	O	7210

Deficiency	B-Disease	7211
of	I-Disease	7211
the	I-Disease	7211
sixth	I-Disease	7211
component	I-Disease	7211
of	I-Disease	7211
human	I-Disease	7211
complement	I-Disease	7211
(	O	7211
C6	O	7211
)	O	7211
has	O	7211
been	O	7211
reported	O	7211
in	O	7211
a	O	7211
number	O	7211
of	O	7211
families	O	7211
from	O	7211
the	O	7211
western	O	7211
Cape	O	7211
,	O	7211
South	O	7211
Africa	O	7211
.	O	7211

Meningococcal	B-Disease	7212
disease	I-Disease	7212
is	O	7212
endemic	O	7212
in	O	7212
the	O	7212
Cape	O	7212
and	O	7212
almost	O	7212
all	O	7212
pedigrees	O	7212
of	O	7212
total	O	7212
C6	B-Disease	7212
deficiency	I-Disease	7212
(	O	7212
C6Q0	O	7212
)	O	7212
have	O	7212
been	O	7212
ascertained	O	7212
because	O	7212
of	O	7212
recurrent	O	7212
disease	O	7212
.	O	7212

We	O	7217
have	O	7217
also	O	7217
observed	O	7217
the	O	7217
879delG	O	7217
defect	O	7217
in	O	7217
two	O	7217
Dutch	O	7217
C6	B-Disease	7217
-	I-Disease	7217
deficient	I-Disease	7217
kindreds	O	7217
,	O	7217
but	O	7217
the	O	7217
879delG	O	7217
defect	O	7217
in	O	7217
the	O	7217
Cape	O	7217
probably	O	7217
did	O	7217
not	O	7217
come	O	7217
from	O	7217
The	O	7217
Netherlands	O	7217
.	O	7217

Complement	B-Disease	7219
C7	I-Disease	7219
deficiency	I-Disease	7219
:	O	7219
seven	O	7219
further	O	7219
molecular	O	7219
defects	O	7219
and	O	7219
their	O	7219
associated	O	7219
marker	O	7219
haplotypes	O	7219
.	O	7219

Seven	O	7220
further	O	7220
molecular	O	7220
bases	O	7220
of	O	7220
C7	B-Disease	7220
deficiency	I-Disease	7220
are	O	7220
described	O	7220
.	O	7220

The	O	7224
C6	O	7224
/	O	7224
C7	O	7224
marker	O	7224
haplotypes	O	7224
associated	O	7224
with	O	7224
most	O	7224
C7	B-Disease	7224
defects	I-Disease	7224
are	O	7224
tabulated	O	7224
.	O	7224

A	O	7226
genome	O	7226
-	O	7226
wide	O	7226
search	O	7226
for	O	7226
chromosomal	O	7226
loci	O	7226
linked	O	7226
to	O	7226
mental	O	7226
health	O	7226
wellness	O	7226
in	O	7226
relatives	O	7226
at	O	7226
high	O	7226
risk	O	7226
for	O	7226
bipolar	B-Disease	7226
affective	I-Disease	7226
disorder	I-Disease	7226
among	O	7226
the	O	7226
Old	O	7226
Order	O	7226
Amish	O	7226
.	O	7226

Bipolar	B-Disease	7227
affective	I-Disease	7227
disorder	I-Disease	7227
(	O	7227
BPAD	B-Disease	7227
;	O	7227
manic	B-Disease	7227
-	I-Disease	7227
depressive	I-Disease	7227
illness	I-Disease	7227
)	O	7227
is	O	7227
characterized	O	7227
by	O	7227
episodes	O	7227
of	O	7227
mania	B-Disease	7227
and	O	7227
/	O	7227
or	O	7227
hypomania	B-Disease	7227
interspersed	O	7227
with	O	7227
periods	O	7227
of	O	7227
depression	B-Disease	7227
.	O	7227

Compelling	O	7228
evidence	O	7228
supports	O	7228
a	O	7228
significant	O	7228
genetic	O	7228
component	O	7228
in	O	7228
the	O	7228
susceptibility	O	7228
to	O	7228
develop	O	7228
BPAD	B-Disease	7228
.	O	7228

To	O	7229
date	O	7229
,	O	7229
however	O	7229
,	O	7229
linkage	O	7229
studies	O	7229
have	O	7229
attempted	O	7229
only	O	7229
to	O	7229
identify	O	7229
chromosomal	O	7229
loci	O	7229
that	O	7229
cause	O	7229
or	O	7229
increase	O	7229
the	O	7229
risk	O	7229
of	O	7229
developing	O	7229
BPAD	B-Disease	7229
.	O	7229

To	O	7230
determine	O	7230
whether	O	7230
there	O	7230
could	O	7230
be	O	7230
protective	O	7230
alleles	O	7230
that	O	7230
prevent	O	7230
or	O	7230
reduce	O	7230
the	O	7230
risk	O	7230
of	O	7230
developing	O	7230
BPAD	B-Disease	7230
,	O	7230
similar	O	7230
to	O	7230
what	O	7230
is	O	7230
observed	O	7230
in	O	7230
other	O	7230
genetic	B-Disease	7230
disorders	I-Disease	7230
,	O	7230
we	O	7230
used	O	7230
mental	O	7230
health	O	7230
wellness	O	7230
(	O	7230
absence	O	7230
of	O	7230
any	O	7230
psychiatric	B-Disease	7230
disorder	I-Disease	7230
)	O	7230
as	O	7230
the	O	7230
phenotype	O	7230
in	O	7230
our	O	7230
genome	O	7230
-	O	7230
wide	O	7230
linkage	O	7230
scan	O	7230
of	O	7230
several	O	7230
large	O	7230
multigeneration	O	7230
Old	O	7230
Order	O	7230
Amish	O	7230
pedigrees	O	7230
exhibiting	O	7230
an	O	7230
extremely	O	7230
high	O	7230
incidence	O	7230
of	O	7230
BPAD	B-Disease	7230
.	O	7230

These	O	7236
findings	O	7236
are	O	7236
consistent	O	7236
with	O	7236
the	O	7236
hypothesis	O	7236
that	O	7236
certain	O	7236
alleles	O	7236
could	O	7236
prevent	O	7236
or	O	7236
modify	O	7236
the	O	7236
clinical	O	7236
manifestations	O	7236
of	O	7236
BPAD	B-Disease	7236
and	O	7236
perhaps	O	7236
other	O	7236
related	O	7236
affective	B-Disease	7236
disorders	I-Disease	7236
.	O	7236

Segregation	O	7237
distortion	O	7237
in	O	7237
myotonic	B-Disease	7237
dystrophy	I-Disease	7237
.	O	7237

Myotonic	B-Disease	7238
dystrophy	I-Disease	7238
(	O	7238
DM	B-Disease	7238
)	O	7238
is	O	7238
an	O	7238
autosomal	B-Disease	7238
dominant	I-Disease	7238
disease	I-Disease	7238
which	O	7238
,	O	7238
in	O	7238
the	O	7238
typical	O	7238
pedigree	O	7238
,	O	7238
shows	O	7238
a	O	7238
three	O	7238
generation	O	7238
anticipation	O	7238
cascade	O	7238
.	O	7238

This	O	7239
results	O	7239
in	O	7239
infertility	B-Disease	7239
and	O	7239
congenital	B-Disease	7239
myotonic	I-Disease	7239
dystrophy	I-Disease	7239
(	O	7239
CDM	B-Disease	7239
)	O	7239
with	O	7239
the	O	7239
disappearance	O	7239
of	O	7239
DM	B-Disease	7239
in	O	7239
that	O	7239
pedigree	O	7239
.	O	7239

The	O	7240
concept	O	7240
of	O	7240
segregation	O	7240
distortion	O	7240
,	O	7240
where	O	7240
there	O	7240
is	O	7240
preferential	O	7240
transmission	O	7240
of	O	7240
the	O	7240
larger	O	7240
allele	O	7240
at	O	7240
the	O	7240
DM	B-Disease	7240
locus	O	7240
,	O	7240
has	O	7240
been	O	7240
put	O	7240
forward	O	7240
to	O	7240
explain	O	7240
partially	O	7240
the	O	7240
maintenance	O	7240
of	O	7240
DM	B-Disease	7240
in	O	7240
the	O	7240
population	O	7240
.	O	7240

In	O	7241
a	O	7241
survey	O	7241
of	O	7241
DM	B-Disease	7241
in	O	7241
Northern	O	7241
Ireland	O	7241
,	O	7241
59	O	7241
pedigrees	O	7241
were	O	7241
ascertained	O	7241
.	O	7241

Sibships	O	7242
where	O	7242
the	O	7242
status	O	7242
of	O	7242
all	O	7242
the	O	7242
members	O	7242
had	O	7242
been	O	7242
identified	O	7242
were	O	7242
examined	O	7242
to	O	7242
determine	O	7242
the	O	7242
transmission	O	7242
of	O	7242
the	O	7242
DM	B-Disease	7242
expansion	O	7242
from	O	7242
affected	O	7242
parents	O	7242
to	O	7242
their	O	7242
offspring	O	7242
.	O	7242

Studies	O	7246
on	O	7246
meiotic	O	7246
drive	O	7246
in	O	7246
DM	B-Disease	7246
have	O	7246
shown	O	7246
increased	O	7246
transmission	O	7246
of	O	7246
the	O	7246
larger	O	7246
allele	O	7246
at	O	7246
the	O	7246
DM	B-Disease	7246
locus	O	7246
in	O	7246
non	O	7246
-	O	7246
DM	O	7246
heterozygotes	O	7246
for	O	7246
CTGn	O	7246
.	O	7246

This	O	7247
study	O	7247
provides	O	7247
further	O	7247
evidence	O	7247
that	O	7247
the	O	7247
DM	B-Disease	7247
expansion	O	7247
tends	O	7247
to	O	7247
be	O	7247
transmitted	O	7247
preferentially	O	7247
.	O	7247

Diagnosis	O	7248
of	O	7248
hemochromatosis	B-Disease	7248
.	O	7248

If	O	7249
untreated	O	7249
,	O	7249
hemochromatosis	B-Disease	7249
can	O	7249
cause	O	7249
serious	O	7249
illness	O	7249
and	O	7249
early	B-Disease	7249
death	I-Disease	7249
,	O	7249
but	O	7249
the	O	7249
disease	O	7249
is	O	7249
still	O	7249
substantially	O	7249
under	O	7249
-	O	7249
diagnosed	O	7249
.	O	7249

Once	O	7251
the	O	7251
diagnosis	O	7251
is	O	7251
suspected	O	7251
,	O	7251
physicians	O	7251
must	O	7251
use	O	7251
serum	O	7251
ferritin	O	7251
levels	O	7251
and	O	7251
hepatic	O	7251
iron	O	7251
stores	O	7251
on	O	7251
liver	O	7251
biopsy	O	7251
specimens	O	7251
to	O	7251
assess	O	7251
patients	O	7251
for	O	7251
the	O	7251
presence	O	7251
of	O	7251
iron	B-Disease	7251
overload	I-Disease	7251
.	O	7251

Liver	O	7252
biopsy	O	7252
is	O	7252
also	O	7252
used	O	7252
to	O	7252
establish	O	7252
the	O	7252
presence	O	7252
or	O	7252
absence	O	7252
of	O	7252
cirrhosis	B-Disease	7252
,	O	7252
which	O	7252
can	O	7252
affect	O	7252
prognosis	O	7252
and	O	7252
management	O	7252
.	O	7252

A	O	7253
DNA	O	7253
-	O	7253
based	O	7253
test	O	7253
for	O	7253
the	O	7253
HFE	O	7253
gene	O	7253
is	O	7253
commercially	O	7253
available	O	7253
,	O	7253
but	O	7253
its	O	7253
place	O	7253
in	O	7253
the	O	7253
diagnosis	O	7253
of	O	7253
hemochromatosis	B-Disease	7253
is	O	7253
still	O	7253
being	O	7253
evaluated	O	7253
.	O	7253

Currently	O	7254
,	O	7254
the	O	7254
most	O	7254
useful	O	7254
role	O	7254
for	O	7254
this	O	7254
test	O	7254
is	O	7254
in	O	7254
the	O	7254
detection	O	7254
of	O	7254
hemochromatosis	B-Disease	7254
in	O	7254
the	O	7254
family	O	7254
members	O	7254
of	O	7254
patients	O	7254
with	O	7254
a	O	7254
proven	O	7254
case	O	7254
of	O	7254
the	O	7254
disease	O	7254
.	O	7254

It	O	7255
is	O	7255
crucial	O	7255
to	O	7255
diagnose	O	7255
hemochromatosis	B-Disease	7255
before	O	7255
hepatic	B-Disease	7255
cirrhosis	I-Disease	7255
develops	O	7255
because	O	7255
phlebotomy	O	7255
therapy	O	7255
can	O	7255
avert	O	7255
serious	O	7255
chronic	O	7255
disease	O	7255
and	O	7255
can	O	7255
even	O	7255
lead	O	7255
to	O	7255
normal	O	7255
life	O	7255
expectancy	O	7255
.	O	7255

Prevalence	O	7257
of	O	7257
the	O	7257
I1307K	O	7257
APC	B-Disease	7257
gene	O	7257
variant	O	7257
in	O	7257
Israeli	O	7257
Jews	O	7257
of	O	7257
differing	O	7257
ethnic	O	7257
origin	O	7257
and	O	7257
risk	O	7257
for	O	7257
colorectal	B-Disease	7257
cancer	I-Disease	7257
.	O	7257

,	O	7260
Ashkenazim	O	7260
,	O	7260
have	O	7260
the	O	7260
highest	O	7260
colorectal	B-Disease	7260
cancer	I-Disease	7260
incidence	O	7260
of	O	7260
any	O	7260
Israeli	O	7260
ethnic	O	7260
group	O	7260
.	O	7260

The	O	7261
I1307K	O	7261
APC	B-Disease	7261
gene	O	7261
variant	O	7261
was	O	7261
found	O	7261
in	O	7261
6	O	7261
.	O	7261

1	O	7262
%	O	7262
of	O	7262
American	O	7262
Jews	O	7262
,	O	7262
28	O	7262
%	O	7262
of	O	7262
their	O	7262
familial	O	7262
colorectal	B-Disease	7262
cancer	I-Disease	7262
cases	O	7262
,	O	7262
but	O	7262
not	O	7262
in	O	7262
non	O	7262
-	O	7262
Jews	O	7262
.	O	7262

We	O	7263
assessed	O	7263
the	O	7263
I1307K	O	7263
prevalence	O	7263
in	O	7263
Israeli	O	7263
Jews	O	7263
of	O	7263
differing	O	7263
ethnic	O	7263
origin	O	7263
and	O	7263
risk	O	7263
for	O	7263
colorectal	B-Disease	7263
cancer	I-Disease	7263
.	O	7263

METHODS	O	7264
DNA	O	7264
samples	O	7264
from	O	7264
500	O	7264
unrelated	O	7264
Jews	O	7264
of	O	7264
European	O	7264
or	O	7264
non	O	7264
-	O	7264
European	O	7264
origin	O	7264
,	O	7264
with	O	7264
or	O	7264
without	O	7264
a	O	7264
personal	O	7264
and	O	7264
/	O	7264
or	O	7264
family	O	7264
history	O	7264
of	O	7264
neoplasia	B-Disease	7264
,	O	7264
were	O	7264
examined	O	7264
for	O	7264
the	O	7264
I1307K	O	7264
variant	O	7264
by	O	7264
the	O	7264
allele	O	7264
-	O	7264
specific	O	7264
oligonucleotide	O	7264
(	O	7264
ASO	O	7264
)	O	7264
method	O	7264
.	O	7264

RESULTS	O	7265
In	O	7265
persons	O	7265
at	O	7265
average	O	7265
risk	O	7265
for	O	7265
colorectal	B-Disease	7265
cancer	I-Disease	7265
,	O	7265
I1307K	O	7265
was	O	7265
found	O	7265
in	O	7265
5	O	7265
.	O	7265

4	O	7270
%	O	7270
of	O	7270
52	O	7270
Ashkenazi	O	7270
Israelis	O	7270
with	O	7270
familial	O	7270
cancer	B-Disease	7270
(	O	7270
P	O	7270
=	O	7270
0	O	7270
.	O	7270

02	O	7271
)	O	7271
and	O	7271
was	O	7271
not	O	7271
detected	O	7271
in	O	7271
51	O	7271
non	O	7271
-	O	7271
European	O	7271
Jews	O	7271
at	O	7271
increased	O	7271
cancer	B-Disease	7271
risk	O	7271
.	O	7271

Colorectal	B-Disease	7272
neoplasia	I-Disease	7272
occurred	O	7272
personally	O	7272
or	O	7272
in	O	7272
the	O	7272
families	O	7272
of	O	7272
13	O	7272
of	O	7272
20	O	7272
Ashkenazi	O	7272
I1307K	O	7272
carriers	O	7272
,	O	7272
8	O	7272
of	O	7272
whom	O	7272
also	O	7272
had	O	7272
a	O	7272
personal	O	7272
or	O	7272
family	O	7272
history	O	7272
of	O	7272
noncolonic	O	7272
neoplasia	B-Disease	7272
.	O	7272

CONCLUSIONS	O	7273
The	O	7273
I1307K	O	7273
APC	O	7273
variant	O	7273
may	O	7273
represent	O	7273
a	O	7273
susceptibility	O	7273
gene	O	7273
for	O	7273
colorectal	B-Disease	7273
,	I-Disease	7273
or	I-Disease	7273
other	I-Disease	7273
,	I-Disease	7273
cancers	I-Disease	7273
in	O	7273
Ashkenazi	O	7273
Jews	O	7273
,	O	7273
and	O	7273
partially	O	7273
explains	O	7273
the	O	7273
higher	O	7273
incidence	O	7273
of	O	7273
colorectal	B-Disease	7273
cancer	I-Disease	7273
in	O	7273
European	O	7273
Israelis	O	7273
.	O	7273

Systematic	O	7274
analysis	O	7274
of	O	7274
coproporphyrinogen	O	7274
oxidase	O	7274
gene	O	7274
defects	O	7274
in	O	7274
hereditary	B-Disease	7274
coproporphyria	I-Disease	7274
and	O	7274
mutation	O	7274
update	O	7274
.	O	7274

Hereditary	B-Disease	7275
coproporphyria	I-Disease	7275
(	O	7275
HC	B-Disease	7275
)	O	7275
is	O	7275
an	O	7275
acute	O	7275
hepatic	B-Disease	7275
porphyria	I-Disease	7275
with	O	7275
autosomal	O	7275
dominant	O	7275
inheritance	O	7275
caused	O	7275
by	O	7275
deficient	B-Disease	7275
activity	I-Disease	7275
of	I-Disease	7275
coproporphyrinogen	I-Disease	7275
III	I-Disease	7275
oxidase	I-Disease	7275
(	O	7275
CPO	O	7275
)	O	7275
.	O	7275

Clinical	O	7276
manifestations	O	7276
of	O	7276
the	O	7276
disease	O	7276
are	O	7276
characterized	O	7276
by	O	7276
acute	O	7276
attacks	O	7276
of	O	7276
neurological	B-Disease	7276
dysfunction	I-Disease	7276
often	O	7276
precipitated	O	7276
by	O	7276
drugs	O	7276
,	O	7276
fasting	O	7276
,	O	7276
cyclical	O	7276
hormonal	O	7276
changes	O	7276
,	O	7276
or	O	7276
infectious	B-Disease	7276
diseases	I-Disease	7276
.	O	7276

The	O	7278
seven	O	7278
exons	O	7278
,	O	7278
the	O	7278
exon	O	7278
/	O	7278
intron	O	7278
boundaries	O	7278
and	O	7278
part	O	7278
of	O	7278
3	O	7278
noncoding	O	7278
sequence	O	7278
of	O	7278
the	O	7278
CPO	O	7278
gene	O	7278
were	O	7278
systematically	O	7278
analyzed	O	7278
by	O	7278
an	O	7278
exon	O	7278
-	O	7278
by	O	7278
-	O	7278
exon	O	7278
denaturing	O	7278
gradient	O	7278
gel	O	7278
electrophoresis	O	7278
(	O	7278
DGGE	O	7278
)	O	7278
strategy	O	7278
followed	O	7278
by	O	7278
direct	O	7278
sequencing	O	7278
in	O	7278
seven	O	7278
unrelated	O	7278
heterozygous	O	7278
HC	B-Disease	7278
patients	O	7278
from	O	7278
France	O	7278
,	O	7278
Holland	O	7278
,	O	7278
and	O	7278
Czech	O	7278
Republic	O	7278
.	O	7278

Five	O	7284
intragenic	O	7284
dimorphisms	O	7284
are	O	7284
now	O	7284
well	O	7284
characterized	O	7284
and	O	7284
the	O	7284
high	O	7284
degree	O	7284
of	O	7284
allelic	O	7284
heterogeneity	O	7284
in	O	7284
HC	B-Disease	7284
is	O	7284
demonstrated	O	7284
with	O	7284
seven	O	7284
new	O	7284
different	O	7284
mutations	O	7284
making	O	7284
a	O	7284
total	O	7284
of	O	7284
nineteen	O	7284
CPO	O	7284
gene	B-Disease	7284
defects	I-Disease	7284
reported	O	7284
so	O	7284
far	O	7284
.	O	7284

Coincidence	O	7286
of	O	7286
two	O	7286
novel	O	7286
arylsulfatase	O	7286
A	O	7286
alleles	O	7286
and	O	7286
mutation	O	7286
459	O	7286
+	O	7286
1G	O	7286
>	O	7286
A	O	7286
within	O	7286
a	O	7286
family	O	7286
with	O	7286
metachromatic	B-Disease	7286
leukodystrophy	I-Disease	7286
:	O	7286
molecular	O	7286
basis	O	7286
of	O	7286
phenotypic	O	7286
heterogeneity	O	7286
.	O	7286

In	O	7287
a	O	7287
family	O	7287
with	O	7287
three	O	7287
siblings	O	7287
,	O	7287
one	O	7287
developed	O	7287
classical	O	7287
late	O	7287
infantile	O	7287
metachromatic	B-Disease	7287
leukodystrophy	I-Disease	7287
(	O	7287
MLD	B-Disease	7287
)	O	7287
,	O	7287
fatal	O	7287
at	O	7287
age	O	7287
5	O	7287
years	O	7287
,	O	7287
with	O	7287
deficient	O	7287
arylsulfatase	O	7287
A	O	7287
(	O	7287
ARSA	O	7287
)	O	7287
activity	O	7287
and	O	7287
increased	O	7287
galactosylsulfatide	O	7287
(	O	7287
GS	O	7287
)	O	7287
excretion	O	7287
.	O	7287

The	O	7288
two	O	7288
other	O	7288
siblings	O	7288
,	O	7288
apparently	O	7288
healthy	O	7288
at	O	7288
12	O	7288
(	O	7288
1	O	7288
/	O	7288
2	O	7288
)	O	7288
and	O	7288
15	O	7288
years	O	7288
,	O	7288
respectively	O	7288
,	O	7288
and	O	7288
their	O	7288
father	O	7288
,	O	7288
apparently	O	7288
healthy	O	7288
as	O	7288
well	O	7288
,	O	7288
presented	O	7288
ARSA	O	7288
and	O	7288
GS	O	7288
values	O	7288
within	O	7288
the	O	7288
range	O	7288
of	O	7288
MLD	B-Disease	7288
patients	O	7288
.	O	7288

Mutation	O	7293
A464V	O	7293
was	O	7293
not	O	7293
found	O	7293
in	O	7293
18	O	7293
unrelated	O	7293
MLD	B-Disease	7293
patients	O	7293
and	O	7293
50	O	7293
controls	O	7293
.	O	7293

A464V	O	7294
,	O	7294
although	O	7294
clearly	O	7294
modifying	O	7294
ARSA	O	7294
and	O	7294
GS	O	7294
levels	O	7294
,	O	7294
apparently	O	7294
bears	O	7294
little	O	7294
significance	O	7294
for	O	7294
clinical	O	7294
manifestation	O	7294
of	O	7294
MLD	B-Disease	7294
,	O	7294
mimicking	O	7294
the	O	7294
frequent	O	7294
ARSA	O	7294
pseudodeficiency	O	7294
allele	O	7294
.	O	7294

Our	O	7295
results	O	7295
demonstrate	O	7295
that	O	7295
in	O	7295
certain	O	7295
genetic	O	7295
conditions	O	7295
MLD	B-Disease	7295
-	O	7295
like	O	7295
ARSA	O	7295
and	O	7295
GS	O	7295
values	O	7295
need	O	7295
not	O	7295
be	O	7295
paralleled	O	7295
by	O	7295
clinical	O	7295
disease	O	7295
,	O	7295
a	O	7295
finding	O	7295
with	O	7295
serious	O	7295
diagnostic	O	7295
and	O	7295
prognostic	O	7295
implications	O	7295
.	O	7295

Human	O	7298
MLH1	O	7298
deficiency	O	7298
predisposes	O	7298
to	O	7298
hematological	B-Disease	7298
malignancy	I-Disease	7298
and	O	7298
neurofibromatosis	B-Disease	7298
type	I-Disease	7298
1	I-Disease	7298
.	O	7298

Heterozygous	O	7299
germ	O	7299
-	O	7299
line	O	7299
mutations	O	7299
in	O	7299
the	O	7299
DNA	O	7299
mismatch	O	7299
repair	O	7299
genes	O	7299
lead	O	7299
to	O	7299
hereditary	B-Disease	7299
nonpolyposis	I-Disease	7299
colorectal	I-Disease	7299
cancer	I-Disease	7299
.	O	7299

We	O	7301
have	O	7301
identified	O	7301
three	O	7301
offspring	O	7301
in	O	7301
a	O	7301
hereditary	B-Disease	7301
nonpolyposis	I-Disease	7301
colorectal	I-Disease	7301
cancer	I-Disease	7301
family	O	7301
who	O	7301
developed	O	7301
hematological	B-Disease	7301
malignancy	I-Disease	7301
at	O	7301
a	O	7301
very	O	7301
early	O	7301
age	O	7301
,	O	7301
and	O	7301
at	O	7301
least	O	7301
two	O	7301
of	O	7301
them	O	7301
displayed	O	7301
signs	O	7301
of	O	7301
neurofibromatosis	B-Disease	7301
type	I-Disease	7301
1	I-Disease	7301
(	O	7301
NF1	B-Disease	7301
)	O	7301
.	O	7301

Thus	O	7303
,	O	7303
a	O	7303
homozygous	O	7303
germ	O	7303
-	O	7303
line	O	7303
MLH1	O	7303
mutation	O	7303
and	O	7303
consequent	O	7303
mismatch	O	7303
repair	O	7303
deficiency	O	7303
results	O	7303
in	O	7303
a	O	7303
mutator	O	7303
phenotype	O	7303
characterized	O	7303
by	O	7303
leukemia	B-Disease	7303
and	O	7303
/	O	7303
or	O	7303
lymphoma	B-Disease	7303
associated	O	7303
with	O	7303
neurofibromatosis	B-Disease	7303
type	I-Disease	7303
1	I-Disease	7303
.	O	7303

Missense	O	7305
mutations	O	7305
in	O	7305
the	O	7305
most	O	7305
ancient	O	7305
residues	O	7305
of	O	7305
the	O	7305
PAX6	O	7305
paired	O	7305
domain	O	7305
underlie	O	7305
a	O	7305
spectrum	O	7305
of	O	7305
human	O	7305
congenital	B-Disease	7305
eye	I-Disease	7305
malformations	I-Disease	7305
.	O	7305

Mutations	O	7306
of	O	7306
the	O	7306
human	O	7306
PAX6	O	7306
gene	O	7306
underlie	O	7306
aniridia	B-Disease	7306
(	O	7306
congenital	B-Disease	7306
absence	I-Disease	7306
of	I-Disease	7306
the	I-Disease	7306
iris	I-Disease	7306
)	O	7306
,	O	7306
a	O	7306
rare	O	7306
dominant	O	7306
malformation	B-Disease	7306
of	I-Disease	7306
the	I-Disease	7306
eye	I-Disease	7306
.	O	7306

The	O	7307
spectrum	O	7307
of	O	7307
PAX6	O	7307
mutations	O	7307
in	O	7307
aniridia	B-Disease	7307
patients	O	7307
is	O	7307
highly	O	7307
biased	O	7307
,	O	7307
with	O	7307
92	O	7307
%	O	7307
of	O	7307
all	O	7307
reported	O	7307
mutations	O	7307
leading	O	7307
to	O	7307
premature	O	7307
truncation	O	7307
of	O	7307
the	O	7307
protein	O	7307
(	O	7307
nonsense	O	7307
,	O	7307
splicing	O	7307
,	O	7307
insertions	O	7307
and	O	7307
deletions	O	7307
)	O	7307
and	O	7307
just	O	7307
2	O	7307
%	O	7307
leading	O	7307
to	O	7307
substitution	O	7307
of	O	7307
one	O	7307
amino	O	7307
acid	O	7307
by	O	7307
another	O	7307
(	O	7307
missense	O	7307
)	O	7307
.	O	7307

The	O	7308
extraordinary	O	7308
conservation	O	7308
of	O	7308
the	O	7308
PAX6	O	7308
protein	O	7308
at	O	7308
the	O	7308
amino	O	7308
acid	O	7308
level	O	7308
amongst	O	7308
vertebrates	O	7308
predicts	O	7308
that	O	7308
pathological	O	7308
missense	O	7308
mutations	O	7308
should	O	7308
in	O	7308
fact	O	7308
be	O	7308
common	O	7308
even	O	7308
though	O	7308
they	O	7308
are	O	7308
hardly	O	7308
ever	O	7308
seen	O	7308
in	O	7308
aniridia	B-Disease	7308
patients	O	7308
.	O	7308

This	O	7309
indicates	O	7309
that	O	7309
there	O	7309
is	O	7309
a	O	7309
heavy	O	7309
ascertainment	O	7309
bias	O	7309
in	O	7309
the	O	7309
selection	O	7309
of	O	7309
patients	O	7309
for	O	7309
PAX6	O	7309
mutation	O	7309
analysis	O	7309
and	O	7309
that	O	7309
the	O	7309
missing	O	7309
PAX6	O	7309
missense	O	7309
mutations	O	7309
frequently	O	7309
may	O	7309
underlie	O	7309
phenotypes	O	7309
distinct	O	7309
from	O	7309
textbook	O	7309
aniridia	B-Disease	7309
.	O	7309

Here	O	7310
we	O	7310
present	O	7310
four	O	7310
novel	O	7310
PAX6	O	7310
missense	O	7310
mutations	O	7310
,	O	7310
two	O	7310
in	O	7310
association	O	7310
with	O	7310
atypical	O	7310
phenotypes	O	7310
ectopia	B-Disease	7310
pupillae	I-Disease	7310
(	O	7310
displaced	B-Disease	7310
pupils	I-Disease	7310
)	O	7310
and	O	7310
congenital	B-Disease	7310
nystagmus	I-Disease	7310
(	O	7310
searching	B-Disease	7310
gaze	I-Disease	7310
)	O	7310
,	O	7310
and	O	7310
two	O	7310
in	O	7310
association	O	7310
with	O	7310
more	O	7310
recognizable	O	7310
aniridia	B-Disease	7310
phenotypes	O	7310
.	O	7310

Our	O	7312
results	O	7312
support	O	7312
the	O	7312
hypothesis	O	7312
that	O	7312
the	O	7312
under	O	7312
-	O	7312
representation	O	7312
of	O	7312
missense	O	7312
mutations	O	7312
is	O	7312
caused	O	7312
by	O	7312
ascertainment	O	7312
bias	O	7312
and	O	7312
suggest	O	7312
that	O	7312
a	O	7312
substantial	O	7312
burden	O	7312
of	O	7312
PAX6	B-Disease	7312
-	I-Disease	7312
related	I-Disease	7312
disease	I-Disease	7312
remains	O	7312
to	O	7312
be	O	7312
uncovered	O	7312
.	O	7312

The	O	7314
chromosomal	O	7314
order	O	7314
of	O	7314
genes	O	7314
controlling	O	7314
the	O	7314
major	O	7314
histocompatibility	O	7314
complex	O	7314
,	O	7314
properdin	O	7314
factor	O	7314
B	O	7314
,	O	7314
and	O	7314
deficiency	B-Disease	7314
of	I-Disease	7314
the	I-Disease	7314
second	I-Disease	7314
component	I-Disease	7314
of	I-Disease	7314
complement	I-Disease	7314
.	O	7314

The	O	7315
relationship	O	7315
of	O	7315
the	O	7315
genes	O	7315
coding	O	7315
for	O	7315
HLA	O	7315
to	O	7315
those	O	7315
coding	O	7315
for	O	7315
properdin	O	7315
Factor	O	7315
B	O	7315
allotypes	O	7315
and	O	7315
for	O	7315
deficiency	B-Disease	7315
of	I-Disease	7315
the	I-Disease	7315
second	I-Disease	7315
component	I-Disease	7315
of	I-Disease	7315
complement	I-Disease	7315
(	O	7315
C2	O	7315
)	O	7315
was	O	7315
studied	O	7315
in	O	7315
families	O	7315
of	O	7315
patients	O	7315
with	O	7315
connective	O	7315
tissue	O	7315
disorders	O	7315
.	O	7315

Patients	O	7316
were	O	7316
selected	O	7316
because	O	7316
they	O	7316
were	O	7316
heterozygous	O	7316
or	O	7316
homozygous	O	7316
for	O	7316
C2	B-Disease	7316
deficiency	I-Disease	7316
.	O	7316

12	O	7317
families	O	7317
with	O	7317
15	O	7317
matings	O	7317
informative	O	7317
for	O	7317
C2	B-Disease	7317
deficiency	I-Disease	7317
were	O	7317
found	O	7317
.	O	7317

Of	O	7318
57	O	7318
informative	O	7318
meioses	O	7318
,	O	7318
two	O	7318
crossovers	O	7318
were	O	7318
noted	O	7318
between	O	7318
the	O	7318
C2	B-Disease	7318
deficiency	I-Disease	7318
gene	O	7318
and	O	7318
the	O	7318
HLA	O	7318
-	O	7318
B	O	7318
gene	O	7318
,	O	7318
with	O	7318
a	O	7318
recombinant	O	7318
fraction	O	7318
of	O	7318
0	O	7318
.	O	7318

A	O	7320
lod	O	7320
score	O	7320
of	O	7320
13	O	7320
was	O	7320
calculated	O	7320
for	O	7320
linkage	O	7320
between	O	7320
C2	B-Disease	7320
deficiency	I-Disease	7320
and	O	7320
HLA	O	7320
-	O	7320
B	O	7320
at	O	7320
a	O	7320
maximum	O	7320
likelihood	O	7320
value	O	7320
of	O	7320
the	O	7320
recombinant	O	7320
fraction	O	7320
of	O	7320
0	O	7320
.	O	7320

These	O	7328
studies	O	7328
suggest	O	7328
that	O	7328
the	O	7328
genes	O	7328
for	O	7328
Factor	O	7328
B	O	7328
and	O	7328
C2	B-Disease	7328
deficiency	I-Disease	7328
are	O	7328
located	O	7328
outside	O	7328
those	O	7328
for	O	7328
HLA	O	7328
,	O	7328
that	O	7328
the	O	7328
order	O	7328
of	O	7328
genese	O	7328
is	O	7328
HLA	O	7328
-	O	7328
A	O	7328
,	O	7328
-	O	7328
B	O	7328
,	O	7328
-	O	7328
D	O	7328
,	O	7328
Factor	O	7328
B	O	7328
allotype	O	7328
,	O	7328
C2	B-Disease	7328
deficiency	I-Disease	7328
,	O	7328
that	O	7328
the	O	7328
genes	O	7328
coding	O	7328
for	O	7328
C2	B-Disease	7328
deficiency	I-Disease	7328
and	O	7328
Factor	O	7328
B	O	7328
allotypes	O	7328
are	O	7328
approximately	O	7328
3	O	7328
-	O	7328
-	O	7328
5	O	7328
centimorgans	O	7328
from	O	7328
the	O	7328
HLA	O	7328
-	O	7328
A	O	7328
and	O	7328
HLA	O	7328
-	O	7328
B	O	7328
loci	O	7328
,	O	7328
and	O	7328
that	O	7328
the	O	7328
apparent	O	7328
lack	O	7328
of	O	7328
recombinants	O	7328
between	O	7328
the	O	7328
Factor	O	7328
B	O	7328
gene	O	7328
and	O	7328
C2	B-Disease	7328
deficiency	I-Disease	7328
gene	O	7328
suggests	O	7328
that	O	7328
these	O	7328
two	O	7328
genes	O	7328
lie	O	7328
in	O	7328
close	O	7328
proximity	O	7328
to	O	7328
one	O	7328
another	O	7328
.	O	7328

Distribution	O	7329
of	O	7329
emerin	O	7329
and	O	7329
lamins	O	7329
in	O	7329
the	O	7329
heart	O	7329
and	O	7329
implications	O	7329
for	O	7329
Emery	B-Disease	7329
-	I-Disease	7329
Dreifuss	I-Disease	7329
muscular	I-Disease	7329
dystrophy	I-Disease	7329
.	O	7329

Emerin	O	7330
is	O	7330
a	O	7330
nuclear	O	7330
membrane	O	7330
protein	O	7330
which	O	7330
is	O	7330
missing	O	7330
or	O	7330
defective	O	7330
in	O	7330
Emery	B-Disease	7330
-	I-Disease	7330
Dreifuss	I-Disease	7330
muscular	I-Disease	7330
dystrophy	I-Disease	7330
(	O	7330
EDMD	B-Disease	7330
)	O	7330
.	O	7330

These	O	7335
results	O	7335
would	O	7335
not	O	7335
be	O	7335
expected	O	7335
if	O	7335
immunostaining	O	7335
at	O	7335
intercalated	O	7335
discs	O	7335
were	O	7335
due	O	7335
to	O	7335
a	O	7335
product	O	7335
of	O	7335
the	O	7335
emerin	O	7335
gene	O	7335
and	O	7335
,	O	7335
therefore	O	7335
,	O	7335
cast	O	7335
some	O	7335
doubt	O	7335
upon	O	7335
the	O	7335
hypothesis	O	7335
that	O	7335
cardiac	B-Disease	7335
defects	I-Disease	7335
in	O	7335
EDMD	B-Disease	7335
are	O	7335
caused	O	7335
by	O	7335
absence	O	7335
of	O	7335
emerin	O	7335
from	O	7335
intercalated	O	7335
discs	O	7335
.	O	7335

This	O	7337
distribution	O	7337
of	O	7337
emerin	O	7337
was	O	7337
similar	O	7337
to	O	7337
that	O	7337
of	O	7337
lamin	O	7337
A	O	7337
,	O	7337
a	O	7337
candidate	O	7337
gene	O	7337
for	O	7337
an	O	7337
autosomal	O	7337
form	O	7337
of	O	7337
EDMD	B-Disease	7337
.	O	7337

In	O	7340
EDMD	B-Disease	7340
,	O	7340
the	O	7340
additional	O	7340
absence	O	7340
of	O	7340
lamin	O	7340
B1	O	7340
from	O	7340
heart	O	7340
and	O	7340
skeletal	O	7340
muscle	O	7340
nuclei	O	7340
which	O	7340
already	O	7340
lack	O	7340
emerin	O	7340
may	O	7340
offer	O	7340
an	O	7340
alternative	O	7340
explanation	O	7340
of	O	7340
why	O	7340
these	O	7340
tissues	O	7340
are	O	7340
particularly	O	7340
affected	O	7340
.	O	7340

Genetic	O	7342
mapping	O	7342
of	O	7342
the	O	7342
copper	B-Disease	7342
toxicosis	I-Disease	7342
locus	O	7342
in	O	7342
Bedlington	O	7342
terriers	O	7342
to	O	7342
dog	O	7342
chromosome	O	7342
10	O	7342
,	O	7342
in	O	7342
a	O	7342
region	O	7342
syntenic	O	7342
to	O	7342
human	O	7342
chromosome	O	7342
region	O	7342
2p13	O	7342
-	O	7342
p16	O	7342
.	O	7342

Abnormal	O	7343
hepatic	B-Disease	7343
copper	I-Disease	7343
accumulation	I-Disease	7343
is	O	7343
recognized	O	7343
as	O	7343
an	O	7343
inherited	B-Disease	7343
disorder	I-Disease	7343
in	O	7343
man	O	7343
,	O	7343
mouse	O	7343
,	O	7343
rat	O	7343
and	O	7343
dog	O	7343
.	O	7343

The	O	7344
major	O	7344
cause	O	7344
of	O	7344
hepatic	B-Disease	7344
copper	I-Disease	7344
accumulation	I-Disease	7344
in	O	7344
man	O	7344
is	O	7344
a	O	7344
dysfunctional	O	7344
ATP7B	O	7344
gene	O	7344
,	O	7344
causing	O	7344
Wilson	B-Disease	7344
disease	I-Disease	7344
(	O	7344
WD	B-Disease	7344
)	O	7344
.	O	7344

The	O	7346
ATP7B	O	7346
gene	O	7346
has	O	7346
been	O	7346
excluded	O	7346
in	O	7346
the	O	7346
much	O	7346
rarer	O	7346
human	O	7346
copper	B-Disease	7346
overload	I-Disease	7346
disease	O	7346
non	B-Disease	7346
-	I-Disease	7346
Indian	I-Disease	7346
childhood	I-Disease	7346
cirrhosis	I-Disease	7346
,	O	7346
indicating	O	7346
genetic	O	7346
heterogeneity	O	7346
.	O	7346

By	O	7347
investigating	O	7347
the	O	7347
common	O	7347
autosomal	O	7347
recessive	O	7347
copper	B-Disease	7347
toxicosis	I-Disease	7347
(	O	7347
CT	B-Disease	7347
)	O	7347
in	O	7347
Bedlington	O	7347
terriers	O	7347
,	O	7347
we	O	7347
have	O	7347
identified	O	7347
a	O	7347
new	O	7347
locus	O	7347
involved	O	7347
in	O	7347
progressive	O	7347
liver	B-Disease	7347
disease	I-Disease	7347
.	O	7347

We	O	7348
examined	O	7348
whether	O	7348
the	O	7348
WD	B-Disease	7348
gene	O	7348
ATP7B	O	7348
was	O	7348
also	O	7348
causative	O	7348
for	O	7348
CT	B-Disease	7348
by	O	7348
investigating	O	7348
the	O	7348
chromosomal	O	7348
co	O	7348
-	O	7348
localization	O	7348
of	O	7348
ATP7B	O	7348
and	O	7348
C04107	O	7348
,	O	7348
using	O	7348
fluorescence	O	7348
in	O	7348
situ	O	7348
hybridization	O	7348
(	O	7348
FISH	O	7348
)	O	7348
.	O	7348

C04107	O	7349
is	O	7349
an	O	7349
anonymous	O	7349
microsatellite	O	7349
marker	O	7349
closely	O	7349
linked	O	7349
to	O	7349
CT	B-Disease	7349
.	O	7349

However	O	7350
,	O	7350
BAC	O	7350
clones	O	7350
containing	O	7350
ATP7B	O	7350
and	O	7350
C04107	O	7350
mapped	O	7350
to	O	7350
the	O	7350
canine	O	7350
chromosome	O	7350
regions	O	7350
CFA22q11	O	7350
and	O	7350
CFA10q26	O	7350
,	O	7350
respectively	O	7350
,	O	7350
demonstrating	O	7350
that	O	7350
WD	B-Disease	7350
cannot	O	7350
be	O	7350
homologous	O	7350
to	O	7350
CT	B-Disease	7350
.	O	7350

The	O	7351
copper	O	7351
transport	O	7351
genes	O	7351
CTR1	O	7351
and	O	7351
CTR2	O	7351
were	O	7351
also	O	7351
excluded	O	7351
as	O	7351
candidate	O	7351
genes	O	7351
for	O	7351
CT	B-Disease	7351
since	O	7351
they	O	7351
both	O	7351
mapped	O	7351
to	O	7351
canine	O	7351
chromosome	O	7351
region	O	7351
CFA11q22	O	7351
.	O	7351

Molecular	O	7355
analysis	O	7355
of	O	7355
the	O	7355
APC	B-Disease	7355
gene	O	7355
in	O	7355
205	O	7355
families	O	7355
:	O	7355
extended	O	7355
genotype	O	7355
-	O	7355
phenotype	O	7355
correlations	O	7355
in	O	7355
FAP	B-Disease	7355
and	O	7355
evidence	O	7355
for	O	7355
the	O	7355
role	O	7355
of	O	7355
APC	B-Disease	7355
amino	O	7355
acid	O	7355
changes	O	7355
in	O	7355
colorectal	B-Disease	7355
cancer	I-Disease	7355
predisposition	O	7355
.	O	7355

BACKGROUND	O	7356
/	O	7356
AIMS	O	7356
The	O	7356
development	O	7356
of	O	7356
colorectal	B-Disease	7356
cancer	I-Disease	7356
and	O	7356
a	O	7356
variable	O	7356
range	O	7356
of	O	7356
extracolonic	O	7356
manifestations	O	7356
in	O	7356
familial	B-Disease	7356
adenomatous	I-Disease	7356
polyposis	I-Disease	7356
(	O	7356
FAP	B-Disease	7356
)	O	7356
is	O	7356
the	O	7356
result	O	7356
of	O	7356
the	O	7356
dominant	O	7356
inheritance	O	7356
of	O	7356
adenomatous	B-Disease	7356
polyposis	I-Disease	7356
coli	I-Disease	7356
(	O	7356
APC	B-Disease	7356
)	O	7356
gene	O	7356
mutations	O	7356
.	O	7356

In	O	7357
this	O	7357
study	O	7357
,	O	7357
direct	O	7357
mutation	O	7357
analysis	O	7357
of	O	7357
the	O	7357
APC	B-Disease	7357
gene	O	7357
was	O	7357
performed	O	7357
to	O	7357
determine	O	7357
genotype	O	7357
-	O	7357
phenotype	O	7357
correlations	O	7357
for	O	7357
nine	O	7357
extracolonic	O	7357
manifestations	O	7357
and	O	7357
to	O	7357
investigate	O	7357
the	O	7357
incidence	O	7357
of	O	7357
APC	B-Disease	7357
mutations	O	7357
in	O	7357
non	O	7357
-	O	7357
FAP	O	7357
colorectal	B-Disease	7357
cancer	I-Disease	7357
.	O	7357

METHODS	O	7358
The	O	7358
APC	B-Disease	7358
gene	O	7358
was	O	7358
analysed	O	7358
in	O	7358
190	O	7358
unrelated	O	7358
FAP	B-Disease	7358
and	O	7358
15	O	7358
non	O	7358
-	O	7358
FAP	O	7358
colorectal	B-Disease	7358
cancer	I-Disease	7358
patients	O	7358
using	O	7358
denaturing	O	7358
gradient	O	7358
gel	O	7358
electrophoresis	O	7358
,	O	7358
the	O	7358
protein	O	7358
truncation	O	7358
test	O	7358
,	O	7358
and	O	7358
direct	O	7358
sequencing	O	7358
.	O	7358

RESULTS	O	7359
Chain	O	7359
terminating	O	7359
signals	O	7359
were	O	7359
only	O	7359
identified	O	7359
in	O	7359
patients	O	7359
belonging	O	7359
to	O	7359
the	O	7359
FAP	B-Disease	7359
group	O	7359
(	O	7359
105	O	7359
patients	O	7359
)	O	7359
.	O	7359

Amino	O	7360
acid	O	7360
changes	O	7360
were	O	7360
identified	O	7360
in	O	7360
four	O	7360
patients	O	7360
,	O	7360
three	O	7360
of	O	7360
whom	O	7360
belonged	O	7360
to	O	7360
the	O	7360
non	O	7360
-	O	7360
FAP	O	7360
group	O	7360
of	O	7360
colorectal	B-Disease	7360
cancer	I-Disease	7360
patients	O	7360
.	O	7360

Genotype	O	7361
-	O	7361
phenotype	O	7361
correlations	O	7361
identified	O	7361
significant	O	7361
differences	O	7361
in	O	7361
the	O	7361
nature	O	7361
of	O	7361
certain	O	7361
extracolonic	O	7361
manifestations	O	7361
in	O	7361
FAP	B-Disease	7361
patients	O	7361
belonging	O	7361
to	O	7361
three	O	7361
mutation	O	7361
subgroups	O	7361
.	O	7361

This	O	7363
study	O	7363
also	O	7363
provided	O	7363
evidence	O	7363
for	O	7363
the	O	7363
pathological	O	7363
nature	O	7363
of	O	7363
amino	O	7363
acid	O	7363
changes	O	7363
in	O	7363
APC	O	7363
associated	O	7363
with	O	7363
both	O	7363
FAP	B-Disease	7363
and	O	7363
non	O	7363
-	O	7363
FAP	O	7363
colorectal	B-Disease	7363
cancer	I-Disease	7363
patients	O	7363
.	O	7363

Inherited	B-Disease	7365
colorectal	I-Disease	7365
polyposis	I-Disease	7365
and	O	7365
cancer	B-Disease	7365
risk	O	7365
of	O	7365
the	O	7365
APC	O	7365
I1307K	O	7365
polymorphism	O	7365
.	O	7365

Germ	O	7366
-	O	7366
line	O	7366
and	O	7366
somatic	O	7366
truncating	O	7366
mutations	O	7366
of	O	7366
the	O	7366
APC	B-Disease	7366
gene	O	7366
are	O	7366
thought	O	7366
to	O	7366
initiate	O	7366
colorectal	B-Disease	7366
tumor	I-Disease	7366
formation	O	7366
in	O	7366
familial	B-Disease	7366
adenomatous	I-Disease	7366
polyposis	I-Disease	7366
syndrome	I-Disease	7366
and	O	7366
sporadic	O	7366
colorectal	O	7366
carcinogenesis	O	7366
,	O	7366
respectively	O	7366
.	O	7366

Recently	O	7367
,	O	7367
an	O	7367
isoleucine	O	7367
-	O	7367
-	O	7367
>	O	7367
lysine	O	7367
polymorphism	O	7367
at	O	7367
codon	O	7367
1307	O	7367
(	O	7367
I1307K	O	7367
)	O	7367
of	O	7367
the	O	7367
APC	B-Disease	7367
gene	O	7367
has	O	7367
been	O	7367
identified	O	7367
in	O	7367
6	O	7367
%	O	7367
-	O	7367
7	O	7367
%	O	7367
of	O	7367
the	O	7367
Ashkenazi	O	7367
Jewish	O	7367
population	O	7367
.	O	7367

To	O	7368
assess	O	7368
the	O	7368
risk	O	7368
of	O	7368
this	O	7368
common	O	7368
APC	B-Disease	7368
allelic	O	7368
variant	O	7368
in	O	7368
colorectal	O	7368
carcinogenesis	O	7368
,	O	7368
we	O	7368
have	O	7368
analyzed	O	7368
a	O	7368
large	O	7368
cohort	O	7368
of	O	7368
unselected	O	7368
Ashkenazi	O	7368
Jewish	O	7368
subjects	O	7368
with	O	7368
adenomatous	B-Disease	7368
polyps	I-Disease	7368
and	O	7368
.	O	7368

or	O	7369
colorectal	B-Disease	7369
cancer	I-Disease	7369
,	I-Disease	7369
for	O	7369
the	O	7369
APC	O	7369
I1307K	O	7369
polymorphism	O	7369
.	O	7369

7	O	7374
for	O	7374
colorectal	B-Disease	7374
neoplasia	I-Disease	7374
(	O	7374
both	O	7374
P	O	7374
=	O	7374
.	O	7374

Furthermore	O	7376
,	O	7376
compared	O	7376
with	O	7376
noncarriers	O	7376
,	O	7376
APC	O	7376
I1307K	O	7376
carriers	O	7376
had	O	7376
increased	O	7376
numbers	O	7376
of	O	7376
adenomas	B-Disease	7376
and	O	7376
colorectal	B-Disease	7376
cancers	I-Disease	7376
per	O	7376
patient	O	7376
(	O	7376
P	O	7376
=	O	7376
.	O	7376

We	O	7378
conclude	O	7378
that	O	7378
the	O	7378
APC	O	7378
I1307K	O	7378
variant	O	7378
leads	O	7378
to	O	7378
increased	O	7378
adenoma	B-Disease	7378
formation	O	7378
and	O	7378
directly	O	7378
contributes	O	7378
to	O	7378
3	O	7378
%	O	7378
-	O	7378
4	O	7378
%	O	7378
of	O	7378
all	O	7378
Ashkenazi	O	7378
Jewish	O	7378
colorectal	B-Disease	7378
cancer	I-Disease	7378
.	O	7378

The	O	7379
estimated	O	7379
relative	O	7379
risk	O	7379
for	O	7379
carriers	O	7379
may	O	7379
justify	O	7379
specific	O	7379
clinical	O	7379
screening	O	7379
for	O	7379
the	O	7379
360	O	7379
,	O	7379
000	O	7379
Americans	O	7379
expected	O	7379
to	O	7379
harbor	O	7379
this	O	7379
allele	O	7379
,	O	7379
and	O	7379
genetic	O	7379
testing	O	7379
in	O	7379
the	O	7379
setting	O	7379
of	O	7379
long	O	7379
-	O	7379
term	O	7379
-	O	7379
outcome	O	7379
studies	O	7379
may	O	7379
impact	O	7379
significantly	O	7379
on	O	7379
colorectal	B-Disease	7379
cancer	I-Disease	7379
prevention	O	7379
in	O	7379
this	O	7379
population	O	7379
.	O	7379

Localization	O	7380
of	O	7380
human	O	7380
BRCA1	O	7380
and	O	7380
its	O	7380
loss	O	7380
in	O	7380
high	O	7380
-	O	7380
grade	O	7380
,	O	7380
non	B-Disease	7380
-	I-Disease	7380
inherited	I-Disease	7380
breast	I-Disease	7380
carcinomas	I-Disease	7380
.	O	7380

Although	O	7381
the	O	7381
link	O	7381
between	O	7381
the	O	7381
BRCA1	O	7381
tumour	B-Disease	7381
-	O	7381
suppressor	O	7381
gene	O	7381
and	O	7381
hereditary	B-Disease	7381
breast	I-Disease	7381
and	I-Disease	7381
ovarian	I-Disease	7381
cancer	I-Disease	7381
is	O	7381
established	O	7381
,	O	7381
the	O	7381
role	O	7381
,	O	7381
if	O	7381
any	O	7381
,	O	7381
of	O	7381
BRCA1	O	7381
in	O	7381
non	B-Disease	7381
-	I-Disease	7381
familial	I-Disease	7381
cancers	I-Disease	7381
is	O	7381
unclear	O	7381
.	O	7381

BRCA1	O	7382
mutations	O	7382
are	O	7382
rare	O	7382
in	O	7382
sporadic	B-Disease	7382
cancers	I-Disease	7382
,	O	7382
but	O	7382
loss	O	7382
of	O	7382
BRCA1	O	7382
resulting	O	7382
from	O	7382
reduced	O	7382
expression	O	7382
or	O	7382
incorrect	O	7382
subcellular	O	7382
localization	O	7382
is	O	7382
postulated	O	7382
to	O	7382
be	O	7382
important	O	7382
in	O	7382
non	B-Disease	7382
-	I-Disease	7382
familial	I-Disease	7382
breast	I-Disease	7382
and	I-Disease	7382
ovarian	I-Disease	7382
cancers	I-Disease	7382
.	O	7382

These	O	7385
reagents	O	7385
detect	O	7385
a	O	7385
220	O	7385
-	O	7385
kD	O	7385
protein	O	7385
localized	O	7385
in	O	7385
discrete	O	7385
nuclear	O	7385
foci	O	7385
in	O	7385
all	O	7385
epithelial	O	7385
cell	O	7385
lines	O	7385
,	O	7385
including	O	7385
those	O	7385
derived	O	7385
from	O	7385
breast	B-Disease	7385
malignancies	I-Disease	7385
.	O	7385

Immunohistochemical	O	7386
staining	O	7386
of	O	7386
human	O	7386
breast	O	7386
specimens	O	7386
also	O	7386
revealed	O	7386
BRCA1	O	7386
nuclear	O	7386
foci	O	7386
in	O	7386
benign	O	7386
breast	O	7386
,	O	7386
invasive	B-Disease	7386
lobular	I-Disease	7386
cancers	I-Disease	7386
and	O	7386
low	B-Disease	7386
-	I-Disease	7386
grade	I-Disease	7386
ductal	I-Disease	7386
carcinomas	I-Disease	7386
.	O	7386

Conversely	O	7387
,	O	7387
BRCA1	O	7387
expression	O	7387
was	O	7387
reduced	O	7387
or	O	7387
undetectable	O	7387
in	O	7387
the	O	7387
majority	O	7387
of	O	7387
high	O	7387
-	O	7387
grade	O	7387
,	O	7387
ductal	B-Disease	7387
carcinomas	I-Disease	7387
,	O	7387
suggesting	O	7387
that	O	7387
absence	O	7387
of	O	7387
BRCA1	O	7387
may	O	7387
contribute	O	7387
to	O	7387
the	O	7387
pathogenesis	O	7387
of	O	7387
a	O	7387
significant	O	7387
percentage	O	7387
of	O	7387
sporadic	B-Disease	7387
breast	I-Disease	7387
cancers	I-Disease	7387
.	O	7387

Germline	O	7389
mutations	O	7389
in	O	7389
BRCA1	O	7389
are	O	7389
responsible	O	7389
for	O	7389
most	O	7389
cases	O	7389
of	O	7389
inherited	B-Disease	7389
breast	I-Disease	7389
and	I-Disease	7389
ovarian	I-Disease	7389
cancer	I-Disease	7389
.	O	7389

As	O	7394
a	O	7394
regulated	O	7394
secretory	O	7394
protein	O	7394
,	O	7394
BRCA1	O	7394
appears	O	7394
to	O	7394
function	O	7394
by	O	7394
a	O	7394
mechanism	O	7394
not	O	7394
previously	O	7394
described	O	7394
for	O	7394
tumour	B-Disease	7394
suppressor	O	7394
gene	O	7394
products	O	7394
.	O	7394

Ovarian	B-Disease	7396
cancer	I-Disease	7396
risk	O	7396
in	O	7396
BRCA1	O	7396
carriers	O	7396
is	O	7396
modified	O	7396
by	O	7396
the	O	7396
HRAS1	O	7396
variable	O	7396
number	O	7396
of	O	7396
tandem	O	7396
repeat	O	7396
(	O	7396
VNTR	O	7396
)	O	7396
locus	O	7396
.	O	7396

Women	O	7397
who	O	7397
carry	O	7397
a	O	7397
mutation	O	7397
in	O	7397
the	O	7397
BRCA1	O	7397
gene	O	7397
(	O	7397
on	O	7397
chromosome	O	7397
17q21	O	7397
)	O	7397
,	O	7397
have	O	7397
an	O	7397
80	O	7397
%	O	7397
risk	O	7397
of	O	7397
breast	B-Disease	7397
cancer	I-Disease	7397
and	O	7397
a	O	7397
40	O	7397
%	O	7397
risk	O	7397
of	O	7397
ovarian	B-Disease	7397
cancer	I-Disease	7397
by	O	7397
the	O	7397
age	O	7397
of	O	7397
70	O	7397
(	O	7397
ref	O	7397
.	O	7397

5	O	7401
)	O	7401
is	O	7401
one	O	7401
possible	O	7401
genetic	O	7401
modifier	O	7401
of	O	7401
cancer	B-Disease	7401
penetrance	O	7401
.	O	7401

Individuals	O	7402
who	O	7402
have	O	7402
rare	O	7402
alleles	O	7402
of	O	7402
the	O	7402
VNTR	O	7402
have	O	7402
an	O	7402
increased	O	7402
risk	O	7402
of	O	7402
certain	O	7402
types	O	7402
of	O	7402
cancers	B-Disease	7402
,	O	7402
including	O	7402
breast	B-Disease	7402
cancer	I-Disease	7402
(	O	7402
2	O	7402
-	O	7402
4	O	7402
)	O	7402
.	O	7402

To	O	7403
investigate	O	7403
whether	O	7403
the	O	7403
presence	O	7403
of	O	7403
rare	O	7403
HRAS1	O	7403
alleles	O	7403
increases	O	7403
susceptibility	O	7403
to	O	7403
hereditary	B-Disease	7403
breast	I-Disease	7403
and	I-Disease	7403
ovarian	I-Disease	7403
cancer	I-Disease	7403
,	O	7403
we	O	7403
have	O	7403
typed	O	7403
a	O	7403
panel	O	7403
of	O	7403
307	O	7403
female	O	7403
BRCA1	O	7403
carriers	O	7403
at	O	7403
this	O	7403
locus	O	7403
using	O	7403
a	O	7403
PCR	O	7403
-	O	7403
based	O	7403
technique	O	7403
.	O	7403

The	O	7404
risk	O	7404
for	O	7404
ovarian	B-Disease	7404
cancer	I-Disease	7404
was	O	7404
2	O	7404
.	O	7404

The	O	7407
magnitude	O	7407
of	O	7407
the	O	7407
relative	O	7407
risk	O	7407
associated	O	7407
with	O	7407
a	O	7407
rare	O	7407
HRAS1	O	7407
allele	O	7407
was	O	7407
not	O	7407
altered	O	7407
by	O	7407
adjusting	O	7407
for	O	7407
the	O	7407
other	O	7407
known	O	7407
risk	O	7407
factors	O	7407
for	O	7407
hereditary	B-Disease	7407
ovarian	I-Disease	7407
cancer	I-Disease	7407
(	O	7407
5	O	7407
)	O	7407
.	O	7407

Susceptibility	O	7408
to	O	7408
breast	B-Disease	7408
cancer	I-Disease	7408
did	O	7408
not	O	7408
appear	O	7408
to	O	7408
be	O	7408
affected	O	7408
by	O	7408
the	O	7408
presence	O	7408
of	O	7408
rare	O	7408
HRAS1	O	7408
alleles	O	7408
.	O	7408

This	O	7409
study	O	7409
is	O	7409
the	O	7409
first	O	7409
to	O	7409
show	O	7409
the	O	7409
effect	O	7409
of	O	7409
a	O	7409
modifying	O	7409
gene	O	7409
on	O	7409
the	O	7409
penetrance	O	7409
of	O	7409
an	O	7409
inherited	B-Disease	7409
cancer	I-Disease	7409
syndrome	I-Disease	7409
A	O	7409
novel	O	7409
homeodomain	O	7409
-	O	7409
encoding	O	7409
gene	O	7409
is	O	7409
associated	O	7409
with	O	7409
a	O	7409
large	O	7409
CpG	O	7409
island	O	7409
interrupted	O	7409
by	O	7409
the	O	7409
myotonic	B-Disease	7409
dystrophy	I-Disease	7409
unstable	O	7409
(	O	7409
CTG	O	7409
)	O	7409
n	O	7409
repeat	O	7409
.	O	7409

Myotonic	B-Disease	7410
dystrophy	I-Disease	7410
(	O	7410
DM	B-Disease	7410
)	O	7410
is	O	7410
associated	O	7410
with	O	7410
a	O	7410
(	O	7410
CTG	O	7410
)	O	7410
n	O	7410
trinucleotide	O	7410
repeat	O	7410
expansion	O	7410
in	O	7410
the	O	7410
3	O	7410
-	O	7410
untranslated	O	7410
region	O	7410
of	O	7410
a	O	7410
protein	O	7410
kinase	O	7410
-	O	7410
encoding	O	7410
gene	O	7410
,	O	7410
DMPK	O	7410
,	O	7410
which	O	7410
maps	O	7410
to	O	7410
chromosome	O	7410
19q13	O	7410
.	O	7410

The	O	7413
DM	B-Disease	7413
region	O	7413
of	O	7413
chromosome	O	7413
19	O	7413
is	O	7413
gene	O	7413
rich	O	7413
,	O	7413
and	O	7413
it	O	7413
is	O	7413
possible	O	7413
that	O	7413
the	O	7413
repeat	O	7413
expansion	O	7413
may	O	7413
lead	O	7413
to	O	7413
dysfunction	O	7413
of	O	7413
a	O	7413
number	O	7413
of	O	7413
transcription	O	7413
units	O	7413
in	O	7413
the	O	7413
vicinity	O	7413
,	O	7413
perhaps	O	7413
as	O	7413
a	O	7413
consequence	O	7413
of	O	7413
chromatin	O	7413
disruption	O	7413
.	O	7413

RT	O	7419
-	O	7419
PCR	O	7419
analysis	O	7419
shows	O	7419
that	O	7419
this	O	7419
gene	O	7419
,	O	7419
which	O	7419
we	O	7419
have	O	7419
called	O	7419
DM	B-Disease	7419
locus	O	7419
-	O	7419
associated	O	7419
homeodomain	O	7419
protein	O	7419
(	O	7419
DMAHP	O	7419
)	O	7419
,	O	7419
is	O	7419
expressed	O	7419
in	O	7419
a	O	7419
number	O	7419
of	O	7419
human	O	7419
tissues	O	7419
,	O	7419
including	O	7419
skeletal	O	7419
muscle	O	7419
,	O	7419
heart	O	7419
and	O	7419
brain	O	7419
.	O	7419

Germline	O	7420
mutations	O	7420
in	O	7420
the	O	7420
RB1	O	7420
gene	O	7420
in	O	7420
patients	O	7420
with	O	7420
hereditary	B-Disease	7420
retinoblastoma	I-Disease	7420
.	O	7420

We	O	7421
have	O	7421
analyzed	O	7421
the	O	7421
27	O	7421
exons	O	7421
and	O	7421
the	O	7421
promoter	O	7421
region	O	7421
of	O	7421
the	O	7421
RB1	O	7421
gene	O	7421
in	O	7421
familial	B-Disease	7421
or	I-Disease	7421
sporadic	I-Disease	7421
bilateral	I-Disease	7421
retinoblastoma	I-Disease	7421
by	O	7421
using	O	7421
single	O	7421
-	O	7421
strand	O	7421
conformation	O	7421
polymorphism	O	7421
analysis	O	7421
.	O	7421

Type	B-Disease	7427
II	I-Disease	7427
human	I-Disease	7427
complement	I-Disease	7427
C2	I-Disease	7427
deficiency	I-Disease	7427
.	O	7427

Type	B-Disease	7429
II	I-Disease	7429
complement	I-Disease	7429
protein	I-Disease	7429
C2	I-Disease	7429
deficiency	I-Disease	7429
is	O	7429
characterized	O	7429
by	O	7429
a	O	7429
selective	O	7429
block	O	7429
in	O	7429
C2	O	7429
secretion	O	7429
.	O	7429

The	O	7430
Type	O	7430
II	O	7430
C2	O	7430
nan	O	7430
allele	O	7430
(	O	7430
C2Q0	O	7430
)	O	7430
is	O	7430
linked	O	7430
to	O	7430
two	O	7430
major	O	7430
histocompatibility	O	7430
haplotypes	O	7430
(	O	7430
MHC	O	7430
)	O	7430
that	O	7430
differ	O	7430
from	O	7430
the	O	7430
MHC	O	7430
of	O	7430
the	O	7430
more	O	7430
common	O	7430
Type	B-Disease	7430
I	I-Disease	7430
C2	I-Disease	7430
deficiency	I-Disease	7430
.	O	7430

To	O	7431
determine	O	7431
the	O	7431
molecular	O	7431
basis	O	7431
of	O	7431
Type	B-Disease	7431
II	I-Disease	7431
deficiency	I-Disease	7431
the	O	7431
two	O	7431
Type	O	7431
II	O	7431
C2Q0	O	7431
genes	O	7431
were	O	7431
isolated	O	7431
and	O	7431
transfected	O	7431
separately	O	7431
into	O	7431
L	O	7431
-	O	7431
cells	O	7431
.	O	7431

Subsequent	O	7432
molecular	O	7432
biology	O	7432
,	O	7432
biosynthetic	O	7432
,	O	7432
and	O	7432
immunofluorescence	O	7432
studies	O	7432
demonstrated	O	7432
that	O	7432
C2	O	7432
secretion	O	7432
is	O	7432
impaired	O	7432
in	O	7432
Type	B-Disease	7432
II	I-Disease	7432
C2	I-Disease	7432
deficiency	I-Disease	7432
because	O	7432
of	O	7432
different	O	7432
missense	O	7432
mutations	O	7432
at	O	7432
highly	O	7432
conserved	O	7432
residues	O	7432
in	O	7432
each	O	7432
of	O	7432
the	O	7432
C2Q0	O	7432
alleles	O	7432
.	O	7432

Defective	O	7438
dimerization	O	7438
of	O	7438
von	B-Disease	7438
Willebrand	I-Disease	7438
factor	O	7438
subunits	O	7438
due	O	7438
to	O	7438
a	O	7438
Cys	O	7438
-	O	7438
>	O	7438
Arg	O	7438
mutation	O	7438
in	O	7438
type	B-Disease	7438
IID	I-Disease	7438
von	I-Disease	7438
Willebrand	I-Disease	7438
disease	I-Disease	7438
.	O	7438

The	O	7439
same	O	7439
heterozygous	O	7439
T	O	7439
-	O	7439
>	O	7439
C	O	7439
transition	O	7439
at	O	7439
nt	O	7439
8567	O	7439
of	O	7439
the	O	7439
von	B-Disease	7439
Willebrand	I-Disease	7439
factor	O	7439
(	O	7439
vWF	O	7439
)	O	7439
transcript	O	7439
was	O	7439
found	O	7439
in	O	7439
two	O	7439
unrelated	O	7439
patients	O	7439
with	O	7439
type	B-Disease	7439
IID	I-Disease	7439
von	I-Disease	7439
Willebrand	I-Disease	7439
disease	I-Disease	7439
,	O	7439
with	O	7439
no	O	7439
other	O	7439
apparent	O	7439
abnormality	O	7439
.	O	7439

We	O	7445
conclude	O	7445
that	O	7445
CyS2010	O	7445
is	O	7445
essential	O	7445
for	O	7445
normal	O	7445
dimerization	O	7445
of	O	7445
vWF	O	7445
subunits	O	7445
through	O	7445
disulfide	O	7445
bonding	O	7445
of	O	7445
carboxyl	O	7445
-	O	7445
terminal	O	7445
domains	O	7445
and	O	7445
that	O	7445
a	O	7445
heterozygous	O	7445
mutation	O	7445
in	O	7445
the	O	7445
corresponding	O	7445
codon	O	7445
is	O	7445
responsible	O	7445
for	O	7445
defective	O	7445
multimer	O	7445
formation	O	7445
in	O	7445
type	B-Disease	7445
IID	I-Disease	7445
von	I-Disease	7445
Willebrand	I-Disease	7445
disease	I-Disease	7445
.	O	7445

Wiskott	B-Disease	7447
-	I-Disease	7447
Aldrich	I-Disease	7447
syndrome	I-Disease	7447
protein	O	7447
,	O	7447
a	O	7447
novel	O	7447
effector	O	7447
for	O	7447
the	O	7447
GTPase	O	7447
CDC42Hs	O	7447
,	O	7447
is	O	7447
implicated	O	7447
in	O	7447
actin	O	7447
polymerization	O	7447
.	O	7447

We	O	7449
have	O	7449
identified	O	7449
WASP	O	7449
,	O	7449
the	O	7449
protein	O	7449
that	O	7449
is	O	7449
defective	O	7449
in	O	7449
Wiskott	B-Disease	7449
-	I-Disease	7449
Aldrich	I-Disease	7449
syndrome	I-Disease	7449
(	O	7449
WAS	B-Disease	7449
)	O	7449
,	O	7449
as	O	7449
a	O	7449
novel	O	7449
effector	O	7449
for	O	7449
CDC42Hs	O	7449
,	O	7449
but	O	7449
not	O	7449
for	O	7449
the	O	7449
other	O	7449
Rho	O	7449
family	O	7449
members	O	7449
,	O	7449
Rac	O	7449
and	O	7449
Rho	O	7449
.	O	7449

Thus	O	7453
,	O	7453
WASP	O	7453
provides	O	7453
a	O	7453
novel	O	7453
link	O	7453
between	O	7453
CDC42Hs	O	7453
and	O	7453
the	O	7453
actin	O	7453
cytoskeleton	O	7453
,	O	7453
which	O	7453
suggests	O	7453
a	O	7453
molecular	O	7453
mechanism	O	7453
for	O	7453
many	O	7453
of	O	7453
the	O	7453
cellular	O	7453
abnormalities	O	7453
in	O	7453
WAS	B-Disease	7453
.	O	7453

X	B-Disease	7456
-	I-Disease	7456
linked	I-Disease	7456
adrenoleukodystrophy	I-Disease	7456
is	O	7456
a	O	7456
frequent	O	7456
cause	O	7456
of	O	7456
idiopathic	O	7456
Addison	B-Disease	7456
'	I-Disease	7456
s	I-Disease	7456
disease	I-Disease	7456
in	O	7456
young	O	7456
adult	O	7456
male	O	7456
patients	O	7456
.	O	7456

X	B-Disease	7457
-	I-Disease	7457
Linked	I-Disease	7457
adrenoleukodystrophy	I-Disease	7457
(	O	7457
ALD	B-Disease	7457
)	O	7457
is	O	7457
a	O	7457
genetic	B-Disease	7457
disease	I-Disease	7457
associated	O	7457
with	O	7457
demyelination	B-Disease	7457
of	I-Disease	7457
the	I-Disease	7457
central	I-Disease	7457
nervous	I-Disease	7457
system	I-Disease	7457
,	O	7457
adrenal	B-Disease	7457
insufficiency	I-Disease	7457
,	O	7457
and	O	7457
accumulation	O	7457
of	O	7457
very	O	7457
long	O	7457
chain	O	7457
fatty	O	7457
acids	O	7457
in	O	7457
tissue	O	7457
and	O	7457
body	O	7457
fluids	O	7457
.	O	7457

ALD	B-Disease	7458
is	O	7458
due	O	7458
to	O	7458
mutation	O	7458
of	O	7458
a	O	7458
gene	O	7458
located	O	7458
in	O	7458
Xq28	O	7458
that	O	7458
encodes	O	7458
a	O	7458
peroxisomal	O	7458
transporter	O	7458
protein	O	7458
of	O	7458
unknown	O	7458
function	O	7458
.	O	7458

The	O	7459
most	O	7459
common	O	7459
phenotype	O	7459
of	O	7459
ALD	B-Disease	7459
is	O	7459
the	O	7459
cerebral	O	7459
form	O	7459
(	O	7459
45	O	7459
%	O	7459
)	O	7459
that	O	7459
develops	O	7459
in	O	7459
boys	O	7459
between	O	7459
5	O	7459
-	O	7459
12	O	7459
yr	O	7459
.	O	7459

Adrenomyeloneuropathy	B-Disease	7460
(	O	7460
AMN	B-Disease	7460
)	O	7460
involves	O	7460
the	O	7460
spinal	O	7460
cord	O	7460
and	O	7460
peripheral	O	7460
nerves	O	7460
in	O	7460
young	O	7460
adults	O	7460
(	O	7460
35	O	7460
%	O	7460
)	O	7460
.	O	7460

Adrenal	B-Disease	7461
insufficiency	I-Disease	7461
(	O	7461
Addisons	B-Disease	7461
disease	I-Disease	7461
)	O	7461
is	O	7461
frequently	O	7461
associated	O	7461
with	O	7461
AMN	B-Disease	7461
or	O	7461
cerebral	B-Disease	7461
ALD	I-Disease	7461
and	O	7461
may	O	7461
remain	O	7461
the	O	7461
only	O	7461
clinical	O	7461
expression	O	7461
of	O	7461
ALD	B-Disease	7461
(	O	7461
8	O	7461
%	O	7461
of	O	7461
cases	O	7461
)	O	7461
.	O	7461

The	O	7462
prevalence	O	7462
of	O	7462
ALD	B-Disease	7462
among	O	7462
adults	O	7462
with	O	7462
Addisons	B-Disease	7462
disease	I-Disease	7462
remains	O	7462
unknown	O	7462
.	O	7462

To	O	7463
evaluate	O	7463
this	O	7463
prevalence	O	7463
,	O	7463
we	O	7463
performed	O	7463
biochemical	O	7463
analysis	O	7463
of	O	7463
very	O	7463
long	O	7463
chain	O	7463
fatty	O	7463
acids	O	7463
in	O	7463
14	O	7463
male	O	7463
patients	O	7463
(	O	7463
age	O	7463
ranging	O	7463
from	O	7463
12	O	7463
-	O	7463
45	O	7463
yr	O	7463
at	O	7463
diagnosis	O	7463
)	O	7463
previously	O	7463
diagnosed	O	7463
as	O	7463
having	O	7463
primary	O	7463
idiopathic	O	7463
adrenocortical	B-Disease	7463
insufficiency	I-Disease	7463
.	O	7463

By	O	7466
electrophysiological	O	7466
tests	O	7466
and	O	7466
magnetic	O	7466
resonance	O	7466
imaging	O	7466
it	O	7466
was	O	7466
determined	O	7466
that	O	7466
two	O	7466
patients	O	7466
had	O	7466
cerebral	B-Disease	7466
ALD	I-Disease	7466
,	O	7466
one	O	7466
had	O	7466
adrenomyeloneuropathy	B-Disease	7466
with	O	7466
cerebral	O	7466
involvement	O	7466
,	O	7466
and	O	7466
two	O	7466
had	O	7466
preclinical	O	7466
AMN	B-Disease	7466
.	O	7466

Our	O	7467
data	O	7467
support	O	7467
the	O	7467
hypothesis	O	7467
that	O	7467
ALD	B-Disease	7467
is	O	7467
a	O	7467
frequent	O	7467
cause	O	7467
of	O	7467
idiopathic	O	7467
Addisons	B-Disease	7467
disease	I-Disease	7467
in	O	7467
children	O	7467
and	O	7467
adults	O	7467
.	O	7467

Tumor	B-Disease	7469
suppression	O	7469
and	O	7469
apoptosis	O	7469
of	O	7469
human	O	7469
prostate	B-Disease	7469
carcinoma	I-Disease	7469
mediated	O	7469
by	O	7469
a	O	7469
genetic	O	7469
locus	O	7469
within	O	7469
human	O	7469
chromosome	O	7469
10pter	O	7469
-	O	7469
q11	O	7469
.	O	7469

Prostate	B-Disease	7470
cancer	I-Disease	7470
is	O	7470
the	O	7470
second	O	7470
leading	O	7470
cause	O	7470
of	O	7470
male	O	7470
cancer	B-Disease	7470
deaths	O	7470
in	O	7470
the	O	7470
United	O	7470
States	O	7470
.	O	7470

Prostate	O	7472
secretory	O	7472
epithelial	O	7472
cells	O	7472
and	O	7472
androgen	O	7472
-	O	7472
dependent	O	7472
prostate	B-Disease	7472
carcinomas	I-Disease	7472
undergo	O	7472
apoptosis	O	7472
in	O	7472
response	O	7472
to	O	7472
androgen	O	7472
deprivation	O	7472
and	O	7472
,	O	7472
furthermore	O	7472
,	O	7472
most	O	7472
prostate	B-Disease	7472
carcinomas	I-Disease	7472
become	O	7472
androgen	O	7472
independent	O	7472
and	O	7472
refractory	O	7472
to	O	7472
further	O	7472
therapeutic	O	7472
manipulations	O	7472
during	O	7472
disease	O	7472
progression	O	7472
.	O	7472

We	O	7474
report	O	7474
the	O	7474
functional	O	7474
definition	O	7474
of	O	7474
a	O	7474
novel	O	7474
genetic	O	7474
locus	O	7474
within	O	7474
human	O	7474
chromosome	O	7474
10pter	O	7474
-	O	7474
q11	O	7474
that	O	7474
mediates	O	7474
both	O	7474
in	O	7474
vivo	O	7474
tumor	O	7474
suppression	O	7474
and	O	7474
in	O	7474
vitro	O	7474
apoptosis	O	7474
of	O	7474
prostatic	B-Disease	7474
adenocarcinoma	I-Disease	7474
cells	O	7474
.	O	7474

A	O	7475
defined	O	7475
fragment	O	7475
of	O	7475
human	O	7475
chromosome	O	7475
10	O	7475
was	O	7475
transferred	O	7475
via	O	7475
microcell	O	7475
fusion	O	7475
into	O	7475
a	O	7475
prostate	B-Disease	7475
adenocarcinoma	I-Disease	7475
cell	O	7475
line	O	7475
.	O	7475

These	O	7478
data	O	7478
functionally	O	7478
define	O	7478
a	O	7478
novel	O	7478
genetic	O	7478
locus	O	7478
,	O	7478
designated	O	7478
PAC1	O	7478
,	O	7478
for	O	7478
prostate	O	7478
adenocarcinoma	O	7478
1	O	7478
,	O	7478
involved	O	7478
in	O	7478
tumor	O	7478
suppression	O	7478
of	O	7478
human	O	7478
prostate	B-Disease	7478
carcinoma	I-Disease	7478
and	O	7478
furthermore	O	7478
strongly	O	7478
suggest	O	7478
that	O	7478
the	O	7478
cell	O	7478
death	O	7478
pathway	O	7478
can	O	7478
be	O	7478
functionally	O	7478
restored	O	7478
in	O	7478
prostatic	B-Disease	7478
adenocarcinoma	I-Disease	7478
.	O	7478

Low	O	7480
incidence	O	7480
of	O	7480
BRCA2	O	7480
mutations	O	7480
in	O	7480
breast	B-Disease	7480
carcinoma	I-Disease	7480
and	O	7480
other	O	7480
cancers	B-Disease	7480
.	O	7480

Inherited	O	7481
mutant	O	7481
alleles	O	7481
of	O	7481
familial	O	7481
tumour	B-Disease	7481
suppressor	O	7481
genes	O	7481
predispose	O	7481
individuals	O	7481
to	O	7481
particular	O	7481
types	O	7481
of	O	7481
cancer	B-Disease	7481
.	O	7481

In	O	7482
addition	O	7482
to	O	7482
an	O	7482
involvement	O	7482
in	O	7482
inherited	O	7482
susceptibility	O	7482
to	O	7482
cancer	B-Disease	7482
,	O	7482
these	O	7482
tumour	B-Disease	7482
suppressor	O	7482
genes	O	7482
are	O	7482
targets	O	7482
for	O	7482
somatic	O	7482
mutations	O	7482
in	O	7482
sporadic	B-Disease	7482
cancers	I-Disease	7482
of	O	7482
the	O	7482
same	O	7482
type	O	7482
found	O	7482
in	O	7482
the	O	7482
familial	O	7482
forms	O	7482
.	O	7482

An	O	7483
exception	O	7483
is	O	7483
BRCA1	O	7483
,	O	7483
which	O	7483
contributes	O	7483
to	O	7483
a	O	7483
significant	O	7483
fraction	O	7483
of	O	7483
familial	B-Disease	7483
breast	I-Disease	7483
and	I-Disease	7483
ovarian	I-Disease	7483
cancer	I-Disease	7483
,	O	7483
but	O	7483
undergoes	O	7483
mutation	O	7483
at	O	7483
very	O	7483
low	O	7483
rates	O	7483
in	O	7483
sporadic	B-Disease	7483
breast	I-Disease	7483
and	I-Disease	7483
ovarian	I-Disease	7483
cancers	I-Disease	7483
.	O	7483

This	O	7484
finding	O	7484
suggests	O	7484
that	O	7484
other	O	7484
genes	O	7484
may	O	7484
be	O	7484
the	O	7484
principal	O	7484
targets	O	7484
for	O	7484
somatic	O	7484
mutation	O	7484
in	O	7484
breast	B-Disease	7484
carcinoma	I-Disease	7484
.	O	7484

A	O	7485
second	O	7485
,	O	7485
recently	O	7485
identified	O	7485
familial	B-Disease	7485
breast	I-Disease	7485
cancer	I-Disease	7485
gene	O	7485
,	O	7485
BRCA2	O	7485
(	O	7485
refs	O	7485
5	O	7485
-	O	7485
8	O	7485
)	O	7485
,	O	7485
accounts	O	7485
for	O	7485
a	O	7485
proportion	O	7485
of	O	7485
breast	B-Disease	7485
cancer	I-Disease	7485
roughly	O	7485
equal	O	7485
to	O	7485
BRCA1	O	7485
.	O	7485

Like	O	7486
BRCA1	O	7486
,	O	7486
BRCA2	O	7486
behaves	O	7486
as	O	7486
a	O	7486
dominantly	O	7486
inherited	O	7486
tumour	B-Disease	7486
suppressor	O	7486
gene	O	7486
.	O	7486

Individuals	O	7487
who	O	7487
inherit	O	7487
one	O	7487
mutant	O	7487
allele	O	7487
are	O	7487
at	O	7487
increased	O	7487
risk	O	7487
for	O	7487
breast	B-Disease	7487
cancer	I-Disease	7487
,	O	7487
and	O	7487
the	O	7487
tumours	B-Disease	7487
they	O	7487
develop	O	7487
lose	O	7487
the	O	7487
wild	O	7487
-	O	7487
type	O	7487
allele	O	7487
by	O	7487
heterozygous	O	7487
deletion	O	7487
.	O	7487

Here	O	7489
we	O	7489
investigate	O	7489
the	O	7489
rate	O	7489
of	O	7489
BRCA2	O	7489
mutation	O	7489
in	O	7489
sporadic	B-Disease	7489
breast	I-Disease	7489
cancers	I-Disease	7489
and	O	7489
in	O	7489
a	O	7489
set	O	7489
of	O	7489
cell	O	7489
lines	O	7489
that	O	7489
represent	O	7489
twelve	O	7489
other	O	7489
tumour	B-Disease	7489
types	O	7489
.	O	7489

Surprisingly	O	7490
,	O	7490
mutations	O	7490
in	O	7490
BRCA2	O	7490
are	O	7490
infrequent	O	7490
in	O	7490
cancers	B-Disease	7490
including	O	7490
breast	B-Disease	7490
carcinoma	I-Disease	7490
.	O	7490

However	O	7491
,	O	7491
a	O	7491
probable	O	7491
germline	O	7491
mutation	O	7491
in	O	7491
a	O	7491
pancreatic	B-Disease	7491
tumour	I-Disease	7491
cell	O	7491
line	O	7491
suggests	O	7491
a	O	7491
role	O	7491
for	O	7491
BRCA2	O	7491
in	O	7491
susceptibility	O	7491
to	O	7491
pancreatic	B-Disease	7491
cancer	I-Disease	7491
.	O	7491

Founding	O	7493
BRCA1	O	7493
mutations	O	7493
in	O	7493
hereditary	B-Disease	7493
breast	I-Disease	7493
and	I-Disease	7493
ovarian	I-Disease	7493
cancer	I-Disease	7493
in	O	7493
southern	O	7493
Sweden	O	7493
.	O	7493

Nine	O	7494
different	O	7494
germ	O	7494
-	O	7494
line	O	7494
mutations	O	7494
in	O	7494
the	O	7494
BRCA1	O	7494
breast	B-Disease	7494
and	I-Disease	7494
ovarian	I-Disease	7494
cancer	I-Disease	7494
susceptibility	O	7494
gene	O	7494
were	O	7494
identified	O	7494
in	O	7494
15	O	7494
of	O	7494
47	O	7494
kindreds	O	7494
from	O	7494
southern	O	7494
Sweden	O	7494
,	O	7494
by	O	7494
use	O	7494
of	O	7494
SSCP	O	7494
and	O	7494
heteroduplex	O	7494
analysis	O	7494
of	O	7494
all	O	7494
exons	O	7494
and	O	7494
flanking	O	7494
intron	O	7494
region	O	7494
and	O	7494
by	O	7494
a	O	7494
protein	O	7494
-	O	7494
truncation	O	7494
test	O	7494
for	O	7494
exon	O	7494
11	O	7494
,	O	7494
followed	O	7494
by	O	7494
direct	O	7494
sequencing	O	7494
.	O	7494

Eleven	O	7499
of	O	7499
the	O	7499
15	O	7499
kindreds	O	7499
manifesting	O	7499
BRCA1	O	7499
mutations	O	7499
were	O	7499
breast	B-Disease	7499
-	I-Disease	7499
ovarian	I-Disease	7499
cancer	I-Disease	7499
families	O	7499
,	O	7499
several	O	7499
of	O	7499
them	O	7499
with	O	7499
a	O	7499
predominant	O	7499
ovarian	B-Disease	7499
cancer	I-Disease	7499
phenotype	O	7499
.	O	7499

The	O	7500
set	O	7500
of	O	7500
32	O	7500
families	O	7500
in	O	7500
which	O	7500
no	O	7500
BRCA1	O	7500
alterations	O	7500
were	O	7500
detected	O	7500
included	O	7500
1	O	7500
breast	B-Disease	7500
-	I-Disease	7500
ovarian	I-Disease	7500
cancer	I-Disease	7500
kindred	O	7500
manifesting	O	7500
clear	O	7500
linkage	O	7500
to	O	7500
the	O	7500
BRCA1	O	7500
region	O	7500
and	O	7500
loss	O	7500
of	O	7500
the	O	7500
wild	O	7500
-	O	7500
type	O	7500
chromosome	O	7500
in	O	7500
associated	O	7500
tumors	B-Disease	7500
.	O	7500

Other	O	7501
tumor	B-Disease	7501
types	O	7501
found	O	7501
in	O	7501
BRCA1	O	7501
mutation	O	7501
/	O	7501
haplotype	O	7501
carriers	O	7501
included	O	7501
prostatic	B-Disease	7501
,	I-Disease	7501
pancreas	I-Disease	7501
,	I-Disease	7501
skin	I-Disease	7501
,	I-Disease	7501
and	I-Disease	7501
lung	I-Disease	7501
cancer	I-Disease	7501
,	O	7501
a	O	7501
malignant	B-Disease	7501
melanoma	I-Disease	7501
,	O	7501
an	O	7501
oligodendroglioma	B-Disease	7501
,	O	7501
and	O	7501
a	O	7501
carcinosarcoma	B-Disease	7501
.	O	7501

In	O	7502
all	O	7502
,	O	7502
12	O	7502
of	O	7502
16	O	7502
kindreds	O	7502
manifesting	O	7502
BRCA1	O	7502
mutation	O	7502
or	O	7502
linkage	O	7502
contained	O	7502
ovarian	B-Disease	7502
cancer	I-Disease	7502
,	O	7502
as	O	7502
compared	O	7502
with	O	7502
only	O	7502
6	O	7502
of	O	7502
the	O	7502
remaining	O	7502
31	O	7502
families	O	7502
(	O	7502
P	O	7502
<	O	7502
.	O	7502

The	O	7504
present	O	7504
study	O	7504
confirms	O	7504
the	O	7504
involvement	O	7504
of	O	7504
BRCA1	O	7504
in	O	7504
disease	O	7504
predisposition	O	7504
for	O	7504
a	O	7504
subset	O	7504
of	O	7504
hereditary	B-Disease	7504
breast	I-Disease	7504
cancer	I-Disease	7504
families	O	7504
often	O	7504
characterized	O	7504
by	O	7504
ovarian	B-Disease	7504
cancers	I-Disease	7504
.	O	7504

UKCCCR	O	7506
Familial	O	7506
Ovarian	B-Disease	7506
Cancer	I-Disease	7506
Study	O	7506
Group	O	7506
.	O	7506

Germ	O	7507
-	O	7507
line	O	7507
mutations	O	7507
of	O	7507
the	O	7507
BRCA1	O	7507
gene	O	7507
are	O	7507
responsible	O	7507
for	O	7507
a	O	7507
substantial	O	7507
proportion	O	7507
of	O	7507
families	O	7507
with	O	7507
multiple	O	7507
cases	O	7507
of	O	7507
early	O	7507
-	O	7507
onset	O	7507
breast	B-Disease	7507
and	I-Disease	7507
/	I-Disease	7507
or	I-Disease	7507
ovarian	I-Disease	7507
cancer	I-Disease	7507
.	O	7507

We	O	7509
have	O	7509
developed	O	7509
a	O	7509
multiplex	O	7509
heteroduplex	O	7509
analysis	O	7509
that	O	7509
is	O	7509
designed	O	7509
to	O	7509
analyze	O	7509
one	O	7509
-	O	7509
quarter	O	7509
of	O	7509
the	O	7509
coding	O	7509
sequence	O	7509
in	O	7509
a	O	7509
single	O	7509
-	O	7509
step	O	7509
screening	O	7509
procedure	O	7509
and	O	7509
that	O	7509
will	O	7509
detect	O	7509
approximately	O	7509
50	O	7509
%	O	7509
of	O	7509
all	O	7509
BRCA1	O	7509
mutations	O	7509
so	O	7509
far	O	7509
reported	O	7509
in	O	7509
breast	B-Disease	7509
/	I-Disease	7509
ovarian	I-Disease	7509
cancer	I-Disease	7509
families	O	7509
.	O	7509

We	O	7510
have	O	7510
used	O	7510
this	O	7510
technique	O	7510
to	O	7510
analyze	O	7510
BRCA1	O	7510
in	O	7510
162	O	7510
families	O	7510
with	O	7510
a	O	7510
history	O	7510
of	O	7510
breast	B-Disease	7510
and	I-Disease	7510
/	I-Disease	7510
or	I-Disease	7510
ovarian	I-Disease	7510
cancer	I-Disease	7510
and	O	7510
identified	O	7510
12	O	7510
distinct	O	7510
mutations	O	7510
in	O	7510
35	O	7510
families	O	7510
.	O	7510

A	O	7512
previously	O	7512
undescribed	O	7512
mutation	O	7512
within	O	7512
the	O	7512
tetramerisation	O	7512
domain	O	7512
of	O	7512
TP53	O	7512
in	O	7512
a	O	7512
family	O	7512
with	O	7512
Li	B-Disease	7512
-	I-Disease	7512
Fraumeni	I-Disease	7512
syndrome	I-Disease	7512
.	O	7512

We	O	7513
report	O	7513
details	O	7513
of	O	7513
a	O	7513
family	O	7513
with	O	7513
classic	O	7513
Li	B-Disease	7513
-	I-Disease	7513
Fraumeni	I-Disease	7513
syndrome	I-Disease	7513
in	O	7513
which	O	7513
there	O	7513
is	O	7513
a	O	7513
mutation	O	7513
in	O	7513
codon	O	7513
344	O	7513
of	O	7513
the	O	7513
tumour	B-Disease	7513
suppressor	O	7513
gene	O	7513
TP53	O	7513
.	O	7513

This	O	7515
is	O	7515
the	O	7515
first	O	7515
report	O	7515
of	O	7515
a	O	7515
mutation	O	7515
at	O	7515
this	O	7515
residue	O	7515
in	O	7515
either	O	7515
sporadic	B-Disease	7515
tumours	I-Disease	7515
or	O	7515
in	O	7515
the	O	7515
germline	O	7515
and	O	7515
the	O	7515
first	O	7515
report	O	7515
of	O	7515
a	O	7515
germline	O	7515
mutation	O	7515
within	O	7515
the	O	7515
tetramerisation	O	7515
domain	O	7515
.	O	7515

The	O	7516
family	O	7516
does	O	7516
not	O	7516
appear	O	7516
to	O	7516
be	O	7516
remarkable	O	7516
in	O	7516
the	O	7516
spectrum	O	7516
of	O	7516
tumours	B-Disease	7516
,	O	7516
and	O	7516
there	O	7516
is	O	7516
loss	O	7516
of	O	7516
the	O	7516
wild	O	7516
-	O	7516
type	O	7516
allele	O	7516
in	O	7516
a	O	7516
leiomyosarcoma	B-Disease	7516
from	O	7516
the	O	7516
proband	O	7516
.	O	7516

A	O	7517
cell	O	7517
line	O	7517
has	O	7517
been	O	7517
established	O	7517
from	O	7517
the	O	7517
tumour	B-Disease	7517
of	O	7517
the	O	7517
proband	O	7517
and	O	7517
cytogenetic	O	7517
and	O	7517
molecular	O	7517
studies	O	7517
carried	O	7517
out	O	7517
,	O	7517
providing	O	7517
an	O	7517
extensive	O	7517
analysis	O	7517
in	O	7517
this	O	7517
family	O	7517
.	O	7517

The	O	7519
spectrum	O	7519
of	O	7519
RB1	O	7519
germ	O	7519
-	O	7519
line	O	7519
mutations	O	7519
in	O	7519
hereditary	B-Disease	7519
retinoblastoma	I-Disease	7519
.	O	7519

We	O	7520
have	O	7520
searched	O	7520
for	O	7520
germ	O	7520
-	O	7520
line	O	7520
RB1	O	7520
mutations	O	7520
in	O	7520
119	O	7520
patients	O	7520
with	O	7520
hereditary	B-Disease	7520
retinoblastoma	I-Disease	7520
.	O	7520

No	O	7531
correlation	O	7531
between	O	7531
the	O	7531
location	O	7531
of	O	7531
frameshift	O	7531
or	O	7531
nonsense	O	7531
mutations	O	7531
and	O	7531
phenotypic	O	7531
features	O	7531
,	O	7531
including	O	7531
age	O	7531
at	O	7531
diagnosis	O	7531
,	O	7531
the	O	7531
number	O	7531
of	O	7531
tumor	B-Disease	7531
foci	O	7531
,	O	7531
and	O	7531
manifestation	O	7531
of	O	7531
nonocular	B-Disease	7531
tumors	I-Disease	7531
was	O	7531
observed	O	7531
.	O	7531

Phenotypic	O	7533
characterization	O	7533
of	O	7533
individuals	O	7533
with	O	7533
30	O	7533
-	O	7533
40	O	7533
CAG	O	7533
repeats	O	7533
in	O	7533
the	O	7533
Huntington	B-Disease	7533
disease	I-Disease	7533
(	O	7533
HD	B-Disease	7533
)	O	7533
gene	O	7533
reveals	O	7533
HD	B-Disease	7533
cases	O	7533
with	O	7533
36	O	7533
repeats	O	7533
and	O	7533
apparently	O	7533
normal	O	7533
elderly	O	7533
individuals	O	7533
with	O	7533
36	O	7533
-	O	7533
39	O	7533
repeats	O	7533
.	O	7533

Abnormal	O	7534
CAG	O	7534
expansions	O	7534
in	O	7534
the	O	7534
IT	O	7534
-	O	7534
15	O	7534
gene	O	7534
are	O	7534
associated	O	7534
with	O	7534
Huntington	B-Disease	7534
disease	I-Disease	7534
(	O	7534
HD	B-Disease	7534
)	O	7534
.	O	7534

In	O	7535
the	O	7535
diagnostic	O	7535
setting	O	7535
it	O	7535
is	O	7535
necessary	O	7535
to	O	7535
define	O	7535
the	O	7535
limits	O	7535
of	O	7535
the	O	7535
CAG	O	7535
size	O	7535
ranges	O	7535
on	O	7535
normal	O	7535
and	O	7535
HD	B-Disease	7535
-	O	7535
associated	O	7535
chromosomes	O	7535
.	O	7535

Seven	O	7542
HD	B-Disease	7542
patients	O	7542
had	O	7542
36	O	7542
repeats	O	7542
,	O	7542
which	O	7542
confirms	O	7542
that	O	7542
this	O	7542
allele	O	7542
is	O	7542
associated	O	7542
with	O	7542
disease	O	7542
.	O	7542

Individuals	O	7543
without	O	7543
apparent	O	7543
symptoms	O	7543
or	O	7543
signs	O	7543
of	O	7543
HD	B-Disease	7543
were	O	7543
found	O	7543
at	O	7543
36	O	7543
repeats	O	7543
(	O	7543
aged	O	7543
74	O	7543
,	O	7543
78	O	7543
,	O	7543
79	O	7543
,	O	7543
and	O	7543
87	O	7543
years	O	7543
)	O	7543
,	O	7543
37	O	7543
repeats	O	7543
(	O	7543
aged	O	7543
69	O	7543
years	O	7543
)	O	7543
,	O	7543
38	O	7543
repeats	O	7543
(	O	7543
aged	O	7543
69	O	7543
and	O	7543
90	O	7543
years	O	7543
)	O	7543
,	O	7543
and	O	7543
39	O	7543
repeats	O	7543
(	O	7543
aged	O	7543
67	O	7543
,	O	7543
90	O	7543
,	O	7543
and	O	7543
95	O	7543
years	O	7543
)	O	7543
.	O	7543

The	O	7544
detailed	O	7544
case	O	7544
histories	O	7544
of	O	7544
an	O	7544
exceptional	O	7544
case	O	7544
from	O	7544
this	O	7544
series	O	7544
will	O	7544
be	O	7544
presented	O	7544
a	O	7544
95	O	7544
-	O	7544
year	O	7544
-	O	7544
old	O	7544
man	O	7544
with	O	7544
39	O	7544
repeats	O	7544
who	O	7544
did	O	7544
not	O	7544
have	O	7544
classical	O	7544
features	O	7544
of	O	7544
HD	B-Disease	7544
.	O	7544

The	O	7545
apparently	O	7545
healthy	O	7545
survival	O	7545
into	O	7545
old	O	7545
age	O	7545
of	O	7545
some	O	7545
individuals	O	7545
with	O	7545
36	O	7545
-	O	7545
39	O	7545
repeats	O	7545
suggests	O	7545
that	O	7545
the	O	7545
HD	B-Disease	7545
mutation	O	7545
may	O	7545
not	O	7545
always	O	7545
be	O	7545
fully	O	7545
penetrant	O	7545
.	O	7545

Identification	O	7547
and	O	7547
expression	O	7547
of	O	7547
eight	O	7547
novel	O	7547
mutations	O	7547
among	O	7547
non	O	7547
-	O	7547
Jewish	O	7547
patients	O	7547
with	O	7547
Canavan	B-Disease	7547
disease	I-Disease	7547
.	O	7547

Canavan	B-Disease	7548
disease	I-Disease	7548
is	O	7548
inherited	O	7548
as	O	7548
an	O	7548
autosomal	O	7548
recessive	O	7548
trait	O	7548
that	O	7548
is	O	7548
caused	O	7548
by	O	7548
the	O	7548
deficiency	B-Disease	7548
of	I-Disease	7548
aspartoacylase	I-Disease	7548
(	O	7548
ASPA	O	7548
)	O	7548
.	O	7548

The	O	7549
majority	O	7549
of	O	7549
patients	O	7549
with	O	7549
Canavan	B-Disease	7549
disease	I-Disease	7549
are	O	7549
from	O	7549
an	O	7549
Ashkenazi	O	7549
Jewish	O	7549
background	O	7549
.	O	7549

The	O	7551
current	O	7551
study	O	7551
was	O	7551
aimed	O	7551
at	O	7551
finding	O	7551
the	O	7551
molecular	O	7551
basis	O	7551
of	O	7551
Canavan	B-Disease	7551
disease	I-Disease	7551
in	O	7551
25	O	7551
independent	O	7551
patients	O	7551
of	O	7551
non	O	7551
-	O	7551
Jewish	O	7551
background	O	7551
.	O	7551

The	O	7555
homozygous	O	7555
32	O	7555
deltaT	O	7555
deletion	O	7555
was	O	7555
identified	O	7555
in	O	7555
the	O	7555
only	O	7555
known	O	7555
patient	O	7555
of	O	7555
African	O	7555
-	O	7555
American	O	7555
origin	O	7555
with	O	7555
Canavan	B-Disease	7555
disease	I-Disease	7555
.	O	7555

In	O	7559
vitro	O	7559
expression	O	7559
of	O	7559
mutant	O	7559
cDNA	O	7559
clones	O	7559
demonstrated	O	7559
that	O	7559
all	O	7559
of	O	7559
these	O	7559
mutations	O	7559
led	O	7559
to	O	7559
a	O	7559
deficiency	B-Disease	7559
of	I-Disease	7559
ASPA	I-Disease	7559
and	O	7559
should	O	7559
therefore	O	7559
result	O	7559
in	O	7559
Canavan	B-Disease	7559
disease	I-Disease	7559
.	O	7559

Identification	O	7561
and	O	7561
chromosomal	O	7561
localization	O	7561
of	O	7561
Atm	O	7561
,	O	7561
the	O	7561
mouse	O	7561
homolog	O	7561
of	O	7561
the	O	7561
ataxia	B-Disease	7561
-	I-Disease	7561
telangiectasia	I-Disease	7561
gene	O	7561
.	O	7561

Atm	O	7562
,	O	7562
the	O	7562
mouse	O	7562
homolog	O	7562
of	O	7562
the	O	7562
human	O	7562
ATM	O	7562
gene	O	7562
defective	O	7562
in	O	7562
ataxia	B-Disease	7562
-	I-Disease	7562
telangiectasia	I-Disease	7562
(	O	7562
A	B-Disease	7562
-	I-Disease	7562
T	I-Disease	7562
)	O	7562
,	O	7562
has	O	7562
been	O	7562
identified	O	7562
.	O	7562

The	O	7567
mouse	O	7567
homolog	O	7567
of	O	7567
the	O	7567
Wiskott	B-Disease	7567
-	I-Disease	7567
Aldrich	I-Disease	7567
syndrome	I-Disease	7567
protein	O	7567
(	O	7567
WASP	O	7567
)	O	7567
gene	O	7567
is	O	7567
highly	O	7567
conserved	O	7567
and	O	7567
maps	O	7567
near	O	7567
the	O	7567
scurfy	O	7567
(	O	7567
sf	O	7567
)	O	7567
mutation	O	7567
on	O	7567
the	O	7567
X	O	7567
chromosome	O	7567
.	O	7567

The	O	7568
mouse	O	7568
WASP	O	7568
gene	O	7568
,	O	7568
the	O	7568
homolog	O	7568
of	O	7568
the	O	7568
gene	O	7568
mutated	O	7568
in	O	7568
Wiskott	B-Disease	7568
-	I-Disease	7568
Aldrich	I-Disease	7568
syndrome	I-Disease	7568
,	O	7568
has	O	7568
been	O	7568
isolated	O	7568
and	O	7568
sequenced	O	7568
.	O	7568

This	O	7576
localization	O	7576
makes	O	7576
Wasp	O	7576
a	O	7576
candidate	O	7576
for	O	7576
involvement	O	7576
in	O	7576
scurfy	O	7576
,	O	7576
a	O	7576
T	O	7576
cell	O	7576
-	O	7576
mediated	O	7576
fatal	B-Disease	7576
lymphoreticular	I-Disease	7576
disease	I-Disease	7576
of	O	7576
mice	O	7576
that	O	7576
has	O	7576
previously	O	7576
been	O	7576
proposed	O	7576
as	O	7576
a	O	7576
mouse	O	7576
homolog	O	7576
of	O	7576
Wiskott	B-Disease	7576
-	I-Disease	7576
Aldrich	I-Disease	7576
syndrome	I-Disease	7576
.	O	7576

Colchicine	O	7578
in	O	7578
breast	O	7578
milk	O	7578
of	O	7578
patients	O	7578
with	O	7578
familial	B-Disease	7578
Mediterranean	I-Disease	7578
fever	I-Disease	7578
.	O	7578

To	O	7580
clarify	O	7580
whether	O	7580
colchicine	O	7580
is	O	7580
excreted	O	7580
in	O	7580
breast	O	7580
milk	O	7580
,	O	7580
and	O	7580
to	O	7580
compare	O	7580
its	O	7580
concentrations	O	7580
in	O	7580
the	O	7580
serum	O	7580
and	O	7580
breast	O	7580
milk	O	7580
of	O	7580
lactating	O	7580
women	O	7580
who	O	7580
have	O	7580
familial	B-Disease	7580
Mediterranean	I-Disease	7580
fever	I-Disease	7580
(	O	7580
FMF	B-Disease	7580
)	O	7580
.	O	7580

The	O	7583
study	O	7583
evaluated	O	7583
4	O	7583
patients	O	7583
with	O	7583
FMF	B-Disease	7583
who	O	7583
had	O	7583
been	O	7583
taking	O	7583
colchicine	O	7583
on	O	7583
a	O	7583
long	O	7583
-	O	7583
term	O	7583
basis	O	7583
.	O	7583

Furthermore	O	7592
,	O	7592
based	O	7592
on	O	7592
our	O	7592
clinical	O	7592
experience	O	7592
,	O	7592
nursing	O	7592
appears	O	7592
to	O	7592
be	O	7592
safe	O	7592
for	O	7592
lactating	O	7592
women	O	7592
with	O	7592
FMF	B-Disease	7592
who	O	7592
continue	O	7592
to	O	7592
take	O	7592
colchicine	O	7592
.	O	7592

Abnormal	O	7593
myotonic	B-Disease	7593
dystrophy	I-Disease	7593
protein	O	7593
kinase	O	7593
levels	O	7593
produce	O	7593
only	O	7593
mild	O	7593
myopathy	B-Disease	7593
in	O	7593
mice	O	7593
.	O	7593

Myotonic	B-Disease	7594
dystrophy	I-Disease	7594
(	O	7594
DM	B-Disease	7594
)	O	7594
is	O	7594
commonly	O	7594
associated	O	7594
with	O	7594
CTG	O	7594
repeat	O	7594
expansions	O	7594
within	O	7594
the	O	7594
gene	O	7594
for	O	7594
DM	O	7594
-	O	7594
protein	O	7594
kinase	O	7594
(	O	7594
DMPK	O	7594
)	O	7594
.	O	7594

Nullizygous	O	7596
(	O	7596
-	O	7596
/	O	7596
-	O	7596
)	O	7596
mice	O	7596
showed	O	7596
only	O	7596
inconsistent	O	7596
and	O	7596
minor	O	7596
size	O	7596
changes	O	7596
in	O	7596
head	O	7596
and	O	7596
neck	O	7596
muscle	O	7596
fibres	O	7596
at	O	7596
older	O	7596
age	O	7596
,	O	7596
animals	O	7596
with	O	7596
the	O	7596
highest	O	7596
DMPK	O	7596
transgene	O	7596
expression	O	7596
showed	O	7596
hypertrophic	B-Disease	7596
cardiomyopathy	I-Disease	7596
and	O	7596
enhanced	O	7596
neonatal	O	7596
mortality	O	7596
.	O	7596

However	O	7597
,	O	7597
both	O	7597
models	O	7597
lack	O	7597
other	O	7597
frequent	O	7597
DM	B-Disease	7597
symptoms	O	7597
including	O	7597
the	O	7597
fibre	O	7597
-	O	7597
type	O	7597
dependent	O	7597
atrophy	B-Disease	7597
,	O	7597
myotonia	B-Disease	7597
,	O	7597
cataract	B-Disease	7597
and	O	7597
male	B-Disease	7597
-	I-Disease	7597
infertility	I-Disease	7597
.	O	7597

Mice	O	7600
lacking	O	7600
the	O	7600
myotonic	B-Disease	7600
dystrophy	I-Disease	7600
protein	O	7600
kinase	O	7600
develop	O	7600
a	O	7600
late	O	7600
onset	O	7600
progressive	O	7600
myopathy	B-Disease	7600
.	O	7600

Myotonic	B-Disease	7601
dystrophy	I-Disease	7601
(	O	7601
DM	B-Disease	7601
)	O	7601
is	O	7601
an	O	7601
autosomal	B-Disease	7601
dominant	I-Disease	7601
disorder	I-Disease	7601
resulting	O	7601
from	O	7601
the	O	7601
expansion	O	7601
of	O	7601
a	O	7601
CTG	O	7601
repeat	O	7601
in	O	7601
the	O	7601
3	O	7601
untranslated	O	7601
region	O	7601
of	O	7601
a	O	7601
putative	O	7601
protein	O	7601
kinase	O	7601
(	O	7601
DMPK	O	7601
)	O	7601
.	O	7601

To	O	7602
elucidate	O	7602
the	O	7602
role	O	7602
of	O	7602
DMPK	O	7602
in	O	7602
DM	B-Disease	7602
pathogenesis	O	7602
we	O	7602
have	O	7602
developed	O	7602
Dmpk	B-Disease	7602
deficient	I-Disease	7602
(	O	7602
Dmpk	O	7602
-	O	7602
/	O	7602
-	O	7602
)	O	7602
mice	O	7602
.	O	7602

Dmpk	O	7603
-	O	7603
/	O	7603
-	O	7603
mice	O	7603
develop	O	7603
a	O	7603
late	O	7603
-	O	7603
onset	O	7603
,	O	7603
progressive	B-Disease	7603
skeletal	I-Disease	7603
myopathy	I-Disease	7603
that	O	7603
shares	O	7603
some	O	7603
pathological	O	7603
features	O	7603
with	O	7603
DM	B-Disease	7603
.	O	7603

Muscles	O	7604
from	O	7604
mature	O	7604
mice	O	7604
show	O	7604
variation	O	7604
in	O	7604
fibre	O	7604
size	O	7604
,	O	7604
increased	O	7604
fibre	B-Disease	7604
degeneration	I-Disease	7604
and	O	7604
fibrosis	B-Disease	7604
.	O	7604

Our	O	7606
results	O	7606
indicate	O	7606
that	O	7606
DMPK	O	7606
may	O	7606
be	O	7606
necessary	O	7606
for	O	7606
the	O	7606
maintenance	O	7606
of	O	7606
skeletal	O	7606
muscle	O	7606
structure	O	7606
and	O	7606
function	O	7606
and	O	7606
suggest	O	7606
that	O	7606
a	O	7606
decrease	O	7606
in	O	7606
DMPK	O	7606
levels	O	7606
may	O	7606
contribute	O	7606
to	O	7606
DM	B-Disease	7606
pathology	O	7606
.	O	7606

The	O	7608
tumor	B-Disease	7608
suppressor	O	7608
gene	O	7608
Brca1	O	7608
is	O	7608
required	O	7608
for	O	7608
embryonic	O	7608
cellular	O	7608
proliferation	O	7608
in	O	7608
the	O	7608
mouse	O	7608
.	O	7608

Mutations	O	7609
of	O	7609
the	O	7609
BRCA1	O	7609
gone	O	7609
in	O	7609
humans	O	7609
are	O	7609
associated	O	7609
with	O	7609
predisposition	O	7609
to	O	7609
breast	B-Disease	7609
and	I-Disease	7609
ovarian	I-Disease	7609
cancers	I-Disease	7609
.	O	7609

We	O	7610
show	O	7610
here	O	7610
that	O	7610
Brca1	O	7610
+	O	7610
/	O	7610
-	O	7610
mice	O	7610
are	O	7610
normal	O	7610
and	O	7610
fertile	O	7610
and	O	7610
lack	O	7610
tumors	B-Disease	7610
by	O	7610
age	O	7610
eleven	O	7610
months	O	7610
.	O	7610

Increased	O	7619
coronary	B-Disease	7619
heart	I-Disease	7619
disease	I-Disease	7619
in	O	7619
Japanese	O	7619
-	O	7619
American	O	7619
men	O	7619
with	O	7619
mutation	O	7619
in	O	7619
the	O	7619
cholesteryl	O	7619
ester	O	7619
transfer	O	7619
protein	O	7619
gene	O	7619
despite	O	7619
increased	O	7619
HDL	O	7619
levels	O	7619
.	O	7619

Plasma	O	7620
high	O	7620
density	O	7620
lipoprotein	O	7620
(	O	7620
HDL	O	7620
)	O	7620
levels	O	7620
are	O	7620
strongly	O	7620
genetically	O	7620
determined	O	7620
and	O	7620
show	O	7620
a	O	7620
general	O	7620
inverse	O	7620
relationship	O	7620
with	O	7620
coronary	B-Disease	7620
heart	I-Disease	7620
disease	I-Disease	7620
(	O	7620
CHD	B-Disease	7620
)	O	7620
.	O	7620

However	O	7625
,	O	7625
the	O	7625
overall	O	7625
prevalence	O	7625
of	O	7625
definite	O	7625
CHD	B-Disease	7625
was	O	7625
21	O	7625
%	O	7625
in	O	7625
men	O	7625
with	O	7625
mutations	O	7625
and	O	7625
16	O	7625
%	O	7625
in	O	7625
men	O	7625
without	O	7625
mutations	O	7625
.	O	7625

The	O	7626
relative	O	7626
risk	O	7626
(	O	7626
RR	O	7626
)	O	7626
of	O	7626
CHD	B-Disease	7626
was	O	7626
1	O	7626
.	O	7626

05	O	7628
)	O	7628
;	O	7628
after	O	7628
adjustment	O	7628
for	O	7628
CHD	B-Disease	7628
risk	O	7628
factors	O	7628
,	O	7628
the	O	7628
RR	O	7628
was	O	7628
1	O	7628
.	O	7628

Increased	O	7634
CHD	B-Disease	7634
in	O	7634
men	O	7634
with	O	7634
mutations	O	7634
was	O	7634
primarily	O	7634
observed	O	7634
for	O	7634
HDL	O	7634
chol	O	7634
41	O	7634
-	O	7634
60	O	7634
mg	O	7634
/	O	7634
dl	O	7634
;	O	7634
for	O	7634
HDL	O	7634
chol	O	7634
>	O	7634
60	O	7634
mg	O	7634
/	O	7634
dl	O	7634
men	O	7634
with	O	7634
and	O	7634
without	O	7634
mutations	O	7634
had	O	7634
low	O	7634
CHD	B-Disease	7634
prevalence	O	7634
.	O	7634

Thus	O	7635
,	O	7635
genetic	O	7635
CETP	B-Disease	7635
deficiency	I-Disease	7635
appears	O	7635
to	O	7635
be	O	7635
an	O	7635
independent	O	7635
risk	O	7635
factor	O	7635
for	O	7635
CHD	B-Disease	7635
,	O	7635
primarily	O	7635
due	O	7635
to	O	7635
increased	O	7635
CHD	B-Disease	7635
prevalence	O	7635
in	O	7635
men	O	7635
with	O	7635
the	O	7635
D442G	O	7635
mutation	O	7635
and	O	7635
HDL	O	7635
cholesterol	O	7635
between	O	7635
41	O	7635
and	O	7635
60	O	7635
mg	O	7635
/	O	7635
dl	O	7635
.	O	7635

The	O	7640
Rb1	O	7640
gene	O	7640
has	O	7640
been	O	7640
implicated	O	7640
with	O	7640
retinoblastoma	B-Disease	7640
and	O	7640
is	O	7640
located	O	7640
on	O	7640
human	O	7640
Chromosome	O	7640
(	O	7640
Chr	O	7640
)	O	7640
13q14	O	7640
.	O	7640

Wiskott	B-Disease	7644
-	I-Disease	7644
Aldrich	I-Disease	7644
syndrome	I-Disease	7644
:	O	7644
no	O	7644
strict	O	7644
genotype	O	7644
-	O	7644
phenotype	O	7644
correlations	O	7644
but	O	7644
clustering	O	7644
of	O	7644
missense	O	7644
mutations	O	7644
in	O	7644
the	O	7644
amino	O	7644
-	O	7644
terminal	O	7644
part	O	7644
of	O	7644
the	O	7644
WASP	O	7644
gene	O	7644
product	O	7644
.	O	7644

The	O	7645
Wiskott	B-Disease	7645
-	I-Disease	7645
Aldrich	I-Disease	7645
syndrome	I-Disease	7645
protein	O	7645
(	O	7645
WASP	O	7645
)	O	7645
gene	O	7645
was	O	7645
found	O	7645
to	O	7645
be	O	7645
mutated	O	7645
in	O	7645
patients	O	7645
presenting	O	7645
with	O	7645
WAS	B-Disease	7645
and	O	7645
in	O	7645
patients	O	7645
showing	O	7645
X	B-Disease	7645
-	I-Disease	7645
linked	I-Disease	7645
thrombocytopenia	I-Disease	7645
.	O	7645

No	O	7649
genotype	O	7649
-	O	7649
phenotype	O	7649
correlation	O	7649
emerged	O	7649
after	O	7649
a	O	7649
comparison	O	7649
of	O	7649
the	O	7649
identified	O	7649
mutations	O	7649
with	O	7649
the	O	7649
resulting	O	7649
clinical	O	7649
picture	O	7649
for	O	7649
a	O	7649
classical	O	7649
WAS	B-Disease	7649
phenotype	O	7649
.	O	7649

Influence	O	7653
of	O	7653
PAX6	O	7653
gene	O	7653
dosage	O	7653
on	O	7653
development	O	7653
:	O	7653
overexpression	O	7653
causes	O	7653
severe	O	7653
eye	B-Disease	7653
abnormalities	I-Disease	7653
.	O	7653

Aniridia	B-Disease	7654
in	O	7654
man	O	7654
and	O	7654
Small	O	7654
eye	O	7654
in	O	7654
mice	O	7654
are	O	7654
semidominant	B-Disease	7654
developmental	I-Disease	7654
disorders	I-Disease	7654
caused	O	7654
by	O	7654
mutations	O	7654
within	O	7654
the	O	7654
paired	O	7654
box	O	7654
gene	O	7654
PAX6	O	7654
.	O	7654

Whereas	O	7655
heterozygotes	O	7655
suffer	O	7655
from	O	7655
iris	B-Disease	7655
hypoplasia	I-Disease	7655
,	O	7655
homozygous	O	7655
mice	O	7655
lack	O	7655
eyes	O	7655
and	O	7655
nasal	O	7655
cavities	O	7655
and	O	7655
exhibit	O	7655
brain	B-Disease	7655
abnormalities	I-Disease	7655
.	O	7655

Strikingly	O	7658
,	O	7658
mice	O	7658
carrying	O	7658
multiple	O	7658
copies	O	7658
on	O	7658
a	O	7658
wild	O	7658
-	O	7658
type	O	7658
background	O	7658
show	O	7658
specific	O	7658
developmental	B-Disease	7658
abnormalities	I-Disease	7658
of	I-Disease	7658
the	I-Disease	7658
eye	I-Disease	7658
,	O	7658
but	O	7658
not	O	7658
of	O	7658
other	O	7658
tissues	O	7658
expressing	O	7658
the	O	7658
gene	O	7658
.	O	7658

We	O	7660
provide	O	7660
evidence	O	7660
that	O	7660
not	O	7660
only	O	7660
reduced	O	7660
,	O	7660
but	O	7660
also	O	7660
increased	O	7660
levels	O	7660
of	O	7660
transcriptional	O	7660
regulators	O	7660
can	O	7660
cause	O	7660
developmental	B-Disease	7660
defects	I-Disease	7660
.	O	7660

This	O	7664
question	O	7664
is	O	7664
of	O	7664
particular	O	7664
interest	O	7664
for	O	7664
the	O	7664
human	O	7664
enzyme	O	7664
galactose	O	7664
-	O	7664
l	O	7664
-	O	7664
phosphate	O	7664
uridylyl	O	7664
-	O	7664
transferase	O	7664
(	O	7664
GALT	O	7664
)	O	7664
,	O	7664
impairment	O	7664
of	O	7664
which	O	7664
results	O	7664
in	O	7664
the	O	7664
inherited	B-Disease	7664
metabolic	I-Disease	7664
disorder	I-Disease	7664
galactosemia	B-Disease	7664
,	O	7664
because	O	7664
many	O	7664
if	O	7664
not	O	7664
most	O	7664
patients	O	7664
studied	O	7664
to	O	7664
date	O	7664
are	O	7664
compound	O	7664
heterozygotes	O	7664
rather	O	7664
than	O	7664
true	O	7664
molecular	O	7664
homozygotes	O	7664
.	O	7664

These	O	7668
results	O	7668
are	O	7668
significant	O	7668
not	O	7668
only	O	7668
in	O	7668
terms	O	7668
of	O	7668
their	O	7668
implications	O	7668
for	O	7668
furthering	O	7668
our	O	7668
understanding	O	7668
of	O	7668
galactosemia	B-Disease	7668
and	O	7668
GALT	O	7668
holoenzyme	O	7668
structure	O	7668
-	O	7668
function	O	7668
relationships	O	7668
but	O	7668
also	O	7668
because	O	7668
the	O	7668
system	O	7668
described	O	7668
may	O	7668
serve	O	7668
as	O	7668
a	O	7668
model	O	7668
for	O	7668
similar	O	7668
studies	O	7668
of	O	7668
other	O	7668
complexes	O	7668
composed	O	7668
of	O	7668
multiple	O	7668
subunits	O	7668
.	O	7668

Apoptosis	O	7671
has	O	7671
recently	O	7671
been	O	7671
recognized	O	7671
as	O	7671
a	O	7671
mode	O	7671
of	O	7671
cell	O	7671
death	O	7671
in	O	7671
Huntington	B-Disease	7671
disease	I-Disease	7671
(	O	7671
HD	B-Disease	7671
)	O	7671
.	O	7671

Here	O	7673
we	O	7673
show	O	7673
that	O	7673
apoptotic	O	7673
extracts	O	7673
and	O	7673
apopain	O	7673
itself	O	7673
specifically	O	7673
cleave	O	7673
the	O	7673
HD	B-Disease	7673
gene	O	7673
product	O	7673
,	O	7673
huntingtin	O	7673
.	O	7673

Our	O	7675
results	O	7675
show	O	7675
that	O	7675
huntingtin	O	7675
is	O	7675
cleaved	O	7675
by	O	7675
cysteine	O	7675
proteases	O	7675
and	O	7675
suggest	O	7675
that	O	7675
HD	B-Disease	7675
might	O	7675
be	O	7675
a	O	7675
disorder	B-Disease	7675
of	I-Disease	7675
inappropriate	I-Disease	7675
apoptosis	I-Disease	7675
.	O	7675

To	O	7678
begin	O	7678
to	O	7678
address	O	7678
the	O	7678
hypothesis	O	7678
that	O	7678
abnormal	O	7678
regulation	O	7678
of	O	7678
the	O	7678
breast	B-Disease	7678
/	I-Disease	7678
ovarian	I-Disease	7678
cancer	I-Disease	7678
susceptibility	O	7678
gene	O	7678
BRCA1	O	7678
is	O	7678
a	O	7678
critical	O	7678
step	O	7678
in	O	7678
sporadic	O	7678
breast	O	7678
/	O	7678
ovarian	O	7678
tumorigenesis	O	7678
,	O	7678
we	O	7678
have	O	7678
determined	O	7678
the	O	7678
detailed	O	7678
structure	O	7678
of	O	7678
the	O	7678
BRCA1	O	7678
genomic	O	7678
region	O	7678
.	O	7678

Deletion	O	7684
of	O	7684
small	O	7684
nuclear	O	7684
ribonucleoprotein	O	7684
polypeptide	O	7684
N	O	7684
(	O	7684
SNRPN	O	7684
)	O	7684
in	O	7684
Prader	B-Disease	7684
-	I-Disease	7684
Willi	I-Disease	7684
syndrome	I-Disease	7684
detected	O	7684
by	O	7684
fluorescence	O	7684
in	O	7684
situ	O	7684
hybridization	O	7684
:	O	7684
two	O	7684
sibs	O	7684
with	O	7684
the	O	7684
typical	O	7684
phenotype	O	7684
without	O	7684
a	O	7684
cytogenetic	O	7684
deletion	O	7684
in	O	7684
chromosome	O	7684
15q	O	7684
.	O	7684

The	O	7685
small	O	7685
nuclear	O	7685
ribonucleoprotein	O	7685
polypeptide	O	7685
N	O	7685
(	O	7685
SNRPN	O	7685
)	O	7685
gene	O	7685
is	O	7685
regarded	O	7685
as	O	7685
one	O	7685
of	O	7685
the	O	7685
candidates	O	7685
for	O	7685
Prader	B-Disease	7685
-	I-Disease	7685
Willi	I-Disease	7685
syndrome	I-Disease	7685
(	O	7685
PWS	B-Disease	7685
)	O	7685
.	O	7685

We	O	7686
describe	O	7686
two	O	7686
sibs	O	7686
with	O	7686
typical	O	7686
PWS	B-Disease	7686
presenting	O	7686
deletion	O	7686
of	O	7686
SNRPN	O	7686
detected	O	7686
by	O	7686
fluorescence	O	7686
in	O	7686
situ	O	7686
hybridization	O	7686
(	O	7686
FISH	O	7686
)	O	7686
.	O	7686

This	O	7688
implies	O	7688
a	O	7688
smaller	O	7688
deletion	O	7688
limited	O	7688
to	O	7688
the	O	7688
PWS	B-Disease	7688
critical	O	7688
region	O	7688
.	O	7688

FISH	O	7689
with	O	7689
a	O	7689
SNRPN	O	7689
probe	O	7689
will	O	7689
permit	O	7689
analysis	O	7689
of	O	7689
PWS	B-Disease	7689
patients	O	7689
with	O	7689
limited	O	7689
deletions	O	7689
not	O	7689
detectable	O	7689
with	O	7689
other	O	7689
probes	O	7689
.	O	7689

Expression	O	7691
of	O	7691
the	O	7691
von	B-Disease	7691
Hippel	I-Disease	7691
-	I-Disease	7691
Lindau	I-Disease	7691
disease	I-Disease	7691
tumour	I-Disease	7691
suppressor	O	7691
gene	O	7691
during	O	7691
human	O	7691
embryogenesis	O	7691
.	O	7691

The	O	7692
von	B-Disease	7692
Hippel	I-Disease	7692
-	I-Disease	7692
Lindau	I-Disease	7692
(	I-Disease	7692
VHL	I-Disease	7692
)	I-Disease	7692
disease	I-Disease	7692
product	O	7692
is	O	7692
thought	O	7692
to	O	7692
down	O	7692
-	O	7692
regulate	O	7692
transcription	O	7692
by	O	7692
antagonizing	O	7692
elongin	O	7692
-	O	7692
enhanced	O	7692
transcriptional	O	7692
elongation	O	7692
.	O	7692

Germline	O	7693
VHL	B-Disease	7693
gene	O	7693
mutations	O	7693
predispose	O	7693
to	O	7693
the	O	7693
development	O	7693
of	O	7693
retinal	B-Disease	7693
,	I-Disease	7693
cerebellar	I-Disease	7693
and	I-Disease	7693
spinal	I-Disease	7693
haemangioblastomas	I-Disease	7693
,	O	7693
renal	B-Disease	7693
cell	I-Disease	7693
carcinoma	I-Disease	7693
and	O	7693
phaeochromocytoma	B-Disease	7693
.	O	7693

In	O	7694
addition	O	7694
,	O	7694
somatic	O	7694
Inactivation	O	7694
of	O	7694
the	O	7694
VHL	B-Disease	7694
gene	O	7694
is	O	7694
frequent	O	7694
in	O	7694
sporadic	B-Disease	7694
renal	I-Disease	7694
cell	I-Disease	7694
carcinoma	I-Disease	7694
and	O	7694
haemangioblastoma	B-Disease	7694
.	O	7694

Regulation	O	7695
of	O	7695
transcript	O	7695
elongation	O	7695
is	O	7695
an	O	7695
important	O	7695
control	O	7695
mechanism	O	7695
for	O	7695
gene	O	7695
expression	O	7695
and	O	7695
the	O	7695
VHL	B-Disease	7695
gene	O	7695
might	O	7695
modify	O	7695
the	O	7695
expression	O	7695
of	O	7695
proto	O	7695
-	O	7695
oncogenes	O	7695
and	O	7695
growth	O	7695
suppressor	O	7695
genes	O	7695
during	O	7695
embryogenesis	O	7695
.	O	7695

We	O	7696
therefore	O	7696
investigated	O	7696
the	O	7696
expression	O	7696
of	O	7696
VHL	B-Disease	7696
mRNA	O	7696
during	O	7696
human	O	7696
embryogenesis	O	7696
by	O	7696
in	O	7696
situ	O	7696
hybridization	O	7696
studies	O	7696
at	O	7696
4	O	7696
,	O	7696
6	O	7696
and	O	7696
10	O	7696
weeks	O	7696
post	O	7696
conception	O	7696
.	O	7696

Although	O	7697
VHL	B-Disease	7697
mRNA	O	7697
was	O	7697
expressed	O	7697
in	O	7697
all	O	7697
three	O	7697
germ	O	7697
layers	O	7697
,	O	7697
strong	O	7697
expression	O	7697
was	O	7697
noted	O	7697
in	O	7697
the	O	7697
central	O	7697
nervous	O	7697
system	O	7697
,	O	7697
kidneys	O	7697
,	O	7697
testis	O	7697
and	O	7697
lung	O	7697
.	O	7697

Within	O	7698
the	O	7698
kidney	O	7698
,	O	7698
VHL	B-Disease	7698
mRNA	O	7698
was	O	7698
differentially	O	7698
expressed	O	7698
within	O	7698
renal	O	7698
tubules	O	7698
suggesting	O	7698
that	O	7698
the	O	7698
VHL	B-Disease	7698
gene	O	7698
product	O	7698
may	O	7698
have	O	7698
a	O	7698
specific	O	7698
role	O	7698
in	O	7698
kidney	O	7698
development	O	7698
.	O	7698

Two	O	7699
alternatively	O	7699
spliced	O	7699
VHL	B-Disease	7699
mRNAs	O	7699
characterized	O	7699
by	O	7699
inclusion	O	7699
(	O	7699
isoform	O	7699
I	O	7699
)	O	7699
or	O	7699
exclusion	O	7699
(	O	7699
isoform	O	7699
II	O	7699
)	O	7699
of	O	7699
exon	O	7699
2	O	7699
are	O	7699
transcribed	O	7699
in	O	7699
adult	O	7699
tissues	O	7699
.	O	7699

To	O	7700
investigate	O	7700
if	O	7700
the	O	7700
two	O	7700
isoforms	O	7700
are	O	7700
differentially	O	7700
expressed	O	7700
during	O	7700
embryogenesis	O	7700
,	O	7700
VHL	B-Disease	7700
mRNA	O	7700
was	O	7700
reverse	O	7700
transcribed	O	7700
from	O	7700
13	O	7700
fetal	O	7700
tissues	O	7700
(	O	7700
8	O	7700
-	O	7700
10	O	7700
weeks	O	7700
gestation	O	7700
)	O	7700
.	O	7700

The	O	7701
quantitative	O	7701
distribution	O	7701
of	O	7701
VHL	B-Disease	7701
mRNA	O	7701
within	O	7701
fetal	O	7701
tissues	O	7701
reflected	O	7701
that	O	7701
seen	O	7701
by	O	7701
in	O	7701
situ	O	7701
hybridization	O	7701
and	O	7701
the	O	7701
ratio	O	7701
of	O	7701
the	O	7701
two	O	7701
VHL	B-Disease	7701
isoforms	O	7701
was	O	7701
similar	O	7701
between	O	7701
tissues	O	7701
.	O	7701

Although	O	7702
the	O	7702
genes	O	7702
regulated	O	7702
by	O	7702
the	O	7702
VHL	B-Disease	7702
gene	O	7702
product	O	7702
have	O	7702
not	O	7702
yet	O	7702
been	O	7702
identified	O	7702
,	O	7702
our	O	7702
findings	O	7702
are	O	7702
compatible	O	7702
with	O	7702
the	O	7702
hypothesis	O	7702
that	O	7702
VHL	B-Disease	7702
-	O	7702
mediated	O	7702
control	O	7702
of	O	7702
transcriptional	O	7702
elongation	O	7702
may	O	7702
have	O	7702
a	O	7702
role	O	7702
in	O	7702
normal	O	7702
human	O	7702
development	O	7702
.	O	7702

Genetic	O	7704
heterogeneity	O	7704
in	O	7704
hereditary	B-Disease	7704
breast	I-Disease	7704
cancer	I-Disease	7704
:	O	7704
role	O	7704
of	O	7704
BRCA1	O	7704
and	O	7704
BRCA2	O	7704
.	O	7704

The	O	7705
common	O	7705
hereditary	O	7705
forms	O	7705
of	O	7705
breast	B-Disease	7705
cancer	I-Disease	7705
have	O	7705
been	O	7705
largely	O	7705
attributed	O	7705
to	O	7705
the	O	7705
inheritance	O	7705
of	O	7705
mutations	O	7705
in	O	7705
the	O	7705
BRCA1	O	7705
or	O	7705
BRCA2	O	7705
genes	O	7705
.	O	7705

However	O	7706
,	O	7706
it	O	7706
is	O	7706
not	O	7706
yet	O	7706
clear	O	7706
what	O	7706
proportion	O	7706
of	O	7706
hereditary	B-Disease	7706
breast	I-Disease	7706
cancer	I-Disease	7706
is	O	7706
explained	O	7706
by	O	7706
BRCA1	O	7706
and	O	7706
BRCA2	O	7706
or	O	7706
by	O	7706
some	O	7706
other	O	7706
unidentified	O	7706
susceptibility	O	7706
gene	O	7706
(	O	7706
s	O	7706
)	O	7706
.	O	7706

We	O	7707
describe	O	7707
the	O	7707
proportion	O	7707
of	O	7707
hereditary	B-Disease	7707
breast	I-Disease	7707
cancer	I-Disease	7707
explained	O	7707
by	O	7707
BRCA1	O	7707
or	O	7707
BRCA2	O	7707
in	O	7707
a	O	7707
sample	O	7707
of	O	7707
North	O	7707
American	O	7707
hereditary	B-Disease	7707
breast	I-Disease	7707
cancers	I-Disease	7707
and	O	7707
assess	O	7707
the	O	7707
evidence	O	7707
for	O	7707
additional	O	7707
susceptibility	O	7707
genes	O	7707
that	O	7707
may	O	7707
confer	O	7707
hereditary	B-Disease	7707
breast	I-Disease	7707
or	I-Disease	7707
ovarian	I-Disease	7707
cancer	I-Disease	7707
risk	O	7707
.	O	7707

Twenty	O	7708
-	O	7708
three	O	7708
families	O	7708
were	O	7708
identified	O	7708
through	O	7708
two	O	7708
high	O	7708
-	O	7708
risk	O	7708
breast	B-Disease	7708
cancer	I-Disease	7708
research	O	7708
programs	O	7708
.	O	7708

Genetic	O	7709
analysis	O	7709
was	O	7709
undertaken	O	7709
to	O	7709
establish	O	7709
linkage	O	7709
between	O	7709
the	O	7709
breast	B-Disease	7709
or	I-Disease	7709
ovarian	I-Disease	7709
cancer	I-Disease	7709
cases	O	7709
and	O	7709
markers	O	7709
on	O	7709
chromosomes	O	7709
17q	O	7709
(	O	7709
BRCA1	O	7709
)	O	7709
and	O	7709
13q	O	7709
(	O	7709
BRCA2	O	7709
)	O	7709
.	O	7709

The	O	7711
pattern	O	7711
of	O	7711
hereditary	B-Disease	7711
cancer	I-Disease	7711
in	O	7711
14	O	7711
(	O	7711
61	O	7711
%	O	7711
)	O	7711
of	O	7711
the	O	7711
23	O	7711
families	O	7711
studied	O	7711
was	O	7711
attributed	O	7711
to	O	7711
BRCA1	O	7711
by	O	7711
a	O	7711
combination	O	7711
of	O	7711
linkage	O	7711
and	O	7711
mutation	O	7711
analyses	O	7711
.	O	7711

BRCA1	O	7716
and	O	7716
BRCA2	O	7716
probably	O	7716
explain	O	7716
the	O	7716
majority	O	7716
of	O	7716
hereditary	B-Disease	7716
breast	I-Disease	7716
cancer	I-Disease	7716
that	O	7716
exists	O	7716
in	O	7716
the	O	7716
North	O	7716
American	O	7716
population	O	7716
.	O	7716

However	O	7717
,	O	7717
one	O	7717
or	O	7717
more	O	7717
additional	O	7717
genes	O	7717
may	O	7717
yet	O	7717
be	O	7717
found	O	7717
that	O	7717
explain	O	7717
some	O	7717
proportion	O	7717
of	O	7717
hereditary	B-Disease	7717
breast	I-Disease	7717
cancer	I-Disease	7717
.	O	7717

An	O	7719
intronic	O	7719
mutation	O	7719
in	O	7719
a	O	7719
lariat	O	7719
branchpoint	O	7719
sequence	O	7719
is	O	7719
a	O	7719
direct	O	7719
cause	O	7719
of	O	7719
an	O	7719
inherited	B-Disease	7719
human	I-Disease	7719
disorder	I-Disease	7719
(	O	7719
fish	B-Disease	7719
-	I-Disease	7719
eye	I-Disease	7719
disease	I-Disease	7719
)	O	7719
.	O	7719

Three	O	7723
sisters	O	7723
were	O	7723
shown	O	7723
to	O	7723
suffer	O	7723
from	O	7723
fish	B-Disease	7723
-	I-Disease	7723
eye	I-Disease	7723
disease	I-Disease	7723
(	O	7723
FED	B-Disease	7723
)	O	7723
,	O	7723
a	O	7723
disorder	O	7723
which	O	7723
is	O	7723
caused	O	7723
by	O	7723
mutations	O	7723
in	O	7723
the	O	7723
gene	O	7723
coding	O	7723
for	O	7723
lecithin	O	7723
cholesterol	O	7723
acyltransferase	O	7723
(	O	7723
LCAT	O	7723
)	O	7723
.	O	7723

Sequencing	O	7724
of	O	7724
the	O	7724
LCAT	O	7724
gene	O	7724
of	O	7724
all	O	7724
three	O	7724
probands	O	7724
revealed	O	7724
compound	O	7724
heterozygosity	O	7724
for	O	7724
a	O	7724
missense	O	7724
mutation	O	7724
in	O	7724
exon	O	7724
4	O	7724
which	O	7724
is	O	7724
reported	O	7724
to	O	7724
underlie	O	7724
the	O	7724
FED	B-Disease	7724
phenotype	O	7724
,	O	7724
and	O	7724
a	O	7724
point	O	7724
mutation	O	7724
located	O	7724
in	O	7724
intron	O	7724
4	O	7724
(	O	7724
IVS4	O	7724
T	O	7724
-	O	7724
22C	O	7724
)	O	7724
.	O	7724

In	O	7726
conclusion	O	7726
,	O	7726
we	O	7726
demonstrated	O	7726
that	O	7726
a	O	7726
point	O	7726
mutation	O	7726
in	O	7726
a	O	7726
lariat	O	7726
branchpoint	O	7726
consensus	O	7726
sequence	O	7726
causes	O	7726
a	O	7726
nan	O	7726
allele	O	7726
in	O	7726
a	O	7726
patient	O	7726
with	O	7726
FED	B-Disease	7726
.	O	7726

Mutations	O	7730
associated	O	7730
with	O	7730
variant	O	7730
phenotypes	O	7730
in	O	7730
ataxia	B-Disease	7730
-	I-Disease	7730
telangiectasia	I-Disease	7730
.	O	7730

We	O	7731
have	O	7731
identified	O	7731
14	O	7731
families	O	7731
with	O	7731
ataxia	B-Disease	7731
-	I-Disease	7731
telangiectasia	I-Disease	7731
(	O	7731
A	B-Disease	7731
-	I-Disease	7731
T	I-Disease	7731
)	O	7731
in	O	7731
which	O	7731
mutation	O	7731
of	O	7731
the	O	7731
ATM	O	7731
gene	O	7731
is	O	7731
associated	O	7731
with	O	7731
a	O	7731
less	O	7731
severe	O	7731
clinical	O	7731
and	O	7731
cellular	O	7731
phenotype	O	7731
(	O	7731
approximately	O	7731
10	O	7731
%	O	7731
-	O	7731
15	O	7731
%	O	7731
of	O	7731
A	B-Disease	7731
-	I-Disease	7731
T	I-Disease	7731
families	O	7731
identified	O	7731
in	O	7731
the	O	7731
United	O	7731
Kingdom	O	7731
)	O	7731
.	O	7731

The	O	7733
second	O	7733
A	B-Disease	7733
-	I-Disease	7733
T	I-Disease	7733
allele	O	7733
has	O	7733
a	O	7733
different	O	7733
mutation	O	7733
in	O	7733
each	O	7733
patient	O	7733
.	O	7733

The	O	7735
level	O	7735
of	O	7735
the	O	7735
137	O	7735
-	O	7735
bp	O	7735
PCR	O	7735
product	O	7735
containing	O	7735
the	O	7735
insertion	O	7735
was	O	7735
lowest	O	7735
in	O	7735
two	O	7735
patients	O	7735
who	O	7735
showed	O	7735
a	O	7735
later	O	7735
onset	O	7735
of	O	7735
cerebellar	B-Disease	7735
ataxia	I-Disease	7735
.	O	7735

Mutations	O	7737
detected	O	7737
in	O	7737
two	O	7737
of	O	7737
four	O	7737
of	O	7737
these	O	7737
are	O	7737
missense	O	7737
mutations	O	7737
,	O	7737
normally	O	7737
rare	O	7737
in	O	7737
A	B-Disease	7737
-	I-Disease	7737
T	I-Disease	7737
patients	O	7737
.	O	7737

The	O	7738
demonstration	O	7738
of	O	7738
mutations	O	7738
giving	O	7738
rise	O	7738
to	O	7738
a	O	7738
slightly	O	7738
milder	O	7738
phenotype	O	7738
in	O	7738
A	B-Disease	7738
-	I-Disease	7738
T	I-Disease	7738
raises	O	7738
the	O	7738
interesting	O	7738
question	O	7738
of	O	7738
what	O	7738
range	O	7738
of	O	7738
phenotypes	O	7738
might	O	7738
occur	O	7738
in	O	7738
individuals	O	7738
in	O	7738
whom	O	7738
both	O	7738
mutations	O	7738
are	O	7738
milder	O	7738
.	O	7738

Mutation	O	7741
of	O	7741
the	O	7741
VHL	O	7741
gene	O	7741
is	O	7741
associated	O	7741
exclusively	O	7741
with	O	7741
the	O	7741
development	O	7741
of	O	7741
non	B-Disease	7741
-	I-Disease	7741
papillary	I-Disease	7741
renal	I-Disease	7741
cell	I-Disease	7741
carcinomas	I-Disease	7741
.	O	7741

To	O	7742
define	O	7742
the	O	7742
possible	O	7742
role	O	7742
of	O	7742
the	O	7742
VHL	B-Disease	7742
gene	O	7742
in	O	7742
the	O	7742
development	O	7742
of	O	7742
sporadic	B-Disease	7742
renal	I-Disease	7742
cell	I-Disease	7742
carcinomas	I-Disease	7742
,	O	7742
91	O	7742
different	O	7742
parenchymal	B-Disease	7742
tumours	I-Disease	7742
of	I-Disease	7742
the	I-Disease	7742
kidney	I-Disease	7742
have	O	7742
been	O	7742
investigated	O	7742
for	O	7742
mutation	O	7742
of	O	7742
the	O	7742
VHL	B-Disease	7742
gene	O	7742
by	O	7742
single	O	7742
strand	O	7742
conformation	O	7742
polymorphism	O	7742
(	O	7742
SSCP	O	7742
)	O	7742
and	O	7742
/	O	7742
or	O	7742
heteroduplex	O	7742
(	O	7742
HD	O	7742
)	O	7742
techniques	O	7742
.	O	7742

Chromosome	O	7743
3p	O	7743
deletion	O	7743
was	O	7743
detected	O	7743
in	O	7743
98	O	7743
per	O	7743
cent	O	7743
of	O	7743
non	B-Disease	7743
-	I-Disease	7743
papillary	I-Disease	7743
renal	I-Disease	7743
cell	I-Disease	7743
carcinomas	I-Disease	7743
and	O	7743
in	O	7743
25	O	7743
per	O	7743
cent	O	7743
of	O	7743
chromophobe	O	7743
renal	B-Disease	7743
cell	I-Disease	7743
carcinomas	I-Disease	7743
.	O	7743

In	O	7744
22	O	7744
of	O	7744
the	O	7744
43	O	7744
non	B-Disease	7744
-	I-Disease	7744
papillary	I-Disease	7744
renal	I-Disease	7744
cell	I-Disease	7744
carcinomas	I-Disease	7744
,	O	7744
abnormally	O	7744
migrating	O	7744
DNA	O	7744
bands	O	7744
were	O	7744
detected	O	7744
by	O	7744
SSCP	O	7744
and	O	7744
/	O	7744
or	O	7744
HD	O	7744
analysis	O	7744
.	O	7744

No	O	7745
mobility	O	7745
shift	O	7745
was	O	7745
seen	O	7745
in	O	7745
any	O	7745
of	O	7745
the	O	7745
23	O	7745
chromophobe	O	7745
renal	B-Disease	7745
cell	I-Disease	7745
carcinomas	I-Disease	7745
.	O	7745

In	O	7746
addition	O	7746
,	O	7746
15	O	7746
papillary	B-Disease	7746
renal	I-Disease	7746
cell	I-Disease	7746
tumours	I-Disease	7746
and	O	7746
ten	O	7746
renal	B-Disease	7746
oncocytomas	I-Disease	7746
,	O	7746
which	O	7746
are	O	7746
characterized	O	7746
by	O	7746
genetic	O	7746
changes	O	7746
other	O	7746
than	O	7746
loss	O	7746
of	O	7746
chromosome	O	7746
3p	O	7746
sequences	O	7746
,	O	7746
were	O	7746
analysed	O	7746
for	O	7746
mutation	O	7746
of	O	7746
the	O	7746
VHL	B-Disease	7746
gene	O	7746
.	O	7746

None	O	7747
of	O	7747
these	O	7747
tumours	B-Disease	7747
showed	O	7747
abnormal	O	7747
migration	O	7747
patterns	O	7747
.	O	7747

The	O	7748
results	O	7748
indicate	O	7748
that	O	7748
mutation	O	7748
of	O	7748
the	O	7748
VHL	B-Disease	7748
gene	O	7748
is	O	7748
associated	O	7748
exclusively	O	7748
with	O	7748
the	O	7748
development	O	7748
of	O	7748
non	B-Disease	7748
-	I-Disease	7748
papillary	I-Disease	7748
renal	I-Disease	7748
cell	I-Disease	7748
carcinoma	I-Disease	7748
.	O	7748

The	O	7750
Emery	B-Disease	7750
-	I-Disease	7750
Dreifuss	I-Disease	7750
muscular	I-Disease	7750
dystrophy	I-Disease	7750
protein	O	7750
,	O	7750
emerin	O	7750
,	O	7750
is	O	7750
a	O	7750
nuclear	O	7750
membrane	O	7750
protein	O	7750
.	O	7750

A	O	7755
muscle	O	7755
biopsy	O	7755
from	O	7755
an	O	7755
Emery	B-Disease	7755
-	I-Disease	7755
Dreifuss	I-Disease	7755
muscular	I-Disease	7755
dystrophy	I-Disease	7755
(	O	7755
EMDM	B-Disease	7755
)	O	7755
patient	O	7755
showed	O	7755
complete	O	7755
absence	O	7755
of	O	7755
emerin	O	7755
by	O	7755
both	O	7755
Western	O	7755
blotting	O	7755
and	O	7755
immunohistochemistry	O	7755
,	O	7755
suggesting	O	7755
a	O	7755
simple	O	7755
diagnostic	O	7755
antibody	O	7755
test	O	7755
for	O	7755
EDMD	B-Disease	7755
families	O	7755
.	O	7755

Mutation	O	7759
of	O	7759
MSH3	O	7759
in	O	7759
endometrial	B-Disease	7759
cancer	I-Disease	7759
and	O	7759
evidence	O	7759
for	O	7759
its	O	7759
functional	O	7759
role	O	7759
in	O	7759
heteroduplex	O	7759
repair	O	7759
.	O	7759

Many	O	7760
human	O	7760
tumours	B-Disease	7760
have	O	7760
length	O	7760
alterations	O	7760
in	O	7760
repetitive	O	7760
sequence	O	7760
elements	O	7760
.	O	7760

Although	O	7761
this	O	7761
microsatellite	B-Disease	7761
instability	I-Disease	7761
has	O	7761
been	O	7761
attributed	O	7761
to	O	7761
mutations	O	7761
in	O	7761
four	O	7761
DNA	O	7761
mismatch	O	7761
repair	O	7761
genes	O	7761
in	O	7761
hereditary	B-Disease	7761
nonpolyposis	I-Disease	7761
colorectal	I-Disease	7761
cancer	I-Disease	7761
(	O	7761
HNPCC	B-Disease	7761
)	O	7761
kindreds	O	7761
,	O	7761
many	O	7761
sporadic	B-Disease	7761
tumours	I-Disease	7761
exhibit	O	7761
instability	O	7761
but	O	7761
no	O	7761
detectable	O	7761
mutations	O	7761
in	O	7761
these	O	7761
genes	O	7761
.	O	7761

Thus	O	7764
,	O	7764
we	O	7764
screened	O	7764
16	O	7764
endometrial	B-Disease	7764
carcinomas	I-Disease	7764
with	O	7764
microsatellite	O	7764
instability	O	7764
for	O	7764
alterations	O	7764
in	O	7764
FEN1	O	7764
(	O	7764
the	O	7764
human	O	7764
homolog	O	7764
of	O	7764
RTH	O	7764
)	O	7764
and	O	7764
in	O	7764
MSH3	O	7764
(	O	7764
refs	O	7764
12	O	7764
-	O	7764
14	O	7764
)	O	7764
.	O	7764

Although	O	7765
we	O	7765
found	O	7765
no	O	7765
FEN1	O	7765
mutations	O	7765
,	O	7765
a	O	7765
frameshift	O	7765
mutation	O	7765
in	O	7765
MSH3	O	7765
was	O	7765
observed	O	7765
in	O	7765
an	O	7765
endometrial	B-Disease	7765
carcinoma	I-Disease	7765
and	O	7765
in	O	7765
an	O	7765
endometrial	B-Disease	7765
carcinoma	I-Disease	7765
cell	O	7765
line	O	7765
.	O	7765

Together	O	7770
the	O	7770
data	O	7770
suggest	O	7770
that	O	7770
the	O	7770
MSH3	O	7770
gene	O	7770
encodes	O	7770
a	O	7770
product	O	7770
that	O	7770
functions	O	7770
in	O	7770
repair	O	7770
of	O	7770
some	O	7770
but	O	7770
not	O	7770
all	O	7770
pre	O	7770
-	O	7770
mutational	O	7770
intermediates	O	7770
,	O	7770
its	O	7770
mutation	O	7770
in	O	7770
tumours	B-Disease	7770
can	O	7770
result	O	7770
in	O	7770
genomic	O	7770
instability	O	7770
and	O	7770
,	O	7770
as	O	7770
in	O	7770
yeast	O	7770
,	O	7770
MSH3	O	7770
and	O	7770
MSH6	O	7770
are	O	7770
partially	O	7770
redundant	O	7770
for	O	7770
mismatch	O	7770
repair	O	7770
.	O	7770

Comparative	O	7772
genome	O	7772
mapping	O	7772
of	O	7772
the	O	7772
ataxia	B-Disease	7772
-	I-Disease	7772
telangiectasia	I-Disease	7772
region	O	7772
in	O	7772
mouse	O	7772
,	O	7772
rat	O	7772
,	O	7772
and	O	7772
Syrian	O	7772
hamster	O	7772
.	O	7772

Chromosomal	O	7773
locations	O	7773
of	O	7773
the	O	7773
Atm	O	7773
(	O	7773
ataxia	B-Disease	7773
-	I-Disease	7773
telangiectasia	I-Disease	7773
(	O	7773
AT	B-Disease	7773
)	O	7773
-	O	7773
mutated	O	7773
)	O	7773
and	O	7773
Acat1	O	7773
(	O	7773
mitochondrial	O	7773
acetoacetyl	O	7773
-	O	7773
CoA	O	7773
thiolase	O	7773
)	O	7773
genes	O	7773
in	O	7773
mouse	O	7773
,	O	7773
rat	O	7773
,	O	7773
and	O	7773
Syrian	O	7773
hamster	O	7773
were	O	7773
determined	O	7773
by	O	7773
direct	O	7773
R	O	7773
-	O	7773
banding	O	7773
FISH	O	7773
.	O	7773

Fine	O	7777
genetic	O	7777
linkage	O	7777
mapping	O	7777
of	O	7777
the	O	7777
mouse	O	7777
AT	B-Disease	7777
region	O	7777
was	O	7777
performed	O	7777
using	O	7777
the	O	7777
interspecific	O	7777
backcross	O	7777
mice	O	7777
.	O	7777

This	O	7783
type	O	7783
of	O	7783
inversion	O	7783
appeared	O	7783
to	O	7783
be	O	7783
conserved	O	7783
in	O	7783
the	O	7783
three	O	7783
rodent	O	7783
species	O	7783
,	O	7783
mouse	O	7783
,	O	7783
rat	O	7783
,	O	7783
and	O	7783
Syrian	O	7783
hamster	O	7783
,	O	7783
using	O	7783
additional	O	7783
comparative	O	7783
mapping	O	7783
data	O	7783
with	O	7783
the	O	7783
Rck	O	7783
gene	O	7783
An	O	7783
animal	O	7783
model	O	7783
for	O	7783
Norrie	B-Disease	7783
disease	I-Disease	7783
(	O	7783
ND	B-Disease	7783
)	O	7783
:	O	7783
gene	O	7783
targeting	O	7783
of	O	7783
the	O	7783
mouse	O	7783
ND	B-Disease	7783
gene	O	7783
.	O	7783

In	O	7784
order	O	7784
to	O	7784
elucidate	O	7784
the	O	7784
cellular	O	7784
and	O	7784
molecular	O	7784
processes	O	7784
which	O	7784
are	O	7784
involved	O	7784
in	O	7784
Norrie	B-Disease	7784
disease	I-Disease	7784
(	O	7784
ND	B-Disease	7784
)	O	7784
,	O	7784
we	O	7784
have	O	7784
used	O	7784
gene	O	7784
targeting	O	7784
technology	O	7784
to	O	7784
generate	O	7784
ND	B-Disease	7784
mutant	O	7784
mice	O	7784
.	O	7784

The	O	7785
murine	O	7785
homologue	O	7785
of	O	7785
the	O	7785
ND	B-Disease	7785
gene	O	7785
was	O	7785
cloned	O	7785
and	O	7785
shown	O	7785
to	O	7785
encode	O	7785
a	O	7785
polypeptide	O	7785
that	O	7785
shares	O	7785
94	O	7785
%	O	7785
of	O	7785
the	O	7785
amino	O	7785
acid	O	7785
sequence	O	7785
with	O	7785
its	O	7785
human	O	7785
counterpart	O	7785
.	O	7785

Hemizygous	O	7787
mice	O	7787
carrying	O	7787
a	O	7787
replacement	O	7787
mutation	O	7787
in	O	7787
exon	O	7787
2	O	7787
of	O	7787
the	O	7787
ND	B-Disease	7787
gene	O	7787
developed	O	7787
retrolental	O	7787
structures	O	7787
in	O	7787
the	O	7787
vitreous	O	7787
body	O	7787
and	O	7787
showed	O	7787
an	O	7787
overall	O	7787
disorganization	O	7787
of	O	7787
the	O	7787
retinal	O	7787
ganglion	O	7787
cell	O	7787
layer	O	7787
.	O	7787

These	O	7790
ocular	O	7790
findings	O	7790
are	O	7790
consistent	O	7790
with	O	7790
observations	O	7790
in	O	7790
ND	B-Disease	7790
patients	O	7790
and	O	7790
the	O	7790
generated	O	7790
mouse	O	7790
line	O	7790
provides	O	7790
a	O	7790
faithful	O	7790
model	O	7790
for	O	7790
study	O	7790
of	O	7790
early	O	7790
pathogenic	O	7790
events	O	7790
in	O	7790
this	O	7790
severe	O	7790
X	B-Disease	7790
-	I-Disease	7790
linked	I-Disease	7790
recessive	I-Disease	7790
neurological	I-Disease	7790
disorder	I-Disease	7790
.	O	7790

The	O	7792
hybrid	O	7792
PAX3	O	7792
-	O	7792
FKHR	O	7792
fusion	O	7792
protein	O	7792
of	O	7792
alveolar	B-Disease	7792
rhabdomyosarcoma	I-Disease	7792
transforms	O	7792
fibroblasts	O	7792
in	O	7792
culture	O	7792
.	O	7792

Pediatric	B-Disease	7793
alveolar	I-Disease	7793
rhabdomyosarcoma	I-Disease	7793
is	O	7793
characterized	O	7793
by	O	7793
a	O	7793
chromosomal	O	7793
translocation	O	7793
that	O	7793
fuses	O	7793
parts	O	7793
of	O	7793
the	O	7793
PAX3	O	7793
and	O	7793
FKHR	O	7793
genes	O	7793
.	O	7793

Somatic	O	7801
-	O	7801
cell	O	7801
selection	O	7801
is	O	7801
a	O	7801
major	O	7801
determinant	O	7801
of	O	7801
the	O	7801
blood	O	7801
-	O	7801
cell	O	7801
phenotype	O	7801
in	O	7801
heterozygotes	O	7801
for	O	7801
glucose	O	7801
-	O	7801
6	O	7801
-	O	7801
phosphate	O	7801
dehydrogenase	O	7801
mutations	O	7801
causing	O	7801
severe	O	7801
enzyme	B-Disease	7801
deficiency	I-Disease	7801
.	O	7801

In	O	7803
most	O	7803
people	O	7803
with	O	7803
red	O	7803
-	O	7803
blood	O	7803
-	O	7803
cell	O	7803
glucose	B-Disease	7803
-	I-Disease	7803
6	I-Disease	7803
-	I-Disease	7803
phosphate	I-Disease	7803
dehydrogenase	I-Disease	7803
(	I-Disease	7803
G6PD	I-Disease	7803
)	I-Disease	7803
deficiency	I-Disease	7803
,	O	7803
the	O	7803
enzyme	O	7803
-	O	7803
deficient	O	7803
phenotype	O	7803
is	O	7803
only	O	7803
moderately	O	7803
expressed	O	7803
in	O	7803
nucleated	O	7803
cells	O	7803
.	O	7803

However	O	7804
,	O	7804
in	O	7804
a	O	7804
small	O	7804
subset	O	7804
of	O	7804
hemizygous	O	7804
males	O	7804
who	O	7804
suffer	O	7804
from	O	7804
chronic	B-Disease	7804
nonspherocytic	I-Disease	7804
hemolytic	I-Disease	7804
anemia	I-Disease	7804
,	O	7804
the	O	7804
underlying	O	7804
mutations	O	7804
(	O	7804
designated	O	7804
class	O	7804
I	O	7804
)	O	7804
cause	O	7804
more	O	7804
-	O	7804
severe	O	7804
G6PD	B-Disease	7804
deficiency	I-Disease	7804
,	O	7804
and	O	7804
this	O	7804
might	O	7804
provide	O	7804
an	O	7804
opportunity	O	7804
for	O	7804
selection	O	7804
in	O	7804
heterozygous	O	7804
females	O	7804
during	O	7804
development	O	7804
.	O	7804

Thus	O	7808
,	O	7808
it	O	7808
appears	O	7808
that	O	7808
severe	O	7808
G6PD	B-Disease	7808
deficiency	I-Disease	7808
affects	O	7808
adversely	O	7808
the	O	7808
proliferation	O	7808
or	O	7808
the	O	7808
survival	O	7808
of	O	7808
nucleated	O	7808
blood	O	7808
cells	O	7808
and	O	7808
that	O	7808
this	O	7808
phenotypic	O	7808
characteristic	O	7808
is	O	7808
critical	O	7808
during	O	7808
hematopoiesis	O	7808
.	O	7808

Analysis	O	7810
of	O	7810
meiotic	O	7810
segregation	O	7810
,	O	7810
using	O	7810
single	O	7810
-	O	7810
sperm	O	7810
typing	O	7810
:	O	7810
meiotic	O	7810
drive	O	7810
at	O	7810
the	O	7810
myotonic	B-Disease	7810
dystrophy	I-Disease	7810
locus	O	7810
.	O	7810

Meiotic	O	7811
drive	O	7811
at	O	7811
the	O	7811
myotonic	B-Disease	7811
dystrophy	I-Disease	7811
(	O	7811
DM	B-Disease	7811
)	O	7811
locus	O	7811
has	O	7811
recently	O	7811
been	O	7811
suggested	O	7811
as	O	7811
being	O	7811
responsible	O	7811
for	O	7811
maintaining	O	7811
the	O	7811
frequency	O	7811
,	O	7811
in	O	7811
the	O	7811
human	O	7811
population	O	7811
,	O	7811
of	O	7811
DM	B-Disease	7811
chromosomes	O	7811
capable	O	7811
of	O	7811
expansion	O	7811
to	O	7811
the	O	7811
disease	O	7811
state	O	7811
.	O	7811

In	O	7812
order	O	7812
to	O	7812
test	O	7812
this	O	7812
hypothesis	O	7812
,	O	7812
we	O	7812
have	O	7812
studied	O	7812
samples	O	7812
of	O	7812
single	O	7812
sperm	O	7812
from	O	7812
three	O	7812
individuals	O	7812
heterozygous	O	7812
at	O	7812
the	O	7812
DM	B-Disease	7812
locus	O	7812
,	O	7812
each	O	7812
with	O	7812
one	O	7812
allele	O	7812
larger	O	7812
and	O	7812
one	O	7812
allele	O	7812
smaller	O	7812
than	O	7812
19	O	7812
CTG	O	7812
repeats	O	7812
.	O	7812

To	O	7813
guard	O	7813
against	O	7813
the	O	7813
possible	O	7813
problem	O	7813
of	O	7813
differential	O	7813
PCR	O	7813
amplification	O	7813
rates	O	7813
based	O	7813
on	O	7813
the	O	7813
lengths	O	7813
of	O	7813
the	O	7813
alleles	O	7813
,	O	7813
the	O	7813
sperm	O	7813
were	O	7813
also	O	7813
typed	O	7813
at	O	7813
another	O	7813
closely	O	7813
linked	O	7813
marker	O	7813
whose	O	7813
allele	O	7813
size	O	7813
was	O	7813
unrelated	O	7813
to	O	7813
the	O	7813
allele	O	7813
size	O	7813
at	O	7813
the	O	7813
DM	B-Disease	7813
locus	O	7813
.	O	7813

This	O	7818
suggests	O	7818
that	O	7818
any	O	7818
greater	O	7818
amount	O	7818
of	O	7818
segregation	O	7818
distortion	O	7818
at	O	7818
the	O	7818
myotonic	B-Disease	7818
dystrophy	I-Disease	7818
locus	O	7818
must	O	7818
result	O	7818
from	O	7818
events	O	7818
following	O	7818
sperm	O	7818
ejaculation	O	7818
.	O	7818

LPP	O	7819
,	O	7819
the	O	7819
preferred	O	7819
fusion	O	7819
partner	O	7819
gene	O	7819
of	O	7819
HMGIC	O	7819
in	O	7819
lipomas	B-Disease	7819
,	O	7819
is	O	7819
a	O	7819
novel	O	7819
member	O	7819
of	O	7819
the	O	7819
LIM	O	7819
protein	O	7819
gene	O	7819
family	O	7819
.	O	7819

A	O	7820
major	O	7820
cytogenetic	O	7820
subgroup	O	7820
of	O	7820
lipomas	B-Disease	7820
is	O	7820
characterized	O	7820
by	O	7820
recurrent	O	7820
chromosome	O	7820
aberrations	O	7820
,	O	7820
mainly	O	7820
translocations	O	7820
,	O	7820
that	O	7820
involve	O	7820
chromosome	O	7820
segment	O	7820
12q13	O	7820
-	O	7820
q15	O	7820
.	O	7820

Here	O	7823
,	O	7823
we	O	7823
report	O	7823
the	O	7823
identification	O	7823
and	O	7823
characterization	O	7823
of	O	7823
the	O	7823
chromosome	O	7823
3	O	7823
-	O	7823
derived	O	7823
translocation	O	7823
partner	O	7823
gene	O	7823
,	O	7823
which	O	7823
we	O	7823
have	O	7823
designated	O	7823
LPP	O	7823
(	O	7823
lipoma	B-Disease	7823
preferred	O	7823
partner	O	7823
gene	O	7823
)	O	7823
.	O	7823

Using	O	7824
3	O	7824
-	O	7824
RACE	O	7824
analysis	O	7824
of	O	7824
HMGIC	O	7824
fusion	O	7824
transcripts	O	7824
in	O	7824
lipoma	B-Disease	7824
cell	O	7824
line	O	7824
Li	O	7824
-	O	7824
501	O	7824
/	O	7824
SV40	O	7824
,	O	7824
ectopic	O	7824
genetic	O	7824
sequences	O	7824
were	O	7824
obtained	O	7824
,	O	7824
which	O	7824
by	O	7824
CASH	O	7824
(	O	7824
chromosome	O	7824
assignment	O	7824
using	O	7824
somatic	O	7824
cell	O	7824
hybrids	O	7824
)	O	7824
and	O	7824
FISH	O	7824
(	O	7824
fluorescence	O	7824
in	O	7824
situ	O	7824
hybridization	O	7824
)	O	7824
analysis	O	7824
were	O	7824
found	O	7824
to	O	7824
originate	O	7824
from	O	7824
chromosome	O	7824
segment	O	7824
3q27	O	7824
-	O	7824
q28	O	7824
.	O	7824

Using	O	7830
reverse	O	7830
transcriptase	O	7830
combined	O	7830
with	O	7830
polymerase	O	7830
chain	O	7830
reactions	O	7830
in	O	7830
the	O	7830
analysis	O	7830
of	O	7830
a	O	7830
number	O	7830
of	O	7830
lipoma	B-Disease	7830
cell	O	7830
lines	O	7830
and	O	7830
primary	B-Disease	7830
lipomas	I-Disease	7830
,	O	7830
it	O	7830
appeared	O	7830
that	O	7830
LPP	O	7830
is	O	7830
frequently	O	7830
rearranged	O	7830
also	O	7830
in	O	7830
cases	O	7830
without	O	7830
a	O	7830
cytogenetically	O	7830
detectable	O	7830
involvement	O	7830
of	O	7830
3q27	O	7830
-	O	7830
q28	O	7830
.	O	7830

Absence	O	7833
of	O	7833
disease	O	7833
phenotype	O	7833
and	O	7833
intergenerational	O	7833
stability	O	7833
of	O	7833
the	O	7833
CAG	O	7833
repeat	O	7833
in	O	7833
transgenic	O	7833
mice	O	7833
expressing	O	7833
the	O	7833
human	O	7833
Huntington	B-Disease	7833
disease	I-Disease	7833
transcript	O	7833
.	O	7833

The	O	7834
mutation	O	7834
underlying	O	7834
Huntington	B-Disease	7834
disease	I-Disease	7834
(	O	7834
HD	B-Disease	7834
)	O	7834
is	O	7834
CAG	O	7834
expansion	O	7834
in	O	7834
the	O	7834
first	O	7834
exon	O	7834
of	O	7834
the	O	7834
HD	B-Disease	7834
gene	O	7834
.	O	7834

In	O	7835
order	O	7835
to	O	7835
investigate	O	7835
the	O	7835
role	O	7835
of	O	7835
CAG	O	7835
expansion	O	7835
in	O	7835
the	O	7835
pathogenesis	O	7835
of	O	7835
HD	B-Disease	7835
,	O	7835
we	O	7835
have	O	7835
produced	O	7835
transgenic	O	7835
mice	O	7835
containing	O	7835
the	O	7835
full	O	7835
length	O	7835
human	O	7835
HD	B-Disease	7835
cDNA	O	7835
with	O	7835
44	O	7835
CAG	O	7835
repeats	O	7835
.	O	7835

By	O	7836
1	O	7836
year	O	7836
,	O	7836
these	O	7836
mice	O	7836
have	O	7836
no	O	7836
behavioral	B-Disease	7836
abnormalities	I-Disease	7836
and	O	7836
morphometric	O	7836
analysis	O	7836
at	O	7836
6	O	7836
(	O	7836
one	O	7836
animal	O	7836
)	O	7836
and	O	7836
9	O	7836
(	O	7836
two	O	7836
animals	O	7836
)	O	7836
months	O	7836
age	O	7836
revealed	O	7836
no	O	7836
changes	O	7836
.	O	7836

Despite	O	7837
high	O	7837
levels	O	7837
of	O	7837
mRNA	O	7837
expression	O	7837
,	O	7837
there	O	7837
was	O	7837
no	O	7837
evidence	O	7837
of	O	7837
the	O	7837
HD	B-Disease	7837
gene	O	7837
product	O	7837
in	O	7837
any	O	7837
of	O	7837
these	O	7837
transgenic	O	7837
mice	O	7837
.	O	7837

In	O	7838
vitro	O	7838
transfection	O	7838
studies	O	7838
indicated	O	7838
that	O	7838
the	O	7838
inclusion	O	7838
of	O	7838
120	O	7838
bp	O	7838
of	O	7838
the	O	7838
5	O	7838
UTR	O	7838
in	O	7838
the	O	7838
cDNA	O	7838
construct	O	7838
and	O	7838
the	O	7838
presence	O	7838
of	O	7838
a	O	7838
frameshift	O	7838
mutation	O	7838
at	O	7838
nucleotide	O	7838
2349	O	7838
prevented	O	7838
expression	O	7838
of	O	7838
the	O	7838
HD	B-Disease	7838
cDNA	O	7838
.	O	7838

These	O	7839
findings	O	7839
suggest	O	7839
that	O	7839
the	O	7839
pathogenesis	O	7839
of	O	7839
HD	B-Disease	7839
is	O	7839
not	O	7839
mediated	O	7839
through	O	7839
DNA	O	7839
-	O	7839
protein	O	7839
interaction	O	7839
and	O	7839
that	O	7839
presence	O	7839
of	O	7839
the	O	7839
RNA	O	7839
transcript	O	7839
with	O	7839
an	O	7839
expanded	O	7839
CAG	O	7839
repeat	O	7839
is	O	7839
insufficient	O	7839
to	O	7839
cause	O	7839
the	O	7839
disease	O	7839
.	O	7839

Rather	O	7840
,	O	7840
translation	O	7840
of	O	7840
the	O	7840
CAG	O	7840
is	O	7840
crucial	O	7840
for	O	7840
the	O	7840
pathogenesis	O	7840
of	O	7840
HD	B-Disease	7840
.	O	7840

FISH	O	7844
studies	O	7844
in	O	7844
a	O	7844
patient	O	7844
with	O	7844
sporadic	B-Disease	7844
aniridia	I-Disease	7844
and	O	7844
t	O	7844
(	O	7844
7	O	7844
;	O	7844
11	O	7844
)	O	7844
(	O	7844
q31	O	7844
.	O	7844

A	O	7846
2	O	7846
year	O	7846
old	O	7846
female	O	7846
presenting	O	7846
with	O	7846
bilateral	B-Disease	7846
sporadic	I-Disease	7846
aniridia	I-Disease	7846
was	O	7846
found	O	7846
to	O	7846
have	O	7846
an	O	7846
apparently	O	7846
balanced	O	7846
reciprocal	O	7846
translocation	O	7846
with	O	7846
a	O	7846
chromosome	O	7846
11	O	7846
breakpoint	O	7846
within	O	7846
band	O	7846
p13	O	7846
.	O	7846

Fluorescence	O	7847
in	O	7847
situ	O	7847
hybridisation	O	7847
(	O	7847
FISH	O	7847
)	O	7847
studies	O	7847
with	O	7847
distal	O	7847
11p13	O	7847
specific	O	7847
cosmids	O	7847
showed	O	7847
that	O	7847
the	O	7847
chromosome	O	7847
11	O	7847
breakpoint	O	7847
lay	O	7847
between	O	7847
the	O	7847
aniridia	B-Disease	7847
(	O	7847
PAX6	O	7847
)	O	7847
locus	O	7847
and	O	7847
a	O	7847
region	O	7847
approximately	O	7847
100	O	7847
kb	O	7847
distal	O	7847
to	O	7847
PAX6	O	7847
defined	O	7847
by	O	7847
the	O	7847
cosmid	O	7847
FO2121	O	7847
.	O	7847

Although	O	7848
this	O	7848
patient	O	7848
did	O	7848
not	O	7848
have	O	7848
a	O	7848
detectable	O	7848
deletion	O	7848
within	O	7848
PAX6	O	7848
,	O	7848
her	O	7848
aniridia	B-Disease	7848
may	O	7848
have	O	7848
resulted	O	7848
from	O	7848
a	O	7848
disruption	O	7848
of	O	7848
the	O	7848
distal	O	7848
chromatin	O	7848
domain	O	7848
containing	O	7848
either	O	7848
enhancers	O	7848
or	O	7848
regulators	O	7848
for	O	7848
PAX6	O	7848
.	O	7848

This	O	7849
case	O	7849
may	O	7849
therefore	O	7849
be	O	7849
another	O	7849
example	O	7849
of	O	7849
aniridia	B-Disease	7849
caused	O	7849
by	O	7849
a	O	7849
position	O	7849
effect	O	7849
as	O	7849
recently	O	7849
described	O	7849
in	O	7849
two	O	7849
familial	B-Disease	7849
aniridia	I-Disease	7849
patients	O	7849
in	O	7849
which	O	7849
the	O	7849
phenotype	O	7849
cosegregated	O	7849
with	O	7849
chromosome	B-Disease	7849
abnormalities	I-Disease	7849
with	O	7849
11p13	O	7849
breakpoints	O	7849
.	O	7849

Muscle	O	7851
expression	O	7851
of	O	7851
glucose	B-Disease	7851
-	I-Disease	7851
6	I-Disease	7851
-	I-Disease	7851
phosphate	I-Disease	7851
dehydrogenase	I-Disease	7851
deficiency	I-Disease	7851
in	O	7851
different	O	7851
variants	O	7851
.	O	7851

Muscle	O	7852
expression	O	7852
of	O	7852
G6PD	B-Disease	7852
deficiency	I-Disease	7852
has	O	7852
been	O	7852
investigated	O	7852
in	O	7852
Mediterranean	O	7852
,	O	7852
Seattle	O	7852
-	O	7852
like	O	7852
and	O	7852
A	O	7852
-	O	7852
variants	O	7852
.	O	7852

The	O	7862
results	O	7862
suggest	O	7862
that	O	7862
,	O	7862
for	O	7862
a	O	7862
given	O	7862
variant	O	7862
,	O	7862
the	O	7862
extent	O	7862
of	O	7862
the	O	7862
enzyme	O	7862
defect	O	7862
in	O	7862
muscle	O	7862
may	O	7862
be	O	7862
determined	O	7862
,	O	7862
using	O	7862
this	O	7862
equation	O	7862
,	O	7862
from	O	7862
the	O	7862
G6PD	O	7862
activity	O	7862
of	O	7862
erythrocytes	O	7862
Gene	O	7862
therapy	O	7862
for	O	7862
phenylketonuria	B-Disease	7862
.	O	7862

Classical	O	7863
phenylketonuria	B-Disease	7863
(	O	7863
PKU	B-Disease	7863
)	O	7863
is	O	7863
an	O	7863
autosomal	B-Disease	7863
recessive	I-Disease	7863
disorder	I-Disease	7863
caused	O	7863
by	O	7863
a	O	7863
deficiency	B-Disease	7863
of	I-Disease	7863
hepatic	I-Disease	7863
phenylalanine	I-Disease	7863
hydroxylase	I-Disease	7863
(	O	7863
PAH	O	7863
)	O	7863
.	O	7863

Limitations	O	7864
of	O	7864
the	O	7864
current	O	7864
dietary	O	7864
treatment	O	7864
for	O	7864
PKU	B-Disease	7864
have	O	7864
led	O	7864
to	O	7864
the	O	7864
development	O	7864
of	O	7864
potential	O	7864
treatments	O	7864
based	O	7864
on	O	7864
somatic	O	7864
gene	O	7864
transfer	O	7864
.	O	7864

Vectors	O	7866
derived	O	7866
from	O	7866
a	O	7866
recombinant	O	7866
retrovirus	O	7866
or	O	7866
a	O	7866
DNA	O	7866
/	O	7866
protein	O	7866
complex	O	7866
can	O	7866
efficiently	O	7866
transduce	O	7866
the	O	7866
PAH	O	7866
cDNA	O	7866
into	O	7866
PAH	B-Disease	7866
-	I-Disease	7866
deficient	I-Disease	7866
hepatocytes	O	7866
in	O	7866
vitro	O	7866
,	O	7866
but	O	7866
the	O	7866
application	O	7866
of	O	7866
these	O	7866
vector	O	7866
systems	O	7866
is	O	7866
presently	O	7866
limited	O	7866
by	O	7866
their	O	7866
low	O	7866
transduction	O	7866
efficiency	O	7866
in	O	7866
vivo	O	7866
.	O	7866

In	O	7867
contrast	O	7867
,	O	7867
a	O	7867
vector	O	7867
derived	O	7867
from	O	7867
a	O	7867
recombinant	O	7867
adenovirus	O	7867
can	O	7867
restore	O	7867
10	O	7867
%	O	7867
-	O	7867
80	O	7867
%	O	7867
of	O	7867
normal	O	7867
hepatic	O	7867
PAH	O	7867
activity	O	7867
into	O	7867
PAH	B-Disease	7867
-	I-Disease	7867
deficient	I-Disease	7867
mice	O	7867
,	O	7867
which	O	7867
completely	O	7867
normalizes	O	7867
serum	O	7867
phenylalanine	O	7867
levels	O	7867
.	O	7867

However	O	7869
,	O	7869
these	O	7869
findings	O	7869
suggest	O	7869
that	O	7869
PKU	B-Disease	7869
can	O	7869
be	O	7869
completely	O	7869
corrected	O	7869
by	O	7869
somatic	O	7869
gene	O	7869
therapy	O	7869
,	O	7869
and	O	7869
provide	O	7869
some	O	7869
direction	O	7869
for	O	7869
the	O	7869
future	O	7869
development	O	7869
of	O	7869
adenoviral	O	7869
vectors	O	7869
.	O	7869

The	O	7872
human	O	7872
neuronal	O	7872
nicotinic	O	7872
acetylcholine	O	7872
receptor	O	7872
alpha	O	7872
4	O	7872
subunit	O	7872
gene	O	7872
(	O	7872
CHRNA4	O	7872
)	O	7872
is	O	7872
located	O	7872
in	O	7872
the	O	7872
candidate	O	7872
region	O	7872
for	O	7872
three	O	7872
different	O	7872
phenotypes	O	7872
benign	B-Disease	7872
familial	I-Disease	7872
neonatal	I-Disease	7872
convulsions	I-Disease	7872
,	O	7872
autosomal	B-Disease	7872
dominant	I-Disease	7872
nocturnal	I-Disease	7872
frontal	I-Disease	7872
lobe	I-Disease	7872
epilepsy	I-Disease	7872
,	O	7872
and	O	7872
low	O	7872
-	O	7872
voltage	O	7872
EEG	O	7872
.	O	7872

Recently	O	7873
,	O	7873
a	O	7873
missense	O	7873
mutation	O	7873
in	O	7873
transmembrane	O	7873
domain	O	7873
2	O	7873
of	O	7873
CHRNA4	O	7873
was	O	7873
found	O	7873
to	O	7873
be	O	7873
associated	O	7873
with	O	7873
autosomal	B-Disease	7873
dominant	I-Disease	7873
nocturnal	I-Disease	7873
frontal	I-Disease	7873
lobe	I-Disease	7873
epilepsy	I-Disease	7873
in	O	7873
one	O	7873
extended	O	7873
pedigree	O	7873
.	O	7873

The	O	7876
sequence	O	7876
analysis	O	7876
provides	O	7876
the	O	7876
basis	O	7876
for	O	7876
a	O	7876
comprehensive	O	7876
mutation	O	7876
screening	O	7876
of	O	7876
CHRNA4	O	7876
in	O	7876
the	O	7876
above	O	7876
-	O	7876
mentioned	O	7876
phenotypes	O	7876
and	O	7876
possibly	O	7876
in	O	7876
other	O	7876
types	O	7876
of	O	7876
idiopathic	B-Disease	7876
epilepsies	I-Disease	7876
.	O	7876

BRCA1	O	7879
and	O	7879
BRCA2	O	7879
are	O	7879
the	O	7879
two	O	7879
major	O	7879
identified	O	7879
causes	O	7879
of	O	7879
inherited	B-Disease	7879
breast	I-Disease	7879
cancer	I-Disease	7879
,	O	7879
with	O	7879
mutations	O	7879
in	O	7879
either	O	7879
gene	O	7879
conferring	O	7879
up	O	7879
to	O	7879
80	O	7879
-	O	7879
90	O	7879
%	O	7879
lifetime	O	7879
risk	O	7879
of	O	7879
breast	B-Disease	7879
cancer	I-Disease	7879
in	O	7879
carrier	O	7879
females	O	7879
.	O	7879

Mutations	O	7880
in	O	7880
BRCA1	O	7880
account	O	7880
for	O	7880
approximately	O	7880
45	O	7880
%	O	7880
of	O	7880
familial	B-Disease	7880
breast	I-Disease	7880
cancer	I-Disease	7880
and	O	7880
90	O	7880
%	O	7880
of	O	7880
inherited	B-Disease	7880
breast	I-Disease	7880
/	I-Disease	7880
ovarian	I-Disease	7880
cancer	I-Disease	7880
,	O	7880
whereas	O	7880
mutations	O	7880
in	O	7880
BRCA2	O	7880
account	O	7880
for	O	7880
a	O	7880
comparable	O	7880
percentage	O	7880
of	O	7880
inherited	B-Disease	7880
breast	I-Disease	7880
cancer	I-Disease	7880
cases	O	7880
.	O	7880

The	O	7884
6174delT	O	7884
mutation	O	7884
in	O	7884
BRCA2	O	7884
was	O	7884
recently	O	7884
identified	O	7884
as	O	7884
a	O	7884
frequent	O	7884
mutation	O	7884
in	O	7884
8	O	7884
out	O	7884
of	O	7884
107	O	7884
Ashkenazi	O	7884
Jewish	O	7884
women	O	7884
diagnosed	O	7884
with	O	7884
breast	B-Disease	7884
cancer	I-Disease	7884
by	O	7884
age	O	7884
50	O	7884
(	O	7884
ref	O	7884
.	O	7884

8	O	7885
)	O	7885
,	O	7885
as	O	7885
well	O	7885
as	O	7885
in	O	7885
three	O	7885
Ashkenazi	O	7885
male	B-Disease	7885
breast	I-Disease	7885
cancer	I-Disease	7885
patients	O	7885
.	O	7885

We	O	7886
have	O	7886
conducted	O	7886
a	O	7886
large	O	7886
-	O	7886
scale	O	7886
population	O	7886
study	O	7886
to	O	7886
investigate	O	7886
the	O	7886
prevalence	O	7886
of	O	7886
specific	O	7886
BRCA1	O	7886
and	O	7886
BRCA2	O	7886
mutations	O	7886
in	O	7886
Ashkenazi	O	7886
Jewish	O	7886
individuals	O	7886
who	O	7886
were	O	7886
unselected	O	7886
for	O	7886
breast	B-Disease	7886
cancer	I-Disease	7886
.	O	7886

This	O	7892
expanded	O	7892
population	O	7892
-	O	7892
based	O	7892
study	O	7892
confirms	O	7892
that	O	7892
the	O	7892
BRCA1	O	7892
185delAG	O	7892
mutation	O	7892
and	O	7892
the	O	7892
BRCA2	O	7892
6174delT	O	7892
mutation	O	7892
constitute	O	7892
the	O	7892
two	O	7892
most	O	7892
frequent	O	7892
mutation	O	7892
alleles	O	7892
predisposing	O	7892
to	O	7892
hereditary	B-Disease	7892
breast	I-Disease	7892
cancer	I-Disease	7892
among	O	7892
the	O	7892
Ashkenazim	O	7892
,	O	7892
and	O	7892
suggests	O	7892
a	O	7892
relatively	O	7892
lower	O	7892
penetrance	O	7892
for	O	7892
the	O	7892
6174delT	O	7892
mutation	O	7892
in	O	7892
BRCA2	O	7892
Dual	O	7892
roles	O	7892
of	O	7892
ATM	O	7892
in	O	7892
the	O	7892
cellular	O	7892
response	O	7892
to	O	7892
radiation	O	7892
and	O	7892
in	O	7892
cell	O	7892
growth	O	7892
control	O	7892
.	O	7892

The	O	7893
gene	O	7893
mutated	O	7893
in	O	7893
ataxia	B-Disease	7893
-	I-Disease	7893
telangiectasia	I-Disease	7893
(	O	7893
AT	B-Disease	7893
)	O	7893
patients	O	7893
,	O	7893
denoted	O	7893
ATM	O	7893
,	O	7893
encodes	O	7893
a	O	7893
putative	O	7893
protein	O	7893
or	O	7893
lipid	O	7893
kinase	O	7893
.	O	7893

Consistent	O	7895
with	O	7895
cellular	O	7895
defects	O	7895
of	O	7895
AT	B-Disease	7895
patients	O	7895
,	O	7895
the	O	7895
ATM	O	7895
-	O	7895
/	O	7895
-	O	7895
cells	O	7895
are	O	7895
hypersensitive	O	7895
to	O	7895
gamma	O	7895
-	O	7895
irradiation	O	7895
and	O	7895
defective	O	7895
in	O	7895
cell	O	7895
-	O	7895
cycle	O	7895
arrest	O	7895
following	O	7895
radiation	O	7895
,	O	7895
correlating	O	7895
with	O	7895
a	O	7895
defective	O	7895
up	O	7895
-	O	7895
regulation	O	7895
of	O	7895
p53	O	7895
.	O	7895

ATM	O	7900
+	O	7900
/	O	7900
-	O	7900
fibroblasts	O	7900
and	O	7900
thymocytes	O	7900
showed	O	7900
intermediately	O	7900
defective	O	7900
responses	O	7900
to	O	7900
irradiation	O	7900
but	O	7900
no	O	7900
growth	O	7900
defect	O	7900
,	O	7900
suggesting	O	7900
that	O	7900
the	O	7900
increased	O	7900
cancer	B-Disease	7900
risk	O	7900
of	O	7900
AT	B-Disease	7900
heterozygotes	O	7900
could	O	7900
be	O	7900
attributable	O	7900
to	O	7900
poor	O	7900
checkpoint	O	7900
function	O	7900
.	O	7900

Targeted	O	7902
disruption	O	7902
of	O	7902
ATM	O	7902
leads	O	7902
to	O	7902
growth	B-Disease	7902
retardation	I-Disease	7902
,	O	7902
chromosomal	B-Disease	7902
fragmentation	I-Disease	7902
during	I-Disease	7902
meiosis	I-Disease	7902
,	O	7902
immune	B-Disease	7902
defects	I-Disease	7902
,	O	7902
and	O	7902
thymic	B-Disease	7902
lymphoma	I-Disease	7902
.	O	7902

ATM	O	7903
,	O	7903
the	O	7903
gene	O	7903
mutated	O	7903
in	O	7903
the	O	7903
inherited	B-Disease	7903
human	I-Disease	7903
disease	I-Disease	7903
ataxia	B-Disease	7903
-	I-Disease	7903
telangiectasia	I-Disease	7903
,	O	7903
is	O	7903
a	O	7903
member	O	7903
of	O	7903
a	O	7903
family	O	7903
of	O	7903
kinases	O	7903
involved	O	7903
in	O	7903
DNA	O	7903
metabolism	O	7903
and	O	7903
cell	O	7903
-	O	7903
cycle	O	7903
checkpoint	O	7903
control	O	7903
.	O	7903

Initial	O	7905
evaluation	O	7905
of	O	7905
the	O	7905
ATM	O	7905
knockout	O	7905
animals	O	7905
indicates	O	7905
that	O	7905
inactivation	O	7905
of	O	7905
the	O	7905
mouse	O	7905
ATM	O	7905
gene	O	7905
recreates	O	7905
much	O	7905
of	O	7905
the	O	7905
phenotype	O	7905
of	O	7905
ataxia	B-Disease	7905
-	I-Disease	7905
telangiectasia	I-Disease	7905
.	O	7905

The	O	7907
infertility	B-Disease	7907
of	O	7907
ATM	O	7907
-	O	7907
/	O	7907
-	O	7907
mice	O	7907
results	O	7907
from	O	7907
meiotic	O	7907
failure	O	7907
.	O	7907

Immune	B-Disease	7909
defects	I-Disease	7909
also	O	7909
are	O	7909
evident	O	7909
in	O	7909
ATM	O	7909
-	O	7909
/	O	7909
-	O	7909
mice	O	7909
,	O	7909
including	O	7909
reduced	O	7909
numbers	O	7909
of	O	7909
B220	O	7909
+	O	7909
CD43	O	7909
-	O	7909
pre	O	7909
-	O	7909
B	O	7909
cells	O	7909
,	O	7909
thymocytes	O	7909
,	O	7909
and	O	7909
peripheral	O	7909
T	O	7909
cells	O	7909
,	O	7909
as	O	7909
well	O	7909
as	O	7909
functional	O	7909
impairment	O	7909
of	O	7909
T	O	7909
-	O	7909
cell	O	7909
-	O	7909
dependent	O	7909
immune	O	7909
responses	O	7909
.	O	7909

The	O	7910
cerebella	O	7910
of	O	7910
ATM	O	7910
-	O	7910
/	O	7910
-	O	7910
mice	O	7910
appear	O	7910
normal	O	7910
by	O	7910
histologic	O	7910
examination	O	7910
at	O	7910
3	O	7910
to	O	7910
4	O	7910
months	O	7910
and	O	7910
the	O	7910
mice	O	7910
have	O	7910
no	O	7910
gross	O	7910
behavioral	B-Disease	7910
abnormalities	I-Disease	7910
.	O	7910

The	O	7911
majority	O	7911
of	O	7911
mutant	O	7911
mice	O	7911
rapidly	O	7911
develop	O	7911
thymic	B-Disease	7911
lymphomas	I-Disease	7911
and	O	7911
die	O	7911
before	O	7911
4	O	7911
months	O	7911
of	O	7911
age	O	7911
.	O	7911

These	O	7912
findings	O	7912
indicate	O	7912
that	O	7912
the	O	7912
ATM	O	7912
gene	O	7912
product	O	7912
plays	O	7912
an	O	7912
essential	O	7912
role	O	7912
in	O	7912
a	O	7912
diverse	O	7912
group	O	7912
of	O	7912
cellular	O	7912
processes	O	7912
,	O	7912
including	O	7912
meiosis	O	7912
,	O	7912
the	O	7912
normal	O	7912
growth	O	7912
of	O	7912
somatic	O	7912
tissues	O	7912
,	O	7912
immune	O	7912
development	O	7912
,	O	7912
and	O	7912
tumor	B-Disease	7912
suppression	O	7912
.	O	7912

This	O	7923
agrees	O	7923
well	O	7923
with	O	7923
the	O	7923
fact	O	7923
that	O	7923
cardiac	O	7923
and	O	7923
muscle	O	7923
symptoms	O	7923
are	O	7923
characteristic	O	7923
for	O	7923
patients	O	7923
with	O	7923
VLCAD	B-Disease	7923
deficiency	I-Disease	7923
.	O	7923

Northern	O	7924
blot	O	7924
analysis	O	7924
and	O	7924
sequencing	O	7924
of	O	7924
cloned	O	7924
PCR	O	7924
amplified	O	7924
VLCAD	O	7924
cDNA	O	7924
from	O	7924
four	O	7924
unrelated	O	7924
patients	O	7924
with	O	7924
VLCAD	B-Disease	7924
deficiency	I-Disease	7924
showed	O	7924
that	O	7924
VLCAD	O	7924
mRNA	O	7924
was	O	7924
undetectable	O	7924
in	O	7924
one	O	7924
patient	O	7924
and	O	7924
that	O	7924
the	O	7924
other	O	7924
three	O	7924
have	O	7924
mutations	O	7924
in	O	7924
both	O	7924
VLCAD	O	7924
alleles	O	7924
.	O	7924

Molecular	O	7926
bases	O	7926
of	O	7926
combined	B-Disease	7926
subtotal	I-Disease	7926
deficiencies	I-Disease	7926
of	I-Disease	7926
C6	I-Disease	7926
and	I-Disease	7926
C7	I-Disease	7926
:	O	7926
their	O	7926
effects	O	7926
in	O	7926
combination	O	7926
with	O	7926
other	O	7926
C6	B-Disease	7926
and	I-Disease	7926
C7	I-Disease	7926
deficiencies	I-Disease	7926
.	O	7926

Combined	B-Disease	7927
subtotal	I-Disease	7927
deficiency	I-Disease	7927
of	I-Disease	7927
C6	I-Disease	7927
and	I-Disease	7927
C7	I-Disease	7927
,	O	7927
in	O	7927
which	O	7927
both	O	7927
proteins	O	7927
are	O	7927
expressed	O	7927
at	O	7927
very	O	7927
low	O	7927
levels	O	7927
,	O	7927
has	O	7927
been	O	7927
observed	O	7927
in	O	7927
homozygous	O	7927
form	O	7927
in	O	7927
two	O	7927
families	O	7927
.	O	7927

The	O	7932
haplotype	O	7932
has	O	7932
been	O	7932
found	O	7932
in	O	7932
combination	O	7932
with	O	7932
a	O	7932
number	O	7932
of	O	7932
other	O	7932
haplotypes	O	7932
containing	O	7932
defective	O	7932
genes	O	7932
that	O	7932
lead	O	7932
either	O	7932
to	O	7932
C6	B-Disease	7932
or	I-Disease	7932
C7	I-Disease	7932
deficiency	I-Disease	7932
,	O	7932
but	O	7932
with	O	7932
different	O	7932
consequences	O	7932
.	O	7932

Where	O	7933
it	O	7933
is	O	7933
combined	O	7933
with	O	7933
a	O	7933
C6	B-Disease	7933
-	I-Disease	7933
deficient	I-Disease	7933
gene	O	7933
,	O	7933
the	O	7933
serum	O	7933
C7	O	7933
levels	O	7933
can	O	7933
be	O	7933
surprisingly	O	7933
high	O	7933
,	O	7933
possibly	O	7933
because	O	7933
there	O	7933
is	O	7933
no	O	7933
C6	O	7933
generating	O	7933
C56	O	7933
to	O	7933
consume	O	7933
the	O	7933
C7	O	7933
.	O	7933

Genetic	O	7937
bases	O	7937
of	O	7937
human	O	7937
complement	B-Disease	7937
C7	I-Disease	7937
deficiency	I-Disease	7937
.	O	7937

Complement	B-Disease	7938
C7	I-Disease	7938
deficiency	I-Disease	7938
(	O	7938
C7D	B-Disease	7938
)	O	7938
is	O	7938
associated	O	7938
frequently	O	7938
with	O	7938
recurrent	O	7938
bacterial	B-Disease	7938
infections	I-Disease	7938
,	O	7938
especially	O	7938
meningitis	B-Disease	7938
caused	O	7938
by	O	7938
Neisseria	B-Disease	7938
meningitidis	I-Disease	7938
.	O	7938

We	O	7939
report	O	7939
in	O	7939
this	O	7939
work	O	7939
the	O	7939
molecular	O	7939
bases	O	7939
of	O	7939
C7D	B-Disease	7939
in	O	7939
two	O	7939
unrelated	O	7939
Japanese	O	7939
males	O	7939
.	O	7939

Moreover	O	7945
,	O	7945
we	O	7945
detected	O	7945
a	O	7945
novel	O	7945
polymorphism	O	7945
in	O	7945
intron	O	7945
11	O	7945
that	O	7945
presumably	O	7945
is	O	7945
linked	O	7945
to	O	7945
the	O	7945
mutation	O	7945
responsible	O	7945
for	O	7945
C7D	B-Disease	7945
in	O	7945
case	O	7945
1	O	7945
.	O	7945

Our	O	7946
results	O	7946
indicate	O	7946
that	O	7946
the	O	7946
pathogenesis	O	7946
of	O	7946
C7D	B-Disease	7946
is	O	7946
heterogeneous	O	7946
like	O	7946
most	O	7946
of	O	7946
the	O	7946
other	O	7946
deficiencies	B-Disease	7946
of	I-Disease	7946
complement	I-Disease	7946
components	I-Disease	7946
.	O	7946

HPRT	B-Disease	7948
-	I-Disease	7948
APRT	I-Disease	7948
-	I-Disease	7948
deficient	I-Disease	7948
mice	O	7948
are	O	7948
not	O	7948
a	O	7948
model	O	7948
for	O	7948
lesch	B-Disease	7948
-	I-Disease	7948
nyhan	I-Disease	7948
syndrome	I-Disease	7948
.	O	7948

Complete	B-Disease	7949
hypoxanthine	I-Disease	7949
-	I-Disease	7949
guanine	I-Disease	7949
phosphoribosyl	I-Disease	7949
-	I-Disease	7949
transferase	I-Disease	7949
(	I-Disease	7949
HPRT	I-Disease	7949
)	I-Disease	7949
deficiency	I-Disease	7949
in	O	7949
humans	O	7949
results	O	7949
in	O	7949
the	O	7949
Lesch	B-Disease	7949
-	I-Disease	7949
Nyhan	I-Disease	7949
syndrome	I-Disease	7949
which	O	7949
is	O	7949
characterized	O	7949
,	O	7949
among	O	7949
other	O	7949
features	O	7949
,	O	7949
by	O	7949
compulsive	O	7949
self	O	7949
-	O	7949
injurious	O	7949
behavior	O	7949
.	O	7949

HPRT	B-Disease	7950
-	I-Disease	7950
deficient	I-Disease	7950
mice	O	7950
generated	O	7950
using	O	7950
mouse	O	7950
embryonic	O	7950
stem	O	7950
cells	O	7950
exhibit	O	7950
none	O	7950
of	O	7950
the	O	7950
behavioral	O	7950
symptoms	O	7950
associated	O	7950
with	O	7950
the	O	7950
Lesch	B-Disease	7950
-	I-Disease	7950
Nyhan	I-Disease	7950
syndrome	I-Disease	7950
.	O	7950

Administration	O	7951
of	O	7951
drugs	O	7951
that	O	7951
inhibit	O	7951
adenine	O	7951
phosphoribosyltransferase	O	7951
(	O	7951
APRT	O	7951
)	O	7951
in	O	7951
HPRT	B-Disease	7951
-	I-Disease	7951
deficient	I-Disease	7951
mice	O	7951
has	O	7951
produced	O	7951
the	O	7951
suggestion	O	7951
that	O	7951
deficiency	B-Disease	7951
of	I-Disease	7951
APRT	I-Disease	7951
in	O	7951
combination	O	7951
with	O	7951
HPRT	B-Disease	7951
-	I-Disease	7951
deficiency	I-Disease	7951
in	O	7951
mice	O	7951
may	O	7951
lead	O	7951
to	O	7951
self	O	7951
-	O	7951
mutilation	O	7951
behavior	O	7951
[	O	7951
C	O	7951
.	O	7951

To	O	7957
test	O	7957
this	O	7957
proposition	O	7957
,	O	7957
we	O	7957
bred	O	7957
HPRT	B-Disease	7957
-	I-Disease	7957
APRT	I-Disease	7957
-	I-Disease	7957
deficient	I-Disease	7957
mice	O	7957
.	O	7957

Although	O	7958
the	O	7958
doubly	O	7958
-	O	7958
deficient	O	7958
mice	O	7958
excrete	O	7958
adenine	O	7958
and	O	7958
its	O	7958
highly	O	7958
insoluble	O	7958
derivative	O	7958
,	O	7958
2	O	7958
,	O	7958
8	O	7958
-	O	7958
dihydroxyadenine	O	7958
,	O	7958
which	O	7958
are	O	7958
also	O	7958
associated	O	7958
with	O	7958
human	O	7958
APRT	B-Disease	7958
deficiency	I-Disease	7958
,	O	7958
additional	O	7958
abnormalities	O	7958
or	O	7958
any	O	7958
self	O	7958
-	O	7958
injurious	O	7958
behavior	O	7958
were	O	7958
not	O	7958
detected	O	7958
.	O	7958

Thus	O	7959
,	O	7959
APRT	B-Disease	7959
-	I-Disease	7959
HPRT	I-Disease	7959
-	I-Disease	7959
deficient	I-Disease	7959
mice	O	7959
,	O	7959
which	O	7959
are	O	7959
devoid	O	7959
of	O	7959
any	O	7959
purine	O	7959
salvage	O	7959
pathways	O	7959
,	O	7959
show	O	7959
no	O	7959
novel	O	7959
phenotype	O	7959
and	O	7959
are	O	7959
not	O	7959
a	O	7959
model	O	7959
for	O	7959
the	O	7959
behavioral	B-Disease	7959
abnormalities	I-Disease	7959
associated	O	7959
with	O	7959
the	O	7959
Lesch	B-Disease	7959
-	I-Disease	7959
Nyhan	I-Disease	7959
syndrome	I-Disease	7959
as	O	7959
previously	O	7959
suggested	O	7959
Somatic	O	7959
alterations	O	7959
of	O	7959
the	O	7959
DPC4	O	7959
gene	O	7959
in	O	7959
human	O	7959
colorectal	B-Disease	7959
cancers	I-Disease	7959
in	O	7959
vivo	O	7959
.	O	7959

BACKGROUND	O	7960
&	O	7960
AIMS	O	7960
The	O	7960
chromosome	O	7960
region	O	7960
18q21	O	7960
has	O	7960
been	O	7960
shown	O	7960
to	O	7960
be	O	7960
frequently	O	7960
deleted	O	7960
in	O	7960
colorectal	B-Disease	7960
cancers	I-Disease	7960
,	O	7960
and	O	7960
such	O	7960
frequent	O	7960
allelic	O	7960
loss	O	7960
is	O	7960
a	O	7960
hallmark	O	7960
of	O	7960
the	O	7960
presence	O	7960
of	O	7960
a	O	7960
tumor	O	7960
-	O	7960
suppressor	O	7960
gene	O	7960
.	O	7960

The	O	7961
DPC4	O	7961
gene	O	7961
,	O	7961
which	O	7961
is	O	7961
located	O	7961
at	O	7961
18q21	O	7961
,	O	7961
has	O	7961
been	O	7961
identified	O	7961
as	O	7961
a	O	7961
tumor	O	7961
-	O	7961
suppressor	O	7961
gene	O	7961
from	O	7961
examination	O	7961
of	O	7961
pancreatic	B-Disease	7961
cancers	I-Disease	7961
.	O	7961

The	O	7962
aim	O	7962
of	O	7962
the	O	7962
present	O	7962
study	O	7962
was	O	7962
to	O	7962
determine	O	7962
if	O	7962
it	O	7962
might	O	7962
also	O	7962
be	O	7962
altered	O	7962
in	O	7962
colorectal	B-Disease	7962
cancers	I-Disease	7962
.	O	7962

METHODS	O	7963
Mutation	O	7963
analyses	O	7963
of	O	7963
the	O	7963
DPC4	O	7963
gene	O	7963
were	O	7963
performed	O	7963
on	O	7963
complementary	O	7963
DNA	O	7963
samples	O	7963
from	O	7963
31	O	7963
primary	O	7963
colorectal	B-Disease	7963
cancer	I-Disease	7963
specimens	O	7963
using	O	7963
a	O	7963
combination	O	7963
of	O	7963
polymerase	O	7963
chain	O	7963
reaction	O	7963
,	O	7963
single	O	7963
-	O	7963
strand	O	7963
conformation	O	7963
polymorphism	O	7963
,	O	7963
and	O	7963
DNA	O	7963
sequencing	O	7963
.	O	7963

RESULTS	O	7964
Four	O	7964
missense	O	7964
mutations	O	7964
producing	O	7964
amino	O	7964
acid	O	7964
substitutions	O	7964
and	O	7964
a	O	7964
somatic	O	7964
12	O	7964
-	O	7964
base	O	7964
pair	O	7964
deletion	O	7964
in	O	7964
the	O	7964
coding	O	7964
region	O	7964
of	O	7964
the	O	7964
DPC4	O	7964
gene	O	7964
were	O	7964
detected	O	7964
in	O	7964
the	O	7964
31	O	7964
cancers	B-Disease	7964
(	O	7964
16	O	7964
%	O	7964
;	O	7964
5	O	7964
of	O	7964
31	O	7964
)	O	7964
.	O	7964

CONCLUSIONS	O	7965
The	O	7965
DPC4	O	7965
gene	O	7965
may	O	7965
play	O	7965
a	O	7965
role	O	7965
as	O	7965
a	O	7965
tumor	O	7965
-	O	7965
suppressor	O	7965
gene	O	7965
in	O	7965
a	O	7965
fraction	O	7965
of	O	7965
colorectal	B-Disease	7965
cancers	I-Disease	7965
;	O	7965
however	O	7965
,	O	7965
while	O	7965
allelic	O	7965
loss	O	7965
at	O	7965
18q21	O	7965
is	O	7965
very	O	7965
often	O	7965
seen	O	7965
in	O	7965
colorectal	B-Disease	7965
cancers	I-Disease	7965
,	O	7965
only	O	7965
a	O	7965
minority	O	7965
show	O	7965
DPC4	O	7965
mutations	O	7965
,	O	7965
suggesting	O	7965
that	O	7965
there	O	7965
might	O	7965
be	O	7965
another	O	7965
tumor	O	7965
-	O	7965
suppressor	O	7965
gene	O	7965
in	O	7965
this	O	7965
chromosome	O	7965
region	O	7965
.	O	7965

Pleiotropic	O	7967
defects	O	7967
in	O	7967
ataxia	B-Disease	7967
-	I-Disease	7967
telangiectasia	I-Disease	7967
protein	O	7967
-	O	7967
deficient	O	7967
mice	O	7967
.	O	7967

We	O	7968
have	O	7968
generated	O	7968
a	O	7968
mouse	O	7968
model	O	7968
for	O	7968
ataxia	B-Disease	7968
-	I-Disease	7968
telangiectasia	I-Disease	7968
by	O	7968
using	O	7968
gene	O	7968
targeting	O	7968
to	O	7968
generate	O	7968
mice	O	7968
that	O	7968
do	O	7968
not	O	7968
express	O	7968
the	O	7968
Atm	O	7968
protein	O	7968
.	O	7968

Atm	O	7969
-	O	7969
deficient	O	7969
mice	O	7969
are	O	7969
retarded	O	7969
in	O	7969
growth	O	7969
,	O	7969
do	O	7969
not	O	7969
produce	O	7969
mature	O	7969
sperm	O	7969
,	O	7969
and	O	7969
exhibit	O	7969
severe	O	7969
defects	O	7969
in	O	7969
T	O	7969
cell	O	7969
maturation	O	7969
while	O	7969
going	O	7969
on	O	7969
to	O	7969
develop	O	7969
thymomas	B-Disease	7969
.	O	7969

Atm	O	7972
-	O	7972
deficient	O	7972
mice	O	7972
then	O	7972
exhibit	O	7972
many	O	7972
of	O	7972
the	O	7972
same	O	7972
symptoms	O	7972
found	O	7972
in	O	7972
ataxia	B-Disease	7972
-	I-Disease	7972
telangiectasia	I-Disease	7972
patients	O	7972
and	O	7972
in	O	7972
cells	O	7972
derived	O	7972
from	O	7972
them	O	7972
.	O	7972

The	O	7975
DCC	O	7975
protein	O	7975
and	O	7975
prognosis	O	7975
in	O	7975
colorectal	B-Disease	7975
cancer	I-Disease	7975
.	O	7975

BACKGROUND	O	7976
Allelic	O	7976
loss	O	7976
of	O	7976
chromosome	O	7976
18q	O	7976
predicts	O	7976
a	O	7976
poor	O	7976
outcome	O	7976
in	O	7976
patients	O	7976
with	O	7976
stage	B-Disease	7976
II	I-Disease	7976
colorectal	I-Disease	7976
cancer	I-Disease	7976
.	O	7976

Although	O	7977
the	O	7977
specific	O	7977
gene	O	7977
inactivated	O	7977
by	O	7977
this	O	7977
allelic	O	7977
loss	O	7977
has	O	7977
not	O	7977
been	O	7977
elucidated	O	7977
,	O	7977
the	O	7977
DCC	O	7977
(	O	7977
deleted	O	7977
in	O	7977
colorectal	B-Disease	7977
cancer	I-Disease	7977
)	O	7977
gene	O	7977
is	O	7977
a	O	7977
candidate	O	7977
.	O	7977

We	O	7978
investigated	O	7978
whether	O	7978
the	O	7978
expression	O	7978
of	O	7978
the	O	7978
DCC	O	7978
protein	O	7978
in	O	7978
tumor	B-Disease	7978
cells	O	7978
is	O	7978
a	O	7978
prognostic	O	7978
marker	O	7978
in	O	7978
colorectal	B-Disease	7978
carcinoma	I-Disease	7978
.	O	7978

METHODS	O	7979
The	O	7979
expression	O	7979
of	O	7979
DCC	O	7979
was	O	7979
evaluated	O	7979
immunohistochemically	O	7979
in	O	7979
132	O	7979
paraffin	O	7979
-	O	7979
embedded	O	7979
samples	O	7979
from	O	7979
patients	O	7979
with	O	7979
curatively	O	7979
resected	O	7979
stage	B-Disease	7979
II	I-Disease	7979
and	I-Disease	7979
III	I-Disease	7979
colorectal	I-Disease	7979
carcinomas	I-Disease	7979
.	O	7979

The	O	7980
Cox	O	7980
proportional	O	7980
-	O	7980
hazards	O	7980
model	O	7980
was	O	7980
used	O	7980
to	O	7980
adjust	O	7980
for	O	7980
covariates	O	7980
including	O	7980
age	O	7980
,	O	7980
sex	O	7980
,	O	7980
tumor	B-Disease	7980
site	O	7980
,	O	7980
degree	O	7980
of	O	7980
tumor	B-Disease	7980
differentiation	O	7980
,	O	7980
and	O	7980
use	O	7980
of	O	7980
adjuvant	O	7980
therapy	O	7980
.	O	7980

RESULTS	O	7981
The	O	7981
expression	O	7981
of	O	7981
DCC	O	7981
was	O	7981
a	O	7981
strong	O	7981
positive	O	7981
predictive	O	7981
factor	O	7981
for	O	7981
survival	O	7981
in	O	7981
both	O	7981
stage	B-Disease	7981
II	I-Disease	7981
and	I-Disease	7981
stage	I-Disease	7981
III	I-Disease	7981
colorectal	I-Disease	7981
carcinomas	I-Disease	7981
.	O	7981

In	O	7982
patients	O	7982
with	O	7982
stage	O	7982
II	O	7982
disease	O	7982
whose	O	7982
tumors	B-Disease	7982
expressed	O	7982
DCC	O	7982
,	O	7982
the	O	7982
five	O	7982
-	O	7982
year	O	7982
survival	O	7982
rate	O	7982
was	O	7982
94	O	7982
.	O	7982

3	O	7983
percent	O	7983
,	O	7983
whereas	O	7983
in	O	7983
patients	O	7983
with	O	7983
DCC	B-Disease	7983
-	I-Disease	7983
negative	I-Disease	7983
tumors	I-Disease	7983
,	O	7983
the	O	7983
survival	O	7983
rate	O	7983
was	O	7983
61	O	7983
.	O	7983

In	O	7986
patients	O	7986
with	O	7986
stage	B-Disease	7986
III	I-Disease	7986
disease	I-Disease	7986
,	O	7986
the	O	7986
respective	O	7986
survival	O	7986
rates	O	7986
were	O	7986
59	O	7986
.	O	7986

CONCLUSIONS	O	7990
DCC	O	7990
is	O	7990
a	O	7990
prognostic	O	7990
marker	O	7990
in	O	7990
patients	O	7990
with	O	7990
stage	B-Disease	7990
II	I-Disease	7990
or	I-Disease	7990
stage	I-Disease	7990
III	I-Disease	7990
colorectal	I-Disease	7990
cancer	I-Disease	7990
.	O	7990

In	O	7991
stage	B-Disease	7991
II	I-Disease	7991
colorectal	I-Disease	7991
carcinomas	I-Disease	7991
,	O	7991
the	O	7991
absence	O	7991
of	O	7991
DCC	O	7991
identifies	O	7991
a	O	7991
subgroup	O	7991
of	O	7991
patients	O	7991
with	O	7991
lesions	O	7991
that	O	7991
behave	O	7991
like	O	7991
stage	B-Disease	7991
III	I-Disease	7991
cancers	I-Disease	7991
.	O	7991

These	O	7992
findings	O	7992
may	O	7992
thus	O	7992
have	O	7992
therapeutic	O	7992
implications	O	7992
in	O	7992
this	O	7992
group	O	7992
of	O	7992
patients	O	7992
Association	O	7992
of	O	7992
anxiety	B-Disease	7992
-	I-Disease	7992
related	I-Disease	7992
traits	I-Disease	7992
with	O	7992
a	O	7992
polymorphism	O	7992
in	O	7992
the	O	7992
serotonin	O	7992
transporter	O	7992
gene	O	7992
regulatory	O	7992
region	O	7992
.	O	7992

Transporter	O	7993
-	O	7993
facilitated	O	7993
uptake	O	7993
of	O	7993
serotonin	O	7993
(	O	7993
5	O	7993
-	O	7993
hydroxytryptamine	O	7993
or	O	7993
5	O	7993
-	O	7993
HT	O	7993
)	O	7993
has	O	7993
been	O	7993
implicated	O	7993
in	O	7993
anxiety	B-Disease	7993
in	O	7993
humans	O	7993
and	O	7993
animal	O	7993
models	O	7993
and	O	7993
is	O	7993
the	O	7993
site	O	7993
of	O	7993
action	O	7993
of	O	7993
widely	O	7993
used	O	7993
uptake	O	7993
-	O	7993
inhibiting	O	7993
antidepressant	O	7993
and	O	7993
antianxiety	O	7993
drugs	O	7993
.	O	7993

Association	O	7996
studies	O	7996
in	O	7996
two	O	7996
independent	O	7996
samples	O	7996
totaling	O	7996
505	O	7996
individuals	O	7996
revealed	O	7996
that	O	7996
the	O	7996
5	O	7996
-	O	7996
HTT	O	7996
polymorphism	O	7996
accounts	O	7996
for	O	7996
3	O	7996
to	O	7996
4	O	7996
percent	O	7996
of	O	7996
total	O	7996
variation	O	7996
and	O	7996
7	O	7996
to	O	7996
9	O	7996
percent	O	7996
of	O	7996
inherited	O	7996
variance	O	7996
in	O	7996
anxiety	B-Disease	7996
-	I-Disease	7996
related	I-Disease	7996
personality	I-Disease	7996
traits	I-Disease	7996
in	O	7996
individuals	O	7996
as	O	7996
well	O	7996
as	O	7996
sibships	O	7996
.	O	7996

Phenotypic	O	7998
and	O	7998
genotypic	O	7998
overlap	O	7998
between	O	7998
atelosteogenesis	B-Disease	7998
type	I-Disease	7998
2	I-Disease	7998
and	O	7998
diastrophic	B-Disease	7998
dysplasia	I-Disease	7998
.	O	7998

Mutations	O	7999
in	O	7999
the	O	7999
diastrophic	B-Disease	7999
dysplasia	I-Disease	7999
sulfate	O	7999
transporter	O	7999
gene	O	7999
DTDST	O	7999
have	O	7999
been	O	7999
associated	O	7999
with	O	7999
a	O	7999
family	O	7999
of	O	7999
chondrodysplasias	B-Disease	7999
that	O	7999
comprises	O	7999
,	O	7999
in	O	7999
order	O	7999
of	O	7999
increasing	O	7999
severity	O	7999
,	O	7999
diastrophic	B-Disease	7999
dysplasia	I-Disease	7999
(	O	7999
DTD	B-Disease	7999
)	O	7999
,	O	7999
atelosteogenesis	B-Disease	7999
type	I-Disease	7999
2	I-Disease	7999
(	O	7999
AO2	B-Disease	7999
)	O	7999
,	O	7999
and	O	7999
achondrogenesis	B-Disease	7999
type	I-Disease	7999
1B	I-Disease	7999
(	O	7999
ACG1B	B-Disease	7999
)	O	7999
.	O	7999

To	O	8000
learn	O	8000
more	O	8000
about	O	8000
the	O	8000
molecular	O	8000
basis	O	8000
of	O	8000
DTDST	B-Disease	8000
chondrodysplasias	I-Disease	8000
and	O	8000
about	O	8000
genotype	O	8000
-	O	8000
phenotype	O	8000
correlations	O	8000
,	O	8000
we	O	8000
studied	O	8000
fibroblast	O	8000
cultures	O	8000
of	O	8000
three	O	8000
new	O	8000
patients	O	8000
one	O	8000
with	O	8000
AO	B-Disease	8000
-	I-Disease	8000
2	I-Disease	8000
,	O	8000
one	O	8000
with	O	8000
DTD	B-Disease	8000
,	O	8000
and	O	8000
one	O	8000
with	O	8000
an	O	8000
intermediate	O	8000
phenotype	O	8000
(	O	8000
AO2	B-Disease	8000
/	O	8000
DTD	B-Disease	8000
)	O	8000
.	O	8000

In	O	8003
two	O	8003
patients	O	8003
(	O	8003
DTD	B-Disease	8003
and	O	8003
AO2	B-Disease	8003
/	O	8003
DTD	B-Disease	8003
)	O	8003
,	O	8003
no	O	8003
other	O	8003
structural	O	8003
mutation	O	8003
was	O	8003
found	O	8003
,	O	8003
but	O	8003
polymerase	O	8003
chain	O	8003
reaction	O	8003
amplification	O	8003
and	O	8003
single	O	8003
-	O	8003
strand	O	8003
conformation	O	8003
polymorphism	O	8003
analysis	O	8003
of	O	8003
fibroblast	O	8003
cDNA	O	8003
showed	O	8003
reduced	O	8003
mRNA	O	8003
levels	O	8003
of	O	8003
the	O	8003
wild	O	8003
-	O	8003
type	O	8003
DTDST	O	8003
allele	O	8003
these	O	8003
two	O	8003
patients	O	8003
may	O	8003
be	O	8003
compound	O	8003
heterozygotes	O	8003
for	O	8003
the	O	8003
The	O	8006
third	O	8006
patient	O	8006
(	O	8006
with	O	8006
AO2	B-Disease	8006
)	O	8006
had	O	8006
the	O	8006
R279W	O	8006
mutation	O	8006
compounded	O	8006
with	O	8006
a	O	8006
novel	O	8006
mutation	O	8006
,	O	8006
the	O	8006
deletion	O	8006
of	O	8006
cytosine	O	8006
418	O	8006
(	O	8006
delta	O	8006
c418	O	8006
)	O	8006
,	O	8006
predicting	O	8006
a	O	8006
frameshift	O	8006
with	O	8006
premature	O	8006
termination	O	8006
.	O	8006

The	O	8008
presence	O	8008
of	O	8008
the	O	8008
DTDST	O	8008
R279W	O	8008
mutation	O	8008
in	O	8008
a	O	8008
total	O	8008
of	O	8008
11	O	8008
patients	O	8008
with	O	8008
AO2	B-Disease	8008
or	O	8008
DTD	B-Disease	8008
emphasizes	O	8008
the	O	8008
overlap	O	8008
between	O	8008
these	O	8008
conditions	O	8008
.	O	8008

This	O	8009
mutation	O	8009
has	O	8009
not	O	8009
been	O	8009
found	O	8009
so	O	8009
far	O	8009
in	O	8009
8	O	8009
analyzed	O	8009
ACG1B	B-Disease	8009
patients	O	8009
,	O	8009
suggesting	O	8009
that	O	8009
it	O	8009
allows	O	8009
some	O	8009
residual	O	8009
activity	O	8009
of	O	8009
the	O	8009
sulfate	O	8009
transporter	O	8009
.	O	8009

Identification	O	8011
of	O	8011
WASP	O	8011
mutations	O	8011
,	O	8011
mutation	O	8011
hotspots	O	8011
and	O	8011
genotype	O	8011
-	O	8011
phenotype	O	8011
disparities	O	8011
in	O	8011
24	O	8011
patients	O	8011
with	O	8011
the	O	8011
Wiskott	B-Disease	8011
-	I-Disease	8011
Aldrich	I-Disease	8011
syndrome	I-Disease	8011
.	O	8011

The	O	8012
Wiskott	B-Disease	8012
-	I-Disease	8012
Aldrich	I-Disease	8012
syndrome	I-Disease	8012
(	O	8012
WAS	B-Disease	8012
)	O	8012
,	O	8012
an	O	8012
X	B-Disease	8012
-	I-Disease	8012
linked	I-Disease	8012
immunodeficiency	I-Disease	8012
disease	I-Disease	8012
caused	O	8012
by	O	8012
mutation	O	8012
in	O	8012
the	O	8012
recently	O	8012
isolated	O	8012
gene	O	8012
encoding	O	8012
WAS	B-Disease	8012
protein	O	8012
(	O	8012
WASP	O	8012
)	O	8012
,	O	8012
is	O	8012
known	O	8012
to	O	8012
be	O	8012
associated	O	8012
with	O	8012
extensive	O	8012
clinical	O	8012
heterogeneity	O	8012
.	O	8012

Cumulative	O	8013
mutation	O	8013
data	O	8013
have	O	8013
revealed	O	8013
that	O	8013
WASP	O	8013
genotypes	O	8013
are	O	8013
also	O	8013
highly	O	8013
variable	O	8013
among	O	8013
WAS	B-Disease	8013
patients	O	8013
,	O	8013
but	O	8013
the	O	8013
relationship	O	8013
of	O	8013
phenotype	O	8013
with	O	8013
genotype	O	8013
in	O	8013
this	O	8013
disease	O	8013
remains	O	8013
unclear	O	8013
.	O	8013

To	O	8014
address	O	8014
this	O	8014
issue	O	8014
we	O	8014
characterized	O	8014
WASP	O	8014
mutations	O	8014
in	O	8014
24	O	8014
unrelated	O	8014
WAS	B-Disease	8014
patients	O	8014
,	O	8014
including	O	8014
18	O	8014
boys	O	8014
with	O	8014
severe	O	8014
classical	O	8014
WAS	B-Disease	8014
and	O	8014
6	O	8014
boys	O	8014
expressing	O	8014
mild	O	8014
forms	O	8014
of	O	8014
the	O	8014
disease	O	8014
,	O	8014
and	O	8014
then	O	8014
examined	O	8014
the	O	8014
degree	O	8014
of	O	8014
correlation	O	8014
of	O	8014
these	O	8014
as	O	8014
well	O	8014
as	O	8014
all	O	8014
previously	O	8014
published	O	8014
WASP	O	8014
mutations	O	8014
with	O	8014
disease	O	8014
severity	O	8014
.	O	8014

Similarly	O	8017
,	O	8017
while	O	8017
the	O	8017
cumulative	O	8017
data	O	8017
revealed	O	8017
a	O	8017
predominance	O	8017
of	O	8017
missense	O	8017
mutations	O	8017
among	O	8017
the	O	8017
WASP	O	8017
gene	O	8017
lesions	O	8017
observed	O	8017
in	O	8017
boys	O	8017
with	O	8017
isolated	B-Disease	8017
thrombocytopenia	I-Disease	8017
,	O	8017
missense	O	8017
mutations	O	8017
were	O	8017
not	O	8017
exclusively	O	8017
associated	O	8017
with	O	8017
milder	O	8017
WAS	B-Disease	8017
phenotypes	O	8017
,	O	8017
but	O	8017
also	O	8017
comprised	O	8017
a	O	8017
substantial	O	8017
portion	O	8017
(	O	8017
38	O	8017
%	O	8017
)	O	8017
of	O	8017
the	O	8017
WASP	O	8017
gene	O	8017
defects	O	8017
found	O	8017
in	O	8017
patients	O	8017
with	O	8017
severe	O	8017
disease	O	8017
.	O	8017

These	O	8018
findings	O	8018
,	O	8018
as	O	8018
well	O	8018
as	O	8018
the	O	8018
detection	O	8018
of	O	8018
identical	O	8018
WASP	O	8018
mutations	O	8018
in	O	8018
patients	O	8018
with	O	8018
disparate	O	8018
phenotypes	O	8018
,	O	8018
reveal	O	8018
a	O	8018
lack	O	8018
of	O	8018
phenotype	O	8018
concordance	O	8018
with	O	8018
genotype	O	8018
in	O	8018
WAS	B-Disease	8018
and	O	8018
thus	O	8018
imply	O	8018
that	O	8018
phenotypic	O	8018
outcome	O	8018
in	O	8018
this	O	8018
disease	O	8018
cannot	O	8018
be	O	8018
reliably	O	8018
predicted	O	8018
solely	O	8018
on	O	8018
the	O	8018
basis	O	8018
of	O	8018
WASP	O	8018
genotypes	O	8018
.	O	8018

Germline	O	8020
mutations	O	8020
in	O	8020
the	O	8020
3	O	8020
'	O	8020
part	O	8020
of	O	8020
APC	B-Disease	8020
exon	O	8020
15	O	8020
do	O	8020
not	O	8020
result	O	8020
in	O	8020
truncated	O	8020
proteins	O	8020
and	O	8020
are	O	8020
associated	O	8020
with	O	8020
attenuated	O	8020
adenomatous	B-Disease	8020
polyposis	I-Disease	8020
coli	I-Disease	8020
.	O	8020

Familial	B-Disease	8021
adenomatous	I-Disease	8021
polyposis	I-Disease	8021
(	O	8021
FAP	B-Disease	8021
)	O	8021
is	O	8021
an	O	8021
inherited	O	8021
predisposition	O	8021
to	O	8021
colorectal	B-Disease	8021
cancer	I-Disease	8021
characterized	O	8021
by	O	8021
the	O	8021
development	O	8021
of	O	8021
numerous	O	8021
adenomatous	B-Disease	8021
polyps	I-Disease	8021
predominantly	O	8021
in	O	8021
the	O	8021
colorectal	O	8021
region	O	8021
.	O	8021

Germline	O	8022
mutations	O	8022
in	O	8022
the	O	8022
adenomatous	B-Disease	8022
polyposis	I-Disease	8022
coli	I-Disease	8022
(	O	8022
APC	B-Disease	8022
)	O	8022
gene	O	8022
are	O	8022
responsible	O	8022
for	O	8022
most	O	8022
cases	O	8022
of	O	8022
FAP	B-Disease	8022
.	O	8022

Mutations	O	8023
at	O	8023
the	O	8023
5	O	8023
end	O	8023
of	O	8023
APC	B-Disease	8023
are	O	8023
known	O	8023
to	O	8023
be	O	8023
associated	O	8023
with	O	8023
a	O	8023
relatively	O	8023
mild	O	8023
form	O	8023
of	O	8023
the	O	8023
disease	O	8023
,	O	8023
called	O	8023
attenuated	B-Disease	8023
adenomatous	I-Disease	8023
polyposis	I-Disease	8023
coli	I-Disease	8023
(	O	8023
AAPC	B-Disease	8023
)	O	8023
.	O	8023

We	O	8024
identified	O	8024
a	O	8024
frameshift	O	8024
mutation	O	8024
in	O	8024
the	O	8024
3	O	8024
part	O	8024
of	O	8024
exon	O	8024
15	O	8024
,	O	8024
resulting	O	8024
in	O	8024
a	O	8024
stop	O	8024
codon	O	8024
at	O	8024
1862	O	8024
,	O	8024
in	O	8024
a	O	8024
large	O	8024
Dutch	O	8024
kindred	O	8024
with	O	8024
AAPC	B-Disease	8024
.	O	8024

Western	O	8025
blot	O	8025
analysis	O	8025
of	O	8025
lymphoblastoid	O	8025
cell	O	8025
lines	O	8025
derived	O	8025
from	O	8025
affected	O	8025
family	O	8025
members	O	8025
from	O	8025
this	O	8025
kindred	O	8025
,	O	8025
as	O	8025
well	O	8025
as	O	8025
from	O	8025
a	O	8025
previously	O	8025
reported	O	8025
Swiss	O	8025
family	O	8025
carrying	O	8025
a	O	8025
frameshift	O	8025
mutation	O	8025
at	O	8025
codon	O	8025
1987	O	8025
and	O	8025
displaying	O	8025
a	O	8025
similar	O	8025
attenuated	O	8025
phenotype	O	8025
,	O	8025
showed	O	8025
only	O	8025
the	O	8025
wild	O	8025
-	O	8025
type	O	8025
APC	B-Disease	8025
protein	O	8025
.	O	8025

Our	O	8026
study	O	8026
indicates	O	8026
that	O	8026
chain	O	8026
-	O	8026
terminating	O	8026
mutations	O	8026
located	O	8026
in	O	8026
the	O	8026
3	O	8026
part	O	8026
of	O	8026
APC	B-Disease	8026
do	O	8026
not	O	8026
result	O	8026
in	O	8026
detectable	O	8026
truncated	O	8026
polypeptides	O	8026
and	O	8026
we	O	8026
hypothesize	O	8026
that	O	8026
this	O	8026
is	O	8026
likely	O	8026
to	O	8026
be	O	8026
the	O	8026
basis	O	8026
for	O	8026
the	O	8026
observed	O	8026
AAPC	B-Disease	8026
phenotype	O	8026
.	O	8026

Over	O	8029
100	O	8029
distinct	O	8029
disease	O	8029
-	O	8029
associated	O	8029
mutations	O	8029
have	O	8029
been	O	8029
identified	O	8029
in	O	8029
the	O	8029
breast	B-Disease	8029
-	I-Disease	8029
ovarian	I-Disease	8029
cancer	I-Disease	8029
susceptibility	O	8029
gene	O	8029
BRCA1	O	8029
.	O	8029

Loss	O	8030
of	O	8030
the	O	8030
wild	O	8030
-	O	8030
type	O	8030
allele	O	8030
in	O	8030
>	O	8030
90	O	8030
%	O	8030
of	O	8030
tumors	B-Disease	8030
from	O	8030
patients	O	8030
with	O	8030
inherited	O	8030
BRCA1	O	8030
mutations	O	8030
indicates	O	8030
tumor	B-Disease	8030
suppressive	O	8030
function	O	8030
.	O	8030

The	O	8031
low	O	8031
incidence	O	8031
of	O	8031
somatic	O	8031
mutations	O	8031
suggests	O	8031
that	O	8031
BRCA1	O	8031
inactivation	O	8031
in	O	8031
sporadic	O	8031
tumors	B-Disease	8031
occurs	O	8031
by	O	8031
alternative	O	8031
mechanisms	O	8031
,	O	8031
such	O	8031
as	O	8031
interstitial	O	8031
chromosomal	O	8031
deletion	O	8031
or	O	8031
reduced	O	8031
transcription	O	8031
.	O	8031

The	O	8042
hereditary	B-Disease	8042
breast	I-Disease	8042
and	I-Disease	8042
ovarian	I-Disease	8042
cancer	I-Disease	8042
gene	O	8042
,	O	8042
BRCA1	O	8042
,	O	8042
encodes	O	8042
a	O	8042
large	O	8042
polypeptide	O	8042
that	O	8042
contains	O	8042
the	O	8042
cysteine	O	8042
-	O	8042
rich	O	8042
RING	O	8042
motif	O	8042
,	O	8042
a	O	8042
zinc	O	8042
-	O	8042
binding	O	8042
domain	O	8042
found	O	8042
in	O	8042
a	O	8042
variety	O	8042
of	O	8042
regulatory	O	8042
proteins	O	8042
.	O	8042

The	O	8045
BARD1	O	8045
/	O	8045
BRCA1	O	8045
interaction	O	8045
is	O	8045
disrupted	O	8045
by	O	8045
BRCA1	O	8045
missense	O	8045
mutations	O	8045
that	O	8045
segregate	O	8045
with	O	8045
breast	B-Disease	8045
cancer	I-Disease	8045
susceptibility	O	8045
,	O	8045
indicating	O	8045
that	O	8045
BARD1	O	8045
may	O	8045
be	O	8045
involved	O	8045
in	O	8045
mediating	O	8045
tumour	B-Disease	8045
suppression	O	8045
by	O	8045
BRCA1	O	8045
.	O	8045

45	O	8050
-	O	8050
kilobases	O	8050
(	O	8050
kb	O	8050
)	O	8050
exon	O	8050
11	O	8050
of	O	8050
the	O	8050
hereditary	B-Disease	8050
breast	I-Disease	8050
and	I-Disease	8050
ovarian	I-Disease	8050
cancer	I-Disease	8050
gene	O	8050
BRCA1	O	8050
.	O	8050

Autosomal	O	8055
dominant	O	8055
primary	O	8055
hyperparathyroidism	B-Disease	8055
and	I-Disease	8055
jaw	I-Disease	8055
tumor	I-Disease	8055
syndrome	I-Disease	8055
associated	O	8055
with	O	8055
renal	B-Disease	8055
hamartomas	I-Disease	8055
and	O	8055
cystic	B-Disease	8055
kidney	I-Disease	8055
disease	I-Disease	8055
:	O	8055
linkage	O	8055
to	O	8055
1q21	O	8055
-	O	8055
q32	O	8055
and	O	8055
loss	O	8055
of	O	8055
the	O	8055
wild	O	8055
type	O	8055
allele	O	8055
in	O	8055
renal	B-Disease	8055
hamartomas	I-Disease	8055
.	O	8055

Hereditary	B-Disease	8056
hyperparathyroidism	I-Disease	8056
-	I-Disease	8056
jaw	I-Disease	8056
tumor	I-Disease	8056
syndrome	I-Disease	8056
(	O	8056
HPT	B-Disease	8056
-	I-Disease	8056
JT	I-Disease	8056
)	O	8056
is	O	8056
an	O	8056
autosomal	B-Disease	8056
dominant	I-Disease	8056
disease	I-Disease	8056
(	O	8056
OMIM	O	8056
145001	O	8056
)	O	8056
that	O	8056
has	O	8056
recently	O	8056
been	O	8056
mapped	O	8056
to	O	8056
chromosomal	O	8056
region	O	8056
1q21	O	8056
-	O	8056
q32	O	8056
(	O	8056
HRPT2	O	8056
)	O	8056
.	O	8056

Here	O	8057
we	O	8057
report	O	8057
two	O	8057
families	O	8057
with	O	8057
HPT	B-Disease	8057
-	I-Disease	8057
JT	I-Disease	8057
syndrome	I-Disease	8057
in	O	8057
which	O	8057
adult	B-Disease	8057
renal	I-Disease	8057
hamartomas	I-Disease	8057
or	O	8057
cystic	B-Disease	8057
kidney	I-Disease	8057
disease	I-Disease	8057
were	O	8057
prominent	O	8057
associated	O	8057
features	O	8057
,	O	8057
possibly	O	8057
representing	O	8057
a	O	8057
new	O	8057
phenotypic	O	8057
variant	O	8057
of	O	8057
the	O	8057
HPT	B-Disease	8057
-	I-Disease	8057
JT	I-Disease	8057
syndrome	I-Disease	8057
.	O	8057

In	O	8058
the	O	8058
first	O	8058
family	O	8058
,	O	8058
renal	B-Disease	8058
lesions	I-Disease	8058
were	O	8058
present	O	8058
in	O	8058
five	O	8058
out	O	8058
of	O	8058
six	O	8058
affected	O	8058
individuals	O	8058
,	O	8058
whereas	O	8058
HPT	B-Disease	8058
and	O	8058
JT	B-Disease	8058
were	O	8058
seen	O	8058
in	O	8058
four	O	8058
and	O	8058
two	O	8058
cases	O	8058
,	O	8058
respectively	O	8058
.	O	8058

In	O	8059
the	O	8059
second	O	8059
family	O	8059
,	O	8059
JT	B-Disease	8059
was	O	8059
found	O	8059
in	O	8059
three	O	8059
of	O	8059
the	O	8059
five	O	8059
affected	O	8059
individuals	O	8059
and	O	8059
two	O	8059
affected	O	8059
members	O	8059
also	O	8059
exhibited	O	8059
polycystic	B-Disease	8059
kidney	I-Disease	8059
disease	I-Disease	8059
.	O	8059

A	O	8061
sex	O	8061
-	O	8061
dependent	O	8061
penetrance	O	8061
of	O	8061
primary	B-Disease	8061
HPT	I-Disease	8061
,	O	8061
resulting	O	8061
in	O	8061
predominantly	O	8061
male	O	8061
-	O	8061
affected	O	8061
cases	O	8061
was	O	8061
evident	O	8061
in	O	8061
the	O	8061
two	O	8061
families	O	8061
.	O	8061

Twenty	O	8062
microsatellite	O	8062
markers	O	8062
in	O	8062
the	O	8062
HRPT2	O	8062
region	O	8062
were	O	8062
typed	O	8062
,	O	8062
in	O	8062
addition	O	8062
to	O	8062
markers	O	8062
in	O	8062
the	O	8062
multiple	B-Disease	8062
endocrine	I-Disease	8062
neoplasia	I-Disease	8062
(	I-Disease	8062
MEN	I-Disease	8062
)	I-Disease	8062
types	I-Disease	8062
1	I-Disease	8062
and	I-Disease	8062
2	I-Disease	8062
regions	O	8062
at	O	8062
11q13	O	8062
and	O	8062
10q11	O	8062
.	O	8062

2	O	8065
)	O	8065
,	O	8065
whereas	O	8065
linkage	O	8065
to	O	8065
the	O	8065
MEN1	B-Disease	8065
and	O	8065
MEN2	B-Disease	8065
regions	O	8065
was	O	8065
excluded	O	8065
.	O	8065

Loss	O	8067
of	O	8067
heterozygosity	O	8067
was	O	8067
studied	O	8067
in	O	8067
seven	O	8067
renal	B-Disease	8067
hamartomas	I-Disease	8067
from	O	8067
two	O	8067
affected	O	8067
individuals	O	8067
in	O	8067
the	O	8067
first	O	8067
family	O	8067
,	O	8067
as	O	8067
well	O	8067
as	O	8067
in	O	8067
a	O	8067
jaw	B-Disease	8067
tumor	I-Disease	8067
and	O	8067
a	O	8067
parathyroid	B-Disease	8067
tumor	I-Disease	8067
from	O	8067
the	O	8067
second	O	8067
family	O	8067
.	O	8067

All	O	8068
renal	B-Disease	8068
hamartomas	I-Disease	8068
showed	O	8068
loss	O	8068
of	O	8068
heterozygosity	O	8068
at	O	8068
the	O	8068
1q21	O	8068
-	O	8068
q32	O	8068
region	O	8068
.	O	8068

The	O	8069
losses	O	8069
invariably	O	8069
involved	O	8069
the	O	8069
wild	O	8069
type	O	8069
allele	O	8069
derived	O	8069
from	O	8069
the	O	8069
unaffected	O	8069
parent	O	8069
,	O	8069
suggesting	O	8069
the	O	8069
inactivation	O	8069
of	O	8069
a	O	8069
tumor	B-Disease	8069
suppressor	O	8069
gene	O	8069
in	O	8069
this	O	8069
region	O	8069
Independent	O	8069
origin	O	8069
of	O	8069
single	O	8069
and	O	8069
double	O	8069
mutations	O	8069
in	O	8069
the	O	8069
human	O	8069
glucose	O	8069
6	O	8069
-	O	8069
phosphate	O	8069
dehydrogenase	O	8069
gene	O	8069
.	O	8069

In	O	8072
a	O	8072
study	O	8072
of	O	8072
G6PD	B-Disease	8072
deficient	I-Disease	8072
patients	O	8072
who	O	8072
presented	O	8072
with	O	8072
clinical	O	8072
favism	B-Disease	8072
in	O	8072
Spain	O	8072
,	O	8072
we	O	8072
have	O	8072
found	O	8072
a	O	8072
new	O	8072
polymorphic	O	8072
variant	O	8072
that	O	8072
we	O	8072
have	O	8072
called	O	8072
G6PD	O	8072
Malaga	O	8072
,	O	8072
whose	O	8072
only	O	8072
abnormality	O	8072
is	O	8072
a	O	8072
542	O	8072
A	O	8072
-	O	8072
-	O	8072
>	O	8072
T	O	8072
(	O	8072
181	O	8072
Asp	O	8072
-	O	8072
-	O	8072
>	O	8072
Val	O	8072
)	O	8072
mutation	O	8072
.	O	8072

G6PD	O	8074
Malaga	O	8074
is	O	8074
associated	O	8074
with	O	8074
enzyme	B-Disease	8074
deficiency	I-Disease	8074
(	O	8074
class	O	8074
III	O	8074
)	O	8074
,	O	8074
and	O	8074
the	O	8074
enzymic	O	8074
properties	O	8074
of	O	8074
G6PD	O	8074
Malaga	O	8074
and	O	8074
G6PD	O	8074
Santamaria	O	8074
are	O	8074
quite	O	8074
similar	O	8074
,	O	8074
indicating	O	8074
that	O	8074
in	O	8074
this	O	8074
case	O	8074
the	O	8074
effects	O	8074
of	O	8074
the	O	8074
two	O	8074
mutations	O	8074
are	O	8074
additive	O	8074
rather	O	8074
than	O	8074
synergistic	O	8074
.	O	8074

BRCA1	O	8079
mutations	O	8079
cause	O	8079
increased	O	8079
risk	O	8079
for	O	8079
breast	B-Disease	8079
and	I-Disease	8079
ovarian	I-Disease	8079
cancer	I-Disease	8079
,	O	8079
frequently	O	8079
of	O	8079
early	O	8079
onset	O	8079
.	O	8079

Many	O	8080
different	O	8080
mutations	O	8080
occur	O	8080
in	O	8080
BRCA1	O	8080
,	O	8080
including	O	8080
several	O	8080
examples	O	8080
of	O	8080
recurrent	O	8080
mutations	O	8080
,	O	8080
each	O	8080
of	O	8080
which	O	8080
accounts	O	8080
for	O	8080
a	O	8080
significant	O	8080
number	O	8080
of	O	8080
families	O	8080
with	O	8080
heritable	O	8080
cancer	B-Disease	8080
predisposition	O	8080
.	O	8080

These	O	8081
common	O	8081
mutations	O	8081
have	O	8081
an	O	8081
etiological	O	8081
role	O	8081
in	O	8081
many	O	8081
breast	B-Disease	8081
and	I-Disease	8081
ovarian	I-Disease	8081
cancer	I-Disease	8081
cases	O	8081
and	O	8081
provide	O	8081
the	O	8081
opportunity	O	8081
to	O	8081
examine	O	8081
genotype	O	8081
-	O	8081
phenotype	O	8081
correlations	O	8081
and	O	8081
genotype	O	8081
-	O	8081
environment	O	8081
interactions	O	8081
in	O	8081
individuals	O	8081
with	O	8081
the	O	8081
identical	O	8081
BRCA1	O	8081
lesion	O	8081
.	O	8081

We	O	8082
report	O	8082
a	O	8082
novel	O	8082
missense	O	8082
change	O	8082
in	O	8082
BRCA1	O	8082
,	O	8082
2640	O	8082
C	O	8082
-	O	8082
-	O	8082
>	O	8082
T	O	8082
(	O	8082
R841W	O	8082
)	O	8082
,	O	8082
found	O	8082
in	O	8082
3	O	8082
cases	O	8082
from	O	8082
a	O	8082
subject	O	8082
group	O	8082
of	O	8082
305	O	8082
breast	B-Disease	8082
and	I-Disease	8082
79	I-Disease	8082
ovarian	I-Disease	8082
cancer	I-Disease	8082
cases	O	8082
from	O	8082
Orange	O	8082
County	O	8082
,	O	8082
CA	O	8082
.	O	8082

In	O	8084
all	O	8084
three	O	8084
cases	O	8084
,	O	8084
there	O	8084
is	O	8084
a	O	8084
strong	O	8084
family	O	8084
history	O	8084
of	O	8084
breast	B-Disease	8084
,	I-Disease	8084
ovarian	I-Disease	8084
,	I-Disease	8084
or	I-Disease	8084
other	I-Disease	8084
cancers	I-Disease	8084
possibly	O	8084
related	O	8084
to	O	8084
a	O	8084
BRCA1	O	8084
defect	O	8084
and	O	8084
family	O	8084
members	O	8084
showed	O	8084
a	O	8084
high	O	8084
concordance	O	8084
of	O	8084
cancer	B-Disease	8084
incidence	O	8084
with	O	8084
the	O	8084
presence	O	8084
of	O	8084
R841W	O	8084
.	O	8084

The	O	8085
age	O	8085
of	O	8085
cancer	B-Disease	8085
onset	O	8085
was	O	8085
not	O	8085
always	O	8085
distinct	O	8085
from	O	8085
typical	O	8085
sporadic	O	8085
cases	O	8085
.	O	8085

Testing	O	8086
of	O	8086
a	O	8086
sample	O	8086
of	O	8086
413	O	8086
unrelated	O	8086
individuals	O	8086
to	O	8086
examine	O	8086
the	O	8086
hypothesis	O	8086
that	O	8086
R841W	O	8086
might	O	8086
be	O	8086
a	O	8086
rare	O	8086
polymorphism	O	8086
detected	O	8086
one	O	8086
additional	O	8086
instance	O	8086
in	O	8086
a	O	8086
woman	O	8086
with	O	8086
breast	B-Disease	8086
cancer	I-Disease	8086
diagnosed	O	8086
at	O	8086
age	O	8086
77	O	8086
years	O	8086
,	O	8086
and	O	8086
cancer	B-Disease	8086
in	O	8086
one	O	8086
parent	O	8086
.	O	8086

7	O	8088
%	O	8088
)	O	8088
of	O	8088
all	O	8088
breast	B-Disease	8088
and	I-Disease	8088
ovarian	I-Disease	8088
cancers	I-Disease	8088
in	O	8088
this	O	8088
population	O	8088
.	O	8088

Ataxia	B-Disease	8089
-	I-Disease	8089
telangiectasia	I-Disease	8089
:	O	8089
founder	O	8089
effect	O	8089
among	O	8089
north	O	8089
African	O	8089
Jews	O	8089
.	O	8089

The	O	8090
ATM	O	8090
gene	O	8090
is	O	8090
responsible	O	8090
for	O	8090
the	O	8090
autosomal	B-Disease	8090
recessive	I-Disease	8090
disorder	I-Disease	8090
ataxia	B-Disease	8090
-	I-Disease	8090
telangiectasia	I-Disease	8090
(	O	8090
A	B-Disease	8090
-	I-Disease	8090
T	I-Disease	8090
)	O	8090
,	O	8090
characterized	O	8090
by	O	8090
cerebellar	B-Disease	8090
degeneration	I-Disease	8090
,	O	8090
immunodeficiency	B-Disease	8090
and	O	8090
cancer	B-Disease	8090
predisposition	I-Disease	8090
.	O	8090

A	B-Disease	8091
-	I-Disease	8091
T	I-Disease	8091
carriers	O	8091
were	O	8091
reported	O	8091
to	O	8091
be	O	8091
moderately	O	8091
cancer	B-Disease	8091
-	I-Disease	8091
prone	I-Disease	8091
.	O	8091

A	O	8092
wide	O	8092
variety	O	8092
of	O	8092
A	B-Disease	8092
-	I-Disease	8092
T	I-Disease	8092
mutations	O	8092
,	O	8092
most	O	8092
of	O	8092
which	O	8092
are	O	8092
unique	O	8092
to	O	8092
single	O	8092
families	O	8092
,	O	8092
were	O	8092
identified	O	8092
in	O	8092
various	O	8092
ethnic	O	8092
groups	O	8092
,	O	8092
precluding	O	8092
carrier	O	8092
screening	O	8092
with	O	8092
mutation	O	8092
-	O	8092
specific	O	8092
assays	O	8092
.	O	8092

However	O	8093
,	O	8093
a	O	8093
single	O	8093
mutation	O	8093
was	O	8093
observed	O	8093
in	O	8093
32	O	8093
/	O	8093
33	O	8093
defective	O	8093
ATM	O	8093
alleles	O	8093
in	O	8093
Jewish	O	8093
A	B-Disease	8093
-	I-Disease	8093
T	I-Disease	8093
families	O	8093
of	O	8093
North	O	8093
African	O	8093
origin	O	8093
,	O	8093
coming	O	8093
from	O	8093
various	O	8093
regions	O	8093
of	O	8093
Morocco	O	8093
and	O	8093
Tunisia	O	8093
.	O	8093

This	O	8097
founder	O	8097
effect	O	8097
provides	O	8097
a	O	8097
unique	O	8097
opportunity	O	8097
for	O	8097
population	O	8097
-	O	8097
based	O	8097
screening	O	8097
for	O	8097
A	B-Disease	8097
-	I-Disease	8097
T	I-Disease	8097
carriers	O	8097
in	O	8097
a	O	8097
large	O	8097
Jewish	O	8097
community	O	8097
.	O	8097

Mutation	O	8099
analysis	O	8099
of	O	8099
BRCA1	O	8099
and	O	8099
BRCA2	O	8099
in	O	8099
a	O	8099
male	B-Disease	8099
breast	I-Disease	8099
cancer	I-Disease	8099
population	O	8099
.	O	8099

A	O	8100
population	O	8100
-	O	8100
based	O	8100
series	O	8100
of	O	8100
54	O	8100
male	B-Disease	8100
breast	I-Disease	8100
cancer	I-Disease	8100
cases	O	8100
from	O	8100
Southern	O	8100
California	O	8100
were	O	8100
analyzed	O	8100
for	O	8100
germ	O	8100
-	O	8100
line	O	8100
mutations	O	8100
in	O	8100
the	O	8100
inherited	B-Disease	8100
breast	I-Disease	8100
/	I-Disease	8100
ovarian	I-Disease	8100
cancer	I-Disease	8100
genes	O	8100
,	O	8100
BRCA1	O	8100
and	O	8100
BRCA2	O	8100
.	O	8100

Nine	O	8101
(	O	8101
17	O	8101
%	O	8101
)	O	8101
of	O	8101
the	O	8101
patients	O	8101
had	O	8101
a	O	8101
family	O	8101
history	O	8101
of	O	8101
breast	B-Disease	8101
and	I-Disease	8101
/	I-Disease	8101
or	I-Disease	8101
ovarian	I-Disease	8101
cancer	I-Disease	8101
in	O	8101
at	O	8101
least	O	8101
one	O	8101
first	O	8101
-	O	8101
degree	O	8101
relative	O	8101
.	O	8101

A	O	8102
further	O	8102
seven	O	8102
(	O	8102
13	O	8102
%	O	8102
)	O	8102
of	O	8102
the	O	8102
patients	O	8102
reported	O	8102
breast	B-Disease	8102
/	I-Disease	8102
ovarian	I-Disease	8102
cancer	I-Disease	8102
in	O	8102
at	O	8102
least	O	8102
one	O	8102
second	O	8102
-	O	8102
degree	O	8102
relative	O	8102
and	O	8102
in	O	8102
no	O	8102
first	O	8102
-	O	8102
degree	O	8102
relatives	O	8102
.	O	8102

Two	O	8104
male	B-Disease	8104
breast	I-Disease	8104
cancer	I-Disease	8104
patients	O	8104
(	O	8104
4	O	8104
%	O	8104
of	O	8104
the	O	8104
total	O	8104
)	O	8104
were	O	8104
found	O	8104
to	O	8104
carry	O	8104
novel	O	8104
truncating	O	8104
mutations	O	8104
in	O	8104
the	O	8104
BRCA2	O	8104
gene	O	8104
.	O	8104

Only	O	8105
one	O	8105
of	O	8105
the	O	8105
two	O	8105
male	B-Disease	8105
breast	I-Disease	8105
cancer	I-Disease	8105
patients	O	8105
carrying	O	8105
a	O	8105
BRCA2	O	8105
mutation	O	8105
had	O	8105
a	O	8105
family	O	8105
history	O	8105
of	O	8105
cancer	B-Disease	8105
,	O	8105
with	O	8105
one	O	8105
case	O	8105
of	O	8105
ovarian	B-Disease	8105
cancer	I-Disease	8105
in	O	8105
a	O	8105
first	O	8105
-	O	8105
degree	O	8105
relative	O	8105
.	O	8105

The	O	8106
remaining	O	8106
eight	O	8106
cases	O	8106
(	O	8106
89	O	8106
%	O	8106
)	O	8106
of	O	8106
male	B-Disease	8106
breast	I-Disease	8106
cancer	I-Disease	8106
with	O	8106
a	O	8106
family	O	8106
history	O	8106
of	O	8106
breast	B-Disease	8106
/	I-Disease	8106
ovarian	I-Disease	8106
cancer	I-Disease	8106
in	O	8106
first	O	8106
-	O	8106
degree	O	8106
relatives	O	8106
remain	O	8106
unaccounted	O	8106
for	O	8106
by	O	8106
mutations	O	8106
in	O	8106
either	O	8106
the	O	8106
BRCA1	O	8106
gene	O	8106
or	O	8106
the	O	8106
BRCA2	O	8106
gene	O	8106
.	O	8106

Molecular	O	8108
basis	O	8108
for	O	8108
Duarte	B-Disease	8108
and	I-Disease	8108
Los	I-Disease	8108
Angeles	I-Disease	8108
variant	I-Disease	8108
galactosemia	I-Disease	8108
.	O	8108

Human	O	8109
orythrocytes	O	8109
that	O	8109
are	O	8109
homozygous	O	8109
for	O	8109
the	O	8109
Duarte	B-Disease	8109
enzyme	I-Disease	8109
variant	I-Disease	8109
of	I-Disease	8109
galactosemia	I-Disease	8109
(	O	8109
D	O	8109
/	O	8109
D	O	8109
)	O	8109
have	O	8109
a	O	8109
characteristic	O	8109
isoform	O	8109
on	O	8109
isoelectric	O	8109
focusing	O	8109
and	O	8109
50	O	8109
%	O	8109
reduction	O	8109
in	O	8109
galactose	O	8109
-	O	8109
1	O	8109
-	O	8109
phosphate	O	8109
uridyltransferase	O	8109
(	O	8109
GALT	O	8109
)	O	8109
enzyme	O	8109
activity	O	8109
.	O	8109

We	O	8121
conclude	O	8121
that	O	8121
the	O	8121
codon	O	8121
change	O	8121
N314D	O	8121
in	O	8121
cis	O	8121
with	O	8121
the	O	8121
base	O	8121
-	O	8121
pair	O	8121
transition	O	8121
1721C	O	8121
-	O	8121
-	O	8121
>	O	8121
T	O	8121
produces	O	8121
the	O	8121
LA	B-Disease	8121
variant	I-Disease	8121
of	I-Disease	8121
galactosemia	I-Disease	8121
and	O	8121
that	O	8121
this	O	8121
nucleotide	O	8121
change	O	8121
increases	O	8121
GALT	O	8121
activity	O	8121
by	O	8121
increasing	O	8121
GALT	O	8121
protein	O	8121
abundance	O	8121
without	O	8121
increasing	O	8121
transcription	O	8121
or	O	8121
decreasing	O	8121
thermal	O	8121
lability	O	8121
.	O	8121

The	O	8124
TSG101	O	8124
tumor	B-Disease	8124
susceptibility	O	8124
gene	O	8124
is	O	8124
located	O	8124
in	O	8124
chromosome	O	8124
11	O	8124
band	O	8124
p15	O	8124
and	O	8124
is	O	8124
mutated	O	8124
in	O	8124
human	O	8124
breast	B-Disease	8124
cancer	I-Disease	8124
.	O	8124

Recent	O	8125
work	O	8125
has	O	8125
identified	O	8125
a	O	8125
mouse	O	8125
gene	O	8125
(	O	8125
tsg101	O	8125
)	O	8125
whose	O	8125
inactivation	O	8125
in	O	8125
fibroblasts	O	8125
results	O	8125
in	O	8125
cellular	O	8125
transformation	O	8125
and	O	8125
the	O	8125
ability	O	8125
to	O	8125
produce	O	8125
metastatic	B-Disease	8125
tumors	I-Disease	8125
in	O	8125
nude	O	8125
mice	O	8125
.	O	8125

2	O	8128
,	O	8128
a	O	8128
region	O	8128
proposed	O	8128
to	O	8128
contain	O	8128
tumor	B-Disease	8128
suppressor	O	8128
gene	O	8128
(	O	8128
s	O	8128
)	O	8128
,	O	8128
is	O	8128
mutated	O	8128
at	O	8128
high	O	8128
frequency	O	8128
in	O	8128
human	O	8128
breast	B-Disease	8128
cancer	I-Disease	8128
.	O	8128

In	O	8129
7	O	8129
of	O	8129
15	O	8129
uncultured	O	8129
primary	O	8129
human	O	8129
breast	B-Disease	8129
carcinomas	I-Disease	8129
,	O	8129
intragenic	O	8129
deletions	O	8129
were	O	8129
shown	O	8129
in	O	8129
TSG101	O	8129
genomic	O	8129
DNA	O	8129
and	O	8129
transcripts	O	8129
by	O	8129
gel	O	8129
and	O	8129
sequence	O	8129
analysis	O	8129
,	O	8129
and	O	8129
mutations	O	8129
affecting	O	8129
two	O	8129
TSG101	O	8129
alleles	O	8129
were	O	8129
identified	O	8129
in	O	8129
four	O	8129
of	O	8129
these	O	8129
cancers	B-Disease	8129
.	O	8129

No	O	8130
TSG101	O	8130
defects	O	8130
were	O	8130
found	O	8130
in	O	8130
matched	O	8130
normal	O	8130
breast	O	8130
tissue	O	8130
from	O	8130
the	O	8130
breast	B-Disease	8130
cancer	I-Disease	8130
patients	O	8130
.	O	8130

These	O	8131
findings	O	8131
strongly	O	8131
implicate	O	8131
TSG101	O	8131
mutations	O	8131
in	O	8131
human	O	8131
breast	B-Disease	8131
cancer	I-Disease	8131
Moderate	O	8131
intergenerational	O	8131
and	O	8131
somatic	O	8131
instability	O	8131
of	O	8131
a	O	8131
55	O	8131
-	O	8131
CTG	O	8131
repeat	O	8131
in	O	8131
transgenic	O	8131
mice	O	8131
.	O	8131

Myotonic	B-Disease	8132
dystrophy	I-Disease	8132
(	O	8132
DM	B-Disease	8132
)	O	8132
is	O	8132
associated	O	8132
with	O	8132
the	O	8132
expansion	O	8132
of	O	8132
a	O	8132
(	O	8132
CTG	O	8132
)	O	8132
n	O	8132
trinucleotide	O	8132
repeat	O	8132
in	O	8132
the	O	8132
3	O	8132
untranslated	O	8132
region	O	8132
(	O	8132
UTR	O	8132
)	O	8132
of	O	8132
the	O	8132
DM	B-Disease	8132
protein	O	8132
kinase	O	8132
gene	O	8132
(	O	8132
DMPK	O	8132
)	O	8132
.	O	8132

Moreover	O	8136
,	O	8136
mitotic	O	8136
instability	O	8136
analysis	O	8136
of	O	8136
different	O	8136
human	O	8136
DM	B-Disease	8136
tissues	O	8136
shows	O	8136
length	O	8136
mosaicism	O	8136
between	O	8136
different	O	8136
cell	O	8136
lineages	O	8136
.	O	8136

Missense	O	8141
mutations	O	8141
in	O	8141
the	O	8141
Fas	O	8141
gene	O	8141
resulting	O	8141
in	O	8141
autoimmune	B-Disease	8141
lymphoproliferative	I-Disease	8141
syndrome	I-Disease	8141
:	O	8141
a	O	8141
molecular	O	8141
and	O	8141
immunological	O	8141
analysis	O	8141
.	O	8141

The	O	8143
Fas	O	8143
/	O	8143
Apo	O	8143
-	O	8143
1	O	8143
receptor	O	8143
plays	O	8143
a	O	8143
crucial	O	8143
role	O	8143
in	O	8143
the	O	8143
regulation	O	8143
of	O	8143
apoptosis	O	8143
,	O	8143
as	O	8143
demonstrated	O	8143
by	O	8143
lymphoproliferation	O	8143
in	O	8143
MRL	O	8143
-	O	8143
lpr	O	8143
/	O	8143
lpr	O	8143
mice	O	8143
and	O	8143
by	O	8143
the	O	8143
recently	O	8143
described	O	8143
autoimmune	B-Disease	8143
lymphoproliferative	I-Disease	8143
syndrome	I-Disease	8143
(	O	8143
ALPS	B-Disease	8143
)	O	8143
in	O	8143
humans	O	8143
,	O	8143
both	O	8143
of	O	8143
which	O	8143
are	O	8143
due	O	8143
to	O	8143
mutations	O	8143
in	O	8143
the	O	8143
Fas	O	8143
gene	O	8143
.	O	8143

We	O	8144
describe	O	8144
a	O	8144
novel	O	8144
family	O	8144
with	O	8144
ALPS	B-Disease	8144
in	O	8144
which	O	8144
three	O	8144
affected	O	8144
siblings	O	8144
carry	O	8144
two	O	8144
distinct	O	8144
missense	O	8144
mutations	O	8144
on	O	8144
both	O	8144
the	O	8144
Fas	O	8144
gene	O	8144
alleles	O	8144
and	O	8144
show	O	8144
lack	O	8144
of	O	8144
Fas	O	8144
-	O	8144
induced	O	8144
apoptosis	O	8144
.	O	8144

The	O	8145
children	O	8145
share	O	8145
common	O	8145
clinical	O	8145
features	O	8145
including	O	8145
splenomegaly	B-Disease	8145
and	O	8145
lymphadenopathy	B-Disease	8145
,	O	8145
but	O	8145
only	O	8145
one	O	8145
developed	O	8145
severe	O	8145
autoimmune	B-Disease	8145
manifestations	I-Disease	8145
.	O	8145

The	O	8148
ataxia	B-Disease	8148
-	I-Disease	8148
telangiectasia	I-Disease	8148
gene	O	8148
product	O	8148
,	O	8148
a	O	8148
constitutively	O	8148
expressed	O	8148
nuclear	O	8148
protein	O	8148
that	O	8148
is	O	8148
not	O	8148
up	O	8148
-	O	8148
regulated	O	8148
following	O	8148
genome	O	8148
damage	O	8148
.	O	8148

The	O	8149
product	O	8149
of	O	8149
the	O	8149
ataxia	B-Disease	8149
-	I-Disease	8149
telangiectasia	I-Disease	8149
gene	O	8149
(	O	8149
ATM	O	8149
)	O	8149
was	O	8149
identified	O	8149
by	O	8149
using	O	8149
an	O	8149
antiserum	O	8149
developed	O	8149
to	O	8149
a	O	8149
peptide	O	8149
corresponding	O	8149
to	O	8149
the	O	8149
deduced	O	8149
amino	O	8149
acid	O	8149
sequence	O	8149
.	O	8149

Truncated	O	8152
ATM	O	8152
protein	O	8152
was	O	8152
not	O	8152
detected	O	8152
in	O	8152
lymphoblasts	O	8152
from	O	8152
ataxia	B-Disease	8152
-	I-Disease	8152
telangiectasia	I-Disease	8152
patients	O	8152
homozygous	O	8152
for	O	8152
mutations	O	8152
leading	O	8152
to	O	8152
premature	O	8152
protein	O	8152
termination	O	8152
.	O	8152

Mutations	O	8159
in	O	8159
the	O	8159
COL3A1	O	8159
gene	O	8159
have	O	8159
been	O	8159
implicated	O	8159
as	O	8159
a	O	8159
cause	O	8159
of	O	8159
type	B-Disease	8159
IV	I-Disease	8159
Ehlers	I-Disease	8159
-	I-Disease	8159
Danlos	I-Disease	8159
syndrome	I-Disease	8159
,	O	8159
a	O	8159
disease	O	8159
leading	O	8159
to	O	8159
aortic	B-Disease	8159
rupture	I-Disease	8159
in	O	8159
early	O	8159
adult	O	8159
life	O	8159
.	O	8159

The	O	8163
major	O	8163
cause	O	8163
of	O	8163
death	O	8163
of	O	8163
mutant	O	8163
mice	O	8163
was	O	8163
rupture	O	8163
of	O	8163
the	O	8163
major	O	8163
blood	O	8163
vessels	O	8163
,	O	8163
similar	O	8163
to	O	8163
patients	O	8163
with	O	8163
type	B-Disease	8163
IV	I-Disease	8163
Ehlers	I-Disease	8163
-	I-Disease	8163
Danlos	I-Disease	8163
syndrome	I-Disease	8163
.	O	8163

Nonsense	O	8166
mutation	O	8166
in	O	8166
exon	O	8166
3	O	8166
of	O	8166
the	O	8166
proteolipid	O	8166
protein	O	8166
gene	O	8166
(	O	8166
PLP	O	8166
)	O	8166
in	O	8166
a	O	8166
family	O	8166
with	O	8166
an	O	8166
unusual	O	8166
form	O	8166
of	O	8166
Pelizaeus	B-Disease	8166
-	I-Disease	8166
Merzbacher	I-Disease	8166
disease	I-Disease	8166
.	O	8166

We	O	8167
report	O	8167
a	O	8167
G	O	8167
-	O	8167
-	O	8167
>	O	8167
A	O	8167
transition	O	8167
at	O	8167
nucleotide	O	8167
431	O	8167
of	O	8167
the	O	8167
proteolipid	O	8167
protein	O	8167
gene	O	8167
(	O	8167
PLP	O	8167
)	O	8167
results	O	8167
in	O	8167
a	O	8167
nonsense	O	8167
codon	O	8167
in	O	8167
a	O	8167
family	O	8167
with	O	8167
an	O	8167
unusual	O	8167
form	O	8167
of	O	8167
Pelizaeus	B-Disease	8167
-	I-Disease	8167
Merzbacher	I-Disease	8167
disease	I-Disease	8167
(	O	8167
PMD	B-Disease	8167
)	O	8167
.	O	8167

The	O	8169
clinical	O	8169
picture	O	8169
resembles	O	8169
somewhat	O	8169
that	O	8169
of	O	8169
X	B-Disease	8169
-	I-Disease	8169
linked	I-Disease	8169
spastic	I-Disease	8169
paraplegia	I-Disease	8169
(	O	8169
SPG	B-Disease	8169
)	O	8169
.	O	8169

It	O	8170
differs	O	8170
from	O	8170
this	O	8170
and	O	8170
both	O	8170
the	O	8170
classical	O	8170
and	O	8170
connatal	O	8170
forms	O	8170
of	O	8170
PMD	B-Disease	8170
in	O	8170
that	O	8170
it	O	8170
is	O	8170
relatively	O	8170
mild	O	8170
in	O	8170
form	O	8170
,	O	8170
onset	O	8170
is	O	8170
delayed	O	8170
beyond	O	8170
age	O	8170
2	O	8170
years	O	8170
,	O	8170
nystagmus	B-Disease	8170
is	O	8170
absent	O	8170
,	O	8170
tremors	B-Disease	8170
are	O	8170
prominent	O	8170
,	O	8170
mental	B-Disease	8170
retardation	I-Disease	8170
is	O	8170
not	O	8170
severe	O	8170
,	O	8170
some	O	8170
patients	O	8170
show	O	8170
dementia	B-Disease	8170
or	O	8170
personality	B-Disease	8170
disorders	I-Disease	8170
,	O	8170
the	O	8170
disease	O	8170
is	O	8170
progressive	O	8170
rather	O	8170
than	O	8170
static	O	8170
in	O	8170
some	O	8170
,	O	8170
and	O	8170
several	O	8170
females	O	8170
show	O	8170
signs	O	8170
of	O	8170
disease	O	8170
.	O	8170

The	O	8171
nonsense	O	8171
mutation	O	8171
,	O	8171
which	O	8171
is	O	8171
in	O	8171
exon	O	8171
3B	O	8171
,	O	8171
should	O	8171
block	O	8171
the	O	8171
synthesis	O	8171
of	O	8171
normal	O	8171
PLP	O	8171
but	O	8171
spare	O	8171
DM20	O	8171
,	O	8171
the	O	8171
isoform	O	8171
whose	O	8171
persistence	O	8171
has	O	8171
been	O	8171
associated	O	8171
with	O	8171
mild	O	8171
forms	O	8171
of	O	8171
PLP	B-Disease	8171
-	I-Disease	8171
associated	I-Disease	8171
disease	I-Disease	8171
in	O	8171
both	O	8171
humans	O	8171
and	O	8171
mice	O	8171
.	O	8171

Common	O	8173
BRCA1	O	8173
variants	O	8173
and	O	8173
susceptibility	O	8173
to	O	8173
breast	B-Disease	8173
and	I-Disease	8173
ovarian	I-Disease	8173
cancer	I-Disease	8173
in	O	8173
the	O	8173
general	O	8173
population	O	8173
.	O	8173

Most	O	8174
multiple	O	8174
case	O	8174
families	O	8174
of	O	8174
young	O	8174
onset	O	8174
breast	B-Disease	8174
cancer	I-Disease	8174
and	O	8174
ovarian	B-Disease	8174
cancer	I-Disease	8174
are	O	8174
thought	O	8174
to	O	8174
be	O	8174
due	O	8174
to	O	8174
highly	O	8174
penetrant	O	8174
mutations	O	8174
in	O	8174
the	O	8174
predisposing	O	8174
genes	O	8174
BRCA1	O	8174
and	O	8174
BRCA2	O	8174
.	O	8174

However	O	8175
,	O	8175
these	O	8175
mutations	O	8175
are	O	8175
uncommon	O	8175
in	O	8175
the	O	8175
population	O	8175
and	O	8175
they	O	8175
probably	O	8175
account	O	8175
for	O	8175
only	O	8175
a	O	8175
few	O	8175
percent	O	8175
of	O	8175
all	O	8175
breast	B-Disease	8175
cancer	I-Disease	8175
incidence	O	8175
.	O	8175

A	O	8176
much	O	8176
larger	O	8176
fraction	O	8176
of	O	8176
breast	B-Disease	8176
cancer	I-Disease	8176
might	O	8176
,	O	8176
in	O	8176
principle	O	8176
,	O	8176
be	O	8176
due	O	8176
to	O	8176
common	O	8176
variants	O	8176
which	O	8176
confer	O	8176
more	O	8176
modest	O	8176
individual	O	8176
risks	O	8176
.	O	8176

We	O	8178
have	O	8178
examined	O	8178
the	O	8178
frequency	O	8178
of	O	8178
four	O	8178
of	O	8178
these	O	8178
polymorphisms	O	8178
Gln356Arg	O	8178
,	O	8178
Pro871Leu	O	8178
,	O	8178
Glu1038Gly	O	8178
and	O	8178
Ser1613Gly	O	8178
in	O	8178
large	O	8178
series	O	8178
of	O	8178
breast	B-Disease	8178
and	I-Disease	8178
ovarian	I-Disease	8178
cancer	I-Disease	8178
cases	O	8178
and	O	8178
matched	O	8178
controls	O	8178
.	O	8178

Thus	O	8184
the	O	8184
most	O	8184
common	O	8184
polymorphisms	O	8184
of	O	8184
the	O	8184
BRCA1	O	8184
gene	O	8184
do	O	8184
not	O	8184
make	O	8184
a	O	8184
significant	O	8184
contribution	O	8184
to	O	8184
breast	B-Disease	8184
or	I-Disease	8184
ovarian	I-Disease	8184
cancer	I-Disease	8184
risk	O	8184
.	O	8184

However	O	8185
,	O	8185
our	O	8185
data	O	8185
suggest	O	8185
that	O	8185
the	O	8185
Arg356	O	8185
allele	O	8185
may	O	8185
have	O	8185
a	O	8185
different	O	8185
genotype	O	8185
distribution	O	8185
in	O	8185
breast	B-Disease	8185
cancer	I-Disease	8185
patients	O	8185
from	O	8185
that	O	8185
in	O	8185
controls	O	8185
(	O	8185
Arg356	O	8185
homozygotes	O	8185
are	O	8185
more	O	8185
frequent	O	8185
in	O	8185
the	O	8185
control	O	8185
groups	O	8185
,	O	8185
P	O	8185
=	O	8185
0	O	8185
.	O	8185

01	O	8186
)	O	8186
,	O	8186
indicating	O	8186
that	O	8186
it	O	8186
may	O	8186
be	O	8186
protective	O	8186
against	O	8186
breast	B-Disease	8186
cancer	I-Disease	8186
.	O	8186

Kniest	B-Disease	8188
dysplasia	I-Disease	8188
:	O	8188
Dr	O	8188
.	O	8188

Kniest	B-Disease	8191
dysplasia	I-Disease	8191
is	O	8191
a	O	8191
severe	O	8191
chondrodysplasia	B-Disease	8191
caused	O	8191
by	O	8191
the	O	8191
defective	B-Disease	8191
formation	I-Disease	8191
of	I-Disease	8191
type	I-Disease	8191
II	I-Disease	8191
collagen	I-Disease	8191
.	O	8191

Kniest	O	8193
,	O	8193
who	O	8193
first	O	8193
described	O	8193
the	O	8193
condition	O	8193
in	O	8193
1952	O	8193
,	O	8193
and	O	8193
his	O	8193
patient	O	8193
,	O	8193
who	O	8193
,	O	8193
at	O	8193
the	O	8193
age	O	8193
of	O	8193
50	O	8193
years	O	8193
is	O	8193
severely	B-Disease	8193
handicapped	I-Disease	8193
with	O	8193
short	B-Disease	8193
stature	I-Disease	8193
,	O	8193
restricted	B-Disease	8193
joint	I-Disease	8193
mobility	I-Disease	8193
,	O	8193
and	O	8193
blindness	B-Disease	8193
but	O	8193
is	O	8193
mentally	O	8193
alert	O	8193
and	O	8193
leads	O	8193
an	O	8193
active	O	8193
life	O	8193
.	O	8193

This	O	8195
is	O	8195
in	O	8195
accordance	O	8195
with	O	8195
molecular	O	8195
findings	O	8195
in	O	8195
other	O	8195
patients	O	8195
with	O	8195
Kniest	B-Disease	8195
dysplasia	I-Disease	8195
and	O	8195
confirms	O	8195
,	O	8195
in	O	8195
the	O	8195
original	O	8195
patient	O	8195
,	O	8195
that	O	8195
the	O	8195
disorder	O	8195
is	O	8195
caused	O	8195
by	O	8195
small	O	8195
inframe	O	8195
deletions	O	8195
often	O	8195
due	O	8195
to	O	8195
exon	O	8195
skipping	O	8195
as	O	8195
a	O	8195
result	O	8195
of	O	8195
COL2A1	O	8195
splice	O	8195
site	O	8195
mutations	O	8195
.	O	8195

Cloning	O	8197
of	O	8197
the	O	8197
homogentisate	O	8197
1	O	8197
,	O	8197
2	O	8197
-	O	8197
dioxygenase	O	8197
gene	O	8197
,	O	8197
the	O	8197
key	O	8197
enzyme	O	8197
of	O	8197
alkaptonuria	B-Disease	8197
in	O	8197
mouse	O	8197
.	O	8197

This	O	8217
corresponds	O	8217
well	O	8217
to	O	8217
the	O	8217
previous	O	8217
assignment	O	8217
of	O	8217
the	O	8217
locus	O	8217
for	O	8217
the	O	8217
human	O	8217
alkaptonuria	B-Disease	8217
gene	O	8217
(	O	8217
AKU	O	8217
)	O	8217
to	O	8217
the	O	8217
same	O	8217
chromosomal	O	8217
region	O	8217
by	O	8217
multipoint	O	8217
linkage	O	8217
analysis	O	8217
.	O	8217

We	O	8218
therefore	O	8218
conclude	O	8218
that	O	8218
the	O	8218
HGO	O	8218
cDNA	O	8218
encodes	O	8218
the	O	8218
gene	O	8218
responsible	O	8218
for	O	8218
alkaptonuria	B-Disease	8218
.	O	8218

PTEN	O	8219
,	O	8219
a	O	8219
putative	O	8219
protein	O	8219
tyrosine	O	8219
phosphatase	O	8219
gene	O	8219
mutated	O	8219
in	O	8219
human	O	8219
brain	B-Disease	8219
,	I-Disease	8219
breast	I-Disease	8219
,	I-Disease	8219
and	I-Disease	8219
prostate	I-Disease	8219
cancer	I-Disease	8219
.	O	8219

Mapping	O	8220
of	O	8220
homozygous	O	8220
deletions	O	8220
on	O	8220
human	O	8220
chromosome	O	8220
10q23	O	8220
has	O	8220
led	O	8220
to	O	8220
the	O	8220
isolation	O	8220
of	O	8220
a	O	8220
candidate	O	8220
tumor	B-Disease	8220
suppressor	O	8220
gene	O	8220
,	O	8220
PTEN	O	8220
,	O	8220
that	O	8220
appears	O	8220
to	O	8220
be	O	8220
mutated	O	8220
at	O	8220
considerable	O	8220
frequency	O	8220
in	O	8220
human	O	8220
cancers	B-Disease	8220
.	O	8220

In	O	8221
preliminary	O	8221
screens	O	8221
,	O	8221
mutations	O	8221
of	O	8221
PTEN	O	8221
were	O	8221
detected	O	8221
in	O	8221
31	O	8221
%	O	8221
(	O	8221
13	O	8221
/	O	8221
42	O	8221
)	O	8221
of	O	8221
glioblastoma	B-Disease	8221
cell	O	8221
lines	O	8221
and	O	8221
xenografts	O	8221
,	O	8221
100	O	8221
%	O	8221
(	O	8221
4	O	8221
/	O	8221
4	O	8221
)	O	8221
of	O	8221
prostate	B-Disease	8221
cancer	I-Disease	8221
cell	O	8221
lines	O	8221
,	O	8221
6	O	8221
%	O	8221
(	O	8221
4	O	8221
/	O	8221
65	O	8221
)	O	8221
of	O	8221
breast	B-Disease	8221
cancer	I-Disease	8221
cell	O	8221
lines	O	8221
and	O	8221
xenografts	O	8221
,	O	8221
and	O	8221
17	O	8221
%	O	8221
(	O	8221
3	O	8221
/	O	8221
18	O	8221
)	O	8221
of	O	8221
primary	B-Disease	8221
glioblastomas	I-Disease	8221
.	O	8221

These	O	8223
homologies	O	8223
suggest	O	8223
that	O	8223
PTEN	O	8223
may	O	8223
suppress	O	8223
tumor	B-Disease	8223
cell	O	8223
growth	O	8223
by	O	8223
antagonizing	O	8223
protein	O	8223
tyrosine	O	8223
kinases	O	8223
and	O	8223
may	O	8223
regulate	O	8223
tumor	B-Disease	8223
cell	O	8223
invasion	O	8223
and	O	8223
metastasis	B-Disease	8223
through	O	8223
interactions	O	8223
at	O	8223
focal	O	8223
adhesions	O	8223
.	O	8223

Heterogeneity	O	8225
in	O	8225
Schwartz	B-Disease	8225
-	I-Disease	8225
Jampel	I-Disease	8225
chondrodystrophic	I-Disease	8225
myotonia	I-Disease	8225
.	O	8225

The	O	8226
Schwartz	B-Disease	8226
-	I-Disease	8226
Jampel	I-Disease	8226
syndrome	I-Disease	8226
(	O	8226
SJS	B-Disease	8226
;	O	8226
chondrodystrophic	B-Disease	8226
myotonia	I-Disease	8226
;	O	8226
McK	O	8226
255	O	8226
,	O	8226
800	O	8226
)	O	8226
is	O	8226
a	O	8226
recessively	B-Disease	8226
inherited	I-Disease	8226
condition	I-Disease	8226
defined	O	8226
by	O	8226
myotonia	B-Disease	8226
,	O	8226
short	B-Disease	8226
stature	I-Disease	8226
,	O	8226
and	O	8226
bone	B-Disease	8226
dysplasia	I-Disease	8226
.	O	8226

Genetic	O	8227
linkage	O	8227
between	O	8227
SJS	B-Disease	8227
and	O	8227
chromosomal	O	8227
region	O	8227
1q36	O	8227
-	O	8227
34	O	8227
has	O	8227
been	O	8227
observed	O	8227
in	O	8227
several	O	8227
families	O	8227
,	O	8227
but	O	8227
the	O	8227
gene	O	8227
has	O	8227
not	O	8227
yet	O	8227
been	O	8227
identified	O	8227
.	O	8227

In	O	8229
addition	O	8229
,	O	8229
we	O	8229
tested	O	8229
genetic	O	8229
linkage	O	8229
to	O	8229
the	O	8229
SJS	B-Disease	8229
locus	O	8229
on	O	8229
chromosome	O	8229
1	O	8229
in	O	8229
one	O	8229
family	O	8229
with	O	8229
two	O	8229
affected	O	8229
sibs	O	8229
.	O	8229

We	O	8230
found	O	8230
that	O	8230
a	O	8230
group	O	8230
of	O	8230
patients	O	8230
have	O	8230
mild	O	8230
skeletal	O	8230
changes	O	8230
which	O	8230
may	O	8230
be	O	8230
secondary	O	8230
consequences	O	8230
of	O	8230
myotonia	B-Disease	8230
,	O	8230
while	O	8230
another	O	8230
group	O	8230
of	O	8230
patients	O	8230
appear	O	8230
to	O	8230
have	O	8230
primary	O	8230
bone	B-Disease	8230
dysplasia	I-Disease	8230
with	O	8230
myotonia	B-Disease	8230
.	O	8230

We	O	8232
tentatively	O	8232
isolate	O	8232
three	O	8232
different	O	8232
types	O	8232
of	O	8232
SJS	B-Disease	8232
type	I-Disease	8232
1A	I-Disease	8232
,	O	8232
usually	O	8232
recognized	O	8232
in	O	8232
childhood	O	8232
,	O	8232
with	O	8232
moderate	O	8232
bone	B-Disease	8232
dysplasia	I-Disease	8232
,	O	8232
corresponding	O	8232
to	O	8232
the	O	8232
original	O	8232
descriptions	O	8232
of	O	8232
Schwartz	O	8232
,	O	8232
Jampel	O	8232
and	O	8232
Aberfeld	O	8232
;	O	8232
type	O	8232
1B	O	8232
,	O	8232
similar	O	8232
to	O	8232
type	O	8232
1A	O	8232
but	O	8232
recognizable	O	8232
at	O	8232
birth	O	8232
,	O	8232
with	O	8232
more	O	8232
pronounced	O	8232
bone	B-Disease	8232
dysplasia	I-Disease	8232
resembling	O	8232
Kniest	B-Disease	8232
dysplasia	I-Disease	8232
;	O	8232
and	O	8232
type	O	8232
2	O	8232
,	O	8232
manifest	O	8232
at	O	8232
birth	O	8232
,	O	8232
with	O	8232
increased	O	8232
mortality	O	8232
and	O	8232
bone	B-Disease	8232
dysplasia	I-Disease	8232
resembling	O	8232
Pyle	B-Disease	8232
disease	I-Disease	8232
.	O	8232

Genetic	O	8233
analysis	O	8233
of	O	8233
the	O	8233
family	O	8233
with	O	8233
two	O	8233
sibs	O	8233
affected	O	8233
by	O	8233
SJS	B-Disease	8233
type	I-Disease	8233
2	I-Disease	8233
showed	O	8233
evidence	O	8233
against	O	8233
linkage	O	8233
to	O	8233
chromosome	O	8233
1p36	O	8233
-	O	8233
34	O	8233
.	O	8233

CONCLUSIONS	O	8234
SJS	B-Disease	8234
is	O	8234
clinically	O	8234
and	O	8234
radiologically	O	8234
heterogeneous	O	8234
.	O	8234

The	O	8235
causes	O	8235
of	O	8235
heterogeneity	O	8235
are	O	8235
not	O	8235
known	O	8235
yet	O	8235
but	O	8235
are	O	8235
likely	O	8235
to	O	8235
include	O	8235
both	O	8235
different	O	8235
mutations	O	8235
at	O	8235
the	O	8235
SJS	B-Disease	8235
locus	O	8235
on	O	8235
chromosome	O	8235
1	O	8235
and	O	8235
the	O	8235
presence	O	8235
of	O	8235
a	O	8235
second	O	8235
SJS	B-Disease	8235
locus	O	8235
.	O	8235

Mutations	O	8239
in	O	8239
the	O	8239
WT1	O	8239
gene	O	8239
were	O	8239
anticipated	O	8239
to	O	8239
explain	O	8239
the	O	8239
genetic	O	8239
basis	O	8239
of	O	8239
the	O	8239
childhood	O	8239
kidney	B-Disease	8239
cancer	I-Disease	8239
,	O	8239
Wilms	B-Disease	8239
tumour	I-Disease	8239
(	O	8239
WT	B-Disease	8239
)	O	8239
.	O	8239

While	O	8241
only	O	8241
5	O	8241
%	O	8241
of	O	8241
sporadic	B-Disease	8241
Wilms	I-Disease	8241
tumours	I-Disease	8241
have	O	8241
intragenic	O	8241
WT1	O	8241
mutations	O	8241
,	O	8241
>	O	8241
90	O	8241
%	O	8241
of	O	8241
patients	O	8241
with	O	8241
the	O	8241
Denys	B-Disease	8241
-	I-Disease	8241
Drash	I-Disease	8241
syndrome	I-Disease	8241
(	O	8241
renal	B-Disease	8241
nephropathy	I-Disease	8241
,	O	8241
gonadal	B-Disease	8241
anomaly	I-Disease	8241
,	O	8241
predisposition	B-Disease	8241
to	I-Disease	8241
WT	I-Disease	8241
)	O	8241
carry	O	8241
constitutional	O	8241
intragenic	O	8241
WT1	O	8241
mutations	O	8241
.	O	8241

WT1	O	8242
mutations	O	8242
have	O	8242
also	O	8242
been	O	8242
reported	O	8242
in	O	8242
juvenile	B-Disease	8242
granulosa	I-Disease	8242
cell	I-Disease	8242
tumour	I-Disease	8242
,	O	8242
non	B-Disease	8242
-	I-Disease	8242
asbestos	I-Disease	8242
related	I-Disease	8242
mesothelioma	I-Disease	8242
,	O	8242
desmoplastic	B-Disease	8242
small	I-Disease	8242
round	I-Disease	8242
cell	I-Disease	8242
tumour	I-Disease	8242
and	O	8242
,	O	8242
most	O	8242
recently	O	8242
,	O	8242
acute	B-Disease	8242
myeloid	I-Disease	8242
leukemia	I-Disease	8242
.	O	8242

A	O	8244
mutation	O	8244
in	O	8244
autosomal	B-Disease	8244
dominant	I-Disease	8244
myotonia	I-Disease	8244
congenita	I-Disease	8244
affects	O	8244
pore	O	8244
properties	O	8244
of	O	8244
the	O	8244
muscle	O	8244
chloride	O	8244
channel	O	8244
.	O	8244

Autosomal	B-Disease	8245
dominant	I-Disease	8245
myotonia	I-Disease	8245
congenita	I-Disease	8245
is	O	8245
an	O	8245
inherited	B-Disease	8245
disorder	I-Disease	8245
of	I-Disease	8245
skeletal	I-Disease	8245
muscle	I-Disease	8245
caused	O	8245
by	O	8245
mutations	O	8245
in	O	8245
a	O	8245
voltage	O	8245
-	O	8245
gated	O	8245
Cl	O	8245
-	O	8245
channel	O	8245
gene	O	8245
(	O	8245
CLCN1	O	8245
,	O	8245
7q35	O	8245
)	O	8245
.	O	8245

The	O	8254
incidence	O	8254
of	O	8254
PAX6	O	8254
mutation	O	8254
in	O	8254
patients	O	8254
with	O	8254
simple	O	8254
aniridia	B-Disease	8254
:	O	8254
an	O	8254
evaluation	O	8254
of	O	8254
mutation	O	8254
detection	O	8254
in	O	8254
12	O	8254
cases	O	8254
.	O	8254

Twelve	O	8255
aniridia	B-Disease	8255
patients	O	8255
,	O	8255
five	O	8255
with	O	8255
a	O	8255
family	O	8255
history	O	8255
and	O	8255
seven	O	8255
presumed	O	8255
to	O	8255
be	O	8255
sporadic	O	8255
,	O	8255
were	O	8255
exhaustively	O	8255
screened	O	8255
in	O	8255
order	O	8255
to	O	8255
test	O	8255
what	O	8255
proportion	O	8255
of	O	8255
people	O	8255
with	O	8255
aniridia	B-Disease	8255
,	O	8255
uncomplicated	O	8255
by	O	8255
associated	O	8255
anomalies	O	8255
,	O	8255
carry	O	8255
mutations	O	8255
in	O	8255
the	O	8255
human	O	8255
PAX6	O	8255
gene	O	8255
.	O	8255

Insulin	O	8265
gene	O	8265
region	O	8265
contributes	O	8265
to	O	8265
genetic	O	8265
susceptibility	O	8265
to	O	8265
,	O	8265
but	O	8265
may	O	8265
not	O	8265
to	O	8265
low	O	8265
incidence	O	8265
of	O	8265
,	O	8265
insulin	B-Disease	8265
-	I-Disease	8265
dependent	I-Disease	8265
diabetes	I-Disease	8265
mellitus	I-Disease	8265
in	O	8265
Japanese	O	8265
.	O	8265

In	O	8266
the	O	8266
Caucasian	O	8266
population	O	8266
,	O	8266
it	O	8266
has	O	8266
been	O	8266
demonstrated	O	8266
that	O	8266
the	O	8266
insulin	O	8266
gene	O	8266
(	O	8266
INS	O	8266
)	O	8266
region	O	8266
contains	O	8266
the	O	8266
insulin	B-Disease	8266
-	I-Disease	8266
dependent	I-Disease	8266
diabetes	I-Disease	8266
mellitus	I-Disease	8266
locus	O	8266
(	O	8266
IDDM2	O	8266
)	O	8266
.	O	8266

In	O	8267
the	O	8267
Japanese	O	8267
population	O	8267
,	O	8267
however	O	8267
,	O	8267
there	O	8267
has	O	8267
been	O	8267
no	O	8267
report	O	8267
demonstrating	O	8267
the	O	8267
contribution	O	8267
of	O	8267
IDDM2	O	8267
to	O	8267
the	O	8267
pathogenesis	O	8267
of	O	8267
IDDM	B-Disease	8267
.	O	8267

We	O	8268
conducted	O	8268
an	O	8268
association	O	8268
study	O	8268
of	O	8268
IDDM	B-Disease	8268
in	O	8268
a	O	8268
large	O	8268
number	O	8268
of	O	8268
Japanese	O	8268
subjects	O	8268
with	O	8268
multiple	O	8268
polymorphisms	O	8268
in	O	8268
INS	O	8268
region	O	8268
.	O	8268

We	O	8269
found	O	8269
a	O	8269
significant	O	8269
association	O	8269
of	O	8269
the	O	8269
INS	O	8269
region	O	8269
with	O	8269
IDDM	B-Disease	8269
.	O	8269

Alleles	O	8270
positively	O	8270
associated	O	8270
with	O	8270
IDDM	B-Disease	8270
in	O	8270
INS	O	8270
region	O	8270
were	O	8270
the	O	8270
same	O	8270
as	O	8270
those	O	8270
positively	O	8270
-	O	8270
associated	O	8270
with	O	8270
IDDM	B-Disease	8270
in	O	8270
Caucasian	O	8270
population	O	8270
,	O	8270
although	O	8270
positively	O	8270
-	O	8270
associated	O	8270
alleles	O	8270
are	O	8270
very	O	8270
common	O	8270
(	O	8270
allele	O	8270
frequencies	O	8270
>	O	8270
0	O	8270
.	O	8270

These	O	8272
data	O	8272
suggest	O	8272
that	O	8272
IDDM2	O	8272
is	O	8272
involved	O	8272
in	O	8272
the	O	8272
genetic	O	8272
susceptibility	O	8272
to	O	8272
IDDM	B-Disease	8272
in	O	8272
Japanese	O	8272
.	O	8272

The	O	8273
high	O	8273
frequencies	O	8273
of	O	8273
disease	O	8273
-	O	8273
associated	O	8273
alleles	O	8273
in	O	8273
the	O	8273
general	O	8273
population	O	8273
suggest	O	8273
that	O	8273
IDDM2	O	8273
locus	O	8273
is	O	8273
not	O	8273
responsible	O	8273
for	O	8273
the	O	8273
low	O	8273
incidence	O	8273
of	O	8273
IDDM	B-Disease	8273
in	O	8273
Japanese	O	8273
.	O	8273

Deficiency	B-Disease	8277
of	I-Disease	8277
terminal	I-Disease	8277
complement	I-Disease	8277
components	I-Disease	8277
is	O	8277
generally	O	8277
associated	O	8277
with	O	8277
recurrent	O	8277
neisseria	B-Disease	8277
infections	I-Disease	8277
.	O	8277

We	O	8278
studied	O	8278
a	O	8278
previously	O	8278
described	O	8278
Swiss	O	8278
family	O	8278
with	O	8278
inherited	B-Disease	8278
C9	I-Disease	8278
deficiency	I-Disease	8278
.	O	8278

To	O	8279
identify	O	8279
the	O	8279
genetic	O	8279
basis	O	8279
of	O	8279
C9	B-Disease	8279
deficiency	I-Disease	8279
,	O	8279
we	O	8279
developed	O	8279
an	O	8279
approach	O	8279
using	O	8279
exon	O	8279
-	O	8279
specific	O	8279
PCR	O	8279
and	O	8279
direct	O	8279
DNA	O	8279
sequencing	O	8279
.	O	8279

As	O	8280
a	O	8280
cause	O	8280
of	O	8280
C9	B-Disease	8280
deficiency	I-Disease	8280
,	O	8280
we	O	8280
found	O	8280
two	O	8280
different	O	8280
point	O	8280
mutations	O	8280
,	O	8280
both	O	8280
generating	O	8280
TGA	O	8280
stop	O	8280
codons	O	8280
in	O	8280
the	O	8280
coding	O	8280
sequence	O	8280
.	O	8280

In	O	8282
family	O	8282
studies	O	8282
of	O	8282
three	O	8282
first	O	8282
-	O	8282
degree	O	8282
relatives	O	8282
with	O	8282
heterozygous	O	8282
C9	B-Disease	8282
deficiency	I-Disease	8282
,	O	8282
we	O	8282
demonstrated	O	8282
that	O	8282
the	O	8282
two	O	8282
mutations	O	8282
are	O	8282
segregating	O	8282
independently	O	8282
.	O	8282

BRCA1	O	8288
mutations	O	8288
in	O	8288
women	O	8288
attending	O	8288
clinics	O	8288
that	O	8288
evaluate	O	8288
the	O	8288
risk	O	8288
of	O	8288
breast	B-Disease	8288
cancer	I-Disease	8288
.	O	8288

BACKGROUND	O	8289
To	O	8289
define	O	8289
the	O	8289
incidence	O	8289
of	O	8289
BRCA1	O	8289
mutations	O	8289
among	O	8289
patients	O	8289
seen	O	8289
in	O	8289
clinics	O	8289
that	O	8289
evaluate	O	8289
the	O	8289
risk	O	8289
of	O	8289
breast	B-Disease	8289
cancer	I-Disease	8289
,	O	8289
we	O	8289
analyzed	O	8289
DNA	O	8289
samples	O	8289
from	O	8289
women	O	8289
seen	O	8289
in	O	8289
this	O	8289
setting	O	8289
and	O	8289
constructed	O	8289
probability	O	8289
tables	O	8289
to	O	8289
provide	O	8289
estimates	O	8289
of	O	8289
the	O	8289
likelihood	O	8289
of	O	8289
finding	O	8289
a	O	8289
BRCA1	O	8289
mutation	O	8289
in	O	8289
individual	O	8289
families	O	8289
.	O	8289

METHODS	O	8290
Clinical	O	8290
information	O	8290
,	O	8290
family	O	8290
histories	O	8290
,	O	8290
and	O	8290
blood	O	8290
for	O	8290
DNA	O	8290
analysis	O	8290
were	O	8290
obtained	O	8290
from	O	8290
263	O	8290
women	O	8290
with	O	8290
breast	B-Disease	8290
cancer	I-Disease	8290
.	O	8290

RESULTS	O	8292
BRCA1	O	8292
mutations	O	8292
were	O	8292
identified	O	8292
in	O	8292
16	O	8292
percent	O	8292
of	O	8292
women	O	8292
with	O	8292
a	O	8292
family	O	8292
history	O	8292
of	O	8292
breast	B-Disease	8292
cancer	I-Disease	8292
.	O	8292

Only	O	8293
7	O	8293
percent	O	8293
of	O	8293
women	O	8293
from	O	8293
families	O	8293
with	O	8293
a	O	8293
history	O	8293
of	O	8293
breast	B-Disease	8293
cancer	I-Disease	8293
but	O	8293
not	O	8293
ovarian	B-Disease	8293
cancer	I-Disease	8293
had	O	8293
BRCA1	O	8293
mutations	O	8293
.	O	8293

The	O	8294
rates	O	8294
were	O	8294
higher	O	8294
among	O	8294
women	O	8294
from	O	8294
families	O	8294
with	O	8294
a	O	8294
history	O	8294
of	O	8294
both	O	8294
breast	B-Disease	8294
and	I-Disease	8294
ovarian	I-Disease	8294
cancer	I-Disease	8294
.	O	8294

Among	O	8295
family	O	8295
members	O	8295
,	O	8295
an	O	8295
average	O	8295
age	O	8295
of	O	8295
less	O	8295
than	O	8295
55	O	8295
years	O	8295
at	O	8295
the	O	8295
diagnosis	O	8295
of	O	8295
breast	B-Disease	8295
cancer	I-Disease	8295
,	O	8295
the	O	8295
presence	O	8295
of	O	8295
ovarian	B-Disease	8295
cancer	I-Disease	8295
,	O	8295
the	O	8295
presence	O	8295
of	O	8295
breast	B-Disease	8295
and	I-Disease	8295
ovarian	I-Disease	8295
cancer	I-Disease	8295
in	O	8295
the	O	8295
same	O	8295
woman	O	8295
,	O	8295
and	O	8295
Ashkenazi	O	8295
Jewish	O	8295
ancestry	O	8295
were	O	8295
all	O	8295
associated	O	8295
with	O	8295
an	O	8295
increased	O	8295
risk	O	8295
of	O	8295
detecting	O	8295
a	O	8295
BRCA1	O	8295
mutation	O	8295
.	O	8295

No	O	8296
association	O	8296
was	O	8296
found	O	8296
between	O	8296
the	O	8296
presence	O	8296
of	O	8296
bilateral	O	8296
breast	B-Disease	8296
cancer	I-Disease	8296
or	O	8296
the	O	8296
number	O	8296
of	O	8296
breast	B-Disease	8296
cancers	I-Disease	8296
in	O	8296
a	O	8296
family	O	8296
and	O	8296
the	O	8296
detection	O	8296
of	O	8296
a	O	8296
BRCA1	O	8296
mutation	O	8296
,	O	8296
or	O	8296
between	O	8296
the	O	8296
position	O	8296
of	O	8296
the	O	8296
mutation	O	8296
in	O	8296
the	O	8296
BRCA1	O	8296
gene	O	8296
and	O	8296
the	O	8296
presence	O	8296
of	O	8296
ovarian	B-Disease	8296
cancer	I-Disease	8296
in	O	8296
a	O	8296
family	O	8296
.	O	8296

CONCLUSIONS	O	8297
Among	O	8297
women	O	8297
with	O	8297
breast	B-Disease	8297
cancer	I-Disease	8297
and	O	8297
a	O	8297
family	O	8297
history	O	8297
of	O	8297
the	O	8297
disease	O	8297
,	O	8297
the	O	8297
percentage	O	8297
with	O	8297
BRCA1	O	8297
coding	O	8297
-	O	8297
region	O	8297
mutations	O	8297
is	O	8297
less	O	8297
than	O	8297
the	O	8297
45	O	8297
percent	O	8297
predicted	O	8297
by	O	8297
genetic	O	8297
-	O	8297
linkage	O	8297
analysis	O	8297
.	O	8297

Mutations	O	8300
in	O	8300
the	O	8300
arginine	O	8300
-	O	8300
rich	O	8300
protein	O	8300
gene	O	8300
(	O	8300
ARP	O	8300
)	O	8300
in	O	8300
pancreatic	B-Disease	8300
cancer	I-Disease	8300
.	O	8300

At	O	8303
the	O	8303
cytogenetic	O	8303
level	O	8303
this	O	8303
region	O	8303
is	O	8303
frequently	O	8303
deleted	O	8303
in	O	8303
a	O	8303
variety	O	8303
of	O	8303
different	O	8303
solid	B-Disease	8303
tumors	I-Disease	8303
,	O	8303
although	O	8303
not	O	8303
in	O	8303
pancreatic	B-Disease	8303
cancer	I-Disease	8303
.	O	8303

We	O	8304
have	O	8304
reported	O	8304
the	O	8304
presence	O	8304
of	O	8304
a	O	8304
specific	O	8304
mutation	O	8304
(	O	8304
ATG50	O	8304
-	O	8304
-	O	8304
>	O	8304
AGG	O	8304
)	O	8304
or	O	8304
deletion	O	8304
of	O	8304
codon	O	8304
50	O	8304
of	O	8304
the	O	8304
ARP	O	8304
gene	O	8304
in	O	8304
different	O	8304
tumor	B-Disease	8304
types	I-Disease	8304
(	O	8304
Shridhar	O	8304
et	O	8304
al	O	8304
.	O	8304

In	O	8306
the	O	8306
present	O	8306
study	O	8306
,	O	8306
we	O	8306
have	O	8306
observed	O	8306
mutations	O	8306
involving	O	8306
codon	O	8306
50	O	8306
in	O	8306
11	O	8306
of	O	8306
37	O	8306
pancreatic	B-Disease	8306
tumors	I-Disease	8306
.	O	8306

The	O	8307
frequency	O	8307
of	O	8307
codon	O	8307
50	O	8307
mutation	O	8307
is	O	8307
roughly	O	8307
the	O	8307
same	O	8307
in	O	8307
pancreatic	B-Disease	8307
tumors	I-Disease	8307
as	O	8307
in	O	8307
the	O	8307
other	O	8307
types	O	8307
of	O	8307
tumors	B-Disease	8307
previously	O	8307
examined	O	8307
.	O	8307

In	O	8308
addition	O	8308
,	O	8308
we	O	8308
have	O	8308
detected	O	8308
mutations	O	8308
at	O	8308
codon	O	8308
51	O	8308
in	O	8308
multiple	O	8308
PCR	O	8308
subclones	O	8308
in	O	8308
two	O	8308
other	O	8308
pancreatic	B-Disease	8308
tumors	I-Disease	8308
.	O	8308

Mutations	O	8309
in	O	8309
the	O	8309
ARP	O	8309
gene	O	8309
are	O	8309
thus	O	8309
commonly	O	8309
observed	O	8309
in	O	8309
pancreatic	B-Disease	8309
cancer	I-Disease	8309
,	O	8309
as	O	8309
well	O	8309
as	O	8309
many	O	8309
other	O	8309
cancers	B-Disease	8309
.	O	8309

Difficulties	O	8310
in	O	8310
the	O	8310
ascertainment	O	8310
of	O	8310
C9	B-Disease	8310
deficiency	I-Disease	8310
:	O	8310
lessons	O	8310
to	O	8310
be	O	8310
drawn	O	8310
from	O	8310
a	O	8310
compound	O	8310
heterozygote	O	8310
C9	B-Disease	8310
-	I-Disease	8310
deficient	I-Disease	8310
subject	O	8310
.	O	8310

The	O	8314
patient	O	8314
was	O	8314
shown	O	8314
to	O	8314
be	O	8314
heterozygous	O	8314
for	O	8314
DNA	O	8314
markers	O	8314
in	O	8314
the	O	8314
C6	O	8314
,	O	8314
C7	O	8314
and	O	8314
C9	O	8314
region	O	8314
of	O	8314
chromosome	O	8314
5	O	8314
and	O	8314
therefore	O	8314
appears	O	8314
to	O	8314
be	O	8314
a	O	8314
compound	O	8314
heterozygote	O	8314
for	O	8314
two	O	8314
uncharacterized	O	8314
C9	B-Disease	8314
deficiency	I-Disease	8314
genes	O	8314
.	O	8314

We	O	8317
hypothesize	O	8317
that	O	8317
the	O	8317
patient	O	8317
is	O	8317
heterozygous	O	8317
for	O	8317
a	O	8317
complete	B-Disease	8317
deficiency	I-Disease	8317
of	I-Disease	8317
C9	I-Disease	8317
and	O	8317
for	O	8317
a	O	8317
gene	O	8317
directing	O	8317
hyposynthesis	O	8317
of	O	8317
a	O	8317
defective	O	8317
C9	O	8317
.	O	8317

We	O	8318
also	O	8318
suggest	O	8318
that	O	8318
C9	B-Disease	8318
deficiency	I-Disease	8318
may	O	8318
be	O	8318
more	O	8318
common	O	8318
among	O	8318
Caucasians	O	8318
than	O	8318
has	O	8318
been	O	8318
reported	O	8318
.	O	8318

Screening	O	8320
for	O	8320
ESR	O	8320
mutations	O	8320
in	O	8320
breast	B-Disease	8320
and	I-Disease	8320
ovarian	I-Disease	8320
cancer	I-Disease	8320
patients	O	8320
.	O	8320

In	O	8321
the	O	8321
present	O	8321
study	O	8321
,	O	8321
leukocyte	O	8321
DNA	O	8321
from	O	8321
143	O	8321
patients	O	8321
with	O	8321
familial	O	8321
clustering	O	8321
of	O	8321
breast	B-Disease	8321
and	I-Disease	8321
/	I-Disease	8321
or	I-Disease	8321
ovarian	I-Disease	8321
cancer	I-Disease	8321
and	O	8321
tumour	B-Disease	8321
DNA	O	8321
from	O	8321
96	O	8321
breast	B-Disease	8321
carcinomas	I-Disease	8321
were	O	8321
screened	O	8321
for	O	8321
base	O	8321
mutations	O	8321
in	O	8321
the	O	8321
estrogen	O	8321
receptor	O	8321
gene	O	8321
(	O	8321
ESR	O	8321
)	O	8321
.	O	8321

Three	O	8322
patients	O	8322
with	O	8322
a	O	8322
family	O	8322
history	O	8322
of	O	8322
cancer	B-Disease	8322
were	O	8322
carrying	O	8322
a	O	8322
Gly160Cys	O	8322
germline	O	8322
substitution	O	8322
.	O	8322

However	O	8324
,	O	8324
in	O	8324
the	O	8324
229	O	8324
female	O	8324
controls	O	8324
in	O	8324
whom	O	8324
family	O	8324
history	O	8324
of	O	8324
cancer	B-Disease	8324
was	O	8324
known	O	8324
,	O	8324
one	O	8324
of	O	8324
two	O	8324
who	O	8324
had	O	8324
a	O	8324
sister	O	8324
with	O	8324
breast	B-Disease	8324
cancer	I-Disease	8324
was	O	8324
carrying	O	8324
the	O	8324
variant	O	8324
allele	O	8324
.	O	8324

Somatic	O	8326
mutations	O	8326
were	O	8326
not	O	8326
detected	O	8326
in	O	8326
any	O	8326
of	O	8326
the	O	8326
tumours	B-Disease	8326
studied	O	8326
,	O	8326
and	O	8326
the	O	8326
present	O	8326
data	O	8326
do	O	8326
not	O	8326
provide	O	8326
support	O	8326
for	O	8326
somatic	O	8326
ESR	O	8326
base	O	8326
mutations	O	8326
as	O	8326
an	O	8326
important	O	8326
mechanism	O	8326
for	O	8326
hormonal	O	8326
therapy	O	8326
resistance	O	8326
in	O	8326
estrogen	B-Disease	8326
receptor	I-Disease	8326
-	I-Disease	8326
positive	I-Disease	8326
breast	I-Disease	8326
carcinomas	I-Disease	8326
.	O	8326

Molecular	O	8328
bases	O	8328
of	O	8328
C7	B-Disease	8328
deficiency	I-Disease	8328
:	O	8328
three	O	8328
different	O	8328
defects	O	8328
.	O	8328

The	O	8329
molecular	O	8329
basis	O	8329
of	O	8329
C7	B-Disease	8329
deficiency	I-Disease	8329
has	O	8329
been	O	8329
investigated	O	8329
in	O	8329
two	O	8329
Irish	O	8329
families	O	8329
and	O	8329
a	O	8329
number	O	8329
of	O	8329
Israeli	O	8329
families	O	8329
of	O	8329
Moroccan	O	8329
Sephardic	O	8329
Jewish	O	8329
origin	O	8329
.	O	8329

The	O	8333
Israeli	O	8333
C7	B-Disease	8333
-	I-Disease	8333
deficient	I-Disease	8333
cases	O	8333
all	O	8333
share	O	8333
a	O	8333
C7	O	8333
haplotype	O	8333
and	O	8333
are	O	8333
homozygous	O	8333
for	O	8333
a	O	8333
mis	O	8333
-	O	8333
sense	O	8333
mutation	O	8333
in	O	8333
exon	O	8333
9	O	8333
.	O	8333

Molecular	O	8336
heterogeneity	O	8336
of	O	8336
classical	B-Disease	8336
and	I-Disease	8336
Duarte	I-Disease	8336
galactosemia	I-Disease	8336
:	O	8336
mutation	O	8336
analysis	O	8336
by	O	8336
denaturing	O	8336
gradient	O	8336
gel	O	8336
electrophoresis	O	8336
.	O	8336

Classical	B-Disease	8337
galactosemia	I-Disease	8337
is	O	8337
caused	O	8337
by	O	8337
one	O	8337
common	O	8337
missense	O	8337
mutation	O	8337
(	O	8337
Q188R	O	8337
)	O	8337
and	O	8337
by	O	8337
several	O	8337
rare	O	8337
mutations	O	8337
in	O	8337
the	O	8337
galactose	O	8337
-	O	8337
1	O	8337
-	O	8337
phosphate	O	8337
uridyltransferase	O	8337
(	O	8337
GALT	O	8337
)	O	8337
gene	O	8337
.	O	8337

To	O	8340
study	O	8340
the	O	8340
molecular	O	8340
genetics	O	8340
of	O	8340
classical	B-Disease	8340
and	I-Disease	8340
Duarte	I-Disease	8340
galactosemia	I-Disease	8340
,	O	8340
we	O	8340
analyzed	O	8340
the	O	8340
GALT	O	8340
mutations	O	8340
in	O	8340
30	O	8340
families	O	8340
with	O	8340
classical	B-Disease	8340
galactosemia	I-Disease	8340
,	O	8340
in	O	8340
10	O	8340
families	O	8340
with	O	8340
the	O	8340
D	O	8340
-	O	8340
2	O	8340
variant	O	8340
and	O	8340
in	O	8340
3	O	8340
individuals	O	8340
carrying	O	8340
the	O	8340
D	O	8340
-	O	8340
1	O	8340
allele	O	8340
by	O	8340
denaturing	O	8340
gradient	O	8340
gel	O	8340
electrophoresis	O	8340
(	O	8340
DGGE	O	8340
)	O	8340
.	O	8340

DGGE	O	8341
detected	O	8341
59	O	8341
of	O	8341
the	O	8341
60	O	8341
classical	O	8341
galactosemia	B-Disease	8341
alleles	O	8341
.	O	8341

Eight	O	8343
novel	O	8343
candidate	O	8343
galactosemia	B-Disease	8343
mutations	O	8343
were	O	8343
found	O	8343
.	O	8343

We	O	8345
conclude	O	8345
that	O	8345
the	O	8345
mutations	O	8345
causing	O	8345
galactosemia	B-Disease	8345
are	O	8345
highly	O	8345
heterogeneous	O	8345
and	O	8345
that	O	8345
K285N	O	8345
is	O	8345
a	O	8345
second	O	8345
common	O	8345
galactosemia	B-Disease	8345
mutation	O	8345
in	O	8345
our	O	8345
population	O	8345
.	O	8345

Isolation	O	8347
of	O	8347
full	O	8347
-	O	8347
length	O	8347
ATM	O	8347
cDNA	O	8347
and	O	8347
correction	O	8347
of	O	8347
the	O	8347
ataxia	B-Disease	8347
-	I-Disease	8347
telangiectasia	I-Disease	8347
cellular	O	8347
phenotype	O	8347
.	O	8347

A	O	8348
gene	O	8348
mutated	O	8348
in	O	8348
the	O	8348
human	O	8348
genetic	B-Disease	8348
disorder	I-Disease	8348
ataxia	B-Disease	8348
-	I-Disease	8348
telangiectasia	I-Disease	8348
(	O	8348
A	B-Disease	8348
-	I-Disease	8348
T	I-Disease	8348
)	O	8348
,	O	8348
ATM	O	8348
,	O	8348
was	O	8348
recently	O	8348
identified	O	8348
by	O	8348
positional	O	8348
cloning	O	8348
.	O	8348

We	O	8350
describe	O	8350
herein	O	8350
,	O	8350
to	O	8350
our	O	8350
knowledge	O	8350
,	O	8350
for	O	8350
the	O	8350
first	O	8350
time	O	8350
,	O	8350
the	O	8350
cloning	O	8350
of	O	8350
a	O	8350
full	O	8350
-	O	8350
length	O	8350
cDNA	O	8350
for	O	8350
ATM	O	8350
and	O	8350
correction	O	8350
of	O	8350
multiple	O	8350
aspects	O	8350
of	O	8350
the	O	8350
radio	O	8350
-	O	8350
sensitive	O	8350
phenotype	O	8350
of	O	8350
A	B-Disease	8350
-	I-Disease	8350
T	I-Disease	8350
cells	O	8350
by	O	8350
transfection	O	8350
with	O	8350
this	O	8350
cDNA	O	8350
.	O	8350

Overexpression	O	8351
of	O	8351
ATM	O	8351
cDNA	O	8351
in	O	8351
A	B-Disease	8351
-	I-Disease	8351
T	I-Disease	8351
cells	O	8351
enhanced	O	8351
the	O	8351
survival	O	8351
of	O	8351
these	O	8351
cells	O	8351
in	O	8351
response	O	8351
to	O	8351
radiation	O	8351
exposure	O	8351
,	O	8351
decreased	O	8351
radiation	O	8351
-	O	8351
induced	O	8351
chromosome	O	8351
aberrations	O	8351
,	O	8351
reduced	O	8351
radio	O	8351
-	O	8351
resistant	O	8351
DNA	O	8351
synthesis	O	8351
,	O	8351
and	O	8351
partially	O	8351
corrected	O	8351
defective	O	8351
cell	O	8351
cycle	O	8351
checkpoints	O	8351
and	O	8351
induction	O	8351
of	O	8351
stress	O	8351
-	O	8351
activated	O	8351
protein	O	8351
kinase	O	8351
.	O	8351

This	O	8352
correction	O	8352
of	O	8352
the	O	8352
defects	O	8352
in	O	8352
A	B-Disease	8352
-	I-Disease	8352
T	I-Disease	8352
cells	O	8352
provides	O	8352
further	O	8352
evidence	O	8352
of	O	8352
the	O	8352
multiplicity	O	8352
of	O	8352
effector	O	8352
functions	O	8352
of	O	8352
the	O	8352
ATM	O	8352
protein	O	8352
and	O	8352
suggests	O	8352
possible	O	8352
approaches	O	8352
to	O	8352
gene	O	8352
therapy	O	8352
.	O	8352

Fusion	O	8354
genes	O	8354
resulting	O	8354
from	O	8354
alternative	O	8354
chromosomal	O	8354
translocations	O	8354
are	O	8354
overexpressed	O	8354
by	O	8354
gene	O	8354
-	O	8354
specific	O	8354
mechanisms	O	8354
in	O	8354
alveolar	B-Disease	8354
rhabdomyosarcoma	I-Disease	8354
.	O	8354

Chromosomal	O	8355
translocations	O	8355
identified	O	8355
in	O	8355
hematopoietic	B-Disease	8355
and	I-Disease	8355
solid	I-Disease	8355
tumors	I-Disease	8355
result	O	8355
in	O	8355
deregulated	O	8355
expression	O	8355
of	O	8355
protooncogenes	O	8355
or	O	8355
creation	O	8355
of	O	8355
chimeric	O	8355
proteins	O	8355
with	O	8355
tumorigenic	O	8355
potential	O	8355
.	O	8355

In	O	8356
the	O	8356
pediatric	O	8356
solid	B-Disease	8356
tumor	I-Disease	8356
alveolar	B-Disease	8356
rhabdomyosarcoma	I-Disease	8356
,	O	8356
a	O	8356
consistent	O	8356
t	O	8356
(	O	8356
2	O	8356
;	O	8356
13	O	8356
)	O	8356
(	O	8356
q35	O	8356
;	O	8356
q14	O	8356
)	O	8356
or	O	8356
variant	O	8356
t	O	8356
(	O	8356
1	O	8356
;	O	8356
13	O	8356
)	O	8356
(	O	8356
p36	O	8356
;	O	8356
q14	O	8356
)	O	8356
translocation	O	8356
generates	O	8356
PAX3	O	8356
-	O	8356
FKHR	O	8356
or	O	8356
PAX7	O	8356
-	O	8356
FKHR	O	8356
fusion	O	8356
proteins	O	8356
,	O	8356
respectively	O	8356
.	O	8356

Thus	O	8361
,	O	8361
gene	O	8361
-	O	8361
specific	O	8361
mechanisms	O	8361
were	O	8361
selected	O	8361
to	O	8361
overexpress	O	8361
PAX3	O	8361
-	O	8361
FKHR	O	8361
and	O	8361
PAX7	O	8361
-	O	8361
FKHR	O	8361
in	O	8361
alveolar	B-Disease	8361
rhabdomyosarcoma	I-Disease	8361
,	O	8361
presumably	O	8361
due	O	8361
to	O	8361
differences	O	8361
in	O	8361
regulation	O	8361
between	O	8361
the	O	8361
wild	O	8361
-	O	8361
type	O	8361
loci	O	8361
.	O	8361

atm	O	8364
and	O	8364
p53	O	8364
cooperate	O	8364
in	O	8364
apoptosis	O	8364
and	O	8364
suppression	O	8364
of	O	8364
tumorigenesis	O	8364
,	O	8364
but	O	8364
not	O	8364
in	O	8364
resistance	O	8364
to	O	8364
acute	B-Disease	8364
radiation	I-Disease	8364
toxicity	I-Disease	8364
.	O	8364

Mutations	O	8365
in	O	8365
atm	O	8365
and	O	8365
p53	O	8365
cause	O	8365
the	O	8365
human	O	8365
cancer	B-Disease	8365
-	I-Disease	8365
associated	I-Disease	8365
diseases	I-Disease	8365
ataxia	B-Disease	8365
-	I-Disease	8365
telangiectasia	I-Disease	8365
and	O	8365
Li	B-Disease	8365
-	I-Disease	8365
Fraumeni	I-Disease	8365
syndrome	I-Disease	8365
,	O	8365
respectively	O	8365
.	O	8365

Atm	O	8367
-	O	8367
nan	O	8367
mice	O	8367
,	O	8367
as	O	8367
well	O	8367
as	O	8367
those	O	8367
nan	O	8367
for	O	8367
p53	O	8367
,	O	8367
develop	O	8367
mainly	O	8367
T	B-Disease	8367
-	I-Disease	8367
cell	I-Disease	8367
lymphomas	I-Disease	8367
,	O	8367
supporting	O	8367
the	O	8367
view	O	8367
that	O	8367
these	O	8367
genes	O	8367
have	O	8367
similar	O	8367
roles	O	8367
in	O	8367
thymocyte	O	8367
development	O	8367
.	O	8367

Mice	O	8369
doubly	O	8369
nan	O	8369
for	O	8369
atm	O	8369
and	O	8369
p53	O	8369
exhibited	O	8369
a	O	8369
dramatic	O	8369
acceleration	O	8369
of	O	8369
tumour	B-Disease	8369
formation	O	8369
relative	O	8369
to	O	8369
singly	O	8369
nan	O	8369
mice	O	8369
,	O	8369
indicating	O	8369
that	O	8369
both	O	8369
genes	O	8369
collaborate	O	8369
in	O	8369
a	O	8369
significant	O	8369
manner	O	8369
to	O	8369
prevent	O	8369
tumorigenesis	O	8369
.	O	8369

Finally	O	8372
-	O	8372
and	O	8372
in	O	8372
contrast	O	8372
to	O	8372
prior	O	8372
predictions	O	8372
-	O	8372
atm	O	8372
and	O	8372
p53	O	8372
do	O	8372
not	O	8372
appear	O	8372
to	O	8372
interact	O	8372
in	O	8372
acute	B-Disease	8372
radiation	I-Disease	8372
toxicity	I-Disease	8372
,	O	8372
suggesting	O	8372
a	O	8372
separate	O	8372
atm	O	8372
effector	O	8372
pathway	O	8372
for	O	8372
this	O	8372
DNA	O	8372
damage	O	8372
response	O	8372
and	O	8372
having	O	8372
implications	O	8372
for	O	8372
the	O	8372
prognosis	O	8372
and	O	8372
treatment	O	8372
of	O	8372
human	O	8372
tumours	B-Disease	8372
.	O	8372

Trinucleotide	O	8374
repeat	O	8374
expansion	O	8374
at	O	8374
the	O	8374
myotonic	B-Disease	8374
dystrophy	I-Disease	8374
locus	O	8374
reduces	O	8374
expression	O	8374
of	O	8374
DMAHP	O	8374
.	O	8374

Myotonic	B-Disease	8375
dystrophy	I-Disease	8375
,	O	8375
or	O	8375
dystrophia	B-Disease	8375
myotonica	I-Disease	8375
(	O	8375
DM	B-Disease	8375
)	O	8375
,	O	8375
is	O	8375
an	O	8375
autosomal	B-Disease	8375
dominant	I-Disease	8375
multisystem	I-Disease	8375
disorder	I-Disease	8375
caused	O	8375
by	O	8375
the	O	8375
expansion	O	8375
of	O	8375
a	O	8375
CTG	O	8375
trinucleotide	O	8375
repeat	O	8375
in	O	8375
the	O	8375
3	O	8375
untranslated	O	8375
region	O	8375
of	O	8375
the	O	8375
DMPK	O	8375
protein	O	8375
kinase	O	8375
gene	O	8375
on	O	8375
chromosome	O	8375
19q13	O	8375
.	O	8375

Although	O	8377
the	O	8377
DM	B-Disease	8377
mutation	O	8377
was	O	8377
identified	O	8377
more	O	8377
than	O	8377
five	O	8377
years	O	8377
ago	O	8377
,	O	8377
the	O	8377
pathogenic	O	8377
mechanisms	O	8377
underlying	O	8377
this	O	8377
most	O	8377
prevalent	O	8377
form	O	8377
of	O	8377
hereditary	O	8377
adult	O	8377
neuromuscular	B-Disease	8377
disease	I-Disease	8377
remain	O	8377
elusive	O	8377
.	O	8377

Analysis	O	8380
of	O	8380
DMAHP	O	8380
expression	O	8380
in	O	8380
the	O	8380
cells	O	8380
of	O	8380
DM	B-Disease	8380
patients	O	8380
with	O	8380
loss	O	8380
of	O	8380
the	O	8380
hypersensitive	O	8380
site	O	8380
revealed	O	8380
a	O	8380
two	O	8380
-	O	8380
to	O	8380
fourfold	O	8380
reduction	O	8380
in	O	8380
steady	O	8380
-	O	8380
state	O	8380
DMAHP	O	8380
transcript	O	8380
levels	O	8380
relative	O	8380
to	O	8380
wild	O	8380
-	O	8380
type	O	8380
controls	O	8380
.	O	8380

Together	O	8382
,	O	8382
these	O	8382
results	O	8382
demonstrate	O	8382
that	O	8382
CTG	O	8382
-	O	8382
repeat	O	8382
expansions	O	8382
can	O	8382
suppress	O	8382
local	O	8382
gene	O	8382
expression	O	8382
and	O	8382
implicate	O	8382
DMAHP	O	8382
in	O	8382
DM	B-Disease	8382
pathogenesis	O	8382
.	O	8382

Constitutively	O	8383
methylated	O	8383
CpG	O	8383
dinucleotides	O	8383
as	O	8383
mutation	O	8383
hot	O	8383
spots	O	8383
in	O	8383
the	O	8383
retinoblastoma	B-Disease	8383
gene	O	8383
(	O	8383
RB1	O	8383
)	O	8383
.	O	8383

A	O	8384
wide	O	8384
spectrum	O	8384
of	O	8384
mutations	O	8384
,	O	8384
ranging	O	8384
from	O	8384
point	O	8384
mutations	O	8384
to	O	8384
large	O	8384
deletions	O	8384
,	O	8384
have	O	8384
been	O	8384
described	O	8384
in	O	8384
the	O	8384
retinoblastoma	B-Disease	8384
gene	O	8384
(	O	8384
RB1	O	8384
)	O	8384
.	O	8384

The	O	8394
von	B-Disease	8394
Hippel	I-Disease	8394
-	I-Disease	8394
Lindau	I-Disease	8394
tumor	I-Disease	8394
suppressor	O	8394
gene	O	8394
product	O	8394
interacts	O	8394
with	O	8394
Sp1	O	8394
to	O	8394
repress	O	8394
vascular	O	8394
endothelial	O	8394
growth	O	8394
factor	O	8394
promoter	O	8394
activity	O	8394
.	O	8394

The	O	8395
von	B-Disease	8395
Hippel	I-Disease	8395
-	I-Disease	8395
Lindau	I-Disease	8395
tumor	I-Disease	8395
suppressor	O	8395
gene	O	8395
(	O	8395
VHL	O	8395
)	O	8395
has	O	8395
a	O	8395
critical	O	8395
role	O	8395
in	O	8395
the	O	8395
pathogenesis	O	8395
of	O	8395
clear	B-Disease	8395
-	I-Disease	8395
cell	I-Disease	8395
renal	I-Disease	8395
cell	I-Disease	8395
carcinoma	I-Disease	8395
(	O	8395
RCC	B-Disease	8395
)	O	8395
,	O	8395
as	O	8395
VHL	O	8395
mutations	O	8395
have	O	8395
been	O	8395
found	O	8395
in	O	8395
both	O	8395
von	B-Disease	8395
Hippel	I-Disease	8395
-	I-Disease	8395
Lindau	I-Disease	8395
disease	I-Disease	8395
-	I-Disease	8395
associated	I-Disease	8395
and	I-Disease	8395
sporadic	I-Disease	8395
RCCs	I-Disease	8395
.	O	8395

Recent	O	8396
studies	O	8396
suggest	O	8396
that	O	8396
vascular	O	8396
endothelial	O	8396
growth	O	8396
factor	O	8396
(	O	8396
VEGF	O	8396
)	O	8396
mRNA	O	8396
is	O	8396
upregulated	O	8396
in	O	8396
RCC	B-Disease	8396
-	I-Disease	8396
and	I-Disease	8396
von	I-Disease	8396
Hippel	I-Disease	8396
-	I-Disease	8396
Lindau	I-Disease	8396
disease	I-Disease	8396
-	I-Disease	8396
associated	I-Disease	8396
tumors	I-Disease	8396
.	O	8396

VEGF	O	8398
promoter	O	8398
-	O	8398
luciferase	O	8398
constructs	O	8398
were	O	8398
transiently	O	8398
cotransfected	O	8398
with	O	8398
a	O	8398
wild	O	8398
-	O	8398
type	O	8398
VHL	O	8398
(	O	8398
wt	O	8398
-	O	8398
VHL	O	8398
)	O	8398
vector	O	8398
in	O	8398
several	O	8398
cell	O	8398
lines	O	8398
,	O	8398
including	O	8398
293	O	8398
embryonic	O	8398
kidney	O	8398
and	O	8398
RCC	B-Disease	8398
cell	O	8398
lines	O	8398
.	O	8398

Furthermore	O	8404
,	O	8404
endogenous	O	8404
VEGF	O	8404
mRNA	O	8404
levels	O	8404
were	O	8404
suppressed	O	8404
in	O	8404
permanent	O	8404
RCC	B-Disease	8404
cell	O	8404
lines	O	8404
expressing	O	8404
wt	O	8404
-	O	8404
VHL	O	8404
,	O	8404
and	O	8404
nuclear	O	8404
run	O	8404
-	O	8404
on	O	8404
studies	O	8404
indicated	O	8404
that	O	8404
VHL	O	8404
regulation	O	8404
of	O	8404
VEGF	O	8404
occurs	O	8404
at	O	8404
least	O	8404
partly	O	8404
at	O	8404
the	O	8404
transcriptional	O	8404
level	O	8404
.	O	8404

These	O	8405
observations	O	8405
support	O	8405
a	O	8405
new	O	8405
mechanism	O	8405
for	O	8405
VHL	O	8405
-	O	8405
mediated	O	8405
transcriptional	O	8405
repression	O	8405
via	O	8405
a	O	8405
direct	O	8405
inhibitory	O	8405
action	O	8405
on	O	8405
Sp1	O	8405
and	O	8405
suggest	O	8405
that	O	8405
loss	O	8405
of	O	8405
Sp1	O	8405
inhibition	O	8405
may	O	8405
be	O	8405
important	O	8405
in	O	8405
the	O	8405
pathogenesis	O	8405
of	O	8405
von	B-Disease	8405
Hippel	I-Disease	8405
-	I-Disease	8405
Lindau	I-Disease	8405
disease	I-Disease	8405
and	O	8405
RCC	B-Disease	8405
.	O	8405

Adult	B-Disease	8407
onset	I-Disease	8407
globoid	I-Disease	8407
cell	I-Disease	8407
leukodystrophy	I-Disease	8407
(	O	8407
Krabbe	B-Disease	8407
disease	I-Disease	8407
)	O	8407
:	O	8407
analysis	O	8407
of	O	8407
galactosylceramidase	O	8407
cDNA	O	8407
from	O	8407
four	O	8407
Japanese	O	8407
patients	O	8407
.	O	8407

We	O	8408
examined	O	8408
galactosylceramidase	O	8408
(	O	8408
GALC	O	8408
)	O	8408
cDNA	O	8408
in	O	8408
four	O	8408
Japanese	O	8408
patients	O	8408
with	O	8408
adult	B-Disease	8408
onset	I-Disease	8408
globoid	I-Disease	8408
cell	I-Disease	8408
leukodystrophy	I-Disease	8408
(	O	8408
Krabbe	B-Disease	8408
disease	I-Disease	8408
;	O	8408
AO	B-Disease	8408
-	I-Disease	8408
GLD	I-Disease	8408
)	O	8408
by	O	8408
polymerase	O	8408
chain	O	8408
reaction	O	8408
/	O	8408
single	O	8408
-	O	8408
strand	O	8408
conformation	O	8408
polymorphism	O	8408
(	O	8408
PCR	O	8408
-	O	8408
SSCP	O	8408
)	O	8408
analysis	O	8408
,	O	8408
subsequent	O	8408
sequence	O	8408
determination	O	8408
,	O	8408
and	O	8408
restriction	O	8408
enzyme	O	8408
digestion	O	8408
of	O	8408
PCR	O	8408
products	O	8408
,	O	8408
initial	O	8408
symptoms	O	8408
were	O	8408
the	O	8408
onset	O	8408
of	O	8408
slowly	O	8408
progressive	O	8408
spastic	B-Disease	8408
paraplegia	I-Disease	8408
from	O	8408
the	O	8408
middle	O	8408
of	O	8408
the	O	8408
second	O	8408
decade	O	8408
,	O	8408
and	O	8408
all	O	8408
patients	O	8408
had	O	8408
diminished	B-Disease	8408
GALC	I-Disease	8408
activity	I-Disease	8408
in	O	8408
their	O	8408
leukocytes	O	8408
.	O	8408

,	O	8414
G270D	O	8414
,	O	8414
L618S	O	8414
,	O	8414
and	O	8414
exon	O	8414
-	O	8414
6	O	8414
skipping	O	8414
(	O	8414
535	O	8414
-	O	8414
573del	O	8414
)	O	8414
,	O	8414
produced	O	8414
diminished	B-Disease	8414
GALC	I-Disease	8414
activity	I-Disease	8414
as	O	8414
expected	O	8414
.	O	8414

AO	B-Disease	8417
-	I-Disease	8417
GLD	I-Disease	8417
mutations	O	8417
,	O	8417
including	O	8417
those	O	8417
found	O	8417
here	O	8417
,	O	8417
are	O	8417
located	O	8417
in	O	8417
the	O	8417
N	O	8417
-	O	8417
terminus	O	8417
(	O	8417
I66M	O	8417
,	O	8417
G270D	O	8417
,	O	8417
535	O	8417
-	O	8417
573del	O	8417
)	O	8417
or	O	8417
C	O	8417
-	O	8417
terminus	O	8417
(	O	8417
L618S	O	8417
)	O	8417
of	O	8417
the	O	8417
GALC	O	8417
enzyme	O	8417
,	O	8417
whereas	O	8417
the	O	8417
reported	O	8417
mutations	O	8417
in	O	8417
the	O	8417
infantile	O	8417
form	O	8417
(	O	8417
IF	B-Disease	8417
-	I-Disease	8417
GLD	I-Disease	8417
)	O	8417
are	O	8417
in	O	8417
the	O	8417
central	O	8417
domain	O	8417
.	O	8417

This	O	8418
difference	O	8418
in	O	8418
mutation	O	8418
sites	O	8418
may	O	8418
affect	O	8418
the	O	8418
clinical	O	8418
features	O	8418
of	O	8418
GLD	B-Disease	8418
.	O	8418
